PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dube, E; Gagnon, D; Ouakki, M; Bettinger, JA; Guay, M; Halperin, S; Wilson, K; Graham, J; Witteman, HO; MacDonald, S; Fisher, W; Monnais, L; Tran, D; Gagneur, A; Guichon, J; Saini, V; Heffernan, JM; Meyer, S; Driedger, SM; Greenberg, J; MacDougall, H				Dube, Eve; Gagnon, Dominique; Ouakki, Manale; Bettinger, Julie A.; Guay, Maryse; Halperin, Scott; Wilson, Kumanan; Graham, Janice; Witteman, Holly O.; MacDonald, Shannon; Fisher, William; Monnais, Laurence; Tran, Dat; Gagneur, Arnaud; Guichon, Juliet; Saini, Vineet; Heffernan, Jane M.; Meyer, Samantha; Driedger, S. Michelle; Greenberg, Joshua; MacDougall, Heather		Canadian Immunization Res Network	Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network	PLOS ONE			English	Article							PATIENT ENGAGEMENT; WEB 2.0; PHYSICIAN COMMUNICATION; NONMEDICAL EXEMPTIONS; DECISION-MAKING; HERD-IMMUNITY; UNITED-STATES; PUBLIC TRUST; PARENTS; REQUIREMENTS	"Vaccine hesitancy" is a concept now frequently used in vaccination discourse. The increased popularity of this concept in both academic and public health circles is challenging previously held perspectives that individual vaccination attitudes and behaviours are a simple dichotomy of accept or reject. A consultation study was designed to assess the opinions of experts and health professionals concerning the definition, scope, and causes of vaccine hesitancy in Canada. We sent online surveys to two panels (1-vaccination experts and 2-front-line vaccine providers). Two questionnaires were completed by each panel, with data from the first questionnaire informing the development of questions for the second. Our participants defined vaccine hesitancy as an attitude (doubts, concerns) as well as a behaviour (refusing some / many vaccines, delaying vaccination). Our findings also indicate that both vaccine experts and front-line vaccine providers have the perception that vaccine rates have been declining and consider vaccine hesitancy an important issue to address in Canada. Diffusion of negative information online and lack of knowledge about vaccines were identified as the key causes of vaccine hesitancy by the participants. A common understanding of vaccine hesitancy among researchers, public health experts, policy-makers and health care providers will better guide interventions that can more effectively address vaccine hesitancy within Canada.	[Dube, Eve] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Dube, Eve; Gagnon, Dominique; Ouakki, Manale; Guay, Maryse] Inst Natl Sante Publ Quebec, Malad Infect, Quebec City, PQ, Canada; [Dube, Eve] Univ Laval, CHU Quebec, Ctr Rech, Malad Infect & Immunitaires, Quebec City, PQ, Canada; [Bettinger, Julie A.] BC Childrens Hosp, Vaccine Evaluat Ctr, Vancouver, BC, Canada; [Bettinger, Julie A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Guay, Maryse] Univ Sherbrooke, Dept Sci Sante Communautaire, Sherbrooke, PQ J1K 2R1, Canada; [Halperin, Scott] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Wilson, Kumanan] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Graham, Janice] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Witteman, Holly O.] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Witteman, Holly O.] Univ Laval, CHU Quebec, Ctr Rech, Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [MacDonald, Shannon] Univ Alberta, Nursing Fac, Edmonton, AB, Canada; [MacDonald, Shannon] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Fisher, William] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Monnais, Laurence] Univ Montreal, Dept Hist, Montreal, PQ H3C 3J7, Canada; [Tran, Dat] Hosp Sick Children, Div Infect Dis, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Gagneur, Arnaud] Univ Sherbrooke, Serv Neonatol, Dept Pediat, Sherbrooke, PQ J1K 2R1, Canada; [Guichon, Juliet] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Saini, Vineet] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Saini, Vineet] Alberta Hlth Serv, Calgary, AB, Canada; [Heffernan, Jane M.] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Meyer, Samantha] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Driedger, S. Michelle] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Greenberg, Joshua] Carleton Univ, Sch Journalism & Commun, Ottawa, ON K1S 5B6, Canada; [MacDougall, Heather] Univ Waterloo, Dept Hist, Waterloo, ON N2L 3G1, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); Laval University; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Sherbrooke; Dalhousie University; University of Ottawa; Ottawa Hospital Research Institute; Dalhousie University; Laval University; Laval University; University of Alberta; University of Calgary; Western University (University of Western Ontario); Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Sherbrooke; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; York University - Canada; University of Waterloo; University of Manitoba; Carleton University; University of Waterloo	Dube, E (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.; Dube, E (corresponding author), Inst Natl Sante Publ Quebec, Malad Infect, Quebec City, PQ, Canada.; Dube, E (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Malad Infect & Immunitaires, Quebec City, PQ, Canada.	eve.dube@inspq.qc.ca	gagneur, arnaud/AAD-6001-2022	Bettinger, Julie/0000-0002-2118-4174; MacDonald, Shannon E./0000-0003-4675-4433; Driedger, S. Michelle/0000-0003-3769-5785; Graham, Janice/0000-0002-6326-8122; Halperin, Scott/0000-0003-0525-589X; Witteman, Holly/0000-0003-4192-0682	Canadian Immunization Research Network (Canadian Institute of Health Research of Canada); Canadian Immunization Research Network (Public Health Agency of Canada); Alberta Innovates [201201082] Funding Source: researchfish	Canadian Immunization Research Network (Canadian Institute of Health Research of Canada); Canadian Immunization Research Network (Public Health Agency of Canada); Alberta Innovates	This study was funded by the Canadian Immunization Research Network (Canadian Institute of Health Research and Public Health Agency of Canada).	Adler M, 1996, DELPHI METHOD ITS AP, P252; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Basrur S, 2005, RUBELLA OUTBREAK SO; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Betsch C, 2011, EUROSURVEILLANCE, V16, P15; Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Blume S, 2006, SOC SCI MED, V62, P628, DOI 10.1016/j.socscimed.2005.06.020; Brownlie J, 2006, SOC SCI MED, V62, P433, DOI 10.1016/j.socscimed.2005.05.033; Burton-Jeangros C, 2005, REV EPIDEMIOL SANTE, V53, P341, DOI 10.1016/S0398-7620(05)84616-4; Cassell JA, 2006, PUBLIC HEALTH, V120, P783, DOI 10.1016/j.puhe.2006.03.011; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Davies P, 2002, ARCH DIS CHILD, V87, P22, DOI 10.1136/adc.87.1.22; Dempsey AF, 2011, PEDIATRICS, V128, P848, DOI 10.1542/peds.2011-0400; Dentzer S, 2013, HEALTH AFFAIR, V32, P202, DOI 10.1377/hlthaff.2013.0037; Dube E, 2013, HUM VACCINES, V9, P1; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Ekos Research Associates Inc, 2011, SURV PAR KEY ISS REL, P53; Enropean Centrer for Disease Prevention and Control, 2015, VACC HES HEALTHC WOR; Eskola J, 2015, VACCINE, V33, P4215, DOI 10.1016/j.vaccine.2015.04.043; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Gruman J, 2010, PATIENT EDUC COUNS, V78, P350, DOI 10.1016/j.pec.2010.02.002; Guay M, 2009, POURQUOI COUVERTURES, P62; Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538; HALPERIN SA, 2000, CAN J CONTIN MED ED, V12, P62; Healy CM, 2011, PEDIATRICS, V127, pS127, DOI 10.1542/peds.2010-1722S; Henrikson NB, 2015, PEDIATRICS, V136, P70, DOI 10.1542/peds.2014-3199; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hobson-West P, 2003, HEALTH RISK SOC, V5, P273, DOI 10.1080/13698570310001606978; Hsu CC, 2007, PARE, V12, P1; Kahan DM, 2013, SCIENCE, V342, P53, DOI 10.1126/science.1245724; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Kaufman SR, 2010, ETHOS, V38, P8, DOI 10.1111/j.1548-1352.2009.01079.x; Keelan J, 2010, VACCINE, V28, P1535, DOI 10.1016/j.vaccine.2009.11.060; Kennedy A, 2011, HEALTH AFFAIR, V30, P1151, DOI 10.1377/hlthaff.2011.0396; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814; Lantos JD, 2010, CURR PROB PEDIATR AD, V40, P38, DOI 10.1016/j.cppeds.2010.01.003; Laroche J, 2010, 9 CAN IMM C QUEB CAN; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; Leach M., 2007, VACCINE ANXIETIES GL; Leask J, 2015, PEDIATRICS, V136, P180, DOI 10.1542/peds.2015-1382; Leask J, 2014, HUM VACC IMMUNOTHER, V10, P2600, DOI 10.4161/hv.29725; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; Leask J, 2011, NATURE, V473, P443, DOI 10.1038/473443a; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; National Advisory Committee on Immunization, 2006, CAN IMM GUID, P410; National Vaccine Advisory Committee, 2015, ASS STAT VACC CONF U; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Opel DJ, 2012, VACCINE, V30, P1269, DOI 10.1016/j.vaccine.2011.12.129; Opel DJ, 2011, VACCINE, V29, P6598, DOI 10.1016/j.vaccine.2011.06.115; Osborn R, 2012, J AMBUL CARE MANAG, V35, P118, DOI 10.1097/JAC.0b013e31824a579b; Pelletier LR, 2013, NURS OUTLOOK, V61, P51, DOI 10.1016/j.outlook.2012.11.003; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Quebec Gouvervement du, 2003, PROGR NAT SANT PUBL, P133; Rainford J., 2015, POLICY OPTIONS; Remes O, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1047; Richards JL, 2013, VACCINE, V31, P3009, DOI 10.1016/j.vaccine.2013.04.053; Robichaud P, 2012, VACCINE, V30, P3763, DOI 10.1016/j.vaccine.2012.03.074; Safi H, 2012, AM J PREV MED, V42, P602, DOI 10.1016/j.amepre.2012.02.022; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Scullard P, 2010, ARCH DIS CHILD, V95, P580, DOI 10.1136/adc.2009.168856; Shourie S, 2013, VACCINE, V31, P6003, DOI 10.1016/j.vaccine.2013.10.025; Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243; Smith JC, 2013, ADV EXP MED BIOL, V764, P81, DOI 10.1007/978-1-4614-4726-9_6; Smith M, 2015, GLOBE MAIL      0721; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Watanabe M, 2005, EXPERT REV VACCINES, V4, P173, DOI 10.1586/14760584.4.2.173; Wilson Sarah E, 2015, CMAJ Open, V3, pE317, DOI 10.9778/cmajo.20140088; Witteman HO, 2015, RISK ANAL, V35, P1801, DOI 10.1111/risa.12418; Witteman HO, 2015, PEDIATRICS, V136, P215, DOI 10.1542/peds.2015-0949; Witteman HO, 2012, VACCINE, V30, P3734, DOI 10.1016/j.vaccine.2011.12.039; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245; Wroe AL, 2005, HEALTH PSYCHOL, V24, P539, DOI 10.1037/0278-6133.24.6.539; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	84	81	81	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156118	10.1371/journal.pone.0156118	http://dx.doi.org/10.1371/journal.pone.0156118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257809	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700036
J	Qiao, HS; Xia, Y; Li, Y				Qiao, Haishu; Xia, Yue; Li, Ying			Can Network Linkage Effects Determine Return? Evidence from Chinese Stock Market	PLOS ONE			English	Article							HIERARCHICAL STRUCTURE; PORTFOLIO; TREES	This study used the dynamic conditional correlations (DCC) method to identify the linkage effects of Chinese stock market, and further detected the influence of network linkage effects on magnitude of security returns across different industries. Applying two physics-derived techniques, the minimum spanning tree and the hierarchical tree, we analyzed the stock interdependence within the network of the China Securities Index (CSI) industry index basket. We observed that that obvious linkage effects existed among stock networks. CII and CCE, CAG and ITH as well as COU, CHA and REI were confirmed as the core nodes in the three different networks respectively. We also investigated the stability of linkage effects by estimating the mean correlations and mean distances, as well as the normalized tree length of these indices. In addition, using the GMM model approach, we found inter-node influence within the stock network had a pronounced effect on stock returns. Our results generally suggested that there appeared to be greater clustering effect among the indexes belonging to related industrial sectors than those of diverse sectors, and network comovement was significantly affected by impactive financial events in the reality. Besides, stocks that were more central within the network of stock market usually had higher returns for compensation because they endured greater exposure to correlation risk.	[Qiao, Haishu; Xia, Yue; Li, Ying] Hunan Univ, Coll Finance & Stat, Changsha 410082, Hunan, Peoples R China	Hunan University	Xia, Y (corresponding author), Hunan Univ, Coll Finance & Stat, Changsha 410082, Hunan, Peoples R China.	963621885@qq.com			National Social Science Fund of China [14AGL016]	National Social Science Fund of China	This work was supported by the National Social Science Fund of China (Grant No. 14AGL016).	Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; Brida JG, 2010, EXPERT SYST APPL, V37, P3846, DOI 10.1016/j.eswa.2009.11.034; Caporale G.M., 2005, J EMPIR FINANC, V12, P476, DOI [DOI 10.1016/J.JEMPFIN.2004.02.005, 10.1016/j.jempfin.2004.02.005]; Cappiello L, 2006, J FINANCIAL ECONOMET, V4, P537, DOI [10.1093/jjfinec/nbl005, DOI 10.1093/jjfinec/nbl005, DOI 10.1093/JJFINEC/NBL005]; Chen K, 2015, PHYSICA A, V436, P224, DOI 10.1016/j.physa.2015.05.047; Chen TQ, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/513982; Coelho R, 2007, PHYSICA A, V373, P615, DOI 10.1016/j.physa.2006.02.050; Dewandaru G, 2014, ECON SYST, V38, P553, DOI 10.1016/j.ecosys.2014.05.003; Djauhari MA, 2013, PHYSICA A, V392, P2226, DOI 10.1016/j.physa.2012.12.032; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; Eom C, 2009, PHYSICA A, V388, P900, DOI 10.1016/j.physa.2008.12.006; Eryigit M, 2009, PHYSICA A, V388, P3551, DOI 10.1016/j.physa.2009.04.028; Forbes KJ, 2002, J FINANC, V57, P2223, DOI 10.1111/0022-1082.00494; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gilmore CG, 2008, PHYSICA A, V387, P6319, DOI 10.1016/j.physa.2008.07.012; Hafner CM, 2012, COMPUT STAT DATA AN, V56, P3533, DOI 10.1016/j.csda.2010.09.022; [黄飞雪 HUANG Fei-xue], 2009, [系统工程, Systems Engineering], V27, P71; [黄飞雪 Huang Feixue], 2010, [系统工程理论与实践, Systems Engineering-Theory & Practice], V30, P1729; Kantar E, 2012, PHYSICA A, V391, P2342, DOI 10.1016/j.physa.2011.12.014; Kantar E, 2011, PHYSICA A, V390, P3454, DOI 10.1016/j.physa.2011.05.004; Kuzubas TU, 2014, PHYSICA A, V405, P203, DOI 10.1016/j.physa.2014.03.006; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Onnela JP, 2002, EUR PHYS J B, V30, P285, DOI 10.1140/epjb/e2002-00380-9; Panapoulou E., 2008, EMERG MARKETS REV, V9, P280; Pollet JM, 2010, J FINANC ECON, V96, P364, DOI 10.1016/j.jfineco.2010.02.011; Qiao HS, 2015, DISCRETE DYN NAT SOC, V2015, DOI 10.1155/2015/641907; Sensoy A, 2014, PHYSICA A, V414, P387, DOI 10.1016/j.physa.2014.07.067; Tabak BM, 2010, PHYSICA A, V389, P3240, DOI 10.1016/j.physa.2010.04.002; Tse CK, 2010, J EMPIR FINANC, V17, P659, DOI 10.1016/j.jempfin.2010.04.008; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Ulusoy T, 2012, PHYSICA A, V391, P5121, DOI 10.1016/j.physa.2012.01.026; Yang R, 2014, PHYSICA A, V411, P12, DOI 10.1016/j.physa.2014.05.072; Zheng ZL, 2014, CHINA EC Q, V13, P1047	34	19	20	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156784	10.1371/journal.pone.0156784	http://dx.doi.org/10.1371/journal.pone.0156784			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257816	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700126
J	Mukudu, H; Otwombe, K; Laher, F; Lazarus, E; Manentsa, M; Lebina, L; Mapulanga, V; Bowa, K; Martinson, N				Mukudu, Hillary; Otwombe, Kennedy; Laher, Fatima; Lazarus, Erica; Manentsa, Mmatsie; Lebina, Limakatso; Mapulanga, Victor; Bowa, Kasonde; Martinson, Neil			A Cross Sectional Study of the Prevalence of Preputial and Penile Scrotal Abnormalities among Clients Undergoing Voluntary Medical Male Circumcision in Soweto, South Africa	PLOS ONE			English	Article							HIV PREVENTION; DEVICE; PHIMOSIS; SAFETY; MEN	Objective Medical device use is currently approved for males without preputial or major penile scrotal abnormalities for voluntary medical male circumcision (VMMC). We determined the prevalence of preputial abnormalities at a busy VMMC centre in Soweto, South Africa. Methods This was a cross-sectional record review at a high-volume VMMC centre in South Africa. We collated pre-circumcision demographic and genital examination findings from clients 8 years and older who had undergone VMMC from 01 May 2013 to 30 April 2014. Logistic regression was used to determine factors associated with preputial abnormalities. Findings During the review period, 6861 circumcisions were conducted and 37.1%(n = 2543) were 8-13 year olds. Median age was 15 years (IQR: 12-23 years). Fifteen percent (n = 1030) had preputial abnormalities or major penile scrotal abnormalities. Age-specific prevalence of preputial or major genital abnormalities were 27.3%, 10.6% and 6.0% in 8-13, 14-18 and > 18 year olds respectively. The odds of preputial or major penile scrotal abnormality were higher in younger clients aged 8-13 years (OR = 5.9; 95% CI = 4.8-7.1) and 14-18 years (OR = 1.9; 95% CI = 1.5-2.4) compared to older clients above 18 years and in those testing for HIV outside our clinic network (OR = 1.9; 95% CI = 1.4-2.7). Conclusion The high prevalence of preputial and penile scrotal abnormalities observed suggests a need for VMMC sites to provide for both open surgical and devices methods in the provision of VMMC services. This is especially so among young male subjects presenting themselves for VMMC services at the various sites being developed in sub Saharan African countries.	[Mukudu, Hillary; Otwombe, Kennedy; Laher, Fatima; Lazarus, Erica; Manentsa, Mmatsie; Lebina, Limakatso; Martinson, Neil] Univ Witwatersrand, PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Fac Hlth Sci, Johannesburg, South Africa; [Mapulanga, Victor] Univ Zambia, Sch Med, Lusaka, Zambia; [Bowa, Kasonde] Copperbelt Univ, Sch Med, Ndola, Zambia	University of Witwatersrand; University of Zambia; Copperbelt University	Mukudu, H (corresponding author), Univ Witwatersrand, PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Fac Hlth Sci, Johannesburg, South Africa.	hmukudu@mweb.co.za	Manentsa, Mmatsie/B-8658-2017; Bowa, Kasonde/A-8770-2019	Manentsa, Mmatsie/0000-0003-4671-7122; Bowa, Kasonde/0000-0001-7032-7998	PEPFAR through the CDC; Society for Family Health (SFH)	PEPFAR through the CDC; Society for Family Health (SFH)	The KNMMCC was funded by PEPFAR through the CDC, and Society for Family Health (SFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to circumcision clients for the use of their records; Chris Hani Baragwanath Academic Hospital for the clinic facilities and permission to use the records; as well as the data staff, Kedidimetse Matshidiso, Nomvula Zulu and Petros Tlou, for their kind assistance. The KNMMCC was funded by PEPFAR through the CDC, and Society for Family Health (SFH). The views expressed herein do not necessarily reflect those of the US Government, CDC or SFH.	[Anonymous], 2015, WHO PROGR BRIEF VOL; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Chrouser K, 2013, J UROLOGY, V190, P544, DOI 10.1016/j.juro.2013.02.3200; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Galukande M, 2014, PLOS ONE, V9, P2, DOI DOI 10.1371/J0URNAL.P0NE.0086631; Hsieh TF, 2006, INT J UROL, V13, P968, DOI 10.1111/j.1442-2042.2006.01449.x; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Ko MC, 2007, J FORMOS MED ASSOC, V106, P302, DOI 10.1016/S0929-6646(09)60256-4; Mehta SD, 2013, AIDS; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Njeuhmeli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082533; Robertson LM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-141; Shankar KR, 1999, BJU INT, V84, P101; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, 2013, PAED HIV SURV INF CH; WHO, WHO WHO UNAIDS ANN R; WHO, 2013, GUID US DEV AD MAL C; WHO, 2013, WHO TRADITIONAL MED, P15; WHO, 2013, EV 2 AD DEV; WHO, 2016, WHO, V0205, P3111; WHO, GLOB HLTH SECT STRAT; WHO, MAL CIRC LOC AN VERS	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156265	10.1371/journal.pone.0156265	http://dx.doi.org/10.1371/journal.pone.0156265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253372	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700017
J	Kim, YJ; Lee, HS; Kim, YK; Park, S; Kim, JM; Yun, JH; Yu, HY; Kim, BJ				Kim, Yeon-Jung; Lee, Heun-Sik; Kim, Yun Kyoung; Park, Suyeon; Kim, Jeong-Min; Yun, Jun Ho; Yu, Ho-Yeong; Kim, Bong-Jo			Association of Metabolites with Obesity and Type 2 Diabetes Based on FTO Genotype	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; BODY-MASS INDEX; GENETIC-VARIANTS; DIETARY-INTAKE; EARLY-ONSET; FAT MASS; RISK; METAANALYSIS; INSIGHTS	The single nucleotide polymorphism rs9939609 of the gene FTO, which encodes fat mass and obesity-associated protein, is strongly associated with obesity and type 2 diabetes (T2D) in multiple populations; however, the underlying mechanism of this association is unclear. The present study aimed to investigate FTO genotype-dependent metabolic changes in obesity and T2D. To elucidate metabolic dysregulation associated with disease risk genotype, genomic and metabolomic datasets were recruited from 2,577 participants of the Korean Association REsource (KARE) cohort, including 40 homozygous carriers of the FTO risk allele (AA), 570 heterozygous carriers (AT), and 1,967 participants carrying no risk allele (TT). A total of 134 serum metabolites were quantified using a targeted metabolomics approach. Through comparison of various statistical methods, seven metabolites were identified that are significantly altered in obesity and T2D based on the FTO risk allele (adjusted p < 0.05). These identified metabolites are relevant to phosphatidylcholine metabolic pathway, and previously reported to be metabolic markers of obesity and T2D. In conclusion, using metabolomics with the information from genome-wide association studies revealed significantly altered metabolites depending on the FTO genotype in complex disorders. This study may contribute to a better understanding of the biological mechanisms linking obesity and T2D.	[Kim, Yeon-Jung; Lee, Heun-Sik; Kim, Yun Kyoung; Park, Suyeon; Kim, Jeong-Min; Yun, Jun Ho; Yu, Ho-Yeong; Kim, Bong-Jo] Korea Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genome Sci, Chungcheongbuk Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Kim, BJ (corresponding author), Korea Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genome Sci, Chungcheongbuk Do, South Korea.	kbj6181@cdc.go.kr		Kim, Jeong-Min/0000-0002-4305-5162	Korea National Institute of Health [2013-NG73001-00]; Korean Genome Analysis Project [4845-301]; Korea Biobank Project [4851-307, KBP-2014-02]; Korea Center for Disease Control and Prevention, Republic of Korea	Korea National Institute of Health; Korean Genome Analysis Project; Korea Biobank Project; Korea Center for Disease Control and Prevention, Republic of Korea	This work was supported by intramural grants from the Korea National Institute of Health (2013-NG73001-00). Biospecimens and data were obtained from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and the Korea Biobank Project (4851-307, KBP-2014-02), which are supported by the Korea Center for Disease Control and Prevention, Republic of Korea.	Adamski J, 2013, CURR OPIN BIOTECH, V24, P39, DOI 10.1016/j.copbio.2012.10.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hochberge YBY., 1955, CONTROLLING FALSE DI, V50, P289; Isa S. A., 2010, NIGERIAN J BASIC APP, V18, P50; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Kato Makiko, 1996, Tokushima Journal of Experimental Medicine, V43, P1; Kawada T, 1993, Sangyo Igaku, V35, P38; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Lee HJ, 2010, CLIN CHIM ACTA, V411, P1716, DOI 10.1016/j.cca.2010.07.010; Liu GF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-57; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marrachelli VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098227; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nishida Makoto, 2009, Nihon Rinsho, V67, P301; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Omura Minoru, 1993, Fukuoka Acta Medica, V84, P305; Park W, 2013, ERGONOMICS, V56, P692, DOI 10.1080/00140139.2012.752529; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi QB, 2014, HUM MOL GENET, V23, P6961, DOI 10.1093/hmg/ddu411; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ried JS, 2013, ALLERGY, V68, P629, DOI 10.1111/all.12110; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Suzuki Koji, 2003, Asian Pac J Cancer Prev, V4, P259; Then C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078430; Binh TQ, 2013, GENE, V513, P31, DOI 10.1016/j.gene.2012.10.082; Urata H, 2001, Nihon Koshu Eisei Zasshi, V48, P560; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Xie WJ, 2013, DIABETES, V62, P2141, DOI 10.2337/db12-0876; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	25	28	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156612	10.1371/journal.pone.0156612	http://dx.doi.org/10.1371/journal.pone.0156612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249024	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700058
J	Vancayseele, N; Portzky, G; van Heeringen, K				Vancayseele, Nikita; Portzky, Gwendolyn; van Heeringen, Kees			Increase in Self-Injury as a Method of Self-Harm in Ghent, Belgium: 1987-2013	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; ATTEMPTED-SUICIDE; INFLICTED INJURY; CO-PROXAMOL; TRENDS; REPETITION; MULTICENTER; ENGLAND; INTERVENTION; ADOLESCENTS	Background Self-harm is a major health care problem and changes in its prevalence and characteristics can have important implications for suicide prevention. The objective was to describe trends in the epidemiology of self-harm based on emergency department (A&E departments) visits over a 26-year period in Ghent, Belgium. Methods We analyzed data on all self-harm presentations from the three large general hospitals in Ghent between 1987 and 2013. We investigated trends in prevalence (events by year per 100.000), methods and alcohol use. Results Rates of self-harm steadily decreased during the 26-year study period. In general female rates of self-harm were higher than male rates. The mean patient age was 35 years. The most commonly used method of self-harm was self-poisoning by means of an overdose of medication (80.8%), followed by cutting (10.2%) and hanging (4.2%). Psychotropics (including antidepressants, benzodiazepines, barbiturates and other tranquilizers) were the most frequently used drugs (74.5%). A proportional increase in the use of self-injurious methods in self-harm was highly significant, more specifically in the use of hanging, jumping from heights and the use of other violent methods such as the use of firearms, jumping before a moving object or other traffic related injury. Conclusion This epidemiological study showed an increase in the use of high-lethality methods in self-harm which has important implications for suicide prevention. As restrictions in the availability of these methods are difficult or impossible to achieve, prevention programmes will have to emphasize the role of thorough psychosocial assessment and adequate follow-up care of self-harm patients.	[Vancayseele, Nikita; Portzky, Gwendolyn; van Heeringen, Kees] Univ Ghent, Dept Psychiat & Med psychol, B-9000 Ghent, Belgium; [van Heeringen, Kees] Univ Ghent, Unit Suicide Res, B-9000 Ghent, Belgium	Ghent University; Ghent University	Vancayseele, N (corresponding author), Univ Ghent, Dept Psychiat & Med psychol, B-9000 Ghent, Belgium.	Nikita.Vancayseele@ugent.be	van Heeringen, Kees/H-2384-2013	van Heeringen, Kees/0000-0001-5801-194X				Beautrais AL, 2000, AUST NZ J PSYCHIAT, V34, P413, DOI 10.1080/j.1440-1614.2000.00690.x; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; Bergen H, 2012, J AFFECT DISORDERS, V136, P526, DOI 10.1016/j.jad.2011.10.036; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bergen H, 2010, J AFFECT DISORDERS, V127, P257, DOI 10.1016/j.jad.2010.05.001; Bille-Brahe U., 1994, ATTEMPTED SUICIDE EU, P3; Bogdanovica I, 2011, SOC PSYCH PSYCH EPID, V46, P1103, DOI 10.1007/s00127-010-0282-3; Carroll R, 2016, J AFFECT DISORDERS, V192, P8, DOI 10.1016/j.jad.2015.12.007; Centraal Bureau voor de Statistiek (CBS), SUIC RIS SUBST AG; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Corcoran P, 2010, BMC CLIN PHARM, P10; Crawford MJ, 2010, PSYCHOL MED, V40, P1821, DOI 10.1017/S0033291709991899; De Leo D, 2002, BRIT J PSYCHIAT, V181, P226, DOI 10.1192/bjp.181.3.226; De Munck S, 2009, CRISIS, V30, P115, DOI 10.1027/0227-5910.30.3.115; Dieserud G, 2010, CRISIS, V31, P255, DOI 10.1027/0227-5910/a000030; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; FORSTER DP, 1985, ACTA PSYCHIAT SCAND, V71, P567, DOI 10.1111/j.1600-0447.1985.tb02550.x; Frost M, 2016, ARCH SUICIDE RES, V20, P69, DOI 10.1080/13811118.2015.1004470; Gairin I, 2003, BRIT J PSYCHIAT, V183, P28, DOI 10.1192/bjp.183.1.28; Griffin E, 2014, ANN REPORT 2013 NATL; Haw C, 2015, SUICIDE LIFE-THREAT, V45, P732, DOI 10.1111/sltb.12168; Hawton K, 2003, PSYCHOL MED, V33, P987, DOI 10.1017/S0033291703007943; Hawton K, 2009, BRIT MED J, V338; Hawton K., 1987, ATTEMPTED SUICIDE PR; Hawton K, 2006, CRISIS, V27, P157, DOI 10.1027/0227-5910.27.4.157; Hawton K, 2015, SOC PSYCH PSYCH EPID, V50, P695, DOI 10.1007/s00127-014-0990-1; Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062; Hawton K, 2012, J CHILD PSYCHOL PSYC, V53, P1212, DOI 10.1111/j.1469-7610.2012.02559.x; Hawton K, 2012, EUR CHILD ADOLES PSY, V21, P369, DOI 10.1007/s00787-012-0269-6; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hubner-Liebermann B, 2010, GEN HOSP PSYCHIAT, V32, P514, DOI 10.1016/j.genhosppsych.2010.06.008; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kolves K, 2011, SOC PSYCH PSYCH EPID, V46, P805, DOI 10.1007/s00127-010-0251-x; Kuo CJ, 2012, BRIT J PSYCHIAT, V200, P405, DOI 10.1192/bjp.bp.111.099366; Larkin GL, 2008, CRISIS, V29, P73, DOI 10.1027/0227-5910.29.2.73; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Nordentoft M, 2007, CRISIS, V28, P44, DOI 10.1027/0227-5910.28.S1.44; Olfson M, 2005, AM J PSYCHIAT, V162, P1328, DOI 10.1176/appi.ajp.162.7.1328; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Rhodes AE, 2014, CAN J PSYCHIAT, V59, P152, DOI 10.1177/070674371405900307; Runeson B., 2010, BMJ-BRIT MED J, V341, P342, DOI DOI 10.1136/BMJ.C3222; Sandilands EA, 2008, BRIT J CLIN PHARMACO, V66, P290, DOI 10.1111/j.1365-2125.2008.03206.x; SEGEST E, 1993, MED SCI LAW, V33, P41, DOI 10.1177/002580249303300108; Simkin S, 2005, QJM-INT J MED, V98, P159, DOI 10.1093/qjmed/hci026; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; Ting SA, 2012, GEN HOSP PSYCHIAT, V34, P557, DOI 10.1016/j.genhosppsych.2012.03.020; Vandeurzen J, 2012, VLAAMS ACTIEPLAN SUI; VANHEERINGEN C, 1995, PSYCHOL MED, V25, P963, DOI 10.1017/S0033291700037454; Vogels M, 2006, VLAAMS ACTIEPLAN SUI; World Health Organization, PREV SUIC GLOB IMP; World Health Organization (WHO), FACTSH SUIC	51	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156711	10.1371/journal.pone.0156711	http://dx.doi.org/10.1371/journal.pone.0156711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249421	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700072
J	Borkowska, M; Millar, JK; Price, DJ				Borkowska, Malgorzata; Millar, J. Kirsty; Price, David J.			Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism	PLOS ONE			English	Article							DISC1-L100P MUTANT MICE; MAJOR MENTAL-ILLNESS; PREFRONTAL CORTEX; TRANSGENIC MICE; VISUAL-CORTEX; FRONTAL-CORTEX; PSYCHIATRIC-DISORDERS; BEHAVIORAL PHENOTYPES; POSTNATAL-DEVELOPMENT; NEURITE OUTGROWTH	Disrupted-in-Schizophrenia-1 (DISC1) gene has been linked to schizophrenia and related major mental illness. Mouse Disc1 has been implicated in brain development, mainly in the proliferation, differentiation, lamination, neurite outgrowth and synapse formation and maintenance of cortical excitatory neurons. Here, the effects of two loss-of-function point mutations in the mouse Disc1 sequence (Q31L and L100P) on cortical inhibitory interneurons were investigated. None of the mutations affected the overall number of interneurons. However, the 100P, but not the 31L, mutation resulted in a significant decrease in the numbers of interneurons expressing parvalbumin mRNA and protein across the sensory cortex. To investigate role of Disc1 in regulation of parvalbumin expression, mouse wild-type Disc-1 or the 100P mutant form were electroporated in utero into cortical excitatory neurons. Overexpression of wild-type Disc1 in these cells caused increased densities of parvalbumin-expressing interneurons in the electroporated area and in areas connected with it, whereas expression of Disc1-100P did not. We conclude that the 100P mutation prevents expression of parvalbumin by a normally sized cohort of interneurons and that altering Disc1 function in cortical excitatory neurons indirectly affects parvalbumin expression by cortical interneurons, perhaps as a result of altered functional input from the excitatory neurons.	[Borkowska, Malgorzata; Price, David J.] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland; [Millar, J. Kirsty] Univ Edinburgh, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Borkowska, Malgorzata] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus,Du Cane Rd, London W12, England	University of Edinburgh; University of Edinburgh; Imperial College London	Borkowska, M (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.; Borkowska, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus,Du Cane Rd, London W12, England.	malgorzata.borkowska@csc.mrc.ac.uk		Borkowska, Malgorzata/0000-0002-8567-7218	Medical Research Council [G0800429, J003662/1, G0902166]; MRC Capacity Building Studentship; BBSRC [BB/N006542/1] Funding Source: UKRI; MRC [MR/J003662/1, G0800429, G0902166] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N006542/1] Funding Source: researchfish; Medical Research Council [MR/J003662/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by Medical Research Council grants G0800429 and J003662/1 (DJP), G0902166 (JKM) and an MRC Capacity Building Studentship to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Chandran JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108088; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hague FN, 2012, BEHAV BRAIN RES, V233, P337, DOI 10.1016/j.bbr.2012.05.037; HAIECH J, 1979, BIOCHEMISTRY-US, V18, P2752, DOI 10.1021/bi00580a010; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kas MJH, 2009, AM J MED GENET B, V150B, P309, DOI 10.1002/ajmg.b.30815; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Lee FHF, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-20; Lee FHF, 2011, SCHIZOPHR RES, V129, P74, DOI 10.1016/j.schres.2011.03.032; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lewis DA, 2014, CURR OPIN NEUROBIOL, V26, P22, DOI 10.1016/j.conb.2013.11.003; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipina TV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051562; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Millar JK, 2007, J PHYSIOL-LONDON, V584, P401, DOI 10.1113/jphysiol.2007.140210; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Morris HM, 2009, SCHIZOPHR RES, V115, P261, DOI 10.1016/j.schres.2009.09.014; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Patz S, 2004, CEREB CORTEX, V14, P342, DOI 10.1093/cercor/bhg132; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Roberts RC, 2007, SCHIZOPHRENIA BULL, V33, P11, DOI 10.1093/schbul/sbl063; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shoji Hirotaka, 2012, BMC Res Notes, V5, P108, DOI 10.1186/1756-0500-5-108; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steinecke A, 2012, J NEUROSCI, V32, P738, DOI 10.1523/JNEUROSCI.5036-11.2012; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Taniguchi Y, 2012, NEUROSCIENTIST, V18, P169, DOI 10.1177/1073858411399925; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Van de Werd HJJM, 2014, BRAIN STRUCT FUNCT, V219, P433, DOI 10.1007/s00429-013-0630-7; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	72	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156082	10.1371/journal.pone.0156082	http://dx.doi.org/10.1371/journal.pone.0156082			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244370	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100015
J	Hapuarachchige, S; Kato, Y; Ngen, EJ; Smith, B; Delannoy, M; Artemov, D				Hapuarachchige, Sudath; Kato, Yoshinori; Ngen, Ethel J.; Smith, Barbara; Delannoy, Michael; Artemov, Dmitri			Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells	PLOS ONE			English	Review							IN-VIVO MRI; CONTRAST AGENTS; STEM-CELLS	This paper reports the damaging effects of magnetic iron-oxide nanoparticles (MNP) on magnetically labeled cancer cells when subjected to oscillating gradients in a strong external magnetic field. Human breast cancer MDA-MB-231 cells were labeled with MNP, placed in the high magnetic field, and subjected to oscillating gradients generated by an imaging gradient system of a 9.4T preclinical MRI system. Changes in cell morphology and a decrease in cell viability were detected in cells treated with oscillating gradients. The cytotoxicity was determined qualitatively and quantitatively by microscopic imaging and cell viability assays. An approximately 26.6% reduction in cell viability was detected in magnetically labeled cells subjected to the combined effect of a static magnetic field and oscillating gradients. No reduction in cell viability was observed in unlabeled cells subjected to gradients, or in MNP-labeled cells in the static magnetic field. As no increase in local temperature was observed, the cell damage was not a result of hyperthermia. Currently, we consider the coherent motion of internalized and aggregated nanoparticles that produce mechanical moments as a potential mechanism of cell destruction. The formation and dynamics of the intracellular aggregates of nanoparticles were visualized by optical and transmission electron microscopy (TEM). The images revealed a rapid formation of elongated MNP aggregates in the cells, which were aligned with the external magnetic field. This strategy provides a new way to eradicate a specific population of MNP-labeled cells, potentially with magnetic resonance imaging guidance using standard MRI equipment, with minimal side effects for the host.	[Hapuarachchige, Sudath; Kato, Yoshinori; Ngen, Ethel J.; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Div Canc Imaging Res, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Kato, Yoshinori; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Smith, Barbara; Delannoy, Michael] Johns Hopkins Univ, Sch Med, Cell Biol Imaging Facil, Baltimore, MD 21205 USA; [Kato, Yoshinori] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 142, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Hoshi University	Artemov, D (corresponding author), Johns Hopkins Univ, Sch Med, Div Canc Imaging Res, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA.; Artemov, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.	dartemo2@jhmi.edu		Kato, Yoshinori/0000-0002-6218-8710; Ngen, Ethel/0000-0003-2668-5311; Hapuarachchige, Sudath/0000-0002-1166-8247	Susan G. Komen for the Cure [KG100594]; National Institutes of Health [CA154738]	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grants KG100594 from Susan G. Komen for the Cure and CA154738 from the National Institutes of Health.	Bigini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032326; Bouchlaka MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048049; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Carrey J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4810972; Chen C-C, 2013, PLOS ONE, V8; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Creixell M, 2011, ACS NANO, V5, P7124, DOI 10.1021/nn201822b; Domenech M, 2013, ACS NANO, V7, P5091, DOI 10.1021/nn4007048; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Henning TD, 2009, CONTRAST MEDIA MOL I, V4, P165, DOI 10.1002/cmmi.276; Ivkov R, 2005, CLIN CANCER RES, V11, p7093S, DOI 10.1158/1078-0432.CCR-1004-0016; Kim DH, 2010, NAT MATER, V9, P165, DOI [10.1038/NMAT2591, 10.1038/nmat2591]; Kraitchman DL, 2011, METHODS MOL BIOL, V680, P141, DOI 10.1007/978-1-60761-901-7_10; Kut C, 2012, NANOMEDICINE-UK, V7, P1697, DOI [10.2217/NNM.12.65, 10.2217/nnm.12.65]; Li L, 2012, J NANOSCI NANOTECHNO, V12, P9010, DOI 10.1166/jnn.2012.6755; Liu D, 2012, NANO LETT, V12, P5117, DOI 10.1021/nl301928z; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Mitsunaga M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-345; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Ngen EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13628; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Penet MF, 2013, NMR BIOMED, V26, P745, DOI 10.1002/nbm.2980; REIMER P, 1995, RADIOLOGY, V195, P489, DOI 10.1148/radiology.195.2.7724772; Sanchez C, 2014, ACS NANO, V8, P1350, DOI 10.1021/nn404954s; Schafer R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-22; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Swierczewska M, 2012, CHEM SOC REV, V41, P2641, DOI 10.1039/c1cs15238f; Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Willenbrock S, 2012, IN VIVO, V26, P31; Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012; Zhang EM, 2014, ACS NANO, V8, P3192, DOI 10.1021/nn406302j	34	20	20	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156294	10.1371/journal.pone.0156294	http://dx.doi.org/10.1371/journal.pone.0156294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244470	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100025
J	Kong, BW; Lassiter, K; Piekarski-Welsher, A; Dridi, S; Reverter-Gomez, A; Hudson, NJ; Bottje, WG				Kong, Byung-Whi; Lassiter, Kentu; Piekarski-Welsher, Alissa; Dridi, Sami; Reverter-Gomez, Antonio; Hudson, Nicholas James; Bottje, Walter Gay			Proteomics of Breast Muscle Tissue Associated with the Phenotypic Expression of Feed Efficiency within a Pedigree Male Broiler Line: I. Highlight on Mitochondria	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; STIMULATED GLUCOSE-TRANSPORT; COMBINED TRENBOLONE ACETATE; GLOBAL GENE-EXPRESSION; GROWTH-FACTOR-I; SKELETAL-MUSCLE; THYROID-HORMONE; GLYCOGEN-SYNTHASE	As feed represents 60 to 70% of the cost of raising an animal to market weight, feed efficiency (the amount of dry weight intake to amount of wet weight gain) remains an important genetic trait in animal agriculture. To gain greater understanding of cellular mechanisms of feed efficiency (FE), shotgun proteomics was conducted using in-gel trypsin digestion and tandem mass spectrometry on breast muscle samples obtained from pedigree male (PedM) broilers exhibiting high feed efficiency (FE) or low FE phenotypes (n = 4 per group). The high FE group had greater body weight gain (P = 0.004) but consumed the same amount of feed (P = 0.30) from 6 to 7 wk resulting in higher FE (P < 0.001). Over 1800 proteins were identified, of which 152 were different (P < 0.05) by at least 1.3 fold and <= 15 fold between the high and low FE phenotypes. Data were analyzed for a modified differential expression (DE) metric (Phenotypic Impact Factors or PIF) and interpretation of protein expression data facilitated using the Ingenuity Pathway Analysis (IPA) program. In the entire data set, 228 mitochondrial proteins were identified whose collective expression indicates a higher mitochondrial expression in the high FE phenotype (binomial probability P < 0.00001). Within the top up and down 5% PIF molecules in the dataset, there were 15 mitoproteome proteins up-regulated and only 5 down-regulated in the high FE phenotype. Pathway enrichment analysis also identified mitochondrial dysfunction and oxidative phosphorylation as the number 1 and 5 differentially expressed canonical pathways (up-regulated in high FE) in the proteomic dataset. Upstream analysis (based on DE of downstream molecules) predicted that insulin receptor, insulin like growth receptor 1, nuclear factor, erythroid 2-like 2, AMP activated protein kinase (a subunit), progesterone and triiodothyronine would be activated in the high FE phenotype whereas rapamycin independent companion of target of rapamycin, mitogen activated protein kinase 4, and serum response factor would be inhibited in the high FE phenotype. The results provide additional insight into the fundamental molecular landscape of feed efficiency in breast muscle of broilers as well as further support for a role of mitochondria in the phenotypic expression of FE.	[Kong, Byung-Whi; Lassiter, Kentu; Piekarski-Welsher, Alissa; Dridi, Sami; Bottje, Walter Gay] Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA; [Reverter-Gomez, Antonio; Hudson, Nicholas James] Queensland Biosci Precinct, CSIRO Livestock Ind, 306 Carmody Rd, St Lucia, Qld 4067, Australia	University of Arkansas System; University of Arkansas Fayetteville; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bottje, WG (corresponding author), Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	wbottje@uark.edu	Hudson, Nicholas J/D-1606-2011; Reverter, Antonio/C-9699-2013; Dridi, Sami/Q-8207-2019; Hudson, Nick/AAF-5644-2020	Hudson, Nicholas J/0000-0002-3549-9396; Reverter, Antonio/0000-0002-4681-9404; Hudson, Nick/0000-0002-3549-9396	USDA-NIFA [2013-01953]; Arkansas Biosciences Institute (Little Rock, AR); McMaster Fellowship (AUS); Agricultural Experiment Station (Univ. of Arkansas, Fayetteville)	USDA-NIFA(United States Department of Agriculture (USDA)); Arkansas Biosciences Institute (Little Rock, AR); McMaster Fellowship (AUS); Agricultural Experiment Station (Univ. of Arkansas, Fayetteville)	Funding provided by USDA-NIFA (#2013-01953), Arkansas Biosciences Institute (Little Rock, AR), McMaster Fellowship (AUS to WB) and the Agricultural Experiment Station (Univ. of Arkansas, Fayetteville).	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Baumann CA, 2001, J BIOL CHEM, V276, P6065, DOI 10.1074/jbc.C000856200; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Bottje W. G., 2014, BIOCH PHYSL, V3, P1, DOI DOI 10.1093/PS/81.4.546; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chien KY, 2012, J PROTEOME RES, V11, P5663, DOI 10.1021/pr300471y; Clement K, 2002, GENOME RES, V12, P281, DOI 10.1101/gr.207702; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Davis ME, 2012, FEED EFFICIENCY BEEF, P175; Duclos M J, 2005, J Physiol Pharmacol, V56 Suppl 3, P25; Dupont J, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P613; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Fan ZJ, 2012, VIRUS RES, V167, P314, DOI 10.1016/j.virusres.2012.05.016; Fawcett J, 2014, PROTEIN PEPTIDE LETT, V21, P584, DOI 10.2174/0929866521666140221151905; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; Galban VD, 2001, MOL CELL BIOCHEM, V225, P35, DOI 10.1023/A:1012260605910; Galganska H, 2010, BBA-BIOENERGETICS, V1797, P1276, DOI 10.1016/j.bbabio.2010.02.004; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hag K, 2010, VET IMMUNOL IMMUNOP, V138, P292, DOI 10.1016/j.vetimm.2010.10.007; HALL JC, 1960, J BIOL CHEM, V235, P1536; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hu XM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-256; Hudson NJ, 2009, PLOS COMPUTATIONAL B, V5, DOI 10.1371/journal.pcbi.1000382; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Johnson BJ, 1998, J ANIM SCI, V76, P491; Johnson BJ, 1996, J ANIM SCI, V74, P372; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; KIESSLING KH, 1977, COMP BIOCHEM PHYS B, V57, P287, DOI 10.1016/0305-0491(77)90055-4; Kim H, 2001, EXP CELL RES, V265, P339, DOI 10.1006/excr.2001.5207; Kim YB, 2005, MOL CELL BIOL, V25, P9713, DOI 10.1128/MCB.25.21.9713-9723.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kong BW, 2011, POULTRY SCI, V90, P2535, DOI 10.3382/ps.2011-01435; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Krebs HA, 1938, BIOCHEM J, V32, P913, DOI 10.1042/bj0320913; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu YJ, 2013, POULTRY SCI, V92, P1897, DOI 10.3382/ps.2012-02986; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Merforth S, 1999, MOL BIOL REP, V26, P83, DOI 10.1023/A:1006966005662; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Mu PQ, 2013, PROTEOMICS, V13, P3175, DOI 10.1002/pmic.201300015; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015; Nixon R, 2012, NEW YORK TIMES BUSIN; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Ojano-Dirain C, 2005, POULTRY SCI, V84, P782, DOI 10.1093/ps/84.5.782; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Picard B, 2010, BRIEF FUNCT GENOMICS, V9, P259, DOI 10.1093/bfgp/elq005; Piekarski A, 2015, THESIS U ARKANSAS FA; Preston RL, 1999, ADV DRUG DELIVER REV, V38, P123, DOI 10.1016/S0169-409X(99)00012-5; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; QUEST AFG, 1990, FEBS LETT, V262, P299, DOI 10.1016/0014-5793(90)80214-4; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabouille C, 2014, EMBO J, V33, P2604, DOI 10.15252/embj.201489899; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Sharifabadi HR, 2012, J ANIM SCI, V90, P1807, DOI 10.2527/jas.2011-4791; Shorr E, 1939, BIOCHEM J, V33, P1798, DOI 10.1042/bj0331798; SIMMONS J, 2010, TECHNOLOGYS ROLE 21; SMITH OLK, 1989, DIABETES, V38, P1117, DOI 10.2337/diabetes.38.9.1117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sokale A, 2011, PROTEOMICS, V11, P4262, DOI 10.1002/pmic.201000795; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THOMPSON SH, 1989, ENDOCRINOLOGY, V124, P2110, DOI 10.1210/endo-124-5-2110; Tokushima Y, 2005, COMP BIOCHEM PHYS B, V141, P43, DOI 10.1016/j.cbpc.2005.01.008; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang MX, 2013, MOL CELL BIOL, V33, P678, DOI 10.1128/MCB.00618-12; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Zanetti E, 2011, PROTEOMICS, V11, P2613, DOI 10.1002/pmic.201000639; Zhao JP, 2012, J ANIM SCI, V90, P4337, DOI 10.2527/jas.2012-5100; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	110	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155679	10.1371/journal.pone.0155679	http://dx.doi.org/10.1371/journal.pone.0155679			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244447	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100005
J	Zhu, YJ; Wang, GJ; Li, RQ				Zhu, Yajuan; Wang, Guojie; Li, Renqiang			Seasonal Dynamics of Water Use Strategy of Two Salix Shrubs in Alpine Sandy Land, Tibetan Plateau	PLOS ONE			English	Article							SYLVESTRIS VAR. MONGOLICA; STABLE-ISOTOPES; DESERT PLANTS; PRECIPITATION; GRASSLAND; REGION; PULSE; AREA	Water is a limiting factor for plant growth and vegetation dynamics in alpine sandy land of the Tibetan Plateau, especially with the increasing frequency of extreme precipitation events and drought caused by climate change. Therefore, a relatively stable water source from either deeper soil profiles or ground water is necessary for plant growth. Understanding the water use strategy of dominant species in the alpine sandy land ecosystem is important for vegetative rehabilitation and ecological restoration. The stable isotope methodology of delta D, delta O-18, and delta C-13 was used to determine main water source and long-term water use efficiency of Salix psammophila and S. cheilophila, two dominant shrubs on interdune of alpine sandy land in northeastern Tibetan Plateau. The root systems of two Salix shrubs were investigated to determine their distribution pattern. The results showed that S. psammophila and S. cheilophila absorbed soil water at different soil depths or ground water in different seasons, depending on water availability and water use strategy. Salix psammophila used ground water during the growing season and relied on shallow soil water recharged by rain in summer. Salix cheilophila used ground water in spring and summer, but relied on shallow soil water recharged by rain in spring and deep soil water recharged by ground water in fall. The two shrubs had dimorphic root systems, which is coincident with their water use strategy. Higher biomass of fine roots in S. psammophila and longer fine roots in S. cheilophila facilitated to absorb water in deeper soil layers. The long-term water use efficiency of two Salix shrubs increased during the dry season in spring. The long-term water use efficiency was higher in S. psammophila than in S. cheilophila, as the former species is better adapted to semiarid climate of alpine sandy land.	[Zhu, Yajuan] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Zhu, Yajuan] Nanjing Univ Informat Sci & Technol, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Wang, Guojie] Oregon State Univ, Eastern Oregon Univ, Agr Program, La Grande, OR USA; [Li, Renqiang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Nanjing University of Information Science & Technology; Eastern Oregon University; Oregon State University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhu, YJ (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.; Zhu, YJ (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Li, RQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	zhuyajuan80@gmail.com; renqiangli@igsnrr.ac.cn			Natural Science Foundation of China [41301095]; Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry [CAFYBB2014QB023]; Project on Promoting New Rural Construction with Science and Technology in Qinghai Province [2013-N-556]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry; Project on Promoting New Rural Construction with Science and Technology in Qinghai Province	This study was provided by the Natural Science Foundation of China (No. 41301095, YZ) (http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry (No. CAFYBB2014QB023, YZ) (http://www.caf.ac.cn/), and Project on Promoting New Rural Construction with Science and Technology in Qinghai Province (2013-N-556) (http://www.qhlyt.gov.cn).	Cheng XR, 2009, PLANT SOIL, V315, P149, DOI 10.1007/s11104-008-9739-5; Cheng XL, 2006, PLANT ECOL, V184, P1, DOI 10.1007/s11258-005-9047-6; Chimner RA, 2004, PLANT SOIL, V260, P225, DOI 10.1023/B:PLSO.0000030190.70085.e9; Cui YQ, 2015, J ARID LAND, V7, P73, DOI 10.1007/s40333-014-0037-1; Dai Y, 2015, PLANT SOIL, V389, P73, DOI 10.1007/s11104-014-2342-z; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; Feng YM, 2011, INT J SUST DEV WORLD, V18, P357, DOI 10.1080/13504509.2011.562004; [巩国丽 Gong Guoli], 2011, [生态学报, Acta Ecologica Sinica], V31, P7533; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Hou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070114; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jia ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045902; Kowaljow E, 2011, J ARID ENVIRON, V75, P211, DOI 10.1016/j.jaridenv.2010.10.004; Kray JA, 2012, J ARID ENVIRON, V83, P25, DOI 10.1016/j.jaridenv.2012.03.009; Li SG, 2007, J HYDROL, V333, P109, DOI 10.1016/j.jhydrol.2006.07.020; Lin G.H., 2013, STABLE ISOTOPE ECOLO; Liu SB, 2015, ECOL RES, V30, P581, DOI 10.1007/s11284-015-1270-6; Liu SW, 1997, FLORA QINGHAIICA, V1, P117; Ma YQ, 1985, FLORA INTRAMONGOLICA, V1, P53; McCole AA, 2007, J HYDROL, V342, P238, DOI 10.1016/j.jhydrol.2007.05.024; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ohte N, 2003, ECOL APPL, V13, P337, DOI 10.1890/1051-0761(2003)013[0337:WUONAP]2.0.CO;2; Pataki DE, 2005, ECOL APPL, V15, P1009, DOI 10.1890/04-1272; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Schwinning S, 2003, OECOLOGIA, V136, P252, DOI 10.1007/s00442-003-1255-y; Song LN, 2014, TREES-STRUCT FUNCT, V28, P971, DOI 10.1007/s00468-014-1010-5; Su H, 2014, TREES-STRUCT FUNCT, V28, P41, DOI 10.1007/s00468-013-0928-3; Wei YF, 2013, TREES-STRUCT FUNCT, V27, P1249, DOI 10.1007/s00468-013-0873-1; West AG, 2007, OECOLOGIA, V153, P787, DOI 10.1007/s00442-007-0777-0; Xia JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032088; [邢星 Xing Xing], 2014, [生态学报, Acta Ecologica Sinica], V34, P6277; Xu GQ, 2011, ECOL RES, V26, P1071, DOI 10.1007/s11284-011-0858-8; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Zeng FJ, 2013, ARID LAND RES MANAG, V27, P298, DOI 10.1080/15324982.2012.748709; Zhang D.S., 2009, LAND DESERTIFICATION; Zhu Y, 2014, J DES RES, V34, P814; Zhu Y.J., 2011, ACTA ECOL SIN, V31, P341, DOI [10.1016/j.chnaes.2011.09.004, DOI 10.1016/J.CHNAES.2011.09.004]; Zhu YJ, 2011, J FOOD AGRIC ENVIRON, V9, P832; Zhu YaJuan, 2010, Scientia Silvae Sinicae, V46, P15	41	6	10	13	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156586	10.1371/journal.pone.0156586	http://dx.doi.org/10.1371/journal.pone.0156586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243772	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100050
J	Onozato, M; Nishigaki, A; Okoshi, K				Onozato, Mayu; Nishigaki, Atsuko; Okoshi, Kenji			Polycyclic Aromatic Hydrocarbons in Sediments and Bivalves on the Pacific Coast of Japan: Influence of Tsunami and Fire	PLOS ONE			English	Article							RUDITAPES-PHILIPPINARUM; HEAVY-METALS; PAH RATIOS; HONG-KONG; BIOACCUMULATION; BIOAVAILABILITY; DISTRIBUTIONS; EARTHQUAKE; OYSTERS; MARINE	Surface sediments and at least one edible bivalve species (Ruditapes philippinarum, Mytilus galloprovincialis, and Crassostrea gigas) were collected from each of seven intertidal sites in Japan in 2013. The sites had experienced varying levels of tsunami and fire disturbance following the major earthquake of 2011. Eight polycyclic aromatic hydrocarbons (PAHs) were identified and analyzed by gas chromatography-mass spectrometry. Total sediment PAH concentration (C-T), the sum of the average concentrations of the eight PAHs, was 21-1447 mu g kg(-1)-dry. Relative to the average level of one type of PAH in sediments collected around Japan in 2002 (benzo[a] pyrene = 21 mu g kg(-1)-dry), five of the seven sites showed concentrations significantly lower than this average in 2013. The C-Ts for the three bivalves (134-450 mu g kg(-1)-dry) were within the range of the previous reports (2.2-5335 mu g kg(-1)-dry). The data suggest that the natural disaster did not increase PAH concentrations or affect the distribution within sediment or bivalves in Tohoku district. Although PAH concentrations at the sites pose no risk to human health, the findings highlight that the observed PAH levels derive from pre-rather than post-quake processes.	[Onozato, Mayu; Nishigaki, Atsuko; Okoshi, Kenji] Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan; [Onozato, Mayu] Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan	Toho University; Toho University	Onozato, M (corresponding author), Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan.; Onozato, M (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.	mayu.onozato@phar.toho-u.ac.jp						Barreira LA, 2007, J ENVIRON MONITOR, V9, P187, DOI 10.1039/b614919g; Baumard P, 1998, ESTUAR COAST SHELF S, V47, P77, DOI 10.1006/ecss.1998.0337; BLUMER M, 1976, SCI AM, V234, P35; BOEHM PD, 1977, MAR BIOL, V44, P227, DOI 10.1007/BF00387704; Clemons JH, 1998, ENVIRON SCI TECHNOL, V32, P1853, DOI 10.1021/es971124n; Fang JKH, 2009, MAR POLLUT BULL, V58, P615, DOI 10.1016/j.marpolbul.2008.12.016; FREEMAN DJ, 1990, ENVIRON SCI TECHNOL, V24, P1581, DOI 10.1021/es00080a019; Hirai Y, 2013, 22 S ENV CHEM PROGR, P452; Hokugo A, 2013, PROCEDIA ENGINEER, V62, P140, DOI 10.1016/j.proeng.2013.08.051; IRWIN RJ, 1997, ENV CONTAMINANTS ENC; Jaffe R, 1998, MAR POLLUT BULL, V36, P925, DOI 10.1016/S0025-326X(98)00090-3; Japan Weather Association, 2011, SUMM 2011 PAC COAS 3; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Kumar KS, 2008, MAR POLLUT BULL, V56, P136, DOI 10.1016/j.marpolbul.2007.08.011; Landrum PF, 2003, CHEMOSPHERE, V51, P481, DOI 10.1016/S0045-6535(02)00863-9; Li GC, 2006, ENVIRON POLLUT, V144, P985, DOI 10.1016/j.envpol.2006.01.047; Lim LH, 1999, ENVIRON SCI TECHNOL, V33, P3538, DOI 10.1021/es990392d; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Ma HQ, 2009, CHIN J OCEANOL LIMN, V27, P887, DOI 10.1007/s00343-009-9223-y; Ministry of the Environment Government of Japan, 2003, REP ENV SURV MON CHE; Moschino V, 2012, ENVIRON POLLUT, V171, P52, DOI 10.1016/j.envpol.2012.07.024; Moschino V, 2011, ENVIRON MONIT ASSESS, V177, P649, DOI 10.1007/s10661-010-1663-5; Neff J.M., 1980, POLYCYCL AROMAT COMP, V18; Norena-Barroso E, 1999, MAR POLLUT BULL, V38, P637, DOI 10.1016/S0025-326X(98)00165-9; Okoshi K, 2013, J JPN SOC WATER ENV, V36, P44; Okoshi K., 2015, MARINE PRODUCTIVITY, P55; Okoshi K, 2012, JPN J BENTHOLOGY, V66, P117; Onozato M, 2013, BUNSEKI KAGAKU, V62, P25, DOI 10.2116/bunsekikagaku.62.25; Onozato M, 2008, POLYCYCL AROMAT COMP, V28, P462, DOI 10.1080/10406630802414600; Tanaka H., 2010, J ENV CHEM, V20, P137, DOI [10.5985/jec.20.137, DOI 10.5985/JEC.20.137]; Tanaka T, 2012, FIRE SAFETY J, V54, P197, DOI 10.1016/j.firesaf.2012.07.002; The 2011 Tohoku Earthquake Tsunami Joint Survey (TTJS) Group, 2011 PAC COAST TOH E; Thompson RE, 2000, ECOL MODEL, V135, P231, DOI 10.1016/S0304-3800(00)00367-7; Thorsen WA, 2004, ENVIRON SCI TECHNOL, V38, P2029, DOI 10.1021/es0306056; *US EPA, INT RISK INF SYST IR; Yoshimine RV, 2012, J BRAZIL CHEM SOC, V23, P1429, DOI 10.1590/S0103-50532012005000003; Yoshino H, 1996, J JPN SOC ATMOS ENV, V31, P61; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zhang HB, 2006, ENVIRON POLLUT, V141, P107, DOI 10.1016/j.envpol.2005.08.031	41	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156447	10.1371/journal.pone.0156447	http://dx.doi.org/10.1371/journal.pone.0156447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232189	Green Submitted, Green Published, gold			2022-12-27	WOS:000376883000037
J	Trairatphisan, P; Wiesinger, M; Bahlawane, C; Haan, S; Sauter, T				Trairatphisan, Panuwat; Wiesinger, Monique; Bahlawane, Christelle; Haan, Serge; Sauter, Thomas			A Probabilistic Boolean Network Approach for the Analysis of Cancer-Specific Signalling: A Case Study of Deregulated PDGF Signalling in GIST	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; GENE REGULATORY NETWORKS; NEGATIVE FEEDBACK; BAYESIAN NETWORKS; SYSTEMS BIOLOGY; CELL; PATHWAYS; RECEPTOR; ACTIVATION; MODELS	Background Signal transduction networks are increasingly studied with mathematical modelling approaches while each of them is suited for a particular problem. For the contextualisation and analysis of signalling networks with steady-state protein data, we identified probabilistic Boolean network (PBN) as a promising framework which could capture quantitative changes of molecular changes at steady-state with a minimal parameterisation. Results and Conclusion In our case study, we successfully applied the PBN approach to model and analyse the deregulated Platelet-Derived Growth Factor (PDGF) signalling pathway in Gastrointestinal Stromal Tumour (GIST). We experimentally determined a rich and accurate dataset of steady-state profiles of selected downstream kinases of PDGF-receptor-alpha mutants in combination with inhibitor treatments. Applying the tool optPBN, we fitted a literature-derived candidate network model to the training dataset consisting of single perturbation conditions. Model analysis suggested several important crosstalk interactions. The validity of these predictions was further investigated experimentally pointing to relevant ongoing crosstalk from PI3K to MAPK signalling in tumour cells. The refined model was evaluated with a validation dataset comprising multiple perturbation conditions. The model thereby showed excellent performance allowing to quantitatively predict the combinatorial responses from the individual treatment results in this cancer setting. The established optPBN pipeline is also widely applicable to gain a better understanding of other signalling networks at steady-state in a context-specific fashion.	[Trairatphisan, Panuwat; Wiesinger, Monique; Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, Luxembourg, Luxembourg; [Bahlawane, Christelle; Haan, Serge] Univ Luxembourg, Life Sci Res Unit, Mol Dis Mech Grp, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg	Sauter, T (corresponding author), Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, Luxembourg, Luxembourg.	thomas.sauter@uni.lu	Bahlawane, Christelle/AAB-7943-2020; Christelle, Bahlawane/A-8758-2013	Trairatphisan, Panuwat/0000-0001-9015-5855; Sauter, Thomas/0000-0001-8225-2954; Bahlawane, Christelle/0000-0003-2728-2397	University of Luxembourg [F1R-LSC-PUL-09PDGF, F1R-LSC-PUL-11PDGF]; Fonds National de la Recherche Luxembourg (AFR) [1233900]	University of Luxembourg; Fonds National de la Recherche Luxembourg (AFR)(Luxembourg National Research Fund)	This work was supported by the grants F1R-LSC-PUL-09PDGF and F1R-LSC-PUL-11PDGF of the University of Luxembourg. Panuwat Trairatphisan is a recipient of fellowships allocated by the Fonds National de la Recherche Luxembourg (AFR grant number 1233900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bachmann J, 2012, J INTERN MED, V271, P155, DOI 10.1111/j.1365-2796.2011.02492.x; Bahlawane C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0096-8; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bazenet CE, 1996, MOL CELL BIOL, V16, P6926; Bradshaw R, 2009, HDB CELL SIGNALLING; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 2014, J NEUROIMMUNE PHARM, V9, P69, DOI 10.1007/s11481-013-9484-2; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; ISHIZUKA T, 1995, DIABETES RES CLIN PR, V29, P143, DOI 10.1016/0168-8227(95)01111-0; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Konrath F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003528; Lahdesmaki H, 2006, SIGNAL PROCESS, V86, P814, DOI 10.1016/j.sigpro.2005.06.008; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10305; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lommel MJ, 2016, FASEB J, V30, P1218, DOI 10.1096/fj.15-276311; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Markevich N. I., 2004, Systems Biology, V1, P104, DOI 10.1049/sb:20045003; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; MIRANDA EN, 1989, EUROPHYS LETT, V10, P293, DOI 10.1209/0295-5075/10/4/002; Mizera A, 2016, TECHNICAL REPORT; Park HS, 2012, EXPERT SYST APPL, V39, P4240, DOI 10.1016/j.eswa.2011.09.110; Qixia Yuan, 2012, Transactions on Computational Systems Biology XIV. Special Issue on Computational Models for Cell Processes, P151, DOI 10.1007/978-3-642-35524-0_7; Rammohan A, 2013, WORLD J GASTRO ONCOL, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Rangamani P, 2007, J BIOSCIENCES, V32, P157, DOI 10.1007/s12038-007-0014-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Sakhanenko NA, 2012, J COMPUT BIOL, V19, P316, DOI 10.1089/cmb.2011.0234; Sakhanenko NA, 2010, J COMPUT BIOL, V17, P1491, DOI 10.1089/cmb.2010.0044; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Tan Christopher B, 2012, ISRN Gastroenterol, V2012, P595968, DOI 10.5402/2012/595968; Trairatphisan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098001; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wang Zhixiang, 2002, Mol Interv, V2, P352, DOI 10.1124/mi.2.6.352; YU JC, 1994, J CELL BIOL, V127, P479, DOI 10.1083/jcb.127.2.479; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	52	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156223	10.1371/journal.pone.0156223	http://dx.doi.org/10.1371/journal.pone.0156223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232499	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000015
J	Dinh, DM; Ramadass, B; Kattula, D; Sarkar, R; Braunstein, P; Tai, A; Wanke, CA; Hassoun, S; Kane, AV; Naumova, EN; Kang, G; Ward, HD				Dinh, Duy M.; Ramadass, Balamurugan; Kattula, Deepthi; Sarkar, Rajiv; Braunstein, Philip; Tai, Albert; Wanke, Christine A.; Hassoun, Soha; Kane, Anne V.; Naumova, Elena N.; Kang, Gagandeep; Ward, Honorine D.			Longitudinal Analysis of the Intestinal Microbiota in Persistently Stunted Young Children in South India	PLOS ONE			English	Article							HUMAN GUT MICROBIOME; RISK-FACTORS; DEVELOPING-COUNTRIES; LOW-INCOME; BACTERIAL; UNDERNUTRITION; OVERWEIGHT; DIARRHEA; VELLORE; IMPACT	Stunting or reduced linear growth is very prevalent in low-income countries. Recent studies have demonstrated a causal relationship between alterations in the gut microbiome and moderate or severe acute malnutrition in children in these countries. However, there have been no primary longitudinal studies comparing the intestinal microbiota of persistently stunted children to that of non-stunted children in the same community. In this pilot study, we characterized gut microbial community composition and diversity of the fecal microbiota of 10 children with low birth weight and persistent stunting (cases) and 10 children with normal birth weight and no stunting (controls) from a birth cohort every 3 months up to 2 years of age in a slum community in south India. There was an increase in diversity indices (P <0.0001) with increasing age in all children. However, there were no differences in diversity indices or in the rates of their increase with increasing age between cases and controls. The percent relative abundance of the Bacteroidetes phylum was higher in stunted compared to control children at 12 months of age (P = 0.043). There was an increase in the relative abundance of this phylum with increasing age in all children (P = 0.0380) with no difference in the rate of increase between cases and controls. There was a decrease in the relative abundance of Proteobacteria (P = 0.0004) and Actinobacteria (P = 0.0489) with increasing age in cases. The microbiota of control children was enriched in probiotic species Bifidobacterium longum and Lactobacillus mucosae, whereas that of stunted children was enriched in inflammogenic taxa including those in the Desulfovibrio genus and Campylobacterales order. Larger, longitudinal studies on the compositional and functional maturation of the microbiome in children are needed.	[Dinh, Duy M.; Wanke, Christine A.; Kane, Anne V.; Ward, Honorine D.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Dinh, Duy M.; Wanke, Christine A.; Naumova, Elena N.; Kang, Gagandeep; Ward, Honorine D.] Tufts Univ, Sch Med, Dept Publ Hlth, Boston, MA 02111 USA; [Dinh, Duy M.; Wanke, Christine A.; Naumova, Elena N.; Kang, Gagandeep; Ward, Honorine D.] Tufts Univ, Sch Med, Dept Community Med, Boston, MA 02111 USA; [Tai, Albert; Kang, Gagandeep] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Ramadass, Balamurugan; Kattula, Deepthi; Sarkar, Rajiv; Wanke, Christine A.; Naumova, Elena N.; Ward, Honorine D.] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Braunstein, Philip; Hassoun, Soha] Tufts Univ, Sch Engn, Dept Comp Sci, Medford, MA 02155 USA; [Naumova, Elena N.] Tufts Univ, Gerald J & Dorothy R Friedman Sch Nutr Sci & Poli, Boston, MA 02111 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts University; Christian Medical College & Hospital (CMCH) Vellore; Tufts University; Tufts University	Ward, HD (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA.; Ward, HD (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth, Boston, MA 02111 USA.; Ward, HD (corresponding author), Tufts Univ, Sch Med, Dept Community Med, Boston, MA 02111 USA.; Ward, HD (corresponding author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	hward@tuftsmedicalcenter.org	Sarkar, Rajiv/AAU-7203-2021; Naumova, Elena/AAP-3395-2020; Ramadass, Balamurugan/AAW-5640-2021; Ramadass, Balamurugan/D-1420-2017; Ramadass, Balamurugan/AFV-7882-2022	Sarkar, Rajiv/0000-0003-0616-3129; Naumova, Elena/0000-0002-9562-4734; Ramadass, Balamurugan/0000-0002-8158-230X; Ramadass, Balamurugan/0000-0002-8158-230X; 	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI072222]; NIH NIAID [5T32 AI007389]; NIH Fogarty International Center (FIC) [5D43 TW009377]; NIH FIC [5D43 TW009377, 5D43 TW007392]; FOGARTY INTERNATIONAL CENTER [D43TW009377, D43TW007392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072222, T32AI007389] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The parent study was supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) 5R01AI072222 (HW). DD was supported by NIH NIAID 5T32 AI007389 (HW) and NIH Fogarty International Center (FIC) 5D43 TW009377 (GK, CW, HW). BR was supported by NIH FIC 5D43 TW007392 (GK). DK was supported by NIH FIC 5D43 TW007392 and 5D43 TW009377. RS was supported by NIH FIC 5D43 TW007392. The funders had no role in the study design, data collection/analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, NATIONAL FAMILY HEAL; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; David LA, 2015, MBIO, V6, DOI 10.1128/mBio.00381-15; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; El Taguri A, 2009, PUBLIC HEALTH NUTR, V12, P1141, DOI 10.1017/S1368980008003716; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Gordon JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004347; Gough EK, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0089-2; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Jiang Y, 2015, CHILD CARE HLTH DEV, V41, P45, DOI 10.1111/cch.12148; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kane AV, 2015, PEDIATR RES, V77, P256, DOI 10.1038/pr.2014.179; Kattula D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005404; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Keusch GT, 2014, CLIN INFECT DIS, V59, pS207, DOI 10.1093/cid/ciu485; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kotwani A, 2012, VALUE HEALTH, V15, pS116, DOI 10.1016/j.jval.2011.11.008; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2013, CELL HOST MICROBE, V14, P329, DOI 10.1016/j.chom.2013.08.006; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pop M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r76; Praveen P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0104-7; Rehman AM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-44; Rogawski ET, 2015, J PEDIATR-US, V167, P1096, DOI 10.1016/j.jpeds.2015.08.015; Rogawski ET, 2015, PEDIATR INFECT DIS J, V34, P583, DOI 10.1097/INF.0000000000000679; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schulfer A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004903; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sela DA, 2011, INT J FOOD MICROBIOL, V149, P58, DOI 10.1016/j.ijfoodmicro.2011.01.025; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; United Nations Children's Fund World Health Organization Bank. TW, 2012, JOINT CHILD MALN EST; Valeriano VD, 2014, J APPL MICROBIOL, V117, P485, DOI 10.1111/jam.12539; Vitolo MR, 2008, J PEDIAT-BRAZIL, V84, P251, DOI [10.2223/JPED.1776, 10.1590/S0021-75572008000300011]; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2006, WHO CHILD GROWTH STA; WHO UNICEF, 2004, LOW BIRTHW COUNTR RE; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zivkovic AM, 2011, P NATL ACAD SCI USA, V108, P4653, DOI 10.1073/pnas.1000083107	59	58	59	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155405	10.1371/journal.pone.0155405	http://dx.doi.org/10.1371/journal.pone.0155405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228122	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500018
J	Dong, Y; Luo, ZC; Yang, ZJ; Chen, L; Guo, YN; Branch, W; Zhang, J; Huang, H				Dong, Yu; Luo, Zhong-Cheng; Yang, Zu-Jing; Chen, Lu; Guo, Yu-Na; Branch, Ware; Zhang, Jun; Huang, Hong			Is Cesarean Delivery Preferable in Twin Pregnancies at >=36 Weeks Gestation?	PLOS ONE			English	Article							PERINATAL-MORTALITY; NEONATAL OUTCOMES; PRETERM BIRTH; MODE; INCREASES	Background The optimal mode of delivery in twin pregnancies remains controversial. A recent randomized trial did not find any benefit of planned cesarean vs. vaginal delivery at 32-38 weeks gestation, but the trial was not powered to detect a moderate effect. We aimed to evaluate the impact of cesarean delivery on perinatal mortality and severe neonatal morbidity in twin pregnancies at >= 32 weeks through a large database exploration approach with the power to detect moderate risk differences. Methods In a retrospective birth cohort study using the U.S. matched multiple births, 1995-2000 (the available largest multiple birth dataset), we compared perinatal outcomes in twins (n = 181,810 pregnancies) delivered at 32-41 weeks gestation without congenital anomalies. The primary outcome was a composite of perinatal death and severe neonatal morbidity. Cox regression was used to estimate the adjusted hazard ratio (aHR) controlling for the propensity to cesarean delivery, fetal characteristics (sex, birth weight, birth weight discordance, same-sex twin or not) and twin-cluster level dependence. Prospective risks were calculated using the fetuses-at-risk denominators. Results The overall rates of the primary outcome were slightly lower in intended cesarean (6.20%) vs. vaginal (6.45%) deliveries. The aHRs of the primary outcome were in favor of vaginal delivery at 32 (aHR = 1.06, p = 0.03) or 33 (aHR = 1.22, p<0.001) weeks, neutral at 34-35 weeks, but in favor of cesarean delivery at 36 (aHR = 0.94, p = 0.004), 37, 38 and 39+ weeks (aHR: 0.72 to 0.78, all p<0.001). The lower risk of the primary outcome for cesarean vs. vaginal deliveries at 36+ weeks of gestation remained when the analyses were restricted to different-sex (dichorionic) twins (aHR = 0.84, 95% CI 0.80-0.88). Conclusion Cesarean delivery may be beneficial for perinatal outcomes overall in twin pregnancies at >= 36 weeks gestation.	[Dong, Yu; Luo, Zhong-Cheng; Chen, Lu; Zhang, Jun; Huang, Hong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Minist Educ, Shanghai 200092, Peoples R China; [Luo, Zhong-Cheng] Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ, Canada; [Yang, Zu-Jing] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [Guo, Yu-Na] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China; [Branch, Ware] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT 84112 USA; [Branch, Ware] Intermt Hlth Care, Salt Lake City, UT USA	Shanghai Jiao Tong University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Utah System of Higher Education; University of Utah; Intermountain Healthcare	Luo, ZC; Huang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Childrens Environm Hlth, Xinhua Hosp,Minist Educ, Shanghai 200092, Peoples R China.; Luo, ZC (corresponding author), Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ, Canada.	zc_luo@yahoo.com; huanghong1507@gmail.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	National Natural Science Foundation of China (NSFC) [81571451]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a research grant from the National Natural Science Foundation of China (NSFC grant # 81571451 to ZCL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armson BA, 2006, OBSTET GYNECOL, V108, P556, DOI 10.1097/01.AOG.0000227747.37184.0a; Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939; Barzilay E, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.030; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2004, BIRTH COH LINK MATCH; Fell DB, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-103; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P89, DOI 10.1111/1471-0528.12635; Hoffmann E, 2012, ACTA OBSTET GYN SCAN, V91, P463, DOI 10.1111/j.1600-0412.2011.01356.x; Joseph KS, 2001, PEDIATRICS, V108, P1055, DOI 10.1542/peds.108.5.1055; Joseph KS, 2001, OBSTET GYNECOL, V98, P57, DOI 10.1016/S0029-7844(01)01394-1; KIELY JL, 1990, B NEW YORK ACAD MED, V66, P618; Luo ZC, 2006, OBSTET GYNECOL, V108, P1138, DOI 10.1097/01.AOG.0000238335.61452.89; Mathews T J, 2000, Natl Vital Stat Rep, V48, P1; Schmitz T, 2008, OBSTET GYNECOL, V111, P695, DOI 10.1097/AOG.0b013e318163c435; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Smith GCS, 2005, BJOG-INT J OBSTET GY, V112, P1139, DOI 10.1111/j.1471-0528.2005.00631.x; Wilcox LS, 1996, FERTIL STERIL, V65, P361, DOI 10.1016/S0015-0282(16)58100-X	16	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155692	10.1371/journal.pone.0155692	http://dx.doi.org/10.1371/journal.pone.0155692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227678	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500026
J	Iizuka, K; Yokomizo, T; Watanabe, N; Tanaka, Y; Osato, M; Takaku, T; Komatsu, N				Iizuka, Kazuhide; Yokomizo, Tomomasa; Watanabe, Naoki; Tanaka, Yosuke; Osato, Motomi; Takaku, Tomoiku; Komatsu, Norio			Lack of Phenotypical and Morphological Evidences of Endothelial to Hematopoietic Transition in the Murine Embryonic Head during Hematopoietic Stem Cell Emergence	PLOS ONE			English	Article							AORTIC ENDOTHELIUM; MOUSE EMBRYO; AGM REGION; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; RUNX1; CIRCULATION; GENERATION; LINEAGE; VASCULATURE	During mouse ontogeny, hematopoietic cells arise from specialized endothelial cells, i.e., the hemogenic endothelium, and form clusters in the lumen of arterial vessels. Hemogenic endothelial cells have been observed in several embryonic tissues, such as the dorsal aorta, the placenta and the yolk sac. Recent work suggests that the mouse embryonic head also produces hematopoietic stem cells (HSCs)/progenitors. However, a histological basis for HSC generation in the head has not yet been determined because the hematopoietic clusters and hemogenic endothelium in the head region have not been well characterized. In this study, we used whole-mount immunostaining and 3D confocal reconstruction techniques to analyze both c-Kit(+) hematopoietic clusters and Runx1(+) hemogenic endothelium in the whole-head vasculature. The number of c-Kit(+) hematopoietic cells was 20-fold less in the head arteries than in the dorsal aorta. In addition, apparent nascent hematopoietic cells, which are characterized by a "budding" structure and a Runx1(+) hemogenic endothelium, were not observed in the head. These results suggest that head HSCs may not be or are rarely generated from the endothelium in the same manner as aortic HSCs.	[Iizuka, Kazuhide; Yokomizo, Tomomasa; Watanabe, Naoki; Takaku, Tomoiku; Komatsu, Norio] Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan; [Yokomizo, Tomomasa; Osato, Motomi] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Tanaka, Yosuke] RIKEN, Ctr Dev Biol, Lab Stem Cell Biol, Kobe, Hyogo, Japan; [Osato, Motomi] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Osato, Motomi] Natl Univ Singapore, Dept Paediat, Singapore 117548, Singapore	Juntendo University; Kumamoto University; RIKEN; National University of Singapore; National University of Singapore	Yokomizo, T; Takaku, T (corresponding author), Juntendo Univ, Sch Med, Dept Hematol, Tokyo 113, Japan.; Yokomizo, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	tmyokomi@kumamoto-u.ac.jp; ttakaku@juntendo.ac.jp	Osato, Motomi/N-5056-2014	Osato, Motomi/0000-0003-3982-9054	Research Institute for Diseases of Old Age; Center for Biomedical Research Resources at the Juntendo University School of Medicine	Research Institute for Diseases of Old Age; Center for Biomedical Research Resources at the Juntendo University School of Medicine	This work was funded by Research Institute for Diseases of Old Age and the Center for Biomedical Research Resources at the Juntendo University School of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bee T, 2010, BLOOD, V115, P3042, DOI 10.1182/blood-2009-08-238626; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Dieterlen-Lievre F, 2007, CR BIOL, V330, P504, DOI 10.1016/j.crvi.2007.05.003; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Li ZA, 2012, CELL STEM CELL, V11, P663, DOI 10.1016/j.stem.2012.07.004; Lopez MLSS, 2003, AM J PHYSIOL-REG I, V284, pR1126, DOI 10.1152/ajpregu.00543.2002; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2569; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Tanaka Y, 2014, CELL REP, V8, P31, DOI 10.1016/j.celrep.2014.05.055; Tanaka Y, 2012, P NATL ACAD SCI USA, V109, P4515, DOI 10.1073/pnas.1115828109; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Wilson YM, 2004, DEVELOPMENT, V131, P6153, DOI 10.1242/dev.01533; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; You LR, 2005, NATURE, V435, P98, DOI 10.1038/nature03511; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156427	10.1371/journal.pone.0156427	http://dx.doi.org/10.1371/journal.pone.0156427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227884	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500134
J	Kumbhar, BV; Borogaon, A; Panda, D; Kunwar, A				Kumbhar, Bajarang Vasant; Borogaon, Anubhaw; Panda, Dulal; Kunwar, Ambarish			Exploring the Origin of Differential Binding Affinities of Human Tubulin Isotypes alpha beta II, alpha beta III and alpha beta IV for DAMA-Colchicine Using Homology Modelling, Molecular Docking and Molecular Dynamics Simulations	PLOS ONE			English	Article							BIOMOLECULAR SIMULATIONS; MUTATIONS; RESISTANCE; EXPRESSION; INSIGHT; SITE; MICROTUBULES; CHEMOTHERAPY; MECHANISM; KINETICS	Tubulin isotypes are found to play an important role in regulating microtubule dynamics. The isotype composition is also thought to contribute in the development of drug resistance as tubulin isotypes show differential binding affinities for various anti-cancer agents. Tubulin isotypes alpha beta(III) and alpha beta(IV) show differential binding affinity for colchicine. However, the origin of differential binding affinity is not well understood at the molecular level. Here, we investigate the origin of differential binding affinity of a colchicine analogue N-deacetyl-N-(2-mercaptoacetyl)-colchicine (DAMA-colchicine) for human alpha beta(II), alpha beta(III) and alpha beta(IV) isotypes, employing sequence analysis, homology modeling, molecular docking, molecular dynamics simulation and MM-GBSA binding free energy calculations. The sequence analysis study shows that the residue compositions are different in the colchicine binding pocket of apii and , alpha beta(III) whereas no such difference is present in alpha beta(IV) tubulin isotypes. Further, the molecular docking and molecular dynamics simulations results show that residue differences present at the colchicine binding pocket weaken the bonding interactions and the correct binding of DAMA-colchicine at the interface of apii and alpha beta(III) tubulin isotypes. Post molecular dynamics simulation analysis suggests that these residue variations affect the structure and dynamics of apii and alpha beta(III) tubulin isotypes, which in turn affect the binding of DAMA-colchicine. Further, the binding free-energy calculation shows that alpha beta IV tubulin isotype has the highest binding free-energy and apiii has the lowest binding free-energy for DAMA-colchicine. The order of binding free-energy for DAMA-colchicine is alpha beta(IV) similar or equal to alpha beta(II) alpha beta(III). Thus, our computational approaches provide an insight into the effect of residue variations on differential binding of apii, apiii and apiv tubulin isotypes with DAMA-colchicine and may help to design new analogues with higher binding affinities for tubulin isotypes.	[Kumbhar, Bajarang Vasant; Borogaon, Anubhaw; Panda, Dulal; Kunwar, Ambarish] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumbhar, BV (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	akunwar@iitb.ac.in	Kunwar, Ambarish/AAD-3618-2022; Kumbhar, Bajarang/AAR-3309-2020	Kunwar, Ambarish/0000-0002-8671-7816; Kumbhar, Bajarang/0000-0002-3839-9809	Indian Institute of Technology Bombay; DAE-SRC fellowship; Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award, New Delhi, India [BT/06/IYBA/2012]	Indian Institute of Technology Bombay; DAE-SRC fellowship; Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award, New Delhi, India	BVK is supported by the Postdoctoral Fellowship at Indian Institute of Technology Bombay. DP is supported by a DAE-SRC fellowship. AK is supported by Department of Biotechnology, Govt. of India, Innovative Young Biotechnologist Award (Grant Number BT/06/IYBA/2012), New Delhi, India.	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; BAI RL, 1989, BIOCHEMISTRY-US, V28, P5606, DOI 10.1021/bi00439a040; BANERJEE A, 1992, J BIOL CHEM, V267, P13335; BANERJEE A, 1994, J BIOL CHEM, V269, P10324; Banerjee S, 1997, BIOCHEMISTRY-US, V36, P5600, DOI 10.1021/bi962648n; Berrieman HK, 2004, LANCET ONCOL, V5, P158, DOI 10.1016/S1470-2045(04)01411-1; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Case D.A., 2012, AMBER 12 REFERENCE M, P350; Chakraborti S, 2012, BIOCHEMISTRY-US, V51, P7138, DOI 10.1021/bi300474q; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dumortier C, 1997, BIOCHEM J, V327, P685, DOI 10.1042/bj3270685; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Ge Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035941; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; HASTIE SB, 1991, PHARMACOL THERAPEUT, V51, P377, DOI 10.1016/0163-7258(91)90067-V; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jani V, 2014, J MOL MODEL, P20; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Karthick V, 2014, CELL BIOCHEM BIOPHYS, V68, P291, DOI 10.1007/s12013-013-9709-2; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liao SY, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2070-6; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Ma C, 2007, MOL BIOL CELL, V18, P4711, DOI 10.1091/mbc.E07-04-0379; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Natarajan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042351; Perakyla M, 2001, PROTEIN ENG, V14, P753, DOI 10.1093/protein/14.10.753; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Rai A, 2013, BIOCHEM PHARMACOL, V86, P378, DOI 10.1016/j.bcp.2013.05.024; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoshi S, 2014, J COMPUT AID MOL DES, V28, P751, DOI 10.1007/s10822-014-9756-9; Sharma S, 2010, BIOCHEMISTRY-US, V49, P2932, DOI 10.1021/bi100159p; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tseng CY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-131; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; Varzhabetyan LR, 2012, MOL BIOL+, V46, P316, DOI 10.1134/S0026893312020185; Verdier-Pinard P, 2005, BIOCHEMISTRY-US, V44, P15858, DOI 10.1021/bi051004p; Zhang YL, 2013, ONCOL LETT, V6, P220, DOI 10.3892/ol.2013.1323	48	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156048	10.1371/journal.pone.0156048	http://dx.doi.org/10.1371/journal.pone.0156048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227832	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500058
J	Wang, RX; Jiao, HC; Zhao, JP; Wang, XJ; Lin, H				Wang, Ruxia; Jiao, Hongchao; Zhao, Jingpeng; Wang, Xiaojuan; Lin, Hai			Glucocorticoids Enhance Muscle Proteolysis through a Myostatin-Dependent Pathway at the Early Stage	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; UP-REGULATION; ATROPHY; HYPERTROPHY; FOLLISTATIN; MECHANISMS; GENE; CORTICOSTERONE	Myostatin, a member of the TGF-beta superfamily of secreted proteins, is expressed primarily in skeletal muscle. It negatively regulates muscle mass and is associated with glucocorticoid-induced muscle atrophy. However, it remains unclear whether myostatin is involved in glucocorticoid-induced muscle protein turnover. The aim of the present study was to investigate the role of myostatin in protein metabolism during dexamethasone (DEX) treatment. Protein synthesis rates and the expression of the genes for myostatin, ubiquitin-proteasome atrogin-1, MuRF1, FoxO1/3a and mTOR/p70S6K were determined. The results show that DEX decreased (P<0.05) protein synthesis rates while increasing the abundance of myostatin. DEX increased (P<0.05) the level of phospho-FoxO1/3a (Thr 24/32) and the expression of MuRF1. In contrast, DEX treatment had no detectable effect on atrogin-1 protein levels (P>0.05). The phosphorylation levels of mTOR and p70S6K were decreased by DEX treatment (P<0.05). Follistatin treatment inhibited the DEX-induced increase in myostatin (P<0.05) and the activation of phosphor-FoxO1/3a (Thr 24/32) (P<0.05) and MuRF1 (P<0.05). Follistatin treatment had no influence on the protein synthesis rate or on the phosphorylation levels of mTOR (Ser 2448) and p70S6K (Thr 389) (P>0.05). In conclusion, the present study suggests that the myostatin signalling pathway is associated with glucocorticoid-induced muscle protein catabolism at the beginning of exposure. Myostatin is not a main pathway associated with the suppression of muscle protein synthesis by glucocorticoids.	[Wang, Ruxia; Jiao, Hongchao; Zhao, Jingpeng; Wang, Xiaojuan; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University	Lin, H (corresponding author), Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China.	hailin@sdau.edu.cn			National Basic Research Program of China [2012CB124706]; National Natural Science Foundation of China [31272467, 31472114]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by 2012CB124706, the National Basic Research Program of China ( http://www.most.gov.cn/) and 31272467 and 31472114, the National Natural Science Foundation of China ( http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, AM J PHYSIOL-CELL PH, V300, pC124, DOI 10.1152/ajpcell.00142.2010; Allen DL, 2010, AM J PHYSIOL-REG I, V299, pR889, DOI 10.1152/ajpregu.00296.2010; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Barbe C, 2015, AM J PHYSIOL-ENDOC M, V309, pE557, DOI 10.1152/ajpendo.00098.2015; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Castillero E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059726; Gao J, 2008, POULTRY SCI, V87, P1609, DOI 10.3382/ps.2007-00007; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; GOLDBERG AL, 1980, FED PROC, V39, P31; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Liu XS, 2004, ANTICANCER RES, V24, P2697; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Macedo AG, 2016, STEROIDS, V107, P30, DOI 10.1016/j.steroids.2015.12.016; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosler S, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.262; Qin J, 2013, RES VET SCI, V94, P84, DOI 10.1016/j.rvsc.2012.07.018; Qin WP, 2014, BIOCHEM BIOPH RES CO, V450, P979, DOI 10.1016/j.bbrc.2014.06.080; Retamales A, 2015, BIOCHEM BIOPH RES CO, V464, P596, DOI 10.1016/j.bbrc.2015.07.018; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Salehian B, 1999, Endocr Pract, V5, P277; Salehian B, 2006, METABOLISM, V55, P1239, DOI 10.1016/j.metabol.2006.05.009; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; TOMAS FM, 1984, BIOCHEM J, V220, P469, DOI 10.1042/bj2200469; Tsuchida K, 2006, MINI-REV MED CHEM, V6, P1255, DOI 10.2174/138955706778742759; Tsuchida K, 2006, EXPERT OPIN BIOL TH, V6, P147, DOI 10.1517/14712598.6.2.147; Umeki D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128263; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Yuan L, 2008, BRIT POULTRY SCI, V49, P487, DOI 10.1080/00071660802251731; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008	53	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156225	10.1371/journal.pone.0156225	http://dx.doi.org/10.1371/journal.pone.0156225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227776	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500087
J	Wiese, DM; Horst, SN; Brown, CT; Allaman, MM; Hodges, ME; Slaughter, JC; Druce, JP; Beaulieu, DB; Schwartz, DA; Wilson, KT; Coburn, LA				Wiese, Dawn M.; Horst, Sara N.; Brown, Caroline T.; Allaman, Margaret M.; Hodges, Mallary E.; Slaughter, James C.; Druce, Jennifer P.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.; Coburn, Lori A.			Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative Colitis	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PHOSPHOLIPIDS; BOWEL-DISEASE; PROSPECTIVE COHORT; LINOLEIC-ACID; PLASMA; LEUKOTRIENE-B4; EXPRESSION; ETIOLOGY; PATTERN; ENZYMES	Background and Aims Ulcerative colitis (UC) is associated with increased dietary intake of fat and n-6 polyunsaturated fatty acids (PUFA). Modification of fat metabolism may alter inflammation and disease severity. Our aim was to assess differences in dietary and serum fatty acid levels between control and UC subjects and associations with disease activity and inflammatory cytokines. Methods Dietary histories, serum, and colonic tissue samples were prospectively collected from 137 UC subjects and 38 controls. Both histologic injury and the Mayo Disease Activity Index were assessed. Serum and tissue cytokines were measured by Luminex assay. Serum fatty acids were obtained by gas chromatography. Results UC subjects had increased total fat and oleic acid (OA) intake, but decreased arachidonic acid (AA) intake vs controls. In serum, there was less percent saturated fatty acid (SFA) and AA, with higher monounsaturated fatty acids (MUFA), linoleic acid, OA, eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA) in UC. Tissue cytokine levels were directly correlated with SFA and inversely correlated with PUFA, EPA, and DPA in UC subjects, but not controls. 5-aminosalicylic acid therapy blunted these associations. Conclusions In summary, we found differences in serum fatty acids in UC subjects that correlated with pro-inflammatory tissue cytokines. We propose that fatty acids may affect cytokine production and thus be immunomodulatory in UC.	[Wiese, Dawn M.; Horst, Sara N.; Wilson, Keith T.; Coburn, Lori A.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Wiese, Dawn M.; Horst, Sara N.; Brown, Caroline T.; Allaman, Margaret M.; Druce, Jennifer P.; Beaulieu, Dawn B.; Schwartz, David A.; Wilson, Keith T.; Coburn, Lori A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Hodges, Mallary E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Slaughter, James C.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Druce, Jennifer P.] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; State University System of Florida; University of Central Florida	Wilson, KT (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.; Wilson, KT (corresponding author), Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA.	keith.wilson@vanderbilt.edu	Allaman, Margaret/GNO-9854-2022	Slaughter, James/0000-0002-8770-980X; Allaman, Margaret M./0000-0002-2803-1365; Coburn, Lori/0000-0003-3249-9806	National Institutes of Health [R01AT004821, 3R01AT004821-02S1, 5T32DK007673, P30DK058404, UL1TR000445, DK20593]; Department of Veterans Affairs [1IK2BX002126-01]; Vanderbilt Physician Scientist Development Award; Thomas F. Frist Sr. Endowment; NATIONAL CANCER INSTITUTE [R01CA190612, P01CA116087] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, T32DK007673, T35DK007383] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002126, I01BX001453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Vanderbilt Physician Scientist Development Award; Thomas F. Frist Sr. Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health: R01AT004821, 3R01AT004821-02S1 to KTW, 5T32DK007673 to LAC, P30DK058404 (Vanderbilt Digestive Disease Research Center), UL1TR000445 (Vanderbilt CTSA.), DK20593 (Hormone Assay & Analytical Services Core - Vanderbilt Diabetes Research and Training Center); Department of Veterans Affairs 1IK2BX002126-01 to LAC; and a Vanderbilt Physician Scientist Development Award to LAC. Additional support was provided by the Thomas F. Frist Sr. Endowment to KTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab L, 2003, J NUTR, V133, p925S, DOI 10.1093/jn/133.3.925S; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bedard A, 2012, BRIT J NUTR, V108, P1428, DOI 10.1017/S0007114511006969; Belluzzi A, 2000, AM J CLIN NUTR, V71, p339S, DOI 10.1093/ajcn/71.1.339s; Coburn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082300; Dai LY, 2015, DIGEST DIS SCI, V60, P1236, DOI 10.1007/s10620-014-3478-7; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; de Silva PSA, 2014, EUR J GASTROEN HEPAT, V26, P11, DOI 10.1097/MEG.0b013e328365c372; de Silva PSA, 2010, GASTROENTEROLOGY, V139, P1912, DOI 10.1053/j.gastro.2010.07.065; ESTEVECOMAS M, 1993, GUT, V34, P1370, DOI 10.1136/gut.34.10.1370; ESTEVECOMAS M, 1992, GUT, V33, P1365, DOI 10.1136/gut.33.10.1365; FernandezBanares F, 1997, CLIN NUTR, V16, P177, DOI 10.1016/S0261-5614(97)80003-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaya DR, 2006, LANCET, V367, P1271, DOI 10.1016/S0140-6736(06)68345-1; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hettmansperger T, 1998, KENDALLS LIB STAT, V5, P467; Jupp J, 2007, INFLAMM BOWEL DIS, V13, P537, DOI 10.1002/ibd.20094; Kleinbaum D.G., 2013, APPL REGRESSION ANAL, Vxix; LOBOS EA, 1987, DIGEST DIS SCI, V32, P1380, DOI 10.1007/BF01296664; Marion-Letellier R, 2013, INFLAMM BOWEL DIS, V19, P205, DOI [10.1097/MIB.0b013e3182810122, 10.1002/ibd.23001]; Masoodi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076532; MORRISON WR, 1964, J LIPID RES, V5, P600; Patel PS, 2010, AM J CLIN NUTR, V92, P1214, DOI 10.3945/ajcn.2010.29182; Pearl DS, 2014, J CROHNS COLITIS, V8, P70, DOI 10.1016/j.crohns.2013.03.013; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; STENSON WF, 1990, SCAND J GASTROENTERO, V25, P13, DOI 10.3109/00365529009091903; Tjonneland A, 2009, GUT, V58, P1606, DOI 10.1136/gut.2008.169078; Ueda Y, 2008, NUTR RES, V28, P239, DOI 10.1016/j.nutres.2008.02.005	32	33	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156387	10.1371/journal.pone.0156387	http://dx.doi.org/10.1371/journal.pone.0156387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227540	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500130
J	Maeda, J; Froning, CE; Brents, CA; Rose, BJ; Thamm, DH; Kato, TA				Maeda, Junko; Froning, Coral E.; Brents, Colleen A.; Rose, Barbara J.; Thamm, Douglas H.; Kato, Takamitsu A.			Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; RADIATION-INDUCED APOPTOSIS; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; HUMAN TUMOR; PROGNOSTIC-FACTOR; DNA; RADIOTHERAPY; SENSITIVITY; EXPRESSION	Canine cancer cell lines have progressively been developed, but are still underused resources for radiation biology research. Measurement of the cellular intrinsic radiosensitivity is important because understanding the difference may provide a framework for further elucidating profiles for prediction of radiation therapy response. Our studies have focused on characterizing diverse canine cancer cell lines in vitro and understanding parameters that might contribute to intrinsic radiosensitivity. First, intrinsic radiosensitivity of 27 canine cancer cell lines derived from ten tumor types was determined using a clonogenic assay. The 27 cell lines had varying radiosensitivities regardless tumor type (survival fraction at 2 Gy, SF2 = 0.19-0.93). In order to understand parameters that might contribute to intrinsic radiosensitivity, we evaluated the relationships of cellular radiosensitivity with basic cellular characteristics of the cell lines. There was no significant correlation of SF2 with S-phase fraction, doubling time, chromosome number, ploidy, or number of metacentric chromosomes, while there was a statistically significant correlation between SF2 and plating efficiency. Next, we selected the five most radiosensitive cell lines as the radiosensitive group and the five most radioresistant cell lines as the radioresistant group. Then, we evaluated known parameters for cell killing by ionizing radiation, including radiation-induced DNA double strand break (DSB) repair and apoptosis, in the radiosensitive group as compared to the radioresistant group. High levels of residual gamma-H2AX foci at the sites of DSBs were present in the four out of the five radiosensitive canine cancer cell lines. Our studies suggested that substantial differences in intrinsic radiosensitivity exist in canine cancer cell lines, and radiation-induced DSB repair was related to radiosensitivity, which is consistent with previous human studies. These data may assist further investigations focusing on the detection of DSB for predicting individual response to radiation therapy for dogs, regardless of tumor type.	[Maeda, Junko; Froning, Coral E.; Brents, Colleen A.; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Rose, Barbara J.; Thamm, Douglas H.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Kato, TA (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	Takamitsu.Kato@Colostate.edu	Thamm, Douglas H/I-5976-2013; Thamm, Douglas/AAG-3672-2020; Kato, Takamitsu A/D-7969-2015	Thamm, Douglas H/0000-0002-8914-7767; Kato, Takamitsu/0000-0002-6263-600X	Dr. Akiko Ueno Radiobiology Fund (TAK)	Dr. Akiko Ueno Radiobiology Fund (TAK)	Funding was provided by Dr. Akiko Ueno Radiobiology Fund (TAK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge DR, 1998, CANCER RES, V58, P2817; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Begg AC, 2009, INT J RADIAT BIOL, V85, P825, DOI 10.3109/09553000903184366; Bjork-Eriksson T, 2000, INT J RADIAT ONCOL, V46, P13, DOI 10.1016/S0360-3016(99)00373-9; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; BUSH C, 1993, BRIT J CANCER, V67, P102, DOI 10.1038/bjc.1993.17; Chaurasia M, 2016, FREE RADICAL RES, V50, P273, DOI 10.3109/10715762.2015.1129534; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dunne AL, 2003, BRIT J CANCER, V89, P2277, DOI 10.1038/sj.bjc.6601427; Fowlers J, 2016, VET COMP ON IN PRESS; Fujii Y, 2010, ONCOL REP, V23, P199, DOI 10.3892/or_00000623; FURTH EE, 1981, ANAL BIOCHEM, V110, P1, DOI 10.1016/0003-2697(81)90103-2; Genet SC, 2013, J CELL PHYSIOL, V228, P1473, DOI 10.1002/jcp.24302; Hall JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086329; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Mahrhofer H, 2006, INT J RADIAT ONCOL, V64, P573, DOI 10.1016/j.ijrobp.2005.09.037; Matt S, 2016, CELL MOL LIFE SCI, V73, P2829, DOI 10.1007/s00018-016-2130-4; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Paoloni MC, 2007, VET CLIN N AM-SMALL, V37, P1023, DOI 10.1016/j.cvsm.2007.08.003; Peng YL, 2002, CANCER RES, V62, P6400; Reimann N, 1999, J NATL CANCER I, V91, P1688, DOI 10.1093/jnci/91.19.1688; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHWARTZ JL, 1992, RADIAT RES, V129, P96, DOI 10.2307/3577908; Schwartz JL, 1999, BRIT J CANCER, V79, P744, DOI 10.1038/sj.bjc.6690119; Schwartz JL, 1998, RADIAT RES, V149, P319, DOI 10.2307/3579692; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; TOBEY RA, 1971, CANCER RES, V31, P46; Torres-Roca Javier F, 2008, Cancer Control, V15, P151; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P34, DOI 10.1016/j.mrfmmm.2005.01.020; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEST CML, 1995, INT J RADIAT ONCOL, V31, P841, DOI 10.1016/0360-3016(94)00508-7; West CML, 1997, BRIT J CANCER, V76, P1184, DOI 10.1038/bjc.1997.531; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040	40	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156689	10.1371/journal.pone.0156689	http://dx.doi.org/10.1371/journal.pone.0156689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257868	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700107
J	Silva-Andrade, HL; de Andrade, LP; Muniz, LS; Telino, WR; Albuquerque, UP; Lyra-Neves, RM				Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Muniz, Lauana Souza; Telino-Junior, Wallace Rodrigues; Albuquerque, Ulysses Paulino; Lyra-Neves, Rachel Maria			Do Farmers Using Conventional and Non-Conventional Systems of Agriculture Have Different Perceptions of the Diversity of Wild Birds? Implications for Conservation	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; PEOPLE; AREAS	Farmers' perceptions of birds' interactions with agricultural production systems are fundamental to species conservation efforts. In the present study, we evaluated the perceptions of birds held by farmers who engage in conventional and non-conventional agricultural production processes and the implications of potential differences in these perceptions on species conservation. To accomplish this, data were collected using questionnaires, semi-structured interviews, and other complementary sources of information gathered from 191 farmers in northeastern Brazil. Although some similarities were identified among the farmers in their perceptions and local ecological knowledge (LEK) of birds, differences existed between the conventional and non-conventional farmers in their attitudes toward, conflicts with, and usage of bird species. Compared to the conventional farmers, the non-conventional farmers could identify more bird species, possessed more favorable attitudes toward birds, and engaged in practices more beneficial to the conservation of avifauna. The perceptions that were identified were related to the type of agriculture practiced, and such perceptions may affect the conservation of bird species. Therefore, the adoption of certain agricultural practices has important implications for conservation. Our results indicate the need for investment in public policies, programs and actions that account for farmers' knowledge and perceptions. Such investments will contribute to the development and adoption of practices supporting wild bird conservation in agricultural areas.	[Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Telino-Junior, Wallace Rodrigues; Albuquerque, Ulysses Paulino; Lyra-Neves, Rachel Maria] Univ Fed Rural Pernambuco, Grad Program Ethnobiol & Nat Conservat PPGEtno, Dept Biol, Recife, PE, Brazil; [Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Telino-Junior, Wallace Rodrigues; Lyra-Neves, Rachel Maria] Univ Fed Rural Pernambuco, Garanhuns Campus, Garanhuns, PE, Brazil; [Muniz, Lauana Souza] Univ Fed Pernambuco, Grad Program Management Sustainable Local Dev, Recife, PE, Brazil; [Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Lab Ecol & Evolut Social Ecol Syst, Dept Biol, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE)	Silva-Andrade, HL (corresponding author), Univ Fed Rural Pernambuco, Grad Program Ethnobiol & Nat Conservat PPGEtno, Dept Biol, Recife, PE, Brazil.; Silva-Andrade, HL (corresponding author), Univ Fed Rural Pernambuco, Garanhuns Campus, Garanhuns, PE, Brazil.	horasaa@gmail.com	Albuquerque, Ulysses P/I-5037-2012	Albuquerque, Ulysses P/0000-0002-8131-8429; Silva-Andrade, Horasa/0000-0002-5366-6610; Pires de Andrade, Luciano/0000-0001-5818-711X	PPGEtno-UFRPE; LEA/UFRPE; Garanhuns campus at UFRPE; Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus; AGROFAMILIAR Vocational Technological Nucleus; Center at UFRPE/Garanhuns campus	PPGEtno-UFRPE; LEA/UFRPE; Garanhuns campus at UFRPE; Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus; AGROFAMILIAR Vocational Technological Nucleus; Center at UFRPE/Garanhuns campus	We are grateful to the farmers of the Catonho, Lacre, and Mine associations in Jupi, Pernambuco (Brazil), and all other partners and collaborators. We would also like to thank the PPGEtno-UFRPE, LEA/UFRPE, the Garanhuns campus at UFRPE, the Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus, and the AGROFAMILIAR Vocational Technological Nucleus and Center at UFRPE/Garanhuns campus for their support during the development of this research.	Albuquerque U. P., 2014, METHODS TECHNIQUES E, Vfirst, P1, DOI DOI 10.1007/978-1-4614-8636-7; Albuquerque UP, 2014, METHODS TECHNIQUES E, P451; Altieri M., 2012, AGROECOLOGIA UNICA E, V3a; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-12; Alves RRN, 2012, BIRD CONSERV INT, P1, DOI DOI 10.1017/S095927091200010X; [Anonymous], 2011, RELATORIOS TECNICOS; Ayres M, 2007, BIO ESTAT APLICACOES; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bolwing S., 2006, DANISH J GEOGR, V106, P115, DOI DOI 10.1080/00167223.2006.10649561; Caporal F, 2009, AGROECOLOGIA CIENCIA, V1ra; Costa Neto E., 2009, MANUAL ETNOZOOLOGIA; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Fernandes-Ferreira H, 2012, BIODIVERS CONSERV, V21, P221, DOI 10.1007/s10531-011-0179-9; Florentino Alissandra Trajano Nunes, 2007, Acta Bot. Bras., V21, P37, DOI 10.1590/S0102-33062007000100005; Fraser JA, 2011, ECON BOT, V65, P1, DOI 10.1007/s12231-010-9143-y; Freemark KE, 2001, BIOL CONSERV, V101, P337, DOI 10.1016/S0006-3207(01)00079-9; Frisch J.D., 2005, AVES BRASILEIRAS PLA; GLIESSMAN S. R., 2000, AGROECOLOGIA PROCESS; Goulart FF, 2013, AGR ECOSYST ENVIRON, V164, P114, DOI 10.1016/j.agee.2012.09.011; Goulart FF, 2011, AGROFOREST SYST, V82, P239, DOI 10.1007/s10457-011-9398-z; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Herzon I, 2007, J NAT CONSERV, V15, P10, DOI 10.1016/j.jnc.2006.08.001; IBGE, I BRAS GEOGR EST; ICMBio  Instituto Chico Mendes de ConservacAo da Biodiversidade, SUM EX PLAN AC NAC C; Jacobson SK, 2003, CONSERV BIOL, V17, P595, DOI 10.1046/j.1523-1739.2003.01472.x; Kai Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092931; Kaltenborn B.R.P., 2006, HUMAN DIMENSIONS WIL, V11, P397, DOI DOI 10.1080/10871200600984323; Leyequien E, 2010, BIOTROPICA, V42, P236, DOI 10.1111/j.1744-7429.2009.00553.x; Magurran A. E., 2004, MEASUREMENT BIOL DIV; Bezerra DMM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-3; Bezerra DMM, 2012, TROP CONSERV SCI, V5, P50, DOI 10.1177/194008291200500106; McMahon BJ, 2012, ECOL INDIC, V18, P676, DOI 10.1016/j.ecolind.2012.01.013; Medeiros PM, 2014, REV BRAS FARMACOGN, V24, P103, DOI 10.1016/j.bjp.2014.01.010; Nekaris KAI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069215; NOLAN J.M., 2001, J LINGUIST ANTHROPOL, V11, P240; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Primack RB., 2001, BIOL CONSERVACAO; Shen XL, 2012, BIOL CONSERV, V145, P160, DOI 10.1016/j.biocon.2011.10.027; Sick H, 2001, ORNITOLOGIA BRASILEI; Silva J.M.C., 2003, ECOLOGIA CONSERVACA, P237; Silva RW, 2010, ORNITOLOIGA CONSERVA, P505; Tavares Mendonca Livia Emanuelle, 2011, Sitientibus Serie Ciencias Biologicas, V11, P185; Teillard F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119674; Tobias J.A., 2013, KEY TOPICS CONSERVAT, P258; TOLEDO V.M., 2010, ETNOBIOLOGIA ETNOECO, P13; Weladji RB, 2003, ORYX, V37, P72, DOI 10.1017/S0030605303000140; Williams VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105397; Wood BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105203	49	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156307	10.1371/journal.pone.0156307	http://dx.doi.org/10.1371/journal.pone.0156307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243222	Green Submitted, gold, Green Published			2022-12-27	WOS:000377146100027
J	Lu, JH; Wu, PP; Zhang, XH; Feng, L; Dong, B; Chu, X; Liu, XF; Peng, DX; Liu, Y; Ma, HL; Hou, JB; Tang, YH				Lu, Jihu; Wu, Peipei; Zhang, Xuehua; Feng, Lei; Dong, Bin; Chu, Xuan; Liu, Xiufan; Peng, Daxin; Liu, Yuan; Ma, Huailiang; Hou, Jibo; Tang, Yinghua			Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; IMMUNE-RESPONSE; H5N1 VIRUSES; POULTRY; CHINA; PATHOGENICITY; INFECTION; IMMUNIZATION; STRATEGIES; PROTECTION	Combination of CVCVA5 adjuvant and commercial avian influenza (AI) vaccine has been previously demonstrated to provide good protection against different AI viruses in chickens. In this study, we further investigated the protective immunity of CVCVA5-adjuvanted oil-emulsion inactivated AI vaccine in chickens, ducks and geese. Compared to the commercial H5 inactivated vaccine, the H5-CVCVA5 vaccine induced significantly higher titers of hemaglutinin inhibitory antibodies in three lines of broiler chickens and ducks, elongated the antibody persistence periods in geese, elevated the levels of cross serum neutralization antibody against different clade and subclade H5 AI viruses in chicken embryos. High levels of mucosal antibody were detected in chickens injected with the H5 or H9-CVCA5 vaccine. Furthermore, cellular immune response was markedly improved in terms of increasing the serum levels of cytokine interferon-gamma and interleukine 4, promoting proliferation of splenocytes and upregulating cytotoxicity activity in both H5- and H9-CVCVA5 vaccinated chickens. Together, these results provide evidence that AI vaccines supplemented with CVCVA5 adjuvant is a promising approach for overcoming the limitation of vaccine strain specificity of protection.	[Lu, Jihu; Wu, Peipei; Zhang, Xuehua; Feng, Lei; Dong, Bin; Chu, Xuan; Hou, Jibo; Tang, Yinghua] Jiangsu Acad Agr Sci, Key Lab Vet Biol Engn & Technol, Natl Res Ctr Engn & Technol Vet Biol, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Liu, Xiufan; Peng, Daxin] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yuan] Georgia State Univ, Ctr Inflammat Immun & Infect, Dept Biol, Program Cellular Biol & Immunol, Atlanta, GA 30303 USA; [Ma, Huailiang] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Yangzhou University; University System of Georgia; Georgia State University; Emory University	Hou, JB; Tang, YH (corresponding author), Jiangsu Acad Agr Sci, Key Lab Vet Biol Engn & Technol, Natl Res Ctr Engn & Technol Vet Biol, Minist Agr, Nanjing, Jiangsu, Peoples R China.; Peng, DX (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	pengdx@yzu.edu.cn; houjibo@yahoo.com; tyinghua@yahoo.com	Tang, Yinghua/O-6038-2015; Ma, Huailiang/C-3403-2017; Peng, Daxin/AAJ-3476-2021; Feng, Lei/AAO-6967-2020		National Natural Science Foundation [31201904]; Special Fund for Agro-scientific Research in the Public Interest [201303046]; National High Technology Research and Development Program of China [2011AA10A213]; Central Finance Funds for Agro-technical Popularization [TG(14)067]; Independent Innovation of Agricultural Sciences Program of Jiangsu Province [CX(14)5045]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Central Finance Funds for Agro-technical Popularization; Independent Innovation of Agricultural Sciences Program of Jiangsu Province	This work was supported by the National Natural Science Foundation (31201904), Special Fund for Agro-scientific Research in the Public Interest (201303046), National High Technology Research and Development Program of China (2011AA10A213), Central Finance Funds for Agro-technical Popularization (TG(14)067) and the Independent Innovation of Agricultural Sciences Program of Jiangsu Province (CX(14)5045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chua Tze-Hoong, 2010, Influenza Res Treat, V2010, P489213, DOI 10.1155/2010/489213; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Forrest HL, 2013, INFLUENZA OTHER RESP, V7, P1194, DOI 10.1111/irv.12140; Hasegawa H, 2015, CURR TOP MICROBIOL, V386, P371, DOI 10.1007/82_2014_402; Kayali G, 2013, POULTRY SCI, V92, P114, DOI 10.3382/ps.2012-02637; Lee DH, 2011, POULTRY SCI, V90, P1020, DOI 10.3382/ps.2010-01258; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liu CG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-321; Mallick AI, 2012, VIRAL IMMUNOL, V25, P226, DOI 10.1089/vim.2011.0085; Middleton D, 2007, VIROLOGY, V359, P66, DOI 10.1016/j.virol.2006.08.046; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pfeiffer J, 2010, AVIAN DIS, V54, P262, DOI 10.1637/8715-031909-Reg.1; Poetri O, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-74; Santiago FW, 2011, VACCINE, V29, P8888, DOI 10.1016/j.vaccine.2011.09.069; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang YH, 2014, VET MICROBIOL, V172, P120, DOI 10.1016/j.vetmic.2014.05.007; Tang YH, 2009, AVIAN PATHOL, V38, P457, DOI 10.1080/03079450903349147; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Wu ZQ, 2010, POULTRY SCI, V89, P1136, DOI 10.3382/ps.2010-00695; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhang XJ, 2015, VET MICROBIOL, V175, P244, DOI 10.1016/j.vetmic.2014.12.011; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	29	7	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156573	10.1371/journal.pone.0156573	http://dx.doi.org/10.1371/journal.pone.0156573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232188	Green Submitted, Green Published, gold			2022-12-27	WOS:000376883000045
J	Tan, T; Ong, WS; Rajasekaran, T; Koo, KN; Chan, LL; Poon, D; Chowdhury, AR; Krishna, L; Kanesvaran, R				Tan, Tira; Ong, Whee Sze; Rajasekaran, Tanujaa; Koo, Khai Nee; Chan, Li Li; Poon, Donald; Chowdhury, Anupama Roy; Krishna, Lalit; Kanesvaran, Ravindran			Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients	PLOS ONE			English	Article							NUTRITIONAL HEALTH CHECKLIST; OLDER PATIENTS; ONCOLOGY; CHEMOTHERAPY; PREVALENCE; PREDICTORS; MORBIDITY; MORTALITY; CACHEXIA; VALIDITY	Purpose Elderly cancer patients are at increased risk for malnutrition. We aim to identify comprehensive geriatric assessment (CGA) based clinical factors associated with increased nutritional risk and develop a clinical scoring system to identify nutritional risk in elderly cancer patients. Patients and Methods CGA data was collected from 249 Asian patients aged 70 years or older. Nutritional risk was assessed based on the Nutrition Screening Initiative (NSI) checklist. Univariate and multivariate logistic regression analyses were applied to assess the association between patient clinical factors together with domains within the CGA and moderate to high nutritional risk. Goodness of fit was assessed using Hosmer-Lemeshow test. Discrimination ability was assessed based on the area under the receiver operating characteristics curve (AUC). Internal validation was performed using simulated datasets via bootstrapping. Results Among the 249 patients, 184 (74%) had moderate to high nutritional risk. Multivariate logistic regression analysis identified stage 3-4 disease (Odds Ratio [OR] 2.54; 95% CI, 1.14-5.69), ECOG performance status of 2-4 (OR 3.04; 95% CI, 1.57-5.88), presence of depression (OR 5.99; 95% CI, 1.99-18.02) and haemoglobin levels <12 g/dL (OR 3.00; 95% CI 1.54-5.84) as significant independent factors associated with moderate to high nutritional risk. The model achieved good calibration (Hosmer-Lemeshow test's p = 0.17) and discrimination (AUC = 0.80). It retained good calibration and discrimination (bias-corrected AUC = 0.79) under internal validation. Conclusion Having advanced stage of cancer, poor performance status, depression and anaemia were found to be predictors of moderate to high nutritional risk. Early identification of patients with these risk factors will allow for nutritional interventions that may improve treatment tolerance, quality of life and survival outcomes.	[Tan, Tira; Rajasekaran, Tanujaa; Chan, Li Li; Krishna, Lalit; Kanesvaran, Ravindran] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Ong, Whee Sze] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Koo, Khai Nee] Perdana Univ, Grad Sch Med, Selangor, Malaysia; [Poon, Donald] Raffles Canc Ctr, Singapore, Singapore; [Poon, Donald; Krishna, Lalit; Kanesvaran, Ravindran] Duke NUS Grad Med Sch, Singapore, Singapore; [Chowdhury, Anupama Roy] Changi Gen Hosp, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Perdana University; National University of Singapore; Changi General Hospital	Kanesvaran, R (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Kanesvaran, R (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	ravindran.kanesvaran@singhealth.com.sg		Kanesvaran, Ravindran/0000-0002-2351-881X	National Cancer Centre Singapore Research Fund [NRFGO08103]	National Cancer Centre Singapore Research Fund	This work was funded by the National Cancer Centre Singapore Research Fund Grant No. NRFGO08103 (to DP and RK). http://www.nccs.com.sg/GIVING/NCCRESEARCHFUND/Pages/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaldriks AA, 2013, BREAST, V22, P753, DOI 10.1016/j.breast.2013.01.011; Aapro M, 2014, ANN ONCOL, V25, P1492, DOI 10.1093/annonc/mdu085; Attar A, 2012, NUTR CANCER, V64, P535, DOI 10.1080/01635581.2012.670743; Balducci L, 2000, ONCOLOGY-NY, V14, P221; Barret M, 2011, ONCOLOGY-BASEL, V81, P395, DOI 10.1159/000335478; Beck AM, 1999, BRIT J NUTR, V81, P31, DOI 10.1017/S0007114599000860; Bozzetti F, 2012, SUPPORT CARE CANCER, V20, P1919, DOI 10.1007/s00520-012-1387-x; Bozzetti F, 2009, SUPPORT CARE CANCER, V17, P279, DOI 10.1007/s00520-008-0476-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daudt HML, 2012, SUPPORT CARE CANCER, V20, P1417, DOI 10.1007/s00520-011-1224-7; Davies Michelle, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS64, DOI 10.1016/j.ejon.2005.09.005; de Groot LCPGM, 1998, EUR J CLIN NUTR, V52, P877, DOI 10.1038/sj.ejcn.1600658; de Onis M., 2005, ENV BURD DIS SER, V12, P43; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Hopkinson J, 2006, J ADV NURS, V54, P304, DOI 10.1111/j.1365-2648.2006.03818.x; Isenring E, 2015, NUTRITION, V31, P594, DOI 10.1016/j.nut.2014.12.027; Jang RW, 2014, J ONCOL PRACT; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mancuso A, 2006, ANN ONCOL, V17, P146, DOI 10.1093/annonc/mdj038; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paillaud E, 2014, CLIN NUTR, V33, P330, DOI 10.1016/j.clnu.2013.05.014; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; Pressoir M, 2010, BRIT J CANCER, V102, P966, DOI 10.1038/sj.bjc.6605578; Prevost V, 2012, EUR J CANCER CARE, V21, P581, DOI 10.1111/j.1365-2354.2012.01363.x; Sahyoun NR, 1997, J AM DIET ASSOC, V97, P760, DOI 10.1016/S0002-8223(97)00188-0; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Sinnett Stephanie, 2010, Journal of Nutrition for the Elderly, V29, P393, DOI 10.1080/01639366.2010.521031; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Wells JL, 2006, CLIN INTERV AGING, V1, P67, DOI 10.2147/ciia.2006.1.1.67; Wie GA, 2010, NUTRITION, V26, P263, DOI 10.1016/j.nut.2009.04.013; WOLINSKY FD, 1990, J NUTR, V120, P1549, DOI 10.1093/jn/120.suppl_11.1549	41	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156008	10.1371/journal.pone.0156008	http://dx.doi.org/10.1371/journal.pone.0156008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27231951	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000012
J	Ali, F; Wharton, DA				Ali, Farman; Wharton, David A.			Ice-Active Substances from the Infective Juveniles of the Freeze Tolerant Entomopathogenic Nematode, Steinernema feltiae	PLOS ONE			English	Article							THERMAL HYSTERESIS PROTEINS; ANTARCTIC-NEMATODE; PANAGROLAIMUS-DAVIDI; COLD TOLERANCE; ANTIFREEZE PROTEINS; ECTOTHERMIC ANIMALS; RECRYSTALLIZATION; NUCLEATION; CRYOPROTECTANTS; INHIBITION	Steinernema feltiae is a moderately freezing tolerant nematode, that can withstand intracellular ice formation. We investigated recrystallization inhibition, thermal hysteresis and ice nucleation activities in the infective juveniles of S. feltiae. Both the splat cooling assay and optical recrystallometry indicate the presence of ice active substances that inhibit recrystallization in the nematode extract. The substance is relatively heat stable and largely retains the recrystallization inhibition activity after heating. No thermal hysteresis activity was detected but the extract had a typical hexagonal crystal shape when grown from a single seed crystal and weak ice nucleation activity. An ice active substance is present in a low concentration, which may be involved in the freezing survival of this species by inhibiting ice recrystallization.	[Ali, Farman; Wharton, David A.] Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand; [Ali, Farman] Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan	University of Otago	Ali, F (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.; Ali, F (corresponding author), Abdul Wali Khan Univ Mardan, Dept Agr, Mardan, Pakistan.	drfarman@gmail.com	Ali, Farman/GVT-3127-2022					Ali F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141810; Ali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094179; Ali F, 2013, CRYOBIOLOGY, V66, P24, DOI 10.1016/j.cryobiol.2012.10.004; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Block W, 2003, EUR J ENTOMOL, V100, P305, DOI 10.14411/eje.2003.049; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; GREENAWAY P, 1970, J EXP BIOL, V53, P147; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; Lee RE, 1998, ANNU REV PHYSIOL, V60, P55, DOI 10.1146/annurev.physiol.60.1.55; Perry RN, 2011, MOLECULAR AND PHYSIOLOGICAL BASIS OF NEMATODE SURVIVAL, P1, DOI 10.1079/9781845936877.0000; Ramlov H, 1996, CRYOBIOLOGY, V33, P607, DOI 10.1006/cryo.1996.0064; Ramlov H, 2000, HUM REPROD, V15, P26, DOI 10.1093/humrep/15.suppl_5.26; Sidebottom C, 2000, NATURE, V406, P256, DOI 10.1038/35018639; Smith T, 2008, J COMP PHYSIOL B, V178, P93, DOI 10.1007/s00360-007-0202-3; Wharton DA, 2009, J INSECT PHYSIOL, V55, P27, DOI 10.1016/j.jinsphys.2008.09.007; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wharton DA, 1998, CRYOBIOLOGY, V36, P279, DOI 10.1006/cryo.1998.2087; Wharton DA, 2000, J COMP PHYSIOL B, V170, P321, DOI 10.1007/s003600000106; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 1999, PARASITOLOGY, V119, pS7, DOI 10.1017/S0031182000084614; Wharton DA, 2004, CRYOLETTERS, V25, P335; Wharton DA, 2002, CRYOLETTERS, V23, P5; Wharton DA, 2007, CRYOLETTERS, V28, P61; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	30	3	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156502	10.1371/journal.pone.0156502	http://dx.doi.org/10.1371/journal.pone.0156502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227961	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500150
J	Luo, H; Zhou, DF; Liu, XH; Nie, ZH; Quiroga-Sanchez, DL; Chang, YH				Luo, Hui; Zhou, Dafeng; Liu, Xiaohui; Nie, Zhihua; Quiroga-Sanchez, Diego Leandro; Chang, Yanhong			Production of 3-Hydroxypropionic Acid via the Propionyl-CoA Pathway Using Recombinant Escherichia coli Strains	PLOS ONE			English	Article							COENZYME-A-TRANSFERASE; AUTOTROPHIC CARBON FIXATION; BETA-HYDROXYPROPIONIC ACID; METABOLIC PATHWAYS; OXIDIZING SYSTEM; ANIMAL-TISSUES; ACTIVE-SITE; BIOSYNTHESIS; CYCLE; CLOSTRIDIUM	Our study aimed to produce the commercially promising platform chemical 3-hydroxypropionic acid (3-HP) via the propionyl-CoA pathway in genetically engineered Escherichia coli. Recombinant E. coli Ec-P overexpressing propionyl-CoA dehydrogenase (PACD, encoded by the pacd gene from Candida rugosa) under the T7 promoter produced 1.33 mM of 3-HP in a shake flask culture supplemented with 0.5% propionate. When propionate CoA-transferase (PCT, encoded by the pct gene from Megasphaera elsdenii) and 3-hydroxypropionyl-CoA dehydratase (HPCD, encoded by the hpcd gene from Chloroflexus aurantiacus) were expressed along with PACD, the 3-HP titer of the resulting E. coli Ec-PPH strain was improved by 6-fold. The effect of the cultivation conditions on the 3-HP yield from propionate in the Ec-PPH strain was also investigated. When cultured at 30 degrees C with 1% glucose in addition to propionate, 3-HP production by Ec-PPH increased 2-fold and 12-fold compared to the cultivation at 37 degrees C (4.23 mM) or without glucose (0.68 mM). Deletion of the ygfH gene encoding propionyl-CoA: succinate CoA-transferase from Ec-PPH (resulting in the strain Ec-.Y-PPH) led to increase of 3-HP production in shake flask experiments (15.04 mM), whereas the strain Ec-.Y-PPH with deletion of the prpC gene (encoding methylcitrate synthase in the methylcitrate cycle) produced 17.76 mM of 3-HP. The strain Ec-Delta Y-Delta P-PPH with both ygfH and prpC genes deleted produced 24.14 mM of 3-HP, thus showing an 18-fold increase in the 3-HP titer in compare to the strain Ec-P.	[Luo, Hui; Zhou, Dafeng; Liu, Xiaohui; Quiroga-Sanchez, Diego Leandro] Univ Sci & Technol Beijing, Dept Biol Sci & Engn, Beijing 100083, Peoples R China; [Nie, Zhihua; Chang, Yanhong] Univ Sci & Technol Beijing, Dept Environm Engn, Beijing 100083, Peoples R China; [Nie, Zhihua; Chang, Yanhong] Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China	University of Science & Technology Beijing; University of Science & Technology Beijing; University of Science & Technology Beijing	Luo, H (corresponding author), Univ Sci & Technol Beijing, Dept Biol Sci & Engn, Beijing 100083, Peoples R China.; Chang, YH (corresponding author), Univ Sci & Technol Beijing, Dept Environm Engn, Beijing 100083, Peoples R China.; Chang, YH (corresponding author), Univ Sci & Technol Beijing, Key Lab Educ Minist High Efficient Min & Safety M, Beijing 100083, Peoples R China.	luohui@ustb.edu.cn; yhchang@ustb.edu.cn			National Science foundation of China [21276023]	National Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science foundation of China Grant number: 21276023, http://www.nsfc.gov.cn/. HL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN SHG, 1963, J BIOL CHEM, V238, P1637; ASH R, 1973, BIOCHEM J, V136, P311, DOI 10.1042/bj1360311; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; BARKER HA, 1978, J BIOL CHEM, V253, P1219; Berry A, 2009, Methods for producing 3-hydroxypropionic acid and compounds thereof, Patent No. [WO 2009/089457, 2009089457]; Chen Q, 2011, APPL ENVIRON MICROB, V77, P4886, DOI 10.1128/AEM.00091-11; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Della Pina C, 2011, GREEN CHEM, V13, P1624, DOI 10.1039/c1gc15052a; Finley SD, 2009, BIOTECHNOL BIOENG, V103, P532, DOI 10.1002/bit.22285; Gokarn R. R., 2007, US Pat., Patent No. [US 7186541 B2, 7186541, US7186541]; GOKARN RR, 2001, Patent No. 2001043607; GREEN DE, 1954, J BIOL CHEM, V206, P1; Haller T, 2000, BIOCHEMISTRY-US, V39, P4622, DOI 10.1021/bi992888d; HASEGAWA J, 1982, J FERMENT TECHNOL, V60, P591; Henry CS, 2010, BIOTECHNOL BIOENG, V106, P462, DOI 10.1002/bit.22673; Hoffmann F, 2002, BIOTECHNOL BIOENG, V80, P313, DOI 10.1002/bit.10379; Hugler M, 2003, EUR J BIOCHEM, V270, P736, DOI 10.1046/j.1432-1033.2003.03434.x; Jessen HJ, 2011, Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production, Patent No. [US 2011/8030045, 20118030045]; Jiang XL, 2009, APPL MICROBIOL BIOT, V82, P995, DOI 10.1007/s00253-009-1898-7; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Luo LH, 2012, BIORESOURCE TECHNOL, V103, P1, DOI 10.1016/j.biortech.2011.09.099; Lynch MD, 2011, Patent application, Patent No. [2011038364, WO2011038364 A1]; Menendez C, 1999, J BACTERIOL, V181, P1088, DOI 10.1128/JB.181.4.1088-1098.1999; Nikolau BJ, 2008, PLANT J, V54, P536, DOI 10.1111/j.1365-313X.2008.03484.x; Park SJ, 2013, J BIOTECHNOL, V165, P93, DOI 10.1016/j.jbiotec.2013.03.005; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Rathnasingh C, 2012, J BIOTECHNOL, V157, P633, DOI 10.1016/j.jbiotec.2011.06.008; Rathnasingh C, 2009, BIOTECHNOL BIOENG, V104, P729, DOI 10.1002/bit.22429; Saini R, 2011, BIOTECHNOL ADV, V29, P949, DOI 10.1016/j.biotechadv.2011.08.009; Sambrook J., 2001, MOL CLONING LAB MANU; Selmer T, 2002, EUR J BIOCHEM, V269, P372, DOI 10.1046/j.0014-2956.2001.02659.x; SRAMEK SJ, 1975, ARCH BIOCHEM BIOPHYS, V171, P14, DOI 10.1016/0003-9861(75)90002-8; TAKAMIZAWA K, 1993, APPL MICROBIOL BIOT, V40, P196; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; TUNG KK, 1975, J BACTERIOL, V124, P1462, DOI 10.1128/JB.124.3.1462-1474.1975; UCHIYAMA H, 1976, AGR BIOL CHEM TOKYO, V40, P1411, DOI 10.1080/00021369.1976.10862223; WAKIL SJ, 1956, BIOCHIM BIOPHYS ACTA, V19, P497, DOI 10.1016/0006-3002(56)90473-5; Wang ZQ, 2015, METAB ENG, V27, P46, DOI 10.1016/j.ymben.2014.10.005; Warnecke-Lipscomb TE, 2010, PCT patent, Patent No. [WO 2010/011874 A2, 2010011874]; WIESENBORN DP, 1989, APPL ENVIRON MICROB, V55, P323, DOI 10.1128/AEM.55.2.323-329.1989; Yang JE, 2014, APPL MICROBIOL BIOT, V98, P95, DOI 10.1007/s00253-013-5285-z; YANG SY, 1993, J BIOL CHEM, V268, P6588; Yuzawa S, 2012, BIOCHEMISTRY-US, V51, P9779, DOI 10.1021/bi301414q; Zhang HR, 2010, BIOTECHNOL BIOENG, V105, P567, DOI 10.1002/bit.22560; Zhou FL, 2011, APPL BIOCHEM BIOTECH, V165, P1770, DOI 10.1007/s12010-011-9393-x	49	19	22	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156286	10.1371/journal.pone.0156286	http://dx.doi.org/10.1371/journal.pone.0156286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227837	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500103
J	Upasani, ML; Gurjar, GS; Kadoo, NY; Gupta, VS				Upasani, Medha L.; Gurjar, Gayatri S.; Kadoo, Narendra Y.; Gupta, Vidya S.			Dynamics of Colonization and Expression of Pathogenicity Related Genes in Fusarium oxysporum f.sp ciceri during Chickpea Vascular Wilt Disease Progression	PLOS ONE			English	Article							PROTEIN BETA-SUBUNIT; TARGETED DISRUPTION; REDUCED PATHOGENICITY; PLANT COLONIZATION; RESISTANCE; INFECTION; VIRULENCE; GROWTH; ALPHA; PCR	Fusarium wilt caused by Fusarium oxysporum f.sp. ciceri (Foc) is a constant threat to chickpea productivity in several parts of the world. Understanding the molecular basis of chickpea-Foc interaction is necessary to improve chickpea resistance to Foc and thereby the productivity of chickpea. We transformed Foc race 2 using green fluorescent protein (GFP) gene and used it to characterize pathogen progression and colonization in wilt-susceptible (JG62) and wilt-resistant (Digvijay) chickpea cultivars using confocal microscopy. We also employed quantitative PCR (qPCR) to estimate the pathogen load and progression across various tissues of both the chickpea cultivars during the course of the disease. Additionally, the expression of several candidate pathogen virulence genes was analyzed using quantitative reverse transcriptase PCR (qRT-PCR), which showed their characteristic expression in wilt-susceptible and resistant chickpea cultivars. Our results suggest that the pathogen colonizes the susceptible cultivar defeating its defense; however, albeit its entry in the resistant plant, further proliferation is severely restricted providing an evidence of efficient defense mechanism in the resistant chickpea cultivar.	[Upasani, Medha L.; Gurjar, Gayatri S.; Kadoo, Narendra Y.; Gupta, Vidya S.] CSIR Natl Chem Lab, Div Biochem Sci, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Kadoo, NY; Gupta, VS (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	ny.kadoo@ncl.res.in; vs.gupta@ncl.res.in	Kadoo, Narendra/G-2492-2010	Kadoo, Narendra/0000-0002-9079-1226	Council of Scientific and Industrial Research (CSIR), India [BSC0117]	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Grant Number: BSC0117 (Council of Scientific and Industrial Research (CSIR), India (http://www.csir.res.in/) to NYK; and Junior and Senior Research fellowships of Council of Scientific and Industrial Research (CSIR), India (http://www.csir.res.in/) to MLU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboul-Soud MAM, 2004, MYCOPATHOLOGIA, V158, P475, DOI 10.1007/s11046-005-5370-7; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; Bolwerk A, 2005, MOL PLANT MICROBE IN, V18, P710, DOI 10.1094/MPMI-18-0710; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; Cardinale M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00094; Charoensopharat K, 2008, WORLD J MICROB BIOT, V24, P345, DOI 10.1007/s11274-007-9476-6; Cho Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127140; Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401; Dave K, 2011, J BIOTECHNOL, V155, P173, DOI 10.1016/j.jbiotec.2011.06.012; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Dhingra O.D., 1995, BASIC PLANT PATHOLOG, V2, P355; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; Fang XL, 2012, PLANT SOIL, V358, P71, DOI 10.1007/s11104-012-1205-8; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; GOW NAR, 1994, SCANNING MICROSCOPY, V8, P705; Gowda SJM, 2009, MOL BREEDING, V24, P177, DOI 10.1007/s11032-009-9282-y; Gurjar G. S., 2012, American Journal of Plant Sciences, V3, P190, DOI 10.4236/ajps.2012.32023; Hardham AR, 2001, MYCOTA, V8, P91; Haware M. P., 1996, Phytopathologia Mediterranea, V35, P9; HAWARE MP, 1982, PLANT DIS, V66, P809, DOI 10.1094/PD-66-809; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Imazaki I, 2007, MOL MICROBIOL, V63, P737, DOI 10.1111/j.1365-2958.2006.05554.x; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Jain S, 2003, CURR GENET, V43, P79, DOI 10.1007/s00294-003-0372-9; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Jimenez-Diaz RM, 1993, SEM FUS MYC TAX PATH; Jimenez-Fernandez D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061360; Jimenez-Fernandez D, 2011, PHYTOPATHOLOGY, V101, P250, DOI 10.1094/PHYTO-07-10-0190; Jorge I, 2006, CAN J BOT, V84, P1395, DOI 10.1139/B06-103; Josefsen L, 2012, AUTOPHAGY, V8, P326, DOI 10.4161/auto.18705; Kasahara S, 1997, MOL PLANT MICROBE IN, V10, P984, DOI 10.1094/MPMI.1997.10.8.984; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kumar Y, 2015, PHYTOCHEMISTRY, V116, P120, DOI 10.1016/j.phytochem.2015.04.001; Lagopodi AL, 2002, MOL PLANT MICROBE IN, V15, P172, DOI 10.1094/MPMI.2002.15.2.172; Lakshman DK, 2012, EUR J PLANT PATHOL, V133, P729, DOI 10.1007/s10658-012-9953-0; Lee H, 2010, EUKARYOT CELL, V9, P558, DOI 10.1128/EC.00316-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; MCDONNELL K., 1962, TRANS BRIT MYCOL SOC, V45, P55; Mobius N, 2009, CURR OPIN PLANT BIOL, V12, P390, DOI 10.1016/j.pbi.2009.06.004; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Narasimhan ML, 2003, PLANT J, V36, P390, DOI 10.1046/j.1365-313X.2003.01886.x; Nelson DR, 1998, J MOL BIOL, V277, P285, DOI 10.1006/jmbi.1997.1594; Noda J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-38; PALMIERI F, 1994, FEBS LETT, V346, P48, DOI 10.1016/0014-5793(94)00329-7; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Redden RJ, 2007, CHICKPEA BREEDING AND MANAGEMENT, P1, DOI 10.1079/9781845932138.001; Sagaram US, 2007, MOL PLANT PATHOL, V8, P375, DOI 10.1111/J.1364-3703.2007.00398.X; Shih J, 2000, GENE, V243, P139, DOI 10.1016/S0378-1119(99)00546-6; Singh KB, 1997, FIELD CROP RES, V53, P161, DOI 10.1016/S0378-4290(97)00029-4; Tullu A, 1998, EUPHYTICA, V102, P227, DOI 10.1023/A:1018373412281; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; Wang K., 2006, AGROBACTERIUM PROTOC; Wubben JP, 2000, CURR GENET, V37, P152, DOI 10.1007/s002940050022; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10; Zvirin T, 2010, PLANT PATHOL, V59, P576, DOI 10.1111/j.1365-3059.2009.02225.x	62	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156490	10.1371/journal.pone.0156490	http://dx.doi.org/10.1371/journal.pone.0156490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227745	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500147
J	Willems, C; Saija, JD; Akyurek, EG; Martens, S				Willems, Charlotte; Saija, Jefta D.; Akyurek, Elkan G.; Martens, Sander			An Individual Differences Approach to Temporal Integration and Order Reversals in the Attentional Blink Task	PLOS ONE			English	Article							ADAPTIVE-CONTROL; DIFFICULTY; DYNAMICS; MASKING	Background The reduced ability to identify a second target when it is presented in close temporal succession of a first target is called the attentional blink (AB). Studies have shown large individual differences in AB task performance, where lower task performance has been associated with more reversed order reports of both targets if these were presented in direct succession. In order to study the suggestion that reversed order reports reflect loss of temporal information, in the current study, we investigated whether individuals with a larger AB have a higher tendency to temporally integrate both targets into one visual event by using an AB paradigm containing symbol target stimuli. Methodology/Principal Findings Indeed, we found a positive relation between the tendency to temporally integrate information and individual AB magnitude. In contrast to earlier work, we found no relation between order reversals and individual AB magnitude. The occurrence of temporal integration was negatively related to the number of order reversals, indicating that individuals either integrated or separated and reversed information. Conclusion We conclude that individuals with better AB task performance use a shorter time window to integrate information, and therefore have higher preservation of temporal information. Furthermore, order reversals observed in paradigms with alphanumeric targets indeed seem to at least partially reflect temporal integration of both targets. Given the negative relation between temporal integration and 'true' order reversals observed with the current symbolic target set, these two behavioral outcomes seem to be two sides of the same coin.	[Willems, Charlotte; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Willems, Charlotte; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Saija, Jefta D.; Akyurek, Elkan G.] Univ Groningen, Dept Psychol, Expt Psychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Willems, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.; Willems, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	charlot.willems@gmail.com		Martens, Sander/0000-0001-8237-7984; Akyurek, Elkan/0000-0001-9111-5847	grant of the Research School of Behavioural and Cognitive Neuroscience - CW/SM	grant of the Research School of Behavioural and Cognitive Neuroscience - CW/SM	This work was funded by a grant of the Research School of Behavioural and Cognitive Neuroscience. - CW/SM, http://www.rug.nl/research/behavioural-cognitive-neurosciences/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2008, J EXP PSYCHOL HUMAN, V34, P569, DOI 10.1037/0096-1523.34.3.569; Akyurek EG, 2007, PSYCHOPHYSIOLOGY, V44, P383, DOI 10.1111/j.1469-8986.2007.00513.x; Akyurek EG, 2012, J EXP PSYCHOL HUMAN, V38, P1448, DOI 10.1037/a0027610; Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Arnell K. M., 2013, PSYCHOL RES, V77, P1, DOI DOI 10.1007/S00426-011-0403-Y; Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; Choi H, 2012, P NATL ACAD SCI USA, V109, P12242, DOI 10.1073/pnas.1203972109; Dale G., 2014, PSYCHOL RES, P1; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; Kuznetsova A., 2013, LMERTEST TESTS RANDO; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Meng T., 2013, P INT C COMP VIS, P1, DOI DOI 10.3758/513423-013-0491-3; Nieuwenstein MR, 2006, J EXP PSYCHOL HUMAN, V32, P973, DOI 10.1037/0096-1523.32.4.973; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2011, ATTEN PERCEPT PSYCHO, V73, P53, DOI 10.3758/s13414-010-0004-7; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Ouimet C, 2007, VIS COGN, V15, P290, DOI 10.1080/13506280600693741; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Seiffert AE, 1997, J EXP PSYCHOL HUMAN, V23, P1061, DOI 10.1037/0096-1523.23.4.1061; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Willems C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145056; Willems C, 2015, J COGNITIVE NEUROSCI, V27, P1161, DOI 10.1162/jocn_a_00767; Willems C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066185; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156538	10.1371/journal.pone.0156538	http://dx.doi.org/10.1371/journal.pone.0156538			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228118	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500154
J	Tachfouti, N; Najdi, A; Alonso, S; Sicuri, E; El Idrissi, AL; Nejjari, C; Picado, A				Tachfouti, Nabil; Najdi, Adil; Alonso, Sergi; Sicuri, Elisa; Laamrani El Idrissi, Abderahmane; Nejjari, Chakib; Picado, Albert			Cost of Pediatric Visceral Leishmaniasis Care in Morocco	PLOS ONE			English	Article							MANAGEMENT	Background Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated. VL is endemic in Morocco and other countries in North Africa were it mainly affects children from rural areas. In Morocco, the direct observation of Leishmania parasites in bone marrow aspirates and serological tests are used to diagnose VL. Glucantime is the first line of treatment. The objective of this study was to report the costs associated to standard clinical management of pediatric VL from the provider perspective in Morocco. As a secondary objective we described the current clinical practices and the epidemiological characteristics of pediatric VL patients. Methods From March to June 2014 we conducted a survey in eight hospitals treating pediatric VL patients in Morocco. A pro-forma was used to collect demographic, clinical and management data from medical records. We specifically collected data on VL diagnosis and treatment. We also estimated the days of hospitalization and the time to start VL treatment. Costs were estimated by multiplying the use of resources in terms of number of days in hospital, tests performed and drugs provided by the official prices. For patients receiving part of their treatment at Primary Health Centers (PHC) we estimated the cost of administering the Glucantime as outpatient. We calculated the median cost per VL patient. We also estimated the cost of managing a VL case when different treatment strategies were applied: inpatient and outpatient. Results We obtained data from 127 VL patients. The median total cost per pediatric VL case in Morocco is 520 US$. The cost in hospitals applying an outpatient strategy is significantly lower (307 US$) than hospitals keeping the patients for the whole treatment (636 US$). However the outpatient strategy is not yet recommended as VL treatment for children in the Moroccan guidelines. VL diagnosis and treatment regimens should be standardized following the current guidelines in Morocco.	[Tachfouti, Nabil; Najdi, Adil; Nejjari, Chakib] Sidi Mohamed Ben Abdellah Univ, Fac Med & Pharm Fez, Lab Epidemiol Clin Res & Community Hlth, Fes, Morocco; [Alonso, Sergi; Sicuri, Elisa; Picado, Albert] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Laamrani El Idrissi, Abderahmane] Minist Hlth, Ctr Epidemiol & Dis Control, Rabat, Morocco; [Nejjari, Chakib] Minist Hlth, ENSP, Rabat, Morocco	Sidi Mohamed Ben Abdellah University of Fez; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Picado, A (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	albert.picado@isglobal.org	Alonso, Sergi/GQZ-1236-2022; Sicuri, Elisa/L-8012-2014; Alonso, Sergi/AAL-1960-2021	Sicuri, Elisa/0000-0002-2499-2732; Alonso, Sergi/0000-0001-6664-3736; Najdi, Adil/0000-0002-3646-6908; Picado, Albert/0000-0001-7344-628X	Thrasher Research Fund, Salt Lake City, USA-Early Career Award [12021]	Thrasher Research Fund, Salt Lake City, USA-Early Career Award	Funding was provided by Thrasher Research Fund, Salt Lake City, USA-Early Career Award # 12021 (https://www.thrasherresearch.org/). The funder of the study had no role in the study design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Cascio A, 2002, EUR J CLIN MICROBIOL, V21, P277, DOI 10.1007/s10096-002-0707-3; Houda T, 2011, THESIS; Kafetzis DA, 2005, INT J ANTIMICROB AG, V25, P26, DOI 10.1016/j.ijantimicag.2004.09.011; Lakhdar Idrissi M, 2007, JAL PEDIAT PUERICULT, V20, P136; Maltezou HC, 2000, CLIN INFECT DIS, V31, P1139, DOI 10.1086/317455; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Meheus F, 2013, AM J TROP MED HYG, V89, P1146, DOI 10.4269/ajtmh.12-0585; Ministere de la Sante, 2012, LUTT LEISHM GUID ACT; Rhajaoui M, 2011, PATHOL BIOL, V59, P226, DOI 10.1016/j.patbio.2009.09.003; Tachfouti N, 2012, ASIAN PAC J CANCER P, V13, P1547, DOI 10.7314/APJCP.2012.13.4.1547; The World Bank, OFF EXCH RAT LCU PER; The World Bank, INFL CONS PRIC ANN; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; WHO, 2010, WHO TECH REP SER, V949, P1; Zougaghi L, 2009, ARCH PEDIATRIE, V16, P1513, DOI 10.1016/j.arcped.2009.05.003	16	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155482	10.1371/journal.pone.0155482	http://dx.doi.org/10.1371/journal.pone.0155482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257808	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700016
J	Tonelli, A; Brayda, L; Gori, M				Tonelli, Alessia; Brayda, Luca; Gori, Monica			Depth Echolocation Learnt by Novice Sighted People	PLOS ONE			English	Article							PHYSICAL ANALYSIS; ORGANIC SIGNALS; BLIND; DISCRIMINATION; HUMANS; EXPERT; SHAPE; IDENTIFICATION; LISTENERS; ABILITY	Some blind people have developed a unique technique, called echolocation, to orient themselves in unknown environments. More specifically, by self-generating a clicking noise with the tongue, echolocators gain knowledge about the external environment by perceiving more detailed object features. It is not clear to date whether sighted individuals can also develop such an extremely useful technique. To investigate this, here we test the ability of novice sighted participants to perform a depth echolocation task. Moreover, in order to evaluate whether the type of room (anechoic or reverberant) and the type of clicking sound (with the tongue or with the hands) influences the learning of this technique, we divided the entire sample into four groups. Half of the participants produced the clicking sound with their tongue, the other half with their hands. Half of the participants performed the task in an anechoic chamber, the other half in a reverberant room. Subjects stood in front of five bars, each of a different size, and at five different distances from the subject. The dimension of the bars ensured a constant subtended angle for the five distances considered. The task was to identify the correct distance of the bar. We found that, even by the second session, the participants were able to judge the correct depth of the bar at a rate greater than chance. Improvements in both precision and accuracy were observed in all experimental sessions. More interestingly, we found significantly better performance in the reverberant room than in the anechoic chamber. The type of clicking did not modulate our results. This suggests that the echolocation technique can also be learned by sighted individuals and that room reverberation can influence this learning process. More generally, this study shows that total loss of sight is not a prerequisite for echolocation skills this suggests important potential implications on rehabilitation settings for persons with residual vision.	[Tonelli, Alessia; Gori, Monica] Ist Italiano Tecnol, U VIP Unit Visually Impaired People Sci & Technol, Via Morego 30, Genoa, Italy; [Tonelli, Alessia; Brayda, Luca; Gori, Monica] Fdn Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Via Morego 30, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Tonelli, A (corresponding author), Ist Italiano Tecnol, U VIP Unit Visually Impaired People Sci & Technol, Via Morego 30, Genoa, Italy.; Tonelli, A (corresponding author), Fdn Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Via Morego 30, I-16163 Genoa, Italy.	alessia.tonelli@iit.it	Gori, Monica/A-1238-2014; Gori, Monica/AAS-9963-2021; Tonelli, Alessia/AAE-8909-2021; Brayda, Luca/E-5365-2015	Gori, Monica/0000-0002-5616-865X; Brayda, Luca/0000-0002-6673-2971; Tonelli, Alessia/0000-0003-0317-2599				Arnott SR, 2013, NEUROPSYCHOLOGIA, V51, P938, DOI 10.1016/j.neuropsychologia.2013.01.024; BILSEN FA, 1974, J ACOUST SOC AM, V55, P292, DOI 10.1121/1.1914500; DeLong CM, 2007, J ACOUST SOC AM, V121, P605, DOI 10.1121/1.2400848; Gibson J.J., 2014, ECOLOGICAL APPROACH, DOI [DOI 10.4324/9781315740218, 10.4324/9781315740218]; HAUSFELD S, 1982, PERCEPT MOTOR SKILL, V55, P623, DOI 10.2466/pms.1982.55.2.623; Heinrich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061577; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kolarik AJ, 2013, EXP BRAIN RES, V224, P623, DOI 10.1007/s00221-012-3340-0; Libbey B, 2004, J ACOUST SOC AM, V116, P3141, DOI 10.1121/1.1781621; Rojas JAM, 2010, ACTA ACUST UNITED AC, V96, P1069, DOI 10.3813/AAA.918368; Rojas JAM, 2009, ACTA ACUST UNITED AC, V95, P325, DOI 10.3813/AAA.918155; Milne JL, 2015, NEUROCASE, V21, P465, DOI 10.1080/13554794.2014.922994; Milne JL, 2014, ATTEN PERCEPT PSYCHO, V76, P1828, DOI 10.3758/s13414-014-0695-2; Moore BC, 2012, INTRO PSYCHOL HEARIN; Papadopoulos T, 2011, BIOMED SIGNAL PROCES, V6, P280, DOI 10.1016/j.bspc.2011.03.005; RICE CE, 1965, SCIENCE, V148, P1107, DOI 10.1126/science.148.3673.1107; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Schenkman B, 1985, HUMAN ECHOLOCATION D; Schenkman BN, 2011, PERCEPTION, V40, P840, DOI 10.1068/p6898; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2013, ADV EXP MED BIOL, V787, P311, DOI 10.1007/978-1-4614-1590-9_35; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shinn-Cunningham BG, 2005, J ACOUST SOC AM, V117, P3100, DOI 10.1121/1.1872572; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2014, J NEUROPHYSIOL, V111, P112, DOI 10.1152/jn.00501.2013; Thaler L, 2014, EXP BRAIN RES, V232, P1915, DOI 10.1007/s00221-014-3883-3; Thaler L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00098; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Vercillo T, 2015, NEUROPSYCHOLOGIA, V67, P35, DOI 10.1016/j.neuropsychologia.2014.12.001; Wallmeier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115363	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156654	10.1371/journal.pone.0156654	http://dx.doi.org/10.1371/journal.pone.0156654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257689	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700095
J	Makransky, G; Thisgaard, MW; Gadegaard, H				Makransky, Guido; Thisgaard, Malene Warming; Gadegaard, Helen			Virtual Simulations as Preparation for Lab Exercises: Assessing Learning of Key Laboratory Skills in Microbiology and Improvement of Essential Non-Cognitive Skills	PLOS ONE			English	Article							RASCH MEASUREMENT MODEL; COMPUTER-SIMULATIONS; EDUCATION; SCIENCE; TECHNOLOGY; EXAMPLE; GAP	Objective To investigate if a virtual laboratory simulation (vLAB) could be used to replace a face to face tutorial (demonstration) to prepare students for a laboratory exercise in microbiology. Methods A total of 189 students who were participating in an undergraduate biology course were randomly selected into a vLAB or demonstration condition. In the vLAB condition students could use a vLAB at home to 'practice' streaking out bacteria on agar plates in a virtual environment. In the demonstration condition students were given a live demonstration from a lab tutor showing them how to streak out bacteria on agar plates. All students were blindly assessed on their ability to perform the streaking technique in the physical lab, and were administered a pre and post-test to determine their knowledge of microbiology, intrinsic motivation to study microbiology, and self-efficacy in the field of microbiology prior to, and after the experiment. Results The results showed that there were no significant differences between the two groups on their lab scores, and both groups had similar increases in knowledge of microbiology, intrinsic motivation to study microbiology, as well as self-efficacy in the field of microbiology. Conclusion Our data show that vLABs function just as well as face to face tutorials in preparing students for a physical lab activity in microbiology. The results imply that vLABs could be used instead of face to face tutorials, and a combination of virtual and physical lab exercises could be the future of science education.	[Makransky, Guido; Thisgaard, Malene Warming] Univ So Denmark, Odense, Denmark; [Gadegaard, Helen] Univ Glasgow, Glasgow, Lanark, Scotland	University of Southern Denmark; University of Glasgow	Makransky, G (corresponding author), Univ So Denmark, Odense, Denmark.	gmakransky@health.sdu.dk		Makransky, Guido/0000-0003-1862-7824				Adams DJ, 2009, BIOSCI ED, V13, P1; Andrich D, 2010, RASCH MODELS MEASURE; Ayres P, 2009, COMPUT HUM BEHAV, V25, P348, DOI 10.1016/j.chb.2008.12.013; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Beck C, 2014, CBE-LIFE SCI EDUC, V13, P444, DOI 10.1187/cbe.13-12-0245; Bernhard J, 2010, EUR J ENG EDUC, V35, P271, DOI 10.1080/03043791003739759; Bonde MT, 2014, NAT BIOTECHNOL, V32, P694, DOI 10.1038/nbt.2955; CHANDLER P, 1991, COGNITION INSTRUCT, V8, P293, DOI 10.1207/s1532690xci0804_2; de Araujo P, 2013, J ECON PSYCHOL, V34, P120, DOI 10.1016/j.joep.2012.12.001; de Jong T, 2006, SCIENCE, V312, P532, DOI 10.1126/science.1127750; de Jong T, 2013, SCIENCE, V340, P305, DOI 10.1126/science.1230579; DECI EL, 1994, J PERS, V62, P119, DOI 10.1111/j.1467-6494.1994.tb00797.x; Garcia E., 2014, EC POLICY I BRIEF PA, V386, P1; Heckman J, 2006, J LABOUR EC, V24; Heckman JJ, 2012, LABOUR ECON, V19, P451, DOI 10.1016/j.labeco.2012.05.014; Herrmann-Werner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076354; Hofstein A, 2004, SCI EDUC, V88, P28, DOI 10.1002/sce.10106; Huang C, 2004, PLOS BIOL, V2, P734, DOI 10.1371/journal.pbio.0020157; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; LEONARD WH, 1992, J RES SCI TEACH, V29, P93, DOI 10.1002/tea.3660290109; Limniou M, 2009, COMPUT EDUC, V52, P45, DOI 10.1016/j.compedu.2008.06.006; Makransky G, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0620-6; Makransky G, 2015, J CAREER ASSESSMENT, V23, P645, DOI 10.1177/1069072714553555; Maldarelli GA, 2009, J MICROBIOL BIOL EDU, V10, P51, DOI 10.1128/jmbe.v10.99; McGaghie WC, 2010, MED EDUC, V44, P50, DOI 10.1111/j.1365-2923.2009.03547.x; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pellegrino J. W, 2012, ED LIFE WORK DEV TRA; Pintrich P., 1991, ANN ARBOR MICHIGAN, V48109, P1259; Plass JL, 2012, J RES SCI TEACH, V49, P394, DOI 10.1002/tea.21008; Polly P, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-222; Prunuske AJ, 2012, GENETICS, V192, P67, DOI 10.1534/genetics.112.141754; Smetana LK, 2012, INT J SCI EDUC, V34, P1337, DOI 10.1080/09500693.2011.605182; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Waldrop M Mitchell, 2013, Nature, V499, P268, DOI 10.1038/499268a; Wang CY, 2014, EDUC TECHNOL SOC, V17, P307; Weller JM, 2004, MED EDUC, V38, P32, DOI 10.1111/j.1365-2923.2004.01739.x; Yaron D, 2010, SCIENCE, V328, P584, DOI 10.1126/science.1182435; ZIMMERMAN BJ, 1990, EDUC PSYCHOL, V25, P3, DOI 10.1207/s15326985ep2501_2	39	72	75	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155895	10.1371/journal.pone.0155895	http://dx.doi.org/10.1371/journal.pone.0155895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253395	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700009
J	Bouchami, O; de Lencastre, H; Miragaia, M				Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria			Impact of Insertion Sequences and Recombination on the Population Structure of Staphylococcus haemolyticus	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN RESISTANCE; BIOFILM FORMATION; AUREUS; SUSCEPTIBILITY; IDENTIFICATION; TRANSPOSON; ELEMENT; CLONING	Staphylococcus haemolyticus is one of the most common pathogens associated with medical-device related infections, but its molecular epidemiology is poorly explored. In the current study, we aimed to better understand the genetic mechanisms contributing to S. haemolyticus diversity in the hospital environment and their impact on the population structure and clinical relevant phenotypic traits. The analysis of a representative S. haemolyticus collection by multilocus sequence typing (MLST) has identified a single highly prevalent and diverse genetic lineage of nosocomial S. haemolyticus clonal complex (CC) 29 accounting for 91% of the collection of isolates disseminated worldwide. The examination of the sequence changes at MLST loci during clonal diversification showed that recombination had a higher impact than mutation in shaping the S. haemolyticus population. Also, we ascertained that another mechanism contributing significantly to clonal diversification and adaptation was mediated by insertion sequence (IS) elements. We found that all nosocomial S. haemolyticus, belonging to different STs, were rich in IS1272 copies, as determined by Southern hybridization of macrorestriction patterns. In particular, we observed that the chromosome of a S. haemolyticus strain within CC29 was highly unstable during serial growth in vitro which paralleled with IS1272 transposition events and changes in clinically relevant phenotypic traits namely, mannitol fermentation, susceptibility to beta-lactams, biofilm formation and hemolysis. Our results suggest that recombination and IS transposition might be a strategy of adaptation, evolution and pathogenicity of the major S. haemolyticus prevalent lineage in the hospital environment.	[Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria] Inst Tecnol Quim & Biol ITQB Antonio Xavier, Mol Genet Lab, Oeiras, Portugal; [Bouchami, Ons; Miragaia, Maria] Inst Tecnol Quim & Biol ITQB Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Miragaia, M (corresponding author), Inst Tecnol Quim & Biol ITQB Antonio Xavier, Mol Genet Lab, Oeiras, Portugal.; Miragaia, M (corresponding author), Inst Tecnol Quim & Biol ITQB Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; Bouchami, Ons/0000-0002-9425-3513; /0000-0001-6816-8932	Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal [PTDC/BIA-EVF/117507/2010, SFRH/BPD/98317/2013, UID/CBQ/04612/2013]	Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal (Project PTDC/BIA-EVF/117507/2010 to M. M., fellowship SFRH/BPD/98317/2013 to O. B.) and R&D Unit, UID/CBQ/04612/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1996, ANTIMICROB AGENTS CH, V40, P924, DOI 10.1128/AAC.40.4.924; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Boerlin P, 2003, J CLIN MICROBIOL, V41, P767, DOI 10.1128/JCM.41.2.767-771.2003; Bouchami O, 2012, EUR J CLIN MICROBIOL, V31, P605, DOI 10.1007/s10096-011-1354-3; Cavanagh JP, 2014, J ANTIMICROB CHEMOTH, V69, P2920, DOI 10.1093/jac/dku271; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Flahaut S, 2008, J BACTERIOL, V190, P1649, DOI 10.1128/JB.01648-07; Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877, DOI 10.1128/JCM.38.2.877-880.2000; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Hira V, 2013, J CLIN MICROBIOL, V51, P595, DOI 10.1128/JCM.02935-12; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kristof K, 2011, EUR J CLIN MICROBIOL, V30, P691, DOI 10.1007/s10096-010-1142-5; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rosenstein R, 2013, CURR TOP MICROBIOL, V358, P33, DOI 10.1007/82_2012_286; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Silva PV, 2013, MEM I OSWALDO CRUZ, V108, P812, DOI 10.1590/0074-0276108062013022; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang H, 2010, J PAEDIATR CHILD H, V46, P668, DOI 10.1111/j.1440-1754.2010.01814.x; Watanabe S, 2007, J BACTERIOL, V189, P2921, DOI 10.1128/JB.01485-06; Wayne P., 2014, M100S24 CLSI, V34, P50; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15; Zhang ZG, 2011, J MOL MICROB BIOTECH, V21, P59, DOI 10.1159/000333108	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156653	10.1371/journal.pone.0156653	http://dx.doi.org/10.1371/journal.pone.0156653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249649	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700062
J	Kumar, H; Jain, R; Douglas, RG; Tawhai, MH				Kumar, Haribalan; Jain, Ravi; Douglas, Richard G.; Tawhai, Merryn H.			Airflow in the Human Nasal Passage and Sinuses of Chronic Rhinosinusitis Subjects	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; MAXILLARY SINUS; DRUG-DELIVERY; NUMERICAL-SIMULATION; LOTHROP PROCEDURE; SURGERY; CAVITY; DEPOSITION	Endoscopic surgery is performed on patients with chronic inflammatory disease of the paranasal sinuses to improve sinus ventilation. Little is known about how sinus surgery affects sinonasal airflow. In this study nasal passage geometry was reconstructed from computed tomographic imaging from healthy normal, pre-operative, and post-operative subjects. Transient air flow through the nasal passage during calm breathing was simulated. Subject-specific differences in ventilation of the nasal passage were observed. Velocity magnitude at ostium was different between left and right airway. In FESS, airflow in post-surgical subjects, airflow at the maxillary sinus ostium was upto ten times higher during inspiration. In a Lothrop procedure, airflow at the frontal sinus ostium can be upto four times higher during inspiration. In both post-operative subjects, airflow at ostium was not quasi-steady. The subject-specific effect (of surgery) on sinonasal interaction evaluated through airflow simulations may have important consequences for pre- and post-surgical assessment and surgical planning, and design for improvement of the delivery efficiency of nasal therapeutics.	[Kumar, Haribalan; Tawhai, Merryn H.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Jain, Ravi; Douglas, Richard G.] Univ Auckland, Dept Surg, Auckland 1, New Zealand	University of Auckland; University of Auckland	Kumar, H (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	h.kumar@auckland.ac.nz						Abouali O, 2012, RESP PHYSIOL NEUROBI, V181, P335, DOI 10.1016/j.resp.2012.03.002; Chen XB, 2012, J LARYNGOL OTOL, V126, P487, DOI 10.1017/S0022215112000205; Chen XB, 2011, AM J RHINOL ALLERGY, V25, P388, DOI 10.2500/ajra.2011.25.3669; CHIEN WL, 1986, J FLUID MECH, V170, P355, DOI 10.1017/S0022112086000927; Djupesland PG, 2013, DRUG DELIV TRANSL RE, V3, P42, DOI 10.1007/s13346-012-0108-9; Doorly DJ, 2008, RESP PHYSIOL NEUROBI, V163, P100, DOI 10.1016/j.resp.2008.07.027; ElBadawey MR, 2014, AM J RHINOL ALLERGY, V28, P428, DOI 10.2500/ajra.2014.28.4063; Frank DO, 2013, INT FORUM ALLERGY RH, V3, P834, DOI 10.1002/alr.21203; Frank-Ito DO, 2016, J AEROSOL MED PULM D, V29, P46, DOI 10.1089/jamp.2014.1188; Ge QJ, 2012, INHAL TOXICOL, V24, P492, DOI 10.3109/08958378.2012.694494; Hood CM, 2009, J APPL PHYSIOL, V107, P1195, DOI 10.1152/japplphysiol.91615.2008; Horner M, 2002, J FLUID MECH, V452, P199, DOI 10.1017/S0022112001006917; Kennedy D, 2001, DIS SINUSES DIAGNOSI; Kessler R, 2010, NOTES NUMER FLUID ME, V112, P521, DOI 10.1007/978-3-642-14243-7_64; Khong JJ, 2004, J LARYNGOL OTOL, V118, P352, DOI 10.1258/002221504323086534; Kolsek T, 2007, APPL MATH MODEL, V31, P2355, DOI 10.1016/j.apm.2006.10.010; Kountakis S, 2005, THE FRONTAL SINUS; Kumar H, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3567066; Leclerc L, 2014, PHARM RES-DORDR, V31, P2335, DOI 10.1007/s11095-014-1330-6; Liang Jonathan, 2013, Curr Otorhinolaryngol Rep, V1, P51; Lindemann J, 2005, AM J OTOLARYNG, V26, P175, DOI 10.1016/j.amjoto.2005.02.010; Loudon C, 1998, J THEOR BIOL, V191, P63, DOI 10.1006/jtbi.1997.0564; Moller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074991; Penttila M, 1997, ACTA OTO-LARYNGOL, P173; Ramprasad VH, 2016, J BIOMECH, V49, P450, DOI 10.1016/j.jbiomech.2016.01.009; Rennie CE, 2011, OTOLARYNG HEAD NECK, V145, P165, DOI 10.1177/0194599811401202; Snidvongs K, 2013, AM J RHINOL ALLERGY, V27, P221, DOI 10.2500/ajra.2013.27.3880; Taylor DJ, 2010, J R SOC INTERFACE, V7, P515, DOI 10.1098/rsif.2009.0306; Thompson CF, 2015, CURR OPIN OTOLARYNGO, V23, P34, DOI 10.1097/MOO.0000000000000128; Ting JY, 2014, LARYNGOSCOPE, V124, P1066, DOI 10.1002/lary.24422; Vinchurkar S, 2008, COMPUT FLUIDS, V37, P317, DOI 10.1016/j.compfluid.2007.05.001; Wang X, 2014, INFLAMMATION, V37, P871, DOI 10.1007/s10753-013-9807-8; Weber Rainer K, 2015, GMS Curr Top Otorhinolaryngol Head Neck Surg, V14, pDoc08, DOI 10.3205/cto000123; Wen J, 2008, RESP PHYSIOL NEUROBI, V161, P125, DOI 10.1016/j.resp.2008.01.012; Wofford MR, 2015, RHINOLOGY, V53, P41, DOI [10.4193/Rhino13.065, 10.4193/Rhin13.065]; Wood AJ, 2010, POSTGRAD MED J, V86, P359, DOI 10.1136/pgmj.2009.094813; Xiong GX, 2008, AM J RHINOL, V22, P477, DOI 10.2500/ajr.2008.22.3211; Xiong GX, 2008, MED BIOL ENG COMPUT, V46, P1161, DOI 10.1007/s11517-008-0384-1; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zachow S, 2006, INT J COMPUT ASS RAD, V1, P165; Zhao K, 2014, INT FORUM ALLERGY RH, V4, P435, DOI 10.1002/alr.21319; Zhu JH, 2014, RESP PHYSIOL NEUROBI, V194, P29, DOI 10.1016/j.resp.2014.01.004	42	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156379	10.1371/journal.pone.0156379	http://dx.doi.org/10.1371/journal.pone.0156379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249219	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700039
J	Lambie, M; Chess, J; Do, JY; Noh, H; Lee, HB; Kim, YL; Summers, A; Williams, PF; Davison, S; Dorval, M; Topley, N; Davies, SJ				Lambie, Mark; Chess, James; Do, Jun-Young; Noh, Hyunjin; Lee, Hi-Bahl; Kim, Yong-Lim; Summers, Angela; Williams, Paul Ford; Davison, Sara; Dorval, Marc; Topley, Nick; Davies, Simon John		Global Fluid Study Investigators	Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort Study	PLOS ONE			English	Article							HYPERGLYCEMIA; ASSOCIATION; DEFINITION; ICODEXTRIN; TRANSPORT; DISEASE	Background and Objectives Glucose control is a significant predictor of mortality in diabetic peritoneal dialysis (PD) patients. During PD, the local toxic effects of intra-peritoneal glucose are well recognized, but despite large amounts of glucose being absorbed, the systemic effects of this in non-diabetic patients are not clear. We sought to clarify whether dialysate glucose has an effect upon systemic glucose metabolism. Methods and Materials We analysed the Global Fluid Study cohort, a prospective, observational cohort study initiated in 2002. A subset of 10 centres from 3 countries with high data quality were selected (368 incident and 272 prevalent non-diabetic patients), with multilevel, multivariable analysis of the reciprocal of random glucose levels, and a stratified-by-centre Cox survival analysis. Results The median follow up was 5.6 and 6.4 years respectively in incident and prevalent patients. On multivariate analysis, serum glucose increased with age (beta = -0.007, 95% CI -0.010, -0.004) and decreased with higher serum sodium (beta = 0.002, 95% CI 0.0005, 0.003) in incident patients and increased with dialysate glucose (beta = -0.0002, 95% CI -0.0004, -0.00006) in prevalent patients. Levels suggested undiagnosed diabetes in 5.4% of prevalent patients. Glucose levels predicted death in unadjusted analyses of both incident and prevalent groups but in an adjusted survival analysis they did not (for random glucose 6-10 compared with <6, Incident group HR 0.92, 95% CI 0.58, 1.46, Prevalent group HR 1.42, 95% CI 0.86, 2.34). Conclusions In prevalent non-diabetic patients, random glucose levels at a diabetic level are under-recognised and increase with dialysate glucose load. Random glucose levels predict mortality in unadjusted analyses, but this association has not been proven in adjusted analyses.	[Lambie, Mark; Davies, Simon John] Keele Univ, Inst Appl Clin Res, Stoke On Trent, Staffs, England; [Chess, James; Topley, Nick] Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff CF10 3AX, S Glam, Wales; [Chess, James] Morriston Hosp, Renal Unit, Swansea, W Glam, Wales; [Do, Jun-Young] Yeungnam Univ Hosp, Div Nephrol, Daegu, South Korea; [Noh, Hyunjin; Lee, Hi-Bahl] Soonchunhyang Univ, Hyonam Kidney Lab, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Div Nephrol, Daegu, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Clin Res Ctr ESRD Korea, Daegu, South Korea; [Summers, Angela] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Oxford Rd, Manchester M13 9WL, Lancs, England; [Williams, Paul Ford] Ipswich Hosp NHS Trust Ipswich Hosp, Heath Rd, Ipswich, Suffolk, England; [Davison, Sara] Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada; [Dorval, Marc] Dr Georges L Dumont Univ Hosp Ctr, Div Nephrol, Moncton, NB, Canada	Keele University; Cardiff University; Morriston Hospital; Yeungnam University; Yeungnam University Hospital; Soonchunhyang University; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; University of Manchester; Ipswich Hospital NHS Trust; Ipswich Hospital; University of Alberta	Davies, SJ (corresponding author), Keele Univ, Inst Appl Clin Res, Stoke On Trent, Staffs, England.; Topley, N (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	topley@cf.ac.uk; simondavies1@compuserve.com	Dorval, Marc/M-7219-2015; Lambie, Mark/AAA-9104-2020; Summers, Angela/AAC-9038-2019	Dorval, Marc/0000-0002-9548-978X; Lambie, Mark/0000-0002-6285-5368; Davies, Simon/0000-0001-5127-4755	Baxter Healthcare Renal Division; International Society for Peritoneal Dialysis	Baxter Healthcare Renal Division; International Society for Peritoneal Dialysis	Infrastructure support for the establishment of the GLOBAL fluid study was provided as unrestricted educational grants from Baxter Healthcare Renal Division (www.baxter.com) and the International Society for Peritoneal Dialysis (www.ispd.org). This study was officially endorsed by the ISPD (www.ispd.org) and by the British Renal Society (BRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Infrastructure support for the establishment of the GLOBAL fluid study was provided as unrestricted educational grants from Baxter Healthcare Renal Division and the International Society for Peritoneal Dialysis. This study was officially endorsed by the ISPD (www.ispd.org) and by the British Renal Society (BRS) (www.britishrenal.org). The authors would like to acknowledge the support of Anna-Clare Smith, Kathryn Craig, Maureen Fallon and Charlotte James in the co-ordination of the GLOBAL study, Christopher Huckvale in the development of PDDB, and the following clinical staff in the centres for co-ordination of sample and clinical data collection; Hilary Huxtable SRN., Renal Unit, Morriston Hospital, Swansea, UK; Gill Gilbert RGN BSc (Hons), Ipswich Hospital NHS Trust; Catherine Jones RGN, John Torode RGN and Jane Hollis RGN BSc (Hons), Cambridge University Hospitals NHS Foundation Trust; Jung-Ju Seo, RN, MS., Kyungpook National University Hospital, Daegu, South Korea; Kei-Lim Shin, RN., Yeungnam University Hospital, Daegu, South Korea; Sung Hee Chung, R.N., Ph.D., Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, South Korea; Joanne Leblanc-Chiasson, RN, Rachel Belliveau, RN, Regina Arsenault, RN, research assistant, Dr Georges-L.-Dumont Hospital, Moncton, New-Brunswick, Canada; Kathy Yetzer RN and Donna Hackman RN, Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada and the nursing teams on the PD Units of the University Hospital of Wales, Cardiff and University Hospital of North Staffordshire, Stoke-on-Trent.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2005, DIABETES CARE, V28, pS4; Borch-Johnsen K, 1999, LANCET, V354, P617; BOYER J, 1967, ANN INTERN MED, V67, P568, DOI 10.7326/0003-4819-67-3-568; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Caduff A, 2011, DIABETOLOGIA, V54, P2678, DOI 10.1007/s00125-011-2210-9; Chou CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087891; Chung SH, 2015, INT UROL NEPHROL, V47, P1017, DOI 10.1007/s11255-015-0987-z; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Garcia-Lopez E, 2005, PERITON DIALYSIS INT, V25, P181; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jiang N, 2008, BLOOD PURIFICAT, V26, P423, DOI 10.1159/000153248; Lambie M, 2013, J AM SOC NEPHRO 0905; Lee SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057762; Li PKT, 2013, J AM SOC NEPHROL, V24, P1889, DOI 10.1681/ASN.2012100987; Paniagua R, 2009, PERITON DIALYSIS INT, V29, P422; RASBASH J, 2005, MLWIN VERSION 2 02; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Szeto CC, 2007, AM J KIDNEY DIS, V49, P524, DOI 10.1053/j.ajkd.2007.01.018; Wong TYH, 2003, KIDNEY INT, V63, P1404, DOI 10.1046/j.1523-1755.2003.00883.x; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x	22	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155564	10.1371/journal.pone.0155564	http://dx.doi.org/10.1371/journal.pone.0155564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249020	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000377184700018
J	Marino, D; Perkovic, M; Hain, A; Vasudevan, AAJ; Hofmann, H; Hanschmann, KM; Muhlebach, MD; Schumann, GG; Konig, R; Cichutek, K; Haussinger, D; Munk, C				Marino, Daniela; Perkovic, Mario; Hain, Anika; Vasudevan, Ananda A. Jaguva; Hofmann, Henning; Hanschmann, Kay-Martin; Muehlebach, Michael D.; Schumann, Gerald G.; Koenig, Renate; Cichutek, Klaus; Haeussinger, Dieter; Muenk, Carsten			APOBEC4 Enhances the Replication of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA EDITING ENZYME; B MESSENGER-RNA; CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; MALE GENITAL-TRACT; VIF PROTEIN; IN-SITU; ANTIRETROVIRAL THERAPY; MOLECULAR-CLONING	APOBEC4 (A4) is a member of the AID/APOBEC family of cytidine deaminases. In this study we found a high mRNA expression of A4 in human testis. In contrast, there were only low levels of A4 mRNA detectable in 293T, HeLa, Jurkat or A3.01 cells. Ectopic expression of A4 in HeLa cells resulted in mostly cytoplasmic localization of the protein. To test whether A4 has antiviral activity similar to that of proteins of the APOBEC3 (A3) subfamily, A4 was co-expressed in 293T cells with wild type HIV-1 and HIV-1 luciferase reporter viruses. We found that A4 did not inhibit the replication of HIV-1 but instead enhanced the production of HIV-1 in a dose-dependent manner and seemed to act on the viral LTR. A4 did not show detectable cytidine deamination activity in vitro and weakly interacted with single-stranded DNA. The presence of A4 in virus producer cells enhanced HIV-1 replication by transiently transfected A4 or stably expressed A4 in HIV-susceptible cells. APOBEC4 was capable of similarly enhancing transcription from a broad spectrum of promoters, regardless of whether they were viral or mammalian. We hypothesize that A4 may have a natural role in modulating host promoters or endogenous LTR promoters.	[Marino, Daniela; Perkovic, Mario; Hain, Anika; Vasudevan, Ananda A. Jaguva; Hofmann, Henning; Haeussinger, Dieter; Muenk, Carsten] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Marino, Daniela; Perkovic, Mario; Hofmann, Henning; Muehlebach, Michael D.; Schumann, Gerald G.; Cichutek, Klaus; Muenk, Carsten] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany; [Hanschmann, Kay-Martin] Paul Ehrlich Inst, Biostat, Langen, Germany; [Muehlebach, Michael D.] Paul Ehrlich Inst, Prod Testing Immunol Med Prod Vet Uses, Langen, Germany; [Koenig, Renate] Paul Ehrlich Inst, Host Pathogen Interact, Langen, Germany; [Koenig, Renate] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, La Jolla, CA USA; [Perkovic, Mario] Johannes Gutenberg Univ Mainz, TRON Translat Oncol Univ Med Ctr, D-55122 Mainz, Germany; [Hofmann, Henning] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany	Heinrich Heine University Dusseldorf; Paul Ehrlich Institute; Paul Ehrlich Institute; Paul Ehrlich Institute; Paul Ehrlich Institute; Sanford Burnham Prebys Medical Discovery Institute; Johannes Gutenberg University of Mainz; Robert Koch Institute	Munk, C (corresponding author), Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany.; Munk, C (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany.	carsten.muenk@med.uni-duesseldorf.de	Perkovic, Mario/AAZ-2653-2021; Vasudevan, Ananda Ayyappan Jaguva/A-2272-2013; König, Renate/AAB-8918-2019	Vasudevan, Ananda Ayyappan Jaguva/0000-0001-7049-9458; König, Renate/0000-0003-4882-9179; Muehlebach, Michael/0000-0002-7069-5018; Perkovic, Mario/0000-0002-8969-5157	Heinz-Ansmann foundation for AIDS research	Heinz-Ansmann foundation for AIDS research	CM is supported by the Heinz-Ansmann foundation for AIDS research	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bednar MM, 2015, J VIROL, V89, P10688, DOI 10.1128/JVI.01842-15; Beggel B, 2013, J VIRAL HEPATITIS, V20, P882, DOI 10.1111/jvh.12110; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; Crowell RC, 2007, BIOCHEM SOC T, V35, P629, DOI 10.1042/BST0350629; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Fehrholz M, 2012, J GEN VIROL, V93, P565, DOI 10.1099/vir.0.038919-0; Fieni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076367; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Hoffmeyer A, 1999, J BIOL CHEM, V274, P4319, DOI 10.1074/jbc.274.7.4319; Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328; Ikeda T, 2008, NUCLEIC ACIDS RES, V36, P6859, DOI 10.1093/nar/gkn802; Ikeda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19035; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Lowe SH, 2004, AIDS, V18, P1353, DOI 10.1097/01.aids.0000125979.64033.96; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Matusali G, 2015, J VIROL, V89, P5772, DOI 10.1128/JVI.03628-14; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Metzner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049358; Muciaccia B, 1998, J REPROD IMMUNOL, V41, P81, DOI 10.1016/S0165-0378(98)00050-3; Muciaccia B, 1998, FASEB J, V12, P151, DOI 10.1096/fasebj.12.2.151; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2012, VIRUSES-BASEL, V4, P3132, DOI 10.3390/v4113132; Munk C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-71; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Polevoda B, 2015, NUCLEIC ACIDS RES, V43, P9434, DOI 10.1093/nar/gkv970; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Prohaska KM, 2014, WIRES RNA, V5, P493, DOI 10.1002/wrna.1226; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schumann GG, 2010, INT REV CEL MOL BIO, V285, P115, DOI 10.1016/S1937-6448(10)85003-8; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shevchuk MM, 1998, J REPROD IMMUNOL, V41, P69, DOI 10.1016/S0165-0378(98)00049-7; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stavrou S, 2015, CELL HOST MICROBE, V17, P478, DOI 10.1016/j.chom.2015.02.021; Stavrou S, 2013, P NATL ACAD SCI USA, V110, P9078, DOI 10.1073/pnas.1217399110; Steinhoff C, 2004, MOL GENET GENOMICS, V270, P394, DOI 10.1007/s00438-003-0931-2; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vasudevan AAJ, 2013, BIOL CHEM, V394, P1357, DOI 10.1515/hsz-2013-0165; Vasudevan AAJ, 2013, J VIROL, V87, P9030, DOI 10.1128/JVI.03385-12; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	92	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155422	10.1371/journal.pone.0155422	http://dx.doi.org/10.1371/journal.pone.0155422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249646	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700012
J	Pega, F; Wilson, N				Pega, Frank; Wilson, Nick			A Systematic Review of Health Economic Analyses of Housing Improvement Interventions and Insecticide-Treated Bednets in the Home	PLOS ONE			English	Review							COST-EFFECTIVENESS ANALYSIS; MALARIA CONTROL INTERVENTIONS; BENEFIT-ANALYSIS; VECTOR CONTROL; BED NETS; PREVENTION; TRANSMISSION; CHILDREN; PROGRAMS; FALLS	Background Housing improvements have considerable potential for improving health. So does the provision of insecticide-treated bednets for malaria prevention. Therefore we aimed to conduct updated systematic reviews of health economic analyses in both these intervention domains. Methods and findings The search strategy included economic analyses of housing improvement interventions and use of insecticide-treated bednets for community-dwelling, healthy populations (published between 1 January 2000 and 15 April 2014). We searched the Cochrane Database of Systematic Reviews, MEDLINE, PubMed, EMBASE, and three health economics databases. Thirty-five economic analyses of seven types of intervention fulfilled the inclusion criteria. Most included studies adopted a health sector perspective and were cost-effectiveness analyses using decision analytic modeling or conducted alongside trials. The overall quality of the studies was generally likely to be adequate for informing policy-making (albeit with limitations in some areas). There was fairly consistent evidence for the cost-effectiveness/favorable cost-benefit of removing indoor lead to prevent lead poisoning and sequelae, and retrofitting insulation to prevent lung disease. But the value of assessing and improving home safety and providing smoke alarms to prevent injuries was more mixed and the economic evidence was inconclusive or insufficient for: home ventilation to prevent lung disease, installing heaters to prevent lung disease and regulating tap water temperatures to prevent scalding. Few studies (n = 4) considered health equity. The 12 studies of providing insecticide-treated bednets or hammocks to prevent malaria found these interventions to be moderately to highly cost-effective. Conclusions This systematic review provides updated evidence that several housing improvement interventions (such as removing indoor lead and retrofitting insulation) and also the provision of insecticide-treated bednets are cost-effective interventions. Nevertheless, for some interventions additional analyses are required to better clarify their health economic and health equity value.	[Pega, Frank; Wilson, Nick] Univ Otago, Burden Dis Epidemiol Equ & Cost Effectiveness Pro, POB 7343, Wellington, New Zealand	University of Otago	Pega, F (corresponding author), Univ Otago, Burden Dis Epidemiol Equ & Cost Effectiveness Pro, POB 7343, Wellington, New Zealand.	frank.pega@otago.ac.nz			University of Otago through a Health Sciences Career Development Programme Postdoctoral Fellowship; Health Research Council of New Zealand [10/248]	University of Otago through a Health Sciences Career Development Programme Postdoctoral Fellowship; Health Research Council of New Zealand(Health Research Council of New Zealand)	This study was supported by the University of Otago (www.otago.ac.nz) through a Health Sciences Career Development Programme Postdoctoral Fellowship to FP and the Health Research Council of New Zealand (www.hrc.govt.nz) through funding for the Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme (grant number: 10/248) to NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2010, HEALTH ECON, V19, P350, DOI 10.1002/hec.1486; Barton A, 2007, J EPIDEMIOL COMMUN H, V61, P771, DOI 10.1136/jech.2006.048462; Bhatia MR, 2004, SOC SCI MED, V59, P525, DOI 10.1016/j.socscimed.2003.11.005; Brown MJ, 2002, MED DECIS MAKING, V22, P482, DOI 10.1177/0272989X02238298; Chapman R, 2009, J EPIDEMIOL COMMUN H, V63, P271, DOI 10.1136/jech.2007.070037; Chapman R., 2004, COST BENEFIT EVALUAT; Church J, 2012, AUST NZ J PUBL HEAL, V36, P241, DOI 10.1111/j.1753-6405.2011.00811.x; Dixon SL, 2012, ENVIRON RES, V113, P14, DOI 10.1016/j.envres.2012.01.005; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Edwards RT, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X606645; Fenwick E, 2013, J EPIDEMIOL COMMUN H, V67, P835, DOI 10.1136/jech-2012-202124; Franchimon Francesco, 2008, Gerontechnology, V7, P374, DOI 10.4017/gt.2008.07.04.025.00; Frick KD, 2010, J AM GERIATR SOC, V58, P136, DOI 10.1111/j.1532-5415.2009.02575.x; Ginnelly L, 2005, EUR J PUBLIC HEALTH, V15, P448, DOI 10.1093/eurpub/cki146; Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x; Gould E, 2009, ENVIRON HEALTH PERSP, V117, P1162, DOI 10.1289/ehp.0800408; Grimes A., 2012, COST BENEFIT ANAL WA; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Guyatt HL, 2002, HEALTH POLICY PLANN, V17, P144, DOI 10.1093/heapol/17.2.144; Haddix A C, 2001, Inj Prev, V7, P276, DOI 10.1136/ip.7.4.276; Han RK, 2007, INJURY PREV, V13, P248, DOI 10.1136/ip.2006.014480; Housing New Zealand, 2014, HLTH HOUS PROGR OUTC; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Jutkowitz Eric, 2012, J Aging Res, V2012, P680265, DOI 10.1155/2012/680265; Kamolratanakul P, 2001, AM J TROP MED HYG, V65, P279, DOI 10.4269/ajtmh.2001.65.279; Keall MD, 2015, LANCET, V385, P231, DOI 10.1016/S0140-6736(14)61006-0; Kochera Andrew, 2002, Issue Brief (Public Policy Inst (Am Assoc Retired Pers)), P1; Levy Jonathan I, 2003, Environ Health, V2, P4, DOI 10.1186/1476-069X-2-4; Ling Christian, 2008, Hawaii Med J, V67, P65; Liu Y, 2012, AM J PREV MED, V43, P385, DOI 10.1016/j.amepre.2012.06.021; Mackenzie IF BK, 2002, 2 CORNW ISL SCILL HL; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morel CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058205; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Nevin R, 2008, ENVIRON RES, V106, P410, DOI 10.1016/j.envres.2007.09.003; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petrou Stavros, 2011, BMJ, V342, pd1548, DOI 10.1136/bmj.d1548; Phillips CJ, 2011, INJURY PREV, V17, P238, DOI 10.1136/ip.2010.031393; Pichery C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-44; Preval N, 2010, ENERG POLICY, V38, P3965, DOI 10.1016/j.enpol.2010.03.020; Pulkki-Brannstrom Anni-Maria, 2012, Cost Eff Resour Alloc, V10, P5, DOI 10.1186/1478-7547-10-5; Salkeld G, 2000, AUST NZ J PUBL HEAL, V24, P265, DOI 10.1111/j.1467-842X.2000.tb01566.x; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-363; Somerville M, 2000, PUBLIC HEALTH, V114, P434, DOI 10.1016/S0033-3506(00)00383-8; The World Health Organization, 2008, CLOS GAP GEN HLTH EQ; Thomson H., 2013, Campbell Systematic Reviews, V9, P1; Thomson Hilary, 2009, Am J Public Health, V99 Suppl 3, pS681, DOI 10.2105/AJPH.2008.143909; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, ECONOMICS OF SOCIAL DETERMINANTS OF HEALTH AND HEALTH INEQUALITIES: A RESOURCE BOOK, P1; Wiseman V, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.161; World bank, 2021, GDP PER CAP CURR US; World Health Organization, 2014, COST EFF STRAT PLANN; Yukich JO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-51; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258; Zeeb H, 2009, WHO HANDBOOK ON INDOOR RADON: A PUBLIC HEALTH PERSPECTIVE, P1; Zelle SG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-20	58	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0151812	10.1371/journal.pone.0151812	http://dx.doi.org/10.1371/journal.pone.0151812			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249419	gold, Green Submitted, Green Published			2022-12-27	WOS:000377184700002
J	Sena-Velez, M; Redondo, C; Graham, JH; Cubero, J				Sena-Velez, Marta; Redondo, Cristina; Graham, James H.; Cubero, Jaime			Presence of Extracellular DNA during Biofilm Formation by Xanthomonas citri subsp citri Strains with Different Host Range	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; BACTERIAL BIOFILMS; MICROBIAL BIOFILMS; IV PILI; PROTEIN; VIRULENCE; CAMPESTRIS; CANKER	Xanthomonas citri subsp. citri (Xcc) A strain causes citrus bacterial canker, a serious leaf, fruit and stem spotting disease of several Citrus species. X. alfalfae subsp. citrumelonis (Xac) is the cause of citrus bacterial spot, a minor disease of citrus nursery plants and X. campestris pv. campestris (Xc) is a systemic pathogen that causes black rot of cabbage. Xanthomonas spp. form biofilms in planta that facilitate the host infection process. Herein, the role of extracellular DNA (eDNA) was evaluated in the formation and stabilization of the biofilm matrix at different stages of biofilm development. Fluorescence and light microscopy, as well as DNAse treatments, were used to determine the presence of eDNA in biofilms and bacterial cultures. DNAse treatments of Xcc strains and Xac reduced biofilm formation at the initial stage of development, as well as disrupted preformed biofilm. By comparison, no significant effect of the DNAse was detected for biofilm formation by Xc. DNAse effects on biofilm formation or disruption varied among Xcc strains and Xanthomonas species which suggest different roles for eDNA. Variation in the structure of fibers containing eDNA in biofilms, bacterial cultures, and in twitching motility was also visualized by microscopy. The proposed roles for eDNA are as an adhesin in the early stages of biofilm formation, as an structural component of mature bacterial aggregates, and twitching motility structures.	[Sena-Velez, Marta; Redondo, Cristina; Cubero, Jaime] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain; [Graham, James H.] Univ Florida, CREC, Lake Alfred, FL USA	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); State University System of Florida; University of Florida	Cubero, J (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain.	cubero@inia.es	Cubero, Jaime/D-2322-2017; Sena Velez, Marta/HDN-4763-2022	Cubero, Jaime/0000-0002-4314-857X; Sena Velez, Marta/0000-0001-9256-6084; REDONDO, CRISTINA/0000-0001-6303-3297	Citrus Research and Development Foundation [CRDF546]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project [RTA2008-00048]	Citrus Research and Development Foundation; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project	This work was supported by Citrus Research and Development Foundation project CRDF546 (JHG JC) and Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project RTA2008-00048 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Bakkali M, 2013, ARCH MICROBIOL, V195, P279, DOI 10.1007/s00203-013-0870-1; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Catlin WB, 1956, SCIENCE, V124, P441; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Cubero J, 2011, PLANT PATHOL, V60, P977, DOI 10.1111/j.1365-3059.2011.02450.x; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dunger G, 2014, MOL PLANT MICROBE IN, V27, P1132, DOI 10.1094/MPMI-06-14-0184-R; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; GRAHAM JH, 1990, PHYTOPATHOLOGY, V80, P190, DOI 10.1094/Phyto-80-190; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hayward A. C., 1993, Xanthomonas., P1; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Jalan N, 2013, GENOME ANNOUNCEMENTS, V1; Jalan N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-551; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Malamud F, 2013, MICROBIOL-SGM, V159, P1911, DOI 10.1099/mic.0.064709-0; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MOREIRA L, 2014, FUNCTIONAL AND INTEG, V15, P197, DOI DOI 10.1007/S10142-014-0414-Z; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Sena-Velez M, 2015, PLANT PATHOL, V64, P767, DOI 10.1111/ppa.12311; Sena-Velez M, 2012, XII INTERNATIONAL CI, V197; Sgro GG, 2012, MOL PLANT PATHOL, V13, P1047, DOI 10.1111/j.1364-3703.2012.00814.x; Shields RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055339; Strelkova EA, 2013, MICROBIOLOGY+, V82, P119, DOI 10.1134/S002626171302015X; Sun XA, 2004, PLANT DIS, V88, P1179, DOI 10.1094/PDIS.2004.88.11.1179; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; Verniere C, 1998, EUR J PLANT PATHOL, V104, P477, DOI 10.1023/A:1008676508688; Vicente JG, 2013, MOL PLANT PATHOL, V14, P2, DOI 10.1111/j.1364-3703.2012.00833.x; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yaryura PM, 2015, ENV MICROBIOL; Zimaro T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-96; Zimaro T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-186	57	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156695	10.1371/journal.pone.0156695	http://dx.doi.org/10.1371/journal.pone.0156695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248687	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700066
J	Zhang, WD; Wang, WH; Jia, S				Zhang, Wang-Dong; Wang, Wen-Hui; Jia, Shuai			The Distribution of SIgA and IgG Antibody-Secreting Cells in the Small Intestine of Bactrian Camels (Camelus bactrianus) of Different Ages	PLOS ONE			English	Article							AGGREGATED LYMPHOID NODULES; HUMAN GUT MICROBIOME; COMMENSAL BACTERIA; MUCOSAL SURFACES; DENDRITIC CELLS; B-CELLS; RESPONSES; COLONIZATION; HOMEOSTASIS; INFECTION	Secretory immunoglobulin A (SIgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) are two important cell types in the mucosal immune system. This study aimed to explore the distribution of these ASC populations in the small intestine of Bactrian camels of different ages. Twenty-four Alashan Bactrian camels were divided into the following four age groups: young (1-2 years), pubertal (3-5 years), middle-aged (6-16 years) and old (17-20 years). SIgA and IgG ASCs in the intestinal mucosa lamina propria (LP) were observed and analyzed using immunohistochemcal techniques. The results from all age groups show that both SIgA and IgG ASCs were diffusely distributed in the intestinal LP, and some cells aggregated around the crypts. Moreover, the densities of the two ASC populations gradually increased from the duodenum to the jejunum and then decreased in the ileum. Meanwhile, there were more SIgA ASCs than IgG ASCs in the duodenum, jejunum, and ileum, and these differences were significant in the young and pubertal groups (P<0.05). In addition, the SIgA and IgG ASC densities increased from the young to the pubertal period, peaked at puberty, and then gradually decreased with age. The results demonstrate that the SIgA and IgG ASC distributions help to form two immunoglobulin barriers in the intestinal mucosa to provide full protection, helping to maintain homeostasis. These findings also underscore the importance of researching the development and degeneration of intestinal mucosal immunity in Bactrian camels.	[Zhang, Wang-Dong; Wang, Wen-Hui; Jia, Shuai] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Wang, WH (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	wwh777@126.com		, Wang-Dong/0000-0002-4277-3437	National Natural Scientific Foundation [31260595, 30671549]; Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University [2013001]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University	This project was supported in part by the National Natural Scientific Foundation (Project Grant No. 31260595; 30671549) to Professor Wen-Hui Wang (http://www.nsfc.gov.cn), and the Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University (Project Grant No. 2013001) to Professor Wen-Hui Wang (http://www.gsau.edu.cn/).	Abdel-Magied EM, 2003, ANAT HISTOL EMBRYOL, V32, P42, DOI 10.1046/j.1439-0264.2003.00436.x; Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aydar Y, 2004, AGEING RES REV, V3, P15, DOI 10.1016/j.arr.2003.08.002; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Berneman A, 1998, INFECT IMMUN, V66, P4163; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Cerutti A, 2010, SCIENCE, V328, P1646, DOI 10.1126/science.1192488; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kim SC, 2007, INFLAMM BOWEL DIS, V13, P1457, DOI 10.1002/ibd.20246; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lin-Jiang Z, 2012, STUDY DISTRIBUTION B; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Qi SS, 2011, TROP ANIM HEALTH PRO, V43, P1219, DOI 10.1007/s11250-011-9829-x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schmucker Douglas L, 2003, Clin Dev Immunol, V10, P167, DOI 10.1080/10446670310001642168; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Szakal AK, 2002, SEMIN IMMUNOL, V14, P267, DOI 10.1016/S1044-5323(02)00059-3; Tillib SV, 2011, MOL BIOL+, V45, P66, DOI 10.1134/S0026893311010134; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; Wang WH, 2003, VET J, V166, P205, DOI 10.1016/S1090-0233(02)00263-0; Wang-dong Z, 2012, STUDY ON THE PURIFIC; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Xu XH, 2010, VET J, V184, P362, DOI 10.1016/j.tvjl.2009.03.003; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang WD, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0538-y; Zhang WD, 2012, VET IMMUNOL IMMUNOP, V147, P147, DOI 10.1016/j.vetimm.2012.04.007; Zhaxi YP, 2014, ANAT REC, V297, P1292, DOI 10.1002/ar.22939	52	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156635	10.1371/journal.pone.0156635	http://dx.doi.org/10.1371/journal.pone.0156635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249417	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700061
J	Iqbal, Q; Lubeck-Schricker, M; Wells, E; Wolfe, MK; Lantagne, D				Iqbal, Qais; Lubeck-Schricker, Maya; Wells, Emma; Wolfe, Marlene K.; Lantagne, Daniele			Shelf-Life of Chlorine Solutions Recommended in Ebola Virus Disease Response	PLOS ONE			English	Article								In Ebola Virus Disease (EVD) outbreaks, it is widely recommended to wash living things (handwashing) with 0.05% (500 mg/L) chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% (5,000 mg/L) chlorine solution. Chlorine solutions used in EVD response are primarily made from powdered calcium hypochlorite (HTH), granular sodium dichloroisocyanurate (NaDCC), and liquid sodium hypochlorite (NaOCl), and have a pH range of 5-11. Chlorine solutions degrade following a reaction highly dependent on, and unusually sensitive to, pH, temperature, and concentration. We determined the shelf-life of 0.05% and 0.5% chlorine solutions used in EVD response, including HTH, NaDCC, stabilized NaOCl, generated NaOCl, and neutralized NaOCl solutions. Solutions were stored for 30 days at 25, 30, and 35 degrees C, and tested daily for chlorine concentration and pH. Maximum shelf-life was defined as days until initial concentration fell to <90% of initial concentration in ideal laboratory conditions. At 25-35 degrees C, neutralized-NaOCl solutions (pH = 7) had a maximum shelf-life of a few hours, NaDCC solutions (pH = 6) 2 days, generated NaOCl solutions (pH = 9) 6 days, and HTH and stabilized NaOCl solutions (pH 9-11) >30 days. Models were developed for solutions with maximum shelf-lives between 1-30 days. Extrapolating to 40 degrees C, the maximum predicted shelf-life for 0.05% and 0.5% NaDCC solutions were 0.38 and 0.82 hours, respectively; predicted shelf-life for 0.05% and 0.5% generated NaOCl solutions were >30 and 5.4 days, respectively. Each chlorine solution type offers advantages and disadvantages to responders, as: NaDCC is an easy-to-import high-concentration effervescent powder; HTH is similar, but forms a precipitate that may clog pipes; and, NaOCl solutions can be made locally, but are difficult to transport. We recommend responders chose the most appropriate source chlorine compound for their use, and ensure solutions are stored at appropriate temperatures and used or replaced before expiring.	[Iqbal, Qais; Wells, Emma; Wolfe, Marlene K.; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Lubeck-Schricker, Maya] Concord Acad, Concord, MA USA	Tufts University	Lantagne, D (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	daniele.lantagne@tufts.edu			United States Agency for International Development, Office of Foreign Disaster Assistance [AID-OFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance (AID-OFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders were provided a final version of the manuscript before submission, and had only minor grammatical comments.	[Anonymous], EB EB VIR DIS TRANSM; [Anonymous], EB EB VIR DIS SIGNS; [Anonymous], HAND HYG W AFR GEN N; Clasen T, 2006, INT J HYG ENVIR HEAL, V209, P173, DOI 10.1016/j.ijheh.2005.11.004; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Emmanueal Jorge N Babacar, 2015, ASSESSMENT RECOMMEND; Gordon G., 1996, AWWA WAT QUAL TECHN; Gordon G., 1995, MINIMIZING CHLORATE; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; Lantagne D, 2011, J ENVIRON ENG-ASCE, V137, P131, DOI 10.1061/(ASCE)EE.1943-7870.0000299; National Research Council (US) Safe Drinking Water Committee, 1980, DRINK WAT HLTH, V2; Rice E.W., 2012, STANDARD METHODS EXA; Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182; Sterk E, MED SANS FRONTIERES; Walker J., 2014, DECONTAMINATION HOSP; WHO, 2009, WHO GUID HAND HYG HE; WHO CDC, 1998, INF CONTR VIR HAEM F; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, EB VIR DIS	19	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156136	10.1371/journal.pone.0156136	http://dx.doi.org/10.1371/journal.pone.0156136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244552	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100016
J	Naffaa, MM; Absalom, N; Solomon, VR; Chebib, M; Hibbs, DE; Hanrahan, JR				Naffaa, Moawiah M.; Absalom, Nathan; Solomon, V. Raja; Chebib, Mary; Hibbs, David E.; Hanrahan, Jane R.			Investigating the Role of Loop C Hydrophilic Residue 'T244' in the Binding Site of rho 1 GABA(C) Receptors via Site Mutation and Partial Agonism	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; XENOPUS OOCYTES; PHARMACOLOGY; ACID; SUBUNIT; ANTAGONISTS; ACTIVATION; EXPRESSION; TEMPLATES; CHANNELS	The loop C hydrophilic residue, threonine 244 lines the orthosteric binding site of rho 1 GABA(C) receptors was studied by point mutation into serine, alanine and cysteine, and tested with GABA, some representative partial agonists and antagonists. Thr244 has a hydroxyl group essential for GABA activity that is constrained by the threonine methyl group, orienting it toward the binding site. Significant decreases in activation effects of the studied ligands at rho 1 T244S mutant receptors, suggests a critical role for this residue. Results of aliphatic and heteroaromatic partial agonists demonstrate different pharmacological effects at rho 1 T244S mutant receptors when co-applied with GABA EC50 responses. rho 1 T244A and rho 1 T244C mutant receptors have minimal sensitivity to GABA at high mM concentrations, whereas, the rho 1 WT partial agonists, beta-alanine and MTSEA demonstrate more efficacy and potency, respectively, than GABA at these mutant receptors. This study explores the role of Thr244 in the binding of agonists as an initial step during channel gating by moving loop C towards the ligand.	[Naffaa, Moawiah M.; Absalom, Nathan; Solomon, V. Raja; Chebib, Mary; Hibbs, David E.; Hanrahan, Jane R.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Hanrahan, JR (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	jane.hanrahan@sydney.edu.au	Hanrahan, Jane R/A-8155-2010; Viswas, Raja Solomon/AAA-1020-2022; Viswas, Raja Solomon/F-6654-2011	Hanrahan, Jane R/0000-0001-8205-0260; Viswas, Raja Solomon/0000-0002-9863-4452; Viswas, Raja Solomon/0000-0002-9863-4452; naffaa, moawiah/0000-0003-0451-5901				Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; [Anonymous], 2013, GLID VERS 5 9; [Anonymous], 2013, LIGPREP VERS 2 6; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnaud C, 2001, PSYCHOPHARMACOLOGY, V154, P415, DOI 10.1007/s002130000653; Bailey MES, 1999, BBA-GENE STRUCT EXPR, V1447, P307, DOI 10.1016/S0167-4781(99)00167-0; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blednov YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085525; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Boue-Grabot E, 2000, ENDOCRINOLOGY, V141, P1627, DOI 10.1210/en.141.5.1627; Boue-Grabot E, 1998, J NEUROCHEM, V70, P899; Braman J, 1996, Methods Mol Biol, V57, P31; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; FEIGENSPAN A, 1994, EUR J PHARM-MOLEC PH, V288, P97, DOI 10.1016/0922-4106(94)90014-0; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Hanrahan JR, 2001, J CHEM SOC PERK T 1, P2389, DOI 10.1039/b105989k; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; JOHNSTON GA, 1975, J NEUROCHEM, V24, P157, DOI 10.1111/j.1471-4159.1975.tb07642.x; Johnston GAR, 1998, NEUROLOGICALLY ACTIV; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; JOHNSTON TP, 1961, J ORG CHEM, V26, P3780, DOI 10.1021/jo01068a037; KUSAMA T, 1993, BRIT J PHARMACOL, V109, P200, DOI 10.1111/j.1476-5381.1993.tb13554.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lopez-Chavez A, 2005, NEUROSCI RES, V53, P421, DOI 10.1016/j.neures.2005.08.014; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Naffaa MM, 2015, J MOL GRAPH MODEL, V62, P43, DOI 10.1016/j.jmgm.2015.09.002; Ochoa-de la Paz LD, 2008, NEUROSCI RES, V61, P302, DOI 10.1016/j.neures.2008.03.009; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Schrodinger, 2013, MAESTR; Schrodinger, 2013, PRIM VERS 3 2; WOODWARD RM, 1993, MOL PHARMACOL, V43, P609; Yamamoto I, 2012, ACS CHEM NEUROSCI, V3, P665, DOI 10.1021/cn3000229; Yang L, 2003, J NEUROCHEM, V87, P791, DOI 10.1046/j.1471-4159.2003.02069.x; Zhang DX, 2001, TRENDS PHARMACOL SCI, V22, P121, DOI 10.1016/S0165-6147(00)01625-4	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156618	10.1371/journal.pone.0156618	http://dx.doi.org/10.1371/journal.pone.0156618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244450	Green Submitted, gold, Green Published			2022-12-27	WOS:000377146100056
J	Byrt, CS; Betts, NS; Tan, HT; Lim, WL; Ermawar, RA; Nguyen, HY; Shirley, NJ; Lahnstein, J; Corbin, K; Fincher, GB; Knauf, V; Burton, RA				Byrt, Caitlin S.; Betts, Natalie S.; Tan, Hwei-Ting; Lim, Wai Li; Ermawar, Riksfardini A.; Hai Yen Nguyen; Shirley, Neil J.; Lahnstein, Jelle; Corbin, Kendall; Fincher, Geoffrey B.; Knauf, Vic; Burton, Rachel A.			Prospecting for Energy-Rich Renewable Raw Materials: Sorghum Stem Case Study	PLOS ONE			English	Article							CELL-WALL; GENETIC-VARIATION; SWEET SORGHUM; ETHANOL YIELD; CELLULOSE; BARLEY; BIOMASS; COMPONENTS; GENOME; (1,3/1,4)-BETA-D-GLUCAN	Sorghum vegetative tissues are becoming increasingly important for biofuel production. The composition of sorghum stem tissues is influenced by genotype, environment and photoperiod sensitivity, and varies widely between varieties and also between different stem tissues (outer rind vs inner pith). Here, the amount of cellulose, (1,3;1,4)-beta-glucan, arabinose and xylose in the stems of twelve diverse sorghum varieties, including four photoperiod-sensitive varieties, was measured. At maturity, most photoperiod-insensitive lines had 1% w/w (1,3;1,4)-beta-glucan in stem pith tissue whilst photoperiod-sensitive varieties remained in a vegetative stage and accumulated up to 6% w/w (1,3;1,4)-beta-glucan in the same tissue. Three sorghum lines were chosen for further study: a cultivated grain variety (Sorghum bicolor BTx623), a sweet variety (S. bicolor Rio) and a photoperiod-sensitive wild line (S. bicolor ssp. verticilliflorum Arun). The Arun line accumulated 5.5% w/w (1,3;1,4)-beta-glucan and had higher SbCslF6 and SbCslH3 transcript levels in pith tissues than did photoperiodinsensitive varieties Rio and BTx623 (< 1% w/w pith (1,3;1,4)-beta-glucan). To assess the digestibility of the three varieties, stem tissue was treated with either hydrolytic enzymes or dilute acid and the release of fermentable glucose was determined. Despite having the highest lignin content, Arun yielded significantly more glucose than the other varieties, and theoretical calculation of ethanol yields was 10 344 L ha(-1) from this sorghum stem tissue. These data indicate that sorghum stem (1,3;1,4)-beta-glucan content may have a significant effect on digestibility and bioethanol yields. This information opens new avenues of research to generate sorghum lines optimised for biofuel production.	[Byrt, Caitlin S.; Betts, Natalie S.; Tan, Hwei-Ting; Lim, Wai Li; Ermawar, Riksfardini A.; Hai Yen Nguyen; Shirley, Neil J.; Lahnstein, Jelle; Corbin, Kendall; Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Urrbrae, SA, Australia; [Knauf, Vic] Arcadia Biosci, Davis, CA USA	University of Adelaide	Byrt, CS (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Urrbrae, SA, Australia.	caitlin.byrt@adelaide.edu.au	Betts, Natalie/F-2794-2012; Burton, Rachel A/C-4441-2011; Byrt, Caitlin/I-9785-2018	Betts, Natalie/0000-0002-3345-8160; Burton, Rachel A/0000-0002-0638-4709; Byrt, Caitlin/0000-0001-8549-2873; Ermawar, Riksfardini/0000-0001-6356-9999; Shirley, Neil/0000-0001-8114-9891; Lim, Wai Li/0000-0003-2514-3799	Australian Researcher Council [DE150100837]; Arcadia Biosciences	Australian Researcher Council; Arcadia Biosciences	CSB received an Australian Researcher Council Discovery Early Career Research Award (DE150100837); Australian Research Council Centre of Excellence in Plant Cell Walls http://www.arc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Arcadia Biosciences provided support in the form of salaries for author VK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Aditya J, 2015, NEW PHYTOL; Amaducci S, 2004, IND CROP PROD, V20, P111, DOI 10.1016/j.indcrop.2003.12.016; Arundale RA, 2015, BIOENERG RES, P1; Bacic A., 1988, BIOCHEM PLANT, V14, P297, DOI [DOI 10.1016/B978-0-08-092615-5.50014-X, 10.1016/B978-0-08-092615-5.50014-X]; Bennett AS, 2009, BIORESOURCE TECHNOL, V100, P1595, DOI 10.1016/j.biortech.2008.09.023; Betts NS, 2015, J CEREAL SCI, V63, P64, DOI 10.1016/j.jcs.2015.02.007; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Burton RA, 2011, PLANT BIOTECHNOL J, V9, P117, DOI 10.1111/j.1467-7652.2010.00532.x; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Byrt CS, 2013, BIOFUEL CROPS: PRODUCTION, PHYSIOLOGY AND GENETICS, P135, DOI 10.1079/9781845938857.0135; Byrt CS, 2011, J INTEGR PLANT BIOL, V53, P120, DOI 10.1111/j.1744-7909.2010.01023.x; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974; Corbin KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135382; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Dillon Sally L., 2005, Plant Genetic Resources Characterization and Utilization, V3, P19, DOI 10.1079/PGR200454; Dillon SL, 2004, PLANT SYST EVOL, V249, P233, DOI 10.1007/s00606-004-0210-7; Dillon SL, 2001, PLANT SYST EVOL, V230, P97, DOI 10.1007/s006060170007; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Ejeta G, 2005, Crop Ferality and Volunteerism, P123; Energy USDoEEaR, 2014, THEOR ETH YIELD CALC; Ermawar RA, 2015, J INTEGR PLANT BIOL, V57, P429, DOI 10.1111/jipb.12338; Fincher G.B., 2004, ENCY GRAIN SCI, P206, DOI [10.1016/B0-12-765490-9/00107-5, DOI 10.1016/B0-12-765490-9/00107-5]; Folliard A, 2004, FIELD CROP RES, V89, P59, DOI 10.1016/j.fcr.2004.01.006; Grof C. P. L., 2013, PHLOEM TRANSPORT RES; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Martin AP, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-186; MCBEE GG, 1990, AGRON J, V82, P687, DOI 10.2134/agronj1990.00021962008200040008x; MCBEE GG, 1988, BIOMASS, V17, P203, DOI 10.1016/0144-4565(88)90114-X; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Mullet J, 2014, J EXPT BOT; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Nemeth C, 2010, PLANT PHYSIOL, V152, P1209, DOI 10.1104/pp.109.151712; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pauly M, 2011, INVENTORSMAIZE VARIE; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Pollock C, 2003, J EXP BOT, V54, P489, DOI 10.1093/jxb/erg037; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghuwanshi A, 2010, PLANT CELL REP, V29, P997, DOI 10.1007/s00299-010-0885-x; RICHIE WR, 1991, BIORESOURCE TECHNOL, V38, P15, DOI 10.1016/0960-8524(91)90216-7; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; Saballos A, 2012, PLANT J, V70, P818, DOI 10.1111/j.1365-313X.2012.04933.x; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Selig M. J., 2010, Industrial Biotechnology, V6, P104, DOI 10.1089/ind.2010.0009; Shakoor N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-35; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Snider JL, 2012, IND CROP PROD, V37, P527, DOI 10.1016/j.indcrop.2011.07.032; Stefaniak TR, 2012, CROP SCI, V52, P1949, DOI 10.2135/cropsci2011.10.0534; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Tang P, 2015, BIOENERG RES, P1; THEANDER O, 1986, J AGR FOOD CHEM, V34, P330, DOI 10.1021/jf00068a045; Trafford K, 2013, J EXPT BOT; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vancov T, 2012, APPL ENERG, V92, P421, DOI 10.1016/j.apenergy.2011.11.053; Vancov T, 2011, ENERG FUEL, V25, P2754, DOI 10.1021/ef200241s; Vega-Sanchez ME, 2015, PLANT BIOTECHNOLOGY; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406; Wong SC, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0208-6; Zhao YL, 2009, FIELD CROP RES, V111, P55, DOI 10.1016/j.fcr.2008.10.006; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	70	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156638	10.1371/journal.pone.0156638	http://dx.doi.org/10.1371/journal.pone.0156638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232754	Green Submitted, gold, Green Published			2022-12-27	WOS:000376883000049
J	Kahle, K; Sharon, AJ; Baram-Tsabari, A				Kahle, Kate; Sharon, Aviv J.; Baram-Tsabari, Ayelet			Footprints of Fascination: Digital Traces of Public Engagement with Particle Physics on CERN's Social Media Platforms	PLOS ONE			English	Article							SCIENCE; FACEBOOK	Although the scientific community increasingly recognizes that its communication with the public may shape civic engagement with science, few studies have characterized how this communication occurs online. Social media plays a growing role in this engagement, yet it is not known if or how different platforms support different types of engagement. This study sets out to explore how users engage with science communication items on different platforms of social media, and what are the characteristics of the items that tend to attract large numbers of user interactions. Here, user interactions with almost identical items on five of CERN's social media platforms were quantitatively compared over an eight-week period, including likes, comments, shares, click-throughs, and time spent on CERN's site. The most popular items were qualitatively analyzed for content features. Findings indicate that as audience size of a social media platform grows, the total rate of engagement with content tends to grow as well. However, per user, engagement tends to decline with audience size. Across all platforms, similar topics tend to consistently receive high engagement. In particular, awe-inspiring imagery tends to frequently attract high engagement across platforms, independent of newsworthiness. To our knowledge, this study provides the first cross-platform characterization of public engagement with science on social media. Findings, although focused on particle physics, have a multidisciplinary nature; they may serve to benchmark social media analytics for assessing science communication activities in various domains. Evidence-based suggestions for practitioners are also offered.	[Kahle, Kate] CERN, Editorial Content Dev Sect, Educ Commun & Outreach Grp, CH-1211 Geneva 23, Switzerland; [Sharon, Aviv J.; Baram-Tsabari, Ayelet] Technion Israel Inst Technol, Fac Educ Sci & Technol, Haifa, Israel	European Organization for Nuclear Research (CERN); Technion Israel Institute of Technology	Baram-Tsabari, A (corresponding author), Technion Israel Inst Technol, Fac Educ Sci & Technol, Haifa, Israel.	ayelet@technion.ac.il		Sharon, Aviv/0000-0003-1326-2168; Baram-Tsabari, Ayelet/0000-0002-8123-5519	CERN - European Organization for Nuclear Research; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1716/12]	CERN - European Organization for Nuclear Research; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	ABT was supported by subsistence for a month stay at CERN - European Organization for Nuclear Research (URL: http://home.cern/). ABT and AJS were supported by a grant of the I-CORE Program (www.i-core.org.il) of the Planning and Budgeting Committee and The Israel Science Foundation (1716/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AA, 2014, J COMPUT-MEDIAT COMM, V19, P373, DOI 10.1111/jcc4.12009; [Anonymous], SYMMETRY MAGAZINE; [Anonymous], 2013, THE ECONOMIST   0810; Baram-Tsabari A, 2015, PUBLIC UNDERST SCI, V24, P326, DOI 10.1177/0963662513491369; Baram-Tsabari A, 2015, J RES SCI TEACH, V52, P135, DOI 10.1002/tea.21202; Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353; Bhattacharya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112235; Boland B, 2014, FACEBOOK        0605; Bressan Beatrice, 2011, COLLISIONS COLLABORA, P201; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Brossard D, 2013, SCIENCE, V339, P40, DOI 10.1126/science.1232329; CERN, COMM STRAT 2012 2016; Company Info, 2016, FAC NEWSR; Eulenstein M, 2015, FACEBOOK NEWSRO 0421; Fauville G, 2015, COMPUT EDUC, V82, P60, DOI 10.1016/j.compedu.2014.11.003; Haran B, 2010, YOUTUBE; Harp SF, 1997, J EDUC PSYCHOL, V89, P92, DOI 10.1037/0022-0663.89.1.92; Hine C, 2014, PUBLIC UNDERST SCI, V23, P574, DOI 10.1177/0963662512453419; Jahr M, 2016, OFFICAL TWITTER 0210; Kessler E, 2015, OFFICIAL GOOGLE 1117; Knowles R, 2017, JOURNALISM, V18, P350, DOI 10.1177/1464884915620230; Konneker C, 2013, SCIENCE, V342, P49, DOI 10.1126/science.1245848; Krug S, 2016, FACEBOOK NEWSRO 0224; Laslo E, 2011, JOURNALISM, V12, P847, DOI 10.1177/1464884911412709; Len-Rios ME, 2014, SCI COMMUN, V36, P778, DOI 10.1177/1075547014556195; Lufkens M, 2013, TWIPLOMACY HEADS STA; Lufkens M, 2015, TWIPLOMACY INT ORG T; McFarland LA, 2015, J APPL PSYCHOL, V100, P1653, DOI 10.1037/a0039244; Milkman KL, 2014, P NATL ACAD SCI USA, V111, P13642, DOI 10.1073/pnas.1317511111; Nahon K., 2013, GOING VIRAL; National Science Board, 2016, SCI TECHN PUBL ATT U; National Science Board, 2014, SCI TECHN PUBL ATT U; Newman N., 2015, DIGITAL NEWS REPORT; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; NOWOTNY H, 2013, RETHINKING SCI KNOWL; Perrin A, 2015, SOCIAL MEDIA USAGE 2; Reich H, 2012, YOUTUBE; Ross P, 2014, SOCIALBAKERS    1121; Ross P, 2014, SOCIALBAKERS    0408; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Scanlon E, 2014, BRIT J EDUC TECHNOL, V45, P12, DOI 10.1111/bjet.12010; Segev E, 2012, PUBLIC UNDERST SCI, V21, P813, DOI 10.1177/0963662510387560; Simo F., 2016, FACEBOOK NEWSRO 0406; Smith TW, 2015, GEN SOCIAL SURVEYS 1; Tenenboim O, 2015, JOURNALISM, V16, P198, DOI 10.1177/1464884913513996; Thomas G., 1987, SCI LIT PAPERS, V1, P1; Tian Y, 2010, HEALTH COMMUN, V25, P238, DOI 10.1080/10410231003698911; Traweek Sharon, 1988, BEAMTIMES LIFETIMES; Trench B, 2008, COMMUNICATING SCIENCE IN SOCIAL CONTEXTS: NEW MODELS, NEW PRACTICES, P119, DOI 10.1007/978-1-4020-8598-7_7; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904; Xenos MA, 2011, SOC SCI QUART, V92, P1191, DOI 10.1111/j.1540-6237.2011.00814.x	51	23	23	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156409	10.1371/journal.pone.0156409	http://dx.doi.org/10.1371/journal.pone.0156409			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232498	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000031
J	Villuendas-Gonzalez, ER; Gonzalez-Garrido, AA				Rogelio Villuendas-Gonzalez, Erwin; Antonio Gonzalez-Garrido, Andres			Feedback-Related ERP Components Are Modulated by Social Distance during Non-Contingent Evaluation of Someone Else's Performance	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN POTENTIALS; ERROR-DETECTION; NEURAL SYSTEM; REWARD; P300; SELF; NEGATIVITY; RESPONSES; DYNAMICS	Performance monitoring depends on cortical structures that are also activated in vicarious monitoring. While many experiments have shown that vicarious and on-line monitoring have a similar basis, most such experiments have focused on simple tasks. In order to assess the effect of non-contingent feedback on vicarious monitoring, 23 young volunteer adults were evaluated: in one session, they performed a rule-based category formation task, receiving no feedback on their performance. In a second session, Event Related Potentials (ERPs) were obtained while participants passively reviewed performances attributed to themselves and peers they had previously rated as either socially close or distant. Feedback Related Negativity (FRN) and Feedback Related P300 (fP300) components were analyzed with respect to feedback valence and agent. Results show that both components can be elicited through non-contingent feedback related to prior performance. In addition, FRN waves are modulated by the valence of the feedback, and fP300 is modulated by the agent to whom performance feedback is attributed. This experiment constitutes a novel approach to the evaluation of ERP correlates of vicarious monitoring through non-contingent feedback and its relations to empathy processing.	[Rogelio Villuendas-Gonzalez, Erwin] Univ Michoacana, Fac Psicol, Morelia, Michoacan, Mexico; [Rogelio Villuendas-Gonzalez, Erwin; Antonio Gonzalez-Garrido, Andres] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Inst Neurociencias, Lab Neurofisiol Clin, Guadalajara 44430, Jalisco, Mexico; [Antonio Gonzalez-Garrido, Andres] Univ Guadalajara, Hosp Civil Fray Antonio Alcalde, Guadalajara 44430, Jalisco, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad de Guadalajara; Universidad de Guadalajara	Villuendas-Gonzalez, ER (corresponding author), Univ Michoacana, Fac Psicol, Morelia, Michoacan, Mexico.; Villuendas-Gonzalez, ER (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Inst Neurociencias, Lab Neurofisiol Clin, Guadalajara 44430, Jalisco, Mexico.	erwinvilluendas@gmail.com	González-Garrido, Andrés A./T-3044-2019	González-Garrido, Andrés A./0000-0003-4594-5270; Villuendas Gonzalez, Erwin/0000-0001-9141-8514				Apps MAJ, 2015, J NEUROSCI, V35, P2904, DOI 10.1523/JNEUROSCI.3669-14.2015; Bartholow B. D., 2009, METHODS SOCIAL NEURO, P198; Bauchl C, 2010, THESIS U WIEN; Bellebaum C, 2010, CEREB CORTEX, V20, P2874, DOI 10.1093/cercor/bhq038; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Carp J, 2009, SOC NEUROSCI-UK, V4, P85, DOI 10.1080/17470910802083167; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Donchin E, 1998, BEHAV BRAIN SCI, V21, P152, DOI 10.1017/S0140525X98230950; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Koban L, 2012, COGN AFFECT BEHAV NE, V12, P460, DOI 10.3758/s13415-012-0091-0; Leng Y, 2010, NEUROPSYCHOLOGIA, V48, P448, DOI 10.1016/j.neuropsychologia.2009.10.002; Luck S.J., 2005, INTRO EVENT RELATED; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; TREADWELL TW, 1993, SMALL GR RES, V24, P155, DOI 10.1177/1046496493242001; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00197; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Villuendas Erwin, 2016, OPEN SCI FRAMEWORK; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2006, NEUROREPORT, V17, P1649, DOI 10.1097/01.wnr.0000236866.39328.1d; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50	41	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156656	10.1371/journal.pone.0156656	http://dx.doi.org/10.1371/journal.pone.0156656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232887	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000050
J	Marron, B; Ostrowski, J; Torok, M; Timofte, D; Orosz, A; Kosicki, A; Calka, A; Moro, D; Kosa, D; Redl, J; Qureshi, AR; Divino, JC				Marron, Belen; Ostrowski, Janusz; Torok, Marietta; Timofte, Delia; Orosz, Attila; Kosicki, Andrzej; Calka, Alicja; Moro, Daniela; Kosa, Dezider; Redl, Jeno; Qureshi, Abdul Rashid; Divino-Filho, Jose Carolino		PD Clin Eastern Europe	Type of Referral, Dialysis Start and Choice of Renal Replacement Therapy Modality in an International Integrated Care Setting	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LONG-TERM SURVIVAL; PREDIALYSIS EDUCATION; PERITONEAL-DIALYSIS; ESRD; INITIATION; PROGRAMS; IMPACT; PROGRESSION; NEPHROLOGY	Introduction Integrated Care Settings (ICS) provide a holistic approach to the transition from chronic kidney disease into renal replacement therapy (RRT), offering at least both types of dialysis. Objectives To analyze which factors determine type of referral, modality provision and dialysis start on final RRT in ICS clinics. Methods Retrospective analysis of 626 patients starting dialysis in 25 ICS clinics in Poland, Hungary and Romania during 2012. Scheduled initiation of dialysis with a permanent access was considered as planned RRT start. Results Modality information (80% of patients) and renal education (87%) were more frequent (p<0.001) in Planned (P) than in Non-Planned (NP) start. Median time from information to dialysis start was 2 months. 89% of patients started on hemodialysis, 49% were referred late to ICS (<3 months from referral to RRT) and 58% were NP start. Late referral, non-vascular renal etiology, worse clinical status, shorter time from information to RRT and less peritoneal dialysis (PD) were associated with NP start (p<0.05). In multivariate logistic regression analysis, P start (p <= 0.05) was associated with early referral, eGFR >8.2 ml/min, >2 months between information and RRT initiation and with vascular etiology after adjustment for age and gender. "Optimal care," defined as ICS follow-up > 12 months plus modality information and P start, occurred in 23%. Conclusions Despite the high rate of late referrals, information and education were widely provided. However, NP start was high and related to late referral and may explain the low frequency of PD.	[Marron, Belen] Diaverum Home Therapies, Med Off, Munich, Germany; [Ostrowski, Janusz] Wloclawek Diaverum Clin, Wloclawek, Poland; [Torok, Marietta] Szeged Diaverum Clin, Szeged, Hungary; [Timofte, Delia] Semaparc Diaverum Clin, Bucharest, Romania; [Orosz, Attila] Bajcsy Diaverum Clin, Budapest, Hungary; [Kosicki, Andrzej] Przemysl Diaverum Clin, Przemysl, Poland; [Calka, Alicja] Olsztyn Diaverum Clin, Olsztyn, Poland; [Moro, Daniela] Sibiu Distributei Diaverum Clin, Sibiu, Romania; [Kosa, Dezider] Zalaegerszeg Diaverum Clin, Zalaegerszeg, Hungary; [Redl, Jeno] Szolnok Diaverum Clin, Szolnok, Hungary; [Qureshi, Abdul Rashid; Divino-Filho, Jose Carolino] Karolinska Inst, CLINTEC, Div Renal Med, Stockholm, Sweden	Diaverum; Diaverum; Diaverum; Szeged University; Diaverum; Diaverum; Diaverum; Diaverum; Diaverum; Diaverum; Diaverum; Karolinska Institutet	Marron, B (corresponding author), Diaverum Home Therapies, Med Off, Munich, Germany.	belen.marron@diaverum.com	Divino-Filho, Jose/V-5425-2019; Timofte, Delia/AAC-7954-2019	Timofte, Delia/0000-0002-0579-6349; Ostrowski, Janusz/0000-0003-1847-512X				Baer G, 2010, CLIN KIDNEY J, V3, P17, DOI 10.1093/ndtplus/sfp050; Bagnis CI, 2015, NEPHROL DIAL TRANSPL, V30, P1058, DOI 10.1093/ndt/gfu225; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Cass A, 2003, AM J KIDNEY DIS, V42, P1043, DOI 10.1016/j.ajkd.2003.07.006; Cerqueira DC, 2014, CLIN J AM SOC NEPHRO, V9, P728, DOI 10.2215/CJN.06630613; Covic A, 2010, NEPHROL DIAL TRANSPL, V25, P1757, DOI 10.1093/ndt/gfq206; Curtis BM, 2005, NEPHROL DIAL TRANSPL, V20, P147, DOI 10.1093/ndt/gfh585; De Vecchi AF, 1999, NEPHROL DIAL TRANSPL, V14, P31, DOI 10.1093/ndt/14.suppl_6.31; Gayoso-Diz P, 2013, NEFROLOGIA, V33, P223, DOI 10.3265/Nefrologia.pre2013.Jan.11792; Golper TA, 2013, PERITON DIALYSIS INT, V33, P596, DOI 10.3747/pdi.2013.00212; Goovaerts T, 2015, J RENAL CARE, V41, P62, DOI 10.1111/jorc.12106; Gorriz JL, 2005, NEPHROL DIAL TRANSPL, V20, pV17; Gorriz JL, 2002, NEPHROL DIAL TRANSPL, V17, P1354, DOI 10.1093/ndt/17.7.1354-a; Gorriz JL, 2002, NEFROLOGIA, V22, P49; Vilaplana JMG, 2009, J RENAL CARE, V35, P159, DOI 10.1111/j.1755-6686.2009.00113.x; Hanko J, 2011, NEPHROL DIAL TRANSPL, V26, P2302, DOI 10.1093/ndt/gfq669; Heaf J, 2004, JAMA-J AM MED ASSOC, V291, P740, DOI 10.1001/jama.291.6.740; Heatley SA, 2009, PERITON DIALYSIS INT, V29, pS128; Hughes SA, 2013, NEPHROL DIAL TRANSPL, V28, P392, DOI 10.1093/ndt/gfs431; Julian-Mauro JC, 2013, NEFROLOGIA, V33, P333, DOI 10.3265/Nefrologia.pre2012.Dec.11767; Kainer G, 2010, NEPHROLOGY, V15, pS12, DOI 10.1111/j.1440-1797.2010.01225.x; Karkar A, 2011, SAUDI J KIDNEY DIS T, V22, P419; Korevaar JC, 2003, KIDNEY INT, V64, P2222, DOI 10.1046/j.1523-1755.2003.00321.x; Lameire N, 2012, CONTRIB NEPHROL, V178, P47, DOI 10.1159/000337808; Levey AS, 2007, AM J NEPHROL, V27, P108, DOI 10.1159/000099801; Levin A, 1997, AM J KIDNEY DIS, V29, P533, DOI 10.1016/S0272-6386(97)90334-6; Levin Adeera, 2005, Kidney Int Suppl, pS7; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Marron B, 2005, PERITON DIALYSIS INT, V25, pS56; Marron B, 2015, 12 EUR PER DIAL M KR; Marron B, 2006, NEPHROL DIAL TRANSPL, V21, pii51; Marron B, 2010, CLIN KIDNEY J, V3, P431, DOI 10.1093/ndtplus/sfq116; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; Navaneethan SD, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-3; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Orte-Martinez L, 2008, GUIAS SEN NEFROLOGIA, V28, P49; Otero EB, 2008, NEFROLOGIA, V28, P53; Prichard SS, 1996, PERITON DIALYSIS INT, V16, P69; Prieto-Velasco M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138811; Prieto-Velasco Mario, 2014, BMC Res Notes, V7, P730, DOI 10.1186/1756-0500-7-730; Ramos R, 2013, NEFROLOGIA, V33, P301, DOI 10.3265/Nefrologia.pre2013.Feb.11638; Ravani P, 2003, J NEPHROL, V16, P862; Ravani P, 2003, J NEPHROL, V16, P870; Rubin HR, 2004, JAMA-J AM MED ASSOC, V291, P697, DOI 10.1001/jama.291.6.697; Smart NA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007333.pub2; Sprangers B, 2006, MAYO CLIN PROC, V81, P1487, DOI 10.4065/81.11.1487; Stewart JH, 2006, AM J KIDNEY DIS, V48, P183, DOI 10.1053/j.ajkd.2006.04.067; Van Biesen W, 2000, J AM SOC NEPHROL, V11, P116, DOI 10.1681/ASN.V111116; Van Biesen W, 2009, NEPHROL DIAL TRANSPL, V24, P3277, DOI 10.1093/ndt/gfp448; Villa G, 2012, PERITON DIALYSIS INT, V32, P192, DOI 10.3747/pdi.2011.00037; Wu IW, 2009, NEPHROL DIAL TRANSPL, V24, P3426, DOI 10.1093/ndt/gfp259; Yu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112820; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155987	10.1371/journal.pone.0155987	http://dx.doi.org/10.1371/journal.pone.0155987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228101	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500049
J	Mikolajczak, K; Ogrodowicz, P; Gudys, K; Krystkowiak, K; Sawikowska, A; Frohmberg, W; Gorny, A; Kedziora, A; Jankowiak, J; Jozefczyk, D; Karg, G; Andrusiak, J; Krajewski, P; Szarejko, I; Surma, M; Adamski, T; Guzy-Wrobelska, J; Kuczynska, A				Mikolajczak, Krzysztof; Ogrodowicz, Piotr; Gudys, Kornelia; Krystkowiak, Karolina; Sawikowska, Aneta; Frohmberg, Wojciech; Gorny, Andrzej; Kedziora, Andrzej; Jankowiak, Janusz; Jozefczyk, Damian; Karg, Grzegorz; Andrusiak, Joanna; Krajewski, Pawel; Szarejko, Iwona; Surma, Maria; Adamski, Tadeusz; Guzy-Wrobelska, Justyna; Kuczynska, Anetta			Quantitative Trait Loci for Yield and Yield-Related Traits in Spring Barley Populations Derived from Crosses between European and Syrian Cultivars	PLOS ONE			English	Article							RECOMBINANT INBRED LINES; DENSITY CONSENSUS MAP; AGRONOMIC TRAITS; QTL ANALYSIS; LINKAGE MAP; DRYLAND CONDITIONS; PARTIAL RESISTANCE; DROUGHT TOLERANCE; MALTING QUALITY; PUCCINIA-HORDEI	In response to climatic changes, breeding programmes should be aimed at creating new cultivars with improved resistance to water scarcity. The objective of this study was to examine the yield potential of barley recombinant inbred lines (RILs) derived from three cross-combinations of European and Syrian spring cultivars, and to identify quantitative trait loci (QTLs) for yield-related traits in these populations. RILs were evaluated in field experiments over a period of three years (2011 to 2013) and genotyped with simple sequence repeat (SSR) and single nucleotide polymorphism (SNP) markers; a genetic map for each population was constructed and then one consensus map was developed. Biological interpretation of identified QTLs was achieved by reference to Ensembl Plants barley gene space. Twelve regions in the genomes of studied RILs were distinguished after QTL analysis. Most of the QTLs were identified on the 2H chromosome, which was the hotspot region in all three populations. Syrian parental cultivars contributed alleles decreasing traits' values at majority of QTLs for grain weight, grain number, spike length and time to heading, and numerous alleles increasing stem length. The phenomic and molecular approaches distinguished the lines with an acceptable grain yield potential combining desirable features or alleles from their parents, that is, early heading from the Syrian breeding line (Cam/B1/CI08887//CI05761) and short plant stature from the European semidwarf cultivar (Maresi).	[Mikolajczak, Krzysztof; Ogrodowicz, Piotr; Krystkowiak, Karolina; Sawikowska, Aneta; Frohmberg, Wojciech; Gorny, Andrzej; Krajewski, Pawel; Surma, Maria; Adamski, Tadeusz; Kuczynska, Anetta] Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland; [Gudys, Kornelia; Szarejko, Iwona; Guzy-Wrobelska, Justyna] Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Jagiellonska 28, PL-40032 Katowice, Poland; [Kedziora, Andrzej; Jankowiak, Janusz; Jozefczyk, Damian; Karg, Grzegorz; Andrusiak, Joanna] Polish Acad Sci, Inst Agr & Forest Environm, Bukowska 19, PL-60809 Poznan, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Silesia in Katowice; Polish Academy of Sciences	Kuczynska, A (corresponding author), Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland.; Guzy-Wrobelska, J (corresponding author), Univ Silesia, Fac Biol & Environm Protect, Dept Genet, Jagiellonska 28, PL-40032 Katowice, Poland.	justyna.guzy-wrobelska@us.edu.pl; akuc@igr.poznan.pl	Mikołajczak, Krzysztof/AAP-8992-2020; Frohmberg, Wojciech/O-4212-2014; Kuczynska, Anetta/AAG-2610-2022; Kuczynska, Anetta/AFK-3837-2022; Ogrodowicz, Piotr/ABG-2508-2020	Mikołajczak, Krzysztof/0000-0003-3821-4461; Frohmberg, Wojciech/0000-0003-0064-1775; Gudys, Kornelia/0000-0001-6795-8051; Szarejko, Iwona/0000-0001-7390-7234; Krystkowiak, Karolina/0000-0002-7541-5126; Guzy-Wrobelska, Justyna/0000-0002-1886-2587; Krajewski, Pawel/0000-0001-5318-9896; Ogrodowicz, Piotr/0000-0002-9044-8137; Sawikowska, Aneta/0000-0001-5050-8513	European Regional Development Fund through the Innovative Economy Program for Poland [WND-POIG.01.03.01-00-101/08]	European Regional Development Fund through the Innovative Economy Program for Poland	This work was supported by the European Regional Development Fund through the Innovative Economy Program for Poland 2007-2013, project WND-POIG.01.03.01-00-101/08 POLAPGEN-BD "Biotechnological tools for breeding cereals with increased resistance to drought". The project was realized by POLAPGEN Consortium coordinated by Institute of Plant Genetics, Polish Academy of Sciences in Poznan. All information about the project can be found at www.polapgen.pl.	[Anonymous], 2013, GENSTAT WINDOWS; BACKES G, 1995, THEOR APPL GENET, V90, P294, DOI 10.1007/BF00222217; Baum M, 2003, THEOR APPL GENET, V107, P1215, DOI 10.1007/s00122-003-1357-2; BECKER J, 1995, GENOME, V38, P991, DOI 10.1139/g95-130; Bezant J, 1997, MOL BREEDING, V3, P29, DOI 10.1023/A:1009648220852; Calinski T, 2009, STAT PAP, V50, P735, DOI 10.1007/s00362-009-0249-1; Calinski T, 1996, SERGEN ANALYSIS OF S, P1; Cantalapiedra CP, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0253-1; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2011, THEOR APPL GENET, V122, P1363, DOI 10.1007/s00122-011-1537-4; Cuesta-Marcos A, 2009, PLANT BREEDING, V128, P46, DOI 10.1111/j.1439-0523.2008.01510.x; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Gorny AG, 2001, EUPHYTICA, V117, P59, DOI 10.1023/A:1004061709964; Gorny AG, 2008, J APPL GENET, V49, P349, DOI 10.1007/BF03195633; GOULDEN C. H., 1939, Proceedings 7th Int. Genet. Congr., P132; HACKETT CA, 1992, THEOR APPL GENET, V85, P120, DOI 10.1007/BF00223854; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Hellewell KB, 2000, CROP SCI, V40, P352, DOI 10.2135/cropsci2000.402352x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jia QJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2116-x; Jia QJ, 2011, THEOR APPL GENET, V122, P1451, DOI 10.1007/s00122-011-1544-5; Jia QJ, 2009, FUNCT INTEGR GENOMIC, V9, P255, DOI 10.1007/s10142-009-0120-4; Ponce-Molina LJ, 2012, CROP SCI, V52, P2469, DOI 10.2135/cropsci2012.01.0029; Kjaer B, 1996, EUPHYTICA, V90, P39; Kleinhofs A., 1988, Proceedings of the seventh international wheat genetics symposium held at Cambridge, UK, 13-19 July 1988., P541; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kota R, 2008, FUNCT INTEGR GENOMIC, V8, P223, DOI 10.1007/s10142-007-0060-9; Kota R, 2003, MOL GENET GENOMICS, V270, P24, DOI 10.1007/s00438-003-0891-6; Krzeminska A, 2003, J APPL GENET, V44, P481; Kuczynska A, 2014, ELECTRON J BIOTECHN, V17, P217, DOI 10.1016/j.ejbt.2014.07.005; Kuczynska A, 2013, J APPL GENET, V54, P381, DOI 10.1007/s13353-013-0165-x; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; LAURIE DA, 1995, GENOME, V38, P575, DOI 10.1139/g95-074; LAURIE DA, 1994, HEREDITY, V72, P619, DOI 10.1038/hdy.1994.85; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li J, 2005, THEOR APPL GENET, V110, P356, DOI 10.1007/s00122-004-1847-x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li JZ, 2006, GENOME, V49, P454, DOI 10.1139/G05-128; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; Malosetti M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00044; Malosetti M, 2011, THEOR APPL GENET, V122, P1605, DOI 10.1007/s00122-011-1558-z; Maluszynski M., 2005, P INT CONG WAK DOUBL, P403; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Marquez-Cedillo LA, 2001, THEOR APPL GENET, V103, P625, DOI 10.1007/PL00002919; Mathews S, 2010, PLANT CELL, V22, P4, DOI 10.1105/tpc.109.072280; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OLEJNIK J, 1991, EARTH SURF PROCESSES, V16, P601, DOI 10.1002/esp.3290160705; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Peighambari SA, 2005, PLANT SCI, V169, P1008, DOI 10.1016/j.plantsci.2005.05.018; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; Qi XQ, 1996, GENOME, V39, P379, DOI 10.1139/g96-049; Qin X, 2013, MOL PLANT MICROBE IN, V26, P227, DOI 10.1094/MPMI-05-12-0138-R; Ramsay L, 2000, GENETICS, V156, P1997; Ren XiFeng, 2013, Australian Journal of Crop Science, V7, P878; Rollins JA, 2013, THEOR APPL GENET, V126, P2803, DOI 10.1007/s00122-013-2173-y; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Russell J, 2004, GENOME, V47, P389, DOI [10.1139/G03-125, 10.1139/g03-125]; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Teulat B, 2001, THEOR APPL GENET, V103, P774, DOI 10.1007/s001220100619; THOMAS WTB, 1991, HEREDITY, V66, P381, DOI 10.1038/hdy.1991.48; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; Tinker NA, 1996, CROP SCI, V36, P1053, DOI 10.2135/cropsci1996.0011183X003600040040x; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Van Ooijen JW, 2001, JOINMAPR 3 0 SOFTWAR; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; von Korff M, 2008, THEOR APPL GENET, V117, P653, DOI 10.1007/s00122-008-0787-2; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wojcik-Jagla M, 2013, THEOR APPL GENET, V126, P3021, DOI 10.1007/s00122-013-2190-x; Xu Y, 2010, MOLECULAR PLANT BREEDING, P1, DOI [10.1079/9781845933920.0001, 10.1079/9781845933920.0000]	84	33	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155938	10.1371/journal.pone.0155938	http://dx.doi.org/10.1371/journal.pone.0155938			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227880	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500044
J	Oh, SA; Yea, JW; Kim, SK				Oh, Se An; Yea, Ji Woon; Kim, Sung Kyu			Statistical Determination of the Gating Windows for Respiratory-Gated Radiotherapy Using a Visible Guiding System	PLOS ONE			English	Article							VOLUMETRIC-MODULATED ARC; BODY RADIATION-THERAPY; LUNG-TUMORS; RESIDUAL MOTION	Respiratory-gated radiation therapy (RGRT) is used to minimize the radiation dose to normal tissue in lung-cancer patients. Although determining the gating window in the respiratory phase of patients is important in RGRT, it is not easy. Our aim was to determine the optimal gating window when using a visible guiding system for RGRT. Between April and October 2014, the breathing signals of 23 lung-cancer patients were recorded with a real-time position management (RPM) respiratory gating system (Varian, USA). We performed statistical analysis with breathing signals to find the optimal gating window for guided breathing in RGRT. When we compared breathing signals before and after the breathing training, 19 of the 23 patients showed statistically significant differences (p < 0.05). The standard deviation of the respiration signals after breathing training was lowest for phases of 30%-70%. The results showed that the optimal gating window in RGRT is 40% (30%-70%) with respect to repeatability for breathing after respiration training with the visible guiding system. RGRT was performed with the RPM system to confirm the usefulness of the visible guiding system. The RPM system and our visible guiding system improve the respiratory regularity, which in turn should improve the accuracy and efficiency of RGRT.	[Oh, Se An; Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea; [Oh, Se An; Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Coll Med, Inst Med Sci, Daegu, South Korea; [Yea, Ji Woon; Kim, Sung Kyu] Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea	Yeungnam University; Yeungnam University; Yeungnam University	Kim, SK (corresponding author), Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea.; Kim, SK (corresponding author), Yeungnam Univ, Coll Med, Inst Med Sci, Daegu, South Korea.; Kim, SK (corresponding author), Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea.	skkim3@ynu.ac.kr		Oh, SeAn/0000-0002-8835-2814; Kim, Sungkyu/0000-0002-5371-6964	Yeungnam University [215A380156]	Yeungnam University	This work was supported by the 2015 Yeungnam University Research Grant (215A380156).	Beddar AS, 2007, INT J RADIAT ONCOL, V67, P630, DOI 10.1016/j.ijrobp.2006.10.007; Berbeco RI, 2005, PHYS MED BIOL, V50, P3655, DOI 10.1088/0031-9155/50/16/001; Berbeco RI, 2006, MED PHYS, V33, P4149, DOI 10.1118/1.2358197; Ford EC, 2002, INT J RADIAT ONCOL, V52, P522, DOI 10.1016/S0360-3016(01)02681-5; Herman TD, 2010, J APPL CLIN MED PHYS, V11, P158, DOI 10.1120/jacmp.v11i1.3133; Jiang SB, 2006, MED DOSIM, V31, P141, DOI 10.1016/j.meddos.2005.12.005; Jiang XQ, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-140; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Khan F.M., 2014, KHANS PHYS RAD THERA, P135; OHSEAN, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P145, DOI 10.14316/pmp.2013.24.3.145; Ong CL, 2010, RADIOTHER ONCOL, V97, P437, DOI 10.1016/j.radonc.2010.09.027; Otto K, 2008, MED PHYS, V35, P310, DOI 10.1118/1.2818738; Palma DA, 2011, INT J RADIAT ONCOL, V80, P506, DOI 10.1016/j.ijrobp.2010.02.032; R. T. O. Group, 2010, RTOG 0813 SEAML PHAS; Santoro JP, 2009, J APPL CLIN MED PHYS, V10, P132, DOI 10.1120/jacmp.v10i4.2982; Timmerman RD, 2009, INT J RADIAT ONCOL, V75, pS3, DOI 10.1016/j.ijrobp.2009.07.033; Timmerman RD, 2007, RTOG 0618 PHASE 2 TR; Timmerman R, 2011, FRONT RADIAT THER ON, V43, P395, DOI 10.1159/000322503; Vedam SS, 2001, MED PHYS, V28, P2139, DOI 10.1118/1.1406524; Wolff D, 2009, RADIOTHER ONCOL, V93, P226, DOI 10.1016/j.radonc.2009.08.011	20	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156357	10.1371/journal.pone.0156357	http://dx.doi.org/10.1371/journal.pone.0156357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228097	gold, Green Published			2022-12-27	WOS:000376882500123
J	Botesteanu, DA; Lee, JM; Levy, D				Botesteanu, Dana-Adriana; Lee, Jung-Min; Levy, Doron			Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection	PLOS ONE			English	Article							FALLOPIAN-TUBE; CLINICAL-IMPLICATIONS; MUTATION CARRIERS; SURVIVAL; HISTORY; BREAST; BRCA1; WOMEN; RESISTANCE; EVOLUTION	High-grade serous ovarian cancer (HGSOC) represents the majority of ovarian cancers and accounts for the largest proportion of deaths from the disease. A timely detection of low volume HGSOC should be the goal of any screening studies. However, numerous transvaginal ultrasound (TVU) detection-based population studies aimed at detecting low-volume disease have not yielded reduced mortality rates. A quantitative invalidation of TVU as an effective HGSOC screening strategy is a necessary next step. Herein, we propose a mathematical model for a quantitative explanation on the reported failure of TVU-based screening to improve HGSOC low-volume detectability and overall survival. We develop a novel in silico mathematical assessment of the efficacy of a unimodal TVU monitoring regimen as a strategy aimed at detecting low-volume HGSOC in cancer-positive cases, defined as cases for which the inception of the first malignant cell has already occurred. Our findings show that the median window of opportunity interval length for TVU monitoring and HGSOC detection is approximately 1.76 years. This does not translate into reduced mortality levels or improved detection accuracy in an in silico cohort across multiple TVU monitoring frequencies or detection sensitivities. We demonstrate that even a semiannual, unimodal TVU monitoring protocol is expected to miss detectable HGSOC. Lastly, we find that circa 50% of the simulated HGSOC growth curves never reach the baseline detectability threshold, and that on average, 5-7 infrequent, rate-limiting stochastic changes in the growth parameters are associated with reaching HGSOC detectability and mortality thresholds respectively. Focusing on a malignancy poorly studied in the mathematical oncology community, our model captures the dynamic, temporal evolution of HGSOC progression. Our mathematical model is consistent with recent case reports and prospective TVU screening population studies, and provides support to the empirical recommendation against frequent HGSOC screening.	[Botesteanu, Dana-Adriana; Levy, Doron] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Botesteanu, Dana-Adriana; Levy, Doron] Univ Maryland, Ctr Sci Computat & Math Modeling CSCAMM, College Pk, MD 20742 USA; [Botesteanu, Dana-Adriana; Lee, Jung-Min] NCI, Womens Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levy, D (corresponding author), Univ Maryland, Dept Math, College Pk, MD 20742 USA.; Levy, D (corresponding author), Univ Maryland, Ctr Sci Computat & Math Modeling CSCAMM, College Pk, MD 20742 USA.	dlevy@math.umd.edu		Botesteanu, Dana-Adriana/0000-0002-5509-8987	Intramural Research Program of the National Institutes of Health; Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology; John Simon Guggenheim Memorial Foundation; NATIONAL CANCER INSTITUTE [ZIABC011525] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology; John Simon Guggenheim Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology. The work of DL was supported in part by the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse S. F., 1975, SEER CANC STAT REV 1; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bodelon C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju262; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; Callahan MJ, 2007, J CLIN ONCOL, V25, P3985, DOI 10.1200/JCO.2007.12.2622; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carcangiu ML, 2006, AM J SURG PATHOL, V30, P1222, DOI 10.1097/01.pas.0000202161.80739.ac; Carduner L, 2014, EXP CELL RES, V320, P329, DOI 10.1016/j.yexcr.2013.11.011; Chignola R, 2005, IEEE T BIO-MED ENG, V52, P808, DOI 10.1109/TBME.2005.845219; CIAMPI A, 1986, CELL TISSUE KINET, V19, P129, DOI 10.1111/j.1365-2184.1986.tb00723.x; Correa RJM, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0182-y; Cristini V., 2010, MULTISCALE MODELING; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Crum CP, 2012, CLIN OBSTET GYNECOL, V55, P24, DOI 10.1097/GRF.0b013e31824b1725; Danesh K, 2012, J THEOR BIOL, V314, P10, DOI 10.1016/j.jtbi.2012.08.025; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Horiuchi A, 2003, GYNECOL ONCOL, V88, P309, DOI 10.1016/S0090-8258(02)00104-X; Jacobs I, 2011, OBSTET GYNECOL, V118, P1209, DOI 10.1097/AOG.0b013e31823b49b3; Jacobs IJ, 2015, LANCET; Jain HV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081582; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Kobel M, 2014, CONTROVERSIES MANAGE, P29; Kohandel M, 2006, J THEOR BIOL, V242, P62, DOI 10.1016/j.jtbi.2006.02.001; Kohn EC, 2013, ANN ONCOL, V24, P22, DOI 10.1093/annonc/mdt464; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Maini PK, 2006, CANC BIOINFORMATICS, P95; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; Menon U, 2014, GYNECOL ONCOL, V132, P490, DOI 10.1016/j.ygyno.2013.11.030; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Modugno F, 2012, MOL MECH PERS MED M; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Panetta JC, 1997, MATH BIOSCI, V146, P89, DOI 10.1016/S0025-5564(97)00077-1; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SPEER JF, 1984, CANCER RES, V44, P4124; Stirling D, 2005, J CLIN ONCOL, V23, P5588, DOI 10.1200/JCO.2005.05.097; van der Velde NM, 2009, INT J CANCER, V124, P919, DOI 10.1002/ijc.24038; van Nagell JR, 2007, CANCER-AM CANCER SOC, V109, P1887, DOI 10.1002/cncr.22594; van Nagell JR, 2014, INT J WOMENS HEALTH, V6, P25, DOI 10.2147/IJWH.S38347; van Nagell JR, 2011, OBSTET GYNECOL, V118, P1212, DOI 10.1097/AOG.0b013e318238d030; Weinberg R. A., 2013, BIOL CANC; Wodarz D, 2014, DYNAMICS CANC MATH F; Xing H, 2005, J CANCER RES CLIN, V131, P511, DOI 10.1007/s00432-005-0677-9; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	58	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156661	10.1371/journal.pone.0156661	http://dx.doi.org/10.1371/journal.pone.0156661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257824	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700096
J	Brierley, ME; Brooks, KR; Mond, J; Stevenson, RJ; Stephen, ID				Brierley, Mary-Ellen; Brooks, Kevin R.; Mond, Jonathan; Stevenson, Richard J.; Stephen, Ian D.			The Body and the Beautiful: Health, Attractiveness and Body Composition in Men's and Women's Bodies	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; MASS INDEX; RISK-FACTORS; OLDER MEN; FAT; OBESITY; WEIGHT; FITNESS; SIZE; ASSOCIATION	The dominant evolutionary theory of physical attraction posits that attractiveness reflects physiological health, and attraction is a mechanism for identifying a healthy mate. Previous studies have found that perceptions of the healthiest body mass index (weight scaled for height; BMI) for women are close to healthy BMI guidelines, while the most attractive BMI is significantly lower, possibly pointing to an influence of sociocultural factors in determining attractive BMI. However, less is known about ideal body size for men. Further, research has not addressed the role of body fat and muscle, which have distinct relationships with health and are conflated in BMI, in determining perceived health and attractiveness. Here, we hypothesised that, if attractiveness reflects physiological health, the most attractive and healthy appearing body composition should be in line with physiologically healthy body composition. Thirty female and 33 male observers were instructed to manipulate 15 female and 15 male body images in terms of their fat and muscle to optimise perceived health and, separately, attractiveness. Observers were unaware that they were manipulating the muscle and fat content of bodies. The most attractive apparent fat mass for female bodies was significantly lower than the healthiest appearing fat mass (and was lower than the physiologically healthy range), with no significant difference for muscle mass. The optimal fat and muscle mass for men's bodies was in line with the healthy range. Male observers preferred a significantly lower overall male body mass than did female observers. While the body fat and muscle associated with healthy and attractive appearance is broadly in line with physiologically healthy values, deviations from this pattern suggest that future research should examine a possible role for internalization of body ideals in influencing perceptions of attractive body composition, particularly in women.	[Brierley, Mary-Ellen; Brooks, Kevin R.; Mond, Jonathan; Stevenson, Richard J.; Stephen, Ian D.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Stephen, Ian D.] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Brooks, Kevin R.; Stevenson, Richard J.; Stephen, Ian D.] Macquarie Univ, Fac Human Sci, PARC, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University	Stephen, ID (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.; Stephen, ID (corresponding author), ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia.; Stephen, ID (corresponding author), Macquarie Univ, Fac Human Sci, PARC, Sydney, NSW 2109, Australia.	ian.stephen@mq.edu.au	Stephen, Ian/ABA-6218-2021	Stephen, Ian/0000-0001-9714-8295; Mond, Jonathan/0000-0002-0410-091X; Brooks, Kevin/0000-0003-1424-4092; Stevenson, Richard/0000-0002-2461-5777	Macquarie University Research Development Grant [MQRDG9201401548]	Macquarie University Research Development Grant	This work was funded by a Macquarie University Research Development Grant received by IDS, KRB, RJS; mq.edu.au; MQRDG9201401548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONSON FH, 1991, BIOL REPROD, V44, P945, DOI 10.1095/biolreprod44.6.945; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Cafri G, 2005, CLIN PSYCHOL REV, V25, P215, DOI 10.1016/j.cpr.2004.09.003; Cazzato V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00235; Coetzee V, 2011, BODY IMAGE, V8, P190, DOI 10.1016/j.bodyim.2010.12.003; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cornelissen KK, 2016, BRIT J HEALTH PSYCH, V21, P555, DOI 10.1111/bjhp.12185; Cornelissen KK, 2015, BODY IMAGE, V13, P75, DOI 10.1016/j.bodyim.2015.01.001; Cornelissen PL, 2009, J THEOR BIOL, V256, P343, DOI 10.1016/j.jtbi.2008.09.041; Coy AE, 2014, BODY IMAGE, V11, P282, DOI 10.1016/j.bodyim.2014.04.003; Crossley KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050601; Doyle JF., 2009, J SOCIAL EVOLUTIONAR, V3, P81, DOI [DOI 10.1037/H0099329, 10.1037/h0099329]; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Frederick D. A., 2007, PSYCHOL MEN MASCULIN, V8, P103, DOI [10.1037/1524-9220.8.2.103, DOI 10.1037/1524-9220.8.2.103]; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; FRISCH RE, 1994, P NUTR SOC, V53, P113, DOI 10.1079/PNS19940015; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gardner RM, 1996, BRIT J PSYCHOL, V87, P327, DOI 10.1111/j.2044-8295.1996.tb02593.x; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Groesz LM, 2002, EFFECT EXPT PRESENTA, DOI [10.1002/eat.10005, DOI 10.1002/EAT.10005]; Honekopp J, 2007, EVOL HUM BEHAV, V28, P106, DOI 10.1016/j.evolhumbehav.2006.09.001; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Johnson W, 2015, BEHAV GENET, V45, P84, DOI 10.1007/s10519-014-9690-6; Lara-Esqueda A, 2004, INT J OBESITY, V28, P1443, DOI 10.1038/sj.ijo.0802705; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; MISHKIND ME, 1986, AM BEHAV SCI, V29, P545, DOI 10.1177/000276486029005004; Mitchison D, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0058-y; Murray SB, BR J PSYCHIAT; Mvo Z, 1999, Curationis, V22, P27; Nicklas BJ, 2004, AM J EPIDEMIOL, V160, P741, DOI 10.1093/aje/kwh281; Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI [10.1037/1524-9220.5.2.112, DOI 10.1037/1524-9220.5.2.112]; Pasquali R, 2006, MATURITAS, V54, P363, DOI 10.1016/j.maturitas.2006.04.018; Pope HG, 2001, PSYCHOTHER PSYCHOSOM, V70, P189, DOI 10.1159/000056252; Probst M, 1998, J PSYCHOSOM RES, V44, P451, DOI 10.1016/S0022-3999(97)00270-5; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Shinichi Nakagawa, 2016, EFFECTS SEX HORMONES, DOI DOI 10.1111/BRV.12243; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Stephen ID, 2014, BODY IMAGE, V11, P183, DOI 10.1016/j.bodyim.2013.11.007; Stephen ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086302; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2014, HLTH BODY HLTH FACE; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Symons D, 1979, EVOLUTION HUMAN SEXU; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 2007, HLTH BODY EQUALS BEA, P108; Visser M, 1998, AM J CLIN NUTR, V68, P584, DOI 10.1093/ajcn/68.3.584; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; WENTZ AC, 1980, OBSTET GYNECOL, V56, P482; Womersley J, 1973, Br J Nutr, V32, P77, DOI 10.1079/BJN19740060	59	48	49	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156722	10.1371/journal.pone.0156722	http://dx.doi.org/10.1371/journal.pone.0156722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257677	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700115
J	Somal, A; Bhat, IA; Indu, B; Pandey, S; Panda, BSK; Thakur, N; Sarkar, M; Chandra, V; Saikumar, G; Sharma, GT				Somal, Anjali; Bhat, Irfan A.; Indu, B.; Pandey, Sriti; Panda, Bibhudatta S. K.; Thakur, Nipuna; Sarkar, Mihir; Chandra, Vikash; Saikumar, G.; Sharma, G. Taru			A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; AMNIOTIC-FLUID; STROMAL CELLS; BONE-MARROW; ANIMAL-MODELS; CELLULAR-THERAPY; EXPRESSION; CULTURE; REGENERATION; FEATURES	The present study was conducted with an objective of isolation, in vitro expansion, growth kinetics, molecular characterization and in vitro differentiation of fetal adnexa derived caprine mesenchymal stem cells. Mid-gestation gravid caprine uteri (2-3 months) were collected from abattoir to derive mesenchymal stem cells (MSCs) from fetal adnexa {amniotic fluid (cAF), amniotic sac (cAS), Wharton's jelly (cWJ) and cord blood (cCB)} and expanded in vitro. These cultured MSCs were used at the 3rd passage (P3) to study growth kinetics, localization as well as molecular expression of specific surface antigens, pluripotency markers and mesenchymal tri-lineage differentiation. In comparison to cAF and cAS MSCs, cWJ and cCB MSCs showed significantly (P<0.05) higher clonogenic potency, faster growth rate and low population doubling (PDT) time. All the four types of MSCs were positive for alkaline phosphatase (AP) and differentiated into chondrogenic, osteogenic, and adipogenic lineages. These stem cells expressed MSC surface antigens (CD73, CD90 and CD105) and pluripotency markers (Oct4, Sox2, Nanog, KLF, cMyc, FoxD3) but did not express CD34, a hematopoietic stem cell marker (HSC) as confirmed by RT-PCR, immunocytochemistry and flow cytometric analysis. The relative mRNA expression of MSC surface antigens (CD73, CD90 and CD105) was significantly (P<0.05) higher in cWJ MSCs compared to the other cell lines. The mRNA expression of Oct4 was significantly (P<0.05) higher in cWJ, whereas mRNA expression of KLF and cMyc was significantly (P<0.05) higher in cWJ and cAF than that of cAS and cCB. The comparative assessment revealed that cWJ MSCs outperformed MSCs from other sources of fetal adnexa in terms of growth kinetics, relative mRNA expression of surface antigens, pluripotency markers and tri-lineage differentiation potential, hence, these MSCs could be used as a preferred source for regenerative medicine.	[Somal, Anjali; Bhat, Irfan A.; Indu, B.; Pandey, Sriti; Panda, Bibhudatta S. K.; Thakur, Nipuna; Sarkar, Mihir; Chandra, Vikash; Sharma, G. Taru] ICAR Indian Vet Res Inst, Div Physiol & Climatol, Bareilly 243122, Uttar Pradesh, India; [Saikumar, G.] ICAR Indian Vet Res Inst, Div Vet Pathol, Bareilly 243122, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Sharma, GT (corresponding author), ICAR Indian Vet Res Inst, Div Physiol & Climatol, Bareilly 243122, Uttar Pradesh, India.	gts553@gmail.com	CHANDRA, VIKASH/U-6635-2019; Pandey, Sriti/AAA-2247-2020		ICAR-IVRI through the Flagship Project	ICAR-IVRI through the Flagship Project	This study was supported by ICAR-IVRI through the Flagship Project entitled 'Stem cells: Its biology and therapeutic application in livestock and pets'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAS L, 1995, J EXP MED, V182, P1603, DOI 10.1084/jem.182.5.1603; Ansari M.M., 2013, J STEM CELL RES THER, V3, P2, DOI [10.4172/2157-7633.1000141., DOI 10.4172/2157-7633.1000141]; Azari O, 2011, VET RES COMMUN, V35, P211, DOI 10.1007/s11259-011-9464-z; Babaei H., 2008, Iranian Journal of Veterinary Surgery, V3, P57; Cardoso TC, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-18; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Choi SA, 2013, IN VITRO CELL DEV-AN, V49, P42, DOI 10.1007/s11626-012-9569-x; Colleoni S, 2009, VET RES COMMUN, V33, P811, DOI 10.1007/s11259-009-9229-0; Colosimo A, 2013, CYTOTHERAPY, V15, P930, DOI 10.1016/j.jcyt.2013.03.014; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Corradetti B, 2013, REPRODUCTION, V145, P391, DOI 10.1530/REP-12-0437; Cremonesi F, 2011, THERIOGENOLOGY, V75, P1400, DOI 10.1016/j.theriogenology.2010.12.032; da Cunha ER, 2014, REPROD DOMEST ANIM, V49, P806, DOI 10.1111/rda.12372; Dangi SS, 2014, INT J BIOMETEOROL, V58, P2085, DOI 10.1007/s00484-014-0809-5; De Schauwer C, 2013, EQUINE VET J, V45, P518, DOI 10.1111/evj.12003; De Schauwer C, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt395; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fernandes R. A., 2012, Open Journal of Animal Sciences, V2, P166, DOI 10.4236/ojas.2012.23023; Fulton L. K., 1994, ILAR News, V36, P21; Gade NE, 2013, REPROD DOMEST ANIM, V48, P358, DOI 10.1111/j.1439-0531.2012.02156.x; Gao YH, 2014, INT J MOL SCI, V15, P3698, DOI 10.3390/ijms15033698; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Iacono E, 2015, REPROD DOMEST ANIM, V50, P353, DOI 10.1111/rda.12499; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilic D, 2011, BRIT MED BULL, V98, P117, DOI 10.1093/bmb/ldr012; Jin GZ, 2008, J VET MED SCI, V70, P723, DOI 10.1292/jvms.70.723; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; KUMAR M, 2013, STEM CELL DISCOVERY, V3, P226, DOI DOI 10.4236/SCD.2013.34028; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lee KS, 2013, ASIAN AUSTRAL J ANIM, V26, P588, DOI 10.5713/ajas.2012.12488; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Mann A, 2013, CYTOTECHNOLOGY, V65, P23, DOI 10.1007/s10616-012-9464-z; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mohanty N, 2014, IN VITRO CELL DEV-AN, V50, P538, DOI 10.1007/s11626-013-9729-7; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pratheesh MD, 2014, VET RES COMMUN, V38, P139, DOI 10.1007/s11259-014-9597-y; Pratheesh MD, 2013, RES VET SCI, V94, P313, DOI 10.1016/j.rvsc.2012.08.002; Raoufi MF, 2011, REPROD DOMEST ANIM, V46, P95, DOI 10.1111/j.1439-0531.2010.01594.x; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Rossi B, 2014, STEM CELL REV REP, V10, P712, DOI 10.1007/s12015-014-9525-0; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Semb H, 2005, APMIS, V113, P743, DOI 10.1111/j.1600-0463.2005.apm_312.x; Seo MS, 2013, J VET SCI, V14, P151, DOI 10.4142/jvs.2013.14.2.151; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697; Sreekumar T.R., 2014, J STEM CELL RES THER, V4, P207, DOI [10.4172/2157-7633.1000207, DOI 10.4172/2157-7633.1000207]; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Udehiya RK, 2013, RES VET SCI, V94, P743, DOI 10.1016/j.rvsc.2013.01.011; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Uranio MF, 2014, MOL REPROD DEV, V81, P539, DOI 10.1002/mrd.22322; Violini S, 2012, CYTOTECHNOLOGY, V64, P1, DOI 10.1007/s10616-011-9398-x; Witkowska-Zimny M, 2011, CELL MOL BIOL LETT, V16, P493, DOI 10.2478/s11658-011-0019-7	76	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156821	10.1371/journal.pone.0156821	http://dx.doi.org/10.1371/journal.pone.0156821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257959	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700138
J	Simonetti, O; Cirioni, O; Cacciatore, I; Baldassarre, L; Orlando, F; Pierpaoli, E; Lucarini, G; Orsetti, E; Provinciali, M; Fornasari, E; Di Stefano, A; Giacometti, A; Offidani, A				Simonetti, Oriana; Cirioni, Oscar; Cacciatore, Ivana; Baldassarre, Leonardo; Orlando, Fiorenza; Pierpaoli, Elisa; Lucarini, Guendalina; Orsetti, Elena; Provinciali, Mauro; Fornasari, Erika; Di Stefano, Antonio; Giacometti, Andrea; Offidani, Annamaria			Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound	PLOS ONE			English	Article							IN-VITRO ACTIVITY; ANTIBIOTIC-RESISTANCE; AUREUS INFECTIONS; TEMPORIN-A; RAT MODEL; BIOFILM; PEPTIDE; MODULATION; BACTERIA; RIP	In staphylococci, quorum sensing regulates both biofilm formation and toxin production, moreover it has been demonstrated to be inhibited by RNAIII inhibiting peptide (RIP). Aim our study was to evaluate the in vitro activity and its in vivo efficacy of the combined administration of FS10, a novel RIP derivative, and tigecycline in an animal model of methicillin-resistant (MR) and methicillin-sensitive (MS) Staphylococcus aureus wound infection. Using a 1.x2 cm template, one full thickness wound was established through the panniculus carnosus on the back subcutaneous tissue of each animal. Infection was determined by inoculation of 5x10(7) CFU/ml of bacteria, that produced an abscess within 24 h, after this, treatment was initiated. The study included, for each strain, a control group without infection, a control infected group that did not receive any treatment and a control infected group with drug-free foam dressing, and three infected groups treated, respectively, with: FS10-soaked foam dressing (containing 20 mu g FS10), daily intraperitoneal tigecycline (7 mg/Kg), FS10-soaked foam dressing (containing 20 mu g FS10) and daily intraperitoneal injections of tigecycline (7 mg/Kg). The main outcome measures were quantitative culture and histological examination of tissue repair. The highest inhibition of infection was achieved in the group that received FS10-soaked and parenteral tigecycline reducing the bacterial load from 10(7) CFU/ml to about 10(3) CFU/g for MSSA and to about 10(4) CFU/g for MRSA. The group treated with FS10-soaked foam dressing associated with parenteral tigecycline showed, histologically, better overall healing with epithelialization and collagen scores significantly higher than those of the other groups in both strains. In conclusion, the combined use of topical FS10 with i.p. tigecycline induced positive interaction in vivo, resulting in an enhanced therapeutic benefit versus staphylococcal infections in murine wound models.	[Simonetti, Oriana; Offidani, Annamaria] Univ Politecn Marche, Osped Riuniti, Dept Clin & Mol Sci, Dermatol Clin, Ancona, Italy; [Cirioni, Oscar; Orsetti, Elena; Giacometti, Andrea] Clin Infect Dis, Ancona, Italy; [Cirioni, Oscar; Orsetti, Elena; Giacometti, Andrea] Univ Politecn Marche, Osped Riuniti, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Cacciatore, Ivana; Baldassarre, Leonardo; Fornasari, Erika; Di Stefano, Antonio] Univ G DAnnunzio, Dept Pharm, Chieti, Italy; [Orlando, Fiorenza; Pierpaoli, Elisa; Provinciali, Mauro] INRCA IRRCS, Expt Anim Models Aging Units, Res Dept, Ancona, Italy; [Lucarini, Guendalina] Univ Politecn Marche, Dermatol Clin, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; G d'Annunzio University of Chieti-Pescara; IRCCS INRCA; Marche Polytechnic University	Simonetti, O (corresponding author), Univ Politecn Marche, Osped Riuniti, Dept Clin & Mol Sci, Dermatol Clin, Ancona, Italy.	o.simonetti@univpm.it	Lucarini, Guendalina/AAA-7335-2021; Pierpaoli, Elisa/J-5996-2016; Orlando, Fiorenza/AAB-3441-2021; Provinciali, Mauro/K-5683-2016; Baldassarre, Leonardo/E-4509-2013	Pierpaoli, Elisa/0000-0003-4612-7317; Orlando, Fiorenza/0000-0001-7351-4430; Provinciali, Mauro/0000-0002-0568-3002; cacciatore, ivana/0000-0001-6253-0443; Baldassarre, Leonardo/0000-0003-2194-1400; DI STEFANO, Antonio/0000-0002-3042-2234; SIMONETTI, Oriana/0000-0001-7941-5089				Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06; Baldassarre L, 2013, MEDCHEMCOMM, V4, P1114, DOI 10.1039/c3md00122a; Bowler PG, 2012, INT WOUND J, V9, P387, DOI 10.1111/j.1742-481X.2012.00991.x; Cirioni O, 2006, J INFECT DIS, V193, P180, DOI 10.1086/498914; Cirioni O, 2003, CIRCULATION, V108, P767, DOI 10.1161/01.CIR.0000083717.85060.16; Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07; Cirioni O, 2013, PEPTIDES, V40, P77, DOI 10.1016/j.peptides.2012.12.002; Cirioni O, 2010, PEPTIDES, V31, P1231, DOI 10.1016/j.peptides.2010.03.034; Clinical and Laboratory Standards Institute (CLSI), 2012, M07A9 CLSI, VM07-A9; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Dinar S, 2006, PLAST RECONSTR SURG, V117, P717, DOI 10.1097/01.prs.0000197907.75654.24; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Krucke GW, 2009, AM J EMERG MED, V27, P344, DOI 10.1016/j.ajem.2008.03.046; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lowery CA, 2010, J MED CHEM, V53, P7467, DOI 10.1021/jm901742e; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; Oriana S, 2013, BURNS, V39, P776, DOI 10.1016/j.burns.2012.09.013; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Peterson LR, 2008, INT J ANTIMICROB AG, V32, pS215, DOI 10.1016/S0924-8579(09)70005-6; Reffuveille F., 2014, CURR OPIN MICROBIOL, P96; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silvestri C, 2012, EUR J CLIN MICROBIOL, V31, P1759, DOI 10.1007/s10096-011-1498-1; Simonetti O, 2012, EUR J CLIN MICROBIOL, V31, P3047, DOI 10.1007/s10096-012-1663-1; Simonetti O, 2009, PEPTIDES, V30, P1794, DOI 10.1016/j.peptides.2009.06.033; Simonetti O, 2009, BRIT J DERMATOL, V161, P249, DOI 10.1111/j.1365-2133.2009.09166.x; Simonetti O, 2008, ANTIMICROB AGENTS CH, V52, P2205, DOI 10.1128/AAC.01340-07; Simonetti O, 2008, PEPTIDES, V29, P520, DOI 10.1016/j.peptides.2007.12.011; Simonetti O, 2014, PEPTIDES, V55, P17, DOI 10.1016/j.peptides.2014.01.029; Simonetti O, 2013, INT J MOL SCI, V14, P16321, DOI 10.3390/ijms140816321; Simonetti O, 2012, J ANTIMICROB CHEMOTH, V67, P191, DOI 10.1093/jac/dkr440; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Webb DR, 2014, BIOCHEM PHARMACOL, V87, P121, DOI 10.1016/j.bcp.2013.06.014; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966	36	33	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0151956	10.1371/journal.pone.0151956	http://dx.doi.org/10.1371/journal.pone.0151956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253706	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700001
J	Atwood, TC; Peacock, E; McKinney, MA; Lillie, K; Wilson, R; Douglas, DC; Miller, S; Terletzky, P				Atwood, Todd C.; Peacock, Elizabeth; McKinney, Melissa A.; Lillie, Kate; Wilson, Ryan; Douglas, David C.; Miller, Susanne; Terletzky, Pat			Rapid Environmental Change Drives Increased Land Use by an Arctic Marine Predator	PLOS ONE			English	Article							SOUTHERN BEAUFORT SEA; POLAR BEAR DISTRIBUTION; WESTERN HUDSON-BAY; OPEN-WATER PERIOD; CLIMATE-CHANGE; POPULATION ECOLOGY; URSUS-MARITIMUS; ICE; ABUNDANCE; SURVIVAL	In the Arctic Ocean's southern Beaufort Sea (SB), the length of the sea ice melt season (i.e., period between the onset of sea ice break-up in summer and freeze-up in fall) has increased substantially since the late 1990s. Historically, polar bears (Ursus maritimus) of the SB have mostly remained on the sea ice year-round (except for those that came ashore to den), but recent changes in the extent and phenology of sea ice habitat have coincided with evidence that use of terrestrial habitat is increasing. We characterized the spatial behavior of polar bears spending summer and fall on land along Alaska's north coast to better understand the nexus between rapid environmental change and increased use of terrestrial habitat. We found that the percentage of radiocollared adult females from the SB subpopulation coming ashore has tripled over 15 years. Moreover, we detected trends of earlier arrival on shore, increased length of stay, and later departure back to sea ice, all of which were related to declines in the availability of sea ice habitat over the continental shelf and changes to sea ice phenology. Since the late 1990s, the mean duration of the open-water season in the SB increased by 36 days, and the mean length of stay on shore increased by 31 days. While on shore, the distribution of polar bears was influenced by the availability of scavenge subsidies in the form of subsistence-harvested bowhead whale (Balaena mysticetus) remains aggregated at sites along the coast. The declining spatio-temporal availability of sea ice habitat and increased availability of human-provisioned resources are likely to result in increased use of land. Increased residency on land is cause for concern given that, while there, bears may be exposed to a greater array of risk factors including those associated with increased human activities.	[Atwood, Todd C.; Peacock, Elizabeth] US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA; [McKinney, Melissa A.] Univ Connecticut, Ctr Environm Sci & Engn, 1376 Storrs Rd, Storrs, CT 06269 USA; [McKinney, Melissa A.] Dept Nat Resources & Environm, 1376 Storrs Rd, Storrs, CT 06269 USA; [Lillie, Kate; Terletzky, Pat] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Wilson, Ryan; Miller, Susanne] US Fish & Wildlife Serv, Marine Mammals Management, 1011 E Tudor Rd, Anchorage, AK 99503 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, 250 Egan Dr, Juneau, AK 99801 USA	United States Department of the Interior; United States Geological Survey; University of Connecticut; Utah System of Higher Education; Utah State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Atwood, TC (corresponding author), US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.	tatwood@usgs.gov	McKinney, Melissa/W-3407-2019; Douglas, David C./AAU-1087-2021	McKinney, Melissa/0000-0002-8171-7534; Douglas, David C./0000-0003-0186-1104	US Geological Survey's Changing Arctic Ecosystems Initiative; US Geological Survey's Wildlife Program of the Ecosystems Mission Area; Arctic National Wildlife Refuge; Bureau of Land Management	US Geological Survey's Changing Arctic Ecosystems Initiative; US Geological Survey's Wildlife Program of the Ecosystems Mission Area; Arctic National Wildlife Refuge; Bureau of Land Management	Funding was provided by the US Geological Survey's Changing Arctic Ecosystems Initiative, and the US Geological Survey's Wildlife Program of the Ecosystems Mission Area. The authors thank the Arctic National Wildlife Refuge and the Bureau of Land Management for providing significant logistic and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Amstrup led capture efforts from 1986-2008, and G. Durner led capture efforts from 2009-2011. G. York, K. Simac, A, Pagano, T. Donnelly, E. Regehr, and many others assisted with data collection. This work was conducted as part of the U.S. Geological Survey's Changing Arctic Ecosystems Initiative. We thank the communities of Kaktovik, Deadhorse, and Barrow for field support. We thank the Arctic National Wildlife Refuge and the Bureau of Land Management for providing significant logistic and financial support. We thank our excellent pilots for ensuring safe capture operations. This paper was reviewed and approved by USGS under their Fundamental Science Practices policy (http://www.usgs.gov/fsp). We thank K. Rode, R. Rockwell, and an anonymous reviewer for providing helpful comments on a pervious draft of this manuscript. Use of trade names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Allen MR, 2014, NAT CLIM CHANGE, V4, P23, DOI 10.1038/NCLIMATE2077; Allison P. D., 1999, MULTIPLE REGRESSION; Amstrup SC, 2000, CAN J ZOOL, V78, P948, DOI 10.1139/cjz-78-6-948; Amstrup SC, 2006, 20061337 US GEOL SUR; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baruch-Mordo S, 2008, J WILDLIFE MANAGE, V72, P1853, DOI 10.2193/2007-442; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calvert W, 1998, URSUS-SERIES, V10, P449; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Cherry SG, 2009, POLAR BIOL, V32, P383, DOI 10.1007/s00300-008-0530-0; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; Creech TG, 2012, J WILDLIFE MANAGE, V76, P877, DOI 10.1002/jwmg.331; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Gleason JS, 2009, ARCTIC, V62, P405; Gormezano LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128520; Gormezano LJ, 2013, ECOL EVOL, V3, P3509, DOI 10.1002/ece3.740; Hale R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2930; Herreman J, 2013, URSUS, V24, P148, DOI 10.2192/URSUS-D-12-00030.1; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Hooten MB, 2014, STAT METHODOL, V17, P82, DOI 10.1016/j.stamet.2012.12.001; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; IPCC, 2014, CLIM CHANG IMP AD A; Jakobsson M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033520; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Lunn N.J., 2010, POL BEARS P 15 WORK, P87; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Miller S, 2015, J MAMMAL, V96, P1317, DOI 10.1093/jmammal/gyv140; Molnar PK, 2014, BIOL CONSERV, V177, P230, DOI 10.1016/j.biocon.2014.07.001; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Neter J., 1996, APPL LINEAR STAT MOD; Orr HA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004551; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pilfold NW, 2015, OIKOS, V124, P1098, DOI 10.1111/oik.02000; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142213; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Rogers MC, 2015, POLAR BIOL, V38, P1035, DOI 10.1007/s00300-015-1665-4; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Stapleton S, 2016, MAR MAMMAL SCI, V32, P181, DOI 10.1111/mms.12251; Stapleton S, 2014, BIOL CONSERV, V170, P38, DOI 10.1016/j.biocon.2013.12.040; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; Stirling I, 2004, ARCTIC, V57, P15; Stirling I, 2006, ARCTIC, V59, P261; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Taylor MK, 2005, ARCTIC, V58, P203; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Towns L, 2009, POLAR BIOL, V32, P1529, DOI 10.1007/s00300-009-0653-y; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623	71	66	67	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155932	10.1371/journal.pone.0155932	http://dx.doi.org/10.1371/journal.pone.0155932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249673	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700023
J	Dalazen, CE; De Carli, AD; Bomfim, RA; dos Santos, MLM				Dalazen, Chaiane Emilia; De Carli, Alessandro Diogo; Bomfim, Rafael Aiello; Moraes dos Santos, Mara Lisiane			Contextual and Individual Factors Influencing Periodontal Treatment Needs by Elderly Brazilians: A Multilevel Analysis	PLOS ONE			English	Article							INCOME INEQUALITY; DENTAL-CARIES; HEALTH-SURVEY; TOOTH LOSS; SAO-PAULO; DISEASES; POPULATION; SERVICES; ADULTS	Objective To assess the relationship between periodontal treatment needs by elderly Brazilians and contextual as well as individual variables. Methods A cross-sectional study was carried out to assess the need for clinical periodontal treatment, based on National Oral Health Survey (SB Brasil 2010) data on the presence of dental calculus, shallow (3-5 mm) and deep (>= 6 mm) periodontal pockets, and gingival bleeding in elderly people (n = 7,619). The contextual variables included the Municipal Human Development Index (MHDI), income inequality (Gini Index) and coverage of the municipal population by the Family Health Strategy (FHS) program oral health teams.<0} The individual variables were sex, income, education level and self-reported skin color. Multilevel logistic regression models were used to calculate the odds ratio (OR) and 95% confidence intervals (CI95%) between periodontal treatment needs and the contextual as well as individual variables. Results Gingival bleeding was found in 20.7% of the elderly analyzed (n = 1,577), dental calculus in 34% (n = 2,590), shallow periodontal pockets in 15.6%(n = 1,189), and deep periodontal pockets in 4.2% (n = 320). Individual factors were correlated with all the outcomes assessed. Sex was a protective factor in regard to gingival bleeding (OR = 0.87; CI95% 0.76-1.00), dental calculus (OR = 0.86; CI95% 0.75-0.99), shallow periodontal pockets (OR = 0.69; CI95% 0.60-0.80) and deep periodontal pockets (OR = 0.58; CI95% 0.45-0.74). It was found that fewer women needed treatment. Elderly people who self-reported having nonwhite skin had higher chances of needing periodontal treatment. Skin color was a risk factor for gingival bleeding (OR = 1.32; CI95% 1.14-1.53), dental calculus (OR = 1.32; CI95% 1.14-1.54) and shallow periodontal pockets (OR = 1.27; CI95% 1.09-1.49). Education level was associated with the presence of dental calculus (OR = 0.77; CI95% 0.66-0.89), shallow periodontal pockets (OR = 0.86; CI95% 0.73-1.00) and deep periodontal pockets (OR = 0.74; CI95% 0.57-0.97), thus acting as a risk factor for undereducated elderly people. There was a correlation between population coverage by the Family Health Strategy (FHS) program oral health teams and the presence of gingival bleeding (OR = 0.67; CI95% 0.52-0.88), shallow periodontal pockets (OR = 0.76; CI95% 0.58-0.98) and deep periodontal pockets (OR = 0.62; CI95% 0.44-0.89), making these teams act as a protective factor. Conclusions This study showed evidence of the sociocontextual as well as individual sociodemographic characteristics influencing periodontal treatment needed by elderly Brazilians, based on the clinical features of periodontal disease. The results suggest the existence of inequality related to periodontal treatment needs among elderly Brazilians, especially in regard to sex and ethnicity, in addition to a potentially positive impact from the expansion of the Family Health Strategy (FHS) program oral health teams.	[Dalazen, Chaiane Emilia; De Carli, Alessandro Diogo; Bomfim, Rafael Aiello] Univ Fed Mato Grosso do Sul, Saude Colet, Fac Odontol Prof Albino Coimbra Filho, Campo Grande, MS, Brazil; [Moraes dos Santos, Mara Lisiane] Univ Fed Mato Grosso do Sul, Dept Tecnol Alimentos & Saude Colet, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Dalazen, CE (corresponding author), Univ Fed Mato Grosso do Sul, Saude Colet, Fac Odontol Prof Albino Coimbra Filho, Campo Grande, MS, Brazil.	chaiane_1@msn.com	Bomfim, Rafael Aiello/I-9539-2016; Santos, Mara/AAU-3803-2020	Bomfim, Rafael Aiello/0000-0002-6478-8664; 				Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214; Albandar JM, 2002, PERIODONTOL 2000, V29, P177, DOI 10.1034/j.1600-0757.2002.290109.x; de Souza EHA, 2012, CIENC SAUDE COLETIVA, V17, P2063, DOI 10.1590/S1413-81232012000800017; Antunes JLF, 2003, INT DENT J, V53, P7, DOI 10.1111/j.1875-595X.2003.tb00649.x; Antunes José Leopoldo Ferreira, 2008, Rev. Saúde Pública, V42, P191, DOI 10.1590/S0034-89102008000200002; Baldani Márcia Helena, 2002, Cad. Saúde Pública, V18, P755, DOI 10.1590/S0102-311X2002000300019; Barbato PR, 2007, CAD SAUDE PUBLICA, V23, P1803, DOI 10.1590/S0102-311X2007000800007; BASTOS JL, 2011, CAD SAUDE PUBLICA, V27, pS141; Borrell LN, 2004, AM J PUBLIC HEALTH, V94, P748, DOI 10.2105/AJPH.94.5.748; Brazil. Ministry of Health, 2010, DATASUS HLTH INF COV; Celeste RK, 2011, CAD SAUDE PUBLICA, V27, P1111, DOI 10.1590/S0102-311X2011000600008; Corbet EF, 2002, PERIODONTOL 2000, V29, P122, DOI 10.1034/j.1600-0757.2002.290107.x; Carvalho José Alberto Magno de, 2003, Cad. Saúde Pública, V19, P725, DOI 10.1590/S0102-311X2003000300005; Department of Health, 2016, MAN CAR HOM CLOS MAN; Zaitune MPD, 2012, CAD SAUDE PUBLICA, V28, P583; Ferreira CD, 2013, REV SAUDE PUBL, V47, P90, DOI 10.1590/S0034-8910.2013047004721; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Gomes R, 2007, CAD SAUDE PUBLICA, V23, P565, DOI 10.1590/S0102-311X2007000300015; Haas AN, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01818.x; Harford J, 2009, COMMUNITY DENT ORAL, V37, P97, DOI 10.1111/j.1600-0528.2008.00441.x; Hiramatsu Daniel Afonso, 2007, Cien Saude Colet, V12, P1051, DOI 10.1590/S1413-81232007000400026; Jovino-Silveira Renata Cimoes, 2005, Oral Health Prev Dent, V3, P151; Klinge B, 2005, J CLIN PERIODONTOL, V32, P314, DOI 10.1111/j.1600-051X.2005.00801.x; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; de Carvalho JAM, 2008, CAD SAUDE PUBLICA, V24, P597, DOI 10.1590/S0102-311X2008000300013; Martins A.M.E.B.L., 2005, UNIMONTES CIENTIFICA, V7, P55; Moreira Rafael da Silveira, 2005, Cad. Saúde Pública, V21, P1665, DOI 10.1590/S0102-311X2005000600013; Morris AJ, 2001, BRIT DENT J, V191, P186, DOI 10.1038/sj.bdj.4801135a; Vasconcelos AMN, 2012, EPIDEMIOL SERV SAUDE, V21, P539, DOI 10.5123/S1679-49742012000400003; Peixoto Sérgio Viana, 2006, Cad. Saúde Pública, V22, P1925, DOI 10.1590/S0102-311X2006000900024; Peres MA, 2007, J CLIN PERIODONTOL, V34, P196, DOI 10.1111/j.1600-051X.2006.01043.x; Peres MA, 2013, REV SAUDE PUBL, V47, P78, DOI 10.1590/S0034-8910.2013047004226; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2012, PERIODONTOL 2000, V60, P7, DOI 10.1111/j.1600-0757.2012.00452.x; Rodrigues NO, 2012, CIENC SAUDE COLETIVA, V17, P2129, DOI 10.1590/S1413-81232012000800023; Sabbah W, 2007, J DENT RES, V86, P992, DOI 10.1177/154405910708601014; Sabbah W, 2010, INT DENT J, V60, P370, DOI 10.1922/IDJ_2480Sabbah05; Sheiham A, 2002, PERIODONTOL 2000, V29, P104, DOI 10.1034/j.1600-0757.2002.290106.x; Shi L. Y., 2009, Journal of Medical Sciences, V29, P43; Steele J, 2015, J DENT RES, V94, P19, DOI 10.1177/0022034514553978; Teixeira CFS, 1999, CIENCIA SAUDE COLETI, V4, P287; Tesser CD, 2010, R SAUDE PUBL SANTA C, V3; United Nations Development Programme, 2013, ATL HUM DEV BRAZ 199; Veras R., 2009, J PUBLIC HLTH, V43, P548, DOI DOI 10.1590/S0034-89102009000300020; Vettore MV, 2013, REV SAUDE PUBL, V47, P29, DOI 10.1590/S0034-8910.2013047004422; Watt RG, 2012, PERIODONTOL 2000, V60, P147, DOI 10.1111/j.1600-0757.2011.00426.x	46	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156231	10.1371/journal.pone.0156231	http://dx.doi.org/10.1371/journal.pone.0156231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249677	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700033
J	Valverde, GL; Martin, EG; Poves, JML; Llorens, VP; Julvez, LEP				Lopez Valverde, Gloria; Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.			Study of Association between Pre-Senile Cataracts and the Polymorphisms rs2228000 in XPC and rs1042522 in p53 in Spanish Population	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; AGE-RELATED CATARACT; OXIDATIVE DNA-DAMAGE; XERODERMA-PIGMENTOSUM; IN-VIVO; C PROTEIN; LENS; MUTATIONS; APOPTOSIS; RADIATION	Purpose To determine if the presence of certain polymorphisms in the DNA repair gene XPC and the apoptosis inductor gene p53 is associated with pre-senile cataract development. Methods We have performed a retrospective study over three groups of patients. The group with presenile cataract formed by 72 patients younger than 55 with cataract surgery. The group with senile cataract formed by 101 patients older than 55 with cataract surgery. The group without cataract was formed by 42 subjects older than 55 without lens opacities. We analyzed the presence of SNP rs2228000 from XPC and rs1042522 from p53; and the relationship between risk factors such as smoking, alcohol intake, hypertension or diabetes. Results The comparison of the genotype distribution in XPC, within the different groups, did not show any statistically significant association in any of our analysis (p>0,05). The comparison of the genotype distribution in p53 within the different groups did not show any statistically significant association (p>0,05); except for the comparison between the pre-senile cataract group and the group with senile cataract where the genotype Pro/Pro (C/C) in the recessive inheritancemodel showed a higher risk for developing pre-senile cataract (p = 0,031; OR = 1.04-15.97). This association decreased when we performed the analysis adjusting by the studied risk factors (p = 0.056). Conclusions Allelic variants in the gene XPC are not associated with an increased risk for developing pre-senile cataract. The presence of the genotype Pro/Pro in p53 might be associated with a major risk for developing pre-senile cataract.	[Lopez Valverde, Gloria] Hosp Royo Villanova, Zaragoza, Spain; [Lopez Valverde, Gloria; Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.] Hosp Univ Miguel Servet, Zaragoza, Spain; [Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.] Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza, Spain	Miguel Servet University Hospital	Valverde, GL (corresponding author), Hosp Royo Villanova, Zaragoza, Spain.; Valverde, GL (corresponding author), Hosp Univ Miguel Servet, Zaragoza, Spain.	gloria_lpz@hotmail.com		Polo Llorens, Vicente/0000-0002-1402-3129; Pablo, Luis/0000-0003-2389-8282; GARCIA-MARTIN, ELENA/0000-0001-6258-2489				[Anonymous], 2011, PRESCRIRE INT, V20, P41; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bitarafan Rajabi Ahmad, 2015, Res Cardiovasc Med, V4, pe25148, DOI 10.5812/cardiovascmed.25148; Blanco Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI [10.1167/iovs.11-7489, DOI 10.1167/IOVS.11-7489]; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELLEDGE RM, 1995, BIOESSAYS, V17, P923, DOI 10.1002/bies.950171105; Fanny A, 2014, J FR OPHTALMOL, V37, P388, DOI 10.1016/j.jfo.2013.11.011; Galichanin K, 2014, HEALTH PHYS, V107, P523, DOI 10.1097/HP.0000000000000152; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamada N, 2015, CANCER LETT, V368, P262, DOI 10.1016/j.canlet.2015.02.017; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; Hsieh HC, 2005, BIOCHEM BIOPH RES CO, V335, P181, DOI 10.1016/j.bbrc.2005.07.067; Ji WK, 2013, CURR MOL MED, V13, P968, DOI 10.2174/15665240113139990052; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kong Y, 2011, J AGING RES, DOI [10.4061/2011/963172, DOI 10.4061/2011/963172]; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Melis JPM, 2013, ANTIOXID REDOX SIGN, V18, P2409, DOI 10.1089/ars.2012.5036; Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Miller DP, 2011, INT J CHRONIC OBSTR, V6, P467, DOI 10.2147/COPD.S14247; Okuda M, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.13; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Pastor Idoate S, 2013, OPHTHALMOLOGY, V120, P623, DOI [10.1016/j.ophtha.2012.08.019, DOI 10.1016/J.OPHTHA.2012.08.019]; Phang BH, 2015, P NATL ACAD SCI USA, V112, pE6349, DOI 10.1073/pnas.1510043112; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Qin Y, 2014, BBA-MOL BASIS DIS, V1842, P2439, DOI 10.1016/j.bbadis.2014.10.002; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Sayin N, 2015, WORLD J DIABETES, V6, P92, DOI 10.4239/wjd.v6.i1.92; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Snow A, 2015, CHEM-BIOL INTERACT, V234, P247, DOI 10.1016/j.cbi.2014.12.017; SOUSSI T, 1990, ONCOGENE, V5, P945; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Tsentalovich YP, 2015, EXP EYE RES, V134, P15, DOI 10.1016/j.exer.2015.03.008; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wang L, 2011, MOL VIS, V17, P3423; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wiggs JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045613; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Yang Mei, 2014, Zhonghua Yi Xue Za Zhi, V94, P1147; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zrzeszinski JY, 2014, MOL BIOL CELL, V25, P213, DOI [10.1091/mbc.E13-05-0293, DOI 10.1091/MBC.E13-05-0293]	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156317	10.1371/journal.pone.0156317	http://dx.doi.org/10.1371/journal.pone.0156317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248495	gold, Green Published			2022-12-27	WOS:000377184700035
J	Ruzicka, M; Akbari, A; Bruketa, E; Kayibanda, JF; Baril, C; Hiremath, S				Ruzicka, Marcel; Akbari, Ayub; Bruketa, Eva; Kayibanda, Jeanne Francoise; Baril, Claude; Hiremath, Swapnil			How Accurate Are Home Blood Pressure Devices in Use? A Cross-Sectional Study	PLOS ONE			English	Article							HYPERTENSION-INTERNATIONAL-PROTOCOL; EUROPEAN-SOCIETY; SELF-MEASUREMENT; SPHYGMOMANOMETERS; VALIDATION; PREVALENCE; GUIDELINES; INACCURACY; READINGS	Background Out of office blood pressure measurements, using either home monitors or 24 hour ambulatory monitoring, is widely recommended for management of hypertension. Though validation protocols, meant to be used by manufacturers, exist for blood pressure monitors, there is scant data in the literature about the accuracy of home blood pressure monitors in actual clinical practice. We performed a chart review in the blood pressure assessment clinic at a tertiary care centre. Methods We assessed the accuracy of home blood pressure monitors used by patients seen in the nephrology clinic in Ottawa between the years 2011 to 2014. We recorded patient demographics and clinical data, including the blood pressure measurements, arm circumference and the manufacturer of the home blood pressure monitor. The average of BP measurements performed with the home blood pressure monitor, were compared to those with the mercury sphygmomanometer. We defined accuracy based on a difference of 5 mm Hg in the blood pressure values between the home monitor and mercury sphygmomanometer readings. The two methods were compared using a Bland-Altman plot and a student's t-test. Results The study included 210 patients. The mean age of the study population was 67 years and 61% was men. The average mid-arm circumference was 32.2 cms. 30% and 32% of the home BP monitors reported a mean systolic and diastolic BP values, respectively, different from the mercury measurements by 5 mm Hg or more. There was no significant difference between the monitors that were accurate versus those that were not when grouped according to the patient characteristics, cuff size or the brand of the home monitor. Conclusions An important proportion of home blood pressure monitors used by patients seen in our nephrology clinic were inaccurate. A re-validation of the accuracy and safety of the devices already in use is prudent before relying on these measurements for clinical decisions.	[Ruzicka, Marcel; Akbari, Ayub; Hiremath, Swapnil] Univ Ottawa, Fac Med, Div Nephrol, Ottawa, ON, Canada; [Ruzicka, Marcel] Univ Ottawa, Inst Heart, Div Cardiol, Ottawa, ON, Canada; [Ruzicka, Marcel; Akbari, Ayub; Baril, Claude; Hiremath, Swapnil] Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada; [Akbari, Ayub; Hiremath, Swapnil] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Bruketa, Eva; Kayibanda, Jeanne Francoise; Hiremath, Swapnil] Ottawa Hlth Res Inst, Kidney Res Ctr, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Hiremath, S (corresponding author), Univ Ottawa, Fac Med, Div Nephrol, Ottawa, ON, Canada.; Hiremath, S (corresponding author), Ottawa Hosp, Div Nephrol, Ottawa, ON, Canada.; Hiremath, S (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Hiremath, S (corresponding author), Ottawa Hlth Res Inst, Kidney Res Ctr, Ottawa, ON, Canada.	shiremath@toh.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416				ABBOTT D, 1994, CAN J PUBLIC HEALTH, V85, pS29; Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; Akpolat T, 2011, BLOOD PRESS MONIT, V16, P168, DOI 10.1097/MBP.0b013e328348ca52; Akpolat T, 2009, BLOOD PRESS MONIT, V14, P208, DOI 10.1097/MBP.0b013e328330d47b; Akpolat T, 2009, BLOOD PRESS MONIT, V14, P26, DOI 10.1097/MBP.0b013e3283262f31; ASSOCIATION for the Advancement of Medical Instrumentation, 2003, MAN EL AUT SPHYGM; Bancej Christina M, 2010, Can J Cardiol, V26, pe152; Baral-Grant S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/582068; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Campbell NRC, 2001, BLOOD PRESS MONIT, V6, P133, DOI 10.1097/00126097-200106000-00003; Cuspidi C, 2005, BLOOD PRESSURE, V14, P251, DOI 10.1080/08037050500210765; Dasgupta K, 2014, CAN J CARDIOL, V30, P485, DOI 10.1016/j.cjca.2014.02.002; Dilek M, 2008, BLOOD PRESSURE, V17, P34, DOI 10.1080/08037050701758018; FDA UFaDA, 1997, NON BLOOD PRESS NIBP; HAHN LP, 1987, AM J PUBLIC HEALTH, V77, P1459, DOI 10.2105/AJPH.77.11.1459; Jones DW, 2003, JAMA-J AM MED ASSOC, V289, P1027, DOI 10.1001/jama.289.8.1027; Little P, 2002, BRIT MED J, V325, P258, DOI 10.1136/bmj.325.7358.258; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Merrick RD, 1997, SOUTH MED J, V90, P1110, DOI 10.1097/00007611-199711000-00011; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P3, DOI 10.1097/00126097-200202000-00002; O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; OBRIEN E, 1990, J HYPERTENS, V8, P607, DOI 10.1097/00004872-199007000-00004; Ogedegbe G, 2010, CARDIOL CLIN, V28, P571, DOI 10.1016/j.ccl.2010.07.006; Pickering TG, 2008, J AM SOC HYPERTENS, V2, P119, DOI 10.1016/j.jash.2008.04.002; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Stryker T, 2004, BLOOD PRESS MONIT, V9, P143, DOI 10.1097/01.mbp.0000130224.18777.ce; Ward AM, 2012, J HYPERTENS, V30, P449, DOI 10.1097/HJH.0b013e32834e4aed; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Wong WCW, 2005, J ROY SOC MED, V98, P111, DOI 10.1258/jrsm.98.3.111	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155677	10.1371/journal.pone.0155677	http://dx.doi.org/10.1371/journal.pone.0155677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249056	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700019
J	Fjeldbo, CS; Aarnes, EK; Malinen, E; Kristensen, GB; Lyng, H				Fjeldbo, Christina S.; Aarnes, Eva-Katrine; Malinen, Eirik; Kristensen, Gunnar B.; Lyng, Heidi			Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients	PLOS ONE			English	Article							STANNIOCALCIN 2 OVEREXPRESSION; TIME QUANTITATIVE PCR; HOUSEKEEPING GENES; TUMOR HYPOXIA; CELL CARCINOMA; CLINICAL-SIGNIFICANCE; EXPRESSION ANALYSIS; ENDOGENOUS CONTROL; PROGNOSTIC MARKER; PROSTATE-CANCER	Hypoxia is an adverse factor in cervical cancer, and hypoxia-related gene expression could be a powerful biomarker for identifying the aggressive hypoxic tumors. Reverse transcription quantitative PCR (RT-qPCR) is a valuable method for gene expression studies, but suitable reference genes for data normalization that are independent of hypoxia status and clinical parameters of cervical tumors are lacking. In the present work, we aimed to identify reference genes for RT-qPCR studies of hypoxia in squamous cervical cancer. From 422 candidate reference genes selected from the literature, we used Illumina array-based expression profiles to identify 182 genes not affected by hypoxia in cervical cancer, i.e. genes regulated by hypoxia in eight cervical cancer cell lines or correlating with the hypoxia-associated dynamic contrast-enhanced magnetic resonance imaging parameter A(Brix) in 42 patients, were excluded. Among the 182 genes, nine candidates (CHCHD1, GNB2L1, IPO8, LASP1, RPL27A, RPS12, SOD1, SRSF9, TMBIM6) that were not associated with tumor volume, stage, lymph node involvement or disease progression in array data of 150 patients, were selected for further testing by RT-qPCR. geNorm and NormFinder analyses of RT-qPCR data of 74 patients identified CHCHD1, SRSF9 and TMBIM6 as the optimal set of reference genes, with stable expression both overall and across patient subgroups with different hypoxia status (A(Brix)) and clinical parameters. The suitability of the three reference genes were validated in studies of the hypoxia-induced genes DDIT3, ERO1A, and STC2. After normalization, the RT-qPCR data of these genes showed a significant correlation with Illumina expression (P < 0.001, n = 74) and A(Brix) (P < 0.05, n = 32), and the STC2 data were associated with clinical outcome, in accordance with the Illumina data. Thus, CHCHD1, SRSF9 and TMBIM6 seem to be suitable reference genes for studying hypoxia-related gene expression in squamous cervical cancer samples by RT-qPCR. Moreover, STC2 is a promising prognostic hypoxia biomarker in cervical cancer.	[Fjeldbo, Christina S.; Aarnes, Eva-Katrine; Lyng, Heidi] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Radiat Biol, Oslo, Norway; [Malinen, Eirik] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Phys, Oslo, Norway; [Malinen, Eirik] Univ Oslo, Dept Phys, Oslo, Norway; [Kristensen, Gunnar B.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynaecol Oncol, Oslo, Norway; [Kristensen, Gunnar B.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Oslo, Norway; [Kristensen, Gunnar B.] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Lyng, H (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Radiat Biol, Oslo, Norway.	heidi.lyng@rr-research.no	Lyng, Heidi/AAQ-3873-2020	Lyng, Heidi/0000-0002-7938-0514; Malinen, Eirik/0000-0002-1308-9871	Research Council of Norway [226120/O30]	Research Council of Norway(Research Council of Norway)	This work was supported by The Research Council of Norway, Grant number 226120/O30, (http://www.forskningsradet.no/en/Home_page/1177315753906). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Betts GNJ, 2013, EUR J CANCER, V49, P156, DOI 10.1016/j.ejca.2012.07.028; Bruge F, 2011, J BIOTECHNOL, V156, P153, DOI 10.1016/j.jbiotec.2011.09.018; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Daud II, 2008, CLIN VACCINE IMMUNOL, V15, P1369, DOI 10.1128/CVI.00074-08; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dhani N, 2015, SEMIN NUCL MED, V45, P110, DOI 10.1053/j.semnuclmed.2014.11.002; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ersahin T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093341; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.2002.20.3.680; Leitao MDG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111021; Gray B, 2014, CMPRSK SUBDISTRIBUTI; Halle C, 2012, CANCER RES, V72, P5285, DOI 10.1158/0008-5472.CAN-12-1085; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hockel M, 1996, CANCER RES, V56, P4509; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Ieta K, 2009, INT J CANCER, V125, P926, DOI 10.1002/ijc.24453; Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1; Law AYS, 2010, EXP CELL RES, V316, P3425, DOI 10.1016/j.yexcr.2010.06.026; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Lin SJ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-26; Lindqvist Annika, 2013, BMC Res Notes, V6, P34, DOI 10.1186/1756-0500-6-34; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Low AYS, 2010, EXP CELL RES, V316, P466, DOI 10.1016/j.yexcr.2009.09.018; Lyng H, 2000, CLIN CANCER RES, V6, P1104; McNeill RE, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-107; Meyer HA, 2009, EUR UROL, V55, P669, DOI 10.1016/j.eururo.2008.04.001; Miyazaki S, 2014, INT J CANCER, V135, P295, DOI 10.1002/ijc.28686; Na SS, 2015, BBA-PROTEINS PROTEOM, V1854, P668, DOI 10.1016/j.bbapap.2014.11.002; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Punt S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0350-0; R Core Team, 2013, R LANG ENV STAT COMP; Shen XJ, 2014, INT J CLIN EXP PATHO, V7, P8770; Shen YM, 2010, ANAL BIOCHEM, V405, P224, DOI 10.1016/j.ab.2010.06.029; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Soes S, 2013, LUNG CANCER, V81, P180, DOI 10.1016/j.lungcan.2013.04.007; Sorensen BS, 2015, RADIOTHER ONCOL, V116, P346, DOI 10.1016/j.radonc.2015.06.028; Sorensen BS, 2005, RADIOTHER ONCOL, V76, P187, DOI 10.1016/j.radonc.2005.06.037; Steinau M, 2006, J MOL DIAGN, V8, P113, DOI 10.2353/jmoldx.2006.050088; Tamura K, 2009, CANCER SCI, V100, P914, DOI 10.1111/j.1349-7006.2009.01117.x; Thomas A, 2013, CANCER MED-US, V2, P836, DOI 10.1002/cam4.152; Toustrup K, 2011, CANCER RES, V71, P5923, DOI 10.1158/0008-5472.CAN-11-1182; Tramm T, 2013, DIAGN MOL PATHOL, V22, P181, DOI 10.1097/PDM.0b013e318285651e; Vajda A, 2013, PROSTATE, V73, P382, DOI 10.1002/pros.22578; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Yokobori T, 2010, ANN SURG ONCOL, V17, P2601, DOI 10.1245/s10434-010-1086-0; Yoon JH, 2014, PROTEOMICS, V14, P1494, DOI 10.1002/pmic.201300554	50	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156259	10.1371/journal.pone.0156259	http://dx.doi.org/10.1371/journal.pone.0156259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244197	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100023
J	Lee, SH; Kim, KT; Kwon, OD; Ock, Y; Kim, T; Choi, D; Kwak, D				Lee, Seung-Hun; Kim, Kyoo-Tae; Kwon, Oh-Deog; Ock, Younsung; Kim, Taeil; Choi, Donghag; Kwak, Dongmi			Novel Detection of Coxiella spp., Theileria luwenshuni, and T. ovis Endosymbionts in Deer Keds (Lipoptena fortisetosa)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BURGDORFERI-SENSU-LATO; DIPTERA HIPPOBOSCIDAE; CERVI; INFECTION; TICKS; SCHOENBUCHENSIS; BURNETII; RECORD	We describe for the first time the detection of Coxiella-like bacteria (CLB), Theileria luwenshuni, and T. ovis endosymbionts in blood-sucking deer keds. Eight deer keds attached to a Korean water deer were identified as Lipoptena fortisetosa (Diptera: Hippoboscidae) by morphological and genetic analyses. Among the endosymbionts assessed, CLB, Theileria luwenshuni, and T. ovis were identified in L. fortisetosa by PCR and nucleotide sequencing. Based on phylogeny, CLB 16S rRNA sequences were classified into clade B, sharing 99.4% identity with CLB from Haemaphysalis longicornis in South Korea. Although the virulence of CLB to vertebrates is still controversial, several studies have reported clinical symptoms in birds due to CLB infections. The 18S rRNA sequences of T. luwenshuni and T. ovis in this study were 98.8-100% identical to those in GenBank, and all of the obtained sequences of T. ovis and T. luwenshuni in this study were 100% identical to each other, respectively. Although further studies are required to positively confirm L. fortisetosa as a biological vector of these pathogens, strong genetic relationships among sequences from this and previous studies suggest potential transmission among mammalian hosts by ticks and keds.	[Lee, Seung-Hun; Kwon, Oh-Deog; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Kim, Kyoo-Tae] Anim Hlth Ctr Zoo Land, Daejeon O World Theme Pk, Daejeon, South Korea; [Ock, Younsung; Kim, Taeil; Choi, Donghag] Dongin Vet Clin, Daegu, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr		Kwak, Dongmi/0000-0003-0876-3179	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan Sandra A., 2001, P18, DOI 10.1002/9780470377000.ch2; Barlough JE, 1996, VET PARASITOL, V63, P319, DOI 10.1016/0304-4017(95)00904-3; BOSE R, 1991, PARASITOL RES, V77, P723, DOI 10.1007/BF00928691; Choi CY, 2013, J MED ENTOMOL, V50, P1173, DOI 10.1603/ME12150; Chu C, 2008, J MED MICROBIOL, V57, P980, DOI 10.1099/jmm.0.47663-0; Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Han JI, 2009, VET PARASITOL, V164, P311, DOI 10.1016/j.vetpar.2009.05.027; Harkonen Sauli, 2009, Alces, V45, P73; Hermosilla C, 2006, VET REC, V159, P286, DOI 10.1136/vr.159.9.286; HO T, 1995, MICROBIOL IMMUNOL, V39, P663, DOI 10.1111/j.1348-0421.1995.tb03254.x; Hornok S, 2011, VECTOR-BORNE ZOONOT, V11, P1319, DOI 10.1089/vbz.2011.0649; Kim HC, 2010, J MED ENTOMOL, V47, P1227, DOI 10.1603/ME09262; Kim KH, 2014, EMERG INFECT DIS, V20, P1708, DOI 10.3201/eid2010.131680; Ko S, 2013, VECTOR-BORNE ZOONOT, V13, P415, DOI 10.1089/vbz.2012.1105; Kowal Jerzy, 2009, Dipteron - Wroclaw, V25, P27; Kubo M, 2010, J PARASITOL, V96, P437, DOI 10.1645/GE-2270.1; Lloyd John E., 2009, P339; Maa T C, 1965, J Med Entomol, V2, P233; MAA TC, 1967, PAC INSECTS, V9, P727; METELITSA AK, 1989, PARAZITOLOGIYA+, V23, P276; Moon KyoungHa, 2014, Journal of Veterinary Clinics, V31, P6; Nelder MP, 2008, EMERG INFECT DIS, V14, P1002, DOI 10.3201/eid1406.071691; Otranto D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-55; Park Joo Young, 1993, Journal of the Korean Society for Microbiology, V28, P285; PARK KH, 1993, J CLIN MICROBIOL, V31, P1831, DOI 10.1128/JCM.31.7.1831-1837.1993; PAVILANIS V, 1958, Can J Public Health, V49, P520; Razmi G, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.635; Seo MG, 2013, RES VET SCI, V94, P579, DOI 10.1016/j.rvsc.2013.01.014; Shivaprasad HL, 2008, AVIAN DIS, V52, P426, DOI 10.1637/8192-120707-Reg; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thrusfield M., 2005, VET EPIDEMIOLOGY, P98; Vapniarsky N, 2012, VET PATHOL, V49, P717, DOI 10.1177/0300985811409251; Woc-Colburn AM, 2008, VET PATHOL, V45, P247, DOI 10.1354/vp.45-2-247; Yamauchi Takeo, 2009, Medical Entomology and Zoology, V60, P131; Yin H, 2007, PARASITOL RES, V101, pS191; Zeman P, 1998, FOLIA PARASIT, V45, P319	40	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156727	10.1371/journal.pone.0156727	http://dx.doi.org/10.1371/journal.pone.0156727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244561	Green Submitted, gold, Green Published			2022-12-27	WOS:000377146100066
J	Palaniappan, A; Ramar, K; Ramalingam, S				Palaniappan, Ashok; Ramar, Karthick; Ramalingam, Satish			Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; MUTATED DRIVER PATHWAYS; PHOSPHOLIPASE C-GAMMA-1; CYTOSCAPE PLUGIN; CELL-SURVIVAL; HUMAN COLON; PROTEIN; EXPRESSION; GENE; OVEREXPRESSION	It is well-known that the conversion of normal colon epithelium to adenoma and then to carcinoma stems from acquired molecular changes in the genome. The genetic basis of colorectal cancer has been elucidated to a certain extent, and much remains to be known about the identity of specific cancer genes that are associated with the advancement of colorectal cancer from one stage to the next. Here in this study we attempted to identify novel cancer genes that could underlie the stage-specific progression and metastasis of colorectal cancer. We conducted a stage-based meta-analysis of the voluminous tumor genome-sequencing data and mined using multiple approaches for novel genes driving the progression to stage-II, stage-III and stage-IV colorectal cancer. The consensus of these driver genes seeded the construction of stage-specific networks, which were then analyzed for the centrality of genes, clustering of subnetworks, and enrichment of gene-ontology processes. Our study identified three novel driver genes as hubs for stage-II progression: DYNC1H1, GRIN2A, GRM1. Four novel driver genes were identified as hubs for stage-III progression: IGF1R, CPS1, SPTA1, DSP. Three novel driver genes were identified as hubs for stage-IV progression: GSK3B, GGT1, EIF2B5. We also identified several non-driver genes that appeared to underscore the progression of colorectal cancer. Our study yielded potential diagnostic biomarkers for colorectal cancer as well as novel stage-specific drug targets for rational intervention. Our methodology is extendable to the analysis of other types of cancer to fill the gaps in our knowledge.	[Palaniappan, Ashok; Ramar, Karthick; Ramalingam, Satish] Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Kelambakkam 603103, Tamil Nadu, India		Palaniappan, A (corresponding author), Chettinad Acad Res & Educ, Fac Allied Hlth Sci, Kelambakkam 603103, Tamil Nadu, India.	aplnppn@gmail.com	Ramalingam, Satish/H-1577-2018; Palaniappan, Ashok/AAD-9018-2020	Ramalingam, Satish/0000-0002-3076-279X; Palaniappan, Ashok/0000-0003-2841-9527				Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; Ali S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103204; ARTEAGA CL, 1991, P NATL ACAD SCI USA, V88, P10435, DOI 10.1073/pnas.88.23.10435; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; Baek HJ, 2011, HEPATOLOGY, V53, P1676, DOI 10.1002/hep.24128; Banda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081126; Booth L, 2015, J CELL PHYSIOL, V230, P1661, DOI 10.1002/jcp.24919; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Cerezo-Guisado MI, 2015, FOOD CHEM TOXICOL, V84, P125, DOI 10.1016/j.fct.2015.08.017; Chakraborty PK, 2014, CANCER RES, V74, P3489, DOI 10.1158/0008-5472.CAN-13-2708; Chang YW, 2015, ONCOGENE; Cheng WC, 2014, NUCLEIC ACIDS RES, V42, pD1048, DOI 10.1093/nar/gkt1025; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Corti A, 2010, ANTICANCER RES, V30, P1169; D'mello SAN, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00333; Davalos V, 2012, J BIOL CHEM, V287, P43472, DOI 10.1074/jbc.M112.428466; Davies EL, 1999, EUR J CANCER, V35, P902, DOI 10.1016/S0959-8049(99)00031-3; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Fentiman IS, 2012, BRIT J CANCER, V106, P1467, DOI 10.1038/bjc.2012.128; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gallego-Ortega D, 2011, ADV ENZYME REGUL, V51, P183, DOI 10.1016/j.advenzreg.2010.09.010; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Goode EL, 2010, CLIN CANCER RES, V16, P995, DOI 10.1158/1078-0432.CCR-09-2553; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Handa K, 2007, J VIROL, V81, P1379, DOI 10.1128/JVI.01712-06; Hering H, 2002, FEBS LETT, V521, P185, DOI 10.1016/S0014-5793(02)02831-4; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang CC, 2015, ONCOTARGET, V6, P8698, DOI 10.18632/oncotarget.3537; Huang HL, 2014, WORLD J GASTROENTERO, V20, P5511, DOI 10.3748/wjg.v20.i18.5511; Huang Hao, 2014, Beijing Da Xue Xue Bao Yi Xue Ban, V46, P183; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Je EM, 2014, APMIS, V122, P499, DOI 10.1111/apm.12193; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Jiang XH, 2010, HISTOL HISTOPATHOL, V25, P1497, DOI 10.14670/HH-25.1497; Kaoud TS, 2011, ACS CHEM BIOL, V6, P658, DOI 10.1021/cb200017n; Ketscher A, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.34; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Kucab Jill E, 2003, Breast Dis, V17, P41; Kunze K, 2014, CANCER RES, V74, P6173, DOI 10.1158/0008-5472.CAN-14-1162; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee YY, 2014, TUMOR BIOL, V35, P11097, DOI 10.1007/s13277-014-2425-8; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Li X, 2014, ONCOGENE, V33, P4077, DOI 10.1038/onc.2013.370; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; Liu T, 2015, CANC RES; Maeda O, 2012, INT J CANCER, V130, P113, DOI 10.1002/ijc.25983; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Malinowsky K, 2014, BRIT J CANCER, V110, P2081, DOI 10.1038/bjc.2014.100; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; McInroy L, 2011, EXP CELL RES, V317, P2468, DOI 10.1016/j.yexcr.2011.07.013; Milinkovic V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082108; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mooz J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005484; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nagahashi M, 2010, WORLD J GASTROENTERO, V16, P4003, DOI 10.3748/wjg.v16.i32.4003; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Papagerakis S, 2009, HUM PATHOL, V40, P1320, DOI 10.1016/j.humpath.2009.02.002; PARK JG, 1994, CANCER RES, V54, P2240; Park SY, 2011, VIRCHOWS ARCH, V458, P73, DOI 10.1007/s00428-010-1013-6; Prickett TD, 2014, J INVEST DERMATOL, V134, P2390, DOI 10.1038/jid.2014.190; Raimondi C, 2012, J CELL SCI, V125, P3153, DOI 10.1242/jcs.100511; Ramalingam S, 2008, AM J PHYSIOL-GASTR L, V294, pG971, DOI 10.1152/ajpgi.00540.2007; Ramalingam Satish, 2012, Immunogastroenterology, V1, P27; Raymond JR, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-6; Reimand J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.68; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi ZZ, 2013, CLIN CANCER RES, V19, P5867, DOI 10.1158/1078-0432.CCR-12-3753; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Shiba-Ishii A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0414-1; Shiba-Ishii A, 2012, AM J PATHOL, V180, P1653, DOI 10.1016/j.ajpath.2011.12.014; Shiratsuchi I, 2011, ANTICANCER RES, V31, P2541; Sureban SM, 2008, ONCOGENE, V27, P4544, DOI 10.1038/onc.2008.97; Szalay-Beko M, 2012, BIOINFORMATICS, V28, P2202, DOI 10.1093/bioinformatics/bts352; Tuominen H, 1996, BRIT J DERMATOL, V135, P576, DOI 10.1046/j.1365-2133.1996.d01-1043.x; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Wang JW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1085-4; Wang Q, 2012, INT J ONCOL, V41, P652, DOI 10.3892/ijo.2012.1471; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Wen Y, 2014, CANCER RES, V74, P2499, DOI 10.1158/0008-5472.CAN-13-1531; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Wu ZB, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/131494; Yang Y, 2013, MOL CELL BIOCHEM, V381, P209, DOI 10.1007/s11010-013-1704-9; Yoneyama MS, 2014, EUR J CELL BIOL, V93, P157, DOI 10.1016/j.ejcb.2014.03.002; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Yuan KY, 2007, LAB INVEST, V87, P938, DOI 10.1038/labinvest.3700658; Zhang JH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-271; Zhang XP, 2014, INT J CANCER, V134, P257, DOI 10.1002/ijc.28141; Zhang YF, 2013, ONCOL LETT, V5, P749, DOI 10.3892/ol.2013.1116; Zhao JF, 2012, BIOINFORMATICS, V28, P2940, DOI 10.1093/bioinformatics/bts564	95	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156665	10.1371/journal.pone.0156665	http://dx.doi.org/10.1371/journal.pone.0156665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243824	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100061
J	Ventura, BA; von Keyserlingk, MAG; Wittman, H; Weary, DM				Ventura, Beth Ann; von Keyserlingk, Marina A. G.; Wittman, Hannah; Weary, Daniel M.			What Difference Does a Visit Make? Changes in Animal Welfare Perceptions after Interested Citizens Tour a Dairy Farm	PLOS ONE			English	Article							NATIONAL-SURVEY; ATTITUDES; PIG; PRODUCERS; FACULTY; VIEWS	Citizens' concerns about farm animal welfare are often dismissed on the assumption that they are not well informed about farming practices. We conducted exploratory surveys of interested citizens (n = 50) before and after a self-guided tour of a 500-head dairy farm. 'Before' survey questions explored perceptions, concerns, and values about dairy cattle farming and welfare, in addition to a short knowledge-based quiz on dairy cattle husbandry. An 'after' survey explored the extent to which these constructs shifted after the tour. Before, most participants correctly answered quiz questions about general feeding and housing practices, but scores were low on questions about specific practices such as cow-calf separation. Participants considered several elements as necessary for a 'good' life for dairy cattle: fresh food and water, pasture access, gentle handling, space, shelter, hygiene, fresh air and sunshine, social companions, absence of stress, health, and safety from predators. These elements reflect a diverse conception of animal welfare that incorporates values for physical and mental well-being, natural living, and humane care. The visit had a mixed effect on perceptions of whether dairy cows had a 'good' life, improving perceptions for a quarter of participants, worsening perceptions in a third, with no shift in the remaining participants. The visit appeared to mitigate some concerns (e.g., provision of adequate food and water, gentle humane care) while reinforcing or eliciting others (e.g., lack of pasture access, early cow-calf separation). Moreover, animal welfare-relevant values held by participants (e.g., natural living, care) appeared to play an important role in influencing perceptions of farm practices. These results suggest that education and exposure to livestock farming may resolve certain concerns, but other concerns will likely persist, especially when practices conflict with deeply held values around animal care.	[Ventura, Beth Ann; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Wittman, Hannah] Univ British Columbia, Ctr Sustainable Food Syst, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada.	dan.weary@ubc.ca	von Keyserlingk, Marina/AAB-6353-2019; Ventura, Beth/H-7085-2019; Weary, Daniel M/A-8868-2010	von Keyserlingk, Marina/0000-0002-1427-3152; Ventura, Beth/0000-0001-9476-6901; Weary, Daniel M/0000-0002-0917-3982	University of British Columbia; Animal Welfare Program; University of British Columbia Four Year Doctoral Fellowship Program	University of British Columbia; Animal Welfare Program; University of British Columbia Four Year Doctoral Fellowship Program	Funding for this study was provided by the University of British Columbia, together with the Animal Welfare Program and its donors. BV was supported through the University of British Columbia Four Year Doctoral Fellowship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors extend our deepest appreciation to our participants. Special thanks to N. Dinn and J.R. Thompson at the University of British Columbia Dairy Education and Research Centre for allowing us to conduct this project. We are grateful to G. Busch at Georg-August-University Gottingen for her assistance in data coding and analysis. Thanks also to K. Knowlton at Virginia Polytechnic Institute and State University for her assistance in data collection, and to D. Fraser for providing feedback on earlier versions of the manuscript. The University of British Columbia, together with the Animal Welfare Program and its donors, provided the funding for this study. B. A. Ventura was supported through the University of British Columbia Four Year Doctoral Fellowship Program.	[Anonymous], 2009, COD PRACT CAR HANDL; AWI, 2011, CONS PERC FARM AN WE; Benard M, 2013, J AGR ENVIRON ETHIC, V26, P1015, DOI 10.1007/s10806-013-9438-y; Bock BB, 2007, BRIT FOOD J, V109, P931, DOI 10.1108/00070700710835732; Boogaard BK, 2008, LIVEST SCI, V117, P24, DOI 10.1016/j.livsci.2007.11.004; Boogaard BK, 2006, LIVEST SCI, V104, P13, DOI 10.1016/j.livsci.2006.02.010; Boogaard BK, 2011, LIVEST SCI, V140, P189, DOI 10.1016/j.livsci.2011.03.028; Boogaard BK, 2011, J AGR ENVIRON ETHIC, V24, P259, DOI 10.1007/s10806-010-9256-4; Cardoso CS, 2016, J DAIRY SCI, V99, P1663, DOI 10.3168/jds.2015-9925; Coffey A., 1994, MAKING SENSE QUALITA, P26; Costa JHC, 2016, J DAIRY SCI, V99, P1; Da Silva S, 2015, DAIRY FARMERS CANADA; De Greef K, 2006, J AGR ENVIRON ETHIC, V19, P57, DOI 10.1007/s10806-005-4527-1; Einsedel E. F., 2000, UNDERSTANDING TRUST, P205; Ellis KA, 2009, ANIM WELFARE, V18, P267; Fraser D, 1997, ANIM WELFARE, V6, P187; Hansen J, 2003, APPETITE, V41, P111, DOI 10.1016/S0195-6663(03)00079-5; Harper G. C., 2002, British Food Journal, V104, P287, DOI 10.1108/00070700210425723; Heleski CR, 2005, JAVMA-J AM VET MED A, V226, P1538, DOI 10.2460/javma.2005.226.1538; Heleski CR, 2004, J ANIM SCI, V82, P2806; Hubbard C, 2011, ANIM WELFARE, V20, P79; Hubbard C, 2007, BRIT FOOD J, V109, P919, DOI 10.1108/00070700710835723; Lassen J, 2006, LIVEST SCI, V103, P221, DOI 10.1016/j.livsci.2006.05.008; Maniaci MR, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P443; Maria GA, 2006, LIVEST SCI, V103, P250, DOI 10.1016/j.livsci.2006.05.011; Mench JA, 2008, APPL ANIM BEHAV SCI, V113, P298, DOI 10.1016/j.applanim.2008.01.009; Pirog RS., 2004, CONSUMER PERCEPTIONS; Prickett RW, 2010, ANIM WELFARE, V19, P335; Rauch A, 2005, A TOPICAL REPORT FRO; Robbins JA, 2015, ANIM WELFARE, V24, P399, DOI 10.7120/09627286.24.4.399; Rokeach M., 1973, NATURE HUMAN VALUES; Rutgers, 2003, NEW JERS OP HUM STAN; Ryan EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141878; Schwartz SH, 1999, APPL PSYCHOL-INT REV, V48, P23, DOI 10.1080/026999499377655; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Seligman C., 1996, PSYCHOL VALUES ONTAR, V8; Spooner JM, 2012, ANIM WELFARE, V21, P273, DOI 10.7120/09627286.21.2.273; Spooner JM, 2014, J AGR ENVIRON ETHIC, V27, P569, DOI 10.1007/s10806-013-9477-4; Spooner JM, 2014, LIVEST SCI, V163, P150, DOI 10.1016/j.livsci.2014.02.011; Vanhonacker F, 2008, LIVEST SCI, V116, P126, DOI 10.1016/j.livsci.2007.09.017; Velde HT, 2002, J AGR ENVIRON ETHIC, V15, P203; Ventura BA, 2013, J DAIRY SCI, V96, P6105, DOI 10.3168/jds.2012-6040; Weary DM, 2011, J ANIM SCI, V89, P3831, DOI 10.2527/jas.2011-3858; Wynne B., 1996, MISUNDERSTANDING SCI	44	79	81	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0154733	10.1371/journal.pone.0154733	http://dx.doi.org/10.1371/journal.pone.0154733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243965	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100002
J	Atkinson, QD; Coomber, T; Passmore, S; Greenhill, SJ; Kushnick, G				Atkinson, Quentin D.; Coomber, Ties; Passmore, Sam; Greenhill, Simon J.; Kushnick, Geoff			Cultural and Environmental Predictors of Pre-European Deforestation on Pacific Islands	PLOS ONE			English	Article							EVOLUTION; DETERMINISM; PHYLOGENY	The varied islands of the Pacific provide an ideal natural experiment for studying the factors shaping human impact on the environment. Previous research into pre-European deforestation across the Pacific indicated a major effect of environment but did not account for cultural variation or control for dependencies in the data due to shared cultural ancestry and geographic proximity. The relative importance of environment and culture on Pacific deforestation and forest replacement and the extent to which environmental impact is constrained by cultural ancestry therefore remain unexplored. Here we use comparative phylogenetic methods to model the effect of nine ecological and two cultural variables on pre-European Pacific forest outcomes at 80 locations across 67 islands. We show that some but not all ecological features remain important predictors of forest outcomes after accounting for cultural covariates and non-independence in the data. Controlling for ecology, cultural variation in agricultural intensification predicts deforestation and forest replacement, and there is some evidence that land tenure norms predict forest replacement. These findings indicate that, alongside ecology, cultural factors also predict pre-European Pacific forest outcomes. Although forest outcomes covary with cultural ancestry, this effect disappears after controlling for geographic proximity and ecology. This suggests that forest outcomes were not tightly constrained by colonists' cultural ancestry, but instead reflect a combination of ecological constraints and the short-term responses of each culture in the face of those constraints.	[Atkinson, Quentin D.; Coomber, Ties; Passmore, Sam] Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1142, New Zealand; [Atkinson, Quentin D.; Greenhill, Simon J.] Max Planck Inst Hist & Sci, Kahlaische Str 10, D-07745 Jena, Germany; [Greenhill, Simon J.] Australian Natl Univ, Sch Culture Hist & Language, ANU Coll Asia & Pacific, Canberra, ACT, Australia; [Greenhill, Simon J.] Australian Natl Univ, ARC Ctr Excellence Dynam Language, Canberra, ACT, Australia; [Kushnick, Geoff] Australian Natl Univ, Sch Archaeol & Anthropol, ANU Coll Arts & Social Sci, Canberra, ACT, Australia	University of Auckland; Max Planck Society; Australian National University; Australian National University; Australian National University	Atkinson, QD (corresponding author), Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1142, New Zealand.; Atkinson, QD (corresponding author), Max Planck Inst Hist & Sci, Kahlaische Str 10, D-07745 Jena, Germany.	q.atkinson@auckland.ac.nz	Greenhill, Simon/I-3554-2019; Passmore, Sam/Q-6645-2019	Greenhill, Simon/0000-0001-7832-6156; Passmore, Sam/0000-0002-5302-356X; Atkinson, Quentin/0000-0002-8499-7535	Rutherford Discovery Fellowship [RDF- UOA1101]; Australian Research Council [DE120101954]	Rutherford Discovery Fellowship; Australian Research Council(Australian Research Council)	Q.D.A., T.C. and S.P. were supported by a Rutherford Discovery Fellowship (RDF- UOA1101) to Q.D.A. during completion of this work. S.J.G. was supported by the Australian Research Council's Discovery Projects funding scheme (project number DE120101954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1997, GUNS GERMS STEEL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Currie TE, 2013, CROSS-CULT RES, V47, P102, DOI 10.1177/1069397112471803; DIAMOND J., 2005, COLLAPSE SOC CHOOSE, p[XI, 575]; Diamond J, 2007, SCIENCE, V317, P1692, DOI 10.1126/science.1138442; Drummond A.J., 2012, MOL BIOL EVOLUTION; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fagan BM, 2008, GREAT WARMING CLIMAT; Firth Raymond, 1936, WE THE TIKOPIA; Flenley J., 2003, ENIGMAS EASTER ISLAN; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Galton F., 1889, J ROYAL ANTHR I, V18, P245; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; JOHNSON OEG, 1972, J LAW ECON, V15, P259, DOI 10.1086/466736; Judkins G, 2008, GEOGR J, V174, P17, DOI 10.1111/j.1475-4959.2008.00265.x; Kirch P.V., 1997, HIST ECOLOGY PACIFIC; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Kirch Patrick Vinton, 1994; KIRCH PV, 1987, CURR ANTHROPOL, V28, P431, DOI 10.1086/203547; Kirch PV, 2007, GROWTH COLLAPSE PACI, pxvi; Kushnick G, 2014, EVOL HUM BEHAV, V35, P309, DOI 10.1016/j.evolhumbehav.2014.03.001; Landes D. S., 1999, WEALTH POVERTY NATIO; Livingstone DN, 2012, B HIST MED, V86, P564, DOI 10.1353/bhm.2012.0071; Merrett CD, 2003, ANTIPODE, V35, P801, DOI 10.1046/j.1467-8330.2003.00352.x; Ostrom E, 1990, GOVERNING COMMONS EV, pXVIII; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Rolett BV, 2008, QUATERN INT, V184, P4, DOI 10.1016/j.quaint.2007.10.016; Sachs JD, 2001, SCI AM, V284, P70, DOI 10.1038/scientificamerican0301-70; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Sluyter A, 2003, ANTIPODE, V35, P813, DOI 10.1046/j.1467-8330.2003.00354.x; SMITH RJ, 1981, CATO J, V1, P438; Stevenson CM, 2015, P NATL ACAD SCI USA, V112, P1025, DOI 10.1073/pnas.1420712112; SWADESH M, 1952, P AM PHILOS SOC, V96, P453; Tuffley C, 1998, MATH BIOSCI, V147, P63, DOI 10.1016/S0025-5564(97)00081-3; Whistler WA, 1990, ISLANDS PLANTS POLYN, P41; Wilson E.O., 1975, P1	41	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156340	10.1371/journal.pone.0156340	http://dx.doi.org/10.1371/journal.pone.0156340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232713	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000025
J	Kurebayashi, Y; Takahashi, T; Tamoto, C; Sahara, K; Otsubo, T; Yokozawa, T; Shibahara, N; Wada, H; Minami, A; Ikeda, K; Suzuki, T				Kurebayashi, Yuuki; Takahashi, Tadanobu; Tamoto, Chihiro; Sahara, Keiji; Otsubo, Tadamune; Yokozawa, Tatsuya; Shibahara, Nona; Wada, Hirohisa; Minami, Akira; Ikeda, Kiyoshi; Suzuki, Takashi			High-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase Activity	PLOS ONE			English	Article							A H3N2 VIRUSES; NEURAMINIDASE INHIBITORS; OSELTAMIVIR RESISTANCE; ANTIVIRAL RESISTANCE; IN-VITRO; PANDEMIC INFLUENZA; SUSCEPTIBILITY; MUTATION; SUBSTRATE; FITNESS	Influenza A and B viruses possess a neuraminidase protein that shows sialidase activity. Influenza virus-specific neuraminidase inhibitors (NAIs) are commonly used for clinical treatment of influenza. However, some influenza A and B viruses that are resistant to NAIs have emerged in nature. NAI-resistant viruses have been monitored in public hygiene surveys and the mechanism underlying the resistance has been studied. Here, we describe a new assay for selective detection and isolation of an NAI-resistant virus in a speedy and easy manner by live fluorescence imaging of viral sialidase activity, which we previously developed, in order to achieve high-efficiency capture of an NAI-resistant virus. An NAI-resistant virus maintains sialidase activity even at a concentration of NAI that leads to complete deactivation of the virus. Infected cells and focuses (infected cell populations) of an oseltamivir-resistant virus were selectively visualized by live fluorescence sialidase imaging in the presence of oseltamivir, resulting in high-efficiency isolation of the resistant viruses. The use of a combination of other NAIs (zanamivir, peramivir, and laninamivir) in the imaging showed that the oseltamivir-resistant virus isolated in 2008 was sensitive to zanamivir and laninamivir but resistant to peramivir. Fluorescence imaging in the presence of zanamivir also succeeded in selective live-cell visualization of cells that expressed zanamivir-resistant NA. Fluorescence imaging of NAI-resistant sialidase activity will be a powerful method for study of the NAI resistance mechanism, for public monitoring of NAI-resistant viruses, and for development of a new NAI that shows an effect on various NAI-resistant mutations.	[Kurebayashi, Yuuki; Takahashi, Tadanobu; Tamoto, Chihiro; Yokozawa, Tatsuya; Shibahara, Nona; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka 4228526, Japan; [Sahara, Keiji] Shizuoka Inst Environm & Hyg, Shizuoka, Shizuoka, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima, Japan; [Shibahara, Nona] Shizuoka City Inst Environm Sci & Publ Hlth, Shizuoka, Shizuoka, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780; Kurebayashi, Yuuki/0000-0002-7523-6160	Pharmacological Research Foundation, Tokyo; Shimabara Science Promotion Foundation; Research Foundation for Electrotechnology of Chubu; Consortium of Universities in Shizuoka; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Research Foundation for Opto-Science and Technology; Noguchi Institute; Fujikura Foundation; Sugiyama-houkoukai; University of Shizuoka; JSPS KAKENHI [26670064, 16K15151, 15H05644]; Grants-in-Aid for Scientific Research [26460166, 15K08037] Funding Source: KAKEN	Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Shimabara Science Promotion Foundation; Research Foundation for Electrotechnology of Chubu; Consortium of Universities in Shizuoka; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation(Izumi Science and Technology Foundation); Kurata Memorial Hitachi Science and Technology Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Research Foundation for Opto-Science and Technology; Noguchi Institute; Fujikura Foundation; Sugiyama-houkoukai; University of Shizuoka; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by a grant from The Pharmacological Research Foundation, Tokyo, The Shimabara Science Promotion Foundation, Research Foundation for Electrotechnology of Chubu, The Consortium of Universities in Shizuoka, the Futaba Electronics Memorial Foundation, Tokai Foundation for Technology, Takahashi Industrial and Economic Research Foundation, Izumi Science and Technology Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Research Foundation for Opto-Science and Technology, The Noguchi Institute, The Fujikura Foundation, Sugiyama-houkoukai, University of Shizuoka and JSPS KAKENHI Grant Numbers Challenging Exploratory Research 26670064, 16K15151 and Young Scientists (A) 15H05644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baranovich T, 2011, CURR OPIN VIROL, V1, P574, DOI 10.1016/j.coviro.2011.08.006; Barnett JM, 2000, ANTIMICROB AGENTS CH, V44, P78, DOI 10.1128/AAC.44.1.78-87.2000; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boivin G, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/irv.12176; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Dixit Rashmi, 2013, Infectious Disorders - Drug Targets, V13, P34; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI 10.1093/infdis/jiq012; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; Le TH, 2014, CLIN EXP VACCINE RES, V3, P117, DOI 10.7774/cevr.2014.3.2.117; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nayak DP, 2004, J VIROL METHODS, V122, P9, DOI 10.1016/j.jviromet.2004.07.005; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Samson M, 2014, ANTIMICROB AGENTS CH, V58, P5220, DOI 10.1128/AAC.03313-14; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shtyrya YA, 2009, ACTA NATURAE, V1, P26, DOI 10.32607/20758251-2009-1-2-26-32; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Takahashi T, 2015, BIOL PHARM BULL, V38, P1214, DOI 10.1248/bpb.b15-00298; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; Thompson CI, 2004, J ANTIMICROB CHEMOTH, V53, P759, DOI 10.1093/jac/dkh155; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Yen HL, 2014, J INFECT DIS, V210, P1900, DOI 10.1093/infdis/jiu353; Yingsakmongkon S, 2008, BIOL PHARM BULL, V31, P511, DOI 10.1248/bpb.31.511; Zhang XN, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.80	49	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156400	10.1371/journal.pone.0156400	http://dx.doi.org/10.1371/journal.pone.0156400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232333	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000030
J	Na, BR; Kwon, MS; Chae, MW; Kim, HR; Kim, CH; Jun, CD; Park, ZY				Na, Bo-Ra; Kwon, Min-Sung; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk; Park, Zee-Yong			Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; F-ACTIN; CYTOSKELETAL DYNAMICS; CUTTING EDGE; EXPRESSION; CANCER; TRAFFICKING; LYMPHOCYTES	The immunological synapse (IS), a dynamic and organized junction between T-cells and antigen presenting cells (APCs), is critical for initiating adaptive immunity. The actin cytoskeleton plays a major role in T-cell reorganization during IS formation, and we previously reported that transgelin-2, an actin-binding protein expressed in T-cells, stabilizes cortical F-actin, promoting T-cell activation in response to antigen stimulation. Transgelin-2 is also highly expressed in B-cells, although no specific function has been reported. In this study, we found that deficiency in transgelin-2 (TAGLN2(-/-)) in B-cells had little effect on B-cell development and activation, as measured by the expression of CD69, MHC class II molecules, and CD80/86. Nevertheless, in B-cells, transgelin-2 accumulated in the IS during the interaction with T-cells. These results led us to hypothesize that transgelin-2 may also be involved in IS stability in B-cells, thereby influencing T-cell function. Notably, we found that transgelin-2 deficiency in B-cells reduced T-cell activation, as determined by the release of IL-2 and interferon-. and the expression of CD69. Furthermore, the reduced T-cell activation was correlated with reduced B-cell-T-cell conjugate formation. Collectively, these results suggest that actin stability in B-cells during IS formation is critical for the initiation of adaptive T-cell immunity.	[Na, Bo-Ra; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea; [Na, Bo-Ra; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Na, Bo-Ra; Kwon, Min-Sung; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk; Park, Zee-Yong] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Kwon, Min-Sung] World Inst Kimchi, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea.; Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea.; Jun, CD; Park, ZY (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.	cdjun@gist.ac.kr; zeeyong@gist.ac.kr			Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2015R1A2A1A15052658]; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2015R1A3A2066253]; Basic Science Program through NRF - Ministry of Education (MOE), Korea [2013R1A6A3A04064259]; Silver Health Bio Research Center of Gwangju Institute of Science and Technology	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Basic Science Program through NRF - Ministry of Education (MOE), Korea; Silver Health Bio Research Center of Gwangju Institute of Science and Technology	This work was funded by the Basic Science Program (2015R1A2A1A15052658) and the Creative Research Initiative Program (2015R1A3A2066253) through the National Research Foundation (NRF) grants funded by the Ministry of Science, ICT & Future Planning (MSIP) given to CDJ; the Basic Science Program (2013R1A6A3A04064259) through the NRF grants funded by the Ministry of Education (MOE), Korea, given to HRK; and a grant from the Silver Health Bio Research Center of Gwangju Institute of Science and Technology, given to ZYP. Image acquisition was performed using the imaging facility of the Bio Imaging Research Center at GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Alarcon B, 2011, IMMUNOLOGY, V133, P420, DOI 10.1111/j.1365-2567.2011.03458.x; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Camoretti-Mercado B, 1998, GENOMICS, V49, P452, DOI 10.1006/geno.1998.5267; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Depaz I, 2003, ALCOHOL CLIN EXP RES, V27, P1481, DOI 10.1097/01.ALC.0000086060.18032.59; Depaz IM, 2005, J NEUROSCI RES, V81, P253, DOI 10.1002/jnr.20563; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; Dustin ML, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002873; Dvorakova M, 2014, EXPERT REV PROTEOMIC, V11, P149, DOI 10.1586/14789450.2014.860358; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Li M, 2008, J STRUCT BIOL, V162, P229, DOI 10.1016/j.jsb.2008.01.005; Liu CH, 2012, J IMMUNOL, V188, P3237, DOI 10.4049/jimmunol.1103065; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mori K, 2004, NEUROSCI RES, V48, P439, DOI 10.1016/j.neures.2003.12.012; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Paccani SR, 2005, BLOOD, V106, P626, DOI 10.1182/blood-2004-05-2051; Piragyte Indre, 2012, Immune Netw, V12, P71, DOI 10.4110/in.2012.12.3.71; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Spranger S, 2012, BLOOD, V119, P3440, DOI 10.1182/blood-2011-06-357939; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Zhang JCL, 2002, MECH DEVELOP, V115, P161, DOI 10.1016/S0925-4773(02)00088-6; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	49	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156429	10.1371/journal.pone.0156429	http://dx.doi.org/10.1371/journal.pone.0156429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232882	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000034
J	Javed, S; Marsay, L; Wareham, A; Lewandowski, KS; Williams, A; Dennis, MJ; Sharpe, S; Vipond, R; Silman, N; Ball, G; Kempsell, KE				Javed, Sajid; Marsay, Leanne; Wareham, Alice; Lewandowski, Kuiama S.; Williams, Ann; Dennis, Michael J.; Sharpe, Sally; Vipond, Richard; Silman, Nigel; Ball, Graham; Kempsell, Karen E.			Temporal Expression of Peripheral Blood Leukocyte Biomarkers in a Macaca fascicularis Infection Model of Tuberculosis; Comparison with Human Datasets and Analysis with Parametric/Non-parametric Tools for Improved Diagnostic Biomarker Identification	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; SUPPRESSOR-CELLS; RHESUS MACAQUES; AEROSOL CHALLENGE; IMMUNE-RESPONSE; T-CELLS; PROTEIN; PROFILES; GAMMA	A temporal study of gene expression in peripheral blood leukocytes (PBLs) from a Mycobacterium tuberculosis primary, pulmonary challenge model Macaca fascicularis has been conducted. PBL samples were taken prior to challenge and at one, two, four and six weeks post-challenge and labelled, purified RNAs hybridised to Operon Human Genome AROS V4.0 slides. Data analyses revealed a large number of differentially regulated gene entities, which exhibited temporal profiles of expression across the time course study. Further data refinements identified groups of key markers showing group-specific expression patterns, with a substantial reprogramming event evident at the four to six week interval. Selected statistically-significant gene entities from this study and other immune and apoptotic markers were validated using qPCR, which confirmed many of the results obtained using microarray hybridisation. These showed evidence of a step-change in gene expression from an 'early' FOS-associated response, to a 'late' predominantly type I interferon-driven response, with coincident reduction of expression of other markers. Loss of T-cell-associate marker expression was observed in responsive animals, with concordant elevation of markers which may be associated with a myeloid suppressor cell phenotype e.g. CD163. The animals in the study were of different lineages and these Chinese and Mauritian cynomolgous macaque lines showed clear evidence of differing susceptibilities to Tuberculosis challenge. We determined a number of key differences in response profiles between the groups, particularly in expression of T-cell and apoptotic makers, amongst others. These have provided interesting insights into innate susceptibility related to different host 'phenotypes. Using a combination of parametric and non-parametric artificial neural network analyses we have identified key genes and regulatory pathways which may be important in early and adaptive responses to TB. Using comparisons between data outputs of each analytical pipeline and comparisons with previously published Human TB datasets, we have delineated a subset of gene entities which may be of use for biomarker diagnostic test development.	[Javed, Sajid; Marsay, Leanne; Wareham, Alice; Lewandowski, Kuiama S.; Williams, Ann; Dennis, Michael J.; Sharpe, Sally; Vipond, Richard; Silman, Nigel; Kempsell, Karen E.] Hlth Protect Agcy Porton, Infect Serv, Publ Hlth England, Salisbury, Wilts, England; [Ball, Graham] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham, England	Public Health England; Nottingham Trent University	Kempsell, KE (corresponding author), Hlth Protect Agcy Porton, Infect Serv, Publ Hlth England, Salisbury, Wilts, England.	karen.kempsell@phe.gov.uk	Kempsell, Karen/ABA-4635-2021	Ball, Graham/0000-0001-5828-7129; Kempsell, Karen/0000-0002-3059-9718	Public Health England; Department of Health [103348]; Department of Health (DH); Public Health England (PHE)	Public Health England; Department of Health; Department of Health (DH); Public Health England (PHE)	Public Health England and the Department of Health funded this work under project number 103348. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Department of Health (DH) and Public Health England (PHE). The views expressed in this publication are those of the authors and not necessarily those of the PHE or the DH. We acknowledge Joanne Underwood for assistance with data analysis and compiling the manuscript and the Biological Investigations Group at PHE for conducting the animal procedures.	Abollo-Jimenez F, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28629; Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez GG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-3; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Andersson H, 2006, GENES IMMUN, V7, P503, DOI 10.1038/sj.gene.6364321; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bai WJ, 2014, CELL SIGNAL, V26, P942, DOI 10.1016/j.cellsig.2014.01.015; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Berry MPR, 2013, CURR OPIN IMMUNOL, V25, P579, DOI 10.1016/j.coi.2013.08.003; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Bochner BS, 2015, J ALLERGY CLIN IMMUN, V135, P598, DOI 10.1016/j.jaci.2014.11.031; Cai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092340; CALABRESE G, 1995, CYTOGENET CELL GENET, V69, P223, DOI 10.1159/000133969; Capaldo CT, 2012, MUCOSAL IMMUNOL, V5, P681, DOI 10.1038/mi.2012.41; Chen GY, 2014, ELIFE, V3, DOI 10.7554/eLife.04066; Chernykh E R, 2002, Probl Tuberk, P43; Dawany N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089925; Day CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094949; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Field N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-127; Fieschi C, 2003, EUR J IMMUNOL, V33, P1461, DOI 10.1002/eji.200324038; Forster F, 2014, J IMMUNOL, V192, P771, DOI 10.4049/jimmunol.1300377; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Ghazawi FM, 2013, IMMUNOL CELL BIOL, V91, P149, DOI 10.1038/icb.2012.69; Gruffat H, 2011, J VIROL, V85, P784, DOI 10.1128/JVI.01397-10; Haaland RE, 2005, MOL IMMUNOL, V42, P627, DOI 10.1016/j.molimm.2004.09.012; Hanson EM, 2009, J IMMUNOL, V183, P937, DOI 10.4049/jimmunol.0804253; Herrmann H, 2012, HAEMATOL-HEMATOL J, V97, P219, DOI 10.3324/haematol.2010.035006; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Khyatti M, 2014, EUR J PUBLIC HEALTH, V24, P47, DOI 10.1093/eurpub/cku109; Laubli H, 2014, J BIOL CHEM, V289, P33481, DOI 10.1074/jbc.M114.593129; Lancashire LJ, 2010, BREAST CANCER RES TR, V120, P83, DOI 10.1007/s10549-009-0378-1; Lancashire LJ, 2009, BRIEF BIOINFORM, V10, P315, DOI 10.1093/bib/bbp012; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Lupo J, 2012, EXP CELL RES, V318, P509, DOI 10.1016/j.yexcr.2011.12.020; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Maertzdorf J, 2012, INT J TUBERC LUNG D, V16, P1140, DOI 10.5588/ijtld.12.0246; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Martin A, 2010, LANCET, V376, P1539, DOI 10.1016/S0140-6736(10)62027-2; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mei B, 2014, GENE, V551, P255, DOI 10.1016/j.gene.2014.08.062; Mihret A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-257; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; O'Connor JA, 2015, BRIT J BIOMED SCI, V72, P32; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Ostler N, 2014, MOL CELL BIOL, V34, P196, DOI 10.1128/MCB.00664-13; Page KR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-158; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Park J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074893; Parnell G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023162; Pottie K, 2011, CAN MED ASSOC J, V183, pE824, DOI 10.1503/cmaj.090313; Public Health England, 2014, TUB UK; Rayner EL, 2015, J COMP PATHOL, V152, P217, DOI 10.1016/j.jcpa.2014.10.002; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Rumelhart DE H G, NATURE, V323, P533; Sable SB, 2013, J INFECT DIS, V208, P541, DOI 10.1093/infdis/jit211; Seitzer U, 2001, IMMUNOLOGY, V104, P269, DOI 10.1046/j.1365-2567.2001.01323.x; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Songane M, 2012, TUBERCULOSIS, V92, P388, DOI 10.1016/j.tube.2012.05.004; SPENCE DPS, 1993, BRIT MED J, V307, P759, DOI 10.1136/bmj.307.6907.759; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; StopTB, 2015, STOP TB PARTN; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sutherland JS, 2014, CLIN MICROBIOL INFEC, V20, pO230, DOI 10.1111/1469-0691.12383; Tamarit B, 2013, J BIOL CHEM, V288, P8691, DOI 10.1074/jbc.M113.449918; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tientcheu LD, 2015, GENES IMMUN, V16, P347, DOI 10.1038/gene.2015.21; Vafadar-Isfahani B, 2010, PROTEOM CLIN APPL, V4, P682, DOI 10.1002/prca.200900218; Vahey MT, 2003, AIDS RES HUM RETROV, V19, P369, DOI 10.1089/088922203765551728; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Villasenor-Cardoso MI, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/562984; Vogel DYS, 2014, IMMUNOBIOLOGY, V219, P695, DOI 10.1016/j.imbio.2014.05.002; Waldmann Thomas A, 2013, J Investig Dermatol Symp Proc, V16, pS28, DOI 10.1038/jidsymp.2013.8; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Wang J, 2010, EUR J CLIN MICROBIOL, V29, P1291, DOI 10.1007/s10096-010-0985-0; Wareham AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088149; Weiner J, 2014, J INTERN MED, V275, P467, DOI 10.1111/joim.12212; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097953; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organisation, 2015, STP TN STRAT; World Health Organisation, 2014, TUBERCULOSIS; World Health Organization, 2015, IMPL TUB DIAGN POL F; World Health Organization, 2013, SYST SCREEN ACT TUB; Yamada H, 2007, J NUTR, V137, P2696, DOI 10.1093/jn/137.12.2696; Yan LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071245; Yang BF, 2014, IMMUNOL LETT, V158, P66, DOI 10.1016/j.imlet.2013.12.003; Ylostalo J, 2005, J INFECT DIS, V191, P400, DOI 10.1086/426868; Zumla AI, 2014, LANCET INFECT DIS, V14, P267, DOI 10.1016/S1473-3099(14)70028-3	101	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154320	10.1371/journal.pone.0154320	http://dx.doi.org/10.1371/journal.pone.0154320			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228113	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500004
J	Salvalaio, M; Rigon, L; Belletti, D; D'Avanzo, F; Pederzoli, F; Ruozi, B; Marin, O; Vandelli, MA; Forni, F; Scarpa, M; Tomanin, R; Tosi, G				Salvalaio, Marika; Rigon, Laura; Belletti, Daniela; D'Avanzo, Francesca; Pederzoli, Francesca; Ruozi, Barbara; Marin, Oriano; Vandelli, Maria Angela; Forni, Flavio; Scarpa, Maurizio; Tomanin, Rosella; Tosi, Giovanni			Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; HUNTER-SYNDROME; MOUSE MODELS; BARRIER; THERAPY; INFLAMMATION; CONVECTION; TRANSPORT; DISEASES	Lysosomal Storage Disorders (LSDs) are a group of metabolic syndromes, each one due to the deficit of one lysosomal enzyme. Many LSDs affect most of the organ systems and overall about 75% of the patients present neurological impairment. Enzyme Replacement Therapy, although determining some systemic clinical improvements, is ineffective on the CNS disease, due to enzymes' inability to cross the blood-brain barrier (BBB). With the aim to deliver the therapeutic enzymes across the BBB, we here assayed biodegradable and biocompatible PLGA-nanoparticles (NPs) in two murine models for LSDs, Mucopolysaccharidosis type I and II (MPS I and MPS II). PLGA-NPs were modified with a 7-aminoacid glycopeptide (g7), yet demonstrated to be able to deliver low molecular weight (MW) molecules across the BBB in rodents. We specifically investigated, for the first time, the g7-NPs ability to transfer a model drug (FITC-albumin) with a high MW, comparable to the enzymes to be delivered for LSDs brain therapy. In vivo experiments, conducted on wild-type mice and knockout mouse models for MPS I and II, also included a whole series of control injections to obtain a broad preliminary view of the procedure efficiency. Results clearly showed efficient BBB crossing of albumin in all injected mice, underlying the ability of NPs to deliver high MW molecules to the brain. These results encourage successful experiments with enzyme-loaded g7-NPs to deliver sufficient amounts of the drug to the brain district on LSDs, where exerting a corrective effect on the pathological phenotype.	[Salvalaio, Marika; Rigon, Laura; D'Avanzo, Francesca; Scarpa, Maurizio; Tomanin, Rosella] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Belletti, Daniela; Pederzoli, Francesca; Ruozi, Barbara; Vandelli, Maria Angela; Forni, Flavio; Tosi, Giovanni] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Marin, Oriano] Univ Padua, Dept Biomed Sci, Padua, Italy; [Salvalaio, Marika; Pederzoli, Francesca] Pediat Res Inst Citta Speranza, Padua, Italy; [Marin, Oriano] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [D'Avanzo, Francesca; Scarpa, Maurizio] Brains Brain Fdn Onlus, Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua; Fondazione Citta della Speranza; University of Padua	Tomanin, R (corresponding author), Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.; Tosi, G (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	rosella.tomanin@unipd.it; gtosi@unimore.it	Salvalaio, Marika/G-9538-2014; D'Avanzo, Francesca/H-5081-2016; Rigon, Laura/D-2853-2016; Scarpa, Maurizio/AAC-1467-2019; Belletti, Daniela/L-5288-2016; Tosi, Giovanni/D-4547-2011	D'Avanzo, Francesca/0000-0002-2790-6481; Rigon, Laura/0000-0002-0233-1677; Belletti, Daniela/0000-0003-2872-445X; Salvalaio, Marika/0000-0002-0221-1237; Tosi, Giovanni/0000-0001-8318-667X; SCARPA, MAURIZIO/0000-0002-0382-3251	Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica) [13/09]; Brains for Brain Foundation-Onlus	Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica); Brains for Brain Foundation-Onlus	The project was partly funded by Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica 2012/2014, grant #13/09) and by the Brains for Brain Foundation-Onlus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr. Neufeld (UCLA, CA, USA) and Dr. Heard (Pasteur Institute, Paris, France) for kindly providing the MPS I mouse model and Dr. Muenzer (UCLA, CA, USA) for kindly providing the MPS II mouse model. The project was partly funded by Fondazione Cassa di Risparmio di Padova e Rovigo-Fondazione Istituto di Ricerca Pediatrica "Citta della Speranza" (Bando Ricerca Pediatrica 2012/2014, grant #13/09) and by the Brains For Brain Foundation Onlus.	Begley DJ, 2008, CURR PHARM DESIGN, V14, P1566, DOI 10.2174/138161208784705504; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bondioli L, 2011, PARASITOLOGY, V138, P1384, DOI 10.1017/S0031182011001119; Bondioli L, 2010, BIOMATERIALS, V31, P3395, DOI 10.1016/j.biomaterials.2010.01.049; BOVE KE, 1995, HUM PATHOL, V26, P1040, DOI 10.1016/0046-8177(95)90097-7; Boyle J, BIND THERAPEUTICS RE; Cardone M, 2006, HUM MOL GENET, V15, P1225, DOI 10.1093/hmg/ddl038; Chhabra R, 2014, INT J PHARMACEUT, V471, P349, DOI 10.1016/j.ijpharm.2014.05.054; Clarke L.A., 1993, GENEREVIEWS R; Date PV, 2010, AAPS PHARMSCITECH, V11, P304, DOI 10.1208/s12249-010-9382-3; Friso A, 2005, J GENE MED, V7, P1482, DOI 10.1002/jgm.790; Fuller M, 2006, FABRY DIS PERSPECTIV; Garbuzova-Davis S, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-174; Garbuzova-Davis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016601; Garcia AR, 2007, J INHERIT METAB DIS, V30, P924, DOI 10.1007/s10545-007-0641-8; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Kabanov AV, 2007, PROG POLYM SCI, V32, P1054, DOI 10.1016/j.progpolymsci.2007.05.014; Kreuter J, 2014, ADV DRUG DELIVER REV, V71, P2, DOI 10.1016/j.addr.2013.08.008; Kroll RA, 1996, NEUROSURGERY, V38, P746, DOI 10.1227/00006123-199604000-00024; Liu YT, 2010, BIOMATERIALS, V31, P330, DOI 10.1016/j.biomaterials.2009.09.036; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nobs L, 2004, EUR J PHARM BIOPHARM, V58, P483, DOI 10.1016/j.ejpb.2004.04.006; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Pardridge William M, 2005, NeuroRx, V2, P3; Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007; Ruozi B, 2014, CNS NEUROL DISORD-DR, V13, P1475, DOI 10.2174/1871527313666140806145540; Sands MS, 2008, ACTA PAEDIATR, V97, P22, DOI 10.1111/j.1651-2227.2008.00660.x; Scarpa M., 1993, GENEREVIEWS R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siegal T, 2000, J NEUROSURG, V92, P599, DOI 10.3171/jns.2000.92.4.0599; Tosi G, 2007, J CONTROL RELEASE, V122, P1, DOI 10.1016/j.jconrel.2007.05.022; Tosi G, 2011, J NEURAL TRANSM, V118, P145, DOI 10.1007/s00702-010-0497-1; Tosi G, 2008, EXPERT OPIN DRUG DEL, V5, P155, DOI 10.1517/17425247.5.2.155; Tosi G, 2014, J CONTROL RELEASE, V177, P96, DOI 10.1016/j.jconrel.2014.01.004; Tosi G, 2013, NANOMEDICINE-UK, V8, P1373, DOI [10.2217/nnm.12.172, 10.2217/NNM.12.172]; Tosi G, 2011, NANOMEDICINE-UK, V6, P423, DOI [10.2217/nnm.11.11, 10.2217/NNM.11.11]; Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078; Vilella A, 2014, J CONTROL RELEASE, V174, P195, DOI 10.1016/j.jconrel.2013.11.023; Vitner EB, 2012, BRAIN, V135, P1724, DOI 10.1093/brain/aws095; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Werner ME, 2013, INT J RADIAT ONCOL, V86, P463, DOI 10.1016/j.ijrobp.2013.02.009; Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017	43	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156452	10.1371/journal.pone.0156452	http://dx.doi.org/10.1371/journal.pone.0156452			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228099	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500139
J	Su, CH; Cheng, C; Tzeng, TY; Lin, IH; Hsu, MT				Su, Chia-Hsin; Cheng, Ching; Tzeng, Tsai-Yu; Lin, I-Hsuan; Hsu, Ming-Ta			An H2A Histone Isotype, H2ac, Associates with Telomere and Maintains Telomere Integrity	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; END-PROTECTION; POT1; PROTEIN; TRF2; CHROMATIN; REPAIR; LENGTH	Telomeres are capped at the ends of eukaryotic chromosomes and are composed of TTAGGG repeats bound to the shelterin complex. Here we report that a replication-dependent histone H2A isotype, H2ac, was associated with telomeres in human cells and co-immunoprecipitates with telomere repeat factor 2 (TRF2) and protection of telomeres protein 1 (POT1), whereas other histone H2A isotypes and mutations of H2ac did not bind to telomeres or these two proteins. The amino terminal basic domain of TRF2 was necessary for the association with H2ac and for the recruitment of H2ac to telomeres. Depletion of H2ac led to loss of telomeric repeat sequences, the appearance of dysfunctional telomeres, and chromosomal instability, including chromosomal breaks and anaphase bridges, as well as accumulation of telomere-associated DNA damage factors in H2ac depleted cells. Additionally, knockdown of H2ac elicits an ATM-dependent DNA damage response at telomeres and depletion of XPF protects telomeres against H2ac-deficiency-induced G-strand overhangs loss and DNA damage response, and prevents chromosomal instability. These findings suggest that the H2A isotype, H2ac, plays an essential role in maintaining telomere functional integrity.	[Su, Chia-Hsin; Cheng, Ching; Lin, I-Hsuan; Hsu, Ming-Ta] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 11221, Taiwan; [Tzeng, Tsai-Yu; Hsu, Ming-Ta] Univ Syst Taiwan, Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 11221, Taiwan; [Hsu, Ming-Ta] Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, MT (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Univ Syst Taiwan, Natl Yang Ming Univ, VYM Genome Res Ctr, Taipei 11221, Taiwan.; Hsu, MT (corresponding author), Chien Tien Hsu Canc Res Fdn, Taipei 11221, Taiwan.	mth@ym.edu.tw	Lin, I-Hsuan/N-6501-2013	Lin, I-Hsuan/0000-0002-6207-1299; Tzeng, Tsai-Yu/0000-0001-7334-6270	Ministry of Education, Aim for the Top University Plan	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This work was supported by a grant from the Ministry of Education, Aim for the Top University Plan.	Ahmad A, 2008, MOL CELL BIOL, V28, P5082, DOI 10.1128/MCB.00293-08; Badie S, 2010, NAT STRUCT MOL BIOL, V17, P1461, DOI 10.1038/nsmb.1943; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gomez D, 2004, J BIOL CHEM, V279, P41487, DOI 10.1074/jbc.M406123200; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemann MT, 1999, NUCLEIC ACIDS RES, V27, P3964, DOI 10.1093/nar/27.20.3964; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ortega LM, 2011, BIOTECHNIQUES, V50, P407, DOI 10.2144/000113687; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wan BB, 2013, CELL REP, V4, P861, DOI 10.1016/j.celrep.2013.08.017; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Wu YL, 2007, DNA REPAIR, V6, P157, DOI 10.1016/j.dnarep.2006.09.005; Wu YL, 2008, MECH AGEING DEV, V129, P602, DOI 10.1016/j.mad.2008.08.004; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao Y, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1063; Zhou BO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001272; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156378	10.1371/journal.pone.0156378	http://dx.doi.org/10.1371/journal.pone.0156378			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228173	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500126
J	Haramura, T; Takeuchi, H; Crossland, MR; Shine, R				Haramura, Takashi; Takeuchi, Hirohiko; Crossland, Michael R.; Shine, Richard			Biotic Resistance to an Alien Amphibian: Larval Competition between Japanese Frogs and Invasive Cane Toads	PLOS ONE			English	Article							BUFO-MARINUS; TADPOLES; INTERFERENCE; PREDATION	Understanding negative effects of native species on introduced taxa may suggest novel ways to control the invasive species by enhancing such effects. Previous studies have reported that the larvae of invasive cane toads (Rhinella marina) are suppressed by competition with the larvae of native anurans in Australia, but not in North America. We conducted laboratory trials to measure the effect of exposure to the larvae of Japanese frogs (Micro-hyla ornata, Fejervarya sakishimensis, Rhacophorus owstoni) on rates of survival, growth and development of cane toad tadpoles in Ishigaki Island, in southern Japan. Survival rates were not affected by native species, but competition with Dicroglossids and Rhacophorids (but not Microhylids) strongly reduced rates of growth and development in the tadpoles of cane toads. Dicroglossid tadpoles also reduced the body condition to toad tadpoles in addition to effects on SVL and mass. Encouraging populations of native frogs in toad-invaded areas of Japan thus may help to reduce the numbers of invasive cane toads.	[Haramura, Takashi] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Haramura, Takashi; Takeuchi, Hirohiko] Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan; [Crossland, Michael R.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci A08, Sydney, NSW 2006, Australia	Kyoto University; Kyoto University; University of Sydney	Haramura, T (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan.; Haramura, T (corresponding author), Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan.	haramura.takashi.2n@kyoto-u.ac.jp	Crossland, Michael R/G-1091-2012	Crossland, Michael R/0000-0001-9967-7158	Hakubi Center, Kyoto University; Research and Technology Development Fund of the Ministry of the Environment, Japan [4FR-1402]; Australian Research Council	Hakubi Center, Kyoto University; Research and Technology Development Fund of the Ministry of the Environment, Japan; Australian Research Council(Australian Research Council)	This work was supported by an internal grant from The Hakubi Center, Kyoto University, the Environment Research and Technology Development Fund (4FR-1402) of the Ministry of the Environment, Japan, and the Australian Research Council.	Alford RA, 1999, TADPOLES, P240; Cabrera-Guzman E, 2013, FRESHWATER BIOL, V58, P2584, DOI 10.1111/fwb.12235; Cabrera-Guzman E, 2013, AUSTRAL ECOL, V38, P896, DOI 10.1111/aec.12029; Cabrera-Guzman E, 2011, J APPL ECOL, V48, P462, DOI 10.1111/j.1365-2664.2010.01933.x; Crossland MR, 2009, OECOLOGIA, V158, P625, DOI 10.1007/s00442-008-1167-y; Dumont CP, 2011, BIOL INVASIONS, V13, P2023, DOI 10.1007/s10530-011-0018-7; Gosner K. L., 1960, Herpetologica, V16, P183; GRIFFITHS RA, 1993, J ANIM ECOL, V62, P274, DOI 10.2307/5358; GRIFFITHS RA, 1991, J ANIM ECOL, V60, P1065, DOI 10.2307/5431; Klug T, 2008, B ENTOMOL RES, V98, P379, DOI 10.1017/S0007485308005695; LEVER C., 2001, CANE TOAD HIST ECOLO; MAEDA N, 1989, FROGS TOADS JAPAN; MORIN PJ, 1988, OIKOS, V53, P398, DOI 10.2307/3565542; Ota H, 1999, PROBLEM SNAKE MANAGEMENT, P439; Prober SM, 2009, BIOL INVASIONS, V11, P171, DOI 10.1007/s10530-008-9222-5; R Core Team, 2021, R LANGUAGE ENV STAT; Richter-Boix A, 2007, AMPHIBIA-REPTILIA, V28, P247, DOI 10.1163/156853807780202549; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D, 1996, BIOL CONSERV, V78, P185, DOI 10.1016/0006-3207(96)00027-4; Smith KG, 2005, BIOL CONSERV, V123, P433, DOI 10.1016/j.biocon.2005.01.005; STEINWASCHER K, 1978, ECOLOGY, V59, P1039, DOI 10.2307/1938556; Ward-Fear G, 2010, BIOL J LINN SOC, V99, P738, DOI 10.1111/j.1095-8312.2010.01395.x; Werner EE, 1996, ECOLOGY, V77, P157, DOI 10.2307/2265664	23	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156396	10.1371/journal.pone.0156396	http://dx.doi.org/10.1371/journal.pone.0156396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253973	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700024
J	Neophytou, AM; Noth, EM; Liu, S; Costello, S; Hammond, SK; Cullen, MR; Eisen, EA				Neophytou, Andreas M.; Noth, Elizabeth M.; Liu, Sa; Costello, Sadie; Hammond, S. Katharine; Cullen, Mark R.; Eisen, Ellen A.			Ischemic Heart Disease Incidence in Relation to Fine versus Total Particulate Matter Exposure in a US Aluminum Industry Cohort	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; AIR-POLLUTION; OCCUPATIONAL-EXPOSURE; ULTRAFINE PARTICLES; MORTALITY; ASSOCIATIONS; PM2.5	Ischemic heart disease (IHD) has been linked to exposures to airborne particles with an aerodynamic diameter < 2.5 mu m (PM2.5) in the ambient environment and in occupational settings. Routine industrial exposure monitoring, however, has traditionally focused on total particulate matter (TPM). To assess potential benefits of PM2.5 monitoring, we compared the exposure-response relationships between both PM2.5 and TPM and incidence of IHD in a cohort of active aluminum industry workers. To account for the presence of time varying confounding by health status we applied marginal structural Cox models in a cohort followed with medical claims data for IHD incidence from 1998 to 2012. Analyses were stratified by work process into smelters (n = 6,579) and fabrication (n = 7,432). Binary exposure was defined by the 10th-percentile cut-off from the respective TPM and PM2.5 exposure distributions for each work process. Hazard Ratios (HR) comparing always exposed above the exposure cut-off to always exposed below the cut-off were higher for PM2.5, with HRs of 1.70 (95% confidence interval (CI): 1.11-2.60) and 1.48 (95% CI: 1.02-2.13) in smelters and fabrication, respectively. For TPM, the HRs were 1.25 (95% CI: 0.89-1.77) and 1.25 (95% CI: 0.88-1.77) for smelters and fabrication respectively. Although TPM and PM2.5 were highly correlated in this work environment, results indicate that, consistent with biologic plausibility, PM2.5 is a stronger predictor of IHD risk than TPM. Cardiovascular risk management in the aluminum industry, and other similar work environments, could be better guided by exposure surveillance programs monitoring PM2.5.	[Neophytou, Andreas M.; Noth, Elizabeth M.; Liu, Sa; Costello, Sadie; Hammond, S. Katharine; Eisen, Ellen A.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Cullen, Mark R.] Stanford Univ, Div Gen Med Disciplines, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Neophytou, AM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	aneophytou@berkeley.edu		cullen, mark/0000-0001-7996-1864	National Institutes of Health, Institute of Aging [R01AG026291-01]; Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health [R01 OH009939-01]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH009939] Funding Source: NIH RePORTER	National Institutes of Health, Institute of Aging; Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by the National Institutes of Health, Institute of Aging (grant R01AG026291-01) and the Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health (grant R01 OH009939-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benke G, 1998, ANN OCCUP HYG, V42, P173, DOI 10.1093/annhyg/42.3.173; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown DM, 2015, EPIDEMIOLOGY, V26, P806, DOI 10.1097/EDE.0000000000000329; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Costello S, 2014, J EXPO SCI ENV EPID, V24, P82, DOI 10.1038/jes.2013.47; Debia M, 2012, ENVIRON POLLUT, V1, P2; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Donoghue AM, 2011, AM J IND MED, V54, P224, DOI 10.1002/ajim.20925; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Franck U, 2011, SCI TOTAL ENVIRON, V409, P4217, DOI 10.1016/j.scitotenv.2011.05.049; Hamad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126054; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hopke PK, 2008, ATMOS ENVIRON, V42, P3192, DOI 10.1016/j.atmosenv.2008.03.002; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Liu Sa, 2014, Environ Pollut (Tor), V3, P79; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Neophytou AM, 2014, AM J EPIDEMIOL, V180, P608, DOI 10.1093/aje/kwu175; Nieboer E, 2005, J ENVIRON MONITOR, V7, P412; Noth E, 2014, OCCUPATIONAL ENV S1, V71, pA14; Noth EM, 2014, J EXPO SCI ENV EPID, V24, P89, DOI 10.1038/jes.2013.53; Occupational Safety Health Association OSHA, 2012, CHEM SAMPL INF; Ostro B, 2015, ENVIRON HEALTH PERSP, V123, P549, DOI 10.1289/ehp.1408565; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; RONNEBERG A, 1995, OCCUP ENVIRON MED, V52, P250, DOI 10.1136/oem.52.4.250; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Stayner L, 2003, SCAND J WORK ENV HEA, V29, P317, DOI 10.5271/sjweh.737; Thomassen Y, 2006, J ENVIRON MONITOR, V8, P127, DOI [10.1039/b514939h, 10.1039/B514939H]; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; United States Environmental Protection Agency (USEPA), 2012, NAT AMB AIR QUAL STA; Weichenthal S, 2012, ENVIRON RES, V115, P26, DOI 10.1016/j.envres.2012.03.001	34	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156613	10.1371/journal.pone.0156613	http://dx.doi.org/10.1371/journal.pone.0156613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249060	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700059
J	Siener, R; Buchholz, N; Daudon, M; Hess, B; Knoll, T; Osther, PJ; Reis-Santos, J; Sarica, K; Traxer, O; Trinchieri, A				Siener, Roswitha; Buchholz, Noor; Daudon, Michel; Hess, Bernhard; Knoll, Thomas; Osther, Palle J.; Reis-Santos, Jose; Sarica, Kemal; Traxer, Olivier; Trinchieri, Alberto		EAU Sect Urolithiasis EULIS	Quality Assessment of Urinary Stone Analysis: Results of a Multicenter Study of Laboratories in Europe	PLOS ONE			English	Article							1ST RENAL STONE; INFRARED-SPECTROSCOPY; METABOLIC EVALUATION; KIDNEY-STONES; UNITED-STATES; RISK-FACTORS; PREVALENCE; UROLITHIASIS; RECURRENCE; SEX	After stone removal, accurate analysis of urinary stone composition is the most crucial laboratory diagnostic procedure for the treatment and recurrence prevention in the stone-forming patient. The most common techniques for routine analysis of stones are infrared spectroscopy, X-ray diffraction and chemical analysis. The aim of the present study was to assess the quality of urinary stone analysis of laboratories in Europe. Nine laboratories from eight European countries participated in six quality control surveys for urinary calculi analyses of the Reference Institute for Bioanalytics, Bonn, Germany, between 2010 and 2014. Each participant received the same blinded test samples for stone analysis. A total of 24 samples, comprising pure substances and mixtures of two or three components, were analysed. The evaluation of the quality of the laboratory in the present study was based on the attainment of 75% of the maximum total points, i.e. 99 points. The methods of stone analysis used were infrared spectroscopy (n = 7), chemical analysis (n = 1) and X-ray diffraction (n = 1). In the present study only 56% of the laboratories, four using infrared spectroscopy and one using X-ray diffraction, fulfilled the quality requirements. According to the current standard, chemical analysis is considered to be insufficient for stone analysis, whereas infrared spectroscopy or X-ray diffraction is mandatory. However, the poor results of infrared spectroscopy highlight the importance of equipment, reference spectra and qualification of the staff for an accurate analysis of stone composition. Regular quality control is essential in carrying out routine stone analysis.	[Siener, Roswitha] Univ Bonn, Univ Stone Ctr, Dept Urol, Bonn, Germany; [Buchholz, Noor] Barts & London NHS Trust, Endourol Serv, London, England; [Buchholz, Noor] Barts & London NHS Trust, Stone Serv, London, England; [Daudon, Michel] Univ Paris 06, Tenon Univ Hosp, APHP, Serv Explorat Fonct, Paris, France; [Hess, Bernhard] Klin Pk, Internal Med & Nephrol, Zurich, Switzerland; [Hess, Bernhard] Univ Zurich, Zurich, Switzerland; [Knoll, Thomas] Univ Tubingen, Dept Urol, Klinikum Sindelfingen Boblingen, Sindelfingen, Germany; [Osther, Palle J.] Univ Southern Denmark, Urol Res Ctr, Dept Urol, Lillebaelt Hosp, Fredericia, Denmark; [Reis-Santos, Jose] Univ Catolica Portuguesa, Fac Engn Clin & Biomed, Lisbon, Portugal; [Sarica, Kemal] Dr Lufti Kirdar Kartal Res & Training Hosp, Dept Urol, Istanbul, Turkey; [Traxer, Olivier] Univ Paris 06, Tenon Univ Hosp, Dept Urol, Paris, France; [Trinchieri, Alberto] A Manzoni Hosp, Dept Urol, Lecce, Italy	University of Bonn; Barts Health NHS Trust; Barts Health NHS Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Zurich; Eberhard Karls University of Tubingen; University of Southern Denmark; Universidade Catolica Portuguesa; Istanbul Kartal Dr Lutfi Kirdar Training & Research Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Siener, R (corresponding author), Univ Bonn, Univ Stone Ctr, Dept Urol, Bonn, Germany.	Roswitha.Siener@ukb.uni-bonn.de	Hess, Bernhard/GNP-1214-2022; Trinchieri, Alberto/AAH-6934-2019	Osther, Palle Jorn Sloth/0000-0001-7962-1640				AHLSTRAND C, 1990, UROL RES, V18, P397, DOI 10.1007/BF00297372; DAUDON M, 1995, UROL RES, V23, P319, DOI 10.1007/BF00300021; Daudon M, 2010, UROL RES, V38, P459, DOI 10.1007/s00240-010-0320-3; DRETLER SP, 1988, J UROLOGY, V139, P1124, DOI 10.1016/S0022-5347(17)42801-1; Hesse A, 2005, CLIN CHEM LAB MED, V43, P298, DOI 10.1515/CCLM.2005.051; Hesse A, 2003, EUR UROL, V44, P709, DOI 10.1016/S0302-2838(03)00415-9; HESSE A, 1989, J CLIN CHEM CLIN BIO, V27, P639; Hesse A., 1988, ATLAS INFRARED SPECT; Hesse AT, 2009, URINARY STONES DIAGN; Kasidas GP, 2004, ANN CLIN BIOCHEM, V41, P91, DOI 10.1258/000456304322879962; Knoll T, 2011, J UROLOGY, V185, P1304, DOI 10.1016/j.juro.2010.11.073; Kourambas J, 2001, J ENDOUROL, V15, P181, DOI 10.1089/089277901750134548; Krambeck AE, 2010, J UROLOGY, V184, P1543, DOI 10.1016/j.juro.2010.05.089; Lieske JC, 2014, CLIN J AM SOC NEPHRO, V9, P2141, DOI 10.2215/CJN.05660614; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schubert G, 2006, UROL RES, V34, P146, DOI 10.1007/s00240-005-0028-y; Siener R, 2003, EUR UROL, V44, P467, DOI 10.1016/S0302-2838(03)00317-8; Siener R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078996; Skolarikos A, 2015, EUR UROL, V67, P750, DOI 10.1016/j.eururo.2014.10.029; Smith CL, 1998, CURR OPIN NEPHROL HY, V7, P703, DOI 10.1097/00041552-199811000-00014; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Trinchieri A, 1999, J UROLOGY, V162, P27, DOI 10.1097/00005392-199907000-00007; YOSHIDA O, 1990, UROL INT, V45, P104, DOI 10.1159/000281680	23	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156606	10.1371/journal.pone.0156606	http://dx.doi.org/10.1371/journal.pone.0156606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248840	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700057
J	Unterberg, M; Kreuzer, MJ; Schafer, ST; Bazzi, Z; Adamzik, M; Rump, K				Unterberg, Matthias; Kreuzer, Maxmiliane Julia; Schaefer, Simon Thomas; Bazzi, Zainab; Adamzik, Michael; Rump, Katharina			NFKB1 Promoter DNA from nt+402 to nt+99 Is Hypomethylated in Different Human Immune Cells	PLOS ONE			English	Article							INSERTION/DELETION ATTG POLYMORPHISM; GENE-EXPRESSION; METHYLATION; LIPOPOLYSACCHARIDE; RISK; ACTIVATION	Sepsis, with a persistently high 90-day mortality of about 46%, is the third most frequent cause of death in intensive care units worldwide. Further understanding of the inflammatory signaling pathways occurring in sepsis is important for new efficient treatment options. Key regulator of the inflammatory response is the transcription factor NF kappa B. As we have recently shown, the -94 Ins/Del NFKB1 promoter polymorphism influences sepsis mortality. However, a molecular explanation is still missing. Thus, promoter activity might be varying depending on the NFKB1 genotype, explaining the genotype dependent mortality from sepsis, and one likely mechanism is the degree of promoter methylation. Therefore, we tested the hypothesis that NF kappa B mRNA expression is regulated by promoter methylation in human cell lines and primary immune cell cultures. First, we examined the methylation of the NFKB1 promoter in U937, REH and HL-60 cells. In the promoter region of nt+99/+229 methylation in all analyzed cell lines was below 1%. Following incubation with bacterial cell wall components, no significant changes in the frequency of promoter methylation in U937 and REH cells were measured and the methylation frequency was under 1%. However, NF kappa B1 mRNA expression was two-fold increased in U937 cells after 24 h incubation with LPS. By contrast, demethylation by 5-Aza-2 '-deoxycytidine incubation enhanced NF kappa B1 expression significantly. In addition, we analyzed NFKB1 promoter methylation in primary cells from healthy volunteers depending on the NFKB1-94 Ins/Del genotype. Methylation in the promoter region from nt+402 to nt+99 was below 1%. Genotype dependent differences occurred in neutrophil cells, where DD-genotype was significantly more methylated compared to II genotype at nt+284/+402. Besides in the promoter region from nt-227/-8 in ID-genotypes methylation of neutrophils was significantly decreased compared to lymphocytes and in II-genotypes methylation in neutrophils was significantly decreased compared to lymphocytes and monocytes. In addition, CHART-PCR showed that the hypomethylated promoter regions are highly accessible. Therefore we assume that the demethylated regions are very important for NFKB1 promoter activity.	[Unterberg, Matthias; Kreuzer, Maxmiliane Julia; Bazzi, Zainab; Adamzik, Michael; Rump, Katharina] Ruhr Univ Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Schornau 23-25, D-44892 Bochum, Germany; [Schaefer, Simon Thomas] Klinikum Univ Ludwig Maximilians Univ Munchen, Klin Anaesthesiol, Munich, Germany	Ruhr University Bochum; University of Munich	Unterberg, M (corresponding author), Ruhr Univ Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Schornau 23-25, D-44892 Bochum, Germany.	Matthias.unterberg@kk-bochum.de	Rump, Katharina/AAJ-9090-2020; Schaefer, Simon Thomas/AAA-8869-2021; Adamzik, Michael/HGE-9286-2022	Rump, Katharina/0000-0003-2220-519X; Schaefer, Simon Thomas/0000-0001-7289-6000; Unterberg, Matthias/0000-0002-1500-1984	Ruhr-Univeritat Bochum [FoRUM: Az: F837N-2014]	Ruhr-Univeritat Bochum	The funding the authors received for this study was FoRUM: Az: F837N-2014 from the Ruhr-Univeritat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2013, ANESTHESIOLOGY, V118, P123, DOI 10.1097/ALN.0b013e318277a652; Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Bone RC, 2009, CHEST, V136, pe28; Chang GJ, 2015, VET J, V203, P339, DOI 10.1016/j.tvjl.2014.12.023; Eskandari-Nasab E, 2016, CANCER BIOMARK, V16, P109, DOI 10.3233/CBM-150546; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Ibrahim-Zada I, 2014, J TRAUMA ACUTE CARE, V76, P8; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Mymryk JS, 1997, METHODS, V12, P105, DOI 10.1006/meth.1997.0452; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Poplutz MK, 2014, IMMUNOBIOLOGY, V219, P619, DOI 10.1016/j.imbio.2014.03.016; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Rump K, 2015, METHYLIERUNGSMUSTER, V56; Rump K, 2013, SHOCK; Sakamoto Y, 2014, BIOCH BIOPHYS RES CO; Schaefer ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104953; Schorr CA, 2014, VIRULENCE, V5, P190, DOI 10.4161/viru.27409; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tan YH, 2015, J TRAUMA ACUTE CARE, V78, P784, DOI 10.1097/TA.0000000000000588; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Thomas RM, 2003, J IMMUNOL, V170, P218, DOI 10.4049/jimmunol.170.1.218; Weiterer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121748; Yin JY, 2016, TUMOR BIOL, V37, P5467, DOI 10.1007/s13277-015-4373-3; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Zhang XQ, 2013, MOL MED REP, V7, P1417, DOI 10.3892/mmr.2013.1405	30	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156702	10.1371/journal.pone.0156702	http://dx.doi.org/10.1371/journal.pone.0156702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249028	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700069
J	Wang, MY; He, B; Wang, YH; Wu, FC; Chen, XF; Wang, WT; Yang, X				Wang, Meiyan; He, Bin; Wang, Yuhuan; Wu, Fuchen; Chen, Xuefeng; Wang, Wenting; Yang, Xue			Depression among Low-Income Female Muslim Uyghur and Kazakh Informal Caregivers of Disabled Elders in Far Western China: Influence on the Caregivers' Burden and the Disabled Elders' Quality of Life	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; FAMILY CAREGIVERS; STRESS PROCESS; MENTAL-HEALTH; DEMENTIA; CARE; ASSOCIATION; DISABILITY; SUPPORT; GENDER	Background Paying attention to and improving the mental health of the informal caregivers of disabled elders has become a global public health priority. This study focused on low-income female Uyghur and Kazakh informal caregivers of disabled elders residing in China's far west. It investigated the prevalence of and the major related factors of depressive emotion. Methods A cross-sectional study was performed from September 2013 to January 2014 in Shawan Prefectures, Tuokexun Prefectures, Bole Prefecture and Urumchi city. Shawan Prefecture has the highest proportion of Kazakhs, whereas Tuokexun Prefectures, Bole Prefecture and Urumchi city have the highest proportion of Uyghurs in Muslim ethnic Uygur and Kazakh communities. Xinjiang Uyghur Autonomous Region is located in remote western China; this area is approximately 3,105 km (1,929 miles) away from Beijing. A total of 444 female Uyghur and Kazakh informal caregivers of disabled elders participated in this study. The self-rating depression scale, the Zarit burden interview, and the SF-36 questionnaire were used to evaluate the state of caregiver depression, caregiver burden, and quality of life (QOL), respectively. Statistical analyses were performed using multivariate logistic regression analyses, correlation with Spearman's rho and independent-sample t-tests; a P-value of <0.05 was considered statistically significant. Results Up to 38.5% (n = 217) of informal caregivers reported having depression, whereas 61.5% (n = 273) of them reported a lack of depression. Age of disabled elders more than 60 years old, total hours spent on caring daily >= 8h, duration of caring >= 5 years, negative self-evaluation of health condition, having caregiver burden, elders' medium degree of disability and elders' heavy degree of disability had a higher risk of caregiver depression. By contrast, daughter/daughter-in-law of disabled elders; unemployed carers, family's per capita income >US$ 235.48( 1500 yuan), high social support, and high QOL of disabled elders were each associated with a lower risk of depressive emotion. Moreover, informal caregivers with depression obtained high care burden scores; at the same time, disabled elders who were looked after by caregivers with depression obtained low QOL scores. Conclusions Our findings suggest that the demographics characteristics of informal caregivers, and caregiver burden, and the disabled elders' degree of disability and QOL had the most significant correlation with depressive emotion among women informal caregivers. The results had a enlighten that these variables should be considered while planning interventions to improve depression of informal caregivers.	[Wang, Meiyan; He, Bin; Wang, Yuhuan; Wu, Fuchen; Chen, Xuefeng; Wang, Wenting; Yang, Xue] Shihezi Univ, Sch Med, Shihezi, Xinjiang, Peoples R China	Shihezi University	Wang, YH (corresponding author), Shihezi Univ, Sch Med, Shihezi, Xinjiang, Peoples R China.	wangyuhuan@shzu.edu.cn			National Natural Science Fund of China (NSFC) [81260443]	National Natural Science Fund of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by The National Natural Science Fund of China (NSFC) (project number: 81260443). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggar C, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-66; [Anonymous], 2006, COLE CROAT FOLK CULT; [Anonymous], 2014, IMPLEMENTING NEW AGR; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; Donelan K, 2002, HEALTH AFFAIR, V21, P222, DOI 10.1377/hlthaff.21.4.222; Emerson M., 2009, ETHNORELIGIOUS CONFL; Ferrans C E, 1990, Semin Oncol Nurs, V6, P248, DOI 10.1016/0749-2081(90)90026-2; Ferrell B R, 1998, Nursing, V28, P59; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goldberg A., 2002, ISLAM EUROPES 2 RELI, P29; Goode KT, 1998, HEALTH PSYCHOL, V17, P190, DOI 10.1037/0278-6133.17.2.190; GURLAND BJ, 1988, INT J GERIATR PSYCH, V3, P163, DOI 10.1002/gps.930030304; Hammond T, 2014, QUAL LIFE RES, V23, P1535, DOI 10.1007/s11136-013-0577-4; Hansen T, 2013, SOC INDIC RES, V114, P323, DOI 10.1007/s11205-012-0148-z; Holland JM, 2010, AGEING INT, V35, P109, DOI 10.1007/s12126-010-9057-0; Jenkins R, 1997, PSYCHOL MED, V27, P775, DOI 10.1017/S0033291797005308; Kagotho N, 2012, AIDS CARE, V24, P1226, DOI 10.1080/09540121.2012.658754; Kuscu MK, 2009, PSYCHO-ONCOLOGY, V18, P927, DOI 10.1002/pon.1441; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liu J, 2008, J XINJIANG MED U, V31, P1, DOI DOI 10.3969/J.ISSN.1009-5551.2008.01.001; Lopez-Hartmann M, 2012, INT J INTEGR CARE, V12; Gratao ACM, 2013, REV ESC ENFERM USP, V47, P134; McCallum TJ, 2008, J CROSS-CULT GERONTO, V23, P77, DOI 10.1007/s10823-007-9049-z; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Mittelman MS, 2004, AM J PSYCHIAT, V161, P850, DOI 10.1176/appi.ajp.161.5.850; MITTELMAN MS, 1995, GERONTOLOGIST, V35, P792, DOI 10.1093/geront/35.6.792; Navaie-Waliser M, 2002, AM J PUBLIC HEALTH, V92, P409, DOI 10.2105/AJPH.92.3.409; Neri AL, 2012, INT PSYCHOGERIATR, V24, P472, DOI 10.1017/S1041610211001700; Niu YF, 2010, COMMUNIST PARTY CHIN, V2, P41; Ory MG, 1999, GERONTOLOGIST, V39, P177, DOI 10.1093/geront/39.2.177; Pinquart M, 2006, J GERONTOL B-PSYCHOL, V61, pP33, DOI 10.1093/geronb/61.1.P33; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Robinson A, 2012, AGEING SOC, V32, P196, DOI 10.1017/S0144686X11000195; SCHUMACHER KL, 1993, RES NURS HEALTH, V16, P395, DOI 10.1002/nur.4770160603; The national aging working committee office, 2014, ELDERLY POPULATION R; THOMPSON EH, 1993, J GERONTOL, V48, pS245, DOI 10.1093/geronj/48.5.S245; Toonsiri C, 2011, J NURS EDUC, V4, P62; Wang L, 2006, CHINESE J PUBLIC HLT, V22, P970, DOI DOI 10.11847/ZGGGWS2006-22-08-47.(IN; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHO, 2001, WORLD HLTH REPORT 20; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; Wu FC, 2014, CHINESE J GERONTOLOG, V35, P3100; Yang L, 2002, HLTH SERVICES SURVEY; [杨筱多 YANG Xiaoduo], 2007, [中华护理杂志, Chinese Journal of Nursing], V42, P271; Yee JL, 2000, GERONTOLOGIST, V40, P147, DOI 10.1093/geront/40.2.147; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zhao, 2009, NW POPULATION J, V30, P84, DOI 10.15884/j.cnki.issn.1007-0672.2009.04.019; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	50	11	11	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156382	10.1371/journal.pone.0156382	http://dx.doi.org/10.1371/journal.pone.0156382			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27244459	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100035
J	Barbado, D; Lopez-Valenciano, A; Juan-Recio, C; Montero-Carretero, C; van Dieen, JH; Vera-Garcia, FJ				Barbado, David; Lopez-Valenciano, Alejandro; Juan-Recio, Casto; Montero-Carretero, Carlos; van Dieen, Jaap H.; Vera-Garcia, Francisco J.			Trunk Stability, Trunk Strength and Sport Performance Level in Judo	PLOS ONE			English	Article							PHYSIOLOGICAL PROFILES; BALANCE	Although trunk muscle function has been suggested to be a determinant of judo performance, its contribution to high-level performance in this sport has been poorly studied. Therefore, several tests were used to assess the differences in trunk muscle function between 11 international and 14 national level judo practitioners (judokas). Trunk strength and endurance were assessed using isokinetic tests and core stability was assessed using two protocols: 1) sudden loading, to assess trunk responses to unexpected external perturbations; 2) stable and unstable sitting, to assess the participants' ability to control trunk balance. No differences between groups were found for trunk flexor isokinetic strength, trunk responses against lateral and posterior loading and trunk control while sitting. However, international level judokas showed significantly higher trunk extensor isokinetic strength (p < 0.05) and lower trunk angular displacement after anterior trunk loading (p < 0.05) than national level judokas. Few and low (r < 0.512) significant correlations were found between strength, endurance and stability parameters, which suggests that trunk strength and endurance are not limiting factors for trunk stability in competitive judokas. These results support the importance of trunk extensor strength and trunk stability against forward perturbations in elite judo performance.	[Barbado, David; Lopez-Valenciano, Alejandro; Juan-Recio, Casto; Montero-Carretero, Carlos; Vera-Garcia, Francisco J.] Miguel Hernandez Univ, Sport Res Ctr, Elche, Spain; [van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Universidad Miguel Hernandez de Elche; Vrije Universiteit Amsterdam	Vera-Garcia, FJ (corresponding author), Miguel Hernandez Univ, Sport Res Ctr, Elche, Spain.	fvera@umh.es	van Dieen, Jaap/B-3937-2013; Barbado, David/P-7436-2019; Lopez-Valenciano, Alejandro/AAD-1515-2021; JUAN-RECIO, CASTO/U-2167-2019; Montero, Carlos/P-6920-2019; Montero-Carretero, Carlos/ABI-6748-2020; Vera-Garcia, Francisco J/L-7755-2014	van Dieen, Jaap/0000-0002-7719-5585; Lopez-Valenciano, Alejandro/0000-0002-5443-5101; Montero, Carlos/0000-0002-1565-8169; Vera-Garcia, Francisco J/0000-0003-4792-8087	Ministerio de Ciencia e Innovacion, Spain [DEP2010-16493]; Conselleria de Educacion de la Generalitat Valenciana, Spain [ACOMP/2011/130]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Educacion de la Generalitat Valenciana, Spain	This study was made possible by financial support from: Ministerio de Ciencia e Innovacion (Plan Nacional de I+D+I; Ref.: DEP2010-16493), Spain, Conselleria de Educacion de la Generalitat Valenciana (Ref.: ACOMP/2011/130), Spain.	Azevedo PHSM, 2007, J SPORT SCI MED, V6, P10; Barbado D, 2016, GAIT POSTUR IN PRESS; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; Cort JA, 2013, J ELECTROMYOGR KINES, V23, P1334, DOI 10.1016/j.jelekin.2013.09.006; Franchini E, 2003, J SPORT MED PHYS FIT, V43, P424; Franchini E., 2000, HUMAN MOVEMENT, V2, P23; Franchini E, 2011, SPORTS MED, V41, P147, DOI 10.2165/11538580-000000000-00000; GRABINER M D, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P590; HANCOCK GR, 1995, J MOTOR BEHAV, V27, P241, DOI 10.1080/00222895.1995.9941714; Heyward VH, 2010, ADV FITNESS ASSESSME, Vxiii; Imamura Rodney, 2003, Sports Biomech, V2, P191, DOI 10.1080/14763140308522817; Imamura RT, 2006, J SPORT SCI MED, V5, P122; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; Juan-Recio C, 2016, J STRENGTH IN PRESS; KORT HD, 1992, J ORTHOP SPORT PHYS, V16, P92, DOI 10.2519/jospt.1992.16.2.92; Krstulovic S, 2006, COLLEGIUM ANTROPOL, V30, P845; LANGRANA NA, 1984, SPINE, V9, P287, DOI 10.1097/00007632-198404000-00011; Lech G, 2015, J HUM KINET, V45, P167, DOI 10.1515/hukin-2015-0017; Margnes E, 2011, IDO MOV CULT, V11, P42; MAYER T, 1995, SPINE, V20, P920, DOI 10.1097/00007632-199504150-00007; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Perrot C, 1998, J HUMAN MOVEMENT SCI, V35, P37; TAYLOR AW, 1981, J SPORT MED PHYS FIT, V21, P160; THOMAS SG, 1989, CAN J SPORT SCI, V14, P142; van Dieen JH, 2012, EUR J APPL PHYSIOL, V112, P1307, DOI 10.1007/s00421-011-2082-1; Watkins M P, 1983, Clin Sports Med, V2, P37; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Yoshitomi Sheylla Kyoko, 2006, Rev Bras Med Esporte, V12, P159, DOI 10.1590/S1517-86922006000300010	29	46	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156267	10.1371/journal.pone.0156267	http://dx.doi.org/10.1371/journal.pone.0156267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232602	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000016
J	Lee, JW; Soman, P; Park, JH; Chen, SC; Cho, DW				Lee, Jin Woo; Soman, Pranav; Park, Jeong Hun; Chen, Shaochen; Cho, Dong-Woo			A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; VASCULAR GRAFTS; BIODEGRADABLE POLYMER; PULMONARY-ARTERY; AUXETIC BEHAVIOR; BLOOD-VESSEL; HOLY-GRAIL; IN-VITRO; GROWTH; MODEL	Developing functional small-diameter vascular grafts is an important objective in tissue engineering research. In this study, we address the problem of compliance mismatch by designing and developing a 3D tubular construct that has a negative Poisson's ratio v(xy) (NPR). NPR constructs have the unique ability to expand transversely when pulled axially, thereby resulting in a highly-compliant tubular construct. In this work, we used projection stereolithography to 3D-print a planar NPR sheet composed of photosensitive poly(ethylene) glycol diacrylate biomaterial. We used a step-lithography exposure and a stitch process to scale up the projection printing process, and used the cut-missing rib unit design to develop a centimeter-scale NPR sheet, which was rolled up to form a tubular construct. The constructs had Poisson's ratios of -0.6 <= -v(xy) <= -0.1. The NPR construct also supports higher cellular adhesion than does the construct that has positive v(xy). Our NPR design offers a significant advance in the development of highly-compliant vascular grafts.	[Lee, Jin Woo] Gachon Univ, Sch Med, Dept Mol Med, 7-45 Songdo Dong, Inchon 406840, South Korea; [Soman, Pranav] Syracuse Univ, Dept Biomed & Chem Engn, 318 Browne Hall, Syracuse, NY 13244 USA; [Park, Jeong Hun; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea; [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA	Gachon University; Syracuse University; Pohang University of Science & Technology (POSTECH); University of California System; University of California San Diego	Cho, DW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.; Chen, SC (corresponding author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.	chen168@eng.ucsd.edu; dwcho@postech.ac.kr			National Institutes of Health [EB012597, EB017876]; National Research Foundation of Korea (NRF) [2014R1A1A2A16054777, 2010-0018294]; Korea Health Industry Development Institute (KHIDI) [HI14C3228]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017876, R01EB012597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by the National Institutes of Health (EB012597 and EB017876, http://www.nih.gov/) to SC; National Research Foundation of Korea (NRF)(2014R1A1A2A16054777, http://www.nrf.re.kr/) to JWL; National Research Foundation of Korea (NRF) (2010-0018294, http://www.nrf.re.kr/) to D-WC; Korea Health Industry Development Institute (KHIDI) (HI14C3228, http://www.khidi.or.kr/) to JWL.; We greatly appreciate the financial support from National Institutes of Health (EB012597 and EB017876) to S.C, National Research Foundation (NRF) of Korea (No. 2014R1A1A2A16054777 & No. 2010-0018294) and the Korea Health Industry Development Institute (KHIDI) (HI14C3228). And We also appreciate the donation of human turbinate mesenchymal stromal cells from Prof. Sung-Won Kim (Seoul Saint Mary Hospital).	Association AH, 2003, BIOST FACTSH CARD PR; Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208; BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5; Buckmann T, 2012, ADV MATER, V24, P2710, DOI 10.1002/adma.201200584; CANHAM PB, 1991, CONNECT TISSUE RES, V26, P121, DOI 10.3109/03008209109152168; Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032; Conte MS, 1998, FASEB J, V12, P43, DOI 10.1096/fasebj.12.1.43; COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Eisenstadt MM, 1971, INTRO MECH PROPERTIE; EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0; Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022; Fozdar DY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215303; Fung YC, 1993, BIOMECHANICS MECH PR, DOI [10.1007/978-1-4757-2257-4_8, DOI 10.1038/NCOMMS7205]; Gaspar N, 2005, ACTA MATER, V53, P2439, DOI 10.1016/j.actamat.2005.02.006; Gibson L. J., 1997, CELLULAR SOLIDS STRU, P510, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087; GLAGOV S, 1979, ARTERY, V5, P295; Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4; Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595; Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2; Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5; Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880; Perler BA, 1995, J VASC INTERV RADIOL, V6, pS111, DOI 10.1016/S1051-0443(95)71259-3; Popov E.P., 1990, ENG MECH SOLID, V1st ed., P82; Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2; Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X; SANDUSKY GE, 1992, AM J PATHOL, V140, P317; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3; Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X; Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997; Pranav S, 2012, BIOMATERIALS, V33, P7064, DOI 10.1016/j.biomaterials.2012.06.012; Soman P, 2012, ACTA BIOMATER, V8, P2587, DOI 10.1016/j.actbio.2012.03.035; Soman P, 2012, SOFT MATTER, V8, P4946, DOI 10.1039/c2sm07354d; Sung HW, 1997, ARTIF ORGANS, V21, P50; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5; Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481; WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400; Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6	51	27	27	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155681	10.1371/journal.pone.0155681	http://dx.doi.org/10.1371/journal.pone.0155681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232181	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000005
J	Muthengi, E; Gitau, T; Austrian, K				Muthengi, Eunice; Gitau, Tabither; Austrian, Karen			Is Working Risky or Protective for Married Adolescent Girls in Urban Slums in Kenya? Understanding the Association between Working Status, Savings and Intimate-Partner Violence	PLOS ONE			English	Article							PHYSICAL VIOLENCE; INTERVENTION; EMPOWERMENT; WOMEN	Introduction Previous studies have shown that women's empowerment, though beneficial in many aspects, can also increase the risk of intimate-partner violence (IPV). This study seeks to examine the association between work and experience of physical violence among married adolescents, and to understand the impact of access to independent financial resources on this risk. Authors draw on the asset-building framework and the ecological model. Methods The data is from a baseline survey of girls aged 15-19 residing in urban slums in four cities and towns in Kenya (Nairobi, Thika, Nakuru and Kisumu). The analytic sample is 452 married girls. Logistic regression is used to examine associations between working status, savings and experience of IPV in the previous six months, controlling for other factors. This is complemented by content analysis of in-depth interviews with 32 adolescent girls and 16 young men. Results Compared to girls who did not work, working with no regular savings was significantly associated with greater odds (OR = 1.96, p < 0.01) of experiencing IPV. There was no difference between girls who did not work and those who worked but had regular savings. Qualitative findings indicate savings decrease girls' dependency on men and allow them to leave abusive partners. Discussion Findings imply that in these communities with patriarchal gender norms and high levels of poverty, female employment and financial conflicts can be triggers of violence in marriages. On the other hand, girls' management of and access to independent financial resources through savings can potentially help to reduce this risk.	[Muthengi, Eunice; Gitau, Tabither; Austrian, Karen] Populat Council, Poverty Gender & Youth Program, Nairobi, Kenya		Muthengi, E (corresponding author), Populat Council, Poverty Gender & Youth Program, Nairobi, Kenya.	emuthengi@popcouncil.org			NoVo Foundation	NoVo Foundation	The project was funded by the NoVo Foundation (http://novofoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austrian K., 2010, GIRL CENTERED PROGRA; Austrian K, 2015, SEX EDUC-SEX SOC LEA, V15, P64, DOI 10.1080/14681811.2014.947364; Austrian K, 2014, CHILD YOUTH SERV REV, V47, P168, DOI 10.1016/j.childyouth.2014.08.012; Blanc AK, 2013, REV EVIDENCE MULTISE, V15, P358; Bott S., 2005, PREVENTING RESPONDIN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bruce J, 2004, AD GIRLS LIV M; Dalal Koustuv, 2011, J Inj Violence Res, V3, P35, DOI 10.5249/jivr.v3i1.76; Duvvury N., 2013, INTIMATE PARTNER VIO; Erulkar A, 2005, EVALUATION SAVINGS M; Gupta J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-46; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hindin M.J., 2008, INTIMATE PARTNER VIO; Hjort Jonas, 2011, BACKLASH FEMALE EMPL; Kenya National Bureau of Statistics (KNBS) ICF International., 2014, KEN DEM HLTH SURV KE; Kim JC, 2007, AM J PUBLIC HEALTH, V97, P1794, DOI 10.2105/AJPH.2006.095521; Kishor S., 2004, PROFILING DOMESTIC V; Naved RT, 2005, STUD FAMILY PLANN, V36, P289, DOI 10.1111/j.1728-4465.2005.00071.x; Sabarwal S, 2014, J INTERPERS VIOLENCE, V29, P332, DOI 10.1177/0886260513505144; Ssewamala FM, 2008, J ADOLESCENT HEALTH, V42, P102, DOI 10.1016/j.jadohealth.2007.08.011; Vyas S, 2009, J INT DEV, V21, P577, DOI 10.1002/jid.1500; World Health Organization, 2021, VIOL WOM PREV EST 20	22	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155988	10.1371/journal.pone.0155988	http://dx.doi.org/10.1371/journal.pone.0155988			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232997	Green Submitted, Green Published, gold			2022-12-27	WOS:000376883000011
J	Kawashima, N; Mita, T				Kawashima, Noritaka; Mita, Tomoki			Psychophysical Evaluation of the Capability for Phantom Limb Movement in Forearm Amputees	PLOS ONE			English	Article							CORTICAL REORGANIZATION; ARM AMPUTATION; PAIN; HAND; AWARENESS; MIRRORS; BRAIN	A phantom limb is the sensation that an amputated limb is still attached to the body and is moving together with other body parts. Phantom limb phenomenon is often described on the basis of the patient's subjective sense, for example as represented using a visual analog scale (VAS). The aim of this study was to propose a novel quantification method for behavioral aspect of phantom limb by psychophysics. Twelve unilateral forearm amputees were asked to perform phantom wrist motion with various motion frequencies (60, 80, 100, 120, 140, 160, 180, 200, 220, 240% of preferred speed). The attainment of phantom limb motion in each session was rated by the VAS ranging from 0 (hard) to 10 (easy). The relationship between the VAS and motion frequency was mathematically fitted by quadric function, and the value of shift and the degree of steepness were obtained as evaluation variables for the phantom limb movement. In order to test whether the proposed method can reasonably quantify the characteristics of phantom limb motion, we compared the variables among three different phantom limb movement conditions: (1) unilateral (phantom only), (2) bimanual, and (3) bimanual wrist movement with mirror reflection-induced visual feedback (MVF). While VAS rating showed a larger extent of inter-and intra-subject variability, the relationship of the VAS in response to motion frequency could be fitted by quadric curve, and the obtained parameters based on quadric function well characterize task-dependent changes in phantom limb movement. The present results suggest the potential usefulness of psychophysical evaluation as a validate assessment tool of phantom limb condition.	[Kawashima, Noritaka; Mita, Tomoki] Natl Rehabil Ctr Persons Disabil, Res Inst, Tokorozawa, Saitama, Japan		Kawashima, N (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Tokorozawa, Saitama, Japan.	kawashima-noritaka@rehab.go.jp			Japan Society for the Promotion of Science (JSPS) [24650361]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work is supported by Grant-in-Aid for Challenging Exploratory Research (No. 24650361) from Japan Society for the Promotion of Science (JSPS).	FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Flor H, 2006, NAT REV NEUROSCI, V7, P873, DOI 10.1038/nrn1991; Hunter JP, 2003, BRAIN, V126, P579, DOI 10.1093/brain/awg054; Kawashima N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069324; Kawashima N, 2009, NEUROCASE, V15, P478, DOI 10.1080/13554790902950442; Lotze M, 2001, BRAIN, V124, P2268, DOI 10.1093/brain/124.11.2268; Lotze M, 1999, NAT NEUROSCI, V2, P501, DOI 10.1038/9145; Makin TR, 2015, BRAIN, V138, P2140, DOI 10.1093/brain/awv161; Makin TR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2571; MELZACK R, 1992, SCI AM, V266, P120, DOI 10.1038/scientificamerican0492-120; Nikolajsen L, 1997, PAIN, V72, P393, DOI 10.1016/S0304-3959(97)00061-4; Philip BA, 2014, J NEUROSCI, V34, P3622, DOI 10.1523/JNEUROSCI.3770-13.2014; RAMACHANDRAN VS, 1992, SCIENCE, V258, P1159, DOI 10.1126/science.1439826; Ramachandran VS, 1996, P ROY SOC B-BIOL SCI, V263, P377, DOI 10.1098/rspb.1996.0058; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reilly KT, 2006, BRAIN, V129, P2211, DOI 10.1093/brain/awl154; Sathian K, 2000, NEUROREHAB NEURAL RE, V14, P73, DOI 10.1177/154596830001400109; Sumitani M, 2008, RHEUMATOLOGY, V47, P1038, DOI 10.1093/rheumatology/ken170; Willoch F, 2000, ANN NEUROL, V48, P842	19	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156349	10.1371/journal.pone.0156349	http://dx.doi.org/10.1371/journal.pone.0156349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227973	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500120
J	Ohashi, N; Isobe, S; Ishigaki, S; Suzuki, T; Iwakura, T; Ono, M; Fujikura, T; Tsuji, T; Otsuka, A; Ishii, Y; Furuse, H; Kato, A; Ozono, S; Yasuda, H				Ohashi, Naro; Isobe, Shinsuke; Ishigaki, Sayaka; Suzuki, Takahisa; Iwakura, Takamasa; Ono, Masafumi; Fujikura, Tomoyuki; Tsuji, Takayuki; Otsuka, Atsushi; Ishii, Yasuo; Furuse, Hiroshi; Kato, Akihiko; Ozono, Seiichiro; Yasuda, Hideo			Plasma Soluble (Pro)renin Receptor Reflects Renal Damage	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; AT(1) RECEPTOR; PRORENIN; HYPERTENSION; ACTIVATION; RATS	Background (Pro)renin receptor [(P)RR], a specific receptor for renin and prorenin, was identified as a member of the renin-angiotensin system (RAS). (P)RR is cleaved by furin, and soluble (P) RR [s(P)RR] is secreted into the extracellular space. Previous reports have indicated that plasma s(P)RR levels show a significant positive relationship with urinary protein levels, which represent renal damage. However, it is not fully known whether plasma s(P)RR reflects renal damage. Methods We recruited 25 patients who were admitted to our hospital to undergo heminephrectomy. Plasma s(P)RR levels were examined from blood samples drawn before nephrectomy. The extent of renal damage was evaluated by the levels of tubulointerstitial fibrosis. Immunohistochemical analysis of intrarenal (P)RR and cell surface markers (cluster of differentiation [CD] 3, CD19, and CD68) was performed on samples taken from the removed kidney. Moreover, double staining of (P)RR and cell surface markers was also performed. Results There were significant positive relationships between plasma s(P)RR and tubulointerstitial fibrosis in all the patients and those not receiving RAS blocker therapy. Significant positive relationships were found between plasma s(P)RR levels and the extent of tubulointerstitial fibrosis after adjustment for age, sex, body weight, blood pressure, and plasma angiotensin II, in all the patients and those not receiving RAS blockers. Moreover, (P)RR expression was elevated in infiltrated mononuclear cells but not connecting tubules or collecting ducts and vessels. Infiltrated cells positive for (P)RR consisted of CD3 and CD68 but not CD19. Conclusions These data suggest that plasma s(P) RR levels may reflect (P)RR expression levels in infiltrated mononuclear cells, which can be a surrogate marker of renal damage.	[Ohashi, Naro; Isobe, Shinsuke; Ishigaki, Sayaka; Iwakura, Takamasa; Fujikura, Tomoyuki; Tsuji, Takayuki; Yasuda, Hideo] Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Takahisa; Otsuka, Atsushi; Ishii, Yasuo; Furuse, Hiroshi; Ozono, Seiichiro] Hamamatsu Univ Sch Med, Urol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Ono, Masafumi; Kato, Akihiko] Hamamatsu Univ Sch Med, Blood Purificat Unit, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Ohashi, N (corresponding author), Hamamatsu Univ Sch Med, Internal Med 1, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	ohashi-n@hama-med.ac.jp	Fujikura, Tomoyuki/HDO-2837-2022					Batenburg WW, 2007, J HYPERTENS, V25, P2441, DOI 10.1097/HJH.0b013e3282f05bae; Cousin C, 2009, HYPERTENSION, V53, P1077, DOI 10.1161/HYPERTENSIONAHA.108.127258; Gonzalez AA, 2011, HYPERTENSION, V57, P859, DOI 10.1161/HYPERTENSIONAHA.110.167957; Hamada K, 2013, CLIN EXP NEPHROL, V17, P848, DOI 10.1007/s10157-013-0803-y; Hirose T, 2010, REGUL PEPTIDES, V159, P93, DOI 10.1016/j.regpep.2009.11.006; Huang YJ, 2012, AM J PHYSIOL-RENAL, V303, pF130, DOI 10.1152/ajprenal.00275.2011; Ichihara A, 2008, J AM SOC HYPERTENS, V2, P15, DOI 10.1016/j.jash.2007.08.001; Isobe S, 2015, CLIN EXP NEPHROL, V19, P231, DOI 10.1007/s10157-014-0973-2; Kobori H, 2005, J AM SOC NEPHROL, V16, P2073, DOI 10.1681/ASN.2004080676; Kobori H, 2009, HYPERTENSION, V53, P344, DOI 10.1161/HYPERTENSIONAHA.108.123802; Macconi D, 2011, KIDNEY INT S, V2014, P58, DOI DOI 10.1038/KISUP.2014.11; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Morimoto S, 2014, HYPERTENS RES, V37, P642, DOI 10.1038/hr.2014.46; Narumi K, 2015, AM J PHYSIOL-RENAL, V308, pF487, DOI 10.1152/ajprenal.00206.2014; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2014, HYPERTENSION, V63, P297, DOI 10.1161/HYPERTENSIONAHA.113.02217; Nguyen G, 2011, CURR HYPERTENS REP, V13, P79, DOI 10.1007/s11906-010-0172-9; Nishijima T, 2014, PEPTIDES, V56, P14, DOI 10.1016/j.peptides.2014.03.008; Ohashi N, 2008, AM J PHYSIOL-RENAL, V295, pF1512, DOI 10.1152/ajprenal.00058.2008; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P750, DOI 10.1111/j.1440-1681.2009.05172.x; Ohashi N, 2009, CLIN EXP PHARMACOL P, V36, P509, DOI 10.1111/j.1440-1681.2008.05107.x; Oshima Yoichi, 2014, World J Nephrol, V3, P302, DOI 10.5527/wjn.v3.i4.302; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Siragy HM, 2008, EXP PHYSIOL, V93, P709, DOI 10.1113/expphysiol.2007.040550; Watanabe N, 2012, HYPERTENSION, V60, P1250, DOI 10.1161/HYPERTENSIONAHA.112.197418	26	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156165	10.1371/journal.pone.0156165	http://dx.doi.org/10.1371/journal.pone.0156165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228084	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500075
J	Tshimanga, M; Mangwiro, T; Mugurungi, O; Xaba, S; Murwira, M; Kasprzyk, D; Montano, DE; Nyamukapa, D; Tambashe, B; Chatikobo, P; Gundidza, P; Gwinji, G				Tshimanga, Mufuta; Mangwiro, Tonderayi; Mugurungi, Owen; Xaba, Sinokuthemba; Murwira, Munyaradzi; Kasprzyk, Danuta; Montano, Daniel E.; Nyamukapa, Daisy; Tambashe, Basile; Chatikobo, Pesanai; Gundidza, Patricia; Gwinji, Gerald			A Phase II Randomized Controlled Trial Comparing Safety, Procedure Time, and Cost of the PrePex (TM) Device to Forceps Guided Surgical Circumcision in Zimbabwe	PLOS ONE			English	Article							HIV PREVENTION; INFECTION; RISK; MEN; METAANALYSIS; NURSES	Background The World Health Organization (WHO) and the Joint United Nations Program on HIV/AIDS promote MC (male circumcision) as a key HIV prevention strategy where HIV prevalence and incidence are high and MC prevalence is low. In Zimbabwe, to achieve the 1.26 million circumcisions needed to be performed by 2015 to achieve optimal MC coverage, a new approach was needed. The primary objective of the current trial was to assess the performance (safety, procedure time, and cost) of the PrePex device compared to forceps-guided surgical circumcision. Methods and Findings This Phase II, randomized, open-label trial in Zimbabwe involved healthy, non-circumcised adult male volunteers who were randomly assigned to the PrePex device (n = 160) or surgical arm (n = 80). Three doctors and 4 nurses, all certified on both circumcision methods, performed the procedures. The PrePex device procedure involves a plastic ring with a rubber 0 -ring that necrotizes the foreskin to facilitate easy and minimally invasive removal. Total procedure time was the primary endpoint. Adverse event (AE) data were also gathered for 90 days post-procedure. All 80 participants in the surgical arm and 158 participants in the PrePex arm achieved complete circumcision. The total procedure time for the PrePex device was approximately one-third of the total surgical procedure (4.8 minutes, Standard Deviation [SD]: 1.2 versus 14.6 minutes; SD: 4.2; p<0.00001). There were 2 AEs for 2 participants (rate of 1.3%, 95% Confidence Interval: 0.0025-4.53%), which were resolved with simple intervention. The AEs were device related, including 1 case of pain leading to device removal and 1 case of removal of the device. Conclusions The trial supports previous studies' conclusions that the PrePex procedure is safe, quick, easy to apply, and effective in terms of procedure time as an alternative to traditional surgical circumcision. The PrePex device has great potential for use in overburdened health systems and in resource-limited settings and is recommended for use in rapid scale-up of adult MC in Zimbabwe.	[Tshimanga, Mufuta; Chatikobo, Pesanai; Gundidza, Patricia] Univ Zimbabwe, Dept Community Med, Coll Hlth Sci, Harare, Zimbabwe; [Mangwiro, Tonderayi] Univ Zimbabwe, Dept Surg, Coll Hlth Sci, Harare, Zimbabwe; [Mugurungi, Owen; Xaba, Sinokuthemba; Gwinji, Gerald] Minist Hlth & Child Care, Harare, Zimbabwe; [Murwira, Munyaradzi] Zimbabwe Natl Family Planning Council, Harare, Zimbabwe; [Kasprzyk, Danuta; Montano, Daniel E.] Battelle Hlth & Analyt, Seattle, WA USA; [Nyamukapa, Daisy; Tambashe, Basile] United Nations Populat Fund, Harare, Zimbabwe	University of Zimbabwe; University of Zimbabwe; United Nations Population Fund	Tshimanga, M (corresponding author), Univ Zimbabwe, Dept Community Med, Coll Hlth Sci, Harare, Zimbabwe.	tshimangamufuta@gmail.com			United Nations Population Fund; Zimbabwe National Family Planning Council; National Pharmaceutical Company of Zimbabwe; National AIDS Council of Zimbabwe; Population Services International; Medical Research Council of Zimbabwe; Battelle Memorial Institute	United Nations Population Fund; Zimbabwe National Family Planning Council; National Pharmaceutical Company of Zimbabwe; National AIDS Council of Zimbabwe; Population Services International; Medical Research Council of Zimbabwe; Battelle Memorial Institute	The United Nations Population Fund funded this study (http://www.unfpa.org/public/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would also like to thank Circ MedTech for their technical support in this study and, specifically, for the timely transportation of all PrePex devices and consumables procured. We also sincerely thank the Permanent Secretary of the Ministry of Health of Rwanda and Rwanda PrePex clinical trial team for their invaluable technical support and contribution to this study. The following government institutions and implementing partners are also acknowledged for their sustained encouragement and support: Zimbabwe National Family Planning Council, National Pharmaceutical Company of Zimbabwe, National AIDS Council of Zimbabwe, Population Services International, Medical Research Council of Zimbabwe, and Battelle Memorial Institute. Finally, the authors would like to thank Kristen Eckert and Dr Marissa Carter (Strategic Solutions, Inc, Cody, WY), who helped to write and edit the article in concert with the authors and also provided written permission to have their name and information included in the acknowledgment.	[Anonymous], 2012, EV SAF EFF PREPEX DE; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, J ACQ IMMUN DEF SYND, V15, pe127; Bollinger L, 2009, MALE CIRCUMCISION DE; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Feldblum PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095357; Galukande M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086631; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Mills E, 2008, HIV MED, V9, P332, DOI 10.1111/j.1468-1293.2008.00596.x; Ministry of Health and Child Welfare (MOHCW) of Zimbabwe. Strategic Plan: Ministry of Health and Child Welfare [MOHCW], 2010, STRAT SAF MED MAL CI; Mutabazi V, 2012, J ACQ IMMUN DEF SYND, V61, P41; Mutabazi V, 2014, AFR J REPROD HEALTH, V18, P61; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Njeuhmeli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082533; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Sumithra J, 2010, J THORAC ONCOL, V5, P932, DOI [10.1097/JTO.0b013e3181e2eadf, DOI 10.1097/JTO.0B013E3181E2EADF]; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WHO/UNAIDS, 2007, WHO UNAID TECHN CONS; World Health Organization, ETH PRINC MED RES IN; World Health Organization, 2008, MAN MAL CIRC LOC AN; Zimbabwe Central Statistical Office, 2007, ZIMB DEM HLTH SURV Z	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156220	10.1371/journal.pone.0156220	http://dx.doi.org/10.1371/journal.pone.0156220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227679	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500086
J	Yang, QS; Shen, GC; Liu, HM; Wang, ZH; Ma, ZP; Fang, XF; Zhang, J; Wang, XH				Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Wang, Zhang-Hua; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua			Detangling the Effects of Environmental Filtering and Dispersal Limitation on Aggregated Distributions of Tree and Shrub Species: Life Stage Matters	PLOS ONE			English	Article							BROAD-LEAVED FOREST; HABITAT ASSOCIATIONS; SPATIAL-PATTERNS; SUBTROPICAL FOREST; COMMUNITY MODELS; SOIL NUTRIENTS; BETA DIVERSITY; HETEROGENEITY; COEXISTENCE; PLOT	The pervasive pattern of aggregated tree distributions in natural communities is commonly explained by the joint effect of two clustering processes: environmental filtering and dispersal limitation, yet little consensus remains on the relative importance of the two clustering processes on tree aggregations. Different life stages of examined species were thought to be one possible explanation of this disagreement, because the effect of environmental filtering and dispersal limitation are expected to increase and decrease with tree life stages, respectively. However, few studies have explicitly tested these expectations. In this study, we evaluated these expectations by three different methods (species-habitat association test based on Poisson Clustering model and spatial point pattern analyses based on Heterogeneous Poisson model and the jointly modeling approach) using 36 species in a 20-ha subtropical forest plot. Our results showed that the percentage of species with significant habitat association increased with life stages, and there were fewer species affected by dispersal limitation in later life stages compared with those in earlier stages. Percentage of variance explained by the environmental filtering and dispersal limitation also increases and decreases with life stages. These results provided a promising alternative explanation on the existing mixed results about the relative importance of the two clustering processes. These findings also highlighted the importance of plant life stages for fully understanding species distributions and species coexistence.	[Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua] E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Yang, Qing-Song; Shen, Guo-Chun; Liu, He-Ming; Ma, Zun-Ping; Fang, Xiao-Feng; Zhang, Jian; Wang, Xi-Hua] Chinese Natl Ecosyst Observat & Res Network, Tiantong Natl Stn Forest Ecosyst, Ningbo, Zhejiang, Peoples R China; [Wang, Zhang-Hua] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China	East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, XH (corresponding author), E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China.	xhwang@des.ecnu.edu.cn	Zhang, Jian/A-7878-2008	Zhang, Jian/0000-0003-0589-6267; Liu, Heming/0000-0002-6873-4735; Shen, Guochun/0000-0001-9853-6062; Yang, QingSong/0000-0003-0531-5418	National Natural Science Foundation of China [31210103920, 31470487]; Division Of Environmental Biology [1545761, 1354741] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Natural Science Foundation of China (Grant No. 31210103920 to XHW and 31470487 to GCS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baddeley A, 2014, ECOL MONOGR, V84, P477, DOI 10.1890/13-2042.1; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Chang LW, 2013, ECOLOGY, V94, P2145, DOI 10.1890/12-2053.1; Chase J.M., 2009, ECOLOGICAL NICHES; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; CRESSIE N, 1990, MATH GEOL, V22, P239, DOI 10.1007/BF00889887; Diggle P. J., 2003, STAT ANAL POINT PATT; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Gunatilleke CVS, 2006, J TROP ECOL, V22, P371, DOI 10.1017/S0266467406003282; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; He FL, 1997, J VEG SCI, V8, P105, DOI 10.2307/3237248; Hu YH, 2012, OIKOS, V121, P952, DOI 10.1111/j.1600-0706.2011.19831.x; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Hubbell Stephen P., 2001, V32, pi; Illian J, 2008, STAT ANAL MODELLING; Jabot F, 2008, OIKOS, V117, P1308, DOI 10.1111/j.0030-1299.2008.16724.x; Jalilian A, 2013, SCAND J STAT, V40, P119, DOI 10.1111/j.1467-9469.2012.00795.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jara-Guerrero A, 2015, OIKOS, V124, P1360, DOI 10.1111/oik.02098; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kanagaraj R, 2011, J ECOL, V99, P1441, DOI 10.1111/j.1365-2745.2011.01878.x; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; [雷霄 Lei Xiao], 2015, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P122; Li L, 2009, OIKOS, V118, P495, DOI 10.1111/j.1600-0706.2009.16753.x; Lin YC, 2011, OECOLOGIA, V165, P175, DOI 10.1007/s00442-010-1718-x; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Moller J, 2004, J R STAT SOC A STAT, V168, P258; Murrell DJ, 2009, J ECOL, V97, P256, DOI 10.1111/j.1365-2745.2008.01475.x; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; PARRISH JAD, 1985, ECOLOGY, V66, P1296; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Quero JL, 2008, BASIC APPL ECOL, V9, P635, DOI 10.1016/j.baae.2007.06.012; R Core Team, 2014, R 3 1 1 R LANG ENV S; Seidler TG, 2006, PLOS BIOL, V4, P2132, DOI 10.1371/journal.pbio.0040344; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Song YC, 2013, EVERGREEN BROAD LEVA; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Stoyan D., 1994, FRACTALS RANDOM SHAP; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Waagepetersen R, 2009, J R STAT SOC B, V71, P685, DOI 10.1111/j.1467-9868.2008.00702.x; Wang XH, 2007, FOREST ECOL MANAG, V245, P76, DOI 10.1016/j.foreco.2007.03.043; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; Webb CO, 2000, J ECOL, V88, P464, DOI 10.1046/j.1365-2745.2000.00462.x; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2007, ECOLOGY, V88, P3088, DOI 10.1890/06-1350.1; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wu Z.Y., 1994, FLORA CHINA; Xie YuBin, 2012, Biodiversity Science, V20, P159, DOI 10.3724/SP.J.1003.2012.09242; Yamada T, 2006, J VEG SCI, V17, P559, DOI 10.1658/1100-9233(2006)17[559:HAOSTI]2.0.CO;2; Yamakura T., 1995, TROPICS, V5, P41, DOI [10.3759/tropics.5.41, DOI 10.3759/tropics.5.41, DOI 10.3759/TROPICS.5.41]; Yan ER, 2006, PLANT SOIL, V289, P187, DOI 10.1007/s11104-006-9128-x; Yang QingSong, 2011, Biodiversity Science, V19, P215, DOI 10.3724/SP.J.1003.2011.09013; Zhang Na, 2012, Yingyong Shengtai Xuebao, V23, P2361; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	68	19	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156326	10.1371/journal.pone.0156326	http://dx.doi.org/10.1371/journal.pone.0156326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227538	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500115
J	Chylikova, B; Hrdlicka, I; Vesela, K; Rezabek, K; Liska, F				Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Rezabek, Karel; Liska, Frantisek			Recurrent Microdeletions at Xq27.3-Xq28 and Male Infertility: A Study in the Czech Population	PLOS ONE			English	Article								Background Genetic causes of male infertility are hypothesized to involve multiple types of mutations, from single gene defects to complex chromosome rearrangements. Recently, several recurrent X-chromosome microdeletions (located in subtelomeric region of the long arm) were reported to be associated with male infertility in Spanish and Italian males. The aim of our study was to test their prevalence and infertility association in population of men from the Czech Republic. Methods 107 males with pathological sperm evaluation resulting in nonobstructive infertility were compared to 131 males with normal fecundity. X-chromosome microdeletions were assessed by +/- PCR with three primer pairs for each region Xcnv64 (Xq27.3), Xcnv67 (Xq28) and Xcnv69 (Xq28). The latter microdeletion was further characterized by amplification across the deleted region, dividing the deletion into three types; A, B and C. Results We detected presence of isolated Xcnv64 deletion in 3 patients and 14 controls, and Xcnv69 in 3 patients and 6 controls (1 and 1 patient vs. 4 and 1 control for types A and B respectively). There was one control with combined Xcnv64 and Xcnv69 type B deletions, and one patient with combination of Xcnv64 and Xcnv69 type C deletions. The frequency of the deletions was thus not higher in patient compared to control group, Xcnv64 was marginally associated with controls (adjusted Fisher's exact test P = 0.043), Xcnv69 was not associated (P = 0.452). We excluded presence of more extensive rearrangements in two subjects with combined Xcnv64 and Xcnv69 deletions. There was no Xcnv67 deletion in our cohort. Conclusion In conclusion, the two previously reported X-linked microdeletions (Xcnv64 and Xcnv69) do not seem to confer a significant risk to impaired spermatogenesis in the Czech population. The potential clinical role of the previously reported patient-specific Xcnv67 remains to be determined in a larger study population.	[Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Liska, Frantisek] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Rezabek, Karel; Liska, Frantisek] Gen Univ Hosp, Prague, Czech Republic; [Rezabek, Karel] Charles Univ Prague, Fac Med 1, Clin Gynecol & Obstet, Ctr Assisted Reprod, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Liska, F (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Liska, F (corresponding author), Gen Univ Hosp, Prague, Czech Republic.	frantisek.liska@lf1.cuni.cz	Liska, Frantisek/N-9192-2017; Chylikova, Blanka/D-2976-2017; Vesela, Kamila/L-2254-2017	Liska, Frantisek/0000-0002-9588-806X; Chylikova, Blanka/0000-0002-3439-1850; Vesela, Kamila/0000-0003-0270-3845	Ministry of Health of the Czech Republic [NT12269-5]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by Ministry of Health of the Czech Republic (www.mzcr.cz) grant No. NT12269-5 to FL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; Bablok L, 2011, NEUROENDOCRINOL LETT, V32, P799; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Choe JH, 2015, UROLOGY, V86, P1123, DOI 10.1016/j.urology.2015.08.014; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Gudeman SR, 2015, J UROLOGY, V193, P1318, DOI 10.1016/j.juro.2014.10.048; Hotaling J, 2014, ANDROLOGY-US, V2, P339, DOI 10.1111/j.2047-2927.2014.00200.x; Hotaling JM, 2014, UROL CLIN N AM, V41, P1, DOI 10.1016/j.ucl.2013.08.009; Krausz C, 2014, CURR OPIN ENDOCRINOL, V21, P244, DOI 10.1097/MED.0000000000000058; Lo Giacco D, 2014, J MED GENET, V51, P340, DOI 10.1136/jmedgenet-2013-101988; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Vincent MC, 2002, J ANDROL, V23, P18, DOI 10.1002/j.1939-4640.2002.tb02597.x	16	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156102	10.1371/journal.pone.0156102	http://dx.doi.org/10.1371/journal.pone.0156102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257673	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700035
J	Samuelsen, SV; Maity, A; Nybo, M; Macaubas, C; Lonstrup, L; Balboni, IM; Mellins, ED; Astakhova, K				Samuelsen, Simone V.; Maity, Arindam; Nybo, Mads; Macaubas, Claudia; Lonstrup, Lars; Balboni, Imelda M.; Mellins, Elizabeth D.; Astakhova, Kira			Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases	PLOS ONE			English	Article							BINDING PLASMA-PROTEINS; ANTIPHOSPHOLIPID SYNDROME; LUPUS; AUTOANTIBODIES; PATHOGENESIS; THROMBOSIS; GENETICS; PROFILE	Reliable measurement of clinically relevant autoimmune antibodies toward phospholipid-protein conjugates is highly desirable in research and clinical assays. To date, the development in this field has been limited to the use of natural heterogeneous antigens. However, this approach does not take structural features of biologically active antigens into account and leads to low reliability and poor scientific test value. Here we describe novel phospholipid- protein conjugates for specific detection of human autoimmune antibodies. Our synthetic approach includes mild oxidation of synthetic phospholipid cardiolipin, and as the last step, coupling of the product with azide-containing linker and copper-catalyzed click chemistry with beta 2-glycoprotein I and prothrombin. To prove utility of the product antigens, we used enzyme-linked immunosorbent assay and three cohorts of samples obtained from patients in Denmark (n = 34) and the USA (n = 27 and n = 14). Afterwards we analyzed correlation of the obtained autoantibody titers with clinical parameters for each patient. Our results prove that using novel antigens clinically relevant autoantibodies can be detected with high repeatability, sensitivity and specificity. Unlike previously used antigens the obtained autoantibody titers strongly correlate with high disease activity and in particular, with arthritis, renal involvement, anti-Smith antibodies and high lymphocyte count. Importantly, chemical composition of antigens has a strong influence on the correlation of detected autoantibodies with disease activity and manifestations. This confirms the crucial importance of antigens' composition on research and diagnostic assays, and opens up exciting perspectives for synthetic antigens in future studies of autoimmunity.	[Samuelsen, Simone V.; Maity, Arindam; Astakhova, Kira] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Nybo, Mads] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Macaubas, Claudia; Balboni, Imelda M.; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA; [Lonstrup, Lars] Univ Southern Denmark, Dept Business & Econ, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Stanford University; University of Southern Denmark	Astakhova, K (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark.	ias@sdu.dk	Nybo, Mads/J-6040-2019; Lonstrup, Lars/AAP-3138-2020; Maity, Arindam/AAQ-4943-2020; Astakhova, Kira/D-1432-2014	Nybo, Mads/0000-0002-3029-2855; Lonstrup, Lars/0000-0002-8343-9291; Maity, Arindam/0000-0002-9418-6963; Astakhova, Kira/0000-0003-4878-0301; Mellins, Elizabeth/0000-0003-2577-139X	Villum Foundation [73516]; Augustinus Foundation [95-305-73070]	Villum Foundation(Villum Fonden); Augustinus Foundation	This study was supported by research funding from Villum Foundation (Grant. No. 73516) and Augustinus Foundation (Grant. No. 95-305-73070). URL: veluxfoundations.dk/. This grant covered expenses for the preparation of this manuscript. URL: http://www.augustinusfonden.dk/. This grant covered expenses of reagents for the preparation and testing of new complexes.	Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; [Anonymous], DRUG IND LUP ERYTH; Arroyo-Avila M, 2015, CLIN RHEUMATOL, V34, P1217, DOI 10.1007/s10067-015-2941-y; Bertolaccini Maria Laura, 2004, Clin Lab, V50, P653; Ceccarelli F, 2015, AUTOIMMUN REV, V14, P601, DOI 10.1016/j.autrev.2015.02.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; de Laat HB, 2004, BLOOD, V104, P3598, DOI 10.1182/blood-2004-03-1107; Feldborg LN, 2012, BIOCONJUGATE CHEM, V23, P2444, DOI 10.1021/bc3005057; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Gonnet-Gracia C, 2008, CLIN EXP RHEUMATOL, V26, P401; Grossman JM, 2009, BEST PRACT RES CL RH, V23, P495, DOI 10.1016/j.berh.2009.04.003; Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010; KWEE IL, 1988, MAGNET RESON MED, V6, P296, DOI 10.1002/mrm.1910060307; Borba HHL, 2014, BIODRUGS, V28, P211, DOI 10.1007/s40259-013-0074-x; Macmillan H, 2014, J IMMUNOL, V193, P2641, DOI 10.4049/jimmunol.1400075; Maity A, 2015, MOLECULES, V20, P10253, DOI 10.3390/molecules200610253; Mao ZF, 2014, NEUROL RES, V36, P1106, DOI 10.1179/1743132814Y.0000000400; Marion TN, 2014, SEMIN IMMUNOPATHOL, V36, P495, DOI 10.1007/s00281-014-0440-x; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Milne K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-33; MINASSIAN AA, 1988, P NATL ACAD SCI USA, V85, P6939, DOI 10.1073/pnas.85.18.6939; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Pengo V, 1996, THROMB HAEMOSTASIS, V75, P721; Pengo V, 2014, SEMIN THROMB HEMOST, V40, P860, DOI 10.1055/s-0034-1395158; Pericleous C, 2014, METHODS MOL BIOL, V1134, P221, DOI 10.1007/978-1-4939-0326-9_17; Pierangeli SS, 2008, SEMIN THROMB HEMOST, V34, P236, DOI 10.1055/s-0028-1082267; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07; Riedhammer C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00322; ROUBEY RAS, 1994, BLOOD, V84, P2854; Sacks JJ, 2002, MMWR-MORBID MORTAL W, V51, P371; Schmidheiny K, 2014, SHORT GUIDE MICROECO; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Sheng YH, 1996, J IMMUNOL, V157, P3744; Stephenson FH, 2010, CALCULATIONS FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY: A GUIDE TO MATHEMATICS IN THE LABORATORY, 2ND EDITION, P1; Su DL, 2014, CLIN RHEUMATOL, V33, P1025, DOI 10.1007/s10067-014-2560-z; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Tron GC, 2008, MED RES REV, V28, P278, DOI 10.1002/med.20107; Wolfe F., 2009, KELLEYS TXB RHEUMATO, P569; Zieve GW, 2003, AUTOIMMUN REV, V2, P235, DOI 10.1016/S1568-9972(03)00018-1	42	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156125	10.1371/journal.pone.0156125	http://dx.doi.org/10.1371/journal.pone.0156125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257889	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700037
J	Xie, W; Li, L; Zhang, M; Cheng, HP; Gong, D; Lv, YC; Yao, F; He, PP; Ouyang, XP; Lan, G; Liu, D; Zhao, ZW; Tan, YL; Zheng, XL; Yin, WD; Tang, CK				Xie, Wei; Li, Liang; Zhang, Min; Cheng, Hai-Peng; Gong, Duo; Lv, Yun-Cheng; Yao, Feng; He, Ping-Ping; Ouyang, Xin-Ping; Lan, Gang; Liu, Dan; Zhao, Zhen-Wang; Tan, Yu-Lin; Zheng, Xi-Long; Yin, Wei-Dong; Tang, Chao-Ke			MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE SECRETION; APOE-DEFICIENT MICE; AORTIC ATHEROSCLEROSIS; THP-1 MACROPHAGES; ACCELERATES ATHEROSCLEROSIS; CORONARY-ARTERIES; CHOLESTEROL; EXPRESSION; METABOLISM; GENE	Atherosclerotic lesions are lipometabolic disorder characterized by chronic progressive inflammation in arterial walls. Previous studies have shown that macrophage-derived lipoprotein lipase (LPL) might be a key factor that promotes atherosclerosis by accelerating lipid accumulation and proinflammatory cytokine secretion. Increasing evidence indicates that microRNA-27 (miR-27) has beneficial effects on lipid metabolism and inflammatory response. However, it has not been fully understood whether miR-27 affects the expression of LPL and subsequent development of atherosclerosis in apolipoprotein E knockout (apoE KO) mice. To address these questions and its potential mechanisms, oxidized low-density lipoprotein (ox-LDL)-treated THP-1 macrophages were transfected with the miR-27 mimics/inhibitors and apoE KO mice fed high-fat diet were given a tail vein injection with miR-27 agomir/antagomir, followed by exploring the potential roles of miR-27. MiR-27 agomir significantly down-regulated LPL expression in aorta and peritoneal macrophages by western blot and real-time PCR analyses. We performed LPL activity assay in the culture media and found that miR-27 reduced LPL activity. ELISA showed that miR-27 reduced inflammatory response as analyzed in vitro and in vivo experiments. Our results showed that miR-27 had an inhibitory effect on the levels of lipid both in plasma and in peritoneal macrophages of apoE KO mice as examined by HPLC. Consistently, miR-27 suppressed the expression of scavenger receptors associated with lipid uptake in ox-LDL-treated THP-1 macrophages. In addition, transfection with LPL siRNA inhibited the miR-27 inhibitor-induced lipid accumulation and proinflammatory cytokines secretion in ox-LDL-treated THP-1 macrophages. Finally, systemic treatment revealed that miR-27 decreased aortic plaque size and lipid content in apoE KO mice. The present results provide evidence that a novel antiatherogenic role of miR-27 was closely related to reducing lipid accumulation and inflammatory response via downregulation of LPL gene expression, suggesting a potential strategy to the diagnosis and treatment of atherosclerosis.	[Xie, Wei; Li, Liang; Zhang, Min; Cheng, Hai-Peng; Gong, Duo; Yao, Feng; He, Ping-Ping; Ouyang, Xin-Ping; Lan, Gang; Liu, Dan; Zhao, Zhen-Wang; Tan, Yu-Lin; Yin, Wei-Dong; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang, Hunan, Peoples R China; [Xie, Wei; Lv, Yun-Cheng] Univ South China, Lab Clin Anat, Hengyang, Hunan, Peoples R China; [Li, Liang] Univ South China, Dept Pathophysiol, Hengyang, Hunan, Peoples R China; [Zheng, Xi-Long] Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta,Cumming Sch Med, Hosp Dr NW, Calgary, AB, Canada	University of South China; University of South China; University of South China; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Yin, WD; Tang, CK (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang, Hunan, Peoples R China.	wdy20042004@126.com; tangchaoke@qq.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Sciences Foundation of China, China [81570408, 81270269, 81170278]	National Natural Sciences Foundation of China, China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial supports from the National Natural Sciences Foundation of China (http://www.nsfc.gov.cn/) (81570408, 81270269, 81170278), China. The funders had a key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi H, 2003, CARDIOVASC RES, V58, P647, DOI 10.1016/S0008-6363(03)00287-6; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beauchamp MC, 2002, J LIPID RES, V43, P215; Bodary PF, 2005, ARTERIOSCL THROM VAS, V25, P119, DOI 10.1161/01.ATV.0000173306.47722.ec; Boon RA, 2012, THROMB HAEMOSTASIS, V108, P616, DOI 10.1160/TH12-07-0491; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goedeke L, 2015, ATHEROSCLEROSIS, V243, P499, DOI 10.1016/j.atherosclerosis.2015.09.033; Goldberg IJ, 1996, J LIPID RES, V37, P693; He PP, 2014, BIOCHIMIE, V106, P81, DOI 10.1016/j.biochi.2014.08.003; Hosin AA, 2014, J VASC RES, V51, P338, DOI 10.1159/000368193; Ichikawa T, 2005, ATHEROSCLEROSIS, V179, P87, DOI 10.1016/j.atherosclerosis.2004.10.044; Kobayashi J., 2015, ANN CLIN BIOCH; Koike T, 2005, CARDIOVASC RES, V65, P524, DOI 10.1016/j.cardiores.2004.10.022; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Lv YC, 2014, ATHEROSCLEROSIS, V236, P215, DOI 10.1016/j.atherosclerosis.2014.07.005; Moore KJ, 2013, J LIPID RES, V54, P1159, DOI 10.1194/jlr.E036954; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nazari-Jahantigh M, 2015, J MOL CELL CARDIOL, V89, P35, DOI 10.1016/j.yjmcc.2014.10.021; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Pirillo A, 2011, ATHEROSCLEROSIS, V214, P331, DOI 10.1016/j.atherosclerosis.2010.11.006; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Qiu GS, 2007, J LIPID RES, V48, P385, DOI 10.1194/jlr.M600304-JLR200; Rao XQ, 2014, CIRC RES, V115, P770, DOI 10.1161/CIRCRESAHA.115.304666; Shimada M, 1996, P NATL ACAD SCI USA, V93, P7242, DOI 10.1073/pnas.93.14.7242; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Tian GP, 2014, BIOCHEM BIOPH RES CO, V443, P428, DOI 10.1016/j.bbrc.2013.11.109; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; TSUTSUMI K, 1993, J CLIN INVEST, V92, P411, DOI 10.1172/JCI116582; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Voloshyna I, 2013, EXP BIOL MED, V238, P1192, DOI 10.1177/1535370213503262; Wang JY, 2007, ARTERIOSCL THROM VAS, V27, P197, DOI 10.1161/01.ATV.0000249683.80414.d9; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Yagyu H, 1999, J LIPID RES, V40, P1677; Yang HT, 2015, J CELL BIOCHEM, V116, P580, DOI 10.1002/jcb.25009; Zhang M, 2014, ATHEROSCLEROSIS, V234, P54, DOI 10.1016/j.atherosclerosis.2014.02.008; Zou B, 2015, EUR J NUTR, V54, P1333, DOI 10.1007/s00394-014-0814-9	48	56	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157085	10.1371/journal.pone.0157085	http://dx.doi.org/10.1371/journal.pone.0157085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257686	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700175
J	Mosca, O; Lauriola, M; Carleton, RN				Mosca, Oriana; Lauriola, Marco; Carleton, R. Nicholas			Intolerance of Uncertainty: A Temporary Experimental Induction Procedure	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; CONSTRUCT-VALIDITY; NEGATIVE AFFECT; WORRY; MODEL; SCALE; MANIPULATION; METAANALYSIS; DECISIONS; VERSION	Background and Objectives Intolerance of uncertainty (IU) is a trans-diagnostic construct involved in anxiety and related disorders. Research focused on cross-sectional reporting, manipulating attitudes toward objective and impersonal events or on treatments designed to reduce IU in clinical populations. The current paper presents an experimental procedure for laboratory manipulations of IU and tests mediation hypotheses following the Intolerance of Uncertainty Model. Methods On pre-test, undergraduate volunteers (Study 1, n = 43; 68% women. Study 2, n = 169; 83.8% women) were asked to provide an idiosyncratic future negative life event. State-IU, Worry, Positive and Negative Affect were assessed after that a standardized procedure was used to identify event's potential negative consequences. The same variables were assessed on post-test, after that participants were asked to read-through increasing and decreasing IU statements. Results Temporary changes on IU were consistently reproduced in both studies. Participants receiving increasing IU instructions reported greater state-IU, Worry and Negative Affect than those receiving decreasing IU instructions. However, this latter condition was not different from a control one (Study 2). Both studies revealed significant indirect effects of IU induction instructions on Worry and Negative Affect through state-IU. Limitations Both studies used undergraduate psychology students samples, younger than average population and predominantly female. Experimental manipulation and outcome measures belongs to the same semantic domain, uncertainty, potentially limiting generalizability. Conclusions Results supported the feasibility and efficacy of the proposed IU manipulation for non-clinical sample. Findings parallel clinical research showing that state-IU preceded Worry and Negative Affect states.	[Mosca, Oriana; Lauriola, Marco] Univ Roma La Sapienza, Dept Social & Dev Psychol, Rome, Italy; [Carleton, R. Nicholas] Univ Regina, Anxiety & Illness Behav Lab, Regina, SK S4S 0A2, Canada	Sapienza University Rome; University of Regina	Mosca, O (corresponding author), Univ Roma La Sapienza, Dept Social & Dev Psychol, Rome, Italy.	oriana.mosca@uniroma1.it	Mosca, Oriana/ABI-1729-2020					Balsamo M., 2012, PSYCHOLOGY, V3, P399, DOI DOI 10.4236/psych.2012.35056; Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bentler P. M., 2004, EQS 6 STRUCTURAL EQU; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Birrell J, 2011, CLIN PSYCHOL REV, V31, P1198, DOI 10.1016/j.cpr.2011.07.009; BONATE PL, 2000, ANAL PRETEST POSTTES; Boswell JF, 2013, J CLIN PSYCHOL, V69, P630, DOI 10.1002/jclp.21965; Bowlby J, 1973, ATTACHMENT LOSS; Bredemeier K, 2008, BEHAV RES THER, V46, P28, DOI 10.1016/j.brat.2007.09.006; Buhr K, 2006, J ANXIETY DISORD, V20, P222, DOI 10.1016/j.janxdis.2004.12.004; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Burns D. D., 1989, FEELING GOOD HDB; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carleton RN, 2016, J ANXIETY DISORD, V39, P30, DOI 10.1016/j.janxdis.2016.02.007; Carleton RN, 2016, J BEHAV THER EXP PSY, V51, P58, DOI 10.1016/j.jbtep.2015.12.004; Carleton RN, 2012, EXPERT REV NEUROTHER, V12, P937, DOI 10.1586/ERN.12.82; Conover W. J, 1999, PRACTICAL NONPARAMET, P130; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; Dugas MJ, 1997, COGNITIVE THER RES, V21, P593, DOI 10.1023/A:1021890322153; Dugas MJ, 2005, COGNITIVE THER RES, V29, P57, DOI 10.1007/s10608-005-1648-9; Dugas MJ, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P143; Dugas MJ, 1998, BEHAV RES THER, V36, P215, DOI 10.1016/S0005-7967(97)00070-3; Dugas MJ, 2001, COGNITIVE THER RES, V25, P551, DOI 10.1023/A:1005553414688; Dugas MJ, 2003, J CONSULT CLIN PSYCH, V71, P821, DOI 10.1037/0022-006X.71.4.821; Dugas MJ, 2000, BEHAV MODIF, V24, P635, DOI 10.1177/0145445500245002; Einstein DA, 2014, CLIN PSYCHOL-SCI PR, V21, P280, DOI 10.1111/cpsp.12077; Fergus TA, 2014, PERS INDIV DIFFER, V58, P128, DOI 10.1016/j.paid.2013.10.017; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Gentes EL, 2011, CLIN PSYCHOL REV, V31, P923, DOI 10.1016/j.cpr.2011.05.001; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Grenier S, 2004, CAN J BEHAV SCI, V36, P56, DOI 10.1037/h0087216; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Holaway RM, 2006, J ANXIETY DISORD, V20, P158, DOI 10.1016/j.janxdis.2005.01.002; Hong RY, 2015, CLIN PSYCHOL SCI, V3, P892, DOI 10.1177/2167702614553789; Iani L, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-84; Jacoby RJ, 2016, J ANXIETY DISORD; Jacoby RJ, 2014, J ANXIETY DISORD, V28, P495, DOI 10.1016/j.janxdis.2014.05.005; Ladouceur R, 2000, BEHAV RES THER, V38, P933, DOI 10.1016/S0005-7967(99)00133-3; Laugesen N, 2003, J ABNORM CHILD PSYCH, V31, P55, DOI 10.1023/A:1021721332181; Luhmann CC, 2011, BEHAV THER, V42, P378, DOI 10.1016/j.beth.2010.09.002; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P212, DOI 10.1080/16506073.2011.622130; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P26, DOI 10.1080/16506073.2011.622131; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Mueller EM, 2010, J BEHAV THER EXP PSY, V41, P165, DOI 10.1016/j.jbtep.2009.12.002; Nelson BD, 2011, INT J PSYCHOPHYSIOL, V81, P107, DOI 10.1016/j.ijpsycho.2011.05.003; Ottaviani C, 2014, INT J PSYCHOPHYSIOL, V93, P349, DOI 10.1016/j.ijpsycho.2014.05.010; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scherer KR, 2013, EMOT REV, V5, P150, DOI 10.1177/1754073912468166; Scherer KR, 2009, EUR J PERSONALITY, V23, P265, DOI 10.1002/per.714; Terracciano A, 2003, EUR J PSYCHOL ASSESS, V19, P131, DOI 10.1027//1015-5759.19.2.131; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; van Breukelen GJP, 2013, MULTIVAR BEHAV RES, V48, P895, DOI 10.1080/00273171.2013.831743; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wu XW, 2015, COMMUN STAT-SIMUL C, V44, P284, DOI 10.1080/03610918.2013.775295; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127189	58	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155130	10.1371/journal.pone.0155130	http://dx.doi.org/10.1371/journal.pone.0155130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27254099	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700004
J	Heckmann, BL; Zhang, XD; Saarinen, AM; Liu, J				Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun			Regulation of G0/G1 Switch Gene 2 (G0S2) Protein Ubiquitination and Stability by Triglyceride Accumulation and ATGL Interaction	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; ENERGY-METABOLISM; LIPID-METABOLISM; LIPOLYSIS; DEGRADATION; MICE; ALPHA; LIVER	Intracellular triglyceride (TG) hydrolysis or lipolysis is catalyzed by the key intracellular triglyceride hydrolase, adipose triglyceride lipase (ATGL). The G0/G1 Switch Gene 2 (G0S2) was recently identified as the major selective inhibitor of ATGL and its hydrolase function. Since G0S2 levels are dynamically linked and rapidly responsive to nutrient status or metabolic requirements, the identification of its regulation at the protein level is of significant value. Earlier evidence from our laboratory demonstrated that G0S2 is a short-lived protein degraded through the proteasomal pathway. However, little is currently known regarding the underlying mechanisms. In the current study we find that 1) protein degradation is initiated by K48-linked polyubiquitination of the lysine-25 in G0S2; and 2) G0S2 protein is stabilized in response to ATGL expression and TG accumulation. Mutation of lysine-25 of G0S2 abolished ubiquitination and increased protein stability. More importantly, G0S2 was stabilized via different mechanisms in the presence of ATGL vs. in response to fatty acid (FA)-induced TG accumulation. Furthermore, G0S2 protein but not mRNA levels were reduced in the adipose tissue of ATGL-deficient mice, corroborating the involvement of ATGL in the stabilization of G0S2. Taken together our data illustrate for the first time a crucial multifaceted mechanism for the stabilization of G0S2 at the protein level.	[Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85054 USA; [Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85054 USA; [Heckmann, Bradlee L.] Mayo Grad Sch, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Liu, J (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85054 USA.; Liu, J (corresponding author), Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85054 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109096, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grant from the National Institutes of Health (DK089178) to J.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Faggiano S, 2016, ANAL BIOCHEM, V492, P82, DOI 10.1016/j.ab.2015.09.013; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Suryadinata Randy, 2014, Cells, V3, P674, DOI 10.3390/cells3030674; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156742	10.1371/journal.pone.0156742	http://dx.doi.org/10.1371/journal.pone.0156742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248498	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700075
J	Skvortsova, YV; Kondratieva, SA; Zinovyeva, MV; Nikolaev, LG; Azhikina, TL; Gainetdinov, IV				Skvortsova, Yulia V.; Kondratieva, Sofia A.; Zinovyeva, Marina V.; Nikolaev, Lev G.; Azhikina, Tatyana L.; Gainetdinov, Ildar V.			Intragenic Locus in Human PIWIL2 Gene Shares Promoter and Enhancer Functions	PLOS ONE			English	Article							ENCODE DATA; CHROMATIN INTERACTIONS; TRANSCRIPTION FACTORS; UNIFIED ARCHITECTURE; DROSOPHILA GENOME; HUMAN TUMORS; 3D GENOME; ELEMENTS; ORGANIZATION; EXPRESSION	Recently, more evidence supporting common nature of promoters and enhancers has been accumulated. In this work, we present data on chromatin modifications and non-polyadenylated transcription characteristic for enhancers as well as results of in vitro luciferase reporter assays suggesting that PIWIL2 alternative promoter in exon 7 also functions as an enhancer for gene PHYHIP located 60Kb upstream. This finding of an intragenic enhancer serving as a promoter for a shorter protein isoform implies broader impact on understanding enhancer-promoter networks in regulation of gene expression.	[Skvortsova, Yulia V.; Kondratieva, Sofia A.; Zinovyeva, Marina V.; Nikolaev, Lev G.; Azhikina, Tatyana L.; Gainetdinov, Ildar V.] Russian Acad Sci, Dept Genom & Postgen Technol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gainetdinov, IV (corresponding author), Russian Acad Sci, Dept Genom & Postgen Technol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	ildargv@gmail.com	Azhikina, Tatyana/X-8411-2018; Skvortsova, Yulia/AAP-4597-2021; Kondrateva, Sofia/ABB-3389-2020	Skvortsova, Yuliya/0000-0002-7605-8570; Kondratieva, Sofia/0000-0002-1354-5275; Gainetdinov, Ildar/0000-0003-1719-043X	Russian Foundation for Basic Research [14-04-32314-mol_a]; program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'	This work was supported by the Russian Foundation for Basic Research grant no. 14-04-32314-mol_a to YVS and the program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2015, TRENDS GENET, V31, P426, DOI 10.1016/j.tig.2015.05.007; ANDREWS PW, 1984, LAB INVEST, V50, P147; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Benabdallah NS, 2015, COLD SH Q B, V80, P45, DOI 10.1101/sqb.2015.80.027268; Bescond M, 2005, INT J BIOCHEM CELL B, V37, P775, DOI 10.1016/j.biocel.2004.12.006; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Deng BW, 2013, SEMIN CANCER BIOL, V23, P65, DOI 10.1016/j.semcancer.2012.01.003; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2012, CURR OPIN GENET DEV, V22, P125, DOI 10.1016/j.gde.2011.12.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gainetdinov IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112528; Gainetdinov IV, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7074; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gushchanskaya ES, 2014, EPIGENETICS-US, V9, P951, DOI 10.4161/epi.28794; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JE, 2009, CELL CYCLE, V8, P2932; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YW, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140126; Koh JT, 2001, MOL BRAIN RES, V87, P223, DOI 10.1016/S0169-328X(01)00004-3; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li C, 2009, GENE THER, V16, P43, DOI 10.1038/gt.2008.134; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Matharu N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005640; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; van Arensbergen J, 2014, TRENDS CELL BIOL, V24, P695, DOI 10.1016/j.tcb.2014.07.004; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	66	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156454	10.1371/journal.pone.0156454	http://dx.doi.org/10.1371/journal.pone.0156454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248499	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700045
J	Aktas, B; De Wolfe, TJ; Safdar, N; Darien, BJ; Steele, JL				Aktas, Busra; De Wolfe, Travis J.; Safdar, Nasia; Darien, Benjamin J.; Steele, James L.			The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GERM-FREE; EXPRESSION; RECOGNITION; MATURATION; DEFENSINS; PRODUCTS; COLITIS; OBESITY; MILK	The probiotic function to impact human health is thought to be related to their ability to alter the composition of the gut microbiota and modulate the human innate immune system. The ability to function as a probiotic is believed to be strain specific. Strains of Lactobacillus casei are commonly utilized as probiotics that when consumed alter the composition of the gut microbiota and modulate the host immune response. L. casei strains are known to differ significantly in gene content. The objective of this study was to investigate seven different L. casei strains for their ability to alter the murine gut microbiota and modulate the murine immune system. C57BL/6 mice were fed L. casei strains at a dose of 108 CFU/day/mouse for seven days and sacrificed 3.5h after the last administration. The cecal content and the ileum tissue were collected for microbiota analysis and immune profiling, respectively. While 5 of the L. casei strains altered the gut microbiota in a strain specific manner, two of the strains did not alter the overall cecal microbiota composition. The observed changes cluster into three groups containing between 1 and 2 strains. Two strains that did not affect the gut microbiota composition cluster together with the control in their impact on pattern recognition receptors (PRRs) expression, suggesting that the ability to alter the cecal microbiota correlates with the ability to alter PRR expression. They also cluster together in their impact on the expression of intestinal antimicrobial peptides (AMPs). This result suggests that a relationship exists between the capability of a L. casei strains to alter the composition of the gut microbiota, PRR regulation, and AMP regulation.	[Aktas, Busra; De Wolfe, Travis J.; Steele, James L.] Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA; [Safdar, Nasia] Univ Wisconsin, Dept Med, Div Infect Dis, Madison, WI USA; [Safdar, Nasia] William S Middleton Vet Affairs Hosp, Madison, WI USA; [Darien, Benjamin J.] Univ Wisconsin, Anim Hlth & Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	JLSteele@wisc.edu	De Wolfe, Travis J/C-6827-2013	De Wolfe, Travis J/0000-0001-6261-1235; Aktas, Busra/0000-0001-9863-683X	DuPont Inc. [PRJ19MQ]; WARF [PRJ66JZ]	DuPont Inc.; WARF	This work was funded by DuPont Inc. (Grant no. PRJ19MQ) and by the WARF (Grant no. PRJ66JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aktas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145784; [Anonymous], 2014, YAKULT ANN REPORT; Barbara G, 2012, J CLIN GASTROENTEROL, V46, pS52, DOI 10.1097/MCG.0b013e318264e918; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceapa C, 2013, BEST PRACT RES CL GA, V27, P139, DOI 10.1016/j.bpg.2013.04.004; Chessel D., 2004, R NEWS, V4, P5; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; de Carcer DA, 2011, ISME J, V5, P801, DOI 10.1038/ismej.2010.177; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FAO, 2006, PROB FOOD HLTH NUTR; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hormannsperger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004365; Hwang I, 2013, J PHYSIOL PHARMACOL, V64, P11; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kandler O, 1986, BERGEYS MANUAL SYSTE, V2, P1063; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kirschning CJ, 2002, TOLL LIKE RECEPTOR F; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Natividad JMM, 2013, APPL ENVIRON MICROB, V79, P7745, DOI 10.1128/AEM.02470-13; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Owyang C, 2014, GASTROENTEROLOGY, V146, P1433, DOI 10.1053/j.gastro.2014.03.032; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Paul W. E., 2003, FUNDAMENTAL IMMUNOLO, V5th; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; R Core Team, 2021, R LANGUAGE ENV STAT; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Salminen SJ, 2005, J NUTR, V135, P1294, DOI 10.1093/jn/135.5.1294; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schuijt TJ, 2013, TRENDS MICROBIOL, V21, P221, DOI 10.1016/j.tim.2013.02.001; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Tandee K., 2013, THESIS U WISCONSIN M; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yin XC, 2014, J DAIRY SCI, V97, P2049, DOI 10.3168/jds.2013-7477; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05654; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	67	23	26	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156374	10.1371/journal.pone.0156374	http://dx.doi.org/10.1371/journal.pone.0156374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244133	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100033
J	Klein, E; Schlembach, D; Ramoni, A; Langer, E; Bahlmann, F; Grill, S; Schaffenrath, H; van der Does, R; Messinger, D; Verhagen-Kamerbeek, WDJ; Reim, M; Hund, M; Stepan, H				Klein, Evelyn; Schlembach, Dietmar; Ramoni, Angela; Langer, Elena; Bahlmann, Franz; Grill, Sabine; Schaffenrath, Helene; van der Does, Reinhard; Messinger, Diethelm; Verhagen-Kamerbeek, Wilma D. J.; Reim, Manfred; Hund, Martin; Stepan, Holger			Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; ANGIOGENIC FACTORS; GROWTH-FACTOR; RISK; PREDICTION; HYPERTENSION; PREVENTION; DIAGNOSIS	Objective To evaluate the influence of the soluble fms-like tyrosine kinase 1/placental growth factor ratio in physicians' decision making in pregnant women with signs and symptoms of preeclampsia in routine clinical practice. Methods A multicenter, prospective, open, non-interventional study enrolled pregnant women presenting with preeclampsia signs and symptoms in several European perinatal care centers. Before the soluble fms-like tyrosine kinase 1/placental growth factor ratio result was known, physicians documented intended clinical procedures using an iPad1 (R) application (data locked/time stamped). After the result was available, clinical decisions were confirmed or revised and documented. An independent adjudication committee evaluated the appropriateness of decisions based on maternal/fetal outcomes. Clinician decision making with regard to hospitalization was the primary outcome. Results In 16.9% of mothers (20/118) the hospitalization decision was changed after knowledge of the ratio. In 13 women (11.0%), the initial decision to hospitalize was changed to no hospitalization. In seven women (5.9%) the revised decision was hospitalization. All revised decisions were considered appropriate by the panel of adjudicators (McNemar test; p < 0.0001). Conclusions The use of the soluble fms-like tyrosine kinase 1/placental growth factor test influenced clinical decision making towards appropriate hospitalization in a considerable proportion of women with suspected preeclampsia. This is the first study to demonstrate the impact of angiogenic biomarkers on decision making in a routine clinical practice.	[Klein, Evelyn; Grill, Sabine] Tech Univ Munich, Klinikum Rechts Isar, Dept Gynecol & Obstet, Munich, Germany; [Schlembach, Dietmar] Univ Hosp, Dept Obstet, Jena, Germany; [Ramoni, Angela; Schaffenrath, Helene] Univ Innsbruck Hosp, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria; [Langer, Elena; Stepan, Holger] Univ Leipzig, Dept Obstet, D-04109 Leipzig, Germany; [Bahlmann, Franz] Burger Hosp, Dept Obstet, Frankfurt, Germany; [van der Does, Reinhard; Messinger, Diethelm] IST GmbH, Mannheim, Germany; [Verhagen-Kamerbeek, Wilma D. J.; Hund, Martin] Roche Diagnost Int Ltd, Med & Sci Affairs, Rotkreuz, Switzerland; [Reim, Manfred] Roche Diagnost GmbH, Med & Sci Affairs, Penzberg, Germany; [Schlembach, Dietmar] Vivantes Clin Neukolln, Clin Obstet, Berlin, Germany	Technical University of Munich; Friedrich Schiller University of Jena; Medical University of Innsbruck; Leipzig University; IST GmbH - Innovation Systems Technology; Roche Holding; Roche Holding; VIivantes Klinikum Neukolln	Stepan, H (corresponding author), Univ Leipzig, Dept Obstet, D-04109 Leipzig, Germany.	Holger.Stepan@medizin.uni-leipzig.de	Grill, Sabine/AAM-3978-2020; Hund, Martin/AAY-6541-2021; Schlembach, Dietmar/AAJ-4433-2020	Schlembach, Dietmar/0000-0003-3641-5278	Roche Diagnostics International, Rotkreuz, Switzerland; Roche Diagnostics; IST GmbH	Roche Diagnostics International, Rotkreuz, Switzerland; Roche Diagnostics; IST GmbH	The study was funded by Roche Diagnostics International, Rotkreuz, Switzerland. PreOS study number CIM RD-001450. Co-authors Wilma D.J. Verhagen-Kamerbeek, Manfred Reim and Martin Hund are employed by Roche Diagnostics. Roche Diagnostics provided support in the form of salaries for authors WDJV-K, MR and MH. WDJV-K, MR and MH were involved in the study design, data analysis, decision to publish, and preparation of the manuscript. Co-author Reinhard van der Does is employed by IST GmbH and co-author Diethelm Messinger was employed by IST GmbH during the course of the study. IST GmbH provided support in the form of salaries for authors RvdD and DM. RvdD and DM were involved in the study design, data analysis, decision to publish, and preparation of the manuscript.	Alvarez-Fernandez I, 2014, CLIN CHEM LAB MED, V52, P1159, DOI 10.1515/cclm-2013-0901; Ananth CV, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6564; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P531, DOI 10.1038/nrneph.2014.103; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Henderson JT, 2014, ANN INTERN MED, V160, P695, DOI 10.7326/M13-2844; Hernandez-Diaz Sonia, 2009, BMJ, V338, pb2255, DOI 10.1136/bmj.b2255; Hund M, 2015, HYPERTENS PREGNANCY, V34, P102, DOI 10.3109/10641955.2014.982331; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Makris A, 2007, KIDNEY INT, V71, P977, DOI 10.1038/sj.ki.5002175; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Milne F, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3129; Ohkuchi A, 2010, HYPERTENS RES, V33, P422, DOI 10.1038/hr.2010.15; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roche Diagnostics GmbH, EL PIGF IMM METH SHE; Roche Diagnostics GmbH, EL SFLT 1 IMM METH S; Skjaerven R, 2002, NEW ENGL J MED, V346, P33, DOI 10.1056/NEJMoa011379; Stepan H, 2015, ULTRASOUND OBST GYN, V45, P241, DOI 10.1002/uog.14799; Verlohren S, 2014, HYPERTENSION, V63, P346, DOI 10.1161/HYPERTENSIONAHA.113.01787; Verlohren S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.037; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; World Health Organization, WORLD HLTH REP 2005; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	26	43	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156013	10.1371/journal.pone.0156013	http://dx.doi.org/10.1371/journal.pone.0156013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243815	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100011
J	Tripathi, S; Mathur, S; Deshmukh, P; Manjula, R; Padmanabhan, B				Tripathi, Shailesh; Mathur, Shruti; Deshmukh, Prashant; Manjula, Ramu; Padmanabhan, Balasundaram			A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex	PLOS ONE			English	Article							HISTONE H4 RECOGNITION; SCORING FUNCTION; BET; CHROMATIN; PROTEINS; DOCKING	Bromodomain containing proteins recognize the level of histone acetylation and regulate epigenetically controlled processes like gene transcription and chromatin modification. The BET (bromodomain and extra-terminal) family proteins, which are transcriptional co-regulators, have been implicated in the pathogenesis of cancer, neurodegenerative disorders, and defects in embryonic stem cell differentiation. Inhibitors selectively targeting the BET bromodomains can pave the path for new drug discovery against several forms of major diseases. By a rational structure-based approach, we have identified a new inhibitor (NSC127133) of the second bromodomain (BD2) of the BET family protein BRD2 using the NCI Diversity Set III library. A high-resolution crystal structure of the BRD2-BD2 in complex with this compound and in apo-form is refined to 0.91 and 0.94 angstrom, respectively. The compound, which is a phenanthridinone derivative, binds well to the acetyl-lysine binding pocket of BD2 and displays significant hydrophobic and hydrophilic interactions. Moreover, the atomic resolution data obtained in this study allowed us to visualize certain structural features of BD2 which remained unobserved so far. We propose that the discovered compound may be a potential molecule to develop a new library for inhibiting the BRD2-BD2 function.	[Tripathi, Shailesh; Mathur, Shruti; Deshmukh, Prashant; Manjula, Ramu; Padmanabhan, Balasundaram] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biophys, Hosur Rd, Bangalore 560029, Karnataka, India	National Institute of Mental Health & Neurosciences - India	Padmanabhan, B (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biophys, Hosur Rd, Bangalore 560029, Karnataka, India.	paddy@nimhans.ac.in		Ramu, Manjula/0000-0002-2237-2599	Department of Biotechnology (DBT) [BT/PR7079/BID/7/426/2012]; Department of Science and Technology (DST) Government of India, India [SR/SO/BB-0108/2012]; DST [SR/WOS-A/LS-100/2013]; Council of Scientific and Industrial Research (CSIR) [09/490(0093) 2012-EMR-1]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST) Government of India, India(Department of Science & Technology (India)); DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	BP is grateful to the Department of Biotechnology (DBT) (No. BT/PR7079/BID/7/426/2012), and Department of Science and Technology (DST) (No. SR/SO/BB-0108/2012) Government of India, India for the financial support; SM to DST for DST WOS-A fellowship (SR/WOS-A/LS-100/2013); RM is thankful to Council of Scientific and Industrial Research (CSIR) for SRF fellowship (09/490(0093) 2012-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, PHENIX A COMPREHENSI, V66, P213; [Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.003; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Brand M, 2015, ACS CHEM BIOL, V10, P22, DOI 10.1021/cb500996u; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Chen RC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232870; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Deeney JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151329; Delano, PYMOL MOL GRAPH SYST; Denis GV, 2010, FEBS LETT, V584, P3260, DOI 10.1016/j.febslet.2010.05.030; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Ferri E, 2016, BIOCHEM PHARMACOL, V106, P1, DOI 10.1016/j.bcp.2015.12.005; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Ghoshal A, 2016, EXPERT OPIN THER PAT, V26, P505, DOI 10.1517/13543776.2016.1159299; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Kaur G, 2016, CANCER LETT, V371, P225, DOI 10.1016/j.canlet.2015.12.001; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; McLure KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083190; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Patel AJ, 2014, CELL REP, V6, P81, DOI 10.1016/j.celrep.2013.12.001; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umehara T, 2010, FEBS LETT, V584, P3901, DOI 10.1016/j.febslet.2010.08.013; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Wang JH, 2013, CURR MED CHEM, V20, P2032, DOI 10.2174/0929867311320150008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu XC, 2016, MOL CANCER THER, V15, P1029, DOI 10.1158/1535-7163.MCT-15-0750	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156344	10.1371/journal.pone.0156344	http://dx.doi.org/10.1371/journal.pone.0156344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243809	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100030
J	Kim, HG; Park, HK; Paick, SH; Choi, WS				Kim, Hyeong Gon; Park, Hyoung Keun; Paick, Sung Hyun; Choi, Woo Suk			Comparison of Effectiveness between Tension-Free Vaginal Tape (TVT) and Trans-Obturator Tape (TOT) in Patients with Stress Urinary Incontinence and Intrinsic Sphincter Deficiency	PLOS ONE			English	Article							URETHRAL CLOSURE PRESSURE; LEAK POINT PRESSURE; TRANSOBTURATOR TAPE; FOLLOW-UP; SLINGS; WOMEN; STANDARDIZATION; TERMINOLOGY; SUSPENSION; OUTCOMES	Background The aim of this study was to compare the two types of mid-urethral slings for stress urinary incontinence (SUI) with intrinsic sphincter deficiency (ISD). Methods This retrospective study included patients who underwent tension-free vaginal tape (TVT) procedure or transobturator tape (TOT) procedure by a single surgeon for SUI with ISD, defined as Valsalva leak point pressure (VLPP) < 60 cmH(2)O in a urodynamic study. Cases of neurogenic bladder, previous SUI surgery, and concomitant cystocele repair were excluded. The primary outcome was treatment success at 12 months, defined by self-reported absence of symptoms, no leakage episodes recorded, and no retreatment. Results Among the 157 women who were included in the final analysis, 105 patients received TVT and 52 patients received TOT. Age, underlying diseases, Stamey grade, cystocele grade, and presence of urge incontinence were not significantly different between the two groups. Urodynamic parameters including maximal urethral closing pressure, detrusor overactivity, VLPP, urethral hypermobility (Q-tip >= 30 degrees), were also comparable between the two groups. Success rate was significantly higher in the TVT group than in the TOT group (95.2% vs. 82.7%, p = 0.009). On multivariate analysis, only TOT surgery (OR = 3.922, 95% CI = 1.223-12.582, p = 0.022) was a risk factor for failure following surgical treatment. Conclusion TVT is more effective than TOT in treatment of female SUI with ISD.	[Kim, Hyeong Gon; Park, Hyoung Keun; Paick, Sung Hyun; Choi, Woo Suk] Konkuk Univ, Med Ctr, Sch Med, Dept Urol, Seoul, South Korea	Konkuk University; Konkuk University Medical Center	Choi, WS (corresponding author), Konkuk Univ, Med Ctr, Sch Med, Dept Urol, Seoul, South Korea.	20140123@kuh.ac.kr			Konkuk University	Konkuk University	This paper was written as part of Konkuk University's research support program for its faculty on sabbatical leave in 2015. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Barber MD, 2008, OBSTET GYNECOL, V111, P611, DOI 10.1097/AOG.0b013e318162f22e; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Chen Y, 2014, INT UROL NEPHROL, V46, P2103, DOI 10.1007/s11255-014-0772-4; Choo GY, 2012, INT NEUROUROL J, V16, P47, DOI 10.5213/inj.2012.16.1.47; Costantini E, 2008, INT BRAZ J UROL, V34, P73, DOI 10.1590/S1677-55382008000100011; Delorme E, 2001, PROG UROL, V11, P1306; Dietz HP, 2006, INT UROGYNECOL J, V17, P566, DOI 10.1007/s00192-006-0065-2; Doo CK, 2006, EUR UROL, V50, P333, DOI 10.1016/j.eururo.2006.04.007; Fischer A, 2005, EUR UROL, V48, P799, DOI 10.1016/j.eururo.2005.07.019; Haliloglu B, 2010, INT UROGYNECOL J, V21, P173, DOI 10.1007/s00192-009-1010-y; Heidler S, 2011, CURR OPIN UROL, V21, P488, DOI 10.1097/MOU.0b013e32834b1317; Hsiao SM, 2009, UROLOGY, V73, P981, DOI 10.1016/j.urology.2009.01.004; Jeon MJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.060; Kim Sun-Ouck, 2011, Int Neurourol J, V15, P211, DOI 10.5213/inj.2011.15.4.211; Liapis A, 2004, EUR J OBSTET GYN R B, V116, P67, DOI 10.1016/j.ejogrb.2004.02.009; Long CY, 2009, CURR OPIN OBSTET GYN, V21, P342, DOI 10.1097/GCO.0b013e32832e07bf; Miller JJR, 2006, AM J OBSTET GYNECOL, V195, P1799, DOI 10.1016/j.ajog.2006.07.011; Minaglia S, 2009, J REPROD MED, V54, P15; de Toledo LGM, 2012, INT BRAZ J UROL, V38, P667, DOI 10.1590/S1677-55382012000500012; Nager CW, 2007, NEUROUROL URODYNAM, V26, P333, DOI 10.1002/nau.20348; Novara G, 2010, EUR UROL, V58, P218, DOI 10.1016/j.eururo.2010.04.022; Oh TH, 2012, KOREAN J UROL, V53, P98, DOI 10.4111/kju.2012.53.2.98; Paick JS, 2004, J UROLOGY, V172, P1001, DOI 10.1097/01.ju.0000135616.13160.3c; Porena M, 2007, EUR UROL, V52, P1481, DOI 10.1016/j.eururo.2007.04.059; Rapp DE, 2009, INT BRAZ J UROL, V35, P68, DOI 10.1590/S1677-55382009000100011; Rezapour M, 2001, INT UROGYNECOL J PEL, V12, pS12, DOI 10.1007/s001920170005; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; Ryu JG, 2014, KOREAN J UROL, V55, P265, DOI 10.4111/kju.2014.55.4.265; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; STAMEY TA, 1973, SURG GYNECOL OBSTET, V136, P547; Tincello DG, 2011, J UROLOGY, V186, P2310, DOI 10.1016/j.juro.2011.07.078; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Ulmsten U, 1996, INT UROGYNECOL J PEL, V7, p[81, 85]; Wang FM, 2009, INT UROGYNECOL J, V20, P1277, DOI 10.1007/s00192-009-0859-0; Whiteside JL, 2004, INT UROGYNECOL J, V15, P223, DOI 10.1007/s00192-004-1143-y; Withington J, 2014, BJU INT, V114, P268, DOI 10.1111/bju.12650	37	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156306	10.1371/journal.pone.0156306	http://dx.doi.org/10.1371/journal.pone.0156306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228092	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500108
J	Qi, HS; Liu, MQ; Zhang, LH; Wang, DH				Qi, Hongsheng; Liu, Meiqi; Zhang, Lihui; Wang, Dianhai			Tracing Road Network Bottleneck by Data Driven Approach	PLOS ONE			English	Article							TRAFFIC FLOW	Urban road congestions change both temporally and spatially. They are essentially caused by network bottlenecks. Therefore, understanding bottleneck dynamics is critical in the goal of reasonably allocating transportation resources. In general, a typical bottleneck experiences the stages of formation, propagation and dispersion. In order to understand the three stages of a bottle neck and how the bottleneck moves on a road network, traffic flow data can be used to reconstruct these dynamics. However, raw traffic flow data is usually flawed in many ways. For instance some portion of data may be missing due to the failure of data collection devices, or some random factors in the data make it hard to identify real bottlenecks. In this paper a "user voting method" is proposed to deal with such raw-data-related issues. In this method, road links are ranked according to the weighed sum of certain performance measures and the links that are ranked relatively high are regarded as recurrent bottlenecks in a network, and several bottlenecks form a bottleneck area. A series of bottleneck parameters can be defined based on the identified bottleneck areas, such as bottleneck coverage, bottleneck link length, etc. Identifying bottleneck areas and calculating the bottleneck parameters for each time interval can reflect the evolution of the bottlenecks and also help trace how the bottlenecks move.	[Qi, Hongsheng; Liu, Meiqi; Zhang, Lihui; Wang, Dianhai] Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Zhang, LH (corresponding author), Zhejiang Univ, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	lihuizhang@zju.edu.cn			State Key Development Program for Basic Research of China [2012CB725402]; National Natural Science Foundation of China [51338008, 51408538, 51278454]; Key Science and Technology Innovation Team of Zhejiang Province [2013TD09]; Fundamental Research Funds for the Central Universities [2015QNA4025]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Innovation Team of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by the State Key Development Program for Basic Research of China ( Grant No. 2012CB725402); the National Natural Science Foundation of China ( Grant No. 51338008, 51408538, 51278454); Key Science and Technology Innovation Team of Zhejiang Province ( 2013TD09); Fundamental Research Funds for the Central Universities: ( 2015QNA4025).	Chen DJ, 2015, TRANSPORT RES C-EMER, V51, P210, DOI 10.1016/j.trc.2014.10.015; Dong SJ, 2015, J TRANSP ENG, V141, DOI 10.1061/(ASCE)TE.1943-5436.0000788; Hino Y, 2014, PHYSICA A, V395, P425, DOI 10.1016/j.physa.2013.10.044; John W, 2014, P 93 TRANSP RES BOAR; Kerner BS, 2015, PHYSICA A, V438, P365, DOI 10.1016/j.physa.2015.05.102; Li D, 2014, P 93 TRANSP RES BOAR; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Nakata M, 2010, PHYSICA A, V389, P5353, DOI 10.1016/j.physa.2010.08.005; Schrank DL, 2013, P 92 TRANSP RES BOAR; Seeherman J, 2013, P 92 TRANSP RES BOAR; Sun J, 2014, TRANSPORT RES REC, P64, DOI 10.3141/2421-08; Tang TQ, 2012, COMMUN THEOR PHYS, V58, P300, DOI 10.1088/0253-6102/58/2/23; VICKREY WS, 1969, AM ECON REV, V59, P251; Xiao LL, 2014, TRANSPORT RES E-LOG, V64, P48, DOI 10.1016/j.tre.2014.02.003; Yang, 2014, SCI REP-UK, V4, P1, DOI DOI 10.1038/SREP03735; Zhang J, 2012, PHYSICA A, V391, P2381, DOI 10.1016/j.physa.2011.11.045	16	8	8	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156089	10.1371/journal.pone.0156089	http://dx.doi.org/10.1371/journal.pone.0156089			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228150	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500065
J	Thuy, B; Stohr, S				Thuy, Ben; Stohr, Sabine			A New Morphological Phylogeny of the Ophiuroidea (Echinodermata) Accords with Molecular Evidence and Renders Microfossils Accessible for Cladistics	PLOS ONE			English	Article							BRITTLE STARS ECHINODERMATA; ATLANTIC-OCEAN; CLASSIFICATION; PERSPECTIVES; SYSTEMATICS; TAXONOMY; GENES	Ophiuroid systematics is currently in a state of upheaval, with recent molecular estimates fundamentally clashing with traditional, morphology-based classifications. Here, we attempt a long overdue recast of a morphological phylogeny estimate of the Ophiuroidea taking into account latest insights on microstructural features of the arm skeleton. Our final estimate is based on a total of 45 ingroup taxa, including 41 recent species covering the full range of extant ophiuroid higher taxon diversity and 4 fossil species known from exceptionally preserved material, and the Lower Carboniferous Aganaster gregarius as the outgroup. A total of 130 characters were scored directly on specimens. The tree resulting from the Bayesian inference analysis of the full data matrix is reasonably well resolved and well supported, and refutes all previous classifications, with most traditional families discredited as poly-or paraphyletic. In contrast, our tree agrees remarkably well with the latest molecular estimate, thus paving the way towards an integrated new classification of the Ophiuroidea. Among the characters which were qualitatively found to accord best with our tree topology, we selected a list of potential synapomorphies for future formal clade definitions. Furthermore, an analysis with 13 of the ingroup taxa reduced to the lateral arm plate characters produced a tree which was essentially similar to the full dataset tree. This suggests that dissociated lateral arm plates can be analysed in combination with fully known taxa and thus effectively unlocks the extensive record of fossil lateral arm plates for phylogenetic estimates. Finally, the age and position within our tree implies that the ophiuroid crown-group had started to diversify by the Early Triassic.	[Thuy, Ben] Nat Hist Museum Luxembourg, Dept Palaeontol, Luxembourg, Luxembourg; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden	Swedish Museum of Natural History	Thuy, B (corresponding author), Nat Hist Museum Luxembourg, Dept Palaeontol, Luxembourg, Luxembourg.; Stohr, S (corresponding author), Swedish Museum Nat Hist, Dept Zool, S-10405 Stockholm, Sweden.	bthuy@mnhn.lu; sabine.stohr@nrm.se	Stöhr, Sabine/B-8629-2011	Stöhr, Sabine/0000-0002-2586-7239	Riksmusei Vanner (Friends of the Swedish Museum of Natural History)	Riksmusei Vanner (Friends of the Swedish Museum of Natural History)	SS received funding from the Riksmusei Vanner (Friends of the Swedish Museum of Natural History). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Thuy B, 2011, ZOOTAXA, P1; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Fell H. B., 1962, Publications of the Seto Marine Biological Laboratory, V10, P145; FELL H. BARRACLOUGH, 1960, ZOOL PUBL VICTORIA UNIV WELLINGTON, V26, P1; FELL HB, 1963, PHILOS T ROY SOC B, V246, P381, DOI 10.1098/rstb.1963.0010; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gondim AI, 2015, ZOOTAXA, V3925, P341, DOI 10.11646/zootaxa.3925.3.2; Hess H., 1965, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V5, P151; HESS HANS, 1962, ECLOGAE GEOL HELV, V55, P595; Hotchkiss FHC, 2004, ECH MUNCH P 11 INT E, P425; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter RL, 2016, J ZOOL SYST EVOL RES, V54, P269, DOI 10.1111/jzs.12135; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; LeClair EE, 1996, J ZOOL, V240, P245, DOI 10.1111/j.1469-7998.1996.tb05283.x; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Martynov A, 2010, ZOOTAXA, P1; Matsumoto H., 1915, P ACAD NAT SCI PHILA, V67, P43; Matsumoto H, 1917, MONOGRAPH JAPANESE O, V38, P1; Mortensen T, 1927, HDB ECHINODERMS BRIT; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Okanishi M, 2013, MOL PHYLOGENET EVOL, V69, P566, DOI 10.1016/j.ympev.2013.07.021; Okanishi M, 2011, MOL PHYLOGENET EVOL, V61, P392, DOI 10.1016/j.ympev.2011.07.003; Parameswaran UV, 2016, MAR BIODIVERS, V46, P151, DOI 10.1007/s12526-015-0344-6; SMITH AB, 1995, ZOOL J LINN SOC-LOND, V114, P213, DOI 10.1006/zjls.1995.0024; SPENCER WK, 1966, ECHINODERMATA, V3, pU4; Stohr S, 2005, J MAR BIOL ASSOC UK, V85, P383, DOI 10.1017/S0025315405011318h; Stohr S, 2005, ZOOL J LINN SOC-LOND, V143, P543, DOI 10.1111/j.1096-3642.2005.00155.x; Stohr S., 2015, WORLD OPHIUROIDEA DA; Stohr S, 2012, ECHINODERM RES 2010, P147; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Stohr Sabine, 2006, Species Diversity, V11, P7; Sumida PYG, 1998, ZOOL J LINN SOC-LOND, V124, P267, DOI 10.1111/j.1096-3642.1998.tb00577.x; Thuy B, 2015, ACTA PALAEONTOL POL, V60, P923, DOI 10.4202/app.00093.2014; Thuy B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2624; Thuy B, 2013, EUR J TAXON, V48, P1, DOI 10.5852/ejt.2013.48; Thuy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046913; Thuy B, 2011, PALAEONTOLOGY, V54, P215, DOI 10.1111/j.1475-4983.2010.00981.x; Ung V, 2010, BIOINFORMATICS, V26, P703, DOI 10.1093/bioinformatics/btp715; Wortley AH, 2006, SYST BIOL, V55, P677, DOI 10.1080/10635150600899798; Wright AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109210	41	59	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156140	10.1371/journal.pone.0156140	http://dx.doi.org/10.1371/journal.pone.0156140			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227685	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500071
J	Tuncel, J; Haag, S; Hoffmann, MH; Yau, ACY; Hultqvist, M; Olofsson, P; Backlund, J; Nandakumar, KS; Weidner, D; Fischer, A; Leichsenring, A; Lange, F; Haase, C; Lu, S; Gulko, PS; Steiner, G; Holmdahl, R				Tuncel, Jonatan; Haag, Sabrina; Hoffmann, Markus H.; Yau, Anthony C. Y.; Hultqvist, Malin; Olofsson, Peter; Backlund, Johan; Nandakumar, Kutty Selva; Weidner, Daniela; Fischer, Anita; Leichsenring, Anna; Lange, Franziska; Haase, Claus; Lu, Shemin; Gulko, Percio S.; Steiner, Gunter; Holmdahl, Rikard			Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; AUTOIMMUNE ARTHRITIS; T-CELLS; DA RATS; DISEASE; SUSCEPTIBILITY; IDENTIFICATION; RESISTANCE	Background To facilitate the development of therapies for rheumatoid arthritis ( RA), the Innovative Medicines Initiative BTCure has combined the experience from several laboratories worldwide to establish a series of protocols for different animal models of arthritis that reflect the pathogenesis of RA. Here, we describe chronic pristane-induced arthritis (PIA) model in DA rats, and provide detailed instructions to set up and evaluate the model and for reporting data. Methods We optimized dose of pristane and immunization procedures and determined the effect of age, gender, and housing conditions. We further assessed cage-effects, reproducibility, and frequency of chronic arthritis, disease markers, and efficacy of standard and novel therapies. Results Out of 271 rats, 99.6% developed arthritis after pristane-administration. Mean values for day of onset, day of maximum arthritis severity and maximum clinical scores were 11.8 +/- 2.0 days, 20.3 +/- 5.1 days and 34.2 +/- 11 points on a 60-point scale, respectively. The mean frequency of chronic arthritis was 86% but approached 100% in long-term experiments over 110 days. Pristane was arthritogenic even at 5 microliters dose but needed to be administrated intradermally to induce robust disease with minimal variation. The development of arthritis was age-dependent but independent of gender and whether the rats were housed in conventional or barrier facilities. PIA correlated well with weight loss and acute phase reactants, and was ameliorated by etanercept, dexamethasone, cyclosporine A and fingolimod treatment. Conclusions PIA has high incidence and excellent reproducibility. The chronic relapsing-remitting disease and limited systemic manifestations make it more suitable than adjuvant arthritis for long-term studies of joint-inflammation and screening and validation of new therapeutics.	[Tuncel, Jonatan; Haag, Sabrina; Yau, Anthony C. Y.; Backlund, Johan; Nandakumar, Kutty Selva; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden; [Hoffmann, Markus H.; Weidner, Daniela] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany; [Hoffmann, Markus H.; Fischer, Anita; Steiner, Gunter] Med Univ Vienna, Div Rheumatol, Vienna, Austria; [Hultqvist, Malin; Olofsson, Peter] Redoxis AB, Lund, Sweden; [Leichsenring, Anna; Lange, Franziska] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Haase, Claus] Novo Nordisk AS, Dept Immunopharmacol, Malov, Denmark; [Lu, Shemin] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Gulko, Percio S.] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA; [Tuncel, Jonatan] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Karolinska Institutet; University of Erlangen Nuremberg; Medical University of Vienna; Fraunhofer Gesellschaft; Novo Nordisk; Xi'an Jiaotong University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School	Tuncel, J; Holmdahl, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Med Inflammat Res, Stockholm, Sweden.; Tuncel, J (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.	jonatan_tuncel@hms.harvard.edu; rikard.holmdahl@ki.se	Yau, Anthony CY/P-5379-2016; Lu, Shemin/M-3350-2018; Nandakumar, Kutty Selva/D-5438-2011; Lu, Shemin/AAI-6479-2021; Holmdahl, Rikard/AAI-7682-2020; Fischer, Anita/AAD-7766-2020	Yau, Anthony CY/0000-0002-1570-7813; Lu, Shemin/0000-0001-8250-850X; Nandakumar, Kutty Selva/0000-0001-7790-8197; Lu, Shemin/0000-0002-5535-8320; Fischer, Anita/0000-0001-6728-7649; Steiner, Guenter/0000-0002-5089-7405; Olofsson, Peter/0000-0003-4849-8541; Hoffmann, Markus/0000-0001-9698-9922	Innovative Medicines Initiative (IMI); European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA); Swedish Strategic Science Foundation; Knut and Alice Wallenberg Foundation; Konung Gustaf V:s 80-ars fond; Swedish Research Council; Swedish Rheumatism Association; European Union FP7 Neurinox	Innovative Medicines Initiative (IMI); European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA); Swedish Strategic Science Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Konung Gustaf V:s 80-ars fond; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; European Union FP7 Neurinox	BTCure is funded by the Innovative Medicines Initiative (IMI), a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). This study was also supported by the Swedish Strategic Science Foundation, the Knut and Alice Wallenberg Foundation, the Konung Gustaf V:s 80-ars fond, the Swedish Research Council, the Swedish Rheumatism Association, and European Union FP7 Neurinox to RH. Redoxis provided support in the form of salaries for authors MH and PO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; AVIGAN J, 1967, BIOCHIM BIOPHYS ACTA, V144, P127, DOI 10.1016/0005-2760(67)90084-7; Avigan J, 1968, J LIPID RES; Backdahl L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-391; Bakharevski O, 1998, J RHEUMATOL, V25, P1945; Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P377; BJORK J, 1994, SCAND J IMMUNOL, V40, P648, DOI 10.1111/j.1365-3083.1994.tb03518.x; Bolon B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569068; Brenner M, 2007, ANN RHEUM DIS, V66, P952, DOI 10.1136/ard.2006.066225; BRODERSON JR, 1989, LAB ANIM SCI, V39, P400; CANNON GW, 1993, J RHEUMATOL, V20, P7; Finzel S, 2011, ANN RHEUM DIS, V70, P122, DOI 10.1136/ard.2010.132423; Guo XS, 2013, GENETICS, V194, P1017, DOI 10.1534/genetics.113.153049; Haag S, 2015, J IMMUNOL, V194, P2539, DOI 10.4049/jimmunol.1402238; Hegen M, 2008, ANN RHEUM DIS, V67, P1505, DOI 10.1136/ard.2007.076430; Herman S, 2012, AUTOIMMUNITY, V45, P602, DOI 10.3109/08916934.2012.719948; Hoffmann MH, 2007, J IMMUNOL, V179, P7568, DOI 10.4049/jimmunol.179.11.7568; Hoffmann MH, 2013, ANN RHEUM DIS, V72, P1239, DOI 10.1136/annrheumdis-2012-202218; Hoffmann MH, 2011, J AUTOIMMUN, V36, P288, DOI 10.1016/j.jaut.2011.02.007; Holmberg J, 2006, J IMMUNOL, V176, P1172, DOI 10.4049/jimmunol.176.2.1172; HOLMDAHL R, 1992, IMMUNOLOGY, V76, P197; Kawahito Y, 1998, J IMMUNOL, V161, P4411; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KLEINAU S, 1995, INT J IMMUNOPHARMACO, V17, P393, DOI 10.1016/0192-0561(95)00020-3; KOHASHI O, 1979, INFECT IMMUN, V26, P791, DOI 10.1128/IAI.26.3.791-794.1979; Kollias G, 2011, ANN RHEUM DIS, V70, P1357, DOI 10.1136/ard.2010.148551; Kuroda Y, 2004, TOXICOL SCI, V78, P222, DOI 10.1093/toxsci/kfh063; Lange F, 2005, ANN RHEUM DIS, V64, P599, DOI 10.1136/ard.2004.026120; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Meng HC, 2004, ARTHRITIS RHEUM-US, V50, P2695, DOI 10.1002/art.20366; Mikulowska A., 1997, HUMAN GENOME METHODS, V215, P215; Nicklas W, 2010, LAB ANIMAL, V39, P43, DOI 10.1038/laban0210-43; Olofsson P, 2002, ARTHRITIS RHEUM, V46, P259, DOI 10.1002/1529-0131(200201)46:1<259::AID-ART10035>3.0.CO;2-2; PEARSON CM, 1963, J CHRON DIS, V16, P863, DOI 10.1016/0021-9681(63)90136-X; Rintisch C, 2008, MAMM GENOME, V19, P420, DOI 10.1007/s00335-008-9125-x; Rintisch C, 2008, P NATL ACAD SCI USA, V105, P14005, DOI 10.1073/pnas.0803956105; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Roubenoff R, 1997, ARTHRITIS RHEUM, V40, P534, DOI 10.1002/art.1780400320; SAMUELSON CO, 1984, ARTHRITIS RHEUM, V27, P689, DOI 10.1002/art.1780270613; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2644, DOI 10.1002/art.24767; Tuncel J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004151; Tuncel J, 2012, ARTHRITIS RHEUM-US, V64, P2537, DOI 10.1002/art.34461; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76; VANDENBROEK MF, 1992, CLIN EXP IMMUNOL, V88, P313; VANEDEN W, 1989, CURR TOP MICROBIOL, V145, P27; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Vossenaar ER, 2004, ARTHRITIS RHEUM, V50, P2370, DOI 10.1002/art.20296; WARD JR, 1962, ARTHRITIS RHEUM, V5, P557, DOI 10.1002/art.1780050604; Wekerle H, 2012, NAT MED, V18, P66, DOI 10.1038/nm.2635; Wooley PH, 2004, BEST PRACT RES CL RH, V18, P47, DOI 10.1016/j.berh.2003.09.007; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	54	47	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155936	10.1371/journal.pone.0155936	http://dx.doi.org/10.1371/journal.pone.0155936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227821	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500043
J	Yang, KC; Rozycki, B; Cui, FC; Shi, C; Chen, WD; Li, YQ				Yang, Kecheng; Rozycki, Bartosz; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi			Sampling Enrichment toward Target Structures Using Hybrid Molecular Dynamics-Monte Carlo Simulations	PLOS ONE			English	Article							X-RAY-SCATTERING; PROTEIN-STRUCTURE PREDICTION; STRUCTURE REFINEMENT; CHEMICAL-SHIFTS; BIOLOGY; CASP10; SAXS; CONFORMATIONS; INTEGRATION; ASSEMBLIES	Sampling enrichment toward a target state, an analogue of the improvement of sampling efficiency (SE), is critical in both the refinement of protein structures and the generation of near-native structure ensembles for the exploration of structure-function relationships. We developed a hybrid molecular dynamics (MD)-Monte Carlo (MC) approach to enrich the sampling toward the target structures. In this approach, the higher SE is achieved by perturbing the conventional MD simulations with a MC structure-acceptance judgment, which is based on the coincidence degree of small angle x-ray scattering (SAXS) intensity profiles between the simulation structures and the target structure. We found that the hybrid simulations could significantly improve SE by making the top-ranked models much closer to the target structures both in the secondary and tertiary structures. Specifically, for the 20 mono-residue peptides, when the initial structures had the root-mean-squared deviation (RMSD) from the target structure smaller than 7 angstrom, the hybrid MD-MC simulations afforded, on average, 0.83 angstrom and 1.73 angstrom in RMSD closer to the target than the parallel MD simulations at 310K and 370K, respectively. Meanwhile, the average SE values are also increased by 13.2% and 15.7%. The enrichment of sampling becomes more significant when the target states are gradually detectable in the MD-MC simulations in comparison with the parallel MD simulations, and provide >200% improvement in SE. We also performed a test of the hybrid MD-MC approach in the real protein system, the results showed that the SE for 3 out of 5 real proteins are improved. Overall, this work presents an efficient way of utilizing solution SAXS to improve protein structure prediction and refinement, as well as the generation of near native structures for function annotation.	[Yang, Kecheng; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China; [Yang, Kecheng; Cui, Fengchao; Shi, Ce; Chen, Wenduo; Li, Yunqi] Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China; [Rozycki, Bartosz] Polish Acad Sci, Inst Phys, Aleja Lotnikow 32-46, PL-02668 Warsaw, Poland; [Yang, Kecheng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, FC; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Synthet Rubber, Changchun 130022, Peoples R China.; Cui, FC; Li, YQ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, Lab Adv Power Sources, Changchun 130022, Peoples R China.	fccui@ciac.ac.cn; yunqi@ciac.ac.cn	Rozycki, Bartosz/B-7005-2009; Yang, kecheng/Y-8236-2018; Li, Yunqi/C-8372-2016	Rozycki, Bartosz/0000-0001-5938-7308; Li, Yunqi/0000-0002-5190-3037; Yang, Kecheng/0000-0001-9664-1395	National Natural Science Foundation of China [21374117, 21404105, 21504092]; 100 Talents Program of the Chinese Academy of Sciences; grant FiberFuel - National Centre for Research and Development in Poland [ERA-NET-IB/06/2013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); grant FiberFuel - National Centre for Research and Development in Poland	This work was supported by National Natural Science Foundation of China (21374117, 21404105, 21504092; http://www.nsfc.gov.cn/publish/portal1/), the 100 Talents Program of the Chinese Academy of Sciences (no grant number), and grant FiberFuel funded by the National Centre for Research and Development in Poland (ERA-NET-IB/06/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bjorling A, 2015, J CHEM THEORY COMPUT, V11, P780, DOI 10.1021/ct5009735; Chen PC, 2015, BIOPHYS J, V108, P2573, DOI 10.1016/j.bpj.2015.03.062; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gabel F, 2008, J BIOMOL NMR, V41, P199, DOI 10.1007/s10858-008-9258-y; Grant BJ, 2010, CURR OPIN STRUC BIOL, V20, P142, DOI 10.1016/j.sbi.2009.12.004; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MR, 2010, J AM CHEM SOC, V132, P1270, DOI 10.1021/ja909973n; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kryshtafovych A, 2014, PROTEINS, V82, P26, DOI 10.1002/prot.24489; Kryshtafovych A, 2014, PROTEINS, V82, P164, DOI 10.1002/prot.24448; Li YQ, 2013, J PHYS CHEM B, V117, P2615, DOI 10.1021/jp309135m; Li YQ, 2012, J PHYS CHEM B, V116, P12057, DOI 10.1021/jp305709y; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mirjalili V, 2014, PROTEINS, V82, P196, DOI 10.1002/prot.24336; Neylon C, 2008, EUR BIOPHYS J BIOPHY, V37, P531, DOI 10.1007/s00249-008-0259-2; Nugent T, 2014, PROTEINS, V82, P98, DOI 10.1002/prot.24377; Orzechowski M, 2008, BIOPHYS J, V95, P5692, DOI 10.1529/biophysj.108.139451; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; Prevelige P., 1989, PREDICTION PROTEIN S, P391; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, ANNU REV BIOPHYS, V42, P415, DOI 10.1146/annurev-biophys-083012-130301; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Ravikumar KM, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4774148; Reva BA, 1998, FOLD DES, V3, P141, DOI 10.1016/S1359-0278(98)00019-4; Robustelli P, 2010, STRUCTURE, V18, P923, DOI 10.1016/j.str.2010.04.016; Rozycki B, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/46/463103; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Weinbach Y, 2005, J COMPUT PHYS, V209, P193, DOI 10.1016/j.jcp.2005.03.015; Yang SC, 2014, ADV MATER, V26, P7902, DOI 10.1002/adma.201304475; Yang SC, 2011, STRUCTURE, V19, P3, DOI 10.1016/j.str.2010.12.008; Yang SC, 2010, P NATL ACAD SCI USA, V107, P15757, DOI 10.1073/pnas.1004569107; Zhang Y, 2004, J COMPUT CHEM, V25, P865, DOI 10.1002/jcc.20011; Zheng WJ, 2011, BIOPHYS J, V101, P2981, DOI 10.1016/j.bpj.2011.11.003; Zhou HY, 2009, BIOPHYS J, V96, P2119, DOI 10.1016/j.bpj.2008.12.3898; Zuckerman DM, 2011, ANNU REV BIOPHYS, V40, P41, DOI 10.1146/annurev-biophys-042910-155255	56	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156043	10.1371/journal.pone.0156043	http://dx.doi.org/10.1371/journal.pone.0156043			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227775	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500057
J	Adkins-Regan, E				Adkins-Regan, Elizabeth			Pairing Behavior of the Monogamous King Quail, Coturnix chinensis	PLOS ONE			English	Article							JAPANESE-QUAIL; PRAIRIE VOLE; PREFERENCES; VASOPRESSIN; MAINTENANCE; EVOLUTION; BOND	Animals with socially monogamous mating systems are valuable for discovering proximate mechanisms of prosocial behavior and close social relationships. Especially powerful are comparisons between related species that differ in monogamous tendency. Birds are the most socially monogamous vertebrates. Thus far most research on mechanisms of pairing has used zebra finches, which do not have a relative with a different mating system, however. The goal of the experiments reported here was to develop a new comparative avian system by studying the pairing behavior of a reportedly strongly monogamous quail, the king quail (Coturnix chinensis), a species in the same clade as the less monogamous Japanese quail (Coturnix japonica), the subject of much prior research. In Experiment 1 male-female pairs of king quail housed together were initially avoidant or aggressive but most rapidly progressed to allopreening and huddling. A separation-reunion paradigm reliably elicited both of these behaviors in males that had cohabited for one week. In Experiment 2 the allopreening and huddling behavior of males in cohabiting pairs was highly selective, and a majority of the males were aggressive toward a familiar female that was not the cohabitation partner. In Experiment 3 males were separated from their female cohabitation partners for 9-10 weeks and then given two-choice tests. All but one male spent more time near an unfamiliar female, which may have reflected aggression and shows recognition of and memory for the past pairing experience. Thus king quail show robust, selective and easy to measure pairing behavior that can be reliably elicited with simple separation-reunion testing procedures. Copulation is rarely seen during tests. The behavior of king quail is a striking contrast to that of Japanese quail, providing a new comparative system for discovering mechanisms of behavior related to close social relationships and monogamy.	[Adkins-Regan, Elizabeth] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Adkins-Regan, Elizabeth] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Adkins-Regan, E (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.; Adkins-Regan, E (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	er12@cornell.edu			US National Science Foundation [IOS 1146891]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by US National Science Foundation Grant IOS 1146891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131786; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Banerjee SB, 2013, EUR J NEUROSCI, V38, P3731, DOI 10.1111/ejn.12378; Baran NM, 2016, FRONTIERS B IN PRESS; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Black J.M., 1996, PARTNERSHIPS BIRDS S; BLOHOWIAK CC, 1983, BEHAV PROCESS, V8, P255, DOI 10.1016/0376-6357(83)90016-5; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Crowe TM, 2006, CLADISTICS, V22, P495, DOI 10.1111/j.1096-0031.2006.00120.x; Cushing BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150373; Finseth FR, 2013, J EVOLUTION BIOL, V26, P1875, DOI 10.1111/jeb.12189; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2009, SCIENCE, V325, P862, DOI 10.1126/science.1174929; Goodson JL, 1997, CONDOR, V99, P990, DOI 10.2307/1370153; Goodwin, 1982, ESTRILDID FINCHES WO; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; Kimball Rebecca T., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/423938; Kingsbury MA, 2014, BEHAV BRAIN RES, V272, P264, DOI 10.1016/j.bbr.2014.06.042; Lack D., 1968, pvii; Le Bot O, 2014, J EXP BIOL, V217, P4184, DOI 10.1242/jeb.108738; Madge S., 2002, PHEASANTS PARTRIDGES; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Payne RB., 2010, HDB BIRDS WORLD WEAV, P234; Persaud KN, 2003, ANIM BEHAV, V65, P89, DOI 10.1006/anbe.2002.2057; POTASH LM, 1975, BEHAVIOUR, V54, P153, DOI 10.1163/156853975X00245; Prior NH, 2015, HORM BEHAV, V76, P11, DOI 10.1016/j.yhbeh.2015.04.014; Reichard U. H., 2003, MONOGAMY MATING STRA; Riters LV, 1998, BEHAVIOUR, V135, P551, DOI 10.1163/156853998792897941; Rodriguez-Teijeiro JD, 2003, ETHOLOGY, V109, P291, DOI 10.1046/j.1439-0310.2003.00873.x; SCHLEIDT WM, 1984, Z TIERPSYCHOL, V64, P193; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; TSUDZUKI M, 1994, POULTRY SCI, V73, P763, DOI 10.3382/ps.0730763; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; White DJ, 1999, ANIM BEHAV, V58, P865, DOI 10.1006/anbe.1999.1210; Winkler DW, 2015, BIRD FAMILIES WORLD; Zann RA., 1996, ZEBRA FINCH SYNTHESI	42	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155877	10.1371/journal.pone.0155877	http://dx.doi.org/10.1371/journal.pone.0155877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257681	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700025
J	Harhay, MN; Hill, AS; Wang, W; Even-Shoshan, O; Mussell, AS; Bloom, RD; Feldman, HI; Karlawish, JH; Silber, JH; Reese, PP				Harhay, Meera N.; Hill, Alexander S.; Wang, Wei; Even-Shoshan, Orit; Mussell, Adam S.; Bloom, Roy D.; Feldman, Harold I.; Karlawish, Jason H.; Silber, Jeffrey H.; Reese, Peter P.			Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation	PLOS ONE			English	Article							EARLY HOSPITAL READMISSION; PHYSICAL FUNCTIONING SCALE; STAGE RENAL-DISEASE; COMORBIDITY INDEXES; 30-DAY READMISSIONS; ADMINISTRATIVE DATA; PREDICTION-MODEL; UNITED-STATES; WAITING TIME; FRAILTY	Background Early rehospitalization (<30 days) after discharge from kidney transplantation (KT) is associated with poor outcomes. We explored summary metrics of pre-transplant health status that may improve the identification of KT recipients at risk for early rehospitalization and mortality after transplant. Materials and Methods We performed a retrospective cohort study of 8,870 adult (>= 18 years) patients on hemodialysis who received KT between 2000 and 2010 at United States transplant centers. We linked Medicare data to United Network for Organ Sharing data and data from a national dialysis provider to examine pre-KT (1) Elixhauser Comorbidity Index, (2) physical function (PF) measured by the Short Form 36 Health Survey, and (3) the number of hospitalizations during the 12 months before KT as potential predictors of early rehospitalization after KT. We also explored whether these metrics are confounders of the known association between early rehospitalization and post-transplant mortality. Results The median age was 52 years (interquartile range [IQR] 41, 60) and 63% were male. 29% were rehospitalized in < 30 days, and 20% died during a median follow-up time of five years (IQR 3.6-6.5). In a multivariable logistic model, kidney recipients with more pre-KT Elixhauser comorbidities (adjusted odds ratio [aOR] 1.09 per comorbidity, 95% Confidence Interval [CI] 1.07-1.11), the poorest pre-KT PF (aOR 1.24, 95% CI 1.08-1.43), or >1 pre-KT hospitalizations (aOR 1.32, 95% CI 1.17-1.49) were more likely to be rehospitalized. All three health status metrics and early rehospitalization were independently associated with post-T mortality in a multivariable Cox model (adjusted hazard ratio for rehospitalization: 1.41, 95% CI 1.28-1.56) Conclusions Pre-transplant metrics of health status, measured by dialysis providers or administrative data, are independently associated with early rehospitalization and mortality risk after KT. Transplant providers may consider utilizing metrics of pre-KT global health status as early signals of vulnerability when transitioning care after KT.	[Harhay, Meera N.] Drexel Univ, Coll Med, Dept Med, Div Nephrol, Philadelphia, PA 19104 USA; [Hill, Alexander S.; Even-Shoshan, Orit; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Wang, Wei] Kaiser Permanente, Dept Surg Outcomes & Anal, San Diego, CA USA; [Mussell, Adam S.; Feldman, Harold I.; Reese, Peter P.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA USA; [Bloom, Roy D.; Feldman, Harold I.; Reese, Peter P.] Univ Penn, Renal Elect & Hypertens Div, Perelman Sch Med, Philadelphia, PA USA; [Karlawish, Jason H.] Univ Penn, Div Geriatr, Perelman Sch Med, Philadelphia, PA USA	Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Harhay, MN (corresponding author), Drexel Univ, Coll Med, Dept Med, Div Nephrol, Philadelphia, PA 19104 USA.	meera.harhay@drexelmed.edu			NIH [F32DK096758-01, K23 DK105207-01, R01-DK090388-01A1]; Development Award in Geriatric Nephrology - American Society of Nephrology; Association of Specialty Professors; John A. Hartford Foundation; Atlantic Philanthropies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK105207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Development Award in Geriatric Nephrology - American Society of Nephrology; Association of Specialty Professors; John A. Hartford Foundation; Atlantic Philanthropies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants F32DK096758-01 and K23 DK105207-01 (Dr. Harhay) and R01-DK090388-01A1 (Drs. Reese, Feldman, Bloom). Dr. Reese's efforts were also supported by a Development Award in Geriatric Nephrology co-sponsored by American Society of Nephrology, the Association of Specialty Professors, John A. Hartford Foundation and the Atlantic Philanthropies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, HEMODIAL INT, V17, P50, DOI 10.1111/j.1542-4758.2012.00726.x; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Barcellos FC, 2015, CLIN KIDNEY J, V8, P753, DOI 10.1093/ckj/sfv099; Bureau UNfOSN, OPTN UNOS BOARD APPR; Cook WL, 2008, KIDNEY INT, V73, P1289, DOI 10.1038/ki.2008.62; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeMarco MAG M.E., 2012, AM J TRANSPLANTA SS3, V12, P27, DOI [10.1111/j.1600-6143.2012.04112.x, DOI 10.1111/J.1600-6143.2012.04112.X]; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Englesbe MJ, 2009, AM J TRANSPLANT, V9, P1108, DOI 10.1111/j.1600-6143.2009.02592.x; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; Friedewald JJ, 2012, ADV CHRONIC KIDNEY D, V19, P252, DOI 10.1053/j.ackd.2012.05.001; Garonzik-Wang JM, 2012, ARCH SURG-CHICAGO, V147, P190, DOI 10.1001/archsurg.2011.1229; Grams ME, 2012, TRANSPLANTATION, V94, P750, DOI 10.1097/TP.0b013e31826205b9; Grams ME, 2012, J AM GERIATR SOC, V60, P1, DOI 10.1111/j.1532-5415.2011.03652.x; Greysen SR, 2015, JAMA INTERN MED, V175, P559, DOI 10.1001/jamainternmed.2014.7756; Group. USC, 2016, MISS DAT SAS 1; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Harhay M, 2013, AM J TRANSPLANT, V13, P3164, DOI 10.1111/ajt.12513; Hartmann EL, 2009, CLIN J AM SOC NEPHRO, V4, P588, DOI 10.2215/CJN.03860808; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hummel SL, 2014, MAYO CLIN PROC, V89, P623, DOI 10.1016/j.mayocp.2013.12.018; Jassal SV, 2005, AM J KIDNEY DIS, V46, P136, DOI 10.1053/j.ajkd.2005.03.006; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Joshi S, 2013, TRANSPLANTATION, V95, P309, DOI 10.1097/TP.0b013e31827191d4; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kendall MGaJDG, 1990, RANK CORRELATION MET; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Kutner NG, 2006, CLIN J AM SOC NEPHRO, V1, P837, DOI 10.2215/CJN.01341005; Kutner NG, 2013, JAMA INTERN MED, V173, P78, DOI 10.1001/2013.jamainternmed.750; Machnicki G, 2009, AM J TRANSPLANT, V9, P494, DOI 10.1111/j.1600-6143.2008.02486.x; Machnicki G, 2011, ARCH MED SCI, V7, P278, DOI 10.5114/aoms.2011.22079; Machnicki G, 2011, SAUDI J KIDNEY DIS T, V22, P24; Massie AB, 2014, AM J TRANSPLANT, V14, P1723, DOI 10.1111/ajt.12777; McAdams-DeMarco MA, 2014, AM J TRANSPLANT, V14, P397, DOI 10.1111/ajt.12563; McAdams-DeMarco MA, 2013, AM J TRANSPLANT, V13, P2091, DOI 10.1111/ajt.12300; McAdams-DeMarco MA, 2012, AM J TRANSPLANT, V12, P3283, DOI 10.1111/j.1600-6143.2012.04285.x; McHorney CA, 1997, J CLIN EPIDEMIOL, V50, P451, DOI 10.1016/S0895-4356(96)00424-6; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Painter P, 2013, NEPHROL NURS J, V40, P529; Painter P, 2013, CURR OPIN NEPHROL HY, V22, P615, DOI 10.1097/MNH.0b013e328365b43a; Painter P, 2013, HEMODIAL INT, V17, P41, DOI 10.1111/j.1542-4758.2012.00719.x; Reese PP, 2014, TRANSPLANTATION, V97, P189, DOI 10.1097/TP.0b013e3182a89338; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Roshanravan B, 2012, AM J KIDNEY DIS, V60, P912, DOI 10.1053/j.ajkd.2012.05.017; Schold JD, 2014, J AM SOC NEPHROL, V25, P1617, DOI 10.1681/ASN.2014030235; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Services CfMM, READM RED PROGR 2012; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Tennankore KK, 2014, J AM SOC NEPHROL, V25, P2113, DOI 10.1681/ASN.2013111180; USRDS U.S. Renal Data System., 2012, USRDS 2012 ANN DAT R; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Weinhandl ED, 2009, AM J TRANSPLANT, V9, P506, DOI 10.1111/j.1600-6143.2008.02527.x; Weinhandl ED, 2015, AM J KIDNEY DIS, V65, P98, DOI 10.1053/j.ajkd.2014.06.015; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth; Yan Y, 2005, MED CARE, V43, P1073, DOI 10.1097/01.mlr.0000182477.29129.86	69	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156532	10.1371/journal.pone.0156532	http://dx.doi.org/10.1371/journal.pone.0156532			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257680	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700075
J	Javalkar, P; Prakash, R; Isac, S; Washington, R; Halli, SS				Javalkar, Prakash; Prakash, Ravi; Isac, Shajy; Washington, Reynold; Halli, Shiva S.			An Estimation of Mortality Risks among People Living with HIV in Karnataka State, India: Learnings from an Intensive HIV/AIDS Care and Support Programme	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; ADHERENCE; SURVIVAL; DEATH; COUNTRIES; OUTCOMES; TRENDS; ADULTS; HAART	Background In Indian context, limited attempts have been made to estimate the mortality risks among people living with HIV (PLHIV). We estimated the rates of mortality among PLHIV covered under an integrated HIV-prevention cum care and support programme implemented in Karnataka state, India, and attempted to identify the key programme components associated with the higher likelihood of their survival. Methods Retrospective programme data of 55,801 PLHIV registered with the Samastha programme implemented in Karnataka state during 2006-11 was used. Kaplan-Meier survival methods were used to estimate the ten years expected survival probabilities and Cox-proportional hazard model was used to examine the factors associated with risk of mortality among PLHIV. We also calculated mortality rates (per 1000 person-year) across selected demographic and clinical parameters. Results Of the total PLHIV registered with the programme, about nine percent died within the 5-years of programme period with an overall death rate of 38 per 1000 person-years. The mortality rate was higher among males, aged 18 and above, among illiterates, and those residing in rural areas. While the presence of co-infections such as Tuberculosis leads to higher mortality rate, adherence to ART was significantly associated with reduction in overall death rate. Cox proportional hazard model revealed that increase in CD4 cell counts and exposure to intensive care and support programme for at least two years can bring significant reduction in risk of death among PLHIV [(hazard ratio: 0.234; CI: 0.211-0.260) & (hazard ratio: 0.062; CI: 0.054-0.071), respectively] even after adjusting the effect of other sociodemographic, economic and health related confounders. Conclusion Study confirms that while residing in rural areas and presence of co-infection significantly increases the mortality risk among PLHIV, adherence to ART and improvement in CD4 counts led to significant reduction in their mortality risk. Longer exposure to the intervention contributed significantly to reduce mortality among PLHIV.	[Javalkar, Prakash; Prakash, Ravi; Isac, Shajy; Washington, Reynold] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Isac, Shajy; Washington, Reynold; Halli, Shiva S.] Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba	Javalkar, P (corresponding author), Karnataka Hlth Promot Trust, Bangalore, Karnataka, India.	prakashj@khpt.org	Prakash, Ravi/ABB-8711-2020; Washington, Reynold/AAD-7447-2020	Javalkar, Prakash/0000-0001-5569-5792; Prakash, Ravi/0000-0003-3715-5789	USAID	USAID(United States Agency for International Development (USAID))	This paper was written as a part of an evaluation of Samastha project funded by USAID and implemented by KHPT. However the project funding does not relates to this manuscript. The views expressed herein are those of the authors and do not necessarily represent the official policy or position of the USAID. We are grateful to the our colleagues of KHPT and University of Manitoba for providing the necessary inputs while preparing this paper. We appreciate the comments of the academic editor and anonymous reviewers for providing valuable suggestions that helped in improving the quality of the paper.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Aggarwal Pravesh, 2009, J Assoc Physicians India, V57, P745; Arrivillaga M, 2009, REV PANAM SALUD PUBL, V26, P502, DOI 10.1590/S1020-49892009001200005; Avert, 2013, HIV AIDS IND; Bachani D, 2010, NATL MED J INDIA, V23, P7; Bajpai R. C., 2014, PUBLIC HLTH RES, V4, P31; Banandur P, 2011, SEX TRANSM INFECT, V87, pA340, DOI 10.1136/sextrans-2011-050108.592; Bhattacharjya C, 2015, WORLD J AIDS, V5, P90, DOI [10.4236/wja.2015.52011, DOI 10.4236/WJA.2015.52011]; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chakraborty N, 2008, JPN J INFECT DIS, V61, P49; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; Georgia A., 2011, HIV AIDS HAITI ANAL; Ghate Manisha, 2009, Int J Infect Dis, V13, pe1, DOI 10.1016/j.ijid.2008.03.029; Gonzalez MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-605; Halli SS, 2015, J HIV AIDS IN PRESS; Hambisa Mitiku Teshome, 2013, ISRN AIDS, V2013, P491601, DOI 10.1155/2013/491601; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Kee MK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-128; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Lifson AR, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-4; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; NACO N, 2012, TECHN REP IND HIV ES; National AIDS Control Organisation (NACO), 2014, NAT AIDS CONTR PROGR; National Health Mission, 2014, COMPR AB CAR PROV MA; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pandey A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000926; Rai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066860; Raj Y, 2016, INT J STD AIDS, V27, P1257, DOI 10.1177/0956462415612650; Rajagopalan N, 2009, AM J INFECT DIS, V5, P219, DOI 10.3844/ajidsp.2009.219.224; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Ryavanki SP, 2013, NATL J COMMUNITY MED, P4; Shaboltas AV, 2006, JAIDS-J ACQ IMM DEF, V41, P657; StataCorp, 2015, STAT SOFTW REL 14; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; UNAIDS, 2014, GLOB FACT SHEET; UNAIDS, 2010, UNAIDS REP GLOB AIDS; USAID, 2011, SAM PROJ USAID INDIA; Venkatesh KK, 2012, INDIAN J CANCER, V49, P176, DOI 10.4103/0019-509X.98947; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Washington RG, 2014, ASIA-PAC J PUBLIC HE, V26, P349, DOI 10.1177/1010539514537677; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156611	10.1371/journal.pone.0156611	http://dx.doi.org/10.1371/journal.pone.0156611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253974	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700043
J	Modlinska, K; Stryjek, R				Modlinska, Klaudia; Stryjek, Rafal			Food Neophobia in Wild Rats (Rattus norvegicus) Inhabiting a Changeable Environment-A Field Study	PLOS ONE			English	Article							NORWAY RATS; LABORATORY RATS; BEHAVIOR; TASTE; PREFERENCE; EXPOSURE; FLAVOR; STRAIN; SHEEP	Food neophobia is a reaction to novel food observed in many animal species, particularly omnivores, including Rattus norvegicus. A neophobic reaction is typically characterised by avoidance of novel food and the necessity to assess both its potential value and toxicity by the animal. It has been hypothesised that this reaction is not observed in rats inhabiting a changeable environment with a high level of variability with regard to food and food sources. This study was conducted in such changeable conditions and it aims to demonstrate the behaviour of wild rats R. norvegicus in their natural habitat. The rats were studied in a farm setting, and the experimental arena was demarcated by a specially constructed pen which was freely accessible to the rats. At regular intervals, the rats were given new flavour-and smell-altered foods, while their behaviour was video-recorded. The results obtained in the study seem to confirm the hypothesis that rats inhabiting a highly changeable environment do not exhibit food neophobia. The observed reaction to novel food may be connected with a reaction to a novel object to a larger extent than to food neophobia. The value of the results obtained lies primarily in the fact that the study was conducted in the animals' natural habitat, and that it investigated their spontaneous behaviours.	[Modlinska, Klaudia; Stryjek, Rafal] Polish Acad Sci, Inst Psychol, Warsaw, Poland	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences	Modlinska, K (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	kmodlinska@wp.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Modlinska, Klaudia/0000-0002-2161-9019; Stryjek, Rafal/0000-0003-3889-9341	National Science Centre (Poland) [UMO-2013/09/B/HS6/03435]	National Science Centre (Poland)	This research project was supported by the National Science Centre (Poland) - grant No. UMO-2013/09/B/HS6/03435.	Addessi Elsa, 2004, Primatologie, V6, P101; BARNETT S.A, 1956, BEHAVIOUR, V9, P24, DOI 10.1163/156853956X00237; Barnett S.A., 2001, STORY RATS THEIR IMP; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Barnett SA, 2009, RAT STUDY BEHAV; Beach FA, 1950, AM PSYCHOL, V5, P115, DOI 10.1037/h0056510; BLANCHARD DC, 1994, AGGRESSIVE BEHAV, V20, P387, DOI 10.1002/1098-2337(1994)20:5&lt;387::AID-AB2480200506&gt;3.0.CO;2-D; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BOICE R, 1971, BEHAV RES METH INSTR, V3, P177, DOI 10.3758/BF03208127; Burritt EA, 1997, APPL ANIM BEHAV SCI, V54, P317, DOI 10.1016/S0168-1591(97)00005-1; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; CHAPPLE RS, 1987, APPL ANIM BEHAV SCI, V18, P157, DOI 10.1016/0168-1591(87)90189-4; Cheney CD, 1997, APPL ANIM BEHAV SCI, V53, P213, DOI 10.1016/S0168-1591(96)01160-4; COWAN PE, 1977, J COMP PHYSIOL PSYCH, V91, P63, DOI 10.1037/h0077297; Fraga RM, 2005, ORNITOL NEOTROP, V16, P15; Galef BG, 1998, ANIM BEHAV, V56, P1015, DOI 10.1006/anbe.1998.0867; Galef BG, 2003, J COMP PSYCHOL, V117, P96, DOI 10.1037/0735-7036.117.1.96; GALEF BG, 1983, J COMP PSYCHOL, V97, P358, DOI 10.1037/0735-7036.97.4.358; HANKINS WG, 1973, BEHAV BIOL, V8, P407, DOI 10.1016/S0091-6773(73)80081-1; Himmler BT, 2013, J COMP PSYCHOL, V127, P453, DOI 10.1037/a0032187; Inglis IR, 1996, APPL ANIM BEHAV SCI, V47, P175, DOI 10.1016/0168-1591(95)00674-5; JONES RB, 1987, BIRD BEHAV, V7, P78, DOI 10.3727/015613887791918051; KING HELEN DEAN, 1939, AMER ANAT MEMOIR, V17, P1; KRONENBERGER JP, 1985, BEHAV PROCESS, V11, P53, DOI 10.1016/0376-6357(85)90102-0; Launchbaugh KL, 1997, APPL ANIM BEHAV SCI, V54, P327, DOI 10.1016/S0168-1591(96)01194-X; LOCKARD RB, 1968, AM PSYCHOL, V23, P734, DOI 10.1037/h0026726; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; Modlinska K, 2015, BEHAV PROCESS, V113, P41, DOI 10.1016/j.beproc.2014.12.005; Pisula W., 2015, PSYCHOLOGY, V6, P251, DOI [10.4236/psych.2015.63025, DOI 10.4236/PSYCH.2015.63025]; Pisula W, 2006, ACTA NEUROBIOL EXP, V66, P235; REVUSKY SH, 1967, SCIENCE, V155, P219, DOI 10.1126/science.155.3759.219; RICHTER CP, 1959, AM PSYCHOL, V14, P18, DOI 10.1037/h0043834; Rozin P, 2000, AM BEHAV SCI, V43, P970, DOI 10.1177/0002764200043006006; SHUMAKE SA, 1971, J COMP PHYSIOL PSYCH, V77, P489, DOI 10.1037/h0031900; SIEGEL S., 1956, NONPARAMETRIC STAT B; Stryjek R., 2012, POL PSYCHOL B, V43, P124; Stryjek R, 2016, INT J PEST MANAGE, V62, P158, DOI 10.1080/09670874.2016.1147622; Stryjek R, 2013, LAB ANIMAL, V42, P321, DOI 10.1038/laban.328; Stryjek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066055; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; TAYLOR RH, 1989, NEW ZEAL J ECOL, V12, P23	43	21	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156741	10.1371/journal.pone.0156741	http://dx.doi.org/10.1371/journal.pone.0156741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254150	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700053
J	Nyakundi, DO; Vuko, LAM; Bentley, SJ; Hoppe, H; Blatch, GL; Boshoff, A				Nyakundi, David O.; Vuko, Loyiso A. M.; Bentley, Stephen J.; Hoppe, Heinrich; Blatch, Gregory L.; Boshoff, Aileen			Plasmodium falciparum Hep1 Is Required to Prevent the Self Aggregation of PfHsp70-3	PLOS ONE			English	Article							MITOCHONDRIAL HSP70; ATPASE DOMAIN; PROTEIN ZIM17; CHAPERONE; TRANSLOCATION; LOCALIZATION; IMPORT; MATRIX; BIOGENESIS; DNLZ/HEP	The majority of mitochondrial proteins are encoded in the nucleus and need to be imported from the cytosol into the mitochondria, and molecular chaperones play a key role in the efficient translocation and proper folding of these proteins in the matrix. One such molecular chaperone is the eukaryotic mitochondrial heat shock protein 70 (Hsp70); however, it is prone to self-aggregation and requires the presence of an essential zinc-finger protein, Hsp70-escort protein 1 (Hep1), to maintain its structure and function. PfHsp70-3, the only Hsp70 predicted to localize in the mitochondria of P. falciparum, may also rely on a Hep1 orthologue to prevent self-aggregation. In this study, we identified a putative Hep1 orthologue in P. falciparum and co-expression of PfHsp70-3 and PfHep1 enhanced the solubility of PfHsp70-3. PfHep1 suppressed the thermally induced aggregation of PfHsp70-3 but not the aggregation of malate dehydrogenase or citrate synthase, thus showing specificity for PfHsp70-3. Zinc ions were indeed essential for maintaining the function of PfHep1, as EDTA chelation abrogated its abilities to suppress the aggregation of PfHsp70-3. Soluble and functional PfHsp70-3, acquired by co-expression with PfHep-1, will facilitate the biochemical characterisation of this particular Hsp70 protein and its evaluation as a drug target for the treatment of malaria.	[Nyakundi, David O.; Vuko, Loyiso A. M.; Bentley, Stephen J.; Boshoff, Aileen] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa; [Hoppe, Heinrich] Rhodes Univ, Dept Biochem & Microbiol, ZA-6140 Grahamstown, South Africa; [Blatch, Gregory L.] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa; [Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Rhodes University; Rhodes University; Rhodes University; Victoria University	Boshoff, A (corresponding author), Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa.	A.Boshoff@ru.ac.za	Blatch, Gregory Lloyd/Q-5900-2019	Blatch, Gregory Lloyd/0000-0003-0778-8577; Hoppe, Heinrich/0000-0003-4409-1955	National Research Foundation (NRF) [87663]; Deutsche Forschungsgemeinschaft (DFG) [LI 402/14-1]; Mwenge Catholic University, Moshi, Tanzania; NRF Doctoral Innovation Scholarship	National Research Foundation (NRF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Mwenge Catholic University, Moshi, Tanzania; NRF Doctoral Innovation Scholarship	This work was funded by grants from the National Research Foundation (NRF); grant number 87663 and Deutsche Forschungsgemeinschaft (DFG); grant number LI 402/14-1. D.O.N. is the recipient of academic development and training funds from Mwenge Catholic University, Moshi, Tanzania. S.J.B. is the recipient of an NRF Doctoral Innovation Scholarship.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Biasini M, 2014, NUCL ACIDS RES, V42; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Botha M, 2011, CELL STRESS CHAPERON, V16, P389, DOI 10.1007/s12192-010-0250-6; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Buchberger A, 1994, NAT STRUCT BIOL, P195; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burger Adelle, 2014, Journal of Parasitology Research, P172582, DOI 10.1155/2014/172582; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Craig EA, PROCNATLACADSCI US, V84, P4156; DeLano W., 2002, CCP4 NEWSL; Dores-Silva PR, 2015, INT J BIOL MACROMOL, V79, P903, DOI 10.1016/j.ijbiomac.2015.05.042; Fraga H, 2013, BBA-GEN SUBJECTS, V1830, P2139, DOI 10.1016/j.bbagen.2012.10.002; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kluth J, 2012, FEBS LETT, V586, P3071, DOI 10.1016/j.febslet.2012.07.052; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lewrenz I, 2013, J BIOL CHEM, V288, P30931, DOI 10.1074/jbc.M113.465997; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488; Njunge JM, 2013, CURR PHARM DESIGN, V19, P387, DOI 10.2174/138161213804143734; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Toft DO, EXP BIOL MED MAYWOOD, V228, P111; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Vu MT, 2012, PROTEIN SCI, V21, P258, DOI 10.1002/pro.2012; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066	53	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156446	10.1371/journal.pone.0156446	http://dx.doi.org/10.1371/journal.pone.0156446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253881	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700031
J	Amir, D; Jordan, MR; Bribiescas, RG				Amir, Dorsa; Jordan, Matthew R.; Bribiescas, Richard G.			A Longitudinal Assessment of Associations between Adolescent Environment, Adversity Perception, and Economic Status on Fertility and Age of Menarche	PLOS ONE			English	Article							LIFE-HISTORY; REPRODUCTIVE STRATEGIES; CHILDHOOD EXPERIENCE; SOCIOECONOMIC-STATUS; PUBERTAL MATURATION; FOOD INSECURITY; GIRLS; MORTALITY; RISK; EVOLUTION	Purpose Perceptions of environmental adversity and access to economic resources in adolescence can theoretically affect the timing of life history transitions and investment in reproductive effort. Here we present evidence of correlations between variables associated with subjective extrinsic mortality, economic status, and reproductive effort in a nationally representative American population of young adults. Methods We used a longitudinal database that sampled American participants (N >= 1,579) at four points during early adolescence and early adulthood to test whether perceptions of environmental adversity and early economic status were associated with reproductive effort. Results We found that subjectively high ratings of environmental danger and low access to economic resources in adolescence were significantly associated with an earlier age of menarche in girls and earlier, more robust fertility in young adulthood. Conclusion While energetics and somatic condition remain as possible sources of variation, the results of this study support the hypothesis that perceptions of adversity early in life and limited access to economic resources are associated with differences in reproductive effort and scheduling. How these factors may covary with energetics and somatic condition merits further investigation.	[Amir, Dorsa; Bribiescas, Richard G.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Jordan, Matthew R.] Yale Univ, Dept Psychol, New Haven, CT USA	Yale University; Yale University	Amir, D (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	Dorsa.amir@yale.edu		Amir, Dorsa/0000-0003-0255-0228				Belachew T, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-125; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 2012, CURR DIR PSYCHOL SCI, V21, P310, DOI 10.1177/0963721412453588; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P619, DOI 10.1111/j.1469-7610.2010.02327.x; Belsky J, 2009, PERSPECT PSYCHOL SCI, V4, P345, DOI 10.1111/j.1745-6924.2009.01136.x; Boynton-Jarrett R, 2013, J ADOLESCENT HEALTH, V52, P241, DOI 10.1016/j.jadohealth.2012.06.006; Brumbach BH, 2009, HUM NATURE-INT BIOS, V20, P25, DOI 10.1007/s12110-009-9059-3; Carey JR, 1998, J GERONTOL A-BIOL, V53, pB245, DOI 10.1093/gerona/53A.4.B245; Charnov Eric L., 1993, P1; Chipman A, 2015, PSYCHONEUROENDOCRINO, V62, P89, DOI 10.1016/j.psyneuen.2015.07.611; Daly M., 1978, SEX EVOLUTION BEHAV; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2007, CHILD DEV, V78, P1799, DOI 10.1111/j.1467-8624.2007.01092.x; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; Ellison PT, 1996, AM J HUM BIOL, V8, P725, DOI 10.1002/(SICI)1520-6300(1996)8:6<725::AID-AJHB4>3.0.CO;2-S; ELLISON PT, 1993, HUM REPROD, V8, P2248, DOI 10.1093/oxfordjournals.humrep.a138015; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Emaus A, 2008, HUM REPROD, V23, P919, DOI 10.1093/humrep/dem432; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; GOLDEN WL, 1981, ACTA GENET MED GEMEL, V30, P91, DOI 10.1017/S000156600000773X; Gordon CM, 1999, PEDIATR CLIN N AM, V46, P519, DOI 10.1016/S0031-3955(05)70135-8; Graber JA, 1997, J AM ACAD CHILD PSY, V36, P1768, DOI 10.1097/00004583-199712000-00026; GRABER JA, 1995, CHILD DEV, V66, P346, DOI 10.1111/j.1467-8624.1995.tb00875.x; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P241, DOI 10.1037/a0021082; Harris KM, 2009, NATL LONGITUDINAL ST; Harris KM, 2009, RES DESIGN; James-Todd T, 2010, ANN EPIDEMIOL, V20, P836, DOI 10.1016/j.annepidem.2010.08.006; Jean RT, 2011, AM J EPIDEMIOL, V173, P1203, DOI 10.1093/aje/kwq498; Kaplan H. S., 2005, HDB EVOLUTIONARY PSY, P68, DOI DOI 10.1002/9780470939376.CH2; KAPRIO J, 1995, HUM BIOL, V67, P739; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Khan AD, 1996, AM J HUM BIOL, V8, P717, DOI 10.1002/(SICI)1520-6300(1996)8:6<717::AID-AJHB3>3.0.CO;2-Q; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kuzawa CW, 2007, AM J HUM BIOL, V19, P654, DOI 10.1002/ajhb.20659; Leitao Raquel Beatriz, 2013, Int J Adolesc Med Health, V25, P55, DOI 10.1515/ijamh-2013-0007; Lipson SF, 1996, HUM REPROD, V11, P2090; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Martin JA, 2010, NATL VITAL STAT REP, V61, P1; Mishra GD, 2009, EARLY LIFE CIRCUMSTA; MOFFITT TE, 1992, CHILD DEV, V63, P47, DOI 10.1111/j.1467-8624.1992.tb03594.x; Mpora BO, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-66; Nackers LM, 2013, J NUTR EDUC BEHAV, V45, P780, DOI 10.1016/j.jneb.2013.08.001; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Phipps SA, 2006, OBES REV, V7, P5, DOI 10.1111/j.1467-789X.2006.00217.x; Polak M, 1998, P ROY SOC B-BIOL SCI, V265, P2197, DOI 10.1098/rspb.1998.0559; Prebeg Z, 2000, AM J HUM BIOL, V12, P503; Quinlan RJ, 2010, HUM NATURE-INT BIOS, V21, P124, DOI 10.1007/s12110-010-9085-1; Roff Derek A., 1992; Rutherford JN, 2010, AM J HUM BIOL, V22, P310, DOI 10.1002/ajhb.20986; Saez E., 2014, 20625 NBER; Santos-Ruiz A, 2012, PSYCHONEUROENDOCRINO, V37, P1912, DOI 10.1016/j.psyneuen.2012.04.002; Schultz TP, 2005, FERTILITY AND INCOME; Simpson JA, 2012, DEV PSYCHOL, V48, P674, DOI 10.1037/a0027293; Slovic P, 2000, PERCEPTION RISK; Snyder JK, 2011, EVOL HUM BEHAV, V32, P127, DOI 10.1016/j.evolhumbehav.2010.08.007; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; STJOHN C, 1990, SOC SCI QUART, V71, P152; Trusts PC, 2012, PURSUING AM DREAM EC; Valeggia CR, 2001, FOUND HUM B, P85; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Wang Xiaofei, 2013, Evolution Medicine and Public Health, P241, DOI 10.1093/emph/eot013; Wattigney WA, 1998, ETHNIC DIS, V9, P181; Wildsmith E, 2006, J MARRIAGE FAM, V68, P491, DOI 10.1111/j.1741-3737.2006.00267.x; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Yermachenko A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/371583	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155883	10.1371/journal.pone.0155883	http://dx.doi.org/10.1371/journal.pone.0155883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249338	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700021
J	Broeckling, BE; Watson, RA; Steinwand, B; Bush, DR				Broeckling, Bettina E.; Watson, Ruth A.; Steinwand, Blaire; Bush, Daniel R.			Intronic Sequence Regulates Sugar-Dependent Expression of Arabidopsis thaliana Production of Anthocyanin Pigment-1/MYB75	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; SUCROSE-INDUCIBLE EXPRESSION; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; SWEET-POTATO; BETA-AMYLASE; GUS GENE; ELEMENTS; PROMOTER; INDUCTION	Sucrose-specific regulation of gene expression is recognized as an important signaling response, distinct from glucose, which serves to modulate plant growth, metabolism, and physiology. The Arabidopsis MYB transcription factor Production of Anthocyanin Pigment-1 (PAP1) plays a key role in anthocyanin biosynthesis and expression of PAP1 is known to be regulated by sucrose. Sucrose treatment of Arabidopsis seedlings led to a 20-fold induction of PAP1 transcript, which represented a 6-fold increase over levels in glucose-treated seedlings. The PAP1 promoter was not sufficient for conferring a sucrose response to a reporter gene and did not correctly report expression of PAP1 in plants. Although we identified 3 putative sucrose response elements in the PAP1 gene, none were found to be necessary for this response. Using deletion analysis, we identified a 90 bp sequence within intron 1 of PAP1 that is necessary for the sucrose response. This sequence was sufficient for conferring a sucrose response to a minimal promoter: luciferase reporter when present in multiple copies upstream of the promoter. This work lays the foundation for dissecting the sucrose signaling pathway of PAP1 and contributes to understanding the interplay between sucrose signaling, anthocyanin biosynthesis, and stress responses.	[Broeckling, Bettina E.; Watson, Ruth A.; Steinwand, Blaire; Bush, Daniel R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Watson, Ruth A.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Steinwand, Blaire] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Colorado State University; Colorado State University; University of North Carolina; University of North Carolina Chapel Hill	Bush, DR (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	d.bush@colostate.edu	Bush, Daniel R/AAG-8444-2019	Bush, Daniel/0000-0002-9160-5077				Ainsworth EA, 2011, PLANT PHYSIOL, V155, P157; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comelli RN, 2009, PHYSIOL PLANTARUM, V137, P213, DOI 10.1111/j.1399-3054.2009.01285.x; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; FU HY, 1995, PLANT CELL, V7, P1387, DOI 10.1105/tpc.7.9.1387; Geisler M, 2006, PLANT J, V45, P384, DOI 10.1111/j.1365-313X.2005.02634.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Han L, 2015, GENET MOL RES, V14, P4784, DOI 10.4238/2015.May.11.11; Hatier JHB, 2008, J THEOR BIOL, V253, P625, DOI 10.1016/j.jtbi.2008.04.018; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; ISHIGURO S, 1992, PLANT MOL BIOL, V18, P97, DOI 10.1007/BF00018460; JEFFERSON R, 1990, PLANT MOL BIOL, V14, P995, DOI 10.1007/BF00019396; Jeong SW, 2010, PLANT PHYSIOL, V154, P1514, DOI 10.1104/pp.110.161869; JOHNSON R, 1990, PLANT MOL BIOL, V14, P527, DOI 10.1007/BF00027498; Khoshnoodi J, 1998, PLANT SCI, V135, P183, DOI 10.1016/S0168-9452(98)00093-4; Kim KN, 1999, PLANT PHYSIOL, V121, P225, DOI 10.1104/pp.121.1.225; KIM SR, 1991, PLANT MOL BIOL, V17, P973, DOI 10.1007/BF00037137; Kunz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100312; Kwak MS, 2006, GENE, V366, P87, DOI 10.1016/j.gene.2005.09.021; Li XY, 2002, PLANT SCI, V162, P239, DOI 10.1016/S0168-9452(01)00565-9; Li Y, 2014, MOL PLANT, V7, P570, DOI 10.1093/mp/sst161; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Maeo K, 2001, PLANT MOL BIOL, V46, P627, DOI 10.1023/A:1010684908364; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; MITA S, 1995, PLANT PHYSIOL, V107, P895, DOI 10.1104/pp.107.3.895; Morikami A, 2005, MOL GENET GENOMICS, V272, P690, DOI 10.1007/s00438-004-1100-y; Mutisya J, 2006, J PLANT PHYSIOL, V163, P770, DOI 10.1016/j.jplph.2005.04.038; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Scarpella E, 2005, PLANT CELL PHYSIOL, V46, P1400, DOI 10.1093/pcp/pci153; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Sheen J, 2014, J PLANT BIOL, V57, P67, DOI 10.1007/s12374-014-0902-7; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; Shin DH, 2013, BIOCHEM BIOPH RES CO, V430, P634, DOI 10.1016/j.bbrc.2012.11.100; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sivitz AB, 2008, PLANT PHYSIOL, V147, P92, DOI 10.1104/pp.108.118992; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tang ZJ, 2001, PLANT PHYSIOL, V125, P797, DOI 10.1104/pp.125.2.797; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Vaughn MW, 2002, P NATL ACAD SCI USA, V99, P10876, DOI 10.1073/pnas.172198599; VISSER RGF, 1991, PLANT MOL BIOL, V17, P691, DOI 10.1007/BF00037054; Weiner M, 1995, PCR PRIMER LAB MANUA; Weise A, 2008, PLANT MOL BIOL, V68, P251, DOI 10.1007/s11103-008-9366-9; WENZLER H, 1989, PLANT MOL BIOL, V13, P347, DOI 10.1007/BF00015546; WENZLER HC, 1989, PLANT MOL BIOL, V12, P41, DOI 10.1007/BF00017446; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; YOKOYAMA R, 1994, MOL GEN GENET, V244, P15, DOI 10.1007/BF00280182; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zourelidou M, 2002, PLANT J, V30, P489, DOI 10.1046/j.1365-313X.2002.01302.x	72	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156673	10.1371/journal.pone.0156673	http://dx.doi.org/10.1371/journal.pone.0156673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248141	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700064
J	M'ng, JCP; Mehralizadeh, M				M'ng, Jacinta Chan Phooi; Mehralizadeh, Mohammadali			Forecasting East Asian Indices Futures via a Novel Hybrid of Wavelet-PCA Denoising and Artificial Neural Network Models	PLOS ONE			English	Article							STOCK-MARKET; EMERGING MARKETS; COMPLEX NETWORK; TIME-SERIES; PREDICTION; RETURNS; RULE; SELECTION; GA	The motivation behind this research is to innovatively combine new methods like wavelet, principal component analysis (PCA), and artificial neural network (ANN) approaches to analyze trade in today's increasingly difficult and volatile financial futures markets. The main focus of this study is to facilitate forecasting by using an enhanced denoising process on market data, taken as a multivariate signal, in order to deduct the same noise from the open-high-low-close signal of a market. This research offers evidence on the predictive ability and the profitability of abnormal returns of a new hybrid forecasting model using Wavelet-PCA denoising and ANN (named WPCA-NN) on futures contracts of Hong Kong's Hang Seng futures, Japan's NIKKEI 225 futures, Singapore's MSCI futures, South Korea's KOSPI 200 futures, and Taiwan's TAIEX futures from 2005 to 2014. Using a host of technical analysis indicators consisting of RSI, MACD, MACD Signal, Stochastic Fast % K, Stochastic Slow % K, Stochastic % D, and Ultimate Oscillator, empirical results show that the annual mean returns of WPCA-NN are more than the threshold buy-and-hold for the validation, test, and evaluation periods; this is inconsistent with the traditional random walk hypothesis, which insists that mechanical rules cannot outperform the threshold buy-andhold. The findings, however, are consistent with literature that advocates technical analysis.	[M'ng, Jacinta Chan Phooi; Mehralizadeh, Mohammadali] Univ Malaya, Fac Business & Accountancy, Kuala Lumpur 50603, Malaysia	Universiti Malaya	M'ng, JCP (corresponding author), Univ Malaya, Fac Business & Accountancy, Kuala Lumpur 50603, Malaysia.	jacinta@um.edu.my	Chan, Jacinta/ABB-1210-2021	Chan, Jacinta/0000-0002-0083-6014				Aminghafari M, 2006, COMPUT STAT DATA AN, V50, P2381, DOI 10.1016/j.csda.2004.12.010; [Anonymous], 2014, NARX TOOLB US MATLAB; [Anonymous], 2014, LEV MARQ FUNCT US MA; [Anonymous], 2014, WMULDEN FUNCT US MAT; Antoniadis A., 2001, J STAT SOFTW, V6, P1, DOI [10.18637/jss.v006.i06, DOI 10.18637/JSS.V006.I06]; Atsalakis GS, 2009, EXPERT SYST APPL, V36, P5932, DOI 10.1016/j.eswa.2008.07.006; Bahrammirzaee A, 2010, NEURAL COMPUT APPL, V19, P1165, DOI 10.1007/s00521-010-0362-z; Bakshi BR, 1999, J CHEMOMETR, V13, P415, DOI 10.1002/(SICI)1099-128X(199905/08)13:3/4<415::AID-CEM544>3.0.CO;2-8; Boboc I-A, 2013, ALGORITHM TESTING EF; Booth A, 2014, EXPERT SYST APPL, V41, P3651, DOI 10.1016/j.eswa.2013.12.009; Chen AS, 2004, COMPUT OPER RES, V31, P1049, DOI 10.1016/S0305-0548(03)00064-9; Cheng CH, 2010, INFORM SCIENCES, V180, P1610, DOI 10.1016/j.ins.2010.01.014; Chiang T. C., 2001, REV QUANTITATIVE FIN, V17, P301, DOI DOI 10.1023/A:1012296727217; Coronel-Brizio HF, 2007, PHYSICA A, V380, P391, DOI 10.1016/j.physa.2007.02.109; Dempster M. A. H., 2001, Quantitative Finance, V1, P397, DOI 10.1088/1469-7688/1/4/301; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Dunis CL, 2005, J ASSET MANAG, V6, P168, DOI 10.1057/palgrave.jam.2240174; Enke D, 2005, EXPERT SYST APPL, V29, P927, DOI 10.1016/j.eswa.2005.06.024; ERRUNZA VR, 1994, J PORTFOLIO MANAGE, V20, P82, DOI 10.3905/jpm.1994.82; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; Fama EF, 1965, FINANC ANAL J, V21, P55, DOI 10.2469/faj.v51.n1.1861; Fernandez-Rodriguez F, 2000, ECON LETT, V69, P89, DOI 10.1016/S0165-1765(00)00270-6; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Garliauskas A, 1999, SYST MAN CYB 1999 IE; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Guo ZQ, 2013, SOFT COMPUT, V17, P805, DOI 10.1007/s00500-012-0953-y; Harris L, 2013, FINANC ANAL J, V69, P6; Hassan MR, 2007, EXPERT SYST APPL, V33, P171, DOI 10.1016/j.eswa.2006.04.007; He K, 2014, MATH PROBLEMS ENG, V2014; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Hu Y, 2015, EXPERT SYST APPL, V42, P212, DOI 10.1016/j.eswa.2014.07.059; Huang H, 2009, IEEE T EVOLUT COMPUT, V13, P56, DOI 10.1109/TEVC.2008.911682; Jin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142064; Johnstone I. M., 2011, GAUSSIAN ESTIM UNPUB; KARHUNEN J, 1995, NEURAL NETWORKS, V8, P549, DOI 10.1016/0893-6080(94)00098-7; Karlis D, 2003, COMMUN STAT-THEOR M, V32, P643, DOI 10.1081/STA-120018556; Kim HJ, 2007, APPL SOFT COMPUT, V7, P569, DOI 10.1016/j.asoc.2006.03.004; Kim K, 1998, EXTRACTING TRADING R; Lee SJ, 2010, APPL INTELL, V32, P364, DOI 10.1007/s10489-008-0150-y; LEITCH G, 1991, AM ECON REV, V81, P580; Lertpalangsunti N, 1998, ENG APPL ARTIF INTEL, V11, P549, DOI 10.1016/S0952-1976(98)00013-X; Leung MT, 2000, INT J FORECASTING, V16, P173, DOI 10.1016/S0169-2070(99)00048-5; Li K., 2003, J EMPIR FINANC, V10, P57, DOI DOI 10.1016/S0927-5398(02)00027-0; Lotric U, 2004, NEUROCOMPUTING, V62, P179, DOI 10.1016/j.neucom.2004.02.003; Lotric U, 2005, NEURAL COMPUT APPL, V14, P11, DOI 10.1007/s00521-004-0434-z; MAKRIDAKIS S, 1993, INT J FORECASTING, V9, P527, DOI 10.1016/0169-2070(93)90079-3; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Moazzami M, 2013, APPL ENERG, V101, P489, DOI 10.1016/j.apenergy.2012.06.009; Necula C, 2009, ROM J ECON FORECAST, V10, P118; Ni H, 2009, NEUROCOMPUTING, V72, P2815, DOI 10.1016/j.neucom.2008.09.023; Olson D, 2004, J BANK FINANC, V28, P85, DOI 10.1016/S0378-4266(02)00399-0; Pei-Chann Chang, 2004, Journal of the Chinese Institute of Industrial Engineers, V21, P358, DOI 10.1080/10170660409509416; PESARAN MH, 1994, J FORECASTING, V13, P335, DOI 10.1002/for.3980130402; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Pukthuanthong K, 2006, FOREIGN EXCHANGE MAR; Quah TS, 1999, EXPERT SYST APPL, V17, P295, DOI 10.1016/S0957-4174(99)00041-X; Ramsey J.B., 1997, J EMPIR FINANC, P341, DOI DOI 10.1016/S0927-5398(96)00013-8; REFENES AN, 1994, NEURAL NETWORKS, V7, P375, DOI 10.1016/0893-6080(94)90030-2; Roman J, 1996, SYST SCI 1996 P 29 H; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Siegelmann HT, 1997, IEEE T SYST MAN CY B, V27, P208, DOI 10.1109/3477.558801; Taha I, 1997, INT J SMART ENG SYST, V1, P59; Taylor S., 1986, MODELLING FINANCIAL; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Wang L., 2013, TIME SERIES ANAL MOD, P229; Wang L. P., 2006, DATA MINING COMPUTAT; Xiao Y, 2014, INT J COMPUT INT SYS, V7, P272, DOI 10.1080/18756891.2013.864472; Yao J., 1999, INT J THEOR APPL FIN, V2, P221; YOON YO, 1993, J OPER RES SOC, V44, P51, DOI 10.2307/2584434; ZADEH LA, 1994, MODEL IDENT CONTROL, V15, P191, DOI 10.4173/mic.1994.3.9; Zhang XZ, 2014, NEUROCOMPUTING, V142, P48, DOI 10.1016/j.neucom.2014.01.057; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028; Zurada J.M., 1992, INTRO ARTIFICIAL NEU	77	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156338	10.1371/journal.pone.0156338	http://dx.doi.org/10.1371/journal.pone.0156338			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248692	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700036
J	Nagai-Okatani, C; Nagasawa, H; Nagata, S				Nagai-Okatani, Chiaki; Nagasawa, Hiromichi; Nagata, Shinji			Tachykinin-Related Peptides Share a G Protein-Coupled Receptor with Ion Transport Peptide-Like in the Silkworm Bombyx mori	PLOS ONE			English	Article							NEUROPEPTIDE; EXPRESSION; IDENTIFICATION; NEURONS; GENES; CDNA; ITP	Recently, we identified an orphan Bombyx mori neuropeptide G protein-coupled receptor (BNGR)-A24 as an ion transport peptide-like (ITPL) receptor. BNGR-A24 belongs to the same clade as BNGR-A32 and -A33, which were recently identified as natalisin receptors. Since these three BNGRs share high similarities with known receptors for tachykinin-related peptides (TRPs), we examined whether these BNGRs can function as physiological receptors for five endogenous B. mori TRPs (TK-1-5). In a heterologous expression system, BNGR-A24 acted as a receptor for all five TRPs. In contrast, BNGR-A32 responded only to TK-5, and BNGR-A33 did not respond to any of the TRPs. These findings are consistent with recent studies on the ligand preferences for B. mori natalisins. Furthermore, we evaluated whether the binding of ITPL and TRPs to BNGR-A24 is competitive by using a Ca2+ imaging assay. Concomitant addition of a TRP receptor antagonist, spantide I, reduced the responses of BNGR-A24 not only to TK-4 but also to ITPL. The results of a binding assay using fluorescent-labeled BNGR-A24 and ligands demonstrated that the binding of ITPL to BNGR-A24 was inhibited by TK-4 as well as by spantide I, and vice versa. In addition, the ITPL-induced increase in cGMP levels of BNGR-A24-expressing BmN cells was suppressed by the addition of excess TK-4 or spantide I. The intracellular levels of cAMP and cGMP, as second messenger candidates of the TRP signaling, were not altered by the five TRPs, suggesting that these peptides act via different signaling pathways from cAMP and cGMP signaling at least in BmN cells. Taken together, the present findings suggest that ITPL and TRPs are endogenous orthosteric ligands of BNGR-A24 that may activate discrete signaling pathways. This receptor, which shares orthosteric ligands, may constitute an important model for studying ligand-biased signaling.	[Nagai-Okatani, Chiaki; Nagasawa, Hiromichi; Nagata, Shinji] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nagata, Shinji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Nagai-Okatani, Chiaki] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, Tsukuba, Japan; [Nagasawa, Hiromichi] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Zhejiang University	Nagata, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	chiaki-okatani@aist.go.jp; shinjin@edu.k.u-tokyo.ac.jp	Nagai-Okatani, Chiaki/L-2883-2018	Nagai-Okatani, Chiaki/0000-0003-4084-3128	JSPS KAKENHI [22-1424]; MEXT KAKENHI [24580157]; NAITO Foundation; Grants-in-Aid for Scientific Research [15H04609] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NAITO Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (Grant-in-Aid for JSPS Fellows [22-1424]) to CN-O (URL: https://www.jsps.go.jp/english/e-grants/) and MEXT KAKENHI (Grant-in-Aid for Scientific Research (C) [24580157]) to SN (URL: https://www.jsps.go.jp/english/e-grants/) and the NAITO Foundation to SN (URL: https://www.naito-f.or.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Audsley N, 2013, PEPTIDES, V41, P74, DOI 10.1016/j.peptides.2012.11.001; Begum K, 2009, INSECT BIOCHEM MOLEC, V39, P717, DOI 10.1016/j.ibmb.2009.08.005; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Dai L, 2007, J COMP NEUROL, V500, P353, DOI 10.1002/cne.21192; Damulewicz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021258; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; Drexler AL, 2007, CELL TISSUE RES, V329, P391, DOI 10.1007/s00441-007-0391-9; Endo H, 2000, INSECT BIOCHEM MOLEC, V30, P355, DOI 10.1016/S0965-1748(99)00129-0; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; FONAGY A, 1992, BIOSCI BIOTECH BIOCH, V56, P1692, DOI 10.1271/bbb.56.1692; He XB, 2014, BIOCHEMISTRY-US, V53, P6667, DOI 10.1021/bi5007207; Hermann C, 2013, J COMP NEUROL, V521, P367, DOI 10.1002/cne.23178; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Katayama Hidekazu, 2013, Aqua-Bioscience Monographs, V6, P49; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; LIU XY, 2012, ABSTR APPL ANAL, P40359, DOI DOI 10.1155/2012/; Meredith J, 1996, J EXP BIOL, V199, P1053; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nassel D. R., 2013, HDB BIOL ACTIVE PEPT, P315, DOI DOI 10.1016/B978-0-12-385095-9.00044-0; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Poels J, 2004, J NEUROCHEM, V90, P472, DOI 10.1111/j.1471-4159.2004.02506.x; Poels J, 2007, PEPTIDES, V28, P103, DOI 10.1016/j.peptides.2006.06.014; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Satake H, 2013, PROTEIN PEPTIDE LETT, V20, P615, DOI 10.2174/0929866511320060002; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Torfs Herbert, 2002, Invertebrate Neuroscience, V4, P119, DOI 10.1007/s10158-001-0013-2; Van Loy T, 2010, PEPTIDES, V31, P520, DOI 10.1016/j.peptides.2009.09.023; Vanden Broeck J, 1999, ANN NY ACAD SCI, V897, P374, DOI 10.1111/j.1749-6632.1999.tb07907.x; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048	40	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156501	10.1371/journal.pone.0156501	http://dx.doi.org/10.1371/journal.pone.0156501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248837	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700047
J	Rao, SJ; Meleppattu, S; Pal, JK				Rao, Shilpa J.; Meleppattu, Shimi; Pal, Jayanta K.			A GCN2-Like eIF2 alpha Kinase (LdeK1) of Leishmania donovani and Its Possible Role in Stress Response	PLOS ONE			English	Article							INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; GCN2; PHOSPHORYLATION; ACTIVATION; DOMAIN; METACYCLOGENESIS; DIFFERENTIATION; IDENTIFICATION; PROMASTIGOTE	Translation regulation in Leishmania parasites assumes significance particularly because they encounter myriad of stresses during their life cycle. The eukaryotic initiation factor 2 alpha (eIF2 alpha) kinases, the well-known regulators of translation initiation in higher eukaryotes have now been found to control various processes in these protozoan parasites as well. Here, we report on cloning and characterization of a GCN2-like eIF2 alpha kinase from L. donovani and also on its modulation during nutrient starvation. We cloned a GCN2-like kinase from L. donovani, which we named as LdeK1 and validated it to be a functional eIF2 alpha kinase by in vitro kinase assay. LdeK1 was found to be localized in the cytoplasm of the promastigotes with a five-fold higher expression in this stage of the parasite as compared to the axenic amastigotes. Phosphorylation of eIF2 alpha and a G1-arrest was observed in response to nutrient starvation in the wild-type parasites. In contrast, phosphorylation was significantly impaired in a dominant-negative mutant of LdeK1 during this stress with a subsequent failure to bring about a G1-arrest during cell cycle. Thus, LdeK1 is a functional GCN2-like kinase of L. donovani which responds to nutrient starvation by phosphorylating its substrate, eIF2 alpha and a G1-arrest in the cell cycle. Nutrient starvation is encountered by the parasites inside the vector which triggers metacyclogenesis. We therefore propose that global translational regulation by activation of LdeK1 followed by eIF2 alpha phosphorylation and G1-arrest during nutrient starvation in the gut of sandfly vector could be one of the mechanisms to retool the cellular machinery required for metacyclogenesis of Leishmania promastigotes.	[Rao, Shilpa J.; Pal, Jayanta K.] Savitribai Phule Pune Univ, Dept Biotechnol, Cell & Mol Biol Lab, Pune 411007, Maharashtra, India; [Rao, Shilpa J.] Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, Pune 411007, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Pal, JK (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Cell & Mol Biol Lab, Pune 411007, Maharashtra, India.	jkpal@unipune.ac.in	Meleppattu, Shimi/AAY-9070-2020	Meleppattu, Shimi/0000-0003-3929-9997; Pal, Jayanta/0000-0003-1840-6458	Department of Science and Technology (DST), Govt. of India (DST PURSE programme); Department Research and Development program of the Savitribai Phule Pune University; Department of Biotechnology, Govt. of India [BT/PR5553/BRB/10/1086/2012]; Council of Scientific and Industrial Research	Department of Science and Technology (DST), Govt. of India (DST PURSE programme); Department Research and Development program of the Savitribai Phule Pune University; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the financial supports received from the Department of Science and Technology (DST), Govt. of India (DST PURSE programme), Department Research and Development program of the Savitribai Phule Pune University and Department of Biotechnology, Govt. of India (BT/PR5553/BRB/10/1086/2012) to JKP. SJR and SM thank Department of Biotechnology, Govt. of India, and Council of Scientific and Industrial Research, respectively for their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; CHEN JJ, 1989, J BIOL CHEM, V264, P9559; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Konrad C, 2011, A GCN2 LIKE EUKARYOT, V10, P1403, DOI 10.1128/EC.05117-11; Konrad C, 2014, INT J PARASITOL, V44, P139, DOI 10.1016/j.ijpara.2013.08.005; Lageix S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004326; Lahav T, 2010, MULTIPLE LEVELS GENE, P1, DOI [10.1096/fj.10-157529, DOI 10.1096/FJ.10-157529]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Mohrle JJ, 1997, BIOCHEM J, V328, P677; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Olsen DS, 1998, GENETICS, V149, P1495; Ouakad M, 2007, PARASITOL RES, V101, P473, DOI 10.1007/s00436-007-0491-1; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Serafim TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001833; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sood R, 2000, GENETICS, V154, P787; Sreejith RK, 2009, BIOCHEM BIOPH RES CO, V390, P273, DOI 10.1016/j.bbrc.2009.09.106; Sullivan WJ, 2004, BIOCHEM J, V380, P523, DOI 10.1042/BJ20040262; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	48	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156032	10.1371/journal.pone.0156032	http://dx.doi.org/10.1371/journal.pone.0156032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248816	gold, Green Submitted, Green Published			2022-12-27	WOS:000377184700027
J	Al-Majedy, YK; Al-Amiery, AA; Kadhum, AAH; Mohamad, AB				Al-Majedy, Yasameen K.; Al-Amiery, Ahmed A.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar			Antioxidant Activities of 4-Methylumbelliferone Derivatives	PLOS ONE			English	Article							COUMARIN 1,2-BENZOPYRONE; NITRIC-OXIDE; PHASE-II; CIMETIDINE; 3-ARYLCOUMARINS; CARCINOMA; TOXICITY; SERIES	The synthesis of derivatives of 4-Methylumbelliferone (4-MUs), which are structurally interesting antioxidants, was performed in this study. The modification of 4-Methylumbelliferone (4-MU) by different reaction steps was performed to yield the target compounds, the 4-MUs. The 4-MUs were characterized by different spectroscopic techniques (Fourier transform infrared; FT-IR and Nuclear magnetic resonance; NMR) and micro-elemental analysis (CHNS). The in vitro antioxidant activity of the 4-MUs was evaluated in terms of their free radical scavenging activities against 2,2-diphenyl-1-picrylhydrazyl (DPPH), Nitric oxide radical scavenging activity assay, chelating activity and their (FRAP) ferric-reducing antioxidant power, which were compared with a standard antioxidant. Our results reveal that the 4-MUs exhibit excellent radical scavenging activities. The antioxidant mechanisms of the 4-MUs were also studied. Density Function Theory (DFT)-based quantum chemical studies were performed with the basis set at 3-21G. Molecular models of the synthesized compounds were studied to understand the antioxidant activity. The electron levels, namely HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital), for these synthesized antioxidants were also studied.	[Al-Majedy, Yasameen K.; Al-Amiery, Ahmed A.; Kadhum, Abdul Amir H.] Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia; [Mohamad, Abu Bakar] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43000, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Al-Amiery, AA (corresponding author), Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia.	dr.ahmed1975@gmail.com	, Abu Bakar Mohamad/J-5638-2014; Almajedy, yasameen Kadhim H./AAX-3695-2021; Kadhum, Abdul Amir/AAB-7234-2021; Al-Amiery, Ahmed/C-1520-2013	, Abu Bakar Mohamad/0000-0001-5135-7956; Kadhum, Abdul Amir/0000-0003-4074-9123; Al-Amiery, Ahmed/0000-0003-1033-4904	Universiti Kebangsaan Malaysia [DIP-2012-02]	Universiti Kebangsaan Malaysia	This study was supported by Universiti Kebangsaan Malaysia under the DIP-2012-02 Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amiery A.A, 2012, ORG MED CHEM LETT, V2, P1, DOI [DOI 10.1186/2191-2858-2-1, DOI 10.1186/2191-2858-2-4]; Al-Amiery AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132175; Al-Amiery AA, 2013, CHEM NAT COMPD+, V48, P950, DOI 10.1007/s10600-013-0436-0; Al-Amiery AA, 2012, RES CHEM INTERMEDIAT, V38, P559, DOI 10.1007/s11164-011-0371-2; ALAMIERY A, 2013, BIOINORG CHEM APPL, V2013, P1; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Chan EWC, 2007, FOOD CHEM, V104, P1586, DOI 10.1016/j.foodchem.2007.03.023; Chang R., 2001, CHEMISTRY, V7th, P253; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; COX D, 1989, HUM TOXICOL, V8, P501, DOI 10.1177/096032718900800612; DEXEUS FH, 1990, J CLIN ONCOL, V8, P325, DOI 10.1200/JCO.1990.8.2.325; Gocer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963; GUYER RL, 1989, SCIENCE, V246, P1543, DOI 10.1126/science.2688087; Inati A, 2009, BLOOD REV, V23, pS9, DOI 10.1016/S0268-960X(09)70004-9; Janeiro P, 2013, J ELECTROANAL CHEM, V689, P243, DOI 10.1016/j.jelechem.2012.10.020; Jimenez-Orozco FA, 2001, LUNG CANCER, V34, P185, DOI 10.1016/S0169-5002(01)00263-X; Matos MJ, 2013, BIOORGAN MED CHEM, V21, P3900, DOI 10.1016/j.bmc.2013.04.015; Matos MJ, 2012, CURR TOP MED CHEM, V12, P2210; Kadhum AAH, 2011, INT J MOL SCI, V12, P5747, DOI 10.3390/ijms12095747; Kadhum AAH, 2011, MOLECULES, V16, P6969, DOI 10.3390/molecules16086969; Koncic MZ, 2011, MOLECULES, V16, P6232, DOI 10.3390/molecules16086232; KONTOGHIORGHES GJ, 1995, TOXICOL LETT, V80, P1, DOI 10.1016/0378-4274(95)03415-H; KROL W, 1995, BIOCHEM PHARMACOL, V50, P1031, DOI 10.1016/0006-2952(95)00237-T; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; MARSHALL ME, 1987, J CLIN ONCOL, V5, P862, DOI 10.1200/JCO.1987.5.6.862; MARSHALL ME, 1990, PROSTATE, V17, P95, DOI 10.1002/pros.2990170203; Martins Borges Maria Fernanda, 2009, V4, P23; Matos MJ, 2011, J MED CHEM, V54, P7127, DOI 10.1021/jm200716y; MOHLER JL, 1992, PROSTATE, V20, P123, DOI 10.1002/pros.2990200208; Nath M, 2005, J ORGANOMET CHEM, V690, P134, DOI 10.1016/j.jorganchem.2004.08.043; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perez C, 2007, QSAR COMB SCI, V26, P368, DOI 10.1002/qsar.200630067; Perez-Cruz F, 2013, J MED CHEM, V56, P6136, DOI 10.1021/jm400546y; Perez-Cruz F, 2012, BIOORG MED CHEM LETT, V22, P5569, DOI 10.1016/j.bmcl.2012.07.013; Reische D.W., 2008, FOOD LIPIDS CHEM NUT, Vthird, P409; Sardari S, 1999, BIOORGAN MED CHEM, V7, P1933, DOI 10.1016/S0968-0896(99)00138-8; THORNES D, 1989, EUR J SURG ONCOL, V15, P431; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; Vazquez-Rodriguez S, 2013, MEDCHEMCOMM, V4, P993, DOI 10.1039/c3md00025g; Widjaja A, 2008, J CHIN INST CHEM ENG, V39, P413, DOI 10.1016/j.jcice.2008.05.003	40	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156625	10.1371/journal.pone.0156625	http://dx.doi.org/10.1371/journal.pone.0156625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243231	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100057
J	Lefcheck, JS; Marion, SR; Lombana, AV; Orth, RJ				Lefcheck, Jonathan S.; Marion, Scott R.; Lombana, Alfonso V.; Orth, Robert J.			Faunal Communities Are Invariant to Fragmentation in Experimental Seagrass Landscapes	PLOS ONE			English	Article							ZOSTERA-MARINA L; SUBMERGED AQUATIC VEGETATION; RAOS QUADRATIC ENTROPY; LOWER CHESAPEAKE BAY; GULF-OF-MEXICO; HABITAT FRAGMENTATION; SPECIES COOCCURRENCE; PATCH SIZE; DIVERSITY; BEDS	Human-driven habitat fragmentation is cited as one of the most pressing threats facing many coastal ecosystems today. Many experiments have explored the consequences of fragmentation on fauna in one foundational habitat, seagrass beds, but have either surveyed along a gradient of existing patchiness, used artificial materials to mimic a natural bed, or sampled over short timescales. Here, we describe faunal responses to constructed fragmented landscapes varying from 4-400 m(2) in two transplant garden experiments incorporating live eelgrass (Zostera marina L.). In experiments replicated within two subestuaries of the Chesapeake Bay, USA across multiple seasons and non-consecutive years, we comprehensively censused mesopredators and epifaunal communities using complementary quantitative methods. We found that community properties, including abundance, species richness, Simpson and functional diversity, and composition were generally unaffected by the number of patches and the size of the landscape, or the intensity of sampling. Additionally, an index of competition based on species co-occurrences revealed no trends with increasing patch size, contrary to theoretical predictions. We extend conclusions concerning the invariance of animal communities to habitat fragmentation from small-scale observational surveys and artificial experiments to experiments conducted with actual living plants and at more realistic scales. Our findings are likely a consequence of the rapid life histories and high mobility of the organisms common to eelgrass beds, and have implications for both conservation and restoration, suggesting that even small patches can rapidly promote abundant and diverse faunal communities.	[Lefcheck, Jonathan S.; Lombana, Alfonso V.; Orth, Robert J.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Marion, Scott R.] Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR 97365 USA	William & Mary; Virginia Institute of Marine Science	Lefcheck, JS (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	jslefche@vims.edu	Lefcheck, Jonathan/H-8768-2019	Lefcheck, Jonathan/0000-0002-8787-1786; Orth, Robert/0000-0003-2491-7430	Virginia Recreational Fishing License Fund; Allied-Signal Foundation; Keith Campbell Foundation for the Environment	Virginia Recreational Fishing License Fund; Allied-Signal Foundation; Keith Campbell Foundation for the Environment	Funding was provided by the grants from the Virginia Recreational Fishing License Fund, as well as private grants from the Allied-Signal Foundation and the Keith Campbell Foundation for the Environment.	ANDERSON G., 1985, BIOL REPORT, V82, P1; [Anonymous], 1973, SHALLOW WATER GAMMAR; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Arponen H, 2012, HYDROBIOLOGIA, V680, P1, DOI 10.1007/s10750-011-0895-x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Azovsky AI, 2011, ECOGRAPHY, V34, P18, DOI 10.1111/j.1600-0587.2010.06288.x; Bell SS, 2001, BIOL CONSERV, V100, P115, DOI 10.1016/S0006-3207(00)00212-3; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; BROAD AC, 1957, BIOL BULL, V112, P144, DOI 10.2307/1539193; Brooks RA, 2001, J EXP MAR BIOL ECOL, V264, P67, DOI 10.1016/S0022-0981(01)00310-0; CAUSTON D. R, 1988, INTRO VEGETATION ANA; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Connolly RM, 2006, ESTUAR COAST SHELF S, V68, P433, DOI 10.1016/j.ecss.2006.01.023; Douglass JG, 2010, LIMNOL OCEANOGR, V55, P1499, DOI 10.4319/lo.2010.55.4.1499; EDGAR GJ, 1993, OECOLOGIA, V95, P115, DOI 10.1007/BF00649514; EDGAR GJ, 1993, OECOLOGIA, V95, P122, DOI 10.1007/BF00649515; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Fox J., 2011, CAR COMPANION APPL R; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; FREDETTE TJ, 1986, J CRUSTACEAN BIOL, V6, P57, DOI 10.2307/1547931; FREDETTE TJ, 1990, ESTUARIES, V13, P431, DOI 10.2307/1351787; Frost MT, 1999, AQUAT CONSERV, V9, P255, DOI 10.1002/(SICI)1099-0755(199905/06)9:3<255::AID-AQC346>3.0.CO;2-F; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Healey D, 2004, J EXP MAR BIOL ECOL, V313, P155, DOI 10.1016/j.jembe.2004.08.002; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Hector A, 2010, J ANIM ECOL, V79, P308, DOI 10.1111/j.1365-2656.2009.01634.x; Hirst JA, 2008, ESTUAR COAST SHELF S, V78, P811, DOI 10.1016/j.ecss.2008.02.020; Hovel KA, 2002, MAR ECOL PROG SER, V243, P11, DOI 10.3354/meps243011; Hovel KA, 2001, ECOLOGY, V82, P1814; HOWARD RK, 1985, MAR ECOL PROG SER, V22, P163, DOI 10.3354/meps022163; Jackson EL, 2006, ESTUAR COAST SHELF S, V68, P421, DOI 10.1016/j.ecss.2006.01.024; Johnson MW, 2006, MAR ECOL PROG SER, V306, P233, DOI 10.3354/meps306233; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; Lefcheck JS, 2015, ECOLOGY, V96, P2973, DOI 10.1890/14-1977.1; Lefcheck JS, 2015, TOP DOWN VERSUS BUTT; Lefcheck JS, 2015, PEERJ PREPR; Lombana AL, 1999, THESIS; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marion SR, 2002, THESIS COLL WILLIAM; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; MCNEILL SE, 1993, J BIOGEOGR, V20, P429, DOI 10.2307/2845591; Merigot B, 2010, ECOLOGY, V91, P1850, DOI 10.1890/09-1387.1; Mills VS, 2009, ESTUAR COAST SHELF S, V81, P123, DOI 10.1016/j.ecss.2008.10.005; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Murdy EO, 2013, FISHES CHESAPEAKE BA; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Nakaoka M, 2001, MAR ECOL-P S Z N I, V22, P379, DOI 10.1046/j.1439-0485.2001.01726.x; NECKLES HA, 1993, OECOLOGIA, V93, P285, DOI 10.1007/BF00317683; NELSON WG, 1982, B MAR SCI, V32, P121; Oksanen J., 2013, R PACKAGE VERSION 23, V2; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; ORTH RJ, 1987, MAR ECOL PROG SER, V41, P283, DOI 10.3354/meps041283; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; ORTH RJ, 1992, SYST ASSOC SPEC VOL, V46, P147; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paling E.I., 2009, COAST WETLANDS INTEG, P687; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pinheiro J, 2015, NLME LINEAR NONLINEA; Podani J, 1999, TAXON, V48, P331, DOI 10.2307/1224438; Pollock LW, 1998, PRACTICAL GUIDE MARI; Smith TM, 2010, J ANIM ECOL, V79, P275, DOI 10.1111/j.1365-2656.2009.01605.x; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; STONER AW, 1980, CONTRIB MAR SCI, V23, P63; STONER AW, 1980, B MAR SCI, V30, P537; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; Tanner JE, 2003, OIKOS, V100, P517, DOI 10.1034/j.1600-0706.2003.12060.x; Tilman D, 1997, AM NAT, V149, P407, DOI 10.1086/285998; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; vanMontfrans J, 1995, B MAR SCI, V57, P834; Warry FY, 2009, OECOLOGIA, V159, P883, DOI 10.1007/s00442-008-1258-9; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams JA, 2016, J EXP MAR BIOL ECOL, V479, P97, DOI 10.1016/j.jembe.2016.03.008; Wyda JC, 2002, ESTUARIES, V25, P86, DOI 10.1007/BF02696052	87	28	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156550	10.1371/journal.pone.0156550	http://dx.doi.org/10.1371/journal.pone.0156550			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244652	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100046
J	Lopez, I; Pineda, C; Munoz, L; Raya, A; Lopez, G; Aguilera-Tejero, E				Lopez, Ignacio; Pineda, Carmen; Munoz, Luis; Raya, Ana; Lopez, Guillermo; Aguilera-Tejero, Escolastico			Chronic Vitamin D Intoxication in Captive Iberian Lynx (Lynx pardinus)	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; D TOXICITY; HYPERCALCEMIA; CAT; SECONDARY; CALCIUM	To document the biochemical and pathologic features of vitamin D intoxication in lynx and to characterize mineral metabolism in healthy lynx, blood samples were obtained from 40 captive lynx that had been receiving excessive (approximately 30 times the recommended dose) vitamin D3 in the diet, and from 29 healthy free ranging lynx. Tissue samples (kidney, stomach, lung, heart and aorta) were collected from 13 captive lynx that died as a result of renal disease and from 3 controls. Vitamin D intoxication resulted in renal failure in most lynx (n = 28), and widespread extraskeletal calcification was most severe in the kidneys and less prominent in cardiovascular tissues. Blood minerals and calciotropic hormones in healthy lynx were similar to values reported in domestic cats except for calcitriol which was higher in healthy lynx. Changes in mineral metabolism after vitamin D intoxication included hypercalcemia (12.0 +/- 0.3 mg/dL), hyperphosphatemia (6.3 +/- 0.4 mg/dL), increased plasma calcidiol (381.5 +/- 28.2 ng/mL) and decreased plasma parathyroid hormone (1.2 +/- 0.7 pg/mL). Hypercalcemia and, particularly, hyperphosphatemia were of lower magnitude that what has been previously reported in the course of vitamin D intoxication in other species. However, extraskeletal calcifications were severe. The data suggest that lynx are sensitive to excessive vitamin D and extreme care should be taken when supplementing this vitamin in captive lynx diets.	[Lopez, Ignacio; Pineda, Carmen; Raya, Ana; Aguilera-Tejero, Escolastico] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain; [Munoz, Luis] Hosp Vet San Francisco La Carolina, Jaen, Spain; [Lopez, Guillermo] Agencia Medio Ambiente & Agua Andalucia, Proyecto Life Iberlince, Seville, Spain	Universidad de Cordoba	Aguilera-Tejero, E (corresponding author), Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain.	eaguilera@uco.es	Pineda, Carmen/AAF-4385-2020; Raya, Ana I/A-9548-2017	Raya, Ana I/0000-0002-4489-9447; Pineda Martos, Carmen Maria/0000-0002-3664-8699	Junta de Andalucia [CTS179]; Iberian lynx conservation LIFE project [LIFE06NAT/E/000209]	Junta de Andalucia(Junta de Andalucia); Iberian lynx conservation LIFE project	The authors received no specific funding for this work. General research funds were provided by Junta de Andalucia CTS179.; The work reported here was supported by Junta de Andalucia (CTS-179). The Andalusian Regional Government of Environment and the Spanish Ministry of Environment facilitated the work at many different levels. Personnel of the Iberian lynx captive breeding program collected all data that helped to identify the origin of the intoxication. The Iberian lynx conservation LIFE project (LIFE06NAT/E/000209) provided the samples of wild individuals. All veterinarians working in any Iberian lynx conservation program worked hard to identify all potential factors underlying the detected renal disease.	Aguilera-Tejero E, 2000, EQUINE VET J, V32, P167, DOI 10.2746/042516400777591552; Araki T, 2011, J CLIN ENDOCR METAB, V96, P3603, DOI 10.1210/jc.2011-1443; Barber PJ, 1998, J SMALL ANIM PRACT, V39, P108, DOI 10.1111/j.1748-5827.1998.tb03613.x; Bas S, 2004, DOMEST ANIM ENDOCRIN, V26, P99, DOI 10.1016/j.domaniend.2003.08.006; Block GA, 2000, CLIN NEPHROL, V54, P318; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; Garcia I, 2010, VET J, V183, P201, DOI 10.1016/j.tvjl.2008.10.012; Gerspach C, 2010, J VET INTERN MED, V24, P443, DOI 10.1111/j.1939-1676.2009.0462.x; Harmeyer J, 2004, J STEROID BIOCHEM, V89-90, P595, DOI 10.1016/j.jsbmb.2004.03.034; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Klontz KC, 2007, NEW ENGL J MED, V357, P308, DOI 10.1056/NEJMc063341; LEVI M, 1983, J CLIN INVEST, V71, P1624, DOI 10.1172/JCI110918; Liborio AB, 2014, KIDNEY INT, V85, P1247, DOI 10.1038/ki.2013.230; Martinez F, 2013, J ZOO WILDLIFE MED, V44, P845, DOI 10.1638/2011-0165R4.1; Moore FM, 1998, J AM VET MED ASSOC, V193, P1099; Palomares F, 2011, CONSERV BIOL, V25, P4, DOI 10.1111/j.1523-1739.2010.01607.x; Peralta-Ramirez A, 2014, AM J PHYSIOL-RENAL, V306, pF422, DOI 10.1152/ajprenal.00355.2013; PETERSON EN, 1991, J AM VET MED ASSOC, V199, P904; Pineda C, 2012, DOMEST ANIM ENDOCRIN, V42, P256, DOI 10.1016/j.domaniend.2012.01.003; Pineda C, 2013, J FELINE MED SURG, V15, P866, DOI 10.1177/1098612X13478264; SELBY PL, 1995, CLIN ENDOCRINOL, V43, P531, DOI 10.1111/j.1365-2265.1995.tb02916.x; Simon MA, 2012, CONSERV BIOL, V26, P731, DOI 10.1111/j.1523-1739.2012.01871.x; THOMAS JB, 1990, AUST VET J, V67, P274, DOI 10.1111/j.1751-0813.1990.tb07792.x; Tryfonidou MA, 2003, AM J PHYSIOL-ENDOC M, V284, pE505, DOI 10.1152/ajpendo.00236.2002; VIETH R, 1990, BONE MINER, V11, P267, DOI 10.1016/0169-6009(90)90023-9; Wehner A, 2013, J FELINE MED SURG, V15, P730, DOI 10.1177/1098612X12472180; Wimsatt J, 1998, J VET INTERN MED, V12, P42, DOI 10.1111/j.1939-1676.1998.tb00495.x; Zebger-Gong H, 2011, J HYPERTENS, V29, P339, DOI 10.1097/HJH.0b013e328340aa30	29	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156331	10.1371/journal.pone.0156331	http://dx.doi.org/10.1371/journal.pone.0156331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243456	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100028
J	Liu, XQ; Kiefl, R; Roskopf, C; Tian, F; Huber, RM				Liu, Xiao-qing; Kiefl, Rosemarie; Roskopf, Claudia; Tian, Fei; Huber, Rudolf M.			Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELL; METASTASIS; ANGIOGENESIS; TARGETS	In vitro cell-based models of lung cancer are frequently employed to study invasion and the mechanisms behind metastasis. However, these models often study only one cell type with two-dimensional (2D) monolayer cell cultures, which do not accurately reflect the complexity of inflammation in vivo. Here, a three-dimensional (3D) cell co-culture collagen gel model was employed, containing human lung adenocarcinoma cells (HCC), human lung fibroblast cells (MRC-5), and macrophages. Cell culture media and cell images were collected, and matrix metalloproteinase-1 (MMP-1) and vascular endothelial growth factor (VEGF) production was monitored under different cell culture conditions. We found that simulating hypoxia and/or serum starvation conditions induced elevated secretion of VEGF in the 3D co-culture model in vitro, but not MMP-1; the morphology of HCC in the 2D versus the 3D co-culture system was extremely different. MMP-1 and VEGF were secreted at higher levels in mixed cell groups rather than mono-culture groups. Therefore, incorporating lung cancer cells, fibroblasts, and macrophages may better reflect physiological metastasis mechanisms compared to mono-culture systems. Tumour stromal cells, macrophages, and fibroblast cells may promote invasion and metastasis, which also provides a new direction for the design of therapies targeted at destroying the stroma of tumor tissues.	[Liu, Xiao-qing; Kiefl, Rosemarie; Tian, Fei; Huber, Rudolf M.] Univ Munich, Med Klin 5, Div Resp Med & Thorac Oncol, Thorac Oncol Ctr Munich,Comprehens Pneumol Ctr Mu, Munich, Bavaria, Germany; [Liu, Xiao-qing] First Peoples Hosp Lianyungang City, Dept Med Oncol, Lianyungang, Jiangsu, Peoples R China; [Roskopf, Claudia] Univ Munich, Med Klin Innenstadt, Div Hematooncol, Ziemssenstr 1, D-80539 Munich, Bavaria, Germany	University of Munich; University of Munich	Huber, RM (corresponding author), Univ Munich, Med Klin 5, Div Resp Med & Thorac Oncol, Thorac Oncol Ctr Munich,Comprehens Pneumol Ctr Mu, Munich, Bavaria, Germany.	huber@med.uni-muenchen.de	Huber, Rudolf M./L-2464-2019	Huber, Rudolf M./0000-0001-7041-6368				Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; International Agency for Research on Cancer W, 2008, GLOB 2008 CANC FACT; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; MORIKAWA K, 1988, CANCER RES, V48, P6863; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910	20	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156268	10.1371/journal.pone.0156268	http://dx.doi.org/10.1371/journal.pone.0156268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232698	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000017
J	Park, J; Kotani, T; Konno, T; Setiawan, J; Kitamura, Y; Imada, S; Usui, Y; Hatano, N; Shinohara, M; Saito, Y; Murata, Y; Matozaki, T				Park, Jung-ha; Kotani, Takenori; Konno, Tasuku; Setiawan, Jajar; Kitamura, Yasuaki; Imada, Shinya; Usui, Yutaro; Hatano, Naoya; Shinohara, Masakazu; Saito, Yasuyuki; Murata, Yoji; Matozaki, Takashi			Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; STEM-CELLS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; MICROBIOTA; RECEPTORS; MARKER; COLON; CRYPT	The life span of intestinal epithelial cells (IECs) is short (3-5 days), and its regulation is thought to be important for homeostasis of the intestinal epithelium. We have now investigated the role of commensal bacteria in regulation of IEC turnover in the small intestine. The proliferative activity of IECs in intestinal crypts as well as the migration of these cells along the crypt-villus axis were markedly attenuated both in germ-free mice and in specific pathogen-free (SPF) mice treated with a mixture of antibiotics, with antibiotics selective for Gram-positive bacteria being most effective in this regard. Oral administration of chloroform- treated feces of SPF mice to germ-free mice resulted in a marked increase in IEC turnover, suggesting that spore-forming Gram-positive bacteria contribute to this effect. Oral administration of short-chain fatty acids (SCFAs) as bacterial fermentation products also restored the turnover of IECs in antibiotic-treated SPF mice as well as promoted the development of intestinal organoids in vitro. Antibiotic treatment reduced the phosphorylation levels of ERK, ribosomal protein S6, and STAT3 in IECs of SPF mice. Our results thus suggest that Gram-positive commensal bacteria are a major determinant of IEC turnover, and that their stimulatory effect is mediated by SCFAs.	[Park, Jung-ha; Kotani, Takenori; Konno, Tasuku; Setiawan, Jajar; Kitamura, Yasuaki; Imada, Shinya; Usui, Yutaro; Saito, Yasuyuki; Murata, Yoji; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan; [Hatano, Naoya; Shinohara, Masakazu] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan; [Park, Jung-ha] Dong Eui Univ, Dept Life Sci & Biotechnol, Coll Nat Sci & Human Ecol, Busan, South Korea	Kobe University; Kobe University; Dong-Eui University	Kotani, T; Matozaki, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan.	kotani@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp	Saito, Yasuyuki/AAD-1436-2019; Saito, Yasuyuki/C-2541-2015; Setiawan, Jajar/GLT-9019-2022; Imada, Shinya/GQY-7056-2022	Saito, Yasuyuki/0000-0002-9291-1383; Saito, Yasuyuki/0000-0002-9291-1383; Kotani, Takenori/0000-0001-8571-4210; Murata, Yoji/0000-0002-9576-7030	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23659155, 25114709, 16K08586]; Uehara Memorial Foundation; Institute for Molecular and Cellular Regulation, Gunma University [16036]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Institute for Molecular and Cellular Regulation, Gunma University	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (23659155 to TM), a Grant-in-Aid for Scientific Research on Innovative Areas (25114709 to T. Kotani) and a Grant-in-Aid for Scientific Research (C) (16K08586 to T. Kotani) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan as well as by the Uehara Memorial Foundation (T. Kotani). This work was also supported by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (16036 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Heuberger J, 2014, P NATL ACAD SCI USA, V111, P3472, DOI 10.1073/pnas.1309342111; Holt PR, 1997, CANCER EPIDEM BIOMAR, V6, P131; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hsieh EA, 2004, J INVEST DERMATOL, V123, P530, DOI 10.1111/j.0022-202X.2004.23303.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; JENSEN JE, 1977, J INVEST DERMATOL, V68, P23, DOI 10.1111/1523-1747.ep12485145; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Murata Y, 2015, P NATL ACAD SCI USA, V112, pE4264, DOI 10.1073/pnas.1510167112; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Puhl NJ, 2012, ANAEROBE, V18, P67, DOI 10.1016/j.anaerobe.2011.12.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Solanas G, 2011, EXP CELL RES, V317, P2695, DOI 10.1016/j.yexcr.2011.07.019; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Zhou Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.588	46	128	133	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156334	10.1371/journal.pone.0156334	http://dx.doi.org/10.1371/journal.pone.0156334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232601	Green Published, gold			2022-12-27	WOS:000376883000024
J	Foy, HJ; Runham, P; Chapman, P				Foy, Hannah J.; Runham, Patrick; Chapman, Peter			Prefrontal Cortex Activation and Young Driver Behaviour: A fNIRS Study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; NOVICE DRIVERS; DRIVING BEHAVIOR; DECISION-MAKING; TRAFFIC SAFETY; FMRI; CHILDHOOD; ATTENTION; ATTITUDES; WORKLOAD	Road traffic accidents consistently show a significant over-representation for young, novice and particularly male drivers. This research examines the prefrontal cortex activation of young drivers and the changes in activation associated with manipulations of mental workload and inhibitory control. It also considers the explanation that a lack of prefrontal cortex maturation is a contributing factor to the higher accident risk in this young driver population. The prefrontal cortex is associated with a number of factors including mental workload and inhibitory control, both of which are also related to road traffic accidents. This experiment used functional near infrared spectroscopy to measure prefrontal cortex activity during five simulated driving tasks: one following task and four overtaking tasks at varying traffic densities which aimed to dissociate workload and inhibitory control. Age, experience and gender were controlled for throughout the experiment. The results showed that younger drivers had reduced prefrontal cortex activity compared to older drivers. When both mental workload and inhibitory control increased prefrontal cortex activity also increased, however when inhibitory control alone increased there were no changes in activity. Along with an increase in activity during overtaking manoeuvres, these results suggest that prefrontal cortex activation is more indicative of workload in the current task. There were no differences in the number of overtakes completed by younger and older drivers but males overtook significantly more than females. We conclude that prefrontal cortex activity is associated with the mental workload required for overtaking. We additionally suggest that the reduced activation in younger drivers may be related to a lack of prefrontal maturation which could contribute to the increased crash risk seen in this population.	[Foy, Hannah J.; Runham, Patrick; Chapman, Peter] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Foy, HJ; Chapman, P (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	lpxhf@nottingham.ac.uk; peter.chapman@nottingham.ac.uk		Chapman, Peter/0000-0002-3891-4241	Driving Standards Agency; Economic and Social Research Council as part of a CASE studentship	Driving Standards Agency; Economic and Social Research Council as part of a CASE studentship	This research was part-funded by the Driving Standards Agency (became Driver and Vehicle Standards Agency in April 2014: https://www.gov.uk/government/organisations/driver-and-vehicle-standards-agency) and the Economic and Social Research Council (http://www.esrc.ac.uk) as part of a CASE studentship supporting PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasted CM, ANATOMICAL GUIDANCE; Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; [Anonymous], 2013, REP ROAD CAUS GREAT; Arjona A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04526; Ayaz H, 2012, NEUROIMAGE, V59, P36, DOI 10.1016/j.neuroimage.2011.06.023; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Bayliss D., 2009, ACCIDENT TRENDS ROAD; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; Begg DJ, 2004, ACCIDENT ANAL PREV, V36, P1067, DOI 10.1016/j.aap.2004.03.001; Benders M., 2014, CEREB CORTEX; Boyle LN, 2008, TRANSPORT RES F-TRAF, V11, P126, DOI 10.1016/j.trf.2007.08.001; Braitman KA, 2008, J SAFETY RES, V39, P47, DOI 10.1016/j.jsr.2007.12.002; Brigadoi S, 2014, NEUROIMAGE, V85, P181, DOI 10.1016/j.neuroimage.2013.04.082; Brookhuis KA, 2001, HUM FAC TRANSP, P321; Bultitude JH, 2006, NEUROPSYCHOLOGIA, V44, P1849, DOI 10.1016/j.neuropsychologia.2006.03.001; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; CLARKE DD, 2002, TRL542; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Cooper RJ, 2012, FRONT NEUROSCI; Cui X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015474; De Craen S, 2011, ACCIDENT ANAL PREV, V43, P1660, DOI 10.1016/j.aap.2011.03.024; de Craen S, 2008, ACCIDENT ANAL PREV, V40, P1524, DOI 10.1016/j.aap.2008.03.018; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Eckel CC, 2008, J ECON BEHAV ORGAN, V68, P1, DOI 10.1016/j.jebo.2008.04.006; Eggemeier GF., 1991, MULTIPLE TASK PERFOR, P207; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; European Conference of Ministers of Transport, 2006, YOUNG DRIV ROAD SAF; Fastenmeier W, 2007, SAFETY SCI, V45, P952, DOI 10.1016/j.ssci.2006.08.023; Franceschini MA, 2007, PEDIATR RES, V61, P546, DOI 10.1203/pdr.0b013e318045be99; Fuller R, 2008, TRANSPORT, P1; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Giedd JN, 1999, NATURE NEUROSCIENCE; Glendon AI, 2011, HANDBOOK OF TRAFFIC PSYCHOLOGY, P109, DOI 10.1016/B978-0-12-381984-0.10009-8; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gunning-Dixon FM, 2003, NEUROPSYCHOLOGIA, V41, P1929, DOI 10.1016/S0028-3932(03)00129-5; HENDY KC, 1993, HUM FACTORS, V35, P579, DOI 10.1177/001872089303500401; Herff C, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00935; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Ishii-Takahashi A, 2014, NEUROIMAGE-CLIN, V4, P53, DOI 10.1016/j.nicl.2013.10.002; Ivers R, 2009, AM J PUBLIC HEALTH, V99, P1638, DOI 10.2105/AJPH.2008.150367; Iversen H, 2004, ERGONOMICS, V47, P555, DOI 10.1080/00140130410001658709; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Jones SJ, 2013, INT J INJ CONTROL SA, V20, P321, DOI 10.1080/17457300.2012.726631; Kwon H, 2002, P NATL ACAD SCI USA, V99, P13336, DOI 10.1073/pnas.162486399; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liao CH, 2002, NEUROIMAGE, V16, P593, DOI 10.1006/nimg.2002.1096; Luijten M, 2014, J PSYCHIATR NEUROSCI, V39, P149, DOI 10.1503/jpn.130052; Macaluso E, 1991, CEREBRAL CORTEX; MacIntosh BJ, 2003, NEUROIMAGE, V20, P1246, DOI 10.1016/S1053-8119(03)00417-8; Maior HA, 2014, INT F 2014 P 2014 C; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Maycock G., 2001, NOVICE DRIVE RACCIDE; Maycock G., 1991, ACCIDENT LIABILITY C; Mayhew DR, 2003, ACCIDENT ANAL PREV, V35, P683, DOI 10.1016/S0001-4575(02)00047-7; Mccartt AT, 2009, TRAFFIC INJ PREV, V10, P209, DOI 10.1080/15389580802677807; McCartt AT, 2003, ACCIDENT ANAL PREV, V35, P311, DOI 10.1016/S0001-4575(02)00006-4; Meuleners LB, 2006, ACCIDENT ANAL PREV, V38, P1006, DOI 10.1016/j.aap.2006.04.005; Molavi B, 2012, PHYSIOL MEAS, V33, P259, DOI 10.1088/0967-3334/33/2/259; Molteni E, 2008, IEEE ENG MED BIO, P4024, DOI 10.1109/IEMBS.2008.4650092; Monarrez-Espino J, 2006, SAFETY SCI, V44, P75, DOI 10.1016/j.ssci.2005.07.004; Noah JA, 2015, JOVE-J VIS EXP, DOI 10.3791/52116; Organisation WH, 2002, GENDER AND ROAD TRAF; Patten CJD, 2004, ACCIDENT ANAL PREV, V36, P341, DOI 10.1016/S0001-4575(03)00014-9; Paulsen DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00072; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Rakauskas ME, 2008, ACCIDENT ANAL PREV, V40, P1742, DOI 10.1016/j.aap.2008.06.009; Rakow T, 2010, J BEHAV DECIS MAKING, V23, P69, DOI 10.1002/bdm.672; Rozanski M, 2014, STROKE, V45, P1007, DOI 10.1161/STROKEAHA.114.004740; Sabey B.E, 1975, INTERACTING ROLES RO; Salmon PM, 2011, P 9 INT C ENG PSYCH; Schroeter ML, 2006, NEUROIMAGE, V30, P349, DOI 10.1016/j.neuroimage.2005.09.048; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Sherman RC, 1999, PERS SOC PSYCHOL B, V25, P177, DOI 10.1177/0146167299025002004; Shimizu T, 2011, SAE INT J PASSENG CA; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tomita Y, 2014, IEEE T BIO-MED ENG, V61, P1274, DOI 10.1109/TBME.2014.2300492; Troutbeck RJ., 1981, OVERTAKING BEHAV AUS; Ulleberg P, 2002, SCAND J PSYCHOL, V43, P227, DOI 10.1111/1467-9450.00291; Ullman H, 2014, J NEUROSCI, V34, P1592, DOI 10.1523/JNEUROSCI.0842-13.2014; Williams AF, 2003, J SAFETY RES, V34, P5, DOI 10.1016/S0022-4375(02)00075-0; World Health Organization, 2015, COR COMP AD HLTH DEV	88	45	46	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156512	10.1371/journal.pone.0156512	http://dx.doi.org/10.1371/journal.pone.0156512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227990	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500151
J	Hooijmans, CR; Geessink, FJ; Ritskes-Hoitinga, M; Scheffer, GJ				Hooijmans, Carlijn R.; Geessink, Florentine J.; Ritskes-Hoitinga, Merel; Scheffer, Gert Jan			A Systematic Review of the Modifying Effect of Anaesthetic Drugs on Metastasis in Animal Models for Cancer	PLOS ONE			English	Review							SEARCH FILTER; RECURRENCE; SURGERY; METAANALYSIS; ANALGESIA; QUALITY; REDUCE	Background Distant metastasis or local recurrence after primary tumour resection remain a major clinical problem. The anaesthetic technique used during oncologic surgery is suggested to influence the metastatic process. While awaiting the results of ongoing randomised controlled trials (RCTs), we have analyzed the evidence regarding the influence of anaesthetic drugs on experimental tumour metastasis in animal studies. Methods PubMed and Embase were searched until April 21st, 2015. Studies were included in the systematic review when they 1) assessed the effect of an anaesthetic drug used in clinical practice on the number or incidence of metastasis in animal models with experimental cancer, 2) included an appropriate control group, and 3) presented unique data. Results 20 studies met the inclusion criteria (published between 1958-2010). Data on number of metastases could be retrieved from 17 studies. These studies described 41 independent comparisons, 33 of which could be included in the meta-analysis (MA). The incidence of metastases was studied in 3 unique papers. From these 3 papers, data on 7 independent comparisons could be extracted and included in the MA. Locally administered local anaesthetics appear to decrease the number of metastases (SMD -6.15 [-8.42; -3.88]), whereas general anaesthetics (RD: 0.136 [0.045, 0.226]), and more specifically volatile anaesthetics (SMD 0.54 [0.24; 0.84]), appear to increase the number and risk of metastases in animal models for cancer. Conclusions Anaesthetics influence the number and incidence of metastases in experimental cancer models. Although more high quality experimental research is necessary, based on the currently available evidence from animal studies, there is no indication to suggest that locally administered local anaesthetics are harmful during surgery in cancer patients. Volatile anaesthetics, however, might increase metastasis in animal models and clinical trials investigating this possibly harmful effect should receive priority. The results of our systematic review in animal studies are broadly consistent with clinical reports that anaesthetic technique does seem to affect the tumour metastasis process.	[Hooijmans, Carlijn R.; Ritskes-Hoitinga, Merel] Radboud Univ Nijmegen, Med Ctr, Dept SYstemat Review, Ctr Lab Anim Expt SYRCLE, NL-6500 HB Nijmegen, Netherlands; [Hooijmans, Carlijn R.; Geessink, Florentine J.; Scheffer, Gert Jan] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hooijmans, CR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept SYstemat Review, Ctr Lab Anim Expt SYRCLE, NL-6500 HB Nijmegen, Netherlands.; Hooijmans, CR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol Pain & Palliat Med, NL-6500 HB Nijmegen, Netherlands.	Carlijn.Hooijmans@radboudumc.nl	Hooijmans, C.R./L-4390-2015; Scheffer, G.J./H-8086-2014; Ritskes-Hoitinga, Merel/GLT-8517-2022; Ritskes-Hoitinga, J./H-8083-2014	Hooijmans, C.R./0000-0001-6435-5714; Ritskes-Hoitinga, Merel/0000-0001-5315-284X; 				Agostino D, 1964, ANESTHETIC EFFECT PU, P735; Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; Ben-Eliyahu S, 1999, ANESTHESIOLOGY, V91, P732, DOI 10.1097/00000542-199909000-00026; Buggy DJ, 2015, BRIT J ANAESTH, V114, P2, DOI 10.1093/bja/aeu262; Cakmakkaya OS, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008877.pub2; Cassinello F, 2015, J CLIN ANESTH, V27, P262, DOI 10.1016/j.jclinane.2015.02.007; de Vries RBM, 2014, LAB ANIM-UK, V48, P88, DOI 10.1177/0023677213494374; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Forget P, 2010, EUR J ANAESTH, V27, P233, DOI 10.1097/EJA.0b013e32832d540e; FRID IA, 1984, EKSP ONKOL, V6, P57; Heaney A, 2012, BRIT J ANAESTH, V109, pI17, DOI 10.1093/bja/aes421; Hooijmans CR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001482; Hooijmans CR, 2015, PAIN, V156, P1835, DOI 10.1097/j.pain.0000000000000296; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Hooijmans CR, 2015, PAIN; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087; LUNDY J, 1977, SURGERY, V82, P254; LUNDY J, 1978, CANCER, V41, P827, DOI 10.1002/1097-0142(197803)41:3<827::AID-CNCR2820410307>3.0.CO;2-#; Mammoto T, 2002, J CELL PHYSIOL, V192, P351, DOI 10.1002/jcp.10145; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moudgil GC, 1997, CAN J ANAESTH, V44, P90, DOI 10.1007/BF03014331; Nicolson GL, 1986, JNCI-J NATL CANCER I, P511; PAGE GG, 1993, PAIN, V54, P21, DOI 10.1016/0304-3959(93)90095-7; POLLARD M, 1977, ONCOLOGY, V34, P129, DOI 10.1159/000225205; Pollard M, 1977, FEDERATION P, V4306; SCHATTEN WE, 1958, CANCER, V11, P460, DOI 10.1002/1097-0142(195805/06)11:3<460::AID-CNCR2820110304>3.0.CO;2-E; Sessler DI, 2008, EUR J CANCER PREV, V17, P269, DOI 10.1097/CEJ.0b013e3282f0c005; SIMON RH, 1980, SCIENCE, V209, P1132, DOI 10.1126/science.6250220; Singh SK, 1987, SURG RES COMMUNICATI, P19; Stanculescu M, 1981, ONCOLOGIA, P95; Stanculescu M, 1983, ONCOLOGIA, P239; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Votta-Velis EG, 2013, ACTA ANAESTH SCAND, V57, P1211, DOI 10.1111/aas.12210; Wada H, 2007, ANESTHESIOLOGY, V106, P499, DOI 10.1097/00000542-200703000-00014; Wigmore TJ, 2016, ANESTHESIOLOGY, V124, P69, DOI 10.1097/ALN.0000000000000936	39	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156152	10.1371/journal.pone.0156152	http://dx.doi.org/10.1371/journal.pone.0156152			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227779	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500072
J	Jang, CH; Piao, YL; Huang, XQ; Yoon, EJ; Park, SH; Lee, K; Zhan, CG; Cho, H				Jang, Chul Ho; Piao, Yu Lan; Huang, Xiaoqin; Yoon, Eun Jeong; Park, So Hee; Lee, Kyoung; Zhan, Chang-Guo; Cho, Hoon			Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation	PLOS ONE			English	Article							MUCOID PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; CHRONIC WOUNDS; O-ACETYLATION; GENE-CLUSTER; FORCE-FIELD; SEQUENCE; BINDING	Alginate is known to prevent elimination of Pseudomonas aeruginosa biofilms. Alginate lyase (AlgL) might therefore facilitate treatment of Pseudomonas aeruginosa-infected cystic fibrosis patients. However, the catalytic activity of wild-type AlgL is not sufficiently high. Therefore, molecular modeling and site-directed mutagenesis of AlgL might assist in enzyme engineering for therapeutic development. AlgL, isolated from Azotobacter vinelandii, catalyzes depolymerization of alginate via a beta-elimination reaction. AlgL was modeled based on the crystal structure template of Sphingomonas AlgL species A1-III. Based on this computational analysis, AlgL was subjected to site-directed mutagenesis to improve its catalytic activity. The k(cat)/K-m of the K194E mutant showed a nearly 5-fold increase against the acetylated alginate substrate, as compared to the wild-type. Double and triple mutants (K194E/K245D, K245D/K319A, K194E/K245D/E312D, and K194E/K245D/K319A) were also prepared. The most potent mutant was observed to be K194E/K245D/K319A, which has a 10-fold improved k(cat) value (against acetylated alginate) compared to the wild-type enzyme. The antibiofilm effect of both AlgL forms was identified in combination with pipera-cillin/tazobactam (PT) and the disruption effect was significantly higher in mutant AlgL combined with PT than wild-type AlgL. However, for both the wild-type and K194E/K245D/K319A mutant, the use of the AlgL enzyme alone did not show significant antibiofilm effect.	[Jang, Chul Ho] Chonnam Natl Univ, Sch Med, Dept Otolaryngol, Gwangju 501757, South Korea; [Piao, Yu Lan; Yoon, Eun Jeong; Park, So Hee; Cho, Hoon] Chosun Univ, Dept Polymer Sci & Engn, Kwangju 501759, South Korea; [Huang, Xiaoqin; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Mol Modeling & Biopharmaceut Ctr, 789 South Limestone St, Lexington, KY 40536 USA; [Huang, Xiaoqin; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 South Limestone St, Lexington, KY 40536 USA; [Lee, Kyoung] Changwon Natl Univ, Dept Microbiol, Chang Won 641773, Kyongnam, South Korea	Chonnam National University; Chosun University; University of Kentucky; University of Kentucky; Changwon National University	Cho, H (corresponding author), Chosun Univ, Dept Polymer Sci & Engn, Kwangju 501759, South Korea.; Zhan, CG (corresponding author), Univ Kentucky, Coll Pharm, Mol Modeling & Biopharmaceut Ctr, 789 South Limestone St, Lexington, KY 40536 USA.; Zhan, CG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 South Limestone St, Lexington, KY 40536 USA.	zhan@uky.edu; hcho@chosun.ac.kr	Jang, Chul/AAJ-8790-2020	Jang, Chul/0000-0003-4084-2301	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education; Human Resource Training Program for Regional Innovation and Creativity through the National Research Foundation of Korea [NRF-2014H1C1A1067030]; National Science Foundation (NSF) [CHE-1111761]	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education; Human Resource Training Program for Regional Innovation and Creativity through the National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This work was supported by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1067030), and the National Science Foundation (NSF grant CHE-1111761).; This work was supported in part by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1067030) and the National Science Foundation (NSF grant CHE-1111761).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; BAYER AS, 1992, INFECT IMMUN, V60, P3979, DOI 10.1128/IAI.60.10.3979-3985.1992; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Braman J, 1996, Methods Mol Biol, V57, P31; Case DA, 2012, AMBER 12; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIDSON IW, 1977, J GEN MICROBIOL, V98, P603, DOI 10.1099/00221287-98-2-603; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Frederiksen B, 2006, ACTA PAEDIATR, V95, P1070, DOI 10.1080/08035250600752466; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1; GRASDALEN H, 1981, CARBOHYD RES, V89, P179, DOI 10.1016/S0008-6215(00)85243-X; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hay ID, 2009, APPL ENVIRON MICROB, V75, P6022, DOI 10.1128/AEM.01078-09; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOIBY N, 1986, ANNU REV MICROBIOL, V40, P29, DOI 10.1146/annurev.mi.40.100186.000333; Huang XQ, 2013, MOL BIOSYST, V9, P3047, DOI 10.1039/c3mb70231f; Huang XQ, 2012, J PHYS CHEM B, V116, P532, DOI 10.1021/jp210579b; Jang CH, 2007, INT J PEDIATR OTORHI, V71, P591, DOI 10.1016/j.ijporl.2006.12.005; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kotra LP, 2000, ASM NEWS, V66, P675; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; MacDonald LC, 2014, J BIOL CHEM, V289, P18022, DOI 10.1074/jbc.M114.571299; MAI GT, 1993, INFECT IMMUN, V61, P4338, DOI 10.1128/IAI.61.10.4338-4343.1993; Masak J, 2014, FEMS MICROBIOL ECOL, V89, P1, DOI 10.1111/1574-6941.12344; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trampuz A, 2005, SWISS MED WKLY, V135, P243; Veeranagouda Y, 2011, PROCESS BIOCHEM, V46, P328, DOI 10.1016/j.procbio.2010.09.009; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wingender J, 2001, METHOD ENZYMOL, V336, P302, DOI 10.1016/S0076-6879(01)36597-7; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x	51	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156197	10.1371/journal.pone.0156197	http://dx.doi.org/10.1371/journal.pone.0156197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253324	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700016
J	Rade, M; Kononen, M; Marttila, J; Shacklock, M; Vanninen, R; Kankaanpaa, M; Airaksinen, O				Rade, M.; Kononen, M.; Marttila, J.; Shacklock, M.; Vanninen, R.; Kankaanpaa, M.; Airaksinen, O.			In Vivo MRI Measurement of Spinal Cord Displacement in the Thoracolumbar Region of Asymptomatic Subjects with Unilateral and Sham Straight Leg Raise Tests	PLOS ONE			English	Article							RESONANCE-IMAGING MEASUREMENT; INTRARADICULAR BLOOD-FLOW; NERVE ROOT DISPLACEMENT; 2006 YOUNG INVESTIGATOR; LUMBAR DISC HERNIATION; UNEMBALMED CADAVERS; SCIATIC-NERVE; WINNER; MOTION	Background Normal displacement of the conus medullaris with unilateral and bilateral SLR has been quantified and the "principle of linear dependence" has been described. Purpose Explore whether previously recorded movements of conus medullaris with SLRs are i) primarily due to transmission of tensile forces transmitted through the neural tissues during SLR or ii) the result of reciprocal movements between vertebrae and nerves. Study design Controlled radiologic study. Methods Ten asymptomatic volunteers were scanned with a 1.5T magnetic resonance (MR) scanner using T2 weighted spc 3D scanning sequences and a device that permits greater ranges of SLR. Displacement of the conus medullaris during the unilateral and sham SLR was quantified reliably with a randomized procedure. Conus displacement in response to unilateral and sham SLRs was quantified and the results compared. Results The conus displaced caudally in the spinal canal by 3.54 +/- 0.87 mm (mean +/- SD) with unilateral (p <=.001) and proximally by 0.32 +/- 1.6 mm with sham SLR (p <=.542). Pearson correlations were higher than 0.99 for both intra- and inter-observer reliability and the observed power was 1 for unilateral SLRs and 0.054 and 0.149 for left and right sham SLR respectively. Conclusions Four relevant points emerge from the presented data: i) reciprocal movements between the spinal cord and the surrounding vertebrae are likely to occur during SLR in asymptomatic subjects, ii) conus medullaris displacement in the vertebral canal with SLR is primarily due to transmission of tensile forces through the neural tissues, iii) when tensile forces are transmitted through the neural system as in the clinical SLR, the magnitude of conus medullaris displacement prevails over the amount of bone adjustment.	[Rade, M.; Shacklock, M.; Airaksinen, O.] Kuopio Univ Hosp, Dept Phys & Rehabil Med, SF-70210 Kuopio, Finland; [Rade, M.] Josip Juraj Strossmayer Univ Osijek, Fac Med, Orthopaed & Rehabil Hosp Prim Dr Martin Horvat, Rovinj, Croatia; [Kononen, M.; Marttila, J.; Vanninen, R.] Kuopio Univ Hosp, Dept Radiol, SF-70210 Kuopio, Finland; [Shacklock, M.] Neurodynam Solut, Adelaide, SA, Australia; [Kankaanpaa, M.] Tampere Univ Hosp, Dept Phys & Rehabil Med, Tampere, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Rade, M (corresponding author), Kuopio Univ Hosp, Dept Phys & Rehabil Med, SF-70210 Kuopio, Finland.; Rade, M (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Med, Orthopaed & Rehabil Hosp Prim Dr Martin Horvat, Rovinj, Croatia.	marinko.rade@kuh.fi	Rade, Marinko/T-1628-2018	Rade, Marinko/0000-0001-7753-7736	Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland) [5960441]	Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland)	The authors acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (project 5960441, Kuopio, Finland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (project 5960441, Kuopio, Finland). The authors would here like to thank the medical illustrator Dr. Ivan Barun (ivan.barun@email.t-com.hr) for providing the excellent illustration presented in Fig 6.	Beith ID, 1995, MOVING IN ON PAIN, P194; BREIG A, 1979, Spine, V4, P242, DOI 10.1097/00007632-197905000-00011; Breig A., 1978, ADVERSE MECH TENSION; CHARNLEY J, 1951, LANCET, V260, P186; Coppieters MW, 2015, J ORTHOP SPORT PHYS, V45, P731, DOI 10.2519/jospt.2015.5743; De Beurmann L., 1884, ARCH PHVSIOL NORM PA, V3, P375; FALCONER MA, 1948, J NEUROL NEUROSUR PS, V11, P13, DOI 10.1136/jnnp.11.1.13; Gilbert KK, 2007, SPINE, V32, P1521, DOI 10.1097/BRS.0b013e318067dd72; Gilbert KK, 2007, SPINE, V32, P1513, DOI 10.1097/BRS.0b013e318067dd55; GODDARD MD, 1965, J NEUROL NEUROSUR PS, V28, P12, DOI 10.1136/jnnp.28.1.12; Inman VT, 1942, RADIOLOGY, V38, P669; JONSSON B, 1995, SPINE, V20, P27; Kobayashi S, 2003, SPINE, V28, P1427, DOI 10.1097/00007632-200307010-00014; Kobayashi S, 2003, J NEUROSURG, V99, P298, DOI 10.3171/spi.2003.99.3.0298; Kobayashi S, 2010, SPINE, V35, P2004, DOI 10.1097/BRS.0b013e3181d4164d; PORTER RW, 1990, SPINE, V15, P103, DOI 10.1097/00007632-199002000-00010; Rade M, 2015, SPINE, V40, P935, DOI 10.1097/BRS.0000000000000914; Rade M, 2014, SPINE, V39, P1288, DOI 10.1097/BRS.0000000000000263; Rade M, 2014, SPINE, V39, P1294, DOI 10.1097/BRS.0000000000000264; Shacklock M, 2007, BIOMECHANICS NERVOUS; Sjoqvist O, 1947, ACTA PSYCH NEUROL SU, P290; SMITH SA, 1993, SPINE, V18, P992, DOI 10.1097/00007632-199306150-00007	22	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155927	10.1371/journal.pone.0155927	http://dx.doi.org/10.1371/journal.pone.0155927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253708	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700012
J	Geva, R; Orr, E				Geva, Ronny; Orr, Edna			Talk the Walk: Does Socio-Cognitive Resource Reallocation Facilitate the Development of Walking?	PLOS ONE			English	Article							CHIMPANZEE; ACQUISITION; BIPEDALISM; ORIGIN; POSTURE; STEP; GAIT	Walking is of interest to psychology, robotics, zoology, neuroscience and medicine. Human's ability to walk on two feet is considered to be one of the defining characteristics of hominoid evolution. Evolutionary science propses that it emerged in response to limited environmental resources; yet the processes supporting its emergence are not fully understood. Developmental psychology research suggests that walking elicits cognitive advancements. We postulate that the relationship between cognitive development and walking is a bi-directional one; and further suggest that the initiation of novel capacities, such as walking, is related to internal socio-cognitive resource reallocation. We shed light on these notions by exploring infants' cognitive and socio-communicative outputs prospectively from 6-18 months of age. Structured bi/tri weekly evaluations of symbolic and verbal development were employed in an urban cohort (N = 9) for 12 months, during the transition from crawling to walking. Results show links between preemptive cognitive changes in socio-communicative output, symbolic-cognitive tool-use processes, and the age of emergence of walking. Plots of use rates of lower symbolic play levels before and after emergence of new skills illustrate reductions in use of previously attained key behaviors prior to emergence of higher symbolic play, language and walking. Further, individual differences in age of walking initiation were strongly related to the degree of reductions in complexity of object-use (r = .832, p < .005), along with increases, counter to the general reduction trend, in skills that serve recruitment of external resources [socio-communication bids before speech (r = -.696, p < .01), and speech bids before walking; r = .729, p < .01)]. Integration of these proactive changes using a computational approach yielded an even stronger link, underscoring internal resource reallocation as a facilitator of walking initiation (r = .901, p < 0.001). These preliminary data suggest that representational capacities, symbolic object use, language and social developments, form an integrated adaptable composite, which possibly enables proactive internal resource reallocation, designed to support the emergence of new developmental milestones, such as walking.	[Geva, Ronny] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Dept Psychol, IL-5290002 Ramat Gan, Israel; [Geva, Ronny; Orr, Edna] Bar Ilan Univ, Dev Neuropsychol Lab, IL-5290002 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Geva, R (corresponding author), Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Dept Psychol, IL-5290002 Ramat Gan, Israel.; Geva, R (corresponding author), Bar Ilan Univ, Dev Neuropsychol Lab, IL-5290002 Ramat Gan, Israel.	Ronny.Geva@biu.ac.il		Geva, Ronny/0000-0002-5724-2153	National Office of Science, Technology and Space	National Office of Science, Technology and Space	This work was supported by an Infrastructure grant from the National Office of Science, Technology and Space awarded to R.G.; http://most.gov.il/English/Pages/default.aspx. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2015, NATURE, V521, P426, DOI 10.1038/521426a; Adolph K., 2010, HDB CROSS CULTURAL D; Adolph K. E., 2013, ROAD WALKING WHAT LE, V1, P403, DOI DOI 10.1093/OXFORDHB/9780199958450.013.0015; Adolph KE, 2014, CHILD DEV PERSPECT, V8, P187, DOI 10.1111/cdep.12085; Adolph KE, 2014, CURR DIR PSYCHOL SCI, V23, P60, DOI 10.1177/0963721413498895; Adolph KE, 2011, DEVELOPMENTAL SCIENCE: AN ADVANCED TEXTBOOK, SIXTH EDITION, P241; ADOLPH KE, 2009, LEARNING INFANT MIND, P172; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Berger SE, 2015, BRIT J DEV PSYCHOL, V33, P106, DOI 10.1111/bjdp.12076; Berger SE, 2014, INFANCY, V19, P117, DOI 10.1111/infa.12042; Berger SE, 2004, INFANCY, V5, P217, DOI 10.1207/s15327078in0502_7; Brand RJ, 2015, INFANCY, V20, P405, DOI 10.1111/infa.12084; BRIL B, 1986, INT J BEHAV DEV, V9, P439, DOI 10.1177/016502548600900403; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Delisle R, 2015, DABATING HUMANKINDS; Gavrilov Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00286; Harcourt-Smith William E.H., 2007, P1483, DOI 10.1007/978-3-540-33761-4_48; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hoff E., 2014, LANGUAGE DEV; HOPKINS WD, 1993, CURR ANTHROPOL, V34, P786, DOI 10.1086/204224; HREIDARSSON SJ, 1983, CLIN PEDIATR, V22, P248, DOI 10.1177/000992288302200402; Huber N, 2011, INT S SOFTWARE ENG A, P90, DOI DOI 10.1145/1988008.1988021; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; JABLONSKI NG, 1993, J HUM EVOL, V24, P259, DOI 10.1006/jhev.1993.1021; Karasik LB, 2011, CHILD DEV, V82, P1199, DOI 10.1111/j.1467-8624.2011.01595.x; Karasik LB, 2010, BEHAV BRAIN SCI, V33, P95, DOI 10.1017/S0140525X10000117; Kretch KS, 2013, DEVELOPMENTAL SCI, V16, P336, DOI 10.1111/desc.12045; Kretch KS, 2013, CHILD DEV, V84, P226, DOI 10.1111/j.1467-8624.2012.01842.x; Leavens DA, 2005, CURR DIR PSYCHOL SCI, V14, P185, DOI 10.1111/j.0963-7214.2005.00361.x; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; McCune L., 2008, CHILDREN LEARN LANGU; Nakatsukasa M, 2004, J ANAT, V204, P385, DOI 10.1111/j.0021-8782.2004.00290.x; Orr E, 2015, INFANT BEHAV DEV, V38, P147, DOI 10.1016/j.infbeh.2015.01.002; Rabain-Jamin J., 1993, EARLY DEV PARENTING, V2, P107, DOI DOI 10.1002/EDP.2430020205; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rovee-Collier C, 1999, CURR DIR PSYCHOL SCI, V8, P80, DOI 10.1111/1467-8721.00019; Ryou Jae-Wook, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P430, DOI 10.3758/CABN.4.4.430; Sayers K, 2008, CURR ANTHROPOL, V49, P87, DOI 10.1086/523675; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Shetreat-Klein M, 2014, BRAIN DEV-JPN, V36, P91, DOI 10.1016/j.braindev.2012.02.005; Soska KC, 2010, DEV PSYCHOL, V46, P129, DOI 10.1037/a0014618; Taatgen NA, 2013, PSYCHOL REV, V120, P439, DOI 10.1037/a0033138; THELEN E, 1984, INFANT BEHAV DEV, V7, P479, DOI 10.1016/S0163-6383(84)80007-7; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064; Walle EA, 2014, DEV PSYCHOL, V50, P336, DOI 10.1037/a0033238; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wuttke J., 2013, LECT NOTES COMPUT SC, V7475, P1, DOI [DOI 10.1007/978-3-642-35813-5_1, 10.1007/978- 3- 642-35813- 5{_}1]; Zelazo PR, 1998, DEV REV, V18, P449, DOI 10.1006/drev.1997.0460	51	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156351	10.1371/journal.pone.0156351	http://dx.doi.org/10.1371/journal.pone.0156351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248834	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700037
J	Hu, XS; Liu, YJ; Wang, YH; Wang, Z; Yu, XL; Wang, B; Zhang, GS; Liu, XF; Hu, ZQ; Zhao, HY; Liu, TX				Hu, Xiang-Shun; Liu, Ying-Jie; Wang, Yu-Han; Wang, Zhe; Yu, Xin-lin; Wang, Bo; Zhang, Gai-Sheng; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian			Resistance of Wheat Accessions to the English Grain Aphid Sitobion avenae	PLOS ONE			English	Article							CEREAL APHID; HEMIPTERA APHIDIDAE; GENETIC-STRUCTURE; SPATIAL-DISTRIBUTION; RHOPALOSIPHUM-PADI; WINTER-WHEAT; VARIETIES; POPULATIONS; ANTIBIOSIS; HOMOPTERA	The English grain aphid, Sitobion avenae, is a major pest species of wheat crops; however, certain varieties may have stronger resistance to infestation than others. Here, we investigated 3 classical resistance mechanisms (antixenosis, antibiosis, and tolerance) by 14 wheat varieties/lines to S. avenae under laboratory and field conditions. Under laboratory conditions, alatae given the choice between 2 wheat varieties, strongly discriminated against certain varieties. Specifically, the 'Amigo' variety had the lowest palatability to S. avenae alatae of all varieties. 'Tm' (Triticum monococcum), 'Astron,' 'Xanthus,' 'Ww2730,' and 'Batis' varieties also had lower palatability than other varieties. Thus, these accessions may use antibiosis as the resistant mechanism. In contrast, under field conditions, there were no significant differences in the number of alatae detected on the 14 wheat varieties. One synthetic line (98-10-30, a cross between of Triticum aestivum (var. Chris) and Triticum turgidum (var. durum) hybridization) had low aphid numbers but high yield loss, indicating that it has high antibiosis, but poor tolerance. In comparison, 'Amigo,' 'Xiaoyan22,' and some '186Tm' samples had high aphid numbers but low yield loss rates, indicating they have low antibiosis, but good tolerance. Aphid population size and wheat yield loss rates greatly varied in different fields and years for '98-10-35,' 'Xiaoyan22,' 'Tp,' 'Tam200,' 'PI high,' and other '186Tm' samples, which were hybrid offspring of T. aestivum and wheat related species. Thus, these germplasm should be considered for use in future studies. Overall, S. avenae is best adapted to 'Xinong1376,' because it was the most palatable variety, with the greatest yield loss rates of all 14 wheat varieties. However, individual varieties/lines influenced aphid populations differently in different years. Therefore, we strongly recommend a combination of laboratory and long-term field experiments in targeted planting regions to identify varieties/lines that consistently show high resistance to S. avenae infestation.	[Hu, Xiang-Shun; Wang, Zhe; Yu, Xin-lin; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Hu, Xiang-Shun; Liu, Ying-Jie; Wang, Yu-Han; Wang, Zhe; Yu, Xin-lin; Wang, Bo; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Crop Pest Management Nrothwest Loess Plat, Minist Agr, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Gai-Sheng] Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhao, HY; Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Zhao, HY; Liu, TX (corresponding author), Northwest A&F Univ, Key Lab Crop Pest Management Nrothwest Loess Plat, Minist Agr, Yangling 712100, Shaanxi, Peoples R China.	zhaohy@nwsuaf.edu.cn; txliu@nwsuaf.edu.cn	Hu, Xiangshun/M-9935-2013		Basic Research Foundation of Northwest AF University [Z222021316, Z109021122]; National Natural Science Foundation of China [31401735]	Basic Research Foundation of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the Basic Research Foundation of Northwest A&F University (Z222021316, Z109021122) and the National Natural Science Foundation of China (31401735).	Boeve PJ, 1998, CAN ENTOMOL, V130, P67, DOI 10.4039/Ent13067-1; [蔡凤环 Cai Fenghuan], 2004, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V32, P21; Cai QN, 2009, BIOL CONTROL, V49, P134, DOI 10.1016/j.biocontrol.2008.12.009; CAILLAUD CM, 1995, B ENTOMOL RES, V85, P189, DOI 10.1017/S000748530003426X; CAILLAUD CM, 1994, ANN APPL BIOL, V125, P219, DOI 10.1111/j.1744-7348.1994.tb04964.x; Cao H-H, 2014, THESIS NW A F U YANG; CHU H. F., 1961, Acta Entomologica Sinica, V10, P411; Di Pietro JP, 1998, PLANT BREEDING, V117, P407, DOI 10.1111/j.1439-0523.1998.tb01964.x; Ding H-S, 1958, ENTOMOL KNOWLE, V2, P70; Dogimont C, 2010, CR BIOL, V333, P566, DOI 10.1016/j.crvi.2010.04.003; Dong H, 2006, THESIS SHANDONG AGR; DONG QZ, 1987, ACTA ENTOMOL SINICA, V30, P277; Du L.-F., 1999, ACTA BOT BOREALI-OCC, V19, P68; Duan C.X., 2006, J PLANT GENET RESOUR, V7, P297; Fievet V, 2007, AGR FOREST ENTOMOL, V9, P125, DOI 10.1111/j.1461-9563.2007.00331.x; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; [付晶 FU Jing], 2008, [河北农业大学学报, Journal of Agricultural University of Hebei], V31, P1; Graybosch RA, 1999, PLANT BREEDING, V118, P125, DOI 10.1046/j.1439-0523.1999.118002125.x; Guo Xiao, 2010, Scientia Agricultura Sinica, V43, P2056; HAVLICKOVA H, 1993, J AGRON CROP SCI, V171, P133, DOI 10.1111/j.1439-037X.1993.tb00122.x; Hesler LS, 2005, EUPHYTICA, V143, P153, DOI 10.1007/s10681-005-3060-7; HOLLENHORST MM, 1983, CROP SCI, V23, P91, DOI 10.2135/cropsci1983.0011183X002300010026x; [胡秉芬 HU Bing-fen], 2009, [甘肃农业大学学报, Journal of Gansu Agricultural University], V44, P58; Hu Xiang-Shun, 2014, Chinese Journal of Applied Entomology, V51, P1459, DOI 10.7679/j.issn.2095-1353.2014.170; Hu XS, 2013, J ECON ENTOMOL, V106, P1894, DOI 10.1603/EC13071; Hu Xiang-shun, 2008, Agricultural Sciences in China, V7, P180, DOI 10.1016/S1671-2927(08)60037-1; [胡想顺 Hu Xiangshun], 2011, [植物保护, Plant Protection], V37, P81; Hu XiangShun, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1221; Huang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122343; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Li Feng-Qi, 2013, Plant Science Journal, V31, P228, DOI 10.3724/SP.J.1142.2013.30228; Li FQ, 2013, J ECON ENTOMOL, V106, P1473, DOI 10.1603/EC12327; Li Jun, 2007, Chinese Bulletin of Entomology, V44, P509; Li S-J, 1998, PLANT PROT, V5, P15; Li Su-Juan, 2001, Entomological Knowledge, V38, P355; Li Xian-Qing, 2006, Acta Entomologica Sinica, V49, P963; Liang Hui, 2004, Acta Genetica Sinica, V31, P189; Liu S-Y, 1993, ACTA AGR BOREALI OCC, V3, P76; Liu XL, 2012, THEOR APPL GENET, V124, P287, DOI 10.1007/s00122-011-1704-7; Liu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106639; Liu XinLun, 2014, Acta Phytophylacica Sinica, V41, P216; Liu XinLun, 2006, Journal of Triticeae Crops, V26, P24; Liu Yong, 2001, Acta Phytophylacica Sinica, V28, P203; Llewellyn KS, 2004, HEREDITY, V93, P143, DOI 10.1038/sj.hdy.6800466; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; LOWE HJB, 1984, J AGR SCI, V102, P487, DOI 10.1017/S0021859600042854; Lu Z-Y, 2014, J HEBEI AGR SCI, V3, P24; Luo R-W, 1988, ACTA PHYTOPHYL SIN, V3, P153; [欧行奇 Ou Xingqi], 2005, [麦类作物学报, Journal of triticeae crops], V25, P125; Painter RH, 1951, INSECT RESISTANCE CR; Pan J-X, 2013, THESIS HEBEI U SCI T; Panda N, 1995, HOST PLANT RESISTANC, P448; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peng L-N, 2000, CHINESE J PESTIC SCI, V3, P13; Qi M-W, 1987, J SHANDONG AGR U, V4, P59; Qu F, 2012, J SHANXI AGR SCI, V4, p[386, 392]; Qu H-X, 2004, ACTA AGR BOREALI SIN, V4, P102; Riazuddin, 2004, Pakistan Entomologist, V26, P13; Shi Z., 1999, ACTA AGR BOREALI SIN, V14, P98; Silva AM, 2013, NEOTROP ENTOMOL, V42, P304, DOI 10.1007/s13744-013-0117-5; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Smith CM, 1999, GLOBAL PLANT GENETIC RESOURCES FOR INSECT-RESISTANT CROPS, P25; Sun J-W, 1993, J HENAN AGR SCI, V1, P26; Thackray DJ, 2009, PLANT PATHOL, V58, P186, DOI 10.1111/j.1365-3059.2008.01950.x; Thieme Thomas, 1996, IOBC-WPRS Bulletin, V19, P1; Wang C-P, 2011, J NW A F U NATU SCI, V4, P41; Wang CP, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9001; Wang M-F, 2011, J HENNAN AGR SCI, V4, P16; Wang Y-M, 1983, J SHANXI AGR SCI, V04, P16; Wei Hui-Ting, 2014, Chinese Journal of Applied Entomology, V51, P1524, DOI 10.7679/j.issn.2095-1353.2014.177; Winder L, 1999, ENTOMOL EXP APPL, V93, P277, DOI 10.1023/A:1003982111689; Wu R., 1996, PLANT PROTECTION TEC, V1, P3; Wu WQ, 2014, ECOL MODEL, V288, P55, DOI 10.1016/j.ecolmodel.2014.05.017; Xie N, 2014, HENAN SCI, V3, P1020; Xin JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109349; Xu LanJie, 2014, Journal of China Agricultural University, V19, P21; Xu LL, 2014, J ORTHOP TRANSL, V2, P1, DOI 10.1016/j.jot.2013.11.002; Xu QiongFang, 2005, Journal of Triticeae Crops, V25, P7; Xu ZH, 2011, J ECON ENTOMOL, V104, P1080, DOI 10.1603/EC10204; Ye S-H, 2012, GRASSLAND TURF, V3, p[78, 83]; Yin Q-Y, 2003, J WHEAT RES, V3, P30; Yu Y, 2008, PLANT CELL TISS ORG, V94, P33, DOI 10.1007/s11240-008-9384-y; Yu Yang, 2006, Yingyong Shengtai Xuebao, V17, P354; Zhang R-L, 1999, ENTOMOL KNOWLE, V3, P135; Zhang X-C, 1985, ACTA PHYTOPHYL SIN, V1, P9; Zhang Z-Y, 2000, ACTA AGR BOREALI SIN, V1, P57; Zhao Z-J, 1996, PLANT PROT, V2, P78; Zheng W-Y, 1999, J WHEAT RES, V1, P1	89	21	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156158	10.1371/journal.pone.0156158	http://dx.doi.org/10.1371/journal.pone.0156158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249206	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700030
J	Lee, SW; Kim, S; Na, KY; Cha, RH; Kang, SW; Park, CW; Cha, DR; Kim, SG; Yoon, SA; Han, SY; Park, JH; Chang, JH; Lim, CS; Kim, YS				Lee, Sung Woo; Kim, Sejoong; Na, Ki Young; Cha, Ran-hui; Kang, Shin Wook; Park, Cheol Whee; Cha, Dae Ryong; Kim, Sung Gyun; Yoon, Sun Ae; Han, Sang Youb; Park, Jung Hwan; Chang, Jae Hyun; Lim, Chun Soo; Kim, Yon Su			Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; ELDERLY POPULATION; UREMIC TOXINS; CYSTATIN-C; BETA(2)-MICROGLOBULIN; HEMODIALYSIS; BICARBONATE; PROTEIN; ADULTS	Background and Objectives Cardiovascular outcomes and mortality rates are poor in advanced chronic kidney disease (CKD) patients. Novel risk factors related to clinical outcomes should be identified. Methods A retrospective analysis of data from a randomized controlled study was performed in 440 CKD patients aged > 18 years, with estimated glomerular filtration rate 15-60 mL/min/1.73m(2). Clinical data were available, and the albumin-adjusted serum anion gap (A-SAG) could be calculated. The outcome analyzed was all-cause mortality. Results Of 440 participants, the median (interquartile range, IQR) follow-up duration was 5.1 (3.0-5.5) years. During the follow-up duration, 29 participants died (all-cause mortality 6.6%). The area under the receiver operating characteristic curve of A-SAG for all-cause mortality was 0.616 (95% CI 0.520-0.712, P = 0.037). The best threshold of A-SAG for all-cause mortality was 9.48 mmol/L, with sensitivity 0.793 and specificity 0.431. After adjusting for confounders, A-SAG above 9.48 mmol/L was independently associated with increased risk of all-cause mortality, with hazard ratio 2.968 (95% CI 1.143-7.708, P = 0.025). In our study, serum levels of beta-2 microglobulin and blood urea nitrogen (BUN) were positively associated with A-SAG. Conclusions A-SAG is an independent risk factor for all-cause mortality in advanced CKD patients. The positive correlation between A-SAG and serum beta-2 microglobulin or BUN might be a potential reason. Future study is needed.	[Lee, Sung Woo] Eulji Gen Hosp, Dept Internal Med, Seoul 01830, South Korea; [Kim, Sejoong; Na, Ki Young] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam 13620, South Korea; [Na, Ki Young; Lim, Chun Soo; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 03080, South Korea; [Cha, Ran-hui] Natl Med Ctr, Dept Internal Med, Seoul 04564, South Korea; [Kang, Shin Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 03722, South Korea; [Park, Cheol Whee] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul 06591, South Korea; [Cha, Dae Ryong] Korea Univ, Korea Univ Ansan Hosp, Dept Internal Med, Ansan 15355, Gyeonggi Do, South Korea; [Kim, Sung Gyun] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Anyang 14068, Gyeonggi Do, South Korea; [Yoon, Sun Ae] Catholic Univ Korea, Uijeongbu St Marys Hosp, Dept Internal Med, Uijongbu 11765, Gyeonggi Do, South Korea; [Han, Sang Youb] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Goyang 10380, Gyeonggi Do, South Korea; [Park, Jung Hwan] Konkuk Univ, Sch Med, Dept Internal Med, Seoul 05030, South Korea; [Chang, Jae Hyun] Gachon Univ Med & Sci, Gil Med Ctr, Gachon Univ, Dept Internal Med, Incheon 21565, South Korea; [Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul 08708, South Korea; [Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul 03080, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Medical Center - Korea; Yonsei University; Yonsei University Health System; Catholic University of Korea; Seoul St. Mary's Hospital; Korea University; Korea University Medicine (KU Medicine); Hallym University; Catholic University of Korea; Inje University; Konkuk University; Konkuk University Medical Center; Gachon University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam 13620, South Korea.	sejoong2@snu.ac.kr	Kim, Sejoong/J-5356-2015	Kim, Sejoong/0000-0002-7238-9962; Park, Jung Hwan/0000-0002-8737-0084	CJ HealthCare Corporation; Kureha Corporation	CJ HealthCare Corporation; Kureha Corporation	Commercial companies CJ HealthCare Corporation and Kureha Corporation provided funding for this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz MK, 2012, KIDNEY INT, V82, P701, DOI 10.1038/ki.2012.196; Abramowitz MK, 2012, KIDNEY INT, V81, P1033, DOI 10.1038/ki.2011.479; Ahn SY, 2014, EXP GERONTOL, V50, P122, DOI 10.1016/j.exger.2013.12.002; Canaud B, 2006, KIDNEY INT, V69, P1297, DOI 10.1038/sj.ki.5000389; Cha RH, 2016, CLIN J AM SOC NEPHRO, V11, P559, DOI 10.2215/CJN.12011214; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Farwell WR, 2008, DIABETIC MED, V25, P798, DOI 10.1111/j.1464-5491.2008.02471.x; Farwell Wildon R, 2010, CMAJ, V182, P137, DOI 10.1503/cmaj.090329; Figge J, 1998, CRIT CARE MED, V26, P1807, DOI 10.1097/00003246-199811000-00019; Filipowicz R, 2013, ADV CHRONIC KIDNEY D, V20, P175, DOI 10.1053/j.ackd.2012.12.007; Frank Jr E.H., 2015, RMS REGRESSION MODEL, V5.1-4; Gannon RHT, 2008, BRIT J NUTR, V100, P615, DOI 10.1017/S0007114508901240; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Haider DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133426; Kiuchi MG, 2016, KIDNEY RES CLIN PRAC, V35, P3, DOI 10.1016/j.krcp.2015.11.003; Kovesdy CP, 2008, KIDNEY INT, V73, P1296, DOI 10.1038/ki.2008.64; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Lee SW, 2011, NEPHROL DIAL TRANSPL, V26, P3975, DOI 10.1093/ndt/gfr154; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Lindstrom V, 2008, SCAND J CLIN LAB INV, V68, P685, DOI 10.1080/00365510802047693; Lipnick MS, 2013, CRIT CARE MED, V41, P49, DOI 10.1097/CCM.0b013e31826764cd; Masereeuw R, 2014, SEMIN NEPHROL, V34, P191, DOI 10.1016/j.semnephrol.2014.02.010; Mehta AN, 2008, LANCET, V372, P892, DOI 10.1016/S0140-6736(08)61398-7; R Core Team, 2014, R A LANGUAGE AND ENV; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodriguez-Benot A, 2005, AM J KIDNEY DIS, V46, P68, DOI 10.1053/j.ajkd.2005.04.006; Sahu A, 2006, CORONARY ARTERY DIS, V17, P409, DOI 10.1097/00019501-200608000-00002; Shinkai S, 2008, ARCH INTERN MED, V168, P200, DOI 10.1001/archinternmed.2007.64; Sun Wenhui, 2014, Ann Transplant, V19, P513, DOI 10.12659/AOT.891207; Taylor EN, 2007, HYPERTENSION, V50, P320, DOI 10.1161/HYPERTENSIONAHA.107.092643; Togawa A, 2013, NEPHRON EXTRA, V3, P113, DOI 10.1159/000356461; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156381	10.1371/journal.pone.0156381	http://dx.doi.org/10.1371/journal.pone.0156381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249416	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700040
J	Mawrie, D; Kumar, A; Magdalene, D; Bhattacharyya, J; Jaganathan, BG				Mawrie, Darilang; Kumar, Atul; Magdalene, Damaris; Bhattacharyya, Jina; Jaganathan, Bithiah Grace			Mesenchymal Stem Cells from Human Extra Ocular Muscle Harbor Neuroectodermal Differentiation Potential	PLOS ONE			English	Article							EXTRAOCULAR-MUSCLES; NEURAL CREST; BONE-MARROW; PROGENITORS; THERAPY	Mesenchymal stem cells (MSC) have been proposed as suitable candidates for cell therapy for neurological disorderssince they exhibit good neuronal differentiation capacity. However, for better therapeutic outcomes, it is necessary to isolate MSC from a suitable tissue sourcethat posses high neuronal differentiation. In this context, we isolated MSC from extra ocular muscle (EOM) tissue and tested the in vitro neuronal differentiation potential. In the current study, EOM tissue derived MSC were characterized and compared with bone marrow derived MSC. We found that EOM derived MSC proliferated as a monolayer and showed similarities in morphology, growth properties and cell surface marker expression with bone marrow derived MSC and expressed high levels of NES, OCT4, NANOG and SOX2 in its undifferentiated state. They also expressed embryonic cell surface marker SSEA4 and their intracellular mitochondrial distribution pattern was similar to that of multi-potent stem cells. Although EOM derived MSC differentiated readily into adipocytes, osteocytes and chondrocytes, they differentiated more efficiently into neuroectodermal cells. The differentiation into neuroectodermal cellswas confirmed by the expression of neuronal markers NGFR and MAP2B. Thus, EOM derived MSC might be good candidates for stem cell based therapies for treating neurodegenerative diseases.	[Mawrie, Darilang; Kumar, Atul; Jaganathan, Bithiah Grace] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell & Canc Biol Lab, Gauhati, Assam, India; [Magdalene, Damaris] Sri Sankaradeva Nethralaya Hosp, Dept Strabismus, Gauhati, Assam, India; [Bhattacharyya, Jina] Gauhati Med Coll & Hosp, Dept Hematol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati Medical College & Hospital	Jaganathan, BG (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell & Canc Biol Lab, Gauhati, Assam, India.	bithiahgj@iitg.ernet.in		Kumar, Atul/0000-0001-9682-5725	Indian council of Medical Research (ICMR) [5/7/526/2011-RHN]	Indian council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	Funded by Indian council of Medical Research (ICMR, No. 5/7/526/2011-RHN). http://www.icmr.nic.in/. ICMR provided seed grant for preliminary studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Himanshu Vyas for performing the preliminary studies. We thank the Central Instrument Facility, Indian Institute of Technology Guwahati (IITG) for performing the FESEM analysis. Primers for calcium channel related genes were kindly provided by Dr. Piruthivi Sukumar (IITG). This project was supported by seed grant from Indian Council of Medical Research (ICMR, No. 5/7/526/2011-RHN) to BGJ and D Magdalene. ICMR did not have any role in designing the experiment, data collection or analysis.	Arrighi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.79; BJORK A, 1952, EXPERIENTIA, V8, P226, DOI 10.1007/BF02170722; Bohnsack BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1030, DOI 10.1001/archophthalmol.2011.75; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; De Kock J, 2012, STEM CELLS DEV, V21, P3309, DOI 10.1089/scd.2011.0723; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ewart J C, 1894, J Anat Physiol, V28, P342; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McDonald AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086424; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Olson SD, 2012, MOL NEUROBIOL, V45, P87, DOI 10.1007/s12035-011-8219-8; Pacheco-Pinedo EC, 2009, PHYSIOL GENOMICS, V37, P35, DOI 10.1152/physiolgenomics.00051.2008; Polisetty N, 2008, MOL VIS, V14, P431; Somaiah C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220; Wright KW, 2003, PEDIAT OPHTHALMOLOGY, Vxxiii, P1084; Wyse RD, 2014, INT J MOL SCI, V15, P1719, DOI 10.3390/ijms15021719; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156697	10.1371/journal.pone.0156697	http://dx.doi.org/10.1371/journal.pone.0156697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248788	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700067
J	Ozono, H; Kamijo, Y; Shimizu, K				Ozono, Hiroki; Kamijo, Yoshio; Shimizu, Kazumi			Institutionalize Reciprocity to Overcome the Public Goods Provision Problem	PLOS ONE			English	Article							COLLECTIVE SANCTIONS; RATIONAL COOPERATION; PRISONERS-DILEMMA; PUNISHMENT; HETEROGENEITY; EVOLUTION; GAMES	Cooperation is fundamental to human societies, and one of the important paths for its emergence and maintenance is reciprocity. In prisoner's dilemma (PD) experiments, reciprocal strategies are often effective at attaining and maintaining high cooperation. In many public goods (PG) games or n-person PD experiments, however, reciprocal strategies are not successful at engendering cooperation. In the present paper, we attribute this difficulty to a coordination problem against free riding among reciprocators: Because it is difficult for the reciprocators to coordinate their behaviors against free riders, this may lead to inequality among players, which will demotivate them from cooperating in future rounds. We propose a new mechanism, institutionalized reciprocity (IR), which refers to embedding the reciprocal strategy as an institution (i.e., institutionalizing the reciprocal strategy). We experimentally demonstrate that IR can prevent groups of reciprocators from falling into coordination failure and achieve high cooperation in PG games. In conclusion, we argue that a natural extension of the present study will be to investigate the possibility of IR to serve as a collective punishment system.	[Ozono, Hiroki] Kagoshima Univ, Fac Law Econ & Humanities, Kagoshima 890, Japan; [Kamijo, Yoshio] Kochi Univ Technol, Sch Econ & Management, Kochi, Japan; [Shimizu, Kazumi] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan	Kagoshima University; Kochi University Technology; Waseda University	Shimizu, K (corresponding author), Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan.	skazumi1961@gmail.com		Shimizu, Kazumi/0000-0003-4860-7007; Kamijo, Yoshio/0000-0002-2184-9594	Japanese Ministry of Education, Culture, Sports, Science and Technology [19046002]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Grant-in-Aid for Scientific Research on Priority Areas (19046002) provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology, http://www.jsps.go.jp/j-grantsinaid/12_kiban/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We gratefully acknowledge financial support from the Grant-in-Aid for Scientific Research on Priority Areas (19046002) provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Alexander R., 2008, ESSAYS PEDAGOGY; Anderson L. R., 2008, J SOCIO-ECON, V37, P1010, DOI [10.1016/j.socec.2006.12.073, DOI 10.1016/J.SOCEC.2006.12.073, DOI 10.1016/j.socec.2006.12.073]; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; [Anonymous], 1965, LOGIC COLLECTIVE ACT; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; COOPER R, 1989, RAND J ECON, V20, P568, DOI 10.2307/2555734; Croson R, 2005, ECON LETT, V87, P95, DOI 10.1016/j.econlet.2004.10.007; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; De Herdt T., 2003, REV SOC ECON, V61, P183, DOI [10.1080/0034676032000098219, DOI 10.1080/0034676032000098219, 10.1080/]; de Oliveira ACM, 2015, EXP ECON, V18, P116, DOI 10.1007/s10683-014-9412-1; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Devetag G, 2007, EXP ECON, V10, P331, DOI 10.1007/s10683-007-9178-9; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, NATURE, V433, DOI 10.1038/nature03256; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Gachter S., 2006, DISCUSSION PAPERS U; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Grujic J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00638; HECKATHORN DD, 1988, AM J SOCIOL, V94, P535, DOI 10.1086/229029; HECKATHORN DD, 1990, AM SOCIOL REV, V55, P366, DOI 10.2307/2095762; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kamijo Y, 2016, EXP ECON, V19, P202, DOI 10.1007/s10683-015-9433-4; KIM O, 1984, PUBLIC CHOICE, V43, P3, DOI 10.1007/BF00137902; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Levinson DJ, 2003, STANFORD LAW REV, V56, P345; Levy DM, 2011, J ECON BEHAV ORGAN, V77, P40, DOI 10.1016/j.jebo.2010.02.018; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nosenzo D, 2015, EXP ECON, V18, P4, DOI 10.1007/s10683-013-9382-8; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rapoport A, 1996, J ECON BEHAV ORGAN, V30, P173, DOI 10.1016/S0167-2681(96)00856-6; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Sherratt TN, 2002, J THEOR BIOL, V215, P47, DOI 10.1006/jtbi.2001.2495; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154321	10.1371/journal.pone.0154321	http://dx.doi.org/10.1371/journal.pone.0154321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248493	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700005
J	Rosignolo, F; Sponziello, M; Durante, C; Puppin, C; Mio, C; Baldan, F; Di Loreto, C; Russo, D; Filetti, S; Damante, G				Rosignolo, Francesca; Sponziello, Marialuisa; Durante, Cosimo; Puppin, Cinzia; Mio, Catia; Baldan, Federica; Di Loreto, Carla; Russo, Diego; Filetti, Sebastiano; Damante, Giuseppe			Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLYPICAN-3 EXPRESSION; BREAST-CANCER; CELLS; NGAL; HEDGEHOG; PROTEIN; TUMORS; DIFFERENTIATION; COMBINATION	PAX8 is a thyroid-specific transcription factor whose expression is dysregulated in thyroid cancer. A recent study using a conditional knock-out mouse model identified 58 putative PAX8 target genes. In the present study, we evaluated the expression of 11 of these genes in normal and tumoral thyroid tissues from patients with papillary thyroid cancer (PTC). ATP1B1, GPC3, KCNIP3, and PRLR transcript levels in tumor tissues were significantly lower in PTCs than in NT, whereas LCN2, LGALS1 and SCD1 expression was upregulated in PTC compared with NT. Principal component analysis of the expression of the most markedly dysregulated PAX8 target genes was able to discriminate between PTC and NT. Immunohistochemistry was used to assess levels of proteins encoded by the two most dyregulated PAX8 target genes, LCN2 and GPC3. Interestingly, GPC3 was detectable in all of the NT samples but none of the PTC samples. Collectively, these findings point to significant PTC-associated dysregulation of several PAX8 target genes, supporting the notion that PAX8-regulated molecular cascades play important roles during thyroid tumorigenesis.	[Rosignolo, Francesca; Sponziello, Marialuisa; Durante, Cosimo; Filetti, Sebastiano] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00161 Rome, Italy; [Puppin, Cinzia; Mio, Catia; Baldan, Federica; Di Loreto, Carla; Damante, Giuseppe] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Di Loreto, Carla; Damante, Giuseppe] Univ Hosp S Maria della Misericordia, Dept Oncol, I-33100 Udine, Italy; [Russo, Diego] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy	Sapienza University Rome; University of Udine; Hospital Santa Maria della Misericordia; Magna Graecia University of Catanzaro	Rosignolo, F (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00161 Rome, Italy.	francesca.rosignolo@uniroma1.it	Baldan, Federica/AAK-6349-2021; mio, catia/AAW-1604-2021; Durante, Cosimo/E-4926-2014; Damante, Giuseppe/AAC-5200-2022; Sponziello, Marialuisa/AAK-3530-2020	Baldan, Federica/0000-0003-1164-1316; mio, catia/0000-0002-6245-8266; Durante, Cosimo/0000-0002-1791-5915; Sponziello, Marialuisa/0000-0003-0736-1047; Rosignolo, Francesca/0000-0001-8913-1848; Damante, Giuseppe/0000-0003-2312-4009	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 10296]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2010NFEB9L_003]; Fondazione Umberto Di Mario ONLUS	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Umberto Di Mario ONLUS	This work was supported by a grant to GD from Associazione Italiana per la Ricerca sul Cancro (AIRC) (http://www.airc.it/) (project no IG 10296), by a grant to DR from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (http://www.miuristruzione.com/miur/)(project no 2010NFEB9L_003), and by the Fondazione Umberto Di Mario ONLUS (http://www.fondazionedimario.org/it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Arturi F, 2001, EUR J ENDOCRINOL, V145, P129, DOI 10.1530/eje.0.1450129; Barresi V, 2012, HISTOL HISTOPATHOL, V27, P329, DOI 10.14670/HH-27.329; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2009, EMBO REP, V10, P901, DOI 10.1038/embor.2009.98; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; FABBRO D, 1994, CANCER RES, V54, P4744; Filmus J, 2014, MATRIX BIOL, V35, P248, DOI 10.1016/j.matbio.2013.12.007; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hinterseher U, 2014, ENDOCRINE, V45, P439, DOI 10.1007/s12020-013-0015-y; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kim H, 2003, AM J RESP CELL MOL, V29, P694, DOI 10.1165/rcmb.2003-0061OC; Lacroix L, 2004, EUR J ENDOCRINOL, V151, P367, DOI 10.1530/eje.0.1510367; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lippi G, 2014, ADV CLIN CHEM, V64, P179, DOI 10.1016/B978-0-12-800263-6.00004-5; Liu Y, 2015, TUMOR BIOL, V36, P7997, DOI 10.1007/s13277-015-3528-6; Ma H, 2014, POL J PATHOL, V65, P202, DOI 10.5114/PJP.2014.45782; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marotta P, 2014, MOL CELL ENDOCRINOL, V396, P26, DOI 10.1016/j.mce.2014.08.004; Nettore IC, 2013, J ENDOCRINOL INVEST, V36, P654, DOI 10.3275/8973; Pellizzari L, 1996, BIOCHEM J, V315, P363, DOI 10.1042/bj3150363; Puglisi F, 2000, ANTICANCER RES, V20, P311; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raman P, 2014, NAT REV ENDOCRINOL, V10, P616, DOI 10.1038/nrendo.2014.115; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Ros P, 1999, BIOCHIMIE, V81, P389, DOI 10.1016/S0300-9084(99)80086-8; Rosignolo F, 2015, J ENDOCRINOL INVEST, V38, P1283, DOI 10.1007/s40618-015-0309-4; Ruiz-Morales JM, 2015, TUMOR BIOL, V36, P3601, DOI 10.1007/s13277-014-2997-3; Sponziello M, 2015, ENDOCRINE, V50, P434, DOI 10.1007/s12020-015-0586-x; Sponziello M, 2013, ENDOCRINOLOGY, V154, P3043, DOI 10.1210/en.2013-1028; Tovey S, 2005, CLIN CANCER RES, V11, P4835, DOI 10.1158/1078-0432.CCR-05-0196; Volpe V, 2013, J CLIN ENDOCR METAB, V98, P228, DOI 10.1210/jc.2012-2528; Wang SK, 2014, ADV ANAT PATHOL, V21, P450, DOI 10.1097/PAP.0000000000000043; Wang Y, 2014, GENET MOL RES, V13, P7102, DOI 10.4238/2014.February.21.11; Xiang YY, 2001, ONCOGENE, V20, P7408, DOI 10.1038/sj.onc.1204925; Xu XL, 2012, ENDOCR-RELAT CANCER, V19, P167, DOI 10.1530/ERC-11-0305; Yamanaka K, 2007, ONCOLOGY-BASEL, V73, P389, DOI 10.1159/000136159	44	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156658	10.1371/journal.pone.0156658	http://dx.doi.org/10.1371/journal.pone.0156658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249794	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700063
J	Amoras, EDG; Gomes, STM; Freitas, FB; Santana, BB; Ishak, G; de Araujo, MTF; Demachki, S; Conde, SRSD; Ishak, MDG; Ishak, R; Vallinoto, ACR				Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Ishak, Geraldo; Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos			Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC HEPATITIS-C; CHRONIC HBV; LIVER FIBROSIS; APOPTOSIS; LYMPHOCYTES; PROLIFERATION; TRANSAMINASE; TOLERANCE; MECHANISM	This study aimed to evaluate the relative mRNA expression of Fas receptor (FAS), Fas ligand (FASL), and forkhead box protein 3 (FOXP3) in liver biopsy specimens obtained from patients with viral and non-viral chronic hepatitis and correlate their expression with the fibrosis stage. A total of 51 liver biopsy specimens obtained from HBV (n = 6), HCV (n = 28), and non-viral hepatic disease (NVHD) (n = 9) patients and from individuals with normal liver histology (n = 8) (control-CT) were analyzed. Quantifications of the target genes were assessed using qPCR, and liver biopsies according to the METAVIR classification. The mRNA expression levels of FAS and FASL were lower in the CT group compared to the groups of patients. The increase in the mRNA expression of FAS and FASL was correlated with higher levels of inflammation and disease progression, followed by a decline in tissues with cirrhosis, and it was also associated with increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Higher mRNA expression of FOXP3 was observed in the HCV and NVHD groups, with the peak observed among patients with cirrhosis. The increased FOXP3 mRNA expression was positively correlated with increased FAS and FASL mRNA expression and the AST and ALT levels in all patients. Conclusions: These results suggest that regardless of the cause, the course of chronic liver disease may be modulated by the analyzed genes and correlated with an increase in regulatory T cells during the liver damage followed by hepatocyte destruction by Fas/FasL system and subsequent non specific lymphocytic infiltrate accumulation.	[Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos] Fed Univ Para, Inst Biol Sci, Virol Lab, BR-66059 Belem, Para, Brazil; [Ishak, Geraldo] Fed Univ Para, Joao de Barros Barreto Hosp, BR-66059 Belem, Para, Brazil; [Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina] Fed Univ Para, Sch Med, Inst Hlth Sci, BR-66059 Belem, Para, Brazil; [Souza da Silva Conde, Simone Regina] Holy House Mercy Fdn Para Santa Casa Misericordia, Hepatol Outpatient Serv, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Vallinoto, ACR (corresponding author), Fed Univ Para, Inst Biol Sci, Virol Lab, BR-66059 Belem, Para, Brazil.	vallinoto@ufpa.br	Vallinoto, Antonio Carlos/AAL-9501-2020; Gomes, Samara Tatielle Monteiro/GVT-9626-2022	Vallinoto, Antonio Carlos/0000-0003-1135-6507; /0000-0001-7079-4844	Brazilian National Council for Scientific and Technological Development (CNPq); Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	This work was partially supported by grants from the Brazilian National Council for Scientific and Technological Development (CNPq), and the Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA).	Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Aygun C., 2010, Firat Tip Dergisi, V15, P74; Ayres M, BIOESTAT 2008 5 0 AP; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bolacchi F, 2006, CLIN EXP IMMUNOL, V144, P188, DOI 10.1111/j.1365-2249.2006.03048.x; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Chaudhary B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00052; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Ciccaglione AR, 2004, VIRUS RES, V104, P1, DOI 10.1016/j.virusres.2004.02.002; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; CLERMONT RJ, 1967, MEDICINE, V46, P197, DOI 10.1097/00005792-196703000-00012; Conde SRS, 2013, CYTOKINE, V61, P940, DOI 10.1016/j.cyto.2013.01.004; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Ehrmann Jiri Jr., 2000, Pathology and Oncolgy Research, V6, P130; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Germanidis G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00207; Amoras EDG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121754; GraphPad Software. Inc, PRISM 2007 DAT AN SO; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hahn CS, 2000, VIROLOGY, V276, P127, DOI 10.1006/viro.2000.0541; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Karrar A, 2007, GUT, V56, P243, DOI 10.1136/gut.2006.093906; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; MEYER DH, 1990, BIOCHEM BIOPH RES CO, V171, P1122, DOI 10.1016/0006-291X(90)90801-S; MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Mossong Joel, 2011, Bull Soc Sci Med Grand Duche Luxemb, P19; Oo YH, 2013, J HEPATOL, V59, P1127, DOI 10.1016/j.jhep.2013.05.034; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Sakaki M, 2008, HEPATOL RES, V38, P354, DOI 10.1111/j.1872-034X.2007.00284.x; Speletas M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/827565; Stoop JN, 2008, CLIN IMMUNOL, V129, P419, DOI 10.1016/j.clim.2008.07.029; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zhu LX, 2004, WORLD J GASTROENTERO, V10, P2972	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156604	10.1371/journal.pone.0156604	http://dx.doi.org/10.1371/journal.pone.0156604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243827	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100052
J	Kao, JK; Wang, SC; Ho, LW; Huang, SW; Chang, SH; Yang, RC; Ke, YY; Wu, CY; Wang, JY; Shieh, JJ				Kao, Jun-Kai; Wang, Shih-Chung; Ho, Li-Wei; Huang, Shi-Wei; Chang, Shu-Hao; Yang, Rei-Cheng; Ke, Yu-Yuan; Wu, Chun-Ying; Wang, Jiu-Yao; Shieh, Jeng-Jer			Chronic Iron Overload Results in Impaired Bacterial Killing of THP-1 Derived Macrophage through the Inhibition of Lysosomal Acidification	PLOS ONE			English	Article							THALASSEMIA MAJOR; CELL-DEATH; IMMUNE-SYSTEM; IN-VITRO; AUTOPHAGY; BIOGENESIS; DEFEROXAMINE; HOMEOSTASIS; ACTIVATION; CHILDREN	Iron is essential for living organisms and the disturbance of iron homeostasis is associated with altered immune function. Additionally, bacterial infections can cause major complications in instances of chronic iron overload, such as patients with transfusion-dependent thalassemia. Monocytes and macrophages play important roles in maintaining systemic iron homoeostasis and in defense against invading pathogens. However, the effect of iron overload on the function of monocytes and macrophages is unclear. We elucidated the effects of chronic iron overload on human monocytic cell line (THP-1) and THP-1 derived macrophages (TDM) by continuously exposing them to high levels of iron (100 mu M) to create I-THP-1 and I-TDM, respectively. Our results show that iron overload did not affect morphology or granularity of I-THP-1, but increased the granularity of I-TDM. Bactericidal assays for non-pathogenic E. coli DH5 alpha, JM109 and pathogenic P. aeruginosa all revealed decreased efficiency with increasing iron concentration in I-TDM. The impaired P. aeruginosa killing ability of human primary monocyte derived macrophages (hMDM) was also found when cells are cultured in iron contained medium. Further studies on the bactericidal activity of I-TDM revealed lysosomal dysfunction associated with the inhibition of lysosomal acidification resulting in increasing lysosomal pH, the impairment of post-translational processing of cathepsins (especially cathepsin D), and decreased autophagic flux. These findings may explain the impaired innate immunity of thalassemic patients with chronic iron overload, suggesting the manipulation of lysosomal function as a novel therapeutic approach.	[Kao, Jun-Kai; Ho, Li-Wei; Shieh, Jeng-Jer] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Kao, Jun-Kai; Wang, Shih-Chung; Ho, Li-Wei; Yang, Rei-Cheng] Changhua Christian Hosp, Childrens Hosp, Dept Pediat, Changhua, Taiwan; [Huang, Shi-Wei; Shieh, Jeng-Jer] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chang, Shu-Hao] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Ke, Yu-Yuan] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol & Hepatol, Taichung, Taiwan; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Allergy & Clin Immunol Res ACIR Ctr, Tainan 70101, Taiwan; [Wang, Jiu-Yao] China Med Univ, Childrens Hosp, Taichung, Taiwan; [Shieh, Jeng-Jer] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan	National Chung Hsing University; Changhua Christian Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Cheng Kung University; China Medical University Taiwan; National Chung Hsing University	Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.; Shieh, JJ (corresponding author), Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.; Wang, JY (corresponding author), Natl Cheng Kung Univ, Coll Med, Allergy & Clin Immunol Res ACIR Ctr, Tainan 70101, Taiwan.; Wang, JY (corresponding author), China Med Univ, Childrens Hosp, Taichung, Taiwan.; Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan.	a122@mail.ncku.edu.tw; shiehjj@vghtc.gov.tw	Shieh, Jeng-Jer/AAX-6903-2020; Wu, Chun-Ying/AAX-5077-2021	Shieh, Jeng-Jer/0000-0001-8412-3603; Wu, Chun-Ying/0000-0001-5053-1801	Chang-hua Christian Hospital [101-CCH-IRP-28]; Taichung Veterans General Hospital [TCVGH-1047307C]; Ministry of Science and Technology, Taiwan [MOST-103-2320-B-005-003, MOST-104-2320-B-005-009-MY3]	Chang-hua Christian Hospital; Taichung Veterans General Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Chang-hua Christian Hospital http://www.cch.org.tw/ (101-CCH-IRP-28), recipient: JKK; Taichung Veterans General Hospital http://www.vghtc.gov.tw/home/index.html/ (TCVGH-1047307C), recipient: JJS; The Ministry of Science and Technology, Taiwan https://www.most.gov.tw/ (MOST-103-2320-B-005-003, MOST-104-2320-B-005-009-MY3), recipient: JJS.	Arifin AJ, 2014, MICROBES INFECT, V16, P967, DOI 10.1016/j.micinf.2014.09.003; Baath JS, 2008, RETINA-J RET VIT DIS, V28, P894, DOI 10.1097/IAE.0b013e3181679f67; BALLART IJ, 1986, BLOOD, V67, P105; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; BOELAERT JR, 1988, CLIN NEPHROL, V29, P261; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Borgna-Pignatti C, 2011, EXPERT REV HEMATOL, V4, P353, DOI [10.1586/EHM.11.29, 10.1586/ehm.11.29]; CANTINIEAUX B, 1987, EUR J HAEMATOL, V39, P28; Cherayil BJ, 2010, ARCH IMMUNOL THER EX, V58, P407, DOI 10.1007/s00005-010-0095-9; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Deretic V, 2015, J CLIN INVEST, V125, P75, DOI 10.1172/JCI73945; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gursel O, 2012, J PEDIAT HEMATOL ONC, V34, P630, DOI 10.1097/MPH.0b013e3182707f4d; Ishida JH, 2014, SEMIN DIALYSIS, V27, P26, DOI 10.1111/sdi.12168; Italiani P, 2015, IMMUNE NETW, V15, P167, DOI 10.4110/in.2015.15.4.167; Kenney DL, 2015, NEUROLOGY, V85, P634, DOI 10.1212/WNL.0000000000001860; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Komohara Y, 2016, ADV DRUG DELIVER REV, V99, P180, DOI 10.1016/j.addr.2015.11.009; Kontoghiorghes GJ, 2010, HEMOGLOBIN, V34, P227, DOI 10.3109/03630269.2010.483662; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kutukculer N, 1996, PEDIATR HEMAT ONCOL, V13, P239, DOI 10.3109/08880019609030822; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lee DH, 2013, EXP HEMATOL, V41, P539, DOI 10.1016/j.exphem.2013.02.004; Lesic B, 2002, ANTIMICROB AGENTS CH, V46, P1741, DOI 10.1128/AAC.46.6.1741-1745.2002; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Marx JJM, 2002, BEST PRACT RES CL HA, V15, P411, DOI 10.1053/beha.2002.0001; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nairz M, 2015, IMMUNOBIOLOGY, V220, P280, DOI 10.1016/j.imbio.2014.09.010; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; Pullarkat V, 2014, LEUKEMIA RES, V38, P988, DOI 10.1016/j.leukres.2014.06.005; Raiten DJ, 2015, J PEDIATR-US, V167, pS3, DOI 10.1016/j.jpeds.2015.07.013; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Romo MR, 2016, IMMUNOLOGY, V148, P125, DOI 10.1111/imm.12597; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Castrejon-Jimenez NS, 2015, BIOSCI TRENDS, V9, P149, DOI 10.5582/bst.2015.01035; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Taneja R, 2010, INDIAN J OPHTHALMOL, V58, P125, DOI 10.4103/0301-4738.60083; Walker EM, 2000, ANN CLIN LAB SCI, V30, P354; Wiener Edith, 2003, Hematology, V8, P35, DOI 10.1080/1024533031000081414; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu FF, 2016, TUMOR BIOL, V37, P1427, DOI 10.1007/s13277-015-4516-6; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	57	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156713	10.1371/journal.pone.0156713	http://dx.doi.org/10.1371/journal.pone.0156713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244448	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100065
J	Pino, M; Parry, R; Land, V; Faull, C; Feathers, L; Seymour, J				Pino, Marco; Parry, Ruth; Land, Victoria; Faull, Christina; Feathers, Luke; Seymour, Jane			Engaging Terminally Ill Patients in End of Life Talk: How Experienced Palliative Medicine Doctors Navigate the Dilemma of Promoting Discussions about Dying	PLOS ONE			English	Article							INTERACTION ORDER; DECISION-MAKING; ADVANCED CANCER; ADVANCE CARE; COMMUNICATION; CONSULTATIONS; PREFERENCES; INFORMATION; PHYSICIANS; PROGNOSIS	Objective To examine how palliative medicine doctors engage patients in end-of-life (hereon, EoL) talk. To examine whether the practice of "eliciting and responding to cues", which has been widely advocated in the EoL care literature, promotes EoL talk. Design Conversation analysis of video-and audio-recorded consultations. Participants Unselected terminally ill patients and their companions in consultation with experienced palliative medicine doctors. Setting Outpatient clinic, day therapy clinic, and inpatient unit of a single English hospice. Results Doctors most commonly promoted EoL talk through open elaboration solicitations; these created opportunities for patients to introduce-then later further articulate-EoL considerations in such a way that doctors did not overtly ask about EoL matters. Importantly, the wording of elaboration solicitations avoided assuming that patients had EoL concerns. If a patient responded to open elaboration solicitations without introducing EoL considerations, doctors sometimes pursued EoL talk by switching to a less participatory and more presumptive type of solicitation, which suggested the patient might have EoL concerns. These more overt solicitations were used only later in consultations, which indicates that doctors give precedence to patients volunteering EoL considerations, and offer them opportunities to take the lead in initiating EoL talk. There is evidence that doctors treat elaboration of patients' talk as a resource for engaging them in EoL conversations. However, there are limitations associated with labelling that talk as "cues" as is common in EoL communication contexts. We examine these limitations and propose "possible EoL considerations" as a descriptively more accurate term. Conclusions Through communicating-via open elaboration solicitations-in ways that create opportunities for patients to volunteer EoL considerations, doctors navigate a core dilemma in promoting EoL talk: giving patients opportunities to choose whether to engage in conversations about EoL whilst being sensitive to their communication needs, preferences and state of readiness for such dialogue.	[Pino, Marco] Univ Loughborough, Dept Social Sci, Loughborough, Leics, England; [Parry, Ruth; Land, Victoria] Univ Nottingham, Sch Hlth Sci, Nottingham NG7 2RD, England; [Faull, Christina; Feathers, Luke] LOROS Hosp, Leicester, Leics, England; [Seymour, Jane] Univ Sheffield, Sch Nursing & Midwifery, Sheffield, S Yorkshire, England	Loughborough University; University of Nottingham; University of Sheffield	Pino, M (corresponding author), Univ Loughborough, Dept Social Sci, Loughborough, Leics, England.	marco.pino75@gmail.com		Pino, Marco/0000-0003-1571-5028; Land, Victoria/0000-0003-4542-6163; faull, christina/0000-0002-0064-8056	Health Foundation via an Insight grant [RU33]; National Institute for Health Research [CDF-2014-07-046] Funding Source: researchfish	Health Foundation via an Insight grant; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was funded by The Health Foundation via an Insight grant RU33. The researchers were independent from the funder.	Abdul-Razzak A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005653; Abdul-Razzak A, 2014, J PALLIAT CARE, V30, P218; Almack K, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-15; Antaki C., 2008, CONVERSATION ANAL PS, P26, DOI DOI 10.1017/CB09780511490002.003; Antaki C, 2011, APPL CONVERSATION AN; Barnes K, 2007, PALLIATIVE MED, V21, P23, DOI 10.1177/0269216306073638; Beach WA, 2015, J HEALTH COMMUN, V20, P1243, DOI 10.1080/10810730.2015.1018644; Belanger E, 2011, PALLIATIVE MED, V25, P242, DOI 10.1177/0269216310389348; Borgstrom E, 2015, BMJ SUPPORT PALLIAT, V5, P216, DOI 10.1136/bmjspcare-2015-000979; Canadian Hospice Palliative Care Association, 2008, JUST ASK CONV GUID G; Clayman S.E., 2011, HDB DATA ANAL, P589, DOI DOI 10.4135/9781848608184.N26; Clayton JA, 2005, J PAIN SYMPTOM MANAG, V30, P132, DOI 10.1016/j.jpainsymman.2005.02.014; Clemente Ignasi., 2015, UNCERTAIN FUTURE COM; Del Piccolo L, 2011, PATIENT EDUC COUNS, V82, P149, DOI 10.1016/j.pec.2010.02.024; Department of Health, 2008, END LIF CAR STRAT PR; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Eide H, 2011, PATIENT EDUC COUNS, V82, P156, DOI 10.1016/j.pec.2010.04.036; Gaston CM, 2005, SOC SCI MED, V61, P2252, DOI 10.1016/j.socscimed.2005.04.015; Hepburn A., 2013, HDB CONVERSATION ANA, P57, DOI DOI 10.1002/9781118325001.CH4; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Heritage J, 2007, J GEN INTERN MED, V22, P1429, DOI 10.1007/s11606-007-0279-0; Heritage J, 2006, ANNU REV SOCIOL, V32, P351, DOI 10.1146/annurev.soc.32.082905.093959; Heritage J, 2011, PATIENT EDUC COUNS, V84, P338, DOI 10.1016/j.pec.2011.05.022; Heyland DK, 2003, J CRIT CARE, V18, P3, DOI 10.1053/jcrc.2003.YJCRC2; Heyn L, 2012, PATIENT EDUC COUNS, V86, P158, DOI 10.1016/j.pec.2011.04.024; Holt E, 1993, TEXT, V13, P189, DOI DOI 10.1515/TEXT.1.1993.13.2.189; Innes S, 2009, PALLIATIVE MED, V23, P29, DOI 10.1177/0269216308098799; JEFFERSON G, 1988, SOC PROBL, V35, P418, DOI 10.1525/sp.1988.35.4.03a00070; Jefferson G., 2004, CONVERSATION ANAL ST, P13, DOI DOI 10.1075/PBNS.125.02JEF; Jefferson G., 1984, STRUCTURES SOCIAL AC, P191; Kendrick KH, 2016, RES LANG SOC INTERAC, V49, P1, DOI 10.1080/08351813.2016.1126436; Kurtz SM, 1996, MED EDUC, V30, P83, DOI 10.1111/j.1365-2923.1996.tb00724.x; Leadership Alliance for the Care of Dying People, 2014, ON CHANC GET RIGHT I; Lutfey K, 1998, SOC PSYCHOL QUART, V61, P321, DOI 10.2307/2787033; Maynard DW, 2016, PATIENT EDUC COUNS, V99, P92, DOI 10.1016/j.pec.2015.07.015; Maynard DW, 1992, TALK WORK INTERACTIO, P331; Mid Trent Cancer Network, 2008, COMM END LIF CAR GUI; Munday D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2391; Muntigl P, 2014, PSYCHOTHER RES, V24, P327, DOI 10.1080/10503307.2013.807525; National Cancer Action Team, 2008, NAT ADV COMM SKILLS; National Institute for Health and Care Excellence, 2015, CAR DYING AD LAST DA; National Palliative and End of Life Care Partnership, 2015, NATL GEOGR; Parry R, 2014, BMJ SUPPORT PALLIAT, V00, P1; Parry R, 2013, RAPID EVIDENCE REV P; Parry R, 2016, ACCEPTABILITY DESIGN; Parry RH, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-69; Partnership NPaEoLC, 2015, AMB PALL END LIF CAR; Perakyla Anssi, 1995, AIDS COUNSELING I IN; Piccolo Lidia Del, 2005, Patient Educ Couns, V57, P241; POMERANTZ A, 1980, SOCIOL INQ, V50, P186, DOI 10.1111/j.1475-682X.1980.tb00020.x; Pomerantz Anita, 2013, HDB CONVERSATION ANA, P210; Pomerantz Anita M., 1984, STUDIES CONVERSATION, P57, DOI DOI 10.1017/CBO9780511665868.008; Robinson JD, 2010, DISCOURSE STUD, V12, P501, DOI 10.1177/1461445610371051; Royal College of General Practitioners and Royal College of Nursing, 2012, MATT LIF DEATH HELP; Schegloff E. A., 1984, STRUCTURES SOCIAL AC, P28; Schegloff E.A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; Schegloff EA, 2006, DISCOURSE STUD, V8, P141, DOI 10.1177/1461445606059563; Schegloff EA, 1996, AM J SOCIOL, V102, P161, DOI 10.1086/230911; Schegloff EA, 2007, SEQUENCE ORGANIZATION IN INTERACTION: A PRIMER IN CONVERSATION ANALYSIS I, P1, DOI 10.2277/ 0521532795; Schegloff Emanuel Abraham, 1982, ANAL DISCOURSE TEXT, P71, DOI DOI 10.2307/324165; Seccareccia D, 2015, J PALLIAT MED, V18, P758, DOI 10.1089/jpm.2014.0408; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; Shaw C, INVITING END OF LIFE; Sidnell Jack., 2013, HDB CONVERSATION ANA; Steensig J, 2008, DISCOURSE STUD, V10, P113, DOI 10.1177/1461445607085593; Stephen N, 2013, J PALLIAT MED, V16, P555, DOI 10.1089/jpm.2012.0442; Walczak A, 2016, PATIENT EDUC COUNS, V99, P3, DOI 10.1016/j.pec.2015.08.017; Walczak A, 2013, PATIENT EDUC COUNS, V90, P307, DOI 10.1016/j.pec.2011.08.009; Weiste E, 2013, RES LANG SOC INTERAC, V46, P299, DOI 10.1080/08351813.2013.839093; Worldwide Palliative Care Alliance World Health Organization, 2014, GLOB ATL PALL CAR EN; Zimmermann C, 2011, PATIENT EDUC COUNS, V82, P141, DOI 10.1016/j.pec.2010.03.017	71	38	38	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156174	10.1371/journal.pone.0156174	http://dx.doi.org/10.1371/journal.pone.0156174			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27243630	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000377146100019
J	Brown, N; McBain, C; Nash, S; Hopkins, K; Sanghera, P; Saran, F; Phillips, M; Dungey, F; Clifton-Hadley, L; Wanek, K; Krell, D; Jeffries, S; Khan, I; Smith, P; Mulholland, P				Brown, Nicholas; McBain, Catherine; Nash, Stephen; Hopkins, Kirsten; Sanghera, Paul; Saran, Frank; Phillips, Mark; Dungey, Fiona; Clifton-Hadley, Laura; Wanek, Katharina; Krell, Daniel; Jeffries, Sarah; Khan, Iftekhar; Smith, Paul; Mulholland, Paul			Multi-Center Randomized Phase II Study Comparing Cediranib plus Gefitinib with Cediranib plus Placebo in Subjects with Recurrent/Progressive Glioblastoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; FACTOR RECEPTOR GENE; HIGH-GRADE GLIOMAS; HUMAN CANCER-CELLS; ADJUVANT TEMOZOLOMIDE; ACQUIRED-RESISTANCE; PROGNOSTIC-FACTORS; BRAIN-TUMORS; EXPRESSION	Background Cediranib, an oral pan-vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor, failed to show benefit over lomustine in relapsed glioblastoma. One resistance mechanism for cediranib is up-regulation of epidermal growth factor receptor (EGFR). This study aimed to determine if dual therapy with cediranib and the oral EGFR inhibitor gefitinib improved outcome in recurrent glioblastoma. Methods and Findings This was a multi-center randomized, two-armed, double-blinded phase II study comparing cediranib plus gefitinib versus cediranib plus placebo in subjects with first relapse/first progression of glioblastoma following surgery and chemoradiotherapy. The primary outcome measure was progression free survival (PFS). Secondary outcome measures included overall survival (OS) and radiologic response rate. Recruitment was terminated early following suspension of the cediranib program. 38 subjects (112 planned) were enrolled with 19 subjects in each treatment arm. Median PFS with cediranib plus gefitinib was 3.6 months compared to 2.8 months for cediranib plus placebo (HR; 0.72, 90% CI; 0.41 to 1.26). Median OS was 7.2 months with cediranib plus gefitinib and 5.5 months with cediranib plus placebo (HR; 0.68, 90% CI; 0.39 to 1.19). Eight subjects (42%) had a partial response in the cediranib plus gefitinib arm versus five patients (26%) in the cediranib plus placebo arm. Conclusions Cediranib and gefitinib in combination is tolerated in patients with glioblastoma. Incomplete recruitment led to the study being underpowered. However, a trend towards improved survival and response rates with the addition of gefitinib to cediranib was observed. Further studies of the combination incorporating EGFR and VEGF inhibition are warranted.	[Brown, Nicholas] Univ Coll London Hosp, London, England; [McBain, Catherine] Christie NHS Fdn Trust, Manchester, Lancs, England; [Nash, Stephen; Phillips, Mark; Dungey, Fiona; Clifton-Hadley, Laura; Wanek, Katharina; Khan, Iftekhar; Smith, Paul] Canc Res UK & UCL Canc Trials Ctr, London, England; [Hopkins, Kirsten] Bristol Haematol & Oncol Ctr, Bristol, Avon, England; [Sanghera, Paul] Univ Hosp Birmingham, Hall Edwards Radiotherapy Res Grp, Birmingham, W Midlands, England; [Saran, Frank] Royal Marsden NHS Trust, Dept Radiotherapy & Paediat Oncol, Sutton, Surrey, England; [Krell, Daniel] Royal Free Hosp, Dept Acad Oncol, Pond St, London NW3 2QG, England; [Jeffries, Sarah] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Mulholland, Paul] UCL, UCL Canc Inst, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Christie NHS Foundation Trust; Cancer Research UK; University of London; University College London; Bristol Haematology & Oncology Centre; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Cambridge; University of London; University College London	Mulholland, P (corresponding author), UCL, UCL Canc Inst, London, England.	paul.mulholland@nhs.net		Khan, Iftekhar/0000-0001-6041-8837; Mulholland, Paul/0000-0002-7926-824X	Astra Zeneca; Cancer Research UK [E/10/044]; National Institute of Health Research/Wellcome University College Hospital (NIHR/UCH) Clinical Research Facility; University College Hospital/University College London (UCH/UCL) Biomedical Research Centre; UCL Experimental Cancer Medicine Centre; National Brain Appeal; Cancer Research UK [15953] Funding Source: researchfish	Astra Zeneca(AstraZeneca); Cancer Research UK(Cancer Research UK); National Institute of Health Research/Wellcome University College Hospital (NIHR/UCH) Clinical Research Facility; University College Hospital/University College London (UCH/UCL) Biomedical Research Centre; UCL Experimental Cancer Medicine Centre; National Brain Appeal; Cancer Research UK(Cancer Research UK)	This study was supported by Astra Zeneca, Cancer Research UK E/10/044, the National Institute of Health Research/Wellcome University College Hospital (NIHR/UCH) Clinical Research Facility, the University College Hospital/University College London (UCH/UCL) Biomedical Research Centre and UCL Experimental Cancer Medicine Centre, and the National Brain Appeal. www.astrazeneca.co.uk, www.cancerresearchuk.org, www.uclh.nhs.uk/Research/CRF, www.uclhospitals.brc.nihr.ac.uk, www.ecmcnetwork.org.uk/network-centres/london-ucl, www.nationalbrainappeal.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Batchelor TT, 2014, CLIN CANCER RES, V20, P5612, DOI 10.1158/1078-0432.CCR-14-0834; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Bianco R, 2008, BRIT J CANCER, V98, P923, DOI 10.1038/sj.bjc.6604269; Brandes AA, 2013, EXPERT REV ANTICANC, V13, P583, DOI [10.1586/era.13.32, 10.1586/ERA.13.32]; Brodbelt A, 2015, EUR J CANCER, V51, P533, DOI 10.1016/j.ejca.2014.12.014; Camp ER, 2005, CLIN CANCER RES, V11, P397; Cappuzzo F, 2003, LUNG CANCER, V41, P227, DOI 10.1016/S0169-5002(03)00189-2; Carson KA, 2007, J CLIN ONCOL, V25, P2601, DOI 10.1200/JCO.2006.08.1661; Ciardiello F, 2006, ANN ONCOL, V17, pVII109, DOI 10.1093/annonc/mdl962; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Clarke K, 2001, BRIT J CANCER, V84, P1322, DOI 10.1054/bjoc.2001.1805; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Ellis LM, 2004, HEMATOL ONCOL CLIN N, V18, P1007, DOI 10.1016/j.hoc.2004.06.002; Forshew T, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.1; Franceschi E, 2007, BRIT J CANCER, V96, P1047, DOI 10.1038/sj.bjc.6603669; Frederick L, 2000, CANCER RES, V60, P1383; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Maity A, 2000, CANCER RES, V60, P5879; Mulholland Paul J, 2005, Expert Opin Emerg Drugs, V10, P845, DOI 10.1517/14728214.10.4.845; Naumov GN, 2009, CLIN CANCER RES, V15, P3484, DOI 10.1158/1078-0432.CCR-08-2904; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Parikh AA, 2003, CANCER, V98, P720, DOI 10.1002/cncr.11560; Pelloski CE, 2007, J CLIN ONCOL, V25, P2288, DOI 10.1200/JCO.2006.08.0705; Perrotte P, 1999, CLIN CANCER RES, V5, P257; Pillay V, 2009, NEOPLASIA, V11, P448, DOI 10.1593/neo.09230; Pore N, 2003, CANCER RES, V63, P236; Rich JN, 2004, J CLIN ONCOL, V22, P133, DOI 10.1200/JCO.2004.08.110; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; Rubin BP, 2006, LAB INVEST, V86, P981, DOI 10.1038/labinvest.3700466; Salmaggi A, 2003, J NEURO-ONCOL, V62, P297, DOI 10.1023/A:1023367223575; Scagliotti GV, 2007, ANN ONCOL, V18, P32, DOI 10.1093/annonc/mdm412; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; van Cruijsen H, 2005, INT J CANCER, V117, P883, DOI 10.1002/ijc.21479; van Cruijsen H, 2010, EUR J CANCER, V46, P901, DOI 10.1016/j.ejca.2009.12.023; Viloria-Petit A, 2001, CANCER RES, V61, P5090; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899	50	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156369	10.1371/journal.pone.0156369	http://dx.doi.org/10.1371/journal.pone.0156369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232884	gold, Green Published			2022-12-27	WOS:000376883000026
J	Kecse-Nagy, C; Szittner, Z; Papp, K; Hegyi, Z; Rovero, P; Migliorini, P; Lorand, V; Homolya, L; Prechl, J				Kecse-Nagy, Csilla; Szittner, Zoltan; Papp, Krisztian; Hegyi, Zoltan; Rovero, Paolo; Migliorini, Paola; Lorand, Veronika; Homolya, Laszlo; Prechl, Jozsef			Characterization of NF-kappa B Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes	PLOS ONE			English	Article							FC-GAMMA-RIIA; HIGH-AFFINITY IGG; RHEUMATOID-ARTHRITIS; RECEPTOR EXPRESSION; KEY ROLE; ACTIVATION; AUTOANTIBODIES; INDUCTION; MONOCYTES; MACROPHAGES	Our study tested the hypothesis that immunoglobulins differ in their ability to activate the nuclear factor-kappa B pathway mediated cellular responses. These responses are modulated by several properties of the immune complex, including the ratio of antibody isotypes binding to antigen. Immunoassays allow the measurement of antigen specific antibodies belonging to distinct immunoglobulin classes and subclasses but not the net biological effect of the combination of these antibodies. We set out to develop a biosensor that is suitable for the detection and characterization of antigen specific serum antibodies. We genetically modified the monocytoid U937 cell line carrying Fc receptors with a plasmid encoding NF-kappa B promoter-driven GFP. This clone, U937-NF-kappa B, was characterized with respect to FcR expression and response to solid-phase immunoglobulins. Human IgG3, IgG4 and IgG1 induced GFP production in a time-and dose-dependent manner, in this order of efficacy, while IgG2 triggered no activation at the concentrations tested. IgA elicited no response alone but showed significant synergism with IgG3 and IgG4. We confirmed the importance of activation via Fc gamma RI by direct stimulation with monoclonal antibody and by competition assays. We used citrullinated peptides and serum from rheumatoid arthritis patients to generate immune complexes and to study the activation of U937-NF-kappa B, observing again a synergistic effect between IgG and IgA. Our results show that immunoglobulins have distinct pro-inflammatory potential, and that U937-NF-kappa B is suitable for the estimation of biological effects of immune-complexes, offering insight into monocyte activation and pathogenesis of antibody mediated diseases.	[Kecse-Nagy, Csilla] Eotvos Lorand Univ, Dept Immunol, Pazmany Peter S 1-C, H-1117 Budapest, Hungary; [Szittner, Zoltan; Papp, Krisztian; Prechl, Jozsef] MTA ELTE Immunol Res Grp, Pazmany Peter S 1-C, H-1117 Budapest, Hungary; [Hegyi, Zoltan; Homolya, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Rovero, Paolo] Univ Florence, Dept NeuroFarBa, Sect Pharmaceut Sci & Nutraceut, Lab Peptide & Prot Chem & Biol, Via Ugo Schiff 6, I-50019 Sesto Fiorentino, Italy; [Migliorini, Paola] Univ Pisa, Clin Immunol Unit, Dept Clin & Expt Med, Pisa, Italy; [Lorand, Veronika] PTE, Dept Rheumatol & Immunol, Ctr Clin, Pecs, Hungary; [Prechl, Jozsef] Diagnosticum Inc, Res & Dev Lab, Attila Ut 146, H-1047 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Florence; University of Pisa; University of Pecs	Szittner, Z (corresponding author), MTA ELTE Immunol Res Grp, Pazmany Peter S 1-C, H-1117 Budapest, Hungary.	zoltan.szittner@gmail.com	Rovero, Paolo/AAB-6775-2022; Migliorini, Paola/P-6176-2015; Homolya, Laszlo/N-1154-2016; Prechl, Jozsef/B-2094-2009	Rovero, Paolo/0000-0001-9577-5228; Migliorini, Paola/0000-0001-6433-4964; Homolya, Laszlo/0000-0003-1639-8140; Prechl, Jozsef/0000-0003-3859-4353; Papp, Krisztian/0000-0003-0619-8233	TAMOP by European Social Fund [4.2.1/B-09/1/KMR-2010-0003]; National Research, Development and Innovation Office of Hungary; FACS-ARIA III; European Union [GAPAID-314971, FP7-SME-2012]; OTKA by National Research, Development and Innovation Office of Hungary [109683]; MedInProt Protein Science Research Synergy Program; Diagnosticum Inc.	TAMOP by European Social Fund; National Research, Development and Innovation Office of Hungary; FACS-ARIA III; European Union(European Commission); OTKA by National Research, Development and Innovation Office of Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MedInProt Protein Science Research Synergy Program; Diagnosticum Inc.	This work was funded by TAMOP (4.2.1/B-09/1/KMR-2010-0003) awarded to Eotvos Lorand University by the European Social Fund (http://ec.europa.eu/esf/main.jsp?catId=384) and National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english) for supporting cell sorting experiments with FACS-ARIA III. This work was also supported by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement (GAPAID-314971, FP7-SME-2012, http://cordis.europa.eu/project/rcn/105440_en.html), entitled 'Genes and proteins for autoimmunity diagnostics' and OTKA grant (109683) awarded to JP by the National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english). KP was awarded Synergy I. Grant by the MedInProt Protein Science Research Synergy Program (http://medinprot.chem.elte.hu/). The funder (Diagnosticum Inc.) provided support in the form of salaries for authors [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Anzilotti C, 2007, RHEUMATOLOGY, V46, P1579, DOI 10.1093/rheumatology/kem193; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Brandsma AM, 2015, IMMUNOL REV, V268, P74, DOI 10.1111/imr.12332; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burska A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/545493; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Drechsler Y, 2002, J LEUKOCYTE BIOL, V72, P657; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hargreaves CE, 2015, IMMUNOL REV, V268, P6, DOI 10.1111/imr.12341; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; LegrandPoels S, 1997, BIOCHEM PHARMACOL, V53, P339; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Magnusson SE, 2014, IMMUNOL LETT, V162, P200, DOI 10.1016/j.imlet.2014.08.016; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Swisher JFA, 2014, MABS-AUSTIN, V6, P1377, DOI 10.4161/19420862.2014.975657; Szittner Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072401; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toes REM, 2015, CURR OPIN RHEUMATOL, V27, P262, DOI 10.1097/BOR.0000000000000166; Torsteinsdottir I, 1999, CLIN EXP IMMUNOL, V115, P554; Valenzuela NM, 2015, AM J TRANSPLANT, V15, P1502, DOI 10.1111/ajt.13174; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vogelpoel LTC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00079; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; Wang R, 2003, HYBRIDOMA HYBRIDOM, V22, P357, DOI 10.1089/153685903771797057; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; Yamamoto M, 2014, NAT REV RHEUMATOL, V10, P148, DOI 10.1038/nrrheum.2013.183	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156328	10.1371/journal.pone.0156328	http://dx.doi.org/10.1371/journal.pone.0156328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232500	Green Published, Green Accepted, gold			2022-12-27	WOS:000376883000023
J	Ariki, NK; Munoz, LE; Armitage, EL; Goodstein, FR; George, KG; Smith, VL; Vetter, I; Herzig, V; King, GF; Loening, NM				Ariki, Nathanial K.; Munoz, Lisa E.; Armitage, Elizabeth L.; Goodstein, Francesca R.; George, Kathryn G.; Smith, Vanessa L.; Vetter, Irina; Herzig, Volker; King, Glenn F.; Loening, Nikolaus M.			Characterization of Three Venom Peptides from the Spitting Spider Scytodes thoracica	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; NMR CHEMICAL-SHIFTS; CYSTINE KNOT; TOXINS; ASSIGNMENT; PROTEINS; PROGRAMS; SEQUENCE; PORE	We present the solution-state NMR structures and preliminary functional characterizations of three venom peptides identified from the spitting spider Scytodes thoracica. Despite little sequence identity to other venom peptides, structural characterization reveals that these peptides contain an inhibitor cystine knot motif common to many venom peptides. These are the first structures for any peptide or protein from spiders of the Scytodidae family. Many venom peptides target neuronal ion channels or receptors. However, we have not been able to determine the target of these Scytodes peptides so we can only state with certainty the channels and receptors that they do not target.	[Ariki, Nathanial K.; Munoz, Lisa E.; Armitage, Elizabeth L.; Goodstein, Francesca R.; George, Kathryn G.; Smith, Vanessa L.; Loening, Nikolaus M.] Lewis & Clark Coll, Dept Chem, 0615 SW Palatine Hill Rd, Portland, OR 97219 USA; [Vetter, Irina; Herzig, Volker; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Loening, NM (corresponding author), Lewis & Clark Coll, Dept Chem, 0615 SW Palatine Hill Rd, Portland, OR 97219 USA.	loening@lclark.edu	King, Glenn F/J-5059-2012; Herzig, Volker/A-7177-2008; Vetter, Irina/A-6035-2010	King, Glenn F/0000-0002-2308-2200; Herzig, Volker/0000-0003-2514-3983; Vetter, Irina/0000-0002-3594-9588; Smith, Vanessa/0000-0002-0431-503X; Loening, Nikolaus/0000-0002-5074-6906	National Institute of General Medical Sciences [R15GM085733]; Australian National Health & Medical Research Council from the Australian Research Council [DP130103813]; John S. Rogers Science Research Program at Lewis Clark College; National Institute of Mental Health's Psychoactive Drug Screening Program (NIMH PDSP) [HHSN-271-2013-00017-C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085733] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian National Health & Medical Research Council from the Australian Research Council(Australian Research Council); John S. Rogers Science Research Program at Lewis Clark College; National Institute of Mental Health's Psychoactive Drug Screening Program (NIMH PDSP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.M.L. was supported by Award Number R15GM085733 from the National Institute of General Medical Sciences. G.F.K. is supported by a Principal Research Fellowship from the Australian National Health & Medical Research Council and Discovery Grant DP130103813 from the Australian Research Council. N.K.A., L.E.M., E.L.A., F.R.G, and K.G.G. acknowledge support from the John S. Rogers Science Research Program at Lewis & Clark College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Greta Binford and Dr. Pamela Zobel-Thropp (Department of Biology, Lewis & Clark College, Portland, Oregon, United States) for their work in discovering the venom peptide sequences characterized in this paper, and Dr. Geoff Brown (Department of Agriculture, Fisheries and Forestry, Brisbane, Australia) for supplying the blowflies used for the injection studies. Screening for binding to vertebrate receptors was generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract # HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bende NS, 2015, FEBS J, V282, P904, DOI 10.1111/febs.13189; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Binford GJ, 2008, MOL PHYLOGENET EVOL, V49, P538, DOI 10.1016/j.ympev.2008.08.003; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daly NL, 2011, CURR OPIN CHEM BIOL, V15, P362, DOI 10.1016/j.cbpa.2011.02.008; Dutertre S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4521; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; King GF, 2007, TOXICON, V49, P513, DOI 10.1016/j.toxicon.2006.11.012; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063865; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kuhn-Nentwig L, 2011, ADV INSECT PHYSIOL, V40, P1, DOI 10.1016/B978-0-12-387668-3.00001-5; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liang SP, 1999, J PROTEIN CHEM, V18, P619, DOI 10.1023/A:1020693920990; Loening NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054401; Lucio AD, 2008, PROTEIN PEPTIDE LETT, V15, P700, DOI 10.2174/092986608785133708; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; Nicholson GM, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P369, DOI 10.1016/B978-012369442-3/50057-X; Nicholson GM, 2007, TOXICON, V49, P490, DOI 10.1016/j.toxicon.2006.11.027; Nilges M, 2008, STRUCTURE, V16, P1305, DOI 10.1016/j.str.2008.07.008; Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4; Ostrow KL, 2003, TOXICON, V42, P263, DOI 10.1016/S0041-0101(03)00141-7; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pineda SS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-177; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; World Spider Catalog, 2016, WORLD SPID CAT VERS; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zobel-Thropp PA, 2014, J PROTEOME RES, V13, P817, DOI 10.1021/pr400875s	52	6	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156291	10.1371/journal.pone.0156291	http://dx.doi.org/10.1371/journal.pone.0156291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227898	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500104
J	Dai, XF; Zhang, H; Han, JJ; He, Y; Zhang, YY; Qi, Y; Pang, JJ				Dai, Xufeng; Zhang, Hua; Han, Juanjuan; He, Ying; Zhang, Yangyang; Qi, Yan; Pang, Ji-Jing			Effects of Subretinal Gene Transfer at Different Time Points in a Mouse Model of Retinal Degeneration	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; ACYLTRANSFERASE 1 LPCAT1; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; RETINITIS-PIGMENTOSA; PHOTORECEPTOR DEGENERATION; REPLACEMENT THERAPY; CONE FUNCTION; RD10 MOUSE; II CELLS; MICE	Lysophosphatidylcholine acyltransferase 1 (LPCAT1) is necessary for photoreceptors to generate an important lipid component of their membranes. The absence of LPCAT1 results in early and rapid rod and cone degeneration. Retinal degeneration 11 (rd11) mice carry a mutation in the Lpcat1 gene, and are an excellent model of early-onset rapid retinal degeneration (RD). To date, no reports have documented gene therapy administration in the rd11 mouse model at different ages. In this study, the AAV8 (Y733F)-smCBA-Lpcat1 vector was subretinally injected at postnatal day (P) 10, 14, 18, or 22. Four months after injection, immunohistochemistry and analysis of retinal morphology showed that treatment at P10 rescued about 82% of the wild-type retinal thickness. However, the diffusion of the vector and the resulting rescue were limited to an area around the injection site that was only 31% of the total retinal area. Injection at P14 resulted in vector diffusion that covered approximately 84% of the retina, and we found that gene therapy was more effective against RD when exposure to light was limited before and after treatment. We observed long-term preservation of electroretinogram (ERG) responses, and preservation of retinal structure, indicating that early treatment followed by limited light exposure can improve gene therapy effectiveness for the eyes of rd11 mice. Importantly, delayed treatment still partially preserved M-cones, but not S-cones, and M-cones in the rd11 retina appeared to have a longer window of opportunity for effective preservation with gene therapy. These results provide important information regarding the effects of subretinal gene therapy in the mouse model of LPCAT1-deficiency.	[Dai, Xufeng; Zhang, Hua; Han, Juanjuan; He, Ying; Zhang, Yangyang; Qi, Yan; Pang, Ji-Jing] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Han, Juanjuan] Shanxi Med Univ, Fenyang Coll, Fenyang, Shanxi, Peoples R China	Wenzhou Medical University; Shanxi Medical University	Dai, XF; Pang, JJ (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	daixufeng@sohu.com; jpangoph@hotmail.com	zhang, yangyang/GZG-7467-2022		Natural Science Foundation of Zhejiang Province of China [LY15H120002]; General Scientific Research Program from Zhejiang Provincial Education Commission of China [Y201431063]; Wenzhou Municipal Science and Technology Bureau of China [Y20140352, Y20140355]; National Natural Science Foundation of China [81371060]	Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); General Scientific Research Program from Zhejiang Provincial Education Commission of China; Wenzhou Municipal Science and Technology Bureau of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Zhejiang Province of China (LY15H120002, http://www.zjnsf.gov.cn/b/02/fundapply/fundapply_edit.aspx?appid=GUDA9222519E7379B345F01F2BE3C7B95B5, XD), General Scientific Research Program from Zhejiang Provincial Education Commission of China (Y201431063, http://www.zjkysz.cn/left_pthy.php, XD), grants from Wenzhou Municipal Science and Technology Bureau of China (Y20140352, http://kjxm.wzkj.gov.cn/Company/report/CR_apply.aspx?type=0&id=9408, XD and Y20140355, http://kjxm.wzkj.gov.cn/Company/report/CR_apply.aspx?type=0&id=9240, HZ), the National Natural Science Foundation of China (81371060, https://isisn.nsfc.gov.cn/egrantweb/contract/index?datetimestamp=1457056907909###, JP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Byrne LC, 2015, J CLIN INVEST, V125, P105, DOI 10.1172/JCI65654; Campbell JP, 2016, DEV OPHTHALMOL, V55, P317, DOI 10.1159/000434698; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cho JH, 2007, MECH DEVELOP, V124, P543, DOI 10.1016/j.mod.2007.06.001; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Dalkara D, 2011, MOL THER, V19, P1602, DOI 10.1038/mt.2011.62; Ekesten B, 2005, VISUAL NEUROSCI, V22, P893, DOI 10.1017/S0952523805226172; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Han JJ, 2013, MOL VIS, V19, P2579; Hanif AM, 2015, INVEST OPHTH VIS SCI, V56, P6839, DOI 10.1167/iovs.15-16792; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Jacobs GH, 2007, DOC OPHTHALMOL, V115, P137, DOI 10.1007/s10633-007-9055-z; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Lewis GP, 2010, MOL VIS, V16, P1361; Li WS, 2009, MOL VIS, V15, P267; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Lyubarsky AL, 2002, VISION RES, V42, P401, DOI 10.1016/S0042-6989(01)00214-0; Maddox DM, 2015, INVEST OPHTH VIS SCI, V56, P3776, DOI 10.1167/iovs.14-16047; Marangoni D, 2015, INVEST OPHTH VIS SCI, V56, P6810, DOI 10.1167/iovs.15-16866; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136523; Sarra GM, 2001, HUM MOL GENET, V10, P2353, DOI 10.1093/hmg/10.21.2353; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Takahashi M, 1999, J VIROL, V73, P7812, DOI 10.1128/JVI.73.9.7812-7816.1999; Tsai TI, 2015, J NEUROPHYSIOL, V114, P2230, DOI 10.1152/jn.00188.2015; Tummala P, 2010, MOL VIS, V16, P252; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wilson-Ashworth HA, 2004, J MEMBRANE BIOL, V200, P25, DOI 10.1007/s00232-004-0691-x; Wu J, 2015, MOL MED REP, V12, P5983, DOI 10.3892/mmr.2015.4204; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Ye GJ, 2016, HUM GENE THER CL DEV, V27, P27, DOI 10.1089/humc.2015.163; Ye GJ, 2016, HUM GENE THER, V27, P72, DOI 10.1089/hum.2015.130; Zeng R, 2012, INVEST OPHTH VIS SCI, V53, P1685, DOI 10.1167/iovs.11-8241	46	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156542	10.1371/journal.pone.0156542	http://dx.doi.org/10.1371/journal.pone.0156542			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228218	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500156
J	Li, JY; Tao, XY; Li, L; Mao, LC; Luo, ZS; Khan, ZU; Ying, TJ				Li, Jiayin; Tao, Xiaoya; Li, Li; Mao, Linchun; Luo, Zisheng; Khan, Zia Ullah; Ying, Tiejin			Comprehensive RNA-Seq Analysis on the Regulation of Tomato Ripening by Exogenous Auxin	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; NAC TRANSCRIPTION FACTORS; OXIDASE GENE FAMILY; VITIS-VINIFERA L.; ETHYLENE BIOSYNTHESIS; FRUIT-DEVELOPMENT; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE; LYCOPERSICON-ESCULENTUM; DIFFERENTIAL EXPRESSION; SOLANUM-LYCOPERSICON	Auxin has been shown to modulate the fruit ripening process. However, the molecular mechanisms underlying auxin regulation of fruit ripening are still not clear. Illumina RNA sequencing was performed on mature green cherry tomato fruit 1 and 7 days after auxin treatment, with untreated fruit as a control. The results showed that exogenous auxin maintained system 1 ethylene synthesis and delayed the onset of system 2 ethylene synthesis and the ripening process. At the molecular level, genes associated with stress resistance were significantly up-regulated, but genes related to carotenoid metabolism, cell degradation and energy metabolism were strongly down-regulated by exogenous auxin. Furthermore, genes encoding DNA demethylases were inhibited by auxin, whereas genes encoding cytosine-5 DNA methyltransferases were induced, which contributed to the maintenance of high methylation levels in the nucleus and thus inhibited the ripening process. Additionally, exogenous auxin altered the expression patterns of ethylene and auxin signaling-related genes that were induced or repressed in the normal ripening process, suggesting significant crosstalk between these two hormones during tomato ripening. The present work is the first comprehensive transcriptome analysis of auxin-treated tomato fruit during ripening. Our results provide comprehensive insights into the effects of auxin on the tomato ripening process and the mechanism of crosstalk between auxin and ethylene.	[Li, Jiayin; Tao, Xiaoya; Li, Li; Mao, Linchun; Luo, Zisheng; Ying, Tiejin] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Khan, Zia Ullah] Abdul Wali Khan Univ, Dept Agr, Mardan, Khyber Pakhtunk, Pakistan	Zhejiang University; Abdul Wali Khan University	Ying, TJ (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	tjying@zju.edu.cn	Li, JiaYin/N-9516-2016	Li, Jiayin/0000-0002-6532-5485	National Basic Research Program of China [2013CB127101]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Basic Research Program of China (2013CB127101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Amoros A, 2004, SCI HORTIC-AMSTERDAM, V101, P387, DOI 10.1016/j.scienta.2003.11.010; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Audran-Delalande C, 2012, PLANT CELL PHYSIOL, V53, P659, DOI 10.1093/pcp/pcs022; Barry CS, 2007, J PLANT GROWTH REGUL, V26, P143, DOI 10.1007/s00344-007-9002-y; Barry CS, 1996, PLANT J, V9, P525, DOI 10.1046/j.1365-313X.1996.09040525.x; Barry CS, 2000, PLANT PHYSIOL, V123, P979, DOI 10.1104/pp.123.3.979; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bottcher C, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-222; Bottcher C, 2012, FUNCT PLANT BIOL, V39, P745, DOI 10.1071/FP12132; Bottcher C, 2010, J EXP BOT, V61, P3615, DOI 10.1093/jxb/erq174; Bu JW, 2013, POSTHARVEST BIOL TEC, V86, P337, DOI 10.1016/j.postharvbio.2013.07.026; Cao DY, 2014, GENE, V550, P230, DOI 10.1016/j.gene.2014.08.034; Cara B, 2008, PLANT SCI, V175, P106, DOI 10.1016/j.plantsci.2008.03.021; Chaabouni S, 2009, J EXP BOT, V60, P1349, DOI 10.1093/jxb/erp009; Chen JX, 2016, PLANTA, V243, P183, DOI 10.1007/s00425-015-2402-5; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; CURRY EA, 1993, HORTSCIENCE, V28, P115, DOI 10.21273/HORTSCI.28.2.115; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Fagundes C, 2015, POSTHARVEST BIOL TEC, V109, P73, DOI 10.1016/j.postharvbio.2015.05.017; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; George S, 2010, J PLANT PHYSIOL, V167, P311, DOI 10.1016/j.jplph.2009.09.004; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hao Y., 2014, THESIS U TOULOUSE; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jafari Z, 2013, MOL BIOL REP, V40, P1341, DOI 10.1007/s11033-012-2178-7; Jones B, 2002, PLANT J, V32, P603, DOI 10.1046/j.1365-313X.2002.01450.x; Karavangeli M, 2005, BIOMOL ENG, V22, P121, DOI 10.1016/j.bioeng.2005.03.001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kondo S, 2000, J AM SOC HORTIC SCI, V125, P242, DOI 10.21273/JASHS.125.2.242; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li JG, 2008, J PLANT GROWTH REGUL, V27, P283, DOI 10.1007/s00344-008-9055-6; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; LINCOLN JE, 1993, J BIOL CHEM, V268, P19422; Liu KD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2182-0; Liu KD, 2005, PLANT MOL BIOL, V58, P447, DOI 10.1007/s11103-005-6505-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma QL, 2014, J EXP BOT, V65, P61, DOI 10.1093/jxb/ert344; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Muday GK, 2012, TRENDS PLANT SCI, V17, P181, DOI 10.1016/j.tplants.2012.02.001; Nakatsuka A, 1998, PLANT PHYSIOL, V118, P1295, DOI 10.1104/pp.118.4.1295; Oetiker JH, 1997, PLANT MOL BIOL, V34, P275, DOI 10.1023/A:1005800511372; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pirrello J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-190; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sell S, 2005, DNA SEQUENCE, V16, P80, DOI 10.1080/10425170500050817; Seymour GB, 2013, ANNU REV PLANT BIOL, V64, P219, DOI 10.1146/annurev-arplant-050312-120057; Seymour GB, 2013, PLANT BIOTECHNOL J, V11, P269, DOI 10.1111/j.1467-7652.2012.00738.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Shi HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089926; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; Stopar M, 2001, SCI HORTIC-AMSTERDAM, V87, P65, DOI 10.1016/S0304-4238(00)00169-2; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Symons GM, 2012, J EXP BOT, V63, P4741, DOI 10.1093/jxb/ers147; Tatsuki M, 2013, J EXP BOT, V64, P1049, DOI 10.1093/jxb/ers381; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; WANG CY, 1987, HORTSCIENCE, V22, P276; Xiang CB, 1996, PLANT MOL BIOL, V32, P415, DOI 10.1007/BF00019093; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu T, 2003, J PLANT PHYSIOL, V160, P1305, DOI 10.1078/0176-1617-01205; Yuan RC, 2007, HORTSCIENCE, V42, P101, DOI 10.21273/HORTSCI.42.1.101; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462; ZHOU JM, 1993, PLANT MOL BIOL, V22, P517, DOI 10.1007/BF00015980; Zouine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084203	74	35	36	12	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156453	10.1371/journal.pone.0156453	http://dx.doi.org/10.1371/journal.pone.0156453			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228127	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500140
J	Patel, SK; Prabhakar, P; Jain, AK; Saggurti, N; Adhikary, R				Patel, Sangram Kishor; Prabhakar, Parimi; Jain, Anrudh Kumar; Saggurti, Niranjan; Adhikary, Rajatashuvra			Relationship between Community Collectivization and Financial Vulnerability of Female Sex Workers in Southern India	PLOS ONE			English	Article							CONDOM USE; INTERVENTION; HIV; MOBILIZATION; PREVENTION; KARNATAKA; AVAHAN; RISK	Introduction Studies exploring the linkages between financial vulnerabilities and community collectivization of female sex workers (FSWs) are scarce in India despite having potential policy implications. To fill this gap in the literature, this study attempts to understand the financial vulnerabilities among FSWs and assess the relationship between community collectivization and financial vulnerabilities in southern India. Data and Methods Data were drawn from a cross-sectional, behavioral tracking survey (BTS)-2014, conducted among FSWs (N = 2400) in Andhra Pradesh, a southern state of India under the Avahan-India AIDS initiative program. Adjusted odds ratios (AOR) and their 95% confidence intervals (CI) were estimated through multivariate logistic regression, to assess the independent relationships of the degree of community collectivization indicators with financial vulnerability indicators, adjusting for socio-demographic characteristics. Results Most FSWs (87%) reported having either one or more financial vulnerability and nearly one-fifth had a high financial vulnerability. The risk of facing financial vulnerability was significantly lower among FSWs with a high degree of perceived collective efficacy (15% vs 31%; AOR: 0.4; 95% CI: 0.3-0.5) and collective agency (4% vs 21%; AOR: 0.2; 95% CI: 0.1-0.3) as compared to their respective counterparts, after controlling for their individual socio-demographic characteristics. FSWs with a high degree of collective efficacy are also less likely to report different components of financial vulnerability (e.g. income, saving, expenditure, and debt). Conclusion This study finding suggests that community-led interventions such as improving collectivization are promising strategies to address financial vulnerabilities and a path to a sustainable reduction of HIV risk. This study calls for further evidence-based research and measurement of the effects of community-led approaches in addressing the financial vulnerabilities of the key population at risk for HIV.	[Patel, Sangram Kishor; Adhikary, Rajatashuvra] Populat Council, HIV & AIDS Program, 142 Golf Links, New Delhi, India; [Prabhakar, Parimi] India HIV AIDS Alliance, Sarovar Ctr, Secretariat Rd, Hyderabad, Andhra Pradesh, India; [Jain, Anrudh Kumar] Populat Council, 1230 York Ave, New York, NY 10021 USA; [Saggurti, Niranjan] Bill & Melinda Gates Fdn, New Delhi, India	Population Council	Patel, SK (corresponding author), Populat Council, HIV & AIDS Program, 142 Golf Links, New Delhi, India.	sangramkishor@gmail.com		Saggurti, Niranjan/0000-0002-5267-8425	Knowledge Network project of the Population Council through Avahan, its India AIDS Initiative	Knowledge Network project of the Population Council through Avahan, its India AIDS Initiative	This paper was written as part of the Knowledge Network project of the Population Council, which is a grantee of the Bill & Melinda Gates Foundation through Avahan, its India AIDS Initiative. The views expressed herein are those of the authors and do not necessarily reflect the official policy or position of the Bill & Melinda Gates Foundation and Avahan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avahan, 2008, AV IND AIDS IN BUS H; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blanchard JF, 2005, J INFECT DIS, V191, pS139, DOI 10.1086/425273; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; Chambers R., 1997, WHOSE REALITY COUNTS; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Fin Mark Trust, 2009, CONS FIN VULN IND S; Ford K, 2002, SEX TRANSM DIS, V29, P50, DOI 10.1097/00007435-200201000-00009; Galavotti C, 2012, J EPIDEMIOL COMMUN H, V66, pII9, DOI 10.1136/jech-2011-200465; Ghose T, 2008, SOC SCI MED, V67, P311, DOI 10.1016/j.socscimed.2008.03.045; Halli SS, 2006, AIDS CARE, V18, P739, DOI 10.1080/09540120500466937; India HIV/AIDS Alliance, 2014, CBOS CBGS STAT REP; India HIV/AIDS Alliance and Population Council, 2014, AV DISS M BEST PRACT; Jana S, 1995, Indian J Public Health, V39, P125; Kothari U., 2001, Participation: the new tyranny?, P139; Kuhlmann AS, 2014, AIDS BEHAV, V18, P752, DOI 10.1007/s10461-013-0626-6; Parimi P, 2012, J EPIDEMIOL COMMUN H, V66, pII62, DOI 10.1136/jech-2011-200832; Pillai P., 2012, IMPACT 2 VULNERABILI; Prabhakar P, 2014, AIDS 2014 INT C MELB; Rou KM, 2007, AIDS, V21, pS95, DOI 10.1097/01.aids.0000304703.77755.c7; Saggurti N, 2013, AIDS CARE, V25, pS55, DOI 10.1080/09540121.2012.749334; Souverein D, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.22943; Swarup P, 2012, J EPIDEMIOL COMMUNIT, V66, pii87, DOI [10.1136/jech-2011-200478, DOI 10.1136/JECH-2011-200478]; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; UNAIDS, 2010, COMB HIV PREV TAIL C; UNAIDS, 2012, UNAIDS GUID NOT HIV; Vejella S, 2016, AIDS BEHAV, V20, P776, DOI 10.1007/s10461-015-1171-2; Wheeler T, 2012, J EPIDEMIOL COMMUN H, V66, pII16, DOI 10.1136/jech-2012-201081; Whitney Moret ASPIRES FHI 360, 2014, EC STRENGTH FEM SEX	32	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156060	10.1371/journal.pone.0156060	http://dx.doi.org/10.1371/journal.pone.0156060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227998	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500061
J	Verroken, A; Defourny, L; de Waroux, OL; Belkhir, L; Laterre, PF; Delmee, M; Glupczynski, Y				Verroken, Alexia; Defourny, Lydwine; de Waroux, Olivier le Polain; Belkhir, Leila; Laterre, Pierre-Francois; Delmee, Michel; Glupczynski, Youri			Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; BETA-LACTA TEST; TIME; INFECTIONS; BACTEREMIA; RESISTANCE; SYSTEM	Shortening the turn-around time (TAT) of positive blood culture (BC) identification (ID) and susceptibility results is essential to optimize antimicrobial treatment in patients with sepsis. We aimed to evaluate the impact on antimicrobial prescription of a modified workflow of positive BCs providing ID and partial susceptibility results for Enterobacteriaceae (EB), Pseudomonas aeruginosa and Staphylococcus aureus on the day of BC positivity detection. This study was divided into a pre-intervention period (P0) with a standard BC workflow followed by 2 intervention periods (P1, P2) with an identical modified workflow. ID was performed with MALDI-TOF MS from blood, on early or on overnight subcultures. According to ID results, rapid phenotypic assays were realized to detect third generation cephalosporin resistant EB/P. aeruginosa or methicillin resistant S. aureus. Results were transmitted to the antimicrobial stewardship team for patient's treatment revision. Times to ID, to susceptibility results and to optimal antimicrobial treatment (OAT) were compared across the three study periods. Overall, 134, 112 and 154 positive BC episodes in P0, P1 and P2 respectively were included in the analysis. Mean time to ID (28.3 hours in P0) was reduced by 65.3% in P1 (10.2 hours) and 61.8% in P2 (10.8 hours). Mean time to complete susceptibility results was reduced by 27.5% in P1 and 27% in P2, with results obtained after 32.4 and 32.6 hours compared to 44.7 hours in P0. Rapid tests allowed partial susceptibility results to be obtained after a mean time of 11.8 hours in P1 and 11.7 hours in P2. Mean time to OAT was decreased to 21.6 hours in P1 and to 17.9 hours in P2 compared to 36.1 hours in P0. Reducing TAT of positive BC with MALDI-TOF MS ID and rapid susceptibility testing accelerated prescription of targeted antimicrobial treatment thereby potentially improving the patients' clinical outcome.	[Verroken, Alexia; Delmee, Michel] Catholic Univ Louvain, IREC, Pole Microbiol MBLG, B-1200 Brussels, Belgium; [Verroken, Alexia; Defourny, Lydwine; Delmee, Michel] Catholic Univ Louvain, Lab Microbiol, Clin Univ St Luc, B-1200 Brussels, Belgium; [de Waroux, Olivier le Polain] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Belkhir, Leila] Catholic Univ Louvain, Clin Univ St Luc, Dept Med Interne & Pathol Infect, B-1200 Brussels, Belgium; [Laterre, Pierre-Francois] Catholic Univ Louvain, Clin Univ St Luc, Dept Soins Intensifs, B-1200 Brussels, Belgium; [Glupczynski, Youri] CHU UCL Namur, Natl Reference Ctr Monitoring Antimicrobial Resis, Yvoir, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of London; London School of Hygiene & Tropical Medicine; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Verroken, A (corresponding author), Catholic Univ Louvain, IREC, Pole Microbiol MBLG, B-1200 Brussels, Belgium.; Verroken, A (corresponding author), Catholic Univ Louvain, Lab Microbiol, Clin Univ St Luc, B-1200 Brussels, Belgium.	alexia.verroken@uclouvain.be		le Polain de Waroux, Olivier/0000-0003-3458-2945; Verroken, Alexia/0000-0001-5486-964X				Beekmann SE, 2003, J CLIN MICROBIOL, V41, P3119, DOI 10.1128/JCM.41.7.3119-3125.2003; Beuving J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-156; Bizzini A, 2010, CLIN MICROBIOL INFEC, V16, P1614, DOI 10.1111/j.1469-0691.2010.03311.x; Bogaerts P, 2013, J ANTIMICROB CHEMOTH, V68, P1576, DOI 10.1093/jac/dkt065; Bogaerts P, 2007, J ANTIMICROB CHEMOTH, V59, P459, DOI 10.1093/jac/dkl527; Centers for Disease Control and Prevention, CS257671C CDCP NAT C; Centers for Disease Control and Prevention, NAT HEALTHC SAF NETW; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; Deresinski S, 2007, CLIN INFECT DIS, V45, pS177, DOI 10.1086/519472; Dortet L, 2014, CLIN MICROBIOL INFEC, V20, P340, DOI 10.1111/1469-0691.12318; Eigner U, 2009, CLIN LAB, V55, P289; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Eveillard M, 2010, CLIN MICROBIOL INFEC, V16, P1084, DOI 10.1111/j.1469-0691.2009.03044.x; Heraud S, 2015, ANN LAB MED, V35, P454, DOI 10.3343/alm.2015.35.4.454; Huang AM, 2013, CLIN INFECT DIS, V57, P1237, DOI 10.1093/cid/cit498; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kohlmann R, 2015, INT J MED MICROBIOL, V305, P469, DOI 10.1016/j.ijmm.2015.04.004; Laurent T, 2013, J CLIN MICROBIOL, V51, P1951, DOI 10.1128/JCM.00524-13; Martiny D, 2013, CLIN MICROBIOL INFEC, V19, pE568, DOI 10.1111/1469-0691.12282; Morgenthaler Nils G, 2015, Int J Microbiol, V2015, P827416, DOI 10.1155/2015/827416; Renvoise A, 2013, J CLIN MICROBIOL, V51, P4012, DOI 10.1128/JCM.01936-13; Verroken A, 2015, EUR J CLIN MICROBIOL, V34, P405, DOI 10.1007/s10096-014-2242-4; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589; Walewski V, 2015, DIAGN MICR INFEC DIS, V83, P216, DOI 10.1016/j.diagmicrobio.2015.07.005	24	55	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156299	10.1371/journal.pone.0156299	http://dx.doi.org/10.1371/journal.pone.0156299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228001	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500106
J	Wu, YY; Kumar, R; Iida, R; Bagavant, H; Alarcon-Riquelme, ME				Wu, Ying-Yu; Kumar, Ramesh; Iida, Ryuji; Bagavant, Harini; Alarcon-Riquelme, Marta E.			BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B-CELL RESPONSES; AUTOANTIBODY PRODUCTION; SYSTEMIC AUTOIMMUNITY; MURINE LUPUS; ERYTHEMATOSUS; DISEASE; MICE; TLR7; EXPRESSION	The purpose of our study was to investigate the effects of the adaptor Bank1 in TLR7 signaling using the B6.Sle1.yaa mouse, a lupus model that develops disease through exacerbated TLR7 expression. Crosses of B6.Sle1.yaa with Bank1(-/-) mice maintained several B and myeloid cell phenotypes close to normal wild-type levels. Most striking was the reduction in total serum IgG antibodies, but not of IgM, and reduced serum levels of autoantibodies, IL-6, and BAFF. Bank1 deficiency did modify numbers of MZ B cells and total B cell numbers, as well as expression of CXCR4 by follicular helper T cells. Other T cell changes were not observed. Bank1 deficiency did not modify numbers of germinal center B cells or plasma cells or clinical disease outcomes. Purified B cells from Bank1 deficient mice had strongly reduced Ifnb, Ifna4, Irf7, Aicda and Stat1 gene expression following TLR7 agonist stimulation. Interestingly, phosphorylation of Tyr701, but not of Ser727 of STAT1, was impaired in splenic B cells from B6.Sle1.yaa. Bank1(-/-) mice, as was the nuclear translocation of IRF7 in response to TLR7 agonist stimulation. Further, Bank1 deficiency in B6. Sle1. yaa mice reduced the production of IgG2c after in vitro TLR7 agonist stimulation. Our results demonstrate that Bank1 controls TLR7-mediated type I interferon production. Combined with the control of the nuclear translocation of IRF7, the modulation of STAT1 transcription and phosphorylation, Bank1 contributes to IgG production during development of autoimmune disease.	[Wu, Ying-Yu; Kumar, Ramesh; Iida, Ryuji; Bagavant, Harini; Alarcon-Riquelme, Marta E.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta E.] Univ Granada, Dept Med Genom, Andalusian Govt Ctr Genom & Oncol Res GENYO, Pfizer, Granada 18016, Spain; [Iida, Ryuji] Natl Inst Biomed Innovat, Hlth & Nutr Lab Cell Cultures, Osaka 5670085, Japan	Oklahoma Medical Research Foundation; Pfizer; University of Granada; National Institute of Health Sciences - Japan	Alarcon-Riquelme, ME (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	marta.alarcon@genyo.es	Bagavant, Harini/V-7735-2019; Alarcón-Riquelme, Marta E./ABF-8163-2020; Kumar, Ramesh/U-8358-2019; Kumar, Ramesh/A-8258-2019	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; 	Alliance for Lupus Research; National Institutes of Health COBRE [GM103456-09]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103456] Funding Source: NIH RePORTER	Alliance for Lupus Research; National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Alliance for Lupus Research to MEAR (www.lupusresearch.org < http://www.lupusresearch.org >) and National Institutes of Health COBRE grant GM103456-09 to Pat Gaffney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marta E. Alarcon-Riquelme works at the Pfizer/University of Granada/Andalusian Government Center for Genomics and Oncological Research (GENYO) as an employee of the Fundacion Publica Andaluza Progreso y Salud of the Andalusian Government. Pfizer/University of Granada/Andalusian Government Center for Genomics and Oncological Research (GENYO) did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Davidson A, 2012, CURR RHEUMATOL REP, V14, P295, DOI 10.1007/s11926-012-0258-2; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Dieude P, 2009, ARTHRITIS RHEUM-US, V60, P3447, DOI 10.1002/art.24885; Elsner RA, 2012, J VIROL, V86, P7146, DOI 10.1128/JVI.06904-11; Fairhurst AM, 2008, EUR J IMMUNOL, V38, P1971, DOI 10.1002/eji.200838138; Green NM, 2009, J IMMUNOL, V183, P1569, DOI 10.4049/jimmunol.0803899; Nguyen HV, 2012, BLOOD, V119, P4174, DOI 10.1182/blood-2011-09-378182; Hwang SH, 2012, J IMMUNOL, V189, P5786, DOI 10.4049/jimmunol.1202195; Joshi S, 2010, CYTOKINE, V52, P123, DOI 10.1016/j.cyto.2010.03.019; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Liu Z, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00306; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Maeda K, 2009, BLOOD, V113, P4534, DOI 10.1182/blood-2008-12-192559; Maier-Moore JS, 2014, ARTHRITIS RHEUMATOL, V66, P2521, DOI 10.1002/art.38716; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Pan ZJ, 2010, ANN RHEUM DIS, V69, P1195, DOI 10.1136/ard.2009.108282; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rozco G, 2009, ARTHRITIS RHEUM, V60, P372, DOI 10.1002/art.24244; Santiago-Raber ML, 2010, J AUTOIMMUN, V34, P339, DOI 10.1016/j.jaut.2009.11.001; Stohl W, 2005, ARTHRITIS RHEUM-US, V52, P2080, DOI 10.1002/art.21138; Suarez-Gestal M, 2009, ARTHRITIS RHEUM-US, V60, P2558, DOI 10.1002/art.24748; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Tangye SG, 2015, CURR OPIN IMMUNOL, V34, P107, DOI 10.1016/j.coi.2015.02.010; Thibault DL, 2008, J CLIN INVEST, V118, P1417, DOI 10.1172/JCI30065; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Walsh ER, 2012, P NATL ACAD SCI USA, V109, P16276, DOI 10.1073/pnas.1209372109; Wang A, 2009, J IMMUNOL, V182, P4448, DOI 10.4049/jimmunol.0801920; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Wu YY, 2013, J IMMUNOL, V191, P6110, DOI 10.4049/jimmunol.1301203; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83; Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006	44	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156302	10.1371/journal.pone.0156302	http://dx.doi.org/10.1371/journal.pone.0156302			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228057	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500107
J	Bing, PF; Xia, W; Wang, L; Zhang, YH; Lei, SF; Deng, FY				Bing, Peng-Fei; Xia, Wei; Wang, Lan; Zhang, Yong-Hong; Lei, Shu-Feng; Deng, Fei-Yan			Common Marker Genes Identified from Various Sample Types for Systemic Lupus Erythematosus	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; EXPRESSION; ASSOCIATION; BIOMARKERS; MONOCYTES; RESPONSES; STAT1; GEO	Objective Systemic lupus erythematosus (SLE) is a complex auto-immune disease. Gene expression studies have been conducted to identify SLE-related genes in various types of samples. It is unknown whether there are common marker genes significant for SLE but independent of sample types, which may have potentials for follow-up translational research. The aim of this study is to identify common marker genes across various sample types for SLE. Methods Based on four public microarray gene expression datasets for SLE covering three representative types of blood-born samples (monocyte; peripheral blood mononuclear cell, PBMC; whole blood), we utilized three statistics (fold-change, FC; t-test p value; false discovery rate adjusted p value) to scrutinize genes simultaneously regulated with SLE across various sample types. For common marker genes, we conducted the Gene Ontology enrichment analysis and Protein-Protein Interaction analysis to gain insights into their functions. Results We identified 10 common marker genes associated with SLE (IFI6, IFI27, IFI44L, OAS1, OAS2, EIF2AK2, PLSCR1, STAT1, RNASE2, and GSTO1). Significant up-regulation of IFI6, IFI27, and IFI44L with SLE was observed in all the studied sample types, though the FC was most striking in monocyte, compared with PBMC and whole blood (8.82-251.66 vs. 3.73-74.05 vs. 1.19-1.87). Eight of the above 10 genes, except RNASE2 and GSTO1, interact with each other and with known SLE susceptibility genes, participate in immune response, RNA and protein catabolism, and cell death. Conclusion Our data suggest that there exist common marker genes across various sample types for SLE. The 10 common marker genes, identified herein, deserve follow-up studies to dissert their potentials as diagnostic or therapeutic markers to predict SLE or treatment response.	[Bing, Peng-Fei; Xia, Wei; Wang, Lan; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China; [Bing, Peng-Fei; Xia, Wei; Wang, Lan; Zhang, Yong-Hong; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China.; Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China.	fdeng@suda.edu.cn			Natural Science Foundation of China [81373010, 81541068, 81473046, 31401079, 81401343, 31271336]; Natural Science Foundation of Jiangsu Province [BK20130300]; Startup Fund from Soochow University [Q413900112, Q413900712]; China Postdoctoral Science Foundation [2014M551649]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Startup Fund from Soochow University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by Natural Science Foundation of China (FYD and SFL; 81373010, 81541068, 81473046, 31401079, 81401343 and 31271336; http://www.nsfc.gov.cn/), the Natural Science Foundation of Jiangsu Province (FYD, BK20130300, http://www.jskjjh.gov.cn/), the Startup Fund from Soochow University (SFL, Q413900112; FYD, Q413900712; www.suda.edu.cn), China Postdoctoral Science Foundation (2014M551649), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (FYD and SFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DL, 2014, GENES IMMUN, V15, P347, DOI 10.1038/gene.2014.23; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Carpintero M F, 2015, DIAGNOSIS RISK STRAT; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Dominguez-Gutierrez PR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4448; Dominguez-Gutierrez PR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4451; Dominguez-Gutierrez PR, 2014, J CLIN IMMUNOL, V34, P171, DOI 10.1007/s10875-013-9973-3; Feng XB, 2015, CLIN RHEUMATOL, V34, P71, DOI 10.1007/s10067-014-2799-4; Fodil M, 2015, SCAND J RHEUMATOL, V44, P2, DOI 10.3109/03009742.2014.918175; Grammatikos AP, 2014, CLIN IMMUNOL, V150, P192, DOI 10.1016/j.clim.2013.12.002; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Huang Jing, 2010, Zhonghua Nei Ke Za Zhi, V49, P45; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Kennedy WP, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000080; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Li Min, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P268; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; O'Hanlon TP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3330; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Raya MA, 2013, J REHABIL RES DEV, V50, P951, DOI 10.1682/JRRD.2012.05.0096; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rodriguez-Pla A, 2014, J IMMUNOL, V192, P5586, DOI 10.4049/jimmunol.1301319; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Shi XJ, 2014, BRIEF BIOINFORM, V15, P671, DOI 10.1093/bib/bbt044; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Ye S, 2007, CLIN RHEUMATOL, V26, P186, DOI 10.1007/s10067-006-0260-z	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156234	10.1371/journal.pone.0156234	http://dx.doi.org/10.1371/journal.pone.0156234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257790	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700045
J	Marston, CK; Ibrahim, H; Lee, P; Churchwell, G; Gumke, M; Stanek, D; Gee, JE; Boyer, AE; Gallegos-Candela, M; Barr, JR; Li, H; Boulay, D; Cronin, L; Quinn, CP; Hoffmaster, AR				Marston, Chung K.; Ibrahim, Hisham; Lee, Philip; Churchwell, George; Gumke, Megan; Stanek, Danielle; Gee, Jay E.; Boyer, Anne E.; Gallegos-Candela, Maribel; Barr, John R.; Li, Han; Boulay, Darbi; Cronin, Li; Quinn, Conrad P.; Hoffmaster, Alex R.			Anthrax Toxin-Expressing Bacillus cereus Isolated from an Anthrax-Like Eschar	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PROTECTIVE ANTIGEN; INHALATION ANTHRAX; LETHAL FACTOR; GENES; IDENTIFICATION; VALIDATION; STRAINS	Bacillus cereus isolates have been described harboring Bacillus anthracis toxin genes, most notably B. cereus G9241, and capable of causing severe and fatal pneumonias. This report describes the characterization of a B. cereus isolate, BcFL2013, associated with a naturally occurring cutaneous lesion resembling an anthrax eschar. Similar to G9241, BcFL2013 is positive for the B. anthracis pXO1 toxin genes, has a multi-locus sequence type of 78, and a pagA sequence type of 9. Whole genome sequencing confirms the similarity to G9241. In addition to the chromosome having an average nucleotide identity of 99.98% when compared to G9241, BcFL2013 harbors three plasmids with varying homology to the G9241 plasmids (pBCXO1, pBC210 and pBFH_1). This is also the first report to include serologic testing of patient specimens associated with this type of B. cereus infection which resulted in the detection of anthrax lethal factor toxemia, a quantifiable serum antibody response to protective antigen (PA), and lethal toxin neutralization activity.	[Marston, Chung K.; Gee, Jay E.; Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA; [Ibrahim, Hisham] Villages Reg Hosp, Lady Lake, FL USA; [Lee, Philip; Churchwell, George] Bur Publ Hlth Labs, Florida Dept Hlth, Jacksonville, FL USA; [Gumke, Megan; Stanek, Danielle] Bur Epidemiol, Florida Dept Hlth, Tallahassee, FL USA; [Boyer, Anne E.; Gallegos-Candela, Maribel; Barr, John R.] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Li, Han; Boulay, Darbi; Cronin, Li; Quinn, Conrad P.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Florida Department of Health; Florida Department of Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Marston, CK (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30329 USA.	cdk5@cdc.gov	Ibrahim, Hisham/AAB-3945-2021	Ibrahim, Hisham/0000-0002-7809-900X; Gumke, Megan/0000-0002-4158-8790; Gee, Jay/0000-0003-4308-1659	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This publication made use of the Bacillus cereus Multi Locus Sequence Typing website (http://pubmlst.org/bcereus/) developed by Keith Jolley and sited at the University of Oxford (Jolley & Maiden 2010, BMC Bioinformatics, 11:595). The development of this site has been funded by the Wellcome Trust.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Boyer AE, 2007, ANAL CHEM, V79, P8463, DOI 10.1021/ac701741s; Boyer AE, 2011, J INFECT DIS, V204, P1321, DOI 10.1093/infdis/jir543; Brezillon C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003455; Gee JE, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00469-14; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1111, DOI 10.3201/eid0810.020394; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1178, DOI 10.3201/eid0810.020393; Jackson PJ, 1998, P NATL ACAD SCI USA, V95, P1224, DOI 10.1073/pnas.95.3.1224; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00151-15; Kaiser J., 2011, UPDATED U CHICAGO MI; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Li H, 2008, J IMMUNOL METHODS, V333, P89, DOI 10.1016/j.jim.2008.01.007; Marston CK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-22; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Semenova VA, 2012, J IMMUNOL METHODS, V376, P97, DOI 10.1016/j.jim.2011.12.002; Turenne C.Y., 2015, MANUAL CLIN MICROBIO, V11th, P441; Wright AM, 2011, ARCH PATHOL LAB MED, V135, P1447, DOI 10.5858/2011-0362-SAIR.1	23	30	32	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156987	10.1371/journal.pone.0156987	http://dx.doi.org/10.1371/journal.pone.0156987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257909	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700167
J	Adams, J; McNaughton, RJ; Wigham, S; Flynn, D; Ternent, L; Shucksmith, J				Adams, Jean; McNaughton, Rebekah J.; Wigham, Sarah; Flynn, Darren; Ternent, Laura; Shucksmith, Janet			Acceptability of Parental Financial Incentives and Quasi-Mandatory Interventions for Preschool Vaccinations: Triangulation of Findings from Three Linked Studies	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; IMPROVE HEALTH; OLDER-PEOPLE; BEHAVIORS; UK; CHILDREN; OUTCOMES; SCHEMES; CARE	Background Childhood vaccinations are a core component of public health programmes globally. Recent measles outbreaks in the UK and USA have prompted debates about new ways to increase uptake of childhood vaccinations. Parental financial incentives and quasi-mandatory interventions (e.g. restricting entry to educational settings to fully vaccinated children) have been successfully used to increase uptake of childhood vaccinations in developing countries, but there is limited evidence of effectiveness in developed countries. Even if confirmed to be effective, widespread implementation of these interventions is dependent on acceptability to parents, professionals and other stakeholders. Methods We conducted a systematic review (n = 11 studies included), a qualitative study with parents (n = 91) and relevant professionals (n = 24), and an on-line survey with embedded discrete choice experiment with parents (n = 521) exploring acceptability of parental financial incentives and quasi-mandatory interventions for preschool vaccinations. Here we use Triangulation Protocol to synthesise findings from the three studies. Results There was a consistent recognition that incentives and quasi-mandatory interventions could be effective, particularly in more disadvantaged groups. Universal incentives were consistently preferred to targeted ones, but relative preferences for quasi-mandatory interventions and universal incentives varied between studies. The qualitative work revealed a consistent belief that financial incentives were not considered an appropriate motivation for vaccinating children. The costs of financial incentive interventions appeared particularly salient and there were consistent concerns in the qualitative work that incentives did not represent the best use of resources for promoting preschool vaccinations. Various suggestions for improving delivery of the current UK vaccination programme as an alternative to incentives and quasi-mandates were made. Conclusions Parental financial incentives and quasi-mandatory interventions for increasing uptake of preschool vaccinations do not currently attract widespread enthusiastic support in the UK; but some potential benefits of these approaches are recognised.	[Adams, Jean] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [McNaughton, Rebekah J.; Shucksmith, Janet] Univ Teesside, Sch Hlth & Social Care, Middlesbrough, Cleveland, England; [Wigham, Sarah] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Flynn, Darren; Ternent, Laura] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Cambridge; University of Teesside; Newcastle University - UK; Newcastle University - UK	Adams, J (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Cambridge, England.	jma79@medschl.cam.ac.uk	McNaughton, Rebekah J./I-1054-2019; Adams, Jean/G-2402-2010	McNaughton, Rebekah J./0000-0002-9917-6289; Flynn, Darren/0000-0001-7390-632X; Ternent, laura/0000-0001-7056-298X; Wigham, Sarah/0000-0002-7722-9108; Shucksmith, Janet/0000-0003-3825-413X; Adams, Jean/0000-0002-5733-7830	UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme [HTA 11/97/01]; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence [MR/K023187/1]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K02325X/1] Funding Source: researchfish; National Institute for Health Research [CDF-2011-04-001, 11/97/01] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K023187/1] Funding Source: UKRI	UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme; Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (grant no. HTA 11/97/01). JA is currently funded by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence (grant no. MR/K023187/1). Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abertawe Bro Morgannwg University Health Board Powys Health Board Hywel Dda Health Board Public Health Wales, 2013, OUTBR MEASL WAL NOV; Adams J, 2013, PARENTAL INCENTIVES; Adams J, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19940; Babones SJ, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P1, DOI 10.1332/policypress/9781847423207.001.0001; Casiday RE, 2007, SOC SCI MED, V65, P1059, DOI 10.1016/j.socscimed.2007.04.023; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Denzin N. K., 1978, RES ACT THEORETICAL; Diepeveen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-756; Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0; Farmer T, 2006, QUAL HEALTH RES, V16, P377, DOI 10.1177/1049732305285708; Flynn Terry N, 2008, Popul Health Metr, V6, P6, DOI 10.1186/1478-7954-6-6; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Giles EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0549-5; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1409-y; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Hoddinott P, 2014, LANCET, V384, P37; Ierfino D, 2015, ADDICTION, V110, P680, DOI 10.1111/add.12817; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; McLaren L, 2010, INT J EPIDEMIOL, V39, P372, DOI 10.1093/ije/dyp315; McNaughton RJ, 2016, VACCINE, V34, P2259, DOI 10.1016/j.vaccine.2016.03.009; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; OCathain A, 2010, 3 TECHNIQUES INTEGRA, V11, P23; Oliver A, 2009, J HEALTH SERV RES PO, V14, P1, DOI 10.1258/jhsrp.2008.008132; Owen L, 2012, J PUBLIC HEALTH-UK, V34, P37, DOI 10.1093/pubmed/fdr075; Parke H, 2013, HEALTH EXPECT, V16, P292, DOI 10.1111/j.1369-7625.2011.00719.x; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Promberger M, 2011, J MED ETHICS, V37, P682, DOI 10.1136/jme.2010.039347; Radley A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-343; Ryan M, 2006, J HEALTH ECON, V25, P927, DOI 10.1016/j.jhealeco.2006.01.001; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Whelan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-355; Wigham S, 2014, PEDIATRICS, V134, pE1117, DOI 10.1542/peds.2014-1279; World Health Organization, 2010, IMM COV; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P1	37	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156843	10.1371/journal.pone.0156843	http://dx.doi.org/10.1371/journal.pone.0156843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253196	Green Accepted, Green Published, gold			2022-12-27	WOS:000377218700065
J	de Stoppelaar, SF; Claushuis, TAM; Schaap, MCL; Hou, BD; van der Poll, T; Nieuwland, R; van't Veer, C				de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; Schaap, Marianne C. L.; Hou, Baidong; van der Poll, Tom; Nieuwland, Rienk; van't Veer, Cornelis			Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo	PLOS ONE			English	Article							ACUTE LUNG INJURY; ORGAN DYSFUNCTION; ESCHERICHIA-COLI; ACTIVATION; LIPOPOLYSACCHARIDE; THROMBOCYTOPENIA; SEPSIS; BLOOD; TLR4; INFLAMMATION	Streptococcus (S.) pneumoniae strains vary considerably in their ability to cause invasive disease in humans, which is at least in part determined by the capsular serotype. Platelets have been implicated as sentinel cells in the circulation for host defence. One of their utensils for this function is the expression of Toll-like receptors (TLRs). We here aimed to investigate platelet response to S. pneumoniae and a role for TLRs herein. Platelets were stimulated using four serotypes of S. pneumonia including an unencapsulated mutant strain. In vitro aggregation and flow cytometry assays were performed using blood of healthy volunteers, or blood of TLR knock out and WT mice. For in vivo pneumonia experiments, platelet specific Myd88 knockout (Plt-Myd88(-/-)) mice were used. We found that platelet aggregation was induced by unencapsulated S. pneumoniae only. Whole blood incubation with all S. pneumoniae serotypes tested resulted in platelet degranulation and platelet-leukocyte complex formation. Platelet activation was TLR independent, as responses were not inhibited by TLR blocking antibodies, not induced by TLR agonists and were equally induced in wild-type and Tlr2(-/-), Tlr4(-/-), Tlr2/4(-/-), Tlr9(-/-) and Myd88(-/-) blood. Plt-Myd88(-/-) and control mice displayed no differences in bacterial clearance or immune response to pneumonia by unencapsulated S. pneumoniae. In conclusion, S. pneumoniae activates platelets through a TLR-independent mechanism that is impeded by the bacterial capsule. Additionally, platelet MyD88-dependent TLR signalling is not involved in host defence to unencapsulated S. pneumoniae in vivo.	[de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; van der Poll, Tom; van't Veer, Cornelis] Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; van der Poll, Tom; van't Veer, Cornelis] Univ Amsterdam, Ctr Expt & Mol Med CEMM, Amsterdam, Netherlands; [Schaap, Marianne C. L.; Nieuwland, Rienk] Univ Amsterdam, Lab Expt & Clin Chem LEKC, Amsterdam, Netherlands; [Hou, Baidong] Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China; [van der Poll, Tom] Univ Amsterdam, Div Infect Dis, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Amsterdam	de Stoppelaar, SF (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands.	s.f.destoppelaar@amc.uva.nl	Nieuwland, Rienk/AAC-9591-2019	Hou, Baidong/0000-0002-0892-0181	AMC PhD Graduate School Scholarship	AMC PhD Graduate School Scholarship	This work was supported by the AMC PhD Graduate School Scholarship to SFS. Landsteiner Foundation for Blood Transfusion Research (LSBR 1351) for TAMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arman M, 2014, BLOOD, V123, P3166, DOI 10.1182/blood-2013-11-540526; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; BAUGHMAN RP, 1993, CHEST, V104, P1243, DOI 10.1378/chest.104.4.1243; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Bozza FA, 2009, AM J RESP CELL MOL, V40, P123, DOI 10.1165/rcmb.2008-0241TR; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Claushuis TA, 2016, BLOOD IN PRESS; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; de Stoppelaar SF, 2015, J THROMB HAEMOST, V13, P1709, DOI 10.1111/jth.13048; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; de Stoppelaar SF, 2013, THROMB HAEMOSTASIS, V110, P582, DOI 10.1160/TH13-01-0052; de Vos AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118181; Denes A, 2014, ANN NEUROL, V75, P670, DOI 10.1002/ana.24146; Fung CYE, 2012, BLOOD, V119, P3613, DOI 10.1182/blood-2011-10-386052; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Iovino F, 2014, INFECT IMMUN, V82, P3555, DOI 10.1128/IAI.00046-14; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kalvegren H, 2010, THROMB HAEMOSTASIS, V103, P398, DOI 10.1160/TH09-07-0442; Keane C, 2010, J THROMB HAEMOST, V8, P2757, DOI 10.1111/j.1538-7836.2010.04093.x; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Koupenova M, 2015, ARTERIOSCL THROM VAS, V35, P1030, DOI 10.1161/ATVBAHA.114.304954; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin YT, 2012, CURR GENOMICS, V13, P633, DOI 10.2174/138920212803759712; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Montrucchio G, 2003, THROMB HAEMOSTASIS, V90, P872, DOI 10.1160/TH03-02-0085; NIEUWENHUIS HK, 1987, BLOOD, V70, P838; Panigrahi S, 2013, CIRC RES, V112, P103, DOI 10.1161/CIRCRESAHA.112.274241; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stark RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041254; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van den Boogaard F, 2015, CRITICAL CARE MED; van den Boogaard FE, 2015, CRIT CARE MED, V43, pE75, DOI 10.1097/CCM.0000000000000853; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van 't Veer C, 2011, J BIOL CHEM, V286, P36603, DOI 10.1074/jbc.M110.189126; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325	62	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156977	10.1371/journal.pone.0156977	http://dx.doi.org/10.1371/journal.pone.0156977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253707	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700068
J	Doyle, O; McGlanaghy, E; O'Farrelly, C; Tremblay, RE				Doyle, Orla; McGlanaghy, Edel; O'Farrelly, Christine; Tremblay, Richard E.			Can Targeted Intervention Mitigate Early Emotional and Behavioral Problems?: Generating Robust Evidence within Randomized Controlled Trials	PLOS ONE			English	Article							HOME-VISITING PROGRAMS; FAMILY CHECK-UP; CONDUCT PROBLEMS; PSYCHIATRIC-DISORDERS; ANTISOCIAL-BEHAVIOR; CHILD-DEVELOPMENT; PHYSICAL HEALTH; LIFE-COURSE; FOLLOW-UP; VISITATION	This study examined the impact of a targeted Irish early intervention program on children's emotional and behavioral development using multiple methods to test the robustness of the results. Data on 164 Preparing for Life participants who were randomly assigned into an intervention group, involving home visits from pregnancy onwards, or a control group, was used to test the impact of the intervention on Child Behavior Checklist scores at 24-months. Using inverse probability weighting to account for differential attrition, permutation testing to address small sample size, and quantile regression to characterize the distributional impact of the intervention, we found that the few treatment effects were largely concentrated among boys most at risk of developing emotional and behavioral problems. The average treatment effect identified a 13% reduction in the likelihood of falling into the borderline clinical threshold for Total Problems. The interaction and subgroup analysis found that this main effect was driven by boys. The distributional analysis identified a 10-point reduction in the Externalizing Problems score for boys at the 90(th) percentile. No effects were observed for girls or for the continuous measures of Total, Internalizing, and Externalizing problems. These findings suggest that the impact of this prenatally commencing home visiting program may be limited to boys experiencing the most difficulties. Further adoption of the statistical methods applied here may help to improve the internal validity of randomized controlled trials and contribute to the field of evaluation science more generally.	[Doyle, Orla] Univ Coll Dublin, UCD Sch Econ, Dublin 2, Ireland; [Doyle, Orla] Univ Coll Dublin, UCD Geary Inst Publ Policy, Dublin 2, Ireland; [McGlanaghy, Edel] Univ Edinburgh, Clin Psychol, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [O'Farrelly, Christine] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London, England; [Tremblay, Richard E.] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Tremblay, Richard E.] Univ Coll Dublin, UCD Sch Publ Hlth Physiotherapy & Sport Sci, Dublin 2, Ireland	University College Dublin; University College Dublin; University of Edinburgh; Imperial College London; Universite de Montreal; Universite de Montreal; University College Dublin	Doyle, O (corresponding author), Univ Coll Dublin, UCD Sch Econ, Dublin 2, Ireland.; Doyle, O (corresponding author), Univ Coll Dublin, UCD Geary Inst Publ Policy, Dublin 2, Ireland.	orla.doyle@ucd.ie	Tremblay, Richard E./O-1360-2014; Mc Glanaghy, Edel/GZG-4513-2022	Doyle, Orla/0000-0001-7197-8012	Irish government's Department of Children and Youth Affairs; Atlantic Philanthropies	Irish government's Department of Children and Youth Affairs; Atlantic Philanthropies	The trial was funded by the Northside Partnership (http://northsidepartnership.ie/) through the Irish government's Department of Children and Youth Affairs and the Atlantic Philanthropies. The funding was provided to OD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2014, COMMUNICATION   0514; Avellar SA, 2013, PEDIATRICS, V132, pS90, DOI 10.1542/peds.2013-1021G; Azzi-Lessing L, 2013, INFANT MENT HEALTH J, V34, P376, DOI 10.1002/imhj.21399; Azzi-Lessing L, 2011, EARLY CHILD RES Q, V26, P387, DOI 10.1016/j.ecresq.2011.03.005; Baillargeon RH, 2007, INFANT MENT HEALTH J, V28, P12, DOI 10.1002/imhj.20120; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bayer JK, 2012, AUST NZ J PSYCHIAT, V46, P659, DOI 10.1177/0004867412450076; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; Booth A, 2014, J COMMUNITY PSYCHOL, V42, P29, DOI 10.1002/jcop.21592; Bowlby J, 1969, ATTACHMENT, V1; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; BrooksGunn J, 1997, FUTURE CHILD, V7, P55, DOI 10.2307/1602387; Burns BJ, 2004, J AM ACAD CHILD PSY, V43, P960, DOI 10.1097/01.chi.0000127590.95585.65; Caldera D, 2007, CHILD ABUSE NEGLECT, V31, P829, DOI 10.1016/j.chiabu.2007.02.008; Campbell F, 2014, SCIENCE, V343, P1478, DOI 10.1126/science.1248429; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Dishion TJ, 2008, CHILD DEV, V79, P1395, DOI 10.1111/j.1467-8624.2008.01195.x; Dishion TJ, 2014, J ABNORM CHILD PSYCH, V42, P343, DOI 10.1007/s10802-013-9768-2; Doyle O., 2013, NATL BUREAU EC RES W, V9316; Doyle O, 2012, J STAT SOC INQ SO I, V41, P92; Doyle O, 2015, ECON HUM BIOL, V19, P224, DOI 10.1016/j.ehb.2015.09.004; Doyle O, 2012, EUR J PSYCHOL EDUC, V27, P133, DOI 10.1007/s10212-011-0072-7; Drotar D, 2009, CHILD CARE HLTH DEV, V35, P643, DOI 10.1111/j.1365-2214.2008.00915.x; Duncan GJ, 2014, DEV PSYCHOL, V50, P2417, DOI 10.1037/a0037996; Eckenrode J, 2010, ARCH PEDIAT ADOL MED, V164, P9, DOI 10.1001/archpediatrics.2009.240; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Fergusson DM, 2011, BRIT J PSYCHIAT, V198, P457, DOI 10.1192/bjp.bp.110.086991; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Flay BR, 2005, PREV SCI, V6, P151, DOI 10.1007/s11121-005-5553-y; Gardner F., 2008, RUTTERS CHILD ADOLES, P882, DOI [10. 1002/9781444300895. ch53, DOI 10.1002/97814443008, 10.1002/9781444300895]; Gomby DS, 1999, FUTURE CHILD, V9, P4, DOI 10.2307/1602719; Gomby DS, 2005, HOME VISITATION 2005; Goodman A, 2011, P NATL ACAD SCI USA, V108, P6032, DOI 10.1073/pnas.1016970108; Goodson BD, 2000, EARLY CHILD RES Q, V15, P5, DOI 10.1016/S0885-2006(99)00040-X; Harden BJ, 2012, J COMMUNITY PSYCHOL, V40, P438, DOI 10.1002/jcop.20525; Heckman J, 2010, QUANT ECON, V1, P1, DOI 10.3982/QE8; Hertzman C, 2010, BMJ, V340, P346; Hofler M, 2005, SOC PSYCH PSYCH EPID, V40, P291, DOI 10.1007/s00127-005-0882-5; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Huston AC, 2001, CHILD DEV, V72, P318, DOI 10.1111/1467-8624.00281; Kamphaus R.W., 2002, CLIN ASSESSMENT CHIL; Keenan K, 1998, J ABNORM CHILD PSYCH, V26, P441, DOI 10.1023/A:1022647717926; Kitzman H, 1997, JAMA-J AM MED ASSOC, V278, P644, DOI 10.1001/jama.278.8.644; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lavigne JV, 1996, J AM ACAD CHILD PSY, V35, P204, DOI 10.1097/00004583-199602000-00014; Lowell DI, 2011, CHILD DEV, V82, P193, DOI 10.1111/j.1467-8624.2010.01550.x; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; Mewhort DJK, 2005, BEHAV RES METHODS, V37, P426, DOI 10.3758/BF03192711; Miller S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008131.pub2; Olds D, 1998, JAMA-J AM MED ASSOC, V280, P1238, DOI 10.1001/jama.280.14.1238; Olds DL, 2004, PEDIATRICS, V114, P1550, DOI 10.1542/peds.2004-0962; Olds DL, 2002, PEDIATRICS, V110, P486, DOI 10.1542/peds.110.3.486; Palamaro Munsell E, 2016, COMMUNITY PSYCHOL GL, V2, P52; Peacock S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-17; Petitclerc A, 2009, CAN J PSYCHIAT, V54, P222, DOI 10.1177/070674370905400403; Petscher Y, 2014, CHILD DEV, V85, P861, DOI 10.1111/cdev.12190; Preparing for Life & The, 2008, PREP LIF PROGR MAN; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rescorla LA., 2000, ASEBA PRESCHOOL FORM; Shadish WR, 2002, EXPT QUASIEXPERIMENT, P314; Shaw DS, 2009, DEV PSYCHOPATHOL, V21, P417, DOI 10.1017/S0954579409000236; Shaw DS, 2003, DEV PSYCHOL, V39, P189, DOI 10.1037/0012-1649.39.2.189; Shaw DS, 2006, J CONSULT CLIN PSYCH, V74, P1, DOI 10.1037/0022-006X.74.1.1; Supplee LH, 2013, PREV SCI, V14, P107, DOI 10.1007/s11121-012-0335-9; Sweet MA, 2004, CHILD DEV, V75, P1435, DOI 10.1111/j.1467-8624.2004.00750.x; Tamminen T, 2015, RUTTERS CHILD ADOLES, P882; WebsterStratton C, 1996, J CONSULT CLIN PSYCH, V64, P540, DOI 10.1037/0022-006X.64.3.540; Weisz JR, 2012, ARCH GEN PSYCHIAT, V69, P274, DOI 10.1001/archgenpsychiatry.2011.147; Zero to Three, 2001, DEF INF MENT HLTH	69	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156397	10.1371/journal.pone.0156397	http://dx.doi.org/10.1371/journal.pone.0156397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253184	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700025
J	Tulloss, EM; Cadenasso, ML				Tulloss, Elise M.; Cadenasso, Mary L.			The Effect of Nitrogen Deposition on Plant Performance and Community Structure: Is It Life Stage Specific?	PLOS ONE			English	Article							QUERCUS-AGRIFOLIA; CRITICAL LOADS; COMPETITION; PATTERNS; NUTRIENT; WATER; ESTABLISHMENT; BIODIVERSITY; GERMINATION; GRASSLANDS	Nitrogen (N) deposition is a key global change factor that is increasing and affecting the structure and function of many ecosystems. To determine the influence of N deposition on specific systems, however, it is crucial to understand the temporal and spatial patterns of deposition as well as the response to that deposition. Response of the receiving plant communities may depend on the life stage-specific performance of individual species. We focus on the California oak savanna because N deposition to this system is complex-characterized by hotspots on the landscape and seasonal pulses. In a greenhouse experiment, we investigated the relative influence of N deposition on plant performance during early growth, peak biomass, and senescent life stages across different soil types, light, and community compositions. To represent the community we used three grass species-a native, naturalized exotic, and invasive exotic. At early growth and peak biomass stages performance was measured as height, and shoot and root biomass, and at the senescent stage as seed production. Simulated N deposition 1) increased shoot biomass and height of the native and, even more so, the naturalized exotic during early growth, 2) positively affected root biomass in all species during peak biomass, and 3) had no influence on seed production at the senescent stage. Alone, N deposition was not a strong driver of plant performance; however, small differences in performance among species in response to N deposition could affect community composition in future years. In particular, if there is a pulse of N deposition during the early growth stage, the naturalized exotic may have a competitive advantage that could result in its spread. Including spatial and temporal heterogeneity in a complex, manipulative experiment provides a clearer picture of not only where N management efforts should be targeted on the landscape, but also when.	[Tulloss, Elise M.; Cadenasso, Mary L.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Tulloss, Elise M.] La Salle High Sch, Yakima, WA USA	University of California System; University of California Davis	Tulloss, EM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Tulloss, EM (corresponding author), La Salle High Sch, Yakima, WA USA.	emtulloss@ucdavis.edu			Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis; Department of Plant Sciences, University of California Davis	Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis; Department of Plant Sciences, University of California Davis(University of California System)	This work was supported by Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis (EMT); Department of Plant Sciences, University of California Davis (MLC). The authors received no specific funding for this work.	Abraham JK, 2009, HERBACEOUS PLANT ECOLOGY: RECENT ADVANCES IN PLANT ECOLOGY, P81, DOI 10.1007/978-90-481-2798-6_7; Allen-Diaz B, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P313; Arnon DI, 347 U CAL COLL AGR C; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Bartolome JW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P367; BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; Bilbrough CJ, 1997, ECOLOGY, V78, P231; Bobbink R, 1995, WATER AIR SOIL POLL, V85, P2413, DOI 10.1007/BF01186195; Brown CS, 2000, RESTOR ECOL, V8, P10, DOI 10.1046/j.1526-100x.2000.80003.x; CALLAWAY RM, 1991, PLANT SOIL, V137, P209, DOI 10.1007/BF00011199; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Dukes J. S., 2007, CALIFORNIA GRASSLAND, P218; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Garcia-Palacios P, 2012, J ECOL, V100, P1303, DOI 10.1111/j.1365-2745.2012.02014.x; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Harpole WS., 2007, CALIFORNIA GRASSLAND; Holmes TH, 1996, ANN BOT-LONDON, V78, P233, DOI 10.1006/anbo.1996.0117; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; JACKSON LE, 1988, PLANT SOIL, V110, P9, DOI 10.1007/BF02143533; Jackson LE., 2007, CALIFORNIA GRASSLAND; James JJ, 2011, ECOL APPL, V21, P490, DOI 10.1890/10-0280.1; KELLMAN M, 1979, J ECOL, V67, P565, DOI 10.2307/2259112; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; MARANON T, 1993, J ECOL, V81, P673, DOI 10.2307/2261665; Marchant R, 2010, CURR OPIN ENV SUST, V2, P101, DOI 10.1016/j.cosust.2010.03.001; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; PARKER VT, 1982, AM MIDL NAT, V107, P69, DOI 10.2307/2425189; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Rice KJ, 2000, AM J BOT, V87, P1699, DOI 10.2307/2656747; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; SCHWARTZ SE, 1989, SCIENCE, V243, P753, DOI 10.1126/science.243.4892.753; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Stamps RH, 2009, HORTSCIENCE, V44, P239, DOI 10.21273/HORTSCI.44.2.239; Tulloss EM, 2016, PLANT ECOL, V217, P43, DOI 10.1007/s11258-015-0558-5; Tulloss EM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00440.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; USEPA, 2010, EPA454 RES TRIANGL P; Vallano DM, 2012, PLANT ECOL, V213, P1015, DOI 10.1007/s11258-012-0061-1; Weathers KC, 2000, ECOL APPL, V10, P528, DOI 10.1890/1051-0761(2000)010[0528:TEOLFO]2.0.CO;2; Weathers KC, 2001, CONSERV BIOL, V15, P1506, DOI 10.1046/j.1523-1739.2001.01090.x; Weiss SB, 1999, CONSERV BIOL, V13, P1476, DOI 10.1046/j.1523-1739.1999.98468.x; Wigand PE., 2007, CALIFORNIA GRASSLAND, P37; YOUNG JA, 1992, GREAT BASIN NAT, V52, P245	50	13	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156685	10.1371/journal.pone.0156685	http://dx.doi.org/10.1371/journal.pone.0156685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253718	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700050
J	Urrutia, O; Mendizabal, JA; Insausti, K; Soret, B; Purroy, A; Arana, A				Urrutia, Olaia; Antonio Mendizabal, Jose; Insausti, Kizkitza; Soret, Beatriz; Purroy, Antonio; Arana, Ana			Effects of Addition of Linseed and Marine Algae to the Diet on Adipose Tissue Development, Fatty Acid Profile, Lipogenic Gene Expression, and Meat Quality in Lambs	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FISH-OIL; RUMEN BIOHYDROGENATION; SEMITENDINOUS MUSCLE; CARCASS COMPOSITION; GROWTH-PERFORMANCE; INTRAMUSCULAR FAT; ENERGY-METABOLISM; LIPID-METABOLISM; FEEDING SYSTEM	This study examined the effect of linseed and algae on growth and carcass parameters, adipocyte cellularity, fatty acid profile and meat quality and gene expression in subcutaneous and intramuscular adipose tissues (AT) in lambs. After weaning, 33 lambs were fed three diets up to 26.7 +/- 0.3 kg: Control diet (barley and soybean); L diet (barley, soybean and 10% linseed) and L-A diet (barley, soybean, 5% linseed and 3.89% algae). Lambs fed L-A diet showed lower average daily gain and greater slaughter age compared to Control and L (P < 0.001). Carcass traits were not affected by L and L-A diets, but a trend towards greater adipocyte diameter was observed in L and L-A in the subcutaneous AT (P = 0.057). Adding either linseed or linseed and algae increased a-linolenic acid and eicosapentaenoic acid contents in both AT (P < 0.001); however, docosahexaenoic acid was increased by L-A (P < 0.001). The n-6/n-3 ratio decreased in L and L-A (P < 0.001). Algae had adverse effects on meat quality, with greater lipid oxidation and reduced ratings for odor and flavor. The expression of lipogenic genes was downregulated in the subcutaneous AT (P < 0.05): acetyl-CoA carboxylase 1 (ACACA) in L and L-A and lipoprotein lipase (LPL) and stearoyl-CoA desaturase (SCD) in L-A. Fatty acid desaturase 1 (FADS1), fatty acid desaturase 2 (FADS2) and fatty acid elongase 5 (ELOVL5) were unaffected. In the subcutaneous AT, supplementing either L or L-A increased peroxisome proliferator-activated receptor gamma (PPARG) and CAAT-enhancer binding protein alpha (CEBPA) (P < 0.05), although it had no effect on sterol regulatory element-binding factor 1 (SREBF1). In the intramuscular AT, expression of ACACA, SCD, FADS1 and FADS2 decreased in L and L-A (P < 0.001) and LPL in L (P < 0.01), but PPARG, CEBPA and SREBF1 were unaffected.	[Urrutia, Olaia; Antonio Mendizabal, Jose; Insausti, Kizkitza; Soret, Beatriz; Purroy, Antonio; Arana, Ana] Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain	Universidad Publica de Navarra	Arana, A (corresponding author), Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain.	aarana@unavarra.es	Urrutia, Olaia/K-8281-2017; Insausti, Kizkitza/AAH-8956-2021; Soret, Beatriz/L-5776-2014; Mendizabal, José Antonio/F-9844-2014	Urrutia, Olaia/0000-0003-4701-4314; Insausti, Kizkitza/0000-0002-3821-814X; Mendizabal, José Antonio/0000-0003-1316-4293; Soret, Beatriz/0000-0001-9214-8595				Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; ASHES JR, 1992, LIPIDS, V27, P629, DOI 10.1007/BF02536122; Atti N., 2007, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P57; Atti N, 2013, J APPL ANIM RES, V41, P404, DOI 10.1080/09712119.2013.792730; Berthelot V, 2010, MEAT SCI, V84, P114, DOI 10.1016/j.meatsci.2009.08.034; Boeckaert C, 2007, EUR J LIPID SCI TECH, V109, P767, DOI 10.1002/ejlt.200700052; Boque N, 2009, J PHYSIOL BIOCHEM, V65, P387, DOI 10.1007/BF03185934; Brenner R., 1989, R FACTORS INFLUENCIN, VVolume 1989, P45; British Department of Health, 1994, NUTR ASP CARD DIS; Cant JP, 1997, CAN J ANIM SCI, V77, P125, DOI 10.4141/A95-125; COLOMER-ROCHER F., 1988, METODO NORMALIZADO E, P19; Corazzin M, 2013, J ANIM SCI, V91, P405, DOI 10.2527/jas.2011-5057; de la Fuente-Vazquez J, 2014, SPAN J AGRIC RES, V12, P436, DOI 10.5424/sjar/2014122-4639; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Dervishi E, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-40; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Duckett SK, 2009, J ANIM SCI, V87, P1120, DOI 10.2527/jas.2008-1420; Ebrahimi M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/194625; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Flint D, 1993, VERTEBRATE ENDOCRINO, P469; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Griinari JM, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P180; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Herdmann A, 2010, ANIMAL, V4, P755, DOI 10.1017/S1751731110000431; Hiller B, 2011, LIPIDS, V46, P557, DOI 10.1007/s11745-011-3571-z; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hopkins DL, 2014, MEAT SCI, V98, P135, DOI 10.1016/j.meatsci.2014.05.016; Huang FR, 2008, LIVEST SCI, V118, P132, DOI 10.1016/j.livsci.2008.01.002; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Jing M, 2013, PROSTAG LEUKOTR ESS, V89, P107, DOI 10.1016/j.plefa.2013.05.006; Juarez M, 2008, MEAT SCI, V79, P203, DOI 10.1016/j.meatsci.2007.08.014; Juarez M, 2010, MEAT SCI, V84, P578, DOI 10.1016/j.meatsci.2009.10.015; Klein CM, 2011, J DAIRY SCI, V94, P4676, DOI 10.3168/jds.2011-4344; Kouba M, 2011, BIOCHIMIE, V93, P13, DOI 10.1016/j.biochi.2010.02.027; Kronberg SL, 2006, LIPIDS, V41, P1059, DOI 10.1007/s11745-006-5056-z; Lourenco M, 2010, ANIMAL, V4, P1008, DOI 10.1017/S175173111000042X; Meale SJ, 2014, J ANIM SCI, V92, P2202, DOI 10.2527/jas.2013-7024; Mendizabal J., 2005, INIA SER GANAD, V3, P251; Mendizabal JA, 2004, SMALL RUMINANT RES, V53, P173, DOI 10.1016/j.smallrumres.2003.09.004; Mendizabal JA, 1997, ANIM SCI, V64, P283, DOI 10.1017/S135772980001585X; Mourot J., 2014, Journees de la Recherche Porcine en France, V46, P55; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nassu RT, 2011, MEAT SCI, V89, P469, DOI 10.1016/j.meatsci.2011.05.016; Noci F, 2007, J ANIM SCI, V85, P1062, DOI 10.2527/jas.2006-105; Nute GR, 2007, MEAT SCI, V77, P547, DOI 10.1016/j.meatsci.2007.05.003; Overland M, 1996, ACTA AGR SCAND A-AN, V46, P11, DOI 10.1080/09064709609410919; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickworth CL, 2011, J ANIM SCI, V89, P355, DOI 10.2527/jas.2010-3229; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; ROBELIN J, 1986, LIVEST PROD SCI, V14, P349, DOI 10.1016/0301-6226(86)90014-X; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sardi L, 2006, LIVEST SCI, V103, P95, DOI 10.1016/j.livsci.2006.01.009; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; SMITH SB, 1987, J ANIM SCI, V65, P1525, DOI 10.2527/jas1987.6561525x; Sul HS, 2013, BIOCH PHYSL MOL ASPE, P357; TARLADGIS BG, 1960, J AM OIL CHEM SOC, V37, P44, DOI 10.1007/BF02630824; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Urrutia O, 2015, SMALL RUMINANT RES, V123, P204, DOI 10.1016/j.smallrumres.2014.12.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vatansever L, 2000, ANIM SCI, V71, P471, DOI 10.1017/S135772980005548X; VERNON R G, 1980, Progress in Lipid Research, V19, P23, DOI 10.1016/0163-7827(80)90007-7; Wachira AM, 2002, BRIT J NUTR, V88, P697, DOI 10.1079/BJN2002727; Wachira AM, 2000, J AGR SCI, V135, P419, DOI 10.1017/S0021859699008370; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; WHITTINGTON FM, 1986, J SCI FOOD AGR, V37, P753, DOI 10.1002/jsfa.2740370807; Woods VB, 2009, LIVEST SCI, V126, P1, DOI 10.1016/j.livsci.2009.07.002; YIN MC, 1993, J AGR FOOD CHEM, V41, P853, DOI 10.1021/jf00030a002	71	39	43	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156765	10.1371/journal.pone.0156765	http://dx.doi.org/10.1371/journal.pone.0156765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253325	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700056
J	Flahault, A; Metzger, M; Chasse, JF; Haymann, JP; Boffa, JJ; Flamant, M; Vrtovsnik, F; Houillier, P; Stengel, B; Thervet, E; Pallet, N				Flahault, Adrien; Metzger, Marie; Chasse, Jean-Francois; Haymann, Jean-Philippe; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Houillier, Pascal; Stengel, Benedicte; Thervet, Eric; Pallet, Nicolas		NephroTest Study Grp	Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; MUSCLE MASS; URINARY CREATININE; ENZYME-ACTIVITIES; SKELETAL-MUSCLE; BLOOD-PRESSURE; RENAL-FUNCTION; CYSTATIN-C; PHOSPHOKINASE; EXERCISE	Background Serum creatine kinase (sCK) reflects CK activity from striated skeletal muscle. Muscle wasting is a risk factor for mortality in patients with chronic kidney disease (CKD). The aim of this study is to evaluate whether sCK is a predictor of mortality and end-stage renal disease (ESRD) in a CKD population. Methods We included 1801 non-dialysis-dependent CKD patients from the NephroTest cohort. We used time-fixed and time-dependent cause-specific Cox models to estimate hazard ratios (HRs) for the risk of death and for the risk of ESRD associated with gender-specific sCK tertiles. Results Higher sCK level at baseline was associated with a lower age, a higher body mass index, and a higher level of 24 h urinary creatinine excretion, serum albumin and prealbumin (p<0.001). Men, patients of sub-Saharan ancestry, smokers and statin users also experienced a higher level of sCK. In a time-fixed Cox survival model (median follow-up 6.0 years), the lowest gender-specific sCK tertile was associated with a higher risk of death before and after adjustment for confounders (Crude model: hazard ratio (HR) 1.77 (95% CI: 1.34-2.32) compared to the highest tertile; fully-adjusted model: HR 1.37 (95% CI: 1.02-1.86)). Similar results were obtained with a time-dependent Cox model. The sCK level was not associated with the risk of ESRD. Conclusion A low level of sCK is associated with an increased risk of death in a CKD population. sCK levels might reflect muscle mass and nutritional status.	[Flahault, Adrien; Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] INSERM, UMRS 1018, CESP Team Renal & Cardiovasc Epidemiol 5, Villejuif, France; [Chasse, Jean-Francois; Thervet, Eric; Pallet, Nicolas] Paris Descartes Univ, Paris, France; [Chasse, Jean-Francois; Thervet, Eric; Pallet, Nicolas] Sorbonne Paris Cite, Paris, France; [Chasse, Jean-Francois; Pallet, Nicolas] Hop Europeen Georges Pompidou, AP HP, Clin Chem, Paris, France; [Haymann, Jean-Philippe] Univ Paris 06, INSERM, U702, Paris, France; [Haymann, Jean-Philippe] Hop Tenon, AP HP, Serv Explorat Fonct, F-75970 Paris, France; [Boffa, Jean-Jacques] Hop Tenon, AP HP, Serv Nephrol, F-75970 Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Serv Nephrol, F-75877 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, AP HP, Serv Explorat Fonct, Paris, France; [Flahault, Adrien] Coll France, INSERM, Lab Cent Neuropeptides Regulat Body Fluid Homeost, CIRB,U1050, U114, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Pallet, N (corresponding author), Paris Descartes Univ, Paris, France.; Pallet, N (corresponding author), Sorbonne Paris Cite, Paris, France.; Pallet, N (corresponding author), Hop Europeen Georges Pompidou, AP HP, Clin Chem, Paris, France.	npallet@yahoo.fr	Houillier, Pascal/AAD-4903-2019; Stengel, Benedicte/G-5730-2015; Flahault, Adrien/Q-4576-2017; Metzger, Marie/K-9772-2018	Houillier, Pascal/0000-0003-4953-6917; Stengel, Benedicte/0000-0001-9469-0804; Flahault, Adrien/0000-0003-4632-6332; Metzger, Marie/0000-0003-3597-5409; Pallet, Nicolas/0000-0002-8486-3596; Vrtovsnik, Francois/0000-0003-1554-314X	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR, French Ministry of Health AOM 09114, INSERM AO 8022LS, Agence de la Biomedecine R0 8156LL, AURA and Roche 2009-152-447G.	Amir KA, 2009, AM J MED SCI, V338, P353, DOI 10.1097/MAJ.0b013e3181b1226a; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; BORGES O, 1989, ACTA PHYSIOL SCAND, V136, P29, DOI 10.1111/j.1748-1716.1989.tb08626.x; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Clarkson PM, 2006, MED SCI SPORT EXER, V38, P623, DOI 10.1249/01.mss.0000210192.49210.fc; EPSTEIN Y, 1995, ISRAEL J MED SCI, V31, P698; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.7.1171-1178; HESS JW, 1964, ANN INTERN MED, V61, P1015, DOI 10.7326/0003-4819-61-6-1015; HORDER M, 1991, EUR J CLIN CHEM CLIN, V29, P435; HORTOBAGYI T, 1989, INT J SPORTS MED, V10, P69, DOI 10.1055/s-2007-1024878; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Johnsen SH, 2014, J CLIN HYPERTENS, V16, P820, DOI 10.1111/jch.12422; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; Kaya S, 2014, MIKROBIYOL BUL, V48, P179; Keltz Eran, 2013, Muscles Ligaments Tendons J, V3, P303; Kenney K, 2012, MUSCLE NERVE, V45, P356, DOI 10.1002/mus.22317; KOUTEDAKIS Y, 1993, J SPORT MED PHYS FIT, V33, P252; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macdonald JH, 2006, NEPHROL DIAL TRANSPL, V21, P3488, DOI 10.1093/ndt/gfl430; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOAKES TD, 1987, SPORTS MED, V4, P245, DOI 10.2165/00007256-198704040-00003; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sowards KJ, 2014, INJURY, V45, P2096, DOI 10.1016/j.injury.2014.09.009; Stollwerck PL, 2011, BURNS, V37, P240, DOI 10.1016/j.burns.2010.09.009; SWAMINATHAN R, 1988, ANN CLIN BIOCHEM, V25, P389, DOI 10.1177/000456328802500411; Tynkevich E, 2015, NEPHROL DIAL TRANSPL, V30, P1386, DOI 10.1093/ndt/gfv047; Tynkevich E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111949; Uchida K, 2002, CLIN CHIM ACTA, V323, P121, DOI 10.1016/S0009-8981(02)00177-8; Wilson FP, 2014, CLIN J AM SOC NEPHRO, V9, P2095, DOI 10.2215/CJN.03790414; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582	37	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156433	10.1371/journal.pone.0156433	http://dx.doi.org/10.1371/journal.pone.0156433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248151	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700044
J	Graham, JP; Hirai, M; Kim, SS				Graham, Jay P.; Hirai, Mitsuaki; Kim, Seung-Sup			An Analysis of Water Collection Labor among Women and Children in 24 Sub-Saharan African Countries	PLOS ONE			English	Article							HEALTH; DISTANCE; ACCESS; POLICY	Background It is estimated that more than two-thirds of the population in sub-Saharan Africa (SSA) must leave their home to collect water, putting them at risk for a variety of negative health outcomes. There is little research, however, quantifying who is most affected by long water collection times. Objectives This study aims to a) describe gender differences in water collection labor among both adults and children (< 15 years of age) in the households (HHs) that report spending more than 30 minutes collecting water, disaggregated by urban and rural residence; and b) estimate the absolute number of adults and children affected by water collection times greater than 30 minutes in 24 SSA countries. Methods We analyzed data from the Demographic Health Survey (DHS) and the Multiple Indicator Cluster Survey (MICS) (2005-2012) to describe water collection labor in 24 SSA countries. Results Among households spending more than 30 minutes collecting water, adult females were the primary collectors of water across all 24 countries, ranging from 46% in Liberia (17,412 HHs) to 90% in Cote d'Ivoire (224,808 HHs). Across all countries, female children were more likely to be responsible for water collection than male children (62% vs. 38%, respectively). Six countries had more than 100,000 households (HHs) where children were reported to be responsible for water collection (greater than 30 minutes): Burundi (181,702 HHs), Cameroon (154,453 HHs), Ethiopia (1,321,424 HHs), Mozambique (129,544 HHs), Niger (171,305 HHs), and Nigeria (1,045,647 HHs). Conclusion In the 24 SSA countries studied, an estimated 3.36 million children and 13.54 million adult females were responsible for water collection in households with collection times greater than 30 minutes. We suggest that accessibility to water, water collection by children, and gender ratios for water collection, especially when collection times are great, should be considered as key indicators for measuring progress in the water, sanitation and hygiene sector.	[Graham, Jay P.] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Environm & Occupat Hlth, Washington, DC USA; [Graham, Jay P.; Hirai, Mitsuaki] George Washington Univ, Milken Inst, Sch Publ Hlth, Dept Global Hlth, Washington, DC USA; [Kim, Seung-Sup] Korea Univ, Dept Publ Hlth Sci, Seoul, South Korea	George Washington University; George Washington University; Korea University	Kim, SS (corresponding author), Korea Univ, Dept Publ Hlth Sci, Seoul, South Korea.	ssk3@korea.ac.kr		Graham, Jay/0000-0001-7062-6293				Bain R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001644; Bimla, 2003, INDIAN J SOC WORK, V64, P65; CAIRNCROSS S, 1987, T ROY SOC TROP MED H, V81, P51, DOI 10.1016/0035-9203(87)90280-X; Chattopadhyay R, 2004, ECONOMETRICA, V72, P1409, DOI 10.1111/j.1468-0262.2004.00539.x; Cook J, 2016, COSTS COPING POOR WA; Davis J., 2012, MEASURING WATER COLL, P114; Fry LM, 2010, ENVIRON SCI TECHNOL, V44, P9535, DOI 10.1021/es100798j; Geere JAL, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-52; Hemson D, 2007, POLICY FUTURES EDUC, V5, P315, DOI 10.2304/pfie.2007.5.3.315; Ho JC, 2014, J WATER HEALTH, V12, P173, DOI 10.2166/wh.2013.042; Howard G., 2003, DOMESTIC WATER QUANT; Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; Koolwal G, 2013, ECON DEV CULT CHANGE, V61, P369, DOI 10.1086/668280; Majuru B, 2011, INT J HYG ENVIR HEAL, V214, P162, DOI 10.1016/j.ijheh.2010.10.005; Mehta L, 2012, CHALLENGES ACHIEVEME; Mogues T., 2010, ACCESS IMPROVE WATER; Nygren BL, 2016, AM J TROPICAL MED HY, P15; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Pickering AJ, 2010, ENVIRON SCI TECHNOL, V44, P3267, DOI 10.1021/es903524m; Porter G, 2012, WORLD DEV, V40, P2136, DOI 10.1016/j.worlddev.2012.05.004; Sommer M, 2015, ENVIRON URBAN, V27, P105, DOI 10.1177/0956247814564528; Sorenson SB, 2011, SOC SCI MED, V72, P1522, DOI 10.1016/j.socscimed.2011.03.010; Wang X, 2010, AM J TROP MED HYG, V83, P582, DOI 10.4269/ajtmh.2010.10-0215; White G.F., 1972, DRAWERS OF WATER	25	92	92	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155981	10.1371/journal.pone.0155981	http://dx.doi.org/10.1371/journal.pone.0155981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248494	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700025
J	Li, Y; Xia, P; Xu, LB; Wang, Y; Chen, LM				Li, Yang; Xia, Peng; Xu, Lubin; Wang, Yang; Chen, Limeng			A Meta-Analysis on Prehypertension and Chronic Kidney Disease	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; CARDIOVASCULAR EVENTS; GENERAL-POPULATION; BLOOD-PRESSURE; TASK-FORCE; PREVALENCE; RISK; PREVENTION; GUIDELINES; MANAGEMENT	Background Recent studies have demonstrated that there is an association between prehypertension and an increased risk of end-stage renal disease. However, there is conflicting evidence regarding the relationship between prehypertension and chronic kidney disease (CKD). This meta-analysis aimed to demonstrate the association between prehypertension and the incidence of CKD and identify the impacts of gender and ethnic differences. Methods MEDLINE, EMBASE, Cochrane Library (from inception through March 2016) and article reference lists were searched for relevant studies regarding blood pressure and CKD. Blood pressure (BP) measurements were classified as follows: optimal BP (less than 120/80 mmHg), prehypertension (120-139/80-89 mmHg) and hypertension (over 140/90 mmHg). CKD was defined by estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m(2) or proteinuria. Two investigators independently extracted the data and assessed the quality of studies enrolled in this meta-analysis using the Newcastle-Ottawa Scale (NOS). We performed the meta-analysis using Stata/SE 12.0 (StataCorp LP). The random-effect models were used in the heterogeneous analyses. Results After retrieving data from 4,537 potentially relevant articles, we identified 7 cohort studies including 261,264 subjects, according to the predefined selection criteria. Five studies were conducted in Mongolians from East Asia, and the other two studies were performed in Indo-Europeans from Austria and Iran. The participants ranged in age from 20 to 89 years, and the proportion of females ranged from 27.2% to 63.8%. The follow-up period ranged from 2 to 11 years. Compared with the optimal BP values, prehypertension showed an increased risk of CKD (pooled RR = 1.28; 95% CI = 1.13-1.44; P = 0.000; I-2 = 77.9%). In the sex-stratified analysis, we found a similar trend in women (pooled RR = 1.29; 95% CI = 1.01-1.63; P = 0.039; I-2 = 76.1%) but not in men. This effect was observed only in Mongolians from East Asia (pooled RR = 1.37; 95% CI = 1.18-1.59; P = 0.000; I-2 = 81.3%) and not in Indo-Europeans. Conclusions Prehypertension is considered a potential cause of CKD. Gender and ethnic differences are exhibited in this association.	[Li, Yang; Xia, Peng; Xu, Lubin; Chen, Limeng] Chinese Acad Med Sci, Dept Nephrol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Li, Yang; Xia, Peng; Xu, Lubin; Wang, Yang; Chen, Limeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Yang] Chinese Acad Med Sci, Biol Informat & Stat Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Chen, LM (corresponding author), Chinese Acad Med Sci, Dept Nephrol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.; Chen, LM (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	chenlimeng@pumch.cn		Xu, Lubin/0000-0002-1291-7700	Key Project of Chinese National Program for Fundamental Research and Development (973 Program) [2012CB517803]; National Natural Scientific Foundation, China [81170674, 81470937]	Key Project of Chinese National Program for Fundamental Research and Development (973 Program)(National Basic Research Program of China); National Natural Scientific Foundation, China(National Natural Science Foundation of China (NSFC))	This work was supported by 1) Name: Key Project of Chinese National Program for Fundamental Research and Development (973 Program). Grant Numbers 2012CB517803 to LMC. URLs: http://www. 973.gov.cn/English/Index.aspx; and 2) Name: National Natural Scientific Foundation, China. Grant Number: 81170674, 81470937 to LMC. URLs: http://www.nsfc.gov.cn/publish/portal1/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin HA, 2009, J AM SOC NEPHROL, V20, P901, DOI 10.1681/ASN.2008060665; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Fuchs FD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-65; Fuchs FD, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0505-1; Fuchs FD, 2012, VASC HEALTH RISK MAN, V8, P437, DOI 10.2147/VHRM.S32585; Fukuhara M, 2012, J HYPERTENS, V30, P893, DOI 10.1097/HJH.0b013e328351d380; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Guo X, 2012, CARDIOVASC J AFR, V23, P44, DOI 10.5830/CVJA-2011-058; Gupta P, 2012, SAUDI J KIDNEY DIS T, V23, P223; Hall YN, 2005, KIDNEY INT, V68, P2310, DOI 10.1111/j.1523-1755.2005.00691.x; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jee SH, 2005, ARCH INTERN MED, V165, P2299, DOI 10.1001/archinte.165.19.2299; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054; Kim MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-960; Kurioka S, 2014, J HYPERTENS, V32, P236, DOI 10.1097/HJH.0000000000000031; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Luders S, 2008, J HYPERTENS, V26, P1487, DOI 10.1097/HJH.0b013e3282ff8864; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mok CC, 2014, NEPHROLOGY, V19, P11, DOI 10.1111/nep.12136; Moreira LB, 2008, J HUM HYPERTENS, V22, P48, DOI 10.1038/sj.jhh.1002252; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Xue H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144438; Yano Y, 2014, J HYPERTENS, V32, P2371, DOI 10.1097/HJH.0000000000000344; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zheng H., 2014, BMJ OPEN, V4, DOI [DOI 10.1136/bmjopen-2014-004920, 10.1136/bmjopen-2014-004920]	32	11	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156575	10.1371/journal.pone.0156575	http://dx.doi.org/10.1371/journal.pone.0156575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248143	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700054
J	Lu, JC; Kundrat, M; Shen, C				Lu, Junchang; Kundrat, Martin; Shen, Caizhi			New Material of the Pterosaur Gladocephaloideus Lu et al., 2012 from the Early Cretaceous of Liaoning Province, China, with Comments on Its Systematic Position	PLOS ONE			English	Article							YIXIAN FORMATION; PTERODACTYLOIDEA; BONE	Although there are nine genera of ctenochasmatoids reported from the Jehol Biota, at present each is known from a specimen that has either a skull or a relatively complete postcranial skeleton. A nearly complete juvenile specimen of Gladocephaloideus from the Lower Cretaceous Jiufotang Formation of Sihedang, Lingyuan of Liaoning Province is the most complete ctenochasmatoid preserved to date with a skull and postcranial skeleton. Based on the holotype (IG-CAGS 08-07) and the nearly complete new specimen (JPM 2014-004), the diagnosis of Gladocephaloideus is amended: approximately 50 teeth in total with sharp tips; small nasoantorbital opening, occupying approximately 13% of total skull length; ratio of prenarial rostrum length to skull length approximately 0.63; deep groove along the mid-line of the mandibular symphysis; length to width ratio of the longest cervical vertebra = 4.1; ratio of femur length to tibia length = 0.61; tibia as long as the wing-phalange 1. Phylogenetic analysis recovers Gladocephaloideus within the clade Ctenochasmatidae. Gladocephaloideus has a closer relationship to the Chinese Pterofiltrus rather than to other ctenochasmatid pterosaurs. Microstructure of limb bones implies that JPM 2014-004 represents an early juvenile of Gladocephaloideus jingangshanensis, and that the type specimen is not a fully grown specimen either. We assume that the holotype may equate to the late juvenile or sub-adult developmental stage of Gladocephaloideus.	[Lu, Junchang; Shen, Caizhi] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Lu, Junchang] Minist Land & Resources, Key Lab Stratig & Paleontol, Beijing, Peoples R China; [Kundrat, Martin] Comenius Univ, Fac Nat Sci, Dept Ecol, Bratislava, Slovakia; [Kundrat, Martin] Safarik Univ, Fac Sci, Ctr Interdisciplinary Biosci, Kosice, Slovakia	Chinese Academy of Geological Sciences; Ministry of Natural Resources of the People's Republic of China; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.; Lu, JC (corresponding author), Minist Land & Resources, Key Lab Stratig & Paleontol, Beijing, Peoples R China.	Lujc2008@126.com	Kundrát, Martin/F-4959-2017	Kundrát, Martin/0000-0001-9361-2273	National Natural Science Foundation of China [41272022]; Fundamental Research Funds for Chinese Academy of Geological Sciences [JB1504]; China Geological Survey [12120114026801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Chinese Academy of Geological Sciences; China Geological Survey(China Geological Survey)	This study was supported by the National Natural Science Foundation of China (No. 41272022), the Fundamental Research Funds for the Chinese Academy of Geological Sciences (No. JB1504), and the project from the China Geological Survey (No. 12120114026801) to Junchang Lu.; We thank Drs. Dale Winkler (Southern Methodist University, Dallas, TX, USA) and David W. E. Hone (Queen Mary University of London, UK) for providing careful comments on the earlier version of the MS. Mr. Zhang Yuqing prepared the specimen. This study was supported by the National Natural Science Foundation of China (No. 41272022), the Fundamental Research Funds for the Chinese Academy of Geological Sciences (No. JB1504), and the project from the China Geological Survey (No. 12120114026801) to Junchang Lu.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Bennett SC, 2003, PALAEONTOLOGY, V46, P185, DOI 10.1111/1475-4983.00293; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Francillon-Vieillot H., 1990, P471; Goloboff P, 2008, CLADISTICS, V24, P91; Ji S.-A., 1997, ACT GEOL SIN, V71, P1; Jiang Shun-Xing, 2011, Vertebrata Palasiatica, V49, P172; Jiang SX, 2011, AN ACAD BRAS CIENC, V83, P1243, DOI 10.1590/S0001-37652011000400011; Kaup J, 1834, ISIS, V3, P311; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Liaoning Provincial Institute of Geological Exploration, 2015, EV REP FOSS RE UNPUB; Lu Jun-Chang, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P153; Lu JC, 2012, ACTA GEOL SIN-ENGL, V86, P287, DOI 10.1111/j.1755-6724.2012.00658.x; Lu JC, 2012, CRETACEOUS RES, V34, P26, DOI 10.1016/j.cretres.2011.09.010; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; PADIAN K, 1995, CR ACAD SCI II, V320, P77; Plieninger F, PALAEONTOLOGICA, V190, P65; Sayao JM, 2000, J VERTEBR PALEONTOL, V20, P67; Steel Lorna, 2008, Zitteliana Reihe B, V28, P109; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 1995, P69; Wang XL, 2007, CRETACEOUS RES, V28, P245, DOI 10.1016/j.cretres.2006.08.004; Wang Xiaolin, 2006, P665; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Zhou CF, 2010, NEUES JAHRB GEOL P-A, V255, P277, DOI 10.1127/0077-7749/2009/0022	27	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154888	10.1371/journal.pone.0154888	http://dx.doi.org/10.1371/journal.pone.0154888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249021	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700008
J	Moffa, G; Erdmann, G; Voloshanenko, O; Hundsrucker, C; Sadeh, MJ; Boutros, M; Spang, R				Moffa, Giusi; Erdmann, Gerrit; Voloshanenko, Oksana; Hundsrucker, Christian; Sadeh, Mohammad J.; Boutros, Michael; Spang, Rainer			Refining Pathways: A Model Comparison Approach	PLOS ONE			English	Article							BETA-CATENIN; COLON-CANCER; MUTATIONS; GENE	Cellular signalling pathways consolidate multiple molecular interactions into working models of signal propagation, amplification, and modulation. They are described and visualized as networks. Adjusting network topologies to experimental data is a key goal of systems biology. While network reconstruction algorithms like nested effects models are well established tools of computational biology, their data requirements can be prohibitive for their practical use. In this paper we suggest focussing on well defined aspects of a pathway and develop the computational tools to do so. We adapt the framework of nested effect models to focus on a specific aspect of activated Wnt signalling in HCT116 colon cancer cells: Does the activation of Wnt target genes depend on the secretion of Wnt ligands or do mutations in the signalling molecule beta-catenin make this activation independent from them? We framed this question into two competing classes of models: Models that depend on Wnt ligands secretion versus those that do not. The model classes translate into restrictions of the pathways in the network topology. Wnt dependent models are more flexible than Wnt independent models. Bayes factors are the standard Bayesian tool to compare different models fairly on the data evidence. In our analysis, the Bayes factors depend on the number of potential Wnt signalling target genes included in the models. Stability analysis with respect to this number showed that the data strongly favours Wnt ligands dependent models for all realistic numbers of target genes.	[Moffa, Giusi; Hundsrucker, Christian; Sadeh, Mohammad J.; Spang, Rainer] Univ Regensburg, Inst Funct Genom, Dept Stat Bioinformat, D-93053 Regensburg, Germany; [Erdmann, Gerrit; Voloshanenko, Oksana; Boutros, Michael] Heidelberg Univ, Fac Med Mannheim, German Canc Res Ctr DKFZ, Div Signaling & Funct Genom, Heidelberg, Germany; [Erdmann, Gerrit; Voloshanenko, Oksana; Boutros, Michael] Heidelberg Univ, Fac Med Mannheim, Dept Cell & Mol Biol, Heidelberg, Germany	University of Regensburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Moffa, G (corresponding author), Univ Regensburg, Inst Funct Genom, Dept Stat Bioinformat, D-93053 Regensburg, Germany.	giusi.moffa@gmail.com	Boutros, Michael/C-3566-2008; Moffa, Giusi/AAN-3272-2021	Boutros, Michael/0000-0002-9458-817X; Moffa, Giusi/0000-0002-2739-0454; Erdmann, Gerrit/0000-0002-4183-3995; Spang, Rainer/0000-0002-1326-4297	NGFN-Project - Verbund Kolonkarzinom [FKZ01GS08183]; BioSysNet-Project - Bavarian Research Network for Molecular Biosystems; BMBF [NGFN-plus 01GS08181-6]; BMBF GERF	NGFN-Project - Verbund Kolonkarzinom; BioSysNet-Project - Bavarian Research Network for Molecular Biosystems; BMBF(Federal Ministry of Education & Research (BMBF)); BMBF GERF	Work in the group of R.S. was supported by the NGFN-Project FKZ01GS08183 - Verbund Kolonkarzinom and the BioSysNet-Project - Bavarian Research Network for Molecular Biosystems. Work in the laboratory of M.B. was supported by grants from the BMBF (NGFN-plus 01GS08181-6) and BMBF GERF.	Anchang B, 2009, P NATL ACAD SCI USA, V106, P6447, DOI 10.1073/pnas.0809822106; Frohlich H, 2008, BIOINFORMATICS, V24, P2650, DOI 10.1093/bioinformatics/btm634; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; MacNeil LT, 2015, CELL SYST, V1, P152, DOI 10.1016/j.cels.2015.08.003; Markowetz F, 2005, BIOINFORMATICS, V21, P4026, DOI 10.1093/bioinformatics/bti662; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Niederberger T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002568; Pirkl M, 2015, BIOINFORMATICS; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Sekine S, 2002, ONCOGENE, V21, P5906, DOI 10.1038/sj.onc.1205756; Siebourg-Polster J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004078; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610	19	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155999	10.1371/journal.pone.0155999	http://dx.doi.org/10.1371/journal.pone.0155999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248690	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700026
J	Heinrichs, J; Scheben, A; Bechteler, J; Lee, GE; Schafer-Verwimp, A; Hedenas, L; Singh, H; Pocs, T; Nascimbene, PC; Peralta, DF; Renner, M; Schmidt, AR				Heinrichs, Jochen; Scheben, Armin; Bechteler, Julia; Lee, Gaik Ee; Schafer-Verwimp, Alfons; Hedenas, Lars; Singh, Hukam; Pocs, Tamas; Nascimbene, Paul C.; Peralta, Denilson F.; Renner, Matt; Schmidt, Alexander R.			Crown Group Lejeuneaceae and Pleurocarpous Mosses in Early Eocene (Ypresian) Indian Amber	PLOS ONE			English	Article							EARLY LAND PLANTS; DIVERGENCE TIMES; GENUS LEJEUNEA; LONG BRANCHES; LIVERWORTS; MARCHANTIOPHYTA; ORIGIN; JUNGERMANNIOPSIDA; PORELLALES; EVOLUTION	Cambay amber originates from the warmest period of the Eocene, which is also well known for the appearance of early angiosperm-dominated megathermal forests. The humid climate of these forests may have triggered the evolution of epiphytic lineages of bryophytes; however, early Eocene fossils of bryophytes are rare. Here, we present evidence for lejeuneoid liverworts and pleurocarpous mosses in Cambay amber. The preserved morphology of the moss fossil is inconclusive for a detailed taxonomic treatment. The liverwort fossil is, however, distinctive; its zig-zagged stems, suberect complicate-bilobed leaves, large leaf lobules, and small, deeply bifid underleaves suggest a member of Lejeuneaceae subtribe Lejeuneinae (Harpalejeunea, Lejeunea, Microlejeunea). We tested alternative classification possibilities by conducting divergence time estimates based on DNA sequence variation of Lejeuneinae using the age of the fossil for corresponding age constraints. Consideration of the fossil as a stem group member of Microlejeunea or Lejeunea resulted in an Eocene to Late Cretaceous age of the Lejeuneinae crown group. This reconstruction is in good accordance with published divergence time estimates generated without the newly presented fossil evidence. Balancing available evidence, we describe the liverwort fossil as the extinct species Microlejeunea nyiahae, representing the oldest crown group fossil of Lejeuneaceae.	[Heinrichs, Jochen; Scheben, Armin; Bechteler, Julia; Lee, Gaik Ee] Univ Munich LMU, Dept Biol, Munich, Germany; [Heinrichs, Jochen; Scheben, Armin; Bechteler, Julia; Lee, Gaik Ee] Univ Munich LMU, Geobioctr, Munich, Germany; [Lee, Gaik Ee] Univ Malaysia Terengganu, Sch Marine & Environm Sci, Terengganu, Malaysia; [Schafer-Verwimp, Alfons] Mittlere Letten 11, Herdwangen Schonach, Germany; [Hedenas, Lars] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Singh, Hukam] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India; [Pocs, Tamas] Eszterhazy Univ, Dept Bot, Eger, Hungary; [Nascimbene, Paul C.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Peralta, Denilson F.] Inst Bot, Sao Paulo, Brazil; [Renner, Matt] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia; [Schmidt, Alexander R.] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany	University of Munich; University of Munich; Universiti Malaysia Terengganu; Swedish Museum of Natural History; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); American Museum of Natural History (AMNH); Instituto de Botanica - Sao Paulo; University of Gottingen	Heinrichs, J (corresponding author), Univ Munich LMU, Dept Biol, Munich, Germany.; Heinrichs, J (corresponding author), Univ Munich LMU, Geobioctr, Munich, Germany.; Schmidt, AR (corresponding author), Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany.	jheinrichs@lmu.de; alexander.schmidt@geo.uni-goettingen.de	Bechteler, Julia/AAH-8961-2019; Lee, Gaik Ee G/W-3683-2018; Lee, Gaik Ee/O-8353-2019; Scheben, Armin/AAS-2136-2020; Peralta, Denilson/D-3777-2015	Bechteler, Julia/0000-0002-5115-657X; Lee, Gaik Ee G/0000-0001-5161-6196; Lee, Gaik Ee/0000-0001-5161-6196; Scheben, Armin/0000-0002-2230-2013; Peralta, Denilson/0000-0003-4304-7258	German Research Foundation [HE 3584/6]; Alexander von Humboldt Foundation; German Research Foundation (DFG); University of Gottingen	German Research Foundation(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Gottingen	This work was supported by the German Research Foundation (grant HE 3584/6 to JH) and the Alexander von Humboldt Foundation (research fellowship to GEL): The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen: The publication fee in an open access publication will be covered by the funders.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alimohammadian H, 2005, CURR SCI INDIA, V89, P1328; Bechteler J, 2016, PLANT SYST EVOL, V302, P187, DOI 10.1007/s00606-015-1252-8; Beimforde C, 2011, NEW PHYTOL, V192, P988, DOI 10.1111/j.1469-8137.2011.03868.x; Bischler H, 1962, NOVA HEDWIGIA, V4, P173; Bischler H, 1963, NOVA HEDWIGIA, V5, P359; Blumenstengel H., 2004, EXKURSIONSFUHRER VER, V224, P17; Boyce CK, 2010, P ROY SOC B-BIOL SCI, V277, P3437, DOI 10.1098/rspb.2010.0485; Chomicki G, 2015, NEW PHYTOL, V205, P1330, DOI 10.1111/nph.13106; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; Cooper ED, 2012, BIOL J LINN SOC, V107, P425, DOI 10.1111/j.1095-8312.2012.01946.x; Cox CJ, 2014, SYST BIOL, V63, P272, DOI 10.1093/sysbio/syt109; Crum H.A., 1972, J HATTORI BOT LAB, V35, P269; Dong SS, 2013, PHYTOTAXA, V85, P41, DOI 10.11646/phytotaxa.85.2.2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Engel Michael S., 2013, Journal of Melittology, V25, P1; Engel MS, 2011, ZOOKEYS, P105, DOI 10.3897/zookeys.148.1797; Feldberg K, 2014, SCI REP-UK, V4, DOI 10.1038/srep05974; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fiz-Palacios O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-341; Frahm J-P., 2010, LAUBMOOSFLORA BALTIS; Frahm JP, 2005, BRYOLOGIST, V108, P526, DOI 10.1639/0007-2745(2005)108[0526:ANCTTM]2.0.CO;2; Frey W., 2009, SYLLABUS PLANT FAM 3, P13; Gradstein SR, 2013, PHYTOTAXA, V100, P6, DOI 10.11646/phytotaxa.100.1.2; Gradstein SR, 2003, BOT J LINN SOC, V143, P391, DOI 10.1111/j.1095-8339.2003.00235.x; Grolle R, 2004, CRYPTOGAMIE BRYOL, V25, P117; He X. L., 1999, BRYOBROTHERA, V5, P93; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hedenas L, 2001, BRYOLOGIST, V104, P72, DOI 10.1639/0007-2745(2001)104[0072:EFPACS]2.0.CO;2; Hedenas L, 2012, J BRYOL, V34, P79, DOI 10.1179/1743282011Y.0000000049; Heinrichs J, 2005, CRYPTOGAMIE BRYOL, V26, P131; Heinrichs J, 2007, TAXON, V56, P31, DOI 10.2307/25065733; Heinrichs J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140977; Heinrichs J, 2015, REV PALAEOBOT PALYNO, V221, P59, DOI 10.1016/j.revpalbo.2015.05.007; Heinrichs J, 2015, TAXON, V64, P216, DOI 10.12705/642.5; Heinrichs J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082547; Heinrichs J, 2014, PLANT SYST EVOL, V300, P63, DOI 10.1007/s00606-013-0860-4; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kenrick P, 2012, PHILOS T R SOC B, V367, P519, DOI 10.1098/rstb.2011.0271; Knuth G., 2002, HALLESCH JB GEOWISSE, V24, P35; Krassilov VA, 1984, NEW MANUAL BRYOLOGY, VII, P1172; Laenen B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6134; Lai MJ, 2008, ANN BOT FENN, V45, P321, DOI 10.5735/085.045.0501; Lee GE, 2015, CRYPTOGAMIE BRYOL, V36, P335, DOI 10.7872/cryb/v36.iss4.2015.335; Lee GE, 2015, REV PALAEOBOT PALYNO, V222, P16, DOI 10.1016/j.revpalbo.2015.07.002; Lee GE, 2013, CRYPTOGAMIE BRYOL, V34, P381, DOI 10.7872/cryb.v34.iss4.2013.381; Ligrone R, 2012, ANN BOT-LONDON, V109, P851, DOI 10.1093/aob/mcs017; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Magallon S, 2014, BOT SCI, V92, P1; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; McCann T, 2010, Z DTSCH GES GEOWISS, V161, P335, DOI 10.1127/1860-1804/2010/0161-0335; Miller HA, 1967, NOVA HEDWIGIA, V14, P61; Morley RJ, 2011, S-P B ENVIRON SCI, P1; Nagori ML, 2013, J GEOL SOC INDIA, V81, P514, DOI 10.1007/s12594-013-0066-y; Nascimbene Paul, 2000, P93; Newton AE, 2007, SYST ASSOC SPEC VOL, V71, P337; Oostendorp C., 1987, BRYOPHYTORUM BIBLIOT, V34, P5; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Perkovsky Evgeny E., 2010, P116; Pocs Tamas, 1996, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V67, P109; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Reiner-Drehwald ME, 2012, CRYPTOGAMIE BRYOL, V33, P33, DOI 10.7872/cryb.v33.iss1.2012.033; Renner MAM, 2015, BOT J LINN SOC, V178, P222, DOI 10.1111/boj.12279; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Sadowski EM, 2012, FUNGAL BIOL-UK, V116, P1099, DOI 10.1016/j.funbio.2012.08.003; Sanderson MJ, 2003, AM J BOT, V90, P954, DOI 10.3732/ajb.90.6.954; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schuettpelz E, 2009, P NATL ACAD SCI USA, V106, P11200, DOI 10.1073/pnas.0811136106; SCHUSTER RM, 1979, CAN J BOT, V57, P2179, DOI 10.1139/b79-271; SCHUSTER RM, 1989, REV PALAEOBOT PALYNO, V57, P277, DOI 10.1016/0034-6667(89)90025-0; Schuster RM, 1983, NEW MANUAL BRYOLOGY, P463; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Soderstrom L, 2016, PHYTOKEYS, P1, DOI 10.3897/phytokeys.59.6261; Standke G, 2008, EXKURSIONSFUHRER VER, V236, P11; Standke G., 1998, SCHRIFTENREIHE F R G, V7, P93; Stotler R. E., 1974, BRYOPHYTORUM BIBLIOT, V3, P1; Sun Y, 2014, MOL PHYLOGENET EVOL, V76, P189, DOI 10.1016/j.ympev.2014.03.018; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor T. N., 2009, BIOL EVOLUTION FOSSI; Villarreal JC, 2014, MOL PHYLOGENET EVOL, V78, P25, DOI 10.1016/j.ympev.2014.04.014; Wellman CH, 2003, NATURE, V425, P282, DOI 10.1038/nature01884; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wilson R, 2007, BIOLOGY LETT, V3, P566, DOI 10.1098/rsbl.2007.0287; Wilson R, 2007, MOL PHYLOGENET EVOL, V43, P270, DOI 10.1016/j.ympev.2006.10.017; Wolfe AP, 2016, REV PALAEOBOT PALYNO, V225, P21, DOI 10.1016/j.revpalbo.2015.11.002; Yang XJ, 2011, SCI CHINA EARTH SCI, V54, P228, DOI 10.1007/s11430-010-4153-2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhu R.-L., 2001, NOVA HEDWIGIA S, V121, P1, DOI DOI 10.1179/037366802125001097; Zhu RL, 2003, ANN BOT FENN, V40, P101	91	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156301	10.1371/journal.pone.0156301	http://dx.doi.org/10.1371/journal.pone.0156301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244582	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100026
J	Kumar, AMV; Gupta, D; Kumar, A; Gupta, RS; Kanchar, A; Rao, R; Shastri, S; Suryakanth, MD; Rangaraju, C; Naik, B; Guddemane, DK; Bhat, P; Nair, AS; Harries, AD; Dewan, P				Kumar, Ajay M. V.; Gupta, Devesh; Kumar, Ashok; Gupta, R. S.; Kanchar, Avinash; Rao, Raghuram; Shastri, Suresh; Suryakanth, M. D.; Rangaraju, Chethana; Naik, Balaji; Guddemane, Deepak K.; Bhat, Prashant; Nair, Achuthan Sreenivas; Harries, Anthony David; Dewan, Puneet			HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from India	PLOS ONE			English	Article							SUSPECTS	Background In March 2012, World Health Organization recommended that HIV testing should be offered to all patients with presumptive TB (previously called TB suspects). How this is best implemented and monitored in routine health care settings in India was not known. An operational research was conducted in Karnataka State (South India, population 64 million, accounts for 10% of India's HIV burden), to test processes and learn results and challenges of screening presumptive TB patients for HIV within routine health care settings. Methods In this cross-sectional study conducted between January-March 2012, all presumptive TB patients attending public sector sputum microscopy centres state-wide were offered HIV testing by the laboratory technician, and referred to the nearest public sector HIV counselling and testing services, usually within the same facility. The HIV status of the patients was recorded in the routine TB laboratory form and TB laboratory register. The laboratory register was compiled to obtain the number of presumptive TB patients whose HIV status was ascertained, and the number found HIV positive. Aggregate data on reasons for non-testing were compiled at district level. Results Overall, 115,308 patients with presumptive TB were examined for sputum smear microscopy at 645 microscopy centres state-wide. Of these, HIV status was ascertained for 62,847(55%) among whom 7,559(12%) were HIV-positive, and of these, 3,034(40%) were newly diagnosed. Reasons for non-testing were reported for 37,700(72%) of the 52,461 patients without HIV testing; non-availability of testing services at site of sputum collection was cited by health staff in 54% of respondents. Only 4% of patients opted out of HIV testing. Conclusion Offering HIV testing routinely to presumptive TB patients detected large numbers of previously-undetected instances of HIV infection. Several operational challenges were noted which provide useful lessons for improving uptake of HIV testing in this important group.	[Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Gupta, Devesh; Kumar, Ashok; Gupta, R. S.] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Kumar, Ashok; Gupta, R. S.; Kanchar, Avinash; Rao, Raghuram] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Kanchar, Avinash] WHO, CH-1211 Geneva, Switzerland; [Shastri, Suresh; Suryakanth, M. D.] Directorate Hlth Serv, State TB Cell, Bangalore, Karnataka, India; [Rangaraju, Chethana] Karnataka State AIDS Prevent & Control Soc, Bangalore, Karnataka, India; [Naik, Balaji; Guddemane, Deepak K.; Bhat, Prashant; Nair, Achuthan Sreenivas] World Hlth Org Country Off India, New Delhi, India; [Harries, Anthony David] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England; [Dewan, Puneet] Bill & Melinda Gates Fdn, New Delhi, India	World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Kumar, AMV (corresponding author), Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India.	akumar@theunion.org	Bhat, Prashant G/H-6696-2012	Bhat, Prashant G/0000-0002-2130-210X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Achanta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041378; Adjei A A, 2006, West Afr J Med, V25, P38; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dlodlo RA, 2015, PUBLIC HEALTH ACTION, V5, P217, DOI 10.5588/pha.15.0036; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS, 2014, AMB TREATM TARG HELP, DOI [10.7448/IAS.16.4.18751, DOI 10.7448/IAS.16.4.18751]; Kumar AMV, 2013, PUBLIC HEALTH ACTION, V3, P60, DOI 10.5588/pha.13.0004; Kumar AMV, 2017, J EPIDEMIOL GLOB HEA, V7, P11, DOI 10.1016/j.jegh.2015.12.002; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Naik B, 2012, JAIDS-J ACQ IMM DEF, V59, pE72, DOI 10.1097/QAI.0b013e318245c9df; *NAT AIDS CONTR OR, 2013, TECHN REP IND HIV ES; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization, 2014, GHUL NAB AZ LAUNCH N; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Ofice of the Registrar General and Census Commissioner, 2011, 12011 OFF REG GEN CE; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; STOP TB Partnership, GLOB PLAN STOP TB 20; UNAIDS, 2015, AIDS CHANG EV MDG6 1; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2014, WHOHTMTB201408	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156487	10.1371/journal.pone.0156487	http://dx.doi.org/10.1371/journal.pone.0156487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244055	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000377146100042
J	Sagebakken, G; Ahnesjo, I; Kvarnemo, C				Sagebakken, Gry; Ahnesjo, Ingrid; Kvarnemo, Charlotta			Costs and Benefits to Pregnant Male Pipefish Caring for Broods of Different Sizes	PLOS ONE			English	Article							ROLE REVERSED PIPEFISH; FILIAL CANNIBALISM; REPRODUCTIVE SUCCESS; PARENTAL EFFORT; CLUTCH-SIZE; ICTALURUS-PUNCTATUS; CHANNEL CATFISH; MATE CHOICE; SYNGNATHIDAE; CARE	Trade-offs between brood size and offspring size, offspring survival, parental condition or parental survival are classic assumptions in life history biology. A reduction in brood size may lessen these costs of care, but offspring mortality can also result in an energetic gain, if parents are able to utilize the nutrients from the demised young. Males of the broad-nosed pipefish (Syngnathus typhle) care for the offspring by brooding embryos in a brood pouch. Brooding males can absorb nutrients that emanate from embryos, and there is often a reduction in offspring number over the brooding period. In this study, using two experimentally determined brood sizes (partially and fully filled brood pouches), we found that full broods resulted in larger number of developing offspring, despite significantly higher absolute and relative embryo mortality, compared to partial broods. Male survival was also affected by brood size, with males caring for full broods having poorer survival, an effect that together with the reduced embryo survival was found to negate the benefit of large broods. We found that embryo mortality was lower when the brooding males were in good initial condition, that embryos in broods with low embryo mortality weighed more, and surprisingly, that males in higher initial condition had embryos of lower weight. Brood size, however, did not affect embryo weight. Male final condition, but not initial condition, correlated with higher male survival. Taken together, our results show costs and benefits of caring for large brood sizes, where the numerical benefits come with costs in terms of both embryo survival and survival of the brooding father, effects that are often mediated via male condition.	[Sagebakken, Gry; Kvarnemo, Charlotta] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Ahnesjo, Ingrid] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	University of Gothenburg; Uppsala University	Kvarnemo, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	lotta.kvarnemo@bioenv.gu.se			Goteborgs Universitets Marina Forskningscentrum (GMF); Helge Ax:son Johnssons Stiftelse; Radman och Fru Ernst Collianders Stiftelse; Knut och Alice Wallenbergs stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond; Inez Johanssons stiftelse (Uppsala University); GMF; Swedish Research Council	Goteborgs Universitets Marina Forskningscentrum (GMF); Helge Ax:son Johnssons Stiftelse; Radman och Fru Ernst Collianders Stiftelse; Knut och Alice Wallenbergs stiftelse(Knut & Alice Wallenberg Foundation); Wilhelm och Martina Lundgrens Vetenskapsfond; Inez Johanssons stiftelse (Uppsala University); GMF; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Goteborgs Universitets Marina Forskningscentrum (GMF), Helge Ax:son Johnssons Stiftelse, Radman och Fru Ernst Collianders Stiftelse, Knut och Alice Wallenbergs stiftelse and Wilhelm och Martina Lundgrens Vetenskapsfond to G.S., Inez Johanssons stiftelse (Uppsala University) to I.A. and GMF and the Swedish Research Council to C.K.	AHNESJO I, 1992, J FISH BIOL, V41, P53, DOI 10.1111/j.1095-8649.1992.tb03868.x; AHNESJO I, 1992, FUNCT ECOL, V6, P274, DOI 10.2307/2389517; Ahnesjo I, 1996, BEHAV ECOL SOCIOBIOL, V38, P167, DOI 10.1007/s002650050229; AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; BERGLUND A, 1986, MAR ECOL PROG SER, V29, P209, DOI 10.3354/meps029209; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; BERGLUND A, 1988, OIKOS, V51, P184, DOI 10.2307/3565641; Braga Goncalves I, 2011, J FISH BIOL, V78, P1847, DOI 10.1111/j.1095-8649.2011.02984.x; Braga Goncalves I, 2015, EVOLUTIONARY PUZZLE, V282, DOI [10.1098/rspb.2015.0690, DOI 10.1098/RSPB.2015.0690]; Braga Goncalves I, 2015, J EXP BIOL, V218, P1639, DOI 10.1242/jeb.120907; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Brooker RM, 2013, OECOLOGIA, V172, P409, DOI 10.1007/s00442-012-2521-7; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; CHELLAPPA S, 1989, J FISH BIOL, V35, P275, DOI 10.1111/j.1095-8649.1989.tb02976.x; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; COLEMAN RM, 1985, BEHAV ECOL SOCIOBIOL, V18, P59; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; Dufresne F, 1990, BEHAV ECOL, V1, P140, DOI 10.1093/beheco/1.2.140; Elgar M. A., 1992, CANNIBALISM ECOLOGY, P1; Engstrand SM, 2002, FUNCT ECOL, V16, P782, DOI 10.1046/j.1365-2435.2002.00681.x; Gaylord TG, 2000, J WORLD AQUACULT SOC, V31, P326, DOI 10.1111/j.1749-7345.2000.tb00884.x; GODFRAY HCJ, 1991, ANNU REV ECOL SYST, V22, P409, DOI 10.1146/annurev.es.22.110191.002205; Hunt J, 2002, J EVOLUTION BIOL, V15, P57, DOI 10.1046/j.1420-9101.2002.00374.x; Hussey NE, 2009, MAR ECOL PROG SER, V380, P199, DOI 10.3354/meps07918; Ito S, 2010, ENVIRON BIOL FISH, V87, P135, DOI 10.1007/s10641-009-9573-5; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kindsvater HK, 2010, EVOL ECOL RES, V12, P327; Klug H, 2006, EVOLUTION, V60, P2087, DOI 10.1111/j.0014-3820.2006.tb01846.x; Kvarnemo C, 2011, J FISH BIOL, V78, P1725, DOI 10.1111/j.1095-8649.2011.02989.x; Lissaker M, 2003, BEHAV ECOL, V14, P374, DOI 10.1093/beheco/14.3.374; Luo Z, 2009, J APPL ICHTHYOL, V25, P184, DOI 10.1111/j.1439-0426.2009.01216.x; Manica A, 2002, BIOL REV, V77, P261, DOI 10.1017/S1464793101005905; MARCONATO A, 1988, J FISH BIOL, V33, P905, DOI 10.1111/j.1095-8649.1988.tb05539.x; Mock D. W., 1997, EVOLUTION SIBLING RI; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Nord A, 2010, FUNCT ECOL, V24, P1031, DOI 10.1111/j.1365-2435.2010.01719.x; Paczolt KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124147; Paczolt KA, 2010, NATURE, V464, P401, DOI 10.1038/nature08861; Partridge C, 2009, BEHAV ECOL SOCIOBIOL, V63, P345, DOI 10.1007/s00265-008-0668-3; PARTRIDGE L, 1991, PHILOS T R SOC B, V332, P3, DOI 10.1098/rstb.1991.0027; Payne AG, 2004, ECOL MODEL, V174, P253, DOI 10.1016/j.ecolmodel.2003.09.026; Payne AG, 2002, P ROY SOC B-BIOL SCI, V269, P2095, DOI 10.1098/rspb.2002.2144; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; RIDGWAY MS, 1989, ETHOLOGY, V80, P47; Ripley JL, 2009, COMP BIOCHEM PHYS A, V154, P98, DOI 10.1016/j.cbpa.2009.05.003; Ripley JL, 2009, J COMP PHYSIOL B, V179, P325, DOI 10.1007/s00360-008-0316-2; Ripley JL, 2006, J EXP BIOL, V209, P1112, DOI 10.1242/jeb.02119; Roff Derek A., 1992; ROHWER S, 1978, AM NAT, V112, P429, DOI 10.1086/283284; ROSENQVIST G, 1995, ANIM BEHAV, V49, P1039, DOI 10.1006/anbe.1995.0133; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; SABAT AM, 1994, BEHAV ECOL, V5, P195, DOI 10.1093/beheco/5.2.195; Sagebakken G, 2012, THESIS U GOTHENBURG; Sagebakken G, 2011, BEHAV ECOL, V22, P625, DOI 10.1093/beheco/arr023; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; Sargent Robert Craig, 1992, P38; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; Sommer S, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-39; Stearns S.C., 1992, pi; SVENSSON I, 1988, J ANIM ECOL, V57, P929, DOI 10.2307/5102; TRIVERS RL, 1974, AM ZOOL, V14, P249; VINCENT A, 1994, BEHAV ECOL SOCIOBIOL, V34, P435, DOI 10.1007/s002650050060; Vincent ACJ, 1995, ENVIRON BIOL FISH, V44, P347, DOI 10.1007/BF00008250; Watanabe S, 2002, ENVIRON BIOL FISH, V65, P319, DOI 10.1023/A:1020510422509; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AB, 2001, J HERED, V92, P159, DOI 10.1093/jhered/92.2.159; Wolfe RK, 1998, J GREAT LAKES RES, V24, P731; Wootton R.J., 1998, ECOLOGY TELEOST FISH	71	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156484	10.1371/journal.pone.0156484	http://dx.doi.org/10.1371/journal.pone.0156484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243937	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100041
J	Man-Kupisinska, A; Michalski, M; Maciejewska, A; Swierzko, AS; Cedzynski, M; Lugowski, C; Lukasiewicz, J				Man-Kupisinska, Aleksandra; Michalski, Mateusz; Maciejewska, Anna; Swierzko, Anna S.; Cedzynski, Maciej; Lugowski, Czeslaw; Lukasiewicz, Jolanta			A New Ligand-Based Method for Purifying Active Human Plasma-Derived Ficolin-3 Complexes Supports the Phenomenon of Crosstalk between Pattern-Recognition Molecules and Immunoglobulins	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; H-FICOLIN; COMPLEMENT ACTIVATION; PATHWAY ACTIVATION; HAFNIA-ALVEI; SERINE-PROTEASE; HAKATA ANTIGEN; CORE OLIGOSACCHARIDE; HUMAN SERUM; PURIFICATION	Despite recombinant protein technology development, proteins isolated from natural sources remain important for structure and activity determination. Ficolins represent a class of proteins that are difficult to isolate. To date, three methods for purifying ficolin-3 from plasma/serum have been proposed, defined by most critical step: (i) hydroxyapatite absorption chromatography (ii) N-acetylated human serum albumin affinity chromatography and (iii) anti-ficolin-3 monoclonal antibody-based affinity chromatography. We present a new protocol for purifying ficolin-3 complexes from human plasma that is based on an exclusive ligand: the O-specific polysaccharide of Hafnia alvei PCM 1200 LPS (O-PS 1200). The protocol includes (i) poly(ethylene glycol) precipitation; (ii) yeast and L-fucose incubation, for depletion of mannose-binding lectin; (iii) affinity chromatography using O-PS 1200-Sepharose; (iv) size-exclusion chromatography. Application of this protocol yielded average 2.2 mg of ficolin-3 preparation free of mannose-binding lectin (MBL), ficolin-1 and -2 from 500 ml of plasma. The protein was complexed with MBL-associated serine proteases (MASPs) and was able to activate the complement in vitro. In-process monitoring of MBL, ficolins, and total protein content revealed the presence of difficult-to-remove immunoglobulin G, M and A, in some extent in agreement with recent findings suggesting crosstalk between IgG and ficolin-3. We demonstrated that recombinant ficolin-3 interacts with IgG and IgM in a concentration-dependent manner. Although this association does not appear to influence ficolin-3-ligand interactions in vitro, it may have numerous consequences in vivo. Thus our purification procedure provides Ig-ficolin-3/MASP complexes that might be useful for gaining further insight into the crosstalk and biological activity of ficolin-3.	[Man-Kupisinska, Aleksandra; Maciejewska, Anna; Lugowski, Czeslaw; Lukasiewicz, Jolanta] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland; [Michalski, Mateusz; Swierzko, Anna S.; Cedzynski, Maciej] Polish Acad Sci, Inst Med Biol, Lab Immunobiol Infect, Lodz, Poland; [Michalski, Mateusz] Univ Lodz, Inst Microbiol Immunol & Biotechnol, PL-90131 Lodz, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz	Lukasiewicz, J (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland.	jolanta.lukasiewicz@iitd.pan.wroc.pl		Lugowski, Czeslaw/0000-0002-2336-0530; Cedzynski, Maciej/0000-0002-4486-9256; Maciejewska, Anna/0000-0003-4057-2997; Lukasiewicz, Jolanta/0000-0001-8081-7261	Polish Ministry of Science and Higher Education [N40108432/1944]; National Science Centre [2012/07/N/NZ6/04115, 2015/16/T/NZ6/00412]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	This research was supported by The Polish Ministry of Science and Higher Education grant N40108432/1944 to JL, http://www.nauka.gov.pl/en/, and by the National Science Centre grant 2012/07/N/NZ6/04115 to AMK, https://www.ncn.gov.pl/?language=en. MM is the recipient of fellowship for PhD students from the National Science Center, 2015/16/T/NZ6/00412, https://www.ncn.gov.pl/?language=en. Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, http://know.wroc.pl/?lang=en.	ABDELAKHER M, 1951, J AM CHEM SOC, V73, P4691, DOI 10.1021/ja01154a061; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bartlomiejczyk MA, 2014, CLIN EXP IMMUNOL, V178, P310, DOI 10.1111/cei.12416; Bidula S, 2015, IMMUNOLOGY, V146, P281, DOI 10.1111/imm.12501; Breen KA, 2014, BLOOD COAGUL FIBRIN, V25, P644, DOI 10.1097/MBC.0000000000000060; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Degn SE, 2013, J IMMUNOL, V191, P1334, DOI 10.4049/jimmunol.1300780; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Endo Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/105891; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Evans-Osses I, 2010, BIOCHEM BIOPH RES CO, V395, P382, DOI 10.1016/j.bbrc.2010.04.025; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1110, DOI 10.1021/bi00905a035; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Hein E, 2013, MOL IMMUNOL, V56, P406, DOI 10.1016/j.molimm.2013.05.233; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; JACHYMEK W, 1994, CARBOHYD RES, V251, P327, DOI 10.1016/0008-6215(94)84295-7; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Le Y, 1997, J IMMUNOL METHODS, V204, P43, DOI 10.1016/S0022-1759(97)00029-X; Lei XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07824; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Matsushita M, 2014, METHODS MOL BIOL, V1100, P141, DOI 10.1007/978-1-62703-724-2_12; Matsushita M, 2013, ARCH IMMUNOL THER EX, V61, P273, DOI 10.1007/s00005-013-0229-y; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Michalski M, 2015, IMMUNOBIOLOGY, V220, P711, DOI 10.1016/j.imbio.2015.01.003; Michalski M, 2015, IMMUNOBIOLOGY, V220, P117, DOI 10.1016/j.imbio.2014.08.012; Michalski M, 2012, IMMUNOBIOLOGY, V217, P730, DOI 10.1016/j.imbio.2011.12.004; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Niedziela T, 2006, BIOCHEMISTRY-US, V45, P10422, DOI 10.1021/bi0607709; Panda S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03675; Panda S, 2013, EMBO J, V32, P2905, DOI 10.1038/emboj.2013.199; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Petersson C, 1997, EUR J BIOCHEM, V244, P580, DOI 10.1111/j.1432-1033.1997.00580.x; PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Presanis JS, 2003, BIOCHEM SOC T, V31, P748, DOI 10.1042/BST0310748; Sahagun-Ruiz A, 2015, IMMUNOBIOLOGY, V220, P1177, DOI 10.1016/j.imbio.2015.06.001; SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Szala A, 2013, CANCER IMMUNOL IMMUN, V62, P1411, DOI 10.1007/s00262-013-1445-3; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Thiel S, 2009, ADV EXP MED BIOL, V653, P58; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YAE Y, 1991, BIOCHIM BIOPHYS ACTA, V1078, P369, DOI 10.1016/0167-4838(91)90158-V; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044	59	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156691	10.1371/journal.pone.0156691	http://dx.doi.org/10.1371/journal.pone.0156691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232184	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000053
J	Mittermann, I; Wikberg, G; Johansson, C; Lupinek, C; Lundeberg, L; Crameri, R; Valenta, R; Scheynius, A				Mittermann, Irene; Wikberg, Gustav; Johansson, Catharina; Lupinek, Christian; Lundeberg, Lena; Crameri, Reto; Valenta, Rudolf; Scheynius, Annika			IgE Sensitization Profiles Differ between Adult Patients with Severe and Moderate Atopic Dermatitis	PLOS ONE			English	Article							YEAST MALASSEZIA-SYMPODIALIS; SEQUENCE SIMILARITIES; FURFUR ALLERGENS; MAJOR ALLERGEN; SERUM IGE; SKIN; POLLEN; EXPRESSION; DIAGNOSIS; CLONING	Background Atopic dermatitis (AD) is a complex chronic inflammatory disease where allergens can act as specific triggering factors. Aim To characterize the specificities of IgE-reactivity in patients with AD to a broad panel of exogenous allergens including microbial and human antigens. Methodology Adult patients with AD were grouped according to the SCORAD index, into severe (n = 53) and moderate AD (n = 126). As controls 43 patients were included with seborrhoeic eczema and 97 individuals without history of allergy or skin diseases. Specific IgE reactivity was assessed in plasma using Phadiatop1, ImmunoCap T, micro-arrayed allergens, dot-blotted recombinant Malassezia sympodialis allergens, and immune-blotted microbial and human proteins. Results IgE reactivity was detected in 92% of patients with severe and 83% of patients with moderate AD. Sensitization to cat allergens occurred most frequently, followed by sensitization to birch pollen, grass pollen, and to the skin commensal yeast M. sympodialis. Patients with severe AD showed a significantly higher frequency of IgE reactivity to allergens like cat (rFel d 1) and house dust mite (rDer p 4 and 10), to Staphylococcus aureus, M. sympodialis, and to human antigens. In contrast, there were no significant differences in the frequencies of IgE reactivity to the grass pollen allergens rPhl p 1, 2, 5b, and 6 between the two AD groups. Furthermore the IgE reactivity profile of patients with severe AD was more spread towards several different allergen molecules as compared to patients with moderate AD. Conclusion We have revealed a hitherto unknown difference regarding the molecular sensitization profile in patients with severe and moderate AD. Molecular profiling towards allergen components may provide a basis for future investigations aiming to explore the environmental, genetic and epigenetic factors which could be responsible for the different appearance and severity of disease phenotypes in AD.	[Mittermann, Irene] Med Univ Vienna, Christian Doppler Lab Dev Allergen Chips, Vienna, Austria; [Mittermann, Irene; Lupinek, Christian; Valenta, Rudolf] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Div Immunopathol, Vienna, Austria; [Wikberg, Gustav; Lundeberg, Lena] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Wikberg, Gustav; Lundeberg, Lena] Karolinska Univ Hosp, Dermatol & Venereol Unit, Stockholm, Sweden; [Johansson, Catharina; Scheynius, Annika] Karolinska Inst, Dept Clin Sci & Educ, SE-11883 Stockholm, Sweden; [Johansson, Catharina; Scheynius, Annika] Sachs Children & Youth Hosp, SE-11883 Stockholm, Sweden; [Crameri, Reto] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland	Medical University of Vienna; Medical University of Vienna; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Swiss Institute of Allergy & Asthma Research; University of Zurich	Scheynius, A (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, SE-11883 Stockholm, Sweden.; Scheynius, A (corresponding author), Sachs Children & Youth Hosp, SE-11883 Stockholm, Sweden.	annika.scheynius@ki.se	Lupinek, Christian/I-3311-2019	Lupinek, Christian/0000-0002-8612-8245; Mittermann, Irene/0000-0002-6240-6730; Valenta, Rudolf/0000-0001-5944-3365	Swedish Research Council; Centre for Allergy Research; Karolinska Institutet; Stockholm County Council; Karolinska University Hospital; Christian Doppler Research Association, Thermo Fisher, Uppsala, Sweden; Austrian Science Fund (FWF) [F4605, P26728-B20]; FP7; Swiss National Science Foundation [320030_149978/1]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Allergy Research; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Karolinska University Hospital(Karolinska Institutet); Christian Doppler Research Association, Thermo Fisher, Uppsala, Sweden; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); FP7; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants from the Swedish Research Council, the Centre for Allergy Research, Karolinska Institutet, through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet and the Karolinska University Hospital, and in part by grants from the Christian Doppler Research Association, Thermo Fisher, Uppsala, Sweden, the Austrian Science Fund (FWF) (grants F4605, P26728-B20) and by the FP7-funded research program MeDALL. Work at SIAF was supported by the Swiss National Science Foundation ( grant 320030_149978/1). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, ALLERGY, V61, P969, DOI 10.1111/j.1398-9995.2006.01153.x; Andersson A, 2004, EUR J BIOCHEM, V271, P1885, DOI 10.1111/j.1432-1033.2004.04098.x; Balaji H, 2011, J ALLERGY CLIN IMMUN, V128, P92, DOI 10.1016/j.jaci.2011.02.043; Banerjee S, 2015, J INVEST DERMATOL, V135, P102, DOI 10.1038/jid.2014.271; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bousquet J, 2015, ALLERGY, V70, P1062, DOI 10.1111/all.12637; Campana R, 2015, J ALLERGY CLIN IMMUN; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; Caubet JC, 2010, IMMUNOL ALLERGY CLIN, V30, P289, DOI 10.1016/j.iac.2010.06.002; Engebretsen KA, 2016, J EUR ACAD DERMATOL, V30, P223, DOI 10.1111/jdv.13301; Falk MHS, 2005, ACTA DERM-VENEREOL, V85, P17, DOI 10.1080/00015550410022276; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Gioti A, 2013, MBIO, V4, DOI 10.1128/mBio.00572-12; Harwanegg C, 2003, CLIN EXP ALLERGY, V33, P7, DOI 10.1046/j.1365-2222.2003.01550.x; Jagielski T, 2014, BMC DERMATOL, V14, DOI 10.1186/1471-5945-14-3; Johansson C, 2003, BRIT J DERMATOL, V148, P479, DOI 10.1046/j.1365-2133.2003.05093.x; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Lagier B, 1995, J ALLERGY CLIN IMMUN, V96, P932, DOI 10.1016/S0091-6749(95)70231-8; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Limacher A, 2007, J IMMUNOL, V178, P389, DOI 10.4049/jimmunol.178.1.389; Lindborg M, 1999, J INVEST DERMATOL, V113, P156, DOI 10.1046/j.1523-1747.1999.00661.x; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Natter S, 1998, FASEB J, V12, P1559, DOI 10.1096/fasebj.12.14.1559; Pahr S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111483; Rasool O, 2000, EUR J BIOCHEM, V267, P4355, DOI 10.1046/j.1432-1327.2000.01475.x; Reekers R, 1999, J ALLERGY CLIN IMMUN, V104, P466, DOI 10.1016/S0091-6749(99)70395-7; Reginald K, 2011, J ALLERGY CLIN IMMUN, V128, P82, DOI 10.1016/j.jaci.2011.02.034; Resch Y, 2015, J ALLERGY CLIN IMMUN; Saunders CW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002701; Schappi GF, 1999, CLIN EXP ALLERGY, V29, P633, DOI 10.1046/j.1365-2222.1999.00567.x; Schappi GF, 1997, J ALLERGY CLIN IMMUN, V100, P656, DOI 10.1016/S0091-6749(97)70170-2; Schmidt M, 1997, EUR J BIOCHEM, V246, P181, DOI 10.1111/j.1432-1033.1997.00181.x; Schneider L, 2013, J ALLERGY CLIN IMMUN, V131, P295, DOI 10.1016/j.jaci.2012.12.672; Selander C, 2009, J IMMUNOL, V182, P4208, DOI 10.4049/jimmunol.0800885; Sonesson A, 2013, ACTA DERM-VENEREOL, V93, P340, DOI 10.2340/00015555-1465; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valenta R, 2009, TRENDS IMMUNOL, V30, P109, DOI 10.1016/j.it.2008.12.004; Werfel T, 2015, J ALLERGY CLIN IMMUN, V136, P96, DOI 10.1016/j.jaci.2015.04.015; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Zargari A, 2007, ALLERGY, V62, P695, DOI 10.1111/j.1398-9995.2006.01291.x; Zargari A, 2001, ACTA DERM-VENEREOL, V81, P418, DOI 10.1080/000155501317208363	43	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156077	10.1371/journal.pone.0156077	http://dx.doi.org/10.1371/journal.pone.0156077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228091	Green Published, Green Accepted, gold			2022-12-27	WOS:000376882500063
J	Sun, LW; Jiang, WJ; Sato, H; Kawachi, M; Lu, XW				Sun, Li-Wei; Jiang, Wen-Jing; Sato, Hiroaki; Kawachi, Masanobu; Lu, Xi-Wu			Rapid Classification and Identification of Microcystis aeruginosa Strains Using MALDI-TOF MS and Polygenetic Analysis	PLOS ONE			English	Article							RIBOSOMAL-RNA; INTACT MICROORGANISMS; GENUS MICROCYSTIS; MASS-SPECTROMETRY; CYANOBACTERIA; PHYCOCYANIN; PROTEINS; BACTERIA; GENES; 16S	Matrix-assisted laser desorption-ionization-time-of-flight mass spectrometry (MALDI-TOF MS) was used to establish a rapid, simple, and accurate method to differentiate among strains of Microcystis aeruginosa, one of the most prevalent types of bloom-forming cyanobacteria. M. aeruginosa NIES-843, for which a complete genome has been sequenced, was used to characterize ribosomal proteins as biomarkers and to optimize conditions for observing ribosomal proteins as major peaks in a given mass spectrum. Thirty-one of 52 ribosomal subunit proteins were detected and identified along the mass spectrum. Fifty-five strains of M. aeruginosa from different habitats were analyzed using MALDI-TOF MS; among these samples, different ribosomal protein types were observed. A polygenetic analysis was performed using an unweighted pair-group method with arithmetic means and different ribosomal protein types to classify the strains into five major clades. Two clades primarily contained toxic strains, and the other three clades contained exclusively non-toxic strains. This is the first study to differentiate cyanobacterial strains using MALDI-TOF MS.	[Sun, Li-Wei; Jiang, Wen-Jing; Lu, Xi-Wu] Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China; [Sato, Hiroaki] Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Environm Measurement Technol Grp, Tsukuba, Ibaraki, Japan; [Kawachi, Masanobu] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Biodivers Resource Conservat Sect, Tsukuba, Ibaraki, Japan	Southeast University - China; National Institute of Advanced Industrial Science & Technology (AIST); National Institute for Environmental Studies - Japan	Sun, LW (corresponding author), Southeast Univ, Sch Energy & Environm, Nanjing, Jiangsu, Peoples R China.; Sato, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Environm Management Res Inst, Environm Measurement Technol Grp, Tsukuba, Ibaraki, Japan.	liwei-sun@seu.edu.cn; sato-hiroaki@aist.go.jp	Sato, Hiroaki/N-4160-2013; Sato, Hiroaki/AAC-3683-2019	Sato, Hiroaki/0000-0003-2558-9248; Sato, Hiroaki/0000-0003-2558-9248	Jiangsu Environmental Monitoring Foundation, China [1411]	Jiangsu Environmental Monitoring Foundation, China	The present study was supported by the Jiangsu Environmental Monitoring Foundation, China ( Project No. 1411), to LWS.	[Anonymous], 2008, DNA RES, DOI DOI 10.1093/dnares/dsm026; [Anonymous], 1999, TOXIC CYANOBACTERIA; Arnold RJ, 1999, ANAL BIOCHEM, V269, P105, DOI 10.1006/abio.1998.3077; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; Enora B, 2009, ISME J, V3, P419, DOI [10.1038/ismej.2008.121, DOI 10.1038/ISMEJ.2008.121]; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Francis G., 1878, NATURE, V18, P11, DOI [10.1038/018011d0, DOI 10.1038/018011D0]; Friedrichs C, 2007, J CLIN MICROBIOL, V45, P2392, DOI 10.1128/JCM.00556-07; Hettick JM, 2006, PROTEOMICS, V6, P6416, DOI 10.1002/pmic.200600335; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Kanae T, 2007, J PROTEOME RES, V6, P3899; Kanae T, 2007, ANAL CHEM, V79, P8712; Kardinaal WEA, 2005, AQUAT ECOL SER, V3, P41; Kasai F, 2004, NIES COLLECTION LIST, V7; Keys CJ, 2004, INFECT GENET EVOL, V4, P221, DOI 10.1016/j.meegid.2004.02.004; Krishnamurthy T, 1996, RAPID COMMUN MASS SP, V10, P1992, DOI 10.1002/(SICI)1097-0231(199612)10:15<1992::AID-RCM789>3.0.CO;2-V; Kuiper-Goodman T., 1999, TOXIC CYANOBACTERIA, P125; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; Lay JO, 2001, MASS SPECTROM REV, V20, P172, DOI 10.1002/mas.10003; Linda E G, 2009, ALGAE, P96; Lyra C, 2001, INT J SYST EVOL MICR, V51, P513, DOI 10.1099/00207713-51-2-513; MOERSCHELL RP, 1990, J BIOL CHEM, V265, P19638; Neilan BA, 1997, INT J SYST BACTERIOL, V47, P693, DOI 10.1099/00207713-47-3-693; NEILAN BA, 1995, APPL ENVIRON MICROB, V61, P2286, DOI 10.1128/AEM.61.6.2286-2291.1995; Nishizawa T, 1999, J BIOCHEM-TOKYO, V126, P520, DOI 10.1093/oxfordjournals.jbchem.a022481; Otsuka S, 1999, FEMS MICROBIOL LETT, V172, P15, DOI 10.1111/j.1574-6968.1999.tb13443.x; Pineda FJ, 2003, ANAL CHEM, V75, P3817, DOI 10.1021/ac034069b; Randy JA, 1998, RAPID COMMUN MASS SP, V12, P630; Rantala A, 2004, P NATL ACAD SCI USA, V101, P568, DOI 10.1073/pnas.0304489101; Ressom R., 1994, HLTH EFFECTS TOXIC C; Ryzhov V, 2001, ANAL CHEM, V73, P746, DOI 10.1021/ac0008791; Simis SGH, 2005, LIMNOL OCEANOGR, V50, P237, DOI 10.4319/lo.2005.50.1.0237; Strickland J.D.H., 1968, BULLETIN, V167, P185; Sun LW, 2006, RAPID COMMUN MASS SP, V20, P3789, DOI 10.1002/rcm.2801; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; World Health Organization (WHO), 1998, HLTH CRIT OTH SUPP I, V2; YENTSCH CS, 1963, DEEP-SEA RES, V10, P221, DOI 10.1016/0011-7471(63)90358-9	38	7	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156275	10.1371/journal.pone.0156275	http://dx.doi.org/10.1371/journal.pone.0156275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227555	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500100
J	Buss, LW; Buss, ED; Anderson, CP; Power, M; Zinter, J				Buss, Leo W.; Buss, Evan D.; Anderson, Christopher P.; Power, Michael; Zinter, Joseph			Control of Hydroid Colony Form by Surface Heterogeneity	PLOS ONE			English	Article							PODOCORYNE-CARNEA; HYDRACTINIID HYDROIDS; CELL MOVEMENTS; GROWTH; DIFFERENTIATION; PHYSIOLOGY; DYNAMICS; FLEXUOSA; STOLONS; BIOLOGY	The colonial hydroid Podocoryna carnea grows adherent to surfaces progressing along them by a motile stolon tip. We here ask whether the stolon tip grows preferentially within grooves etched in silicon wafers. In a series of pilot experiments, we varied the dimensions of grooves and found that stolons did not utilize grooves with a width: depth of 5: 5 mu m or 10: 10 mu m, occasionally followed grooves 25: 25 mu m in size, and preferentially grew within grooves of a width: depth of 50: 50 mu m and 100: 50 mu m. We then grew colonies in grids, with fixed 50: 50 mu m width: depth channels intersecting at 90 degrees every 950, 700, 450, or 150 mu m. We find that stolons grew within grooves early in colony ontogeny, but remained restricted to them only in the grid pattern with channel intersections every 150 mu m. Finally, we created a grid in the shape of the Yale Y logo, with channels of 50: 50 mu m width: depth and intersections every 100 mu m. The resulting colonies conformed to that of the logo. Our findings demonstrate that stolons respond to surface heterogeneity and that surface etching can be used to fabricate microfluidic circuits comprised of hydroid perisarc.	[Buss, Leo W.; Buss, Evan D.; Anderson, Christopher P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Buss, Leo W.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Power, Michael] Yale Univ, Sch Engn & Appl Sci, New Haven, CT USA; [Zinter, Joseph] Yale Univ, Ctr Engn Design & Innovat, New Haven, CT USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; Yale University; Yale University	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Buss, LW (corresponding author), Smithsonian Marine Stn, Ft Pierce, FL USA.	leo.buss@yale.edu						Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; Blackstone NW, 1999, J EXP BIOL, V202, P3541; Blackstone NW, 1998, J EXP BIOL, V201, P2821; Blackstone NW, 2005, J EXP BIOL, V208, P383, DOI 10.1242/jeb.01394; Blackstone NW, 2004, INVERTEBR BIOL, V123, P43; Blackstone NW, 2003, J EXP BIOL, V206, P651, DOI 10.1242/jeb.00138; Blackstone NW, 2001, J EXP BIOL, V204, P1845; Blackstone NW, 1996, BIOL BULL, V190, P56, DOI 10.2307/1542675; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BOARDMAN RS, 1973, ANIMAL COLONIES; BRAVERMAN M, 1974, AM ZOOL, V14, P673; BRAVERMAN M, 1971, J MORPHOL, V135, P131, DOI 10.1002/jmor.1051350202; BRAVERMAN M, 1968, J MORPHOL, V126, P95, DOI 10.1002/jmor.1051260106; Braverman M, 1966, CNIDARIA THEIR EVOLU, P169; Braverman M, 1974, ANN REV OCEANOGRAPHY, V12, P129; BRAVERMAN MH, 1963, J EMBRYOL EXP MORPH, V11, P239; BRAVERMAN MH, 1962, SCIENCE, V135, P310, DOI 10.1126/science.135.3500.310; Brown C. H., 1975, STRUCTURAL MAT ANIMA; Bumann D, 2008, INVERTEBR BIOL, V127, P368, DOI 10.1111/j.1744-7410.2008.00135.x; Buss LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136814; Buss LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072221; BUSS LW, 1991, PHILOS T ROY SOC B, V332, P49, DOI 10.1098/rstb.1991.0032; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3; BUSS LW, 1988, ECOLOGY, V69, P646, DOI 10.2307/1941013; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; CHAPMAN D M, 1969, Tissue and Cell, V1, P619, DOI 10.1016/S0040-8166(69)80036-4; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; Dudgeon SR, 1996, AM NAT, V147, P667, DOI 10.1086/285874; Franssila S, 2010, INTRO MICROFABRICATI; HALE LJ, 1960, Q J MICROSC SCI, V101, P339; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; Harmata KL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P481, DOI 10.1086/661952; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Jansen HV, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/033001; Kern W, 1993, HDB SEMICONDUCTOR CL; Knight D. P., 1970, Tissue Cell, V2, P467, DOI 10.1016/S0040-8166(70)80045-3; KNIGHT DP, 1968, NATURE, V218, P585, DOI 10.1038/218584a0; KNIGHT DP, 1971, TISSUE CELL, V3, P57, DOI 10.1016/S0040-8166(71)80030-7; Kosevich I. A., 2006, Russian Journal of Developmental Biology, V37, P90, DOI 10.1134/S1062360406020056; LARWOOD G, 1979, BIOL SYSTEMATICS COL; MARCUM BA, 1978, TISSUE CELL, V10, P113, DOI 10.1016/0040-8166(78)90010-1; MCFADDEN CS, 1984, BIOL BULL, V166, P54, DOI 10.2307/1541430; Moreau WM, 2012, SEMICONDUCTOR LITHOG; Nicotra ML, 2005, BIOL BULL-US, V208, P157, DOI 10.2307/3593147; TARDENT P, 1983, MECH AGEING DEV, V21, P257, DOI 10.1016/0047-6374(83)90045-3; Thomas MB, 1991, SCOPIC ANATOMY INVER, P91; Tidball J.G., 1984, BIOL INTEGUMENT, P69; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699; YUND PO, 1987, ECOLOGY, V68, P971, DOI 10.2307/1938368; YUND PO, 1991, EVOLUTION, V45, P1564, DOI 10.1111/j.1558-5646.1991.tb02663.x	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156249	10.1371/journal.pone.0156249	http://dx.doi.org/10.1371/journal.pone.0156249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257948	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700047
J	Herencia, C; Diaz-Tocados, JM; Jurado, L; de Oca, AM; Rodriguez-Ortiz, ME; Martin-Alonso, C; Martinez-Moreno, JM; Vergara, N; Rodriguez, M; Almaden, Y; Munoz-Castaneda, JR				Herencia, Carmen; Miguel Diaz-Tocados, Juan; Jurado, Lidia; Montes de Oca, Addy; Encarnacion Rodriguez-Ortiz, Maria; Martin-Alonso, Carmen; Martinez-Moreno, Julio M.; Vergara, Noemi; Rodriguez, Mariano; Almaden, Yolanda; Munoz-Castaneda, Juan R.			Procaine Inhibits Osteo/Odontogenesis through Wnt/beta-Catenin Inactivation	PLOS ONE			English	Article							DIFFERENTIATION; SCLEROSTIN; PERIODONTITIS	Introduction Periodontitis is a complex pathology characterized by the loss of alveolar bone. The causes and the mechanisms that promote this bone resorption still remain unknown. The knowledge of the critical regulators involved in the alteration of alveolar bone homeostasis is of great importance for developing molecular therapies. Procaine is an anesthetic drug with demethylant properties, mainly used by dentists in oral surgeries. The inhibitor role of Wnt signaling of procaine was described in vitro in colon cancer cells. Methods In this work we evaluated the role of procaine (1 uM) in osteo/odontogenesis of rat bone marrow mesenchymal stem cells. Similarly, the mechanisms whereby procaine achieves these effects were also studied. Results Procaine administration led to a drastic decrease of calcium content, alkaline phosphatase activity, alizarin red staining and an increase in the expression of Matrix Gla Protein. With respect to osteo/odontogenic markers, procaine decreased early and mature osteo/odontogenic markers. In parallel, procaine inhibited canonical Wnt/beta-catenin pathway, observing a loss of nuclear beta-catenin, a decrease in Lrp5 and Frizzled 3, a significant increase of sclerostin and Gsk3 beta and an increase of phosphorylated beta-catenin. The combination of osteo/odontogenic stimuli and Lithium Chloride decreased mRNA expression of Gsk3 beta, recovered by Procaine. Furthermore it was proved that Procaine alone dose dependently increases the expression of Gsk3 beta and beta-catenin phosphorylation. These effects of procaine were also observed on mature osteoblast. Interestingly, at this concentration of procaine no demethylant effects were observed. Conclusions Our results demonstrated that procaine administration drastically reduced the mineralization and osteo/odontogenesis of bone marrow mesenchymal stem cells inhibiting Wnt/beta-catenin pathway through the increase of Gsk3 beta expression and beta-catenin phosphorylation.	[Herencia, Carmen; Miguel Diaz-Tocados, Juan; Jurado, Lidia; Montes de Oca, Addy; Martin-Alonso, Carmen; Martinez-Moreno, Julio M.; Vergara, Noemi; Rodriguez, Mariano; Munoz-Castaneda, Juan R.] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, Maria] REDinREN, Fdn Jimenez Diaz, Nephrol Lab, Madrid, Spain; [Almaden, Yolanda] REDinREN, Lipids & Atherosclerosis Unit, CIBEROBN, Hosp Univ Reina Sofia,IMIBIC, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Munoz-Castaneda, JR (corresponding author), Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain.	juanr.munoz.exts@juntadeandalucia.es	Muñoz-Castañeda, Juan R./AFQ-3443-2022; Herencia, Carmen/AAA-6843-2020; Tocados, Juan Miguel Díaz/I-8254-2018; Martínez, Julio Manuel/AAA-6724-2020	Martínez, Julio Manuel/0000-0002-1945-5078; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Rodriguez, Mariano/0000-0002-9380-6614; Diaz Tocados, Juan Miguel/0000-0001-5192-5212	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia) [P09-CTS-05205]; Consejeria de Salud (Junta de Andalucia) [SAS111221]; Instituto de Salud Carlos III [FIS PI11/02055]; Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia); Consejeria de Salud (Junta de Andalucia)(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain(Junta de Andalucia)	This study was supported by grants from Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia: P09-CTS-05205), Consejeria de Salud (Junta de Andalucia: SAS111221) and Instituto de Salud Carlos III (FIS PI11/02055). JRM-C and YA are supported by Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain.; The authors deny any potential conflict of interest related to this study and they have no financial affiliations. This study was supported by grants from Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia: P09-CTS-05205), Consejeria de Salud ( Junta de Andalucia: SAS111221) and Instituto de Salud Carlos III (FIS PI11/02055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JR. M-C and YA are supported by Nicolas Monardes Program from Consejeria de Salud from Junta de Andalucia, Spain. Authors state no conflicts of interest.	Abbayya K, 2015, N AM J MED SCI, V7, P241, DOI 10.4103/1947-2714.159325; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Galli C, 2011, J PERIODONTAL RES, V46, P397, DOI 10.1111/j.1600-0765.2011.01354.x; Gambardella A, 2011, J BONE MINER RES, V26, P811, DOI 10.1002/jbmr.266; Gao Z, 2009, ONCOL REP, V22, P1479, DOI 10.3892/or_00000590; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Kaipatur NR, 2008, J DENT RES, V87, P839, DOI 10.1177/154405910808700907; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kucher U, 2014, INT J ORAL SCI, V6, P70, DOI 10.1038/ijos.2014.12; Lee SI, 2014, J DENT RES, V93, P678, DOI 10.1177/0022034514535214; Lim WH, 2015, J PERIODONTOL, V86, P319, DOI 10.1902/jop.2014.140286; Lim WH, 2014, AM J ORTHOD DENTOFAC, V146, P337, DOI 10.1016/j.ajodo.2014.05.027; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; de Oca AM, 2010, J BONE MINER RES, V25, P1996, DOI 10.1002/jbmr.93; Napimoga MH, 2014, J CLIN PERIODONTOL, V41, P550, DOI 10.1111/jcpe.12245; Pihlstrom BL, 2014, J AM DENT ASSOC, V145, P1208, DOI 10.14219/jada.2014.112; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Ren YS, 2015, FASEB J, V29, P2702, DOI 10.1096/fj.14-265496; Rogers CL, 2001, J EXP BIOL, V204, P2657; Shan TF, 2015, CELL BIOL INT, V39, P35, DOI 10.1002/cbin.10340; Singh N, 2009, CHEMMEDCHEM, V4, P792, DOI 10.1002/cmdc.200900017; Taut AD, 2013, J BONE MINER RES, V28, P2347, DOI 10.1002/jbmr.1984; Villar-Garea A, 2003, CANCER RES, V63, P4984; Yamaguchi Akira, 2010, Clin Calcium, V20, P1669, DOI CliCa101116691676; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156788	10.1371/journal.pone.0156788	http://dx.doi.org/10.1371/journal.pone.0156788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257912	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700127
J	De Stefano, C; Normand, D; Jabre, P; Azoulay, E; Kentish-Barnes, N; Lapostolle, F; Baubet, T; Reuter, PG; Javaud, N; Borron, SW; Vicaut, E; Adnet, F				De Stefano, Carla; Normand, Domitille; Jabre, Patricia; Azoulay, Elie; Kentish-Barnes, Nancy; Lapostolle, Frederic; Baubet, Thierry; Reuter, Paul-Georges; Javaud, Nicolas; Borron, Stephen W.; Vicaut, Eric; Adnet, Frederic			Family Presence during Resuscitation: A Qualitative Analysis from a National Multicenter Randomized Clinical Trial	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; WITNESSED RESUSCITATION; EMERGENCY-DEPARTMENT; RELATIVES; DEATH; CARE; INTERVENTIONS; GUIDELINES; EXPERIENCE; HEALTH	Background The themes of qualitative assessments that characterize the experience of family members offered the choice of observing cardiopulmonary resuscitation (CPR) of a loved one have not been formally identified. Methods and Findings In the context of a multicenter randomized clinical trial offering family members the choice of observing CPR of a patient with sudden cardiac arrest, a qualitative analysis, with a sequential explanatory design, was conducted. The aim of the study was to understand family members' experience during CPR. All participants were interviewed by phone at home three months after cardiac arrest. Saturation was reached after analysis of 30 interviews of a randomly selected sample of 75 family members included in the trial. Four themes were identified: 1-choosing to be actively involved in the resuscitation; 2-communication between the relative and the emergency care team; 3-perception of the reality of the death, promoting acceptance of the loss; 4-experience and reactions of the relatives who did or did not witness the CPR, describing their feelings. Twelve sub-themes further defining these four themes were identified. Transferability of our findings should take into account the country-specific medical system. Conclusions Family presence can help to ameliorate the pain of the death, through the feeling of having helped to support the patient during the passage from life to death and of having participated in this important moment. Our results showed the central role of communication between the family and the emergency care team in facilitating the acceptance of the reality of death.	[De Stefano, Carla; Jabre, Patricia; Lapostolle, Frederic; Reuter, Paul-Georges; Javaud, Nicolas; Adnet, Frederic] Hop Avicenne, AP HP, Urgences, Samu 93, F-93000 Bobigny, France; [Lapostolle, Frederic; Reuter, Paul-Georges; Javaud, Nicolas; Adnet, Frederic] Univ Paris 13, Paris Cite, EA 3509, F-93000 Bobigny, France; [Jabre, Patricia] Univ Paris 05, Ctr Rech Cardiovasc Paris, Inserm U970, Paris, France; [Jabre, Patricia] Hop Necker Enfants Malad, AP HP, Samu Paris, Paris, France; [Azoulay, Elie; Kentish-Barnes, Nancy] Hop St Louis, AP HP, Reanimat Med, Paris, France; [De Stefano, Carla; Normand, Domitille; Baubet, Thierry] Avicenne Hosp, AP HP, Dept Child & Adolescent Psychiat & Gen Psychiat, Paris, France; [De Stefano, Carla; Baubet, Thierry] Univ Paris 13, Paris Cite, Lab UTRPP EA 4403, Inserm 669, F-93000 Bobigny, France; [Borron, Stephen W.] Texas Tech Univ HSC, Dept Emergency Med, El Paso, TX USA; [Vicaut, Eric] Hop Fernand Widal, AP HP, Unite Rech Clin, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Texas Tech University System; Texas Tech University Health Science Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	De Stefano, C (corresponding author), Hop Avicenne, AP HP, Urgences, Samu 93, F-93000 Bobigny, France.; De Stefano, C (corresponding author), Avicenne Hosp, AP HP, Dept Child & Adolescent Psychiat & Gen Psychiat, Paris, France.; De Stefano, C (corresponding author), Univ Paris 13, Paris Cite, Lab UTRPP EA 4403, Inserm 669, F-93000 Bobigny, France.	carla.destefano85@gmail.com	Reuter, Paul-Georges/C-1347-2016	Reuter, Paul-Georges/0000-0001-9022-5876; Baubet, Thierry/0000-0002-4112-1592; kentish-barnes, nancy/0000-0003-0024-0429	French Ministry of Health; Research Delegation of the Assistance Publique - Hopitaux de Paris	French Ministry of Health; Research Delegation of the Assistance Publique - Hopitaux de Paris	This study was supported by the Programme Hospitalier de Recherche Clinique 2008 of the French Ministry of Health and by the Research Delegation of the Assistance Publique - Hopitaux de Paris. The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Boyd R, 2000, RESUSCITATION, V43, P171, DOI 10.1016/S0300-9572(99)00147-1; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chapple A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2032; Compton S, 2009, ACAD EMERG MED, V16, P226, DOI 10.1111/j.1553-2712.2008.00336.x; David N, 2008, CONSCIOUS COGN, V17, P523, DOI 10.1016/j.concog.2008.03.004; DOYLE CJ, 1987, ANN EMERG MED, V16, P673, DOI 10.1016/S0196-0644(87)80069-0; DUBIN WR, 1986, ANN EMERG MED, V15, P54, DOI 10.1016/S0196-0644(86)80488-7; Fulbrook Paul, 2007, Eur J Cardiovasc Nurs, V6, P255, DOI 10.1016/j.ejcnurse.2007.07.003; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Jabre P, 2014, INTENS CARE MED, V40, P981, DOI 10.1007/s00134-014-3337-1; Jabre P, 2013, NEW ENGL J MED, V368, P1008, DOI 10.1056/NEJMoa1203366; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Lippert FK, 2010, RESUSCITATION, V81, P1445, DOI 10.1016/j.resuscitation.2010.08.013; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Maxton FJC, 2008, J CLIN NURS, V17, P3168, DOI 10.1111/j.1365-2702.2008.02525.x; McClenathan BM, 2002, CHEST, V122, P2204, DOI 10.1378/chest.122.6.2204; Mcmahon-Parkes K, 2009, INT J NURS STUD, V46, P220, DOI 10.1016/j.ijnurstu.2008.08.007; Miller JH, 2009, QUAL HEALTH RES, V19, P1431, DOI 10.1177/1049732309348365; Morrison LJ, 2010, CIRCULATION, V122, pS665, DOI 10.1161/CIRCULATIONAHA.110.970905; Mortelmans LJM, 2010, EUR J EMERG MED, V17, P203, DOI 10.1097/MEJ.0b013e328331477e; O'Connell KJ, 2007, PEDIATRICS, V120, pE565, DOI 10.1542/peds.2006-2914; Osuagwu C C, 1991, J Emerg Nurs, V17, P363; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Rusinova K, 2009, CRIT CARE MED, V37, pS140, DOI [10.1097/CCM.0b013e31819207e7, 10.1097/CCM.0b013e3181b6e145]; Timmermans S, 1998, SOCIOL HEALTH ILL, V20, P144, DOI 10.1111/1467-9566.00095; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tsai E, 2002, NEW ENGL J MED, V346, P1019, DOI 10.1056/NEJM200203283461312; Wray N, 2007, QUAL HEALTH RES, V17, P1392, DOI 10.1177/1049732307308308	30	39	40	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156100	10.1371/journal.pone.0156100	http://dx.doi.org/10.1371/journal.pone.0156100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253993	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700014
J	Hentze, K; Thonfeld, F; Menz, G				Hentze, Konrad; Thonfeld, Frank; Menz, Gunter			Evaluating Crop Area Mapping from MODIS Time-Series as an Assessment Tool for Zimbabwe's "Fast Track Land Reform Programme"	PLOS ONE			English	Article							RANDOM FOREST CLASSIFIER; MONITORING VEGETATION; SOUTHERN AFRICA; COVER; PHENOLOGY; RESETTLEMENT; DEGRADATION; LANDSCAPES; ECOSYSTEM; SUPPORT	Moderate Resolution Imaging Spectroradiometer (MODIS) data forms the basis for numerous land use and land cover (LULC) mapping and analysis frameworks at regional scale. Compared to other satellite sensors, the spatial, temporal and spectral specifications of MODIS are considered as highly suitable for LULC classifications which support many different aspects of social, environmental and developmental research. The LULC mapping of this study was carried out in the context of the development of an evaluation approach for Zimbabwe's land reform program. Within the discourse about the success of this program, a lack of spatially explicit methods to produce objective data, such as on the extent of agricultural area, is apparent. We therefore assessed the suitability of moderate spatial and high temporal resolution imagery and phenological parameters to retrieve regional figures about the extent of cropland area in former freehold tenure in a series of 13 years from 2001-2013. Time-series data was processed with TIMESAT and was stratified according to agro-ecological potential zoning of Zimbabwe. Random Forest (RF) classifications were used to produce annual binary crop/non crop maps which were evaluated with high spatial resolution data from other satellite sensors. We assessed the cropland products in former freehold tenure in terms of classification accuracy, inter-annual comparability and heterogeneity. Although general LULC patterns were depicted in classification results and an overall accuracy of over 80% was achieved, user accuracies for rainfed agriculture were limited to below 65%. We conclude that phenological analysis has to be treated with caution when rainfed agriculture and grassland in semi-humid tropical regions have to be separated based on MODIS spectral data and phenological parameters. Because classification results significantly underestimate redistributed commercial farmland in Zimbabwe, we argue that the method cannot be used to produce spatial information on land-use which could be linked to tenure change. Hence capabilities of moderate resolution data are limited to assess Zimbabwe's land reform. To make use of the unquestionable potential of MODIS time-series analysis, we propose an analysis of plant productivity which allows to link annual growth and production of vegetation to ownership after Zimbabwe's land reform.	[Hentze, Konrad; Thonfeld, Frank; Menz, Gunter] Univ Bonn, Dept Geog, Remote Sensing Res Grp, Bonn, Germany; [Thonfeld, Frank; Menz, Gunter] Univ Bonn, Ctr Remote Sensing Land Surfaces, Bonn, Germany	University of Bonn; University of Bonn	Hentze, K (corresponding author), Univ Bonn, Dept Geog, Remote Sensing Res Grp, Bonn, Germany.	k.hentze@geographie.uni-bonn.de		Thonfeld, Frank/0000-0002-3371-7206				Alcantara C, 2012, REMOTE SENS ENVIRON, V124, P334, DOI 10.1016/j.rse.2012.05.019; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Battrick B, 2005, GLOBAL EARTH OBSERVA; Brown Molly E., 2008, FAMINE EARLY WARNING; Chaumba J, 2003, J MOD AFR STUD, V41, P533, DOI 10.1017/S0022278X03004397; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cliffe L, 2011, J PEASANT STUD, V38, P907, DOI 10.1080/03066150.2011.643387; Cousins B, 2010, J PEASANT STUD, V37, P31, DOI 10.1080/03066150903498739; Deininger K, 2004, WORLD DEV, V32, P1697, DOI 10.1016/j.worlddev.2004.06.006; Dubovyk O, 2013, ERDKUNDE, V67, P167, DOI 10.3112/erdkunde.2013.02.05; Eklundh L., 2012, TIMESAT 3 1 SOFTWARE; European Commision Joint Research Centre, 2016, GLOB LAND COV 2000 P; FAO, 2006, FERT US CROP ZIMB; FORMAN RTT, 1995, LANDSCAPE ECOL, V10, P133, DOI 10.1007/BF00133027; Fraser A, 2008, GEOGR REV, V98, P309, DOI 10.1111/j.1931-0846.2008.tb00303.x; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Garcia-Mora TJ, 2012, INT J DIGIT EARTH, V5, P63, DOI 10.1080/17538947.2011.565080; Gstraunthaler T, 2011, Q J AUSTRIAN EC, V14, P311; Hanlon Joseph, 2013, ZIMBABWE TAKES BACK; Hentze K, 2015, LAND-BASEL, V4, P355, DOI 10.3390/land4020355; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; IUSS W.G.W, 2006, WORLD REF BAS SOIL R; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kuri F, 2014, INT J APPL EARTH OBS, V33, P39, DOI 10.1016/j.jag.2014.04.021; Lhermitte S, 2011, REMOTE SENS ENVIRON, V115, P3129, DOI 10.1016/j.rse.2011.06.020; Lobell DB, 2004, REMOTE SENS ENVIRON, V93, P412, DOI 10.1016/j.rse.2004.08.002; Lotsch A., 2003, International Journal of Remote Sensing, V24, P1997, DOI 10.1080/01431160210154858; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Lunetta RS, 2010, INT J APPL EARTH OBS, V12, P81, DOI 10.1016/j.jag.2009.11.005; Maguranyanga C, 2015, J INDIAN SOC REMOTE, V43, P79, DOI 10.1007/s12524-014-0395-3; Matavire MS, 2015, T R SOC S AFR, V70, P1, DOI [10.1080/0035919X.2015.1017865, DOI 10.1080/0035919X.2015.1017865]; Matsa M., 2011, ETHIOP J ENV STUD MA, V4, P88, DOI [10.4314/ejesm.v4i2.10, DOI 10.4314/EJESM.V4I2.10]; Mlambo Alois S., 2014, HIST ZIMBABWE; Moody A, 1995, LANDSCAPE ECOL, V10, P363, DOI 10.1007/BF00130213; Nuding MA, 1999, NATURRESSOURCEN NUTZ; Olivieri F, 2008, AM J PHYS ANTHROPOL, V136, P214, DOI 10.1002/ajpa.20797; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Pal M, 2005, INT J REMOTE SENS, V26, P1007, DOI 10.1080/01431160512331314083; PALMER R, 1990, AFR AFFAIRS, V89, P163, DOI 10.1093/oxfordjournals.afraf.a098283; Pan ZK, 2015, INT J APPL EARTH OBS, V34, P188, DOI 10.1016/j.jag.2014.08.011; Petit C, 2001, INT J REMOTE SENS, V22, P3435, DOI 10.1080/01431160010006881; Pittman K, 2010, REMOTE SENS-BASEL, V2, P1844, DOI 10.3390/rs2071844; Potts D., 2012, HDB LAND WATER GRABS, P24; Prince SD, 2009, REMOTE SENS ENVIRON, V113, P1046, DOI 10.1016/j.rse.2009.01.016; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Saura S, 2004, LANDSCAPE ECOL, V19, P197, DOI 10.1023/B:LAND.0000021724.60785.65; Scoones I., 2014, DEBATING ZIMBABWES L; Senf C, 2012, INT GEOSCI REMOTE SE, P6733, DOI 10.1109/IGARSS.2012.6352560; Sibanda M, 2012, INT J REMOTE SENS, V33, P4841, DOI 10.1080/01431161.2011.635715; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TUCKER CJ, 1980, PHOTOGRAMM ENG REM S, V46, P657; van der Linden S, 2015, REMOTE SENS-BASEL, V7, P11249, DOI 10.3390/rs70911249; van Straaten H. P., 2002, ROCKS CROPS AGROMINE; Vina A, 2004, AGRON J, V96, P1139, DOI 10.2134/agronj2004.1139; Vincent V, AGR SURVEY SO RHOD 1; Vintrou E, 2012, INT J APPL EARTH OBS, V14, P83, DOI 10.1016/j.jag.2011.06.010; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wessels KJ, 2004, REMOTE SENS ENVIRON, V92, P67, DOI 10.1016/j.rse.2004.05.002; Wessels KJ, 2004, REMOTE SENS ENVIRON, V91, P47, DOI 10.1016/j.rse.2004.02.005; Wessels KJ, 2009, INFLUENCE COMPOSITE; *Wild H., 1967, VEGETATION MAP FLORA; Woodcock CE, 1994, PHOTOGRAMM ENG REMOT, P60; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zimbabwe National Statistics Agency, 2014, FACTS FIG 2014	68	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156630	10.1371/journal.pone.0156630	http://dx.doi.org/10.1371/journal.pone.0156630			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253327	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700046
J	Kawamura, T; Sato, I; Kawakami, K				Kawamura, Taichi; Sato, Izumi; Kawakami, Koji			Factors Influencing the Placebo Effect in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: An Analysis of Two Randomized Clinical Trials	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; DIURNAL-VARIATION; FLUCTUATIONS; PROGRESSION; EFFICACY; DISEASE; STRESS	Objective To explore factors related to the placebo effect in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OH). Methods This was a retrospective cohort study of patients with POAG and patients with OH who were treated with placebo. The patients' data were extracted from two randomized, double-masked, parallel, multicenter clinical trials (trial 1 and trial 2) in Japan. We explored the baseline factors that were associated with the intraocular pressure (IOP)-lowering effect of placebo ophthalmic solution after 4 weeks of instillation treatment at two time points by using multivariable models. The time points were Hour 0 (between 08: 30 and 10: 30 before instillation) and Hour 2 (within 1.5 to 2.5 h after instillation and by 12: 30) at the baseline date and after 4 weeks. The changes in IOP from baseline to 4 weeks at the two time points were evaluated for the IOP-lowering effect induced by placebo instillation. Results Of the 330 patients included in the two trials, 89 patients were eligible for the analysis. The results of the multivariable analysis for Hour 0 indicated a high IOP at the baseline date (coefficient: 0.24, 95% confidence interval (CI): 0.02 to 0.46, P = 0.03), and the magnitude of the IOP fluctuation at the baseline date (coefficient: 0.57, 95% CI: 0.24 to 0.90, P = 0.001) was associated with the IOP-lowering effect after 4 weeks. With respect to Hour 2, the trial type was associated with the IOP-lowering effect (coefficient: -1.15, 95% CI: -2.14 to -0.16, P = 0.02). Conclusions A large fluctuation in IOP during the day is associated with the IOP-lowering effect induced by placebo in patients with POAG or OH. This finding would be helpful to researchers when designing studies related to glaucoma in the early stages of clinical development of drugs.	[Kawamura, Taichi; Sato, Izumi; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Kawamura, Taichi] Senju Pharmaceut Co Ltd, Osaka, Japan; [Sato, Izumi] Keihanshin Consortium Fostering Next Generat Glob, Kyoto, Japan	Kyoto University; Senju Pharmaceutical Co. Ltd.	Kawakami, K (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan.	kawakami.koji.4e@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022	Kawakami, Koji/0000-0002-7477-4071	Senju Pharmaceutical Co., Ltd.; Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX); Human Resource Development Program for Science and Technology, MEXT	Senju Pharmaceutical Co., Ltd.; Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX); Human Resource Development Program for Science and Technology, MEXT	This work was supported by Senju Pharmaceutical Co., Ltd. Senju Pharmaceutical Co., Ltd. provided research data and support in the form of salaries for Taichi Kawamura, but did not play any additional role in the study design, analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We are grateful to Senju Pharmaceutical Company Limited for allowing us to access their placebo data. This research is also supported by the Keihanshin Consortium for Fostering the Next Generation of Global Leaders in Research (K-CONNEX), established by Human Resource Development Program for Science and Technology, MEXT.	American Academy of Ophthalmology Glaucoma Panel, 2010, PREF PRACT PATT GUID; Araie M, 2012, J EYE, V29, P1303; Asrani S, 2000, J GLAUCOMA, V9, P134; BLUMENTHAL M, 1970, AM J OPHTHALMOL, V69, P608, DOI 10.1016/0002-9394(70)91628-4; Bosch PC, 2014, UROLOGY, V84, P321, DOI 10.1016/j.urology.2014.04.011; Brody S, 1999, BIOL PSYCHOL, V51, P43, DOI 10.1016/S0301-0511(99)00012-5; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; Espay AJ, 2015, NEUROLOGY, V84, P794, DOI 10.1212/WNL.0000000000001282; Foulks Gary N, 2003, Ocul Surf, V1, P20; Hasegawa K, 2006, JPN J OPHTHALMOL, V50, P449, DOI 10.1007/s10384-006-0343-z; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HORIE T, 1979, JPN J OPHTHALMOL, V23, P310; Kaluza G, 1996, J BEHAV MED, V19, P587, DOI 10.1007/BF01904906; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; King A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3518; KITAZAWA Y, 1975, AM J OPHTHALMOL, V79, P557, DOI 10.1016/0002-9394(75)90792-8; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Realini T, 2011, OPHTHALMOLOGY, V118, P47, DOI 10.1016/j.ophtha.2010.04.027; Rutherford BR, 2014, JAMA PSYCHIAT, V71, P1409, DOI 10.1001/jamapsychiatry.2014.1319; Sacca SC, 1998, OPHTHALMOLOGICA, V212, P115, DOI 10.1159/000027290; Sall K, 2000, OPHTHALMOLOGY, V107, P631, DOI 10.1016/S0161-6420(99)00176-1; Sharpe RA, 2015, OPHTHALMIC RES, V54, P3, DOI 10.1159/000381782; Sharpe RA, 2015, CURR EYE RES, V40, P653, DOI 10.3109/02713683.2014.946519; Sharpe RA, 2013, BRIT J OPHTHALMOL, V97, P121, DOI 10.1136/bjophthalmol-2012-302046; SHIOSE Y, 1991, JPN J OPHTHALMOL, V35, P133; Stewart WC, 2001, AM J OPHTHALMOL, V131, P798, DOI 10.1016/S0002-9394(00)00930-2; Strahlman E, 1996, AM J OPHTHALMOL, V122, P183, DOI 10.1016/S0002-9394(14)72009-4; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; Yoshida M, 2014, ACTA MED OKAYAMA, V68, P27; Zeimer RC, 1996, GLAUCOMAS, P429	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156706	10.1371/journal.pone.0156706	http://dx.doi.org/10.1371/journal.pone.0156706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254076	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700052
J	Sabir, H; Osredkar, D; Maes, E; Wood, T; Thoresen, M				Sabir, Hemmen; Osredkar, Damjan; Maes, Elke; Wood, Thomas; Thoresen, Marianne			Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats	PLOS ONE			English	Article							BRAIN-INJURY; HYPOXIA/ISCHEMIA; INHIBITION; ANESTHESIA; ASPHYXIA; RECEPTOR; MODELS; DAMAGE; DEATH	Background Therapeutic hypothermia (TH) is standard treatment following perinatal asphyxia in newborn infants. Experimentally, TH is neuroprotective after moderate hypoxia-ischemia (HI) in seven-day-old (P7) rats. However, TH is not neuroprotective after severe HI. After a moderate HI insult in newborn brain injury models, the anesthetic gas xenon (Xe) doubles TH neuroprotection. The aim of this study was to examine whether combining Xe and TH is neuroprotective as applied in a P7 rat model of severe HI. Design/Methods 120 P7 rat pups underwent a severe HI insult; unilateral carotid artery ligation followed by hypoxia (8% O-2 for 150min at experimental normothermia (NT-37: T-rectal 37 degrees C). Surviving pups were randomised to immediate NT-37 for 5h (n = 36), immediate TH-32: T-rectal 32 degrees C for 5h (n = 25) or immediate TH-32 plus 50% inhaled Xe for 5h (n = 24). Pups were sacrificed after one week of survival. Relative area loss of the ligated hemisphere was measured, and neurons in the subventricular zone of this injured hemisphere were counted, to quantify brain damage. Results Following the HI insult, median (interquartile range, IQR) hemispheric brain area loss was similar in all groups: 63.5% (55.5-75.0) for NT-37 group, 65.0%(57.0-65.0) for TH-32 group, and 66.5% (59.0-72.0) for TH-32+Xe50% group (not significant). Correspondingly, there was no difference in neuronal cell count (NeuN marker) in the subventricular zone across the three treatment groups. Conclusions Immediate therapeutic hypothermia with or without additional 50% inhaled Xe, does not provide neuroprotection one week after severe HI brain injury in the P7 neonatal rat. This model aims to mimic the clinical situation in severely asphyxiated neonates and treatment these newborns remains an ongoing challenge.	[Sabir, Hemmen; Osredkar, Damjan; Maes, Elke; Wood, Thomas; Thoresen, Marianne] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Sabir, Hemmen] Univ Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany; [Thoresen, Marianne] Univ Bristol, St Michaels Hosp, Sch Clin Sci, Bristol, Avon, England	University of Oslo; Heinrich Heine University Dusseldorf; University of Bristol	Thoresen, M (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway.; Thoresen, M (corresponding author), Univ Bristol, St Michaels Hosp, Sch Clin Sci, Bristol, Avon, England.	marianne.thoresen@medisin.uio.no	Osredkar, Damjan/M-3739-2019; Wood, Tommy/AAC-8252-2019; Osredkar, Damjan/B-6293-2011; Wood, Thomas/GWZ-2481-2022	Osredkar, Damjan/0000-0002-2188-420X; Wood, Tommy/0000-0002-1130-2720; Osredkar, Damjan/0000-0002-2188-420X; Wood, Thomas/0000-0001-8962-8571	Sport Aiding Medical Research for Kids (SPARKS, UK); Norwegian Research Council (NFR); Laerdal Foundation for Acute Medicine; Deutscher Akademischer Austauschdienst (DAAD); Sparks Charity [05BTL01, 14BTL01] Funding Source: researchfish	Sport Aiding Medical Research for Kids (SPARKS, UK); Norwegian Research Council (NFR)(Research Council of Norway); Laerdal Foundation for Acute Medicine; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Sparks Charity	This study was funded by Sport Aiding Medical Research for Kids (SPARKS, UK), Norwegian Research Council (NFR), The Laerdal Foundation for Acute Medicine, and Deutscher Akademischer Austauschdienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Chakkarapani E, 2013, J CEREBR BLOOD F MET, V33, P1752, DOI 10.1038/jcbfm.2013.123; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gunn AJ, 1999, PEDIATR RES, V46, P274, DOI 10.1203/00006450-199909000-00005; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Liu X, 2015, PEDIATR RES, V77, P779, DOI 10.1038/pr.2015.49; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; Neukirchen M, 2012, BRIT J ANAESTH, V109, P887, DOI 10.1093/bja/aes303; Osredkar D, 2014, RESUSCITATION, V85, P567, DOI 10.1016/j.resuscitation.2013.12.006; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Romanko MJ, 2007, J NEUROCHEM, V103, P1121, DOI 10.1111/j.1471-4159.2007.04820.x; Sabir H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109845; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Tooley JR, 2003, ANN NEUROL, V53, P65, DOI 10.1002/ana.10402; Wood T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23430	30	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156759	10.1371/journal.pone.0156759	http://dx.doi.org/10.1371/journal.pone.0156759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253085	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700055
J	Rosli, R; Ming, LC; Aziz, NA; Manan, MM				Rosli, Rosliana; Ming, Long Chiau; Aziz, Noorizan Abd; Manan, Mohamed Mansor			A Retrospective Analysis of Spontaneous Adverse Drug Reactions Reports Relating to Paediatric Patients	PLOS ONE			English	Article							MEDICINES AGENCY; CLINICAL-TRIALS; CHILDREN; PHARMACOVIGILANCE; SURVEILLANCE; PERSPECTIVE; MULTICENTER; VIGIBASE; DATABASE; COHORT	Background Spontaneous reporting on adverse drug reactions (ADR) has been established in Malaysia since 1987, and although these reports are monitored by the Malaysia drug monitoring authority, the National Pharmaceutical Control Bureau, information about ADRs in the paediatric patient population still remains unexplored. The aims of this study, therefore, were to characterize the ADRs reported in respect to the Malaysian paediatric population and to relate the data to specific paediatric age groups. Methods Data on all ADRs reported to the National Pharmaceutical Control Bureau between 2000 and 2013 for individuals aged from birth to 17 years old were analysed with respect to age and gender, type of reporter, suspected medicines (using the Anatomical Therapeutic Chemical classification), category of ADR (according to system organ class) as well as the severity of the ADR. Results In total, 11,523 ADR reports corresponding to 22,237 ADRs were analysed, with half of these reporting one ADR per report. Vaccines comprised 55.7% of the 11,523 ADR reports with the remaining being drug related ADRs. Overall, 63.9% of ADRs were reported for paediatric patients between 12 and 17 years of age, with the majority of ADRs reported in females (70.7%). The most common ADRs reported were from the following system organ classes: application site disorders (32.2%), skin and appendages disorders (20.6%), body as a whole general disorders (12.8%) and central and peripheral nervous system disorders (11.2%). Meanwhile, ADRs in respect to anti-infectives for systemic use (2194/5106; 43.0%) were the most frequently reported across all age groups, followed by drugs from the nervous system (1095/ 5106; 21.4%). Only 0.28% of the ADR cases were reported as fatal. A large proportion of the reports were received from healthcare providers in government health facilities. Discussion ADR reports concerning vaccines and anti-infectives were the most commonly reported in children, and are mainly seen in adolescents, with most of the ADRs manifesting in skin reactions. The majority of the ADR reports were received from nurses in the public sector, reporting ADRs associated with vaccine administration. The low fatality rate of ADR cases reported could potentially be caused by reporting bias due to the very low reporting percentage from the private healthcare institutions. This study indicates that ADR rates among Malaysian children are higher than in developed countries. Constant ADR reporting and monitoring, especially in respect to paediatric patients, should be undertaken to ensure their safety.	[Rosli, Rosliana; Ming, Long Chiau; Aziz, Noorizan Abd; Manan, Mohamed Mansor] Univ Teknol MARA, Fac Pharm, Dept Pharm Practice, Puncak Alam, Selangor, Malaysia; [Ming, Long Chiau] Univ Tasmania, Sch Med, Pharm, UMORE, Hobart, Tas, Australia; [Manan, Mohamed Mansor] KPJ Healthcare Univ Coll, Sch Pharm, Nilai, Negeri Sembilan, Malaysia	Universiti Teknologi MARA; University of Tasmania	Ming, LC; Manan, MM (corresponding author), Univ Teknol MARA, Fac Pharm, Dept Pharm Practice, Puncak Alam, Selangor, Malaysia.; Ming, LC (corresponding author), Univ Tasmania, Sch Med, Pharm, UMORE, Hobart, Tas, Australia.; Manan, MM (corresponding author), KPJ Healthcare Univ Coll, Sch Pharm, Nilai, Negeri Sembilan, Malaysia.	longchiauming@gmail.com; mmmanan2002@yahoo.com	MANSOR, MANAN MOHAMED/AAU-6040-2020; Ming, L C/J-5210-2015	Ming, L C/0000-0002-6971-1383	Academic and Research Assimilation grants [600-RMI/DANA, 5/3/ARAS (46/2015)]; Ministry of Higher Education, Malaysia; Universiti Teknologi MARA (UiTM), Malaysia	Academic and Research Assimilation grants; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); Universiti Teknologi MARA (UiTM), Malaysia	This work was supported by Academic and Research Assimilation grants: 600-RMI/DANA 5/3/ARAS (46/2015). The authors would like to express their gratitude to Ministry of Higher Education and Universiti Teknologi MARA (UiTM), Malaysia for financial support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2008, BRIT J CLIN PHARMACO, V65, P364, DOI 10.1111/j.1365-2125.2007.03019.x; Aagaard L, 2012, DRUG SAFETY, V35, P1171, DOI 10.2165/11631940-000000000-00000; Aagaard L, 2010, DRUG SAFETY, V33, P327, DOI 10.2165/11319100-000000000-00000; Aldea A, 2012, EUR J CLIN PHARMACOL, V68, P1329, DOI 10.1007/s00228-012-1255-0; [Anonymous], 2015, GUID ATC CLASS DDD A; Arencibia ZB, 2012, EUR J CLIN PHARMACOL, V68, P1079, DOI 10.1007/s00228-012-1222-9; Aripin KNBN, 2012, EUR J CLIN PHARMACOL, V68, P189, DOI 10.1007/s00228-011-1112-6; Aziz Z, 2007, PHARMACOEPIDEM DR S, V16, P223, DOI 10.1002/pds.1313; Belton KJ, 1997, EUR J CLIN PHARMACOL, V52, P423, DOI 10.1007/s002280050314; Blake KV, 2014, PEDIATR DRUGS, V16, P309, DOI 10.1007/s40272-014-0076-2; Clarkson A, 2002, ARCH DIS CHILD, V87, P462, DOI 10.1136/adc.87.6.462; Du W, 2013, J CLIN PHARMACOL, V53, P87, DOI 10.1177/0091270011433327; Eliasson E, 2006, BRIT MED J, V332, P1163, DOI 10.1136/bmj.332.7551.1163; Goldman SA, 1998, CLIN THER, V20, pC40, DOI 10.1016/S0149-2918(98)80007-6; Hadi MA, 2011, S MED REV, V4, P55, DOI DOI 10.5655/SMR.V4I2.1009; Hadi MA, 2013, J PHARM HEALTH SERV, V4, P155, DOI 10.1111/jphs.12022; HARTWIG SC, 1992, AM J HOSP PHARM, V49, P2229, DOI 10.1093/ajhp/49.9.2229; Hawcutt DB, 2012, BRIT J CLIN PHARMACO, V73, P437, DOI 10.1111/j.1365-2125.2011.04113.x; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; International Conference on Harmonisation, 2000, CLINICAL INVESTIGATI; JAAFAR S, 2013, HLTH SYSTEM TRANSITI, V3, P1; Jaafar S, 2013, HLTH SYST TRANSITION, V3, P15; Lindquist M, 2008, DRUG INF J, V42, P409, DOI 10.1177/009286150804200501; Malaysia MoH, 2010, ANN REP NONC DIS NCD, P1; Ministry of Health Malaysia: Pharmaceutical Service Division, 2010, MAL STAT MED 2009 20; National Pharmaceutical Control Bureau, 2011, ANN REPORT; National Pharmaceutical Control Bureau, 2012, ANN REPORT; Pharmacutical Services Division Ministry of Health Malaysia, 2002, MAL GUID REP MON ADR; Rashed AN, 2012, DRUG SAFETY, V35, P481, DOI 10.2165/11597920-000000000-00000; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Roughead EE, 2013, WHO S E ASIA J PUBLI, V2; Salmasi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136545; Sammons HM, 2011, ARCH DIS CHILD, V96, P291, DOI 10.1136/adc.2010.203737; Sammons HM, 2005, EUR J CLIN PHARMACOL, V61, P165, DOI 10.1007/s00228-005-0894-9; Smyth RL, 1999, LANCET, V354, pS21; Star K, 2011, DRUG SAFETY, V34, P415, DOI 10.2165/11587540-000000000-00000; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Thiessard F, 2005, DRUG SAFETY, V28, P731, DOI 10.2165/00002018-200528080-00007; U.S.D. of Defence, 2014, 810GWCHANGE1 MIL STD; Wallerstedt SM, 2011, DRUG SAFETY, V34, P669, DOI 10.2165/11591730-000000000-00000; WHO, 2015, REP TRENDS; WHO, 1972, INT DRUG MON ROL NAT, P1; WHO International Working Group for Drug Statistics Methodology, 2011, WHO COLL CTR DRUG ST; World Health Organization, 2002, IMP PHARM SAF MON ME, P7	45	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155385	10.1371/journal.pone.0155385	http://dx.doi.org/10.1371/journal.pone.0155385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249414	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700011
J	Wu, XG; Shi, Y; Yan, DW; Li, XS; Yan, PX; Gao, XY; Zhang, YE; Yu, L; Ren, CC; Li, GX; Yan, LP; Teng, QY; Li, ZJ				Wu, Xiaogang; Shi, Ying; Yan, Dawei; Li, Xuesong; Yan, Pixi; Gao, Xuyuan; Zhang, Yuee; Yu, Lei; Ren, Chaochao; Li, Guoxin; Yan, Liping; Teng, Qiaoyang; Li, Zejun			Development of a PCR-Based Reverse Genetics System for an Attenuated Duck Tembusu Virus Strain	PLOS ONE			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; INFECTIOUS CDNA-CLONE; FULL-LENGTH CDNA; WEST NILE VIRUS; POLYMERASE-CHAIN-REACTION; COMPLETE GENOME SEQUENCE; EGG-DROP SYNDROME; CAPSID PROTEIN; FEVER VIRUS; IN-VITRO	The infectious disease caused by the duck Tembusu virus (DTMUV) has resulted in massive economic losses to the Chinese duck industry in China since 2010. Research on the molecular basis of DTMUV pathogenicity has been hampered by the lack of a reliable reverse genetics system for this virus. Here we developed a PCR-based reverse genetics system with high fidelity for the attenuated DTMUV strain FX2010-180P. The rescued virus was characterized by using both indirect immunofluorescence assays (IFA) and whole genome sequencing. The rescued virus (rFX2010-180P) grew to similar titers as compared with the wild-type virus in DF-1 cells, and had similar replication and immunogenicity properties in ducks. To determine whether exogenous proteins could be expressed from DTMUV, both an internal ribosomal entry site (IRES) and the enhanced green fluorescent protein (eGFP) gene were introduced between the NS5 gene and the 3' non-coding sequence of FX2010-180P. A recombinant DTMUV expressing eGFP was rescued, but eGFP expression was unstable after 4 passages in DF-1 cells due to a deletion of 1,294 nucleotides. The establishment of a reliable reverse genetics system for FX2010-180P provides a foundation for future studies of DTMUV.	[Li, Zejun] Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China; Chinese Acad Agr Sci, Innovat Team Pathogen Ecol Res Anim Influenza Vir, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Li, ZJ (corresponding author), Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China.	lizejun@shvri.ac.cn	Wu, Xiaogang/N-8920-2018	Wu, Xiaogang/0000-0002-7552-5616	National Natural Science Foundation of China [31172332, 31472205, 31402150]; Shanghai Science and Technology Program for Agriculture [2012-2-6]; "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission [12JC1410600]; "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission [13391901601]; Special Fund for Central Nonprofit Research Institutes Fundamental Research [2011JB02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program for Agriculture; "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission; "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission; Special Fund for Central Nonprofit Research Institutes Fundamental Research	This study was supported by the National Natural Science Foundation of China (no. 31172332, 31472205 and 31402150), the Shanghai Science and Technology Program for Agriculture (no. 2012-2-6), the "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission (no. 12JC1410600), the "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission (no. 13391901601), and the Special Fund for Central Nonprofit Research Institutes Fundamental Research (no. 2011JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Cameron-Wilson CL, 2002, J MOL MICROB BIOTECH, V4, P127; Campbell MS, 2000, VIROLOGY, V269, P225, DOI 10.1006/viro.2000.0220; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1128/GEN0MEA.00789-13; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; Huang XM, 2013, RES VET SCI, V94, P774, DOI 10.1016/j.rvsc.2012.11.014; Jiang XH, 2011, VACCINE, V29, P1248, DOI 10.1016/j.vaccine.2010.11.079; Kawaguchi Yasushi, 2004, Uirusu, V54, P255, DOI 10.2222/jsv.54.255; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028; Li LL, 2012, VIRUS GENES, V45, P105, DOI 10.1007/s11262-012-0753-6; Li S, 2013, VIRUS RES, V171, P238, DOI 10.1016/j.virusres.2012.10.019; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026; Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12; Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0; Maeda A, 2009, VIRUS RES, V144, P35, DOI 10.1016/j.virusres.2009.03.021; McElroy KL, 2005, J GEN VIROL, V86, P1747, DOI 10.1099/vir.0.80746-0; Miyanishi M, 2002, ARCH VIROL, V147, P1141, DOI 10.1007/s00705-002-0798-2; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Qiu J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018106, DOI 10.1371/JOURNAL.PONE.0018106]; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; Tang Y, 2015, TRANSBOUND EMERG DIS, V62, P209, DOI 10.1111/tbed.12111; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P336, DOI 10.1111/j.1865-1682.2011.01275.x; Wan CH, 2012, J VIROL, V86, P10912, DOI 10.1128/JVI.01582-12; YAMSHCHIKOV VF, 1994, GENE, V149, P193, DOI 10.1016/0378-1119(94)90150-3; YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994; Yan LP, 2012, J VIROL METHODS, V182, P50, DOI 10.1016/j.jviromet.2012.03.007; Yan LP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-464; Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003; Yoshii K, 2011, VIRUS RES, V155, P61, DOI 10.1016/j.virusres.2010.08.023; Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003; Yun T, 2012, VET MICROBIOL, V157, P311, DOI 10.1016/j.vetmic.2012.01.013; Yun T, 2012, J VIROL, V86, P3406, DOI 10.1128/JVI.07132-11; Zhang FQ, 2001, J VIROL METHODS, V96, P171, DOI 10.1016/S0166-0934(01)00331-7; Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0; Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156579	10.1371/journal.pone.0156579	http://dx.doi.org/10.1371/journal.pone.0156579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248497	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700055
J	Ivanova, NV; Kuzmina, ML; Braukmann, TWA; Borisenko, AV; Zakharov, EV				Ivanova, Natalia V.; Kuzmina, Maria L.; Braukmann, Thomas W. A.; Borisenko, Alex V.; Zakharov, Evgeny V.			Authentication of Herbal Supplements Using Next-Generation Sequencing	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; DNA-BASED AUTHENTICATION; ENDOPHYTIC FUNGI; BIOACTIVE COMPOUNDS; GINKGO-BILOBA; MARKET SUBSTITUTION; DIETARY-SUPPLEMENTS; GENOMIC DNA; ITS2 REGION; SEED SET	Background DNA-based testing has been gaining acceptance as a tool for authentication of a wide range of food products; however, its applicability for testing of herbal supplements remains contentious. Methods We utilized Sanger and Next-Generation Sequencing (NGS) for taxonomic authentication of fifteen herbal supplements representing three different producers from five medicinal plants: Echinacea purpurea, Valeriana officinalis, Ginkgo biloba, Hypericum perforatum and Trigonella foenum-graecum. Experimental design included three modifications of DNA extraction, two lysate dilutions, Internal Amplification Control, and multiple negative controls to exclude background contamination. Ginkgo supplements were also analyzed using HPLC-MS for the presence of active medicinal components. Results All supplements yielded DNA from multiple species, rendering Sanger sequencing results for rbcL and ITS2 regions either uninterpretable or non-reproducible between the experimental replicates. Overall, DNA from the manufacturer-listed medicinal plants was successfully detected in seven out of eight dry herb form supplements; however, low or poor DNA recovery due to degradation was observed in most plant extracts (none detected by Sanger; three out of seven-by NGS). NGS also revealed a diverse community of fungi, known to be associated with live plant material and/or the fermentation process used in the production of plant extracts. HPLC-MS testing demonstrated that Ginkgo supplements with degraded DNA contained ten key medicinal components. Conclusion Quality control of herbal supplements should utilize a synergetic approach targeting both DNA and bioactive components, especially for standardized extracts with degraded DNA. The NGS workflow developed in this study enables reliable detection of plant and fungal DNA and can be utilized by manufacturers for quality assurance of raw plant materials, contamination control during the production process, and the final product. Interpretation of results should involve an interdisciplinary approach taking into account the processes involved in production of herbal supplements, as well as biocomplexity of plant-plant and plant- fungal biological interactions.	[Ivanova, Natalia V.; Kuzmina, Maria L.; Braukmann, Thomas W. A.; Borisenko, Alex V.; Zakharov, Evgeny V.] Univ Guelph, Ctr Biodivers Gen, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of Guelph	Ivanova, NV (corresponding author), Univ Guelph, Ctr Biodivers Gen, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	nivanova@uoguelph.ca	Borisenko, Alex/GQZ-9054-2022; Braukmann, Thomas/N-7333-2019	Braukmann, Thomas/0000-0002-2452-3776; Kuzmina, Maria/0000-0003-2725-9146	International Barcode of Life project - Ontario Ministry of Research and Innovation; Genome Canada through the Ontario Genomics Institute	International Barcode of Life project - Ontario Ministry of Research and Innovation; Genome Canada through the Ontario Genomics Institute(Genome Canada)	This work was supported by the International Barcode of Life project funded by the Ontario Ministry of Research and Innovation and by Genome Canada through the Ontario Genomics Institute.	Aly AH, 2013, PHARMAZIE, V68, P499, DOI 10.1691/ph.2013.6517; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; ARROYO J, 1992, ISRAEL J BOT, V41, P225; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bansal Ankit, 2014, J Pharm Anal, V4, P223, DOI 10.1016/j.jpha.2013.12.001; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Bottero MT, 2011, VET J, V190, P34, DOI 10.1016/j.tvjl.2010.09.024; Brown BJ, 2001, OECOLOGIA, V129, P43, DOI 10.1007/s004420100700; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coghlan ML, 2012, PLOS GENET, V8, P436, DOI 10.1371/journal.pgen.1002657; Cohen NJ, 2009, J FOOD PROTECT, V72, P810, DOI 10.4315/0362-028X-72.4.810; Cui YN, 2012, FITOTERAPIA, V83, P913, DOI 10.1016/j.fitote.2012.04.009; de Boer HJ, 2015, DRUG SAFETY, V38, P611, DOI 10.1007/s40264-015-0306-8; DEBOER E, 1985, A VAN LEEUW J MICROB, V51, P435, DOI 10.1007/BF02275058; Deshmukh SK, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00715; Ding SJ, 2006, RAPID COMMUN MASS SP, V20, P2753, DOI 10.1002/rcm.2646; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; El-Nagerabi SAF, 2002, PHYTOPARASITICA, V30, P61, DOI 10.1007/BF02983971; Elshafie AE, 2002, MYCOPATHOLOGIA, V155, P155, DOI 10.1023/A:1020427527963; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; FEINSINGER P, 1986, ECOLOGY, V67, P449, DOI 10.2307/1938589; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlay RD, 2008, J EXP BOT, V59, P1115, DOI 10.1093/jxb/ern059; Focke F, 2011, J AGR FOOD CHEM, V59, P513, DOI 10.1021/jf103702s; GANDERS FR, 1979, NEW ZEAL J BOT, V17, P607, DOI 10.1080/0028825X.1979.10432574; Government of Canada HCHP and FBNHPD, 2013, QUAL NAT HLTH PROD G; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Handy SM, 2011, J AOAC INT, V94, P201; Hanner R, 2011, MITOCHONDR DNA, V22, P27, DOI 10.3109/19401736.2011.596833; Haouala R, 2008, J ENVIRON SCI, V20, P1453, DOI 10.1016/S1001-0742(08)62548-6; Hashem Mohamed, 2010, Saudi Journal of Biological Sciences, V17, P167, DOI 10.1016/j.sjbs.2010.02.011; Hawes MC, 2011, PLANT SCI, V180, P741, DOI 10.1016/j.plantsci.2011.02.007; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hidalgo O., 2010, Journal of Botany, V2010, P797246, DOI 10.1155/2010/797246; Hidalgo O, 2012, CARYOLOGIA, V65, P243, DOI 10.1080/00087114.2012.740193; Holker U, 2005, CURR OPIN MICROBIOL, V8, P301, DOI 10.1016/j.mib.2005.04.006; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Holmes BH, 2009, FISH RES, V95, P280, DOI 10.1016/j.fishres.2008.09.036; Hoorfar J, 2004, J CLIN MICROBIOL, V42, P1863, DOI 10.1128/JCM.42.5.1863-1868.2004; Hoorfar J, 2003, J CLIN MICROBIOL, V41, P5835, DOI 10.1128/JCM.41.12.5835.2003; Howitz KT, 2008, CELL, V133, P387, DOI 10.1016/j.cell.2008.04.019; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JENNERSTEN O, 1988, J ECOL, V76, P1111, DOI 10.2307/2260638; Jiang Y, 2010, ANAL CHIM ACTA, V657, P9, DOI 10.1016/j.aca.2009.10.024; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068518; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kusari S, 2012, METABOLOMICS, P241; Kusari S, 2012, CHEM BIOL, V19, P792, DOI 10.1016/j.chembiol.2012.06.004; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Lazarowych NJ, 1998, DRUG INF J, V32, P497, DOI 10.1177/009286159803200222; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li R, 2014, J NAT PROD, V77, P571, DOI 10.1021/np400821r; Lim SH, 1998, BIOL PLANTARUM, V41, P313, DOI 10.1023/A:1001863924917; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mandeel QA, 2005, MYCOPATHOLOGIA, V159, P291, DOI 10.1007/s11046-004-5496-z; Martins S, 2013, APPL BIOCHEM BIOTECH, V171, P1227, DOI 10.1007/s12010-013-0222-2; Martins S, 2011, BIOTECHNOL ADV, V29, P365, DOI 10.1016/j.biotechadv.2011.01.008; Mohamed E, 2002, PAKISTAN J PLANT PAT; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Moraes DFC, 2015, PLANTA MED, V81, P687, DOI 10.1055/s-0035-1545843; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Novak J, 2007, FOOD RES INT, V40, P388, DOI 10.1016/j.foodres.2006.10.015; Nyren Pal, 2007, V373, P1; Oikonomou I, 2008, LETT APPL MICROBIOL, V46, P456, DOI 10.1111/j.1472-765X.2008.02340.x; Omezzine F, 2017, ARAB J CHEM, V10, pS3622, DOI 10.1016/j.arabjc.2014.03.013; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; POOLE SK, 1990, ANAL CHIM ACTA, V236, P3, DOI 10.1016/S0003-2670(00)83297-3; Posadzki P, 2013, EUR J CLIN PHARMACOL, V69, P295, DOI 10.1007/s00228-012-1353-z; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Radstrom P, 2003, PCR PRIMER LAB MANUA, P149; Rathcke B., 1983, P305; Rekosz-Burlaga H, 2014, ACTA SCI POL-HORTORU, V13, P117; Reynaud DTH, 2015, CAPABILITIES LIMITAT, P1; Rizzo I, 2004, MICROBIOL RES, V159, P113, DOI 10.1016/j.micres.2004.01.013; Rodriguez R.J., 2012, BIOCOMPLEXITY PLANT, V6, P155, DOI [10.1002/9781118314364.ch7, DOI 10.1002/9781118314364.CH7]; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; SCHEMSKE DW, 1981, ECOLOGY, V62, P946, DOI 10.2307/1936993; Schneiderman ET, 2015, CEASE DESIST NOTIFIC; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Skorska C, 2005, ANN AGR ENV MED, V12, P119; Southworth D, 2012, DEFINING COMPLEX INT, P205, DOI [10.1002/9781118314364.ch10, DOI 10.1002/9781118314364.CH10]; Steinmann D, 2011, J PHARMACEUT BIOMED, V55, P744, DOI 10.1016/j.jpba.2010.11.015; Stull GW, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200497; Swetha VP, 2014, TURK J BIOL, V38, P151, DOI 10.3906/biy-1308-5; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Toju H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6273; Tournas V, 2006, INT J FOOD MICROBIOL, V108, P178, DOI 10.1016/j.ijfoodmicro.2005.11.009; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; Waser N.M., 1983, P277; WASER NM, 1978, ECOLOGY, V59, P934, DOI 10.2307/1938545; Weiss S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0564-2; Wen FS, 2009, PLANT PHYSIOL, V151, P820, DOI 10.1104/pp.109.142067; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitlock R, 2008, MOL ECOL RESOUR, V8, P736, DOI 10.1111/j.1755-0998.2007.02074.x; WHO, 2011, WORLD MED SIT 2011 T; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Xin TY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08337; Ye YH, 2013, APPL MICROBIOL BIOT, V97, P7131, DOI 10.1007/s00253-013-5013-8; Zhang HW, 2014, PAK J PHARM SCI, V27, P1153; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492; Zhou H, 2015, EUR FOOD RES TECHNOL, V240, P379, DOI 10.1007/s00217-014-2337-2	123	79	83	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156426	10.1371/journal.pone.0156426	http://dx.doi.org/10.1371/journal.pone.0156426			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227830	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500133
J	Kohlmann, S; Gierk, B; Murray, AM; Scholl, A; Lehmann, M; Lowe, B				Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd			Base Rates of Depressive Symptoms in Patients with Coronary Heart Disease: An Individual Symptom Analysis	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; MYOCARDIAL-INFARCTION; CARDIOVASCULAR PROGNOSIS; HEALTH QUESTIONNAIRE; ENHANCING RECOVERY; COGNITIVE SYMPTOMS; SOMATIC SYMPTOMS; ARTERY-DISEASE; VALIDITY; EVENTS	Background Major depression is common in coronary heart disease (CHD) but challenging to diagnose. Instead of focusing on the overall diagnosis of depression, base rates of depressive symptoms could facilitate screening and management of psychopathology in CHD. The present study investigates the frequency of individual depressive symptoms in CHD and their impact on cardiac and subjective health. Methods In total, 1337 in-and outpatients with CHD were screened for depressive symptoms with the Patient Health Questionnaire-9 (PHQ-9) at three different cardiac treatment sites. Tables stratified by age and gender were designed to illustrate base rates of depressive symptoms. Multiple regression analyses adjusted for sociodemographic and clinical data were conducted to test associations between individual depressive symptoms and quality of life as well impairment caused angina pectoris and dyspnea. Results During the last 14 days, more than half of patients reported a loss of energy (74.9%, 95% Confidence Interval (CI): 70.6-79.2), sleeping problems (69.4%, 95% CI: 64.9-74.0), loss of interest (55.7%, 95% CI: 50.8-60.7). In contrast, psychomotor change (25.6%, 95% CI: 21.3-30.0), feelings of failure (21.9%, 95% CI: 17.7-26.0), suicidal ideations (14.1%, 95% CI: 10.7-17.6) were less frequently reported. Depending on the outcome, only particular depressive symptoms were highly associated with low quality of life and impairment caused by angina pectoris and dyspnea. Loss of energy was the only depressive symptom that reliably predicted all three outcomes. Conclusions Depressive symptoms in CHD are frequent but vary widely in terms of frequency. Findings underline the differential effects of individual depressive symptoms on cardiac health. Presented base rates of depressive symptoms offer clinicians a new way to judge the severity of individual depressive symptoms and to communicate individual PHQ-9 profiles with patients with respect to gender, age, cardiac symptoms and quality of life.	[Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Kohlmann, Sebastian; Gierk, Benjamin; Murray, Alexandra M.; Scholl, Arne; Lehmann, Marco; Lowe, Bernd] Schon Clin Hamburg Eilbek, Hamburg, Germany; [Gierk, Benjamin] Asklepios Clin North Ochsenzoll, Dept Psychiat, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kohlmann, S (corresponding author), Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.; Kohlmann, S (corresponding author), Schon Clin Hamburg Eilbek, Hamburg, Germany.	s.kohlmann@uke.de	Löwe, Bernd/AAG-4038-2020	Lowe, Bernd/0000-0003-4220-3378; Kohlmann, Sebastian/0000-0003-1307-4618	German Federal Ministry of Education and Research, Germany; Asklepios Clinic North Ochsenzoll	German Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); Asklepios Clinic North Ochsenzoll	The study DEPCSREEN-INFO was funded by the German Federal Ministry of Education and Research (https://www.bmbf.de/en/index.html), Germany (# 01GX1004; Principal Investigator: BL). Asklepios Clinic North Ochsenzoll provided support in the form of salaries for BG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Alderson SL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005146; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Azevedo RD, 2014, PSYCHOL MED, V44, P2689, DOI 10.1017/S0033291714000063; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-1; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Carney RM, 2012, PSYCHOSOM MED, V74, P33, DOI 10.1097/PSY.0b013e3182405ac4; Davidsen AS, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.24866; Davidson KW, 2013, JAMA INTERN MED, V173, P997, DOI 10.1001/jamainternmed.2013.915; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; de Jonge P, 2006, AM J PSYCHIAT, V163, P138, DOI 10.1176/appi.ajp.163.1.138; de Jonge P, 2012, BRIT J PSYCHIAT, V201, P337, DOI 10.1192/bjp.bp.112.110502; De Smedt D, 2013, INT J CARDIOL, V167, P2294, DOI 10.1016/j.ijcard.2012.06.025; Denollet J, 2013, PSYCHOSOM MED, V75, P701, DOI 10.1097/PSY.0b013e31829dbd36; Dowrick C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b663; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fried EI, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0325-4; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; Hemingway H, 2004, CAN J CARDIOL, V20, P305; Hoen PW, 2010, J AM COLL CARDIOL, V56, P838, DOI 10.1016/j.jacc.2010.03.080; Hoen PW, 2010, PSYCHOTHER PSYCHOSOM, V79, P319, DOI 10.1159/000319528; Holland R, 2010, J CARD FAIL, V16, P150, DOI 10.1016/j.cardfail.2009.08.010; Kessler RC, 2010, PSYCHOL MED, V40, P225, DOI 10.1017/S0033291709990213; Kessler RC, 2010, DEPRESS ANXIETY, V27, P351, DOI 10.1002/da.20634; Kohlmann S, 2013, JAMA INTERN MED, V173, P1469, DOI 10.1001/jamainternmed.2013.6835; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lesperance F, 2007, JAMA-J AM MED ASSOC, V297, P367, DOI 10.1001/jama.297.4.367; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Malpass A, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X502119; Maxwell M, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-46; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nowels D, 2005, QUAL LIFE RES, V14, P95, DOI 10.1007/s11136-004-0614-4; Ormel J, 2011, PSYCHOTHER PSYCHOSOM, V80, P264, DOI 10.1159/000323165; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Rief W, 2004, J AFFECT DISORDERS, V82, P271, DOI 10.1016/j.jad.2003.11.006; Roest AM, 2013, J AFFECT DISORDERS, V149, P335, DOI 10.1016/j.jad.2013.02.008; Roest AM, 2011, J AFFECT DISORDERS, V131, P158, DOI 10.1016/j.jad.2010.11.018; Schumann I, 2012, FAM PRACT, V29, P255, DOI 10.1093/fampra/cmr092; Shah A. J., 2014, AM HEART ASS, V3; Stewart JC, 2012, CIRCULATION, V126, P410, DOI 10.1161/CIRCULATIONAHA.112.094946; Thombs BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052654; Tully PJ, 2011, J HEALTH PSYCHOL, V16, P584, DOI 10.1177/1359105310383604; Uher R, 2012, PSYCHOL MED, V42, P967, DOI 10.1017/S0033291711001905; van der Feltz-Cornelis CM, 2014, NEUROPSYCH DIS TREAT, V10, P1057, DOI 10.2147/NDT.S59958; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Warrings B, 2012, CIRCULATION SUPPLEME, V126; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	54	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156167	10.1371/journal.pone.0156167	http://dx.doi.org/10.1371/journal.pone.0156167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228158	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500077
J	Kumar, N; Barua, S; Riyesh, T; Chaubey, KK; Rawat, KD; Khandelwal, N; Mishra, AK; Sharma, N; Chandel, SS; Sharma, S; Singh, MK; Sharma, DK; Singh, SV; Tripathi, BN				Kumar, Naveen; Barua, Sanjay; Riyesh, Thachamvally; Chaubey, Kundan K.; Rawat, Krishan Dutt; Khandelwal, Nitin; Mishra, Anil K.; Sharma, Nitika; Chandel, Surender S.; Sharma, Shalini; Singh, Manoj K.; Sharma, Dinesh K.; Singh, Shoor V.; Tripathi, Bhupendra N.			Complexities in Isolation and Purification of Multiple Viruses from Mixed Viral Infections: Viral Interference, Persistence and Exclusion	PLOS ONE			English	Article							DES PETITS RUMINANTS; MOUTH-DISEASE VIRUS; RESPIRATORY-TRACT INFECTIONS; DUAL INFECTION; DENGUE VIRUS; CELL-CULTURE; PESTE; PARTICLES; RISK; TRANSMISSION	Successful purification of multiple viruses from mixed infections remains a challenge. In this study, we investigated peste des petits ruminants virus (PPRV) and foot-and-mouth disease virus (FMDV) mixed infection in goats. Rather than in a single cell type, cytopathic effect (CPE) of the virus was observed in cocultured Vero/BHK-21 cells at 6th blind passage (BP). PPRV, but not FMDV could be purified from the virus mixture by plaque assay. Viral RNA (mixture) transfection in BHK-21 cells produced FMDV but not PPRV virions, a strategy which we have successfully employed for the first time to eliminate the negative-stranded RNA virus from the virus mixture. FMDV phenotypes, such as replication competent but noncytolytic, cytolytic but defective in plaque formation and, cytolytic but defective in both plaque formation and standard FMDV genome were observed respectively, at passage level BP8, BP15 and BP19 and hence complicated virus isolation in the cell culture system. Mixed infection was not found to induce any significant antigenic and genetic diversity in both PPRV and FMDV. Further, we for the first time demonstrated the viral interference between PPRV and FMDV. Prior transfection of PPRV RNA, but not Newcastle disease virus (NDV) and rotavirus RNA resulted in reduced FMDV replication in BHK-21 cells suggesting that the PPRV RNA-induced interference was specifically directed against FMDV. On long-term-coinfection of some acute pathogenic viruses (all possible combinations of PPRV, FMDV, NDV and buffalo-pox virus) in Vero cells, inmost cases, one of the coinfecting viruses was excluded at passage level 5 suggesting that the long-term coinfection may modify viral persistence. To the best of our knowledge, this is the first documented evidence describing a natural mixed infection of FMDV and PPRV. The study not only provides simple and reliable methodologies for isolation and purification of two epidemiologically and economically important groups of viruses, but could also help in establishing better guidelines for trading animals that could transmit further infections and epidemics in disease free nations.	[Kumar, Naveen; Chaubey, Kundan K.; Mishra, Anil K.; Sharma, Nitika; Singh, Manoj K.; Sharma, Dinesh K.; Singh, Shoor V.] ICAR Cent Inst Res Goats, Div Anim Hlth, Makhdoom, Mathura, India; [Kumar, Naveen; Barua, Sanjay; Riyesh, Thachamvally; Rawat, Krishan Dutt; Khandelwal, Nitin; Chandel, Surender S.; Tripathi, Bhupendra N.] ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Culture Collect, Hisar, Haryana, India; [Sharma, Shalini] Lala Lajpat Rai Univ Vet & Anim Sci, Dept Vet Physiol & Biochem, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute for Research on Goats; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Lala Lajpat Rai University of Veterinary & Animal Sciences	Kumar, N (corresponding author), ICAR Cent Inst Res Goats, Div Anim Hlth, Makhdoom, Mathura, India.; Kumar, N (corresponding author), ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Culture Collect, Hisar, Haryana, India.	naveenkumar.icar@gmail.com	Kumar, Naveen/AAR-9084-2021	Chaubey, Kundan/0000-0002-5940-4638; Singh, Manoj Kumar/0000-0003-0118-3614	Indian Council of Agricultural Research (ICAR), India [IXX10113]; Science and Engineering Research Board, Department of Science and Technology, Government of India [SB/SO/AS-20/2014]	Indian Council of Agricultural Research (ICAR), India(Indian Council of Agricultural Research (ICAR)); Science and Engineering Research Board, Department of Science and Technology, Government of India	The project was partially funded through Indian Council of Agricultural Research (ICAR), India, to N. Kumar ( project code, IXX10113) as well as Science and Engineering Research Board, Department of Science and Technology, Government of India under project SB/SO/AS-20/2014 to N. Kumar. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Balamurugan V, 2011, REV SCI TECH OIE, V30, P889; Bangham C R, 1993, Trends Microbiol, V1, P260, DOI 10.1016/0966-842X(93)90048-V; Bara Jeffrey J, 2014, Acta Trop, V130, P71, DOI 10.1016/j.actatropica.2013.10.016; Barnett PV, 1999, VET J, V158, P6, DOI 10.1053/tvjl.1998.0338; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Belsham GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014621; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; BRUMBACK BG, 1994, J CLIN MICROBIOL, V32, P2289, DOI 10.1128/JCM.32.9.2289-2290.1994; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Callens M, 1997, J VIROL METHODS, V67, P35, DOI 10.1016/S0166-0934(97)00074-8; Callis JJ, 1996, REV SCI TECH OIE, V15, P1075, DOI 10.20506/rst.15.3.974; Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10; Chang YY, 2009, ACTA BIOCH BIOPH SIN, V41, P998, DOI 10.1093/abbs/gmp093; Chua K B, 2004, Malays J Pathol, V26, P69; COONEY MK, 1976, AM J MED TECHNOL, V42, P158; DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; DOWNHAM MAP, 1975, BRIT MED J, V1, P235, DOI 10.1136/bmj.1.5952.235; Elnekave E, 2016, PREV VET MED, V125, P82, DOI 10.1016/j.prevetmed.2015.12.019; Escarmis C, 2008, J MOL BIOL, V376, P367, DOI 10.1016/j.jmb.2007.11.042; Ezeibe MCO, 2008, TROP ANIM HEALTH PRO, V40, P517, DOI 10.1007/s11250-008-9128-3; FRIEDMAN RM, 1964, NATURE, V201, P848, DOI 10.1038/201848a0; Garcia-Arriaza J, 2005, VIROLOGY, V335, P155, DOI 10.1016/j.virol.2005.02.012; Garcia-Arriaza J, 2004, J VIROL, V78, P11678, DOI 10.1128/JVI.78.21.11678-11685.2004; Garland AJM, 2011, REV SCI TECH OIE, V30, P189; Geale DW, 2015, TRANSBOUND EMERG DIS, V62, P388, DOI 10.1111/tbed.12165; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Gonzalez-Lopez C, 2004, J VIROL, V78, P3319, DOI 10.1128/JVI.78.7.3319-3324.2004; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Haller O, 2015, J INTERF CYTOK RES, V35, P239, DOI 10.1089/jir.2015.1500; Heddini A, 2009, EUROSURVEILLANCE, V14; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; JANDA JM, 1979, J VIROL, V32, P697, DOI 10.1128/JVI.32.2.697-702.1979; Jorna T, 2003, TIJDSCHR DIERGENEESK, V128, P146; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Kumar N, 2013, J VIROL METHODS, V189, P388, DOI 10.1016/j.jviromet.2013.03.002; Kumar N, 2011, ANTIMICROB AGENTS CH, V55, P5553, DOI 10.1128/AAC.00725-11; Lefevre P C, 1990, Rev Sci Tech, V9, P935; Leland DS, 2007, CLIN MICROBIOL REV, V20, P49, DOI 10.1128/CMR.00002-06; LUNDQUIST RE, 1979, CELL, V18, P759, DOI 10.1016/0092-8674(79)90129-6; Malik YS, 2011, TRANSBOUND EMERG DIS, V58, P268, DOI 10.1111/j.1865-1682.2011.01201.x; MALIRAT V, 1994, VIRUS RES, V34, P31, DOI 10.1016/0168-1702(94)90117-1; Marriott AC, 2010, REV MED VIROL, V20, P51, DOI 10.1002/rmv.641; MEISSNER HC, 1984, J PEDIATR-US, V104, P680, DOI 10.1016/S0022-3476(84)80943-9; Mondal B, 2009, TROP ANIM HEALTH PRO, V41, P1661, DOI 10.1007/s11250-009-9362-3; Moss A, 1999, J VIROL METHODS, V80, P59, DOI 10.1016/S0166-0934(99)00031-2; Nanda YP, 1996, VET MICROBIOL, V51, P207, DOI 10.1016/0378-1135(96)00025-9; NOMOTO A, 1979, J MOL BIOL, V128, P179, DOI 10.1016/0022-2836(79)90125-6; OLSON LC, 1973, AM J EPIDEMIOL, V97, P34, DOI 10.1093/oxfordjournals.aje.a121481; Padhi A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07040; Paton DJ, 2010, TRANSBOUND EMERG DIS, V57, P115, DOI 10.1111/j.1865-1682.2010.01137.x; Pepin KM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-28; Piccone ME, 2009, J VIROL, V83, P6681, DOI 10.1128/JVI.01729-08; RAHMAN M, 1990, REV INFECT DIS, V12, pS899; Reid SM, 2000, J VIROL METHODS, V89, P167, DOI 10.1016/S0166-0934(00)00213-5; Rodriguez-Calvo T, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-22; Rohani A, 2009, SE ASIAN J TROP MED, V40, P443; Saeed IK, 2015, TROP ANIM HEALTH PRO, V47, P995, DOI 10.1007/s11250-015-0798-3; Salas-Benito JS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/873404; Saravanan P, 2007, VET REC, V160, P410, DOI 10.1136/vr.160.12.410; Schultz-Cherry S, 2015, J INFECT DIS, V212, P1690, DOI 10.1093/infdis/jiv261; Shaila MS, 1996, VIRUS RES, V43, P149, DOI 10.1016/0168-1702(96)01312-3; Sharma S, 2014, J LEUKOCYTE BIOL, V95, P405, DOI 10.1189/jlb.0713386; Sivaram A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-95; SNOWDON WA, 1966, NATURE, V210, P1079, DOI 10.1038/2101079a0; STROHMAIER K, 1982, J GEN VIROL, V59, P295, DOI 10.1099/0022-1317-59-2-295; Subramaniam S, 2013, TRANSBOUND EMERG DIS, V60, P197, DOI 10.1111/j.1865-1682.2012.01332.x; Sutmoller P, 2003, VIRUS RES, V91, P101, DOI 10.1016/S0168-1702(02)00262-9; Tang MB, 2014, SE ASIAN J TROP MED, V45, P1326; Tekleghiorghis T., 2014, TRANSBOUND EMERG DIS; Toplu N, 2012, J COMP PATHOL, V146, P289, DOI 10.1016/j.jcpa.2011.07.004; Vagnozzi A, 2007, J VIROL, V81, P11669, DOI 10.1128/JVI.00557-07; van Engelenburg FAC, 2002, J HOSP INFECT, V51, P121, DOI 10.1053/jhin.2002.1211; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; Vento S, 2013, LANCET INFECT DIS, V13, P9, DOI 10.1016/S1473-3099(12)70312-2; WAGNER RR, 1960, BACTERIOL REV, V24, P151, DOI 10.1128/MMBR.24.1.151-166.1960; WANER JL, 1994, CLIN MICROBIOL REV, V7, P143, DOI 10.1128/CMR.7.2.143-151.1994; Wernery U, 2004, VET J, V168, P134, DOI 10.1016/j.tvjl.2003.10.005; WHITAKERDOWLING P, 1987, MICROBIOL REV, V51, P179, DOI 10.1128/MMBR.51.2.179-191.1987; Yeh JY, 2011, J CLIN MICROBIOL, V49, P1389, DOI 10.1128/JCM.00710-10	84	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156110	10.1371/journal.pone.0156110	http://dx.doi.org/10.1371/journal.pone.0156110			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227480	Green Published, gold			2022-12-27	WOS:000376882500069
J	Li, MM; Li, YH; Zhao, JY; Liu, H; Jia, SH; Li, J; Zhao, HP; Han, SC; Wang, YD				Li, Mengmeng; Li, Yihao; Zhao, Junyi; Liu, Hai; Jia, Shenghua; Li, Jie; Zhao, Heping; Han, Shengcheng; Wang, Yingdian			GpDSR7, a Novel E3 Ubiquitin Ligase Gene in Grimmia pilifera Is Involved in Tolerance to Drought Stress in Arabidopsis	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; ABIOTIC STRESS; 26S PROTEASOME; SALT; DESICCATION; MOSS; REHYDRATION; EXPRESSION; RESPONSES; ATAIRP1	The growth and development of plants under drought stress depends mainly on the expression levels of various genes and modification of proteins. To clarify the molecular mechanism of drought-tolerance of plants, suppression subtractive hybridisation cDNA libraries were screened to identify drought-stress-responsive unigenes in Grimmia pilifera, and a novel E3 ubiquitin ligase gene, GpDSR7, was identified among the 240 responsive unigenes. GpDSR7 expression was induced by various abiotic stresses, particularly by drought. GpDSR7 displayed E3 ubiquitin ligase activity in vitro and was exclusively localised on the ER membrane in Arabidopsis mesophyll protoplasts. GpDSR7-overexpressing transgenic Arabidopsis plants showed a high water content and survival ratio under drought stress. Moreover, the expression levels of some marker genes involved in drought stress were higher in the transgenic plants than in wild-type plants. These results suggest that GpDSR7, an E3 ubiquitin ligase, is involved in tolerance to drought stress at the protein modification level.	[Li, Mengmeng; Li, Yihao; Zhao, Junyi; Liu, Hai; Jia, Shenghua; Li, Jie; Zhao, Heping; Han, Shengcheng; Wang, Yingdian] Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Coll Life Sci, Beijing 100875, Peoples R China	Beijing Normal University	Wang, YD (corresponding author), Beijing Normal Univ, Beijing Key Lab Gene Resource & Mol Dev, Coll Life Sci, Beijing 100875, Peoples R China.	ydwang@bnu.edu.cn			National High Technology Research and Development Program (863 Program) [2007AA02140]	National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program (863 Program, No. 2007AA02140). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazari A, 2014, CRYOBIOLOGY, V69, P511; Arya D, 2016, FEBS J, V283, P556, DOI 10.1111/febs.13611; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Chen X, 2003, BIOL PLANTARUM, V46, P363, DOI 10.1023/A:1024369917715; Cho SK, 2011, PLANT PHYSIOL, V157, P2240, DOI 10.1104/pp.111.185595; DHINDSA RS, 1987, PLANT PHYSIOL, V83, P816, DOI 10.1104/pp.83.4.816; Fernandez CC, 2006, P NATL ACAD SCI USA, V103, P637, DOI 10.1073/pnas.0510267103; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Guerra D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00057; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; KEEVER C, 1957, ECOLOGY, V38, P422, DOI 10.2307/1929885; Kim JH, 2013, PLANT PHYSIOL, V162, P1733, DOI 10.1104/pp.113.220103; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Li YS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0653-8; Liang XW, 2013, ANTIOXID REDOX SIGN, V19, P998, DOI 10.1089/ars.2012.5074; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; McKAY ELIZABETH, 1935, PLANT PHYSIOL, V10, P803, DOI 10.1104/pp.10.4.803; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Munoz J, 1999, ANN MO BOT GARD, V86, P118, DOI 10.2307/2666219; OLIVER MJ, 1984, PLANT PHYSIOL, V74, P21, DOI 10.1104/pp.74.1.21; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Rodriguez-Rosales M, 2009, PLANT SIGNAL BEHAV, V4, P265, DOI 10.4161/psb.4.4.7919; Proctor MCF, 2004, PHYSIOL PLANTARUM, V122, P21, DOI 10.1111/j.1399-3054.2004.00348.x; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Ryu MY, 2010, PLANT PHYSIOL, V154, P1983, DOI 10.1104/pp.110.164749; Sahu BB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-69; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Verslues PE, 2014, PLANT PHYSIOL, V164, P144, DOI 10.1104/pp.113.224014; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Yang L, 2016, J INTEGR PLANT BIOL, V58, P67, DOI 10.1111/jipb.12364; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yu FF, 2016, MOL PLANT, V9, P21, DOI 10.1016/j.molp.2015.09.015; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593; Zhang HW, 2015, PLANT CELL, V27, P214, DOI 10.1105/tpc.114.134163; Zhang YY, 2007, PLANT CELL, V19, P1912, DOI 10.1105/tpc.106.048488; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	45	4	7	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155455	10.1371/journal.pone.0155455	http://dx.doi.org/10.1371/journal.pone.0155455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228205	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500021
J	Luna-Nacar, M; Navarrete-Perea, J; Moguel, B; Bobes, RJ; Laclette, JP; Carrero, JC				Luna-Nacar, Milka; Navarrete-Perea, Jose; Moguel, Barbara; Bobes, Raul J.; Laclette, Juan P.; Carrero, Julio C.			Proteomic Study of Entamoeba histolytica Trophozoites, Cysts, and Cyst-Like Structures	PLOS ONE			English	Article							PSEUDOCYST FORMATION; PROTEIN; ENCYSTATION; DIFFERENTIATION; PHAGOCYTOSIS; INVADENS; GENOME; CHITIN; STRESS; LECTIN	The cyst stage of Entamoeba histolytica is a promising therapeutic target against human amoebiasis. Our research team previously reported the production in vitro of Cyst-Like Structures (CLS) sharing structural features with cysts, including rounded shape, size reduction, multinucleation, and the formation of a chitin wall coupled to the overexpression of glucosamine 6-phosphate isomerase, the rate-limiting enzyme of the chitin synthesis pathway. A proteomic study of E. histolytica trophozoites, cysts, and in vitro-produced CLS is reported herein to determine the nature of CLS, widen our knowledge on the cyst stage, and identify possible proteins and pathways involved in the encystment process. Total protein extracts were obtained from E. histolytica trophozoites, CLS, and partially purified cysts recovered from the feces of amoebic human patients; extracts were trypsin-digested and analyzed by LC-MS/MS. In total, 1029 proteins were identified in trophozoites, 550 in CLS, and 411 in cysts, with 539, 299, and 84 proteins unique to each sample, respectively, and only 74 proteins shared by all three stages. About 70% of CLS proteins were shared with trophozoites, even though differences were observed in the relative protein abundance. While trophozoites showed a greater abundance of proteins associated to a metabolically active cell, CLS showed higher expression of proteins related to proteolysis, redox homeostasis, and stress response. In addition, the expression of genes encoding for the cyst wall proteins Jessie and Jacob was detected by RT-PCR and the Jacob protein identified by Western blotting and immunofluorescence in CLS. However, the proteomic profile of cysts as determined by LC-MS/MS was very dissimilar to that of trophozoites and CLS, with almost 40% of hypothetical proteins. Our global results suggest that CLS are more alike to trophozoites than to cysts, and they could be generated as a rapid survival response of trophozoites to a stressful condition, which allows the parasite to survive temporarily inside a chitin-like resistant cover containing Jacob protein. Our findings lead us to suggest that encystment and CLS formation could be distinct stress responses. In addition, we show that cysts express a high number of genes with unknown function, including four new, highly antigenic, possibly membrane-located proteins that could be targets of therapeutic and diagnostic usefulness.	[Luna-Nacar, Milka; Navarrete-Perea, Jose; Moguel, Barbara; Bobes, Raul J.; Laclette, Juan P.; Carrero, Julio C.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Immunol, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Carrero, JC (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Immunol, Tercer Circuito Exterior S-N,Ciudad Univ, Mexico City 04510, DF, Mexico.	carrero@unam.mx		Carrero, Julio/0000-0003-1055-5774; Moguel, Barbara/0000-0002-4489-0055; Navarrete, Jose/0000-0002-6984-1495; Navarrete-Perea, Jose/0000-0001-6265-6214	Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico [167788]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM [IN213611]; Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico; Conacyt [389536/255914]	Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM; Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Conacyt(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACyT) de Mexico, Number 167788 granted to JCC and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Direccion General de Asuntos del Personal Academico-UNAM, Number IN213611 granted to JCC. MLN gratefully acknowledges the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and Conacyt for the scholarship PhD 389536/255914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was part of the doctoral thesis of Milka Azucena Luna Nacar, who gratefully acknowledges the Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico, and Conacyt for the scholarship PhD 389536/255914. We thank Mario Nequiz-Avendano for amoeba culturing, Salvador Rodriguez and CARPERMOR Laboratories for providing stool samples, Jeovanis Gil for bioinformatic assistance and Pavel Petrosyan for technical assistance.	Aguilar-Diaz H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/758341; Aguilar-Diaz H, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000607; Ali IKM, 2015, CLIN LAB MED, V35, P393, DOI 10.1016/j.cll.2015.02.009; Ali IKM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001643; AVRON B, 1986, J PROTOZOOL, V33, P522, DOI 10.1111/j.1550-7408.1986.tb05655.x; BAILEY GB, 1980, ARCH INVEST MED, V11, P11; Barron-Gonzalez MP, 2008, EXP PARASITOL, V118, P600, DOI 10.1016/j.exppara.2007.11.002; Biller L, 2014, MOL CELL PROTEOMICS, V13, P132, DOI 10.1074/mcp.M113.031393; Boettner DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buss SN, 2010, INT J PARASITOL, V40, P833, DOI 10.1016/j.ijpara.2009.12.007; Campos-Gongora E, 2000, ARCH MED RES, V31, P162, DOI 10.1016/S0188-4409(00)00054-0; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Davis PH, 2006, MOL MICROBIOL, V61, P1523, DOI 10.1111/j.1365-2958.2006.05344.x; Davis PH, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000415; de la Cruz OH, 2014, J PROTEOMICS, V111, P46, DOI 10.1016/j.jprot.2014.03.041; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Eichinger D, 2001, J EUKARYOT MICROBIOL, V48, P17, DOI 10.1111/j.1550-7408.2001.tb00411.x; Falda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S14; Fontana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004619; Ghosh SK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000750; Hamzah Z, 2006, J CLIN MICROBIOL, V44, P3196, DOI 10.1128/JCM.00778-06; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Husain A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001831; Kliescikova J, 2011, EXP PARASITOL, V127, P326, DOI 10.1016/j.exppara.2010.08.014; Kliescikova J, 2011, PROTIST, V162, P58, DOI 10.1016/j.protis.2010.03.006; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Leitsch D, 2005, EXP PARASITOL, V110, P191, DOI 10.1016/j.exppara.2005.02.016; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lopez-Rosas I, 2014, J PROTEOMICS, V111, P59, DOI 10.1016/j.jprot.2014.06.019; Lorenzi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000716; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lujan HD, 1997, MICROBIOL MOL BIOL R, V61, P294; MacFarlane R, 2005, EXP PARASITOL, V110, P196, DOI 10.1016/j.exppara.2005.03.006; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; MacFarlane RC, 2005, INT J PARASITOL, V35, P533, DOI 10.1016/j.ijpara.2005.02.006; Marion S, 2005, CELL MICROBIOL, V7, P1504, DOI 10.1111/j.1462-5822.2005.00573.x; McCoy JJ, 2005, EXP PARASITOL, V110, P220, DOI 10.1016/j.exppara.2005.02.013; Mi H, 2013, NUCLEIC ACIDS RES, V4, P377; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Okada M, 2006, MOL BIOCHEM PARASIT, V145, P171, DOI 10.1016/j.molbiopara.2005.10.001; Okada M, 2005, EUKARYOT CELL, V4, P827, DOI 10.1128/EC.4.4.827-831.2005; Perdomo D, 2015, J PROTEOMICS, V112, P125, DOI 10.1016/j.jprot.2014.07.034; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; RENGPIEN S, 1975, J PARASITOL, V61, P24, DOI 10.2307/3279100; Said-Fernandez S, 2001, J PARASITOL, V87, P919, DOI 10.2307/3285156; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Tolstrup J, 2007, PARASITOLOGY, V134, P289, DOI 10.1017/S0031182006001442; Valdes J, 2014, J PROTEOMICS, V111, P30, DOI 10.1016/j.jprot.2014.07.027; Van Dellen KL, 2006, EUKARYOT CELL, V5, P836, DOI 10.1128/EC.5.5.836-848.2006; VAZQUEZDELARACISNEROS LG, 1984, J PARASITOL, V70, P629, DOI 10.2307/3281741; Walderich B, 1997, PARASITOL RES, V83, P719, DOI 10.1007/s004360050326; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Ximenez C, 2009, INFECT GENET EVOL, V9, P1023, DOI 10.1016/j.meegid.2009.06.008; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	59	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156018	10.1371/journal.pone.0156018	http://dx.doi.org/10.1371/journal.pone.0156018			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228164	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500051
J	Ortiz, AM; Carnathan, DG; Yu, J; Sheehan, KM; Kim, P; Reynaldi, A; Vanderford, TH; Klatt, NR; Brenchley, JM; Davenport, MP; Silvestri, G				Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Kim, Peter; Reynaldi, Arnold; Vanderford, Thomas H.; Klatt, Nichole R.; Brenchley, Jason M.; Davenport, Miles P.; Silvestri, Guido			Analysis of the In Vivo Turnover of CD4+T-Cell Subsets in Chronically SIV-Infected Sooty Mangabeys	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; LYMPHOCYTE TURNOVER; HIV-1 INFECTION; MACAQUES; SUBPOPULATIONS; DYNAMICS; RATES	Aberrant turnover of memory CD4+ T-cells is central to Acquired Immunodeficiency Syndrome (AIDS) progression. Understanding the relationship between the turnover of CD4+ subsets and immunological homeostasis during simian immunodeficiency virus (SIV) infection in natural hosts may provide insight into mechanisms of immune regulation that may serve as models for therapeutic intervention in Human Immunodeficiency Virus (HIV)infected persons. Sooty mangabeys (SMs) have naturally evolved with SIV to avoid AIDS progression while maintaining healthy peripheral CD4+ T-cell counts and thus represent a model by which therapeutic interventions for AIDS progression might be elucidated. To assess the relationship between the turnover of CD4+ subsets and immunological homeostasis during SIV infection in non-progressive hosts, we treated 6 SIV-uninfected and 9 SIVinfected SMs with 2'-bromo-5'-deoxyuridine (BrdU) for 14 days and longitudinally assessed CD4+ T-cell subset turnover by polychromatic flow cytometry. We observed that, in SIVinfected SMs, turnover of CD4+ T-cell naive and central, transitional, and effector memory subsets is comparable to that in uninfected animals. Comparable turnover of CD4+ T-cell subsets irrespective of SIV-infection status likely contributes to the lack of aberrant immune activation and disease progression observed after infection in non-progressive hosts.	[Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Vanderford, Thomas H.; Silvestri, Guido] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Ortiz, Alexandra M.; Carnathan, Diane G.; Yu, Joana; Sheehan, Katherine M.; Vanderford, Thomas H.; Silvestri, Guido] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Kim, Peter; Reynaldi, Arnold; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Complex Syst Biol Grp, Sydney, NSW 2052, Australia; [Ortiz, Alexandra M.; Klatt, Nichole R.; Brenchley, Jason M.] NIH, Mol Microbiol Lab, Bldg 10, Bethesda, MD 20892 USA; [Klatt, Nichole R.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	Emory University; Emory University; University of New South Wales Sydney; National Institutes of Health (NIH) - USA; University of Washington; University of Washington Seattle	Silvestri, G (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Silvestri, G (corresponding author), Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA.	gsilves@emory.edu	Brenchley, Jason/AAC-5085-2019	Davenport, Miles/0000-0002-4751-1831; Reynaldi, Arnold/0000-0002-5529-5542; Kim, Peter/0000-0002-1492-4744; Brenchley, Jason/0000-0001-8357-2984	National Institutes of Health/National Center for Research Resources [P51RR000165]; Office of Research Infrastructure Programs / OD [P51OD011132];  [R37-AI066998]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI066998, ZIAAI001029] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD010425] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs / OD; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by R37-AI066998 to GS (URL: www.grants.nih.gov). In addition, it was supported by the National Institutes of Health/National Center for Research Resources (P51RR000165) and is currently supported by the Office of Research Infrastructure Programs / OD P51OD011132 to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2012, BLOOD, V120, P4172, DOI 10.1182/blood-2012-06-437608; Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; De Boer RJ, 2003, J IMMUNOL, V170, P2479, DOI 10.4049/jimmunol.170.5.2479; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Kaur A, 2008, J VIROL, V82, P1084, DOI 10.1128/JVI.02197-07; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Paiardini M, 2011, NAT MED, V17, P830, DOI 10.1038/nm.2395; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Rosenzweig M, 1998, P NATL ACAD SCI USA, V95, P6388, DOI 10.1073/pnas.95.11.6388; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8	15	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156352	10.1371/journal.pone.0156352	http://dx.doi.org/10.1371/journal.pone.0156352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227993	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500121
J	Pian, C; Zhang, GL; Chen, Z; Chen, YY; Zhang, J; Yang, T; Zhang, LY				Pian, Cong; Zhang, Guangle; Chen, Zhi; Chen, Yuanyuan; Zhang, Jin; Yang, Tao; Zhang, Liangyun			LncRNApred: Classification of Long Non-Coding RNAs and Protein-Coding Transcripts by the Ensemble Algorithm with a New Hybrid Feature	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; PREDICTION; GENOME; DNA; GENES; IDENTIFICATION; EVOLUTION; ELEMENTS; DATABASE; REGIONS	As a novel class of noncoding RNAs, long noncoding RNAs (lncRNAs) have been verified to be associated with various diseases. As large scale transcripts are generated every year, it is significant to accurately and quickly identify lncRNAs from thousands of assembled transcripts. To accurately discover new lncRNAs, we develop a classification tool of random forest (RF) named LncRNApred based on a new hybrid feature. This hybrid feature set includes three new proposed features, which are MaxORF, RMaxORF and SNR. LncRNApred is effective for classifying lncRNAs and protein coding transcripts accurately and quickly. Moreover, our RF model only requests the training using data on human coding and non-coding transcripts. Other species can also be predicted by using LncRNApred. The result shows that our method is more effective compared with the Coding Potential Calculate (CPC). The web server of LncRNApred is available for free at http://mm20132014.wicp.net:57203/LncRNApred/home.jsp.	[Pian, Cong; Zhang, Guangle; Chen, Zhi; Chen, Yuanyuan; Zhang, Jin; Yang, Tao; Zhang, Liangyun] Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhang, LY (corresponding author), Nanjing Agr Univ, Coll Sci, Dept Math, Nanjing, Jiangsu, Peoples R China.	zlyun@njau.edu.cn	Chen, Yuanyuan/GXG-2130-2022	Pian, Cong/0000-0001-7401-2926	National Natural Science Foundation of China [11571173, 11401311, 31301229]; Natural Science Foundation of Jiangsu Province [BK20141358]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work is supported by the National Natural Science Foundation of China (11571173, 11401311, 31301229) and the Natural Science Foundation of Jiangsu Province (BK20141358). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Bao Michael, 2012, Genomics Proteomics & Bioinformatics, V10, P114, DOI 10.1016/j.gpb.2012.05.004; Bernhart Stephan H., 2009, Briefings in Functional Genomics & Proteomics, V8, P461, DOI 10.1093/bfgp/elp043; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; Cao JW, 2012, INFORM SCIENCES, V185, P66, DOI 10.1016/j.ins.2011.09.015; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilebrecht S, 2011, NUCLEIC ACIDS RES, V39, P2057, DOI 10.1093/nar/gkq1153; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; FICKETT JW, 1992, NUCLEIC ACIDS RES, V20, P6441, DOI 10.1093/nar/20.24.6441; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Guay C, 2012, DIABETES OBES METAB, V14, P12, DOI 10.1111/j.1463-1326.2012.01654.x; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Hung T, 2010, RNA BIOL, V7, P582, DOI 10.4161/rna.7.5.13216; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lertampaiporn S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks878; Li DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077938; Li GB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/780521; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Managadze D, 2011, GENOME BIOL EVOL, V3, P1390, DOI 10.1093/gbe/evr116; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moskalev EA, 2012, GENE CHROMOSOME CANC, V51, P105, DOI 10.1002/gcc.20943; Muniz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001152; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Raasch P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-491; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Saetrom P, 2005, NUCLEIC ACIDS RES, V33, P3263, DOI 10.1093/nar/gki644; Salari R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005433; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Storz G, 2002, SCIENCE, V296, P1260, DOI 10.1126/science.1072249; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139654; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; Tran TT, 2009, BIOINFORMATICS, V25, P2897, DOI 10.1093/bioinformatics/btp537; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Vucicevic D, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00048; Wang CL, 2006, BIOINFORMATICS, V22, P2590, DOI 10.1093/bioinformatics/btl441; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2011, RNA, V17, P578, DOI 10.1261/rna.2536111; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang F, 2012, RNA BIOL, V9, P110, DOI 10.4161/rna.9.1.18332; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yin CC, 2007, J THEOR BIOL, V247, P687, DOI 10.1016/j.jtbi.2007.03.038; Yoon W, 2010, AIDS, V24, P155, DOI 10.1097/QAD.0b013e32833202f5; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12	79	38	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154567	10.1371/journal.pone.0154567	http://dx.doi.org/10.1371/journal.pone.0154567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228152	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500005
J	Quittner, AL; Cejas, I; Wang, NY; Niparko, JK; Barker, DH				Quittner, Alexandra L.; Cejas, Ivette; Wang, Nae-Yuh; Niparko, John K.; Barker, David H.		CDaCI Investigative Team	Symbolic Play and Novel Noun Learning in Deaf and Hearing Children: Longitudinal Effects of Access to Sound on Early Precursors of Language	PLOS ONE			English	Article							COCHLEAR IMPLANT USERS; ATTENTION; SPEECH; SKILLS; PRESCHOOLERS; ALGORITHM; ABILITIES; AUDITION; IMPACT	In the largest, longitudinal study of young, deaf children before and three years after cochlear implantation, we compared symbolic play and novel noun learning to age-matched hearing peers. Participants were 180 children from six cochlear implant centers and 96 hearing children. Symbolic play was measured during five minutes of videotaped, structured solitary play. Play was coded as "symbolic" if the child used substitution (e.g., a wooden block as a bed). Novel noun learning was measured in 10 trials using a novel object and a distractor. Cochlear implant vs. normal hearing children were delayed in their use of symbolic play, however, those implanted before vs. after age two performed significantly better. Children with cochlear implants were also delayed in novel noun learning (median delay 1.54 years), with minimal evidence of catch-up growth. Quality of parent-child interactions was positively related to performance on the novel noun learning, but not symbolic play task. Early implantation was beneficial for both achievement of symbolic play and novel noun learning. Further, maternal sensitivity and linguistic stimulation by parents positively affected noun learning skills, although children with cochlear implants still lagged in comparison to hearing peers.	[Quittner, Alexandra L.] Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA; [Cejas, Ivette] Univ Miami, Miller Sch Med, Barton G Kids Hear Now Cochlear Implant Family Re, Dept Otolaryngol, Miami, FL 33136 USA; [Wang, Nae-Yuh] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Niparko, John K.] Univ So Calif, Dept Otolaryngol Head & Neck Surg, Los Angeles, CA USA; [Barker, David H.] Brown Univ, Dept Child & Adolescent Psychiat, Providence, RI 02912 USA	University of Miami; University of Miami; Johns Hopkins University; University of Southern California; Brown University	Quittner, AL (corresponding author), Univ Miami, Dept Psychol, POB 248185, Coral Gables, FL 33124 USA.	aquittner@miami.edu		Wang, Nae-Yuh/0000-0001-6513-9730	National Institute on Deafness and Other Communication Disorders [R01 DC004797]; CityBridge Foundation; Sidgmore Family Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004797] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CityBridge Foundation; Sidgmore Family Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The CDaCI Study was supported by grant R01 DC004797 from the National Institute on Deafness and Other Communication Disorders, the CityBridge Foundation, and the Sidgmore Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelbaum M, 1999, DEV PSYCHOL, V35, P1399; Appelbaum M, 2000, CHILD DEV, V71, P960; Barker DH, 2009, DEV PSYCHOPATHOL, V21, P373, DOI 10.1017/S0954579409000212; Barnard JM, 2015, OTOL NEUROTOL, V36, P985, DOI 10.1097/MAO.0000000000000723; BELSKY J, 1981, DEV PSYCHOL, V17, P630, DOI 10.1037/0012-1649.17.5.630; Blamey PJ, 2011, OXFORD HDB DEAF STUD, V1, P241, DOI [10.1093/oxfordhb/9780199750986.013.0018, DOI 10.1093/OXFORDHB/9780199750986.013.0018]; Bornstein MH, 1999, CHILD DEV, V70, P833, DOI 10.1111/1467-8624.00060; Brown P M, 2001, J Deaf Stud Deaf Educ, V6, P15, DOI 10.1093/deafed/6.1.15; Cruz I, 2013, CHILD DEV, V84, P543, DOI 10.1111/j.1467-8624.2012.01863.x; Cruz I, 2012, OTOL NEUROTOL, V33, P751, DOI 10.1097/MAO.0b013e3182595309; Davidson Lisa S, 2014, Cochlear Implants Int, V15, P211, DOI 10.1179/1754762813Y.0000000051; DesJardin JL, 2009, J DEAF STUD DEAF EDU, V14, P22, DOI 10.1093/deafed/enn011; Dunn CC, 2014, EAR HEARING, V35, P148, DOI 10.1097/AUD.0b013e3182a4a8f0; FEIN GG, 1981, CHILD DEV, V52, P1095, DOI 10.1111/j.1467-8624.1981.tb03157.x; Fenson L, 1993, MACARTUR COMMUNICATI; Fink Nancy E, 2007, Cochlear Implants Int, V8, P92, DOI 10.1002/cii.333; Geers AE, 2003, EAR HEARING, V24, p46S, DOI 10.1097/01.AUD.0000051689.57380.1B; Gentleman R, 2008, ICENS NPMLE CENSORED; Gershkoff-Stowe L, 2004, CHILD DEV, V75, P1098, DOI 10.1111/j.1467-8624.2004.00728.x; GILBERTSON M, 1995, J SPEECH HEAR RES, V38, P630, DOI 10.1044/jshr.3803.630; Goldfield E. C., 1993, DYNAMIC APPROACHES D; Gomez G, 2009, STAT MODEL, V9, P259, DOI 10.1177/1471082X0900900402; Gregory S, 1983, ACQUISITION SYMBOLIC, P221; Henschel V, 2007, INTCOX COMPENDIUM AP; Holt RF, 2008, EAR HEARING, V29, P492, DOI 10.1097/AUD.0b013e31816c409f; Houston DM, 2012, DEVELOPMENTAL SCI, V15, P448, DOI 10.1111/j.1467-7687.2012.01140.x; Kirk KI, 2002, ANN OTO RHINOL LARYN, V111, P69, DOI 10.1177/00034894021110S515; Kluwin TN, 2000, AM ANN DEAF, V145, P26, DOI 10.1353/aad.2012.0247; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; Laing GJ, 2002, BRIT MED J, V325, P1152, DOI 10.1136/bmj.325.7373.1152; Lederberg AR, 2009, J DEAF STUD DEAF EDU, V14, P44, DOI 10.1093/deafed/enn021; Lederberg AR, 2000, CHILD DEV, V71, P1571, DOI 10.1111/1467-8624.00249; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; Mayne AM, 1998, VOLTA REV, V100, P29; MCCUNENICOLICH L, 1981, CHILD DEV, V52, P785, DOI 10.2307/1129078; Niparko JK, 2010, JAMA-J AM MED ASSOC, V303, P1498, DOI 10.1001/jama.2010.451; Pan W, 1999, J COMPUT GRAPH STAT, V8, P109, DOI 10.2307/1390923; Parmet Sharon, 2004, JAMA, V291, P2398, DOI 10.1001/jama.291.19.2398; Quittner A.L, 2007, AUDIOL MED, V5, P242, DOI DOI 10.1080/16513860701745401; Quittner AL, 2004, ARCH OTOLARYNGOL, V130, P547, DOI 10.1001/archotol.130.5.547; QUITTNER AL, 1994, PSYCHOL SCI, V5, P347, DOI 10.1111/j.1467-9280.1994.tb00284.x; Quittner AL, 2013, J PEDIATR-US, V162, P343, DOI 10.1016/j.jpeds.2012.08.003; Quittner AL, 2010, PARENT-SCI PRACT, V10, P136, DOI 10.1080/15295190903212851; Reynell J. K., 1990, REYNELL DEV LANGUAGE; Samuelson LK, 2005, DEVELOPMENTAL SCI, V8, P182, DOI 10.1111/j.1467-7687.2005.00405.x; Sharma A, 2009, J COMMUN DISORD, V42, P272, DOI 10.1016/j.jcomdis.2009.03.003; Smith LB, 1998, DEV PSYCHOL, V34, P840, DOI 10.1037/0012-1649.34.5.840; Smith LB, 2002, PSYCHOL SCI, V13, P13, DOI 10.1111/1467-9280.00403; Spencer PE, 1996, CHILD DEV, V67, P867, DOI 10.1111/j.1467-8624.1996.tb01769.x; Stelmachowicz PG, 2004, EAR HEARING, V25, P47, DOI 10.1097/01.AUD.0000111258.98509.DE; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Thal DJ, 1999, J SPEECH LANG HEAR R, V42, P482, DOI 10.1044/jslhr.4202.482; VYGOTSKY LS, 1967, SOV PSYCHOL-USSR, V5, P6, DOI 10.2753/RPO1061-040505036; Walker EA, 2013, J SPEECH LANG HEAR R, V56, P375, DOI 10.1044/1092-4388(2012/11-0343); Wellner JA, 1997, J AM STAT ASSOC, V92, P945, DOI 10.2307/2965558	55	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155964	10.1371/journal.pone.0155964	http://dx.doi.org/10.1371/journal.pone.0155964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228032	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500047
J	Selimkhanov, J; Thompson, WC; Patterson, TA; Hadcock, JR; Scott, DO; Maurer, TS; Musante, CJ				Selimkhanov, Jangir; Thompson, W. Clayton; Patterson, Terrell A.; Hadcock, John R.; Scott, Dennis O.; Maurer, Tristan S.; Musante, Cynthia J.			Evaluation of a Mathematical Model of Rat Body Weight Regulation in Application to Caloric Restriction and Drug Treatment Studies	PLOS ONE			English	Article							ENERGY-EXPENDITURE; RIMONABANT; OBESITY; MASS	The purpose of this work is to develop a mathematical model of energy balance and body weight regulation that can predict species-specific response to common pre-clinical interventions. To this end, we evaluate the ability of a previously published mathematical model of mouse metabolism to describe changes in body weight and body composition in rats in response to two short-term interventions. First, we adapt the model to describe body weight and composition changes in Sprague-Dawley rats by fitting to data previously collected from a 26-day caloric restriction study. The calibrated model is subsequently used to describe changes in rat body weight and composition in a 23-day cannabinoid receptor 1 antagonist (CB1Ra) study. While the model describes body weight data well, it fails to replicate body composition changes with CB1Ra treatment. Evaluation of a key model assumption about deposition of fat and fat-free masses shows a limitation of the model in short-term studies due to the constraint placed on the relative change in body composition components. We demonstrate that the model can be modified to overcome this limitation, and propose additional measurements to further test the proposed model predictions. These findings illustrate how mathematical models can be used to support drug discovery and development by identifying key knowledge gaps and aiding in the design of additional experiments to further our understanding of disease-relevant and species-specific physiology.	[Selimkhanov, Jangir; Thompson, W. Clayton; Patterson, Terrell A.; Hadcock, John R.; Musante, Cynthia J.] Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA; [Scott, Dennis O.; Maurer, Tristan S.] Pfizer Worldwide Res & Dev, Pharmacokinet Dynam & Metab, Cambridge, MA USA; [Patterson, Terrell A.] Pfizer Global Innovat Pharmaceut Business, Global Med Dev, Rare Dis Clin Sci, Groton, CT USA; [Hadcock, John R.] Novartis Inst Biomed Res, Vivo Pharmacol Cardiovasc & Metab Dis, Cambridge, MA USA	Pfizer; Pfizer; Pfizer; Novartis	Musante, CJ (corresponding author), Pfizer Worldwide Res & Dev, Cardiovasc & Metab Dis Res Unit, Cambridge, MA USA.	cynthia.j.musante@pfizer.com	Thompson, Clay/AAH-3843-2019	Thompson, Clay/0000-0002-9099-5480; Scott, Dennis/0000-0003-1385-6812	Pfizer Inc.	Pfizer Inc.(Pfizer)	JS, WCT, TAP, DOS, TSM, and CJM were employees of Pfizer Inc. during the completion and/or analyses of these studies. At the time the research was conducted, JRH was an employee of Pfizer Inc.; JRH currently is an employee of Novartis Institutes of Biomedical Research. Pfizer Inc. has provided all funding for these studies and was responsible for the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2008, DRUG METABOLISM R S2, V40, P1; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; DICKER SE, 1949, BIOCHEM J, V44, P274, DOI 10.1042/bj0440274; Doyon C, 2006, DIABETES, V55, P3403, DOI 10.2337/db06-0504; FORBES GB, 1987, NUTR REV, V45, P225; Gennemark P, 2015, J PHARMACOKINET PHAR, V42, P79, DOI 10.1007/s10928-014-9399-4; Gennemark P, 2013, J PHARMACOKINET PHAR, V40, P651, DOI 10.1007/s10928-013-9337-x; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Herling AW, 2008, ENDOCRINOLOGY, V149, P2557, DOI 10.1210/en.2007-1515; Heymsfield SB, 2014, OBES REV, V15, P310, DOI 10.1111/obr.12143; Jacquier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100073; Kalliokoski O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058460; MORRISON SD, 1967, Q J EXP PHYSIOL CMS, V52, P51, DOI 10.1113/expphysiol.1967.sp001885; Petras I, 2010, ACTA MONTAN SLOVACA, V15, P158; Poirier B, 2005, DIABETES OBES METAB, V7, P65, DOI 10.1111/j.1463-1326.2004.00374.x; Rodgers RJ, 2012, DIS MODEL MECH, V5, P621, DOI 10.1242/dmm.009621; Sam AH, 2011, J OBES, V2011, DOI 10.1155/2011/432607; Smoliga JM, 2012, J GERONTOL A-BIOL, V67, P158, DOI 10.1093/gerona/glr062; Thompson WC, 2016, PF 05231023 LO UNPUB; Thornton-Jones ZD, 2006, PHARMACOL BIOCHEM BE, V84, P353, DOI 10.1016/j.pbb.2006.06.001; Valsamakis G, 2014, CLIN OBES, V4, P209, DOI 10.1111/cob.12064; Williams EP, 2015, CURR OBES REP, V4, P363, DOI 10.1007/s13679-015-0169-4; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155674	10.1371/journal.pone.0155674	http://dx.doi.org/10.1371/journal.pone.0155674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227543	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500025
J	Sulatskaya, AI; Kuznetsova, IM; Belousov, MV; Bondarev, SA; Zhouravleva, GA; Turoverov, KK				Sulatskaya, Anna I.; Kuznetsova, Irina M.; Belousov, Mikhail V.; Bondarev, Stanislav A.; Zhouravleva, Galina A.; Turoverov, Konstantin K.			Stoichiometry and Affinity of Thioflavin T Binding to Sup35p Amyloid Fibrils	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION-PROTEIN; SPECTRAL PROPERTIES; FLUORESCENT DYE; PEPTIDE FIBRILS; QUANTUM YIELD; BOUND DYE; SCRAPIE; SITES; YEAST	In this work two modes of binding of the fluorescent probe thioflavin T to yeast prion protein Sup35p amyloid fibrils were revealed by absorption spectrometry of solutions prepared by equilibrium microdialysis. These binding modes exhibited significant differences in binding affinity and stoichiometry. Moreover, the absorption spectrum and the molar extinction coefficient of the dye bound in each mode were determined. The fluorescence quantum yield of the dye bound in each mode was determined via a spectrofluorimetric study of the same solutions in which the recorded fluorescence intensity was corrected for the primary inner filter effect. As previously predicted, the existence of one of the detected binding modes may be due to the incorporation of the dye into the grooves along the fiber axis perpendicular to the beta-sheets of the fibrils. It was assumed that the second type of binding with higher affinity may be due to the existence of ThT binding sites that are localized to areas where amyloid fibrils are clustered.	[Sulatskaya, Anna I.; Kuznetsova, Irina M.; Turoverov, Konstantin K.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, Tikhoretsky Ave 4, St Petersburg 194064, Russia; [Turoverov, Konstantin K.] Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Polytech Skaya 29, St Petersburg 195251, Russia; [Belousov, Mikhail V.; Bondarev, Stanislav A.; Zhouravleva, Galina A.] St Petersburg State Univ, Dept Genet & Biotechnol, Univ Skaya Emb 7-9, St Petersburg 199034, Russia; [Bondarev, Stanislav A.; Zhouravleva, Galina A.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS; Peter the Great St. Petersburg Polytechnic University; Saint Petersburg State University; Saint Petersburg State University	Turoverov, KK (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, Tikhoretsky Ave 4, St Petersburg 194064, Russia.; Turoverov, KK (corresponding author), Peter Great St Petersburg Polytech Univ, Inst Phys Nanotechnol & Telecommun, Polytech Skaya 29, St Petersburg 195251, Russia.	kkt@incras.ru	Bondarev, Stanislav/AAD-5124-2022; Zhouravleva, Galina/G-8651-2013; Belousov, Mikhail V./K-6017-2014; Kuznetsova, Irina M./R-9844-2017; Sulatskaya, Anna/I-6042-2014; Bondarev, Stanislav/F-7518-2014; Turoverov, Konstantin/S-2079-2016	Bondarev, Stanislav/0000-0003-3137-944X; Zhouravleva, Galina/0000-0002-3013-4662; Belousov, Mikhail V./0000-0002-7856-9075; Kuznetsova, Irina M./0000-0002-3336-4834; Sulatskaya, Anna/0000-0002-1207-3384; Bondarev, Stanislav/0000-0003-3137-944X; Turoverov, Konstantin/0000-0002-6977-1896	"Molecular and Cell Biology" Program of the Russian Academy of Sciences; Russian Foundation of Basic Research [16-54-00230 Bel, 16-04-01614]; RF President Fellowship [SP-1982.2015.4]; Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University; Saint-Petersburg State University [1.37.291.2015, 1.50.1041.2014]	"Molecular and Cell Biology" Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); RF President Fellowship; Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University; Saint-Petersburg State University	This work was supported in part by the "Molecular and Cell Biology" Program of the Russian Academy of Sciences, Russian Foundation of Basic Research, grants 16-54-00230 Bel (KKT) and 16-04-01614 (AIS), the RF President Fellowship SP-1982.2015.4 (AIS), and the Research Resource Center "Molecular and Cell Technologies" of Saint-Petersburg State University. The authors acknowledge Saint-Petersburg State University for the following research grants: 1.37.291.2015 (GAZ), 1.50.1041.2014 (GAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Allen KD, 2005, GENETICS, V169, P1227, DOI 10.1534/genetics.104.037168; Almstedt K, 2009, PRION, V3, P224, DOI 10.4161/pri.3.4.10112; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; De Ferrari GV, 2001, J BIOL CHEM, V276, P23282, DOI 10.1074/jbc.M009596200; DEARMOND SJ, 1993, BRIT MED BULL, V49, P725, DOI 10.1093/oxfordjournals.bmb.a072644; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DIENER TO, 1982, P NATL ACAD SCI-BIOL, V79, P5220, DOI 10.1073/pnas.79.17.5220; Fodera V, 2008, J PHYS CHEM B, V112, P15174, DOI 10.1021/jp805560c; Fonin AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103878; GAJDUSEK DC, 1957, NEW ENGL J MED, V257, P974, DOI 10.1056/NEJM195711142572005; GIBBS CJ, 1978, P NATL ACAD SCI USA, V75, P6268, DOI 10.1073/pnas.75.12.6268; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004; Groenning M, 2007, J STRUCT BIOL, V158, P358, DOI 10.1016/j.jsb.2006.12.010; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; HADLOW WJ, 1959, LANCET, V2, P289; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; HSIAO K, 1990, NEUROLOGY, V40, P1820, DOI 10.1212/WNL.40.12.1820; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Kitts CC, 2009, J PHYS CHEM B, V113, P12090, DOI 10.1021/jp903509u; KLATZO I, 1959, LAB INVEST, V8, P799; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040845; Kuznetsova IM, 2012, MOL NEUROBIOL, V45, P488, DOI 10.1007/s12035-012-8272-y; Kuznetsova IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030724; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Mao XB, 2011, ACS CHEM NEUROSCI, V2, P281, DOI 10.1021/cn200006h; Maskevich AA, 2007, J PROTEOME RES, V6, P1392, DOI 10.1021/pr0605567; Morimoto K, 2009, J BIOCHEM, V145, P677, DOI 10.1093/jb/mvp025; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Narayanan S, 2006, CHEMBIOCHEM, V7, P757, DOI 10.1002/cbic.200500382; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Serio TR, 1999, METHOD ENZYMOL, V309, P649; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Sulatskaya AI, 2010, SPECTROSC-INT J, V24, P169, DOI 10.1155/2010/620781; Sulatskaya A. I., 2015, P 7 EUR C BIOL MED S, P11; Sulatskaya Anna I, 2012, Methods Mol Biol, V895, P441, DOI 10.1007/978-1-61779-927-3_26; Sulatskaya AI, 2012, J PHYS CHEM B, V116, P2538, DOI 10.1021/jp2083055; Sulatskaya AI, 2011, J PHYS CHEM B, V115, P11519, DOI 10.1021/jp207118x; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Sutharsan J, 2010, CHEMMEDCHEM, V5, P56, DOI 10.1002/cmdc.200900440; Turoverov K. K., 2007, P SPIE, V6733; Ye L, 2005, J BIOL CHEM, V280, P23599, DOI 10.1074/jbc.M501285200; Ye L, 2008, J NEUROCHEM, V105, P1428, DOI 10.1111/j.1471-4159.2008.05245.x	52	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156314	10.1371/journal.pone.0156314	http://dx.doi.org/10.1371/journal.pone.0156314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228180	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500111
J	Zeng, WF; Li, Y; Sheng, CS; Huang, QF; Kang, YY; Zhang, L; Wang, S; Cheng, YB; Li, FK; Wang, JG				Zeng, Wei-Fang; Li, Yan; Sheng, Chang-Sheng; Huang, Qi-Fang; Kang, Yuan-Yuan; Zhang, Lu; Wang, Shuai; Cheng, Yi-Bang; Li, Fei-Ka; Wang, Ji-Guang			Association of Anthropometric and Bioelectrical Impedance Analysis Measures of Adiposity with High Molecular Weight Adiponectin Concentration	PLOS ONE			English	Article							METABOLIC SYNDROME; BODY-COMPOSITION; OBESITY; POPULATION; MEN; HYPOADIPONECTINEMIA; HYPERTENSION; DISEASE; CHINESE; HUMANS	Objective To investigate the relationship between adiposity measures and plasma concentration of high molecular weight (HMW) adiponectin. Methods In a Chinese sample (n = 1081), we performed measurements of anthropometry and bioelectrical impedance analysis (B broken vertical bar A). We defined overweight and obesity as a body mass index between 24 and 27.4 kg/m(2) and >= 27.5 kg/m(2), respectively, and central obesity as a waist circumference >= 90 cm in men and >= 80 cm in women. Plasma HMW adiponectin concentration was measured by the ELISA method. Results Plasma HMW adiponectin concentration was significantly (P < 0.0001) higher in women (n = 677, 2.47 mu g/mL) than men (n = 404, 1.58 mu g/mL) and correlated with advancing age in men (r = 0.28) and women (r = 0.29). In adjusted analyses, it was lower in the presence of overweight (n = 159, 1.26 mu g/mL in men and n = 227, 2.15 mu g/mL in women) and obesity (n = 60, 1.31 mu g/mL and n = 82, 2.10 mu g/mL, respectively) than normal weight subjects (n = 185, 2.07 mu g/mL and n = 368, 2.94 mu g/mL, respectively) and in the presence of central obesity (n = 106, 1.28 mu g/mL and n = 331, 2.12 mu g/mL, respectively) than subjects with a normal waist circumference (n = 298, 1.74 mu g/mL and n = 346, 2.74 mu g/mL, respectively). In multiple regression analyses stratified for gender, adjusted for confounders and considered separately each of the adiposity measures, all adiposity measures were significantly (r -0.18 to -0.31, P < 0.001) associated with plasma HMWadiponectin concentration. However, in further stratified and adjusted regression analyses considered stepwise all adiposity measures, only waist-to-hip ratio was significantly (P < 0.05) associated with plasma HMW adiponectin concentration inmen (r = -0.10) and women (r = -0.15). Conclusions Anthropometric measures of obesity, such as waist-to-hip ratio, but not BIA measures, are independently associated with plasma adiponectin concentration.	[Zeng, Wei-Fang; Li, Yan; Sheng, Chang-Sheng; Huang, Qi-Fang; Kang, Yuan-Yuan; Zhang, Lu; Wang, Shuai; Cheng, Yi-Bang; Li, Fei-Ka; Wang, Ji-Guang] Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Shanghai Key Lab Hypertens,Ruijin Hosp, Shanghai Inst Hypertens,Dept Hypertens,Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, JG (corresponding author), Shanghai Jiao Tong Univ, Ctr Epidemiol Studies & Clin Trials, Shanghai Key Lab Hypertens,Ruijin Hosp, Shanghai Inst Hypertens,Dept Hypertens,Sch Med, Shanghai 200030, Peoples R China.	jiguangwang@aim.com	Wang, Ji Guang/AAP-4045-2021	Wang, Ji Guang/0000-0001-8511-1524; Cheng, Yi-Bang/0000-0002-3822-3504	National Natural Science Foundation of China [81170245, 81270373, 81470533]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was financially supported by grants from the National Natural Science Foundation of China, grant number: 81170245, 81270373 and 81470533, http://www.nsfc.gov.cn/. JGW received the funding.	Araki S, 2006, J CLIN ENDOCR METAB, V91, P5113, DOI 10.1210/jc.2006-1051; Basu R, 2007, DIABETES, V56, P2174, DOI 10.2337/db07-0185; Bray M, 2013, OBESITY, V21, pE435, DOI 10.1002/oby.20125; Browning LM, 2010, OBESITY, V18, P2385, DOI 10.1038/oby.2010.71; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Dulloo AG, 2010, INT J OBESITY, V34, pS4, DOI 10.1038/ijo.2010.234; Gavrila A, 2003, J CLIN ENDOCR METAB, V88, P4823, DOI 10.1210/jc.2003-030214; Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061; Hirose H, 2010, J ATHEROSCLER THROMB, V17, P1201, DOI 10.5551/jat.6106; Huang QF, 2013, AM J HYPERTENS, V26, P754, DOI 10.1093/ajh/hpt014; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Karmelic I, 2012, ARCH MED RES, V43, P145, DOI 10.1016/j.arcmed.2012.02.004; Koenig W, 2006, J AM COLL CARDIOL, V48, P1369, DOI 10.1016/j.jacc.2006.06.053; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Maruyama C, 2009, J ATHEROSCLER THROMB, V16, P207, DOI 10.5551/jat.E067; Poonawalla AH, 2013, J MAGN RESON IMAGING, V37, P707, DOI 10.1002/jmri.23846; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sheng CS, 2013, BLOOD PRESSURE, V22, P158, DOI 10.3109/08037051.2012.748998; Sheng CS, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-6; Snijder MB, 2006, DIABETES CARE, V29, P2498, DOI 10.2337/dc06-0952; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Torigoe M, 2007, CLIN ENDOCRINOL, V67, P276, DOI 10.1111/j.1365-2265.2007.02876.x; Unno M, 2012, J ATHEROSCLER THROMB, V19, P462; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang JG, 2013, J STRENGTH COND RES, V27, P236, DOI 10.1519/JSC.0b013e31824f2040	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156041	10.1371/journal.pone.0156041	http://dx.doi.org/10.1371/journal.pone.0156041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227680	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500056
J	Brownlow, A; Onoufriou, J; Bishop, A; Davison, N; Thompson, D				Brownlow, Andrew; Onoufriou, Joseph; Bishop, Amanda; Davison, Nicholas; Thompson, Dave			Corkscrew Seals: Grey Seal (Halichoerus grypus) Infanticide and Cannibalism May Indicate the Cause of Spiral Lacerations in Seals	PLOS ONE			English	Article							GRAY SEALS; POSTWEANING FAST; PHOCA-VITULINA; SABLE-ISLAND; POPULATION; BEHAVIOR; PUPS; MOVEMENTS; MORTALITY; DURATION	Large numbers of dead seals with characteristic spiral lesions have been washing ashore around the North Atlantic over the past two decades. Interactions with ship propellers and shark predation have been suggested as the likely causal mechanisms. However, new evidence points towards a more likely candidate: grey seal predation. An adult male grey seal was observed and recorded catching, killing and eating five weaned grey seal pups over a period of one week on the Isle of May, Scotland. A further 9 carcasses found in the same area exhibited similar injuries. Post mortem analysis of lesions indicated the wound characteristics were similar to each other and in 12 of the 14 carcasses analysed, were indistinguishable from carcasses previously attributed to propeller interaction. We therefore propose that most of the seal carcasses displaying spiral lacerations in the UK are caused by grey seal predation. Cases in other locations should be re-evaluated using the scoring system presented here to identify whether grey seal predation is a major cause of mortality in phocid seals.	[Brownlow, Andrew; Davison, Nicholas] SAC Vet Serv Drummondhill, Scottish Marine Anim Stranding Scheme, Stratherrick Rd, Inverness 1V2 4JZ, Scotland; [Onoufriou, Joseph; Thompson, Dave] Univ St Andrews, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Bishop, Amanda] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Scottish Agricultural College; University of St Andrews; Durham University	Onoufriou, J (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland.	jo26@st-andrews.ac.uk	Brownlow, Andrew C/P-6593-2018; Brownlow, Andrew/ABA-4653-2020	Brownlow, Andrew/0000-0001-9885-7480; Thompson, David/0000-0003-1546-2876; Davison, Nicholas/0000-0001-7286-1836	Marine Scotland [MMS001/11]; National Capability funding from the Natural Environment Research Council [SMRU1001]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Marine Scotland; National Capability funding from the Natural Environment Research Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Marine Scotland (http://www.gov.scot/Topics/marine/Publications/TopicSheets/MSScience, project: MMS001/11) and additionally supported by National Capability funding from the Natural Environment Research Council (http://www.nerc.ac.uk/) to the Sea Mammal Research Unit (grant no. SMRU1001).	[Anonymous], 1998, CAN COOOPERATIVE WIL, V5, P6; ARNBOM T, 1993, CAN J ZOOL, V71, P1772, DOI 10.1139/z93-252; BEDARD C, 1993, MAR MAMMAL SCI, V9, P421, DOI 10.1111/j.1748-7692.1993.tb00474.x; Bennett KA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P911, DOI 10.1086/656925; Bexton S, 2012, AQUAT MAMM, V38, P229, DOI 10.1578/AM.38.3.2012.229; Bishop A, 2016, AQUAT MAMM; Bonner W., 1972, OCEANGR MAR BIOL ANN, V10, P461; BOWEN WD, 1992, J ZOOL, V227, P607, DOI 10.1111/j.1469-7998.1992.tb04418.x; Boyle D, 2009, CCWWW104; Boyle D, 2011, CCWWW111; Crocker DE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P11, DOI 10.1086/663634; FEDAK MA, 1982, J ZOOL, V198, P473, DOI 10.1111/jzo.1982.198.4.473; Gaydos Joseph K., 2005, Northwestern Naturalist, V86, P150, DOI 10.1898/1051-1733(2005)086[0150:SSKOHS]2.0.CO;2; Haelters J, 2015, AQUAT MAMM, V41, P351, DOI 10.1578/AM.41.3.2015.351; Haelters J, 2012, AQUAT MAMM, V38, P343, DOI 10.1578/AM.38.4.2012.343; Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748-7692.2007.00132.x; HAMMOND PS, 1994, J APPL ECOL, V31, P340, DOI 10.2307/2404548; Hanson N, 2015, AQUAT CONSERV MAR FR; Jauniaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108993; KRUUK H, 1972, J ZOOL, V166, P233, DOI 10.1111/j.1469-7998.1972.tb04087.x; Leopold M, 2015, P R SOC B, V282; Lidgard DC, 2001, J ZOOL SOC LONDON, V255; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lucas Z, 2000, J ZOOL, V252, P405, DOI 10.1017/S0952836900000157; Lucas Zoe N., 2010, Proceedings of the Nova Scotian Institute of Science, V45, P64; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MILLER FL, 1985, CAN J ZOOL, V63, P295, DOI 10.1139/z85-045; Noren SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P269, DOI 10.1086/528777; Onoufriou J, 2014, MMS00111; PRIME JH, 1990, J APPL ECOL, V27, P435, DOI 10.2307/2404292; REILLY JJ, 1991, AM J PHYSIOL, V260, pR267, DOI 10.1152/ajpregu.1991.260.2.R267; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCOS, 2015, SCI ADV MATT REL MAN; SOLHEIM R, 1984, ANN ZOOL FENN, V21, P301; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Thompson D, 2010, MMS00111; THOMPSON PM, 1990, J APPL ECOL, V27, P924, DOI 10.2307/2404387; TRIGGS GS, 1991, J ZOOL, V225, P449, DOI 10.1111/j.1469-7998.1991.tb03828.x; Twiss S, 1994, J ZOOL SOC LONDON, V233; van Bleijswijk JDL, 2014, MAR ECOL PROG SER, V513, P277, DOI 10.3354/meps11004; van Neer A, 2015, J SEA RES, V97, P1, DOI 10.1016/j.seares.2014.11.006	43	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156464	10.1371/journal.pone.0156464	http://dx.doi.org/10.1371/journal.pone.0156464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254025	gold, Green Published, Green Accepted			2022-12-27	WOS:000377218700032
J	Liang, D; Wang, TF; Rotgans, BA; McManus, DP; Cummins, SF				Liang, Di; Wang, Tianfang; Rotgans, Bronwyn A.; McManus, Donald P.; Cummins, Scott F.			Ionotropic Receptors Identified within the Tentacle of the Freshwater Snail Biomphalaria glabrata, an Intermediate Host of Schistosoma mansoni	PLOS ONE			English	Article							PROTEIN; NEURONS; KAINATE; PRAZIQUANTEL; EVOLUTION; AFRICA; GENOME	Biomphalaria glabrata (B. glabrata) is an air-breathing aquatic mollusc found in freshwater habitats across the Western Hemisphere. It is most well-known for its recognized capacity to act as a major intermediate host for Schistosoma mansoni, the human blood fluke parasite. Ionotropic receptors (IRs), a variant family of the ionotropic glutamate receptors (iGluR), have an evolutionary ancient function in detecting odors to initiate chemosensory signaling. In this study, we applied an array of methods towards the goal of identifying IR-like family members in B. glabrata, ultimately revealing two types, the iGluR and IR. Sequence alignment showed that three ligand-binding residues are conserved in most Biomphalaria iGluR sequences, while the IRs did exhibit a variable pattern, lacking some or all known glutamate-interactingresidues, supporting their distinct classification from the iGluRs. We show that B. glabrata contains 7 putative IRs, some of which are expressed within its chemosensory organs. To further investigate a role for the more ancient IR25a type in chemoreception, we tested its spatial distribution pattern within the snail cephalic tentacle by in situ hybridization. The presence of IR25a within presumptive sensory neurons supports a role for this receptor in olfactory processing, contributing to our understanding of the molecular pathways that are involved in Biomphalaria olfactory processing.	[Liang, Di; Wang, Tianfang; Rotgans, Bronwyn A.; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld 4558, Australia; [McManus, Donald P.] QIMR Berghofer Med Res Inst, Mol Parasitol Lab, Brisbane, Qld 4006, Australia	University of the Sunshine Coast; QIMR Berghofer Medical Research Institute	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	McManus, Don/AAC-5394-2020; Wang, Tianfang/GRO-0844-2022; Wang, Tianfang/AAG-4290-2020; Wang, Tianfang/L-5192-2016; Cummins, Scott/I-6420-2016	McManus, Don/0000-0001-6443-1449; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [FT110100990]; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council (Future Fellowship, FT110100990 to SFC). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bonfardin VDJ, 2010, J NEUROSCI, V30, P985, DOI 10.1523/JNEUROSCI.3389-09.2010; Case D. A., 2014, AMBER 14; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Corey EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060551; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cummins SF, 2007, GENOMICS, V90, P110, DOI 10.1016/j.ygeno.2007.03.020; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; Derby CD, 1997, J EXP BIOL, V200, P2073; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Groh-Lunow Katrin C, 2014, Front Cell Neurosci, V8, P448, DOI 10.3389/fncel.2014.00448; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Pravin S, 2012, J COMP PHYSIOL A, V198, P669, DOI 10.1007/s00359-012-0738-x; Rodriguez-Moreno A, 2007, J NEUROCHEM, V103, P2121, DOI 10.1111/j.1471-4159.2007.04924.x; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Shaham S, 2010, NAT REV NEUROSCI, V11, P212, DOI 10.1038/nrn2740; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stepanyan R, 2004, CHEM SENSES, V29, P179, DOI 10.1093/chemse/bjh023; Tadesse T, 2011, DEV NEUROBIOL, V71, P316, DOI 10.1002/dneu.20862; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Tuchina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096430; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	34	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156380	10.1371/journal.pone.0156380	http://dx.doi.org/10.1371/journal.pone.0156380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253696	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700022
J	Yip, EC; Berner-Aharon, N; Smith, DR; Lubin, Y				Yip, Eric C.; Berner-Aharon, Na'ama; Smith, Deborah R.; Lubin, Yael			Coy Males and Seductive Females in the Sexually Cannibalistic Colonial Spider, Cyrtophora citricola	PLOS ONE			English	Article							MALE MATE CHOICE; CONDITIONAL MONOGYNY; SPERM COMPETITION; SIZE DIMORPHISM; EVOLUTION; SELECTION; ARANEAE; PREFERENCE; POLYANDRY; SACRIFICE	The abundance of sperm relative to eggs selects for males that maximize their number of mates and for females that choose high quality males. However, in many species, males exercise mate choice, even when they invest little in their offspring. Sexual cannibalism may promote male choosiness by limiting the number of females a male can inseminate and by biasing the sex ratio toward females because, while females can reenter the mating pool, cannibalized males cannot. These effects may be insufficient for male choosiness to evolve, however, if males face low sequential encounter rates with females. We hypothesized that sexual cannibalism should facilitate the evolution of male choosiness in group living species because a male is likely to encounter multiple receptive females simultaneously. We tested this hypothesis in a colonial orb-weaving spider, Cyrtophora citricola, with a high rate of sexual cannibalism. We tested whether mated females would mate with multiple males, and thereby shift the operational sex ratio toward females. We also investigated whether either sex chooses mates based on nutritional state and age, and whether males choose females based on reproductive state. We found that females are readily polyandrous and exhibit no mate choice related to male feeding or age. Males courted more often when the male was older and the female was younger, and males copulated more often with well-fed females. The data show that males are choosier than females for the traits we measured, supporting our hypothesis that group living and sexual cannibalism may together promote the evolution of male mate choice.	[Yip, Eric C.; Berner-Aharon, Na'ama; Lubin, Yael] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Swiss Inst Dryland Environm & Energy Res, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Smith, Deborah R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Ben Gurion University; University of Kansas	Yip, EC (corresponding author), Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Swiss Inst Dryland Environm & Energy Res, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel.	ecy7@cornell.edu	Smith, Deborah/V-1676-2019; Lubin, Yael D/F-1382-2012	Smith, Deborah/0000-0002-2581-5009; Lubin, Yael D/0000-0003-3876-1668; Yip, Eric/0000-0002-3543-3717	U.S.-Israel Binational Science Foundation [2010178]; Jacob Blaustein Center for Scientific Cooperation; Kreitman School for Advanced Graduate Studies	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Jacob Blaustein Center for Scientific Cooperation; Kreitman School for Advanced Graduate Studies	The study was funded by the U.S.-Israel Binational Science Foundation, grant #2010178. Additional funding to ECY was provided by the Jacob Blaustein Center for Scientific Cooperation and the Kreitman School for Advanced Graduate Studies.	Aisenberg A, 2007, BEHAV ECOL SOCIOBIOL, V62, P29, DOI 10.1007/s00265-007-0435-x; Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berner-Aharon N., 2013, THESIS BEN GURION U; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BUCHLI HHR, 1969, AM ZOOL, V9, P175; Darwin C., 1871, P423; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Elgar MA, 1996, BEHAV ECOL, V7, P195, DOI 10.1093/beheco/7.2.195; Elgar MA, 2003, AUST J ZOOL, V51, P357, DOI 10.1071/ZO02079; Elgar MA, 2004, ADV STUD BEHAV, V34, P135, DOI 10.1016/S0065-3454(04)34004-0; Elgar Mark A., 1992, P128; Fromhage L, 2005, EVOLUTION, V59, P1400; Fromhage L, 2012, ECOL EVOL, V2, P2572, DOI 10.1002/ece3.372; Gaskett AC, 2007, BIOL REV, V82, P26, DOI 10.1111/j.1469-185X.2006.00002.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; JENNI DA, 1972, AUK, V89, P743, DOI 10.2307/4084107; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; Kvarnemo C, 2000, J EVOLUTION BIOL, V13, P882, DOI 10.1046/j.1420-9101.2000.00228.x; Rao D, 2010, ISR J ECOL EVOL, V56, P21, DOI 10.1560/IJEE.56.1.21; RIECHERT SE, 1995, ANIM BEHAV, V49, P715, DOI 10.1016/0003-3472(95)80204-5; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; RYPSTRA AL, 1979, BEHAV ECOL SOCIOBIOL, V5, P291, DOI 10.1007/BF00293677; Scharer L, 2012, TRENDS ECOL EVOL, V27, P260, DOI 10.1016/j.tree.2011.12.006; Schneider J., 2015, CRYPTIC FEMALE CHOIC, P55; Schneider JM, 2001, BEHAV ECOL, V12, P547, DOI 10.1093/beheco/12.5.547; Schneider Jutta, 2011, P215; Schneider J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P441, DOI 10.1007/978-3-642-02624-9_15; Schneider JM, 2016, ETHOLOGY, V122, P257, DOI 10.1111/eth.12466; Schulte KF, 2010, ANIM BEHAV, V80, P699, DOI 10.1016/j.anbehav.2010.07.005; Schulz S, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P110, DOI 10.1017/CBO9780511542664.005; SINGER F, 1995, BEHAV ECOL SOCIOBIOL, V36, P313, DOI 10.1007/BF00167792; Snow LSE, 2005, P ROY SOC B-BIOL SCI, V272, P1139, DOI 10.1098/rspb.2005.3088; South SH, 2012, EVOLUTION, V66, P3722, DOI 10.1111/j.1558-5646.2012.01716.x; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uetz George W., 1997, P458; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; Vollrath F., 1987, P357; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Welke KW, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-7; Wilgers DJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P29, DOI 10.1007/s00265-011-1248-5; Yip EC, 2016, BIOL J LINN SOC, V118, P410, DOI 10.1111/bij.12730; Zimmer SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031389	51	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155433	10.1371/journal.pone.0155433	http://dx.doi.org/10.1371/journal.pone.0155433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249787	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700013
J	Di Tullio, JC; Gandra, TBR; Zerbini, AN; Secchi, ER				Di Tullio, Juliana Couto; Gandra, Tiago B. R.; Zerbini, Alexandre N.; Secchi, Eduardo R.			Diversity and Distribution Patterns of Cetaceans in the Subtropical Southwestern Atlantic Outer Continental Shelf and Slope	PLOS ONE			English	Article							WHALES MEGAPTERA-NOVAEANGLIAE; GULF-OF-CALIFORNIA; RELATIVE ABUNDANCE; BETA-DIVERSITY; SOUTHERN; HABITAT; BRAZIL; DOLPHINS; DENSITY; WATERS	Temporal and spatial patterns of cetacean diversity and distribution were investigated through eight ship-based surveys carried out during spring and autumn between 2009 and 2014 on the outer continental shelf (similar to 150m) and slope (1500m) off southeastern and southern Brazil (similar to 23 degrees S to similar to 34 degrees S). The survey area was divided into southeast and south areas according to their oceanographic characteristics. Twenty-one species were observed in 503 sightings. The overall number of species was similar between the two areas, though it was higher in the spring in the south area. Five species were dominant and diversity varied more seasonally than spatially. ANOVA and kernel analyses showed that overall cetacean densities were higher in spring compared to autumn. Physeter macrocephalus, the most frequent species, concentrated throughout the south area at depths over 1000m in both seasons. Despite the overlapped occurrence at a broader scale, small delphinids presented latitudinal and in-offshore gradients as well as seasonal variation in distribution patterns, which could indicate habitat partitioning between some species. Delphinus delphis was only recorded in the south and its density decreased in areas where the presence of Stenella frontalis increased, mainly beyond the 250m isobath. Densities of S. longirostris and S. attenuata increased in lower latitudes and beyond the shelf break. The large delphinids Tursiops truncatus and Globicephala melas formed mixed groups in many occasions and were observed along the study area around depths of 500m. Grampus griseus was twice as frequent in the south area and densities increased in waters deeper than 600m. As expected, densities of both small and large migratory whales were higher during spring, over the continental slope, in the southeast area. The results presented here provided strong evidence on the importance of the outer continental shelf and slope to a diverse community of cetaceans occurring in the subtropical Southwestern Atlantic.	[Di Tullio, Juliana Couto; Secchi, Eduardo R.] Univ Fed Rio Grande, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha ECOMEGA, Rio Grande, RS, Brazil; [Gandra, Tiago B. R.] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul IFR, Lab Geotecnol & Meio Ambiente GEOMA, Rio Grande, RS, Brazil; [Zerbini, Alexandre N.] Cascadia Res Collect, Olympia, WA USA; [Zerbini, Alexandre N.] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Zerbini, Alexandre N.] Inst Aqualie, R Dr Paulo Japiassu Coelho 714-206, Juiz De Fora, MG, Brazil	Universidade Federal do Rio Grande; National Oceanic Atmospheric Admin (NOAA) - USA	Di Tullio, JC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha ECOMEGA, Rio Grande, RS, Brazil.	ditullio.juliana@gmail.com	Gandra, Tiago/AAC-1457-2020; Secchi, Eduardo R./ABF-1191-2020; Zerbini, Alexandre/ABH-3916-2020	Gandra, Tiago/0000-0002-7165-770X; Secchi, Eduardo R./0000-0001-9087-9909; Zerbini, Alexandre/0000-0002-9776-6605	Chevron Brasil Upstrem Frade Ltda; BG Group, Brasil; National Counsel of Technological and Scientific Development (CNPq) [143263/2011-0, PQ 307843/2014-0]; CNPq [610012/2011-8]	Chevron Brasil Upstrem Frade Ltda; BG Group, Brasil; National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was mostly funded by Chevron Brasil Upstrem Frade Ltda. Additional funding was provided by BG Group, Brasil. The Brazilian Inter-Ministerial Commission for the Resources of the Sea (CIRM) supplied diesel for the ship for all surveys. The National Counsel of Technological and Scientific Development (CNPq) provided a scholarship to JCDT (Process 143263/2011-0) and a research fellowship to ERS (PQ 307843/2014-0). This study is a contribution of the Research Group "Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq" and the Brazilian National Institute of Science and Technology - INCT-Mar COI funded by CNPq Grant Number 610012/2011-8. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all researchers and students from the Federal University of Rio Grande-FURG and many other institutions who helped collecting the data at sea and especially F Abdala, M Bassoi, F Castro, PF Fruet, R Genoves, J Prado and E Seyboth. We also thank the crew of FURG's R/V "Atlantico Sul" for helping us in all onboard activities. A Andriolo, S Botta, L Fidelix, G Miranda, M Pinho, S Weigert, and the personnel of the Fleet Division provided logistical support. L Dalla Rosa, V Tavano, LS Madureira, A Azevedo and the anonymous referees provided useful suggestions to improve the manuscript. We dedicate this study to the late skipper of the R/V "Atlantico Sul" Mr. Homero Poujeaux Alvariz for his lifetime dedication to our research vessel. This study is a contribution of the Research Group "Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq" and the Brazilian National Institute of Science and Technology - INCT-Mar COI funded by CNPq Grant Number 610012/2011-8.	Mandiola M. Agustina, 2015, Mastozool. neotrop., V22, P397; Andriolo A, 2010, ZOOLOGIA-CURITIBA, V27, P741, DOI 10.1590/S1984-46702010000500011; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Azzellino A, 2012, OCEAN COAST MANAGE, V67, P63, DOI 10.1016/j.ocecoaman.2012.05.024; Baines Mick E., 2014, Journal of Cetacean Research and Management, V14, P57; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barlow J, 2007, FISH B-NOAA, V105, P509; Bastida R, 2007, MAMIFEROS ACUATICOS; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braga ES, 2008, CONT SHELF RES, V28, P1649, DOI 10.1016/j.csr.2007.06.018; BRANDINI FP, 1990, HYDROBIOLOGIA, V196, P111, DOI 10.1007/BF00006105; Campbell GS, 2015, DEEP-SEA RES PT II, V112, P143, DOI 10.1016/j.dsr2.2014.10.008; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Chen Y., 2012, MULTIPLE SITE BIODIV; CLARKE MR, 1980, MAR BIOL, V59, P235, DOI 10.1007/BF00404746; Cords M., 2014, PRIMATES CETACEANS F, P409, DOI DOI 10.1007/978-4-431-54523-1_21; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Danilewicz Daniel, 2013, Marine Biodiversity Records, V6, pe6, DOI 10.1017/S1755267212000929; Davis RW, 2002, DEEP-SEA RES PT I, V49, P121, DOI 10.1016/S0967-0637(01)00035-8; de Mahiques MM, 2004, CONT SHELF RES, V24, P1685, DOI 10.1016/j.csr.2004.05.013; de Vivo M, 2011, BIOTA NEOTROP, V11, P111, DOI 10.1590/S1676-06032011000500007; do Amaral KB, 2015, J EXP MAR BIOL ECOL, V472, P166, DOI 10.1016/j.jembe.2015.07.013; Doksaeter L, 2008, DEEP-SEA RES PT II, V55, P243, DOI 10.1016/j.dsr2.2007.09.009; dos Santos RA, 2002, B MAR SCI, V71, P753; dos Santos RA, 2001, FISH RES, V52, P99; Edwards EF, 2015, MAMMAL REV, V45, P197, DOI 10.1111/mam.12048; Fertl D, 2003, MAMMAL REV, V33, P253, DOI 10.1046/j.1365-2907.2003.00033.x; Fox J., 2015, COMPANION APPL REGRE; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Gill PC, 2015, J WILDLIFE MANAGE, V79, P672, DOI 10.1002/jwmg.867; Goncalves LR, 2016, J MAR BIOL ASSOC UK, V96, P943, DOI 10.1017/S0025315415001812; Haimovici M, 2014, FISH RES, V152, P1, DOI 10.1016/j.fishres.2013.09.007; Haimovici M, 2009, LAT AM J AQUAT RES, V37, P395, DOI 10.3856/vol37-issue3-fulltext-10; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Hiby A.R., 1989, Reports of the International Whaling Commission Special Issue, P47; Jaquet N, 2002, MAR BIOL, V141, P591, DOI 10.1007/s00227-002-0839-0; Jefferson TA, 2014, MAMMAL REV, V44, P56, DOI 10.1111/mam.12008; Knoppers B., 2010, BIOL MARINHA, P529; Lodi L, 2014, MAR ECOL-EVOL PERSP, V35, P516, DOI 10.1111/maec.12108; Macleod K, 2004, MAR ECOL PROG SER, V277, P263, DOI 10.3354/meps277263; Madureira LASP, 2005, SERIE DOCUMENTOS REV; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martins AS, 2005, J MAR BIOL ASSOC UK, V85, P1223, DOI 10.1017/S002531540501235X; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; Moreno IB, 2005, MAR ECOL PROG SER, V300, P229, DOI 10.3354/meps300229; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Nino-Torres C, 2014, MAR MAMMAL SCI, V30, P1748; Obe RO, 2011, POSTGIS IN ACTION, P492; Oksanen J, 2015, COMMUNITY ECOLOGY PA; Ott PH, 2013, MAMIFEROS RIO GRANDE, P457; Parente Cristiano Leite, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000100007; Pastene LA, 2015, REV BIOL MAR OCEANOG, V50, P453, DOI 10.4067/S0718-19572015000400005; Pinedo M. C., 2002, Journal of Cetacean Research and Management, V4, P323; Piola A. R., 2000, Journal of Geophysical Research, V105, P6565, DOI 10.1029/1999JC000300; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; Prado JHF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146339; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Ripley B, 2015, SUPPORT FUNCTIONS DA; Salvadeo CJ, 2011, CIENC MAR, V37, P215, DOI 10.7773/cm.v37i2.1840; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Signorini S, 2006, J GEO RES, V33; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Thomas PO, 2016, MAR MAMMAL SCI, V32, P682, DOI 10.1111/mms.12281; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tynan CT, 2005, DEEP-SEA RES PT II, V52, P145, DOI 10.1016/j.dsr2.2004.09.024; VINOGRADOV M, 1981, ANAL MARINE ECOSYSTE; Whitehead H, 2010, MAR ECOL PROG SER, V408, P1, DOI 10.3354/meps08619; Wickham H., 2014, IMPLEMENTATION GRAMM; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; WOLDA H, 1983, OECOLOGIA, V58, P290, DOI 10.1007/BF00385226; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Zerbini A N, 2004, SERIE DOCUMENTOS REV, P40; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113; Zerbini Alexandre N., 1996, Report of the International Whaling Commission, V46, P333	82	33	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155841	10.1371/journal.pone.0155841	http://dx.doi.org/10.1371/journal.pone.0155841			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243455	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100008
J	Dorow, M; Lobner, M; Stein, J; Pabst, A; Konnopka, A; Meisel, HJ; Gunther, L; Meixensberger, J; Stengler, K; Konig, HH; Riedel-Heller, SG				Dorow, Marie; Loebner, Margrit; Stein, Janine; Pabst, Alexander; Konnopka, Alexander; Meisel, Hans J.; Guenther, Lutz; Meixensberger, Juergen; Stengler, Katarina; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			The Course of Pain Intensity in Patients Undergoing Herniated Disc Surgery: A 5-Year Longitudinal Observational Study	PLOS ONE			English	Article							LONG-TERM OUTCOMES; LOW-BACK-PAIN; LUMBAR DISKECTOMY; FOLLOW-UP; NONOPERATIVE TREATMENT; END-PLATE; PREDICTORS; DISABILITY; DEPRESSION; ANXIETY	Objectives The aims of this study are to answer the following questions (1) How does the pain intensity of lumbar and cervical disc surgery patients change within a postoperative time frame of 5 years? (2) Which sociodemographic, medical, work-related, and psychological factors are associated with postoperative pain in lumbar and cervical disc surgery patients? Methods The baseline survey (T0; n = 534) was conducted 3.6 days (SD 2.48) post-surgery in the form of face-to-face interviews. The follow-up interviews were conducted 3 months (T1; n = 486 patients), 9 months (T2; n = 457), 15 months (T3; n = 438), and 5 years (T4; n = 404) post-surgery. Pain intensity was measured on a numeric rating-scale (NRS 0-100). Estimated changes to and influences on postoperative pain by random effects were accounted by regression models. Results Average pain decreased continuously over time in patients with lumbar herniated disc (Wald Chi(2) = 25.97, p< 0.001). In patients with cervical herniated disc a reduction of pain was observed, albeit not significant (Chi(2) = 7.02, p = 0.135). Two predictors were associated with postoperative pain in lumbar and cervical disc surgery patients: the subjective prognosis of gainful employment (p< 0.001) and depression (p< 0.001). Conclusion In the majority of disc surgery patients, a long-term reduction of pain was observed. Cervical surgery patients seemed to benefit less from surgery than the lumbar surgery patients. A negative subjective prognosis of gainful employment and stronger depressive symptoms were associated with postoperative pain. The findings may promote multimodal rehabilitation concepts including psychological and work-related support.	[Dorow, Marie; Loebner, Margrit; Stein, Janine; Pabst, Alexander; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany; [Konnopka, Alexander; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Meisel, Hans J.] Berufsgenossenschaftliche Kliniken Bergmannstrost, Dept Neurosurg, Halle, Saale, Germany; [Guenther, Lutz] Klinikum St Georg gGmbH, Dept Neurosurg, Leipzig, Germany; [Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany; [Stengler, Katarina] Univ Leipzig, Dept Psychiat & Psychotherapy, D-04109 Leipzig, Germany	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; Leipzig University	Dorow, M (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, D-04109 Leipzig, Germany.	Marie.Dorow@medizin.uni-leipzig.de	Löbner, Margrit/AAD-7309-2022; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021	Löbner, Margrit/0000-0001-5984-8127; König, Hans-Helmut/0000-0001-5711-6862; Pabst, Alexander/0000-0003-0432-5681	Deutsche Rentenversicherung Bund [8011-106-31/31.81]; Medical Faculty, University of Leipzig [971000-072]; German Research Foundation (DFG); Universitat Leipzig within program of Open Access Publishing; Division of Neurosurgery Hospital St. Georg Leipzig; Department of Neurosurgery at the University Hospital Leipzig; Department of Neurosurgery at the Hospital "Bergmannstrost" Halle (Saale)	Deutsche Rentenversicherung Bund; Medical Faculty, University of Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within program of Open Access Publishing; Division of Neurosurgery Hospital St. Georg Leipzig; Department of Neurosurgery at the University Hospital Leipzig; Department of Neurosurgery at the Hospital "Bergmannstrost" Halle (Saale)	This publication was funded by the Deutsche Rentenversicherung Bund (Project: Psychiatric comorbidity and early retirement in patients with somatic diseases. Reference Number: 8011-106-31/31.81) and by junior research grant of the Medical Faculty, University of Leipzig (Project number 971000-072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.; This study was supported by the Division of Neurosurgery Hospital St. Georg Leipzig, the Department of Neurosurgery at the University Hospital Leipzig and the Department of Neurosurgery at the Hospital "Bergmannstrost" Halle (Saale).	Anderson PA, 2006, SPINE, V31, P2510, DOI 10.1097/01.brs.0000239180.14933.b7; Arpino L, 2004, NEUROL SCI, V25, P145, DOI 10.1007/s10072-004-0248-x; Asch HL, 2002, J NEUROSURG, V96, P34, DOI 10.3171/spi.2002.96.1.0034; Atlas SJ, 2005, SPINE, V30, P927, DOI 10.1097/01.brs.0000158954.68522.2a; Basler H D, 1997, Eur J Pain, V1, P197, DOI 10.1016/S1090-3801(97)90105-1; Chaichana KL, 2011, J NEUROSURG-SPINE, V14, P261, DOI 10.3171/2010.10.SPINE10190; Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5; D'Angelo C, 2010, NEUROSURGERY, V67, P265, DOI 10.1227/01.NEU.0000371971.51755.1C; DeBerard MS, 2009, SPINE J, V9, P193, DOI 10.1016/j.spinee.2008.02.001; den Boer JJ, 2006, PAIN, V123, P45, DOI 10.1016/j.pain.2006.02.008; Deutsche Rentenversicherung, 2005, MEDIZINISCHE VORAUSS; Folman Y, 2008, SURG NEUROL, V70, P398, DOI 10.1016/j.surneu.2007.04.022; Freidl M, 2016, PSYCHIAT PRAX, V43, P273, DOI 10.1055/s-0034-1387563; Gebremariam L, 2012, SPINE, V37, pE109, DOI 10.1097/BRS.0b013e318221b5af; Graver V, 1999, BRIT J NEUROSURG, V13, P178, DOI 10.1080/02688699943952; Hakkinen A, 2003, J REHABIL MED, V35, P236, DOI 10.1080/16501970306096; Hakkinen A, 2003, DISABIL REHABIL, V25, P968, DOI 10.1080/0963828031000122258; Hasenbring M, 1992, CHRONIFIZIERUNG BAND; Hegarty D, 2012, PAIN PHYSICIAN, V15, P421; Herda C, 1991, Schmerz, V5, P148, DOI 10.1007/BF02528100; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Johansson AC, 2010, DISABIL REHABIL, V32, P521, DOI 10.3109/09638280903177243; JUNGE A, 1995, SPINE, V20, P460, DOI 10.1097/00007632-199502001-00009; JUNGE A, 1995, SCHMERZ, V9, P70, DOI 10.1007/BF02528537; Kramer J, 1994, BANDSCHEIBENBEDINGTE; Lebow R, 2012, NEUROSURGERY, V70, P306, DOI [10.1227/NEU.0b013e3182302ec3, 10.1227/NEU.0b013e3182302ec3.]; Lurie JD, 2014, SPINE, V39, P3, DOI 10.1097/BRS.0000000000000088; McCulloch JA, 1992, SURG SPINE, P695; Mittag O, 2003, Rehabilitation (Stuttg), V42, P169; Ohtori S, 2010, SPINE, V35, pE596, DOI 10.1097/BRS.0b013e3181cd2cb8; Peolsson A, 2008, EUR SPINE J, V17, P406, DOI 10.1007/s00586-007-0560-2; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI, VII, P501; Robert Koch Institut, 2012, RUCK; Schade V, 1999, PAIN, V80, P239, DOI 10.1016/S0304-3959(98)00210-3; Schnake KJ, 2012, Z ORTHOP UNFALLCHIR, V150, P657, DOI 10.1055/s-0032-1328067; Silverplats K, 2010, EUR SPINE J, V19, P1459, DOI 10.1007/s00586-010-1433-7; Snaith RP, 1995, TESTDOKUMENTATION HA; Snow AL, 2004, GERONTOLOGIST, V44, P807, DOI 10.1093/geront/44.6.807; Stengler K, 2012, J NEUROL SURG PART A, V73, P29, DOI 10.1055/s-0032-1304502; Stromqvist F, 2008, ACTA ORTHOP, V79, P643, DOI 10.1080/17453670810016669; Sudhaus S, 2012, APPL PSYCHOPHYS BIOF, V37, P121, DOI 10.1007/s10484-012-9186-1; Sun EC, 2004, SPINE, V29, pE22, DOI 10.1097/01.BRS.0000105986.16783.A9; Theodoridis T, 2006, ORTHOPADIE UNFALLCHI, V1, P495; van Dieen JH, 1999, MED HYPOTHESES, V53, P246, DOI 10.1054/mehy.1998.0754; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Wheeler AH, 2005, NEUROLOGICAL BASIS P, P421; Wilkinson HA, 1983, FAILED BACK SYNDROME; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019; Zieger M, 2010, CENT EUR NEUROSURG, V71, P26, DOI 10.1055/s-0029-1225325	51	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156647	10.1371/journal.pone.0156647	http://dx.doi.org/10.1371/journal.pone.0156647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27243810	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100060
J	Habener, A; Chowdhury, A; Echtermeyer, F; Lichtinghagen, R; Theilmeier, G; Herzog, C				Habener, Anika; Chowdhury, Arpita; Echtermeyer, Frank; Lichtinghagen, Ralf; Theilmeier, Gregor; Herzog, Christine			MitoNEET Protects HL-1 Cardiomyocytes from Oxidative Stress Mediated Apoptosis in an In Vitro Model of Hypoxia and Reoxygenation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GLUTATHIONE-REDUCTASE INHIBITION; MITOCHONDRIAL-MEMBRANE PROTEIN; IRON-SULFUR CLUSTERS; CARDIAC MYOCYTES; FREE-RADICALS; RAT-HEART; GENERATION; PIOGLITAZONE; ANTIOXIDANTS	The iron-sulfur cluster containing protein mitoNEET is known to modulate the oxidative capacity of cardiac mitochondria but its function during myocardial reperfusion injury after transient ischemia is unknown. The purpose of this study was to analyze the impact of mitoNEET on oxidative stress induced cell death and its relation to the glutathione-redox system in cardiomyocytes in an in vitro model of hypoxia and reoxygenation (H/R). Our results show that siRNA knockdown (KD) of mitoNEET caused an 1.9-fold increase in H/R induced apoptosis compared to H/R control while overexpression of mitoNEET caused a 53% decrease in apoptosis. Necrosis was not affected. Apoptosis of both, mitoNEET-KD and control cells was diminished to comparable levels by using the antioxidants Tiron and glutathione compound glutathione reduced ethyl ester (GSH-MEE), indicating that mitoNEETdependent apoptosis is mediated by oxidative stress. The interplay between mitoNEET and glutathione redox system was assessed by treating cardiomyocytes with 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthio-carbonylamino) phenylthiocarbamoylsulfanyl] propionic acid (2-AAPA), known to effectively inhibit glutathione reductase (GSR) and to decrease the GSH/GSSG ratio. Surprisingly, inhibition of GSR-activity to 20% by 2-AAPA decreased apoptosis of control and mitoNEET-KD cells to 23% and 25% respectively, while at the same time mitoNEET-protein was increased 4-fold. This effect on mitoNEET-protein was not accessible by mitoNEET-KD but was reversed by GSH-MEE. In conclusion we show that mitoNEET protects cardiomyocytes from oxidative stress-induced apoptosis during H/R. Inhibition of GSH-recycling, GSR-activity by 2-AAPA increased mitoNEET-protein, accompanied by reduced apoptosis. Addition of GSH reversed these effects suggesting that mitoNEET can in part compensate for imbalances in the antioxidative glutathione-system and therefore could serve as a potential therapeutic approach for the oxidatively stressed myocardium.	[Habener, Anika; Chowdhury, Arpita; Echtermeyer, Frank; Theilmeier, Gregor; Herzog, Christine] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Habener, Anika] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany; [Chowdhury, Arpita] Univ Med Ctr Gottingen, Dept Cellular Biochem, Gottingen, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Clin Chem, Hannover, Germany; [Theilmeier, Gregor] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Dept Hlth Serv Sci, D-26111 Oldenburg, Germany	Hannover Medical School; Hannover Medical School; University of Gottingen; Hannover Medical School; Carl von Ossietzky Universitat Oldenburg	Herzog, C (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany.	herzog.christine@mh-hannover.de		Chowdhury, Arpita/0000-0001-5025-0268	Deutsche Forschungsgemeinschaft (DFG) [Th667/6-1, 7-1, KFO136, TP12]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, grant numbers: Th667/6-1 and 7-1; KFO136, TP12 (GT and CH)). The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Andersen AD, 2009, AM J PHYSIOL-CELL PH, V296, pC1227, DOI 10.1152/ajpcell.00370.2008; ANDERSON ME, 1989, ANAL BIOCHEM, V183, P16, DOI 10.1016/0003-2697(89)90164-4; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Belka C, 2006, ONCOGENE, V25, P969, DOI 10.1038/sj.onc.1209175; Carlson DL, 2002, AM J PHYSIOL-HEART C, V282, pH1907, DOI 10.1152/ajpheart.00393.2001; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Du Y, 2005, LIFE SCI, V77, P2770, DOI 10.1016/j.lfs.2005.03.027; Dwivedi VK, 2006, J ENZYM INHIB MED CH, V21, P43, DOI 10.1080/14756360500286070; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Jiao XY, 2009, J PHARMACOL EXP THER, V328, P777, DOI 10.1124/jpet.108.144352; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0; Kitta K, 2001, FREE RADICAL BIO MED, V31, P902, DOI 10.1016/S0891-5849(01)00663-3; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Lievre V, 2001, NEUROSCIENCE, V105, P287, DOI 10.1016/S0306-4522(01)00189-0; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; MIZUI T, 1992, AM J PHYSIOL, V262, pH313, DOI 10.1152/ajpheart.1992.262.2.H313; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Park JW, 1997, LIFE SCI, V60, P2207, DOI 10.1016/S0024-3205(97)00236-1; Rozanski GJ, 2002, AM J PHYSIOL-HEART C, V282, pH2346, DOI 10.1152/ajpheart.00894.2001; Sadhu SS, 2013, J ENZYM INHIB MED CH, V28, P456, DOI 10.3109/14756366.2011.649267; Seefeldt T, 2009, J BIOL CHEM, V284, P2729, DOI 10.1074/jbc.M802683200; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Tavazzi B, 1998, FREE RADICAL RES, V28, P25, DOI 10.3109/10715769809097873; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Webster KA, 1999, J CLIN INVEST, V104, P239; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Xie JS, 2014, FREE RADICAL BIO MED, V70, P214, DOI 10.1016/j.freeradbiomed.2014.02.022; Yang HJ, 2009, TOXICOL MECH METHOD, V19, P66, DOI 10.1080/15376510802428583; Yuan ZK, 2010, MOL CELL ENDOCRINOL, V325, P1, DOI 10.1016/j.mce.2010.04.013; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	46	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156054	10.1371/journal.pone.0156054	http://dx.doi.org/10.1371/journal.pone.0156054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243905	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100012
J	Lee, CY; Song, H; Park, CW; Chung, YH; Kim, JS; Park, JC				Lee, Chae Young; Song, Hankyeol; Park, Chan Woo; Chung, Yong Hyun; Kim, Jin Sung; Park, Justin C.			Optimization of Proton CT Detector System and Image Reconstruction Algorithm for On-Line Proton Therapy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RESOLUTION	The purposes of this study were to optimize a proton computed tomography system (pCT) for proton range verification and to confirm the pCT image reconstruction algorithm based on projection images generated with optimized parameters. For this purpose, we developed a new pCT scanner using the Geometry and Tracking (GEANT) 4.9.6 simulation toolkit. GEANT4 simulations were performed to optimize the geometric parameters representing the detector thickness and the distance between the detectors for pCT. The system consisted of four silicon strip detectors for particle tracking and a calorimeter to measure the residual energies of the individual protons. The optimized pCT system design was then adjusted to ensure that the solution to a CS-based convex optimization problem would converge to yield the desired pCT images after a reasonable number of iterative corrections. In particular, we used a total variation-based formulation that has been useful in exploiting prior knowledge about the minimal variations of proton attenuation characteristics in the human body. Examinations performed using our CS algorithm showed that high-quality pCT images could be reconstructed using sets of 72 projections within 20 iterations and without any streaks or noise, which can be caused by under-sampling and proton starvation. Moreover, the images yielded by this CS algorithm were found to be of higher quality than those obtained using other reconstruction algorithms. The optimized pCT scanner system demonstrated the potential to perform high-quality pCT during on-line image-guided proton therapy, without increasing the imaging dose, by applying our CS based proton CT reconstruction algorithm. Further, we make our optimized detector system and CS-based proton CT reconstruction algorithm potentially useful in on-line proton therapy.	[Lee, Chae Young; Song, Hankyeol; Park, Chan Woo; Chung, Yong Hyun] Yonsei Univ, Dept Radiol Sci, Wonju, South Korea; [Kim, Jin Sung] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Justin C.] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA	Yonsei University; Yonsei University; Yonsei University Health System; State University System of Florida; University of Florida	Chung, YH (corresponding author), Yonsei Univ, Dept Radiol Sci, Wonju, South Korea.; Kim, JS (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	ychung@yonsei.ac.kr; jinsung@yuhs.ac		Kim, Jin Sung/0000-0003-1415-6471	Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe); Nuclear Safety and Security Commission (NSSC), Republic of Korea [1402015]	Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe); Nuclear Safety and Security Commission (NSSC), Republic of Korea	This work was supported by the Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe) and the Nuclear Safety and Security Commission (NSSC), Republic of Korea (Grant No. 1402015).	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Anderson HH, 1977, STOPPING RANGES IONS, P3; Berger M. J., 2010, ESTAR PSTAR ASTAR CO; Bichsel H., 1972, AM I PHYS HDB, V42, P8; Choi K, 2010, MED PHYS, V37, P5113, DOI 10.1118/1.3481510; Chung K, 2015, RADIAT ONCOL J, V33, P337, DOI 10.3857/roj.2015.33.4.337; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Li TF, 2006, MED PHYS, V33, P699, DOI 10.1118/1.2171507; Sadrozinski HFW, 2004, IEEE T NUCL SCI, V51, P3, DOI 10.1109/TNS.2003.823044; Schaffner B, 1998, PHYS MED BIOL, V43, P1579, DOI 10.1088/0031-9155/43/6/016; SCHNEIDER U, 1994, MED PHYS, V21, P1657, DOI 10.1118/1.597212; Schulte RW, 2005, MED PHYS, V32, P1035, DOI 10.1118/1.1884906; SLATER JM, 1992, INT J RADIAT ONCOL, V22, P383, DOI 10.1016/0360-3016(92)90058-P; Williams DC, 2004, PHYS MED BIOL, V49, P2899, DOI 10.1088/0031-9155/49/13/010; Zhang J, 2013, P IEEE INT S CIRC SY, P2135	16	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156226	10.1371/journal.pone.0156226	http://dx.doi.org/10.1371/journal.pone.0156226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243822	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100021
J	Merino, H; Senra, C; Ferreiro, F				Merino, Hipolito; Senra, Carmen; Ferreiro, Fatima			Are Worry and Rumination Specific Pathways Linking Neuroticism and Symptoms of Anxiety and Depression in Patients with Generalized Anxiety Disorder, Major Depressive Disorder and Mixed Anxiety-Depressive Disorder?	PLOS ONE			English	Article							REPETITIVE NEGATIVE THINKING; PERSONALITY; COMORBIDITY; MOOD; ASSOCIATIONS; ADOLESCENCE; PREDICTOR; BEHAVIOR; THERAPY; THOUGHT	This study examines the relationships between neuroticism (higher-order vulnerability factor), the cognitive styles of worry, brooding and reflection (second-order vulnerability factors) and symptoms of anxiety and depression in three groups of patients: patients with Generalized Anxiety Disorder (GAD), with Major Depressive Disorder (MDD) and with Mixed Anxiety-Depressive Disorder (MADD). One hundred and thirty four patients completed a battery of questionnaires including measures of neuroticism, worry, rumination (brooding and reflection), anxiety and depression. Multiple mediation analyses indicate that worry may act as a mediating mechanism linking neuroticism and anxiety symptoms in the three diagnostic groups, whereas brooding-rumination may play a mediating role between neuroticism and depressive symptoms in patients with MDD and MADD and, with less certainty, in patients with GAD. Overall, our findings suggest that neuroticism may increase the risk of anxious and depressive symptoms via specific links involving either worry or brooding, respectively, and that both worry and brooding may operate in the three groups examined, irrespectively of whether anxiety or depression are the main emotions or whether they coexist without any clear predominance; consequently, we hypothesize the existence of "specific transdiagnostic" mechanisms.	[Merino, Hipolito; Senra, Carmen; Ferreiro, Fatima] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, A Coruna, Spain	Universidade de Santiago de Compostela	Senra, C (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, A Coruna, Spain.	carmen.senra@usc.es	Senra, Carmen/H-5315-2015	Senra, Carmen/0000-0001-5980-6680				Aguilar A, 1990, ANU PSICOL, V46, P01; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Axelson DA, 2001, DEPRESS ANXIETY, V14, P67, DOI 10.1002/da.1048; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004; Borkovec TD, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P77; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Broeren S, 2011, J CHILD FAM STUD, V20, P135, DOI 10.1007/s10826-010-9380-9; Burwell RA, 2007, J CLIN CHILD ADOLESC, V36, P56, DOI 10.1207/s15374424jccp3601_6; Chelminski I, 2003, J ANXIETY DISORD, V17, P533, DOI 10.1016/S0887-6185(02)00246-3; Claridge G, 2001, PERS INDIV DIFFER, V31, P383, DOI 10.1016/S0191-8869(00)00144-6; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; D'Avanzato C, 2013, COGNITIVE THER RES, V37, P968, DOI 10.1007/s10608-013-9537-0; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; EYSENCK SBG, 1985, PERS INDIV DIFFER, V6, P21, DOI 10.1016/0191-8869(85)90026-1; First M. B., 1997, STRUCTURED CLIN INTE; Fresco DM, 2002, COGNITIVE THER RES, V26, P179, DOI 10.1023/A:1014517718949; Griffith JW, 2010, PSYCHOL MED, V40, P1125, DOI 10.1017/S0033291709991449; Hervas G., 2008, REV PSICOPATOLOGIA P, V13, P111, DOI DOI 10.5944/RPPC.VOL.13.NUM.2.2008.4054; Hong RY, 2007, BEHAV RES THER, V45, P277, DOI 10.1016/j.brat.2006.03.006; Hong RY, 2013, J PSYCHOPATHOL BEHAV, V35, P407, DOI 10.1007/s10862-013-9350-9; Just N, 1997, J ABNORM PSYCHOL, V106, P221, DOI 10.1037/0021-843X.106.2.221; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Klein DN, 2002, HANDBOOK OF DEPRESSION, P115; Kotov R, 2007, BEHAV RES THER, V45, P1485, DOI 10.1016/j.brat.2006.11.011; Krueger RF, 2001, PERS INDIV DIFFER, V30, P1245, DOI 10.1016/S0191-8869(00)00106-9; Kuder GF, 1937, PSYCHOMETRIKA, V2; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; McEvoy PM, 2013, J AFFECT DISORDERS, V151, P313, DOI 10.1016/j.jad.2013.06.014; McEvoy PM, 2012, BEHAV THER, V43, P533, DOI 10.1016/j.beth.2011.02.007; McLaughlin KA, 2007, BEHAV THER, V38, P23, DOI 10.1016/j.beth.2006.03.003; Merino H, 2014, J PSYCHOPATHOL BEHAV, V36, P136, DOI 10.1007/s10862-013-9374-1; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Muris P, 2005, PERS INDIV DIFFER, V39, P1105, DOI 10.1016/j.paid.2005.04.005; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Olatunji BO, 2013, CLIN PSYCHOL-SCI PR, V20, P225, DOI 10.1111/cpsp.12037; Ormel J, 2004, SOC PSYCH PSYCH EPID, V39, P906, DOI 10.1007/s00127-004-0873-y; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Roelofs J, 2008, BEHAV RES THER, V46, P1283, DOI 10.1016/j.brat.2008.10.002; Sandin B., 2009, REV PSICOPATOLOGIA P, V14, P107, DOI DOI 10.5944/RPPC.VOL.14.NUM.2.2009.4070; Sanz J., 2003, ANAL MODIF CONDUCT, P239, DOI DOI 10.6018/ANALESPS.29.1.130532; Schoofs H, 2010, J PSYCHOPATHOL BEHAV, V32, P609, DOI 10.1007/s10862-010-9182-9; Segerstrom SC, 2000, COGNITIVE THER RES, V24, P671, DOI 10.1023/A:1005587311498; Spielberger C.D., 1982, CUESTIONARIO ANSIEDA; Treynor W, 2003, COGNITIVE THER RES, V27, P247, DOI 10.1023/A:1023910315561; van der Heiden C, 2010, J ANXIETY DISORD, V24, P284, DOI 10.1016/j.janxdis.2009.12.005; Verstraeten K, 2011, BRIT J CLIN PSYCHOL, V50, P364, DOI 10.1348/014466510X532715; Verstraeten K, 2010, PERS INDIV DIFFER, V48, P367, DOI 10.1016/j.paid.2009.11.001; VIRELLA B, 1994, J PERS ASSESS, V63, P401, DOI 10.1207/s15327752jpa6303_1; Watkins E, 2007, BEHAV RES THER, V45, P2144, DOI 10.1016/j.brat.2006.09.018; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Wells A, 2006, J BEHAV THER EXP PSY, V37, P206, DOI 10.1016/j.jbtep.2005.07.002; Yang MJ, 2014, PSYCHIAT CLIN NEUROS, V68, P712, DOI 10.1111/pcn.12193; Yook K, 2010, J ANXIETY DISORD, V24, P623, DOI 10.1016/j.janxdis.2010.04.003	62	39	41	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156169	10.1371/journal.pone.0156169	http://dx.doi.org/10.1371/journal.pone.0156169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27243462	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100018
J	Gerchen, JF; Reichert, SJ; Rohr, JT; Dieterich, C; Kloas, W; Stock, M				Gerchen, Joern F.; Reichert, Samuel J.; Roehr, Johannes T.; Dieterich, Christoph; Kloas, Werner; Stoeck, Matthias			A Single Transcriptome of a Green Toad (Bufo viridis) Yields Candidate Genes for Sex Determination and -Differentiation and Non-Anonymous Population Genetic Markers	PLOS ONE			English	Article							MICROSATELLITE LOCI; WIDE-RANGE; CHROMOSOMES; EVOLUTION; GENOME; AMPLIFICATION; AMPHIBIA; SUBGROUP; SEQUENCE; UTILITY	Large genome size, including immense repetitive and non-coding fractions, still present challenges for capacity, bioinformatics and thus affordability of whole genome sequencing in most amphibians. Here, we test the performance of a single transcriptome to understand whether it can provide a cost-efficient resource for species with large unknown genomes. Using RNA from six different tissues from a single Palearctic green toad ( Bufo viridis) specimen and Hiseq2000, we obtained 22,5 Mio reads and publish >100,000 unigene sequences. To evaluate efficacy and quality, we first use this data to identify green toad specific candidate genes, known from other vertebrates for their role in sex determination and differentiation. Of a list of 37 genes, the transcriptome yielded 32 ( 87%), many of which providing the first such data for this non-model anuran species. However, for many of these genes, only fragments could be retrieved. In order to allow also applications to population genetics, we further used the transcriptome for the targeted development of 21 non-anonymous microsatellites and tested them in genetic families and backcrosses. Eleven markers were specifically developed to be located on the B. viridis sex chromosomes; for eight markers we can indeed demonstrate sex-specific transmission in genetic families. Depending on phylogenetic distance, several markers, which are sex-linked in green toads, show high cross-amplification success across the anuran phylogeny, involving nine systematic anuran families. Our data support the view that single transcriptome sequencing (based on multiple tissues) provides a reliable genomic resource and cost-efficient method for non-model amphibian species with large genome size and, despite limitations, should be considered as long as genome sequencing remains unaffordable for most species.	[Gerchen, Joern F.; Reichert, Samuel J.; Kloas, Werner; Stoeck, Matthias] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Roehr, Johannes T.] Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Roehr, Johannes T.] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Cologne, Germany; [Gerchen, Joern F.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Max Planck Society; University of Lausanne	Stock, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecophysiol & Aquaculture, Berlin, Germany.	matthias.stoeck@igb-berlin.de	Dieterich, Christoph/ABF-8459-2021; Stöck, Matthias/E-7245-2014	Stöck, Matthias/0000-0003-4888-8371	DFG [STO493/2-2, STO493/3-1]; Leibniz Association	DFG(German Research Foundation (DFG)); Leibniz Association	This work was funded by DFG, STO493/2-2, STO493/3-1, Open Access Fund of the Leibniz Association.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auguie B, 2017, GRIDEXTRA MISCELLANE; Betto-Colliard C, 2015, HEREDITY, V114, P300, DOI 10.1038/hdy.2014.100; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Carreras-Carbonell J, 2007, CONSERV GENET, V9, P181; Colliard C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-232; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dawson DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-176; Doyle JM, 2013, GENOME, V56, P407, DOI 10.1139/gen-2013-0056; Dufresnes C, 2014, HEREDITY, V113, P9, DOI 10.1038/hdy.2014.26; Dufresnes C, 2014, MOL ECOL RESOUR, V14, P716, DOI 10.1111/1755-0998.12215; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Gregory TR, 2015, ANIMAL GENOME SIZE D; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hendrix R, 2010, MOL ECOL RESOUR, V10, P1038, DOI 10.1111/j.1755-0998.2010.02861.x; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mesak F, 2014, FRONTIERS ECOLOGY EV, V2; MIURA I, 1995, CHROMOSOMA, V103, P567, DOI 10.1007/BF00355322; Nair Abhilash, 2012, BMC Research Notes, V5, P389, DOI 10.1186/1756-0500-5-389; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Singhal S, 2013, MOL ECOL RESOUR, V13, P403, DOI 10.1111/1755-0998.12077; Stock M, 2013, J EVOLUTION BIOL, V26, P674, DOI 10.1111/jeb.12086; Stock M, 2011, J EVOLUTION BIOL, V24, P1064, DOI 10.1111/j.1420-9101.2011.02239.x; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; Sun YB, 2015, P NATL ACAD SCI USA, V112, pE1257, DOI 10.1073/pnas.1501764112; Tamschick S, 2014, CYTOGENET GENOME RES, V144, P315, DOI 10.1159/000380841; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	37	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156419	10.1371/journal.pone.0156419	http://dx.doi.org/10.1371/journal.pone.0156419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232626	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000032
J	Lei, L; Yu, XF; Chen, B; Chen, ZH; Wang, XJ				Lei, Lei; Yu, Xingfei; Chen, Bo; Chen, Zhanhong; Wang, Xiaojia			Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study	PLOS ONE			English	Article							DUCTAL CARCINOMA; PURE; MEDULLARY; FEATURES	Background Mucinous breast carcinoma (MC) is a special type of breast cancer that presents with a large amount of extracellular mucin. MC comprises approximately 4% of all invasive breast cancers. This type of tumor has a better prognosis and higher incidence in peri-and postmenopausal patients. Pathologically, there are two main subtypes of MC: pure and mixed. In this study, we describe 10 years of experience with MC at the Zhejiang Cancer Hospital in China, specifically, clinical data, histological findings and immunohistochemical features. Methods We identified MC patients who were diagnosed as operable and completed clinical treatment from January 2001 to January 2011. The clinicopathological data included the age at diagnosis, tumor size, TNM stage, presence and number of lymph node (LN) metastases, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) status and p53 expression. If the tumor was defined as mixed mucinous carcinoma (MMC), IHC was performed on a non-mucinous part, such as invasive ductal and lobular cancer. We evaluated the clinical characteristics of all MC patients using chi-square, one-way ANOVA and LSD tests. We also studied the correlations between all of the clinical parameters and LN metastasis in a binary logistic regression analysis. We used ten consecutive years of data that were collected at Zhejiang Cancer Hospital. Results We identified 48 cases of pure mucinous carcinoma (PMC) and 77 cases of MMC. The 48 PMC cases consisted of 38 PMC-A and 10 PMC-B subtypes. The MMCs were divided into two groups, those with partial mixed mucinous breast carcinoma (pMMC, 58 cases) and those with main mixed mucinous breast carcinoma (mMMC, 19 cases). pMMC was defined by tumors with less than 50% mucinous components, while mMMC was defined by tumors where the mucinous component accounted for 50% to 90% of the tumor. No significant differences in the clinicopathological characteristics were noted between the patients with PMC-A and those with PMC-B. The tumor size was larger in the mMMC than PMC cases (44.84 mm vs. 30.06 mm, p = 0.021). The number of positive LN metastases was greater in pMMC than PMC patients (p = 0.024). The clinical stages were significantly different among the three groups, with the pMMC group having more stage III-IV patients than the other two groups (p = 0.005). The incidence of LN metastasis was also higher in the pMMC cases (pMMC vs. mMMC and PMC, 50% vs. 31.58% and 18.75%, p = 0.003). The PMC patients had much lower p53 expression than the other two groups (PMC vs. pMMC and mMMC, 27.08% vs. 55.17% and 57.89%, p = 0.007). The tumor size (>30mm), p53 expression and less proportion of the mucinous component are associated with risk of LN metastasis. Conclusion Based on the results of this study, we conclude that the tumor size, status of LN metastasis, clinical stage, and p53 mutation rate may differ between MMC and PMC patients. The tumor size (>30mm), p53 mutation and less proportion of the mucinous component should be considered risk factors of LN metastasis in MC patients.	[Lei, Lei; Chen, Zhanhong; Wang, Xiaojia] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Yu, Xingfei] Zhejiang Canc Hosp, Dept Breast Tumor Surg, Hangzhou, Zhejiang, Peoples R China; [Chen, Bo] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Wang, XJ (corresponding author), Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	wangxj@zjcc.org.cn			Zhejiang Province Medical Science Fund Project of China [2015KYB052]; Zhejiang Province Medical Science Research Foundation of China [2015PYA001, 2009A030, 2008B022]	Zhejiang Province Medical Science Fund Project of China; Zhejiang Province Medical Science Research Foundation of China	This work was funded by the Zhejiang Province Medical Science Fund Project of China (No. 2015KYB052) and the Zhejiang Province Medical Science Research Foundation of China (Nos. 2015PYA001, 2009A030, and 2008B022).	Aljarrah Adil, 2013, Oman Med J, V28, P350, DOI 10.5001/omj.2013.100; Anderson WF, 2004, CANCER EPIDEM BIOMAR, V13, P1128; ANDRE S, 1995, J SURG ONCOL, V58, P162, DOI 10.1002/jso.2930580305; Bae SY, 2011, J BREAST CANCER, V14, P308, DOI 10.4048/jbc.2011.14.4.308; Barkley CR, 2008, AM J SURG, V196, P549, DOI 10.1016/j.amjsurg.2008.06.013; Cao AY, 2012, ANN SURG ONCOL, V19, P3019, DOI 10.1245/s10434-012-2322-6; CAPELLA C, 1980, HISTOPATHOLOGY, V4, P613, DOI 10.1111/j.1365-2559.1980.tb02957.x; Cyrta J, 2013, CYTOPATHOLOGY, V24, P377, DOI 10.1111/cyt.12016; Dhillon R, 2006, CLIN RADIOL, V61, P423, DOI 10.1016/j.crad.2005.10.008; Di Saverio S, 2008, BREAST CANCER RES TR, V111, P541, DOI 10.1007/s10549-007-9809-z; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Dumitru Adrian, 2015, Maedica (Bucur), V10, P14; Erhan Y, 2009, ACTA CHIR BELG, V109, P204; Hanagiri T, 2010, INT SURG, V95, P126; Karan B, 2012, DIAGN INTERV RADIOL, V18, P270, DOI 10.4261/1305-3825.DIR.4454-11.2; Kashiwagi S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-481; KOMAKI K, 1988, CANCER, V61, P989, DOI 10.1002/1097-0142(19880301)61:5<989::AID-CNCR2820610522>3.0.CO;2-E; Lakhani SR, 2012, WHO CLASSIFICATION T, V4; Laucirica R, 2011, ARCH PATHOL LAB MED, V135, P1533, DOI 10.5858/arpa.2010-0652-CP; Li Christopher I., 2010, Hormones & Cancer, V1, P156, DOI 10.1007/s12672-010-0016-8; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Morand C, 2009, CYTOM PART B-CLIN CY, V76B, P56, DOI 10.1002/cyto.b.20436; Park S, 2010, J KOREAN MED SCI, V25, P361, DOI 10.3346/jkms.2010.25.3.361; Ranade A, 2010, J CLIN PATHOL, V63, P1043, DOI 10.1136/jcp.2010.082495; Reimer T, 2008, BREAST CARE, V3, P190, DOI 10.1159/000136826; Sas-Korczynska B, 2014, WSPOLCZESNA ONKOL, V18, P120, DOI 10.5114/wo.2014.42727; Tan JZY, 2013, J MED IMAG RADIAT ON, V57, P25, DOI 10.1111/1754-9485.12006; Thurman SA, 2004, INT J RADIAT ONCOL, V59, P152, DOI 10.1016/j.ijrobp.2003.10.029; Vo T, 2007, AM J SURG, V194, P527, DOI 10.1016/j.amjsurg.2007.06.012	29	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155132	10.1371/journal.pone.0155132	http://dx.doi.org/10.1371/journal.pone.0155132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232881	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000002
J	Bazzone, A; Madej, MG; Kaback, HR; Fendler, K				Bazzone, Andre; Madej, M. Gregor; Kaback, H. Ronald; Fendler, Klaus			pH Regulation of Electrogenic Sugar/H+ Symport in MFS Sugar Permeases	PLOS ONE			English	Article							LAC CARRIER PROTEIN; MIX-AND-MATCH; ESCHERICHIA-COLI; ELECTROPHYSIOLOGICAL CHARACTERIZATION; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; BINDING; MECHANISM; PROTONATION; TRANSPORT	Bacterial sugar symporters in the Major Facilitator Superfamily (MFS) use the H+ (and in a few cases Na+) electrochemical gradients to achieve active transport of sugar into the cell. Because a number of structures of MFS sugar symporters have been solved recently, molecular insight into the transport mechanism is possible from detailed functional analysis. We present here a comparative electrophysiological study of the lactose permease (LacY), the fucose permease (FucP) and the xylose permease (XylE), which reveals common mechanistic principles and differences. In all three symporters energetically downhill electrogenic sugar/H+ symport is observed. Comparison of the pH dependence of symport at symmetrical pH exhibits broad bell-shaped pH profiles extending over 3 to 6 pH units and a decrease at extremely alkaline pH >= 9.4 and at acidic to neutral pH = 4.6-7.5. The pH dependence can be described by an acidic to neutral apparent pK (pK(app)) and an alkaline pK(app). Experimental evidence suggests that the alkaline pK(app) is due to H+ depletion at the protonation site, while the acidic pK(app) is due to inhibition of deprotonation. Since previous studies suggest that a single carboxyl group in LacY (Glu325) may be the only side chain directly involved in H+ translocation and a carboxyl side chain with similar properties has been identified in FucP (Asp46) and XylE (Asp27), the present results imply that the pK of this residue is switched during H+/sugar symport in all three symporters.	[Bazzone, Andre; Madej, M. Gregor; Fendler, Klaus] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Physiol & Microbiol, Los Angeles, CA 90024 USA; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Immunol, Los Angeles, CA 90024 USA; [Madej, M. Gregor; Kaback, H. Ronald] Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Genet, Los Angeles, CA 90024 USA	Max Planck Society; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	fendler@biophys.mpg.de		Bazzone, Andre/0000-0002-2419-3519; Fendler, Klaus/0000-0002-5699-7060; Madej, M. Gregor/0000-0001-9181-6387	Deutsche Forschungsgemeinschaft [SFB807]; NSF; Direct For Biological Sciences [1547801] Funding Source: National Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/) SFB807 to KF and by an NSF Eager Grant (https://www.nsf.gov/about/transformative_research/submit.jsp) to HRK.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bazzone A, 2013, JOVE-J VIS EXP, P50230; Bazzone A, 2013, JOVE-J VIS EXP, DOI 10.3791/50230; CARRASCO N, 1989, BIOCHEMISTRY-US, V28, P2533, DOI 10.1021/bi00432a028; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Gaiko O, 2013, BIOCHEMISTRY-US, V52, P8261, DOI 10.1021/bi4013269; Garcia-Celma JJ, 2008, LANGMUIR, V24, P8119, DOI 10.1021/la800428h; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Garcia-Celma JJ, 2009, P NATL ACAD SCI USA, V106, P7373, DOI 10.1073/pnas.0902471106; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; HERZLINGER D, 1984, BIOCHEMISTRY-US, V23, P3688, DOI 10.1021/bi00311a018; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaback HR, 2015, P NATL ACAD SCI USA, V112, P1259, DOI 10.1073/pnas.1419325112; Kumar H, 2015, P NATL ACAD SCI USA, V112, P9004, DOI 10.1073/pnas.1509854112; Kumar H, 2014, P NATL ACAD SCI USA, V111, P1784, DOI 10.1073/pnas.1324141111; Madej MG, 2014, SPRINGER SER BIOPHYS, V17, P121, DOI 10.1007/978-3-642-53839-1_6; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Madej MG, 2013, P NATL ACAD SCI USA, V110, pE4831, DOI 10.1073/pnas.1319754110; Madej MG, 2013, P NATL ACAD SCI USA, V110, P5870, DOI 10.1073/pnas.1303538110; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Smirnova IN, 2008, P NATL ACAD SCI USA, V105, P8896, DOI 10.1073/pnas.0803577105; Sugihara J, 2012, P NATL ACAD SCI USA, V109, P14847, DOI 10.1073/pnas.1213445109; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; VIITANEN P, 1983, BIOCHEMISTRY-US, V22, P2531, DOI 10.1021/bi00279a034; Wisedchaisri G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5521; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	36	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156392	10.1371/journal.pone.0156392	http://dx.doi.org/10.1371/journal.pone.0156392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227677	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500131
J	Brioude, G; Bregeon, F; Trousse, D; Flaudrops, C; Secq, V; De Dominicis, F; Chabrieres, E; D'journo, XB; Raoult, D; Thomas, PA				Brioude, Geoffrey; Bregeon, Fabienne; Trousse, Delphine; Flaudrops, Christophe; Secq, Veronique; De Dominicis, Florence; Chabrieres, Eric; D'journo, Xavier-Benoit; Raoult, Didier; Thomas, Pascal-Alexandre			Rapid Diagnosis of Lung Tumors, a Feasability Study Using Maldi-Tof Mass Spectrometry	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FROZEN-SECTION; CANCER; IDENTIFICATION; CLASSIFICATION	Objective Despite recent advances in imaging and core or endoscopic biopsies, a percentage of patients have a major lung resection without diagnosis. We aimed to assess the feasibility of a rapid tissue preparation/analysis to discriminate cancerous from non-cancerous lung tissue. Methods Fresh sample preparations were analyzed with the Microflex LTTM MALDI-TOF analyzer. Each main reference spectra (MSP) was consecutively included in a database. After definitive pathological diagnosis, each MSP was labeled as either cancerous or non-cancerous (normal, inflammatory, infectious nodules). A strategy was constructed based on the number of concordant responses of a mass spectrometry scoring algorithm. A 3-step evaluation included an internal and blind validation of a preliminary database (n = 182 reference spectra from the 100 first patients), followed by validation on a whole cohort database (n = 300 reference spectra from 159 patients). Diagnostic performance indicators were calculated. Results 127 cancerous and 173 non-cancerous samples (144 peripheral biopsies and 29 inflammatory or infectious lesions) were processed within 30 minutes after biopsy sampling. At the most discriminatory level, the samples were correctly classified with a sensitivity, specificity and global accuracy of 92.1%, 97.1% and 95%, respectively. Conclusions The feasibility of rapid MALDI-TOF analysis, coupled with a very simple lung preparation procedure, appears promising and should be tested in several surgical settings where rapid on-site evaluation of abnormal tissue is required. In the operating room, it appears promising in case of tumors with an uncertain preoperative diagnosis and should be tested as a complementary approach to frozen-biopsy analysis.	[Brioude, Geoffrey; Trousse, Delphine; De Dominicis, Florence; D'journo, Xavier-Benoit; Thomas, Pascal-Alexandre] Aix Marseille Univ, Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Serv Chirurg Thorac & Malad Oesophage,Pole Cardio, Marseille, France; [Brioude, Geoffrey; Bregeon, Fabienne; Flaudrops, Christophe; Chabrieres, Eric; D'journo, Xavier-Benoit; Raoult, Didier; Thomas, Pascal-Alexandre] Aix Marseille Univ, Fac Med, URMITE,IHU Mediterranee Infect, CNRS 7278,INSERM,U1905,IRD 198,Unite Rech Malad I, Marseille, France; [Secq, Veronique] Aix Marseille Univ, Hop Nord, Serv Anat Pathol, Marseille, France; [Chabrieres, Eric; Raoult, Didier] Ctr Hosp Univ Timone, Assistance Publ Hop Marseille, Pole Malad Infect & Trop Clin & Biol, Federat Bacteriol Hyg Virol, Marseille, France; [Bregeon, Fabienne] Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Serv Explorat Fonct Resp, Pole Cardiovasc & Thorac, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bregeon, F (corresponding author), Aix Marseille Univ, Fac Med, URMITE,IHU Mediterranee Infect, CNRS 7278,INSERM,U1905,IRD 198,Unite Rech Malad I, Marseille, France.; Bregeon, F (corresponding author), Ctr Hosp Univ Nord, Assistance Publ Hop Marseille, Serv Explorat Fonct Resp, Pole Cardiovasc & Thorac, Marseille, France.		D'journo, Xavier Benoit/AAJ-4457-2021; Thomas, Pascal A/E-5036-2010; RAOULT, Didier/A-8434-2008; Thomas, Pascal/L-3355-2019	D'journo, Xavier Benoit/0000-0001-6747-4583; Thomas, Pascal A/0000-0002-3305-6989; RAOULT, Didier/0000-0002-0633-5974; Thomas, Pascal/0000-0002-3305-6989				Balluff B, 2010, J PROTEOME RES, V9, P6317, DOI 10.1021/pr100573s; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Chatelain D, 2012, J VISC SURG, V149, pE134, DOI 10.1016/j.jviscsurg.2012.01.005; de Noo ME, 2006, EUR J CANCER, V42, P1068, DOI 10.1016/j.ejca.2005.12.023; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eberlin LS, 2013, P NATL ACAD SCI USA, V110, P1611, DOI 10.1073/pnas.1215687110; Esteve C, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0926-0; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Lee GK, 2012, LUNG CANCER, V76, P197, DOI 10.1016/j.lungcan.2011.10.016; Maier SK, 2013, MOL CELL PROTEOMICS, V12, P2901, DOI 10.1074/mcp.M113.027599; Meding S, 2012, J PROTEOME RES, V11, P1996, DOI 10.1021/pr200784p; Rahman SMJ, 2011, CANCER RES, V71, P3009, DOI 10.1158/0008-5472.CAN-10-2510; Schone C, 2013, CLIN BIOCHEM, V46, P539, DOI 10.1016/j.clinbiochem.2013.01.018; Seng P, 2010, FUTURE MICROBIOL, V5, P1733, DOI [10.2217/fmb.10.127, 10.2217/FMB.10.127]; Shinohara S, 2014, RADIOL ONCOL, V48, P50, DOI 10.2478/raon-2013-0064; Sienko A, 2005, ARCH PATHOL LAB MED, V129, P1602; Sihoe ADL, 2013, EUR J CARDIO-THORAC, V44, P231, DOI 10.1093/ejcts/ezs671; Sobin L, 2009, TNM CLASSIFICATION M; Walts AE, 2012, ARCH PATHOL LAB MED, V136, P1515, DOI 10.5858/arpa.2012-0042-OA; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yssouf A, 2013, J CLIN MICROBIOL, V51, P522, DOI 10.1128/JCM.02665-12	22	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155449	10.1371/journal.pone.0155449	http://dx.doi.org/10.1371/journal.pone.0155449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228175	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500020
J	Gau, D; Veon, W; Zeng, XM; Yates, N; Shroff, SG; Koes, DR; Roy, P				Gau, David; Veon, William; Zeng, Xuemei; Yates, Nathan; Shroff, Sanjeev G.; Koes, David R.; Roy, Partha			Threonine 89 Is an Important Residue of Profilin-1 That Is Phosphorylatable by Protein Kinase A	PLOS ONE			English	Article							POLY L-PROLINE; ACTIN; BINDING	Objective Dynamic regulation of actin cytoskeleton is at the heart of all actin-based cellular events. In this study, we sought to identify novel post-translational modifications of Profilin-1 (Pfn1), an important regulator of actin polymerization in cells. Methodology We performed in vitro protein kinase assay followed by mass-spectrometry to identify Protein Kinase A (PKA) phosphorylation sites of Pfn1. By two-dimensional gel electrophoresis (2D-GE) analysis, we further examined the changes in the isoelectric profile of ectopically expressed Pfn1 in HEK-293 cells in response to forskolin (FSK), an activator of cAMP/PKA pathway. Finally, we combined molecular dynamics simulations (MDS), GST pull-down assay and F-actin analyses of mammalian cells expressing site-specific phosphomimetic variants of Pfn1 to predict the potential consequences of phosphorylation of Pfn1. Results and Significance We identified several PKA phosphorylation sites of Pfn1 including Threonine 89 (T89), a novel site. Consistent with PKA's ability to phosphorylate Pfn1 in vitro, FSK stimulation increased the pool of the most negatively charged form of Pfn1 in HEK-293 cells which can be attenuated by PKA inhibitor H89. MDS predicted that T89 phosphorylation destabilizes an intramolecular interaction of Pfn1, potentially increasing its affinity for actin. The T89D phosphomimetic mutation of Pfn1 elicits several changes that are hallmarks of proteins folded into alternative three-dimensional conformations including detergent insolubility, protein aggregation and accelerated proteolysis, suggesting that T89 is a structurally important residue of Pfn1. Expression of T89D-Pfn1 induces actin: T89D-Pfn1 co-clusters and dramatically reduces overall actin polymerization in cells, indicating an actin-sequestering action of T89D-Pfn1. Finally, rendering T89 non-phosphorylatable causes a positive charge shift in the isoelectric profile of Pfn1 in a 2D gel electrophoresis analysis of cell extracts, a finding that is consistent with phosphorylation of a certain pool of intracellular Pfn1 on the T89 residue. In summary, we propose that T89 phosphorylation could have major functional consequences on Pfn1. This study paves the way for further investigation of the potential role of Pfn1 phosphorylation in PKA-mediated regulation of actin-dependent biological processes.	[Gau, David; Veon, William; Shroff, Sanjeev G.; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Zeng, Xuemei; Yates, Nathan] Univ Pittsburgh, Biomed Mass Spectrometry Ctr, Pittsburgh, PA USA; [Yates, Nathan; Roy, Partha] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Koes, David R.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roy, P (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.; Roy, P (corresponding author), Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA.; Roy, P (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.	par19@pitt.edu	Gau, David M/G-8375-2011; Koes, David Ryan/M-4523-2018	Gau, David M/0000-0002-3079-3692; Koes, David Ryan/0000-0002-6892-6614; Roy, Partha/0000-0002-4946-8531	NIH [2R01CA108607, R01GM108340, 2T32HL076124]; McGinnis Endowed Chair funds; NSF [2012139050, 12-29064]; Biomedical Mass Spectrometry Center; University of Pittsburgh Cancer Institute Cancer Proteomics Facility [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McGinnis Endowed Chair funds; NSF(National Science Foundation (NSF)); Biomedical Mass Spectrometry Center; University of Pittsburgh Cancer Institute Cancer Proteomics Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the NIH grants 2R01CA108607 (to PR), R01GM108340 (to DK), and McGinnis Endowed Chair funds (to SGS). WV and DG were supported by the NIH training grant 2T32HL076124 (to SGS) and the NSF Graduate Research Fellowship grant 2012139050 (to DG), respectively. Molecular dynamics simulations were performed at the Center for Simulation and Modeling at the University of Pittsburgh using equipment funded through NSF Grant 12-29064. This study also used the Biomedical Mass Spectrometry Center and University of Pittsburgh Cancer Institute Cancer Proteomics Facility supported in part by award P30CA047904.	Bjorkegren C, 1993, FEBS LETT, P123; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Case DA, 2014, AMBER 14; Craft JW, 2005, J BIOMOL NMR, V33, P15, DOI 10.1007/s10858-005-1199-0; Ding ZJ, 2006, J CELL SCI, V119, P4127, DOI 10.1242/jcs.03178; Ding ZJ, 2012, CELL ADHES MIGR, V6, P442, DOI 10.4161/cam.21832; Fan Y, 2012, NAT CELL BIOL, V14, P1046, DOI 10.1038/ncb2580; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kasina S, 2006, NITRIC OXIDE-BIOL CH, V14, P65, DOI 10.1016/j.niox.2005.09.008; Kasina S, 2005, J BIOCHEM, V138, P687, DOI 10.1093/jb/mvi163; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korupolu RV, 2009, INT J BIOL MACROMOL, V45, P265, DOI 10.1016/j.ijbiomac.2009.06.001; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schweinhuber SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117244; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Suetsugu S, 1999, FEBS LETT, V457, P470, DOI 10.1016/S0014-5793(99)01086-8; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280	26	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156313	10.1371/journal.pone.0156313	http://dx.doi.org/10.1371/journal.pone.0156313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228149	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500110
J	Pelissie, B; Piou, C; Jourdan-Pineau, H; Pages, C; Blondin, L; Chapuis, MP				Pelissie, Benjamin; Piou, Cyril; Jourdan-Pineau, Helene; Pages, Christine; Blondin, Laurence; Chapuis, Marie-Pierre			Extra Molting and Selection on Nymphal Growth in the Desert Locust	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; SCHISTOCERCA-GREGARIA; LIFE-HISTORY; QUANTITATIVE GENETICS; CHORTHIPPUS-BRUNNEUS; MULTIMODEL INFERENCE; LARVAL DEVELOPMENT; PHASE POLYPHENISM; JUVENILE-HORMONE; TOBACCO HORNWORM	In insects, extra-molting has been viewed as a compensatory mechanism for nymphal growth that contributes to optimize body weight for successful reproduction. However, little is known on the capacity of extra-molting to evolve in natural populations, which limits our understanding of how selection acts on nymphal growth. We used a multi-generational pedigree, individual monitoring and quantitative genetics models to investigate the evolution of extra-molting and its impact on nymphal growth in a solitarious population of the desert locust, Schistocerca gregaria. Growth compensation via extra-molting was observed for 46% of the females, whose adult weight exceeded by 4% that of other females, at a cost of a 22% longer development time. We found a null heritability for body weight threshold only, and the highest and a strongly female-biased heritability for extra molting. Our genetic estimates show that (1) directional selection can act on growth rate, development time and extra-molting to optimize body weight threshold, the target of stabilizing selection, (2) extra-molting can evolve in natural populations, and (3) a genetic conflict, due to sexually antagonistic selection on extra-molting, might prevent its fixation. Finally, we discuss how antagonistic selection between solitarious and gregarious environments and/or genetic correlations between growth and phase traits might also impact the evolution of extra-molting in locusts.	[Pelissie, Benjamin; Piou, Cyril; Jourdan-Pineau, Helene; Chapuis, Marie-Pierre] CIRAD, UMR CBGP, F-34398 Montpellier, France; [Pages, Christine; Blondin, Laurence] CIRAD, UPR B AMR, F-34398 Montpellier, France; [Pelissie, Benjamin] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	CIRAD; Institut de Recherche pour le Developpement (IRD); CIRAD; University of Wisconsin System; University of Wisconsin Madison	Pelissie, B (corresponding author), CIRAD, UMR CBGP, F-34398 Montpellier, France.; Pelissie, B (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	benjamin.pelissie@icloud.com	Jourdan-Pineau, Hélène/AAR-3967-2021; Pélissié, Benjamin/AAL-5970-2021	Pélissié, Benjamin/0000-0001-8705-7023; Chapuis, Marie-Pierre/0000-0003-4405-7722	CIRAD (Agricultural Research for Development)	CIRAD (Agricultural Research for Development)	This work was funded by CIRAD (Agricultural Research for Development). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT F. O., 1955, Journal d'Agriculture Tropicale et de Botanique Appliquee, V2, P109; ALBRECHT FO, 1957, EVOLUTION, V11, P166, DOI 10.1111/j.1558-5646.1957.tb02886.x; Andersson Malte, 1994; Applebaum SW, 1997, ARCH INSECT BIOCHEM, V35, P375, DOI 10.1002/(SICI)1520-6327(1997)35:4<375::AID-ARCH3>3.0.CO;2-R; Auer SK, 2010, ECOL LETT, V13, P998, DOI 10.1111/j.1461-0248.2010.01491.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blondin L, 2013, J APPL ENTOMOL, V137, P673, DOI 10.1111/jen.12052; Bolund E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2002; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chapuis M- P, 2016, AFRICAN ENT IN PRESS, V24; Chapuis MP, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-37; Clynen E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-201; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; DEMPSTER ER, 1950, GENETICS, V35, P212; Dirsh VM, 1953, ANTILOCUST B, P1; Elston RC, 1977, JSTOR, P231; Esperk T, 2007, J ECON ENTOMOL, V100, P627, DOI 10.1603/0022-0493(2007)100[627:IVINOL]2.0.CO;2; Esperk T, 2007, ECOL ENTOMOL, V32, P243, DOI 10.1111/j.1365-2311.2007.00872.x; GANGWERE S. K., 1964, ANN ENTOMOL SOC AMER, V57, P662, DOI 10.1093/aesa/57.6.662; Gilmour A. R., 2014, ASREML USER GUIDE; GOTTHARD K, 2001, ANIMAL DEV ECOLOGY, P1; Greenlee KJ, 2005, J EXP BIOL, V208, P1385, DOI 10.1242/jeb.01521; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Haag CR, 2005, P ROY SOC B-BIOL SCI, V272, P2449, DOI 10.1098/rspb.2005.3235; Hagele BF, 2004, J INSECT PHYSIOL, V50, P621, DOI 10.1016/j.jinsphys.2004.04.008; Hammerschmidt K, 2012, HEREDITY, V108, P569, DOI 10.1038/hdy.2011.125; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; HASSALL M, 1987, J NAT HIST, V21, P329, DOI 10.1080/00222938700771051; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; HOULE D, 1992, GENETICS, V130, P195; HUGHES TD, 1980, PHYSIOL ENTOMOL, V5, P47, DOI 10.1111/j.1365-3032.1980.tb00210.x; Hunter-Jones P, 1958, ANTILOCUST B; INJEYAN HS, 1981, J INSECT PHYSIOL, V27, P97, DOI 10.1016/0022-1910(81)90115-3; JOLY L, 1954, CR SOC BIOL, V148, P579; Joly P, 1953, ANN SCI NAT, V11, P331; Joly P, 1962, ROLE JOUE CORPORA AL, P77; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kingsolver JG, 2007, P ROY SOC B-BIOL SCI, V274, P977, DOI 10.1098/rspb.2006.0036; Kvist J, 2013, MOL ECOL, V22, P602, DOI 10.1111/j.1365-294X.2012.05521.x; Maeno K, 2008, B ENTOMOL RES, V98, P527, DOI 10.1017/S0007485308006044; Maeno K, 2004, B ENTOMOL RES, V94, P349, DOI 10.1079/BER2004310; Maeno K, 2010, APPL ENTOMOL ZOOL, V45, P513, DOI 10.1303/aez.2010.513; Maeno K, 2009, J INSECT PHYSIOL, V55, P1013, DOI 10.1016/j.jinsphys.2009.07.005; Maeno K, 2009, J INSECT PHYSIOL, V55, P849, DOI 10.1016/j.jinsphys.2009.05.012; Mathur CB, 1938, AN EXTRA HOPPER STAG, P177; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Morrissey MB, 2014, QUANTITATIVE GENETICS IN THE WILD, P228; Mukerji S., 1938, Compte Rendu Conf int antiacrid Brussels, V5, P410; Nickerson B, 1956, ANTILOCUST B; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Popov GB, 1958, ANTILOCUST B, P70; Price T, 1991, LOW HERITABILITY LIF, V45, P853; Ramachandra Rao Y., 1939, Indian Journal of Agricultural Science, V9, P727; Reinhold K, 2013, EVOLUTION, V67, P3662, DOI 10.1111/evo.12224; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rodriguez-Munoz R, 2010, SCIENCE, V328, P1269, DOI 10.1126/science.1188102; ROFF DA, 1997, EVOLUTIONARY QUANTIT, P493; Rungs C., 1954, Compte Rendu Soc Sci nat Maroc Rabat, P130; Saastamoinen M, 2013, J ANIM ECOL, V82, P529, DOI 10.1111/1365-2656.12034; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Simons AM, 1998, J EVOLUTION BIOL, V11, P721, DOI 10.1007/s000360050115; Simpson SJ, 2008, CURR BIOL, V18, pR364, DOI 10.1016/j.cub.2008.02.029; Song Hojun, 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/741769; Stearns SC, 1992, THE EVOLUTION OF LIF, P249; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Telfer MG, 1999, OECOLOGIA, V121, P245, DOI 10.1007/s004420050926; Uvarov BP., 1966, GRASSHOPPERS LOCUSTS, V1; Volkonsky M, 1938, ARCH I PASTEUR ALGER, V4, P523; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wilson K, 2002, P NATL ACAD SCI USA, V99, P5471, DOI 10.1073/pnas.082461999; Wyman MJ, 2014, AM NAT, V184, P326, DOI 10.1086/677310; Zavodska R, 2003, J BIOL RHYTHM, V18, P106, DOI 10.1177/0748730403251711	77	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155736	10.1371/journal.pone.0155736	http://dx.doi.org/10.1371/journal.pone.0155736			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227885	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500029
J	Placke, A; Kumar, A; Priya, S				Placke, Astrid; Kumar, Ashok; Priya, Shashank			Synthesis and Behavior of Cetyltrimethyl Ammonium Bromide Stabilized Zn1+xSnO3, (0 <= x <= 1) Nano-Crystallites	PLOS ONE			English	Article							HYDROTHERMAL SYNTHESIS; ZINC STANNATE; ZN2SNO4; NANOPARTICLES; EMISSION; PROPERTY	We report synthesis of cetyltrimethyl ammonium bromide (CTAB) stabilized Zn1+x SnO3 (0 <= x <= 1) nano-crystallites by facile cost-effective wet chemistry route. The X-ray diffraction patterns of as-synthesized powders at the Zn/Sn ratio of 1 exhibited formation of ZnSn (OH)(6). Increasing the Zn/Sn ratio further resulted in the precipitation of an additional phase corresponding to Zn(OH)(2). The decomposition of these powders at 650 degrees C for 3h led to the formation of the orthorhombic phase of ZnSnO3 and tetragonal SnO2-type phase of Zn2SnO4 at the Zn/Sn ratio of 1 and 2, respectively, with the formation of their mixed phases at intermediate compositions, i.e., at Zn/Sn ratio of 1.25, 1.50 and 1.75, respectively. The lattice parameters of orthorhombic and tetragonal phases were a - 3.6203 angstrom, b similar to 4.2646 A and c 12.8291A (for ZnSnO3) and a = b similar to 5.0136 A and c similar to 3.3055A (for Zn2SnO4). The transmission electron micrographs revealed the formation of nano-crystallites with aspect ratio - 2; the length and thickness being 24, 13 nm (for ZnSnO3) and 47, 22 nm (for Zn2Sn04), respectively. The estimated direct bandgap values for the ZnSnO3 and Zn2SnO4 were found to be 4.21 eV and 4.12 eV, respectively. The ac conductivity values at room temperature (at 10 kHz) for the ZnSnO3 and Zn2SnO4 samples were 8.02 x 10(-8) Omega(-1) cm-land 6.77 x 10(-8) Omega(-1) cm(-1), respectively. The relative permittivity was found to increase with increase in temperature, the room temperature values being 14.24 and 25.22 for the samples ZnSnO3 and Zn2SnO4, respectively. Both the samples, i.e., ZnSnO3 and Zn2SnO4, exhibited low values of loss tangent up to 300 K, the room temperature values being 0.89 and 0.72, respectively. A dye-sensitized solar cell has been fabricated using the optimized sample of zinc stannate photo-anode, i.e., Zn2SnO4. The cyclic voltammetry revealed oxidation and reduction around 0.40 V (current density similar to 11.1 mA/cm2) and 0.57 V (current density- 11.7 mA/cm(2)) for Zn2SnO4 photo -anode in presence of light.	[Placke, Astrid; Kumar, Ashok] Natl Inst Technol Kurukshetra, Dept Phys, Kurukshetra 136119, Haryana, India; [Placke, Astrid] Univ Appl Sci & Art, Dept Phys Technol, D-37083 Gottingen, Germany; [Priya, Shashank] Virginia Tech, CEHMS, Blacksburg, VA 24061 USA	National Institute of Technology (NIT System); National Institute of Technology Kurukshetra; HAWK University of Applied Sciences & Arts Hildesheim Holzminden Gottingen; Virginia Polytechnic Institute & State University	Kumar, A (corresponding author), Natl Inst Technol Kurukshetra, Dept Phys, Kurukshetra 136119, Haryana, India.	ashokku@nitkkr.ac.in	Priya, S/GQH-7176-2022	Kumar, Ashok/0000-0001-9152-9062; Priya, Shashank/0000-0003-1367-3434	SERB-DST, Government of India [SERB/F/1769/2013-2014]; DAAD	SERB-DST, Government of India; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by SERB-DST, Government of India (SERB/F/1769/2013-2014), and a DAAD fellowship to AP.	Alpuche-Aviles MA, 2009, J AM CHEM SOC, V131, P3216, DOI 10.1021/ja806719x; Baruah S, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/013004; Cai P, 2013, J MATER CHEM A, V1, P5217, DOI 10.1039/c3ta10228a; Chen YC, 2004, MATER TRANS, V45, P1684, DOI 10.2320/matertrans.45.1684; Errandonea D, 2008, PROG MATER SCI, V53, P711, DOI 10.1016/j.pmatsci.2008.02.001; Hu LH, 2008, J AM CHEM SOC, V130, P16136, DOI 10.1021/ja806400e; Hwang D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07353; Jia TK, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/197824; Kumar A, 2015, ADV CHEM LETT, V2, P3; Kumar A, 2013, J SOL-GEL SCI TECHN, V68, P46, DOI 10.1007/s10971-013-3132-4; Kumar AA, 2015, RSC ADV, V5, P17202, DOI 10.1039/c4ra16775a; Kumar V, 2016, PHYSICA B, V480, P36, DOI 10.1016/j.physb.2015.07.020; Kumar V, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135701; Lan JL, 2010, CURR APPL PHYS, V10, pS168, DOI 10.1016/j.cap.2009.11.064; Lupan O, 2016, SENSOR ACTUAT B-CHEM, V224, P434, DOI 10.1016/j.snb.2015.10.042; Mali SS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11424; Minami T, 2000, MRS BULL, V25, P38, DOI 10.1557/mrs2000.149; Miyauchi M, 2010, CHEM COMMUN, V46, P1529, DOI 10.1039/b921010e; Najim M, 2015, PHYS CHEM CHEM PHYS, V17, P22923, DOI 10.1039/c5cp03488d; Ong KP, 2015, APL MATER, V3, DOI 10.1063/1.4919564; Paulowicz I, 2015, ADV ELECTRON MATER, V1, DOI 10.1002/aelm.201500081; Sevik C, 2006, PHYS REV B, V74, P193; Singh R., 2011, J SENS TECHNOL, V01, P116, DOI DOI 10.4236/JST.2011.14016; Som S, 2016, ULTRASON SONOCHEM, V28, P79, DOI 10.1016/j.ultsonch.2015.07.003; Som S, 2014, DALTON T, V43, P9860, DOI 10.1039/c4dt00349g; Som S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4876316; Som S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/41/415102; Suhaimi S, 2015, INT J ELECTROCHEM SC, V10, P2859; Suzuki Y, 2015, J PHYS C SER, V4, P596; Tan B, 2007, J AM CHEM SOC, V129, P4162, DOI 10.1021/ja070804f; Wu Y, 2011, CHEM NANOSTRUCTURED, P127; Xu JQ, 2006, SOLID STATE ELECTRON, V50, P504, DOI 10.1016/j.sse.2006.02.001; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Young DL, 2002, J APPL PHYS, V92, P310, DOI 10.1063/1.1483104; Zeng J, 2008, J PHYS CHEM C, V112, P4159, DOI 10.1021/jp7113797; Zhao Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06847; Zhao Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4745034; Zhu HL, 2006, J PHYS CHEM B, V110, P7631, DOI 10.1021/jp060304t; Zou ZG, 2001, NATURE, V414, P625, DOI 10.1038/414625a	39	10	10	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156246	10.1371/journal.pone.0156246	http://dx.doi.org/10.1371/journal.pone.0156246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228102	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500093
J	Petito, A; Altamura, M; Iuso, S; Padalino, FA; Sessa, F; D'Andrea, G; Margaglione, M; Bellomo, A				Petito, Annamaria; Altamura, Mario; Iuso, Salvatore; Padalino, Flavia A.; Sessa, Francesco; D'Andrea, Giovanna; Margaglione, Maurizio; Bellomo, Antonello			The Relationship between Personality Traits, the 5HTT Polymorphisms, and the Occurrence of Anxiety and Depressive Symptoms in Elite Athletes	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; ALLELIC VARIATION; 5-HTTLPR; METAANALYSIS; ASSOCIATION; NEUROTICISM; PREVALENCE; SPORT; ADOLESCENTS	The purpose of this study was to determine the relationship between personality, the serotonin transporter (5HTT) polymorphisms and the occurrence of anxiety and depressive symptoms in elite athletes. 133 healthy participants completed the NEO Five-Factor Inventory (NEO-FFI). The mood states were assessed using the Profile of Mood States (POMS) questionnaire. The athlete's mental skills were assessed through the Sport Performance Psychological Inventory (IPPS-48). The occurrence of psychiatric and personality disorders was assessed using the Clinical Interview for DSM-IV Disorders. A polymerase chain reaction was employed to identify genotypes at the 5HTTLPR polymorphism. The 5HTTLPR s/s genotype was associated with both neuroticism (p<0.001) and tension/anxiety symptoms according to the POMS (p<0.02), cognitive anxiety and emotional arousal control according to the IPPS-48 (p<0.01). Significant correlations were proved between neuroticism and symptoms of anxiety and depression (p<0.05). Neuroticism mediates the association between the 5HTTLPR polymorphism and symptoms of cognitive anxiety and emotional arousal control (p<0.05). These results suggest a significant interaction between the 5HTTLPR polymorphism, neuroticism and sport related stress that predict adverse mental health outcomes in athletes. Identification of homogeneous groups of athletes having predispositions to anxiety and depressive symptoms may help to implement early prevention programs.	[Petito, Annamaria; Altamura, Mario; Iuso, Salvatore; Padalino, Flavia A.; Bellomo, Antonello] Univ Foggia, Psychiat Unit, Dept Clin & Expt Med, Foggia, Italy; [Sessa, Francesco; D'Andrea, Giovanna; Margaglione, Maurizio] Univ Foggia, Med Genet, Dept Clin & Expt Med, Foggia, Italy	University of Foggia; University of Foggia	Altamura, M (corresponding author), Univ Foggia, Psychiat Unit, Dept Clin & Expt Med, Foggia, Italy.	m_altamura@virgilio.it	Sessa, Francesco/G-1754-2018	Sessa, Francesco/0000-0003-0357-8791; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221				Bar KJ, 2013, EUR ARCH PSY CLIN N, V263, pS205, DOI 10.1007/s00406-013-0458-4; Barnhofer T, 2010, BEHAV RES THER, V48, P275, DOI 10.1016/j.brat.2009.12.005; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Burke TA, 2006, INT J STROKE, V1, P208, DOI 10.1111/j.1747-4949.2006.00060.x; Carron A. V., 1998, GROUP DYNAMICS SPORT, V2nd; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516; Costa Jr PT, 1989, NEO PIINEO FFI MAN S; Culverhouse RC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-304; Dale GA, 1996, SPORT PSYCHOL, V10, P307, DOI 10.1123/tsp.10.4.307; Eccles JS, 1999, J ADOLESCENT RES, V14, P10, DOI 10.1177/0743558499141003; First MB, 2003, SCID 2 STRUCTURED CL; First MB, 2000, SCID 1 STRUCTURED CL; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Fredricks JA, 2002, J ADOLESCENT RES, V17, P68, DOI 10.1177/0743558402171004; Gill EL, 2008, SOC WORK, V53, P85, DOI 10.1093/sw/53.1.85; Gonda X, 2005, J AFFECT DISORDERS, V87, P291, DOI 10.1016/j.jad.2005.05.007; Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008; GOULD D, 1993, J SPORT EXERCISE PSY, V15, P134, DOI 10.1123/jsep.15.2.134; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Hansen DM, 2003, J RES ADOLESCENCE, V13, P25, DOI 10.1111/1532-7795.1301006; Hansen Hans C, 2003, Pain Physician, V6, P179; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hauser J, 2003, EUR PSYCHIAT, V18, P129, DOI 10.1016/S0924-9338(03)00026-9; Heils A, 1996, J NEUROCHEM, V66, P2621; Hutchinson JG, 2007, PERS INDIV DIFFER, V42, P1367, DOI 10.1016/j.paid.2006.10.014; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lieben CKJ, 2004, NEUROCHEM INT, V44, P9, DOI 10.1016/S0197-0186(03)00102-5; Maloney JL, 2000, CHILD DEV, V71, P502, DOI 10.1111/1467-8624.00160; McNair D.M., 1971, MANUAL PROFILES MOOD; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50; Ming QS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-142; Mossner R, 2001, MOL PSYCHIATR, V6, P350, DOI 10.1038/sj.mp.4000849; Munafo MR, 2006, NEUROPSYCHOBIOLOGY, V53, P1, DOI 10.1159/000089915; Munafo MR, 2004, PERS INDIV DIFFER, V37, P621, DOI 10.1016/j.paid.2003.09.031; Nixdorf I., 2015, Advances in Physical Education, V5, P255, DOI 10.4236/ape.2015.54030; Nixdorf I, 2013, J CLIN SPORT PSYCHOL, V7, P313, DOI 10.1123/jcsp.7.4.313; OCONNOR PJ, 1989, PSYCHONEUROENDOCRINO, V14, P303, DOI 10.1016/0306-4530(89)90032-2; Oo KZ, 2016, AUST NZ J PSYCHIAT; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P387, DOI 10.1001/archpsyc.61.4.387; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Piedmont RL, 1991, J PERS SOC PSYCHOL, V60, P630, DOI DOI 10.1037/0022-3514.60.4.630; Proctor SL, 2010, J CLIN SPORT PSYCHOL, V4, P204, DOI 10.1123/jcsp.4.3.204; Puente-Diaz R, 2005, J SOC PSYCHOL, V145, P429, DOI 10.3200/SOCP.145.4.429-446; PUFFER JC, 1992, CLIN SPORT MED, V11, P327; PULVER A, 1995, EUR J PERSONALITY, V9, P109, DOI 10.1002/per.2410090205; Richman EL, 2000, PSYCHOL WOMEN QUART, V24, P189, DOI 10.1111/j.1471-6402.2000.tb00200.x; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Robazza C, 2009, GIORNALE ITALIANO PS, V4, P14, DOI DOI 10.1007/S40279-016-0492-2; Rolland JP, 1998, J PERS ASSESS, V71, P269, DOI 10.1207/s15327752jpa7102_13; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; SMOLL FL, 1989, J APPL SOC PSYCHOL, V19, P1522, DOI 10.1111/j.1559-1816.1989.tb01462.x; Snow A., 1994, Journal of Sport Behavior, V17, P207; Spirrison CL, 1998, PSYCHOL REP, V83, P263, DOI 10.2466/PR0.83.5.263-274; Storch E. A., 2005, J SPORT BEHAV, V28, P86; Weinberg R.S., 2003, FDN SPORT EXERCISE P; Williams J. M., 2006, APPL SPORT PSYCHOL P, V5th, P285; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	70	53	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156601	10.1371/journal.pone.0156601	http://dx.doi.org/10.1371/journal.pone.0156601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257942	Green Published, gold			2022-12-27	WOS:000377369700087
J	Sornkarn, N; Dasgupta, P; Nanayakkara, T				Sornkarn, Nantachai; Dasgupta, Prokar; Nanayakkara, Thrishantha			Morphological Computation of Haptic Perception of a Controllable Stiffness Probe	PLOS ONE			English	Article							IMPEDANCE CONTROL	When people are asked to palpate a novel soft object to discern its physical properties such as texture, elasticity, and even non-homogeneity, they not only regulate probing behaviors, but also the co-contraction level of antagonistic muscles to control the mechanical impedance of fingers. It is suspected that such behavior tries to enhance haptic perception by regulating the function of mechanoreceptors at different depths of the fingertips and proprioceptive sensors such as tendon and spindle sensors located in muscles. In this paper, we designed and fabricated a novel two-degree of freedom variable stiffness indentation probe to investigate whether the regulation of internal stiffness, indentation, and probe sweeping velocity (PSV) variables affect the accuracy of the depth estimation of stiff inclusions in an artificial silicon phantom using information gain metrics. Our experimental results provide new insights into not only the biological phenomena of haptic perception but also new opportunities to design and control soft robotic probes.	[Sornkarn, Nantachai; Nanayakkara, Thrishantha] Kings Coll London, Dept Informat, Ctr Robot Res, London WC2R 2LS, England; [Dasgupta, Prokar] Kings Coll London, Guys Hosp, MRC Ctr Transplantat, DTIMB, London SE1 9RT, England; [Dasgupta, Prokar] Kings Coll London, Guys Hosp, NIHR BRC, London SE1 9RT, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Sornkarn, N (corresponding author), Kings Coll London, Dept Informat, Ctr Robot Res, London WC2R 2LS, England.	nantachai.sornkarn@kcl.ac.uk	Nanayakkara, Thrishantha/AAM-5964-2020	Nanayakkara, Thrishantha/0000-0002-1882-1232; Dasgupta, Prokar/0000-0001-8690-0445	U.K. Engineering and Physical Sciences Research Council [EP/I028765/1]; EPSRC [EP/I028765/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I028765/1] Funding Source: researchfish	U.K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work is supported in part by the U.K. Engineering and Physical Sciences Research Council under Grant EP/I028765/1. The grant is obtained by TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum Y, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/2/026006; De Luca A, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P1623; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Hajian AZ, 1997, J BIOMECH ENG-T ASME, V119, P109, DOI 10.1115/1.2796052; Hoffmann M, 2012, CORR; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1, DOI 10.1115/1.3140702; Holzapfel GA, 2014, BIOMECHANICS SOFT TI, V441; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; Konstantinova J, 2014, BIOMEDICAL ENG IEEE, VPP, P1; Lungarella M, 2006, PLOS COMPUT BIOL, V2, P1301, DOI 10.1371/journal.pcbi.0020144; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; McManus LM, 2014, PATHOBIOLOGY OF HUMAN DISEASE: A DYNAMIC ENCYCLOPEDIA OF DISEASE MECHANISMS, P1; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sensinger JW, 2008, IEEE T BIO-MED ENG, V55, P1043, DOI 10.1109/TBME.2007.905385; Simpkins A., 2013, ROBOTICS AUTOMATION, V20, P107, DOI [10.1109/MRA.2013.2255515, DOI 10.1109/MRA.2013.2255515]; Sornkarn N, 2014, IEEE INT CONF ROBOT, P6685, DOI 10.1109/ICRA.2014.6907846; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tafazoli S, 2002, IEEE T CONTR SYST T, V10, P355, DOI 10.1109/87.998021; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Wang NH, 2010, IEEE T INF TECHNOL B, V14, P1088, DOI 10.1109/TITB.2010.2041064; Woodward WA, 2003, J CLIN ONCOL, V21, P3244, DOI 10.1200/JCO.2003.03.052; Yang Y, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P914, DOI 10.1109/ROBIO.2006.340342	23	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156982	10.1371/journal.pone.0156982	http://dx.doi.org/10.1371/journal.pone.0156982			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257814	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700166
J	Adams, SV; Ceballos, R; Newcomb, PA				Adams, Scott V.; Ceballos, Rachel; Newcomb, Polly A.			Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry	PLOS ONE			English	Article							FORM HEALTH SURVEY; POSTTRAUMATIC GROWTH; COLON-CANCER; OLDER-ADULTS; POPULATION; DIAGNOSIS; ASSOCIATIONS; OUTCOMES; PREDICT; 1-YEAR	Background and Aim Because most colorectal cancer patients survive beyond five years, understanding quality of life among these long-term survivors is essential to providing comprehensive survivor care. We sought to identify personal characteristics associated with reported quality of life in colorectal cancer survivors, and sub-groups of survivors potentially vulnerable to very low quality of life. Methods We assessed quality of life using the Veterans RAND 12-item Health Survey within a population-based sample of 1,021 colorectal cancer survivors in the Seattle Colorectal Cancer Family Registry, approximately 5 years post-diagnosis. In this case-only study, mean physical component summary scores and mental component summary scores were examined with linear regression. To identify survivors with substantially reduced ability to complete daily tasks, logistic regression was used to estimate odds ratios for "very low" summary scores, defined as a score in the lowest decile of the reference US population. All cases were followed for vital status following QoL assessment, and mortality was analyzed with Cox proportional hazards regression. Results Lower mean physical component summary score was associated with older age, female sex, obesity, smoking, and diabetes or other co-morbidity; lower mean mental component summary score was associated with younger age and female sex. Higher odds of very low physical component summary score was associated with older age, obesity, less education, smoking, co-morbidities, and later stage at diagnosis; smoking was associated with higher odds of very low mental component summary score. A very low physical component score was associated with higher risk of mortality (hazard ratio (95% confidence interval): 3.97 (2.95-5.34)). Conclusions Our results suggest that identifiable sub-groups of survivors are vulnerable to very low physical components of quality of life, decrements that may represent meaningful impairment in completing everyday tasks and are associated with higher risk of death.	[Adams, Scott V.; Ceballos, Rachel; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Newcomb, PA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	pnewcomb@fhcrc.org			National Cancer Institute, National Institutes of Health [UM1 CA167551]; Colorectal Cancer Family Registry Cohort infrastructure [U01CA074794]; Seattle Colorectal Cancer Family Registry;  [K05 CA152715]; NATIONAL CANCER INSTITUTE [K05CA152715, U24CA074794, U01CA074794, UM1CA167551] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colorectal Cancer Family Registry Cohort infrastructure; Seattle Colorectal Cancer Family Registry; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health grant UM1 CA167551 to R.M. Haile to support the Colorectal Cancer Family Registry Cohort infrastructure, grant U01CA074794 to P.A. Newcomb to support the Seattle Colorectal Cancer Family Registry, and grant K05 CA152715 to P.A. Newcomb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2004, J CLIN ONCOL, V22, P4829, DOI 10.1200/JCO.2004.02.018; Brown DS, 2015, PREV SCI, V16, P21, DOI 10.1007/s11121-013-0437-z; Buffart LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036164; Coghill AE, 2011, GUT, V60, P491, DOI 10.1136/gut.2010.221143; Diouf M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-69; Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351; Efficace F, 2006, EUR J CANCER, V42, P42, DOI 10.1016/j.ejca.2005.07.025; Fournier E, 2016, DIGEST LIVER DIS, V48, P87, DOI 10.1016/j.dld.2015.09.006; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Harding S, 2014, PEERJ, V2, DOI 10.7717/peerj.256; Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335; Jansen L, 2010, EUR J CANCER, V46, P2879, DOI 10.1016/j.ejca.2010.06.010; Jansen L, 2011, J CLIN ONCOL, V29, P3263, DOI 10.1200/JCO.2010.31.4013; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Jones D, 2001, J Ambul Care Manage, V24, P68; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1; Kroenke CH, 2008, AM J PUBLIC HEALTH, V98, P2085, DOI 10.2105/AJPH.2007.114041; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Mosher CE, 2009, CANCER-AM CANCER SOC, V115, P4001, DOI 10.1002/cncr.24436; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Phipps AI, 2011, CANCER-AM CANCER SOC, V117, P4948, DOI 10.1002/cncr.26114; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Rodriguez JL, 2015, AM J PREV MED, V49, pS518, DOI 10.1016/j.amepre.2015.08.007; Sapp AL, 2003, CANCER-AM CANCER SOC, V98, P1749, DOI 10.1002/cncr.11717; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sharma A, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/269510; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Soerjomataram I, 2012, CANCER CAUSE CONTROL, V23, P1421, DOI 10.1007/s10552-012-0010-2; Thraen-Borowski KM, 2013, J CANCER SURVIV, V7, P369, DOI 10.1007/s11764-013-0277-7; Trentham-Dietz A, 2003, ONCOLOGIST, V8, P342, DOI 10.1634/theoncologist.8-4-342; Tsai SY, 2007, EUR J EPIDEMIOL, V22, P19, DOI 10.1007/s10654-006-9092-z; Ul-Haq Z, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1197; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740; Wong CKH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-337; Yost KJ, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-66; Yost KJ, 2005, J CLIN EPIDEMIOL, V58, P1241, DOI 10.1016/j.jclinepi.2005.07.008	42	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156534	10.1371/journal.pone.0156534	http://dx.doi.org/10.1371/journal.pone.0156534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253385	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700038
J	Storsve, AB; Fjell, AM; Yendiki, A; Walhovd, KB				Storsve, Andreas B.; Fjell, Anders M.; Yendiki, Anastasia; Walhovd, Kristine B.			Longitudinal Changes in White Matter Tract Integrity across the Adult Lifespan and Its Relation to Cortical Thinning	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; OLDER-ADULTS; BRAIN ATROPHY; IN-VIVO; MRI; MICROSTRUCTURE; THICKNESS; TRAJECTORIES	A causal link between decreases in white matter (WM) integrity and cortical degeneration is assumed, but there is scarce knowledge on the relationship between these changes across the adult human lifespan. We investigated changes in thickness throughout the cortical mantle and WM tract integrity derived from T1 and diffusion weighted magnetic resonance imaging (MRI) scans in 201 healthy adults aged 23-87 years over a mean interval of 3.6 years. Fractional anisotropy (FA), mean (MD), radial (RD) and axial (AD) diffusivity changes were calculated for forceps minor and major and eight major white matter tracts in each hemisphere by use of a novel automated longitudinal tractography constrained by underlying anatomy (TRACULA) approach. We hypothesized that increasing MD and decreasing FA across tracts would relate to cortical thinning, with some anatomical specificity. WM integrity decreased across tracts non-uniformly, with mean annual percentage decreases ranging from 0.20 in the Inferior Longitudinal Fasciculus to 0.65 in the Superior Longitudinal Fasciculus. For most tracts, greater MD increases and FA decreases related to more cortical thinning, in areas in part overlapping with but also outside the projected tract endings. The findings indicate a combination of global and tract-specific relationships between WM integrity and cortical thinning.	[Storsve, Andreas B.; Fjell, Anders M.; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, N-0373 Oslo, Norway; [Fjell, Anders M.; Walhovd, Kristine B.] Oslo Univ Hosp, Unit Neuropsychol, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Yendiki, Anastasia] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Yendiki, Anastasia] Harvard Univ, Sch Med, Boston, MA USA	University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Storsve, AB (corresponding author), Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, N-0373 Oslo, Norway.	a.b.storsve@psykologi.uio.no		Storsve, Andreas B/0000-0001-6807-8638; Yendiki, Anastasia/0000-0003-1386-3828	Department of Psychology, University of Oslo; Norwegian Research Council; European Research Council [313440, 283634]; US-Norway Fulbright Foundation; National Institute for Biomedical Imaging and Bioengineering [R00-EB008129, R01-EB006758]; National Institutes of Health Blueprint for Neuroscience Research [5U01-MH093765]; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [P41EB015896]; NIH Shared Instrumentation Grants [S10RR023401, S10RR019307, S10RR019254, S10RR023043]	Department of Psychology, University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); European Research Council(European Research Council (ERC)European Commission); US-Norway Fulbright Foundation; National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health Blueprint for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH Shared Instrumentation Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Psychology, University of Oslo (A.B.S., K.B.W.), the Norwegian Research Council (to K.B.W., A.M.F.), the European Research Council's Starting Grant scheme (Grant 313440 to K.B.W. and Grant 283634 to A.M.F.), the US-Norway Fulbright Foundation (to A.B.S.), the National Institute for Biomedical Imaging and Bioengineering (R00-EB008129, R01-EB006758) (to A.Y.) and the National Institutes of Health Blueprint for Neuroscience Research (5U01-MH093765) (to A.Y.), part of the multi-institutional Human Connectome Project. Additional resources were provided by the Center for Functional Neuroimaging Technologies, P41EB015896, a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (to A.Y.). This work also involved the use of instrumentation supported by the NIH Shared Instrumentation Grants S10RR023401, S10RR019307, S10RR019254, S10RR023043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Beck A.T., 1987, BECK DEPRESSION INVE; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bender AR, 2016, NEUROIMAGE, V131, P193, DOI 10.1016/j.neuroimage.2015.10.085; Benner T, 2011, MAGN RESON MED, V66, P154, DOI 10.1002/mrm.22837; Bennett IJ, 2014, NEUROSCIENCE, V276, P187, DOI 10.1016/j.neuroscience.2013.11.026; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Brouwer RM, 2014, NEUROIMAGE, V100, P676, DOI 10.1016/j.neuroimage.2014.04.072; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Chetelat G, 2013, NEUROIMAGE, V76, P167, DOI 10.1016/j.neuroimage.2013.03.009; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ehrlich S, 2014, SCHIZOPHRENIA BULL, V40, P665, DOI 10.1093/schbul/sbt056; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson MA, 2015, BRAIN STRUCT FUNCT, V220, P2705, DOI 10.1007/s00429-014-0822-9; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kucyi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035589; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Lovden M, 2013, HUM BRAIN MAPP, V34, P1386, DOI 10.1002/hbm.21518; Mailhard P, 2013, AM J NEURORADIOL, V34, P54, DOI 10.3174/ajnr.A3146; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Navas-Sanchez FJ, 2014, HUM BRAIN MAPP, V35, P2619, DOI 10.1002/hbm.22355; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Peters A, 1998, CEREB CORTEX, V8, P295, DOI 10.1093/cercor/8.4.295; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Phillips OR, 2011, HUM BRAIN MAPP, V32, P1788, DOI 10.1002/hbm.21147; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; RAZ N, 2001, AGEING AND THE BRAIN; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Resnick SM, 2003, J NEUROSCI, V23, P3295; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Sexton CE, 2014, NEUROLOGY, V83, P967, DOI 10.1212/WNL.0000000000000774; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Sullivan EV, 2010, NEUROPSYCHOLOGIA, V48, P4155, DOI 10.1016/j.neuropsychologia.2010.10.023; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Vergani F, 2014, CORTEX, V56, P145, DOI 10.1016/j.cortex.2014.03.002; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Westlye LT, 2010, NEUROIMAGE, V52, P172, DOI 10.1016/j.neuroimage.2010.03.056; Yap QJ, 2013, J NEURAL TRANSM, V120, P1369, DOI 10.1007/s00702-013-0971-7; Yendiki A, 2016, NEUROIMAGE, V127, P277, DOI 10.1016/j.neuroimage.2015.12.003; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	89	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156770	10.1371/journal.pone.0156770	http://dx.doi.org/10.1371/journal.pone.0156770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253393	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700057
J	Adler, FR; Liou, TG				Adler, Frederick R.; Liou, Theodore G.			The Dynamics of Disease Progression in Cystic Fibrosis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FORCED EXPIRATORY VOLUME; PSEUDOMONAS-AERUGINOSA; LUNG-FUNCTION; BACTERIAL COMMUNITIES; YOUNG-CHILDREN; FEV1 DECLINE; INFECTION; SURVIVAL; MODEL	In cystic fibrosis, statistical models have been more successful in predicting mortality than the time course of clinical status. We develop a system of partial differential equations that simultaneously track mortality and patient status, with all model parameters estimated from the extensive and carefully maintained database from the Cystic Fibrosis Foundation. Cystic fibrosis is an autosomal recessive disease that leads to loss of lung function, most commonly assessed using the Forced Expiratory Volume in 1 second (FEV1%). This loss results from inflammation secondary to chronic bacterial infections, particularly Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus (MSSA) and members of the virulent Burkholderia complex. The model tracks FEV1% and carriage of these three bacteria over the course of a patient's life. Analysis of patient state changes from year to year reveals four feedback loops: a damaging positive feedback loop between P. aeruginosa carriage and lower FEV1%, negative feedback loops between P. aeruginosa and MSSA and between P. aeruginosa and Burkholderia, and a protective positive feedback loop between MSSA carriage and higher FEV1%. The partial differential equations built from this data analysis accurately capture the life-long progression of the disease, quantify the key role of high annual FEV1% variability in reducing survivorship, the relative unimportance of short-term bacterial interactions for long-term survival, and the potential benefits of eradicating the most harmful bacteria.	[Adler, Frederick R.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Adler, Frederick R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Liou, Theodore G.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Adler, FR (corresponding author), Univ Utah, Dept Math, Salt Lake City, UT 84112 USA.; Adler, FR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	adler@math.utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	21st Century Science Initiative Grant, James S. McDonnell Foundation; Cystic Fibrosis Foundation [LIOU14P0]; Ben B. and Iris M. Margolis Family Foundation of Utah; National Institutes of Health [R01HL125520]; 21st Century Science Initiative Grant from the James S McDonnell Foundation; Ben B and Iris M Margolis Family Foundation of Utah; NIH/NHLBI [R01HL125520]; Cystic Fibrosis Foundation (Bethesda, MD, USA) [LIOU14P0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125520] Funding Source: NIH RePORTER	21st Century Science Initiative Grant, James S. McDonnell Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Ben B. and Iris M. Margolis Family Foundation of Utah; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 21st Century Science Initiative Grant from the James S McDonnell Foundation; Ben B and Iris M Margolis Family Foundation of Utah; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation (Bethesda, MD, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 21st Century Science Initiative Grant, James S. McDonnell Foundation (https://www.jsmf.org/) (to F.R.A.). This work was also supported by Cystic Fibrosis Foundation, LIOU14P0 (https://www.cff.org/); Ben B. and Iris M. Margolis Family Foundation of Utah; and National Institutes of Health, R01HL125520 (www.nih.gov) (to T.G.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a 21st Century Science Initiative Grant from the James S McDonnell Foundation (to F.R.A.), and by research grants from the Cystic Fibrosis Foundation, LIOU14P0, (Bethesda, MD, USA), the Ben B and Iris M Margolis Family Foundation of Utah and the NIH/NHLBI, R01HL125520 (to T.G.L.). Opinions expressed in this manuscript by the authors do not necessarily state or reflect those of the NIH, the NHLBI, or the Margolis or CF Foundations.	Aaron SD, 2015, J CLIN EPIDEMIOL, V68, P1336, DOI 10.1016/j.jclinepi.2014.12.010; Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; Ashish A, 2013, J CYST FIBROS, V12, P790, DOI 10.1016/j.jcf.2013.04.003; Barrett J, 2014, J R STAT SOC B, V67, P860; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Dayananda PWA, 2004, MATH BIOSCI, V190, P113, DOI 10.1016/j.mbs.2004.04.001; Diggle P, 2009, CH CRC HANDB MOD STA, P349; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Horsley A, 2015, RESPIROLOGY, V20, P33, DOI 10.1111/resp.12382; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Knapp EA, 2016, ANN AM THORAC SOC, V13, P1173, DOI 10.1513/AnnalsATS.201511-781OC; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Konstan Michael W, 2009, J Cyst Fibros, V8 Suppl 1, pS15, DOI 10.1016/S1569-1993(09)60006-0; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; Madec Y, 2004, MATH BIOSCI, V189, P131, DOI 10.1016/j.mbs.2004.02.001; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Mayer-Hamblett N, 2014, AM J RESP CRIT CARE, V190, P289, DOI 10.1164/rccm.201404-0681OC; Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009; Miller M, 2013, THORAX, V68, P294, DOI 10.1136/thoraxjnl-2012-202838; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Prisman EZ, 2011, STAT MED, V30, P3038, DOI 10.1002/sim.4329; R Development Core Team, 2012, R LANG ENV STAT COMP; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Rosenfeld M, 2012, J CYST FIBROS, V11, P446, DOI 10.1016/j.jcf.2012.04.003; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Stanbrook MB, 2004, CHEST, V125, P150, DOI 10.1378/chest.125.1.150; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Stutman HR, 2002, J PEDIATR-US, V140, P299, DOI 10.1067/mpd.2002.121930; Szczesniak RD, 2013, ANN EPIDEMIOL, V23, P771, DOI 10.1016/j.annepidem.2013.08.009; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; Tsiatis AA, 2004, STAT SINICA, V14, P809; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Zemanick ET, 2014, PEDIAT PULMONOL, V13, P542; Zhao J, 2014, SCI REPORTS, V4; Zhu L, 2011, STAT MED, V30, P2435, DOI 10.1002/sim.4294	52	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156752	10.1371/journal.pone.0156752	http://dx.doi.org/10.1371/journal.pone.0156752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248696	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700076
J	Fournier, D; de Biseau, JC; De Laet, S; Lenoir, A; Passera, L; Aron, S				Fournier, Denis; de Biseau, Jean-Christophe; De laet, Sophie; Lenoir, Alain; Passera, Luc; Aron, Serge			Social Structure and Genetic Distance Mediate Nestmate Recognition and Aggressiveness in the Facultative Polygynous Ant Pheidole pallidula	PLOS ONE			English	Article							DIRECT BEHAVIORAL EVIDENCE; DEAR-ENEMY PHENOMENON; QUEEN NUMBER; COLONY SIZE; INTRASPECIFIC AGGRESSION; CHEMICAL RECOGNITION; CAMPONOTUS-FELLAH; MATE RECOGNITION; KIN RECOGNITION; ARGENTINE ANT	In social insects, the evolutionary stability of cooperation depends on the privileged relationships between individuals of the social group, which is facilitated by the recognition of relatives. Nestmate recognition is based on genetically determined cues and/or environmentally derived chemical components present on the cuticle of individuals. Here, we studied nestmate recognition in the ant Pheidole pallidula, a species where both single-queen (monogyne) and multiple-queen (polygyne) colonies co-occur in the same population. We combined geographical, genetic and chemical analyses to disentangle the factors influencing the level of intraspecific aggressiveness. We show that encounters between workers from neighbouring colonies (i.e., nests less than 5 m away) are on average less aggressive than those between workers from more distant colonies. Aggressive behaviour is associated with the level of genetic difference: workers from monogyne colonies are more aggressive than workers from polygyne colonies, and the intensity of aggressiveness is positively associated with the genetic distance between colonies. Since the genetic distance is correlated with the spatial distance between pairs of colonies, the lower level of aggression toward neighbours may result from their higher relatedness. In contrast, the analysis of overall cuticular hydrocarbon profiles shows that aggressive behaviour is associated neither with the chemical diversity of colonies, nor with the chemical distances between them. When considering methyl-branched alkanes only, however, chemical distances differed between monogyne and polygyne colonies and were significantly associated with aggressiveness. Altogether, these results show that the social structure of colonies and the genetic distances between colonies are two major factors influencing the intensity of agonistic behaviours in the ant P. pallidula.	[Fournier, Denis; de Biseau, Jean-Christophe; De laet, Sophie; Aron, Serge] Univ Libre Bruxelles, Evolutionary Biol & Ecol, CP 160-12,Ave FD Roosevelt 50, B-1050 Brussels, Belgium; [Lenoir, Alain] Univ Tours, IRBI, UMR CNRS 7261, Parc Grandmont, F-37200 Tours, France; [Passera, Luc] Univ Toulouse 3, UMR 5169, Ctr Rech Cognit Anim, F-31062 Toulouse, France	Universite Libre de Bruxelles; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fournier, D (corresponding author), Univ Libre Bruxelles, Evolutionary Biol & Ecol, CP 160-12,Ave FD Roosevelt 50, B-1050 Brussels, Belgium.	Denis.Fournier@ulb.ac.be	Fournier, Denis/EZX-2474-2022	Fournier, Denis/0000-0003-4094-0390	Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique) [FRFC 2.4516.11]; Universite libre de Bruxelles (ARC)	Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); Universite libre de Bruxelles (ARC)	This work was funded by the Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique, FRFC 2.4516.11) and Universite libre de Bruxelles (ARC 2010-2015 #5).	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Aron S, 1999, ETHOL ECOL EVOL, V11, P209, DOI 10.1080/08927014.1999.9522824; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bagneres AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P75, DOI 10.1017/CBO9780511711909.006; Bargum K, 2007, J EVOLUTION BIOL, V20, P1351, DOI 10.1111/j.1420-9101.2007.01345.x; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; Beye M, 1997, INSECT SOC, V44, P49, DOI 10.1007/s000400050022; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bontpart H, 1964, THESIS U TOULOUSE; Boulay R, 2014, J EVOLUTION BIOL, V27, P2856, DOI 10.1111/jeb.12515; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Breed MD, 1987, KIN RECOGNITION ANIM, P209; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Chirino MG, 2012, ANN ENTOMOL SOC AM, V105, P740, DOI 10.1603/AN11073; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; CROSLAND MWJ, 1990, ANIM BEHAV, V39, P413, DOI 10.1016/S0003-3472(05)80404-X; Crozier R.H., 1996, EVOLUTION SOCIAL INS; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dalecky A, 2005, BIOL J LINN SOC, V86, P133, DOI 10.1111/j.1095-8312.2005.00524.x; DESLIPPE RJ, 1995, ECOLOGY, V76, P375, DOI 10.2307/1941196; Dimarco RD, 2010, BEHAV ECOL, V21, P304, DOI 10.1093/beheco/arp190; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foitzik S, 2007, ANIM BEHAV, V73, P999, DOI 10.1016/j.anbehav.2006.07.017; Fournier D, 2003, EVOLUTION, V57, P1336, DOI 10.1111/j.0014-3820.2003.tb00341.x; Fournier D, 2002, MOL ECOL, V11, P1805, DOI 10.1046/j.1365-294X.2002.01573.x; Fournier D, 2004, THESIS U LIBRE BRUXE; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; Fournier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031480; Frizzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137919; Furst MA, 2012, P ROY SOC B-BIOL SCI, V279, P516, DOI 10.1098/rspb.2011.0581; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hamidi R, 2012, EUR J ENTOMOL, V109, P95, DOI 10.14411/eje.2012.012; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Herbers Joan M., 1993, P262; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holldobler B., 1990, pi; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; KELLER L, 1989, ANIM BEHAV, V37, P733, DOI 10.1016/0003-3472(89)90059-6; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; Keller L., 1993, QUEEN NUMBER SOCIALI; Keller Laurent, 1993, P16; Krasnec MO, 2013, J CHEM ECOL, V39, P59, DOI 10.1007/s10886-012-0227-2; Lach L., 2009, ANT ECOLOGY; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; Lenoir A, 2001, PHYSIOL ENTOMOL, V26, P275, DOI 10.1046/j.0307-6962.2001.00244.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Martin SJ, 2012, BEHAV GENET, V42, P323, DOI 10.1007/s10519-011-9503-0; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; Nei M., 1987, MOL EVOLUTIONARY GEN; Nonacs Peter, 1993, P110; NOWBAHARI E, 1990, BIOCHEM SYST ECOL, V18, P63, DOI 10.1016/0305-1978(90)90036-F; Passera L, 1967, VIE MILIEU, V1, P189; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen J.S., 1997, P157; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosset H, 2007, ANIM BEHAV, V74, P951, DOI 10.1016/j.anbehav.2006.11.028; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saar Maya, 2014, Frontiers in Ecology and Evolution, V2, P13; Sambrook J., 2001, MOL CLONING LAB MANU; Silva AR, 2015, J APPL STAT, V42, P1984, DOI 10.1080/02664763.2015.1014894; Singer TL, 1998, AM ZOOL, V38, P394; Sobotnik J, 2012, SCIENCE, V337, P436, DOI 10.1126/science.1219129; Sokal R. H., 1995, BIOMETRY PRINCIPLES; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Starks PT, 1998, ETHOLOGY, V104, P573, DOI 10.1111/j.1439-0310.1998.tb00092.x; STUART RJ, 1988, P NATL ACAD SCI USA, V85, P4572, DOI 10.1073/pnas.85.12.4572; STUART RJ, 1991, ANIM BEHAV, V42, P277, DOI 10.1016/S0003-3472(05)80559-7; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Thurin N, 2008, ANIM BEHAV, V75, P1023, DOI 10.1016/j.anbehav.2007.08.013; Tripet F, 2006, INSECT SOC, V53, P127, DOI 10.1007/s00040-005-0846-5; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Vander Meer Robert K., 1998, P79; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Zar J.H., 1996, BIOSTAT ANAL; Zinck L, 2008, ENTOMOL EXP APPL, V126, P211, DOI 10.1111/j.1570-7458.2007.00654.x	109	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156440	10.1371/journal.pone.0156440	http://dx.doi.org/10.1371/journal.pone.0156440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243627	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100039
J	Smith, GR; Xie, L; Schwartz, R				Smith, Gregory R.; Xie, Lu; Schwartz, Russell			Modeling Effects of RNA on Capsid Assembly Pathways via Coarse-Grained Stochastic Simulation	PLOS ONE			English	Article							SINGLE-STRANDED RNA; PROTEIN-PROTEIN INTERACTIONS; VIRUS; GENOME; BINDING; SUFFICIENT; NUCLEATION; MOLECULES; MECHANISM; KINETICS	The environment of a living cell is vastly different from that of an in vitro reaction system, an issue that presents great challenges to the use of in vitro models, or computer simulations based on them, for understanding biochemistry in vivo. Virus capsids make an excellent model system for such questions because they typically have few distinct components, making them amenable to in vitro and modeling studies, yet their assembly can involve complex networks of possible reactions that cannot be resolved in detail by any current experimental technology. We previously fit kinetic simulation parameters to bulk in vitro assembly data to yield a close match between simulated and real data, and then used the simulations to study features of assembly that cannot be monitored experimentally. The present work seeks to project how assembly in these simulations fit to in vitro data would be altered by computationally adding features of the cellular environment to the system, specifically the presence of nucleic acid about which many capsids assemble. The major challenge of such work is computational: simulating fine-scale assembly pathways on the scale and in the parameter domains of real viruses is far too computationally costly to allow for explicit models of nucleic acid interaction. We bypass that limitation by applying analytical models of nucleic acid effects to adjust kinetic rate parameters learned from in vitro data to see how these adjustments, singly or in combination, might affect fine-scale assembly progress. The resulting simulations exhibit surprising behavioral complexity, with distinct effects often acting synergistically to drive efficient assembly and alter pathways relative to the in vitro model. The work demonstrates how computer simulations can help us understand how assembly might differ between the in vitro and in vivo environments and what features of the cellular environment account for these differences.	[Smith, Gregory R.; Schwartz, Russell] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Xie, Lu] Joint Carnegie Mellon Univ Pittsburgh, PhD Program Computat Biol, Pittsburgh, PA USA; [Xie, Lu; Schwartz, Russell] Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Schwartz, R (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.; Schwartz, R (corresponding author), Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA 15213 USA.	russells@andrew.cmu.edu	Schwartz, Russell/A-1998-2016	Schwartz, Russell/0000-0002-4970-2252; Smith, Gregory/0000-0003-0112-6134	United States National Institutes of Health [R01AI076318, R01CA140214]; Computational Biology Department, Carnegie Mellon University	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computational Biology Department, Carnegie Mellon University	This work was supported by United States National Institutes of Health awards R01AI076318 (to L.X., G.S., and R.S.) and R01CA140214 (to R.S.), and the Computational Biology Department, Carnegie Mellon University (to L.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelescu DG, 2008, EUR PHYS J E, V25, P323, DOI 10.1140/epje/i2007-10301-6; Angelescu DG, 2007, J PHYS CHEM B, V111, P8477, DOI 10.1021/jp068384o; Baschek JE, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-22; Belyi VA, 2006, P NATL ACAD SCI USA, V103, P17174, DOI 10.1073/pnas.0608311103; Cadena-Nava RD, 2012, J VIROL, V86, P3318, DOI 10.1128/JVI.06566-11; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Colby R.H., 2003, POLYM PHYS; Comas-Garcia M, 2012, J VIROL, V86, P12271, DOI 10.1128/JVI.01695-12; Dykeman EC, 2014, P NATL ACAD SCI USA, V111, P5361, DOI 10.1073/pnas.1319479111; Dykeman EC, 2013, J MOL BIOL, V425, P3235, DOI 10.1016/j.jmb.2013.06.005; Dykeman EC, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022717; Elrad OM, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045003; Erdemci-Tandogan G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032707; Flory PJ, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Fox JM, 1998, VIROLOGY, V244, P212, DOI 10.1006/viro.1998.9107; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grime JMA, 2012, BIOPHYS J, V103, P1774, DOI 10.1016/j.bpj.2012.09.007; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; Hagan MF, 2010, BIOPHYS J, V98, P1065, DOI 10.1016/j.bpj.2009.11.023; Hemberg M, 2006, BIOPHYS J, V90, P3029, DOI 10.1529/biophysj.105.076737; Jamalyaria F, 2005, J COMPUT PHYS, V204, P100, DOI 10.1016/j.jcp.2004.10.004; Johnston IG, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104101; Jones SA, 2014, J VIROL, V88, P1564, DOI 10.1128/JVI.02852-13; Kegel WK, 2004, BIOPHYS J, V86, P3905, DOI 10.1529/biophysj.104.040055; Kler S, 2012, J AM CHEM SOC, V134, P8823, DOI 10.1021/ja2110703; Krishna V, 2010, BIOPHYS J, V98, P18, DOI 10.1016/j.bpj.2009.09.049; Kumar MS, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045005; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Misra N, 2008, COMPUT MATH METHOD M, V9, P277, DOI 10.1080/17486700802168379; Moisant P, 2010, BIOPHYS J, V99, P1350, DOI 10.1016/j.bpj.2010.06.030; Morales L, 2013, J VIROL, V87, P11579, DOI 10.1128/JVI.01836-13; Morozov AY, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3212694; Murakami S, 2012, J VIROL, V86, P4034, DOI 10.1128/JVI.06700-11; Nguyen HD, 2007, NANO LETT, V7, P338, DOI 10.1021/nl062449h; Nikolaitchik OA, 2014, J VIROL, V88, P4040, DOI 10.1128/JVI.03745-13; Perlmutter JD, 2014, J MOL BIOL, V426, P3148, DOI 10.1016/j.jmb.2014.07.004; Perlmutter JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00632; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Rapaport DC, 1999, COMPUT PHYS COMMUN, V121, P231, DOI 10.1016/S0010-4655(99)00319-7; Sakaue T, 2006, MACROMOLECULES, V39, P2621, DOI 10.1021/ma0514424; Schwartz R, 1998, BIOPHYS J, V75, P2626, DOI 10.1016/S0006-3495(98)77708-2; Siber A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051919; Siber A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051915; Smith GR, 2014, BIOPHYS J, V106, P310, DOI 10.1016/j.bpj.2013.11.022; Stockley PG, 2013, J BIOL PHYS, V39, P277, DOI 10.1007/s10867-013-9313-0; Strobl G., 2007, PHYS POLYM CONCEPTS; Sweeney B, 2008, BIOPHYS J, V94, P772, DOI 10.1529/biophysj.107.107284; Ting CL, 2011, P NATL ACAD SCI USA, V108, P16986, DOI 10.1073/pnas.1109307108; Tsiang M, 2012, BIOCHEMISTRY-US, V51, P4416, DOI 10.1021/bi300052h; van der Schoot P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061928; van der Schoot P, 2013, J BIOL PHYS, V39, P289, DOI 10.1007/s10867-013-9307-y; Venter PA, 2005, J VIROL, V79, P6239, DOI 10.1128/JVI.79.10.6239-6248.2005; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; Xie L, 2012, BIOPHYS J, V103, P1545, DOI 10.1016/j.bpj.2012.08.057; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zandi R, 2009, BIOPHYS J, V96, P9, DOI 10.1529/biophysj.108.137489; Zeng YY, 2012, J STRUCT BIOL, V180, P110, DOI 10.1016/j.jsb.2012.06.008; Zhang TQ, 2005, Proceedings of the 2005 Winter Simulation Conference, Vols 1-4, P2223; Zhang TQ, 2006, BIOPHYS J, V90, P57, DOI 10.1529/biophysj.105.072207; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156547	10.1371/journal.pone.0156547	http://dx.doi.org/10.1371/journal.pone.0156547			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244559	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100045
J	Anigilaje, EA; Aderibigbe, SA; Adeoti, AO; Nweke, NO				Anigilaje, Emmanuel A.; Aderibigbe, Sunday A.; Adeoti, Adekunle O.; Nweke, Nnamdi O.			Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COHORT; EPIDEMIOLOGY; REINFECTION; RELAPSE; DISEASE; IMPACT; HAART	Introduction In Nigeria, there is a dearth of pediatric data on the risk factors associated with tuberculosis (TB), before and after antiretroviral therapy (ART). Methodology A retrospective observational cohort study, between October 2010 and December 2013, at the Federal Medical Centre, Makurdi, Nigeria. TB was noted among children less than 15 years of age at ART enrolment (prevalent TB-PrevTB), within 6 months (early incident tuberculosis-EITB) and after 6 months (late incident tuberculosis-LITB) of a 12-month follow-up on ART. Potential risk factors for PrevTB and incident TB were assessed using the multivariate logistic and Cox regression models respectively. Results Among 368 HIV-1 infected children, PrevTB was diagnosed in 73 children (19.8%). Twenty-eight EITB cases were diagnosed among 278 children over 132 person-years (py) with an EITB rate of 21.2/100 py. Twelve LITB cases were seen among 224 children over 221.9 py with a LITB rate of 5.4/100 py. A significant reduction in the incidence rates of TB was found over time (75%, p < 0.001). Young age of children (12-35 months, aOR; 24, 95% CI; 4.1-146.6, p < 0.001; 36-59 months, aOR; 21, 95% CI; 4.0-114.3, p < 0.001); history of TB in children (aOR; 29, 95% CI; 7.3-119.4, P < 0.001); severe immunosuppression (aOR; 38, 95% CI; 12-123.2, p < 0.001); oropharyngeal candidiasis (aOR; 3.3, 95% CI; 1.4-8.0, p = 0.009) and sepsis (aOR; 3.2, 95% CI; 1.0-9.6, p = 0.043) increased the risk of PrevTB. Urban residency was protective against EITB (aHR; 0.1, 95% CI; 0.0-0.4, p = 0.001). Virological failure (aHR; 4.7, 95% CI; 1.3-16.5, p < 0.001) and sepsis (aHR; 26, 95% CI; 5.3-131.9, p < 0.001) increased the risk of LITB. Conclusions In our cohort of HIV-infected children, a significant reduction in cases of incident TB was seen following a 12-month use of ART. After ART initiation, TB screening should be optimized among children of rural residency, children with sepsis, and those with poor virological response to ART.	[Anigilaje, Emmanuel A.; Nweke, Nnamdi O.] Fed Med Ctr, Dept Paediat, Makurdi, Benue State, Nigeria; [Aderibigbe, Sunday A.] Univ Ilorin, Dept Community Med, Ilorin, Kwara State, Nigeria; [Adeoti, Adekunle O.] Ekiti State Univ Teaching Hosp, Dept Med, Ado Ekiti, Ekiti State, Nigeria; [Anigilaje, Emmanuel A.] Univ Abuja, Coll Hlth Sci, Dept Paediat, Abuja, Nigeria	University of Ilorin	Anigilaje, EA (corresponding author), Fed Med Ctr, Dept Paediat, Makurdi, Benue State, Nigeria.; Anigilaje, EA (corresponding author), Univ Abuja, Coll Hlth Sci, Dept Paediat, Abuja, Nigeria.	demolaanigilaje@yahoo.co.uk			US Department of Health and Human Services, Health Resources and Services Administration [U51HA02522]; CDC through AIDS Preventive Initiative Nigeria-APIN [PS001058]	US Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); CDC through AIDS Preventive Initiative Nigeria-APIN	This work was funded in part by the US Department of Health and Human Services, Health Resources and Services Administration (U51HA02522) and CDC through AIDS Preventive Initiative Nigeria-APIN-(PS001058).	Agbaji O., 2013, Journal of AIDS and Clinical Research, V4, P222; Akanbi MO, 2013, AIDS RES HUM RETROV, V29, P931, DOI [10.1089/aid.2012.0231, 10.1089/AID.2012.0231]; Anigilaje EA, 2014, HIV AIDS-RES PALLIAT, V6, P127, DOI 10.2147/HIV.S64964; [Anonymous], 2010, NAT TUB LEPR CONTR P; [Anonymous], 2009, INT J HLTH RES; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2006, J INFECT DIS; Ayalaw GS, 2015, INCIDENCE PREDICTORS; Bakeera-Kitaka S, 2011, INT J TUBERC LUNG D, V15, P1082, DOI 10.5588/ijtld.10.0538; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; Bugaje M. A., 2006, Annals of African Medicine, V5, P73; Cohen JM, 2008, HIV MED, V9, P277, DOI 10.1111/j.1468-1293.2008.00559.x; Coovadia HM, 1998, INT J TUBERC LUNG D, V2, P844; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Daniel OJ, 2005, NIGER J PEADIAT, V32, P83; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Federal Ministry of Health, 2007, NAT GUID PAED HIV AI; Federal Ministry of Health, 2010, NAT GUID PAED HIV AI; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; International Union against Tuberculosis and Lung Disease, 2010, DESK GUIDE DIAGNOSIS; Jensen J, 2012, PEDIATR INFECT DIS J, V31, P278, DOI 10.1097/INF.0b013e318239e268; Joint United Nations Programme on HIV/ AIDS, 2013 PROGR REP GLOB; Kouakoussui A, 2004, Paediatr Respir Rev, V5, P311, DOI 10.1016/j.prrv.2004.07.008; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Moreira J, 2015, CLIN RES HIV AIDS, V2, P1021; Mu WW, 2014, AIDS CARE, V26, P1127, DOI 10.1080/09540121.2014.882492; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Nelson LJ, 2004, PEDIATRICS, V114, P333, DOI 10.1542/peds.114.2.333; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Ogunbosi BO, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-29; Okechukwu AA, 2011, NIGER J CLIN PRACT, V14, P206, DOI 10.4103/1119-3077.84018; Oladokun RE, 2014, CLIN RES INFECT DIS, V1, P1007; Otu AA, 2013, ANN TROP MED PUBLIC, V6, P491, DOI 10.4103/1755-6783.133685; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; Saharia KK, 2013, CELL, V155, P505, DOI 10.1016/j.cell.2013.09.045; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Ugochukwu E F, 2006, West Afr J Med, V25, P10; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; World Health Organization, 2011, ANTHR PERS COMP VERS; World Health Organization, 2021, 10 THREATS GLOB HLTH	49	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156177	10.1371/journal.pone.0156177	http://dx.doi.org/10.1371/journal.pone.0156177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232185	gold, Green Published, Green Submitted			2022-12-27	WOS:000376883000013
J	Jang, HS; Hong, YJ; Choi, HW; Song, H; Byun, SJ; Uhm, SJ; Seo, HG; Do, JT				Jang, Hyun Sik; Hong, Yean Ju; Choi, Hyun Woo; Song, Hyuk; Byun, Sung June; Uhm, Sang Jun; Seo, Han Geuk; Do, Jeong Tae			Changes in Parthenogenetic Imprinting Patterns during Reprogramming by Cell Fusion	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; SOMATIC-CELLS; MOUSE EMBRYOS; HYBRID-CELLS; GENERATION; EXPRESSION; CULTURE; MICE; LINE	Differentiated somatic cells can be reprogrammed into the pluripotent state by cell-cell fusion. In the pluripotent state, reprogrammed cells may then self-renew and differentiate into all three germ layers. Fusion-induced reprogramming also epigenetically modifies the somatic cell genome through DNA demethylation, X chromosome reactivation, and histone modification. In this study, we investigated whether fusion with embryonic stem cells (ESCs) also reprograms genomic imprinting patterns in somatic cells. In particular, we examined imprinting changes in parthenogenetic neural stem cells fused with biparental ESCs, as well as in biparental neural stem cells fused with parthenogenetic ESCs. The resulting hybrid cells expressed the pluripotency markers Oct4 and Nanog. In addition, methylation of several imprinted genes except Peg3 was comparable between hybrid cells and ESCs. This finding indicates that reprogramming by cell fusion does not necessarily reverse the status of all imprinted genes to the state of pluripotent fusion partner.	[Jang, Hyun Sik; Hong, Yean Ju; Choi, Hyun Woo; Song, Hyuk; Seo, Han Geuk; Do, Jeong Tae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Byun, Sung June] Rural Dev Adm, Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, South Korea; [Uhm, Sang Jun] Sangji Youngseo Coll, Dept Anim Sci & Biotechnol, Wonju, South Korea	Konkuk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Do, JT (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea.	dojt@konkuk.ac.kr		Do, Jeong Tae/0000-0001-6721-1441	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A1009701]; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea [PJ01133802]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2015R1A5A1009701); and the Next-Generation BioGreen 21 Program (grant no. PJ01133802) funded by the Rural Development Administration, Republic of Korea.	Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Choi HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021367; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Do JT, 2009, STEM CELLS, V27, P2962, DOI 10.1002/stem.233; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kaffer CR, 2000, GENE DEV, V14, P1908; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sumer H, 2010, STEM CELLS DEV, V19, P239, DOI 10.1089/scd.2009.0142; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156491	10.1371/journal.pone.0156491	http://dx.doi.org/10.1371/journal.pone.0156491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232503	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000039
J	Nguyen, MT; Krupa, M; Koo, BK; Song, JA; Vu, TTT; Do, BH; Nguyen, AN; Seo, T; Yoo, J; Jeong, B; Jin, J; Lee, KJ; Oh, HB; Choe, H				Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Jin, Jonghwa; Lee, Kyung Jin; Oh, Heung-Bum; Choe, Han			Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESCHERICHIA-COLI; TUMOR ANGIOGENESIS; INCLUSION-BODIES; EXPRESSION; CELLS; DIFFERENTIATION; OPTIMIZATION; FACTOR(165); SOLUBILITY	Human vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and plays a central role in the process of tumor growth and metastatic dissemination. Escherichia coli is one of the most common expression systems used for the production of recombinant proteins; however, expression of human VEGF in E. coli has proven difficult because the E. coli-expressed VEGF tends to be misfolded and forms inclusion bodies, resulting in poor solubility. In this study, we successfully produced semi-preparative amounts of soluble bioactive human VEGF165 (hVEGF). We created seven N-terminal fusion tag constructs with hexahistidine (His6), thioredoxin (Trx), glutathione S-transferase (GST), maltose-binding protein (MBP), N-utilization substance protein A (NusA), human protein disulfide isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), and tested each construct for soluble overexpression in E. coli. We found that at 18o C, 92.8% of the MBP-tagged hVEGF to be soluble and that this tag significantly increased the protein's solubility. We successfully purified 0.8 mg of pure hVEGF per 500 mL cell culture. The purified hVEGF is stable after tag cleavage, contains very low levels of endotoxin, and is 97.6% pure. Using an Flk1(+) mesodermal precursor cell (MPC) differentiation assay, we show that the purified hVEGF is not only bioactive but has similar bioactivity to hVEGF produced in mammalian cells. Previous reports on producing hVEGF in E. coli have all been based on refolding of the protein from inclusion bodies. To our knowledge, this is the first report on successfully expressing and purifying soluble hVEGF in E. coli.	[Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Choe, Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Physiol, Seoul 05505, South Korea; [Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Choe, Han] Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Inst Technol, Seoul 05505, South Korea; [Jin, Jonghwa] Osong Med Innovat Fdn, New Drug Dev Ctr, Div Drug Screening & Evaluat, Chungbuk 363951, South Korea; [Lee, Kyung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med,Asan Inst Life Sci, Seoul 05505, South Korea; [Oh, Heung-Bum] Univ Ulsan, Coll Med, Dept Lab Med, Seoul 05505, South Korea; [Oh, Heung-Bum] Asan Med Ctr, Seoul 05505, South Korea	University of Ulsan; University of Ulsan; Osong Medical Innovation Foundation; University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Physiol, Seoul 05505, South Korea.; Choe, H (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Inst Technol, Seoul 05505, South Korea.	hchoe@ulsan.ac.kr	Hang, Bich/AAI-6230-2021; Nguyen, Minh Tan/AAH-7865-2019	Hang, Bich/0000-0002-8951-175X; 	Medical Research Center Program [2008-0062286]; National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2015K1A4A3046807]; Asan Institute for Life Sciences, Seoul, Korea [2015219]	Medical Research Center Program; National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Asan Institute for Life Sciences, Seoul, Korea	This work was supported by Medical Research Center Program (2008-0062286) and a grant (2015K1A4A3046807) through the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, and a grant (2015219) from the Asan Institute for Life Sciences, Seoul, Korea.	Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carlevaro MF, 2000, J CELL SCI, V113, P59; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chung ND, 2014, ENZYME MICROB TECH, V63, P58, DOI 10.1016/j.enzmictec.2014.05.007; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Cothran A, 2011, BIOTECHNOL PROGR, V27, P1273, DOI 10.1002/btpr.642; Do BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089906; Drake Christopher J., 2003, Birth Defects Research, V69, P73, DOI 10.1002/bdrc.10003; El-Sheikh A, 2002, CANCER RES, V62, P7118; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Han M, 2009, BIOTECHNOL LETT, V31, P1677, DOI 10.1007/s10529-009-0060-z; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Joo HJ, 2012, BLOOD, V120, P2733, DOI 10.1182/blood-2012-04-421610; Kang W, 2013, PROTEIN EXPRES PURIF, V87, P55, DOI 10.1016/j.pep.2012.10.004; Kang WK, 2013, J BIOTECHNOL, V164, P441, DOI 10.1016/j.jbiotec.2013.02.004; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; Lee GY, 2006, PROTEIN EXPRES PURIF, V46, P503, DOI 10.1016/j.pep.2005.09.023; Lee IL, 2011, PROTEIN EXPRES PURIF, V76, P54, DOI 10.1016/j.pep.2010.08.014; Lee SB, 2008, J MICROBIOL BIOTECHN, V18, P183; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Nguyen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089038; MOHANRAJ D, 1995, GROWTH FACTORS, V12, P17, DOI 10.3109/08977199509003210; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Pizarro SA, 2010, PROTEIN EXPRES PURIF, V72, P184, DOI 10.1016/j.pep.2010.03.007; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Song JA, 2013, PLOS ONE, V8, DOI [DOI 10.1371/J0URNAL.P0NE.0083781, 10.1371/journal.pone.0083781]; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Vu TTT, 2014, TOXICON, V92, P157, DOI 10.1016/j.toxicon.2014.10.017; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333; Wu XF, 2004, J BIOTECHNOL, V111, P253, DOI 10.1016/j.jbiotec.2004.04.016; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; Zou JP, 2009, AFR J BIOTECHNOL, V8, P2362	46	16	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156296	10.1371/journal.pone.0156296	http://dx.doi.org/10.1371/journal.pone.0156296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231876	Green Published, gold			2022-12-27	WOS:000376883000020
J	Wallen, MP; Gomersall, SR; Keating, SE; Wisloff, U; Coombes, JS				Wallen, Matthew P.; Gomersall, Sjaan R.; Keating, Shelley E.; Wisloff, Ulrik; Coombes, Jeff S.			Accuracy of Heart Rate Watches: Implications for Weight Management	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; WEARABLE DEVICES; SKIN TYPE; VALIDITY; HEALTH; VALIDATION; ADULTS	Background Wrist-worn monitors claim to provide accurate measures of heart rate and energy expenditure. People wishing to lose weight use these devices to monitor energy balance, however the accuracy of these devices to measure such parameters has not been established. Aim To determine the accuracy of four wrist-worn devices (Apple Watch, Fitbit Charge HR, Samsung Gear S and Mio Alpha) to measure heart rate and energy expenditure at rest and during exercise. Methods Twenty-two healthy volunteers (50% female; aged 24 +/- 5.6 years) completed similar to 1-hr protocols involving supine and seated rest, walking and running on a treadmill and cycling on an ergometer. Data from the devices collected during the protocol were compared with reference methods: electrocardiography (heart rate) and indirect calorimetry (energy expenditure). Results None of the devices performed significantly better overall, however heart rate was consistently more accurate than energy expenditure across all four devices. Correlations between the devices and reference methods were moderate to strong for heart rate (0.67-0.95 [0.35 to 0.98]) and weak to strong for energy expenditure (0.16-0.86 [-0.25 to 0.95]). All devices underestimated both outcomes compared to reference methods. The percentage error for heart rate was small across the devices (range: 1-9%) but greater for energy expenditure (9-43%). Similarly, limits of agreement were considerably narrower for heart rate (ranging from -27.3 to 13.1 bpm) than energy expenditure (ranging from -266.7 to 65.7 kcals) across devices. Conclusion These devices accurately measure heart rate. However, estimates of energy expenditure are poor and would have implications for people using these devices for weight loss.	[Wallen, Matthew P.; Gomersall, Sjaan R.; Keating, Shelley E.; Coombes, Jeff S.] Univ Queensland, Ctr Res Exercise Phys Act & Hlth CRExPAH, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway	University of Queensland; Norwegian University of Science & Technology (NTNU)	Coombes, JS (corresponding author), Univ Queensland, Ctr Res Exercise Phys Act & Hlth CRExPAH, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia.	jcoombes@uq.edu.au	Coombes, Jeff/F-1764-2010; Wallen, Matthew/AAY-1989-2020; Gomersall, Sjaan/J-9665-2013; Keating, Shelley E/P-2520-2015	Coombes, Jeff/0000-0002-6990-3596; Wallen, Matthew/0000-0002-2201-7933; Gomersall, Sjaan/0000-0001-6808-0180; Keating, Shelley E/0000-0001-5357-2721; Wisloff, Ulrik/0000-0002-7211-3587	Coca Cola [2014002786]	Coca Cola	The principal investigator on the study (Coombes) received an unrestricted grant from Coca Cola that was used to partially fund this study (Research Master Number 2014002786, http://transparency.coca-colajourney.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, FORECAST UNIT SALES; [Anonymous], 2014, CCS INSIGHT; Brown R, 2005, EUR J ORTHODONT, V27, P286, DOI 10.1093/ejo/cjh078; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Fallow BA, 2013, J CLIN MONIT COMPUT, V27, P313, DOI 10.1007/s10877-013-9436-7; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Keytel LR, 2005, J SPORT SCI, V23, P289, DOI 10.1080/02640410470001730089; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Luke A, 1997, MED SCI SPORT EXER, V29, P144, DOI 10.1097/00005768-199701000-00021; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Parak J, 2014, IEEE ENG MED BIO, P3670, DOI 10.1109/EMBC.2014.6944419; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Sasaki JE, 2015, J PHYS ACT HEALTH, V12, P149, DOI 10.1123/jpah.2012-0495; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	19	172	176	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0154420	10.1371/journal.pone.0154420	http://dx.doi.org/10.1371/journal.pone.0154420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232714	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000001
J	Christy, AG; Hirsch, KA; Schlegel, RJ				Christy, Andrew G.; Hirsch, Kelly A.; Schlegel, Rebecca J.			Animal Magnetism: Metaphoric Cues Alter Perceptions of Romantic Partners and Relationships	PLOS ONE			English	Article							MEDIATION; WARMTH; SCALE; POWER; LOVE	The psychological state of love is difficult to define, and we often rely on metaphors to communicate about this state and its constituent experiences. Commonly, these metaphors liken love to a physical force-it sweeps us off our feet, causes sparks to fly, and ignites flames of passion. Even the use of "attraction" to refer to romantic interest, commonplace in both popular and scholarly discourse, implies a force propelling two objects together. The present research examined the effects of exposing participants to a physical force (magnetism) on subsequent judgments of romantic outcomes. Across two studies, participants exposed to magnets reported greater levels of satisfaction, attraction, intimacy, and commitment.	[Christy, Andrew G.; Hirsch, Kelly A.; Schlegel, Rebecca J.] Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Christy, AG (corresponding author), Texas A&M Univ, Dept Psychol, College Stn, TX 77843 USA.	andrew.christy4@gmail.com		Christy, Andrew/0000-0002-6181-1312				ALLBRITTON DW, 1995, J EXP PSYCHOL LEARN, V21, P612, DOI 10.1037/0278-7393.21.3.612; Eastwick PW, 2008, J PERS SOC PSYCHOL, V94, P245, DOI 10.1037/0022-3514.94.2.245; Fay AJ, 2012, J EXP SOC PSYCHOL, V48, P1369, DOI 10.1016/j.jesp.2012.05.017; GIBBS RW, 1992, J MEM LANG, V31, P485, DOI 10.1016/0749-596X(92)90025-S; Grady JE, 1997, COGN LINGUIST, V8, P267, DOI 10.1515/cogl.1997.8.4.267; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Kay AC, 2009, J PERS SOC PSYCHOL, V97, P421, DOI 10.1037/a0015997; Knee CR, 2003, PERS SOC PSYCHOL REV, V7, P41, DOI 10.1207/S15327957PSPR0701_3; LAKOFF G, 1980, COGNITIVE SCI, V4, P195, DOI 10.1207/s15516709cog0402_4; Lakoff George., 1999, PHILOS FLESH EMBODIE; Landau MJ, 2011, J EXP SOC PSYCHOL, V47, P79, DOI 10.1016/j.jesp.2010.08.012; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; LEE JA, 1977, PERS SOC PSYCHOL B, V3, P173, DOI 10.1177/014616727700300204; Lee SWS, 2014, J EXP SOC PSYCHOL, V54, P61, DOI 10.1016/j.jesp.2014.04.007; Lee SWS, 2012, J PERS SOC PSYCHOL, V103, P737, DOI 10.1037/a0029708; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; McDonald MJ, 2013, HUMAN QUEST MEANING; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2004, PSYCHOL SCI, V15, P82, DOI 10.1111/j.0963-7214.2004.01502002.x; Meier BP, 2007, J PERS SOC PSYCHOL, V93, P699, DOI 10.1037/0022-3514.93.5.699; Ren DN, 2015, J SOC PERS RELAT, V32, P905, DOI 10.1177/0265407514554512; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; Sinclair VG, 2005, J NURS MEAS, V13, P193, DOI 10.1891/106137405780954415; Spencer SJ, 2005, J PERS SOC PSYCHOL, V89, P845, DOI 10.1037/0022-3514.89.6.845; Tsai JL, 2007, PERSPECT PSYCHOL SCI, V2, P242, DOI 10.1111/j.1745-6916.2007.00043.x; Wei MF, 2007, J PERS ASSESS, V88, P187, DOI 10.1080/00223890701268041; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2008, PSYCHOL SCI, V19, P302, DOI 10.1111/j.1467-9280.2008.02084.x	34	1	1	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155943	10.1371/journal.pone.0155943	http://dx.doi.org/10.1371/journal.pone.0155943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227965	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500045
J	He, ZF; Riva, M; Bjork, P; Sward, K; Morgelin, M; Leanderson, T; Ivars, F				He, Zhifei; Riva, Matteo; Bjork, Per; Sward, Karl; Morgelin, Matthias; Leanderson, Tomas; Ivars, Fredrik			CD14 Is a Co-Receptor for TLR4 in the S100A9-Induced Pro-Inflammatory Response in Monocytes	PLOS ONE			English	Article							INNATE IMMUNE RECOGNITION; FACTOR-KAPPA-B; LIPID RAFTS; BACTERIAL LIPOPOLYSACCHARIDE; SIGNALING PATHWAYS; BINDING-PROTEINS; S100A9 PROTEIN; RECEPTOR; LPS; ENDOCYTOSIS	The cytosolic Ca2+-binding S100A9 and S100A8 proteins form heterodimers that are primarily expressed in human neutrophils and monocytes. We have recently shown that S100A9 binds to TLR4 in vitro and induces TLR4-dependent NF-kappa B activation and a proinflammatory cytokine response in monocytes. In the present report we have further investigated the S100A9-mediated stimulation of TLR4 in monocytes. Using transmission immunoelectron microscopy, we detected focal binding of S100A9 to monocyte membrane subdomains containing the caveolin-1 protein and TLR4. Furthermore, the S100A9 protein was detected in early endosomes of the stimulated cells, indicating that the protein could be internalized by endocytosis. Although stimulation of monocytes with S100A9 was strictly TLR4-dependent, binding of S100A9 to the plasma membrane and endocytosis of S100A9 was still detectable and coincided with CD14 expression in TLR4-deficient cells. We therefore investigated whether CD14 would be involved in the TLR4-dependent stimulation and could show that the S100A9-induced cytokine response was inhibited both in CD14-deficient cells and in cells exposed to CD14 blocking antibodies. Further, S100A9 was not internalized into CD14-deficient cells suggesting a direct role of CD14 in endocytosis of S100A9. Finally, we could detect satiable binding of S100A9 to CD14 in surface plasmon resonance experiments. Taken together, these results indicate that CD14 is a co-receptor of TLR4 in the S100A9-induced cytokine response.	[He, Zhifei; Riva, Matteo; Leanderson, Tomas; Ivars, Fredrik] Lund Univ, Dept Expt Med Sci, Immunol Sect, Immunol Grp, Lund, Sweden; [Riva, Matteo; Bjork, Per; Leanderson, Tomas] Act Biotech AB, Lund, Sweden; [Sward, Karl] Lund Univ, Dept Expt Med Sci, Sect Cell & Tissue Biol, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Sect Infect Biol, Lund, Sweden	Lund University; Lund University; Lund University	Ivars, F (corresponding author), Lund Univ, Dept Expt Med Sci, Immunol Sect, Immunol Grp, Lund, Sweden.	fredrik.ivars@med.lu.se		Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Society [100591]; Swedish Research Council [7480]; Swedish Strategic Research Foundation; Alfred Osterlunds Stiftelse; Greta and Johan Kocks Stiftelser; King Gustav V Memorial Fund; Inga Britt och Arne Lundbergs Forskningsstiftelse; Active Biotech AB	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Strategic Research Foundation(Swedish Foundation for Strategic Research); Alfred Osterlunds Stiftelse; Greta and Johan Kocks Stiftelser; King Gustav V Memorial Fund; Inga Britt och Arne Lundbergs Forskningsstiftelse; Active Biotech AB	This work was funded by Swedish Cancer Society grant #100591; https://www.cancerfonden.se/forskning (TL); Swedish Research Council project #7480; http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html (TL); The Swedish Strategic Research Foundation; http://www.stratresearch.se (MM); Alfred Osterlunds Stiftelse; http://www.alfredosterlundsstiftelse.se (FI and MM); Greta and Johan Kocks Stiftelser; http://www.kockskastiftelsen.se (FI and MM); King Gustav V Memorial Fund; http://www.kungahuset.se/monarkinhovstaterna/kungligastiftelser/forskning/konunggustafvs80arsfond/english.4.67e94750148caf4ad27d21.html (MM); Inga Britt och Arne Lundbergs Forskningsstiftelse; http://www.lundbergsstiftelsen.se/index_en.html (Institutional grant). Active Biotech AB provided support in the form of salaries for authors MR, PB and TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albinsson S, 2007, AM J PHYSIOL-REG I, V293, pR1222, DOI 10.1152/ajpregu.00092.2007; Arakawa R, 2000, J LIPID RES, V41, P1952; Arnold V, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-122; Beutler B, 2003, J LEUKOCYTE BIOL, V74, P479, DOI 10.1189/jlb.0203082; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Borzecka K, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/824919; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Feng H, 2013, LIFE SCI, V93, P1, DOI 10.1016/j.lfs.2013.05.016; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Gaus K, 2005, J LIPID RES, V46, P1526, DOI 10.1194/jlr.M500103-JLR200; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Grevers LC, 2011, ARTHRITIS RHEUM-US, V63, P1365, DOI 10.1002/art.30290; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hibino T, 2013, CANCER RES, V73, P172, DOI 10.1158/0008-5472.CAN-11-3843; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lee HK, 2006, IMMUNITY, V24, P153, DOI 10.1016/j.immuni.2005.12.012; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; Matveev S, 1999, J LIPID RES, V40, P1647; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; Rajaiah R, 2015, P NATL ACAD SCI USA, V112, P8391, DOI 10.1073/pnas.1424980112; Rammes A, 1997, J BIOL CHEM, V272, P9496; Razani B, 2001, J BIOL CHEM, V276, P38121; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Saitoh S, 2004, J ENDOTOXIN RES, V10, P257, DOI 10.1179/096805104225005904; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Shuto T, 2005, BIOCHEM BIOPH RES CO, V338, P1402, DOI 10.1016/j.bbrc.2005.10.102; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tan YH, 2014, MOL CELL, V54, P212, DOI 10.1016/j.molcel.2014.03.012; Thieblemont N, 1998, IMMUNITY, V8, P771, DOI 10.1016/S1074-7613(00)80582-8; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; TOBIAS PS, 1988, J BIOL CHEM, V263, P13479; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/186093; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Wang PY, 1996, J INFLAMM, V47, P126; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	73	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156377	10.1371/journal.pone.0156377	http://dx.doi.org/10.1371/journal.pone.0156377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228163	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500125
J	de Godoy, LBM; Luz, GP; Palombini, LO; Silva, LOE; Hoshino, W; Guimaraes, TM; Tufik, S; Bittencourt, L; Togeiro, SM				Mello de Godoy, Luciana Balester; Luz, Gabriela Pontes; Palombini, Luciana Oliveira; Oliveira e Silva, Luciana; Hoshino, Wilson; Guimaraes, Thais Moura; Tufik, Sergio; Bittencourt, Lia; Togeiro, Sonia Maria			Upper Airway Resistance Syndrome Patients Have Worse Sleep Quality Compared to Mild Obstructive Sleep Apnea	PLOS ONE			English	Article							DAYTIME SLEEPINESS; OF-LIFE; PSYCHOMOTOR VIGILANCE; ASSOCIATION; PERFORMANCE; VALIDATION; SCALE; HYPERTENSION; INSTRUMENT; DISORDERS	Purpose To compare sleep quality and sustained attention of patients with Upper Airway Resistance Syndrome (UARS), mild Obstructive Sleep Apnea (OSA) and normal individuals. Methods UARS criteria were presence of excessive daytime sleepiness (Epworth Sleepiness Scale ESS >= 10) and/or fatigue (Modified Fatigue Impact Scale MFIS >= 38) associated to Apnea/hypopnea index (AHI) <= 5 and Respiratory Disturbance Index (RDI) > 5 events/hour of sleep or more than 30% of total sleep time with flow limitation. Mild OSA was considered if the presence of excessive daytime sleepiness (ESS > 10) and/or fatigue (MFIS > 38) associated to AHI > 5 and <= 15 events/hour. "Control group" criteria were AHI < 5 events/hour and RDI < 5 events/hour and ESS < 9, without any sleep, clinical, neurological or psychiatric disorder. 115 individuals (34 UARS and 47 mild OSA patients and 34 individuals in "control group"), adjusted for age, gender, body mass index (BMI) and schooling years, performed sleep questionnaires and sustained attention evaluation. Psychomotor Vigilance Task (PVT) was performed five times (each two hours) from 8 a.m. to 4 p.m. Results UARS patients had worse sleep quality (Functional Outcomes of Sleep Questionnaire FOSQ and Pittsburgh Sleep Quality Index PSQI: p < 0.05) and more fatigue than mild OSA patients (p = 0.003) and scored significantly higher in both Beck inventories than "control group" (p < 0.02). UARS patients had more lapses early in the morning (in time 1) compared to the results in the afternoon (time 5) than mild OSA (p = 0.02). Mild OSA patients had more lapses in times 2 than in time 5 compared to "control group" (p = 0.04). Conclusions UARS patients have a worse sleep quality, more fatigue and a worse early morning sustained attention compared to mild OSA. These last had a worse sustained attention than controls.	[Mello de Godoy, Luciana Balester; Luz, Gabriela Pontes; Palombini, Luciana Oliveira; Oliveira e Silva, Luciana; Hoshino, Wilson; Guimaraes, Thais Moura; Tufik, Sergio; Bittencourt, Lia; Togeiro, Sonia Maria] Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Palombini, LO (corresponding author), Univ Fed Sao Paulo, Dept Psicobiol, Sao Paulo, Brazil.	lu_bmg@hotmail.com	Bittencourt, Lia/C-6551-2012	Bittencourt, Lia/0000-0001-7738-0927; Togeiro, Sonia Maria/0000-0001-7103-9007	Associacao Fundo de Incentivo a Pesquisa	Associacao Fundo de Incentivo a Pesquisa	This study was funded by the Associacao Fundo de Incentivo a Pesquisa.	*AASM, 2005, INT CLASS SLEEP DIS; Bao G, 2004, CURR OPIN PULM MED, V10, P461, DOI 10.1097/01.mcp.0000143689.86819.c2; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Black JE, 2000, AM J RESP CRIT CARE, V162, P406, DOI 10.1164/ajrccm.162.2.9901026; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cunha JA., 2001, MANUAL VERSAO PORTUG; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Exar EN, 1999, CHEST, V115, P1127, DOI 10.1378/chest.115.4.1127; FINDLEY LJ, 1988, AM REV RESPIR DIS, V138, P337, DOI 10.1164/ajrccm/138.2.337; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; George CFP, 2001, THORAX, V56, P508, DOI 10.1136/thorax.56.7.508; Gold AR, 2003, CHEST, V123, P87, DOI 10.1378/chest.123.1.87; Gold AR, 2002, CHEST, V121, P1531, DOI 10.1378/chest.121.5.1531; Gold AR, 2008, SLEEP MED, V9, P675, DOI 10.1016/j.sleep.2007.08.013; Guilleminault C, 2000, AM J RESP CRIT CARE, V161, P1412, DOI 10.1164/ajrccm.161.5.16158a; Guilleminault C, 2005, SLEEP MED, V6, P451, DOI 10.1016/j.sleep.2005.03.014; Guilleminault C, 2001, EUR RESPIR J, V17, P838, DOI 10.1183/09031936.01.17508380; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; Guilleminault C, 2001, AM J RESP CRIT CARE, V164, P1242, DOI 10.1164/ajrccm.164.7.2011036; Guilleminault C, 2002, CHEST, V122, P866, DOI 10.1378/chest.122.3.866; Iber CACA, 2007, AAM MANUAL SCORING S; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kim H, 2007, SLEEP, V30, P1309, DOI 10.1093/sleep/30.10.1309; Lee IS, 2011, J CLIN SLEEP MED, V7, P251, DOI 10.5664/JCSM.1064; Lee SA, 2015, J NEUROL SCI, V359, P445, DOI 10.1016/j.jns.2015.10.017; Luz GP, 2016, SLEEP BREATH, V20, P681, DOI 10.1007/s11325-015-1279-7; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Palombini LO, 2013, SLEEP, V36, P1663, DOI 10.5665/sleep.3122; Pavan K, 2007, ARQ NEURO-PSIQUIAT, V65, P669, DOI 10.1590/S0004-282X2007000400024; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Quan Stuart F, 2014, Southwest J Pulm Crit Care, V9, P44; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; So SJ, 2015, PSYCHIAT INVEST, V12, P183, DOI 10.4306/pi.2015.12.2.183; Stoohs RA, 2008, SLEEP MED, V9, P121, DOI 10.1016/j.sleep.2007.02.010; Stoohs RA, 2009, SLEEP MED, V10, P1000, DOI 10.1016/j.sleep.2008.11.005; Ulfberg J, 2000, SCAND J WORK ENV HEA, V26, P237, DOI 10.5271/sjweh.537; Weaver TE, 1997, SLEEP, V20, P835; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Yang EH, 2000, SLEEP, V23, P535	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156244	10.1371/journal.pone.0156244	http://dx.doi.org/10.1371/journal.pone.0156244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228081	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500092
J	Schaal, C; Chellappan, S				Schaal, Courtney; Chellappan, Srikumar			Nicotine-Mediated Regulation of Nicotinic Acetylcholine Receptors in Non-Small Cell Lung Adenocarcinoma by E2F1 and STAT1 Transcription Factors	PLOS ONE			English	Article							PROMOTES TUMOR-GROWTH; SUSCEPTIBILITY LOCUS; MICROARRAY DATA; TARGET GENES; CANCER CELLS; PROLIFERATION; METASTASIS; ACTIVATION; INVASION; SMOKING	Cigarette smoking is the major risk factor for non-small cell lung cancer (NSCLC), which accounts for 80% of all lung cancers. Nicotine, the addictive component of tobacco smoke, can induce proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), angiogenesis, and survival in NSCLC cell lines, as well as growth and metastasis of NSCLC in mice. This nicotine-mediated tumor progression is facilitated through activation of nicotinic acetylcholine receptors (nAChRs), specifically the alpha 7 subunit; however, how the alpha 7 nAChR gene is regulated in lung adenocarcinoma is not fully clear. Here we demonstrate that the alpha 7 nAChR gene promoter is differentially regulated by E2F and STAT transcription factors through a competitive interplay; E2F1 induces the promoter, while STAT transcription factors repress it by binding to an overlapping site at a region -294 through -463bp upstream of the transcription start site. Treatment of cells with nicotine induced the mRNA and protein levels of alpha 7 nAChR; this could be abrogated by treatment with inhibitors targeting Src, PI3K, MEK, alpha 7 nAChR, CDK4/6 or a disruptor of the Rb-Raf-1 interaction. Further, nicotine-mediated induction of alpha 7 nAChR was reduced when E2F1 was depleted and in contrast elevated when STAT1 was depleted by siRNAs. Interestingly, extracts from e-cigarettes, which have recently emerged as healthier alternatives to traditional cigarette smoking, can also induce alpha 7 nAChR expression in a manner similar to nicotine. These results suggest an autoregulatory feed-forward loop that induces the levels of alpha 7 nAChR upon exposure to nicotine, which enhances the strength of the signal. It can be imagined that such an induction of alpha 7 nAChR contributes to the tumor-promoting functions of nicotine.	[Schaal, Courtney; Chellappan, Srikumar] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA; [Schaal, Courtney] Univ S Florida, Dept Cell Biol Microbiol & Mol Biol, Canc Biol PhD Program, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Chellappan, S (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL 33612 USA.	srikumar.chellappan@moffitt.org			NCI [CA127725]; Lung Cancer Center of Excellence at Moffitt; Lung Cancer Center of Excellence at the Moffitt Cancer Center; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA127725] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Center of Excellence at Moffitt; Lung Cancer Center of Excellence at the Moffitt Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grant CA127725 from the NCI as well as internal funds form the Lung Cancer Center of Excellence at Moffitt. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors thank Drs. Uwe Rix and Eric Haura for helpful discussions, as well as the Moffitt Cancer Center Microscopy Core Facility for their assistance. These studies were supported by the grant CA127725 from the NCI to SPC as well as the Lung Cancer Center of Excellence at the Moffitt Cancer Center.	Aali N, 2015, CELL MOL BIOL LETT, V20, P948, DOI 10.1515/cmble-2015-0056; Abrams DB, 2014, JAMA-J AM MED ASSOC, V311, P135, DOI 10.1001/jama.2013.285347; Al-Wadei HAN, 2012, CURR CANCER DRUG TAR, V12, P97; Al-Wadei HAN, 2009, CARCINOGENESIS, V30, P506, DOI 10.1093/carcin/bgp010; Al-Wadei MH, 2016, EUR J CANCER, V52, P188, DOI 10.1016/j.ejca.2015.10.003; Alberg AJ, 2005, J CLIN ONCOL, V23, P3175, DOI 10.1200/JCO.2005.10.462; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Auf R, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i425; Beregovyi S M, 2015, Ukr Biochem J, V87, P70; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Calderon LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143277; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; Furrukh Muhammad, 2013, Sultan Qaboos Univ Med J, V13, P345; Grando SA, 2015, INT IMMUNOPHARMACOL, V29, P1, DOI 10.1016/j.intimp.2015.08.023; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Guha P, 2014, BREAST CANCER RES TR, V145, P5, DOI 10.1007/s10549-014-2912-z; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Improgo MR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00251; Itier V, 2001, FEBS LETT, V504, P118, DOI 10.1016/S0014-5793(01)02702-8; Johnson JL, 2012, CANCER RES, V72, P516, DOI 10.1158/0008-5472.CAN-11-2647; Khalil AA, 2013, BRAIN TUMOR PATHOL, V30, P73, DOI 10.1007/s10014-012-0101-5; Kunigal S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-24; Lee CH, 2011, J ONCOL, V2011, DOI 10.1155/2011/693424; Lee J, 2012, LIFE SCI, V91, P1058, DOI 10.1016/j.lfs.2012.06.032; Lee SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18146; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Ma XL, 2014, TOXICOL APPL PHARM, V278, P172, DOI 10.1016/j.taap.2014.04.023; Medjber K, 2015, LUNG CANCER, V87, P258, DOI 10.1016/j.lungcan.2015.01.001; Momi N, 2013, ONCOGENE, V32, P1384, DOI 10.1038/onc.2012.163; Muxel SM, 2016, J PINEAL RES, V60, P394, DOI 10.1111/jpi.12321; Nair S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-173; Nieh S, 2015, HEAD NECK-J SCI SPEC, V37, P1712, DOI 10.1002/hed.23820; Phillips DH, 2002, CARCINOGENESIS, V23, P1979, DOI 10.1093/carcin/23.12.1979; Pillai S, 2015, METHODS MOL BIOL, V1288, P429, DOI 10.1007/978-1-4939-2474-5_25; Pillai S, 2015, CANCER RES, V75, P1009, DOI 10.1158/0008-5472.CAN-14-0681; Pillai S, 2011, MOL CELL BIOL, V31, P3052, DOI 10.1128/MCB.01311-10; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Shah M, 2015, CELL CYCLE, V14, P323, DOI 10.4161/15384101.2014.980643; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh T, 2016, MMWR-MORBID MORTAL W, V64, P1403, DOI 10.15585/mmwr.mm6452a3; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Sun HJ, 2015, EXP TOXICOL PATHOL, V67, P477, DOI 10.1016/j.etp.2015.07.001; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Togashi Y, 2015, LUNG CANCER, V88, P16, DOI 10.1016/j.lungcan.2015.01.027; Trevino JG, 2012, NEOPLASIA, V14, P1102, DOI 10.1593/neo.121044; Vuong LM, 2015, MOL CELL BIOL, V35, P3471, DOI 10.1128/MCB.00030-15; Walton KM, 2015, NICOTINE TOB RES, V17, P259, DOI 10.1093/ntr/ntu214; Yoo SS, 2014, LUNG CANCER, V86, P85, DOI 10.1016/j.lungcan.2014.08.002; Yuge K, 2015, MOL CANCER THER, V14, P2112, DOI 10.1158/1535-7163.MCT-15-0140	62	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156451	10.1371/journal.pone.0156451	http://dx.doi.org/10.1371/journal.pone.0156451			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228072	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500138
J	Zhao, Y; Tu, P; Zhou, GY; Zhou, ZC; Lin, XX; Yang, HL; Lu, Z; Gao, TW; Tu, YT; Xie, HF; Zheng, QS; Gu, Y; Tao, JN; Zhu, XJ				Zhao, Yi; Tu, Ping; Zhou, Guoyu; Zhou, Zhanchao; Lin, Xiaoxi; Yang, Huilan; Lu, Zhong; Gao, Tianwen; Tu, Yating; Xie, Hongfu; Zheng, Qingshan; Gu, Ying; Tao, Jining; Zhu, Xuejun			Hemoporfin Photodynamic Therapy for Port Wine Stain: A Randomized Controlled Trial	PLOS ONE			English	Article							PULSED-DYE-LASER; PWS BIRTHMARKS; ERYTHEMA; EFFICACY; PDT; CANCER	Background and Objectives Photodynamic therapy (PDT) has shown potentially beneficial results in treating port-wine stain, but its benefit risk profile remains undefined. This study aimed to evaluate the efficacy and safety of PDT conducted with hemoporfin and a 532 nm continuous wave laser to treat port-wine stain clinically. Patients and Methods This randomized clinical trial was conducted in eight hospitals in China. Participants were adolescent and adult patients (age range: 14-65 years old) with port-wine stain. During stage 1 (day 1 to week 8) all patients were randomized at a 3:1 ratio to treatment (532 nm laser irradiation (96-120 J/cm(2)) with hemoporfin (5mg/kg; PDT-hemoporfin, n = 330)) or placebo groups (irradiation with placebo (PDT -placebo, n = 110)); during stage 2 (week 8 to 16) patients in both groups were offered treatment. Clinician-evaluators, who were blind to the study, classified each case on the following four-level scale according to assessment of before and after standardized pictures of the lesion area: no improvement: <20%; some improvement: 20-59%; great improvement: 60-89%; or nearly completely resolved: >= 90%. The primary efficacy endpoint was proportion of patients achieving at least some improvement at week 8. The secondary efficacy endpoints were proportion of patients achieving nearly completely resolved or at least great improvement at week 8, proportion of patients achieving early completely resolved, at least great improvement, or at least some improvement at week 16, and the corresponding satisfaction of the investigators and the patients (designated as 'excellent', 'good', 'moderate', or 'ineffective') at weeks 8 and 16. Results Compared to the PDT-placebo group, the PDT-hemoporfin group showed a significantly higher proportion of patients that achieved at least some improvement (89.7% [n = 295; 95% CI, 85.9%-92.5%] vs. 24.5% [n = 27; 95% CI, 17.4%-33.3%]) at week 8 (P < 0.0001) and higher improvements for all secondary efficacy endpoints. Treatment reactions occurred in 99.5% (n = 731; 95% CI, 98.7%-99.8%) of the PDT-hemoporfin treatments (n = 735). Hyperpigmentation occurred in 22.9 per 100 patient-treatments (n = 168; 95% CI, 20.0-26.0) in the PDT-hemoporfin treated patients. Conclusions Hemoporfin-mediated PDT is an effective and safe treatment option for adolescent and adult patients with port-wine stain.	[Zhao, Yi; Tu, Ping; Zhu, Xuejun] Peking Univ, Dept Dermatol & Venereol, Hosp 1, Beijing 100871, Peoples R China; [Zhou, Guoyu] Shanghai Jiao Tong Univ, Sch Med, Dept Oral Maxillofacial Surg, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Zhou, Zhanchao] Chinese Acad Med Sci, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Zhou, Zhanchao] Peking Union Med Coll, Nanjing, Jiangsu, Peoples R China; [Lin, Xiaoxi] Shanghai Jiao Tong Univ, Sch Med, Dept Plast & Reconstruct Surg, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yang, Huilan] Guangzhou Mil Command, Gen Hosp, Dept Dermatol, Guangzhou, Guangdong, Peoples R China; [Lu, Zhong] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China; [Gao, Tianwen] Fourth Mil Med Univ, Xijing Hosp, Inst Dermatol Chinese PLA, Xian 710032, Peoples R China; [Tu, Yating] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Dermatol, Wuhan 430074, Peoples R China; [Xie, Hongfu] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Zheng, Qingshan] Shanghai Univ Chinese Tradit Med, Ctr Drug Clin Res, Shanghai, Peoples R China; [Gu, Ying] Chinese Peoples Liberat Army Gen Hosp, Dept Laser Med, Beijing 100853, Peoples R China; [Tao, Jining] Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, Shanghai, Peoples R China	Peking University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shanghai Jiao Tong University; Southern Theater Command General Hospital; Fudan University; Air Force Military Medical University; Huazhong University of Science & Technology; Central South University; Shanghai University of Traditional Chinese Medicine; Chinese People's Liberation Army General Hospital	Zhu, XJ (corresponding author), Shanghai Fudan Zhangjiang Biopharmaceut Co Ltd, Shanghai, Peoples R China.	jntao@fd-zj.com; bjzhuxj@gmail.com	Zhao, Yi/M-5881-2018	Zhao, Yi/0000-0002-4531-8632	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.; Chinese PLA General Hospital	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.; Chinese PLA General Hospital	This study was co-sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. and the Chinese PLA General Hospital, and was funded by the former. The sponsors had no role in the collection, management, or analysis of the data, or interpretation of the data, preparation of the manuscript, or decision to submit the manuscript for publication. In collaboration with the academic coauthors, both cosponsors were involved in the design of the study. The funder was involved in the conduct of the study and reviewed the manuscript prior to submission, and provided support in the form of salaries for authors [JN Tao], but did not have any additional role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Currie CLA, 2000, BRIT J DERMATOL, V143, P360, DOI 10.1046/j.1365-2133.2000.03663.x; DIXON JA, 1984, PLAST RECONSTR SURG, V73, P771, DOI 10.1097/00006534-198405000-00009; Faurschou A, 2009, BRIT J DERMATOL, V160, P359, DOI 10.1111/j.1365-2133.2008.08993.x; Gao K, 2013, BRIT J DERMATOL, V168, P1040, DOI 10.1111/bjd.12130; Greve B, 2004, LASER SURG MED, V34, P168, DOI 10.1002/lsm.20003; Gu Y, 2007, ANN DERMATOL VENER, V134, P241, DOI 10.1016/S0151-9638(07)91816-5; Gu Y, 1994, CHINESE J LASER MED, V3, P215; Huang NY, 2011, LASER MED SCI, V26, P665, DOI 10.1007/s10103-011-0890-5; Huikeshoven M, 2007, NEW ENGL J MED, V356, P1235, DOI 10.1056/NEJMoa064329; JACOBS AH, 1976, PEDIATRICS, V58, P218; Jiang L, 1998, CHINESE MED J-PEKING, V111, P136; Jung B, 2005, LASER SURG MED, V37, P186, DOI 10.1002/lsm.20218; Kelly KM, 2005, ARCH FACIAL PLAST S, V7, P287, DOI 10.1001/archfaci.7.5.287; Klapman MH, 2001, J AM ACAD DERMATOL, V44, P300, DOI 10.1067/mjd.2001.111353; Le KVT, 1999, DERMATOL SURG, V25, P127, DOI 10.1046/j.1524-4725.1999.08166.x; MALM M, 1988, ANN PLAS SURG, V20, P512, DOI 10.1097/00000637-198806000-00002; Mayor S, 2003, BRIT MED J, V327, P698, DOI 10.1136/bmj.327.7417.698-b; ORENSTEIN A, 1990, LASER SURG MED, V10, P334, DOI 10.1002/lsm.1900100406; Orten SS, 1996, ARCH OTOLARYNGOL, V122, P1174; Qin ZP, 2007, PHOTODIAGN PHOTODYN, V4, P53, DOI 10.1016/j.pdpdt.2007.01.001; Rasband W, IMAGEJ IMAGE PROCESS; Song K, 2005, BIOCHEM BIOPH RES CO, V337, P127, DOI 10.1016/j.bbrc.2005.09.021; Stangeland KZ, 2012, J EUR ACAD DERMATOL, V26, P849, DOI 10.1111/j.1468-3083.2011.04167.x; Sun PH, 2011, ACTA PHARMACOL SIN, V32, P1549, DOI 10.1038/aps.2011.132; Tomson N, 2006, BRIT J DERMATOL, V154, P676, DOI 10.1111/j.1365-2133.2005.07113.x; Tournas JA, 2009, PHOTODIAGN PHOTODYN, V6, P195, DOI 10.1016/j.pdpdt.2009.10.002; Uppsala Monitoring Center, 2000, WHO ART ADV REACT TE; Wei YQ, 2007, PHOTOCHEM PHOTOBIOL, V83, P1319, DOI 10.1111/j.1751-1097.2007.00160.x; World Health Organisation, UPPS MON CTR SYST ST; Xiao Q, 2011, J DERMATOL, V38, P1146, DOI 10.1111/j.1346-8138.2011.01292.x; Yamamoto T, 2008, SKIN RES TECHNOL, V14, P26, DOI 10.1111/j.1600-0846.2007.00256.x; Yuan KH, 2008, PHOTODIAGN PHOTODYN, V5, P50, DOI 10.1016/j.pdpdt.2007.12.001; Yuan KH, 2012, PHOTODIAGN PHOTODYN, V9, P332, DOI 10.1016/j.pdpdt.2012.03.007; Yuan KH, 2009, PHOTODIAGN PHOTODYN, V6, P189, DOI 10.1016/j.pdpdt.2009.08.001; Yung A, 2005, BRIT J DERMATOL, V153, P601, DOI 10.1111/j.1365-2133.2005.06707.x; Zhang B, 2014, PHOTODIAGN PHOTODYN, V11, P491, DOI 10.1016/j.pdpdt.2014.06.004; Zhao Y, 2013, PHOTODIAGN PHOTODYN, V10, P96, DOI 10.1016/j.pdpdt.2012.10.001; Zhao Y, 2011, PHOTODERMATOL PHOTO, V27, P17, DOI 10.1111/j.1600-0781.2010.00555.x	39	38	39	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156219	10.1371/journal.pone.0156219	http://dx.doi.org/10.1371/journal.pone.0156219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227544	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500085
J	Altiok, EI; Browne, S; Khuc, E; Moran, EP; Qiu, FF; Zhou, KL; Santiago-Ortiz, JL; Ma, JX; Chan, MF; Healy, KE				Altiok, Eda I.; Browne, Shane; Khuc, Emily; Moran, Elizabeth P.; Qiu, Fangfang; Zhou, Kelu; Santiago-Ortiz, Jorge L.; Ma, Jian-xing; Chan, Matilda F.; Healy, Kevin E.			sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; INTRAVITREAL DRUG-DELIVERY; DIABETIC-RETINOPATHY; EXTRACELLULAR DOMAIN; VASCULAR-DISEASE; EYE DISEASE; PHARMACOKINETICS; RANIBIZUMAB; VITRO	Current anti-VEGF drugs for patients with diabetic retinopathy suffer from short residence time in the vitreous of the eye. In order to maintain biologically effective doses of drug for inhibiting retinal neovascularization, patients are required to receive regular monthly injections of drug, which often results in low patient compliance and progression of the disease. To improve the intravitreal residence time of anti-VEGF drugs, we have synthesized multivalent bioconjugates of an anti-VEGF protein, soluble fms-like tyrosine kinase-1 (sFlt) that is covalently grafted to chains of hyaluronic acid (HyA), conjugates that are termed mvsFlt. Using a mouse corneal angiogenesis assay, we demonstrate that covalent conjugation to HyA chains does not decrease the bioactivity of sFlt and that mvsFlt is equivalent to sFlt at inhibiting corneal angiogenesis. In a rat vitreous model, we observed that mvsFlt had significantly increased intravitreal residence time compared to the unconjugated sFlt after 2 days. The calculated intravitreal half-lives for sFlt and mvsFlt were 3.3 and 35 hours, respectively. Furthermore, we show that mvsFlt is more effective than the unconjugated form at inhibiting retinal neovascularization in an oxygen-induced retinopathy model, an effect that is most likely due to the longer half-life of mvsFlt in the vitreous. Taken together, our results indicate that conjugation of sFlt to HyA does not affect its affinity for VEGF and this conjugation significantly improves drug half-life. These in vivo results suggest that our strategy of multivalent conjugation could substantially improve upon drug half-life, and thus the efficacy of currently available drugs that are used in diseases such as diabetic retinopathy, thereby improving patient quality of life.	[Altiok, Eda I.; Browne, Shane; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Browne, Shane] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland; [Khuc, Emily; Chan, Matilda F.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Moran, Elizabeth P.; Qiu, Fangfang; Zhou, Kelu; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK USA; [Santiago-Ortiz, Jorge L.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California San Francisco; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Healy, KE (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	kehealy@berkeley.edu	Qiu, Fangfang/GLT-3181-2022; Qiu, Fangfang/GLT-3151-2022	Qiu, Fangfang/0000-0002-3584-0275; Qiu, Fangfang/0000-0002-3584-0275; Pearsall, Elizabeth/0000-0003-1013-6238; Browne, Shane/0000-0002-1005-1712; Santiago-Ortiz, Jorge/0000-0003-4560-9963	NIH; NATIONAL EYE INSTITUTE [R01EY022739, P30EY002162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was carried out with NIH funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami M, 2009, RETINA-J RET VIT DIS, V29, P699, DOI 10.1097/IAE.0b013e3181a2f42a; Akula JD, 2010, DOC OPHTHALMOL, V120, P41, DOI 10.1007/s10633-009-9198-1; Altiok EI, 2016, BIOMATERIALS, V93, P95, DOI 10.1016/j.biomaterials.2016.03.017; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Barleon B, 1997, J BIOL CHEM, V272, P10382; Bochot A, 2012, J CONTROL RELEASE, V161, P628, DOI 10.1016/j.jconrel.2012.01.019; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Boyer DS, 2014, OPHTHALMOLOGY; Chan MF, 2013, J CELL SCI, V126, P3948, DOI [10.1242/jcs.28033, 10.1242/jcs.128033]; Cohen SY, 2013, RETINA-J RET VIT DIS, V33, P474, DOI 10.1097/IAE.0b013e31827b6324; Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/nnano.2013.205, 10.1038/NNANO.2013.205]; del Amo EM, 2008, DRUG DISCOV TODAY, V13, P135, DOI 10.1016/j.drudis.2007.11.002; Drolet DW, 2000, PHARMACEUT RES, V17, P1503, DOI 10.1023/A:1007657109012; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Fishburn S. C., 2010, J PHARM SCI, V97, P4167; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Han BW, 2015, TISSUE ENG PT A, V21, P2366, DOI [10.1089/ten.TEA.2014.0281, 10.1089/ten.tea.2014.0281]; Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Kane FE, 2008, EXPERT OPIN DRUG DEL, V5, P1039, DOI [10.1517/17425247.5.9.1039, 10.1517/17425247.5.9.1039 ]; Lee SS, 2009, OPHTHALMIC RES, V41, P124, DOI 10.1159/000209665; Maurice D, 2001, J OCUL PHARMACOL TH, V17, P393, DOI 10.1089/108076801753162807; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mohammad DA, 2007, ANN PHARMACOTHER, V41, P449, DOI 10.1345/aph.1H540; Moradi A, 2013, WORLD J DIABETES, V4, P303, DOI 10.4239/wjd.v4.i6.303; Necas J, 2008, VET MED-CZECH, V53, P397, DOI 10.17221/1930-VETMED; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Oh EJ, 2011, BIOMATERIALS, V32, P3115, DOI 10.1016/j.biomaterials.2011.01.003; Oh EJ, 2009, BIOMATERIALS, V30, P6026, DOI 10.1016/j.biomaterials.2009.07.024; Pagliarini S, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/857148; RICCI B, 1990, DOC OPHTHALMOL, V74, P171, DOI 10.1007/BF02482606; Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Stewart MW, 2012, RETINA-J RET VIT DIS, V32, P434, DOI 10.1097/IAE.0B013E31822C290F; STEWART MW, 2011, EYE REPORTS, V1, P5; Tan LE, 2011, INVEST OPHTH VIS SCI, V52, P1111, DOI 10.1167/iovs.10-5813; Tanaka K, 1997, JPN J CANCER RES, V88, P867, DOI 10.1111/j.1349-7006.1997.tb00463.x; URTTI A, 1993, SURV OPHTHALMOL, V37, P435, DOI 10.1016/0039-6257(93)90141-S; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5	48	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155990	10.1371/journal.pone.0155990	http://dx.doi.org/10.1371/journal.pone.0155990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257918	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700027
J	Baek, SH; Lee, SW; Kim, SW; Ahn, SY; Yu, MY; Kim, KI; Chin, HJ; Na, KY; Chae, DW; Kim, S				Baek, Seon Ha; Lee, Sung Woo; Kim, Sun-Wook; Ahn, Shin Young; Yu, Mi-Yeon; Kim, Kwang-Il; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong			Frailty as a Predictor of Acute Kidney Injury in Hospitalized Elderly Patients: A Single Center, Retrospective Cohort Study	PLOS ONE			English	Article							OLDER-ADULTS; MORTALITY; OUTCOMES; POPULATION; DIALYSIS; RISK	Background Elderly patients have an increased risk for acute kidney injury (AKI). However, few studies have reported on predictors for AKI in geriatric patients. Therefore, we aimed at determining the effect of frailty as a predictor of AKI. Methods We retrospectively enrolled 533 hospitalized elderly patients (aged >= 65 years) who had their creatinine levels measured (>= 1 measurement) during admission for a period of 1 year (2013) and conducted a comprehensive geriatric assessment (CGA) within 1 year before the index hospitalization. We examined five variables (activity of daily living [ADL] and instrumental ADL dependence, dementia, nutrition, and polypharmacy) from CGA. We categorized the patients into 3 groups according to the tertile of aggregate frailty scores: Group 1, score 1-2; Group 2, score 3-4; Group 3, score 5-8). Results Fifty-four patients (10.1%) developed AKI (median duration, 4 days). The frailest group (Group 3) showed an increased risk of AKI as compared to Group 1, (hazard ratio [HR] = 3.536, P = 0.002). We found that discriminatory accuracy for AKI improved with the addition of the tertile of aggregate frailty score to covariates (area under the receiver operator characteristics curves [AUROC] 0.641, AUROC 0.739, P = 0.004). Forty-six patients (8.6%) were transferred to nursing facilities and 477 patients (89.5%) were discharged home. The overall 90-day and 1-year mortality for elderly inpatients were 7.9% and 26.3%. The frailest group also demonstrated an increased risk of discharge to nursing facilities, and 90-day and 1-year mortality as compared to Group 1, independent of AKI severity (nursing facilities: odd ratio = 4.843, P = 0.002; 90-day mortality: HR = 6.555, P = 0.002; 1-year mortality: HR = 3.249, P = 0.001). Conclusions We found that frailty may independently predict the development of AKI and adverse outcomes in geriatric inpatients.	[Baek, Seon Ha; Lee, Sung Woo; Kim, Sun-Wook; Ahn, Shin Young; Yu, Mi-Yeon; Kim, Kwang-Il; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Kim, Kwang-il/D-8024-2012; Yu, Mi-Yeon/ABB-7937-2021; Kim, Kwang-il/AAP-7315-2021; Kim, Sejoong/J-5356-2015	Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Kim, Sejoong/0000-0002-7238-9962				Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Basic D, 2015, J AGING HEALTH, V27, P670, DOI 10.1177/0898264314558202; Bien B, 2015, J NUTR HEALTH AGING, V19, P481, DOI 10.1007/s12603-014-0570-9; Choi JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075583; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Dent E, 2014, AGE AGEING, V43, P477, DOI 10.1093/ageing/aft181; Druml W, 2010, INTENS CARE MED, V36, P1221, DOI 10.1007/s00134-010-1844-2; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; Han SS, 2014, TOHOKU J EXP MED, V232, P177, DOI 10.1620/tjem.232.177; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hilmer SN, 2011, BRIT J CLIN PHARMACO, V71, P224, DOI 10.1111/j.1365-2125.2010.03825.x; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Lee DH, 2010, CIRCULATION, V121, P973, DOI 10.1161/CIRCULATIONAHA.108.841437; Lee DY, 2002, J AM GERIATR SOC, V50, P1233, DOI 10.1046/j.1532-5415.2002.50310.x; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MAHONEY F I, 1965, Md State Med J, V14, P61; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Odden MC, 2009, J GERONTOL A-BIOL, V64, P370, DOI 10.1093/gerona/gln037; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Rosner MH, 2013, CLIN GERIATR MED, V29, P565, DOI 10.1016/j.cger.2013.05.001; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Varrier M, 2014, CURR OPIN NEPHROL HY, V23, P560, DOI 10.1097/MNH.0000000000000061; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	37	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156444	10.1371/journal.pone.0156444	http://dx.doi.org/10.1371/journal.pone.0156444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257823	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700066
J	Grillon, A; Schramm, F; Kleinberg, M; Jehl, F				Grillon, Antoine; Schramm, Frederic; Kleinberg, Magali; Jehl, Francois			Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; FLUOROQUINOLONES; INFECTIONS	The aim of this study was to compare the in vitro susceptibility of Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia to three fluoroquinolones. The minimum inhibitory concentrations (MICs) to ciprofloxacin, levofloxacin and moxifloxacin were examined by E-test((R)) for a total of 40 K. pneumoniae strains, 40 S. maltophilia strains and 40 P. aeruginosa strains. Then, the bactericidal activity of these fluoroquinolones was investigated on five strains of each bacterial species by means of time-kill curves. For K. pneumoniae and P. aeruginosa, the distance of the measured MIC from the clinical break-point is a good indicator of the bactericidal activity for ciprofloxacin and levofloxacin as obtained in our experiments. The lower the MIC, the better the bactericidal activity in term of CFU Log decreases. If MIC of ciprofloxacin and levofloxacin against the considered bacteria are far from clinical breakpoint, these two antibiotics are equivalent. According to our MIC50 and modal MIC, the breakpoints of both ciprofloxacin and levofloxacin seem to be somewhat high and data suggest reducing them. On S. maltophilia, none of the tested antibiotics showed a satisfactory activity.	[Grillon, Antoine] Univ Strasbourg, Fac Med, Inst Bacteriol, Strasbourg, France; Strasbourg Univ Hosp, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grillon, A (corresponding author), Univ Strasbourg, Fac Med, Inst Bacteriol, Strasbourg, France.	antoine.grillon@chru-strasbourg.fr	Schramm, Frédéric/M-8166-2015; Schramm, Frédéric/R-9953-2019	Schramm, Frédéric/0000-0002-6889-515X; Schramm, Frédéric/0000-0002-6889-515X				Balfour JAB, 1999, DRUGS, V57, P363; BALLESTERO S, 1995, EUR J CLIN MICROBIOL, V14, P728, DOI 10.1007/BF01690887; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; EUCAST, 2015, CLIN BREAKP; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Gillespie T, 2002, INT J ANTIMICROB AG, V19, P377, DOI 10.1016/S0924-8579(02)00017-1; HODSON ME, 1987, LANCET, V1, P235; Hoiby N, 1993, Drugs, V45 Suppl 3, P98; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Lode H, 1998, CLIN INFECT DIS, V27, P33, DOI 10.1086/514623; LYE WC, 1992, J INFECTION, V24, P169, DOI 10.1016/0163-4453(92)92876-K; North DS, 1998, PHARMACOTHERAPY, V18, P915; Nseir S, 2006, CRIT CARE, V10, DOI 10.1186/cc5063; O'Donnell JA, 2000, INFECT DIS CLIN N AM, V14, P489, DOI 10.1016/S0891-5520(05)70260-9; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Schentag JJ, 2000, CLIN INFECT DIS, V31, pS40, DOI 10.1086/314059; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Steinkamp G, 2005, J Cyst Fibros, V4, P41, DOI 10.1016/j.jcf.2004.10.002; Torres E, 2015, EUR J CLIN MICROBIOL, V34, P1751, DOI 10.1007/s10096-015-2408-8; VALERIUS NH, 1991, LANCET, V338, P725, DOI 10.1016/0140-6736(91)91446-2; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	22	56	58	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156690	10.1371/journal.pone.0156690	http://dx.doi.org/10.1371/journal.pone.0156690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257956	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700108
J	Martinez-Biarge, M; Groenendaal, F; Kersbergen, KJ; Benders, MJNL; Foti, F; Cowan, FM; de Vries, LS				Martinez-Biarge, Miriam; Groenendaal, Floris; Kersbergen, Karina J.; Benders, Manon J. N. L.; Foti, Francesca; Cowan, Frances M.; de Vries, Linda S.			MRI Based Preterm White Matter Injury Classification: The Importance of Sequential Imaging in Determining Severity of Injury	PLOS ONE			English	Article							CYSTIC PERIVENTRICULAR LEUKOMALACIA; PREMATURE NEWBORNS; CEREBRAL-PALSY; INFANTS; ULTRASOUND; DIAGNOSIS; BRAIN; SPECTRUM; TIME	Background The evolution of non-hemorrhagic white matter injury (WMI) based on sequential magnetic resonance imaging (MRI) has not been well studied. Our aim was to describe sequential MRI findings in preterm infants with non-hemorrhagic WMI and to develop an MRI classification system for preterm WMI based on these findings. Methods Eighty-two preterm infants (gestation <= 35 weeks) were retrospectively included. WMI was diagnosed and classified based on sequential cranial ultrasound (cUS) and confirmed on MRI. Results 138 MRIs were obtained at three time-points: early (<2 weeks; n = 32), mid (2-6 weeks; n = 30) and term equivalent age (TEA; n = 76). 63 infants (77%) had 2 MRIs during the neonatal period. WMI was non-cystic in 35 and cystic in 47 infants. In infants with cystic-WMI early MRI showed extensive restricted diffusion abnormalities, cysts were already present in 3 infants; mid MRI showed focal or extensive cysts, without acute diffusion changes. A significant reduction in the size and/or extent of the cysts was observed in 32% of the infants between early/mid and TEA MRI. In 4/9 infants previously seen focal cysts were no longer identified at TEA. All infants with cystic WMI showed >= 2 additional findings at TEA: significant reduction in WM volume, mild-moderate irregular ventriculomegaly, several areas of increased signal intensity on T1-weighted-images, abnormal myelination of the PLIC, small thalami. Conclusion In infants with extensive WM cysts at 2-6 weeks, cysts may be reduced in number or may even no longer be seen at TEA. A single MRI at TEA, without taking sequential cUS data and pre-TEA MRI findings into account, may underestimate the extent of WMI; based on these results we propose a new MRI classification for preterm non-hemorrhagic WMI.	[Martinez-Biarge, Miriam; Foti, Francesca; Cowan, Frances M.] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Groenendaal, Floris; Kersbergen, Karina J.; Benders, Manon J. N. L.; de Vries, Linda S.] UMCU, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands	Imperial College London; Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	de Vries, LS (corresponding author), UMCU, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	l.s.devries@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Martinez-Biarge, Miriam/HCH-8730-2022; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Wilhelmina Research Fund [OZF2008-19]	Wilhelmina Research Fund	This study includes infants from a study funded by the Wilhelmina Research Fund, OZF2008-19 (KJ Kersbergen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Bozzao A, 2003, EUR RADIOL, V13, P1571, DOI 10.1007/s00330-002-1815-2; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Gano D, 2015, J PEDIATR-US, V166, P39, DOI 10.1016/j.jpeds.2014.09.009; Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Inder T, 1999, J PEDIATR-US, V134, P631, DOI 10.1016/S0022-3476(99)70251-9; Kersbergen KJ, 2011, ARCH DIS CHILD-FETAL, V96, pF404, DOI 10.1136/adc.2010.201129; Kersbergen KJ, 2015, J PEDIATR-US, V167, P260, DOI 10.1016/j.jpeds.2015.05.013; Kersbergen KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108904; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2008, NEUROPEDIATRICS, V39, P233, DOI 10.1055/s-0028-1103274; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pierrat V, 2001, ARCH DIS CHILD-FETAL, V84, pF151, DOI 10.1136/fn.84.3.F151; Sarkar S, 2015, AM J PERINAT, V32, P973, DOI 10.1055/s-0035-1545666; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Verboon-Maciolek MA, 2012, J PEDIATR-US, V160, P165, DOI 10.1016/j.jpeds.2011.08.053; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	24	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156245	10.1371/journal.pone.0156245	http://dx.doi.org/10.1371/journal.pone.0156245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257863	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700046
J	Martinez-Crego, B; Arteaga, P; Tomas, F; Santos, R				Martinez-Crego, Begona; Arteaga, Pedro; Tomas, Fiona; Santos, Rui			The Role of Seagrass Traits in Mediating Zostera noltei Vulnerability to Mesograzers	PLOS ONE			English	Article							FRESH-WATER MACROPHYTES; CHEMICAL DEFENSES; MARINE HERBIVORES; INTRASPECIFIC VARIATION; NUTRIENT AVAILABILITY; FEEDING PREFERENCES; PLANT TRAITS; FOOD CHOICE; RESISTANCE; TEMPERATE	Understanding how intra-specific differences in plant traits mediate vulnerability to herbivores of relevant habitat-forming plants is vital to attain a better knowledge on the drivers of the structure and functioning of ecosystems. Such studies, however, are rare in seagrass-mesograzer systems despite the increasingly recognized relevance of mesograzers as seagrass consumers. We investigated the role and potential trade-offs of multiple leaf traits in mediating the vulnerability of the seagrass Zostera noltei to different mesograzer species, the amphipod Gammarus insensibilis and the isopod Idotea chelipes. We worked with plants from two different meadows for which contrasting chemical and structural traits were expected based on previous information. We found that plants with high vulnerability to mesograzers (i.e. those preferred and subjected to higher rates of leaf area loss) had not only higher nitrogen content and lower C:N, fibre, and phenolics, but also tender and thinner leaves. No trade-offs between chemical and structural traits of the seagrass were detected, as they were positively correlated. When leaf physical structure was removed using agar-reconstituted food, amphipod preference towards high-susceptibility plants disappeared; thus indicating that structural rather than chemical traits mediated the feeding preference. Removal of plant structure reduced the size of isopod preference to less than half, indicating a stronger contribution of structural traits (>50%) but combined with chemical/nutritional traits in mediating the preference. We then hypothesized that the high environmental nutrient levels recorded in the meadow exhibiting high susceptibility modulate the differences observed between meadows in seagrass traits. To test this hypothesis, we exposed low-vulnerability shoots to eutrophic nutrient levels in a 6-week enrichment experiment. Nutrient enrichment increased Z. noltei nitrogen content and lowered C:N, fibre, and phenolics, but had no effect on structural traits. Overall, our findings help to better understand the trait-mediated seagrass susceptibility to mesograzers and reinforce the increasingly recognized role of structural defences against herbivory.	[Martinez-Crego, Begona; Arteaga, Pedro; Santos, Rui] Ctr Marine Sci CCMAR, Faro, Portugal; [Tomas, Fiona] Mediterranean Inst Adv Studies IMEDEA CSIC, Esporles, Balearic Island, Spain; [Tomas, Fiona] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Oregon State University	Martinez-Crego, B (corresponding author), Ctr Marine Sci CCMAR, Faro, Portugal.	bmcrego@ualg.pt	Martínez-Crego, Begoña/J-4090-2013; Santos, Rui O P/B-4168-2008; Tomas, Fiona/G-3713-2010	Martínez-Crego, Begoña/0000-0002-9051-6961; Santos, Rui O P/0000-0002-7861-4366; Tomas, Fiona/0000-0001-8682-2504	European Regional Development Fund through the COMPETE; Portuguese funds through the FCT project [PEst-C/MAR/LA0015/2011]; FCT post-doctoral fellowship [SFRH/BPD/75307/2010]; COST Action (EU-FP7 program) [ES0906]	European Regional Development Fund through the COMPETE; Portuguese funds through the FCT project; FCT post-doctoral fellowship; COST Action (EU-FP7 program)	This research was partially supported by the European Regional Development Fund through the COMPETE and by Portuguese funds through the FCT project PEst-C/MAR/LA0015/2011 (Fundacao para a Ciencia e a Tecnologia). Mesocosm facilities were provided by ASSEMBLE (EU-FP7 program). BMC was supported by an FCT post-doctoral fellowship (SFRH/BPD/75307/2010). PA was granted with a short-term scientific mission of the COST Action ES0906 (EU-FP7 program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, OIKOS, V89, P493, DOI 10.1034/j.1600-0706.2000.890308.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bailey JK, 2004, ECOLOGY, V85, P603, DOI 10.1890/03-3049; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; Best RJ, 2012, MAR ECOL PROG SER, V456, P29, DOI 10.3354/meps09678; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; Cabaco S, 2008, ESTUAR COAST SHELF S, V78, P1, DOI 10.1016/j.ecss.2007.11.005; Cardenas RE, 2014, J ECOL, V102, P939, DOI 10.1111/1365-2745.12255; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carr LA, 2014, MAR ECOL PROG SER, V508, P117, DOI 10.3354/meps10855; Carvalho S, 2006, CAH BIOL MAR, V47, P321; Cebrian J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004929; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Cruz-Rivera E, 2013, MAR ECOL PROG SER, V490, P69, DOI 10.3354/meps10429; de los Santos CB, 2013, MAR BIOL, V160, P1083, DOI 10.1007/s00227-012-2159-3; de los Santos CB, 2012, MAR ECOL PROG SER, V458, P89, DOI 10.3354/meps09757; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; DUFFY JE, 1990, BIOSCIENCE, V40, P368, DOI 10.2307/1311214; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eklof JS, 2008, ESTUAR COAST SHELF S, V79, P569, DOI 10.1016/j.ecss.2008.05.005; Fredriksen S, 2004, SARSIA, V89, P218, DOI 10.1080/00364820410005593; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Green E.P., 2003, WORLD ATLAS SEAGRASS; GROENENDIJK AM, 1984, NETH J SEA RES, V18, P384, DOI 10.1016/0077-7579(84)90011-5; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; HAY ME, 1990, ECOLOGY, V71, P733, DOI 10.2307/1940326; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heithaus MR, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00028; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kempel A, 2015, ECOLOGY, V96, P2923, DOI 10.1890/14-2125.1; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; La Nafie YA, 2013, J EXP MAR BIOL ECOL, V446, P186, DOI 10.1016/j.jembe.2013.05.020; La Nafie YA, 2012, LIMNOL OCEANOGR, V57, P1664, DOI 10.4319/lo.2012.57.6.1664; Lamberti-Raverot B, 2012, J EXP BOT, V63, P6115, DOI 10.1093/jxb/ers268; Lanyon JM, 2006, J ZOOL, V270, P277, DOI 10.1111/j.1469-7998.2006.00135.x; Lewis LS, 2012, ECOLOGY, V93, P2746, DOI 10.1890/12-0038.1; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; Martinez-Crego B, 2014, BIOGEOSCIENCES, V11, P7237, DOI 10.5194/bg-11-7237-2014; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; Martinez-Crego B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141219; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Maxwell PS, 2014, J ECOL, V102, P54, DOI 10.1111/1365-2745.12167; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Molis M, 2010, J PHYCOL, V46, P76, DOI 10.1111/j.1529-8817.2009.00787.x; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; da Silva DM, 2011, PLANT ECOL, V212, P181, DOI 10.1007/s11258-010-9813-y; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Pennings SC, 1998, ECOLOGY, V79, P1968; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Perez-Harguindeguy N, 2003, AUSTRAL ECOL, V28, P642, DOI 10.1046/j.1442-9993.2003.01321.x; POORE AGB, 1994, MAR ECOL PROG SER, V107, P113, DOI 10.3354/meps107113; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; Prado P, 2010, MAR ECOL PROG SER, V409, P229, DOI 10.3354/meps08585; Prusak AC, 2005, J CHEM ECOL, V31, P1145, DOI 10.1007/s10886-005-4253-1; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Read J, 2009, ANN BOT-LONDON, V103, P757, DOI 10.1093/aob/mcn246; Reynolds LK, 2012, MAR ECOL PROG SER, V451, P107, DOI 10.3354/meps09569; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steele L, 2012, MAR ECOL PROG SER, V466, P81, DOI 10.3354/meps09921; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Targett NM, 1998, J PHYCOL, V34, P195, DOI 10.1046/j.1529-8817.1998.340195.x; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Tomas F, 2015, GLOBAL CHANGE BIOL, V21, P4021, DOI 10.1111/gcb.13024; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Van Alstyne KL, 1999, J PHYCOL, V35, P483, DOI 10.1046/j.1529-8817.1999.3530483.x; Verges A, 2007, OECOLOGIA, V151, P675, DOI 10.1007/s00442-006-0606-x; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; Viejo RM, 2003, MAR BIOL, V142, P1229, DOI 10.1007/s00227-002-0994-3; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wise MJ, 2008, ECOLOGY, V89, P3275, DOI 10.1890/08-0277.1; Wright W, 1996, BIOL REV, V71, P401, DOI 10.1111/j.1469-185X.1996.tb01280.x; Zimmerman RC, 2001, MAR ECOL PROG SER, V218, P127, DOI 10.3354/meps218127	100	22	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156848	10.1371/journal.pone.0156848	http://dx.doi.org/10.1371/journal.pone.0156848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257679	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700145
J	Navas, JF; Vilar-Lopez, R; Perales, JC; Steward, T; Fernandez-Aranda, F; Verdejo-Garcia, A				Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Steward, Trevor; Fernandez-Aranda, Fernando; Verdejo-Garcia, Antonio			Altered Decision-Making under Risk in Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; GAMBLING TASK; SENSITIVITY; REWARD; IMPULSIVITY; BEHAVIORS; DEFICITS	Background The negative consequences of energy dense foods are well known, yet people increasingly make unhealthy food choices leading to obesity (i.e., risky decisions). The aims of this study were: [1] to compare performance in decision-making tasks under risk and under ambiguity between individuals with obesity, overweight and normal weight; [2] to examine the associations between body mass index (BMI) and decision-making, and the degree to which these associations are modulated by reward sensitivity. Methods Seventy-nine adults were recruited and classified in three groups according to their BMI: obesity, overweight and normal-weight. Groups were similar in terms of age, education and socio-economic status, and were screened for comorbid medical and mental health conditions. Decision-making under risk was measured via the Wheel of Fortune Task (WoFT) and decision-making under ambiguity via the Iowa Gambling Task (IGT). Reward sensitivity was indicated by the Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ). Results Individuals with obesity made riskier choices in the WoFT, specifically in choices with an expected value close to zero and in the propensity to risk index. No differences were found in IGT performance or SPSRQ scores. BMI was associated with risk-taking (WoFT performance), independently of reward sensitivity. Conclusions Obesity is linked to a propensity to make risky decisions in experimental conditions analogous to everyday food choices.	[Navas, Juan F.; Perales, Jose C.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Verdejo-Garcia, Antonio] Univ Granada, Red Trastornos Adict, Granada, Spain; [Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Verdejo-Garcia, Antonio] Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Vilar-Lopez, Raquel] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia	University of Granada; University of Granada; University of Granada; University of Granada; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Monash University; Monash University	Verdejo-Garcia, A (corresponding author), Univ Granada, Red Trastornos Adict, Granada, Spain.; Verdejo-Garcia, A (corresponding author), Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Verdejo-Garcia, A (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia.; Verdejo-Garcia, A (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia.	Antonio.verdejo@monash.edu	FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Verdejo-Garcia, Antonio/AAV-1147-2021; Vilar-López, Raquel/I-7847-2016; Fernandez-Aranda, Fernando/L-9762-2014; Navas, Juan/AAD-3302-2019; Steward, Trevor/K-7469-2015	FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Vilar-López, Raquel/0000-0001-9639-0143; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Perales, Jose C./0000-0001-5163-8811; Steward, Trevor/0000-0003-3116-8175; Navas, Juan. F./0000-0002-9521-6642	Andalusian Council of Innovation, Science and Industry [HUM-6635]; Instituto de Salud Carlos III [FIS PI14/00290]; FEDER funds; Ian Potter Foundation; Spanish Ministry of Education, Culture and Sports, FPU Program [FP13/00669]; Spanish Ministry of Economy and Competitiveness [PSI2013-45055]	Andalusian Council of Innovation, Science and Industry; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Ian Potter Foundation; Spanish Ministry of Education, Culture and Sports, FPU Program; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Research was funded by grants HUM-6635 (NEUROECOBE) from the Andalusian Council of Innovation, Science and Industry; RETICS from the Instituto de Salud Carlos III and co-funded by FEDER funds -a way to build Europe-; and "Translational discovery laboratory for brain mechanisms of food choice and obesity" from the Ian Potter Foundation to AVG. JFN was funded by a predoctoral fellowship of the Spanish Ministry of Education, Culture and Sports, FPU Program, (FP13/00669). JCP was funded by grant PSI2013-45055 (G-BRAIN) from the Spanish Ministry of Economy and Competitiveness. TS and FFA were funded by grants FIS PI14/00290; and CIBERobn from the Instituto de Salud Carlos III and co-funded by FEDER funds-a way to build Europe-.	Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Chamberlain SR, 2015, CNS SPECTRUMS, V20, P500, DOI 10.1017/S1092852914000625; Clark L, 2012, PSYCHOPHYSIOLOGY, V49, P1436, DOI 10.1111/j.1469-8986.2012.01454.x; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Davis C, 2007, PERS INDIV DIFFER, V42, P279, DOI 10.1016/j.paid.2006.07.006; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Delgado-Rico E, 2013, OBESITY, V21, P1662, DOI 10.1002/oby.20375; Emrich TE, 2014, APPL PHYSIOL NUTR ME, V39, P417, DOI 10.1139/apnm-2013-0304; Fagundo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043382; Figner B, 2011, CURR DIR PSYCHOL SCI, V20, P211, DOI 10.1177/0963721411415790; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Koritzky G, 2014, OBESITY, V22, P1904, DOI 10.1002/oby.20770; Koritzky G, 2012, APPETITE, V59, P289, DOI 10.1016/j.appet.2012.05.020; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Svaldi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133534; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; Verbeken S, 2013, INT J OBESITY, P1; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zald DH, 2009, ANN BEHAV MED, V38, pS18, DOI 10.1007/s12160-009-9117-4	29	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155600	10.1371/journal.pone.0155600	http://dx.doi.org/10.1371/journal.pone.0155600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257888	gold, Green Published			2022-12-27	WOS:000377369700017
J	Bang, OY; Chung, JW; Cha, J; Lee, MJ; Yeon, JY; Ki, CS; Jeon, P; Kim, JS; Hong, SC				Bang, Oh Young; Chung, Jong-Won; Cha, Jihoon; Lee, Mi Ji; Yeon, Je Young; Ki, Chang-Seok; Jeon, Pyoung; Kim, Jong-Soo; Hong, Seung Chyul			A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis	PLOS ONE			English	Article							MOYAMOYA-DISEASE; ISCHEMIC-STROKE; RISK-FACTORS; VARIANT; C.14576G-GREATER-THAN-A; POPULATION; DIFFERENCE; CAVEOLIN-1; ETHNICITY	Background Both intracranial atherosclerotic stenosis (ICAS) and moyamoya disease (MMD) are prevalent in Asians. We hypothesized that the Ring Finger protein 213 gene polymorphism (RNF213), a susceptibility locus for MMD in East Asians, is also a susceptibility gene for ICAS in patients whose diagnosis had been confirmed by conventional angiography (absence of basal collaterals) and high-resolution MRI (HR-MRI, presence of plaque). Methods We analyzed 532 consecutive patients with ischemic events in the middle cerebral artery (MCA) distribution and relevant stenotic lesion on the distal internal carotid artery or proximal MCA, but no demonstrable carotid or cardiac embolism sources. Additional angiography was performed on 370 (69.5%) patients and HR-MRI on 283 (53.2%) patients. Results Based on angiographic and HR-MRI findings, 234 patients were diagnosed with ICAS and 288 with MMD. The RNF213 variant was observed in 50 (21.4%) ICAS patients and in 119 (69.1%) MMD patients. The variant was observed in 25.2% of patients with HR-MRI-confirmed ICAS. Similarly, 15.8% of ICAS patients in whom MMD was excluded by angiography had this variant. Among the ICAS patients, RNF213 variant carriers were younger and more likely to have a family history of MMD than non-carriers were. Multivariate testing showed that only the age of ICAS onset was independently associated with the RNF213 variant (odds ratio, 0.97; 95% CI, 0.944-0.99). Conclusions RNF213 is a susceptibility gene not only for MMD but also for ICAS in East Asians. Further studies are needed on RNF213 variants in ICAS patients outside East Asian populations.	[Bang, Oh Young; Chung, Jong-Won; Lee, Mi Ji] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Cha, Jihoon; Jeon, Pyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Yeon, Je Young; Kim, Jong-Soo; Hong, Seung Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	ohyoung.bang@samsung.com	ki, cs/O-5931-2014; Ki, Chang-Seok/G-7559-2014	Ki, Chang-Seok/0000-0001-7679-8731; Lee, Mi Ji/0000-0003-1364-1969; Yeon, Je Young/0000-0003-4603-8103; Chung, Jong-Won/0000-0002-9200-8899	Korean Healthcare Technology R&D Project, Ministry of Health Welfare [HI14C15310000]	Korean Healthcare Technology R&D Project, Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (HI14C15310000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2016, J STROKE, V18, P12, DOI 10.5853/jos.2015.01760; Bang OY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130663; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Bang OY, 2009, J NEUROL SCI, V284, P40, DOI 10.1016/j.jns.2009.03.033; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Bower RS, 2013, STROKE, V44, P1997, DOI 10.1161/STROKEAHA.111.000307; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Forouhi NG, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.01.003; Fra AM, 1999, GENOMICS, V56, P355, DOI 10.1006/geno.1998.5723; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Fujimura M, 2014, J STROKE, V16, P65, DOI 10.5853/jos.2014.16.2.65; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kim SJ, 2013, J STROKE, V15, P27, DOI 10.5853/jos.2013.15.1.27; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Koizumi A, 2013, ENVIRON HEALTH PREV, V18, P121, DOI 10.1007/s12199-012-0299-1; Li H, 2011, STROKE, V42, P1138, DOI 10.1161/STROKEAHA.110.608471; Liu J, 2002, J BIOL CHEM, V277, P10661, DOI 10.1074/jbc.M110354200; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Ma JP, 2013, NEUROL INDIA, V61, P35, DOI 10.4103/0028-3886.107927; Mak W, 2005, MED HYPOTHESES, V65, P637, DOI 10.1016/j.mehy.2005.05.017; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; Ryoo S, 2015, STROKE; Ryoo S, 2014, STROKE, V45, P2457, DOI 10.1161/STROKEAHA.114.004761; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Shi ZH, 2014, INT J STROKE, V9, P735, DOI 10.1111/ijs.12177; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179	34	36	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156607	10.1371/journal.pone.0156607	http://dx.doi.org/10.1371/journal.pone.0156607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253870	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700042
J	Liu, XF; Liu, YL; Lu, XH; Wang, QX; Wang, TX				Liu, Xiao Fan; Liu, Yu-Liang; Lu, Xin-Hang; Wang, Qi-Xuan; Wang, Tong-Xing			The Anatomy of the Global Football Player Transfer Network: Club Functionalities versus Network Properties	PLOS ONE			English	Article							COMPLEX NETWORKS; 2-PHASE FLOW; LABOR; GLOBALIZATION; MIGRATION	Professional association football is a game of talent. The success of a professional club hinges largely on its ability of assembling the best team. Building on a dataset of player transfer records among more than 400 clubs in 24 world-wide top class leagues from 2011 to 2015, this study aims to relate a club's success to its activities in the player transfer market from a network perspective. We confirm that modern professional football is indeed a money game, in which larger investment spent on the acquisition of talented players generally yields better team performance. However, further investigation shows that professional football clubs can actually play different strategies in surviving or even excelling this game, and the success of strategies is strongly associated to their network properties in the football player transfer network.	[Liu, Xiao Fan; Liu, Yu-Liang; Lu, Xin-Hang; Wang, Qi-Xuan; Wang, Tong-Xing] Southeast Univ, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Xiao Fan] Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Liu, XF (corresponding author), Southeast Univ, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Liu, XF (corresponding author), Southeast Univ, Minist Educ, Key Lab Comp Network & Informat Integrat, Nanjing, Jiangsu, Peoples R China.	xfliu@seu.edu.cn	Liu, Xiao Fan/I-6403-2015	Liu, Xiao Fan/0000-0001-8342-4623	National Natural Science Foundation of China [61304167, 61374170]; Natural Science Foundation of Jiangsu Province [BK20131301]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (grant nos. 61304167, 61374170) and Natural Science Foundation of Jiangsu Province (grant no. BK20131301).	An F, 2016, PHYSICA A, V447, P276, DOI 10.1016/j.physa.2015.12.050; [Anonymous], 2014, CHOICE REV ONLINE; Attrill MJ, 2008, J SPORT SCI, V26, P577, DOI 10.1080/02640410701736244; Boguna M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.028701; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fagiolo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097331; Frick B, 2007, SCOT J POLIT ECON, V54, P422, DOI 10.1111/j.1467-9485.2007.00423.x; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Grund TU, 2012, SOC NETWORKS, V34, P682, DOI 10.1016/j.socnet.2012.08.004; International Federation of Football History & Statistics (IFFHS), EXPL CWR; Jones D., FOOTBALL MONEY LEAGU; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Khan HU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138359; Latora V, 2013, J STAT PHYS, V151, P745, DOI 10.1007/s10955-013-0722-z; Liu XF, 2014, PHYSICA A, V407, P1, DOI 10.1016/j.physa.2014.03.086; Lu L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10168; Ma A, 2015, P NATL ACAD SCI USA, V112, P14760, DOI 10.1073/pnas.1513651112; Maguire J, 2000, J SPORT SCI, V18, P759, DOI 10.1080/02640410050120131; MAGUIRE J, 1994, SOCIOL REV, V42, P452, DOI 10.1111/j.1467-954X.1994.tb00097.x; Poli R, 2010, INT REV SOCIOL SPORT, V45, P491, DOI 10.1177/1012690210370640; Roderick M, 2013, INT REV SOCIOL SPORT, V48, P387, DOI 10.1177/1012690212442497; Sen A., 1973, EC INEQUALITY; Shen Y, 2010, P NATL ACAD SCI USA, V107, P1082, DOI 10.1073/pnas.0909181107; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zamaraev V, 2014, SOCIAL NETWORKS EC S	28	64	66	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156504	10.1371/journal.pone.0156504	http://dx.doi.org/10.1371/journal.pone.0156504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253198	gold, Green Submitted, Green Published			2022-12-27	WOS:000377218700035
J	Martz, F; Vuosku, J; Ovaskainen, A; Stark, S; Rautio, P				Martz, Francoise; Vuosku, Jaana; Ovaskainen, Anu; Stark, Sari; Rautio, Pasi			The Snow Must Go On: Ground Ice Encasement, Snow Compaction and Absence of Snow Differently Cause Soil Hypoxia, CO2 Accumulation and Tree Seedling Damage in Boreal Forest	PLOS ONE			English	Article							CARBON-DIOXIDE; ROOT-GROWTH; NITROGEN MINERALIZATION; MICROBIAL ACTIVITY; FROZEN SOIL; FROST; TEMPERATURE; RESPONSES; PHYSIOLOGY; RESPIRATION	At high latitudes, the climate has warmed at twice the rate of the global average with most changes observed in autumn, winter and spring. Increasing winter temperatures and wide temperature fluctuations are leading to more frequent rain-on-snow events and freeze-thaw cycles causing snow compaction and formation of ice layers in the snowpack, thus creating ice encasement (IE). By decreasing the snowpack insulation capacity and restricting soil-atmosphere gas exchange, modification of the snow properties may lead to colder soil but also to hypoxia and accumulation of trace gases in the subnivean environment. To test the effects of these overwintering conditions changes on plant winter survival and growth, we established a snow manipulation experiment in a coniferous forest in Northern Finland with Norway spruce and Scots pine seedlings. In addition to ambient conditions and prevention of IE, we applied three snow manipulation levels: IE created by artificial rain-on-snow events, snow compaction and complete snow removal. Snow removal led to deeper soil frost during winter, but no clear effect of IE or snow compaction done in early winter was observed on soil temperature. Hypoxia and accumulation of CO2 were highest in the IE plots but, more importantly, the duration of CO2 concentration above 5% was 17 days in IE plots compared to 0 days in ambient plots. IE was the most damaging winter condition for both species, decreasing the proportion of healthy seedlings by 47% for spruce and 76% for pine compared to ambient conditions. Seedlings in all three treatments tended to grow less than seedlings in ambient conditions but only IE had a significant effect on spruce growth. Our results demonstrate a negative impact of winter climate change on boreal forest regeneration and productivity. Changing snow conditions may thus partially mitigate the positive effect of increasing growing season temperatures on boreal forest productivity.	[Martz, Francoise; Vuosku, Jaana; Ovaskainen, Anu; Stark, Sari; Rautio, Pasi] Nat Resources Inst Finland Luke, Rovaniemi, Finland; [Stark, Sari] Univ Lapland, Arctic Ctr, Rovaniemi, Finland	Natural Resources Institute Finland (Luke); University of Lapland	Martz, F (corresponding author), Nat Resources Inst Finland Luke, Rovaniemi, Finland.	francoise.martz@luke.fi	Stark, Sari/L-4440-2013; Martz, Francoise/C-6354-2017; Rautio, Pasi/A-6595-2013	Rautio, Pasi/0000-0003-0559-7531; Martz, Francoise/0000-0002-5693-4529	Suomen akatemia [267092]; Suomen Kulttuurirahasto, Lapin Rahasto [40121486, 2010-2011]	Suomen akatemia; Suomen Kulttuurirahasto, Lapin Rahasto	This work was supported by Suomen akatemia (www.aka.fi, decision 267092, to PR): complete project funding (field experiment implementation, material collection, data analysis, preparation of manuscript) and Suomen Kulttuurirahasto, Lapin Rahasto (www.skr.fi, grant 40121486, 2010-2011, to FM): running a pilot field experiment, material collection and data analysis.	Al-Traboulsi M, 2013, PLANT SOIL, V365, P267, DOI 10.1007/s11104-012-1390-5; Alvarez-Uria P, 2007, FUNCT ECOL, V21, P211, DOI 10.1111/j.1365-2435.2007.01231.x; Barbeito I, 2012, ECOLOGY, V93, P389, DOI 10.1890/11-0384.1; Bergjord AK, 2008, EUR J AGRON, V28, P321, DOI 10.1016/j.eja.2007.10.002; Bjerke JW, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095007; Bottcher K, 2014, REMOTE SENS ENVIRON, V140, P625, DOI 10.1016/j.rse.2013.09.022; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Castonguay Y, 2009, CROP SCI, V49, P671, DOI 10.2135/cropsci2008.08.0484; CHOMBA BM, 1993, TREE PHYSIOL, V13, P351, DOI 10.1093/treephys/13.4.351; CLEIN JS, 1995, SOIL BIOL BIOCHEM, V27, P1231, DOI 10.1016/0038-0717(95)00044-F; Comerford DP, 2013, OECOLOGIA, V171, P261, DOI 10.1007/s00442-012-2393-x; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; Decker KLM, 2003, SOIL SCI SOC AM J, V67, P1234, DOI 10.2136/sssaj2003.1234; Drescher M, 2013, OIKOS, V122, P541, DOI 10.1111/j.1600-0706.2012.20642.x; FREY W, 1983, ARCTIC ALPINE RES, V15, P241, DOI 10.2307/1550925; Gaul D, 2008, J PLANT NUTR SOIL SC, V171, P690, DOI 10.1002/jpln.200700284; Gonzelez-Meller MA, 2004, ANN BOT-LONDON, V94, P647, DOI 10.1093/aob/mch189; Greenway H, 2006, ANN BOT-LONDON, V98, P9, DOI 10.1093/aob/mcl076; Gudleifsson BE, 2009, PLANT COLD HARDINESS: FROM THE LABORATORY TO THE FIELD, P163, DOI 10.1079/9781845935139.0163; Gudleifsson BE, 2014, METHODS MOL BIOL, V1166, P225, DOI 10.1007/978-1-4939-0844-8_17; Hardy JP, 2001, BIOGEOCHEMISTRY, V56, P151, DOI 10.1023/A:1013036803050; Heiskanen J., 2015, Journal of Forest Science (Prague), V61, P35, DOI 10.17221/97/2014-JFS; Hoglind M, 2010, GRASS FORAGE SCI, V65, P431, DOI 10.1111/j.1365-2494.2010.00762.x; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kammann C, 2001, EUR J SOIL SCI, V52, P297, DOI 10.1046/j.1365-2389.2001.00380.x; Krasowski MJ, 2001, TREE PHYSIOL SER, V1, P253; KRASOWSKI MJ, 1995, WATER AIR SOIL POLL, V82, P133, DOI 10.1007/BF01182827; Kruger M, 2011, INT J GREENH GAS CON, V5, P1093, DOI 10.1016/j.ijggc.2011.05.002; Liston GE, 2011, J CLIMATE, V24, P5691, DOI 10.1175/JCLI-D-11-00081.1; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mikkonen S, 2015, STOCH ENV RES RISK A, V29, P1521, DOI 10.1007/s00477-014-0992-2; Musselman RC, 2005, ARCT ANTARCT ALP RES, V37, P527, DOI 10.1657/1523-0430(2005)037[0527:TTDOCD]2.0.CO;2; Pirinen P., 2012, REPORTS-BASEL; Preece C, 2013, ENVIRON EXP BOT, V85, P7, DOI 10.1016/j.envexpbot.2012.06.003; Preece C, 2012, PHYSIOL PLANTARUM, V146, P460, DOI 10.1111/j.1399-3054.2012.01640.x; QI JE, 1994, NEW PHYTOL, V128, P435, DOI 10.1111/j.1469-8137.1994.tb02989.x; Rasmus S, 2004, ANN GLACIOL, V38, P238, DOI 10.3189/172756404781814843; Repo T, 2005, TREE PHYSIOL, V25, P1053, DOI 10.1093/treephys/25.8.1053; Repo T, 2008, TREE PHYSIOL, V28, P1583, DOI 10.1093/treephys/28.10.1583; Repo T, 2014, FOREST ECOL MANAG, V313, P112, DOI 10.1016/j.foreco.2013.11.002; Repo T, 2011, ENVIRON EXP BOT, V72, P387, DOI 10.1016/j.envexpbot.2011.04.014; RICARD J, 1976, FIELD ASSEMBLED FROS; Rixen C, 2008, ARCT ANTARCT ALP RES, V40, P568, DOI 10.1657/1523-0430(07-044)[RIXEN]2.0.CO;2; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Smith KL, 2013, ENRGY PROCED, V37, P791, DOI 10.1016/j.egypro.2013.05.169; SOLOMON DK, 1987, WATER RESOUR RES, V23, P2257, DOI 10.1029/WR023i012p02257; Sullivan BW, 2012, ARCT ANTARCT ALP RES, V44, P247, DOI 10.1657/1938-4246-44.2.247; Sutinen ML, 1996, CAN J FOREST RES, V26, P1602, DOI 10.1139/x26-180; Sutinen ML, 2000, FOREST ECOL MANAG, V135, P217, DOI 10.1016/S0378-1127(00)00312-1; Sutinen R, 2009, ARCT ANTARCT ALP RES, V41, P373, DOI 10.1657/1938-4246-41.3.373; Sutinen S, 2014, BOREAL ENVIRON RES, V19, P281; Tierney GL, 2001, BIOGEOCHEMISTRY, V56, P175, DOI 10.1023/A:1013072519889; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang D, 2012, OECOLOGIA, V169, P1, DOI 10.1007/s00442-011-2172-0; WILLIAMS BL, 1995, COMMUN SOIL SCI PLAN, V26, P91, DOI 10.1080/00103629509369283; Yanai Y, 2011, SOIL BIOL BIOCHEM, V43, P1779, DOI 10.1016/j.soilbio.2010.06.009; Ylitalo E, 2013, STAT YB FORESTRY	60	19	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156620	10.1371/journal.pone.0156620	http://dx.doi.org/10.1371/journal.pone.0156620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254100	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700044
J	Wehrendt, DP; Carmona, F; Wusener, AEG; Gonzalez, A; Martinez, JML; Arregui, CO				Wehrendt, Diana P.; Carmona, Fernando; Gonzalez Wusener, Ana E.; Gonzalez, Angela; Lazaro Martinez, Juan M.; Arregui, Carlos O.			P120-Catenin Regulates Early Trafficking Stages of the N-Cadherin Precursor Complex	PLOS ONE			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; P120 CATENIN; ENDOPLASMIC-RETICULUM; EXTRACELLULAR DOMAIN; CLASSICAL CADHERINS; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; PLASMA-MEMBRANE; AMPA RECEPTORS; ALPHA-SNAP	It is well established that binding of p120 catenin to the cytoplasmic domain of surface cadherin prevents cadherin endocytosis and degradation, contributing to cell-cell adhesion. In the present work we show that p120 catenin bound to the N-cadherin precursor, contributes to its anterograde movement from the endoplasmic reticulum (ER) to the Golgi complex. In HeLa cells, depletion of p120 expression, or blocking its binding to N-cadherin, increased the accumulation of the precursor in the ER, while it decreased the localization of mature N-cadherin at intercellular junctions. Reconstitution experiments in p120-deficient SW48 cells with all three major isoforms of p120 (1, 3 and 4) had similar capacity to promote the processing of the N-cadherin precursor to the mature form, and its localization at cell-cell junctions. P120 catenin and protein tyrosine phosphatase PTP1B facilitated the recruitment of the N-ethylmaleimide sensitive factor (NSF), an ATPase involved in vesicular trafficking, to the N-cadherin precursor complex. Dominant negative NSF E329Q impaired N-cadherin trafficking, maturation and localization at cell-cell junctions. Our results uncover a new role for p120 catenin bound to the N-cadherin precursor ensuring its trafficking through the biosynthetic pathway towards the cell surface.	[Wehrendt, Diana P.; Carmona, Fernando; Gonzalez Wusener, Ana E.; Gonzalez, Angela; Arregui, Carlos O.] Univ San Martin, IIB INTECH, Inst Invest Biotecnol, San Martin, Argentina; [Lazaro Martinez, Juan M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Organ, Caba, Argentina	University of Buenos Aires	Arregui, CO (corresponding author), Univ San Martin, IIB INTECH, Inst Invest Biotecnol, San Martin, Argentina.	carregui@iib.unsam.edu.ar	Lázaro-Martínez, Juan/AAE-5709-2020; Martinez, Juan/GXM-4393-2022	Lázaro-Martínez, Juan/0000-0002-7189-6874; Arregui, Carlos/0000-0003-0704-3321	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTs 1363, 2129]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt (PICTs 1363 and 2129), to COA; and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), http://www.conicet.gov.ar, to COA, DPW and JMLM.	Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Coppolino MG, 2001, J BIOL CHEM, V276, P4772, DOI 10.1074/jbc.M007792200; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heisler FF, 2014, P NATL ACAD SCI USA, V111, P5030, DOI 10.1073/pnas.1304301111; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Lazaro-Martinez JM, 2015, MACROMOLECULES, V48, P1115, DOI 10.1021/ma5023082; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Mo YY, 1996, CANCER RES, V56, P2633; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Peter F, 1998, J CELL SCI, V111, P2625; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Posthaus H, 1998, FEBS LETT, V438, P306, DOI 10.1016/S0014-5793(98)01330-1; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Sangwan V, 2011, J BIOL CHEM, V286, P45000, DOI 10.1074/jbc.M111.270934; Shi L, 2014, J BIOL CHEM, V289, P8432, DOI 10.1074/jbc.M113.517466; SHORE EM, 1991, J BIOL CHEM, V266, P19672; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2011, MOL BIOL CELL, V22, P4247, DOI 10.1091/mbc.E11-03-0250; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156758	10.1371/journal.pone.0156758	http://dx.doi.org/10.1371/journal.pone.0156758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254316	Green Published, gold			2022-12-27	WOS:000377218700054
J	Zhang, CL; Guo, L; Chu, X; Shen, LM; Guo, YY; Dong, HL; Mao, JF; van der Veen, S				Zhang, Chuanling; Guo, Liang; Chu, Xu; Shen, Limeng; Guo, Yuanyu; Dong, Huali; Mao, Jianfeng; van der Veen, Stijn			Presence of the Panton-Valentine Leukocidin Genes in Methicillin-Resistant Staphylococcus aureus Is Associated with Severity and Clinical Outcome of Hospital-Acquired Pneumonia in a Single Center Study in China	PLOS ONE			English	Article							NECROTIZING PNEUMONIA; COMMUNITY; STRAINS; INFECTIONS; VIRULENCE; SEQUENCE; USA300	The Panton-Valentine leukocidin (PVL) genes of methicillin-resistant Staphylococcus aureus (MRSA) have previously been associated with severe infections. Here, the impact of the PVL genes on severity of disease and clinical outcome of patients with hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) due to MRSA was investigated in a single center observational study in a hospital in China. HAP due to MRSA was diagnosed in 100 patients and 13 of the patients were PVL positive, while VAP was diagnosed in 5 patients and 2 were PVL positive. The PVL positive patient group showed a significantly higher Acute Physiology and Chronic Health Evaluation (APACHE) II score (14.3 +/- 7.8 vs. 10.1 +/- 4.7, P = 0.005) and significantly more patients with CRP levels >80 mg/L (8/15 vs. 12/90, P = 0.006) or WBC counts >15x10(9)/L (7/15 vs. 12/90, P = 0.006), indicating that the severity of disease is affected by the presence of the PVL genes. The outcome of the study was defined by 30-day mortality. Four (27%) of the PVL positive patients and four (4%) of the PVL negative patients died within 30 days (P = 0.01, Fisher exact test). Kaplan-Meier survival curves were generated for the PVL positive and PVL negative patient groups, which differed significantly (P = 0.003). Among the patients that died, the mean interval between diagnosis and death was shorter for the PVL positive patients (9.3 +/- 5.6 vs. 40.8 +/- 6.6 days, P = 0.013). Further analysis within the HAP and VAP patient groups showed that the presence of PVL in MRSA impacted the severity of disease and clinical outcome of HAP, but for VAP the number of patients included in the study was too low. In conclusion, in this single center study in a Chinese hospital the presence of the PVL genes in MRSA impacted the severity of disease and clinical outcome in patients with HAP due to MRSA.	[Zhang, Chuanling; Chu, Xu; Shen, Limeng; Guo, Yuanyu; Dong, Huali; Mao, Jianfeng] Zhejiang Xiaoshan Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Guo, Liang] Zhejiang Xiaoshan Hosp, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China; [van der Veen, Stijn] Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	van der Veen, S (corresponding author), Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	stijnvanderveen@zju.edu.cn		van der Veen, Stijn/0000-0002-8176-391X	Zhejiang Medical and Health Science and Technology Project [2012KYB171]; Major Science and Technology Programs of Xiaoshan in Hangzhou [2013314]	Zhejiang Medical and Health Science and Technology Project; Major Science and Technology Programs of Xiaoshan in Hangzhou	This work was supported by the Zhejiang Medical and Health Science and Technology Project [2012KYB171] and the Major Science and Technology Programs of Xiaoshan in Hangzhou [2013314]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen BJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1032-7; Chen FJ, 2014, ANTIMICROB AGENTS CH, V58, P1047, DOI 10.1128/AAC.02045-13; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096255; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Haque NZ, 2012, J CLIN MICROBIOL, V50, P1640, DOI 10.1128/JCM.06701-11; Hota B, 2011, CLIN INFECT DIS, V53, P757, DOI 10.1093/cid/cir472; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070602; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Peyrani P, 2011, CLIN INFECT DIS, V53, P766, DOI 10.1093/cid/cir541; Sharma-Kuinkel BK, 2012, J CLIN MICROBIOL, V50, P848, DOI 10.1128/JCM.06219-11; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Tacconelli E, 2009, CURR OPIN PULM MED, V15, P218, DOI 10.1097/MCP.0b013e3283292666; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	23	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156704	10.1371/journal.pone.0156704	http://dx.doi.org/10.1371/journal.pone.0156704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249225	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700071
J	Seo, MG; Lee, SH; VanBik, D; Ouh, IO; Yun, SH; Choi, E; Park, YS; Lee, SE; Kim, JW; Cho, GJ; Kwon, OD; Kwak, D				Seo, Min-Goo; Lee, Seung-Hun; VanBik, Dorene; Ouh, In-Ohk; Yun, Sun-Hee; Choi, Eunsang; Park, Yong-Soo; Lee, Sang-Eun; Kim, Jong Wan; Cho, Gil-Jae; Kwon, Oh-Deog; Kwak, Dongmi			Detection and Genotyping of Coxiella burnetii and Coxiella-Like Bacteria in Horses in South Korea	PLOS ONE			English	Article							Q-FEVER; INFECTION; TICKS; TRANSMISSION	Coxiella burnetii and Coxiella-like bacteria (CLB) are genetically and ecologically distinct despite some genetic similarities. Furthermore, CLB are exceptionally diverse and widespread in ticks, but rarely detected in domestic animals. Since Coxiella bacteria can be transmitted from infected horses by inhalation or by coming in contact with ticks during activities such as horseback riding, it is necessary to study their prevalence. To the best of our knowledge, this is the first large-scale nationwide investigation of the prevalence of C. burnetii and CLB among horses reared in South Korea. Of 816 blood samples collected between 2007 and 2013, 11 (1.3%) were identified as C. burnetii by ELISA, and six (0.7%) as CLB by 16S rRNA sequencing. While a sequence from Jeju Island was similar (97.9-100%) to those within clade B, five sequences obtained from the northern region were categorized into a new clade, indicating the sequence diversity of the genus Coxiella. Studies until date had detected CLB only in ticks; here, we describe their detection in mammals. Given their zoonotic potential, strategic monitoring and appropriate control programs for Coxiella species need to be established.	[Seo, Min-Goo; Lee, Seung-Hun; VanBik, Dorene; Cho, Gil-Jae; Kwon, Oh-Deog; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Seo, Min-Goo; Ouh, In-Ohk; Kim, Jong Wan] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Yun, Sun-Hee] Inst Publ Hlth & Environm, Div Vet Serv Lab, Inchon, South Korea; [Choi, Eunsang] Smile Equine Clin, Busan, South Korea; [Park, Yong-Soo] Korea Natl Coll Agr & Fisheries, Dept Horse Ind, Jeonju, South Korea; [Lee, Sang-Eun] Korea Natl Inst Hlth, Div Malaria & Parasit Dis, Cheongju, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Animal & Plant Quarantine Agency; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr		Seo, Min-Goo/0000-0003-1752-5105	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]; Smile Equine Clinic	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Smile Equine Clinic	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Smile Equine Clinic provided support in the form of salary for author EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Acland HM., 1993, EQUINE REPROD, P554; [Anonymous], 1959, ADV VET SCI; [Anonymous], 2015, DANSK VETERINAERTIDS; Dantas-Torres F, 2015, INT J PARASITOL-PAR, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; EKLUND CM, 1947, PUBLIC HEALTH REP, V62, P1413, DOI 10.2307/4586287; Georgiev M, 2013, EURO SURVEILL, V18; Jung BY, 2014, VET MICROBIOL, V173, P152, DOI 10.1016/j.vetmic.2014.06.029; Kirkan S, 2008, TURK J VET ANIM SCI, V32, P215; 우인옥, 2013, [Korean Journal of Veterinary Service, 한국가축위생학회지], V36, P243; Leon A, 2012, PREV VET MED, V104, P179, DOI 10.1016/j.prevetmed.2011.11.001; Marenzoni ML, 2013, VET MICROBIOL, V167, P662, DOI 10.1016/j.vetmic.2013.09.027; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Meredith AL, 2015, TRANSBOUND EMERG DIS, V62, P639, DOI 10.1111/tbed.12211; Ministry of Agriculture, 2015, REP FACT FIND SURV H; Nett RJ, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/916142; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Pan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002231; Racic I, 2014, VET MICROBIOL, V173, P340, DOI 10.1016/j.vetmic.2014.08.016; Roest HIJ, 2013, EMERG INFECT DIS, V19, P834, DOI 10.3201/eid1905.121489; Rolain JM, 2005, CLIN INFECT DIS, V40, P82, DOI 10.1086/426440; Runge M, 2012, PRAKT TIERARZT, V93, P220; Shin GW, 2014, J VET MED SCI, V76, P1069, DOI 10.1292/jvms.13-0575; Shivaprasad HL, 2008, AVIAN DIS, V52, P426, DOI 10.1637/8192-120707-Reg; SKERMAN VBD, 1980, INT J SYST BACTERIOL, V30, P225, DOI 10.1099/00207713-30-1-225; Smith TA, 2015, GENOME BIOL EVOL, V7, P831, DOI 10.1093/gbe/evv016; Tan CK, 2000, DIS AQUAT ORGAN, V41, P115, DOI 10.3354/dao041115; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Tozer SJ, 2014, ZOONOSES PUBLIC HLTH, V61, P105, DOI 10.1111/zph.12051; Vapniarsky N, 2012, VET PATHOL, V49, P717, DOI 10.1177/0300985811409251; Woc-Colburn AM, 2008, VET PATHOL, V45, P247, DOI 10.1354/vp.45-2-247; Zhong JM, 2012, ADV EXP MED BIOL, V984, P365, DOI 10.1007/978-94-007-4315-1_18	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156710	10.1371/journal.pone.0156710	http://dx.doi.org/10.1371/journal.pone.0156710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244230	Green Published, gold			2022-12-27	WOS:000377146100064
J	Thompson, GL; Kao-Kniffin, J				Thompson, Grant L.; Kao-Kniffin, Jenny			Diversity Enhances NPP, N Retention, and Soil Microbial Diversity in Experimental Urban Grassland Assemblages	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; 16S RIBOSOMAL-RNA; PLANT DIVERSITY; ECOSYSTEM MULTIFUNCTIONALITY; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; BIODIVERSITY LOSS; UNITED-STATES; NITROGEN; CARBON	Urban grasslands, landscapes dominated by turfgrasses for aesthetic or recreational groundcovers, are rapidly expanding in the United States and globally. These managed ecosystems are often less diverse than the natural or agricultural lands they replace, leading to potential losses in ecosystem functioning. Research in non-urban systems has provided evidence for increases in multiple ecosystem functions associated with greater plant diversity. To test if biodiversity-ecosystem function findings are applicable to urban grasslands, we examined the effect of plant species and genotypic diversity on three ecosystem functions, using grassland assemblages of increasing diversity that were grown within a controlled environment facility. We found positive effects of plant diversity on reduced nitrate leaching and plant productivity. Soil microbial diversity (Mean Shannon Diversity, H') of bacteria and fungi were also enhanced in multi-species plantings, suggesting that moderate increments in plant diversity influence the composition of soil biota. The results from this study indicate that plant diversity impacts multiple functions that are important in urban ecosystems; therefore, further tests of urban grassland biodiversity should be examined in situ to determine the feasibility of manipulating plant diversity as an explicit landscape design and function trait.	[Thompson, Grant L.; Kao-Kniffin, Jenny] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14853 USA	Cornell University	Kao-Kniffin, J (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14853 USA.	jtk57@cornell.edu	Thompson, Grant/AAH-2241-2021	Thompson, Grant/0000-0002-6818-2176	National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant [1069193]	National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant(National Science Foundation (NSF))	The work for this project was supported by a fellowship from the National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant #1069193 in Cross-Scale Biogeochemistry and Climate at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dan Vandam, Jeremie Blum, Dani Park, Princess Swan, and the staff of Ken Post Lab Greenhouses for their assistance in the greenhouse, Carri Marchner for help with the LECO CN Analyzer, Marty Petrovic and Jeff Barlow for the use of the SEAL autoanalyzer, the Cornell Statistical Consulting Unit for statistical consultation, Frank Rossi and Laurie Drink-water for comments on the manuscript, and Kevin Panke-Buisse, Sarah Carver, Juana Munoz-Ucros for assistance throughout the project. The work for this project was supported by a fellowship from the National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant #1069193 in Cross-Scale Biogeochemistry and Climate at Cornell University. We would also like to thank the journal editorial staff and two anonymous reviewers for guidance in the preparation of this manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barthe CA, 1995, WATERSHED PROTECTION, V2, P239; Berthrong S.T., 2013, MICROB ECOL, P1; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Bormann F. H., 2001, REDESIGNING AM LAWN; Bremer DJ, 2015, HORTTECHNOLOGY, V25, P90, DOI 10.21273/HORTTECH.25.1.90; Bureau UC, 2011, 2010 CENS BRIEFS; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2013, ECOLOGY; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clark CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052821; Clegg CD, 2003, FEMS MICROBIOL ECOL, V43, P263, DOI 10.1111/j.1574-6941.2003.tb01066.x; Duran J, 2013, GLOBA CHANG BIOL; GOLD AJ, 1990, J SOIL WATER CONSERV, V45, P305; Groffman PM, 2009, J ENVIRON QUAL, V38, P1848, DOI 10.2134/jeq2008.0521; Guillard K, 2004, J ENVIRON QUAL, V33, P1822, DOI 10.2134/jeq2004.1822; Ho CY, 1997, PLANT CELL REP, V16, P797, DOI 10.1007/s002990050323; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Jantz P, 2005, ENVIRON MANAGE, V36, P808, DOI 10.1007/s00267-004-0315-3; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Klaus VH, 2013, RESTOR ECOL, V21, P665, DOI 10.1111/rec.12051; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; McCarty L.B., 2011, BEST GOLF COURSE MAN; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Mueller KE, 2013, GLOBAL CHANGE BIOL, V19, P1249, DOI 10.1111/gcb.12096; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Pouyat RV, 2006, J ENVIRON QUAL, V35, P1566, DOI 10.2134/jeq2005.0215; Pouyat Richard V., 2009, Urban Ecosystems, V12, P45, DOI 10.1007/s11252-008-0059-6; Qian YL, 2002, AGRON J, V94, P930; Raciti SM, 2008, ECOL APPL, V18, P1615, DOI 10.1890/07-1062.1; Raciti SM, 2011, J ENVIRON QUAL, V40, P1932, DOI 10.2134/jeq2011.0107; Raciti SM, 2011, ECOSYSTEMS, V14, P287, DOI 10.1007/s10021-010-9409-3; Robbins P, 2003, LAND USE POLICY, V20, P181, DOI 10.1016/S0264-8377(03)00006-1; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Schimel J. P., 2005, Biological diversity and function in soils, P171, DOI 10.1017/CBO9780511541926.011; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Townsend-Small A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041675; Turgeon A.J., 2005, TURFGRASS MANAGEMENT, V7th ed.; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Webster G, 2002, APPL ENVIRON MICROB, V68, P20, DOI 10.1128/AEM.68.1.20-30.2002; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yao HY, 2006, APPL SOIL ECOL, V34, P209, DOI 10.1016/j.apsoil.2006.01.009; Zhang Y, 2013, J ENV QUAL	60	15	15	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155986	10.1371/journal.pone.0155986	http://dx.doi.org/10.1371/journal.pone.0155986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243768	gold, Green Published			2022-12-27	WOS:000377146100010
J	Fang, JY; Wang, HY; Bai, J; Zhang, QY; Li, YF; Liu, F; Jiang, P				Fang, Jianyu; Wang, Haiyan; Bai, Juan; Zhang, Qiaoya; Li, Yufeng; Liu, Fei; Jiang, Ping			Monkey Viperin Restricts Porcine Reproductive and Respiratory Syndrome Virus Replication	PLOS ONE			English	Article							ANTIVIRAL PROTEIN VIPERIN; INTERFERON-INDUCIBLE PROTEIN; AMPHIPATHIC ALPHA-HELIX; WEST NILE VIRUS; MARC-145 CELLS; ENDOPLASMIC-RETICULUM; HUMAN CYTOMEGALOVIRUS; ENCEPHALITIS-VIRUS; LIPID RAFTS; GENE-EXPRESSION	Porcine reproductive and respiratory syndrome virus (PRRSV) is an important pathogen which causes huge economic damage globally in the swine industry. Current vaccination strategies provide only limited protection against PRRSV infection. Viperin is an interferon (IFN) stimulated protein that inhibits some virus infections via IFN-dependent or IFN-independent pathways. However, the role of viperin in PRRSV infection is not well understood. In this study, we cloned the full-length monkey viperin (mViperin) complementary DNA (cDNA) from IFN-alpha-treated African green monkey Marc-145 cells. It was found that the mViperin is up-regulated following PRRSV infection in Marc-145 cells along with elevated IRF-1 gene levels. IFN-alpha induced mViperin expression in a dose-and time-dependent manner and strongly inhibits PRRSV replication in Marc-145 cells. Overexpression of mViperin suppresses PRRSV replication by blocking the early steps of PRRSV entry and genome replication and translation but not inhibiting assembly and release. And mViperin co-localized with PRRSV GP5 and N protein, but only interacted with N protein in distinct cytoplasmic loci. Furthermore, it was found that the 13-16 amino acids of mViperin were essential for inhibiting PRRSV replication, by disrupting the distribution of mViperin protein from the granular distribution to a homogeneous distribution in the cytoplasm. These results could be helpful in the future development of novel antiviral therapies against PRRSV infection.	[Fang, Jianyu; Wang, Haiyan; Bai, Juan; Zhang, Qiaoya; Li, Yufeng; Liu, Fei; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Ping] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Nanjing Agricultural University	Jiang, P (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.; Jiang, P (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	jiangp@njau.edu.cn			National Natural Science Foundation [31230071]; Ministry of Education, China [2012009711004]; Ministry of Agriculture [CARS-36]; priority academic program development of Jiangsu higher education institutions (PAPD)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); priority academic program development of Jiangsu higher education institutions (PAPD)	This work was mainly supported by the National Natural Science Foundation (31230071) and grant from the Ministry of Education, China (2012009711004), and for PRRSV immunology, a grant from the Ministry of Agriculture (CARS-36) for swine disease controlling techniques, and the priority academic program development of Jiangsu higher education institutions (PAPD).	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gao JM, 2014, VET MICROBIOL, V174, P409, DOI 10.1016/j.vetmic.2014.09.030; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2010, J IMMUNOL, V184, P5723, DOI 10.4049/jimmunol.0903752; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Huang L, 2011, BIOCHEM BIOPH RES CO, V414, P545, DOI 10.1016/j.bbrc.2011.09.109; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kappes MA, 2015, VIROLOGY, V479, P475, DOI 10.1016/j.virol.2015.02.012; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kim Y, 2015, VIROLOGY, V484, P181, DOI 10.1016/j.virol.2015.06.007; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Li C, 2013, ANTIVIR RES, V100, P487, DOI 10.1016/j.antiviral.2013.09.002; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lim ES, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-55; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; MEULENBERG JJM, 1993, J GEN VIROL, V74, P1697, DOI 10.1099/0022-1317-74-8-1697; Miller LC, 2004, ARCH VIROL, V149, P2453, DOI 10.1007/s00705-004-0377-9; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sen Tan K, 2012, J GEN VIROL, V93, P1269, DOI 10.1099/vir.0.040824-0; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shi CX, 2015, ARCH MICROBIOL, V197, P503, DOI 10.1007/s00203-015-1088-1; Snijder EJ, 2003, J VIROL, V77, P97, DOI 10.1128/JVI.77.1.97-104.2003; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang YD, 2014, J VIROL, V88, P12296, DOI 10.1128/JVI.01379-14; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; van der Meer Y, 1998, J VIROL, V72, P6689, DOI 10.1128/JVI.72.8.6689-6698.1998; Van Gorp H, 2010, J VIROL, V84, P3101, DOI 10.1128/JVI.02093-09; Veit M, 2014, VIRUS RES, V194, P16, DOI 10.1016/j.virusres.2014.09.010; Wang B, 2015, PLACENTA, V36, P667, DOI 10.1016/j.placenta.2015.03.002; Wang HY, 2016, J INTERF CYTOK RES, V36, P129, DOI 10.1089/jir.2015.0077; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang Q, 2015, VIROLOGY, V484, P170, DOI 10.1016/j.virol.2015.06.005; Yun SI, 2013, J MICROBIOL, V51, P711, DOI 10.1007/s12275-013-3431-z; Zhang LL, 2013, ANTIVIR RES, V99, P197, DOI 10.1016/j.antiviral.2013.06.004; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	64	22	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156513	10.1371/journal.pone.0156513	http://dx.doi.org/10.1371/journal.pone.0156513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232627	gold, Green Submitted, Green Published			2022-12-27	WOS:000376883000040
J	Iden, M; Fye, S; Li, KG; Chowdhury, T; Ramchandran, R; Rader, JS				Iden, Marissa; Fye, Samantha; Li, Keguo; Chowdhury, Tamjid; Ramchandran, Ramani; Rader, Janet S.			The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; C-MYC ONCOGENE; UTERINE CERVIX; INCREASED EXPRESSION; TUMOR OXYGENATION; NUCLEOLIN; TRANSLOCATION; PROLIFERATION; AMPLIFICATION; TRANSCRIPTION	The plasmacytoma variant translocation 1 gene (PVT1) is an lncRNA that has been designated as an oncogene due to its contribution to the phenotype of multiple cancers. Although the mechanism by which PVT1 influences disease processes has been studied in multiple cancer types, its role in cervical tumorigenesis remains unknown. Thus, the present study was designed to investigate the role of PVT1 in cervical cancer in vitro and in vivo. PVT1 expression was measured by quantitative PCR (qPCR) in 121 invasive cervical carcinoma (ICC) samples, 30 normal cervix samples, and cervical cell lines. Functional assays were carried out using both siRNA and LNA-mediated knockdown to examine PVT1' s effects on cervical cancer cell proliferation, migration and invasion, apoptosis, and cisplatin resistance. Our results demonstrate that PVT1 expression is significantly increased in ICC tissue versus normal cervix and that higher expression of PVT1 correlates with poorer overall survival. In cervical cancer cell lines, PVT1 knockdown resulted in significantly decreased cell proliferation, migration and invasion, while apoptosis and cisplatin cytotoxicity were significantly increased in these cells. Finally, we show that PVT1 expression is augmented in response to hypoxia and immune response stimulation and that this lncRNA associates with the multifunctional and stress-responsive protein, Nucleolin. Collectively, our results provide strong evidence for an oncogenic role of PVT1 in cervical cancer and lend insight into potential mechanisms by which PVT1 overexpression helps drive cervical carcinogenesis.	[Iden, Marissa; Fye, Samantha; Li, Keguo; Chowdhury, Tamjid; Ramchandran, Ramani; Rader, Janet S.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Rader, JS (corresponding author), Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.	jrader@mcw.edu	Ogunwobi, Olorunseun/F-3172-2010	Iden, Marissa/0000-0003-3383-1751	Women's Health Research Program at the Medical College of Wisconsin	Women's Health Research Program at the Medical College of Wisconsin	This work was supported by the Women's Health Research Program at the Medical College of Wisconsin (http://obgyn.mcw.edu/research/whrp/). The funders had no role in any part of preparation of this manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MH, 2012, J HEPATOL, V56, P877, DOI 10.1016/j.jhep.2011.10.022; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Ding CF, 2015, ONCOL LETT, V9, P955, DOI 10.3892/ol.2014.2730; Ding J, 2014, ONCOTARGETS THER, V7, P1625, DOI 10.2147/OTT.S68854; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Fyles AW, 1998, RADIOTHER ONCOL, V48, P149, DOI 10.1016/S0167-8140(98)00044-9; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ginisty H, 1999, J CELL SCI, V112, P761; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; HOCKEL M, 1993, GYNECOL ONCOL, V51, P141, DOI 10.1006/gyno.1993.1262; Huang C, 2015, MINERVA MED, V106, P143; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; Iden M, 2014, ANN M AM ASS CANC RE; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Paci P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-83; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Riquelme E, 2014, J THORAC ONCOL, V9, P998, DOI 10.1097/JTO.0000000000000202; Rofstad EK, 2000, BRIT J CANCER, V83, P354, DOI 10.1054/bjoc.2000.1266; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; SHTIVELMAN E, 1990, MOL CELL BIOL, V10, P1835, DOI 10.1128/MCB.10.4.1835; Sundfor K, 2000, RADIOTHER ONCOL, V54, P101, DOI 10.1016/S0167-8140(99)00175-9; Takahashi Y, 2014, BRIT J CANCER, V110, P164, DOI 10.1038/bjc.2013.698; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; WEBB E, 1984, NATURE, V312, P777, DOI 10.1038/312777a0; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang YR, 2014, INT J CLIN EXP PATHO, V7, P6929; Zhang X.-w., 2015, BIOCH BIOPHYS RES CO; Zhao Y, 2009, J ZHEJIANG UNIV-SC B, V10, P404, DOI 10.1631/jzus.B0820293; Zhou Q., 2015, TUMOUR BIOL	47	124	129	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156274	10.1371/journal.pone.0156274	http://dx.doi.org/10.1371/journal.pone.0156274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232880	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000018
J	Kroger, H; Fritzell, J; Hoffmann, R				Kroger, Hannes; Fritzell, Johan; Hoffmann, Rasmus			The Association of Levels of and Decline in Grip Strength in Old Age with Trajectories of Life Course Occupational Position	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC POSITION; MUSCLE STRENGTH; SOCIAL-CLASS; LONGITUDINAL DATA; CHILDHOOD HEALTH; DROP-OUT; LONG ARM; MEN; COHORT	Background The study of the influence of life course occupational position (OP) on health in old age demands analysis of time patterns in both OP and health. We study associations between life course time patterns of OP and decline in grip strength in old age. Methods We analyze 5 waves from the Survey of Health Ageing and Retirement in Europe (n = 5108, ages 65-90). We use a pattern-mixture latent growth model to predict the level and decline in grip strength in old age by trajectory of life course OP. We extend and generalize the structured regression approach to establish the explanatory power of different life course models for both the level and decline of grip strength. Results Grip strength declined linearly by 0.70 kg (95% CI -0.74;-0.66) for men and 0.42 kg (95% CI -0.45;-0.39) for women per year. The level of men's grip strength can best be explained by a critical period during midlife, with those exposed to low OP during this period having 1.67 kg (95% CI -2.33;-1.00) less grip strength. These differences remain constant over age. For women, no association between OP and levels of or decline in grip strength was found. Conclusions Men's OP in midlife seems to be a critical period for the level of grip strength in old age. Inequalities remain constant over age. The integration of the structured regression approach and latent growth modelling offers new possibilities for life course epidemiology.	[Kroger, Hannes; Hoffmann, Rasmus] European Univ Inst, Florence, Italy; [Fritzell, Johan] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fritzell, Johan] Stockholm Univ, S-10691 Stockholm, Sweden	European University Institute; Karolinska Institutet; Stockholm University	Kroger, H (corresponding author), European Univ Inst, Florence, Italy.	hannes.kroger@eui.eu	Kröger, Hannes/AAI-3799-2021	Fritzell, Johan/0000-0003-0496-3085; Kroger, Hannes/0000-0003-1576-5519; Hoffmann, Rasmus/0000-0002-9007-3144	European Research Council (ERC) [ERC: 313532]; NordForsk [74637]; European Commission [QLK6-CT-2001-00360]; European Commission (SHARE-I3) [RII-CT-2006-062193]; European Commission (COMPARE) [CIT5- CT-2005-028857]; European Commission (SHARELIFE) [CIT4-CT-2006-028812]; European Commission (SHARE-PREP) [211909]; European Commission (SHARE-LEAP) [227822]; European Commission (SHARE M4) [261982]; U.S. National Institute on Aging [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, OGHA 04-064]; German Ministry of Education and Research; NATIONAL INSTITUTE ON AGING [R21AG025169, P01AG005842] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); NordForsk; European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission (SHARE-I3)(European Commission); European Commission (COMPARE)(European Commission); European Commission (SHARELIFE)(European Commission); European Commission (SHARE-PREP)(European Commission); European Commission (SHARE-LEAP)(European Commission); European Commission (SHARE M4); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European Research Council (ERC): [ERC: 313532] (https://erc.europa.eu/) and NordForsk [74637] (http://www.nordforsk.org/). The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982). Additional funding from the U.S. National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064), and the German Ministry of Education and Research, as well as from various national sources, is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alomari MA, 2010, EUR J APPL PHYSIOL, V109, P803, DOI 10.1007/s00421-010-1367-0; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; Bartley M., 2004, HLTH INEQUALITY INTR; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Blane D, 2007, REV EPIDEMIOL SANTE, V55, P31, DOI 10.1016/j.respe.2006.12.004; Blane D, 2001, SOC SCI MED, V52, P959, DOI 10.1016/S0277-9536(00)00188-X; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Borsch-Supan A, 2011, SHARELIFE METHODOL, V5; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Corna LM, 2013, ADV LIFE COURSE RES, V18, P150, DOI 10.1016/j.alcr.2013.01.002; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Dex S., 1995, B SOCIOLOGICAL METHO, V49, P58, DOI [10.1177/075910639504900105, DOI 10.1177/075910639504900105]; Diggle P, 2007, J R STAT SOC C-APPL, V56, P499, DOI 10.1111/j.1467-9876.2007.00590.x; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; ERA P, 1992, EUR J APPL PHYSIOL O, V64, P84, DOI 10.1007/BF00376446; ERIKSON R, 1984, SOCIOLOGY, V18, P500, DOI 10.1177/0038038584018004003; Fatouros IG, 2005, BRIT J SPORT MED, V39, P776, DOI 10.1136/bjsm.2005.019117; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Fritzell J, 2007, HLTH INEQUALITIES WE, P67; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Gustafsson PE, 2012, EUR J PUBLIC HEALTH, V22, P322, DOI 10.1093/eurpub/ckr061; Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hallqvist J, 2004, SOC SCI MED, V58, P1555, DOI 10.1016/S0277-9536(03)00344-7; Havari E, 2015, EUR J POPUL, V31, P233, DOI 10.1007/s10680-014-9332-y; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Heraclides A, 2010, J EPIDEMIOL COMMUN H, V64, P714, DOI 10.1136/jech.2009.087692; Hoffmann R, 2011, J GERONTOL B-PSYCHOL, V66, P374, DOI 10.1093/geronb/gbr014; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Hurst L, 2013, AM J PUBLIC HEALTH, V103, P1641, DOI 10.2105/AJPH.2013.301240; International Standard Classification of Occupations, 1990, ISCO88 ILO; Jann B, 2007, STATA J, V7, P227, DOI 10.1177/1536867X0700700207; Jones AM, 2006, J R STAT SOC A STAT, V169, P543, DOI 10.1111/j.1467-985X.2006.00399.x; Kapetanakis VV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114289; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kok A, 2016, J EPIDEMIOL IN PRESS; Kroger H, 2015, STATA J, V15, P155, DOI 10.1177/1536867X1501500110; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2002, AM J EPIDEMIOL, V156, P627, DOI 10.1093/aje/kwf099; Kuh D, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P3; Liang J, 2002, J GERONTOL B-PSYCHOL, V57, pS294, DOI 10.1093/geronb/57.5.S294; Martin-Ruiz C, 2014, LIFE COURSE APPROACH, P177; McDonough P, 2005, SOC SCI MED, V61, P1795, DOI 10.1016/j.socscimed.2005.03.021; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Mishra GD, 2013, EUR J EPIDEMIOL, V28, P139, DOI 10.1007/s10654-013-9777-z; de Quadros LDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136886; Murray ET, 2011, J GERONTOL A-BIOL, V66, P1350, DOI 10.1093/gerona/glr139; Niedzwiedz CL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-628; Nybo H, 2001, J AM GERIATR SOC, V49, P601, DOI 10.1046/j.1532-5415.2001.49121.x; NYGARD CH, 1988, INT ARCH OCC ENV HEA, V60, P291, DOI 10.1007/BF00378476; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Otero-Rodriguez A, 2011, J EPIDEMIOL COMMUN H, V65, P964, DOI 10.1136/jech.2010.113555; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Russo A, 2006, OCCUP ENVIRON MED, V63, P438, DOI 10.1136/oem.2005.023549; Sacker A, 2011, J EPIDEMIOL COMMUN H, V65, P130, DOI 10.1136/jech.2009.091199; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Schibye B, 2001, APPL ERGON, V32, P425, DOI 10.1016/S0003-6870(01)00034-5; Smith ADAC, 2015, EPIDEMIOLOGY, V26, P719, DOI 10.1097/EDE.0000000000000348; Solga H, 2001, QUAL QUANT, V35, P291, DOI 10.1023/A:1010387414959; Sovio U, 2013, EUR J PREV CARDIOL, V20, P844, DOI 10.1177/2047487312446136; Starr JM, 2011, AGE AGEING, V40, P749, DOI 10.1093/ageing/afr070; Sterba SK, 2014, STRUCT EQU MODELING, V21, P630, DOI 10.1080/10705511.2014.919828; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Toraman NF, 2005, BRIT J SPORT MED, V39, P561, DOI 10.1136/bjsm.2004.015420; Torssander J, 2010, EUR SOCIOL REV, V26, P465, DOI 10.1093/esr/jcp034; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712	75	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155954	10.1371/journal.pone.0155954	http://dx.doi.org/10.1371/journal.pone.0155954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232696	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000009
J	Bierowiec, K; Ploneczka-Janeczko, K; Rypula, K				Bierowiec, Karolina; Ploneczka-Janeczko, Katarzyna; Rypula, Krzysztof			Is the Colonisation of Staphylococcus aureus in Pets Associated with Their Close Contact with Owners?	PLOS ONE			English	Article							COAGULASE-POSITIVE STAPHYLOCOCCI; RISK-FACTORS; ANTIBIOTIC-RESISTANCE; COMPANION ANIMALS; FUSIDIC ACID; FELINE STAPHYLOCOCCI; MRSA INFECTION; HEALTHY CATS; FERAL CATS; SPA TYPES	In human beings and animals, staphylococci constitute part of the normal microbial population. Staphylococcus aureus could be classified as an opportunistic pathogen because the bacteria are noted in clinically healthy individuals, but when the immune system becomes compromised, they can also cause a wide range of infections. The objective of this study was to test the hypothesis that cats who are in close contact with their owners are at the greatest risk of being colonised with S. aureus. Two groups of cats were investigated: single, pet (domestic) cats that do not have outdoor access; and a local population of feral cats living in urban areas. The prevalence of S. aureus in domestic cats was 19.17%, while it's prevalence in the feral cat population was only 8.3%; which was statistically significant. Analysis of antibiotic resistance, at the genotypic as well as phenotypic level, showed that S. aureus isolates from pet cats were more likely to harbour antibiotic resistant determinants. The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in households was 10.21%, while in feral cats it was only 1.4%. In conclusion, this study has revealed a correlation between close contact with humans and a higher risk of the cats being colonised with S. aureus and harbouring the antibiotic resistant determinants.	[Bierowiec, Karolina; Ploneczka-Janeczko, Katarzyna; Rypula, Krzysztof] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Epizootiol, Div Infect Dis & Vet Adm,Clin Birds & Exot Anim, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences	Bierowiec, K (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Epizootiol, Div Infect Dis & Vet Adm,Clin Birds & Exot Anim, Wroclaw, Poland.	karolina.bierowiec@up.wroc.pl	Płoneczka-Janeczko, Katarzyna/I-6274-2013; Bierowiec, Karolina/A-6805-2017; Bierowiec, Karolina/K-3064-2019	Płoneczka-Janeczko, Katarzyna/0000-0002-7621-4449; Bierowiec, Karolina/0000-0002-7663-4312; Rypula, Krzysztof/0000-0003-3884-4834	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences [B030/0024/15]; European Union as part of the European Social Fund - Grant Plus edition; Centre of Biotechnology's Leading National Research Centre (KNOW)	Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences; European Union as part of the European Social Fund - Grant Plus edition; Centre of Biotechnology's Leading National Research Centre (KNOW)	This work was supported by the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences ( B030/0024/15), co-financed by the European Union as part of the European Social Fund - Grant Plus edition 2013/2014 and by the Centre of Biotechnology's Leading National Research Centre (KNOW) for the years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JL, 2007, VET DERMATOL, V18, P252, DOI 10.1111/j.1365-3164.2007.00604.x; Bania J, 2006, INT J FOOD MICROBIOL, V108, P36, DOI 10.1016/j.ijfoodmicro.2005.10.013; Bradley SF, 2007, CLIN INFECT DIS, V44, P186, DOI 10.1086/510395; Brink AJ, 2012, S AFR J SURG, V50, P20; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Clinical and Laboratory Standards Institute, 2014, M100S24 CLSI WAYN PA; Cohn LA, 2010, J VET EMERG CRIT CAR, V20, P31, DOI 10.1111/j.1476-4431.2009.00497.x; Porrero MC, 2014, APPL ENVIRON MICROB, V80, P4865, DOI 10.1128/AEM.00647-14; Coughlan K, 2010, ZOONOSES PUBLIC HLTH, V57, P220, DOI 10.1111/j.1863-2378.2009.01302.x; Coutant C, 1996, DIAGN MICR INFEC DIS, V25, P9, DOI 10.1016/0732-8893(96)00070-3; Couto N, 2015, J ANTIMICROB CHEMOTH, V70, P2483, DOI 10.1093/jac/dkv141; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Eckholm NG, 2013, VET DERMATOL, V24, P154, DOI 10.1111/j.1365-3164.2012.01051.x; Emaneini M, 2013, Ann Burns Fire Disasters, V26, P76; Gandolfi-Decristophoris P, 2013, J VET SCI, V14, P449, DOI 10.4142/jvs.2013.14.4.449; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Glaser P, 2016, MBIO, V7, DOI 10.1128/mBio.02183-15; Guardabassi L, 2009, GUIDE TO ANTIMICROBI; Hamilton E, 2013, JAVMA-J AM VET MED A, V243, P990, DOI 10.2460/javma.243.7.990; Hariharan H, 2011, COMP IMMUNOL MICROB, V34, P129, DOI 10.1016/j.cimid.2010.05.001; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2014, MBIO, V5, DOI 10.1128/mBio.00985-13; Heller J, 2010, RISK ANAL, V30, P458, DOI 10.1111/j.1539-6924.2009.01342.x; Iverson SA, 2015, VET MICROBIOL, V176, P202, DOI 10.1016/j.vetmic.2015.01.003; Jeremiah CJ, 2016, J HOSP INFECT, V92, P183, DOI 10.1016/j.jhin.2015.10.023; Johnson RC, 2015, INFECT IMMUN, V83, P802, DOI 10.1128/IAI.02664-14; Kasprzyk Joanna, 2015, Medycyna Doswiadczalna i Mikrobiologia, V67, P79; Kottler S, 2010, J VET INTERN MED, V24, P132, DOI 10.1111/j.1939-1676.2009.0424.x; Krupa P, 2014, POULTRY SCI, V93, P3179, DOI 10.3382/ps.2014-04321; Krupa P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141475; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Larsen J, 2014, J GLOB ANTIMICROB RE, V2, P260, DOI 10.1016/j.jgar.2014.09.003; Leibler JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148789; Lilenbaum W, 1998, LETT APPL MICROBIOL, V27, P224, DOI 10.1046/j.1472-765X.1998.00406.x; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Loeffler A, 2008, J ANTIMICROB CHEMOTH, V62, P1301, DOI 10.1093/jac/dkn398; Loeffler A, 2011, EPIDEMIOL INFECT, V139, P1019, DOI 10.1017/S095026881000227X; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Luczak-Kadlubowska A, 2008, J CLIN MICROBIOL, V46, P2930, DOI 10.1128/JCM.00869-08; Luria BJ, 2004, J FELINE MED SURG, V6, P287, DOI 10.1016/j.jfms.2003.11.005; Magalhaes RJS, 2010, VET RES, V41, DOI 10.1051/vetres/2010028; Almeida GCM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-328; Malaviolle X, 2008, J ANTIMICROB CHEMOTH, V62, P1018, DOI 10.1093/jac/dkn345; Manian FA, 2003, CLIN INFECT DIS, V36, pE26, DOI 10.1086/344772; Martin MC, 2003, FOOD MICROBIOL, V20, P605, DOI 10.1016/S0740-0020(02)00180-6; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McKinnell JA, 2013, INFECT CONT HOSP EP, V34, P1077, DOI 10.1086/673157; Morris DO, 2012, ZOONOSES PUBLIC HLTH, V59, P286, DOI 10.1111/j.1863-2378.2011.01448.x; Muniz IM, 2013, ZOONOSES PUBLIC HLTH, V60, P504, DOI 10.1111/zph.12027; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Patel A, 2002, ADV VET DERMATOL, V4, P85; Patel A, 1999, VET DERMATOL, V10, P257, DOI 10.1046/j.1365-3164.1999.00178.x; Petinaki E, 2012, CLIN MICROBIOL INFEC, V18, P626, DOI 10.1111/j.1469-0691.2012.03881.x; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Qureshi Adnan I, 2009, J Vasc Interv Neurol, V2, P132; Resch M, 2008, INT J FOOD MICROBIOL, V127, P99, DOI 10.1016/j.ijfoodmicro.2008.06.013; Rizzotti L, 2005, J FOOD PROTECT, V68, P955, DOI 10.4315/0362-028X-68.5.955; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Sharma-Kuinkel BK, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv093; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Skramm I, 2014, J BONE JOINT SURG AM, V96A, P882, DOI 10.2106/JBJS.M.00919; Sorum H, 2001, VET RES, V32, P227, DOI 10.1051/vetres:2001121; Coutinho VDS, 2010, BRAZ J INFECT DIS, V14, P564, DOI 10.1016/S1413-8670(10)70113-6; Tilahun B, 2015, AM J CRIT CARE, V24, P8, DOI 10.4037/ajcc2015102; Vincze S, 2014, PLOS ONE, V9; Vincze S, 2014, INT J MED MICROBIOL, V304, P787, DOI 10.1016/j.ijmm.2014.07.007; Walther B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035197; Wan MT, 2012, J APPL MICROBIOL, V112, P205, DOI 10.1111/j.1365-2672.2011.05179.x; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Weiss S, 2013, VET MICROBIOL, V167, P680, DOI 10.1016/j.vetmic.2013.07.036; Wendlandt S, 2015, TRENDS MICROBIOL, V23, P44, DOI 10.1016/j.tim.2014.10.002; Wisniewska Katarzyna, 2013, Medycyna Doswiadczalna i Mikrobiologia, V65, P139	77	34	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156052	10.1371/journal.pone.0156052	http://dx.doi.org/10.1371/journal.pone.0156052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227897	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500059
J	Bourne, A; Holness, S; Holden, P; Scorgie, S; Donatti, CI; Midgley, G				Bourne, Amanda; Holness, Stephen; Holden, Petra; Scorgie, Sarshen; Donatti, Camila I.; Midgley, Guy			A Socio-Ecological Approach for Identifying and Contextualising Spatial Ecosystem-Based Adaptation Priorities at the Sub-National Level	PLOS ONE			English	Article							GLOBAL CHANGE IMPACTS; CLIMATE-CHANGE; SOUTH-AFRICA; LAND-USE; LOCAL-GOVERNMENT; BIODIVERSITY; CONSERVATION; RESILIENCE; VEGETATION; BENEFITS	Climate change adds an additional layer of complexity to existing sustainable development and biodiversity conservation challenges. The impacts of global climate change are felt locally, and thus local governance structures will increasingly be responsible for preparedness and local responses. Ecosystem-based adaptation (EbA) options are gaining prominence as relevant climate change solutions. Local government officials seldom have an appropriate understanding of the role of ecosystem functioning in sustainable development goals, or access to relevant climate information. Thus the use of ecosystems in helping people adapt to climate change is limited partially by the lack of information on where ecosystems have the highest potential to do so. To begin overcoming this barrier, Conservation South Africa in partnership with local government developed a socio-ecological approach for identifying spatial EbA priorities at the sub-national level. Using GIS-based multi-criteria analysis and vegetation distribution models, the authors have spatially integrated relevant ecological and social information at a scale appropriate to inform local level political, administrative, and operational decision makers. This is the first systematic approach of which we are aware that highlights spatial priority areas for EbA implementation. Nodes of socio-ecological vulnerability are identified, and the inclusion of areas that provide ecosystem services and ecological resilience to future climate change is innovative. The purpose of this paper is to present and demonstrate a methodology for combining complex information into user-friendly spatial products for local level decision making on EbA. The authors focus on illustrating the kinds of products that can be generated from combining information in the suggested ways, and do not discuss the nuance of climate models nor present specific technical details of the model outputs here. Two representative case studies from rural South Africa demonstrate the replicability of this approach in rural and peri-urban areas of other developing and least developed countries around the world.	[Bourne, Amanda] Conservat South Africa, Springbok, South Africa; [Holness, Stephen] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, Port Elizabeth, South Africa; [Holden, Petra; Scorgie, Sarshen] Conservat South Africa, Cape Town, South Africa; [Holden, Petra] Univ Cape Town, Plant Conservat Unit, ZA-7925 Cape Town, South Africa; [Donatti, Camila I.] Conservat Int, Gordon & Betty Moore Ctr Sci, Arlington, VA USA; [Midgley, Guy] Univ Stellenbosch, Global Change Biol Unit, ZA-7600 Stellenbosch, South Africa	Nelson Mandela University; University of Cape Town; Conservation International; Stellenbosch University	Bourne, A (corresponding author), Conservat South Africa, Springbok, South Africa.	abourne@conservation.org	Donatti, Camila I./AAV-2324-2020; Donatti, Camila/AAF-3605-2020; Bourne, Amanda/AAO-6825-2020; Holden, Petra/AAQ-3951-2021	Bourne, Amanda/0000-0001-6078-0676; Holden, Petra/0000-0002-3047-1407	International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety by the German Bundestag [11_II_084_Global_A_EbA solutions]; International Climate Initiative; Critical Ecosystem Partnership Fund [61486]	International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety by the German Bundestag; International Climate Initiative; Critical Ecosystem Partnership Fund	The methodology for defining spatial ecosystem-based adaptation priorities was developed in the Namakwa District with funding from the International Climate Initiative, an initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety adopted on the basis of a decision by the German Bundestag, grant number 11_II_084_Global_A_EbA solutions. The International Climate Initiative paid the full-time salary for corresponding author Amanda Bourne from Sept 2011 to June 2015. The same project also funded time for Stephen Holness, Camila Donatti, and Sarshen Scorgie to develop the methodology, conduct the spatial analysis and contribute to technical reporting. The methodology was refined and replicated in the Alfred Nzo District with funding from the Critical Ecosystem Partnership Fund, grant number 61486. The Critical Ecosystem Partnership Fund is a joint initiative of l'Agence Francaise de Developpement, Conservation International, the European Union, the Global Environment Facility, the Government of Japan, the MacArthur Foundation and the World Bank. This project funded time for Stephen Holness and Petra Holden to undertake the spatial analysis, and the stakeholder engagement and report writing processes respectively. Although the authors received funding to conduct the original analyses, as above, the authors received no specific funding to produce this manuscript and all volunteered their time to convert the methodology from technical report into manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessa L, 2008, LANDSCAPE URBAN PLAN, V85, P27, DOI 10.1016/j.landurbplan.2007.09.007; [Anonymous], 2014, NAMAKWA DISTRICT MUN; [Anonymous], 2008, NAMAKWA BIODIVERSITY; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bourne A, 2015, CLIMATE CHANGE VULNE; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; CARE International, 2009, CLIMATE VULNERABILIT; Carrick PJ, 2015, ECOL MANAG RESTOR, V16, P86, DOI 10.1111/emr.12169; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Conservation South Africa, 2015, ALFRED NZO DISTRICT; Conservation South Africa, 2015, CLIMATE CHANGE VULNE; Cousins B, 2007, J ARID ENVIRON, V70, P834, DOI 10.1016/j.jaridenv.2007.04.002; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Cumming GS, 2014, NATURE, V515, P50, DOI 10.1038/nature13945; Davis C, 2016, S AFR J SCI IN PRESS; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; de Sherbinin A, 2014, CLIMATIC CHANGE, V123, P23, DOI 10.1007/s10584-013-0900-7; DEA, 2013, LONG TERM ADAPTATION; DEDEAT (Department of Economic Development Environmental Affairs and Tourism), 2013, THE EASTERN CAPE SOC; Department of Environmental Affairs Department of Cooperative Governance the South African Local Government Association, 2012, LETS RESPOND INTEGRA; Dirnbock T, 2011, GLOBAL CHANGE BIOL, V17, P990, DOI 10.1111/j.1365-2486.2010.02266.x; Doswald N, 2014, CLIM DEV, V6, P185, DOI 10.1080/17565529.2013.867247; Doswald N., 2015, PROMOTING ECOSYSTEMS; Edenhofer O., 2014, CONTRIBUTION WORKING; Egoh B, 2008, AGR ECOSYST ENVIRON, V127, P135, DOI 10.1016/j.agee.2008.03.013; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Engelbrecht FA, 2009, INT J CLIMATOL, V29, P1013, DOI 10.1002/joc.1742; Engelbrecht FA, 2005, CLIMATE CHANGE WATER, P57; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Field C.B., 2014, CLIMATE CHANGE 2014, DOI DOI 10.1017/CBO9781107415379; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Godfree R, 2011, GLOBAL CHANGE BIOL, V17, P943, DOI 10.1111/j.1365-2486.2010.02292.x; Gordon H.B., 2010, 21 CTR AUSTR WEATH C; Government of South Africa, 2008, NATIONAL PROTECTED A; Hamann M, 2015, GLOBAL ENVIRON CHANG, V34, P218, DOI 10.1016/j.gloenvcha.2015.07.008; Hannah L, 2002, CONSERV BIOL, V16, P264, DOI 10.1046/j.1523-1739.2002.00465.x; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoffman MT, 2009, S AFR J SCI, V105, P54; Hoffman MT, 1999, THE KAROO ECOLOGICAL; Holness SD, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1029; Huq S, 2007, ENVIRON URBAN, V19, P3, DOI 10.1177/0956247807078058; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Kelso C, 2007, CLIMATIC CHANGE, V83, P357, DOI 10.1007/s10584-007-9264-1; Klausmeyer KR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006392; Klein RJT, 2001, J COASTAL RES, V17, P531; Kotze D, 2009, WATER RESEARCH COMMI; Lavorel S, 2015, GLOBAL CHANGE BIOL, V21, P12, DOI 10.1111/gcb.12689; Leichenko R. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P1, DOI 10.1023/A:1015860421954; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Ludi E, 2014, COMMUNITY-BASED ADAPTATION TO CLIMATE CHANGE: SCALING IT UP, P36; Magadlela D, 2004, S AFR J SCI, V100, P94; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Measham TG, 2011, MITIG ADAPT STRAT GL, V16, P889, DOI 10.1007/s11027-011-9301-2; Metzger MJ, 2008, REG ENVIRON CHANGE, V8, P91, DOI 10.1007/s10113-008-0044-x; Moncrieff GR, 2015, S AFR J BOT, V101, P16, DOI 10.1016/j.sajb.2015.02.004; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; Mucina L, 2006, THE VEGETATION OF SO; Munroe R, 2012, ENVIRON EVID, V1, DOI 10.1186/2047-2382-1-13; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nel JL, 2012, NATIONAL BIODIVERSIT, V2; Nel JL, 2011, WRC REPORT NO TT 500; Nozawa T., 2007, CGER SUPERCOMPUTER M, V12; Oettle N, 2014, PARTICIPATORY ADAPTA; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Pasquini L, 2013, HABITAT INT, V40, P225, DOI 10.1016/j.habitatint.2013.05.003; Pasquini L, 2015, ENVIRON DEV SUSTAIN, V17, P1121, DOI 10.1007/s10668-014-9594-x; Petersen C, 2008, WORLD RESOURCES REPO; Pramova E, 2012, WIRES CLIM CHANGE, V3, P581, DOI 10.1002/wcc.195; Rannow S, 2010, LANDSCAPE URBAN PLAN, V98, P160, DOI 10.1016/j.landurbplan.2010.08.017; Reid H, 2015, CLIM DEV, DOI [10.1080/17565529.2015.1034233, DOI 10.1080/17565529.2015.1034233]; Roberts D, 2012, ENVIRON URBAN, V24, P167, DOI 10.1177/0956247811431412; Roeckner E, 2003, MAX PLANCK INSTITUTE; Ruckelshaus M, 2013, MAR POLICY, V40, P154, DOI 10.1016/j.marpol.2013.01.009; Samuels MI, 2013, THESIS; SANBI (South African National Biodiversity Institute), 2009, UPDATING NATIONAL LA; Schulze RE, 2010, ATLAS OF CLIMATE CHA; Schulze RE, 2005, CLIMATE CHANGE WATER, P141; Schulze RE, 2011, WATER RESEARCH COMMI; Seavy NE, 2015, ECOL RESTOR, V27, P330; Secretariat of the Convention on Biological Diversity, 2009, TECHNICAL SERIES, V41; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; StatsSA (Statistics South Africa), 2012, CENSUS 2011 STATISTI; Stevens B, 2013, J ADV MODEL EARTH SY, V5, P146, DOI 10.1002/jame.20015; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Travers A, 2012, UNEP WORKING DOCUMEN; Turpie JK, 2011, REPORT PRODUCED FOR; Van Wyk A, 2001, REGIONS OF FLORISTIC; Vetter S, 2009, S AFR J SCI, V105, P29, DOI 10.1590/s0038-23532009000100017; Walker B., 2004, Ecology and Society, V9, P5; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wamsler C, 2014, GLOBAL ENVIRON CHANG, V29, P189, DOI 10.1016/j.gloenvcha.2014.09.008; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	101	22	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155235	10.1371/journal.pone.0155235	http://dx.doi.org/10.1371/journal.pone.0155235			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227671	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500011
J	Li, L; Li, XY; Hu, HJ; Shin, H; Zhou, P				Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping			The Effect of Subcutaneous Fat on Electrical Impedance Myography: Electrode Configuration and Multi-Frequency Analyses	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; NEUROMUSCULAR DISEASE; SKELETAL-MUSCLE; INITIAL ASSESSMENT; ATROPHY; RESISTIVITY; ANISOTROPY; ARRAY; AGE	This study investigates the impact of the subcutaneous fat layer (SFL) thickness on localized electrical impedance myography (EIM), as well as the effects of different current electrodes, varying in distance and direction, on EIM output. Twenty-three healthy subjects underwent localized multi-frequency EIM on their biceps brachii muscles with a hand-held electrode array. The EIM measurements were recorded under three different configurations: wide (or outer) longitudinal configuration 6.8 cm, narrow (or inner) longitudinal configuration 4.5 cm, and narrow transverse configuration 4.5 cm. Ultrasound was applied to measure the SFL thickness. Coefficients of determination (R-2) of three EIM variables (resistance, reactance, and phase) and SFL thickness were calculated. For the longitudinal configuration, the wide distance could reduce the effects of the subcutaneous fat when compared with the narrow distance, but a significant correlation still remained for all three EIM parameters. However, there was no significant correlation between SFL thickness and reactance in the transverse configuration (R-2 = 0.0294, p = 0.434). Utilizing a ratio of 50kHz/100kHz phase was found to be able to help reduce the correlation with SFL thickness for all the three configurations. The findings indicate that the appropriate selection of the current electrode distance, direction and the multi-frequency phase ratio can reduce the impact of subcutaneous fat on EIM. These settings should be evaluated for future clinical studies using hand-held localized arrays to perform EIM.	[Li, Le] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Rehabil Med, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Huijing; Zhou, Ping] Guangdong Prov Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China; [Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Li, Le; Li, Xiaoyan; Hu, Huijing; Shin, Henry; Zhou, Ping] TIRR Mem Hermann Res Ctr, Houston, TX USA	Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston	Zhou, P (corresponding author), Guangdong Prov Work Injury Rehabil Ctr, Guangzhou, Guangdong, Peoples R China.; Zhou, P (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA.; Zhou, P (corresponding author), TIRR Mem Hermann Res Ctr, Houston, TX USA.	ping.zhou.1@uth.tmc.edu	Li, Le/N-1841-2019	Li, Le/0000-0002-9340-9061	Science and Technology Planning Project of Guangdong Province [2015A050502022, 2014A050503052]; China Scholarship Council; National Institutes of Health of the U.S. Department of Health and Human Services [R01NS080839]; Memorial Hermann Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080839] Funding Source: NIH RePORTER	Science and Technology Planning Project of Guangdong Province; China Scholarship Council(China Scholarship Council); National Institutes of Health of the U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Hermann Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Science and Technology Planning Project of Guangdong Province under grants 2015A050502022 and 2014A050503052, the China Scholarship Council, the National Institutes of Health of the U.S. Department of Health and Human Services under grant R01NS080839, and the Memorial Hermann Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron R, 2002, SKELETAL MUSCLE PATO; Aaron R, 2006, PHYSIOL MEAS, V27, P953, DOI 10.1088/0967-3334/27/10/002; Baumgartner RN, 1998, J APPL PHYSIOL, V84, P257, DOI 10.1152/jappl.1998.84.1.257; Chin AB, 2008, MUSCLE NERVE, V37, P560, DOI 10.1002/mus.20981; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Elia M, 2000, ANN NY ACAD SCI, V904, P298; Esper GJ, 2006, MUSCLE NERVE, V34, P595, DOI 10.1002/mus.20626; Faes TJC, 1999, PHYSIOL MEAS, V20, pR1, DOI 10.1088/0967-3334/20/4/201; Garmirian LP, 2009, MUSCLE NERVE, V39, P16, DOI 10.1002/mus.21115; Jafarpoor M, 2013, IEEE T BIO-MED ENG, V60, P1446, DOI 10.1109/TBME.2012.2237030; Kortman HGJ, 2013, PHYSIOL MEAS, V34, P1611, DOI 10.1088/0967-3334/34/12/1611; Narayanaswami P, 2012, MUSCLE NERVE, V46, P257, DOI 10.1002/mus.23307; Rutkove SB, 2002, MUSCLE NERVE, V25, P390, DOI 10.1002/mus.10048; Rutkove SB, 2014, MUSCLE NERVE, V49, P441, DOI 10.1002/mus.24128; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Rutkove SB, 2010, MUSCLE NERVE, V42, P915, DOI 10.1002/mus.21784; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Ryan AS, 2002, ARCH PHYS MED REHAB, V83, P1703, DOI 10.1053/apmr.2002.36399; Sanchez B., 2014, IEEE T BIOMED ENG; Schwartz S, 2015, CLIN NEUROPHYSIOL, V126, P202, DOI 10.1016/j.clinph.2014.05.007; Shiffman CA, 1999, PHYS MED BIOL, V44, P2409, DOI 10.1088/0031-9155/44/10/304; Shklyar I, 2015, PEDIATR NEUROL, V52, P202, DOI 10.1016/j.pediatrneurol.2014.09.014; Sung M, 2013, CLIN NEUROPHYSIOL, V124, P400, DOI 10.1016/j.clinph.2012.07.013; Tarulli AW, 2007, CLIN NEUROPHYSIOL, V118, P2393, DOI 10.1016/j.clinph.2007.07.016; Tarulli AW, 2006, PHYSIOL MEAS, V27, P1269, DOI 10.1088/0967-3334/27/12/002; VALDIOSERA R, 1974, J GEN PHYSIOL, V63, P432, DOI 10.1085/jgp.63.4.432	26	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156154	10.1371/journal.pone.0156154	http://dx.doi.org/10.1371/journal.pone.0156154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227876	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500073
J	Mitchell, JT; Sweitzer, MM; Tunno, AM; Kollins, SH; McClernon, FJ				Mitchell, John T.; Sweitzer, Maggie M.; Tunno, Angela M.; Kollins, Scott H.; McClernon, F. Joseph			"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SUBSTANCE USE; HEALTH INFORMATION; INTERNET; WEB; EXPECTANCY; STRATEGIES; CHILDHOOD; POSTINGS; IMPACT	Background Attention-deficit/hyperactivity disorder (ADHD) is a risk factor for problematic cannabis use. However, clinical and anecdotal evidence suggest an increasingly popular perception that cannabis is therapeutic for ADHD, including via online resources. Given that the Internet is increasingly utilized as a source of healthcare information and may influence perceptions, we conducted a qualitative analysis of online forum discussions, also referred to as threads, on the effects of cannabis on ADHD to systematically characterize the content patients and caregivers may encounter about ADHD and cannabis. Methods A total of 268 separate forum threads were identified. Twenty percent (20%) were randomly selected, which yielded 55 separate forum threads (mean number of individual posts per forum thread = 17.53) scored by three raters (Cohen's kappa = 0.74). A final sample of 401 posts in these forum threads received at least one endorsement on predetermined topics following qualitative coding procedures. Results Twenty-five (25%) percent of individual posts indicated that cannabis is therapeutic for ADHD, as opposed to 8% that it is harmful, 5% that it is both therapeutic and harmful, and 2% that it has no effect on ADHD. This pattern was generally consistent when the year of each post was considered. The greater endorsement of therapeutic versus harmful effects of cannabis did not generalize to mood, other (non-ADHD) psychiatric conditions, or overall domains of daily life. Additional themes emerged (e.g., cannabis being considered sanctioned by healthcare providers). Conclusions Despite that there are no clinical recommendations or systematic research supporting the beneficial effects of cannabis use for ADHD, online discussions indicate that cannabis is considered therapeutic for ADHD-this is the first study to identify such a trend. This type of online information could shape ADHD patient and caregiver perceptions, and influence cannabis use and clinical care.	[Mitchell, John T.; Sweitzer, Maggie M.; Tunno, Angela M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Mitchell, John T.; Sweitzer, Maggie M.; Kollins, Scott H.; McClernon, F. Joseph] Duke Ctr Addict Sci & Technol, Durham, NC USA	Duke University	Mitchell, JT (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA.; Mitchell, JT (corresponding author), Duke Ctr Addict Sci & Technol, Durham, NC USA.	john.mitchell@duke.edu	Kollins, Scott/AAD-6291-2020; Sweitzer, Maggie/GPK-2525-2022	Kollins, Scott/0000-0001-6847-6935; Sweitzer, Maggie/0000-0002-5085-3752	National Institute on Drug Abuse [K23 DA032577, K24 DA023464]; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA032577, K24DA023464] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the National Institute on Drug Abuse (K23 DA032577 to JTM and K24 DA023464 to SHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsop DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044864; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; [Anonymous], 2004, MAR MED NEED SCI BAS; Barkley RA, 2007, J SAFETY RES, V38, P113, DOI 10.1016/j.jsr.2006.09.004; Bidwell LC, 2014, DRUG ALCOHOL DEPEN, V135, P88, DOI 10.1016/j.drugalcdep.2013.11.013; Blakely G, 2014, NURS HEALTH SCI, V16, P387, DOI 10.1111/nhs.12122; Blume A, 2009, NEUROPSYCHIATRIE, V23, P42; Boyer Celia, 2004, Stud Health Technol Inform, V100, P159; Boyer EW, 2007, CYBERPSYCHOL BEHAV, V10, P1, DOI 10.1089/cpb.2006.9999; Boyer EW, 2005, PEDIATRICS, V115, P302, DOI 10.1542/peds.2004-1199; Boyer EW, 2001, NEW ENGL J MED, V345, P469, DOI 10.1056/NEJM200108093450619; Burri M, 2006, NICOTINE TOB RES, V8, pS13, DOI 10.1080/14622200601042513; Bylund CL, 2007, PATIENT EDUC COUNS, V66, P346, DOI 10.1016/j.pec.2007.01.009; Crane NA, 2013, NEUROPSYCHOL REV, V23, P117, DOI 10.1007/s11065-012-9222-1; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Daniulaityte R, 2013, DRUG ALCOHOL DEPEN, V130, P241, DOI 10.1016/j.drugalcdep.2012.11.003; De Alwis D, 2014, ADDICT BEHAV, V39, P1278, DOI 10.1016/j.addbeh.2014.04.003; Del Boca FK, 2002, ALCOHOL CLIN EXP RES, V26, P926, DOI 10.1097/00000374-200206000-00024; Falck RS, 2004, DRUG ALCOHOL DEPEN, V74, P45, DOI 10.1016/j.drugalcdep.2003.11.009; Flower A, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-162; Fox S, 2013, HLTH ONLINE 2013, DOI DOI 10.1186/1471-244X-10-113; Goldman MS, 2002, ALCOHOL CLIN EXP RES, V26, P737, DOI 10.1097/00000374-200205000-00021; Griffiths P, 2000, SUBST USE MISUSE, V35, P811, DOI 10.3109/10826080009148423; Hadland SE, 2015, J DEV BEHAV PEDIATR, V36, P115, DOI 10.1097/DBP.0000000000000129; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; Hall W, 2009, INT J DRUG POLICY, V20, P458, DOI 10.1016/j.drugpo.2009.02.013; Harty SC, 2015, SUBST USE MISUSE, V50, P1470, DOI 10.3109/10826084.2015.1018545; Hechtman L, FUNCTIONAL ADU UNPUB; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Johnston L. D., 2014, MONITORING FUTURE NA; Kummervold PE, 2002, NORD J PSYCHIAT, V56, P59, DOI 10.1080/08039480252803945; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange JE, 2010, DRUG ALCOHOL DEPEN, V108, P138, DOI 10.1016/j.drugalcdep.2009.11.010; Lee SS, 2011, CLIN PSYCHOL REV, V31, P328, DOI 10.1016/j.cpr.2011.01.006; Lipsman A, 2015, US DIGITAL FUTURE FO; Lisdahl KM, 2016, DRUG ALCOHOL DEPEN, V161, P135, DOI 10.1016/j.drugalcdep.2016.01.032; Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Miller PG, 2010, ADDICTION, V105, P1557, DOI 10.1111/j.1360-0443.2010.02992.x; Molina BSG, 2013, J AM ACAD CHILD PSY, V52, P250, DOI 10.1016/j.jaac.2012.12.014; Mounteney J, 2010, SUBST USE MISUSE, V45, P266, DOI 10.3109/10826080903368598; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Poole R, 2015, JMIR MENT HEALTH, V2, DOI 10.2196/mental.4123; Rasmussen J, 2016, BRAIN IMAGING BEHAV, V10, P761, DOI 10.1007/s11682-015-9438-9; Saloner B, 2015, PEDIATRICS, V135, P955, DOI 10.1542/peds.2015-0436; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Schifano F, 2006, PROG NEURO-PSYCHOPH, V30, P640, DOI 10.1016/j.pnpbp.2005.11.035; Strohbeck-Kuehner P, 2008, CANNABINOIDS, V3, P1; Tamm L, 2013, DRUG ALCOHOL DEPEN, V133, P607, DOI 10.1016/j.drugalcdep.2013.08.001; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Wald HS, 2007, PATIENT EDUC COUNS, V68, P218, DOI 10.1016/j.pec.2007.05.016; Wartella E, 2015, TEENS HLTH TECHNOLOG; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zaman T, 2015, J ADDICT MED, V9, P317, DOI 10.1097/ADM.0000000000000138	55	49	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156614	10.1371/journal.pone.0156614	http://dx.doi.org/10.1371/journal.pone.0156614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227537	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500160
J	Peng, J; Zhang, L; Liu, JR; Luo, JY; Zhao, XH; Dong, HL; Ma, Y; Sui, N; Zhou, ZG; Meng, YL				Peng, Jun; Zhang, Lei; Liu, Jingran; Luo, Junyu; Zhao, Xinhua; Dong, Helin; Ma, Yan; Sui, Ning; Zhou, Zhiguo; Meng, Yali			Effects of Soil Salinity on Sucrose Metabolism in Cotton Fiber	PLOS ONE			English	Article							BOLL CHARACTERISTICS; CELLULOSE; SYNTHASE; ELONGATION; EXPRESSION; INVERTASE; QUALITY; LEAVES; PLANTS; YIELDS	Cotton (Gosspium hirsutum L.) is classified as a salt tolerant crop. However, its yield and fiber quality are negatively affected by soil salinity. Studies on the enzymatic differences in sucrose metabolism under different soil salinity levels are lacking. Therefore, field experiments, using two cotton cultivars, CCRI-79 (salt-tolerant) and Simian 3 (salt-sensitive), were conducted in 2013 and 2014 at three different salinity levels (1.15 dS m(-1) [low soil salinity], 6.00 dS m(-1) [medium soil salinity], and 11.46 dS m(-1) [high soil salinity]). The objective was to elucidate the effects of soil salinity on sucrose content and the activity of key enzymes that are related to sucrose metabolism in cotton fiber. Results showed that as the soil salinity increased, cellulose content, sucrose content, and sucrose transformation rate declined; the decreases in cellulose content and sucrose transformation rate caused by the increase in soil salinity were more in Simian 3 than those in CCRI-79. With increase in soil salinity, activities of sucrose metabolism enzymes sucrose phophate synthase (SPS), acidic invertase, and alkaline invertase were decreased, whereas sucrose synthase (SuSy) activity increased. However, the changes displayed in the SuSy and SPS activities in response to increase in soil salinity were different and the differences were large between the two cotton cultivars. These results illustrated that suppressed cellulose synthesis and sucrose metabolism under high soil salinity were mainly due to the change in SPS, SuSy, and invertase activities, and the difference in cellulose synthesis and sucrose metabolism in fiber for the two cotton cultivars in response to soil salinity was determined mainly by both SuSy and SPS activities.	[Peng, Jun; Zhou, Zhiguo; Meng, Yali] Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol Southern China, Nanjing, Jiangsu, Peoples R China; [Peng, Jun; Zhang, Lei; Liu, Jingran; Luo, Junyu; Zhao, Xinhua; Dong, Helin; Ma, Yan] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Sui, Ning] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Zhejiang Chinese Medical University	Zhou, ZG; Meng, YL (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol Southern China, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn; mengyl@njau.edu.cn		Ma, Yan/0000-0001-6897-5064	National Natural Science Foundation of China [31301262, 31501257]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest	The authors are grateful for financial support from the National Natural Science Foundation of China (31301262, 31501257), the Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP), and the Special Fund for Agro-scientific Research in the Public Interest (201503109).	Abdullah Z., 1986, PROSPECTS BIOSALINE, P125; AMOR Y, 1995, P NATL ACAD SCI USA, V92, P9353, DOI 10.1073/pnas.92.20.9353; Ashraf M, 2002, CRIT REV PLANT SCI, V21, P1, DOI 10.1016/S0735-2689(02)80036-3; Ashraf M, 2000, AGRONOMIE, V20, P917, DOI 10.1051/agro:2000168; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; Banks S. W., 1997, 1997 Proceedings Beltwide Cotton Conferences, New Orleans, LA, USA, January 6-10, 1997: Volume 2., P1422; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; But SY, 2015, ARCH MICROBIOL, V197, P471, DOI 10.1007/s00203-015-1080-9; Chao DY, 2005, CELL RES, V15, P796, DOI 10.1038/sj.cr.7290349; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105088; Chowdhry TM, 1972, COTTON SOILS PAKISTA, P275; d'Avo AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068289; Delmer D, 2002, METAB ENG, V20, P22, DOI DOI 10.1006/MBEN.2001.0206; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; DELMER DP, 1995, PLANT CELL, V7, P987, DOI 10.1105/tpc.7.7.987; Dong H., 2012, AUST J CROP SCI, V6, P333, DOI DOI 10.3316/INFORMIT.054789177704118; Dong He-zhong, 2012, Yingyong Shengtai Xuebao, V23, P566; Dong HZ, 2010, EUR J AGRON, V33, P285, DOI 10.1016/j.eja.2010.08.002; Essmann J, 2008, PLANT PHYSIOL, V147, P1288, DOI 10.1104/pp.108.121418; Fernandes FM, 2004, BIOL PLANTARUM, V48, P317, DOI 10.1023/B:BIOP.0000033465.59361.d2; Haigler CH, 2007, PLANT MOL BIOL, V63, P815, DOI 10.1007/s11103-006-9127-6; Haigler CH, 2001, PLANT MOL BIOL, V47, P29, DOI 10.1023/A:1010615027986; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HUBER SC, 1986, PLANT PHYSIOL, V81, P1008, DOI 10.1104/pp.81.4.1008; King SP, 1997, PLANT PHYSIOL, V114, P153, DOI 10.1104/pp.114.1.153; LONGENECKER DE, 1973, SOIL SCI, V115, P294, DOI 10.1097/00010694-197304000-00005; LONGENECKER DE, 1974, SOIL SCI, V118, P387, DOI 10.1097/00010694-197412000-00007; Lu SW, 2010, AFR J BIOTECHNOL, V9, P842; Ma Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089476; Park AY, 2008, TRANSGENIC RES, V17, P181, DOI 10.1007/s11248-007-9090-2; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; Pettigrew WT, 2001, CROP SCI, V41, P1108, DOI 10.2135/cropsci2001.4141108x; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; WAFLER U, 1994, PLANT PHYSIOL BIOCH, V32, P697; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang YH, 2009, PLANT GROWTH REGUL, V57, P203, DOI 10.1007/s10725-008-9337-9; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Zhang Guo-wei, 2011, Yingyong Shengtai Xuebao, V22, P2045; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3	41	15	15	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156398	10.1371/journal.pone.0156398	http://dx.doi.org/10.1371/journal.pone.0156398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227773	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500132
J	Zhou, YQ; Xu, XY; Lv, HB; Wen, QR; Li, J; Tan, LY; Li, JQ; Sheng, XJ				Zhou, Yanqing; Xu, Xiaying; Lv, Huabing; Wen, Qirong; Li, Juan; Tan, Linyu; Li, Jianqi; Sheng, Xiujie			The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-13 EXPRESSION; ADENOCARCINOMA TRANSCRIPT 1; LUNG-CANCER; METASTASIS; CARCINOMA; ADAMTS1; INHIBITION; PROGNOSIS; GENES	Background Metastasis associated in lung adenocarcinoma transcript-1 (MALAT-1) is overexpressed during cancer progression and promotes cell migration and invasion in many solid tumors. However, its role in ovarian cancer remains poorly understood. Methods Expressions of MALAT-1 were detected in 37 normal ovarian tissues and 45 ovarian cancer tissues by reverse transcription polymerase chain reaction (RT-PCR). Cell proliferation was observed by CCK-8 assay; Flow cytometry was used to measure cell cycle and apoptosis; Cell migration was detected by transwell migration and invasion assay. In order to evaluate the function of MALAT-1, shRNA combined with DNA microarray and Functional enrichment analysis were performed to determine the transcriptional effects of MALAT-1 silencing in OVCAR3 cells. RNA and protein expression were measured by qRT-PCR and Western blotting, respectively. Results We found that upregulation of MALAT-1 mRNA in ovarian cancer tissues and enhanced MALAT-1 expression was associated with FIGO stage. Knockdown of MALAT-1 expression in OVCAR3 cells inhibited cell proliferation, migration, and invasion, leading to G0/G1 cell cycle arrest and apoptosis. Overexpressed MALAT-1 expression in SKOV3 cells promoted cell proliferation, migration and invasion. Downregulation of MALAT-1 resulted in significant change of gene expression (at least 2-fold) in 449 genes, which regulate proliferation, cell cycle, and adhesion. As a consequence of MALAT-1 knockdown, MMP13 protein expression decreased, while the expression of MMP19 and ADAMTS1 was increased. Conclusions The present study found that MALAT-1 is highly expressed in ovarian tumors. MALAT-1 promotes the growth and migration of ovarian cancer cells, suggesting that MALAT-1 may be an important contributor to ovarian cancer development.	[Sheng, Xiujie] Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; Guangzhou Med Univ, Key Lab Major Obstetr Dis Guangdong Prov, Key Lab Reprod & Genet, Guangdong Higher Educ Inst Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Sheng, XJ (corresponding author), Guangzhou Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.	xjsheng@gzemail.cn			Science and Information Technology Agency of Guangzhou [2010GNE00221]; Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway [2014A020212517]	Science and Information Technology Agency of Guangzhou; Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway	This study was supported by grants from the Science and Information Technology Agency of Guangzhou (No. 2010GNE00221) and the Mechanism Study of MALAT1 Promote Invasion and Metastasis of Ovarian Cancer by Targeted Regulating STAT3 Signaling Pathway (No. 2014A020212517).	Ahmed FY, 1996, J CLIN ONCOL, V14, P2968, DOI 10.1200/JCO.1996.14.11.2968; Chen J, 2013, DIGEST DIS SCI, V58, P405, DOI 10.1007/s10620-012-2379-x; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fehrmann RSN, 2007, ONCOLOGIST, V12, P960, DOI 10.1634/theoncologist.12-8-960; Foda AM, 2014, TUMOR BIOL, V35, P5653, DOI 10.1007/s13277-014-1748-9; Freitas VM, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-2; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Hantke B, 2003, BIOL CHEM, V384, P1247, DOI 10.1515/BC.2003.137; Horak S, 1992, Ginekol Pol, V63, P619; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Inagaki J, 2014, EXP CELL RES, V323, P263, DOI 10.1016/j.yexcr.2014.03.002; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jost M, 2006, CANCER RES, V66, P5234, DOI 10.1158/0008-5472.CAN-05-4315; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; NAKAJIMA M, 1990, J NATL CANCER I, V82, P1890, DOI 10.1093/jnci/82.24.1890; Obika M, 2012, CANCER SCI, V103, P1889, DOI 10.1111/j.1349-7006.2012.02381.x; Ochi K, 1997, MOL GEN GENET, V256, P488; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Ren SC, 2013, EUR J CANCER, V49, P2949, DOI 10.1016/j.ejca.2013.04.026; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang JR, 2013, EUR REV MED PHARMACO, V17, P427; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583	29	53	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155250	10.1371/journal.pone.0155250	http://dx.doi.org/10.1371/journal.pone.0155250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227769	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500012
J	Inagaki, TK; Irwin, MR; Moieni, M; Jevtic, I; Eisenberger, NI				Inagaki, Tristen K.; Irwin, Michael R.; Moieni, Mona; Jevtic, Ivana; Eisenberger, Naomi I.			A Pilot Study Examining Physical and Social Warmth: Higher (Non-Febrile) Oral Temperature Is Associated with Greater Feelings of Social Connection	PLOS ONE			English	Article							PROMOTES INTERPERSONAL WARMTH; BODY-TEMPERATURE; LONELINESS; COLD; DEPRESSION; DISCONNECTION; PERSONALITY; MOTIVATION; EXPERIENCE; PROXIMITY	An emerging literature suggests that experiences of physical warmth contribute to social warmth-the experience of feeling connected to others. Thus, thermoregulatory systems, which help maintain our relatively warm internal body temperatures, may also support feelings of social connection. However, the association between internal body temperature and feelings of connection has not been examined. Furthermore, the origins of the link between physical and social warmth, via learning during early experiences with a caregiver or via innate, co-evolved mechanisms, remain unclear. The current study examined the relationship between oral temperature and feelings of social connection as well as whether early caregiver experiences moderated this relationship. Extending the existing literature, higher oral temperature readings were associated with greater feelings of social connection. Moreover, early caregiver experiences did not moderate this association, suggesting that the physical-social warmth overlap may not be altered by early social experience. Results provide additional support for the link between experiences of physical warmth and social warmth and add to existing theories that highlight social connection as a basic need on its own.	[Inagaki, Tristen K.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Irwin, Michael R.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Cousins Ctr Psychoneuroimmunol, Los Angeles, CA USA; [Moieni, Mona; Jevtic, Ivana; Eisenberger, Naomi I.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Inagaki, TK (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	inagaki@pitt.edu; neisenbe@ucla.edu	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431; Inagaki, Tristen/0000-0002-8825-2637	National Institute of Mental Health [R01-MH091352]; National Institute of Aging [R01-AG034588, R01-AG026364, P30-AG028748]; National Cancer Institute [R01 CA160245-01, R01-CA119159]; National Heart, Lung, and Blood Institute [R01 HL095799]; National Institute of Drug Abuse [R01 DA032922-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by R01-MH091352 from the National Institute of Mental Health to N.I.E. and R01-AG034588 (National Institute of Aging); R01-AG026364 (National Institute of Aging); R01 CA160245-01 (National Cancer Institute); R01-CA119159 (National Cancer Institute); R01 HL095799 (National Heart, Lung, and Blood Institute); R01 DA032922-01 (National Institute of Drug Abuse); P30-AG028748 (National Institute of Aging) to M.R.I., and the University of California, Los Angeles Cousins Center for Psychoneuroimmunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nsatimba PA, 2016, EUR J NUTR, V55, P1831, DOI 10.1007/s00394-015-1000-4; Aiken L. S., 1991, MULTIPLE REGRESSION; Bargh JA, 2012, EMOTION, V12, P154, DOI 10.1037/a0023527; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; BLAKE MJF, 1967, NATURE, V215, P896, DOI 10.1038/215896a0; BLUMBERG MS, 1992, DEV PSYCHOBIOL, V25, P229, DOI 10.1002/dev.420250402; Bowlby J, 1988, SECURE BASE PARENT C; COLQUHOUN WP, 1978, ERGONOMICS, V21, P811, DOI 10.1080/00140137808931784; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Durkheim, 2006, ON SUICIDE; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; ERIKSSON H, 1985, ACTA MED SCAND, V217, P347; Fay AJ, 2015, BRIT J SOC PSYCHOL, V54, P291, DOI 10.1111/bjso.12088; Fay AJ, 2014, J EXP SOC PSYCHOL, V50, P210, DOI 10.1016/j.jesp.2013.10.006; Fay AJ, 2012, J EXP SOC PSYCHOL, V48, P1369, DOI 10.1016/j.jesp.2012.05.017; Hanusch KU, 2013, AM J PSYCHIAT, V170, P802, DOI 10.1176/appi.ajp.2013.12111395; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Heinrich LA, 2006, CLIN PSYCHOL REV, V26, P695, DOI 10.1016/j.cpr.2006.04.002; IJzerman H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125194; Ijzerman H, 2012, ACTA PSYCHOL, V140, P283, DOI 10.1016/j.actpsy.2012.05.002; Ijzerman H, 2010, J EXP SOC PSYCHOL, V46, P867, DOI 10.1016/j.jesp.2010.07.015; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; Inagaki TK, 2015, EMOTION, V15, P494, DOI 10.1037/emo0000088; Inagaki TK, 2013, PSYCHOL SCI, V24, P2272, DOI 10.1177/0956797613492773; JENSEN BN, 1994, J ADV NURS, V20, P660, DOI 10.1046/j.1365-2648.1994.20040660.x; Joiner TE, 2002, J PERS ASSESS, V79, P472, DOI 10.1207/S15327752JPA7903_05; Kim H, 1998, LANCET, V351, P1492, DOI 10.1016/S0140-6736(05)78875-9; McFarland R, 2015, J ANIM ECOL, V84, P871, DOI 10.1111/1365-2656.12329; Moieni M, 2015, NEUROPSYCHOPHARMACOL, V40, P1709, DOI 10.1038/npp.2015.17; Panksepp J, 1997, ANN NY ACAD SCI, V807, P78, DOI 10.1111/j.1749-6632.1997.tb51914.x; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; Raison CL, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01580; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; STONE EA, 1976, PSYCHOSOM MED, V38, P242, DOI 10.1097/00006842-197607000-00002; Suffredini AF, 1999, J CLIN IMMUNOL, V19, P203, DOI 10.1023/A:1020563913045; Taylor SE, 2004, J PERS, V72, P1365, DOI 10.1111/j.1467-6494.2004.00300.x; Wei WQ, 2015, BRIT J SOC PSYCHOL, V54, P712, DOI 10.1111/bjso.12108; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665; WILSON GD, 1990, PERS INDIV DIFFER, V11, P153, DOI 10.1016/0191-8869(90)90008-F; Zhang Y, 2014, J PERS SOC PSYCHOL, V107, P965, DOI 10.1037/a0038153; Zhong CB, 2008, PSYCHOL SCI, V19, P838, DOI 10.1111/j.1467-9280.2008.02165.x	43	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156873	10.1371/journal.pone.0156873	http://dx.doi.org/10.1371/journal.pone.0156873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257914	Green Published, Green Accepted, gold			2022-12-27	WOS:000377369700147
J	Matsunami, M; Igawa, T; Michimae, H; Miura, T; Nishimura, K				Matsunami, Masatoshi; Igawa, Takeshi; Michimae, Hirofumi; Miura, Toru; Nishimura, Kinya			Population Structure and Evolution after Speciation of the Hokkaido Salamander (Hynobius retardatus)	PLOS ONE			English	Article							DNA CONTROL REGION; BEAR URSUS-ARCTOS; MITOCHONDRIAL-DNA; TOKYOENSIS AMPHIBIA; LANDSCAPE GENETICS; CAUDATA; JAPAN; SOFTWARE; DIFFERENTIATION; PHYLOGEOGRAPHY	The Hokkaido salamander (Hynobius retardatus) is endemic to Hokkaido Island, Japan, and shows intriguing flexible phenotypic plasticity and regional morphological diversity. However, to date, allozymes and partial mitochondria DNA sequences have provided only an outline of its demographic histories and the pattern of its genetic diversification. To understand the finer details of the population structure of this species and its evolution since speciation, we genotyped five regional populations by using 12 recently developed microsatellite polymorphic markers. We found a clear population structure with low gene flow among the five populations, but a close genetic relationship between the Teshio and Kitami populations. Our demographic analysis suggested that Teshio and Erimo had the largest effective population sizes among the five populations. These findings regarding the population structure and demography of H. retardatus improve our understanding of the faunal phylogeography on Hokkaido Island and also provide fundamental genetic information that will be useful for future studies.	[Matsunami, Masatoshi; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan; [Igawa, Takeshi] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan; [Michimae, Hirofumi] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo 1088641, Japan; [Nishimura, Kinya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Hokkaido University; Hiroshima University; Kitasato University; Hokkaido University	Matsunami, M (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan.	mmatsunami@ees.hokudai.ac.jp	Igawa, Takeshi/E-2881-2014; Miura, Toru/P-2456-2019; Matsunami, Masatoshi/AAB-3878-2021	Igawa, Takeshi/0000-0001-6880-6180; Miura, Toru/0000-0002-7456-4402; Matsunami, Masatoshi/0000-0003-4109-2493	KAKENHI [23247004, 16K18613]; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [16K18613] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI Grant-in-Aid for Scientific Research (A) (23247004) to K.N. and a KAKENHI Grand-in-Aid for Young Scientists (B) (16K18613) to M.M. from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 2013, ZOOL SCI, V30, P7, DOI 10.2108/zsj.30.7; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen MY, 2015, MOL PHYLOGENET EVOL, V83, P1, DOI 10.1016/j.ympev.2014.10.010; Donovan MF, 2000, EVOLUTION, V54, P1449, DOI 10.1554/0014-3820(2000)054[1449:BOTSUS]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Iwami T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001084; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Japan Association for Quaternary Research, 1987, QUAT MAPS JAP PLUS E; Kawai K, 2013, ZOOL SCI, V30, P642, DOI 10.2108/zsj.30.642; Kono H, 1933, KONCHU, V7, P86; Matsuhashi T, 1999, MOL BIOL EVOL, V16, P676, DOI 10.1093/oxfordjournals.molbev.a026150; Matsui M, 2000, COMP BIOCHEM PHYS B, V125, P115, DOI 10.1016/S0305-0491(99)00154-6; MATSUI M, 1992, ZOOL SCI, V9, P193; Matsui M, 2001, COMP BIOCHEM PHYS B, V130, P181, DOI 10.1016/S1096-4959(01)00424-9; Matsui M., 1996, NATURAL HIST AMPHIBI; Matsui M, 2007, MOL PHYLOGENET EVOL, V44, P204, DOI 10.1016/j.ympev.2006.11.031; Matsunami M, 2015, CURR HERPETOL, V34, P177, DOI 10.5358/hsj.34.177; Matsunami M, 2015, MOL ECOL, V24, P3064, DOI 10.1111/mec.13228; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2009, OECOLOGIA, V160, P601, DOI 10.1007/s00442-009-1319-8; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nishikawa K, 2001, HERPETOLOGICA, V57, P281; Ohshima K, 1990, QUATERNARY RES, V29, P193, DOI DOI 10.4116/JAQUA.29.193; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakamoto M, 2009, ZOOL SCI, V26, P35, DOI 10.2108/zsj.26.35; Sakata N, 2005, INT J DEV BIOL, V49, P417, DOI 10.1387/ijdb.041916ns; Sasaki M., 1924, J COLL AGR HOKKAIDO, V15, P1; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Sugawara H, 2015, CURR HERPETOL, V34, P1, DOI 10.5358/hsj.34.1; Suzuki H, 2004, GENES GENET SYST, V79, P165, DOI 10.1266/ggs.79.165; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tominaga A, 2003, ZOOL SCI, V20, P1467, DOI 10.2108/zsj.20.1467; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WAKAHARA M, 1995, ZOOL SCI, V12, P467, DOI 10.2108/zsj.12.467; Wakahara M, 1997, ZOOL SCI, V14, P893, DOI 10.2108/zsj.14.893; Weisrock DW, 2013, ZOOTAXA, V3626, P77, DOI 10.11646/zootaxa.3626.1.3; Wilson GA, 2003, GENETICS, V163, P1177; Yamane Akihiro, 2010, Current Herpetology, V29, P79, DOI 10.3105/018.029.0203; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072	53	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156815	10.1371/journal.pone.0156815	http://dx.doi.org/10.1371/journal.pone.0156815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257807	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700136
J	Qian, HS; Weldon, SM; Matera, D; Lee, C; Yang, H; Fryer, RM; Fogo, AB; Reinhart, GA				Qian, Hu Sheng; Weldon, Steve M.; Matera, Damian; Lee, ChungWein; Yang, Haichun; Fryer, Ryan M.; Fogo, Agnes B.; Reinhart, Glenn A.			Quantification and Comparison of Anti-Fibrotic Therapies by Polarized SRM and SHG-Based Morphometry in Rat UUO Model	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; RENAL INTERSTITIAL FIBROSIS; 2ND-HARMONIC IMAGING MICROSCOPY; 2-PHOTON-EXCITED FLUORESCENCE; CONNECTIVE-TISSUE; IN-VIVO; GENERATION; COLLAGEN; INSIGHTS; NEPHROPATHY	Renal interstitial fibrosis (IF) is an important pathologic manifestation of disease progression in a variety of chronic kidney diseases (CKD). However, the quantitative and reproducible analysis of IF remains a challenge, especially in experimental animal models of progressive IF. In this study, we compare traditional polarized Sirius Red morphometry (SRM) to novel Second Harmonic Generation (SHG)-based morphometry of unstained tissues for quantitative analysis of IF in the rat 5 day unilateral ureteral obstruction (UUO) model. To validate the specificity of SHG for detecting fibrillar collagen components in IF, co-localization studies for collagens type I, III, and IV were performed using IHC. In addition, we examined the correlation, dynamic range, sensitivity, and ability of polarized SRM and SHG-based morphometry to detect an anti-fibrotic effect of three different treatment regimens. Comparisons were made across three separate studies in which animals were treated with three mechanistically distinct pharmacologic agents: enalapril (ENA, 15, 30, 60 mg/kg), mycophenolate mofetil (MMF, 2, 20 mg/kg) or the connective tissue growth factor (CTGF) neutralizing antibody, EX75606 (1, 3, 10 mg/kg). Our results demonstrate a strong co-localization of the SHG signal with fibrillar collagens I and III but not non-fibrillar collagen IV. Quantitative IF, calculated as percent cortical area of fibrosis, demonstrated similar response profile for both polarized SRM and SHG-based morphometry. The two methodologies exhibited a strong correlation across all three pharmacology studies (r(2) = 0.89-0.96). However, compared with polarized SRM, SHG-based morphometry delivered a greater dynamic range and absolute magnitude of reduction of IF after treatment. In summary, we demonstrate that SHG-based morphometry in unstained kidney tissues is comparable to polarized SRM for quantitation of fibrillar collagens, but with an enhanced sensitivity to detect treatment-induced reductions in IF. Thus, performing SHG-based morphometry on unstained kidney tissue is a reliable alternative to traditional polarized SRM for quantitative analysis of IF.	[Qian, Hu Sheng; Weldon, Steve M.; Matera, Damian; Lee, ChungWein; Fryer, Ryan M.; Reinhart, Glenn A.] Boehringer Ingelheim Pharmaceut Inc, CardioMetab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [Yang, Haichun; Fogo, Agnes B.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA	Boehringer Ingelheim; Vanderbilt University	Qian, HS (corresponding author), Boehringer Ingelheim Pharmaceut Inc, CardioMetab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA.	husheng.qian@boehringer-ingelheim.com	Yang, Haichun/D-6965-2014		Boehringer Ingelheim Pharmaceutics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056942] Funding Source: NIH RePORTER	Boehringer Ingelheim Pharmaceutics, Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Boehringer Ingelheim Pharmaceutics, Inc. The funder provided support in the form of salaries for authors HSQ, SMW, DM, CWL, RMF, and GAR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2001, J BIOMED OPT, V6, P277, DOI 10.1117/1.1383294; Chen CO, 2007, AM J PHYSIOL-RENAL, V292, pF946, DOI 10.1152/ajprenal.00287.2006; Chen G, 2009, BRIT J DERMATOL, V161, P48, DOI 10.1111/j.1365-2133.2009.09094.x; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cox G, 2003, J STRUCT BIOL, V141, P53, DOI 10.1016/S1047-8477(02)00576-2; Deka G, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061222; Farris AB, 2014, AM J TRANSPLANT, V14, P897, DOI 10.1111/ajt.12641; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Feldman DL, 2000, J CARDIOVASC PHARM, V36, pS255, DOI 10.1097/00005344-200036051-00075; Fogo AB, 2011, J AM SOC NEPHROL, V22, P11, DOI 10.1681/ASN.2010111132; Forbes MS, 2011, AM J PHYSIOL-RENAL, V301, pF110, DOI 10.1152/ajprenal.00022.2011; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; Gailhouste L, 2010, J HEPATOL, V52, P398, DOI 10.1016/j.jhep.2009.12.009; Grimm PC, 2003, J AM SOC NEPHROL, V14, P1662, DOI 10.1097/01.ASN.0000066143.02832.5E; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Martin TP, 2013, INT J CARDIOVAS IMAG, V29, P1733, DOI 10.1007/s10554-013-0270-2; Nast CC, 2015, SEMIN NEPHROL, V35, P266, DOI 10.1016/j.semnephrol.2015.04.006; Pena AM, 2007, MICROSC RES TECHNIQ, V70, P162, DOI 10.1002/jemt.20400; Pierre Bedossa, 2010, J HEPATOL, V52, P313, DOI [10.1016/j.jhep.2009.11.020, DOI 10.1016/J.JHEP.2009.11.020]; Pirhonen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147804; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004; Schenke-Layland K, 2008, J BIOPHOTONICS, V1, P451, DOI 10.1002/jbio.200810045; Strachan CJ, 2011, INT J PHARMACEUT, V417, P163, DOI 10.1016/j.ijpharm.2010.12.017; Street JM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12088; Strupler M, 2007, OPT EXPRESS, V15, P4054, DOI 10.1364/OE.15.004054; Strupler M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981830; Sun WX, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041159; Sund S, 2004, NEPHROL DIAL TRANSPL, V19, P2838, DOI 10.1093/ndt/gfh490; SWEAT F, 1964, ARCH PATHOL, V78, P69; Torres R, 2015, J AM SOC NEPHROL, P27; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Yuan XP, 2011, NEPHROLOGY, V16, P200, DOI 10.1111/j.1440-1797.2010.01359.x; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100; Zoumi A, 2002, P NATL ACAD SCI USA, V99, P11014, DOI 10.1073/pnas.172368799	41	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156734	10.1371/journal.pone.0156734	http://dx.doi.org/10.1371/journal.pone.0156734			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257917	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700117
J	Wei, JZ; Liang, GM; Wang, BJ; Zhong, F; Chen, L; Khaing, MM; Zhang, J; Guo, YY; Wu, KM; Tabashnik, BE				Wei, Jizhen; Liang, Gemei; Wang, Bingjie; Zhong, Feng; Chen, Lin; Khaing, Myint Myint; Zhang, Jie; Guo, Yuyuan; Wu, Kongming; Tabashnik, Bruce E.			Activation of Bt Protoxin Cry1Ac in Resistant and Susceptible Cotton Bollworm	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; LEPIDOPTERA-NOCTUIDAE; HELICOVERPA-ARMIGERA; QUANTITATIVE-ANALYSIS; CROSS-RESISTANCE; PEST RESISTANCE; MAIZE; CROPS	Crystalline (Cry) proteins from Bacillus thuringiensis (Bt) are used extensively for insect control in sprays and transgenic plants, but their efficacy is reduced by evolution of resistance in pests. Here we evaluated reduced activation of Cry1Ac protoxin as a potential mechanism of resistance in the invasive pest Helicoverpa armigera. Based on the concentration killing 50% of larvae (LC50) for a laboratory-selected resistant strain (LF120) divided by the LC50 for its susceptible parent strain (LF), the resistance ratio was 1600 for Cry1Ac protoxin and 1200 for trypsin-activated Cry1Ac toxin. The high level of resistance to activated toxin as well as to protoxin indicates reduced activation of protoxin is not a major mechanism of resistance to Cry1Ac in LF120. For both insect strains, treatment with either the trypsin inhibitor N-a-tosyl-L-lysine chloromethyl ketone (TLCK) or the chymotrypsin inhibitor N-a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) did not significantly affect the LC50 of Cry1Ac protoxin. Enzyme activity was higher for LF than LF120 for trypsin-like proteases, but did not differ between strains for chymotrypsin-like proteases. The results here are consistent with previous reports indicating that reduced activation of protoxin is generally not a major mechanism of resistance to Bt proteins.	[Wei, Jizhen; Liang, Gemei; Wang, Bingjie; Zhong, Feng; Chen, Lin; Khaing, Myint Myint; Zhang, Jie; Guo, Yuyuan; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Tabashnik, Bruce E.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona; University of Arizona	Liang, GM; Guo, YY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	gmliang@ippcaas.cn; yyguo@ippcaas.cn			Key Project for Breeding Genetically Modified Organisms [2016ZX08011-002]; National Natural Science Foundation of China [31321004]	Key Project for Breeding Genetically Modified Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Project for Breeding Genetically Modified Organisms (2016ZX08011-002) and the National Natural Science Foundation of China (No. 31321004).	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; An JJ, 2015, PEST MANAG SCI, V71, P377, DOI 10.1002/ps.3807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budatha M, 2008, BIOTECHNOL LETT, V30, P305, DOI 10.1007/s10529-007-9539-7; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Cao GC, 2013, J ECON ENTOMOL, V106, P2514, DOI 10.1603/EC13301; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Downes SJ, 2015, HELICOVERPA RESISTAN; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; GASSMANN AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI DOI 10.1073/pnas.1317179111; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gonzalez-Cabrera J, 2013, INSECT BIOCHEM MOLEC, V43, P635, DOI 10.1016/j.ibmb.2013.04.001; Herrero S, 2001, APPL ENVIRON MICROB, V67, P1085, DOI 10.1128/AEM.67.3.1085-1089.2001; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LeOra Software, 2003, POLOPLUS US GUID PRO; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07219; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Rasband WS., 1997, IMAGEJ VERSION 1 46, P1997, DOI U. S. National Institutes of Health; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sayyed AH, 2001, APPL ENVIRON MICROB, V67, P4372, DOI 10.1128/AEM.67.9.4372-4373.2001; SPSS Inc. Released, 2009, PASW STAT WIND VERS; Swiatkiewicz S, 2014, ANIM FEED SCI TECH, V198, P1, DOI 10.1016/j.anifeedsci.2014.09.009; Tabashnik BE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15107; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Wang CZ., 1986, ACTA LOGICA SINICA, V1, P7; Wang GJ, 2006, APPL MICROBIOL BIOT, V72, P924, DOI 10.1007/s00253-006-0390-x; Welch KL, 2015, J INVERTEBR PATHOL, V132, P149, DOI 10.1016/j.jip.2015.10.003; Wu KM, 2005, PEST MANAG SCI, V61, P491, DOI 10.1002/ps.999; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	53	18	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156560	10.1371/journal.pone.0156560	http://dx.doi.org/10.1371/journal.pone.0156560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257885	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700077
J	Uzan, VRM; Lengert, AV; Boldrini, E; Penna, V; Scapulatempo-Neto, C; Scrideli, CA; Filho, APD; Cavalcante, CEB; de Oliveira, CZ; Lopes, LF; Vidal, DO				Maciel Uzan, Vanessa Regina; Lengert, Andre van Helvoort; Boldrini, Erica; Penna, Valter; Scapulatempo-Neto, Cristovam; Scrideli, Carlos Alberto; de Moraes Filho, Alberto Paiva; Bezerra Cavalcante, Carlos Eduardo; de Oliveira, Cleyton Zanardo; Lopes, Luiz Fernando; Vidal, Daniel Onofre			High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients	PLOS ONE			English	Article							LONG NONCODING RNA; HIGH-GRADE OSTEOSARCOMA; CELL-PROLIFERATION; CANCER; EXTREMITIES; METASTASIS; GENE; CHEMOTHERAPY; APOPTOSIS	Osteosarcoma (OS) is the most common primary bone cancer in childhood. OS is an aggressive disease, and metastatic patients evolve with very poor clinical outcomes. Genetically, OSs are extremely complex tumors, and the related metastatic process is not well understood in terms of the biology of the disease. In this context, long non-coding RNAs (lncRNAs) have emerged as an important class of gene expression regulators that play key roles in the invasion and metastasis of several human tumors. Here, we evaluated the expression of HULC, which is an lncRNA that is associated with the tumor metastatic process, and assessed its potential role as a prognostic marker in OS. HULC expression was evaluated in primary OS samples using real-time RT-PCR. HULC expression status was determined by receiver operating characteristic (ROC) analysis, and its association with survival was assessed using the Kaplan-Meier method. The HULC expression level was not significantly associated with the clinicopathological characteristics of the OS patients. However, our data demonstrated that higher levels of expression of HULC were associated with lower survival rates in OS patients, both in terms of overall and event-free survival. Elevated HULC expression was associated with poor clinical outcomes among the OS patients, which suggests that HULC could be a potential prognostic biomarker in OS.	[Maciel Uzan, Vanessa Regina; Lengert, Andre van Helvoort; Scapulatempo-Neto, Cristovam; Vidal, Daniel Onofre] Barretos Canc Hosp, Mol Oncol Res Ctr, Pediat Oncol Lab, Barretos, SP, Brazil; [Boldrini, Erica; Lopes, Luiz Fernando] Barretos Childrens Canc Hosp, Barretos, SP, Brazil; [Penna, Valter] Barretos Canc Hosp, Dept Orthoped Surg, Barretos, SP, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil; [Scrideli, Carlos Alberto] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pediat, BR-14049 Ribeirao Preto, SP, Brazil; [de Moraes Filho, Alberto Paiva; de Oliveira, Cleyton Zanardo] Barretos Canc Hosp, Dept Radiol, Barretos, SP, Brazil; [Bezerra Cavalcante, Carlos Eduardo] Barretos Childrens Canc Hosp, Dept Radiol, Barretos, SP, Brazil; [de Oliveira, Cleyton Zanardo] Barretos Canc Hosp, Ctr Res Support NAP, Barretos, SP, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos	Vidal, DO (corresponding author), Barretos Canc Hosp, Mol Oncol Res Ctr, Pediat Oncol Lab, Barretos, SP, Brazil.; Lopes, LF (corresponding author), Barretos Childrens Canc Hosp, Barretos, SP, Brazil.	lf.lopes@yahoo.com; daniel.vidal@hcancerbarretos.com.br	van Helvoort Lengert, André/AAU-1140-2021; Scrideli, Carlos/D-7618-2012; Lopes, Luiz Fernando/L-5513-2016; Vidal, Daniel/C-7203-2012	van Helvoort Lengert, André/0000-0002-3632-343X; Scrideli, Carlos/0000-0001-6618-789X; Lopes, Luiz Fernando/0000-0001-9737-9245; Vidal, Daniel/0000-0003-2117-3640; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579	Barretos Cancer Hospital	Barretos Cancer Hospital	The author(s) received an internal research funding (PAIP) from Barretos Cancer Hospital for this work.	Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Bacci G, 2008, J SURG ONCOL, V98, P415, DOI 10.1002/jso.21140; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Chen LL, 2010, WIRES RNA, V1, P2, DOI 10.1002/wrna.5; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Harting Matthew T, 2006, Semin Pediatr Surg, V15, P25, DOI 10.1053/j.sempedsurg.2005.11.005; Iacoangeli A, 2004, CARCINOGENESIS, V25, P2125, DOI 10.1093/carcin/bgh228; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Peng W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0346-4; Petrilli AS, 2006, J CLIN ONCOL, V24, P1161, DOI 10.1200/JCO.2005.03.5352; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sun XH, 2015, INT J CLIN EXP PATHO, V8, P2994; Tesser-Gamba F, 2012, HUM PATHOL, V43, P994, DOI 10.1016/j.humpath.2011.08.003; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xie H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/136106; Zhang Q, 2013, ASIAN PAC J CANCER P, V14, P2311, DOI 10.7314/APJCP.2013.14.4.2311; Zhao Y, 2014, ONCOL REP, V31, P358, DOI 10.3892/or.2013.2850	29	53	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156774	10.1371/journal.pone.0156774	http://dx.doi.org/10.1371/journal.pone.0156774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253450	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700058
J	Voisin, S; Guilherme, JPFL; Yan, X; Pushkarev, VP; Cieszczyk, P; Massidda, M; Calo, CM; Dyatlov, DA; Kolupaev, VA; Pushkareva, YE; Maciejewska, A; Sawczuk, M; Lancha, AH; Artioli, GG; Eynon, N				Voisin, Sarah; Guilherme, Joao Paulo F. L.; Yan, Xu; Pushkarev, Vladimir P.; Cieszczyk, Pawel; Massidda, Myosotis; Calo, Carla M.; Dyatlov, Dmitry A.; Kolupaev, Vitaliy A.; Pushkareva, Yuliya E.; Maciejewska, Agnieszka; Sawczuk, Marek; Lancha, Antonio H., Jr.; Artioli, Guilherme G.; Eynon, Nir			ACVR1B rs2854464 Is Associated with Sprint/Power Athletic Status in a Large Cohort of Europeans but Not Brazilians	PLOS ONE			English	Article							MYOSTATIN PATHWAY GENES; GROWTH-FACTOR-BETA; SKELETAL-MUSCLE; PERFORMANCE; STRENGTH; SPORTS; VARIANTS; ANCESTRY; LINKAGE; POWER	Skeletal muscle strength and mass, major contributors to sprint/power athletic performance, are influenced by genetics. However, to date, only a handful of genetic variants have been associated with sprint/power performance. The ACVR1B A allele (rs rs2854464) has previously been associated with increased muscle-strength in non-athletic cohort. However, no follow-up and/or replications studies have since been conducted. Therefore, the aim of the present study was to compare the genotype distribution of ACVR1B rs2854464 between endurance athletes (E), sprint/power (S/P) athletes, mixed athletes (M), and non-athletic control participants in 1672 athletes (endurance athletes, n = 482; sprint/power athletes, n = 578; mixed athletes, n = 498) and 1089 controls (C) of both European Caucasians (Italian, Polish and Russians) and Brazilians. We have also compared the genotype distribution according to the athlete's level of competition (elite vs. sub-elite). DNA extraction and genotyping were performed using various methods. Fisher's exact test (adjusted for multiple comparisons) was used to test whether the genotype distribution of rs2854464 (AA, AG and GG) differs between groups. The A allele was overrepresented in S/P athletes compared with C in the Caucasian sample (adjusted p = 0.048), whereas there were no differences in genotype distribution between E athletes and C, in neither the Brazilian nor the Caucasian samples (adjusted p > 0.05). When comparing all Caucasian athletes regardless of their sporting discipline to C, we found that the A allele was overrepresented in athletes compared to C (adjusted p = 0.024). This association was even more pronounced when only elite-level athletes were considered (adjusted p = 0.00017). In conclusion, in a relatively large cohort of athletes from Europe and South America we have shown that the ACVR1B rs2854464 A allele is associated with sprint/power performance in Caucasians but not in Brazilian athletes. This reinforces the notion that phenotype-genotype associations may be ethnicity-dependent.	[Voisin, Sarah] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France; [Voisin, Sarah; Yan, Xu; Eynon, Nir] Victoria Univ, ISEAL, Melbourne, Vic, Australia; [Guilherme, Joao Paulo F. L.; Lancha, Antonio H., Jr.; Artioli, Guilherme G.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Pushkarev, Vladimir P.] Fed Med Biol Agcy Russia, Lab Radiat Genet, Urals Res Ctr Radiat Med, Chelyabinsk, Russia; [Cieszczyk, Pawel] Acad Phys Educ & Sport, Dept Tourism & Recreat, Gdansk, Poland; [Massidda, Myosotis; Calo, Carla M.] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Dyatlov, Dmitry A.; Kolupaev, Vitaliy A.] Ural State Univ Phys Culture, Chelyabinsk, Russia; [Pushkareva, Yuliya E.] South Ural State Med Univ, Chelyabinsk, Russia; [Cieszczyk, Pawel; Maciejewska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Phys Culture & Hlth Promot, PL-70453 Szczecin, Poland; [Pushkarev, Vladimir P.] Chelyabinsk State Univ, Dept Radiat Biol, Chelyabinsk, Russia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Victoria University; Universidade de Sao Paulo; Gdansk University of Physical Education & Sport; University of Cagliari; South Ural State Medical University; University of Szczecin; Chelyabinsk State University	Eynon, N (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic, Australia.	Nir.Eynon@vu.edu.au	Guilherme, João Paulo L. F./C-3490-2017; Artioli, Guilherme Giannini/K-5925-2013; Cieszczyk, Pawel/AFK-4645-2022; Massidda, Myosotis/AAD-7934-2021; Cieszczyk, Pawel/AAG-3328-2022; Lancha, Antonio Herbert/C-9130-2012; Sawczuk, Marek/S-3609-2017; Yan, Xu/T-1427-2019	Guilherme, João Paulo L. F./0000-0001-9165-973X; Artioli, Guilherme Giannini/0000-0001-8463-2213; Cieszczyk, Pawel/0000-0002-7735-7580; Massidda, Myosotis/0000-0001-5726-4435; Cieszczyk, Pawel/0000-0002-7735-7580; Lancha, Antonio Herbert/0000-0003-2128-1182; Yan, Xu/0000-0001-8547-4210; Eynon, Nir/0000-0003-4046-8276; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Sawczuk, Marek/0000-0002-5730-5249; Voisin, Sarah/0000-0002-4074-7083	FAPESP [12/22516-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was partly funded by FAPESP (grant #12/22516-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly funded by FAPESP (grant #12/22516-6).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Chen JL, 2015, MOL THER, V23, P434, DOI 10.1038/mt.2014.221; Costa AM, 2012, SPORTS MED, V42, P449, DOI 10.2165/11650560-000000000-00000; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Eynon N, 2009, INT J SPORTS MED, V30, P888, DOI 10.1055/s-0029-1238291; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Eynon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043132; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; He ZH, 2015, SCAND J MED SCI SPOR, V25, P184, DOI 10.1111/sms.12188; Huygens W, 2005, PHYSIOL GENOMICS, V22, P390, DOI 10.1152/physiolgenomics.00010.2005; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lins TC, 2011, J EPIDEMIOL, V21, P240, DOI 10.2188/jea.JE20100164; Massidda M, 2016, J STRENGTH COND RES, V30, P1171, DOI 10.1519/JSC.0000000000001176; Papadimitriou ID, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2462-3; Peeters MW, 2009, MED SPORT SCI, V54, P28, DOI 10.1159/000235695; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; Pitsiladis YP, 2016, PHYSIOL GENOMICS, V48, P183, DOI 10.1152/physiolgenomics.00105.2015; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Ratzliff ADH, 2001, NEUROSCIENCE, V103, P337, DOI 10.1016/S0306-4522(01)00013-6; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Sawczuk M, 2015, J SCI MED SPORT, V18, P114, DOI 10.1016/j.jsams.2013.12.008; Slater G, 2011, J SPORT SCI, V29, pS67, DOI 10.1080/02640414.2011.574722; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Voisin S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-382; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Webborn N, 2015, BRIT J SPORT MED, V49, P1486, DOI 10.1136/bjsports-2015-095343; Windelinckx A, 2011, EUR J HUM GENET, V19, P208, DOI 10.1038/ejhg.2010.173; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	33	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156316	10.1371/journal.pone.0156316	http://dx.doi.org/10.1371/journal.pone.0156316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253421	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000377218700020
J	Wang, HQ; Xu, CX; Wang, XZ; Zhang, YB; Peng, B				Wang, Haoqian; Xu, Chenxue; Wang, Xingzheng; Zhang, Yongbing; Peng, Bo			Light Field Imaging Based Accurate Image Specular Highlight Removal	PLOS ONE			English	Article							REFLECTION COMPONENTS; COLOR; SEPARATION; SELECTION; DEPTH; MODEL	Specular reflection removal is indispensable to many computer vision tasks. However, most existing methods fail or degrade in complex real scenarios for their individual drawbacks. Benefiting from the light field imaging technology, this paper proposes a novel and accurate approach to remove specularity and improve image quality. We first capture images with specularity by the light field camera (Lytro ILLUM). After accurately estimating the image depth, a simple and concise threshold strategy is adopted to cluster the specular pixels into "unsaturated" and "saturated" category. Finally, a color variance analysis of multiple views and a local color refinement are individually conducted on the two categories to recover diffuse color information. Experimental evaluation by comparison with existed methods based on our light field dataset together with Stanford light field archive verifies the effectiveness of our proposed algorithm.	[Wang, Haoqian; Xu, Chenxue; Wang, Xingzheng; Zhang, Yongbing] Tsinghua Univ, Shenzhen Key Lab Broadband Network & Multimedia, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China; [Peng, Bo] Southwest Jiaotong Univ, Dept Software Engn, Chengdu, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Southwest Jiaotong University	Wang, XZ (corresponding author), Tsinghua Univ, Shenzhen Key Lab Broadband Network & Multimedia, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China.	xingzheng.wang@sz.tsinghua.edu.cn			NSFC fund [61471213]; Shenzhen Fundamental Research fund [JCYJ20140509172959961]; Natural Science Foundation of Guangdong Province [2015A030310173]; National High-tech R&D Program of China (863 Program) [2015AA015901]; Science and Technology Planning Project of Sichuan Province [2014SZ0207]	NSFC fund(National Natural Science Foundation of China (NSFC)); Shenzhen Fundamental Research fund; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); Science and Technology Planning Project of Sichuan Province	This work is partially supported by the NSFC fund (61471213), Shenzhen Fundamental Research fund (JCYJ20140509172959961), Natural Science Foundation of Guangdong Province (2015A030310173), National High-tech R&D Program of China (863 Program, 2015AA015901) and the Science and Technology Planning Project of Sichuan Province under grant 2014SZ0207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partially supported by the NSFC fund (61471213), Shenzhen Fundamental Research fund (JCYJ20140509172959961), Natural Science Foundation of Guangdong Province (2015A030310173), National High-tech R&D Program of China (863 Program, 2015AA015901) and the Science and Technology Planning Project of Sichuan Province under Grant 2014SZ0207.	Adams A, 2008, NEW STANFORD LIGHT F; [Anonymous], P IEEE C COMP VIS PA; Artusi A, 2011, COMPUT GRAPH FORUM, V30, P2208, DOI 10.1111/j.1467-8659.2011.01971.x; Bajcsy R, 1996, INT J COMPUT VISION, V17, P241, DOI 10.1007/BF00128233; Bishop T.E., 2009, 2009 IEEE INT C COMP, P1, DOI DOI 10.1109/ICCPHOT.2009.5559010; Chen T, 2006, IEEE T PATTERN ANAL, V28, P1519, DOI 10.1109/TPAMI.2006.195; Cho D, 2014, LECT NOTES COMPUT SC, V8692, P90, DOI 10.1007/978-3-319-10593-2_7; Criminisi A, 2005, COMPUT VIS IMAGE UND, V97, P51, DOI 10.1016/j.cviu.2004.06.001; Gortler S. J., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P43, DOI 10.1145/237170.237200; Heo YS, 2011, IEEE T PATTERN ANAL, V33, P807, DOI 10.1109/TPAMI.2010.136; Jian MW, 2015, IEEE T CYBERNETICS, V45, P1575, DOI 10.1109/TCYB.2014.2356200; KLINKER GJ, 1988, INT J COMPUT VISION, V2, P7, DOI 10.1007/BF00836279; Kong H, 2016, NEUROCOMPUTING, V177, P198, DOI 10.1016/j.neucom.2015.11.033; Lai ZH, 2016, IEEE T NEUR NET LEAR, V27, P723, DOI 10.1109/TNNLS.2015.2422994; Lai ZH, 2014, IEEE T NEUR NET LEAR, V25, P1942, DOI 10.1109/TNNLS.2013.2297381; Lai ZH, 2014, IEEE T NEUR NET LEAR, V25, P1779, DOI 10.1109/TNNLS.2013.2295717; Lam CP, 2013, P IEEE INT C COMP VI; LEE SW, 1992, IMAGE VISION COMPUT, V10, P643, DOI 10.1016/0262-8856(92)90009-R; Levoy M., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P31, DOI 10.1145/237170.237199; Li JF, 2013, IEEE ICC; Li K, 2015, IEEE T CYBERNETICS, V45, P1401, DOI 10.1109/TCYB.2014.2351831; Li N., 2014, P IEEE C COMP VIS PA; Lin S, 2002, LECT NOTES COMPUT SC, V2352, P210; Lin S, 2001, P IEEE C COMP VIS PA; Liu F, 2015, NEUROCOMPUTING, V168, P599, DOI 10.1016/j.neucom.2015.05.065; Nayar SK, 2006, ACM T GRAPHIC, V25, P935, DOI 10.1145/1141911.1141977; Nayar SK, 1997, INT J COMPUT VISION, V21, P163, DOI 10.1023/A:1007937815113; Ng R., 2005, COMPUTER SCI TECHNIC; Nguyen T, 2014, P IEEE C IM PROC IEE; Raskar Ramesh, 2009, COMPUTATIONAL PHOTOG; SATO Y, 1994, J OPT SOC AM A, V11, P2990, DOI 10.1364/JOSAA.11.002990; SHAFER SA, 1985, COLOR RES APPL, V10, P210, DOI 10.1002/col.5080100409; Shen HL, 2008, PATTERN RECOGN, V41, P2461, DOI 10.1016/j.patcog.2008.01.026; Shen HL, 2009, APPL OPTICS, V48, P2711, DOI 10.1364/AO.48.002711; Shen LL, 2011, INT J PATTERN RECOGN, V25, P273, DOI 10.1142/S0218001411008555; Tan P, 2003, P IEEE INT C COMP VI; Tan RT, 2005, IEEE T PATTERN ANAL, V27, P178, DOI 10.1109/TPAMI.2005.36; Tao MW, 2015, LECT NOTES COMPUT SC, V8926, P533, DOI 10.1007/978-3-319-16181-5_41; Watanabe M, 1998, INT J COMPUT VISION, V27, P203, DOI 10.1023/A:1007905828438; Wong WK, 2015, IEEE T CYBERNETICS, V45, P2425, DOI 10.1109/TCYB.2014.2374452; Yang QX, 2015, IEEE T PATTERN ANAL, V37, P1304, DOI 10.1109/TPAMI.2014.2360402; Yang Y, 2015, INFORM SCIENCES, V320, P306, DOI 10.1016/j.ins.2014.11.014; Yang Y, 2014, INFORM SCIENCES, V281, P601, DOI 10.1016/j.ins.2014.03.016; Zhang J, 2006, P IEEE C COMP VIS PA; Zhu YM, 2014, SIGNAL PROCESS-IMAGE, V29, P875, DOI 10.1016/j.image.2014.06.005; Zhu ZX, 2015, INFORM SCIENCES, V298, P274, DOI 10.1016/j.ins.2014.11.045; Zhu ZX, 2010, IEEE COMPUT INTELL M, V5, P41, DOI 10.1109/MCI.2010.936311	47	7	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156173	10.1371/journal.pone.0156173	http://dx.doi.org/10.1371/journal.pone.0156173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253083	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700015
J	Wang, JW; Zhang, YQ; Zhang, XH; Wang, YP; Li, JP; Li, YJ				Wang, Jia-Wei; Zhang, Yu-Qing; Zhang, Xiao-Hua; Wang, Yun-Peng; Li, Ji-Ping; Li, Yong-Jie			Cognitive and Psychiatric Effects of STN versus GPi Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							SUBTHALAMIC NUCLEUS; GLOBUS-PALLIDUS; MEDICAL THERAPY; DEMENTIA; OUTCOMES; NEUROSTIMULATION; MULTICENTER; DEPRESSION; SURGERY; MOOD	Background Deep brain stimulation (DBS) of either the subthalamic nucleus (STN) or the globus pallidus interna (GPi) can reduce motor symptoms in patients with Parkinson's disease (PD) and improve their quality of life. However, the effects of STN DBS and GPi DBS on cognitive functions and their psychiatric effects remain controversial. The present meta-analysis was therefore performed to clarify these issues. Methods We searched the PUBMED, EMBASE, and the Cochrane Central Register of Controlled Trials databases. Other sources, including internet-based clinical trial registries and grey literature sources, were also searched. After searching the literature, two investigators independently performed literature screens to assess the quality of the included trials and to extract the data. The outcomes included the effects of STN DBS and GPi DBS on multiple cognitive domains, depression, anxiety, and quality of life. Results Seven articles related to four randomized controlled trials that included 521 participants were incorporated into the present meta-analysis. Compared with GPi DBS, STN DBS was associated with declines in selected cognitive domains after surgery, including attention, working memory and processing speed, phonemic fluency, learning and memory, and global cognition. However, there were no significant differences in terms of quality of life or psychiatric effects, such as depression and anxiety, between the two groups. Conclusions A selective decline in frontal-subcortical cognitive functions is observed after STN DBS in comparison with GPi DBS, which should not be ignored in the target selection for DBS treatment in PD patients. In addition, compared to GPi DBS, STN DBS does not affect depression, anxiety, and quality of life.	[Wang, Jia-Wei; Zhang, Yu-Qing; Zhang, Xiao-Hua; Wang, Yun-Peng; Li, Ji-Ping; Li, Yong-Jie] Capital Med Univ, Beijing Inst Funct Neurosurg, Dept Funct Neurosurg, Xuanwu Hosp, Beijing, Peoples R China	Capital Medical University	Li, YJ (corresponding author), Capital Med Univ, Beijing Inst Funct Neurosurg, Dept Funct Neurosurg, Xuanwu Hosp, Beijing, Peoples R China.	lyj8828@vip.sina.com	li, yong/HDN-3885-2022	Wang, Jia-Wei/0000-0002-8606-6873	Beijing Natural Science Foundation [7154200]; Medjaden Academy & Research Foundation for Young Scientists [MJR20150035]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Medjaden Academy & Research Foundation for Young Scientists	This work was supported by Beijing Natural Science Foundation (7154200) and Medjaden Academy & Research Foundation for Young Scientists (MJR20150035). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Aybek S, 2007, MOVEMENT DISORD, V22, P974, DOI 10.1002/mds.21478; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Castrioto A, 2014, LANCET NEUROL, V13, P287, DOI 10.1016/S1474-4422(13)70294-1; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Couto MI, 2014, ACTA MEDICA PORT, V27, P372, DOI 10.20344/amp.4928; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dormont D, 2010, AM J NEURORADIOL, V31, P15, DOI 10.3174/ajnr.A1644; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; Giugni JC, 2014, CURR OPIN NEUROL, V27, P450, DOI 10.1097/WCO.0000000000000118; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Jankovic J, 2014, JAMA NEUROL, V71, P1351, DOI 10.1001/jamaneurol.2014.1717; Jankovic J, 2012, CURR OPIN NEUROL, V25, P433, DOI 10.1097/WCO.0b013e3283542fc2; Krack P, 1998, BRAIN, V121, P451, DOI 10.1093/brain/121.3.451; Liu Y, 2014, J NEUROSURG, V121, P709, DOI 10.3171/2014.4.JNS131711; Muslimovic D, 2007, J INT NEUROPSYCH SOC, V13, P920, DOI 10.1017/S1355617707071160; Odekerken VJJ, 2015, NEUROLOGY, V84, P1355, DOI 10.1212/WNL.0000000000001419; Odekerken VJJ, 2013, LANCET NEUROL, V12, P37, DOI 10.1016/S1474-4422(12)70264-8; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Pahwa R, 2014, CURR OPIN NEUROL, V27, P442, DOI 10.1097/WCO.0000000000000113; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Perestelo-Perez L, 2014, J NEUROL, V261, P2051, DOI 10.1007/s00415-014-7254-6; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rothlind JC, 2007, J INT NEUROPSYCH SOC, V13, P68, DOI 10.1017/S1355617707070105; Russell A, 2014, CNS NEUROL DISORD-DR, V13, P1160, DOI 10.2174/1871527313666140917122739; Sako W, 2014, J NEUROL NEUROSUR PS, V85, P982, DOI 10.1136/jnnp-2013-306090; Schuepbach WMM, 2013, NEW ENGL J MED, V368, P610, DOI 10.1056/NEJMoa1205158; Thobois S, 2010, BRAIN, V133, P1111, DOI 10.1093/brain/awq032; Volkmann J, 2004, ANN NEUROL, V55, P871, DOI 10.1002/ana.20091; Volkmann J, 2001, NEUROLOGY, V56, P548, DOI 10.1212/WNL.56.4.548; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Weaver FM, 2012, NEUROLOGY, V79, P55, DOI 10.1212/WNL.0b013e31825dcdc1; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Williams A, 2010, LANCET NEUROL, V9, P581, DOI 10.1016/S1474-4422(10)70093-4; Willis AW, 2012, ARCH NEUROL-CHICAGO, V69, P601, DOI 10.1001/archneurol.2011.2370; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Zahodne LB, 2009, J NEUROL, V256, P1321, DOI 10.1007/s00415-009-5121-7	44	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156721	10.1371/journal.pone.0156721	http://dx.doi.org/10.1371/journal.pone.0156721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248139	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700074
J	Wei, QG; Feng, SW; Lu, ZW				Wei, Qingguo; Feng, Siwei; Lu, Zongwu			Stimulus Specificity of Brain-Computer Interfaces Based on Code Modulation Visual Evoked Potentials	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; FREQUENCY; CORTEX; SIZE; COMMUNICATION	A brain-computer interface (BCI) based on code modulated visual evoked potentials (c-VEP) is among the fastest BCIs that have ever been reported, but it has not yet been given a thorough study. In this study, a pseudorandom binary M sequence and its time lag sequences are utilized for modulation of different stimuli and template matching is adopted as the method for target recognition. Five experiments were devised to investigate the effect of stimulus specificity on target recognition and we made an effort to find the optimal stimulus parameters for size, color and proximity of the stimuli, length of modulation sequence and its lag between two adjacent stimuli. By changing the values of these parameters and measuring classification accuracy of the c-VEP BCI, an optimal value of each parameter can be attained. Experimental results of ten subjects showed that stimulus size of visual angle 3.8 degrees, white, spatial proximity of visual angle 4.8 degrees center to center apart, modulation sequence of length 63 bits and the lag of 4 bits between adjacent stimuli yield individually superior performance. These findings provide a basis for determining stimulus presentation of a high-performance c-VEP based BCI system.	[Wei, Qingguo; Feng, Siwei; Lu, Zongwu] Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang 330029, Peoples R China	Nanchang University	Wei, QG (corresponding author), Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang 330029, Peoples R China.	wqg07@163.com			National Natural Science Foundation of China [61365013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant 61365013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminaka D, 2015, IEEE ENG MED BIO, P1906, DOI 10.1109/EMBC.2015.7318755; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Cao T, 2012, IEEE ENG MED BIO, P1819, DOI 10.1109/EMBC.2012.6346304; Chen XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046008; COPENHAVER RM, 1964, INVEST OPHTH VISUAL, V3, P665; Dawoud NN, 2012, P INT MULT ENG COMP, VI; DOW BM, 1981, EXP BRAIN RES, V44, P213; Duszyk A, 2014, PLOS ONE, V11, P1; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Hubel David H, 1995, EYE BRAIN VISION, P6; Jain AK, 1998, SIGNAL PROCESS, V71, P109, DOI 10.1016/S0165-1684(98)00139-X; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Nakanishi M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500191; Nezamfar H, 2011, INT J IMAG SYST TECH, V21, P139, DOI 10.1002/ima.20288; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; REGAN D, 1966, NATURE, V210, P1056, DOI 10.1038/2101056a0; Regan David, 2000, HUMAN PERCEPTION OBJ; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Spuler M, 2012, ONLINE ADAPTATION C, V7, P1; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Thielen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133797; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Waytowich NR, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036006; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu MP, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026001; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Yuan P, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046006; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	37	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156416	10.1371/journal.pone.0156416	http://dx.doi.org/10.1371/journal.pone.0156416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243454	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100038
J	Li, Q; Meng, J; Wang, YQ				Li, Qian; Meng, Jin; Wang, Yuanqing			New Cricetid Rodents from Strata near the Eocene-Oligocene Boundary in Erden Obo Section (Nei Mongol, China)	PLOS ONE			English	Article							MAMMALIA; YUNNAN	New cricetids (Eucricetodon wangae sp. nov., Eucricetodon sp. and Pappocricetodon sizi-wangqiensis sp. nov.) are reported from the lower and middle parts of the "Upper Red" beds of the Erden Obo section in Nei Mongol, China. Eucricetodon wangae is more primitive than other known species of the genus from lower Oligocene of Asia and Europe in having a single anterocone on M1, a single connection between the protocone and the paracone, the anterior metalophule connection in M1-2 and weaker anteroconid and ectomesolophid in lower molars. Pappocricetodon siziwangqiensis is more advanced than other species of the genus in permanently missing P4 and having posterior protolophule connection. These fossils suggest that the age of the "Upper Red" of the Erden Obo section is younger than the age of the Upper Eocene Houldjin and Caijiachong formations, but older than those containing the Shandgolian faunas; the "Upper Red" is most closely correlative to the Ergilian beds in age, and probably close to the Eocene/Oligocene boundary. Given the age estimate, Eucricetodon wangae provides the new evidence to support that cricetid dispersal from Asia to Europe occurred prior to the Eocene-Oligocene boundary.	[Li, Qian; Meng, Jin; Wang, Yuanqing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Meng, Jin] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; American Museum of Natural History (AMNH)	Li, Q (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	liqian@ivpp.ac.cn			Major Basic Research Projects of MST of China (973 Program) [2012CB821900]; National Natural Science Foundation of China [41572013]; Chinese Academy of Sciences [KZCX2-EW-106]; Special Fund for Fossil Excavation and Preparation, CAS; Geological Survey of China [1212011120115, 1212011120142]	Major Basic Research Projects of MST of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for Fossil Excavation and Preparation, CAS; Geological Survey of China(China Geological Survey)	This research was supported by the Major Basic Research Projects of MST of China (973 Program) ( 2012CB821900), the National Natural Science Foundation of China ( 41572013), the Chinese Academy of Sciences ( KZCX2-EW-106), the Special Fund for Fossil Excavation and Preparation, CAS, and the Geological Survey of China ( Nos. 1212011120115 and 1212011120142).	Baciu C, 2001, CR ACAD SCI II A, V333, P441, DOI 10.1016/S1251-8050(01)01659-7; Dashzeveg Demberelyin, 1993, Tertiary Research, V14, P141; Dawson Mary R., 1998, Bulletin of Carnegie Museum of Natural History, V34, P278; Daxner-Hock G., 2007, ANN NATURHISTORISC A, V108, P1; Daxner-Hock Gudrun, 2000, Palaeontologische Zeitschrift, V74, P215; de Bruijn Hans, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P47; Emry RJ, 1998, J VERTEBR PALEONTOL, V18, P218, DOI 10.1080/02724634.1998.10011045; Emry RJ, 1998, B CARNEGIE MUSEUM NA, V34, P298; Engesser B., 1985, Eclogae Geologicae Helvetiae, V78, P669; Freudenthal M., 1994, Scripta Geologica, V104, P1; Freudenthal M., 1992, Revista Espanola de Paleontologia, P49; Freudenthal M., 1996, Scripta Geologica, V112, P1; Gomes Rodrigues Helder, 2013, Spanish Journal of Palaeontology, V28, P17; Gudrun DAXNER-HCK, 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P348; Hugueney Marguerite, 1999, P347; Jiang H. X, 1983, GEOLOGY NEI MONGOL, V2, P18; Kowalski K., 1974, Palaeontologia Polonica, VNo. 30, P147; Li Qian, 2012, Vertebrata Palasiatica, V50, P237; LINDSAY EH, 1978, J PALEONTOL, V52, P590; Maridet O, 2013, J VERTEBR PALEONTOL, V33, P185, DOI 10.1080/02724634.2012.710283; Maridet O, 2009, AM MUS NOVIT, P1, DOI 10.1206/676.1; Matthew W. D., 1923, American Museum Novitates, VNo. 102, P1; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Misonne X., 1957, Bull Inst roy Sci nat Belg, V33, P1; Osborn H.F., 1929, AM MUS NOVIT, V353, P1; Qi Tao, 1990, Vertebrata Palasiatica, V28, P25; Qiu Z-X., 2007, PALAEONT SIN C, V29, P1; Rodrigues HG, 2012, J ASIAN EARTH SCI, V56, P160, DOI 10.1016/j.jseaes.2012.05.007; Schaub S., 1925, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V45, P1; Shevyreva N. S, 1967, PALEONTOLOGICHESKIA, V2, P90; Tong Y.S., 1997, PALEONT SIN NEW SER, V26, P1; Tong Yongsheng, 1992, Vertebrata Palasiatica, V30, P1; Vianey-Liaud M., 1972, Palaeovertebrata, V5, P1; Wang Ban-Yue, 2007, Vertebrata Palasiatica, V45, P195; Wang Ban-Yue, 1994, Annals of Carnegie Museum, V63, P239; WANG BY, 1987, VERTEBRAT PALASIATIC, V25, P187; WANG BY, 1986, VERTEBRAT PALASIATIC, V24, P110; Wang BY, 2003, VERTEBRAT PALASIATIC, V45, P195; [王元青 Wang Yuanqing], 2012, [古脊椎动物学报, Vertebrata Palasiatica], V50, P181; Ye Jie, 2005, Vertebrata Palasiatica, V43, P49; Zdansky O., 1930, Palaeontologia Sinica, V6C, P1	41	8	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156233	10.1371/journal.pone.0156233	http://dx.doi.org/10.1371/journal.pone.0156233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227833	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500088
J	Pandey, D; Kaur, S; Kamath, A				Pandey, Deeksha; Kaur, Simar; Kamath, Asha			Banking Umbilical Cord Blood (UCB) Stem Cells: Awareness, Attitude and Expectations of Potential Donors from One of the Largest Potential Repository (India)	PLOS ONE			English	Article							PREGNANT-WOMEN; COLLECTION; KNOWLEDGE; OBSTETRICIANS	Background The concept of Umbilical Cord blood (UCB) stem cells is emerging as a non-invasive, efficacious alternative source of hematopoietic stem cells to treat a variety of blood and bone marrow diseases, blood cancers, metabolic disorders and immune deficiencies. Aim of the present study was to determine the level of awareness about banking UCB among pregnant women in India. We also assessed patient perception for banking of UCB and explored the patient expectations of banking UCB in future. This is the first study to assess current attitudes, in a sample population of potential donors from one of the largest potential UCB repository (India). Obtaining this information may help optimize recruitment efforts and improve patient education. Material and Method Present explorative questionnaire based survey included 254 pregnant women in the final analysis. Results We established only 26.5% pregnant women in our study population knew what exactly is meant by UCB. A large proportion (55.1%) was undecided on whether they want to bank UCB or not. Women were more aware of the more advertised private cord blood banking compared to public banking. More than half of the pregnant women expected their obstetrician to inform them regarding UCB. One-third of the women in our population had undue expectations from banking of the UCB. Conclusion Obstetricians should play a more active role in explaining the patients regarding pros and cons of UCB banking.	[Pandey, Deeksha; Kamath, Asha] Manipal Univ, KMC Manipal, Dept Obstet & Gynaecol, Manipal, Karnataka, India; [Kamath, Asha] Manipal Univ, KMC Manipal, Dept Community Med, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Pandey, D (corresponding author), Manipal Univ, KMC Manipal, Dept Obstet & Gynaecol, Manipal, Karnataka, India.	deekshiiiobg@gmail.com		Kamath, Asha/0000-0003-0727-8067				[Anonymous], 2015, OBSTET GYNECOL, V126, pe127, DOI [10.1097/AOG.0000000000001212, DOI 10.1097/A0G.0000000000001212]; Ballen KK, 2008, BIOL BLOOD MARROW TR, V14, P356, DOI 10.1016/j.bbmt.2007.11.005; Baron F, 2015, EXPERT REV HEMATOL; Cairo MS, 2007, PEDIATRICS, V119, P165, DOI 10.1542/peds.2006-2901; Committee on Obstetric Practice, 2008, Obstet Gynecol, V111, P475, DOI 10.1097/AOG.0b013e318166603c; Fernandez CV, 2003, CAN MED ASSOC J, V168, P695; Fox NS, 2007, J PERINAT MED, V35, P314, DOI 10.1515/JPM.2007.084; Haw J, 2015, MONASH BIOETH REV; Herlihy MM, 2013, OBSTET GYNECOL, V121, P851, DOI 10.1097/AOG.0b013e31828882aa; Katz G, 2011, TRANSFUSION, V51, P578, DOI 10.1111/j.1537-2995.2010.02954.x; Kurtzberg J, 2005, J CLIN INVEST, V115, P2592, DOI 10.1172/JCI26690; Lu HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144001; Magalon J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143440; Martin PL, 2011, AM FAM PHYSICIAN, V84, P661; Sullivan MJ, 2008, NAT REV CANCER, V8, P554, DOI 10.1038/nrc2418; Tuteja M, 2016, INDIAN J PEDIATR, V83, P238, DOI 10.1007/s12098-015-1909-x; Viswanathan C, 2009, INDIAN J HEMATOL BLO, V25, P111, DOI 10.1007/s12288-009-0023-5; Walker T, 2012, TRANSFUSION, V52, P787, DOI 10.1111/j.1537-2995.2011.03383.x	18	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155782	10.1371/journal.pone.0155782	http://dx.doi.org/10.1371/journal.pone.0155782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228155	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500034
J	Tribollet, V; Barenton, B; Kroiss, A; Vincent, S; Zhang, L; Forcet, C; Cerutti, C; Perian, S; Allioli, N; Samarut, J; Vanacker, JM				Tribollet, Violaine; Barenton, Bruno; Kroiss, Auriane; Vincent, Severine; Zhang, Ling; Forcet, Christelle; Cerutti, Catherine; Perian, Severine; Allioli, Nathalie; Samarut, Jacques; Vanacker, Jean-Marc			miR-135a Inhibits the Invasion of Cancer Cells via Suppression of ERR alpha	PLOS ONE			English	Article							ESTROGEN-RELATED-RECEPTOR; BREAST-CANCER; EXPRESSION; PROLIFERATION; MICRORNA; TARGET; BIOMARKERS; CARCINOMA; MIGRATION; GROWTH	MicroRNA-135a (miR-135a) down-modulates parameters of cancer progression and its expression is decreased in metastatic breast cancers (as compared to non-metastatic tumors) as well as in prostate tumors relative to normal tissue. These expression and activity patterns are opposite to those of the Estrogen-Related Receptor alpha (ERR alpha), an orphan member of the nuclear receptor family. Indeed high expression of ERR alpha correlates with poor prognosis in breast and prostate cancers, and the receptor promotes various traits of cancer aggressiveness including cell invasion. Here we show that miR-135a down-regulates the expression of ERR alpha through specific sequences of its 3'UTR. As a consequence miR-135a also reduces the expression of downstream targets of ERR alpha. miR-135a also decreases cell invasive potential in an ERR alpha-dependent manner. Our results suggest that the decreased expression of miR-135a in metastatic tumors leads to elevated ERR alpha expression, resulting in increased cell invasion capacities.	[Tribollet, Violaine; Barenton, Bruno; Kroiss, Auriane; Vincent, Severine; Zhang, Ling; Forcet, Christelle; Cerutti, Catherine; Perian, Severine; Allioli, Nathalie; Samarut, Jacques; Vanacker, Jean-Marc] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, F-69365 Lyon, France; [Allioli, Nathalie] Univ Lyon, Fac Pharm, Inst Sci Pharmaceut & Biol, Lyon, France; [Samarut, Jacques] Univ Lyon, Fac Med Lyon Sud, Lyon, France; [Samarut, Jacques] Hosp Civils Lyon, Ctr Hosp Lyon Sud, UMOMT, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Vanacker, JM (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, UMR5242,Ecole Normale Super Lyon, F-69365 Lyon, France.	jean-marc.vanacker@ens-lyon.fr	Samarut, Jacques/AAD-2587-2019	PERIAN, Severine/0000-0003-0942-7302	Ligue contre le Cancer	Ligue contre le Cancer(Ligue nationale contre le cancer)	This work was funded by Ligue contre le Cancer (comites Puy-de-Dome https://www.liguecancer.net/cd63/journal and Drome https://www.liguecancer.net/cd26/journal) to JS and JMV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi EA, 2002, CANCER RES, V62, P6510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernatchez G, 2013, CARCINOGENESIS, V34, P2253, DOI 10.1093/carcin/bgt180; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Cai Q, 2013, ONCOGENE, V32, P2079, DOI 10.1038/onc.2012.221; Carnesecchi J, 2016, MOL CELL ENDOCRINOL, V432, P47, DOI 10.1016/j.mce.2015.07.019; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chang CY, 2012, CLIN CANCER RES, V18, P6089, DOI 10.1158/1078-0432.CCR-11-3221; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Eichner LJ, 2010, CELL METAB, V12, P352, DOI 10.1016/j.cmet.2010.09.002; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gallet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054837; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Golubovskaya VM, 2014, ANTI-CANCER AGENT ME, V14, P18, DOI 10.2174/187152061401140108113435; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kammerer M, 2013, MOL CELL ENDOCRINOL, V369, P150, DOI 10.1016/j.mce.2013.01.024; Kroiss A, 2015, ONCOGENE, V34, P2846, DOI 10.1038/onc.2014.222; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Ren JW, 2015, INT J CLIN EXP PATHO, V8, P6356; Sailland J, 2014, P NATL ACAD SCI USA, V111, P15108, DOI 10.1073/pnas.1402094111; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Taipaleenmaki H, 2015, CANCER RES, V75, P1433, DOI 10.1158/0008-5472.CAN-14-1026; Teyssier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007942; Tiwari A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17621; Tiwari A, 2014, J BIOL CHEM, V289, P32276, DOI 10.1074/jbc.M114.584136; Vanacker JM, 1999, MOL ENDOCRINOL, V13, P764, DOI 10.1210/me.13.5.764; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wu YM, 2015, ONCOTARGET, V6, P25588, DOI 10.18632/oncotarget.4436; Xi Jianzhong Jeff, 2013, Cancer Treat Res, V158, P119, DOI 10.1007/978-3-642-31659-3_5; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003; Zhao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039102; Zhou WW, 2012, ACTA BIOCH BIOPH SIN, V44, P838, DOI 10.1093/abbs/gms071; Zou C, 2014, J PATHOL, V233, P61, DOI 10.1002/path.4329	45	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156445	10.1371/journal.pone.0156445	http://dx.doi.org/10.1371/journal.pone.0156445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227989	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500136
J	Tsuji, S; Ohbayashi, T; Yamakage, K; Oshimura, M; Tada, M				Tsuji, Saori; Ohbayashi, Tetsuya; Yamakage, Kohji; Oshimura, Mitsuo; Tada, Masako			A Cytoplasmic Form of Gaussia luciferase Provides a Highly Sensitive Test for Cytotoxicity	PLOS ONE			English	Article							GENE-EXPRESSION; CELL LINE; IN-VIVO; BIOLUMINESCENCE; HYBRIDIZATION; TOXICITY; REPORTER; CULTURE; ASSAY; CDNA	The elimination of unfavorable chemicals from our environment and commercial products requires a sensitive and high-throughput in vitro assay system for drug-induced hepatotoxicity. Some previous methods for evaluating hepatotoxicity measure the amounts of cytoplasmic enzymes secreted from damaged cells into the peripheral blood or culture medium. However, most of these enzymes are proteolytically digested in the extracellular milieu, dramatically reducing the sensitivity and reliability of such assays. Other methods measure the decrease in cell viability following exposure to a compound, but such end-point assays are often confounded by proliferation of surviving cells that replace dead or damaged cells. In this study, with the goal of preventing false-negative diagnoses, we developed a sensitive luminometric cytotoxicity test using a stable form of luciferase. Specifically, we converted Gaussia luciferase (G-Luc) from an actively secreted form to a cytoplasmic form by adding an ER-retention signal composed of the four amino acids KDEL. The bioluminescent signal was >30-fold higher in transgenic HepG2 human hepatoblastoma cells expressing G-Luc+KDEL than in cells expressing wild-type G-Luc. Moreover, G-Luc+KDEL secreted from damaged cells was stable in culture medium after 24 hr at 37 degrees C. We evaluated the accuracy of our cytotoxicity test by subjecting identical samples obtained from chemically treated transgenic HepG2 cells to the G-Luc+KDEL assay and luminometric analyses based on secretion of endogenous adenylate kinase or cellular ATP level. Time-dependent accumulation of G-Luc+KDEL in the medium increased the sensitivity of our assay above those of existing tests. Our findings demonstrate that strong and stable luminescence of G-Luc+KDEL in human hepatocyte-like cells, which have high levels of metabolic activity, make it suitable for use in a high-throughput screening system for monitoring time-dependent cytotoxicity in a limited number of cells.	[Tsuji, Saori] Org Tottori Ind Promot, Bio Frontier Project Promot Sect, Nishi Cho 86, Yonago, Tottori 6838503, Japan; [Ohbayashi, Tetsuya] Tottori Univ, Res Ctr Biosci & Technol, Div Lab Anim Sci, Nishi Cho 86, Yonago, Tottori 6838503, Japan; [Yamakage, Kohji] Food & Drug Safety Ctr FDSC, Hatano Res Inst, 729-5 Ochiai, Hatano, Kanagawa 2578523, Japan; [Oshimura, Mitsuo; Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Nishi Cho 86, Yonago, Tottori 6838503, Japan	Tottori University; Tottori University	Tada, M (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Nishi Cho 86, Yonago, Tottori 6838503, Japan.	matada@med.tottori-u.ac.jp			Ministry of Economy, Trade and Industry (METI) of Japan [20150317]	Ministry of Economy, Trade and Industry (METI) of Japan	This work was supported solely by a National Grant [The Japanese Financial Support number 20150317] from The Ministry of Economy, Trade and Industry (METI) of Japan.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Cho MH, 2008, TOXICOL IN VITRO, V22, P1099, DOI 10.1016/j.tiv.2008.02.013; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Mersch-Sundermann V, 2004, TOXICOLOGY, V198, P329, DOI 10.1016/j.tox.2004.02.009; MIYAZAKI J, 1989, GENE, V79, P269; Moghadam AR, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0773-6; Nakajima Y, 2004, BIOSCI BIOTECH BIOCH, V68, P565, DOI 10.1271/bbb.68.565; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; OECD, 2011, WORKSH US MECH INF F; OECD, 2008, TEST NO 407 REP DOS; Olsson T, 1983, J Appl Biochem, V5, P437; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Tsuji S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104123; Verhaegen M, 2002, ANAL BIOCHEM, V306, P314, DOI 10.1006/abio.2002.5724; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243; Westmoreland C, 2014, NAT BIOTECHNOL, V32, P541, DOI 10.1038/nbt.2922; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031; Yuan BZ, 2008, TRANSL ONCOL, V1, P129, DOI 10.1593/tlo.08133	23	5	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156202	10.1371/journal.pone.0156202	http://dx.doi.org/10.1371/journal.pone.0156202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228203	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500079
J	Yang, LL; Yang, X; Kong, XL; Cao, ZW; Zhang, YY; Hu, YY; Tang, KL				Yang, Linlin; Yang, Xue; Kong, Xiangliang; Cao, Zhiwei; Zhang, Yongyu; Hu, Yiyang; Tang, Kailin			Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B	PLOS ONE			English	Article							LIVER-FAILURE; VIRUS; EPIDEMIOLOGY; ALTERS; GENES	Background Chronic hepatitis b (CHB) is one of the most serious viral diseases threatening human health by putting patients at lifelong risk of cirrhosis and hepatocellular carcinoma (HCC). Although some proofs of altered metabolites in CHB were accumulated, its metabolic mechanism remains poorly understood. Analyzing covariations between metabolites may provide new hints toward underlying metabolic pathogenesis in CHB patients. Methods The present study collected paired urine and serum samples from the same subjects including 145 CHB and 23 healthy controls. A large-scale analysis of metabolites' covariation within and across biofluids was systematically done to explore the underlying biological evidences for reprogrammed metabolism in CHB. Randomization and relative ranking difference were introduced to reduce bias caused by different sample size. More importantly, functional indication was interpreted by mapping differentially changed covariations to known metabolic pathways. Results Our results suggested reprogrammed pathways related to glycine metabolism, fatty acids metabolism and TCA cycle in CHB patients. With further improvement, the covariation analysis combined with network association study would pave new alternative way to interpret functional clues in clinical multi-omics data. Conclusions These data suggest that plasma s(P)RR levels may reflect (P)RR expression levels in infiltrated mononuclear cells, which can be a surrogate marker of renal damage.	[Yang, Linlin; Cao, Zhiwei; Tang, Kailin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Yang, Xue] Second Mil Med Univ, Changhai Hosp Tradit Chinese Med, Shanghai, Peoples R China; [Kong, Xiangliang; Zhang, Yongyu] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China; [Hu, Yiyang] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Key Lab Liver & Kidney Dis,Minist Educ, Shanghai, Peoples R China; [Tang, Kailin] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Tongji University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Tongji University	Tang, KL (corresponding author), Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.; Zhang, YY (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China.; Hu, YY (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Inst Liver Dis, Key Lab Liver & Kidney Dis,Minist Educ, Shanghai, Peoples R China.; Tang, KL (corresponding author), Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China.	dryyz@sina.com; yyhuliver@163.com; kltang@tongji.edu.cn		Tang, KaiLin/0000-0002-0508-6056	Ministry of Health [2009ZX10004-601, 2012ZX10005001-008]	Ministry of Health	This work was supported in part by grants from Ministry of Health ( 2009ZX10004-601 and 2012ZX10005001-008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, GUIDELINES FOR THE P; Chen TL, 2011, MOLECULAR CELLULAR P, V10; Cui M, 2014, BIOCHEM BIOPH RES CO, V445, P651, DOI 10.1016/j.bbrc.2014.02.068; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee YI, 2004, J BIOL CHEM, V279, P15460, DOI 10.1074/jbc.M309280200; Levy P, 2015, ONCOGENE; Li HD, 2015, SCIENTIFIC REPORTS, V5; Liu R, 2014, MED RES REV, V34, P455, DOI 10.1002/med.21293; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Longfeng Z, 2004, J SHANXI MED U, V35, P270; Na TY, 2009, HEPATOLOGY, V49, P1122, DOI 10.1002/hep.22740; Nie CY, 2014, J VIRAL HEPATITIS, V21, P53, DOI 10.1111/jvh.12122; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Shirakata Y, 2003, J BIOL CHEM, V278, P22071, DOI 10.1074/jbc.M301606200; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Sun SJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/738245; Wang X, 2015, J PROTEOME RES; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wu ZJ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-146; Yang J, 2012, EUR J CLIN MICROBIOL, V31, P2045, DOI 10.1007/s10096-011-1538-x; Yang LL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S19; Yin M, 1998, J PHARMACOL EXP THER, V286, P1014; Yu K, 2007, J PROTEOME RES, V6, P2413, DOI 10.1021/pr060591d; Zhang HM, 2013, J PROTEOME RES, V12, P2967, DOI 10.1021/pr400247f; 中华医学会肝病学分会、感染病学分会, 2005, [中华肝脏病杂志, Chinese Journal of Hepatology], V13, P881	28	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156166	10.1371/journal.pone.0156166	http://dx.doi.org/10.1371/journal.pone.0156166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228119	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500076
J	Auranen, K; Syrjanen, R; Leino, T; Kilpi, T				Auranen, Kari; Syrjanen, Ritva; Leino, Tuija; Kilpi, Terhi			New Pneumococcal Carriage Acquired in Association with Acute Respiratory Infection Is Prone to Cause Otitis Media	PLOS ONE			English	Article							INFLUENZA-A VIRUS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CHILDREN; DISEASE; COLONIZATION; ACQUISITION; RESISTANCE; BACTERIAL; FAMILIES	For considering vaccine-prevention of pneumococcal acute otitis media (PncAOM), relationships between pneumococcal carriage, respiratory infection and PncAOM need to be understood. We analyzed nasopharyngeal samples collected from 329 unvaccinated Finnish children aged 2-24 months at scheduled visits and at visits during respiratory infection in 1994-97. We assessed temporal associations of respiratory infection with pneumococcal acquisition and whether PncAOM hazard depends on the relative timing of acquisition and the infection onset. The data comprised 607 person-years of risk-time for acquisition, 245 person-months of concurrent respiratory infection and carriage, and 119 episodes of PncAOM. The acquisition hazard was 3-fold in the month preceding respiratory sickness (hazard ratio, HR 3.5, 90% credible interval CI 2.9, 4.1) as compared to acquisition in healthy children. Moreover, the PncAOM hazard was markedly higher (HR 3.7, 90% CI 2.4, 5.3) during the first month of carriage acquired around the acute phase of respiratory infection (between 1 month before and 1 week after the sickness onset), as compared to carriage acquired later during sickness. The high proportion (76%) of PncAOM events occurring within 1 month of acquisition was due to frequent acquisition being associated with respiratory infection as well as the susceptibility of such acquisition to cause otitis media.	[Auranen, Kari; Syrjanen, Ritva; Leino, Tuija; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Hlth Protect, Mannerheimintie 166, Helsinki 00300, Finland; [Auranen, Kari] Univ Turku, Dept Math & Stat, Turku 20014, Finland; [Syrjanen, Ritva] Natl Inst Hlth & Welf, Dept Hlth Protect, Finn Medi I, Biokatu 6, Tampere 33520, Finland	Finland National Institute for Health & Welfare; University of Turku; Finland National Institute for Health & Welfare	Auranen, K (corresponding author), Natl Inst Hlth & Welf, Dept Hlth Protect, Mannerheimintie 166, Helsinki 00300, Finland.; Auranen, K (corresponding author), Univ Turku, Dept Math & Stat, Turku 20014, Finland.	kari.auranen@thl.fi			Pasteur Merieux Connaught; Wyeth-Lederle Vaccines and Pediatrics	Pasteur Merieux Connaught; Wyeth-Lederle Vaccines and Pediatrics	The FinOM studies were supported by Merck & Co., Inc., Pasteur Merieux Connaught and Wyeth-Lederle Vaccines and Pediatrics. These funders had no role in study design, analysis, decision to publish, or preparation of the current manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; ABRAMSON JS, 1982, INFECT IMMUN, V36, P289, DOI 10.1128/IAI.36.1.289-296.1982; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Chonmaitree T, 2000, PEDIATR INFECT DIS J, V19, P258, DOI 10.1097/00006454-200003000-00020; Ciftci E, 2000, PEDIATR INT, V42, P552, DOI 10.1046/j.1442-200x.2000.01269.x; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; GIEBINK GS, 1980, ANN OTO RHINOL LARYN, V89, P339, DOI 10.1177/00034894800890S380; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Hoa M, 2009, ANN OTO RHINOL LARYN, V118, P292, DOI 10.1177/000348940911800410; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; MASTERS PL, 1958, BMJ-BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.5081.1200; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; MOGDASY MC, 1992, PEDIATR INFECT DIS J, V11, P648; Novales MGM, 1997, ARCH MED RES, V28, P559; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sleeman KL, 2005, PEDIATR INFECT DIS J, V24, P121, DOI 10.1097/01.inf.0000151030.10159.b1; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Syrjanen RK, 2006, PEDIATR INFECT DIS J, V25, P1032, DOI 10.1097/01.inf.0000241097.37428.1d; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Tong HH, 2000, ANN OTO RHINOL LARYN, V109, P1021, DOI 10.1177/000348940010901106	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156343	10.1371/journal.pone.0156343	http://dx.doi.org/10.1371/journal.pone.0156343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257789	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700055
J	Liu, WJ; Li, YC; Kou, GH; Lo, CF				Liu, Wang-Jing; Li, Yi-Chieh; Kou, Guang-Hsiung; Lo, Chu-Fang			Laminin Receptor in Shrimp Is a Cellular Attachment Receptor for White Spot Syndrome Virus	PLOS ONE			English	Article							CHITIN-BINDING PROTEIN; WSSV INFECTION; LITOPENAEUS VANNAMEI; TOPOLOGY PREDICTION; ENVELOPE PROTEINS; PENAEUS-MONODON; CAPSID PROTEINS; BETA-INTEGRIN; IDENTIFICATION; ENTRY	White spot syndrome virus (WSSV, genus Whispovirus, family Nimaviridae) is causing huge economic losses in global shrimp farming, but there is no effective control. Shrimp cell laminin receptor (Lamr) may have a role in WSSV infection. The objective was to characterize interactions between Penaeus monodon Lamr (PmLamr) and WSSV structural proteins. In this study, PmLamr interacted with nine WSSV structural proteins (based on yeast two-hybrid screening), of which one (VP31) was characterized. Protein pull-down assay confirmed the interaction between PmLamr and VP31; the latter was an envelope protein exposed outside the WSSV virion (based on membrane topology assays). Furthermore, similar to mammalian Lamr, there were two major protein bands in shrimp cells. Cellular localization assay demonstrated VP31 co-localized with PmLamr on transfected cells. Enzyme-link immunosorbent assay (ELISA) and competitive ELISA demonstrated binding of VP31 on PmLamr was dose-dependent; however, addition of WSSV virion competed for binding affinity. Furthermore, based on an in vivo neutralization assay, both VP31 and PmLamr delayed mortality in shrimp challenged with WSSV. We concluded Lamr was an important receptor for WSSV infection and the viral envelope protein VP31 may have a role in host cell recognition and binding. These data contributed to elucidating pathogenesis of WSSV infection and may help in controlling this disease.	[Liu, Wang-Jing; Li, Yi-Chieh] Univ Taipei, Coll Sci, Dept Earth & Life Sci, Taipei, Taiwan; [Kou, Guang-Hsiung] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan	University of Taipei; National Taiwan University; National Cheng Kung University	Liu, WJ (corresponding author), Univ Taipei, Coll Sci, Dept Earth & Life Sci, Taipei, Taiwan.	liuwjing@utaipei.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	Ministry of Science and Technology, R.O.C [MOST 104-2311-B-845-001]	Ministry of Science and Technology, R.O.C	This investigation was supported financially by the Ministry of Science and Technology, R.O.C (https://www.most.gov.tw/) under grant no. MOST 104-2311-B-845-001. WJL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1997, J BIOL CHEM, V272, P2342; Busayarat N, 2011, FISH SHELLFISH IMMUN, V31, P66, DOI 10.1016/j.fsi.2011.03.007; CASTRONOVO V, 1993, INVAS METAST, V13, P1; Charoensapsri W, 2015, DEV COMP IMMUNOL, V51, P39, DOI 10.1016/j.dci.2015.02.012; Chen JN, 2015, J VIROL, V89, P4894, DOI 10.1128/JVI.00019-15; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; DiGiacomo V, 2015, BIOL REV; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Huang HT, 2015, FISH SHELLFISH IMMUN, V46, P305, DOI 10.1016/j.fsi.2015.06.034; Huang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033216; Huang PY, 2014, J GEN VIROL, V95, P1799, DOI 10.1099/vir.0.064782-0; Kang ST, 2009, VIROLOGY, V387, P353, DOI 10.1016/j.virol.2009.02.012; Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li L, 2005, VIROLOGY, V340, P125, DOI 10.1016/j.virol.2005.06.007; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li L, 2011, ARCH VIROL, V156, P1317, DOI 10.1007/s00705-011-0984-1; Liang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-144; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085779; Lo C.-F., 2005, DIS ASIAN AQUACULTUR, P421; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Senapin S, 2006, VIRUS RES, V122, P69, DOI 10.1016/j.virusres.2006.06.013; Senapin S, 2010, FISH SHELLFISH IMMUN, V29, P422, DOI 10.1016/j.fsi.2010.04.022; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Zhang JY, 2014, J BIOSCIENCES, V39, P381, DOI 10.1007/s12038-014-9418-z	36	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156375	10.1371/journal.pone.0156375	http://dx.doi.org/10.1371/journal.pone.0156375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257954	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700057
J	Michel, G; Ferrua, B; Munro, P; Boyer, L; Mathal, N; Gillet, D; Marty, P; Lemichez, E				Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Mathal, Nassim; Gillet, Daniel; Marty, Pierre; Lemichez, Emmanuel			Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; BACTERIAL TOXINS; BALB/C MICE; GTPASES; ADJUVANTS; ANTIGENS; IMMUNITY; UPDATE	There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines against intracellular pathogens. The activation of Rho GTPases by bacterial cytotoxic necrotizing factor 1 (CNF1) elicits humoral protective responses against protein antigens. Here, we set out to investigate whether CNF1 activity initiates humoral immunity against co-administered parasite antigens and anti-microbial immune signaling. We report that co-administration of wild-type (WT) CNF1 with Leishmania (L.) promastigote antigens at the nasal mucosa triggered prophylactic and curative vaccine responses against this parasite. Vaccination of the mucosa with promastigote lysate antigens combined with WT CNF1 conferred protection against high inoculum L. infantum infection, which reached 82% in the spleen. Immune parameter analysis by antigen recall indicated robust T-helper (Th) 1 polarization of immune memory cells, with high IL-2 and IFN-gamma. production combined with decreased IL-4 production. Additionally, we explored the curative effect of WT CNF1 on previously infected animals. We observed that PL combined with WT CNF1, but not the inactive C866S mutant CNF1 (mCNF1), induced a 58% decrease in the parasite burden in the spleen.	[Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Marty, Pierre; Lemichez, Emmanuel] Fac Med Nice, INSERM, Team Microbial Toxins Host Pathogen Interact, U1065,Ctr Mediterraneen Med Mol,Equipe Labellisee, U210, F-06034 Nice, France; [Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Marty, Pierre; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France; [Michel, Gregory; Marty, Pierre] CHU Nice, Lab Parasitol Mycol, F-06202 Nice, France; [Mathal, Nassim; Gillet, Daniel] Paris Saclay Univ, LabEx LERMIT, CEA, iBiTecS,SIMOPRO, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CEA; UDICE-French Research Universities; Universite Paris Saclay	Michel, G; Lemichez, E (corresponding author), Fac Med Nice, INSERM, Team Microbial Toxins Host Pathogen Interact, U1065,Ctr Mediterraneen Med Mol,Equipe Labellisee, U210, F-06034 Nice, France.; Michel, G; Lemichez, E (corresponding author), Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France.; Michel, G (corresponding author), CHU Nice, Lab Parasitol Mycol, F-06202 Nice, France.	gmichel@unice.fr; lemichez@unice.fr	Lemichez, Emmanuel/G-3559-2013; Michel, Grégory/M-4124-2018; Marty, Pierre/P-6228-2016; Boyer, laurent/F-8921-2015; BOYER, Laurent/AAH-4543-2021; Gillet, Daniel/C-5592-2008; Munro, Patrick/A-6579-2009	Lemichez, Emmanuel/0000-0001-9080-7761; Michel, Grégory/0000-0002-6902-7514; Boyer, laurent/0000-0002-1375-1706; BOYER, Laurent/0000-0002-1375-1706; Gillet, Daniel/0000-0003-0477-3599; Munro, Patrick/0000-0003-4283-4671	Groupe d'Action Contre la Leishmaniose (GACL); INSERM; Fondation Infectiopole Sud; Agence Nationale de la Recherche [ANR 11BSV3 004 01, ANR-10-LABEX-33]; "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; C3M; DGA; joint ministerial program of RD	Groupe d'Action Contre la Leishmaniose (GACL); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Infectiopole Sud; Agence Nationale de la Recherche(French National Research Agency (ANR)); "Investments for the Future" LABEX SIGNALIFE; C3M; DGA; joint ministerial program of RD	This work was supported by the Groupe d'Action Contre la Leishmaniose (GACL), by institutional funding from INSERM, grants from the Fondation Infectiopole Sud, the Agence Nationale de la Recherche (ANR 11BSV3 004 01), the "Investments for the Future" LABEX SIGNALIFE ANR-11-LABX-0028-01 and the C3M animal facility. NM was supported by DGA and the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the laboratory of Excellence LERMIT supported by the grant from the Agence Nationale de la Recherche (ANR-10-LABEX-33).	Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Das A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00099; Diabate M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004732; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Ferrua B, 2006, VACCINE, V24, P589, DOI 10.1016/j.vaccine.2005.08.057; Ferrua B, 2001, J IMMUNOASS IMMUNOCH, V22, P165, DOI 10.1081/IAS-100103227; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Marty P, 2007, ANN TROP MED PARASIT, V101, P563, DOI 10.1179/136485907X229121; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mettouchi Amel, 2012, Small GTPases, V3, P102, DOI 10.4161/sgtp.19221; Michel G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001323; Munro P, 2005, VACCINE, V23, P2551, DOI 10.1016/j.vaccine.2004.11.042; Munro P, 2004, J BIOL CHEM, V279, P35849, DOI 10.1074/jbc.M401580200; Munro P, 2007, VACCINE, V25, P8702, DOI 10.1016/j.vaccine.2007.10.024; Nagill R, 2011, INT IMMUNOPHARMACOL, V11, P1464, DOI 10.1016/j.intimp.2011.05.008; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Roberts MTM, 2005, INFECT IMMUN, V73, P7620, DOI 10.1128/IAI.73.11.7620-7628.2005; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Zamboni DS, 2015, IMMUNOL REV, V265, P156, DOI 10.1111/imr.12291	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156363	10.1371/journal.pone.0156363	http://dx.doi.org/10.1371/journal.pone.0156363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257862	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700056
J	Hao, YA; Dietrich, CH; Dai, W				Hao, Yanan; Dietrich, Christopher H.; Dai, Wu			Structure and Sensilla of the Mouthparts of the Spotted Lanternfly Lycorma delicatula (Hemiptera: Fulgoromorpha: Fulgoridae), a Polyphagous Invasive Planthopper	PLOS ONE			English	Article							EXTERNAL MORPHOLOGY; STYLET PENETRATION; DIGESTIVE ENZYMES; HOMOPTERA; ULTRASTRUCTURE; DELPHACIDAE; INSECTA; MIRIDAE; PARTS; PLANT	Mouthparts are among the most important sensory and feeding structures in insects and comparative morphological study may help explain differences in feeding behavior and diet breadth among species. The spotted lanternfly Lycorma delicatula (White) (Hemiptera: Fulgoromorpha: Fulgoridae) is a polyphagous agricultural pest originating in China, recently established and becoming widespread in Korea, and more recently introduced into eastern North America. It causes severe economic damage by sucking phloem sap and the sugary excrement produced by nymphs and adults serves as a medium for sooty mold. To facilitate future study of feeding mechanisms in this insect, the fine-structural morphology of mouthparts focusing on the distribution of sensilla located on the labium in adult L. delicatula was observed using a scanning electron microscope. The mouthparts consist of a small cone-shaped labrum, a tubular labium and a stylet fascicle consisting of two inner interlocked maxillary stylets partially surrounded by two shorter mandibular stylets similar to those found in other hemipteran insects. The five-segmented labium is unusual (most other Fulgoromorpha have four segments) and is provided with several types of sensilla and cuticular processes situated on the apex of its distal labial segment. In general, nine types of sensilla were found on the mouthparts. Six types of sensilla and four types of cuticular processes are present on sensory fields of the labial apex. The proposed taxonomic and functional significance of the sensilla are discussed. Morphological similarities in the interlocking mechanism of the stylets suggest a relationship between Fulgoromorpha and Heteroptera.	[Hao, Yanan; Dai, Wu] Northwest A&F Univ, Minist Educ, Entomol Museum, Key Lab Plant Protect Resources & Pest Integrated, Yangling, Shaanxi, Peoples R China; [Dietrich, Christopher H.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Urbana, IL 61801 USA	Northwest A&F University - China; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Dai, W (corresponding author), Northwest A&F Univ, Minist Educ, Entomol Museum, Key Lab Plant Protect Resources & Pest Integrated, Yangling, Shaanxi, Peoples R China.	daiwu@nwsuaf.edu.cn	Dietrich, Chris/A-9169-2016	Dietrich, Chris/0000-0003-4005-4305	National Natural Science Foundation of China [31572306, 31272343, 30970385]; Chinese Universities Scientific Fund [YQ2013010]; West Light Foundation of the Chinese Academy of Sciences [2012DF06]; U.S. National Science Foundation [DEB 1239788]; Division Of Environmental Biology [1239788] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Natural Science Foundation of China (Nos. 31572306, 31272343, 30970385,), the Chinese Universities Scientific Fund (YQ2013010)" and the West Light Foundation of the Chinese Academy of Sciences (2012DF06) to Wu Dai; U.S. National Science Foundation grant DEB 1239788 to Christopher H. Dietrich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Anderson WG, 2006, J ECON ENTOMOL, V99, P212, DOI 10.1603/0022-0493(2006)099[0212:CBHBMM]2.0.CO;2; BACKUS EA, 1983, J MORPHOL, V176, P3, DOI 10.1002/jmor.1051760102; Barringer L., 2014, PEST ALERT SPOTTED L; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P239; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P255; Brozek Jolanta, 2004, Polskie Pismo Entomologiczne, V73, P79; Brozek J, 2013, ZOOMORPHOLOGY, V132, P403, DOI 10.1007/s00435-013-0195-2; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Brozek Jolanta, 2010, Zootaxa, V2476, P39; Brozek Jolanta, 2007, P35; Chapman R.F., 1995, P101; Cobben RH, 1987, P 6 AUCH M TUR IT 8, P81; Cobben RH, 1978, EVOLUTIONARY TRENDS, P65; Cohen AC, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P563; Dai W, 2014, MICRON, V56, P8, DOI 10.1016/j.micron.2013.09.005; Ding JQ, 2006, BIOCONTROL SCI TECHN, V16, P547, DOI 10.1080/09583150500531909; Emelyanov A.F., 1987, Trudy Vsesoyuznogo Entomologicheskogo Obshchestva, V69, P19; Forbes A.R., 1977, P83; FOSTER S, 1983, CELL TISSUE RES, V230, P353; Freeman TP, 2001, ANN ENTOMOL SOC AM, V94, P761, DOI 10.1603/0013-8746(2001)094[0761:SPBBAH]2.0.CO;2; Freeman TP, 2000, MICROSC MICROANAL S2, V6, P876; Garzo E, 2012, ARTHROPOD STRUCT DEV, V41, P79, DOI 10.1016/j.asd.2011.07.005; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P86; Han Jung Min, 2008, Entomological Research, V38, P281, DOI 10.1111/j.1748-5967.2008.00188.x; Herczek A, 2001, ACTA ENTOMOL SINICA, V7, P19; Hunter WB, 1996, INT J INSECT MORPHOL, V25, P295, DOI 10.1016/0020-7322(95)00002-X; Kim H, 2013, J ASIA-PAC ENTOMOL, V16, P503, DOI 10.1016/j.aspen.2013.07.003; Kim IK, 2011, J ASIA-PAC ENTOMOL, V14, P213, DOI 10.1016/j.aspen.2011.01.004; Kim S. S., 2005, LUCANUS, V5, P9; Kramer S, 1950, ILLINOIS BIOL MONOGR, V20, pi, DOI 10.5962/bhl.title.50340; Krenn Harald W., 2007, Arthropod Systematics & Phylogeny, V65, P7; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Lee Jeong-Eun, 2009, Korean Journal of Applied Entomology, V48, P467; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; Liang AP, 2005, J ENTOMOL SCI, V40, P428, DOI 10.18474/0749-8004-40.4.428; Liang XM, 2013, ARTHROPOD STRUCT DEV, V42, P495, DOI 10.1016/j.asd.2013.08.002; Lieu KOV, 1934, YB BUREAU ENTOMOLOGY, P1; Liu G., 1939, PSYCHE, V46, P23, DOI DOI 10.1155/1939/74632; Mora R, 2001, ANN ENTOMOL SOC AM, V94, P438, DOI 10.1603/0013-8746(2001)094[0438:EMOTOH]2.0.CO;2; Park Ji-Doo, 2009, Korean Journal of Applied Entomology, V48, P53; Qadri M. A. H., 1959, P237; Rani Pathipati Usha, 2005, International Journal of Tropical Insect Science, V25, P198, DOI 10.1079/IJT200577; RANI PU, 1995, INT J INSECT MORPHOL, V24, P119, DOI 10.1016/0020-7322(94)00020-Q; ROSELL RC, 1995, INT J INSECT MORPHOL, V24, P297, DOI 10.1016/0020-7322(94)00026-M; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Sogawa K., 1977, The rice brown planthopper., P95; TAVELLA L, 1993, B ZOOL, V60, P33, DOI 10.1080/11250009309355788; Uzest M, 2010, ARTHROPOD STRUCT DEV, V39, P221, DOI 10.1016/j.asd.2010.02.005; Wang RR, 2013, MICRON, V44, P261, DOI 10.1016/j.micron.2012.07.003; Wang RR, 2012, MICROSC RES TECHNIQ, V75, P1659, DOI 10.1002/jemt.22113; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Wheeler AG, 2001, BIOL PLANT BUGS HEMI, P147; Wiesenborn WD, 2004, J KANSAS ENTOMOL SOC, V77, P152, DOI 10.2317/0307.28.1; Xiao G.R., 1992, FOREST INSECTS CHINA, V2nd eds; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001	58	15	16	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156640	10.1371/journal.pone.0156640	http://dx.doi.org/10.1371/journal.pone.0156640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253390	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700047
J	Sosulski, A; Horn, H; Zhang, LH; Coletti, C; Vathipadiekal, V; Castro, CM; Birrer, MJ; Nagano, O; Saya, H; Lage, K; Donahoe, PK; Pepin, D				Sosulski, Amanda; Horn, Heiko; Zhang, Lihua; Coletti, Caroline; Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.; Nagano, Osamu; Saya, Hideyuki; Lage, Kasper; Donahoe, Patricia K.; Pepin, David			CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis	PLOS ONE			English	Article							FAVORABLE PROGNOSIS; ADHESION MOLECULE; E-CADHERIN; EXPRESSION; CELLS; SPECTRUM; RESISTANCE; VIMENTIN; CLEAVAGE; SURVIVAL	CD44 is a transmembrane hyaluronic acid receptor gene that encodes over 100 different tissue-specific protein isoforms. The most ubiquitous, CD44 standard, has been used as a cancer stem cell marker in ovarian and other cancers. Expression of the epithelial CD44 variant containing exons v8-10 (CD44v8-10) has been associated with more chemoresistant and metastatic tumors in gastrointestinal and breast cancers, but its role in ovarian cancer is unknown; we therefore investigated its use as a prognostic marker in this disease. The gene expression profiles of 254 tumor samples from The Cancer Genome Atlas RNAseqV2 were analyzed for the presence of CD44 isoforms. A trend for longer survival was observed in patients with high expression of CD44 isoforms that include exons v8-10. Immunohistochemical (IHC) analysis of tumors for presence of CD44v8-10 was performed on an independent cohort of 210 patients with high-grade serous ovarian cancer using a tumor tissue microarray. Patient stratification based on software analysis of staining revealed a statistically significant increase in survival in patients with the highest levels of transmembrane protein expression (top 10 or 20%) compared to those with the lowest expression (bottom 10 and 20%) (p = 0.0181, p = 0.0262 respectively). Expression of CD44v8-10 in primary ovarian cancer cell lines was correlated with a predominantly epithelial phenotype characterized by high expression of epithelial markers and low expression of mesenchymal markers by qPCR, Western blot, and IHC. Conversely, detection of proteolytically cleaved and soluble extracellular domain of CD44v8-10 in patient ascites samples was correlated with significantly worse prognosis (p<0.05). Therefore, presence of transmembrane CD44v8-10 on the surface of primary tumor cells may be a marker of a highly epithelial tumor with better prognosis while enzymatic cleavage of CD44v8-10, as detected by presence of the soluble extracellular domain in ascites fluid, may be indicative of a more metastatic disease and worse prognosis.	[Sosulski, Amanda; Horn, Heiko; Zhang, Lihua; Coletti, Caroline; Lage, Kasper; Donahoe, Patricia K.; Pepin, David] Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs, Boston, MA 02114 USA; [Sosulski, Amanda; Zhang, Lihua; Coletti, Caroline; Donahoe, Patricia K.; Pepin, David] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Horn, Heiko; Lage, Kasper; Donahoe, Patricia K.; Pepin, David] Broad Inst, Cambridge, MA USA; [Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.] Massachusetts Gen Hosp, Dept Med, Gynecol Oncol, Boston, MA 02114 USA; [Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Nagano, Osamu; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan; [Nagano, Osamu; Saya, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Keio University; Japan Science & Technology Agency (JST)	Pepin, D (corresponding author), Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs, Boston, MA 02114 USA.; Pepin, D (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.; Pepin, D (corresponding author), Broad Inst, Cambridge, MA USA.	dpepin@mgh.harvard.edu	Nagano, Osamu/J-5874-2013; Saya, Hideyuki/J-4325-2013	Nagano, Osamu/0000-0002-7630-142X; Horn, Heiko/0000-0003-4898-0557; Saya, Hideyuki/0000-0001-6610-1902				Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Behrens J, 1994, Cancer Treat Res, V71, P251; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Carduner L, 2014, CLIN EXP METASTAS, V31, P675, DOI 10.1007/s10585-014-9658-1; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; Ha TU, 2000, J BIOL CHEM, V275, P37101, DOI 10.1074/jbc.M005701200; Handra-Luca A, 2011, BRIT J CANCER, V104, P1296, DOI 10.1038/bjc.2011.93; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Lau WM, 2014, CANCER RES, V74, P2630, DOI 10.1158/0008-5472.CAN-13-2309; Lockhart MS, 2001, ONCOL REP, V8, P145; Masuko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029728; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Pepin D, 2015, P NATL ACAD SCI USA, V112, pE4418, DOI 10.1073/pnas.1510604112; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rodriguez-Rodriguez L, 2003, MED ONCOL, V20, P255, DOI 10.1385/MO:20:3:255; Shi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-182; Sillanpaa S, 2003, CLIN CANCER RES, V9, P5318; SLIUTZ G, 1995, BRIT J CANCER, V72, P1494, DOI 10.1038/bjc.1995.535; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Woopen H, 2014, J GYNECOL ONCOL, V25, P221, DOI 10.3802/jgo.2014.25.3.221; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156595	10.1371/journal.pone.0156595	http://dx.doi.org/10.1371/journal.pone.0156595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253518	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700040
J	Nagamine, T; Sako, Y				Nagamine, Toshihiro; Sako, Yasushi			A Role for the Anti-Viral Host Defense Mechanism in the Phylogenetic Divergence in Baculovirus Evolution	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; BM-N CELLS; BOMBYX-MORI; ABORTIVE INFECTION; RANGE EXPANSION; RIBOSOMAL-RNA; P143; IE1; GENE; IDENTIFICATION	Although phylogenic analysis often suggests co-evolutionary relationships between viruses and host organisms, few examples have been reported at the microevolutionary level. Here, we show a possible example in which a species-specific anti-viral response may drive phylogenic divergence in insect virus evolution. Two baculoviruses, Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and Bombyx mori nucleopolyhedrovirus (BmNPV), have a high degree of DNA sequence similarity, but exhibit non-overlapping host specificity. In our study of their host-range determination, we found that BmNPV replication in B. mori cells was prevented by AcMNPV-P143 (AcP143), but not BmNPV-P143 (BmP143) or a hybrid P143 protein from a host-range expanded phenotype. This suggests that AcMNPV resistance in B. mori cells depends on AcP143 recognition and that BmNPV uses BmP143 to escapes this recognition. Based on these data, we propose an insectbaculovirus co-evolution scenario in which an ancestor of silkworms exploited an AcMNPVresistant mechanism; AcMNPV counteracted this resistance via P143 mutations, resulting in the birth of BmNPV.	[Nagamine, Toshihiro; Sako, Yasushi] RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN	Nagamine, T (corresponding author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tnaga@riken.jp	Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455	Japan Society for the Promotion of Science (JSPS) [26292173]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (26292173) from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaud O, 1998, J GEN VIROL, V79, P931, DOI 10.1099/0022-1317-79-4-931; Blissard GW, 2000, FAMILY BACULOVIRIDAE, P195; Clarke TE, 2003, J VIROL, V77, P2227, DOI 10.1128/JVI.77.3.2227-2232.2003; CROIZIER G, 1994, P NATL ACAD SCI USA, V91, P48, DOI 10.1073/pnas.91.1.48; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hamajima R, 2015, VIROLOGY, V485, P244, DOI 10.1016/j.virol.2015.08.008; Hamajima R, 2013, J GEN VIROL, V94, P2102, DOI 10.1099/vir.0.053645-0; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Iwanaga M, 2009, J INVERTEBR PATHOL, V101, P124, DOI 10.1016/j.jip.2009.05.004; KAMITA SG, 1993, J VIROL, V67, P455, DOI 10.1128/JVI.67.1.455-463.1993; KAMITA SG, 1993, J VIROL, V67, P6239, DOI 10.1128/JVI.67.10.6239-6245.1993; Kamita SG, 1997, GENE, V190, P173, DOI 10.1016/S0378-1119(96)00671-3; Kamita SG, 1996, J VIROL, V70, P6244, DOI 10.1128/JVI.70.9.6244-6250.1996; Kawasaki Y, 2004, J GEN VIROL, V85, P3575, DOI 10.1099/vir.0.80418-0; KONDO A, 1991, J VIROL, V65, P3625, DOI 10.1128/JVI.65.7.3625-3632.1991; MAEDA S, 1993, J VIROL, V67, P6234, DOI 10.1128/JVI.67.10.6234-6238.1993; Nagamine T, 2005, J VIROL, V79, P39, DOI 10.1128/JVI.79.1.39-46.2005; Nagamine T, 2006, VIROLOGY, V352, P400, DOI 10.1016/j.virol.2006.04.034; Nagamine T, 2011, VIROLOGY, V417, P188, DOI 10.1016/j.virol.2011.06.001; SMITH GE, 1978, VIROLOGY, V89, P517, DOI 10.1016/0042-6822(78)90193-9; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Xu YP, 2012, J GEN VIROL, V93, P2480, DOI 10.1099/vir.0.043836-0	22	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156394	10.1371/journal.pone.0156394	http://dx.doi.org/10.1371/journal.pone.0156394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244571	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100036
J	Mabb, AM; Simon, JM; King, IF; Lee, HM; An, LK; Philpot, BD; Zylka, MJ				Mabb, Angela M.; Simon, Jeremy M.; King, Ian F.; Lee, Hyeong-Min; An, Lin-Kun; Philpot, Benjamin D.; Zylka, Mark J.			Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms	PLOS ONE			English	Article							CELL-CYCLE ARREST; I INHIBITORS; SPINOCEREBELLAR ATAXIA; BREAK REPAIR; DNA; TRANSCRIPTION; AUTISM; UBE3A; MUTATIONS; DISRUPTION	Topoisomerase 1 (TOP1) inhibitors, including camptothecin and topotecan, covalently trap TOP1 on DNA, creating cleavage complexes (cc's) that must be resolved before gene transcription and DNA replication can proceed. We previously found that topotecan reduces the expression of long (>100 kb) genes and unsilences the paternal allele of Ube3a in neurons. Here, we sought to evaluate overlap between TOP1cc-dependent and -independent gene regulation in neurons. To do this, we utilized Top1 conditional knockout mice, Top1 knockdown, the CRISPR-Cas9 system to delete Top1, TOP1 catalytic inhibitors that do not generate TOP1cc's, and a TOP1 mutation (T718A) that stabilizes TOP1cc's. We found that topotecan treatment significantly alters the expression of many more genes, including long neuronal genes, immediate early genes, and paternal Ube3a, when compared to Top1 deletion. Our data show that topotecan has a stronger effect on neuronal transcription than Top1 deletion, and identifies TOP1cc-dependent and -independent contributions to gene expression.	[Mabb, Angela M.; Simon, Jeremy M.; King, Ian F.; Lee, Hyeong-Min; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Mabb, Angela M.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [An, Lin-Kun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia State University; Sun Yat Sen University	Philpot, BD; Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, Carolina Inst Dev Disabil, Chapel Hill, NC USA.	bphilpot@med.unc.edu; zylka@med.unc.edu	, PEP-MX Core/AGV-4051-2022; Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Mabb, Angela/0000-0002-3000-8690; King, Ian/0000-0003-3405-9767	Angelman Syndrome Foundation; National Institute of Environmental Health Sciences [DP1ES024088]; National Institute of Child Health and Human Development [5T32HD040127, P30NS045892, P30HD03110]; National Institute of Neurological Disorders and Stroke; National Natural Science Foundation of China [8137357]; Joseph E. Wagstaff Postdoctoral Research Fellowship from Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110, U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Angelman Syndrome Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joseph E. Wagstaff Postdoctoral Research Fellowship from Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to B.D.P. and M.J.Z. from the Angelman Syndrome Foundation (http://www.angelman.org/), National Institute of Environmental Health Sciences (DP1ES024088; M.J.Z.), National Institute of Child Health and Human Development (5T32HD040127; B.L.P.), National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Human Development (P30NS045892; P30HD03110, J.M.S.), and by the National Natural Science Foundation of China (No. 8137357) to L.K.A. A.M.M. was supported by the Joseph E. Wagstaff Postdoctoral Research Fellowship from the Angelman Syndrome Foundation. The confocal imaging core was funded by grants from National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Human Development (P30NS045892; P30HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Cheng Y, 2008, BIOORGAN MED CHEM, V16, P4617, DOI 10.1016/j.bmc.2008.02.036; Cristini A, 2015, NUCL ACIDS RES; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Katyal S, 2014, NAT NEUROSCI, V17, P813, DOI 10.1038/nn.3715; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Mabb AM, 2014, P NATL ACAD SCI US; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Patel AG, 2016, NUCLEIC ACIDS RES, V44, P2816, DOI 10.1093/nar/gkw109; Pearson BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11173; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Powell WT, 2013, P NATL ACAD SCI USA, V110, P13938, DOI 10.1073/pnas.1305426110; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rudenko A, 2014, NEUROPHARMACOLOGY, V80, P70, DOI 10.1016/j.neuropharm.2014.01.043; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Wu N, 2010, BIOCHEMISTRY-US, V49, P10131, DOI 10.1021/bi1009419; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Yu LM, 2015, EUR J MED CHEM, V101, P525, DOI 10.1016/j.ejmech.2015.07.007; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zylka MJ, 2015, NEURON, V86, P353, DOI 10.1016/j.neuron.2015.03.059	52	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156439	10.1371/journal.pone.0156439	http://dx.doi.org/10.1371/journal.pone.0156439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231886	Green Submitted, Green Published, gold			2022-12-27	WOS:000376883000036
J	Gobbi, E; Elliot, C; Varnier, M; Carraro, A				Gobbi, Erica; Elliot, Catherine; Varnier, Maurizio; Carraro, Attilio			Psychometric Properties of the Physical Activity Questionnaire for Older Children in Italy: Testing the Validity among a General and Clinical Pediatric Population	PLOS ONE			English	Article							SELF-REPORT; PAQ-C; EXERCISE; ADULTS; PARTICIPATION; CALIBRATION; VALIDATION; STATEMENT; ENJOYMENT; PEOPLE	The purpose of this research was to assess an Italian version of the Physical Activity Questionnaire for Older Children (PAQ-C-It). Three separate studies were conducted, whereby testing general psychometric properties, construct validity, concurrent validity and the factor structure of the PAQ-C-It among general and clinical pediatric population. Study 1 (n = 1170) examined the psychometric properties, internal consistency, factor structure (exploratory factor analysis, EFA) and construct validity with enjoyment perception during physical activity. Study 2 (n = 59) reported on reliability, construct validity with enjoyment and BMI, and on cross-sectional concurrent validity with objectively measured MVPA (tri-axial accelerometry) over the span of seven consecutive days. Study 3 (n = 58) examined the PAQ-CIt reliability, construct validity with BMI and VO(2)max as the objective measurement among a population of children with congenital heart defects (CHD). In study 2 and 3, the factor structure of the PAQ-C-It was then re-examined with an EFA. The PAQ-C-It showed acceptable to good reliability (alpha .70 to .83). Results on construct validity showed moderate but significant association with enjoyment perception (r = .30 and .36), with BMI (r = -.30 and -.79 for CHD simple form), and with the VO2max (r = .55 for CHD simple form). Significant concurrent validity with the objectively measured MVPA was reported (rho = .30, p < .05). Findings of the EFA suggested a two-factor structure for the PAQ-C-It, with items 2, 3, and 4 contributing little to the total score. This study supports the PAQ-C-It as an appropriate instrument to assess the MVPA levels of Italian children, including children with simple forms of CHD. Support is given to the possible instrument effectiveness on a large international perspective in order to level out data gathering across the globe.	[Gobbi, Erica; Carraro, Attilio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Elliot, Catherine] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Varnier, Maurizio] Univ Padua, Dept Med, Padua, Italy; [Elliot, Catherine] Lincoln Univ, Dept Tourism Sport & Soc, Lincoln, New Zealand	University of Padua; University of Basel; University of Padua; Lincoln University - New Zealand	Gobbi, E (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	erica.gobbi@unipd.it	/AAD-1762-2020; Gobbi, Erica/AAA-8602-2020; Elliot, Catherine/V-4449-2017	/0000-0002-5103-6236; Gobbi, Erica/0000-0002-4885-4932; Elliot, Catherine/0000-0001-5594-4699				Ahamed Y, 2007, MED SCI SPORT EXER, V39, P371, DOI 10.1249/01.mss.0000241654.45500.8e; Allender S, 2006, HEALTH EDUC RES, V21, P826, DOI 10.1093/her/cyl063; Arem H, 2015, AM J EPIDEMIOL, V181, P656, DOI 10.1093/aje/kwu472; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Biddle SJH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-1; Butt J, 2011, J PHYS ACT HEALTH, V8, P1074, DOI 10.1123/jpah.8.8.1074; Carraro A, 2008, SOC BEHAV PERSONAL, V36, P911, DOI 10.2224/sbp.2008.36.7.911; Chinapaw MJM, 2010, SPORTS MED, V40, P539, DOI 10.2165/11530770-000000000-00000; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connelly MS, 1998, CAN J CARDIOL, V14, P395; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Duppen N, 2013, INT J CARDIOL, V168, P1779, DOI 10.1016/j.ijcard.2013.05.086; Ekkekakis P, 2000, PSYCHOL SPORT EXERC, V1, P71, DOI DOI 10.1016/S1469-0292(00)00010-8; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Ellery CVL, 2014, INT J OBESITY, V38, P1, DOI 10.1038/ijo.2013.125; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ewalt LA, 2012, CARDIOL YOUNG, V22, P34, DOI 10.1017/S1047951111000837; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Friedenreich CM, 2006, AM J EPIDEMIOL, V163, P959, DOI 10.1093/aje/kwj112; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Haskell WL, 2012, J PHYS ACT HEALTH, V9, pS5, DOI 10.1123/jpah.9.s1.s5; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Lagerros YT, 2007, EUR J EPIDEMIOL, V22, P353, DOI 10.1007/s10654-007-9154-x; MacDonald H, 2006, BONE, V39, P598, DOI 10.1016/j.bone.2006.02.057; Matthews C.E., 2002, PHYS ACTIVITY ASSESS, P107; Moore JB, 2007, PEDIATR EXERC SCI, V19, P6, DOI 10.1123/pes.19.1.6; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Mountjoy M, 2011, BRIT J SPORT MED, V45, P839, DOI 10.1136/bjsports-2011-090228; Ray TD, 2011, CARDIOL YOUNG, V21, P603, DOI 10.1017/S1047951111000540; Saint-Maurice PF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-461; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; The Criteria Committee of the New York Heart Association, 1964, NOM CRIT DIAGN DIS H, P253; Thomas EL, 2014, PSYCHOL SPORT EXERC, V15, P280, DOI 10.1016/j.psychsport.2014.02.002; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Poppel MNM, 2010, SPORTS MED, V40, P565, DOI 10.2165/11531930-000000000-00000; Voss C, 2013, PEDIATR INT, V55, P498, DOI 10.1111/ped.12092; World Health Organization (WHO), 2007, PROC TRANSL AD INSTR	39	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156354	10.1371/journal.pone.0156354	http://dx.doi.org/10.1371/journal.pone.0156354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228050	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500122
J	Nedelkovska, H; Rosenberg, AF; Hilchey, SP; Hyrien, O; Burack, WR; Quataert, SA; Baker, CM; Azadniv, M; Welle, SL; Ansell, SM; Kim, M; Bernstein, SH				Nedelkovska, Hristina; Rosenberg, Alexander F.; Hilchey, Shannon P.; Hyrien, Ollivier; Burack, W. Richard; Quataert, Sally A.; Baker, Christina M.; Azadniv, Mitra; Welle, Stephen L.; Ansell, Stephen M.; Kim, Minsoo; Bernstein, Steven H.			Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node	PLOS ONE			English	Article							REGULATORY T-CELLS; IMMUNOLOGICAL SELF-TOLERANCE; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR MICROENVIRONMENT; HIGH NUMBERS; MEDIATED SUPPRESSION; HODGKINS-LYMPHOMA; MESSENGER-RNA; IMMUNE CELLS; ANTIGEN 4	We have previously shown that regulatory T cells (Tregs) infiltrating follicular lymphoma lymph nodes are quantitatively and qualitatively different than those infiltrating normal and reactive nodes. To gain insight into how such Treg populations differ, we performed RNA sequence (RNAseq) analyses on flow sorted Tregs from all three sources. We identify several molecules that could contribute to the observed increased suppressive capacity of follicular lymphoma nodal tregs, including upregulation of CTLA-4, IL-10, and GITR, all confirmed by protein expression. In addition, we identify, and confirm functionally, a novel mechanism by which Tregs target to and accumulate within a human tumor microenvironment, through the down regulation of S1PR1, SELL (L-selectin) and CCR7, potentially resulting in greater lymph node retention. In addition we identify and confirm functionally the upregulation of the chemokine receptor CXCR5 as well as the secretion of the chemokines CXCL13 and IL-16 demonstrating the unique ability of the follicular derived Tregs to localize and accumulate within not only the malignant lymph node, but also localize and accumulate within the malignant B cell follicle itself. Such findings offer significant new insights into how follicular lymphoma nodal Tregs may contribute to the biology of follicular lymphoma and identify several novel therapeutic targets.	[Nedelkovska, Hristina; Hilchey, Shannon P.; Burack, W. Richard; Azadniv, Mitra; Bernstein, Steven H.] Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Ctr,Lymphoma Biol Program, Rochester, NY 14642 USA; [Rosenberg, Alexander F.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Hyrien, Ollivier] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Quataert, Sally A.; Baker, Christina M.; Kim, Minsoo] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol,Aab Inst, Rochester, NY 14642 USA; [Welle, Stephen L.] Univ Rochester, Med Ctr, Genom Res Ctr, Rochester, NY 14642 USA; [Ansell, Stephen M.] Mayo Clin, Div Hematol, Rochester, MN USA; [Nedelkovska, Hristina] SUNY Coll Geneseo, Dept Biol, Geneseo, NY 14454 USA; [Bernstein, Steven H.] Bristol Myers Squibb Co, Immunooncol Translat Res & Dev, Princeton, NJ USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Mayo Clinic; State University of New York (SUNY) System; SUNY Geneseo; Bristol-Myers Squibb	Bernstein, SH (corresponding author), Univ Rochester, Med Ctr, Dept Med, James P Wilmot Canc Ctr,Lymphoma Biol Program, Rochester, NY 14642 USA.; Bernstein, SH (corresponding author), Bristol Myers Squibb Co, Immunooncol Translat Res & Dev, Princeton, NJ USA.	steven.bernstein@bms.com			National Institute for Allergy and Infectious Disease [5-29712, R24 AI054953]; Leukemia and Lymphoma Society Translational Grant [6344-11]; U.S. Public Health Service Grant [R01-CA122645]; U.S. Public Health Service Specialized Programs of Research Excellence (SPORE) [P50-CA130805]; National Institutes for Health [T32 CA09363]; NATIONAL CANCER INSTITUTE [R01CA122645, P50CA130805] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Leukemia and Lymphoma Society Translational Grant; U.S. Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); U.S. Public Health Service Specialized Programs of Research Excellence (SPORE); National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Internal Pilot Project Grant 5-29712 from National Institute for Allergy and Infectious Disease R24 AI054953 awarded to SHB and SPH. Leukemia and Lymphoma Society Translational Grant 6344-11 awarded to SHB. U.S. Public Health Service Grant R01-CA122645 awarded to SHB. U.S. Public Health Service Specialized Programs of Research Excellence (SPORE) P50-CA130805 awarded to SHB. HN was supported by National Institutes for Health Grant T32 CA09363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro T, 2006, J CLIN ONCOL, V24, P5350, DOI 10.1200/JCO.2006.06.4766; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Brady MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097597; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Carreras J, 2009, J CLIN ONCOL, V27, P1470, DOI 10.1200/JCO.2008.18.0513; Cha ZS, 2013, TUMOR BIOL, V34, P3579, DOI 10.1007/s13277-013-0937-2; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Friedberg JW, 2009, J CLIN ONCOL, V27, P1202, DOI 10.1200/JCO.2008.18.1495; Gribben JG, 2010, CURR OPIN ONCOL, V22, P424, DOI 10.1097/CCO.0b013e32833d5938; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Hilchey Shannon P, 2007, Immunol Invest, V36, P629, DOI 10.1080/08820130701674463; Hilchey SP, 2007, J IMMUNOL, V178, P4051, DOI 10.4049/jimmunol.178.7.4051; Hilchey SP, 2011, BLOOD, V118, P3591, DOI 10.1182/blood-2011-03-340646; Hilchey SP, 2009, J IMMUNOL, V183, P6157, DOI 10.4049/jimmunol.0900475; Jia YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117458; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee AM, 2006, J CLIN ONCOL, V24, P5052, DOI 10.1200/JCO.2006.06.4642; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; McFadden C, 2007, J IMMUNOL, V179, P6439, DOI 10.4049/jimmunol.179.10.6439; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Priceman SJ, 2014, CELL REP, V6, P992, DOI 10.1016/j.celrep.2014.02.016; Rawal S, 2013, J IMMUNOL, V190, P6681, DOI 10.4049/jimmunol.1201363; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Sarro SM, 2010, LEUKEMIA RES, V34, P1670, DOI 10.1016/j.leukres.2010.06.031; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Shi WW, 2014, DNA CELL BIOL, V33, P355, DOI 10.1089/dna.2013.2332; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stock P, 2004, NAT IMMUNOL, V5, P1149, DOI 10.1038/ni1122; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Sun L, 2010, IMMUNOL CELL BIOL, V88, P477, DOI 10.1038/icb.2009.117; Sweetenham JW, 2010, ANN ONCOL, V21, P1196, DOI 10.1093/annonc/mdp460; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Taquet N, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/285812; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Wahlin BE, 2010, CLIN CANCER RES, V16, P637, DOI 10.1158/1078-0432.CCR-09-2487; Wang YQ, 2011, IMMUNITY, V35, P337, DOI 10.1016/j.immuni.2011.08.012; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144; Zhang YJ, 2001, J BIOL CHEM, V276, P1299, DOI 10.1074/jbc.M008513200	51	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155347	10.1371/journal.pone.0155347	http://dx.doi.org/10.1371/journal.pone.0155347			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228053	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500016
J	Van der Straeten, C; Byttebier, P; Eeckhoudt, A; Victor, J				Van der Straeten, Catherine; Byttebier, Paul; Eeckhoudt, Annelies; Victor, Jan			Meniscal Allograft Transplantation Does Not Prevent or Delay Progression of Knee Osteoarthritis	PLOS ONE			English	Article							FOLLOW-UP; DEGENERATIVE TEARS; MENISCECTOMY; JOINT; SURGERY; ARTHROPLASTY; ARTHROSCOPY; OUTCOMES; PATIENT	Background Meniscal tears are common knee injuries. Meniscal allograft transplantation (MAT) has been advocated to alleviate symptoms and delay osteoarthritis (OA) after meniscectomy. We investigated (1) the long-term outcome of MAT as a treatment of symptomatic meniscectomy, (2) most important factors affecting survivorship and (3) OA progression. Methods From 1989 till 2013, 329 MAT were performed in 313 patients. Clinical and radiographic results and MAT survival were evaluated retrospectively. Failure was defined as conversion to knee arthroplasty (KA) or total removal of the MAT. Results Mean age at surgery was 33 years (15-57); 60% were males. No-to-mild cartilage damage was found in 156 cases, moderate-to-severe damage in 130. Simultaneous procedures in 118 patients included cartilage procedures, osteotomy or ACL-reconstruction. At a mean follow-up of 6.8 years (0.2-24.3 years), 5 patients were deceased and 48 lost (14.6%), 186 MAT were in situ (56.5%) whilst 90 (27.4%) had been removed, including 63 converted to a KA (19.2%). Cumulative allograft survivorship was 15.1%(95% CI: 13.9-16.3) at 24.0 years. In patients <35 years at surgery, survival was significantly better (24.1%) compared to >= 35 years (8.0%) (p = 0.017). In knees with no-to-mild cartilage damage more allografts survived (43.0%) compared to moderate-to-severe damage (6.6%) (p = 0.003). Simultaneous osteotomy significantly deteriorated survival (0% at 24.0 years) (p = 0.010). 61% of patients underwent at least one additional surgery (1-11) for clinical symptoms after MAT. Consecutive radiographs showed significant OA progression at a mean of 3.8 years (p<0.0001). Incremental Kellgren-Lawrence grade was +1,1 grade per 1000 days (2,7yrs). Conclusions MAT did not delay or prevent tibiofemoral OA progression. 19.2% were converted to a knee prosthesis at a mean of 10.3 years. Patients younger than 35 with no-to-mild cartilage damage may benefit from MAT for relief of symptoms (survivorship 51.9% at 20.2 years), but patients and healthcare payers and providers should be aware of the high number of surgical re-interventions.	[Van der Straeten, Catherine] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Musculoskeletal Sci & Technol, London, England; [Byttebier, Paul; Eeckhoudt, Annelies; Victor, Jan] Ghent Univ Hosp, Dept Orthopaed & Traumatol, Ghent, Belgium	Imperial College London; Ghent University; Ghent University Hospital	Van der Straeten, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Musculoskeletal Sci & Technol, London, England.	c.van-der-straeten@imperial.ac.uk	Van Der Straeten, Catherine/E-2625-2016	Van Der Straeten, Catherine/0000-0001-5659-0853; Victor, Jan/0000-0003-3988-9014				BAKER BE, 1985, AM J SPORT MED, V13, P1, DOI 10.1177/036354658501300101; Bozic KJ, 2005, J ARTHROPLASTY, V20, P17, DOI 10.1016/j.arth.2005.04.021; Carr AJ, 2015, NAT REV RHEUMATOL, V11, P77, DOI 10.1038/nrrheum.2014.174; Cohen SB, 2012, PHYSICIAN SPORTSMED, V40, P66, DOI 10.3810/psm.2012.09.1983; Debeer P, 2000, ARTHROSCOPY, V16, P71, DOI 10.1016/S0749-8063(00)90131-2; Dye SF, 1996, CLIN ORTHOP RELAT R, P10; Edd SN, 2015, J BIOMECH, V48, P1420, DOI 10.1016/j.jbiomech.2015.02.035; ElAttar M, 2011, KNEE SURG SPORT TR A, V19, P147, DOI 10.1007/s00167-010-1351-6; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664, DOI 10.1302/0301-620X.30B4.664; FUKUBAYASHI T, 1980, ACTA ORTHOP SCAND, V51, P871, DOI 10.3109/17453678008990887; Hall MJ, 2006, NATL HLTH STAT REPOR, V0; Herrlin S, 2007, KNEE SURG SPORT TR A, V15, P393, DOI 10.1007/s00167-006-0243-2; Katz JN, 2014, OSTEOARTHR CARTILAGE, V22, P1749, DOI 10.1016/j.joca.2014.07.016; Katz JN, 2013, NEW ENGL J MED, V369, P677, DOI 10.1056/NEJMc1307177; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Khan M, 2014, CAN MED ASSOC J, V186, P1057, DOI 10.1503/cmaj.140433; Khetia EA, 2007, SPORTS MED ARTHROSC, V15, P114, DOI 10.1097/JSA.0b013e3180dca217; Kim S, 2011, J BONE JOINT SURG AM, V93A, P994, DOI 10.2106/JBJS.I.01618; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lyons MC, 2012, CLIN ORTHOP RELAT R, V470, P84, DOI 10.1007/s11999-011-2144-z; MacConaill MA, 1932, J ANAT, V66, P210; McNulty AL, 2007, ARTHRITIS RHEUM-US, V56, P3033, DOI 10.1002/art.22839; Messner K, 1998, J ANAT, V193, P161, DOI 10.1046/j.1469-7580.1998.19320161.x; Moens K, 2014, ACTA ORTHOP BELG, V80, P403; Monllau JC, 2014, J TRANSPLANT TECH RE, V4, P127, DOI DOI 10.4172/2161-0991.1000127; Pengas IP, 2012, J BONE JOINT SURG BR, V94B, P1649, DOI 10.1302/0301-620X.94B12.30562; Petty CA, 2011, ARTHROSCOPY, V27, P419, DOI 10.1016/j.arthro.2010.08.016; Poulsen MR, 2011, PHYSICIAN SPORTSMED, V39, P123, DOI 10.3810/psm.2011.02.1870; Rai MF, 2013, ARTHRITIS RHEUM, V65, P1; Rai MF, 2014, ARTHRITIS RHEUMATOL, V66, P2152, DOI 10.1002/art.38643; Rancel MMS, 2001, COMMUN STAT-THEOR M, V30, P799, DOI 10.1081/STA-100002258; Reed ME, 2013, ORTHOPEDICS, V36, pE1060, DOI 10.3928/01477447-20130724-24; Roemer FW, 2015, OSTEOARTHR CARTILAGE, V23, P2184, DOI 10.1016/j.joca.2015.07.002; Rosso F, 2015, AM J SPORT MED, V43, P998, DOI 10.1177/0363546514536021; Samitier G, 2015, KNEE SURG SPORT TR A, V23, P323, DOI 10.1007/s00167-014-3344-3; Seedholm B, 1971, ARCH ENG MED, V8, P220; Sihvonen R, 2013, NEW ENGL J MED, V369, P2515, DOI 10.1056/NEJMoa1305189; SMILLIE I. S., 1967, CLIN ORTHOP RELATED RES, V51., P117; Smith NA, 2015, KNEE SURG SPORTS TRA; Stone AV, 2014, OSTEOARTHR CARTILAGE, V22, P264, DOI 10.1016/j.joca.2013.11.002; Verdonk R, 2002, Acta Orthop Belg, V68, P118; Vundelinckx B, 2014, AM J SPORT MED, V42, P1592, DOI 10.1177/0363546514530092; Warren R F, 1985, Arthroscopy, V1, P170, DOI 10.1016/S0749-8063(85)80005-0; Zaffagnini S, 2011, AM J SPORT MED, V39, P977, DOI 10.1177/0363546510391179	46	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156183	10.1371/journal.pone.0156183	http://dx.doi.org/10.1371/journal.pone.0156183			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228174	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500078
J	Khateb, M; Fourier, N; Barnea-Yizhar, O; Ram, S; Kovalev, E; Azriel, A; Rand, U; Nakayama, M; Hauser, H; Gepstein, L; Levi, B				Khateb, Mamduh; Fourier, Nitsan; Barnea-Yizhar, Ofer; Ram, Sigal; Kovalev, Ekaterina; Azriel, Aviva; Rand, Ulfert; Nakayama, Manabu; Hauser, Hansjorg; Gepstein, Lior; Levi, Ben-Zion			The Third Intron of the Interferon Regulatory Factor-8 Is an Initiator of Repressed Chromatin Restricting Its Expression in Non-Immune Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; TARGET GENES; ADENOSINE DIALDEHYDE; GENOME BROWSER; MACROPHAGES; IRF-8; DNA; ELEMENTS; DYNAMICS; DIFFERENTIATION	Interferon Regulatory Factor-8 (IRF-8) serves as a key factor in the hierarchical differentiation towards monocyte/dendritic cell lineages. While much insight has been accumulated into the mechanisms essential for its hematopoietic specific expression, the mode of restricting IRF-8 expression in non-hematopoietic cells is still unknown. Here we show that the repression of IRF-8 expression in restrictive cells is mediated by its 3rd intron. Removal of this intron alleviates the repression of Bacterial Artificial Chromosome (BAC) IRF-8 reporter gene in these cells. Fine deletion analysis points to conserved regions within this intron mediating its restricted expression. Further, the intron alone selectively initiates gene silencing only in expression-restrictive cells. Characterization of this intron's properties points to its role as an initiator of sustainable gene silencing inducing chromatin condensation with suppressive histone modifications. This intronic element cannot silence episomal transgene expression underlining a strict chromatin-dependent silencing mechanism. We validated this chromatin-state specificity of IRF-8 intron upon in-vitro differentiation of induced pluripotent stem cells (iPSCs) into cardiomyocytes. Taken together, the IRF-8 3rd intron is sufficient and necessary to initiate gene silencing in non-hematopoietic cells, highlighting its role as a nucleation core for repressed chromatin during differentiation.	[Khateb, Mamduh; Fourier, Nitsan; Barnea-Yizhar, Ofer; Ram, Sigal; Azriel, Aviva; Levi, Ben-Zion] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Kovalev, Ekaterina; Gepstein, Lior] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Kovalev, Ekaterina; Gepstein, Lior] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Rand, Ulfert; Hauser, Hansjorg] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Kazusa Kamatari, Kazusa, Japan	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Kazusa DNA Research Institute	Levi, B (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel.	blevi@technion.ac.il		Rand, Ulfert/0000-0002-5946-4921	Israel Science Foundation [121/10, 224/15]	Israel Science Foundation(Israel Science Foundation)	This research was funded by The Israel Science Foundation [grant numbers121/10, 224/15 to BZL.; We acknowledge the contribution of past members of the Levi's laboratory, Mr. Ron Shalom and Mrs. Revital Schick for their valuable contributions at the early stages of this project. We are grateful for the technical support and valuable input of Dr. Irit Huber, Dr. Limor Zwi-Dantsis, and Dr. Amira Gepstein from Dr. Lior Gepstein lab. This research was funded by The Israel Science Foundation [grant numbers121/10, 224/15 to B.Z.L]. B.Z.L. is an incumbent of the Lily and Silvian Marcus Chair in Life Sciences, Technion.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Campos EI, 2014, TRENDS CELL BIOL, V24, P664, DOI 10.1016/j.tcb.2014.08.004; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frengen E, 1999, GENOMICS, V58, P250, DOI 10.1006/geno.1998.5693; Gaunitz F, 2005, HEPATOLOGY, V41, P1225, DOI 10.1002/hep.20710; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li KK, 2012, MED RES REV, V32, P815, DOI 10.1002/mrr.20228; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TOURMENTE S, 1993, INSECT BIOCHEM MOLEC, V23, P137, DOI 10.1016/0965-1748(93)90092-7; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Yankulov K, 2013, BIOCHEM CELL BIOL, V91, P6, DOI 10.1139/bcb-2012-0048; Zwi-Dantsis L, 2011, TISSUE ENG PT A, V17, P1027, DOI 10.1089/ten.TEA.2010.0235	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156812	10.1371/journal.pone.0156812	http://dx.doi.org/10.1371/journal.pone.0156812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257682	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700135
J	Kwasniewska, J; Jaskowiak, J				Kwasniewska, Jolanta; Jaskowiak, Joanna			Transcriptional Activity of rRNA Genes in Barley Cells after Mutagenic Treatment	PLOS ONE			English	Article							ROOT-TIP CELLS; ALLIUM-CEPA L; PLANT-CELLS; ARABIDOPSIS-THALIANA; MALEIC HYDRAZIDE; NUCLEOLUS; INTERPHASE; SEQUENCES; GROWTH; BODIES	In the present study, the combination of the micronucleus test with analysis of the activity of the rRNA genes in mutagen-treated Hordeum vulgare (barley) by maleic hydrazide (MH) cells was performed. Simultaneously fluorescence in situ hybridization (FISH) with 25S rDNA as probes and an analysis of the transcriptional activity of 35S rRNA genes with silver staining were performed. The results showed that transcriptional activity is always maintained in the micronuclei although they are eliminated during the next cell cycle. The analysis of the transcriptional activity was extended to barley nuclei. MH influenced the fusion of the nucleoli in barley nuclei. The silver staining enabled detection of the nuclear bodies which arose after MH treatment. The results confirmed the usefulness of cytogenetic techniques in the characterization of micronuclei. Similar analyses can be now extended to other abiotic stresses to study the response of plant cells to the environment.	[Kwasniewska, Jolanta; Jaskowiak, Joanna] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Kwasniewska, J (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	jolanta.kwasniewska@us.edu.pl	Kwasniewska, Jolanta/ABF-1547-2020	Kwasniewska, Jolanta/0000-0002-8965-8727				BARLOW PW, 1983, PROTOPLASMA, V118, P104, DOI 10.1007/BF01293066; BARLOW PW, 1983, PROTOPLASMA, V115, P1, DOI 10.1007/BF01293574; DOLEZEL J, 1989, STAIN TECHNOL, V64, P9, DOI 10.3109/10520298909108037; GABARA B, 1995, PLANT SCI, V111, P153, DOI 10.1016/0168-9452(95)04244-O; GUERRERO F, 1989, PROTOPLASMA, V152, P96, DOI 10.1007/BF01323067; Hasterok R, 2000, FOLIA HISTOCHEM CYTO, V38, P181; Hasterok Robert, 2000, Journal of Applied Genetics, V41, P1; HIZUME M, 1980, STAIN TECHNOL, V55, P87; Hubbel HR, 1985, BIOTECH HISTOCHEM, V60, P285; Jabee Farha, 2008, Turkish Journal of Botany, V32, P337; Jiang W, 2000, B ENVIRON CONTAM TOX, V65, P786, DOI 10.1007/s001280000191; Jiang Z, 2014, INT J MOL SCI, V15, P13406, DOI 10.3390/ijms150813406; Juchimiuk J, 2007, J APPL GENET, V48, P99, DOI 10.1007/BF03194666; Juchimiuk-Kwasniewska J, 2011, J APPL GENET, V52, P23, DOI 10.1007/s13353-010-0017-x; LEITCH IJ, 1993, GENOME, V36, P517, DOI 10.1139/g93-071; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Maluszynska J, 1998, RRNA GENES THEIR DIS, P75; Qin R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-225; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; WILLIAMS LM, 1983, PROTOPLASMA, V118, P95, DOI 10.1007/BF01293065	21	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156865	10.1371/journal.pone.0156865	http://dx.doi.org/10.1371/journal.pone.0156865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257817	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700146
J	Tomiyama, Y; Fujita, K; Nishiguchi, KM; Tokashiki, N; Daigaku, R; Tabata, K; Sugano, E; Tomita, H; Nakazawa, T				Tomiyama, Yusuke; Fujita, Kosuke; Nishiguchi, Koji M.; Tokashiki, Naoyuki; Daigaku, Reiko; Tabata, Kitako; Sugano, Eriko; Tomita, Hiroshi; Nakazawa, Toru			Measurement of Electroretinograms and Visually Evoked Potentials in Awake Moving Mice	PLOS ONE			English	Article							KETAMINE-XYLAZINE ANESTHESIA; OPEN-ANGLE GLAUCOMA; OSCILLATORY POTENTIALS; PHOTORECEPTOR FUNCTION; DARK-ADAPTATION; DIABETIC-RATS; RETINOPATHY; RETINA; PREMATURITY; DYSFUNCTION	The development of new treatments for intractable retinal diseases requires reliable functional assessment tools for animal models. In vivo measurements of neural activity within visual pathways, including electroretinogram (ERG) and visually evoked potential (VEP) recordings, are commonly used for such purposes. In mice, the ERG and VEPs are usually recorded under general anesthesia, a state that may alter sensory transduction and neurotransmission, but seldom in awake freely moving mice. Therefore, it remains unknown whether the electrophysiological assessment of anesthetized mice accurately reflects the physiological function of the visual pathway. Herein, we describe a novel method to record the ERG and VEPs simultaneously in freely moving mice by immobilizing the head using a custom-built restraining device and placing a rotatable cylinder underneath to allow free running or walking during recording. Injection of the commonly used anesthetic mixture xylazine plus ketamine increased and delayed ERG oscillatory potentials by an average of 67.5% and 36.3%, respectively, compared to unanesthetized mice, while having minimal effects on the a-wave and b-wave. Similarly, components of the VEP were enhanced and delayed by up to 300.2% and 39.3%, respectively, in anesthetized mice. Our method for electrophysiological recording in conscious mice is a sensitive and robust means to assess visual function. It uses a conventional electrophysiological recording system and a simple platform that can be built in any laboratory at low cost. Measurements using this method provide objective indices of mouse visual function with high precision and stability, unaffected by anesthetics.	[Tomiyama, Yusuke; Tokashiki, Naoyuki; Daigaku, Reiko; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Dept Retinal Dis Control, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Tabata, Kitako; Sugano, Eriko; Tomita, Hiroshi] Iwate Univ, Fac Engn, Lab Visual Neurosci, Dept Chem & Bioengn,Grad Sch Engn, Morioka, Iwate 020, Japan	Tohoku University; Tohoku University; Tohoku University; Iwate University	Nishiguchi, KM (corresponding author), Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan.	nishiguchi@oph.med.tohoku.ac.jp	Tomita, Hiroshi/O-2135-2018	Tomita, Hiroshi/0000-0003-1051-2301	KAKENHI [26893018]; Japan Agency for Medical Research and Development [15lm0103007j0004]; SENJU Pharmaceutical Co., Ltd	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); SENJU Pharmaceutical Co., Ltd	This work was supported in part by KAKENHI Grants-in-Aid for Scientific Research Activity start-up (26893018; KMN; https://www.jsps.go.jp/english/index.html) and Translational Research Network program from the Japan Agency for Medical Research and Development (15lm0103007j0004; HT; http://www.amed.go.jp/en/). This study was also supported by SENJU Pharmaceutical Co., Ltd (TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AU, 2001, EXP EYE RES, V72, P667, DOI 10.1006/exer.2001.1004; Bergman S A, 1999, Anesth Prog, V46, P10; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Charng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074172; Dong CJ, 2004, VISUAL NEUROSCI, V21, P533, DOI 10.1017/S0952523804214043; Ferreri G, 2002, OPHTHALMOLOGICA, V216, P22, DOI 10.1159/000048292; Fulton AB, 1996, J OPT SOC AM A, V13, P566, DOI 10.1364/JOSAA.13.000566; GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x; Guarino Irene, 2004, Neural Plasticity, V11, P241, DOI 10.1155/NP.2004.241; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; HARA A, 1994, DOC OPHTHALMOL, V88, P39, DOI 10.1007/BF01203700; Hart CYT, 2001, AM J PHYSIOL-HEART C, V281, pH1938, DOI 10.1152/ajpheart.2001.281.5.H1938; Holopigian K, 2000, J GLAUCOMA, V9, P163; IMAI R, 1990, Journal of Toxicological Sciences, V15, P263; IMRIE MM, 1990, BRIT J ANAESTH, V64, P346, DOI 10.1093/bja/64.3.346; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Layton CJ, 2007, GRAEF ARCH CLIN EXP, V245, P1335, DOI 10.1007/s00417-006-0506-0; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P2639, DOI 10.1167/iovs.06-0016; Lopez L, 2002, BEHAV BRAIN RES, V131, P105, DOI 10.1016/S0166-4328(01)00351-5; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; SATO S, 1982, J PHARMACOL METHOD, V8, P173; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SEBEL PS, 1986, BRIT J ANAESTH, V58, P580, DOI 10.1093/bja/58.6.580; Szabo-Salfay O, 2001, BRAIN RES BULL, V56, P7, DOI 10.1016/S0361-9230(01)00585-8; Tremblay F, 2003, DOC OPHTHALMOL, V107, P271, DOI 10.1023/B:DOOP.0000005336.08147.fc; Valjakka A, 2007, GRAEF ARCH CLIN EXP, V245, P1199, DOI 10.1007/s00417-006-0519-8; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Xue YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17616; YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19	35	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156927	10.1371/journal.pone.0156927	http://dx.doi.org/10.1371/journal.pone.0156927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257864	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700157
J	Saha, P; San Yeoh, B; Singh, R; Chandrasekar, B; Vemula, PK; Haribabu, B; Vijay-Kumar, M; Jala, VR				Saha, Piu; San Yeoh, Beng; Singh, Rajbir; Chandrasekar, Bhargavi; Vemula, Praveen Kumar; Haribabu, Bodduluri; Vijay-Kumar, Matam; Jala, Venkatakrishna R.			Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases	PLOS ONE			English	Article							PUNICA-GRANATUM L.; COMMENSAL BACTERIA; PROSTATE-CANCER; POMEGRANATE; MYELOPEROXIDASE; HEALTH; MECHANISMS; HOST; BIOAVAILABILITY; CONSUMPTION	Numerous studies signify that diets rich in phytochemicals offer many beneficial functions specifically during pathologic conditions, yet their effects are often not uniform due to inter-individual variation. The host indigenous gut microbiota and their modifications of dietary phytochemicals have emerged as factors that greatly influence the efficacy of phytoceutical-based intervention. Here, we investigated the biological activities of one such active microbial metabolite, Urolithin A (UA or 3,8-dihydroxybenzo[c]chromen-6-one), which is derived from the ellagic acid (EA). Our study demonstrates that UA potently inhibits heme peroxidases i.e. myeloperoxidase (MPO) and lactoperoxidase (LPO) when compared to the parent compound EA. In addition, chrome azurol S (CAS) assay suggests that EA, but not UA, is capable of binding to Fe3+, due to its catechol-like structure, although its modest heme peroxidase inhibitory activity is abrogated upon Fe3+-binding. Interestingly, UA-mediated MPO and LPO inhibition can be prevented by innate immune protein human NGAL or its murine ortholog lipocalin 2 (Lcn2), implying the complex nature of host innate immunity-microbiota interactions. Spectral analysis indicates that UA inhibits heme peroxidase-catalyzed reaction by reverting the peroxidase back to its inactive native state. In support of these in vitro results, UA significantly reduced phorbol myristate acetate (PMA)-induced superoxide generation in neutrophils, however, EA failed to block the superoxide generation. Treatment with UA significantly reduced PMA-induced mouse ear edema and MPO activity compared to EA treated mice. Collectively, our results demonstrate that microbiota-mediated conversion of EA to UA is advantageous to both host and microbiota i.e. UA-mediated inhibition of pro-oxidant enzymes reduce tissue inflammation, mitigate non-specific killing of gut bacteria, and abrogate iron-binding property of EA, thus providing a competitive edge to the microbiota in acquiring limiting nutrient iron and thrive in the gut.	[Saha, Piu; San Yeoh, Beng; Vijay-Kumar, Matam] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Vijay-Kumar, Matam] Penn State Univ, Med Ctr, Dept Med, Hershey, PA USA; [Singh, Rajbir; Haribabu, Bodduluri; Jala, Venkatakrishna R.] Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chandrasekar, Bhargavi; Vemula, Praveen Kumar] Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Vemula, Praveen Kumar] Govt India, Dept Biotechnol, New Delhi, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Louisville; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Department of Biotechnology (DBT) India	Jala, VR (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	mvk13@psu.edu; jvrao001@louisville.edu	Bodduluri, Haribabu/A-2584-2010; Singh, Rajbir/AAT-4666-2020; Jala, Venkatakrishna R/K-7255-2018; Vijay-Kumar, Matam/Q-8988-2019	Bodduluri, Haribabu/0000-0002-8261-3294; Singh, Rajbir/0000-0002-2307-2360; Jala, Venkatakrishna R/0000-0002-4206-7305; 	Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY	Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY	The studies were supported by a pilot grant to VRJ from Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY.	Alasalvar C, 2015, BRIT J NUTR, V113, pS68, DOI 10.1017/S0007114514003729; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Banihani S, 2013, NUTR RES, V33, P341, DOI 10.1016/j.nutres.2013.03.003; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bell C, 2008, J PHARM PHARMACOL, V60, P139, DOI 10.1211/jpp.60.2.0001; Bensalem S, 2014, J ETHNOPHARMACOL, V154, P361, DOI 10.1016/j.jep.2014.03.070; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Capeillere-Blandin C, 1998, BIOCHEM J, V336, P395, DOI 10.1042/bj3360395; Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Cerda B, 2005, J AGR FOOD CHEM, V53, P5571, DOI 10.1021/jf050384i; Cerda B, 2004, EUR J NUTR, V43, P205, DOI 10.1007/s00394-004-0461-7; Cerda B, 2003, EUR J NUTR, V42, P18, DOI 10.1007/s00394-003-0396-4; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Espin JC, 2007, J AGR FOOD CHEM, V55, P10476, DOI 10.1021/jf0723864; Feng BS, 2009, N AM J MED SCI, V1, P200, DOI 10.4297/najms.2009.4200; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Girish C, 2008, FUND CLIN PHARMACOL, V22, P623, DOI 10.1111/j.1472-8206.2008.00618.x; Gonzalez-Sarrias A, 2015, J FUNCT FOODS, V19, P225, DOI 10.1016/j.jff.2015.09.019; Gonzalez-Sarrias A, 2010, MOL NUTR FOOD RES, V54, P311, DOI 10.1002/mnfr.200900152; Griswold DE, 1998, INFLAMM RES, V47, P56, DOI 10.1007/s000110050270; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Heber D, 2008, CANCER LETT, V269, P262, DOI 10.1016/j.canlet.2008.03.043; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Ishimoto H, 2011, BIOORG MED CHEM LETT, V21, P5901, DOI 10.1016/j.bmcl.2011.07.086; Jurenka J, 2008, ALTERN MED REV, V13, P128; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Larrosa M, 2010, J NUTR BIOCHEM, V21, P717, DOI 10.1016/j.jnutbio.2009.04.012; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; McFarlin BK, 2009, BRIT J NUTR, V102, P54, DOI 10.1017/S0007114508159001; Mertens-Talcott SU, 2006, J AGR FOOD CHEM, V54, P8956, DOI 10.1021/jf061674h; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Odobasic D, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2349817; Oikonomou KA, 2012, J GASTROENTEROL, V47, P519, DOI 10.1007/s00535-011-0516-5; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; San Yeoh B, 2016, AM J PATHOL, V186, P912, DOI 10.1016/j.ajpath.2015.12.004; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seeram NP, 2007, J AGR FOOD CHEM, V55, P7732, DOI 10.1021/jf071303g; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selma MV, 2014, FOOD FUNCT, V5, P1779, DOI [10.1039/C4FO00092G, 10.1039/c4fo00092g]; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tomkovich S, 2016, IMMUNOLOGY, V147, P1, DOI 10.1111/imm.12538; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Vyas U, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/872716; Xu KZY, 2009, J ETHNOPHARMACOL, V123, P280, DOI 10.1016/j.jep.2009.03.035; Zhang Hong-Mei, 2014, Cancer Biology Medicine, V11, P92, DOI 10.7497/j.issn.2095-3941.2014.02.004	73	77	79	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156811	10.1371/journal.pone.0156811	http://dx.doi.org/10.1371/journal.pone.0156811			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254317	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700064
J	Chu, TJ; Yeniterzi, S; Yatsenko, SA; Dunkel, M; Shaw, PA; Bunce, KD; Peters, DG				Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Dunkel, Mary; Shaw, Patricia A.; Bunce, Kimberly D.; Peters, David G.			High Levels of Sample-to-Sample Variation Confound Data Analysis for Non-Invasive Prenatal Screening of Fetal Microdeletions	PLOS ONE			English	Article							AMNIOCENTESIS; DNA; DIAGNOSIS; ANXIETY; TRIAL	Our goal was to test the hypothesis that inter-individual genomic copy number variation in control samples is a confounding factor in the non-invasive prenatal detection of fetal microdeletions via the sequence-based analysis of maternal plasma DNA. The database of genomic variants (DGV) was used to determine the "Genomic Variants Frequency" (GVF) for each 50kb region in the human genome. Whole genome sequencing of fifteen karyotypically normal maternal plasma and six CVS DNA controls samples was performed. The coefficient of variation of relative read counts (cv.RTC) for these samples was determined for each 50kb region. Maternal plasma from two pregnancies affected with a chromosome 5p microdeletion was also sequenced, and analyzed using the GCREM algorithm. We found strong correlation between high variance in read counts and GVF amongst controls. Consequently we were unable to confirm the presence of the microdeletion via sequencing of maternal plasma samples obtained from two sequential affected pregnancies. Caution should be exercised when performing NIPT for microdeletions. It is vital to develop our understanding of the factors that impact the sensitivity and specificity of these approaches. In particular, benign copy number variation amongst controls is a major confounder, and their effects should be corrected bioinformatically.	[Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Peters, David G.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Dunkel, Mary; Shaw, Patricia A.; Bunce, Kimberly D.; Peters, David G.] Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Peters, DG (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA.; Peters, DG (corresponding author), Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA USA.	dgp6@pitt.edu	Peters, David/AAD-4629-2019		Magee-Womens Research Institute and Foundation (MWRIF); NIH [R01 HD068578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068578] Funding Source: NIH RePORTER	Magee-Womens Research Institute and Foundation (MWRIF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Magee-Womens Research Institute and Foundation (MWRIF) and the NIH (R01 HD068578) (both to DGP).	Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chu TJ, 2014, PRENATAL DIAG, V34, P469, DOI 10.1002/pd.4331; Chu TJ, 2010, PRENATAL DIAG, V30, P1226, DOI 10.1002/pd.2656; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Hertling-Schaal E, 2001, Gynecol Obstet Fertil, V29, P440, DOI 10.1016/S1297-9589(01)00158-8; Hewison J, 2007, BJOG-INT J OBSTET GY, V114, P462, DOI 10.1111/j.1471-0528.2007.01276.x; Hewison J, 2006, HEALTH TECHNOL ASSES, V10, P1; Hillman SC, 2011, ULTRASOUND OBST GYN, V37, P6, DOI 10.1002/uog.7754; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Orozco AF, 2008, AM J PATHOL, V173, P1595, DOI 10.2353/ajpath.2008.080414; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Shaffer LG, 2012, PRENATAL DIAG, V32, P976, DOI 10.1002/pd.3945; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; TABOR A, 1986, LANCET, V1, P1287; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Yu SCY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060968	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0153182	10.1371/journal.pone.0153182	http://dx.doi.org/10.1371/journal.pone.0153182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249650	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000377184700003
J	Lo, YL; Pan, WH; Hsu, WL; Chien, YC; Chen, JY; Hsu, MM; Lou, PJ; Chen, IH; Hildesheim, A; Chen, CJ				Lo, Yen-Li; Pan, Wen-Harn; Hsu, Wan-Lun; Chien, Yin-Chu; Chen, Jen-Yang; Hsu, Mow-Ming; Lou, Pei-Jen; Chen, I-How; Hildesheim, Allan; Chen, Chien-Jen			Partial Least Square Discriminant Analysis Discovered a Dietary Pattern Inversely Associated with Nasopharyngeal Carcinoma Risk	PLOS ONE			English	Article							PRESERVED FOODS; LOW-CHOLESTEROL; NUTRIENT INTAKE; HEART-DISEASE; CHINESE DIET; CANCER; CONSUMPTION; TAIWAN; VIRUS; FISH	Evidence on the association between dietary component, dietary pattern and nasopharyngeal carcinoma (NPC) is scarce. A major challenge is the high degree of correlation among dietary constituents. We aimed to identify dietary pattern associated with NPC and to illustrate the dose-response relationship between the identified dietary pattern scores and the risk of NPC. Taking advantage of a matched NPC case-control study, data from a total of 319 incident cases and 319 matched controls were analyzed. Dietary pattern was derived employing partial least square discriminant analysis (PLS-DA) performed on energy-adjusted food frequencies derived from a 66-item food-frequency questionnaire. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with multiple conditional logistic regression models, linking pattern scores and NPC risk. A high score of the PLS-DA derived pattern was characterized by high intakes of fruits, milk, fresh fish, vegetables, tea, and eggs ordered by loading values. We observed that one unit increase in the scores was associated with a significantly lower risk of NPC (ORadj = 0.73, 95% CI = 0.60-0.88) after controlling for potential confounders. Similar results were observed among Epstein-Barr virus seropositive subjects. An NPC protective diet is indicated with more phytonutrient-rich plant foods (fruits, vegetables), milk, other protein-rich foods (in particular fresh fish and eggs), and tea. This information may be used to design potential dietary regimen for NPC prevention.	[Lo, Yen-Li; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsu, Wan-Lun; Chien, Yin-Chu; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Chunan, Taiwan; [Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei, Taiwan; [Hsu, Mow-Ming; Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Hsu, Mow-Ming; Lou, Pei-Jen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chen, I-How] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Chen, I-How] Chang Gung Univ, Taoyuan, Taiwan; [Hildesheim, Allan] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Chen, Chien-Jen] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Taiwan University	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Chen, CJ (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.; Chen, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	pan@ibms.sinica.edu.tw; chencj@gate.sinica.edu.tw	Chen, Chien-Jen/N-4723-2019; Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658; LOU, PEI-JEN/0000-0002-3383-8593	National Institutes of Health, USA; Institute of Biomedical Sciences, Academia Sinica, Taiwan; NATIONAL CANCER INSTITUTE [ZIACP010211] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biomedical Sciences, Academia Sinica, Taiwan(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported from the intramural funds from the National Institutes of Health, USA and from Institute of Biomedical Sciences, Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bidoli E, 2013, NUTR CANCER, V65, P1157, DOI 10.1080/01635581.2013.828088; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chen DL, 1997, CANCER LETT, V117, P17, DOI 10.1016/S0304-3835(97)00182-1; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chow KC, 1997, CANCER EPIDEM BIOMAR, V6, P363; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274; Edefonti V, 2015, BRIT J CANCER, V112, P446, DOI 10.1038/bjc.2014.611; Farrow DC, 1998, INT J CANCER, V78, P675, DOI 10.1002/(SICI)1097-0215(19981209)78:6&lt;675::AID-IJC2&gt;3.0.CO;2-J; Feng BJ, 2007, INT J CANCER, V121, P1550, DOI 10.1002/ijc.22813; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Hildesheim A, 1997, J NATL CANCER I, V89, P1207, DOI 10.1093/jnci/89.16.1207; Hildesheim A, 2001, CANCER EPIDEM BIOMAR, V10, P1145; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hsu C, 2006, CANCER EPIDEM BIOMAR, V15, P856, DOI 10.1158/1055-9965.EPI-05-0821; Hsu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041779; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu J, 2012, ANN ONCOL, V23, P491, DOI 10.1093/annonc/mdr155; Huang YC, 2011, ASIA PAC J CLIN NUTR, V20, P134; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kampman E, 2007, FOOD NUTR PHYS ACT P; Key TJ, 2002, LANCET, V360, P861, DOI 10.1016/S0140-6736(02)09958-0; Laouamri S, 2001, REV EPIDEMIOL SANTE, V49, P145; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; LEE MMS, 1992, INT J EPIDEMIOL, V21, P922, DOI 10.1093/ije/21.5.922; Liu MY, 1997, J MED VIROL, V52, P262, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;262::AID-JMV5&gt;3.0.CO;2-0; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; PAN WH, 1992, INT J EPIDEMIOL, V21, P929, DOI 10.1093/ije/21.5.929; Pan WH, 1991, CHOLESTEROL AND FIBE, V16, P1; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Polesel J, 2012, BRIT J CANCER, V107, P1580, DOI 10.1038/bjc.2012.413; Polesel J, 2013, CANCER CAUSE CONTROL, V24, P1157, DOI 10.1007/s10552-013-0195-z; Qin LQ, 2007, ASIA PAC J CLIN NUTR, V16, P467; Ruan Hong-Lian, 2010, Front Med China, V4, P448, DOI 10.1007/s11684-010-0280-6; Salehi M, 2013, NUTR REV, V71, P257, DOI 10.1111/nure.12028; Simko V, 2014, BRATISL MED J, V115, P59, DOI 10.4149/BLL_2014_013; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1988, CANCER RES, V48, P1954; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155892	10.1371/journal.pone.0155892	http://dx.doi.org/10.1371/journal.pone.0155892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249558	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700022
J	Takahashi, H; Uematsu, A; Yamanaka, S; Imamura, M; Nakajima, T; Doi, K; Yasuoka, S; Takahashi, C; Takeda, H; Sawasaki, T				Takahashi, Hirotaka; Uematsu, Atsushi; Yamanaka, Satoshi; Imamura, Mei; Nakajima, Tatsuro; Doi, Kousuke; Yasuoka, Saki; Takahashi, Chikako; Takeda, Hiroyuki; Sawasaki, Tatsuya			Establishment of a Wheat Cell-Free Synthesized Protein Array Containing 250 Human and Mouse E3 Ubiquitin Ligases to Identify Novel Interaction between E3 Ligases and Substrate Proteins	PLOS ONE			English	Article							FREE SYSTEM; MDM-2 ONCOGENE; GENOME-WIDE; P53; DEGRADATION; COMPLEX; SPECIFICITY; IDENTIFICATION; PATHWAY; ENZYMES	Ubiquitination is a key post-translational modification in the regulation of numerous biological processes in eukaryotes. The primary roles of ubiquitination are thought to be the triggering of protein degradation and the regulation of signal transduction. During protein ubiquitination, substrate specificity is mainly determined by E3 ubiquitin ligase (E3). Although more than 600 genes in the human genome encode E3, the E3s of many target proteins remain unidentified owing to E3 diversity and the instability of ubiquitinated proteins in cell. We demonstrate herein a novel biochemical analysis for the identification of E3s targeting specific proteins. Using wheat cell-free protein synthesis system, a protein array containing 227 human and 23 mouse recombinant E3s was synthesized. To establish the high-throughput binding assay using AlphaScreen technology, we selected MDM2 and p53 as the model combination of E3 and its target protein. The AlphaScreen assay specifically detected the binding of p53 and MDM2 in a crude translation mixture. Then, a comprehensive binding assay using the E3 protein array was performed. Eleven of the E3s showed high binding activity, including four previously reported E3s (e.g., MDM2, MDM4, and WWP1) targeting p53. This result demonstrated the reliability of the assay. Another interactors, RNF6 and DZIP3-which there have been no report to bind p53-were found to ubiquitinate p53 in vitro. Further analysis showed that RNF6 decreased the amount of p53 in H1299 cells in E3 activity-dependent manner. These results suggest the possibility that the RNF6 ubiquitinates and degrades p53 in cells. The novel in vitro screening system established herein is a powerful tool for finding novel E3s of a target protein.	[Takahashi, Hirotaka; Uematsu, Atsushi; Yamanaka, Satoshi; Imamura, Mei; Nakajima, Tatsuro; Doi, Kousuke; Yasuoka, Saki; Takahashi, Chikako; Takeda, Hiroyuki; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan	Ehime University	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp			Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS KAKENHI) [25117719, 25290077, 26640130, 15K18468, 15J03774]; Program to Disseminate Tenure Tracking System; Grants-in-Aid for Scientific Research [15J03774] Funding Source: KAKEN	Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program to Disseminate Tenure Tracking System; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (TS), the Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 25117719 to TS), the Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS KAKENHI Grant No. 25290077 and 26640130 to TS, Grant No. 15K18468 to HTakahashi and 15J03774 to AU), and Program to Disseminate Tenure Tracking System (to HTakahashi). All funding or sources of support received during this specific study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUESORAMOS CE, 1993, BLOOD, V82, P2617; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; David Y, 2011, J BIOL CHEM, V286, P44104, DOI 10.1074/jbc.M111.234559; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kruse JP, 2009, J BIOL CHEM, V284, P3250, DOI 10.1074/jbc.M805658200; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kus B, 2005, J BIOL CHEM, V280, P29470, DOI 10.1074/jbc.M502197200; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Ramadan A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0660-9; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sawasaki T, 2005, METH MOL B, V310, P131; Sharp DA, 1999, J BIOL CHEM, V274, P38189, DOI 10.1074/jbc.274.53.38189; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takahashi H, 2012, FEBS LETT, V586, P3134, DOI 10.1016/j.febslet.2012.08.014; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Tan BH, 2014, J BIOL CHEM, V289, P26368, DOI 10.1074/jbc.M114.561662; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu L, 2012, CHEM BIOL, V19, P1515, DOI 10.1016/j.chembiol.2012.09.015; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Xu X, 2016, J BIOL CHEM IN PRESS; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156718	10.1371/journal.pone.0156718	http://dx.doi.org/10.1371/journal.pone.0156718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249653	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700073
J	Eisenmann, P; Fry, B; Holyoake, C; Coughran, D; Nicol, S; Nash, SB				Eisenmann, Pascale; Fry, Brian; Holyoake, Carly; Coughran, Douglas; Nicol, Steve; Nash, Susan Bengtson			Isotopic Evidence of a Wide Spectrum of Feeding Strategies in Southern Hemisphere Humpback Whale Baleen Records	PLOS ONE			English	Article							CARBON STABLE-ISOTOPES; FOOD-WEB STRUCTURE; MEGAPTERA-NOVAEANGLIAE; ORGANOCHLORINE BURDENS; OCEAN ACIDIFICATION; TROPHIC POSITION; WEST-COAST; NITROGEN; MIGRATION; KRILL	Our current understanding of Southern hemisphere humpback whale (Megaptera novaeangliae) ecology assumes high-fidelity feeding on Antarctic krill in Antarctic waters during summer, followed by fasting during their annual migration to and from equatorial breeding grounds. An increase in the number of reported departures from this feeding/fasting model suggests that the current model may be oversimplified or, alternatively, undergoing contemporary change. Information about the feeding and fasting cycles of the two Australian breeding populations of humpback whales were obtained through stable isotope analysis of baleen plates from stranded adult individuals. Comparison of isotope profiles showed that individuals from the West Australian breeding population strongly adhered to the classical feeding model. By contrast, East Australian population individuals demonstrated greater heterogeneity in their feeding. On a spectrum from exclusive Antarctic feeding to exclusive feeding in temperate waters, three different strategies were assigned and discussed: classical feeders, supplemental feeders, and temperate zone feeders. Diversity in the inter-annual feeding strategies of humpback whales demonstrates the feeding plasticity of the species, but could also be indicative of changing dynamics within the Antarctic sea-ice ecosystem. This study presents the first investigation of trophodynamics in Southern hemisphere humpback whales derived from baleen plates, and further provides the first estimates of baleen plate elongation rates in the species.	[Eisenmann, Pascale; Nash, Susan Bengtson] Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia; [Fry, Brian] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Holyoake, Carly] Murdoch Univ, Perth, WA 6150, Australia; [Coughran, Douglas] Dept Pk & Wildlife, Kensington, WA 6151, Australia; [Nicol, Steve] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7000, Australia	Griffith University; Griffith University; Murdoch University; University of Tasmania	Eisenmann, P (corresponding author), Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia.	pascale.eisenmann@griffithuni.edu.au	Nash, Susan Bengtson/I-3942-2015; Bengtson Nash, Susan/GMX-4611-2022	Nash, Susan Bengtson/0000-0001-5928-0850; Bengtson Nash, Susan/0000-0001-5928-0850	Pacific Life Ocean Foundation; Griffith University (GUPRS); Griffith University (GUIPRS)	Pacific Life Ocean Foundation; Griffith University (GUPRS); Griffith University (GUIPRS)	This work was funded by a Pacific Life Ocean Foundation Grant (https://www.oceanfdn.org/partnerships/foundation/pacific-life-foundation) awarded to SBN and Pascale Eisenmann acknowledges two Griffith University (https://www.griffith.edu.au) post-graduate (GUPRS) and international (GUIPRS) scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2013, EVIDENCE SPATIAL STR; Aguilar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092288; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Barendse J, 2010, AFR J MAR SCI, V32, P1, DOI 10.2989/18142321003714203; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bengtson Nash S, 2014, MOBILISATION PERSIST; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Bowes RE, 2014, FRESHWATER BIOL, V59, P1926, DOI 10.1111/fwb.12396; Bruce E, 2014, APPL GEOGR, V54, P83, DOI 10.1016/j.apgeog.2014.06.014; Caraveo-Patino J, 2005, HYDROBIOLOGIA, V539, P99, DOI 10.1007/s10750-004-3370-0; Caraveo-Patino J, 2007, HYDROBIOLOGIA, V586, P17, DOI 10.1007/s10750-006-0477-5; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Christiansen F, 2013, FUNCT ECOL; Constantine R, 2014, MAR BIOL, V161, P1087, DOI 10.1007/s00227-014-2401-2; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Danilewicz Daniel, 2009, Marine Biodiversity Records, V2, pe88, DOI 10.1017/S1755267209000943; Davenport SR, 2002, CAN J FISH AQUAT SCI, V59, P514, DOI 10.1139/F02-031; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Doucett RR, 1999, CAN J FISH AQUAT SCI, V56, P2172, DOI 10.1139/cjfas-56-11-2172; FINDLAY KP, 1995, S AFR J MARINE SCI, V15, P279; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; FRY B, 1981, FISH B-NOAA, V79, P337; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Fry B, 2003, ESTUARIES, V26, P82, DOI 10.1007/BF02691696; Fry B, 1999, B MAR SCI, V65, P419; Gales N, 2009, J CETACEAN RES MANAG; Garrigue C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150489; Gascon V, 2005, ANTARCTIC KRILL CASE; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Gomez-Campos E, 2011, RAPID COMMUN MASS SP, V25, P1343, DOI 10.1002/rcm.4999; Hall-Aspland SA, 2005, OECOLOGIA, V143, P143, DOI 10.1007/s00442-004-1783-0; Harris BP, 2014, J PLANKTON RES; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hodum PJ, 2000, MAR ECOL PROG SER, V198, P273, DOI 10.3354/meps198273; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawamura A., 1994, REP INT WHALING COMM, P261; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Matthews CJD, 2015, MAR ECOL PROG SER, V522, P269, DOI 10.3354/meps11145; McMahon KW, 2015, OECOLOGIA, P1; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Nash SB, 2014, AQUAT TOXICOL, V155, P207, DOI 10.1016/j.aquatox.2014.06.021; Nash SMB, 2013, ENVIRON SCI TECHNOL, V47, P9404, DOI 10.1021/es401441n; Nielsen JM, 2015, OECOLOGIA, V178, P631, DOI 10.1007/s00442-015-3305-7; O'Driscoll RL, 1998, DEEP-SEA RES PT II, V45, P1295, DOI 10.1016/S0967-0645(98)00035-6; Owen K, 2016, POLAR BIOL, P1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Popp BN, 2007, TERR ECOL SER, V1, P173; Ratnarajah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114067; Schell D.M., 1989, Ecological Studies, V68, P260; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stockin Karen A., 2005, Aquatic Mammals, V31, P120, DOI 10.1578/AM.31.1.2005.120; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; Swart PK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041397; Trull TW, 2008, DEEP-SEA RES PT II, V55, P820, DOI 10.1016/j.dsr2.2007.12.035; WADA E, 1987, DEEP-SEA RES, V34, P829, DOI 10.1016/0198-0149(87)90039-2; Waugh CA, 2012, ORGANOHALOGEN COMPOU, V74, P919; Waugh CA, 2012, MAR ECOL PROG SER, V471, P271, DOI 10.3354/meps10059; Wei GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2332, DOI 10.1016/j.gca.2009.02.009; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; YOUNG JW, 1993, MAR BIOL, V116, P9, DOI 10.1007/BF00350726; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y	79	47	47	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156698	10.1371/journal.pone.0156698	http://dx.doi.org/10.1371/journal.pone.0156698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244081	Green Published, gold			2022-12-27	WOS:000377146100063
J	Harlan, FK; Lusk, JS; Mohr, BM; Guzikowski, AP; Batchelor, RH; Jiang, Y; Naleway, JJ				Harlan, Fiona Karen; Lusk, Jason Scott; Mohr, Breanna Michelle; Guzikowski, Anthony Peter; Batchelor, Robert Hardy; Jiang, Ying; Naleway, John Joseph			Fluorogenic Substrates for Visualizing Acidic Organelle Enzyme Activities	PLOS ONE			English	Article							ACCUMULATION; INHIBITION; MODEL	Lysosomes are acidic cytoplasmic organelles that are present in all nucleated mammalian cells and are involved in a variety of cellular processes including repair of the plasma membrane, defense against pathogens, cholesterol homeostasis, bone remodeling, metabolism, apoptosis and cell signaling. Defects in lysosomal enzyme activity have been associated with a variety of neurological diseases including Parkinson's Disease, Lysosomal Storage Diseases, Alzheimer's disease and Huntington's disease. Fluorogenic lysosomal staining probes were synthesized for labeling lysosomes and other acidic organelles in a live-cell format and were shown to be capable of monitoring lysosomal metabolic activity. The new targeted substrates were prepared from fluorescent dyes having a low pKa value for optimum fluorescence at the lower physiological pH found in lysosomes. They were modified to contain targeting groups to direct their accumulation in lysosomes as well as enzyme-cleavable functions for monitoring specific enzyme activities using a live-cell staining format. Application to the staining of cells derived from blood and skin samples of patients with Metachromatic Leukodystrophy, Krabbe and Gaucher Diseases as well as healthy human fibroblast and leukocyte control cells exhibited localization to the lysosome when compared with known lysosomal stain LysoTracker1 Red DND-99 as well as with anti-LAMP1 Antibody staining. When cell metabolism was inhibited with chloroquine, staining with an esterase substrate was reduced, demonstrating that the substrates can be used to measure cell metabolism. When applied to diseased cells, the intensity of staining was reflective of lysosomal enzyme levels found in diseased cells. Substrates specific to the enzyme deficiencies in Gaucher or Krabbe disease patient cell lines exhibited reduced staining compared to that in non-diseased cells. The new lysosome-targeted fluorogenic substrates should be useful for research, diagnostics and monitoring the effect of secondary therapeutic agents on lysosomal enzyme activity in drug development for the lysosomal storage disorders and allied diseases.	[Harlan, Fiona Karen; Lusk, Jason Scott; Guzikowski, Anthony Peter; Batchelor, Robert Hardy; Jiang, Ying] Marker Gene Technol Inc, Res & Dev, Eugene, OR USA; [Mohr, Breanna Michelle; Naleway, John Joseph] Sonas BioPharma Inc, Eugene, OR USA; [Batchelor, Robert Hardy] BT Biotech, Eugene, OR USA; [Jiang, Ying] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Naleway, JJ (corresponding author), Sonas BioPharma Inc, Eugene, OR USA.	john.naleway@sonasbiopharma.com		Mohr, Breanna/0000-0002-5879-5008; Naleway, John/0000-0002-7038-3807	National Institutes of Health [R44NS073225, R43MH079542]; Sonas BioPharma; Marker Gene Technologies, Inc.; Telethon Italy [GTB12001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM108137, R44GM108137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sonas BioPharma; Marker Gene Technologies, Inc.; Telethon Italy(Fondazione Telethon); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by grants to JJN from the National Institutes of Health (R44NS073225, R43MH079542). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of this manuscript. The funders Sonas BioPharma and Marker Gene Technologies, Inc. provided support in the form of salaries for authors [FKH, JSL, BMM, APG, YJ and JJN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Dr. Nicola Longo of the University of Utah Medical Center and Dr. Marzia Pasquali and Dr. Irene De Biase of ARUP Laboratories for the donation of patient blood and cell samples as well as their numerous discussions and advice. We would also like to thank the "Cell Line and DNA Biobank from Patients Affected by Genetic Diseases", member of the Telethon Network of Genetic Biobanks (project no. GTB12001), funded by Telethon Italy, and of the EuroBioBank network, for providing us with specimens.	BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chikte S, 2014, CYTOM PART A, V85, P169, DOI 10.1002/cyto.a.22312; Filocamo M, 2014, OPEN J BIORESOURCES, V1, pe2, DOI [DOI 10.5334/0JB.AB, 10.5334/ojb.ab, DOI 10.5334/OJB.AB]; Hein LK, 2007, MOL GENET METAB, V92, P336, DOI 10.1016/j.ymgme.2007.08.001; IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679; Laughlin ST, 2007, NAT PROTOC, V2, P2930, DOI 10.1038/nprot.2007.422; Mauri V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068060; MILLER G, 1982, YALE J BIOL MED, V55, P305; NEWBURG DS, 1986, BIOCHIM BIOPHYS ACTA, V877, P121, DOI 10.1016/0005-2760(86)90126-8; PETERS SP, 1975, CLIN CHIM ACTA, V60, P391, DOI 10.1016/0009-8981(75)90083-2; Pierzynska-Mach A, 2014, CYTOM PART A, V85A, P729, DOI 10.1002/cyto.a.22495; Poole B, 1989, J CELL BIOL, V63, P665; Raben N, 2009, METHOD ENZYMOL, V453, P417, DOI 10.1016/S0076-6879(08)04021-4; Ribbens J, 2013, ANAL BIOCHEM, V434, P15, DOI 10.1016/j.ab.2012.10.034; Ridley CM, 2013, J BIOL CHEM, V288, P26052, DOI 10.1074/jbc.M113.463562; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; VANDENBROUCKEGRAULS CMJE, 1984, IMMUNOLOGY, V51, P319; VERHOEF J, 1983, J IMMUNOL, V131, P125; Zhang YZ, 1995, US Patent, Patent No. 5869689	20	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156312	10.1371/journal.pone.0156312	http://dx.doi.org/10.1371/journal.pone.0156312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228111	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500109
J	Togao, O; Hiwatashi, A; Keupp, J; Yamashita, K; Kikuchi, K; Yoshiura, T; Yoneyama, M; Kruiskamp, MJ; Sagiyama, K; Takahashi, M; Honda, H				Togao, Osamu; Hiwatashi, Akio; Keupp, Jochen; Yamashita, Koji; Kikuchi, Kazufumi; Yoshiura, Takashi; Yoneyama, Masami; Kruiskamp, Marijn J.; Sagiyama, Koji; Takahashi, Masaya; Honda, Hiroshi			Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique	PLOS ONE			English	Article							BRAIN-TUMORS; PARACEST AGENTS; EXCHANGE; CONTRAST; GLIOBLASTOMA; COMPLEXES; PEPTIDES; PROTEINS; MRI	In this study, we evaluated the dependence of saturation pulse length on APT imaging of diffuse gliomas using a parallel transmission-based technique. Twenty-two patients with diffuse gliomas (9 low-grade gliomas, LGGs, and 13 high-grade gliomas, HGGs) were included in the study. APT imaging was conducted at 3T with a 2-channel parallel transmission scheme using three different saturation pulse lengths (0.5 s, 1.0 s, 2.0 s). The 2D fast spin-echo sequence was used for imaging. Z-spectrum was obtained at 25 frequency offsets from -6 to +6 ppm (step 0.5 ppm). A point-by-point B0 correction was performed with a B0 map. Magnetization transfer ratio (MTRasym) and Delta MTRasym (contrast between tumor and normal white matter) at 3.5 ppm were compared among different saturation lengths. A significant increase in MTRasym (3.5 ppm) of HGG was found when the length of saturation pulse became longer (3.09 +/- 0.54% at 0.5 s, 3.83 +/- 0.67% at 1 s, 4.12 +/- 0.97% at 2 s), but MTRasym (3.5 ppm) was not different among the saturation lengths in LGG Delta MTRasym (3.5 ppm) increased with the length of saturation pulse in both LGG (0.48 +/- 0.56% at 0.5 s, 1.28 +/- 0.56% at 1 s, 1.88 +/- 0.56% at 2 s and HGG (1.72 +/- 0.54% at 0.5 s, 2.90 +/- 0.49% at 1 s, 3.83 +/- 0.88% at 2 s). In both LGG and HGG, APT-weighted contrast was enhanced with the use of longer saturation pulses.	[Togao, Osamu; Hiwatashi, Akio; Yamashita, Koji; Kikuchi, Kazufumi; Yoshiura, Takashi; Sagiyama, Koji; Honda, Hiroshi] Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan; [Keupp, Jochen; Kruiskamp, Marijn J.] Philips Res Europe, Rontgenstr 24-26, D-22335 Hamburg, Germany; [Yoneyama, Masami] Philips Elect Japan, 2-13-37 Konan Minato Ku, Tokyo 1088507, Japan; [Takahashi, Masaya] UT Southwestern Med Ctr, Adv Imaging Res Ctr, 2201 Inwood Rd, Dallas, TX 75235 USA	Kyushu University; Philips; Philips Research; Philips; University of Texas System; University of Texas Southwestern Medical Center Dallas	Togao, O (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Clin Radiol, 3-1-1 Maidashi Higashi Ku, Fukuoka 8128582, Japan.	togao@radiol.med.kyushu-u.ac.jp	Togao, Osamu/AAE-4702-2022; Kikuchi, Kazufumi/AAP-4286-2021	Kikuchi, Kazufumi/0000-0003-1292-1846; Togao, Osamu/0000-0002-5910-7852; Yamashita, Koji/0000-0002-7417-739X; Sagiyama, Koji/0000-0001-7253-0703	Japan Society for the Promotion of Science (JSPS) [26461827, 26293278, 26670564, 26461826, 26461828]; Philips Research Europe and Philips Electronics Japan; JSPS KAKENHI Grant [26461827, 26293278, 26670564, 26461826, 26461828]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Philips Research Europe and Philips Electronics Japan; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research KAKENHI, grant numbers: 26461827 (OT), 26293278 (TY), 26670564 (TY), 26461826 (AH), 26461828 (KY), http://www.jsps.go.jp/english/e-grants/index.html. This work was also supported by Philips Research Europe and Philips Electronics Japan. The funders provided support in the form of salaries for authors [JK and MY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by JSPS KAKENHI Grant Number: 26461827, 26293278, 26670564, 26461826, and 26461828.	KEUPP J, 2011, P INT SOC MAGN RESON, V19, P710; Keupp J, 2012, P INT SOC MAGN RESON, V20, P4258; Mani T, 2009, CONTRAST MEDIA MOL I, V4, P183, DOI 10.1002/cmmi.279; Sagiyama K, 2014, P NATL ACAD SCI USA, V111, P4542, DOI 10.1073/pnas.1323855111; Salhotra A, 2008, NMR BIOMED, V21, P489, DOI 10.1002/nbm.1216; Togao O, 2015, J MAGN RESON IMAGING, V42, P1346, DOI 10.1002/jmri.24895; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; Togao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077019; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Wada T, 2016, RADIOL PHYS TECHNOL, V9, P15, DOI 10.1007/s12194-015-0326-1; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Woods M, 2006, CHEM SOC REV, V35, P500, DOI 10.1039/b509907m; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	18	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155925	10.1371/journal.pone.0155925	http://dx.doi.org/10.1371/journal.pone.0155925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227746	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500042
J	Zhang, XM; Wojtkowiak, JW; Martinez, GV; Cornnell, HH; Hart, CP; Baker, AF; Gillies, R				Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Hart, Charles P.; Baker, Amanda F.; Gillies, Robert			MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR HYPOXIA; NAB-PACLITAXEL; R1 RESECTIONS; CELLS; THERAPY; ANGIOGENESIS; CARCINOGENESIS; GEMCITABINE; PROGRESSION	TH-302 is a hypoxia-activated prodrug known to activate selectively under the hypoxic conditions commonly found in solid tumors. It is currently being evaluated in clinical trials, including two trials in Pancreatic Ductal Adenocarcinomas (PDAC). The current study was undertaken to evaluate imaging biomarkers for prediction and response monitoring of TH-302 efficacy in xenograft models of PDAC. Dynamic contrast-enhanced (DCE) and diffusion weighted (DW) magnetic resonance imaging (MRI) were used to monitor acute effects on tumor vasculature and cellularity, respectively. Three human PDAC xenografts with known differential responses to TH-302 were imaged prior to, and at 24 h and 48 hours following a single dose of TH-302 or vehicle to determine if imaging changes presaged changes in tumor volumes. DW-MRI was performed at five b-values to generate apparent diffusion coefficient of water (ADC) maps. For DCE-MRI, a standard clinically available contrast reagent, Gd-DTPA, was used to determine blood flow into the tumor region of interest. TH-302 induced a dramatic decrease in the DCE transfer constant (K-trans) within 48 hours after treatment in the sensitive tumors, Hs766t and Mia PaCa-2, whereas TH-302 had no effect on the perfusion behavior of resistant SU. 86.86 tumors. Tumor cellularity, estimated from ADC, was significantly increased 24 and 48 hours after treatment in Hs766t, but was not observed in the Mia PaCa-2 and SU. 86.86 groups. Notably, growth inhibition of Hs766t was observed immediately (day 3) following initiation of treatment, but was not observed in Mia-PaCa-2 tumors until 8 days after initiation of treatment. Based on these preclinical findings, DCE-MRI measures of vascular perfusion dynamics and ADC measures of cell density are suggested as potential TH-302 response biomarkers in clinical trials.	[Zhang, Xiaomeng; Wojtkowiak, Jonathan W.; Martinez, Gary V.; Cornnell, Heather H.; Gillies, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA; [Hart, Charles P.] Threshold Pharmaceut, San Francisco, CA USA; [Baker, Amanda F.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Arizona Center Cancer Care; University of Arizona	Zhang, XM (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA.	xmzhang@gmail.com		Gillies, Robert/0000-0002-8888-7747; Hart, Charles/0000-0003-4440-726X	US National Institutes of Health [R01CA125627, R01CA077575, U54CA143970]; Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG [P30-CA76292]; NATIONAL CANCER INSTITUTE [R01CA125627, U54CA143970, R01CA077575] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: US National Institutes of Health: R01CA125627, R01CA077575 and U54CA143970; www.nih.gov; the funding above was used in the study design, data collection and analysis; Moffitt Cancer Center Small Animal Imaging Laboratory, a CCSG funded core facility, CCSG Grant number: P30-CA76292; www.moffitt.org; the funding above was used for part of small animal imaging.	Akakura N, 2001, CANCER RES, V61, P6548; Angst E, 2012, J GASTROINTEST SURG, V16, P673, DOI 10.1007/s11605-011-1791-4; BROWN JM, 1994, INT J RADIAT BIOL, V65, P95, DOI 10.1080/09553009414550131; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Campbell F, 2009, HISTOPATHOLOGY, V55, P277, DOI 10.1111/j.1365-2559.2009.03376.x; Cardenas-Rodriguez J, 2012, MAGN RESON IMAGING, V30, P1002, DOI 10.1016/j.mri.2012.02.015; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Esposito I, 2008, ANN SURG ONCOL, V15, P1651, DOI 10.1245/s10434-008-9839-8; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Galban S, 2010, CURR PHARM BIOTECHNO, V11, P701, DOI 10.2174/138920110792246627; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Guo N, 2012, MOL IMAGING BIOL, V14, P743, DOI 10.1007/s11307-012-0541-7; Hart CP, 2009, CLIN EXP METASTAS, V26, P851; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Howard TJ, 2006, J GASTROINTEST SURG, V10, P1338, DOI 10.1016/j.gassur.2006.09.008; Hu JS, 2010, BLOOD, V116, P1524, DOI 10.1182/blood-2010-02-269126; Ide T, 2007, ANN SURG ONCOL, V14, P2600, DOI 10.1245/s10434-007-9435-3; Jessica D, 2011, AM ASS CANC RES ANN; Jessica D, 2010, AMERICAN ASSOCIATION; Kling J, 2012, NAT BIOTECHNOL, V30, P381, DOI 10.1038/nbt0512-381; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Liu Q, 2012, CANCER CHEMOTH PHARM, V69, P1487, DOI 10.1007/s00280-012-1852-8; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Pizzi S, 2009, HISTOL HISTOPATHOL, V24, P175, DOI 10.14670/HH-24.175; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Sun JD, 2012, CLIN CANCER RES, V18, P758, DOI 10.1158/1078-0432.CCR-11-1980; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Vaupel P, ONCOLOGIST S5, V9, P4; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wojtkowiak JW, 2015, CANCER METAB, V3, DOI 10.1186/s40170-014-0026-z; Yankeelov TE, 2007, MAGN RESON IMAGING, V25, P1, DOI 10.1016/j.mri.2006.09.006; Zafar SF, 2012, AM J CLIN ONCOLOGY; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]	42	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155289	10.1371/journal.pone.0155289	http://dx.doi.org/10.1371/journal.pone.0155289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227903	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500014
J	Kim, KH; Choi, SH; Park, SH				Kim, Ki Hwan; Choi, Seung Hong; Park, Sung-Hong			Feasibility of Quantifying Arterial Cerebral Blood Volume Using Multiphase Alternate Ascending/Descending Directional Navigation (ALADDIN)	PLOS ONE			English	Article							STATE FREE PRECESSION; VASCULAR-SPACE-OCCUPANCY; TRANSIT-TIME CHANGES; SPIN-LABELING MRI; FLOW-VELOCITY; HUMAN BRAIN; PART 1; PERFUSION; QUANTIFICATION; CONTRAST	Arterial cerebral blood volume (aCBV) is associated with many physiologic and pathologic conditions. Recently, multiphase balanced steady state free precession (bSSFP) readout was introduced to measure labeled blood signals in the arterial compartment, based on the fact that signal difference between labeled and unlabeled blood decreases with the number of RF pulses that is affected by blood velocity. In this study, we evaluated the feasibility of a new 2D inter-slice bSSFP-based arterial spin labeling (ASL) technique termed, alternate ascending/descending directional navigation (ALADDIN), to quantify aCBV using multiphase acquisition in six healthy subjects. A new kinetic model considering bSSFP RF perturbations was proposed to describe the multiphase data and thus to quantify aCBV. Since the inter-slice time delay (TD) and gap affected the distribution of labeled blood spins in the arterial and tissue compartments, we performed the experiments with two TDs (0 and 500 ms) and two gaps (300% and 450% of slice thickness) to evaluate their roles in quantifying aCBV. Comparison studies using our technique and an existing method termed arterial volume using arterial spin tagging (AVAST) were also separately performed in five subjects. At 300% gap or 500-ms TD, significant tissue perfusion signals were demonstrated, while tissue perfusion signals were minimized and arterial signals were maximized at 450% gap and 0-ms TD. ALADDIN has an advantage of visualizing bi-directional flow effects (ascending/descending) in a single experiment. Labeling efficiency (alpha) of inter-slice blood flow effects could be measured in the superior sagittal sinus (SSS) (20.8 +/- 3.7%.) and was used for aCBV quantification. As a result of fitting to the proposed model, aCBV values in gray matter (1.4-2.3 mL/100 mL) were in good agreement with those from literature. Our technique showed high correlation with AVAST, especially when arterial signals were accentuated (i.e., when TD = 0 ms) (r = 0.53). The bi-directional perfusion imaging with multiphase ALADDIN approach can be an alternative to existing techniques for quantification of aCBV.	[Kim, Ki Hwan; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea.; Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668	National Research Foundation of Korea [2013R1A1A1061759]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of South Korea [HI16C1111]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of South Korea	This work was supported by National Research Foundation of Korea (2013R1A1A1061759) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare of South Korea (HI16C1111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bieri O, 2013, J MAGN RESON IMAGING, V38, P2, DOI 10.1002/jmri.24163; Bodurka J, 2002, MAGNET RESON MED, V47, P1052, DOI 10.1002/mrm.10159; Brookes MJ, 2007, MAGN RESON MED, V58, P41, DOI 10.1002/mrm.21199; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Carr JP, 2007, MAGN RESON MED, V58, P281, DOI 10.1002/mrm.21317; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Donahue MJ, 2010, J CEREBR BLOOD F MET, V30, P1329, DOI 10.1038/jcbfm.2010.16; Duong TQ, 2000, MAGNET RESON MED, V43, P393, DOI 10.1002/(SICI)1522-2594(200003)43:3<393::AID-MRM11>3.0.CO;2-K; Francis ST, 2008, MAGN RESON MED, V59, P316, DOI 10.1002/mrm.21442; Gonzalez-At JB, 2000, MAGNET RESON MED, V43, P739, DOI 10.1002/(SICI)1522-2594(200005)43:5<739::AID-MRM17>3.0.CO;2-2; Han PK, 2016, NMR BIOMED, V29, P264, DOI 10.1002/nbm.3463; Han PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140560; Hargreaves BA, 2001, MAGNET RESON MED, V46, P149, DOI 10.1002/mrm.1170; Helenius J, 2003, ACTA RADIOL, V44, P538, DOI 10.1034/j.1600-0455.2003.00104.x; Hua J, 2011, NMR BIOMED, V24, P1313, DOI 10.1002/nbm.1693; Hua J, 2011, MAGN RESON MED, V66, P40, DOI 10.1002/mrm.22775; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; Jahanian H, 2015, MAGN RESON MED, V73, P1053, DOI 10.1002/mrm.25220; JORDAN JE, 1994, JMRI-J MAGN RESON IM, V4, P25, DOI 10.1002/jmri.1880040108; Kim T, 2005, MAGNET RESON MED, V54, P333, DOI 10.1002/mrm.20550; Kim T, 2007, J CEREBR BLOOD F MET, V27, P1235, DOI 10.1038/sj.jcbfm.9600429; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; KOBARI M, 1984, J CEREBR BLOOD F MET, V4, P110, DOI 10.1038/jcbfm.1984.15; Krieger SN, 2012, J CEREBR BLOOD F MET, V32, P1618, DOI 10.1038/jcbfm.2012.63; Liu TT, 2007, J INT NEUROPSYCH SOC, V13, P517, DOI 10.1017/S1355617707070646; Lu HZ, 2005, MAGN RESON MED, V54, P1403, DOI 10.1002/mrm.20705; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Martirosian P, 2004, MAGNET RESON MED, V51, P353, DOI 10.1002/mrm.10709; Park SH, 2015, KOREAN J RADIOL, V16, P550, DOI 10.3348/kjr.2015.16.3.550; Park SH, 2013, MAGN RESON IMAGING, V31, P1044, DOI 10.1016/j.mri.2013.03.024; Park SH, 2012, MAGN RESON MED, V68, P1600, DOI 10.1002/mrm.24169; Park SH, 2011, MAGN RESON MED, V65, P1578, DOI 10.1002/mrm.22580; Park SH, 2011, MAGN RESON MED, V65, P1702, DOI 10.1002/mrm.22568; Parkes LM, 2005, J MAGN RESON IMAGING, V22, P732, DOI 10.1002/jmri.20456; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Qin Q, 2014, NMR BIOMED, V27, P116, DOI 10.1002/nbm.3040; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Scheffler K, 2003, MAGNET RESON MED, V49, P781, DOI 10.1002/mrm.10421; WILLIAMS DM, 1987, INVEST RADIOL, V22, P642, DOI 10.1097/00004424-198708000-00005; Yan LR, 2012, MAGN RESON MED, V68, P130, DOI 10.1002/mrm.23218; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342; Ziegelitz D, 2009, MAGN RESON MED, V62, P56, DOI 10.1002/mrm.21975	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156687	10.1371/journal.pone.0156687	http://dx.doi.org/10.1371/journal.pone.0156687			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257674	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700105
J	Sariyer, IK; Sariyer, R; Otte, J; Gordon, J				Sariyer, Ilker Kudret; Sariyer, Rahsan; Otte, Jessica; Gordon, Jennifer			Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SINGLE-STRANDED-DNA; LARGE T-ANTIGEN; BINDING-PROTEIN; BETA-CATENIN; ANTIRETROVIRAL THERAPY; ASSOCIATION; AIDS; RNA; NATALIZUMAB	Objective PML is a rare and fatal demyelinating disease of the CNS caused by the human polyomavirus, JC virus (JCV), which occurs in AIDS patients and those on immunosuppressive monoclonal antibody therapies (mAbs). We sought to identify mechanisms that could stimulate reactivation of JCV in a cell culture model system and targeted pathways which could affect early gene transcription and JCV T-antigen production, which are key steps of the viral life cycle for blocking reactivation of JCV. Two important regulatory partners we have previously identified for T-antigen include Pur-alpha and SRSF1 (SF2/ASF). SRSF1, an alternative splicing factor, is a potential regulator of JCV whose overexpression in glial cells strongly suppresses viral gene expression and replication. Pur-alpha has been most extensively characterized as a sequence-specific DNA-and RNA-binding protein which directs both viral gene transcription and mRNA translation, and is a potent inducer of the JCV early promoter through binding to T-antigen. Methods and Results Pur-alpha and SRSF1 both act directly as transcriptional regulators of the JCV promoter and here we have observed that Pur-alpha is capable of ameliorating SRSF1-mediated suppression of JCV gene expression and viral replication. Interestingly, Pur-alpha exerted its effect by suppressing SRSF1 at both the protein and mRNA levels in glial cells suggesting this effect can occur independent of T-antigen. Pur-alpha and SRSF1 were both localized to oligodendrocyte inclusion bodies by immunohistochemistry in brain sections from patients with HIV-1 associated PML. Interestingly, inclusion bodies were typically positive for either Pur-alpha or SRSF1, though some cells appeared to be positive for both proteins. Conclusions Taken together, these results indicate the presence of an antagonistic interaction between these two proteins in regulating of JCV gene expression and viral replication and suggests that they play an important role during viral reactivation leading to development of PML.	[Sariyer, Ilker Kudret; Sariyer, Rahsan; Otte, Jessica; Gordon, Jennifer] Temple Univ, Dept Neurosci, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,7th Floor, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sariyer, IK (corresponding author), Temple Univ, Dept Neurosci, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,7th Floor, Philadelphia, PA 19140 USA.	isariyer@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI101192, R21NS081447, P30MH092177]; Comprehensive NeuroAIDS Center (CNAC NIMH) at the Lewis Katz School of Medicine at Temple University [P30MH092177]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081447] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Comprehensive NeuroAIDS Center (CNAC NIMH) at the Lewis Katz School of Medicine at Temple University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI101192, R21NS081447 and P30MH092177. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Susan Morgello at the Manhattan HIV Brain Bank of the NNTC for sharing AIDS-PML tissue sections. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI101192 and R21NS081447. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH Grant Number P30MH092177) at the Lewis Katz School of Medicine at Temple University. The funding organizations played no role in the design of the study, in the collection, analysis, and interpretation of the data and in the decision to submit the manuscript for publication.	Atzeni F, 2013, AUTOIMMUN REV, V12, P575, DOI 10.1016/j.autrev.2012.10.020; Beltrami S, 2014, J NEUROVIROL, V20, P137, DOI 10.1007/s13365-013-0222-6; Beltrami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053447; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Brew BJ, 2010, NAT REV NEUROL, V6, P667, DOI 10.1038/nrneurol.2010.164; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; Clifford DB, 1999, NEUROLOGY, V52, P623, DOI 10.1212/WNL.52.3.623; Craigie M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0426-x; Enam S, 2002, CANCER RES, V62, P7093; Gallia GL, 1998, J BIOL CHEM, V273, P32662, DOI 10.1074/jbc.273.49.32662; Gallia GL, 1999, J CELL BIOCHEM, V74, P334, DOI 10.1002/(SICI)1097-4644(19990901)74:3<334::AID-JCB3>3.0.CO;2-O; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Gasnault J, 1999, J NEUROVIROL, V5, P421, DOI 10.3109/13550289909029483; Gualco E, 2010, CELL DEATH DIFFER, V17, P439, DOI 10.1038/cdd.2009.146; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; Miralles P, 1998, AIDS, V12, P2467, DOI 10.1097/00002030-199818000-00016; Mishra M, 2013, J CELL PHYSIOL, V228, P65, DOI 10.1002/jcp.24105; Moulton VR, 2014, J BIOL CHEM, V289, P4126, DOI 10.1074/jbc.M113.518662; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Sariyer IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045000; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Sariyer R, 2016, J NEUROVIROL; Tassie JM, 1999, AIDS, V13, P1881, DOI 10.1097/00002030-199910010-00010; Uleri E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-147; Uleri Elena, 2011, Genes Cancer, V2, P728, DOI 10.1177/1947601911424578; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Vugmeyster Y, 2004, CLIN IMMUNOL, V113, P38, DOI 10.1016/j.clim.2004.06.001; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Wuthrich C, 2006, J NEUROVIROL, V12, P116, DOI 10.1080/13550280600716604	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156819	10.1371/journal.pone.0156819	http://dx.doi.org/10.1371/journal.pone.0156819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257867	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700137
J	Tsai, CL; Yeh, WB				Tsai, Cheng-Lung; Yeh, Wen-Bin			Subspecific Differentiation Events of Montane Stag Beetles (Coleoptera, Lucanidae) Endemic to Formosa Island	PLOS ONE			English	Article							ARC-CONTINENT COLLISION; SPECIES DELIMITATION; POPULATION-STRUCTURE; MOLECULAR-IDENTIFICATION; NEOTROPICAL BIODIVERSITY; GENUS TETTIGETTALNA; WASPS HYMENOPTERA; GENETIC DIVERSITY; SIZE VARIATION; PHYLOGEOGRAPHY	Taxonomic debates have been carrying on for decades over Formosan stag beetles, which consist of a high proportion of endemic species and subspecies featuring morphological variations associated with local adaptation. With the influence of periodical Pleistocene glaciations and the presence of several mountain ranges, the genetic differentiation and taxonomic recognition, within this medium-size island, of two endemic subspecies for each of four montane stag beetles, i.e. Lucanus ogakii, L. kanoi, Prismognathus davidis, and Neolucanus doro, has been an appealing issue. Based on monophyletic lineages and population structure, possible divergent scenarios have been proposed to clarify the subspecific status for each of the above mentioned stag beetles. Phylogenetic inferences based on COI+16S rDNA+28S rDNA of 240 Formosan lucanids have confirmed most species are monophyletic groups; and the intraspecific (<2%) and interspecific (>2%) genetic distances of the two mitochondrial genes could be applied concordantly for taxonomic identification. On account of Bayesian-based species delimitation, geographic distribution, population structure, and sequence divergences, the subspecific status for L. ogakii, L. kanoi, and Pri. davidis are congruent with their geographic distribution in this island; and the calibration time based on the mitochondrial genes shows the subspecific split events occurred 0.7-1 million years ago. In addition, a more complicated scenario, i. e. genetic differentiation including introgression/hybridization events, might have occurred among L. ogakii, L. kanoi, and L. maculifemoratus. The geological effects of mountain hindrance accompanied by periodical glaciations could have been vital in leading to the geographical subspecific differentiation of these montane stag beetles.	[Tsai, Cheng-Lung; Yeh, Wen-Bin] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan	National Chung Hsing University	Yeh, WB (corresponding author), Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan.	wbyeh@nchu.edu.tw						Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Alvarez S, 2016, J AVIAN BIOL, V47, P335, DOI 10.1111/jav.00814; Andersen JJ, 2012, J MAMMAL, V93, P1195, DOI 10.1644/11-MAMM-A-341.3; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blois JL, 2008, J BIOGEOGR, V35, P602, DOI 10.1111/j.1365-2699.2007.01836.x; Cheng HL, 2005, ZOOL STUD, V44, P329; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Ellison AM, 2004, AM J BOT, V91, P1930, DOI 10.3732/ajb.91.11.1930; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fujita H., 2010, LUCANID BEETLES WORL; Germain JF, 2013, B ENTOMOL RES, V103, P354, DOI 10.1017/S000748531200079X; Goka Kouichi, 2004, Global Environmental Research, V8, P67; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Harvey DJ, 2006, PHYSIOL ENTOMOL, V31, P218, DOI 10.1111/j.1365-3032.2006.00509.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hidalgo-Galiana A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0187-y; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hosoya T, 2005, ZOOL SCI, V22, P1305, DOI 10.2108/zsj.22.1305; Hsu YF, 2013, BUTTERFLIES TAIWAN; Huang CW, 2014, ZOOKEYS, P31, DOI 10.3897/zookeys.445.7778; Huang CY, 1997, TECTONOPHYSICS, V281, P31, DOI 10.1016/S0040-1951(97)00157-1; Huang H, 2013, STAG BEETLES CHINA; Huang H, 2010, STAG BEETLES CHINA; Huang Hao, 2012, Zootaxa, V3255, P1; Huang JP, 2010, MOL PHYLOGENET EVOL, V57, P1149, DOI 10.1016/j.ympev.2010.10.012; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Huang SC, 2005, J PLANT RES, V118, P1, DOI 10.1007/s10265-004-0185-z; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Kawano K, 2000, ANN ENTOMOL SOC AM, V93, P198, DOI 10.1603/0013-8746(2000)093[0198:GAAITS]2.0.CO;2; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kozak KM, 2015, SYST BIOL, V64, P505, DOI 10.1093/sysbio/syv007; Krajcik M., 2001, LUCANIDAE WORLD CA 1; Kuo HC, 2014, MOL ECOL, V23, P3566, DOI 10.1111/mec.12838; Lai JS, 2008, HERPETOLOGICA, V64, P63, DOI 10.1655/06-065.1; Le Ru BP, 2014, INVERTEBR SYST, V28, P451, DOI 10.1071/IS13062; Lee CF, 2016, ZOOKEYS, P23, DOI 10.3897/zookeys.568.7125; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Li HY, 2010, J ASIA-PAC ENTOMOL, V13, P267, DOI 10.1016/j.aspen.2010.05.002; Li HY, 2004, TAIWANESE STAG BEETL; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021506; Lin CP, 2011, CONSERV GENET, V12, P337, DOI 10.1007/s10592-009-9996-8; Lin HD, 2008, J FISH BIOL, V72, P2011, DOI 10.1111/j.1095-8649.2008.01836.x; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; Lin Jgun Sian, 2003, Formosan Entomologist, V23, P353; Lin SC, 2014, ODONATOLOGICA, V43, P51; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Mashkaryan V, 2013, AMPHIBIA-REPTILIA, V34, P337, DOI 10.1163/15685381-00002895; Mendes R, 2014, EUR J ENTOMOL, V111, P429, DOI 10.14411/eje.2014.054; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mizunuma T, 1994, LUCANID BEETLES WORL; Ng PKL, 2010, ZOOL STUD, V49, P544; Nunes VL, 2014, MOL ECOL RESOUR, V14, P27, DOI 10.1111/1755-0998.12158; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2014, ZOOTAXA, V3794, P108, DOI 10.11646/zootaxa.3794.1.4; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schwarzfeld MD, 2015, MOL PHYLOGENET EVOL, V93, P234, DOI 10.1016/j.ympev.2015.08.003; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Shirozu T, 1992, LEPIDOPTERA TAIWAN 2, V1, P136; Smith MA, 2013, MOL ECOL RESOUR, V13, P168, DOI 10.1111/1755-0998.12038; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatsuta H, 2004, BIOL J LINN SOC, V81, P219, DOI 10.1111/j.1095-8312.2003.00279.x; Tatsuta H, 2001, ANN ENTOMOL SOC AM, V94, P462, DOI 10.1603/0013-8746(2001)094[0462:APOHAG]2.0.CO;2; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; Toussaint EFA, 2015, MOL PHYLOGENET EVOL, V91, P194, DOI 10.1016/j.ympev.2015.05.015; Tsai CL, 2014, MOL PHYLOGENET EVOL, V78, P245, DOI 10.1016/j.ympev.2014.05.004; Tseng SP, 2015, MOL PHYLOGENET EVOL, V90, P164, DOI 10.1016/j.ympev.2015.04.022; Waldrop E, 2016, J BIOGEOGR, V43, P1116, DOI 10.1111/jbi.12680; Wang LJ., 2000, DRAGONFLIES TAIWAN; Wang TY, 2007, ZOOL STUD, V46, P547; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; Weng YM, 2016, ECOL EVOL, V6, P2061, DOI 10.1002/ece3.2006; Weng YM, 2016, ZOOKEYS IN PRESS; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123437; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wirta H, 2009, BIOL J LINN SOC, V96, P942, DOI 10.1111/j.1095-8312.2008.01156.x; Wu SP, 2016, ZOOKEYS, P121, DOI 10.3897/zookeys.557.6131; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; Yu TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098029; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang LX, 2014, BIOCHEM GENET, V52, P38, DOI 10.1007/s10528-013-9626-5	108	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156600	10.1371/journal.pone.0156600	http://dx.doi.org/10.1371/journal.pone.0156600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257861	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700086
J	Cherif, M; Granados, M; Duffy, S; Robert, P; Pequin, B; Mohit, V; McKindsey, CW; Archambault, P; Myrand, B; Lovejoy, C; Tremblay, R; Plourde, S; Fussmann, GF				Cherif, Mehdi; Granados, Monica; Duffy, Sean; Robert, Pauline; Pequin, Berangere; Mohit, Vani; McKindsey, Christopher W.; Archambault, Philippe; Myrand, Bruno; Lovejoy, Connie; Tremblay, Rejean; Plourde, Stephane; Fussmann, Gregor F.			Potential for Local Fertilization: A Benthocosm Test of Long-Term and Short-Term Effects of Mussel Excretion on the Plankton	PLOS ONE			English	Article							DE-LA-MADELEINE; MYTILUS-EDULIS; MAGDALEN ISLANDS; BIOGEOCHEMICAL FLUXES; ECOSYSTEM APPROACH; SHELLFISH CULTURE; WATER-COLUMN; RAFT CULTURE; ST-LAWRENCE; FOOD-WEB	Mussel aquaculture has expanded worldwide and it is important to assess its impact on the water column and the planktonic food web to determine the sustainability of farming practices. Mussel farming may affect the planktonic food web indirectly by excreting bioavailable nutrients in the water column (a short-term effect) or by increasing nutrient effluxes from bio-deposit-enriched sediments (a long-term effect). We tested both of these indirect effects in a lagoon by using plankton-enclosing benthocosms that were placed on the bottom of a shallow lagoon either inside of a mussel farm or at reference sites with no history of aquaculture. At each site, half of the benthocosms were enriched with seawater that had held mussels (excretion treatment), the other half received non-enriched seawater as a control treatment. We monitored nutrients ([PO43-] and [NH4+]), dissolved oxygen and plankton components (bacteria, the phytoplankton and the zooplankton) over 5 days. We found a significant relationship between long-term accumulation of mussel biodeposits in sediments, water-column nutrient concentrations and plankton growth. Effects of mussel excretion were not detected, too weak to be significant given the spatial and temporal variability observed in the lagoon. Effects of mussels on the water column are thus likely to be coupled to benthic processes in such semi-enclosed water bodies.	[Cherif, Mehdi] Umea Univ, Inst Ekol Miljo & Geovetenskap, SE-90187 Umea, Sweden; [Granados, Monica; Duffy, Sean; Fussmann, Gregor F.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Robert, Pauline; Archambault, Philippe; Tremblay, Rejean] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Pequin, Berangere; Mohit, Vani; Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1V0A6, Canada; [McKindsey, Christopher W.; Plourde, Stephane] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Myrand, Bruno] Merinov, Cap Aux Meules, PQ G4T 1B3, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Umea University; McGill University; University of Quebec; Laval University; Fisheries & Oceans Canada; Stanford University	Cherif, M (corresponding author), Umea Univ, Inst Ekol Miljo & Geovetenskap, Linnaeus Vag 6, SE-90187 Umea, Sweden.	mehdi.cherif@umu.se	Lovejoy, Connie/A-3756-2008; McKindsey, Chris/AAH-6773-2020; Cherif, Mehdi/B-2598-2013; Tremblay, Rejean/A-4971-2013	Lovejoy, Connie/0000-0001-8027-2281; Cherif, Mehdi/0000-0003-0107-9374; Tremblay, Rejean/0000-0003-2590-8915; Fussmann, Gregor/0000-0001-9576-0122; Granados, Monica/0000-0002-6750-9341; McKindsey, Chris/0000-0002-3026-6454	Natural Sciences and Engineering Research Council of Canada [365217-08, STPGP 365217]; Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Ressources Aquatique Quebec; Societe de developpement de l'industrie maricole inc.; Reseau Aquaculture Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Ressources Aquatique Quebec; Societe de developpement de l'industrie maricole inc.; Reseau Aquaculture Quebec	This research was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) with a Strategic Project Grant 365217-08 to G.F., P.A., C.L. and R.T. The authors are also grateful for generous financial and in-kind support by Fisheries and Oceans Canada (http://www.dfo-mpo.gc.ca); Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec (http://www.mapaq.gouv.qc.ca/fr/Pages/Accueil.aspx); Ressources Aquatique Quebec (http://raq.uqar.ca/index.php/fr/); Societe de developpement de l'industrie maricole inc. (http://www.sodim.org). Special thanks to the authors' industrial partner, M. Fournier and Moules de culture des Iles inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the divers, Simon Bourgeois and Frederic Hartog, without whom no experiment would have been possible. We thank them also for granting the publication of the picture in Fig 2. We acknowledge support from the Natural Science and Engineering Research Council of Canada through Strategic Project Grant STPGP 365217. We are also grateful for the generous financial and in-kind support by Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Reseau Aquaculture Quebec; and the Societe de developpement de l'industrie maricole inc. Special thanks to our industrial partner, M. Fournier and Moules de culture des Iles inc. We acknowledge the contribution of anonymous reviewers and editors in the improvement of the earlier versions of the manuscript.	BAUDINET D, 1990, HYDROBIOLOGIA, V207, P187, DOI 10.1007/BF00041456; Belzile C, 2008, J MARINE SYST, V74, P946, DOI 10.1016/j.jmarsys.2007.12.010; BLACKFORD BL, 1978, J PHYS OCEANOGR, V8, P653, DOI 10.1175/1520-0485(1978)008<0653:WDICIT>2.0.CO;2; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; Carlsson MS, 2009, J SHELLFISH RES, V28, P791, DOI 10.2983/035.028.0408; Cranford PJ, 2009, AQUACULTURE, V292, P189, DOI 10.1016/j.aquaculture.2009.04.039; Danovaro R, 2004, MAR POLLUT BULL, V49, P325, DOI 10.1016/j.marpolbul.2004.02.038; Davenport J, 2000, MAR ECOL PROG SER, V198, P131, DOI 10.3354/meps198131; FAO, 2014, THE STATE OF WORLD F; Filgueira R, 2015, MAR ECOL PROG SER, V518, P281, DOI 10.3354/meps11048; Frojan M, 2014, MAR ECOL PROG SER, V498, P43, DOI 10.3354/meps10612; Gosling E, 2003, BIVALVE MOLLUSCS BIO; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grant J, 1996, J EXP MAR BIOL ECOL, V200, P239, DOI 10.1016/S0022-0981(96)02660-3; Grasshoff K, 1999, METHODS OF SEAWATER; Guyondet T, 2005, J MARINE SYST, V58, P35, DOI 10.1016/j.jmarsys.2005.05.004; Guyondet T, 2008, ESTUAR COAST SHELF S, V77, P396, DOI 10.1016/j.ecss.2007.10.009; Guyondet T, 2010, J SEA RES, V64, P341, DOI 10.1016/j.seares.2010.05.003; Holmer M, 2008, AQUACULTURE IN THE E; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jeffrey SW, 1997, PHYTOPLANKTON PIGMEN, P597; Jiang WM, 2005, AQUACULTURE, V244, P171, DOI 10.1016/j.aquaculture.2004.11.050; Koutitonski VG, 2006, TEMPS DE RENOUVELLEM; Koutitonsky VG, 2002, ESTUAR COAST SHELF S, V54, P833, DOI 10.1006/ecss.2001.0860; Lachance AA, 2008, AQUAT BIOL, V2, P119, DOI 10.3354/ab00041; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Lindahl O, 2009, HYDROBIOLOGIA, V629, P59, DOI 10.1007/s10750-009-9771-3; Maar M, 2008, AQUAT BIOL, V4, P127, DOI 10.3354/ab00125; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Mohit V, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv038; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Nielsen TG, 2007, MAR ECOL PROG SER, V339, P185, DOI 10.3354/meps339185; NUSCH E. A., 1980, ERGEBN LIMNOL, V14, P14; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pequin B, 2015, THESIS; Petersen JK, 2008, AQUAT BIOL, V4, P113, DOI 10.3354/ab00124; Porter ET, 2004, MAR ECOL PROG SER, V271, P43, DOI 10.3354/meps271043; Richard M, 2007, CAN J FISH AQUAT SCI, V64, P1491, DOI 10.1139/F07-116; Rinaldi A, 2014, ESTUAR COAST SHELF S, V144, P89, DOI 10.1016/j.ecss.2014.04.013; Sara G, 2007, WATER RES, V41, P3187, DOI 10.1016/j.watres.2007.05.013; Shuntov VP, 2013, RUSS J MAR BIOL+, V39, P455, DOI 10.1134/S1063074013070055; Smaal AC, 2002, HYDROBIOLOGIA, V484, P89, DOI 10.1023/A:1021352904712; Sommer U, 2001, EXPERIMENTAL SYSTEMS; Souchu P, 1991, ATMOS RES, V26, P543, DOI 10.1016/0169-8095(91)90043-V; Trottet A, 2008, J EXP MAR BIOL ECOL, V365, P103, DOI 10.1016/j.jembe.2008.08.001; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Walker TR, 2014, AQUACULTURE, V433, P450, DOI 10.1016/j.aquaculture.2014.07.006; Weise AM, 2009, AQUACULTURE, V288, P239, DOI 10.1016/j.aquaculture.2008.12.001	49	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156411	10.1371/journal.pone.0156411	http://dx.doi.org/10.1371/journal.pone.0156411			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249793	Green Published, gold			2022-12-27	WOS:000377184700042
J	Lee, WJ; Woo, EJ; Oh, CS; Yoo, JA; Kim, YS; Hong, JH; Yoon, AY; Wilkinson, CM; Ju, JO; Choi, SJ; Lee, SD; Shin, DH				Lee, Won-Joon; Woo, Eun Jin; Oh, Chang Seok; Yoo, Jeong A.; Kim, Yi-Suk; Hong, Jong Ha; Yoon, A. Young; Wilkinson, Caroline M.; Ju, Jin Og; Choi, Soon Jo; Lee, Soong Doek; Shin, Dong Hoon			Bio-Anthropological Studies on Human Skeletons from the 6th Century Tomb of Ancient Silla Kingdom in South Korea	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; TECHNICAL NOTE; RECONSTRUCTION; POPULATION; SITE; ACCURACY; BONES; DIET; ASIA	In November and December 2013, unidentified human skeletal remains buried in a mokgwakmyo (a traditional wooden coffin) were unearthed while conducting an archaeological investigation near Gyeongju, which was the capital of the Silla Kingdom (57 BCE-660 CE) of ancient Korea. The human skeletal remains were preserved in relatively intact condition. In an attempt to obtain biological information on the skeleton, physical anthropological, mitochondrial DNA, stable isotope and craniofacial analyses were carried out. The results indicated that the individual was a female from the Silla period, of 155 +/- 5 cm height, who died in her late thirties. The maternal lineage belonged to the haplogroup F1b1a, typical for East Asia, and the diet had been more C3- (wheat, rice and potatoes) than C4-based (maize, millet and other tropical grains). Finally, the face of the individual was reconstructed utilizing the skull (restored from osseous fragments) and three-dimensional computerized modeling system. This study, applying multi-dimensional approaches within an overall bio-anthropological analysis, was the first attempt to collect holistic biological information on human skeletal remains dating to the Silla Kingdom period of ancient Korea.	[Lee, Won-Joon; Lee, Soong Doek; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Inst Forens Sci, Seoul, South Korea; [Woo, Eun Jin] Yonsei Univ, Div Anat & Dev Biol, Dept Oral Biol, PLUS Project BK21,Coll Dent, Seoul 120749, South Korea; [Oh, Chang Seok; Yoo, Jeong A.; Hong, Jong Ha; Shin, Dong Hoon] Seoul Natl Univ, Coll Med, Bioanthropol & Paleopathol Lab, Dept Anat, Seoul, South Korea; [Kim, Yi-Suk] Ewha Womans Univ, Sch Med, Dept Anat, Seoul, South Korea; [Yoon, A. Young] Sungkyunkwan Univ, Visual Commun Design, Seoul, South Korea; [Wilkinson, Caroline M.] Liverpool John Moores Univ, Face Lab, Liverpool Sci Pk IC1,131 Mt Pleasant, Liverpool L3 5UX, Merseyside, England; [Ju, Jin Og; Choi, Soon Jo] Fdn Silla Cultural Heritage Res Inst, Gyeongju, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Ewha Womans University; Sungkyunkwan University (SKKU); Liverpool John Moores University	Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Inst Forens Sci, Seoul, South Korea.; Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Bioanthropol & Paleopathol Lab, Dept Anat, Seoul, South Korea.	cuteminjae@gmail.com		Wilkinson, Caroline/0000-0002-4603-5554; Hong, Jong Ha/0000-0002-9104-3908	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF2015R1C1A1A02036740]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF2015R1C1A1A02036740). WJL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Benazzi S, 2014, AM J PHYS ANTHROPOL, V153, P154, DOI 10.1002/ajpa.22376; Choy K, 2015, INT J OSTEOARCHAEOL, V25, P313, DOI 10.1002/oa.2303; Choy K, 2010, AM J PHYS ANTHROPOL, V142, P74, DOI 10.1002/ajpa.21202; Choy K, 2009, J ARCHAEOL SCI, V36, P1312, DOI 10.1016/j.jas.2009.01.004; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Fantini M, 2008, RAPID PROTOTYPING J, V14, P318, DOI 10.1108/13552540810907992; FUJII A, 1960, B SCH PHYS ED, P49; Gaya National Research Institute of Cultural Heritage, 2009, LIF DEATH 16 YEAR OL, V43, P97; Han SH, 1995, KOREAN J PHYS ANTHR, V8, P205, DOI DOI 10.11637/KJPA.1995.8.2.205; HANIHARA T, 1993, AM J PHYS ANTHROPOL, V91, P173, DOI 10.1002/ajpa.1330910204; Hershkovitz I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102441; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hong SB, 2015, FORENSIC SCI INT-GEN, V17, P99, DOI 10.1016/j.fsigen.2015.03.017; Kang DY, 2012, ANAL SCI TECHNOL, V25, P300, DOI 10.5806/AST.2012.25.5.300; Kho KS, 1999, KOREAN J PHYS ANTHR, V12, P211; Koh KS, 1995, KOREAN J PHYS ANTHR, V8, P195; KVAAL SI, 1995, FORENSIC SCI INT, V74, P175, DOI 10.1016/0379-0738(95)01760-G; Lee HY, 2008, HUM BIOL, V80, P239, DOI 10.3378/1534-6617-80.3.239; Lee WJ, 2014, J ARCHAEOL SCI, V49, P228, DOI 10.1016/j.jas.2014.05.022; Lee WJ, 2015, J FORENSIC SCI, V60, P572, DOI 10.1111/1556-4029.12726; Lee WJ, 2012, J FORENSIC SCI, V57, P318, DOI 10.1111/j.1556-4029.2011.01971.x; Lim DS, 2015, ANTHROPOLOGIST, V19, P131, DOI 10.1080/09720073.2015.11891647; Min Y. S., 2012, THESIS SEOUL NATL U; Nagaoka T, 2013, ANTHROPOL SCI, V121, P203, DOI 10.1537/ase.131010; Nelson MS, 1993, ARCHAEOLOGY KOREA; Pearson K, 1899, PHIL T R SOC LOND A, V192, P169, DOI [DOI 10.1098/RSTA.1899.0004, 10.1098/rsta.1899.0004]; Richards MP, 1999, J ARCHAEOL SCI, V26, P717, DOI 10.1006/jasc.1998.0387; 강소영, 2010, [Journal of Conservation Science, 보존과학회지], V26, P95; Shin DH, 2012, AM J PHYS ANTHROPOL, V147, P433, DOI 10.1002/ajpa.22011; Shin JY., 2009, J KOREAN ARCHAEOL, V70, P84; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Tsutaya T, 2014, ANTHROPOL SCI, V122, P89, DOI 10.1537/ase.140604; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; World Archaeological Congress, 1989, WAC INT C S DAK US; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Yoneda M, 2004, J ARCHAEOL SCI, V31, P97, DOI 10.1016/S0305-4403(03)00103-1; Yu JA, 2014, ANAT CELL BIOL, V47, P244, DOI 10.5115/acb.2014.47.4.244	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156632	10.1371/journal.pone.0156632	http://dx.doi.org/10.1371/journal.pone.0156632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249220	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000377184700060
J	Milewska, A; Kaminski, K; Ciejka, J; Kosowicz, K; Zeglen, S; Wojarski, J; Nowakowska, M; Szczubialka, K; Pyrc, K				Milewska, Aleksandra; Kaminski, Kamil; Ciejka, Justyna; Kosowicz, Katarzyna; Zeglen, Slawomir; Wojarski, Jacek; Nowakowska, Maria; Szczubialka, Krzysztof; Pyrc, Krzysztof			HTCC: Broad Range Inhibitor of Coronavirus Entry	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; ANTIBACTERIAL ACTIVITY; CHITOSAN; NL63; VIRUS; HKU1; CARRAGEENAN; PNEUMONIA; PATHOGENS; MATRICES	To date, six human coronaviruses have been known, all of which are associated with respiratory infections in humans. With the exception of the highly pathogenic SARS and MERS coronaviruses, human coronaviruses (HCoV-NL63, HCoV-OC43, HCoV-229E, and HCoV-HKU1) circulate worldwide and typically cause the common cold. In most cases, infection with these viruses does not lead to severe disease, although acute infections in infants, the elderly, and immunocompromised patients may progress to severe disease requiring hospitalization. Importantly, no drugs against human coronaviruses exist, and only supportive therapy is available. Previously, we proposed the cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), and its hydrophobically-modified derivative (HM-HTCC) as potent inhibitors of the coronavirus HCoV-NL63. Here, we show that HTCC inhibits interaction of a virus with its receptor and thus blocks the entry. Further, we demonstrate that HTCC polymers with different degrees of substitution act as effective inhibitors of all low-pathogenic human coronaviruses.	[Milewska, Aleksandra; Kosowicz, Katarzyna; Pyrc, Krzysztof] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Milewska, Aleksandra; Ciejka, Justyna; Kosowicz, Katarzyna; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Kaminski, Kamil; Nowakowska, Maria; Szczubialka, Krzysztof] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland; [Zeglen, Slawomir; Wojarski, Jacek] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, PL-41800 Zabrze, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Silesian Center for Heart Diseases	Pyrc, K (corresponding author), Jagiellonian Univ, Fac Chem, Ingardena 3, PL-30060 Krakow, Poland.	szczubia@chemia.uj.edu.pl; k.a.pyrc@uj.edu.pl	Szczubiałka, Krzysztof/D-4728-2016; Ciejka, Justyna/AAL-4155-2020; Owczarek, Katarzyna/AAL-6245-2021; Kaminski, Kamil/AAJ-9650-2020	Szczubiałka, Krzysztof/0000-0001-6612-1102; Owczarek, Katarzyna/0000-0002-2166-4688; Kaminski, Kamil/0000-0002-7421-6758; Pyrc, Krzysztof/0000-0002-3867-7688; Wojarski, Jacek/0000-0001-7724-8213; Ciejka, Justyna/0000-0003-2532-3386	Unilab LP (Rockville, MD, USA) [20850]; LIDER grant from the National Centre for Research and Development [Lider/27/55/L-2/10/2011]; National Science Center [UMO-657 2012/07/E/ NZ6/01712, UMO-2012/07/N/NZ6/02955]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of the Republic of Poland	Unilab LP (Rockville, MD, USA); LIDER grant from the National Centre for Research and Development; National Science Center(National Science Centre, Poland); European Union(European Commission); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the grant "Evaluation of anticoronal compounds" from the Unilab LP (966 Hungford Dr. Ste. 3B, Rockville, MD 20850, USA) (KS and KP), by the LIDER grant from the National Centre for Research and Development (Lider/27/55/L-2/10/2011) (KP), and by grants from the National Science Center (UMO-657 2012/07/E/ NZ6/01712 and UMO-2012/07/N/NZ6/02955) (KP and AM, respectively). KP would like to acknowledge networking contribution by the COST Action CM1407 "Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery". The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100; Cho J, 2006, BIOMACROMOLECULES, V7, P3548, DOI 10.1021/bm068002k; Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7; Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4; Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Fields BN, 2013, FIELDS VIROLOGY; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Ikinci G, 2002, INT J PHARM, V235, P121, DOI 10.1016/S0378-5173(01)00974-7; Kaminski K, 2010, J MED CHEM, V53, P4141, DOI 10.1021/jm1001666; Kim MS, 2002, NEUROSCI LETT, V321, P105, DOI 10.1016/S0304-3940(02)00066-6; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Milewska A, 2013, ANTIVIR RES, V97, P112, DOI 10.1016/j.antiviral.2012.11.006; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z; Song S, 2009, IMMUNOPHARM IMMUNOT, V31, P202, DOI 10.1080/08923970802629593; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Tsujimoto K, 2010, INT J MOL MED, V25, P433, DOI 10.3892/ijmm_00000362; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Wang W, 2011, ANTIVIR RES, V92, P237, DOI 10.1016/j.antiviral.2011.08.010; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yeh MY, 2016, EXP THER MED, V11, P1300, DOI 10.3892/etm.2016.3057; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; ZHIRNOV OP, 1990, VIROLOGY, V176, P274, DOI 10.1016/0042-6822(90)90253-N	32	45	48	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156552	10.1371/journal.pone.0156552	http://dx.doi.org/10.1371/journal.pone.0156552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249425	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700051
J	Salamon, J; Hofmann, M; Jung, C; Kaul, MG; Werner, F; Them, K; Reimer, R; Nielsen, P; Scheidt, AV; Adam, G; Knopp, T; Ittrich, H				Salamon, Johannes; Hofmann, Martin; Jung, Caroline; Kaul, Michael Gerhard; Werner, Franziska; Them, Kolja; Reimer, Rudolph; Nielsen, Peter; Scheidt, Annika Vom; Adam, Gerhard; Knopp, Tobias; Ittrich, Harald			Magnetic Particle/Magnetic Resonance Imaging: In-Vitro MPI-Guided Real Time Catheter Tracking and 4D Angioplasty Using a Road Map and Blood Pool Tracer Approach	PLOS ONE			English	Article							FIELD-FREE LINE; CARDIOVASCULAR INTERVENTIONS; RECONSTRUCTION; PERSPECTIVES; INSTRUMENTS; GUIDANCE; THERAPY; MICE; MRI	Purpose In-vitro evaluation of the feasibility of 4D real time tracking of endovascular devices and stenosis treatment with a magnetic particle imaging (MPI) / magnetic resonance imaging (MRI) road map approach and an MPI-guided approach using a blood pool tracer. Materials and Methods A guide wire and angioplasty-catheter were labeled with a thin layer of magnetic lacquer. For real time MPI a custom made software framework was developed. A stenotic vessel phantom filled with saline or superparamagnetic iron oxide nanoparticles (MM4) was equipped with bimodal fiducial markers for co-registration in preclinical 7T MRI and MPI. In-vitro angioplasty was performed inflating the balloon with saline or MM4. MPI data were acquired using a field of view of 37.3x37.3x18.6 mm(3) and a frame rate of 46 volumes/sec. Analysis of the magnetic lacquer-marks on the devices were performed with electron microscopy, atomic absorption spectrometry and micro-computed tomography. Results Magnetic marks allowed for MPI/MRI guidance of interventional devices. Bimodal fiducial markers enable MPI/MRI image fusion for MRI based roadmapping. MRI roadmapping and the blood pool tracer approach facilitate MPI real time monitoring of in-vitro angioplasty. Successful angioplasty was verified with MPI and MRI. Magnetic marks consist of micrometer sized ferromagnetic plates mainly composed of iron and iron oxide. Conclusions 4D real time MP imaging, tracking and guiding of endovascular instruments and in-vitro angioplasty is feasible. In addition to an approach that requires a blood pool tracer, MRI based roadmapping might emerge as a promising tool for radiation free 4D MPI-guided interventions.	[Salamon, Johannes; Jung, Caroline; Kaul, Michael Gerhard; Adam, Gerhard; Knopp, Tobias; Ittrich, Harald] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany; [Hofmann, Martin; Werner, Franziska; Them, Kolja; Knopp, Tobias] Univ Med Ctr Hamburg Eppendorf, Sect Biomed Imaging, Hamburg, Germany; [Hofmann, Martin; Werner, Franziska; Them, Kolja; Knopp, Tobias] Hamburg Univ Technol, Inst Biomed Imaging, Hamburg, Germany; [Reimer, Rudolph] Heinrich Pette Inst, Leibniz Inst Expt Virol, Microscopy & Image Anal, Hamburg, Germany; [Nielsen, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany; [Scheidt, Annika Vom] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hamburg University of Technology; Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Salamon, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol & Nucl Med, Hamburg, Germany.	j.salamon@uke.de	Scheidt, Annika vom/AAH-4263-2020; Knopp, Tobias/AAH-1644-2019	Scheidt, Annika vom/0000-0002-3756-8770; Knopp, Tobias/0000-0002-1589-8517; Them, Kolja/0000-0002-5512-0910	German Research Foundation (DFG) [AD 125/5-1]; city of Hamburg	German Research Foundation (DFG)(German Research Foundation (DFG)); city of Hamburg	The authors thankfully acknowledge funding and support by the German Research Foundation (DFG, grant number AD 125/5-1) and the city of Hamburg.	Bente K, 2015, IEEE T MED IMAGING, V34, P644, DOI 10.1109/TMI.2014.2364891; Bezanson Jeff K S, 2012, CORR; Borgert J, 2013, BIOMED ENG-BIOMED TE, V58, P551, DOI 10.1515/bmt-2012-0064; Borgert J, 2012, J CARDIOVASC COMPUT, V6, P149, DOI 10.1016/j.jcct.2012.04.007; Duschka RL, 2014, J HEALTHC ENG, V5, P79, DOI 10.1260/2040-2295.5.1.79; Erbe M, 2011, MED PHYS, V38, P5200, DOI 10.1118/1.3626481; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Haegele J, 2012, ROFO-FORTSCHR RONTG, V184, P420, DOI 10.1055/s-0031-1281981; Haegele J, 2014, INT J NANOMED, V9, P4203, DOI 10.2147/IJN.S49976; Haegele J, 2013, MAGN RESON MED, V69, P1761, DOI 10.1002/mrm.24421; Haegele J, 2012, RADIOLOGY, V265, P933, DOI 10.1148/radiol.12120424; Han SH, 2014, PHYS MED BIOL, V59, P6521, DOI 10.1088/0031-9155/59/21/6521; Ittrich H, 2013, ROFO-FORTSCHR RONTG, V185, P1149, DOI 10.1055/s-0033-1335438; Kaul MG, 2015, ROFO-FORTSCHR RONTG, V187, P347, DOI 10.1055/s-0034-1399344; Khandhar A. P., 2015, IEEE T MAGN, V51; Knopp T, 2015, PHYS MED BIOL, V60, pL15, DOI 10.1088/0031-9155/60/8/L15; Knopp T, 2010, PHYS MED BIOL, V55, P1577, DOI 10.1088/0031-9155/55/6/003; Knopp T, 2013, IEEE T MED IMAGING, V32, P1473, DOI 10.1109/TMI.2013.2258029; Knopp T, 2010, IEEE T MED IMAGING, V29, P12, DOI 10.1109/TMI.2009.2021612; Kuntz J, 2013, PHYS MED BIOL, V58, P3283, DOI 10.1088/0031-9155/58/10/3283; Kuntz J, 2013, EUR RADIOL, V23, P1669, DOI 10.1007/s00330-012-2761-2; Lampe J, 2012, PHYS MED BIOL, V57, P1113, DOI 10.1088/0031-9155/57/4/1113; Markov DE, 2010, PHYS MED BIOL, V55, P6461, DOI 10.1088/0031-9155/55/21/008; Pablico-Lansigan MH, 2013, NANOSCALE, V5, P4040, DOI 10.1039/c3nr00544e; Raabe N, 2015, CONTRAST MEDIA MOL I, V10, P153, DOI 10.1002/cmmi.1612; Rahmer J, 2015, PHYS MED BIOL, V60, P1775, DOI 10.1088/0031-9155/60/5/1775; Rahmer J, 2013, PHYS MED BIOL, V58, P3965, DOI 10.1088/0031-9155/58/12/3965; Vogel P, 2014, IEEE T MED IMAGING, V33, P1954, DOI 10.1109/TMI.2014.2327515; Weber T, 2015, ADV MATH PHYS; Weizenecker J, 2007, PHYS MED BIOL, V52, P6363, DOI 10.1088/0031-9155/52/21/001; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01; Wojtczyk H, 2013, BIOMED TECH BERL	32	64	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156899	10.1371/journal.pone.0156899	http://dx.doi.org/10.1371/journal.pone.0156899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249022	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700078
J	Karamyan, A; Dunser, MW; Wiebe, DJ; Pilz, G; Wipfler, P; Chroust, V; Novak, HF; Hauer, L; Trinka, E; Sellner, J				Karamyan, Anush; Duenser, Martin W.; Wiebe, Douglas J.; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Hauer, Larissa; Trinka, Eugen; Sellner, Johann			Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study	PLOS ONE			English	Article							ILL PATIENTS; MORTALITY; MULTICENTER; ADMISSION; COST	Background Over the course of multiple sclerosis (MS) several conditions may arise that require critical care. We aimed to study the reasons for admission and outcome in patients with MS admitted to a neuro-intensive care unit (NICU). Methods We retrospectively searched the electronic charts of a 9-bedded NICU in a tertiary hospital for patients with a diagnosis of multiple sclerosis (MS) from 1993-2015, and matched them to NICU controls without MS based on age and gender. Conditional logistic regression was used to compare admission causes, Charlson's Comorbidity Index, indicators of disease severity, and survival between MS and non-MS patients. Results We identified 61 MS patients and 181 non-MS controls. Respiratory dysfunction was the most frequent reason for NICU admission among MS patients (34.4%), having infectious context as a rule. In a matched analysis, after adjusting for co-morbidities and immunosuppressive medications, patients with MS were more likely to be admitted to the NICU because of respiratory dysfunction (OR = 7.86, 95% CI 3.02-20.42, p<0.001), non-respiratory infections (OR = 3.71, 95% CI 1.29-10.68, p = 0.02), had a higher rate of multiple NICU admissions (OR = 2.53, 95% CI 1.05-6.05, p = 0.04) than non-MS patients. Mortality after NICU admission at a median follow-up time of 1 year was higher in MS than control patients (adjusted OR = 4.21, 95% CI 1.49-11.85, p = 0.04). Conclusion The most common reason for NICU admission in MS patients was respiratory dysfunction due to infection. Compared to non-MS patients, critically ill MS patients had a higher NICU re-admission rate, and a higher mortality.	[Karamyan, Anush; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Trinka, Eugen; Sellner, Johann] Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria; [Karamyan, Anush; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Trinka, Eugen; Sellner, Johann] Ctr Cognit Neurosci, Salzburg, Austria; [Duenser, Martin W.] Univ Hosp Salzburg, Dept Anesthesiol Perioperat & Gen Intens Care Med, Salzburg, Austria; [Duenser, Martin W.] Paracelsus Med Univ, Salzburg, Austria; [Wiebe, Douglas J.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hauer, Larissa] Paracelsus Med Univ, Dept Psychiat, Christian Doppler Med Ctr, Salzburg, Austria; [Sellner, Johann] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-80290 Munich, Germany	Paracelsus Private Medical University; Paracelsus Private Medical University; University of Pennsylvania; Pennsylvania Medicine; Paracelsus Private Medical University; Technical University of Munich	Sellner, J (corresponding author), Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria.; Sellner, J (corresponding author), Ctr Cognit Neurosci, Salzburg, Austria.; Sellner, J (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-80290 Munich, Germany.	j.sellner@salk.at	Selllner, Johann/AAB-1263-2019; Wiebe, Douglas J/Q-1168-2017	Pilz, Georg/0000-0001-8764-2628; Wipfler, Peter/0000-0003-4982-4855; Trinka, Eugen/0000-0002-5950-2692	Merck; Paracelsus Medical University; Bayer; Biogen-Idec; Novartis; Genzyme	Merck(Merck & Company); Paracelsus Medical University; Bayer(Bayer AG); Biogen-Idec(Biogen); Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation)	This study was in part supported by an unrestricted grant from Merck. JS has received research funding from the Paracelsus Medical University, Bayer, Biogen-Idec, Merck and Novartis, has acted as paid consultant to Novartis and Genzyme, and has received speakers' honoraria from Biogen-Idec, Ever Neuropharma, Genzyme, Novartis and Teva-Ratiopharm. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Bernal-Macias S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000122; Brinkman S, 2013, CRIT CARE MED, V41, P1229, DOI 10.1097/CCM.0b013e31827ca4e1; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Findling O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121856; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Goodin DS, 2014, HAND CLINIC, V122, P231, DOI 10.1016/B978-0-444-52001-2.00010-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2014, NEUROLOGY, V82, P2112, DOI 10.1212/WNL.0000000000000495; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Montgomery S, 2013, EUR J NEUROL, V20, P1153, DOI 10.1111/ene.12130; Nardone R, 2015, J SPINAL CORD MED, V13, P1; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Scalfari A, 2013, NEUROLOGY, V81, P184, DOI 10.1212/WNL.0b013e31829a3388; Sellner J, 2011, AUTOIMMUN REV, V10, P495, DOI 10.1016/j.autrev.2011.02.006; Tzelepis GE, 2015, RESP MED, V109, P671, DOI 10.1016/j.rmed.2015.01.018; Vezzani A, 2011, GENDER MED, V8, P32, DOI 10.1016/j.genm.2010.11.011; Williamson EM, 2015, CNS DRUGS, V29, P229, DOI 10.1007/s40263-015-0226-2	23	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155795	10.1371/journal.pone.0155795	http://dx.doi.org/10.1371/journal.pone.0155795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244560	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100006
J	Zhang, GH; Zhang, HF; Yu, HXY; Zhao, Z; Yang, J; Zhang, MZ; Zhang, MY				Zhang, Guohong; Zhang, Huifang; Yu, Hongxuyang; Zhao, Zheng; Yang, Jie; Zhang, Mianzhi; Zhang, Minying			Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China	PLOS ONE			English	Article							RECEPTIVE ANAL INTERCOURSE; INTIMATE PARTNER VIOLENCE; URBAN US WOMEN; VAGINAL MICROBICIDE; HIV-INFECTION; CLINICAL-TRIALS; RISK BEHAVIORS; PRODUCTS; HEALTH; GEL	Objectives To measure potential acceptability of rectal microbicides and to explore factors likely to affect their acceptability among men who have sex with men (MSM). Methods Cross-sectional and retrospective surveys were conducted in this study. A questionnaire and a scale were used to measure the acceptability score for physical and functional characteristics of hypothetical rectal microbicides. We also evaluated the involvement of other factors such as sexual behaviors, social context, etc. Results MSMs we interviewed showed a high acceptability to rectal microbicides, indicated by the mean acceptability score of 2.92 (SD, 0.54, scale of 1-4). The results also suggested that microbicides were preferred in a cream form that can moisten and lubricate the rectum, prevent HIV infection and go unnoticed by their partners. Multivariate analysis showed that the microbicides acceptability varied significantly by education level (beta = 0.135; P = 0.028), having casual partners (beta = 0.174; P = 0.007), frequency of lubricant use (beta = 0.134; P = 0.031), history of HIV test (beta = 0.129; P = 0.036), willingness to use lubricant (beta = 0.126; P = 0.045), locus of control by partners regarding STI infection (beta = 0.168; P = 0.009). Conclusions A positive response to rectal microbicides among MSMs was found in our study, suggesting that rectal microbicides might have a potential market in MSMs and they might play an important role in HIV/STIs prevention as a supplement. Further studies may be considered to combine the acceptability study with clinical research together to understand the true feelings of MSMs when they use the products.	[Zhang, Guohong; Zhang, Huifang; Yu, Hongxuyang; Zhang, Minying] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Zhao, Zheng; Yang, Jie] Shenlan MSM Community Org, Tianjin, Peoples R China; [Zhang, Mianzhi] Tianjin Publ Secur Hosp, Tianjin, Peoples R China	Nankai University	Zhang, MY (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	zhangminying@nankai.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Yu, Hongxuyang/0000-0003-0700-7937	Scientific Research Foundation of Nankai University [J02006]	Scientific Research Foundation of Nankai University	The work was funded by Scientific Research Foundation of Nankai University (J02006).	Abdulai MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-40; Baral S, 2013, AIDS BEHAV, V17, pS60, DOI 10.1007/s10461-012-0202-5; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; Carballo-Dieguez A, 2008, SEX TRANSM INFECT, V84, P483, DOI 10.1136/sti.2008.030478; Carballo-Dieguez A, 2000, AM J PUBLIC HEALTH, V90, P1117, DOI 10.2105/AJPH.90.7.1117; Carballo-Dieguez A, 2008, AIDS BEHAV, V12, P860, DOI 10.1007/s10461-007-9301-0; Carballo-Dieguez A, 2007, SEX TRANSM DIS, V34, P224, DOI 10.1097/01.olq.0000233715.59239.83; Coetzee N, 2001, AIDS, V15, P1837, DOI 10.1097/00002030-200109280-00013; Coggins C, 2000, REPROD HEALTH MATTER, V8, P132, DOI 10.1016/S0968-8080(00)90015-6; Davis A, 2015, SEX TRANSM DIS, V42, P387, DOI 10.1097/OLQ.0000000000000302; Dunkle KL, 2013, SEX TRANSM DIS, V40, P362, DOI 10.1097/OLQ.0b013e318283d2af; Fleck F, 2004, B WORLD HEALTH ORGAN, V82, P393; Giguere R, 2015, J SEX RES, P1; Green G, 2001, SOC SCI MED, V52, P585, DOI 10.1016/S0277-9536(00)00162-3; Grulich AE, 2010, INT J EPIDEMIOL, V39, P1064, DOI 10.1093/ije/dyq101; Guo XT, 2016, J MED VIROL, V88, P1098, DOI 10.1002/jmv.24439; Guo XT, 2016, MICROBES INFECT, V18, P148, DOI 10.1016/j.micinf.2015.10.004; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Han L, 2011, CHIN J DIS CONTROL P, V15, P560; Han L, 2009, J WOMENS HEALTH, V18, P1377, DOI 10.1089/jwh.2008.1239; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Jones DL, 2008, SEX TRANSM DIS, V35, P147, DOI 10.1097/OLQ.0b013e3181574dbf; Kinsler JJ, 2010, INT J STD AIDS, V21, P567, DOI 10.1258/ijsa.2010.010134; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Li L, 2013, J ANTIMICROB CHEMOTH, V68, P573, DOI 10.1093/jac/dks458; Lu L, 2013, MICROBES INFECT, V15, P506, DOI 10.1016/j.micinf.2013.03.003; Mantell JE, 2005, SOC SCI MED, V60, P319, DOI 10.1016/j.socscimed.2004.05.011; Marks G., 2000, AIDS BEHAV, V4, P279, DOI DOI 10.1023/A:1009572919712; McGowan I, 2012, CURR OPIN HIV AIDS, V7, P526, DOI 10.1097/COH.0b013e3283582bc2; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Newman PA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18476; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; Rader M, 2001, AIDS EDUC PREV, V13, P149, DOI 10.1521/aeap.13.2.149.19735; Robertson Angela M, 2013, Glob Public Health, V8, P619, DOI 10.1080/17441692.2012.762412; Sakondhavat Chuanchom, 2001, Journal of the Medical Association of Thailand, V84, P973; Severy LJ, 2005, J SOC ISSUES, V61, P45, DOI 10.1111/j.0022-4537.2005.00393.x; Stadler J, 2011, CULT HEALTH SEX, V13, P31, DOI 10.1080/13691058.2010.511270; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Tolley EE, 2006, AM J PUBLIC HEALTH, V96, P79, DOI 10.2105/AJPH.2004.043471; [涂晓雯 Tu Xiaowen], 2010, [生殖与避孕, Reproduction and Contraception], V30, P696; Turner G, 1999, HEALTH EDUC RES, V14, P235, DOI 10.1093/her/14.2.235; Ventuneac A, 2010, AIDS BEHAV, V14, P618, DOI 10.1007/s10461-009-9611-5; Verguet S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015501; Wang Y, 2008, SEX TRANSM DIS, V35, P102, DOI 10.1097/OLQ.0b013e31814b8546; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6	50	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156561	10.1371/journal.pone.0156561	http://dx.doi.org/10.1371/journal.pone.0156561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27243457	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100048
J	Allen, ER; van Diemen, P; Yamaguchi, Y; Lindemann, C; Soilleux, E; Rollier, C; Hill, F; Schneider, J; Wyllie, DH				Allen, Elizabeth R.; van Diemen, Pauline; Yamaguchi, Yuko; Lindemann, Claudia; Soilleux, Elizabeth; Rollier, Christine; Hill, Fergal; Schneider, Jurgen; Wyllie, David H.			MRI Based Localisation and Quantification of Abscesses following Experimental S-aureus Intravenous Challenge: Application to Vaccine Evaluation	PLOS ONE			English	Article							SURFACE-PROTEINS; MODEL; EFFICACY; SORTASE	Purpose To develop and validate a sensitive and specific method of abscess enumeration and quantification in a preclinical model of Staphylococcus aureus infection. Methods S. aureus infected murine kidneys were fixed in paraformaldehyde, impregnated with gadolinium, and embedded in agar blocks, which were subjected to 3D magnetic resonance microscopy on a 9.4T MRI scanner. Image analysis techniques were developed, which could identify and quantify abscesses. The result of this imaging was compared with histological examination. The impact of a S. aureus Sortase A vaccination regime was assessed using the technique. Results Up to 32 murine kidneys could be imaged in a single MRI run, yielding images with voxels of about 25 mu m(3). S. aureus abscesses could be readily identified in blinded analyses of the kidneys after 3 days of infection, with low inter-observer variability. Comparison with histological sections shows a striking correlation between the two techniques: all presumptive abscesses identified by MRI were confirmed histologically, and histology identified no abscesses not evident on MRI. In view of this, simulations were performed assuming that both MRI reconstruction, and histology examining all sections of the tissue, were fully sensitive and specific at abscess detection. This simulation showed that MRI provided more sensitive and precise estimates of abscess numbers and volume than histology, unless at least 5 histological sections are taken through the long axis of the kidney. We used the MRI technique described to investigate the impact of a S. aureus Sortase A vaccine. Conclusion Post mortem MRI scanning of large batches of fixed organs has application in the preclinical assessment of S. aureus vaccines.	[Allen, Elizabeth R.; van Diemen, Pauline; Yamaguchi, Yuko; Lindemann, Claudia; Wyllie, David H.] Univ Oxford, Ctr Cellular & Mol Physiol, Jenner Inst, Oxford, England; [Soilleux, Elizabeth] Univ Oxford, Radcliffe Dept Med, Nuffield Dept Clin Lab Sci, Oxford, England; [Rollier, Christine] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, England; [Rollier, Christine] Univ Oxford, Ctr Clin Vaccinol & Trop Med, NIHR Oxford Biomed Res Ctr, Oxford, England; [Hill, Fergal] Imaxio SA, Lyon, France; [Schneider, Jurgen] Univ Oxford, Radcliffe Dept Med, BHF Expt MR Unit, Oxford, England	University of Oxford; Jenner Institute; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Wyllie, DH (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol, Jenner Inst, Oxford, England.	david.wyllie@ndm.ox.ac.uk	Hill, Fergal/AAI-1329-2021	Soilleux, Elizabeth Jane/0000-0002-4032-7249; Lindemann, Claudia/0000-0002-6987-2398; Allen, Elizabeth/0000-0002-6406-4834	European Union [601783, 316655]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; Imaxio SA; British Heart Foundation [FS/11/50/29038] Funding Source: researchfish	European Union(European Commission); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford; Imaxio SA; British Heart Foundation(British Heart Foundation)	The research leading to these results has received funding from the European Union's Seventh Framework Programme under the grant agreement no 601783 (BELLEROPHON project, to DW) and 316655 (VACTRAIN) (CL). The research was supported in part by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford (to DW). JES is a BHF Senior Basic Science Research Fellow (FS/11/50/29038). The views expressed are those of the author (s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CR is a Jenner Institute Investigator and an Oxford Martin fellow. Imaxio SA provided support in the form of salaries for FH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hertlein T, 2014, ANTIMICROB AGENTS CH, V58, P1630, DOI 10.1128/AAC.01422-13; Hertlein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018246; Hoerr V, 2014, J PHARMACEUT BIOMED, V93, P136, DOI 10.1016/j.jpba.2013.10.034; Hoerr V, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-63; Kim HK, 2014, J IMMUNOL METHODS, V410, P88, DOI 10.1016/j.jim.2014.04.007; Kwiecinski J, 2014, APMIS, V122, P1240, DOI 10.1111/apm.12295; Lee BY, 2013, CLIN MICROBIOL INFEC, V19, P528, DOI 10.1111/j.1469-0691.2012.03914.x; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; Prajsnar TK, 2008, CELL MICROBIOL, V10, P2312, DOI 10.1111/j.1462-5822.2008.01213.x; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Ring J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107179; Schneider JE, 2003, MAGN RESON MATER PHY, V16, P43, DOI 10.1007/s10334-003-0002-z; Schneider Juergen E., 2004, BMC Developmental Biology, V4, P1; Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788; Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; van Diemen PM, 2013, PATHOG DIS, V68, P20, DOI 10.1111/2049-632X.12042	27	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154705	10.1371/journal.pone.0154705	http://dx.doi.org/10.1371/journal.pone.0154705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228181	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500006
J	Cao, GC; Jia, M; Zhao, X; Wang, LB; Tu, XB; Wang, GJ; Nong, XQ; Zhang, ZH				Cao, Guangchun; Jia, Miao; Zhao, Xia; Wang, Lei; Tu, Xiongbing; Wang, Guangjun; Nong, Xiangqun; Zhang, Zehua			Different Effects of Metarhizium anisopliae Strains IMI330189 and IBC200614 on Enzymes Activities and Hemocytes of Locusta migratoria L.	PLOS ONE			English	Article							PROPHENOLOXIDASE-ACTIVATING SYSTEM; BEAUVERIA-BASSIANA; ENTOMOPATHOGENIC FUNGUS; OXIDATIVE STRESS; IMMUNE-RESPONSE; INSECTICIDE-RESISTANCE; PHENOLOXIDASE ACTIVITY; ACETYLCHOLINESTERASE; EXPRESSION; DESTRUXINS	Background Metarhizium is an important class of entomopathogenic fungi in the biocontrol of insects, but its virulence is affected by insect immunity. To clarify the mechanism in virulence of Metarhizium, we compared the immunological differences in Locusta migratoria L. when exposed to two strains of Metarhizium anisopliae (Ma). Results The virulence of Ma IMI330189 was significantly higher than that of Ma IBC200614 to locust, and IMI330189 overcame the hemocytes and began destroying the hemocytes of locust at 72 h after spray, while locust is immune to IBC200614. IMI330189 could overcome the humoral immunity of locust by inhibiting the activities of phenol oxidase (PO), esterases, multi-function oxidases (MFOs) and acetylcholinesterases in locust while increasing the activities of glutathione-S-transferases (GSTs), catalase and aryl-acylamidase (AA). However IBC200614 inhibit the activities of GSTs and AA in locust and increase the activities of MFOs, PO, superoxide dismutase, peroxidase and chitinase in locust. The changes of enzymes activities in period of infection showed that the time period between the 2nd and the 5th day after spray is critical in the pathogenic process. Conclusion These results found the phenomenon that Ma initiatively broke host hemocytes, revealed the correlation between the virulence of Ma and the changes of enzymes activities in host induced by Ma, and clarified the critical period in the infection of Ma. So, these results should provide guidance for the construction of efficient biocontrol Ma strains.	[Cao, Guangchun; Jia, Miao; Zhao, Xia; Wang, Lei; Tu, Xiongbing; Wang, Guangjun; Nong, Xiangqun; Zhang, Zehua] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, ZH (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	zhangzehua@caas.cn		Zehua, Zhang/0000-0002-0648-8954	National Natural Science Foundation of China [31471823]; Special Fund for Agro-scientific Research in the Public Interest [201003079]; earmarked fund for China Agriculture Research System [CARS-35-07]; Innovation Project of Chinese Academy of Agricultural Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; earmarked fund for China Agriculture Research System; Innovation Project of Chinese Academy of Agricultural Sciences	This study was supported by the "National Natural Science Foundation of China, 31471823", "The Special Fund for Agro-scientific Research in the Public Interest, 201003079", "The earmarked fund for China Agriculture Research System, CARS-35-07" and Innovation Project of Chinese Academy of Agricultural Sciences.	AHMAD S, 1992, BIOCHEM SYST ECOL, V20, P269, DOI 10.1016/0305-1978(92)90040-K; Anggraeni T, 2011, ENTOMOL RES, V41, P1, DOI 10.1111/j.1748-5967.2010.00311.x; Barata C, 2004, AQUAT TOXICOL, V66, P125, DOI 10.1016/j.aquatox.2003.07.004; Bartholomay LC, 2004, INSECT MOL BIOL, V13, P125, DOI 10.1111/j.0962-1075.2004.00467.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Chang CC, 2013, AQUAT TOXICOL, V130, P18, DOI 10.1016/j.aquatox.2012.12.024; Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3; Chaurasia A, 2016, PESTIC BIOCHEM PHYS, V127, P28, DOI 10.1016/j.pestbp.2015.09.002; Contreras-Garduno J, 2007, J INSECT PHYSIOL, V53, P612, DOI 10.1016/j.jinsphys.2007.03.003; Dubovskiy I.M., 2012, ENTOMOL REV, V92, P27, DOI DOI 10.1134/S0013873812010022; El-Demerdash FM, 2013, J ENVIRON SCI HEAL B, V48, P593, DOI 10.1080/03601234.2013.774998; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Felton G.W., 1995, OXIDATIVE STRESS ANT, P356, DOI DOI 10.1007/978-1-4615-9689-9_10; FELTON GW, 1995, ARCH INSECT BIOCHEM, V29, P187, DOI 10.1002/arch.940290208; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; Finney DJ, 1971, PROBIT ANAL; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Gillespie JP, 2000, J INSECT PHYSIOL, V46, P429, DOI 10.1016/S0022-1910(99)00128-6; Glupov VV, 2001, INSECT PATHOGENS STR, P475; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gopalakrishnan S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/824962; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; GUPTA S, 1989, J LIQ CHROMATOGR, V12, P383, DOI 10.1080/01483918908051742; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; HANSEN LG, 1971, BIOCHEM PHARMACOL, V20, P1569, DOI 10.1016/0006-2952(71)90285-1; Hicks BJ, 2001, FOREST ECOL MANAG, V149, P275, DOI 10.1016/S0378-1127(00)00561-2; Hillyer JF, 2005, CELL MICROBIOL, V7, P39, DOI 10.1111/j.1462-5822.2004.00430.x; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; Hung SY, 1996, J INVERTEBR PATHOL, V67, P35, DOI 10.1006/jipa.1996.0006; James PJ, 1994, IOBC WPRS B, V17, P218; JEGOROV A, 1990, Microbios Letters, V45, P65; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LeOra Software, 1987, POLO PC US PROB AN L; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li XW, 2010, J NW A F U NATURAL S, V38, P151; Liu Shouzhu, 2009, Open Biochem J, V3, P9, DOI 10.2174/1874091X00903010009; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Matsuda D, 2004, J ANTIBIOT, V57, P1; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Moores GD, 1998, PESTIC BIOCHEM PHYS, V62, P164, DOI 10.1006/pest.1998.2373; Moreno-Garcia M, 2014, INFECT GENET EVOL, V24, P25, DOI 10.1016/j.meegid.2014.02.010; Mullen LM, 2006, J INSECT PHYSIOL, V52, P389, DOI 10.1016/j.jinsphys.2005.10.008; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Oppenoorth F. J., 1976, INSECTICIDE BIOCH PH, P507; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; ROSLAVTSEVA SA, 1993, IZV AKAD NAUK BIOL+, P368; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samson RA, 1988, ATLAS ENTOMOPATHOGIE; Sandhu SS, 2012, J PATHOG, V2012, DOI 10.1155/2012/126819; Serebrov V.V., 2001, Izvestiya Rossiiskoi Akademii Nauk Seriya Biologicheskaya, V5, P588; Serebrov VV, 2003, MIKOL FITOPATOL, V37, P76; Serebrov VV, 2006, IMZV RAN SER BIOL, V6, P581; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Sree KS, 2008, J APPL ENTOMOL, V132, P68, DOI 10.1111/j.1439-0418.2007.01239.x; STLEGER RJ, 1988, J INVERTEBR PATHOL, V52, P459, DOI 10.1016/0022-2011(88)90059-6; SUZUKI A, 1970, AGR BIOL CHEM TOKYO, V34, P813, DOI 10.1080/00021369.1970.10859690; Tang BZ, 2011, PESTIC BIOCHEM PHYS, V101, P80, DOI 10.1016/j.pestbp.2011.08.003; Tartar A, 2005, MYCOPATHOLOGIA, V160, P303, DOI 10.1007/s11046-005-0134-y; TERRIERE LC, 1984, ANNU REV ENTOMOL, V29, P71, DOI 10.1146/annurev.en.29.010184.000443; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; Vilcinskas A, 1999, COMP BIOCHEM PHYS C, V122, P83, DOI 10.1016/S0742-8413(98)10082-8; Vioque-Fernandez A, 2009, BIOMARKERS, V14, P299, DOI 10.1080/13547500902913211; WAHLMAN M, 1993, J NAT PROD, V56, P643, DOI 10.1021/np50094a034; Wang C, 2006, P NATL ACAD SCI USA, V103, P6647, DOI 10.1073/pnas.0601951103; WEISER J, 1988, J INVERTEBR PATHOL, V51, P92, DOI 10.1016/0022-2011(88)90092-4; Wu Qing-Jun, 2011, Chinese Journal of Applied Entomology, V48, P291; Xing Jing, 2011, Chinese Journal of Pesticide Science, V13, P464, DOI 10.3969/j.issn.1008-7303.2011.05.05; Xue CB, 2007, APPL BIOCHEM BIOTECH, V143, P101, DOI 10.1007/s12010-007-8007-0; Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029; Zibaee A, 2009, BIOCONTROL SCI TECHN, V19, P485, DOI 10.1080/09583150902847127	74	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155257	10.1371/journal.pone.0155257	http://dx.doi.org/10.1371/journal.pone.0155257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227835	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500013
J	Li, L; Lei, QS; Zhang, SJ; Kong, LN; Qin, B				Li, Lin; Lei, Qing-song; Zhang, Shu-Jun; Kong, Ling-na; Qin, Bo			Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; ISOPEPTIDASE ACTIVITY; ANTIVIRAL ACTIVITY; CHRONIC INFECTION; STIMULATED GENE; PROTEASE UBP43; IFN-ALPHA; ISG15; EXPRESSION; PROTEINS	Ubiquitin-specific protease 18 (USP18, also known as UBP43) has both interferon stimulated gene 15 (ISG15) dependent and ISG15-independent functions. By silencing the expression of USP18 in HepG2.2.15 cells, we studied the effect of USP18 on the anti-HBV activity of IFN-F and demonstrated that knockdown of USP18 significantly Inhibited the HBV expression and increased the expression of ISGs. Levels of hepatitis B virus surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), HBV DNA and intracellular hepatitis B virus core antigen (HBcAg) were dramatically decreased with or without treatment of indicated dose of IFN-F. Suppression of USP18 activated the JAK/STAT signaling pathway as shown by the increased and prolonged expression of phosphorylated signal transducer and activator of transcription 1 (p-STAT1) in combination with enhanced expression of several interferon stimulated genes (ISGs). Our results indicated that USP18 modulates the anti-HBV activity of IFN-F via activation of the JAK/STAT signaling pathway in Hepg2.2.15 cells.	[Li, Lin; Lei, Qing-song; Zhang, Shu-Jun; Kong, Ling-na; Qin, Bo] Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing 400016, Peoples R China; [Kong, Ling-na] Chongqing Med Univ, Coll Nursing, Chongqing 400016, Peoples R China	Chongqing Medical University; Chongqing Medical University	Qin, B (corresponding author), Chongqing Med Univ, Dept Infect Dis, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	cqqino@126.com			National Science Foundation of China [81271838]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants (81271838) from the National Science Foundation of China, http://www.nsfc.gov.cn. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0; Colonne PM, 2011, BIOCHEM BIOPH RES CO, V416, P153, DOI 10.1016/j.bbrc.2011.11.015; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Guo YL, 2012, MOL CANCER THER, V11, P1968, DOI 10.1158/1535-7163.MCT-12-0248; Hong BX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-132; Honke N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003650; Ketscher L, 2015, P NATL ACAD SCI USA, V112, P1577, DOI 10.1073/pnas.1412881112; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim KI, 2005, J IMMUNOL, V175, P847, DOI 10.4049/jimmunol.175.2.847; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li YJ, 2014, REV MED VIROL, V24, P332, DOI 10.1002/rmv.1795; Liu XX, 2013, SPRINGERBRIEF COMPUT, P1, DOI 10.1007/978-1-4614-9074-6_1; MacParland SA, 2016, J VIROLOGY; Makki MS, 2013, EXP CELL RES, V319, P612, DOI 10.1016/j.yexcr.2012.12.021; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; Malhotra S, 2013, EUR J NEUROL, V20, P1390, DOI 10.1111/ene.12193; Murray EJ, 2011, ANTIMICROB AGENTS CH, V55, P4311, DOI 10.1128/AAC.00644-11; Pang YJ, 2013, LIVER INT, V33, P1230, DOI 10.1111/liv.12185; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043; Salaiegheh M, 2010, ANN NEUROL, V67, P53, DOI 10.1002/ana.21805; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Xiao C, 2012, J VIRAL HEPATITIS, V19, pE1, DOI 10.1111/j.1365-2893.2011.01471.x; Zhang XQ, 2015, NATURE, V517, P89, DOI 10.1038/nature13801	32	25	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156496	10.1371/journal.pone.0156496	http://dx.doi.org/10.1371/journal.pone.0156496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227879	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500149
J	Carmello, JC; Alves, F; Basso, FG; Costa, CAD; Bagnato, VS; Mima, EGD; Pavarina, AC				Carmello, Juliana Cabrini; Alves, Fernanda; Basso, Fernanda G.; de Souza Costa, Carlos Alberto; Bagnato, Vanderlei Salvador; de Oliveira Mima, Ewerton Garcia; Pavarina, Ana Claudia			Treatment of Oral Candidiasis Using Photodithazine (R)-Mediated Photodynamic Therapy In Vivo	PLOS ONE			English	Article							LEVEL LASER IRRADIATION; MURINE MODEL; ALBICANS; INACTIVATION; SUSCEPTIBILITY; EPIDEMIOLOGY; FLUCONAZOLE; NYSTATIN; ADHESION; GROWTH	This study evaluated the effectiveness of antimicrobial photodynamic therapy (aPDT) in the treatment of oral candidiasis in a murine model using Photodithazine (R) (PDZ). This model of oral candidiasis was developed to allow the monitoring of the infection and the establishment of the aPDT treatment. Six-week-old female mice were immunosuppressed and inoculated with C. albicans to induce oral candidiasis. PDZ-mediated aPDT and nystatin treatment were carried out for 5 consecutive days with one application per day. The macroscopic evaluation of oral lesions was performed. After each treatment, the tongue was swabbed to recover C. albicans cells. Viable colonies were quantified and the number of CFU/ml determined. The animals were sacrificed 24 hours and 7 days after treatment and the tongues were surgically removed for histological analysis and analysis of inflammatory cytokines expression (IL-1, TNF-alpha and IL-6) by RT-qPCR. Data were analyzed by two-way ANOVA. PDZ-mediated aPDT was as effective as Nystatin (NYS group) in the inactivation of C. albicans, reducing 3 and 3.2 logs(10) respectively, 24 h after treatment (p<0.05). Animals underwent PDZ-mediated aPDT showed complete remission of oral lesions, while animals treated with NYS presented partial remission of oral lesions in both periods assessed. Histological evaluation revealed mild inflammatory infiltrate in the groups treated with aPDT and NYS in both periods assessed. The aPDT induced the TNF-alpha expression when compared with the control (P-L-) (p<0.05), 24 h and 7 days after treatment. In summary, the murine model developed here was able to mimic the infection and PDZ-mediated aPDT was effective to treat mice with oral candidiasis.	[Carmello, Juliana Cabrini; Alves, Fernanda; de Oliveira Mima, Ewerton Garcia; Pavarina, Ana Claudia] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil; [Basso, Fernanda G.; de Souza Costa, Carlos Alberto] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Physiol & Pathol, Araraquara, SP, Brazil; [Bagnato, Vanderlei Salvador] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Pavarina, AC (corresponding author), UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil.	pavarina@foar.unesp.br	Mima, Ewerton/X-5176-2019; Pavarina, Ana Claudia/J-8640-2013; Mima, Ewerton/F-9496-2014; Bagnato, Vanderlei S/C-3133-2012; Alves, Fernanda/AAJ-3470-2020; Carmello, Juliana Cabrini/J-8305-2016; de Souza Costa, Carlos Alberto/C-6799-2012	Mima, Ewerton/0000-0002-9575-7625; Mima, Ewerton/0000-0002-9575-7625; de Souza Costa, Carlos Alberto/0000-0002-7455-6867; Pavarina, Ana Claudia/0000-0002-9231-1994; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; Bagnato, Vanderlei Salvador/0000-0003-4833-239X; Cabrini Carmello, Juliana/0000-0002-5285-0571	Sao Paulo Research Foundation (FAPESP) [2012/17468-2]; Centro de Pesquisa, Inovacao e Difusao (CEPID) [2013/07276-1]; Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Pesquisa, Inovacao e Difusao (CEPID); Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC)	This work was supported by the Sao Paulo Research Foundation (FAPESP), grants number 2012/17468-2 (http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&q2=% 28id_pesquisador_exact%3A179294%29+AND+%28%28bolsa_exact%3A%22Bolsas+no+Brasil%22+AND+situacao_exact%3A%22Conclu%C3%ADdos%22%29%29) to JCC, Centro de Pesquisa, Inovacao e Difusao (CEPID), grants number 2013/07276-1 (http://www.bv.fapesp.br/pt/auxilios/58564/cepof-centro-de-pesquisa-em-optica-e-fotonica/ ACP) and Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC) to ACP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Blignaut E, 1999, SADJ, V54, P605; Blomgren J, 1998, ACTA ODONTOL SCAND, V56, P202, DOI 10.1080/00016359850142790; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Brackett CM, 2011, PHOTOCH PHOTOBIO SCI, V10, P649, DOI 10.1039/c0pp00354a; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camargo MR, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-98; Carmello JC, 2015, PHOTOCH PHOTOBIO SCI, V14, P1319, DOI 10.1039/c4pp00368c; Quishida CCC, 2015, LASER MED SCI, V30, P685, DOI 10.1007/s10103-013-1397-z; Darwazeh AMG, 1997, J ORAL PATHOL MED, V26, P233, DOI 10.1111/j.1600-0714.1997.tb01229.x; Mima EGD, 2010, ORAL SURG ORAL MED O, V109, P392, DOI 10.1016/j.tripleo.2009.10.006; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Donnelly RF, 2008, MICROBIOL RES, V163, P1, DOI 10.1016/j.micres.2007.08.001; Dovigo LN, 2013, BIOFOULING, V29, P1057, DOI 10.1080/08927014.2013.827668; Dovigo LN, 2013, MED MYCOL, V51, P243, DOI 10.3109/13693786.2012.714081; Dovigo LN, 2011, MYCOSES, V54, P123, DOI 10.1111/j.1439-0507.2009.01769.x; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Engelmann M., 2007, J BIOENERG BIOMEMBR, V39, P175, DOI DOI 10.1007/S10863-007-9075-0; Firczuk M, 2011, PHOTOCH PHOTOBIO SCI, V10, P653, DOI 10.1039/c0pp00308e; Gavish L, 2004, LASER SURG MED, V35, P369, DOI 10.1002/lsm.20108; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Gollnick SO, 1997, CANCER RES, V57, P3904; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Jonker MA, 2010, J TRAUMA, V69, P843, DOI 10.1097/TA.0b013e3181c45284; Junqueira JC, 2009, LASER MED SCI, V24, P877, DOI 10.1007/s10103-009-0673-4; KABBUR MB, 1995, COMP HAEMATOL INT, V5, P47, DOI 10.1007/BF00214490; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Kong EF, 2015, INFECT IMMUN, V83, P604, DOI 10.1128/IAI.02843-14; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; Lushchak, 2001, COMP BIOCH PHYSL C, V153, P175, DOI DOI 10.1016/J.CBPC.2010.10.004; Mima EG, 2012, CLIN MICROBIOL INFEC, V18, pE380, DOI 10.1111/j.1469-0691.2012.03933.x; Monfrecola G, 2004, PHOTOCH PHOTOBIO SCI, V3, P419, DOI 10.1039/b315629j; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ogawa Y, 2006, J INVEST DERMATOL, V126, P349, DOI 10.1038/sj.jid.5700081; Park H, 2014, VIRULENCE, V5, P625, DOI 10.4161/viru.29699; Pires L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085431; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Seneviratne CJ, 2009, ARCH ORAL BIOL, V54, P1052, DOI 10.1016/j.archoralbio.2009.08.002; Shao Lu-Cheng, 2007, Yaoxue Xuebao, V42, P1129; Soares BM, 2009, J PHOTOCH PHOTOBIO B, V94, P65, DOI 10.1016/j.jphotobiol.2008.07.013; Sorgo AG, 2013, FEMS MICROBIOL LETT, V338, P10, DOI 10.1111/1574-6968.12049; Stadler I, 2000, LASER SURG MED, V27, P255, DOI 10.1002/1096-9101(2000)27:3<255::AID-LSM7>3.0.CO;2-L; Strakhovskaya M. G., 2002, Mikrobiologiya, V71, P345; Strakhovskaya M G, 2002, Dokl Biochem Biophys, V384, P155, DOI 10.1023/A:1016072130789; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Takakura N, 2003, MICROBIOL IMMUNOL, V47, P321, DOI 10.1111/j.1348-0421.2003.tb03403.x; Teichert MC, 2002, ORAL SURG ORAL MED O, V93, P155, DOI 10.1067/moe.2002.120051; Totti Marilda Aparecida Gonçalves, 2004, Braz. oral res., V18, P202, DOI 10.1590/S1806-83242004000300005	52	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156947	10.1371/journal.pone.0156947	http://dx.doi.org/10.1371/journal.pone.0156947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253525	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700067
J	Zhou, Q; Li, W; Leng, BJ; Zheng, WF; He, Z; Zuo, MZ; Chen, AH				Zhou, Quan; Li, Wei; Leng, Bingjie; Zheng, Wenfei; He, Ze; Zuo, Manzhen; Chen, Aihua			Circulating Cell Free DNA as the Diagnostic Marker for Ovarian Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EPIDIDYMIS PROTEIN 4; ANTIGEN 125; PLASMA DNA; ACCURACY; SERUM; BENIGN; TESTS; HE-4	Background Quantitative analyses of circulating cell-free DNA (cfDNA) are potential methods for the detection of ovarian cancer. Many studies have evaluated these approaches, but the results were too inconsistent to be conclusive. This study is the first to systematically evaluate the accuracy of circulating cfDNA for the diagnosis of ovarian cancer by conducting meta-analysis. Methods We searched PubMed, Embase, Cochrane Library and the Chinese National Knowledge Infrastructure (CNKI) databases systematically for relevant literatures up to December 10, 2015. All analyses were conducted using Meta-DiSc1.4 and Stata 12.0 software. Sensitivity, specificity and other measures of accuracy of circulating cfDNA for the diagnosis of ovarian cancer were pooled. Meta-regression was performed to identify the sources of heterogeneity. Results This meta-analysis included a total of 9 studies, including 462 ovarian cancer patients and 407 controls. The summary estimates for quantitative analysis of circulating cfDNA in ovarian cancer screen were as follows: sensitivity, 0.70 (95% confidence interval (CI), 0.65-0.74); specificity, 0.90 (95% CI, 0.87-0.93); positive likelihood ratio, 6.60 (95% CI, 3.90-11.17); negative likelihood ratio, 0.34 (95% CI, 0.25-0.47); diagnostic odds ratio, 26.05 (95% CI, 14.67-46.26); and area under the curve, 0.89 (95% CI, 0.83-0.95), respectively. There was no statistical significance for the evaluation of publication bias. Conclusions Current evidence suggests that quantitative analysis of cfDNA has unsatisfactory sensitivity but acceptable specificity for the diagnosis of ovarian cancer. Further large-scale prospective studies are required to validate the potential applicability of using circulating cfDNA alone or in combination with conventional markers as diagnostic biomarker for ovarian cancer and explore potential factors that may influence the accuracy of ovarian cancer diagnosis.	[Zhou, Quan; Li, Wei; Leng, Bingjie; Zheng, Wenfei; He, Ze; Zuo, Manzhen; Chen, Aihua] Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Gynecol & Obstet, Yichang 443000, Peoples R China	China Three Gorges University	Zhou, Q (corresponding author), Three Gorges Univ, Peoples Hosp Yichang 1, Peoples Hosp, Dept Gynecol & Obstet, Yichang 443000, Peoples R China.	zhouquan8519@163.com			National Natural Science Foundation of China [81401187]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81401187) (Quan Zhou).r This study was supported by National Natural Science Foundation of China (No. 81401187).	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Arends LR, 2008, MED DECIS MAKING, V28, P621, DOI 10.1177/0272989X08319957; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Capizzi E, 2008, DIAGN MOL PATHOL, V17, P34, DOI 10.1097/PDM.0b013e3181359e1f; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Ebell MH, 2016, AM J PREV MED, V50, P384, DOI 10.1016/j.amepre.2015.09.023; Ebell MH, 2015, AM J PREV MED, V48, P350, DOI 10.1016/j.amepre.2014.10.007; Francis G, 2015, INT J MOL SCI, V16, P14122, DOI 10.3390/ijms160614122; Fu SL, 2005, CHINESE J PRACTICAL, V21, P659; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Gu XH, 2009, MATERN CHILD HLTH J, V24, P1413; Guan T, 2008, J JILIN U MED EDITIO, V34, P492; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holdenrieder S, 2001, INT J CANCER, V95, P114, DOI 10.1002/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Jayde V, 2009, CONTEMP NURSE, V34, P55; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Kamat AA, 2006, CANCER BIOL THER, V5, P1369, DOI 10.4161/cbt.5.10.3240; Kamat AA, 2010, CANCER-AM CANCER SOC, V116, P1918, DOI 10.1002/cncr.24997; Karampini E, 2016, QJM-INT J MED, V109, P223, DOI 10.1093/qjmed/hcv146; Liao WJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000722; Liao XY, 2014, J CANCER RES THER, V10, pC222, DOI 10.4103/0973-1482.145884; Lin JY, 2013, EUR J OBSTET GYN R B, V167, P81, DOI 10.1016/j.ejogrb.2012.10.036; Marzese DM, 2013, EXPERT REV MOL DIAGN, V13, P827, DOI 10.1586/14737159.2013.845088; Medeiros LR, 2009, INT J GYNECOL CANCER, V19, P230, DOI 10.1111/IGC.0b013e31819c1369; Medeiros LR, 2009, EUR J OBSTET GYN R B, V142, P99, DOI 10.1016/j.ejogrb.2008.08.011; MIDGETTE AS, 1993, MED DECIS MAKING, V13, P253, DOI 10.1177/0272989X9301300313; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moore RG, 2011, OBSTET GYNECOL, V118, P280, DOI 10.1097/AOG.0b013e318224fce2; Ocana A, 2016, CANCER EPIDEM BIOMAR, V25, P399, DOI 10.1158/1055-9965.EPI-15-0893; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; [邵雪峰 Shao Xuefeng], 2014, [临床检验杂志, Chinese Journal of Clinical Laboratory Science], V32, P821; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soletormos G, 2016, INT J GYNECOL CANCER, V26, P43, DOI 10.1097/IGC.0000000000000586; Sundar S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4443; Wang JW, 2014, TUMOR BIOL, V35, P6127, DOI 10.1007/s13277-014-1811-6; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wu L, 2012, INT J GYNECOL CANCER, V22, P1106, DOI 10.1097/IGC.0b013e318263efa2; Zachariah RR, 2008, OBSTET GYNECOL, V112, P843, DOI 10.1097/AOG.0b013e3181867bc0; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang RF, 2010, LUNG CANCER, V69, P225, DOI 10.1016/j.lungcan.2009.11.009; Zhen S, 2014, MOL CLIN ONCOL, V2, P559, DOI 10.3892/mco.2014.279	47	62	67	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155495	10.1371/journal.pone.0155495	http://dx.doi.org/10.1371/journal.pone.0155495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253331	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700006
J	Freund, P; Porpaczy, EA; Le, T; Gruber, M; Pausz, C; Staber, P; Jager, U; Vanura, K				Freund, Patricia; Porpaczy, Edit A.; Trang Le; Gruber, Michaela; Pausz, Clemens; Staber, Philipp; Jaeger, Ulrich; Vanura, Katrina			Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; TYROSINE KINASE INHIBITOR; HUMAN BREAST-CARCINOMA; CB2 RECEPTOR; GROWTH-INHIBITION; OPIOID RECEPTORS; IMMUNE-SYSTEM; MARGINAL ZONE; CROSS-TALK	The cannabinoid receptors 1 and 2 (CNR1&2) are overexpressed in a variety of malignant diseases and cannabinoids can have noteworthy impact on tumor cell viability and tumor growth. Patients diagnosed with chronic lymphocytic leukemia (CLL) present with very heterogeneous disease characteristics translating into highly differential risk properties. To meet the urgent need for refinement in risk stratification at diagnosis and the search for novel therapies we studied CNR expression and response to cannabinoid treatment in CLL. Expression levels of CNR1&2 were determined in 107 CLL patients by real-time PCR and analyzed with regard to prognostic markers and survival. Cell viability of primary CLL cells was determined in suspension and co-culture after incubation in increasing cannabinoid concentrations under normal and reduced serum conditions and in combination with fludarabine. Impact of cannabinoids on migration of CLL cells towards CXCL12 was determined in transwell plates. We found CNR1&2 to be overexpressed in CLL compared to healthy B-cells. Discriminating between high and low expressing subgroups, only high CNR1 expression was associated with two established high risk markers and conferred significantly shorter overall and treatment free survival. Viability of CLL primary cells was reduced in a dose dependent fashion upon incubation with cannabinoids, however, healthy cells were similarly affected. Under serum reduced conditions, no significant differences were observed within suspension and co-culture, respectively, however, the feeder layer contributed significantly to the survival of CLL cells compared to suspension culture conditions. No significant differences were observed when treating CLL cells with cannabinoids in combination with fludarabine. Interestingly, biologic activity of cannabinoids was independent of both CNR1&2 expression. Finally, we did not observe an inhibition of CXCL12-induced migration by cannabinoids. In contrast to other tumor entities, our data suggest a limited usability of cannabinoids for CLL therapy. Nonetheless, we could define CNR1 mRNA expression as novel prognostic marker.	[Freund, Patricia; Porpaczy, Edit A.; Trang Le; Gruber, Michaela; Pausz, Clemens; Staber, Philipp; Jaeger, Ulrich; Vanura, Katrina] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria	Medical University of Vienna	Vanura, K (corresponding author), Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria.	katrina.vanura@meduniwien.ac.at	Vanura, Katrina/AAG-1236-2021; Staber, Philipp Bernhard/ADK-1536-2022	Vanura, Katrina/0000-0002-2217-4998; Staber, Philipp Bernhard/0000-0001-6729-7708	Herzfelder'sche Familienstiftung	Herzfelder'sche Familienstiftung	This work was supported by a grant of the Herzfelder'sche Familienstiftung to KV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almestrand S, 2015, PEERJ, V3, DOI 10.7717/peerj.1056; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Balakrishnan K, 2013, INVEST NEW DRUG, V31, P1384, DOI 10.1007/s10637-013-0002-4; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Benz AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081675; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Duncan M, 2013, AM J PHYSIOL-REG I, V305, pR224, DOI 10.1152/ajpregu.00104.2013; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Farsandaj N, 2012, J ENVIRON PATHOL TOX, V31, P377, DOI 10.1615/JEnvironPatholToxicolOncol.2013005859; Flygare J, 2005, FEBS LETT, V579, P6885, DOI 10.1016/j.febslet.2005.11.020; Fogli S, 2006, FEBS LETT, V580, P1733, DOI 10.1016/j.febslet.2006.02.024; Fowler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015205; Gallotta D, 2010, BIOCHEM PHARMACOL, V80, P370, DOI 10.1016/j.bcp.2010.04.023; Gentilini D, 2010, FERTIL STERIL, V93, P2588, DOI 10.1016/j.fertnstert.2010.02.006; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Graham ES, 2010, INT J IMMUNOPATH PH, V23, P25, DOI 10.1177/039463201002300103; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Guida M, 2010, ENDOCRINOLOGY, V151, P921, DOI 10.1210/en.2009-0883; Gustafsson K, 2008, INT J CANCER, V123, P1025, DOI 10.1002/ijc.23584; Gustafsson K, 2006, MOL PHARMACOL, V70, P1612, DOI 10.1124/mol.106.025981; Gustafsson SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023003; Gustafsson SB, 2009, CANCER CHEMOTH PHARM, V63, P691, DOI 10.1007/s00280-008-0788-5; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; He F, 2007, MOL PHARMACOL, V72, P1289, DOI 10.1124/mol.107.036566; Hoellenriegel J, 2014, BLOOD, V123, P1032, DOI 10.1182/blood-2013-03-493924; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Jorda MA, 2002, BLOOD, V99, P2786; Jung CK, 2013, ONCOL LETT, V5, P870, DOI 10.3892/ol.2012.1081; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kathmann M, 2006, N-S ARCH PHARMACOL, V372, P354, DOI 10.1007/s00210-006-0033-x; Kishimoto S, 2005, J BIOCHEM, V137, P217, DOI 10.1093/jb/mvi021; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Liu YJ, 2013, J BIOL CHEM, V288, P13551, DOI 10.1074/jbc.M113.453811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Martinez-Martinez Esther, 2015, Oncoscience, V2, P131; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDougall JJ, 2008, BRIT J PHARMACOL, V153, P358, DOI 10.1038/sj.bjp.0707565; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mohle R, 2001, ANN NY ACAD SCI, V938, P26; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Nulent TJWK, 2013, BRIT J ORAL MAX SURG, V51, P604, DOI 10.1016/j.bjoms.2013.03.015; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Patil M, 2011, NEUROPHARMACOLOGY, V61, P778, DOI 10.1016/j.neuropharm.2011.05.024; Patinkin D, 2008, EUR J PHARMACOL, V595, P1, DOI 10.1016/j.ejphar.2008.05.002; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Perez-Gomez E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv077; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Piszcz J A, 2007, Exp Oncol, V29, P221; Pourkhalili N, 2013, TOXICOL MECH METHOD, V23, P120, DOI 10.3109/15376516.2012.730559; Powles T, 2005, BLOOD, V105, P1214, DOI 10.1182/blood-2004-03-1182; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Puente XS, 2013, NAT GENET, V45, P229, DOI 10.1038/ng.2556; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Ramer R, 2015, INT REV CEL MOL BIO, V314, P43, DOI 10.1016/bs.ircmb.2014.10.005; Rayman N, 2007, LEUKEMIA LYMPHOMA, V48, P1389, DOI 10.1080/10428190701377030; Rayman N, 2011, EUR J HAEMATOL, V86, P466, DOI 10.1111/j.1600-0609.2011.01596.x; Richardson SJ, 2007, LEUKEMIA LYMPHOMA, V48, P1855, DOI 10.1080/10428190701534465; Rodriguez-Arias M, 2013, NEUROPHARMACOLOGY, V75, P172, DOI 10.1016/j.neuropharm.2013.07.013; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saez TMM, 2014, J NEUROCHEM, V129, P637, DOI 10.1111/jnc.12636; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Seely KA, 2012, NEUROPHARMACOLOGY, V63, P905, DOI 10.1016/j.neuropharm.2012.06.046; Shrivastava A, 2011, MOL CANCER THER, V10, P1161, DOI 10.1158/1535-7163.MCT-10-1100; Song ZH, 2000, J PHARMACOL EXP THER, V294, P204; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Suarez-Pinilla P, 2014, BRAIN BEHAV IMMUN, V40, P269, DOI 10.1016/j.bbi.2014.01.018; TANG JL, 1993, INT J IMMUNOPHARMACO, V15, P665, DOI 10.1016/0192-0561(93)90139-P; Tanikawa T, 2011, BIOL PHARM BULL, V34, P1090, DOI 10.1248/bpb.34.1090; Taylor L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10682; Theocharis S, 2015, TUMOUR BIOL IN PRESS; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Wasik AM, 2015, CELL CYCLE, V14, P291, DOI 10.1080/15384101.2015.1006536; Wasik Agata M, 2014, Oncoscience, V1, P550; Wasik AM, 2011, SEMIN CANCER BIOL, V21, P313, DOI 10.1016/j.semcancer.2011.10.004; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Xie HR, 2012, J BIOL CHEM, V287, P32288, DOI 10.1074/jbc.M112.381145; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	92	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156693	10.1371/journal.pone.0156693	http://dx.doi.org/10.1371/journal.pone.0156693			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248492	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700065
J	Gilmore, JM; Sardiu, ME; Groppe, BD; Thornton, JL; Liu, XY; Dayebgadoh, G; Banks, CA; Slaughter, BD; Unruh, JR; Workman, JL; Florens, L; Washburn, MP				Gilmore, Joshua M.; Sardiu, Mihaela E.; Groppe, Brad D.; Thornton, Janet L.; Liu, Xingyu; Dayebgadoh, Gerald; Banks, Charles A.; Slaughter, Brian D.; Unruh, Jay R.; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.			WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; UBIQUITIN LIGASE; REPAIR; TECHNOLOGY; ABUNDANCE; PEPTIDES; STRESS; CELLS; GENE; HP1	Proteins that respond to DNA damage play critical roles in normal and diseased states in human biology. Studies have suggested that the S. cerevisiae protein CMR1/YDL156w is associated with histones and is possibly associated with DNA repair and replication processes. Through a quantitative proteomic analysis of affinity purifications here we show that the human homologue of this protein, WDR76, shares multiple protein associations with the histones H2A, H2B, and H4. Furthermore, our quantitative proteomic analysis of WDR76 associated proteins demonstrated links to proteins in the DNA damage response like PARP1 and XRCC5 and heterochromatin related proteins like CBX1, CBX3, and CBX5. Co-immunoprecipitation studies validated these interactions. Next, quantitative imaging studies demonstrated that WDR76 was recruited to laser induced DNA damage immediately after induction, and we compared the recruitment of WDR76 to laser induced DNA damage to known DNA damage proteins like PARP1, XRCC5, and RPA1. In addition, WDR76 co-localizes to puncta with the heterochromatin proteins CBX1 and CBX5, which are also recruited to DNA damage but much less intensely than WDR76. This work demonstrates the chromatin and DNA damage protein associations of WDR76 and demonstrates the rapid response of WDR76 to laser induced DNA damage.	[Gilmore, Joshua M.; Sardiu, Mihaela E.; Groppe, Brad D.; Thornton, Janet L.; Liu, Xingyu; Dayebgadoh, Gerald; Banks, Charles A.; Slaughter, Brian D.; Unruh, Jay R.; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Gilmore, Joshua M.] Boehringer Ingelheim Vetmed, St Joseph, MO 64506 USA; [Groppe, Brad D.] Thermo Fisher Sci, Waltham, MA 02451 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Boehringer Ingelheim; Thermo Fisher Scientific	Washburn, MP (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Washburn, MP (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mpw@stowers.org		Unruh, Jay/0000-0003-3077-4990; Florens, Laurence/0000-0002-9310-6650; Banks, Charles/0000-0002-0404-2940; Washburn, Michael/0000-0001-7568-2585	Stowers Institute for Medical Research	Stowers Institute for Medical Research	This work was supported by the Stowers Institute for Medical Research.; This work was solely supported by the Stowers Institute for Medical Research. JMG is now an employee of Boeheringer Ingelheim Vetmedica and BDG is now an employee of Thermo Fisher Scientific. All of JMG's and BDG's contributions to this work was carried out when they were members of the Stowers Institute for Medical Research. Neither Boerheringer Ingelheim Vetmedica nor Thermo Fisher Scientific provided any resources for this project. H2A-Halo, H2B-Halo, H4-Halo with the tag on the C-terminus of each protein was a gift from Marie Schwinn of Promega.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; Banks CAS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08530; Choi DH, 2012, J MICROBIOL, V50, P112, DOI 10.1007/s12275-012-1597-4; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Daniels DL, 2012, J PROTEOME RES, V11, P564, DOI 10.1021/pr200459c; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; EDWARDS MJ, 1980, NATURE, V287, P745, DOI 10.1038/287745a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148897; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Sardiu ME, 2015, EMBO REP, V16, P116, DOI 10.15252/embr.201439403; Sardiu ME, 2014, MOL CELL PROTEOMICS, V13, P3114, DOI 10.1074/mcp.M113.037127; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stagge F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078745; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	32	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155492	10.1371/journal.pone.0155492	http://dx.doi.org/10.1371/journal.pone.0155492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248496	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700015
J	Goral, A; Bieganowski, P; Prus, W; Krzemien-Ojak, L; Kadziolka, B; Fabczak, H; Filipek, A				Goral, Agnieszka; Bieganowski, Pawel; Prus, Wiktor; Krzemien-Ojak, Lucja; Kadziolka, Beata; Fabczak, Hanna; Filipek, Anna			Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone	PLOS ONE			English	Article							HEAT-SHOCK; POSTTRANSLATIONAL MODIFICATIONS; TERMINAL DOMAIN; SGT1; HEAT-SHOCK-PROTEIN-90; DIMERIZATION; CACYBP/SIP; EXPRESSION; NOVOBIOCIN; COMPLEXES	The Hsp90 chaperone activity is tightly regulated by interaction with many co-chaperones. Since CacyBP/SIP shares some sequence homology with a known Hsp90 co-chaperone, Sgt1, in this work we performed a set of experiments in order to verify whether CacyBP/SIP can interact with Hsp90. By applying the immunoprecipitation assay we have found that CacyBP/SIP binds to Hsp90 and that the middle (M) domain of Hsp90 is responsible for this binding. Furthermore, the proximity ligation assay (PLA) performed on HEp-2 cells has shown that the CacyBP/SIP-Hsp90 complexes are mainly localized in the cytoplasm of these cells. Using purified proteins and applying an ELISA we have shown that Hsp90 interacts directly with CacyBP/SIP and that the latter protein does not compete with Sgt1 for the binding to Hsp90. Moreover, inhibitors of Hsp90 do not perturb CacyBP/SIP-Hsp90 binding. Luciferase renaturation assay and citrate synthase aggregation assay with the use of recombinant proteins have revealed that CacyBP/SIP exhibits chaperone properties. Also, CacyBP/SIP-3xFLAG expression in HEp-2 cells results in the appearance of more basic Hsp90 forms in 2D electrophoresis, which may indicate that CacyBP/SIP dephosphorylates Hsp90. Altogether, the obtained results suggest that CacyBP/SIP is involved in regulation of the Hsp90 chaperone machinery.	[Goral, Agnieszka; Prus, Wiktor; Krzemien-Ojak, Lucja; Kadziolka, Beata; Fabczak, Hanna; Filipek, Anna] Nencki Inst Expt Biol PAS, Warsaw, Poland; [Bieganowski, Pawel] Mossakowski Med Res Ctr PAS, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Filipek, A (corresponding author), Nencki Inst Expt Biol PAS, Warsaw, Poland.	a.filipek@nencki.gov.pl	Bieganowski, Pawel/ABC-8554-2021; Kądziołka, Beata/J-1231-2016; Prus, Wiktor/T-8317-2017; Fabczak, Hanna/R-4095-2016	Bieganowski, Pawel/0000-0002-1169-4517; Kądziołka, Beata/0000-0002-9229-440X; Prus, Wiktor/0000-0002-2665-5545; Fabczak, Hanna/0000-0001-6661-4599; Filipek, Anna/0000-0001-9484-9555; Goral, Agnieszka/0000-0002-7324-9718	National Science Centre [2014/15/N/NZ3/04493, 2011/03/B/NZ1/00595, NN303 818640]; statutory funds from Nencki Institute of Experimental Biology	National Science Centre(National Science Centre, Poland); statutory funds from Nencki Institute of Experimental Biology	This work was supported by grants from the National Science Centre: 2014/15/N/NZ3/04493 to AG, 2011/03/B/NZ1/00595 to AF and NN303 818640 to PB, and by statutory funds from the Nencki Institute of Experimental Biology.; Authors would like to thank to Prof. K. Kitagawa (University of British Columbia, Vancouver, Canada) for a generous gift of the pDEST17-hSGT1B plasmid and to Prof. W. Lesniak for a critical reading of the manuscript. This work was supported by grants from the National Science Centre: 2014/15/N/NZ3/04493 to AG, 2011/03/B/NZ1/00595 to AF and NN303 818640 to PB, and by statutory funds from the Nencki Institute of Experimental Biology. We are also grateful to the staff of the Laboratory of Imaging Tissue Structure and Function of the Nencki Institute for skillful technical help.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Cloutier P, 2013, BBA-GENE REGUL MECH, V1829, P443, DOI 10.1016/j.bbagrm.2013.02.010; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kilanczyk E, 2011, BIOCHEM BIOPH RES CO, V404, P179, DOI 10.1016/j.bbrc.2010.11.088; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Koga F, 2009, ANTICANCER RES, V29, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Scroggins BT, 2007, EXPERT OPIN DRUG DIS, V2, P1403, DOI 10.1517/17460441.2.10.1403; Splechowicz M, 2007, BIOCHEM BIOPH RES CO, V357, P1148, DOI 10.1016/j.bbrc.2007.04.073; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tatokoro M, 2015, EXCLI J, V14, P48, DOI 10.17179/excli2015-586; Topolska-Wos AM, 2016, BBA-GEN SUBJECTS, V1860, P79, DOI 10.1016/j.bbagen.2015.10.012; Topolska-Wos AM, 2015, FASEB J, V29, P1711, DOI 10.1096/fj.14-264770; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wasik U, 2013, NEUROBIOL AGING, V34, P1380, DOI 10.1016/j.neurobiolaging.2012.11.007; Zabka M, 2008, BIOCHEM BIOPH RES CO, V370, P179, DOI 10.1016/j.bbrc.2008.03.055; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	42	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156507	10.1371/journal.pone.0156507	http://dx.doi.org/10.1371/journal.pone.0156507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249023	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700048
J	Ihlow, F; Courant, J; Secondi, J; Herrel, A; Rebelo, R; Measey, GJ; Lillo, F; De Villiers, FA; Vogt, S; De Busschere, C; Backeljau, T; Rodder, D				Ihlow, Flora; Courant, Julien; Secondi, Jean; Herrel, Anthony; Rebelo, Rui; Measey, G. John; Lillo, Francesco; De Villiers, F. Andre; Vogt, Solveig; De Busschere, Charlotte; Backeljau, Thierry; Rodder, Dennis			Impacts of Climate Change on the Global Invasion Potential of the African Clawed Frog Xenopus laevis	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOLOGICAL INVASIONS; EXTREME WEATHER; DISTRIBUTIONS; FUTURE; BIODIVERSITY; EXTINCTION; SCENARIOS; PIPIDAE; PHYLOGEOGRAPHY	By altering or eliminating delicate ecological relationships, non-indigenous species are considered a major threat to biodiversity, as well as a driver of environmental change. Global climate change affects ecosystems and ecological communities, leading to changes in the phenology, geographic ranges, or population abundance of several species. Thus, predicting the impacts of global climate change on the current and future distribution of invasive species is an important subject in macroecological studies. The African clawed frog (Xenopus laevis), native to South Africa, possesses a strong invasion potential and populations have become established in numerous countries across four continents. The global invasion potential of X. laevis was assessed using correlative species distribution models (SDMs). SDMs were computed based on a comprehensive set of occurrence records covering South Africa, North America, South America and Europe and a set of nine environmental predictors. Models were built using both a maximum entropy model and an ensemble approach integrating eight algorithms. The future occurrence probabilities for X. laevis were subsequently computed using bioclimatic variables for 2070 following four different IPCC scenarios. Despite minor differences between the statistical approaches, both SDMs predict the future potential distribution of X. laevis, on a global scale, to decrease across all climate change scenarios. On a continental scale, both SDMs predict decreasing potential distributions in the species' native range in South Africa, as well as in the invaded areas in North and South America, and in Australia where the species has not been introduced. In contrast, both SDMs predict the potential range size to expand in Europe. Our results suggest that all probability classes will be equally affected by climate change. New regional conditions may promote new invasions or the spread of established invasive populations, especially in France and Great Britain.	[Ihlow, Flora; Vogt, Solveig; Rodder, Dennis] Zoolog Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany; [Courant, Julien; Herrel, Anthony] UMR7179 CNRS MNHN, Paris, France; [Secondi, Jean] Univ Lyon 1, UMR CNRS LEHNA 5023, F-69365 Lyon, France; [Secondi, Jean] Univ Angers, UMR CNRS LETG LEESA 6554, Angers, France; [Rebelo, Rui] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Measey, G. John; De Villiers, F. Andre] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, Private Bag X1, ZA-7602 Stellenbosch, South Africa; [Lillo, Francesco] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Palermo, Italy; [De Busschere, Charlotte; Backeljau, Thierry] Royal Belgian Inst Nat Sci, Brussels, Belgium; [De Busschere, Charlotte; Backeljau, Thierry] Univ Antwerp, B-2020 Antwerp, Belgium	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite d'Angers; Universidade de Lisboa; Stellenbosch University; University of Palermo; Royal Belgian Institute of Natural Sciences; University of Antwerp	Ihlow, F (corresponding author), Zoolog Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany.	F.Ihlow@ZFMK.de	Herrel, Anthony/C-3712-2013; Rebelo, Rui/D-7054-2013; Rödder, Dennis/AAT-8644-2021; Measey, John/F-2028-2010	Herrel, Anthony/0000-0003-0991-4434; Rebelo, Rui/0000-0003-2544-1470; Rödder, Dennis/0000-0002-6108-1639; Measey, John/0000-0001-9939-7615; Courant, Julien/0000-0002-1946-5444; Secondi, Jean/0000-0001-8130-1195; Ihlow, Flora/0000-0002-0460-4210	biodiversa project "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models"; Deutsche Forschungsgemeinschaft (DFG) [RO 4520/3-1]; Leibniz Association	biodiversa project "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Association	This research was funded by biodiversa (http://www.biodiversa.org/, project title: "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models," grant recipients: AH, RR, TB, DR) and the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, DFG RO 4520/3-1, grant recipient: DR). The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral P, 2012, HERPETOL J, V22, P187; BALINSKY B I, 1969, Zoologica Africana, V4, P37; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beebee TJ., 2009, NATURE, V374, P219; Bertelsmeier C, 2015, BIODIVERS CONSERV, V24, P117, DOI 10.1007/s10531-014-0794-3; Blaustein AR, 2001, CONSERV BIOL, V15, P1804, DOI 10.1046/j.1523-1739.2001.00307.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; Corn P. S., 2005, Animal Biodiversity and Conservation, V28, P59; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Crayon JJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P522; De Busschere C, 2016, PEERJ, V4, DOI 10.7717/peerj.1659; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Faraone FP, 2008, AMPHIBIA-REPTILIA, V29, P405, DOI 10.1163/156853808785112075; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fouquet A, 2001, ZAMENIS, V6, P10; Fouquet A, 2006, ANIM BIOL, V56, P95, DOI 10.1163/157075606775904722; Furman BLS, 2015, MOL ECOL, V24, P909, DOI 10.1111/mec.13076; Harrison PA, 2006, ENVIRON SCI POLICY, V9, P116, DOI 10.1016/j.envsci.2005.11.003; Herrel A, 2014, HERPETOL J, V24, P103; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Kolbe JJ, 2010, ECOL APPL, V20, P2273, DOI 10.1890/09-1973.1; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lillo F, 2013, ITAL J ZOOL, V80, P566, DOI 10.1080/11250003.2013.847502; Lillo Francesco, 2005, Herpetozoa, V18, P63; Lillo F, 2011, BIOL INVASIONS, V13, P1533, DOI 10.1007/s10530-010-9911-8; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobos G, 2005, BIODIVERS CONSERV, V14, P429, DOI 10.1007/s10531-004-6403-0; Lobos G, 2002, HERPETOL J, V12, P163; Lobos G, 2014, STUD NEOTROP FAUNA E, V49, P50, DOI 10.1080/01650521.2014.912865; Lobos G, 2013, STUD NEOTROP FAUNA E, V48, P1, DOI 10.1080/01650521.2012.746050; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lodge DM, 2001, FUTURE SCENARIOS GLO, P277; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MCCOID M J, 1980, Bulletin Southern California Academy of Sciences, V79, P82; MCCOID MJ, 1995, CALIF FISH GAME, V81, P39; MCCOID MJ, 1985, CALIF FISH GAME, V71, P245; McNeely JA, 2001, GLOBAL STRATEGY INVA; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; Measey GJ, 2003, AMPHIBIA-REPTILIA, V24, P321, DOI 10.1163/156853803322440781; Measey GJ, 1998, HERPETOL J, V8, P23; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Miller D, 2004, FERTIL STERIL, V81, P954, DOI 10.1016/j.fertnstert.2003.09.051; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; *NAT INV SPEC COUN, 2001, M INV SPEC CHALL NAT; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; R Development Core Team, R LANG ENV STAT COMP; Ramirez Villejas J., 2010, 1 INT CTR TROP AGR C; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rebelo R, 2010, BIOL INVASIONS, V12, P3383, DOI 10.1007/s10530-010-9757-0; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Sutherst RW, 1996, CONSERV BIOL, V10, P294, DOI 10.1046/j.1523-1739.1996.10010294.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2013, ECOL LETT, V16, P94, DOI 10.1111/ele.12104; Thuiller Wilfried, 2007, V193, P197; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P81; Tinsley RC, 2015, BIOL INVASIONS, V17, P3183, DOI 10.1007/s10530-015-0944-x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; van Sittert Lance, 2016, Transactions of the Royal Society of South Africa, V71, P157, DOI 10.1080/0035919X.2016.1158747; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Villiers De, 2016, THESIS STELLENBOSCH; VilO M., 2007, TERRESTRIAL ECOSYSTE, P93, DOI DOI 10.1007/978-3-540-32730-1_8; Vogel G, 2008, SCIENCE, V319, P1472, DOI 10.1126/science.319.5869.1472a; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x	103	39	39	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154869	10.1371/journal.pone.0154869	http://dx.doi.org/10.1371/journal.pone.0154869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248830	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700007
J	Iijima, K; Umezu, M; Iwasaki, K				Iijima, Kazuo; Umezu, Mitsuo; Iwasaki, Kiyotaka			Time Series Analysis of the Effectiveness and Safety of Capsule Endoscopy between the Premarketing and Postmarketing Settings: A Meta-Analysis	PLOS ONE			English	Article							DOUBLE-BALLOON ENTEROSCOPY; PUSH ENTEROSCOPY; SMALL-BOWEL	Background Clinical studies for assessing the effectiveness and safety in a premarketing setting are conducted under time and cost constraints. In recent years, postmarketing data analysis has been given more attention. However, to our knowledge, no studies have compared the effectiveness and the safety between the pre- and postmarketing settings. In this study, we aimed to investigate the importance of the postmarketing data analysis using clinical data. Methods and Findings Studies on capsule endoscopy with rich clinical data in both pre- and postmarketing settings were selected for the analysis. For effectiveness, clinical studies published before October 10, 2015 comparing capsule endoscopy and conventional flexible endoscopy measuring the detection ratio of obscure gastrointestinal bleeding were selected (premarketing: 4 studies and postmarketing: 8 studies) from PubMed (MEDLINE), Cochrane Library, EMBASE and Web of Science. Among the 12 studies, 5 were blinded and 7 were non-blinded. A time series meta-analysis was conducted. Effectiveness (odds ratio) decreased in the postmarketing setting (premarketing: 5.19 [95% confidence interval: 3.07-8.76] vs. postmarketing: 1.48 [0.81-2.69]). The change in odds ratio was caused by the increase in the detection ratio with flexible endoscopy as the control group. The efficacy of capsule endoscopy did not change between pre- and postmarketing settings. Heterogeneity (I-2) increased in the postmarketing setting because of one study. For safety, in terms of endoscope retention in the body, data from the approval summary and adverse event reports were analyzed. The incidence of retention decreased in the postmarketing setting (premarketing: 0.75% vs postmarketing: 0.095%). The introduction of the new patency capsule for checking the patency of the digestive tract might contribute to the decrease. Conclusions Effectiveness and safety could change in the postmarketing setting. Therefore, time series meta-analyses could be useful to continuously monitor the effectiveness of medical device in clinical practices.	[Iijima, Kazuo; Umezu, Mitsuo; Iwasaki, Kiyotaka] Joint Grad Sch Tokyo Womens Med Univ & Waseda Uni, Cooperat Major Adv Biomed Sci, Tokyo, Japan; [Umezu, Mitsuo; Iwasaki, Kiyotaka] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	Waseda University	Iwasaki, K (corresponding author), Joint Grad Sch Tokyo Womens Med Univ & Waseda Uni, Cooperat Major Adv Biomed Sci, Tokyo, Japan.; Iwasaki, K (corresponding author), Waseda Univ, Fac Sci & Engn, Tokyo, Japan.	iwasaki@waseda.jp			Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine from Ministry of Health, Labour, and Welfare, Japan	Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine from Ministry of Health, Labour, and Welfare, Japan	This study was partially supported by Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine from Ministry of Health, Labour, and Welfare, Japan.	Arakawa D, 2009, GASTROINTEST ENDOSC, V69, P866, DOI 10.1016/j.gie.2008.06.008; Eliakim AR, 2006, CURR OPIN GASTROEN, V22, P124, DOI 10.1097/01.mog.0000203866.25384.be; Ell C, 2002, ENDOSCOPY, V34, P685, DOI 10.1055/s-2002-33446; Food and Drug Administration, 2015, BAL PREM POSTM DAT C; Fukumoto A, 2009, GASTROINTEST ENDOSC, V69, P857, DOI 10.1016/j.gie.2008.06.007; Hadithi M, 2006, AM J GASTROENTEROL, V101, P52, DOI 10.1111/j.1572-0241.2005.00346.x; Hartmann D, 2003, Z GASTROENTEROL, V41, P377; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kameda N, 2008, J GASTROENTEROL, V43, P434, DOI 10.1007/s00535-008-2182-9; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Lewis BS, 2002, GASTROINTEST ENDOSC, V56, P349, DOI 10.1067/mge.2002.126906; Lim RM, 2002, AM J GASTROENTEROL, V97, pS83, DOI 10.1016/S0002-9270(02)04724-X; Marmo R, 2009, ENDOSCOPY, V41, P587, DOI 10.1055/s-0029-1214896; Matsumoto T, 2005, GASTROINTEST ENDOSC, V62, P392, DOI 10.1016/j.gie.2005.04.052; Matsumoto T, 2005, ENDOSCOPY, V37, P827, DOI 10.1055/s-2005-870207; Mehdizadeh S, 2006, GASTROINTEST ENDOSC, V64, P740, DOI 10.1016/j.gie.2006.05.022; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Mylonaki M, 2003, GUT, V52, P1122, DOI 10.1136/gut.52.8.1122; Patel PB, 2015, INDOAMERICAN J PHARM, V5, P1211; Pharmaceutical and Medical Device Agency Japan, 2007, APPR REP CAPS END GI; Pharmaceutical and Medical Device Agency Japan, 2013, REEV REP CAPS END GI; Resnic FS, 2012, NEW ENGL J MED, V366, P875, DOI 10.1056/NEJMp1114865; Shishido T, 2012, HEPATO-GASTROENTEROL, V59, P955, DOI 10.5754/hge12242; Sorenson C, 2014, MILBANK Q, V92, P114, DOI 10.1111/1468-0009.12043; Spada C, 2005, ENDOSCOPY, V37, P793, DOI 10.1055/s-2005-870246; Yamamoto H, 2003, CAN J GASTROENTEROL, V17, P273, DOI 10.1155/2003/309532	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0153662	10.1371/journal.pone.0153662	http://dx.doi.org/10.1371/journal.pone.0153662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248140	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700004
J	Shaik, S; Kumar, N; Lankapalli, AK; Tiwari, SK; Baddam, R; Ahmed, N				Shaik, Sabiha; Kumar, Narender; Lankapalli, Aditya K.; Tiwari, Sumeet K.; Baddam, Ramani; Ahmed, Niyaz			Contig-Layout-Authenticator (CLA): A Combinatorial Approach to Ordering and Scaffolding of Bacterial Contigs for Comparative Genomics and Molecular Epidemiology	PLOS ONE			English	Article							GENERATION SEQUENCING PLATFORMS; TOOL; ALGORITHM; ALIGNMENT; BAMBUS	A wide variety of genome sequencing platforms have emerged in the recent past. High-throughput platforms like Illumina and 454 are essentially adaptations of the shotgun approach generating millions of fragmented single or paired sequencing reads. To reconstruct whole genomes, the reads have to be assembled into contigs, which often require further downstream processing. The contigs can be directly ordered according to a reference, scaffolded based on paired read information, or assembled using a combination of the two approaches. While the reference-based approach appears to mask strain-specific information, scaffolding based on paired-end information suffers when repetitive elements longer than the size of the sequencing reads are present in the genome. Sequencing technologies that produce long reads can solve the problems associated with repetitive elements but are not necessarily easily available to researchers. The most common high-throughput technology currently used is the Illumina short read platform. To improve upon the shortcomings associated with the construction of draft genomes with Illumina paired-end sequencing, we developed Contig-Layout-Authenticator (CLA). The CLA pipeline can scaffold reference-sorted contigs based on paired reads, resulting in better assembled genomes. Moreover, CLA also hints at probable misassemblies and contaminations, for the users to cross-check before constructing the consensus draft. The CLA pipeline was designed and trained extensively on various bacterial genome datasets for the ordering and scaffolding of large repetitive contigs. The tool has been validated and compared favorably with other widely-used scaffolding and ordering tools using both simulated and real sequence datasets. CLA is a user friendly tool that requires a single command line input to generate ordered scaffolds.	[Shaik, Sabiha; Kumar, Narender; Lankapalli, Aditya K.; Tiwari, Sumeet K.; Baddam, Ramani; Ahmed, Niyaz] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Ahmed, N (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India.	niyaz.ahmed@uohyd.ac.in	Kumar, Narender/Y-6398-2019	Kumar, Narender/0000-0003-2089-9626; Tiwari, Sumeet Kumar/0000-0002-3615-447X	Department of Biotechnology, Government of India [BT/PR6921/MED/29/699/2013]; Council for Scientific and Industrial Research, India; HIR project of the University of Malaya (Molecular Genetics) [UM.C/625/1/HIR/MOHE/CHAN-02]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); HIR project of the University of Malaya (Molecular Genetics)	The authors acknowledge funding support from the Department of Biotechnology, Government of India (BT/PR6921/MED/29/699/2013). NK would like to acknowledge Council for Scientific and Industrial Research, India for the award of Senior Research Fellowship. The authors also would like to acknowledge funding support from the HIR project of the University of Malaya (UM.C/625/1/HIR/MOHE/CHAN-02 - Molecular Genetics). NA is a Visiting Professor at the University of Malaya, Malaysia and is an Adjunct Professor of the Academy of Scientific and Innovative Research (AcSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Ahmed N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005831; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bosi E, 2015, BIOINFORMATICS, V31, P2443, DOI 10.1093/bioinformatics/btv171; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Edwards David J, 2013, Microb Inform Exp, V3, P2, DOI 10.1186/2042-5783-3-2; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hunt M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r42; Karlsson E, 2015, SCI REP-UK, V5, DOI 10.1038/srep11996; Kolmogorov M, 2014, BIOINFORMATICS, V30, P302, DOI 10.1093/bioinformatics/btu280; Koren S, 2011, BIOINFORMATICS, V27, P2964, DOI 10.1093/bioinformatics/btr520; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pop M, 2004, GENOME RES, V14, P149; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Silva GGZ, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-23; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	33	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155459	10.1371/journal.pone.0155459	http://dx.doi.org/10.1371/journal.pone.0155459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248146	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700014
J	Fernandez-Egea, E; Vertes, PE; Flint, SM; Turner, L; Mustafa, S; Hatton, A; Smith, KGC; Lyons, PA; Bullmore, ET				Fernandez-Egea, Emilio; Vertes, Petra E.; Flint, Shaun M.; Turner, Lorinda; Mustafa, Syed; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.; Bullmore, Edward T.			Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; HUMAN IMMUNOLOGY PROJECT; T-CELLS; DENDRITIC CELLS; DOPAMINE; LYMPHOCYTES; PSYCHOSIS; PHARMACOLOGY; EXPRESSION; CLOZAPINE	Background Hypothetically, psychotic disorders could be caused or conditioned by immunological mechanisms. If so, one might expect there to be peripheral immune system phenotypes that are measurable in blood cells as biomarkers of psychotic states. Methods We used multi-parameter flow cytometry of venous blood to quantify and determine the activation state of 73 immune cell subsets for 18 patients with chronic schizophrenia (17 treated with clozapine), and 18 healthy volunteers matched for age, sex, BMI and smoking. We used multivariate methods (partial least squares) to reduce dimensionality and define populations of differentially co-expressed cell counts in the cases compared to controls. Results Schizophrenia cases had increased relative numbers of NK cells, naive B cells, CXCR5(+) memory T cells and classical monocytes; and decreased numbers of dendritic cells (DC), HLA-DR+ regulatory T-cells (Tregs), and CD4(+) memory T cells. Likewise, within the patient group, more severe negative and cognitive symptoms were associated with decreased relative numbers of dendritic cells, HLA-DR+ Tregs, and CD4(+) memory T cells. Motivated by the importance of central nervous system dopamine signalling for psychosis, we measured dopamine receptor gene expression in separated CD4(+) cells. Expression of the dopamine D3 (DRD3) receptor was significantly increased in clozapine-treated schizophrenia and covaried significantly with differentiated T cell classes in the CD4(+) lineage. Conclusions Peripheral immune cell populations and dopaminergic signalling are disrupted in clozapine-treated schizophrenia. Immuno-phenotypes may provide peripherally accessible and mechanistically specific biomarkers of residual cognitive and negative symptoms in this treatment-resistant subgroup of patients.	[Fernandez-Egea, Emilio; Turner, Lorinda; Smith, Kenneth G. C.; Bullmore, Edward T.] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Fernandez-Egea, Emilio; Turner, Lorinda; Smith, Kenneth G. C.; Bullmore, Edward T.] Univ Cambridge, Cambridge, England; [Fernandez-Egea, Emilio; Vertes, Petra E.; Mustafa, Syed; Bullmore, Edward T.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England; [Fernandez-Egea, Emilio] Ctr Invest Biomed Red Salud Mental CIBERSAM, G04, Barcelona, Spain; [Fernandez-Egea, Emilio; Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Flint, Shaun M.; Turner, Lorinda; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Flint, Shaun M.; Turner, Lorinda; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.] Univ Cambridge, Cambridge Inst Med Res, Sch Clin Med, Cambridge, England; [Bullmore, Edward T.] GlaxoSmithKline, ImmunoPsychiat Alternat Discovery & Dev, Pharmaceut R&D, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Cambridge; University of Cambridge; GlaxoSmithKline	Bullmore, ET (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Bullmore, ET (corresponding author), Univ Cambridge, Cambridge, England.; Bullmore, ET (corresponding author), Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England.; Bullmore, ET (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England.; Bullmore, ET (corresponding author), GlaxoSmithKline, ImmunoPsychiat Alternat Discovery & Dev, Pharmaceut R&D, Cambridge, England.	etb23@cam.ac.uk	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283; Turner, Lorinda/0000-0001-9032-1796; Vertes, Petra E./0000-0002-0992-3210; Fernandez-Egea, Emilio/0000-0003-4128-8955; Smith, Kenneth/0000-0003-3829-4326	NIHR Cambridge Biomedical Research Centre; NIHR Clinical Research Network: Eastern; Medical Research Council (MRC) Bioinformatics Fellowship [MR/K020706/1]; MRC [MR/L019027/1]; Wellcome Trust; Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; Wellcome Trust Strategic Award [079895]; NARSAD Young investigator Award; GlaxoSmithKline (GSK); Medical Research Council [G1000183B, G0001354, G1000183, MR/K020706/1, MR/L019027/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; MRC [G1000183, MR/K020706/1] Funding Source: UKRI	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Clinical Research Network: Eastern; Medical Research Council (MRC) Bioinformatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; Wellcome Trust Strategic Award(Wellcome Trust); NARSAD Young investigator Award(NARSAD); GlaxoSmithKline (GSK)(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the NIHR Cambridge Biomedical Research Centre and the NIHR Clinical Research Network: Eastern. PEV is supported by a Medical Research Council (MRC) Bioinformatics Fellowship (grant no. MR/K020706/1). The Behavioural & Clinical Neuroscience Institute is supported by the MRC and the Wellcome Trust. SMF is supported by the Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; and SMF, KGCS and PAL are supported by the MRC (MR/L019027/1). The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). EFE was supported in part by 2009 NARSAD Young investigator Award. The authors acknowledge the NIHR Cambridge Bioresource for recruitment of healthy volunteers and clozapine clinic patients and staff members. GlaxoSmithKline (GSK) provided support in the form of salary for ETB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of ETB as an author of this paper is articulated in the 'author contributions' section.	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Barkus EJ, 2006, PSYCHOPATHOLOGY, V39, P175, DOI 10.1159/000092678; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Boneberg EM, 2006, J NEUROIMMUNOL, V173, P180, DOI 10.1016/j.jneuroim.2005.11.018; Brito-Melo GEA, 2012, J PSYCHIATR RES, V46, P738, DOI 10.1016/j.jpsychires.2012.03.004; Brusic V, 2014, NAT BIOTECHNOL, V32, P146, DOI 10.1038/nbt.2777; Bullmore ET, 2014, BIOL PSYCHIAT, V75, P260, DOI 10.1016/j.biopsych.2013.12.006; Carter CS, 2014, BIOL PSYCHIAT, V75, P258, DOI 10.1016/j.biopsych.2013.10.023; Cazzullo CL, 1998, SCHIZOPHR RES, V31, P49, DOI 10.1016/S0920-9964(97)00153-9; Chen ML, 2013, IMMUNOPHARM IMMUNOT, V35, P573, DOI 10.3109/08923973.2013.828744; Chen ML, 2012, IMMUNOPHARM IMMUNOT, V34, P686, DOI 10.3109/08923973.2011.651535; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Craddock RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000692; Drexhage RC, 2011, INT J NEUROPSYCHOPH, V14, P746, DOI 10.1017/S1461145710001653; Drexhage RC, 2010, INT J NEUROPSYCHOPH, V13, P1369, DOI 10.1017/S1461145710000799; Ersche KD, 2011, PSYCHOPHARMACOLOGY, V214, P779, DOI 10.1007/s00213-010-2087-1; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ilani T, 2001, P NATL ACAD SCI USA, V98, P625, DOI 10.1073/pnas.021535398; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kwak Y T, 2001, BMC Med Genet, V2, P3, DOI 10.1186/1471-2350-2-3; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maino K, 2007, PSYCHIAT RES, V152, P173, DOI 10.1016/j.psychres.2006.06.004; Miller BJ, 2013, BIOL PSYCHIAT, V73, P993, DOI 10.1016/j.biopsych.2012.09.007; Miller BJ, 2013, PROG NEURO-PSYCHOPH, V42, P92, DOI 10.1016/j.pnpbp.2012.03.010; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Nakajima S, 2013, EUR NEUROPSYCHOPHARM, V23, P799, DOI 10.1016/j.euroneuro.2013.05.006; National Institute for Health and Care Excellence (NICE), 2014, PSYCH SCHIZ AD, P1; O'Sullivan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104430; Olsson Eric, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01704; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roge R, 2012, SCHIZOPHR RES, V140, P204, DOI 10.1016/j.schres.2012.06.020; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schofield PN, 2010, SCIENCE, V330, P592, DOI 10.1126/science.1191506; Sperner-Unterweger B, 1999, SCHIZOPHR RES, V38, P61, DOI 10.1016/S0920-9964(98)00175-3; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steiner J, 2012, BRAIN BEHAV IMMUN, V26, P564, DOI 10.1016/j.bbi.2012.01.018; Steiner J, 2010, EUR ARCH PSY CLIN N, V260, P509, DOI 10.1007/s00406-010-0098-x; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Tourjman V, 2013, SCHIZOPHR RES, V151, P43, DOI 10.1016/j.schres.2013.10.011; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Urhan-Kucuk M, 2011, MOL BIOL REP, V38, P2569, DOI 10.1007/s11033-010-0396-4; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; WHO, 2011, INT STAT CLASS DIS R	52	48	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155631	10.1371/journal.pone.0155631	http://dx.doi.org/10.1371/journal.pone.0155631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244229	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100004
J	Mitra, A; Guevremont, G; Timofeeva, E				Mitra, Arojit; Guevremont, Genevieve; Timofeeva, Elena			Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; LATERAL SEPTUM; FOOD-INTAKE; GLUTAMATE-DECARBOXYLASE; INSITU HYBRIDIZATION; PREFRONTAL CORTEX; RESTRAINT STRESS; FOOTSHOCK STRESS; LICKING ACTIVITY	The anterior hypothalamic area (AHA) is an important integrative relay structure for a variety of autonomic, endocrine, and behavioral responses including feeding behavior and response to stress. However, changes in the activity of the AHA neurons during stress and feeding in freely moving rats are not clear. The present study investigated the firing rate and burst activity of neurons in the central nucleus of the AHA (cAHA) during sucrose intake in non-stressful conditions and after acute stress in freely behaving rats. Rats were implanted with micro-electrodes into the cAHA, and extracellular multi-unit activity was recorded during 1-h access to 10% sucrose in non-stressful conditions or after acute foot shock stress. Acute stress significantly reduced sucrose intake, total sucrose lick number, and lick frequency in licking clusters, and increased inter-lick intervals. At the cluster start (CS) of sucrose licking, the cAHA neurons increased (CS-excited, 20% of the recorded neurons), decreased (CS-inhibited, 42% of the neurons) or did not change (CS-nonresponsive, 38% of the neurons) their firing rate. Stress resulted in a significant increase in the firing rate of the CS-inhibited neurons by decreasing inter-spike intervals within the burst firing of these neurons. This increase in the stress-induced firing rate of the CS-inhibited neurons was accompanied by a disruption of the correlation between the firing rate of CS-inhibited and CS-nonresponsive neurons that was observed in non-stressful conditions. Stress did not affect the firing rate of the CS-excited and CS-nonresponsive neurons. However, stress changed the pattern of burst firing of the CS-excited and CS-nonresponsive neurons by decreasing and increasing the burst number in the CS-excited and CS-nonresponsive neurons, respectively. These results suggest that the cAHA neurons integrate the signals related to stress and intake of palatable food and play a role in the stress-and eating-related circuitry.	[Mitra, Arojit; Guevremont, Genevieve; Timofeeva, Elena] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Psychiat & Neurosci,Fac Med, Quebec City, PQ G1V 0A6, Canada	Laval University	Timofeeva, E (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Psychiat & Neurosci,Fac Med, Quebec City, PQ G1V 0A6, Canada.	Elena.Timofeeva@fmed.ulaval.ca	Mitra, Arojit/AGE-5058-2022	MITRA, AROJIT/0000-0002-4026-4057	Canadian Institutes of Health Research [102659]; Natural Sciences and Engineering Research Council of Canada [327597]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number 102659 (grant received by ET); and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number 327597 (grant received by ET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE JW, 1991, BRAIN RES, V543, P123; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Bali A, 2015, REV NEUROSCI; Bali B, 2005, NEUROSCI LETT, V380, P60, DOI 10.1016/j.neulet.2005.01.014; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; BOURQUE CW, 1991, BRAIN RES, V540, P349, DOI 10.1016/0006-8993(91)90535-4; Calvez J, 2015, GENES BRAIN BEHAV, V14, P550, DOI 10.1111/gbb.12236; Chen L, 2009, PROG NAT SCI-MATER, V19, P229, DOI 10.1016/j.pnsc.2008.05.027; Christiansen AM, 2011, STRESS, V14, P205, DOI 10.3109/10253890.2010.531331; Christiansen AM, 2011, PHYSIOL BEHAV, V103, P111, DOI 10.1016/j.physbeh.2011.01.015; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Constantin S, 2013, J NEUROSCI, V33, P9394, DOI 10.1523/JNEUROSCI.0533-13.2013; Constantin S, 2012, ENDOCRINOLOGY, V153, P3758, DOI 10.1210/en.2012-1126; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Cottone P, 2007, NEUROPSYCHOPHARMACOL, V32, P1069, DOI 10.1038/sj.npp.1301229; Cottone P, 2012, NEUROPSYCHOPHARMACOL, V37, P2593, DOI 10.1038/npp.2012.89; DAVIS JD, 1990, AM J PHYSIOL, V259, pR1228, DOI 10.1152/ajpregu.1990.259.6.R1228; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; DAVIS JD, 1993, AM J PHYSIOL, V264, pR97, DOI 10.1152/ajpregu.1993.264.1.R97; DYBALL REJ, 1991, J NEUROENDOCRINOL, V3, P383, DOI 10.1111/j.1365-2826.1991.tb00291.x; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; FALLON JH, 1986, J COMP NEUROL, V249, P293, DOI 10.1002/cne.902490302; FERRIS CF, 1990, J COMP NEUROL, V293, P476, DOI 10.1002/cne.902930310; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; FUCHS SAG, 1985, BRAIN RES, V330, P93, DOI 10.1016/0006-8993(85)90010-1; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P87, DOI 10.1007/s11055-008-0012-4; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; GIRARD CL, 1986, CAN J PHYSIOL PHARM, V64, P406, DOI 10.1139/y86-065; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Higgs S, 2004, PROG NEURO-PSYCHOPH, V28, P405, DOI 10.1016/j.pnpbp.2003.11.003; Homayoun H, 2006, CEREB CORTEX, V16, P93, DOI 10.1093/cercor/bhi087; Homayoun L, 2005, J NEUROPHYSIOL, V93, P1989, DOI 10.1152/jn.00875.2004; IMAKI T, 1993, BRAIN RES, V616, P114, DOI 10.1016/0006-8993(93)90199-W; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JOHANSSON O, 1984, NEUROSCIENCE, V13, P265, DOI 10.1016/0306-4522(84)90233-1; KANT GJ, 1983, LIFE SCI, V33, P2657; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kim U, 1998, J NEUROSCI, V18, P9500; Kinzig KP, 2008, PHYSIOL BEHAV, V95, P108, DOI 10.1016/j.physbeh.2008.04.026; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kubo T, 2001, BRAIN RES BULL, V56, P569, DOI 10.1016/S0361-9230(01)00729-8; LAMMERS JHCM, 1988, BRAIN RES, V449, P311, DOI 10.1016/0006-8993(88)91046-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; LARSEN PJ, 1992, J COMP NEUROL, V316, P287, DOI 10.1002/cne.903160304; Lee K, 2010, J NEUROSCI, V30, P6214, DOI 10.1523/JNEUROSCI.6156-09.2010; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Martin J, 2010, AM J PHYSIOL-REG I, V298, pR1383, DOI 10.1152/ajpregu.00371.2009; MCCARTY R, 1978, PHYSIOL BEHAV, V21, P567, DOI 10.1016/0031-9384(78)90132-4; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Mitra A, 2011, NEUROSCIENCE, V192, P459, DOI 10.1016/j.neuroscience.2011.06.033; Mitra A, 2015, EUR J NEUROSCI, V41, P420, DOI 10.1111/ejn.12798; Mitra A, 2014, BEHAV BRAIN RES, V273, P82, DOI 10.1016/j.bbr.2014.07.035; OKAMURA H, 1990, NEUROSCIENCE, V39, P675, DOI 10.1016/0306-4522(90)90252-Y; Orsetti M, 2007, NEUROPSYCHOPHARMACOL, V32, P1783, DOI 10.1038/sj.npp.1301291; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Patel SM, 2008, EUR J PHARMACOL, V601, P106, DOI 10.1016/j.ejphar.2008.10.059; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Richard D., 2009, ENCY NEUROSCIENCE, P1035; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; Rossier MF, 2003, J STEROID BIOCHEM, V85, P383, DOI 10.1016/S0960-0760(03)00201-2; SAKANAKA M, 1989, BRAIN RES, V479, P205, DOI 10.1016/0006-8993(89)91621-1; SAPER CB, 1978, J COMP NEUROL, V182, P575, DOI 10.1002/cne.901820402; Sawchenko PE, 2000, PROG BRAIN RES, V122, P61; Sawchenko PE, 1996, PROG BRAIN RES, V107, P201; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shin SY, 2011, KOREAN J PHYSIOL PHA, V15, P163, DOI 10.4196/kjpp.2011.15.3.163; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Stanley BG, 2011, PHYSIOL BEHAV, V104, P40, DOI 10.1016/j.physbeh.2011.04.046; Tabarean IV, 2005, NEUROSCIENCE, V135, P433, DOI 10.1016/j.neuroscience.2005.06.053; Timofeeva E., 2014, BRAIN DISORD THER, V3, P121; Turenius CI, 2009, BRAIN RES, V1283, P65, DOI 10.1016/j.brainres.2009.05.064; Ulrich-Lai YM, 2007, ENDOCRINOLOGY, V148, P1823, DOI 10.1210/en.2006-1241; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wichmann T, 2006, J NEUROPHYSIOL, V95, P2120, DOI 10.1152/jn.01013.2005	89	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156563	10.1371/journal.pone.0156563	http://dx.doi.org/10.1371/journal.pone.0156563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243579	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100049
J	Silva-O'Hare, J; de Oliveira, IS; Klevorn, T; Almeida, VA; Oliveira, GGS; Atta, AM; de Freitas, LAR; Dos-Santos, WLC				Silva-O'Hare, Joselli; de Oliveira, Isabela Silva; Klevorn, Thais; Almeida, Valter A.; Oliveira, Geraldo G. S.; Atta, Ajax M.; de Freitas, Luiz Antonio R.; dos-Santos, Washington L. C.			Disruption of Splenic Lymphoid Tissue and Plasmacytosis in Canine Visceral Leishmaniasis: Changes in Homing and Survival of Plasma Cells	PLOS ONE			English	Article							PERIPHERAL-BLOOD; B-CELLS; SPLEEN; INFECTION; CHAGASI; DOGS; ARCHITECTURE; ACTIVATION; EXPRESSION; AUTOIMMUNE	Visceral leishmaniasis (VL) is a disease caused by Leishmania infantum, which is transmitted by phlebotomine sandflies. Dogs are the main urban reservoir of this parasite and the disease presents similar characteristics in both humans and dogs. In this paper, we investigated the potential pathways involved in plasma cell replacement of normal cell populations in the spleen, with respect to disease severity in dogs from an endemic area for visceral leishmaniasis. To this end, canine spleen samples were grouped into three categories: TYPE1SC- (non-infected dogs or without active infection with organized white pulp), TYPE1SC+ (infected dogs with organized white pulp) or TYPE3SC+ (infected animals with disorganized white pulp). We analyzed the distribution of different plasma cell isotypes (IgA, IgG and IgM) in the spleen. The expression of cytokines and chemokines involved in plasma cell homing and survival were assessed by real time RT-PCR. Polyclonal B cell activation and hypergammaglobulinemia were also evaluated. The proportion of animals with moderate or intense plasmacytosis was higher in the TYPE3SC+ group than in the other groups (Fisher test, P<0.05). This was mainly due to a higher density of IgG+ plasma cells in the red pulp of this group. The albumin/globulin ratio was lower in the TYPE3SC+ animals than in the TYPE1SC- or TYPE1SC+ animals, which evidences VL-associated dysproteinemia. Interestingly, TYPE3SC+ animals showed increased expression of the BAFF and APRIL cytokines, as well as chemokine CXCL12. Aberrant expression of BAFF, APRIL and CXCL12, together with amplified extrafollicular B cell activation, lead to plasma cell homing and the extended survival of these cells in the splenic red pulp compartment. These changes in the distribution of immunocompetent cells in the spleen may contribute to the progression of VL, and impair the spleen's ability to protect against blood borne pathogens.	[Silva-O'Hare, Joselli; Klevorn, Thais; Almeida, Valter A.; Oliveira, Geraldo G. S.; de Freitas, Luiz Antonio R.; dos-Santos, Washington L. C.] Fundacao Oswaldo Cruz BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [de Oliveira, Isabela Silva; Atta, Ajax M.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil; [de Freitas, Luiz Antonio R.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia	Dos-Santos, WLC (corresponding author), Fundacao Oswaldo Cruz BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	wluis@bahia.fiocruz.br	dos-Santos, Washington LC/AAO-4649-2021; de Sá Oliveira, Geraldo Gileno/AAO-4099-2021	dos-Santos, Washington LC/0000-0002-5075-1254; de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; Almeida, Valter/0000-0001-8380-3391	Fundacao de Amparo a Pesquisa do Estado da Bahia [PET0053/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) AUXPE-CAPES-FAPESB [23038.006718/2013-19]; Fundacao Oswaldo Cruz (Fiocruz)-CNPq PROEP [400905/2013-2]; CNPq	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) AUXPE-CAPES-FAPESB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (Fiocruz)-CNPq PROEP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb.http://www.fapesb.ba.gov.br) grant no. PET0053/2013, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes. http://www.capes.gov.br/) AUXPE-CAPES-FAPESB 2072/2013/PROCESSO #23038.006718/2013-19 and Fundacao Oswaldo Cruz (Fiocruz. http://portal.fiocruz.br/pt-br)-CNPq PROEP grant 400905/2013-2. WLCS received a scholarship from CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Z, 1956, REV ASSOC MED BRAS, V5, P413; Belnoue E, 2012, J IMMUNOL, V188, P1283, DOI 10.4049/jimmunol.1103169; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Camacho AT, 2002, B SOC PATHOL EXOT, V95, P17; Carvalho LJM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-59; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cavalcanti AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123009; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; DOnofrio G, 2015, MORPHOLOGY OF BLOOD DISORDERS, 2ND EDITION, P1; Dos-Santos WLC, 2008, VET IMMUNOL IMMUNOP, V123, P251, DOI 10.1016/j.vetimm.2008.02.004; Ellyard JI, 2005, EUR J IMMUNOL, V35, P699, DOI 10.1002/eji.200425442; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58; Goto Y, 2014, AM J TROP MED HYG, V91, P912, DOI 10.4269/ajtmh.14-0260; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; KEENAN CM, 1984, VET PATHOL, V21, P80, DOI 10.1177/030098588402100114; Kemming G, 2004, EUR SURG RES, V36, P198, DOI 10.1159/000078853; Kirkwood BR, 2003, ESSENTIAL MED STAT; LESTER SJ, 1995, CAN VET J, V36, P444; Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742; Mahevas M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00494; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Ministerio da Saude do Brasil S, 2006, MANUAL DE VIGILANCIA; O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; Peeters D, 2005, J COMP PATHOL, V132, P283, DOI 10.1016/j.jcpa.2004.11.002; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shrestha R, 2014, J NEUROPSYCH CLIN N, V26, pE53, DOI 10.1176/appi.neuropsych.13030057; Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103; Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026; Steiniger B, 1999, MICROANATOMY FUNCTIO; Tagariello G, 2014, BLOOD TRANSFUS-ITALY, V12, P428, DOI 10.2450/2014.0242-13; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Rodrigues CAT, 2009, VET IMMUNOL IMMUNOP, V127, P382, DOI 10.1016/j.vetimm.2008.10.324; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; VERESS B, 1983, BRIT J EXP PATHOL, V64, P505; VERESS B, 1977, IMMUNOLOGY, V33, P605	44	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156733	10.1371/journal.pone.0156733	http://dx.doi.org/10.1371/journal.pone.0156733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243459	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100068
J	Wells, E; Wolfe, MK; Murray, A; Lantagne, D				Wells, Emma; Wolfe, Marlene K.; Murray, Anna; Lantagne, Daniele			Accuracy, Precision, Ease-Of-Use, and Cost of Methods to Test Ebola-Relevant Chlorine Solutions	PLOS ONE			English	Article								To prevent transmission in Ebola Virus Disease (EVD) outbreaks, it is recommended to disinfect living things (hands and people) with 0.05% chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% chlorine solution. In the current West African EVD outbreak, these solutions (manufactured from calcium hypochlorite (HTH), sodium dichloroisocyanurate (NaDCC), and sodium hypochlorite (NaOCl)) have been widely used in both Ebola Treatment Unit and community settings. To ensure solution quality, testing is necessary, however test method appropriateness for these Ebola-relevant concentrations has not previously been evaluated. We identified fourteen commercially-available methods to test Ebola-relevant chlorine solution concentrations, including two titration methods, four DPD dilution methods, and six test strips. We assessed these methods by: 1) determining accuracy and precision by measuring in quintuplicate five different 0.05% and 0.5% chlorine solutions manufactured from NaDCC, HTH, and NaOCl; 2) conducting volunteer testing to assess ease-of-use; and, 3) determining costs. Accuracy was greatest in titration methods (reference-12.4% error compared to reference method), then DPD dilution methods (2.4-19% error), then test strips (5.2-48% error); precision followed this same trend. Two methods had an accuracy of <10% error across all five chlorine solutions with good precision: Hach digital titration for 0.05% and 0.5% solutions (recommended for contexts with trained personnel and financial resources), and Serim test strips for 0.05% solutions (recommended for contexts where rapid, inexpensive, and low-training burden testing is needed). Measurement error from test methods not including pH adjustment varied significantly across the five chlorine solutions, which had pH values 5-11. Volunteers found test strip easiest and titration hardest; costs per 100 tests were $14-37 for test strips and $33-609 for titration. Given the ease-of-use and cost benefits of test strips, we recommend further development of test strips robust to pH variation and appropriate for Ebola-relevant chlorine solution concentrations.	[Wells, Emma; Wolfe, Marlene K.; Murray, Anna; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA	Tufts University	Wells, E (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	emmafayewells@gmail.com		Murray, Anna/0000-0003-0909-2012	United States Agency for International Development, Office of Foreign Disaster Assistance [AID-OFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance (AID-OFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders were provided a final version of the manuscript before submission, and had no comments.	[Anonymous], 2014, WHO REP EB VIR DIS E, P1; [Anonymous], HAND HYG W AFR GEN N; [Anonymous], 2013, HACH DIGITAL TITRATO; [Anonymous], 2014, EBOLA CAN FREE RESID; [Anonymous], 2008, D202289 ASTM; [Anonymous], 2012, STANDARD METHODS EXA; [Anonymous], EB EB VIR DIS SIGNS; Bender DF, 1978, COMP METHODS DETERMI; Centers for Disease Control and Prevention, EB VIR DIS DISTR MAP; Centers for Disease Control and Prevention, EB EB VIR DIS TRANSM; Committee NRC (US) SDW, 1980, DIS DRINK WAT; Current Technology of Chlorine Analysis for Water and Wastewater. Hach Company, 2002, 17 HACH CO; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Ebola KnowledgePoint Forum, EB KNOWLEDGEPOINT FO; Ebola Thomson P., 2007, TOR MED FRONT; Emmanueal Jorge N Babacar, 2015, ASSESSMENT RECOMMEND; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; Murray A, 2015, J WATER HEALTH, V13, P79, DOI 10.2166/wh.2014.195; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; Preparing and Measuring High Chlorine Concentration Solutions for Disinfection. United States Army Public Health Command, 2014, 130341114 US ARM PUB; Quick Robert, 2015, COMMUNICATION; Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182; Sterk E, MED SANS FRONTIERES; Walker J., 2014, DECONTAMINATION HOSP; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, EB VIR DIS	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0152442	10.1371/journal.pone.0152442	http://dx.doi.org/10.1371/journal.pone.0152442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243817	Green Submitted, gold, Green Published			2022-12-27	WOS:000377146100001
J	Dubey, JP; Ferreira, LR; Alsaad, M; Verma, SK; Alves, DA; Holland, GN; McConkey, GA				Dubey, Jitender P.; Ferreira, Leandra R.; Alsaad, Mohammad; Verma, Shiv K.; Alves, Derron A.; Holland, Gary N.; McConkey, Glenn A.			Experimental Toxoplasmosis in Rats Induced Orally with Eleven Strains of Toxoplasma gondii of Seven Genotypes: Tissue Tropism, Tissue Cyst Size, Neural Lesions, Tissue Cyst Rupture without Reactivation, and Ocular Lesions	PLOS ONE			English	Article							CONGENITAL TRANSMISSION; PARASITIC INFECTION; GENETIC DIVERSITY; SANTA ISABEL; MICE; OOCYSTS; CATS; BRAZIL; SCHIZOPHRENIA; PATHOGENICITY	Background The protozoan parasite Toxoplasma gondii is one of the most widely distributed and successful parasites. Toxoplasma gondii alters rodent behavior such that infected rodents reverse their fear of cat odor, and indeed are attracted rather than repelled by feline urine. The location of the parasite encysted in the brain may influence this behavior. However, most studies are based on the highly susceptible rodent, the mouse. Methodology/Principal Findings Latent toxoplasmosis was induced in rats (10 rats per T. gondii strains) of the same age, strain, and sex, after oral inoculation with oocysts (natural route and natural stage of infection) of 11 T. gondii strains of seven genotypes. Rats were euthanized at two months post inoculation (p.i.) to investigate whether the parasite genotype affects the distribution, location, tissue cyst size, or lesions. Tissue cysts were enumerated in different regions of the brains, both in histological sections as well in saline homogenates. Tissue cysts were found in all regions of the brain. The tissue cyst density in different brain regions varied extensively between rats with many regions highly infected in some animals. Overall, the colliculus was most highly infected although there was a large amount of variability. The cerebral cortex, thalamus, and cerebellum had higher tissue cyst densities and two strains exhibited tropism for the colliculus and olfactory bulb. Histologically, lesions were confined to the brain and eyes. Tissue cyst rupture was frequent with no clear evidence for reactivation of tachyzoites. Ocular lesions were found in 23 (25%) of 92 rat eyes at two months p.i. The predominant lesion was focal inflammation in the retina. Tissue cysts were seen in the sclera of one and in the optic nerve of two rats. The choroid was not affected. Only tissue cysts, not active tachyzoite infections, were detected. Tissue cysts were seen in histological sections of tongue of 20 rats but not in myocardium and leg muscle. Conclusion/Significance This study reevaluated in depth the rat model of toxoplasmosis visualizing cyst rupture and clarified many aspects of the biology of the parasite useful for future investigations.	[Dubey, Jitender P.; Ferreira, Leandra R.; Verma, Shiv K.] ARS, USDA, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Beltsville, MD USA; [Alsaad, Mohammad; McConkey, Glenn A.] Univ Leeds, Fac Biol Sci, Miall Bldg,Clarendon Way, Leeds, W Yorkshire, England; [Alves, Derron A.] Vet Pathol Serv Joint Pathol Ctr, 606 Stephen Sitter Ave, Silver Spring, MD USA; [Holland, Gary N.] Univ Calif Los Angeles, Stein Eye Inst, Ocular Inflammatory Dis Ctr, Los Angeles, CA USA; [Holland, Gary N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA	United States Department of Agriculture (USDA); University of Leeds; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dubey, JP (corresponding author), ARS, USDA, Beltsville Agr Res Ctr, Anim Parasit Dis Lab, Beltsville, MD USA.	Jitender.Dubey@ars.usda.gov	Alsaad, Dr Mohammad/GZM-9598-2022; McConkey, Glenn A./I-4062-2019	McConkey, Glenn/0000-0001-6529-794X				Afonso C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032489; Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Berenreiterova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028925; BEVERLEY J K, 1958, Trans Ophthalmol Soc U K, V78, P109; BEVERLEY JKA, 1959, NATURE, V183, P1348, DOI 10.1038/1831348a0; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Burnett AJ, 1998, OPHTHALMOLOGY, V105, P1032, DOI 10.1016/S0161-6420(98)96004-3; Demar M, 2007, CLIN INFECT DIS, V45, pE88, DOI 10.1086/521246; Di CM, 2008, INFECT IMMUN, V76, P3491, DOI [10.1128/IAI.00254-08, DOI 10.1128/IAI.00254-08]; Dubey JP, 2007, VET PARASITOL, V145, P352, DOI 10.1016/j.vetpar.2006.12.016; Dubey JP, 2006, VET PARASITOL, V141, P42, DOI 10.1016/j.vetpar.2006.04.037; Dubey JP, 2011, J PARASITOL, V97, P842, DOI 10.1645/GE-2728.1; Dubey JP, 2011, INT J PARASITOL, V41, P827, DOI 10.1016/j.ijpara.2011.03.006; Dubey JP, 2010, J PARASITOL, V96, P713, DOI 10.1645/GE-2429.1; DUBEY JP, 1976, J PROTOZOOL, V23, P537, DOI 10.1111/j.1550-7408.1976.tb03836.x; DUBEY JP, 1995, J PARASITOL, V81, P410, DOI 10.2307/3283823; Dubey JP, 1996, J PARASITOL, V82, P951, DOI 10.2307/3284205; Dubey JP, 1996, J PARASITOL, V82, P438, DOI 10.2307/3284082; Dubey JP, 1998, VET PARASITOL, V77, P1, DOI 10.1016/S0304-4017(97)00227-6; DUBEY JP, 1988, VET PARASITOL, V30, P97, DOI 10.1016/0304-4017(88)90156-2; DUBEY JP, 1980, AM J VET RES, V41, P427; DUBEY JP, 1992, J PARASITOL, V78, P151, DOI 10.2307/3283705; Dubey JP, 1997, J PARASITOL, V83, P870, DOI 10.2307/3284282; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; DUBEY JP, 1987, EQUINE VET J, V19, P337, DOI 10.1111/j.2042-3306.1987.tb01426.x; DUBEY JP, 1995, J PARASITOL, V81, P48, DOI 10.2307/3284004; DUBEY JP, 1993, J VET DIAGN INVEST, V5, P472, DOI 10.1177/104063879300500334; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; ESCAJADILLO A, 1991, AM J TROP MED HYG, V44, P382, DOI 10.4269/ajtmh.1991.44.382; FERGUSON DJP, 1987, PARASITOL RES, V73, P483, DOI 10.1007/BF00535321; FERGUSON DJP, 1991, INT J EXP PATHOL, V72, P463; FERGUSON DJP, 1989, PARASITOL RES, V75, P599, DOI 10.1007/BF00930955; FRENKEL JK, 1987, AM J TROP MED HYG, V36, P517, DOI 10.4269/ajtmh.1987.36.517; Gatkowska J, 2012, PARASITOL RES, V111, P53, DOI 10.1007/s00436-011-2800-y; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Grigg ME, 2009, INT J PARASITOL, V39, P925, DOI 10.1016/j.ijpara.2009.02.005; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Holland GN, 1999, AM J OPHTHALMOL, V128, P413, DOI 10.1016/S0002-9394(99)00300-1; HOLLAND GN, 1988, AM J OPHTHALMOL, V106, P653, DOI 10.1016/0002-9394(88)90697-6; HOLLAND GN, 1996, OCULAR INFECT IMMUNI, P1183; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Luder CGK, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P217, DOI 10.1016/B978-0-12-396481-6.00007-6; LUNDE MN, 1983, J PARASITOL, V69, P806, DOI 10.2307/3281034; Martin HL, 2015, NEUROSCIENCE, V306, P50, DOI 10.1016/j.neuroscience.2015.08.005; McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; McLeod R, 2012, CLIN INFECT DIS, V54, P1595, DOI 10.1093/cid/cis258; Melzer T C, 2010, J Neuroparasitology, V1, DOI 10.4303/jnp/N100505; NICHOLSON DH, 1976, ARCH OPHTHALMOL-CHIC, V94, P248, DOI 10.1001/archopht.1976.03910030120009; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; REMINGTON J, 1961, J INFECT DIS, V108, P163, DOI 10.1093/infdis/108.2.163; REMINGTON J, 1961, J IMMUNOL, V87, P578; Remington J. S., 2006, INFECT DIS FETUS NEW, P947, DOI DOI 10.1016/B0-72-160537-0/50033-5; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Sibley LD, 2008, ANNU REV MICROBIOL, V62, P329, DOI 10.1146/annurev.micro.62.081307.162925; Silveira C, 2015, AM J OPHTHALMOL, V159, P1013, DOI 10.1016/j.ajo.2015.02.017; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Su E, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P161, DOI 10.1016/B978-0-12-396481-6.00005-2; Sullivan AM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003283; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; VAN DER WAAIJ D., 1959, Tropical and Geographical Medicine, V11, P345; Vaudaux JD, 2010, J INFECT DIS, V202, P1226, DOI 10.1086/656397; Velmurugan GV, 2009, J PARASITOL, V95, P95, DOI 10.1645/GE-1746.1; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Watson C, 2006, RAT BRAIN STEREOTAXI; Watts E, 2015, MBIO, V6, DOI 10.1128/mBio.01155-15; Webster JP, 2006, P ROY SOC B-BIOL SCI, V273, P1023, DOI 10.1098/rspb.2005.3413; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9	76	46	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156255	10.1371/journal.pone.0156255	http://dx.doi.org/10.1371/journal.pone.0156255			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228262	Green Published, gold			2022-12-27	WOS:000376882500095
J	Fetene, N; Linnander, E; Fekadu, B; Alemu, H; Omer, H; Canavan, M; Smith, J; Berman, P; Bradley, E				Fetene, Netsanet; Linnander, Erika; Fekadu, Binyam; Alemu, Hibret; Omer, Halima; Canavan, Maureen; Smith, Janna; Berman, Peter; Bradley, Elizabeth			The Ethiopian Health Extension Program and Variation in Health Systems Performance: What Matters?	PLOS ONE			English	Article							COMMUNITY; WORKERS; MANAGEMENT	Background Primary health care services are fundamental to improving health and health equity, particularly in the context of low and middle-income settings where resources are scarce. During the past decade, Ethiopia undertook an ambitious investment in primary health care known as the Ethiopian Health Extension Program that recorded impressive gains in several health outcomes. Despite this progress, substantial disparities in health outcomes persist across the country. The objective of this study was to understand how variation in the implementation of the primary health care efforts may explain differences in key health outcomes. Methods and Findings We conducted a qualitative study of higher-performing and lower-performing woredas using site visits and in-depth interviews undertaken in 7 woredas. We classified woredas as higher-performing or lower-performing based on data on 5 indicators. We conducted a total of 94 open-ended interviews; 12-15 from each woreda. The data were analyzed using the constant comparative method of qualitative data analysis. Substantial contrasts were apparent between higher-performing and lower-performing woredas in use of data for problemsolving and performance improvement; collaboration and respectful relationships among health extension workers, community members, and health center staff; and coordination between the woreda health office and higher-level regulatory and financing bodies at the zonal and regional levels. We found similarities in what was reported to motivate or demotivate health extension workers and other staff. Additionally, higher-performing and lower-performing woredas shared concerns about hospitals being isolated from health centers and health posts. Participants from both woredas also highlighted a mismatch between the urban health extension program design and the urban-dwelling communities' expectations for primary health care. Conclusions Data-informed problem solving, respectful and supportive relationships with the community, and strong support from zonal and regional health bureaus contributed to woreda performance, suggesting avenues for achieving higher performance in primary health care.	[Fetene, Netsanet; Linnander, Erika; Omer, Halima; Canavan, Maureen; Smith, Janna; Bradley, Elizabeth] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Fetene, Netsanet; Linnander, Erika; Omer, Halima; Canavan, Maureen; Smith, Janna; Bradley, Elizabeth] Global Hlth Inst, New Haven, CT USA; [Fekadu, Binyam] JSI Res & Training Inst, Boston, MA USA; [Alemu, Hibret; Berman, Peter] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health	Bradley, E (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT USA.; Bradley, E (corresponding author), Global Hlth Inst, New Haven, CT USA.	elizabeth.bradley@yale.edu	Desta, Binyam/AAO-4603-2021	Desta, Binyam/0000-0002-2146-9516; Linnander, Erika/0000-0002-3417-1049; Netsanet, Fetene/0000-0002-3208-0055	Bill & Melinda Gates Foundation [R11632]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Bill & Melinda Gates Foundation, Award Number R11632. The funder had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	Afework MF, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-28; Banteyerga H, 2011, MEDICC REV, V13, P46, DOI 10.37757/MR2011V13.N3.11; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bradley EH, 2015, INT J HEALTH POLICY, V4, P411, DOI 10.15171/ijhpm.2015.101; Bradley EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035042; CSA, 2013, POPULATION PROJECTIO; Curry L., 2015, MIXED METHODS HLTH S; Federal Democratic Republic of Ethiopa, HLTH SECT DEV PROGR; Gebrehiwot TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131195; Gilchrist VJ, 1999, DOING QUALITATIVE RE, P71; Gilmore B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-847; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gopinathan U, 2014, TROP MED INT HEALTH, V19, P1437, DOI 10.1111/tmi.12381; Javanparast S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-291; Javanparast S, 2011, AM J PUBLIC HEALTH, V101, P2287, DOI 10.2105/AJPH.2011.300355; Karim AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065160; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kok MC, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0077-4; Lakew Y, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2078-6; Legesse E, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0345-4; Mangham-Jefferies L, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-61; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Medhanyie A, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-44; Medhanyie A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-352; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Ministry of Health, 2013, Q HLTH B POL PRACT I; Pallas SW, 2013, AM J PUBLIC HEALTH, V103, pE74, DOI 10.2105/AJPH.2012.301102; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Pfeffermann G, 2014, LANCET GLOB HEALTH, V2, pE504, DOI 10.1016/S2214-109X(14)70272-4; Shaw B, 2015, AM J TROP MED HYG, V93, P636, DOI 10.4269/ajtmh.14-0660; Skaftun EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106460; Sundararaman T, 2011, B WORLD HEALTH ORGAN, V89, P73, DOI 10.2471/BLT.09.070862; Wang HD, 2014, LANCET, V384, P957, DOI 10.1016/S0140-6736(14)60497-9; World Health Organization, 1978, AL AT INT C PRIM HLT, P6; World Health Organization, 2016, WHO AFR REG ETH; World Health Organization, AFR HLTH OBS AN SUMM; World Health Organization (WHO), 2012, WHO REC ROUT IMM SUM; Yesuf EA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-131; Yesuf EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095439; Yitayal M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-156; Zulu JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-987	43	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156438	10.1371/journal.pone.0156438	http://dx.doi.org/10.1371/journal.pone.0156438			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227972	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500135
J	Hinojosa, JA; Rincon-Perez, I; Romero-Ferreiro, MV; Martinez-Garcia, N; Villalba-Garcia, C; Montoro, PR; Pozo, MA				Hinojosa, Jose A.; Rincon-Perez, Irene; Veronica Romero-Ferreiro, Ma; Martinez-Garcia, Natalia; Villalba-Garcia, Cristina; Montoro, Pedro R.; Pozo, Miguel A.			The Madrid Affective Database for Spanish (MADS): Ratings of Dominance, Familiarity, Subjective Age of Acquisition and Sensory Experience	PLOS ONE			English	Article							ENGLISH WORDS ANEW; AFFECTIVE NORMS; EMOTIONAL WORDS; PSYCHOLINGUISTIC VARIABLES; NEGATIVE CONTENT; FREQUENCY; ADAPTATION; FRENCH; CATEGORIES; VALENCE	The current study presents ratings by 540 Spanish native speakers for dominance, familiarity, subjective age of acquisition (AoA), and sensory experience (SER) for the 875 Spanish words included in the Madrid Affective Database for Spanish (MADS). The norms can be downloaded as supplementary materials for this manuscript from https://figshare.com/s/8e7b445b729527262c88 These ratings may be of potential relevance to researches who are interested in characterizing the interplay between language and emotion. Additionally, with the aim of investigating how the affective features interact with the lexicosemantic properties of words, we performed correlational analyses between norms for familiarity, subjective AoA and SER, and scores for those affective variables which are currently included in the MADs. A distinct pattern of significant correlations with affective features was found for different lexicosemantic variables. These results show that familiarity, subjective AoA and SERs may have independent effects on the processing of emotional words. They also suggest that these psycholinguistic variables should be fully considered when formulating theoretical approaches to the processing of affective language.	[Hinojosa, Jose A.; Pozo, Miguel A.] Univ Complutense, CAI Cartografia Cerebral, E-28040 Madrid, Spain; [Hinojosa, Jose A.; Veronica Romero-Ferreiro, Ma] Univ Complutense, Fac Psicol, E-28040 Madrid, Spain; [Hinojosa, Jose A.; Rincon-Perez, Irene; Martinez-Garcia, Natalia; Villalba-Garcia, Cristina; Pozo, Miguel A.] Univ Complutense, Inst Pluridisciplinar, E-28040 Madrid, Spain; [Martinez-Garcia, Natalia] Univ Lancaster, Dept Psychol, Lancaster LA1 4YF, England; [Montoro, Pedro R.] UNED, Dept Psicol Basica 1, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Lancaster University; Universidad Nacional de Educacion a Distancia (UNED)	Hinojosa, JA (corresponding author), Univ Complutense, CAI Cartografia Cerebral, E-28040 Madrid, Spain.; Hinojosa, JA (corresponding author), Univ Complutense, Fac Psicol, E-28040 Madrid, Spain.; Hinojosa, JA (corresponding author), Univ Complutense, Inst Pluridisciplinar, E-28040 Madrid, Spain.	hinojosa@pluri.ucm.es	Pozo, Miguel A/AAO-3977-2021; Pozo, Miguel A/L-1021-2014; Montoro, Pedro R. R/B-2270-2014; Hinojosa, José A/G-8746-2011; Romero-Ferreiro, M Verónica R/S-9650-2018; Hinojosa, Jose/AAU-8044-2021	Pozo, Miguel A/0000-0001-9303-0513; Pozo, Miguel A/0000-0001-5934-1510; Montoro, Pedro R. R/0000-0002-5665-8587; Hinojosa, José A/0000-0002-7482-9503; Hinojosa, Jose/0000-0002-7482-9503; Villalba - Garcia, Cristina/0000-0003-2174-6955	Ministerio de Economia y Competitividad (MINECO) of Spain [PSI2012-37535]; UNED [2012V/PUNED/0009]; Universidad Complutense of Madrid;  [I2M2: P2010/BMD-2349]	Ministerio de Economia y Competitividad (MINECO) of Spain; UNED; Universidad Complutense of Madrid; 	This study was supported by grant PSI2012-37535 from the Ministerio de Economia y Competitividad (MINECO) of Spain to JAH, URL: www.mineco.gob.es; grant 2012V/PUNED/0009 from the UNED to PRM, URL: www.uned.es; grant I2M2: P2010/BMD-2349 to MAP, URL: www.madrid.org; Pre-doctoral grant from the Universidad Complutense of Madrid to MVRF, URL: www.ucm.es.	Alonso MA, 2015, BEHAV RES METHODS, V47, P268, DOI 10.3758/s13428-014-0454-2; Barsalou L.W., 2012, CAMBRIDGE HDB PSYCHO, P239, DOI [10.1017/CBO9781139029377.017, DOI 10.1017/CBO9781139029377.017]; Bauer LM, 2008, PSYCHOL REC, V58, P465, DOI 10.1007/BF03395629; Bonin P, 2015, BEHAV RES METHODS, V47, P813, DOI 10.3758/s13428-014-0503-x; Bradford MCJ, 1999, CATAL REV, V41, P1, DOI 10.1081/CR-100101948; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Briesemeister BB, 2011, BEHAV RES METHODS, V43, P441, DOI 10.3758/s13428-011-0059-y; BROWN GDA, 1987, MEM COGNITION, V15, P208, DOI 10.3758/BF03197718; Brysbaert M, 2011, Q J EXP PSYCHOL, V64, P545, DOI 10.1080/17470218.2010.503374; CAMPOS A, 1988, PERCEPT MOTOR SKILL, V66, P649, DOI 10.2466/pms.1988.66.2.649; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Citron FM, 2014, APPL PSYCHOLINGUIST, V35, P1; Colombo L, 2006, MEM COGNITION, V34, P1312, DOI 10.3758/BF03193274; CONNINE CM, 1990, J EXP PSYCHOL LEARN, V16, P1084, DOI 10.1037/0278-7393.16.6.1084; Diaz-Lago M, 2015, J NEUROLINGUIST, V36, P79, DOI 10.1016/j.jneuroling.2015.07.001; Duchon A, 2013, BEHAV RES METHODS, V45, P1246, DOI 10.3758/s13428-013-0326-1; Eilola TM, 2010, BEHAV RES METHODS, V42, P134, DOI 10.3758/BRM.42.1.134; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 1999, HDB COGNITION EMOTIO, V16, P301, DOI DOI 10.1002/0470013494.CH16; Ellis AW, 2000, J EXP PSYCHOL LEARN, V26, P1103, DOI 10.1037//0278-7393.26.5.1103; Ferre P, MOVED WORDS AF UNPUB; Ferre P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00976; Ferre P, 2012, BEHAV RES METHODS, V44, P395, DOI 10.3758/s13428-011-0165-x; Fontaine JRJ, 2007, PSYCHOL SCI, V18, P1050, DOI 10.1111/j.1467-9280.2007.02024.x; Fraga I, 2012, Q J EXP PSYCHOL, V65, P1740, DOI 10.1080/17470218.2012.662989; GORDON B, 1985, J MEM LANG, V24, P631, DOI 10.1016/0749-596X(85)90050-6; Guasch M, BEHAV RES M IN PRESS; Havas DA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00294; Hinojosa JA, 2016, BEHAV RES METHODS, V48, P272, DOI 10.3758/s13428-015-0572-5; Hinojosa JA, 2014, BRAIN COGNITION, V87, P109, DOI 10.1016/j.bandc.2014.03.008; Hinojosa JA, 2014, COGN AFFECT BEHAV NE, V14, P1286, DOI 10.3758/s13415-014-0291-x; Hinojosa JA, 2010, NEUROPSYCHOLOGIA, V48, P1725, DOI 10.1016/j.neuropsychologia.2010.02.020; Izura C, 2005, BEHAV RES METHODS, V37, P385, DOI 10.3758/BF03192708; Janschewitz K, 2008, BEHAV RES METHODS, V40, P1065, DOI 10.3758/BRM.40.4.1065; Moreno-Martinez FJ, 2014, BEHAV RES METHODS, V46, P1088, DOI 10.3758/s13428-013-0435-x; Juhasz BJ, 2015, BEHAV RES METHODS, V47, P1004, DOI 10.3758/s13428-014-0523-6; Juhasz BJ, 2013, BEHAV RES METHODS, V45, P160, DOI 10.3758/s13428-012-0242-9; Juhasz BJ, 2011, Q J EXP PSYCHOL, V64, P1683, DOI 10.1080/17470218.2011.605150; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kanske P, 2010, BEHAV RES METHODS, V42, P987, DOI 10.3758/BRM.42.4.987; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; KREUZ RJ, 1987, MEM COGNITION, V15, P154, DOI 10.3758/BF03197027; Kuperman V, 2014, J EXP PSYCHOL GEN, V143, P1065, DOI 10.1037/a0035669; Liu YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016505; Mendez-Bertolo C, 2011, NEUROSCI LETT, V494, P250, DOI 10.1016/j.neulet.2011.03.026; Monnier C, 2014, BEHAV RES METHODS, V46, P1128, DOI 10.3758/s13428-013-0431-1; Montefinese M, 2014, BEHAV RES METHODS, V46, P887, DOI 10.3758/s13428-013-0405-3; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; MORRISON CM, 1995, J EXP PSYCHOL LEARN, V21, P116, DOI 10.1037/0278-7393.21.1.116; Morrison CM, 2003, Q J EXP PSYCHOL-A, V56, P703, DOI 10.1080/02724980244000594; Moseley R, 2012, CEREB CORTEX, V22, P1634, DOI 10.1093/cercor/bhr238; Osgood C.E., 1957, MEASUREMENT MEANING; Panksepp J., 1998, J CONSCIOUSNESS STUD, V5, P566; Redondo J, 2005, PSICOLOGICA, V26, P317; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Riegel M., 2015, BEHAV RES METHODS, V1, P1; Schmidtke DS, 2014, BEHAV RES METHODS, V46, P1108, DOI 10.3758/s13428-013-0426-y; Scott GG, 2012, J EXP PSYCHOL LEARN, V38, P783, DOI 10.1037/a0027209; Soares AP, 2012, BEHAV RES METHODS, V44, P256, DOI 10.3758/s13428-011-0131-7; Soderholm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072859; Stadthagen-Gonzalez H, BEHAVIOR RESEARH MET; Stevenson RA, 2007, BEHAV RES METHODS, V39, P1020, DOI 10.3758/BF03192999; Strauss GP, 2008, COGNITION EMOTION, V22, P114, DOI 10.1080/02699930701319154; Tanaka-Ishii K, 2011, STUD LINGUISTICA, V65, P96, DOI 10.1111/j.1467-9582.2010.01176.x; Vigliocco G, 2009, LANG COGN, V1, P219, DOI 10.1515/LANGCOG.2009.011; Vinson D, 2014, COGNITION EMOTION, V28, P737, DOI 10.1080/02699931.2013.851068; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Vo MLH, 2006, BEHAV RES METHODS, V38, P606, DOI 10.3758/BF03193892; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; White KK, LANGUAGE CO IN PRESS, P1; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114; Widen SC, 2008, COGNITIVE DEV, V23, P291, DOI 10.1016/j.cogdev.2008.01.002; Winkielman P., 2015, APA HDB PERSONALITY, P151, DOI DOI 10.1037/14341-004	76	27	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155866	10.1371/journal.pone.0155866	http://dx.doi.org/10.1371/journal.pone.0155866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227521	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500040
J	Oka, T; Lu, ZY; Phan, T; Delwart, EL; Saif, LJ; Wang, QH				Oka, Tomoichiro; Lu, Zhongyan; Phan, Tung; Delwart, Eric L.; Saif, Linda J.; Wang, Qiuhong			Genetic Characterization and Classification of Human and Animal Sapoviruses	PLOS ONE			English	Article							PORCINE ENTERIC CALICIVIRUSES; MOLECULAR CHARACTERIZATION; IDENTIFICATION; NOROVIRUSES; PREVALENCE; DIVERSITY; SWINE; KOBUVIRUSES; ROTAVIRUSES; DIARRHEA	Sapoviruses (SaVs) are enteric caliciviruses that have been detected in multiple mammalian species, including humans, pigs, mink, dogs, sea lions, chimpanzees, and rats. They show a high level of diversity. A SaV genome commonly encodes seven nonstructural proteins (NSs), including the RNA polymerase protein NS7, and two structural proteins (VP1 and VP2). We classified human and animal SaVs into 15 genogroups (G) based on available VP1 sequences, including three newly characterized genomes from this study. We sequenced the full length genomes of one new genogroup V (GV), one GVII and one GVIII porcine SaV using long range RT-PCR including newly designed forward primers located in the conserved motifs of the putative NS3, and also 5' RACE methods. We also determined the 5'-and 3'-ends of sea lion GV SaV and canine GXIII SaV. Although the complete genomic sequences of GIX-GXII, and GXV SaVs are unavailable, common features of SaV genomes include: 1) "GTG" at the 50-end of the genome, and a short (9 similar to 14 nt) 50-untranslated region; and 2) the first five amino acids (M [A/V] S [K/R] P) of the putative NS1 and the five amino acids (FEMEG) surrounding the putative cleavage site between NS7 and VP1 were conserved among the chimpanzee, two of five genogroups of pig (GV and GVIII), sea lion, canine, and human SaVs. In contrast, these two amino acid motifs were clearly different in three genogroups of porcine (GIII, GVI and GVII), and bat SaVs. Our results suggest that several animal SaVs have genetic similarities to human SaVs. However, the ability of SaVs to be transmitted between humans and animals is uncertain.	[Oka, Tomoichiro; Lu, Zhongyan; Saif, Linda J.; Wang, Qiuhong] Ohio State Univ, Ohio Agr Res & Dev Ctr, Coll Food Agr & Environm Sci, Food Anim Hlth Res Program,Dept Vet Prevent Med, Wooster, OH 44691 USA; [Oka, Tomoichiro] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Phan, Tung; Delwart, Eric L.] Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA USA; [Phan, Tung; Delwart, Eric L.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University System of Ohio; Ohio State University; National Institute of Infectious Diseases (NIID); Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Saif, LJ; Wang, QH (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Coll Food Agr & Environm Sci, Food Anim Hlth Res Program,Dept Vet Prevent Med, Wooster, OH 44691 USA.	saif.2@osu.edu; wang.655@osu.edu	Saif, Linda/E-4005-2011	Phan, Tung/0000-0003-3517-3078	Ohio State University; USDA, National Institute of Food and Agriculture [2011-68003-30395]; Blood Systems Research Institute; NIH [R01-HL-105770]; Ohio Agricultural Research and Development Center (OARDC), The Ohio State University	Ohio State University(Ohio State University); USDA, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Blood Systems Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Agricultural Research and Development Center (OARDC), The Ohio State University(Ohio State University)	This research was supported by The Ohio State University (www.osu.edu) through start-up funding for Q. Wang. This research was also supported by the USDA, National Institute of Food and Agriculture, grant 2011-68003-30395 (to L.J. Saif and Q. Wang; subaward co-PIs)(https://nifa.usda.gov/). E.L. Delwart (PI) and T. Phan were supported by Blood Systems Research Institute and NIH (R01-HL-105770) (http://www.nih.gov/). Salaries and research support were provided by state and federal funds provided to the Ohio Agricultural Research and Development Center (OARDC), The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amimo JO, 2013, VET MICROBIOL, V164, P27, DOI 10.1016/j.vetmic.2013.01.039; Amimo JO, 2013, J CLIN MICROBIOL, V51, P1142, DOI 10.1128/JCM.03193-12; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; Guo M, 1999, J VIROL, V73, P9625, DOI 10.1128/JVI.73.11.9625-9631.1999; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Liu W, 2014, VIRUS GENES, V49, P100, DOI 10.1007/s11262-014-1078-4; Martella V, 2008, J CLIN MICROBIOL, V46, P1907, DOI 10.1128/JCM.00341-08; Mombo IM, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00680-14; Nakamura K, 2010, J CLIN MICROBIOL, V48, P1215, DOI 10.1128/JCM.02130-09; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Oka T, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00349-13; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; SAIF LJ, 1980, J CLIN MICROBIOL, V12, P105, DOI 10.1128/JCM.12.1.105-111.1980; Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13; Shibata S., 2015, Genome Announcements, V3, pe01553; Sisay Z, 2013, ARCH VIROL, V158, P1583, DOI 10.1007/s00705-013-1619-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034987; Wang QH, 2006, J VIROL METHODS, V132, P135, DOI 10.1016/j.jviromet.2005.10.003; Wang QH, 2005, J CLIN MICROBIOL, V43, P5963, DOI 10.1128/JCM.43.12.5963-5972.2005; Wang QH, 2007, VACCINE, V25, P5453, DOI 10.1016/j.vaccine.2006.12.032	23	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156373	10.1371/journal.pone.0156373	http://dx.doi.org/10.1371/journal.pone.0156373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228126	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500124
J	Pyo, JH; Lee, H; Min, BH; Lee, JH; Choi, MG; Lee, JH; Sohn, TS; Bae, JM; Kim, KM; Ahn, HS; Jung, SH; Kim, S; Kim, JJ				Pyo, Jeung Hui; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Choi, Min Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Kyoung-Mee; Ahn, Hyeon Seon; Jung, Sin-Ho; Kim, Sung; Kim, Jae J.			A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer	PLOS ONE			English	Article							ENDOSCOPIC SUBMUCOSAL DISSECTION; RING CELL-CARCINOMA; MUCOSAL RESECTION; CLINICAL-SIGNIFICANCE; ESOPHAGEAL CANCER; HISTOLOGICAL TYPE; ADENOCARCINOMA; SURGERY; MICROMETASTASIS; FEASIBILITY	Background and Aim Endoscopic submucosal dissection (ESD) for undifferentiated type early gastric cancer is regarded as an investigational treatment. Few studies have tried to identify the risk factors that predict lymph-node metastasis (LNM) in intramucosal poorly differentiated adenocarcinomas (PDC). This study was designed to develop a risk scoring system (RSS) for predicting LNM in intramucosal PDC. Methods From January 2002 to July 2015, patients diagnosed with mucosa-confined PDC, among those who underwent curative gastrectomy with lymph node dissection were reviewed. A risk model based on independent predicting factors of LNM was developed, and its performance was internally validated using a split sample approach. Results Overall, LNM was observed in 5.2% (61) of 1169 patients. Four risk factors [Female sex, tumor size >= 3.2 cm, muscularis mucosa (M3) invasion, and lymphatic-vascular involvement] were significantly associated with LNM, which were incorporated into the RSS. The area under the receiver operating characteristic curve for predicting LNM after internal validation was 0.69 [95% confidence interval (CI), 0.59-0.79]. A total score of 2 points corresponded to the optimal RSS threshold with a discrimination of 0.75 (95% CI 0.69-0.81). The LNM rates were 1.6% for low risk (<2 points) and 8.9% for high-risk (>= 2 points) patients, with a negative predictive value of 98.6%(95% CI 0.98-1.00). Conclusions A RSS could be useful in clinical practice to determine which patients with intramucosal PDC have low risk of LNM.	[Pyo, Jeung Hui; Lee, Hyuk; Min, Byung-Hoon; Lee, Jun Haeng; Kim, Jae J.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Choi, Min Gew; Lee, Jun Ho; Sohn, Tae Sung; Bae, Jae Moon; Kim, Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Kyoung-Mee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Ahn, Hyeon Seon; Jung, Sin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Jung, Sin-Ho] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Duke University	Lee, H; Lee, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	leehyuk@skku.edu; stomachlee@gmail.com	Kim, Sung/G-4114-2014; Pyo, Jh/HHD-0876-2022	Lee, Hyuk/0000-0003-4271-7205				Abe N, 2004, GASTROINTEST ENDOSC, V60, P242, DOI 10.1016/S0016-5107(04)01682-7; Abe N, 2002, AM J SURG, V183, P168, DOI 10.1016/S0002-9610(01)00860-1; Abe N, 2004, AM J SURG, V188, P181, DOI 10.1016/j.amjsurg.2003.12.060; [Anonymous], 2000, WHO CLASSIFICATION T; Arigami T, 2013, ANN SURG ONCOL, V20, P515, DOI 10.1245/s10434-012-2355-x; Asakawa Y, 2015, WORLD J GASTROENTERO, V21, P2683, DOI 10.3748/wjg.v21.i9.2683; Cho JW, 2014, CLIN ENDOSC, V47, P523, DOI 10.5946/ce.2014.47.6.523; Edge SB, 2010, AJCC CANC STAGING MA; Gotoda T, 2000, CANCER, V3, P219; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Gotoda T, 2013, DIGEST ENDOSC, V25, P55, DOI 10.1111/den.12003; Ha TK, 2008, ANN SURG ONCOL, V15, P508, DOI 10.1245/s10434-007-9660-9; Hirasawa T, 2009, GASTRIC CANCER, V12, P148, DOI 10.1007/s10120-009-0515-x; Huo ZB, 2012, WORLD J GASTROENTERO, V18, P6489, DOI 10.3748/wjg.v18.i44.6489; Ishida K, 1997, CANCER, V79, P1069, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1069::AID-CNCR3>3.0.CO;2-B; Ishikawa S, 2007, GASTRIC CANCER, V10, P35, DOI 10.1007/s10120-006-0407-2; Kang HY, 2010, SURG ENDOSC, V24, P509, DOI 10.1007/s00464-009-0614-0; Kim HM, 2011, SURG ENDOSC, V25, P3087, DOI 10.1007/s00464-011-1674-5; Kim JH, 2009, GASTROINTEST ENDOSC, V69, pE1, DOI 10.1016/j.gie.2008.10.040; Kitamura K, 1997, J SURG ONCOL, V64, P42, DOI 10.1002/(SICI)1096-9098(199701)64:1<42::AID-JSO9>3.0.CO;2-P; Kunisaki C, 2009, ENDOSCOPY, V41, P498, DOI 10.1055/s-0029-1214758; Lee JH, 2012, BRIT J SURG, V99, P1688, DOI 10.1002/bjs.8934; Lee SH, 2015, EUR J GASTROEN HEPAT, V27, P170, DOI 10.1097/MEG.0000000000000258; Li C, 2008, ANN SURG ONCOL, V15, P764, DOI 10.1245/s10434-007-9707-y; Maehara Y, 1996, SURGERY, V119, P397, DOI 10.1016/S0039-6060(96)80138-3; Park JM, 2009, EUR J GASTROEN HEPAT, V21, P1132, DOI 10.1097/MEG.0b013e32832a21d8; Park YD, 2008, ENDOSCOPY, V40, P7, DOI 10.1055/s-2007-966750; Pyo JH, 2016, AM J GASTROENTEROL, V111, P240, DOI 10.1038/ajg.2015.427; Pyo JH, 2016, ANN SURG; Shim CN, 2014, SURG ENDOSC, V28, P2199, DOI 10.1007/s00464-014-3453-6; Shim CN, 2014, WORLD J GASTROENTERO, V20, P3938, DOI 10.3748/wjg.v20.i14.3938; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Takizawa K, 2013, GASTRIC CANCER, V16, P531, DOI 10.1007/s10120-012-0220-z; Tsuruta O, 2000, Diagn Ther Endosc, V6, P101, DOI 10.1155/DTE.6.101; Ye BD, 2008, J GASTROEN HEPATOL, V23, P46, DOI 10.1111/j.1440-1746.2006.04791.x	37	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156207	10.1371/journal.pone.0156207	http://dx.doi.org/10.1371/journal.pone.0156207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228258	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500080
J	Chand, RP; Kumar, AS; Anuj, K; Vishnupriya, S; Reddy, BM				Chand, Rayabarapu Pranav; Kumar, Arramraju Sreenivas; Anuj, Kapadia; Vishnupriya, Satti; Reddy, Battini Mohan			Distinct Patterns of Association of Variants at 11q23.3 Chromosomal Region with Coronary Artery Disease and Dyslipidemia in the Population of Andhra Pradesh, India	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; HEART-DISEASE; GENE-CLUSTER; LIPID LEVELS; SUSCEPTIBILITY; RISK; LOCI; HAPLOTYPES; BIOMARKERS	In our attempt to comprehensively understand the nature of association of variants at 11q23.3 apolipoprotein gene cluster region, we genotyped a prioritized set of 96 informative SNPs using Fluidigm customized SNP genotyping platform in a sample of 508 coronary artery disease (CAD) cases and 516 controls. We found 12 SNPs as significantly associated with CAD at P < 0.05, albeit only four (rs2849165, rs17440396, rs6589566 and rs633389) of these remained significant after Benjamin Hochberg correction. Of the four, while rs6589566 confers risk to CAD, the other three SNPs reduce risk for the disease. Interaction of variants that belong to regulatory genes BUD13 and ZPR1 with APOA5-APOA4 intergenic variants is also observed to significantly increase the risk towards CAD. Further, ROC analysis of the risk scores of the 12 significant SNPs suggests that our study has substantial power to confer these genetic variants as predictors of risk for CAD, as illustrated by AUC (0.763; 95% CI: 0.729-0.798, p = <0.0001). On the other hand, the protective SNPs of CAD are associated with elevated Low Density Lipoprotein Cholesterol and Total Cholesterol levels, hence with dyslipidemia, in our sample of controls, which may suggest distinct effects of the variants at 11q23.3 chromosomal region towards CAD and dyslipidemia. It may be necessary to replicate these findings in the independent and ethnically heterogeneous Indian samples in order to establish this as an Indian pattern. However, only functional analysis of the significant variants identified in our study can provide more precise understanding of the mechanisms involved in the contrasting nature of their effects in manifesting dyslipidemia and CAD.	[Chand, Rayabarapu Pranav; Reddy, Battini Mohan] Indian Stat Inst, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Kumar, Arramraju Sreenivas; Anuj, Kapadia] Care Hosp, Dept Cardiol, Hyderabad, Andhra Pradesh, India; [Vishnupriya, Satti] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Osmania University	Reddy, BM (corresponding author), Indian Stat Inst, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmrisi@gmail.com			Indian Statistical Institute	Indian Statistical Institute	This work was supported by in-house funding from the Indian Statistical Institute. No specific grant number, etc., is applicable.	Aruna M, 2011, HUM REPROD, V26, P765, DOI 10.1093/humrep/der024; AshokKumar M, 2010, MOL BIOL REP, V37, P521, DOI 10.1007/s11033-009-9728-7; Aung LHH, 2014, J CELL MOL MED, V18, P1417, DOI 10.1111/jcmm.12291; Bhanushali AA, 2010, J COMMUN GENET, V1, P139, DOI 10.1007/s12687-010-0025-x; Braun TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037056; Chandra K Sarat, 2014, Indian Heart J, V66 Suppl 3, pS1, DOI 10.1016/j.ihj.2014.12.001; Chhabra S, 2005, DIS MARKERS, V21, P169, DOI 10.1155/2005/195078; Dasgupta S, 2012, GENE, V503, P140, DOI 10.1016/j.gene.2012.04.060; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Falush D, 2003, GENETICS, V164, P1567; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gangwani L, 2006, J BIOL CHEM, V281, P40330, DOI 10.1074/jbc.M608165200; Henkhaus Rebecca S, 2011, Indian J Hum Genet, V17, P194, DOI 10.4103/0971-6866.92103; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Jyothi KU, 2015, META GENE, V5, P9, DOI 10.1016/j.mgene.2015.05.001; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kumar BAV, 2014, INT J SCI STUDY, V2, P73; Misra A, 2004, J Assoc Physicians India, V52, P137; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Olivier M, 2004, GENOMICS, V83, P912, DOI 10.1016/j.ygeno.2003.11.016; Pranavchand R, 2013, J POSTGRAD MED, V59, P30, DOI 10.4103/0022-3859.109492; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUMAN GENETICS, V81; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; ROSS R, 1977, AM J PATHOL, V86, P675; Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sekhri T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005346; Shanker J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-33; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Walia GK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101688; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Willer C, 2013, NAT GENET, V45, P1, DOI DOI 10.1038/ng.2519; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Yamada Y, 2007, GENOMICS, V90, P551, DOI 10.1016/j.ygeno.2007.08.001; Yin RX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-140	41	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0153720	10.1371/journal.pone.0153720	http://dx.doi.org/10.1371/journal.pone.0153720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257688	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700005
J	Schick, T; Altay, L; Viehweger, E; Hoyng, CB; den Hollander, AI; Felsch, M; Fauser, S				Schick, Tina; Altay, Lebriz; Viehweger, Eva; Hoyng, Carel B.; den Hollander, Anneke I.; Felsch, Moritz; Fauser, Sascha			Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; POLYMORPHISMS; ASSOCIATION; PREVALENCE; PREDICTION; VARIANTS; DRUSEN; GENES; TWIN	Background Age-related macular degeneration (AMD) is a common disease causing visual impairment and blindness. Various gene variants are strongly associated with late stage AMD, but little is known about the genetics of early forms of the disease. This study evaluated associations of genetic factors and different AMD stages depending on unilateral and bilateral disease severity. Methods In this case-control study, participants were assigned to nine AMD severity stages based on the characteristics of each eye. 18 single nucleotide polymorphisms (SNPs) were geno-typed and attempted to correlate with AMD severity stages by uni- and multivariate logistic regression analyses and trend analyses. Area under the receiver operating characteristic curves (AUC) were calculated. Results Of 3444 individuals 1673 were controls, 379 had early AMD, 333 had intermediate AMD and 989 showed late AMD stages. With increasing severity of disease and bilateralism more SNPs with significant associations were found. Odds ratios, especially for the main risk polymorphisms in ARMS2 (rs10490924) and CFH (rs1061170), gained with increasing disease severity and bilateralism (exemplarily: rs1061170: unilateral early AMD: OR = 1.18; bilateral early AMD: OR = 1.20; unilateral intermediate AMD: OR = 1.28; bilateral intermediate AMD: OR = 1.39, unilateral geographic atrophy (GA): OR = 1.50; bilateral GA: OR = 1.71). Trend analyses showed p<0.0001 for ARMS2 (rs10490924) and for CFH (rs1061170), respectively. AUC of risk models for various AMD severity stages was lowest for unilateral early AMD (AUC = 0.629) and showed higher values in more severely and bilaterally affected individuals being highest for late AMD with GA in one eye and neovascular AMD in the other eye (AUC = 0.957). Conclusion The association of known genetic risk factors with AMD became stronger with increasing disease severity, which also led to an increasing discriminative ability of AMD cases and controls. Genetic predisposition was also associated with the disease severity of the fellow-eye, highlighting the importance of both eyes in AMD patients.	[Schick, Tina; Altay, Lebriz; Viehweger, Eva; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Felsch, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands	University of Cologne; University of Cologne; Radboud University Nijmegen	Fauser, S (corresponding author), Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany.	sascha.fauser@gmail.com	Hollander, Anneke den/N-4911-2014					Ardeljan D, 2013, EUR J HUM GENET, V21, P1152, DOI 10.1038/ejhg.2013.14; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Buitendijk GHS, 2013, OPHTHALMOLOGY, V120, P2644, DOI 10.1016/j.ophtha.2013.07.053; Chakravarthy U, 2013, OPHTHALMOLOGY, V120, P342, DOI 10.1016/j.ophtha.2012.08.004; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Delcourt C, 2011, INVEST OPHTH VIS SCI, V52, P5955, DOI 10.1167/iovs.10-6235; Dietzel M, 2014, GRAEF ARCH CLIN EXP, V252, P1273, DOI 10.1007/s00417-014-2690-7; Farwick A, 2009, EYE, V23, P2238, DOI 10.1038/eye.2008.426; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grassmann F, 2015, EUR J PHARM BIOPHARM, V95, P194, DOI 10.1016/j.ejpb.2015.04.039; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Hermann M, 2012, ACTA OPHTHALMOL, V90, pe500, DOI 10.1111/j.1755-3768.2011.02347.x; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Ng TK, 2008, INVEST OPHTH VIS SCI, V49, P3312, DOI 10.1167/iovs.07-1517; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15711; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156778	10.1371/journal.pone.0156778	http://dx.doi.org/10.1371/journal.pone.0156778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257685	Green Submitted, Green Published, gold			2022-12-27	WOS:000377369700125
J	Sulz, MC; Kroger, A; Prakash, M; Manser, CN; Heinrich, H; Misselwitz, B				Sulz, Michael C.; Kroger, Arne; Prakash, Meher; Manser, Christine N.; Heinrich, Henriette; Misselwitz, Benjamin			Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas	PLOS ONE			English	Article							COLONOSCOPY PREPARATION QUALITY; SERRATED POLYP DETECTION; COLORECTAL-CANCER; SCREENING COLONOSCOPY; PREPARATION SCALE; MISS RATES; IMPACT; COLON; RISK; VALIDATION	Background and Aims Low-quality bowel preparation reduces efficacy of colonoscopy. We aimed to summarize effects of bowel preparation on detection of adenomas, advanced adenomas and colorectal cancer. Methods A systematic literature search was performed regarding detection of colonic lesions after normal and low-quality bowel preparation. Reported bowel preparation quality was transformed to the Aronchick scale with its qualities "excellent", "good", "fair", "poor", and "insufficient" or "optimal" (good/excellent), "suboptimal" (fair/poor/insufficient), "adequate" (good/excellent/fair) and "inadequate" (poor/insufficient). We identified two types of studies: i) Comparative studies, directly comparing lesion detection according to bowel preparation quality, and ii) repeat colonoscopy studies, reporting results of a second colonoscopy after previous low-quality preparation. Results The detection of early adenomas was reduced with inadequate vs. adequate bowel preparation (Odds Ratio (OR) 0.53, CI: 0.46-0.62, p<0.001). The advanced adenomas were affected less in comparison (0.74, CI: 0.62-0.87, p<0.001). The large number of subjects considered in the present meta-analysis resulted in smaller confidence intervals compared to earlier studies. Classifying the bowel-preparation quality as suboptimal vs. optimal led to the same qualitative conclusion (OR: 0.81, CI: 0.74-0.89, p<0.001 for early adenomas, OR: 0.94, CI: 0.87-1.01, n.s. for advanced adenomas). Bowel preparation was equally important for right-sided/flat/serrated vs. other lesions in most observational studies but more relevant in some repeat colonoscopy studies; data regarding carcinoma detection were insufficient. Conclusion Inadequate bowel preparation affects detection of early colonic lesions stronger than advanced lesions.	[Sulz, Michael C.; Kroger, Arne; Prakash, Meher; Manser, Christine N.; Heinrich, Henriette; Misselwitz, Benjamin] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Sulz, Michael C.] Kantonsspital St Gallen, Div Gastroenterol & Hepatol, St Gallen, Switzerland; [Manser, Christine N.] See Spital Horgen, CH-8801 Horgen, Switzerland	University of Zurich; University Zurich Hospital; Kantonsspital St. Gallen	Misselwitz, B (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	benjamin.misselwitz@usz.ch	Heinrich, Henriette/A-1918-2017; Misselwitz, Benjamin/L-7193-2016	Heinrich, Henriette/0000-0001-6355-0921; Misselwitz, Benjamin/0000-0002-8719-5175	Swiss Cancer League [KFS-2977-08-2012]; Horten Foundation	Swiss Cancer League; Horten Foundation	This study was funded by the Swiss Cancer League (KFS-2977-08-2012) and the Horten Foundation.	Adler A, 2013, GUT, V62, P236, DOI 10.1136/gutjnl-2011-300167; Anderson JC, 2014, GASTROINTEST ENDOSC, V80, P463, DOI 10.1016/j.gie.2014.03.021; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; Aslanian HR, 2013, AM J GASTROENTEROL, V108, P166, DOI 10.1038/ajg.2012.237; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2011, GASTROENTEROLOGY, V140, P65, DOI 10.1053/j.gastro.2010.09.006; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Bryant RV, 2013, INTERN MED J, V43, P162, DOI 10.1111/j.1445-5994.2012.02963.x; Calderwood AH, 2014, GASTROINTEST ENDOSC, V80, P269, DOI 10.1016/j.gie.2014.01.031; Calderwood AH, 2010, GASTROINTEST ENDOSC, V72, P686, DOI 10.1016/j.gie.2010.06.068; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chokshi RV, 2012, GASTROINTEST ENDOSC, V75, P1197, DOI 10.1016/j.gie.2012.01.005; Clark BT, 2014, AM J GASTROENTEROL, V109, P1714, DOI 10.1038/ajg.2014.232; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; de Jonge V, 2012, GASTROINTEST ENDOSC, V75, P98, DOI 10.1016/j.gie.2011.06.032; de Wijkerslooth TR, 2013, GASTROINTEST ENDOSC, V77, P617, DOI 10.1016/j.gie.2012.10.018; Elmunzer BJ, 2015, GASTROINTEST ENDOSC, V81, P700, DOI 10.1016/j.gie.2014.10.033; Enestvedt BK, 2011, ALIMENT PHARM THER, V34, P775, DOI 10.1111/j.1365-2036.2011.04795.x; Fayad NF, 2013, CLIN GASTROENTEROL H, V11, P1478, DOI 10.1016/j.cgh.2013.05.037; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Gao Y, 2013, DIGEST ENDOSC, V25, P167, DOI 10.1111/j.1443-1661.2012.01356.x; Gerard DP, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.16; Goncalves AR, 2011, CLIN EXP GASTROENTER, V4, P277, DOI 10.2147/CEG.S25596; Gupta S, 2012, CLIN GASTROENTEROL H, V10, P1395, DOI 10.1016/j.cgh.2012.07.004; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Holt EW, 2014, J GASTROINTEST LIVER, V23, P135; Hong SN, 2012, CLIN ENDOSC, V45, P404, DOI 10.5946/ce.2012.45.4.404; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jover R, 2013, GASTROINTEST ENDOSC, V77, P381, DOI 10.1016/j.gie.2012.09.027; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Kim EJ, 2014, SAUDI J GASTROENTERO, V20, P219, DOI 10.4103/1319-3767.136950; Lai EJ, 2009, GASTROINTEST ENDOSC, V69, P620, DOI 10.1016/j.gie.2008.05.057; Lebwohl B, 2011, GASTROINTEST ENDOSC, V73, P1207, DOI 10.1016/j.gie.2011.01.051; Lee TJW, 2014, ENDOSCOPY, V46, P203, DOI 10.1055/s-0033-1358831; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Li Jun, 2010, Diagn Ther Endosc, V2010, DOI 10.1155/2010/419796; Manser CN, 2012, GASTROINTEST ENDOSC, V76, P110, DOI 10.1016/j.gie.2012.02.040; Menees SB, 2013, GASTROINTEST ENDOSC, V78, P510, DOI 10.1016/j.gie.2013.03.1334; Okamoto M, 2005, DIS COLON RECTUM, V48, P101, DOI 10.1007/s10350-004-0754-1; Pontone Stefano, 2014, ISRN Gastroenterol, V2014, P681978, DOI 10.1155/2014/681978; Radaelli F, 2008, AM J GASTROENTEROL, V103, P1122, DOI 10.1111/j.1572-0241.2007.01778.x; Rembacken B, 2012, ENDOSCOPY, V44, P957, DOI 10.1055/s-0032-1325686; Shaukat A, 2009, CLIN GASTROENTEROL H, V7, P1335, DOI 10.1016/j.cgh.2009.07.027; Sherer EA, 2012, GASTROINTEST ENDOSC, V75, P545, DOI 10.1016/j.gie.2011.09.022; Shergill AK, 2015, GASTROINTEST ENDOSC, V82, P529, DOI 10.1016/j.gie.2015.01.053; Singhal S, 2014, SCAND J GASTROENTERO, V49, P885, DOI 10.3109/00365521.2014.915055; Tadros Michael, 2013, Curr Gastroenterol Rep, V15, P342, DOI 10.1007/s11894-013-0342-4; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Xiang L, 2014, WORLD J GASTROENTERO, V20, P10927, DOI 10.3748/wjg.v20.i31.10927	50	46	50	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154149	10.1371/journal.pone.0154149	http://dx.doi.org/10.1371/journal.pone.0154149			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257916	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000377369700007
J	Kim, M; Oh, S				Kim, MinYoung; Oh, Seieun			Assimilating to Hierarchical Culture: A Grounded Theory Study on Communication among Clinical Nurses	PLOS ONE			English	Article							ORGANIZATIONAL SILENCE; SAFETY OUTCOMES; PATIENT SAFETY; PERCEPTIONS	The purpose of this study was to generate a substantive model that accounts for the explanatory social processes of communication in which nurses were engaged in clinical settings in Korea. Grounded theory methodology was used in this study. A total of 15 clinical nurses participated in the in-depth interviews. "Assimilating to the hierarchical culture" emerged as the basic social process of communication in which the participants engaged in their work environments. To adapt to the cultures of their assigned wards, the nurses learned to be silent and engaged in their assimilation into the established hierarchy. The process of assimilation consisted of three phases based on the major goals that nurses worked to achieve: getting to know about unspoken rules, persevering within the culture, and acting as senior nurse. Seven strategies and actions utilized to achieve the major tasks emerged as subcategories, including receiving strong disapproval, learning by observing, going silent, finding out what is acceptable, minimizing distress, taking advantages as senior nurse, and taking responsibilities as senior nurse. The findings identified how the pattern of communication in nursing organizations affected the way in which nurses were assimilated into organizational culture, from individual nurses' perspectives. In order to improve the rigid working atmosphere and culture in nursing organizations and increase members' satisfaction with work and quality of life, managers and staff nurses need training that focuses on effective communication and encouraging peer opinion-sharing within horizontal relationships. Moreover, organization-level support should be provided to create an environment that encourages free expression.	[Kim, MinYoung] Jeju Natl Univ, Coll Nursing, Jeju Si, Jeju Special Se, South Korea; [Oh, Seieun] Dankook Univ, Dept Nursing, Cheonan Si, Chungnam, South Korea	Jeju National University; Dankook University	Oh, S (corresponding author), Dankook Univ, Dept Nursing, Cheonan Si, Chungnam, South Korea.	seieun5@dankook.ac.kr	Oh, Seieun/I-9596-2014		Jeju National University [2013-0678]	Jeju National University	MK received the research grant from the Jeju National University in 2013 (#2013-0678). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams T, 2007, J BROADCAST ELECTRON, V51, P337, DOI 10.1080/08838150701305032; Anderson J, 2015, J CLIN NURS, V24, P662, DOI 10.1111/jocn.12706; Bae JY, 2013, MEDIFONEWS      0726; Cai H., 2013, P 9 INT SPAC SYNT S; Chiang HY, 2006, J NURS SCHOLARSHIP, V38, P392, DOI 10.1111/j.1547-5069.2006.00133.x; Claramita M, 2013, ADV HEALTH SCI EDUC, V18, P15, DOI 10.1007/s10459-012-9352-5; Cresswell J., 2007, QUAL INQ, V3th; Dedahanov AT, 2015, SOC BEHAV PERSONAL, V43, P481, DOI 10.2224/sbp.2015.43.3.481; EISENBERGER R, 1986, J APPL PSYCHOL, V71, P500, DOI 10.1037/0021-9010.75.1.51; Elci M, 2015, PROCEDIA SOCIAL BEHA, V150, P1298, DOI 10.1016/j.sbspro.2015.01.110; Garon M, 2012, J NURS MANAGE, V20, P361, DOI 10.1111/j.1365-2834.2011.01296.x; Henriksen K, 2006, HEALTH SERV RES, V41, P1539, DOI 10.1111/j.1475-6773.2006.00564.x; Hofstede G., 2001, ONLINE READINGS PSYC; Hofstede G., WHAT S KOREA; Huang XW, 2005, J RARE EARTH, V23, P1; Kim Boon Han, 2013, [Korean Journal of Adult Nursing, 성인간호학회지], V25, P701, DOI 10.7475/kjan.2012.24.6.701; Kim MyoungSook, 2008, [Journal of Korean Academy of Nursing Administration, 간호행정학회지], V14, P458; Korean Hospital Nurses Association, 2014, SURV CURR NURS DEPL; Laschinger HKS, 2006, J NURS ADMIN, V36, P259; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Liou SR, 2013, J NURS MANAGE, V21, P614, DOI 10.1111/j.1365-2834.2012.01447.x; Morrison EW, 2000, ACAD MANAGE REV, V25, P706, DOI 10.2307/259200; Park SY, 2008, ARCH PSYCHIAT NURS, V22, P12, DOI 10.1016/j.apnu.2007.06.011; Richards L., 2007, README 1 USERS GUIDE, P25; Shin QH, 2012, KOREAN J HOTEL ADM, V21, P133; Squires M, 2010, J NURS MANAGE, V18, P914, DOI 10.1111/j.1365-2834.2010.01181.x; Strauss A., 1998, BASICS QUALITATIVE R; Van Dyne L, 2003, J MANAGE STUD, V40, P1359, DOI 10.1111/1467-6486.00384; Yang Namyoung, 2014, [Journal of Korean Academy of Nursing Administration, 간호행정학회지], V20, P1, DOI 10.11111/jkana.2014.20.1.1; Yi M, 2011, J KOREAN ACAD NURS, V41, P568, DOI 10.4040/jkan.2011.41.4.568; Zakari NM, 2010, INT NURS REV, V57, P297, DOI 10.1111/j.1466-7657.2009.00764.x	31	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156305	10.1371/journal.pone.0156305	http://dx.doi.org/10.1371/journal.pone.0156305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253389	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700019
J	Takeuchi, T; Yamada, L; Shinzato, C; Sawada, H; Satoh, N				Takeuchi, Takeshi; Yamada, Lixy; Shinzato, Chuya; Sawada, Hitoshi; Satoh, Noriyuki			Stepwise Evolution of Coral Biomineralization Revealed with Genome-Wide Proteomics and Transcriptomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SKELETAL MATRIX PROTEINS; CELL-CELL ADHESION; ORGANIC MATRIX; CALICOBLASTIC EPITHELIUM; SOLUBLE-PROTEIN; E-CADHERIN; DOMAIN; ACID; IDENTIFICATION	Despite the importance of stony corals in many research fields related to global issues, such as marine ecology, climate change, paleoclimatogy, and metazoan evolution, very little is known about the evolutionary origin of coral skeleton formation. In order to investigate the evolution of coral biomineralization, we have identified skeletal organic matrix proteins (SOMPs) in the skeletal proteome of the scleractinian coral, Acropora digitifera, for which large genomic and transcriptomic datasets are available. Scrupulous gene annotation was conducted based on comparisons of functional domain structures among metazoans. We found that SOMPs include not only coral-specific proteins, but also protein families that are widely conserved among cnidarians and other metazoans. We also identified several conserved transmembrane proteins in the skeletal proteome. Gene expression analysis revealed that expression of these conserved genes continues throughout development. Therefore, these genes are involved not only skeleton formation, but also in basic cellular functions, such as cell-cell interaction and signaling. On the other hand, genes encoding coral-specific proteins, including extracellular matrix domain-containing proteins, galaxins, and acidic proteins, were prominently expressed in post-settlement stages, indicating their role in skeleton formation. Taken together, the process of coral skeleton formation is hypothesized as: 1) formation of initial extracellular matrix between epithelial cells and substrate, employing pre-existing transmembrane proteins; 2) additional extracellular matrix formation using novel proteins that have emerged by domain shuffling and rapid molecular evolution and; 3) calcification controlled by coral-specific SOMPs.	[Takeuchi, Takeshi; Shinzato, Chuya; Satoh, Noriyuki] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Yamada, Lixy; Sawada, Hitoshi] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan	Okinawa Institute of Science & Technology Graduate University; Nagoya University	Takeuchi, T (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan.	t.takeuchi@oist.jp	Satoh, Nori/C-4123-2009	Satoh, Nori/0000-0002-4480-3572; Shinzato, Chuya/0000-0001-7843-3381	Japan Society for the Promotion of Science KAKENHI [24241071, 25660172]; Canon Foundation; OIST Graduate University	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Canon Foundation(Canon Foundation); OIST Graduate University	Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp/english/index.html, 24241071 and 25660172) and The Canon Foundation (http://www.canonfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge generous support from OIST Graduate University for the Marine Genomics Unit. We thank Dr. Steven D. Aird for editing the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Araki Y, 2012, EUKARYOT CELL, V11, P638, DOI 10.1128/EC.00028-12; Barneah O, 2002, INVERTEBR BIOL, V121, P81; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Clode PL, 2003, PROTOPLASMA, V220, P153, DOI 10.1007/s00709-002-0046-3; Clode PL, 2002, TISSUE CELL, V34, P187, DOI 10.1016/S0040-8166(02)00031-9; CONSTANTZ B, 1988, J EXP ZOOL, V248, P253, DOI 10.1002/jez.1402480302; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Domart-Coulon I, 2004, J EXP MAR BIOL ECOL, V309, P199, DOI 10.1016/j.jembe.2004.03.021; Drake Jeana L., 2014, Elementa-Science of the Anthropocene, V2, P000026, DOI 10.12952/journal.elementa.000026; Drake JL, 2013, P NATL ACAD SCI USA, V110, pE2147, DOI 10.1073/pnas.1304591110; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Ganot P, 2015, MOL BIOL EVOL, V32, P44, DOI 10.1093/molbev/msu265; Gautret P, 1997, FACIES, V36, P189, DOI 10.1007/BF02536884; Gilis M, 2014, J MORPHOL, V275, P1349, DOI 10.1002/jmor.20307; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; Goldberg WM, 2001, TISSUE CELL, V33, P376, DOI 10.1054/tice.2001.0191; Goldberg WM, 2001, TISSUE CELL, V33, P388, DOI 10.1054/tice.2001.0192; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gunaratne HJ, 2007, BMC GENOMICS, P8; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hayakawa H, 2007, ZOOL SCI, V24, P249, DOI 10.2108/zsj.24.249; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; Hulpiau P, 2011, MOL BIOL EVOL, V28, P647, DOI 10.1093/molbev/msq233; ISA Y, 1987, COMP BIOCHEM PHYS B, V87, P507, DOI 10.1016/0305-0491(87)90045-9; ISA Y, 1986, MAR BIOL, V93, P91, DOI 10.1007/BF00428658; Isowa Y, 2012, J MOL EVOL, V75, P11, DOI 10.1007/s00239-012-9514-3; Jell J.S., 1980, Acta Palaeontologica Polonica, V25, P311; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kawasaki K, 2007, CELLS TISSUES ORGANS, V186, P7, DOI 10.1159/000102678; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LETISSIER MDA, 1988, MAR BIOL, V98, P493, DOI 10.1007/BF00391540; Lowenstam HA, 1989, BIOMINERALIZATION; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Mann S, 2001, BIOMINERALIZATION; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Massa T, 2014, P NATL ACAD SCI USA, V111, P12728, DOI 10.1073/pnas.1408621111; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; MITTERER RM, 1978, B MAR SCI, V28, P173; Miyamoto H, 2013, ZOOL SCI, V30, P801, DOI 10.2108/zsj.30.801; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; Musci G, 1996, BIOMETALS, V9, P66, DOI 10.1007/BF00188092; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Ramos-Silva P, 2013, P NATL ACAD SCI USA, V110, pE2144, DOI 10.1073/pnas.1303657110; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shikina S, 2013, ENDOCRINOLOGY, V154, P3447, DOI 10.1210/en.2013-1086; Shinzato C, 2008, BMC EVOL BIOL, P8; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 2006, PALAEOGEOGR PALAEOCL, V232, P214, DOI 10.1016/j.palaeo.2005.12.010; Stanton R.J. Jr, 1987, Facies, V16, P157, DOI 10.1007/BF02536751; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Vasin A, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.574bcb0f133fe52835911abc4e296141; Vergnes L, 2013, CELL METAB, V17, P916, DOI 10.1016/j.cmet.2013.04.007; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Wilson JM, 1997, J CELL BIOL, V136, P319, DOI 10.1083/jcb.136.2.319; Yamada L, 2009, J BIOL CHEM, V284, P9402, DOI 10.1074/jbc.M809672200; Yonezawa N, 2003, BIOCHEM BIOPH RES CO, V307, P877, DOI 10.1016/S0006-291X(03)01297-X	96	46	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156424	10.1371/journal.pone.0156424	http://dx.doi.org/10.1371/journal.pone.0156424			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253604	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700029
J	Tweedie, D; Fukui, K; Li, YZ; Yu, QS; Barak, S; Tamargo, IA; Rubovitch, V; Holloway, HW; Lehrmann, E; Wood, WH; Zhang, YQ; Becker, KG; Perez, E; Van Praag, H; Luo, Y; Hoffer, BJ; Becker, RE; Pick, CG; Greig, NH				Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Barak, Shani; Tamargo, Ian A.; Rubovitch, Vardit; Holloway, Harold W.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.; Perez, Evelyn; Van Praag, Henriette; Luo, Yu; Hoffer, Barry J.; Becker, Robert E.; Pick, Chaim G.; Greig, Nigel H.			Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; FLUID-PERCUSSION INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITION; GENE-EXPRESSION; RISK-FACTOR; CELL-DEATH	Traumatic brain injury (TBI), often caused by a concussive impact to the head, affects an estimated 1.7 million Americans annually. With no approved drugs, its pharmacological treatment represents a significant and currently unmet medical need. In our prior development of the anti-cholinesterase compound phenserine for the treatment of neurodegenerative disorders, we recognized that it also possesses non-cholinergic actions with clinical potential. Here, we demonstrate neuroprotective actions of phenserine in neuronal cultures challenged with oxidative stress and glutamate excitotoxicity, two insults of relevance to TBI. These actions translated into amelioration of spatial and visual memory impairments in a mouse model of closed head mild TBI (mTBI) two days following cessation of clinically translatable dosing with phenserine (2.5 and 5.0 mg/kg BID x 5 days initiated post mTBI) in the absence of anti-cholinesterase activity. mTBI elevated levels of thiobarbituric acid reactive substances (TBARS), a marker of oxidative stress. Phenserine counteracted this by augmenting homeostatic mechanisms to mitigate oxidative stress, including superoxide dismutase [SOD] 1 and 2, and glutathione peroxidase [GPx], the activity and protein levels of which were measured by specific assays. Microarray analysis of hippocampal gene expression established that large numbers of genes were exclusively regulated by each individual treatment with a substantial number of them co-regulated between groups. Molecular pathways associated with lipid peroxidation were found to be regulated by mTBI, and treatment of mTBI animals with phenserine effectively reversed injury-induced regulations in the 'Blalock Alzheimer's Disease Up' pathway. Together these data suggest that multiple phenserine-associated actions underpin this compound's ability to ameliorate cognitive deficits caused by mTBI, and support the further evaluation of the compound as a therapeutic for TBI.	[Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Tamargo, Ian A.; Holloway, Harold W.; Becker, Robert E.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fukui, Koji] Shibaura Inst Technol, Div Biosci & Engn, Saitama 3378570, Japan; [Barak, Shani; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Perez, Evelyn] NIA, Lab Behav Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Van Praag, Henriette] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Luo, Yu; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Becker, Robert E.] 7123 Pinebrook Rd, Park City, UT 84098 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Shibaura Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; Tel Aviv University	Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	greign@mail.nih.gov	Fukui, Koji/I-7067-2019	Fukui, Koji/0000-0003-2748-3228; Lehrmann, Elin/0000-0002-9869-9475; van Praag, Henriette/0000-0002-5727-434X; Luo, Yu/0000-0002-7939-5505; Holloway, Courtney Jean/0000-0003-3661-1957	Intramural Research Program of the National Institute on Aging, National Institutes of Health; Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Israel Science Foundation [108/09]; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000311, ZIAAG000328] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Allen TGJ, 2006, J NEUROSCI, V26, P1588, DOI 10.1523/JNEUROSCI.3979-05.2006; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Araujo JA, 2011, J ALZHEIMERS DIS, V26, P143, DOI 10.3233/JAD-2011-110005; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barger SW, 2004, FRONT BIOSCI-LANDMRK, V9, P3286, DOI 10.2741/1481; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Boyajyan A, 2015, RECENT ADV DNA GENE; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon CE, 1979, EXP NEUROL, V146, P479; Djordjevic J, 2016, CURR ALZHEIMER RES; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dumas JA, 2011, PHARMACOL BIOCHEM BE, V99, P254, DOI 10.1016/j.pbb.2011.02.022; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; IKARI H, 1995, NEUROREPORT, V6, P481, DOI 10.1097/00001756-199502000-00019; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jenkner FL, 1954, NERVENARZT, V25, P77; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein BD, 2004, EPILEPSY RES, V62, P13, DOI 10.1016/j.eplepsyres.2004.06.007; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LECHNER H, 1963, Wien Klin Wochenschr, V75, ppassim; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reale M, 2014, CURR ALZHEIMER RES, V11, P608, DOI 10.2174/1567205010666131212113218; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUGE D, 1954, J NEUROSURG, V11, P77, DOI 10.3171/jns.1954.11.1.0077; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wang XD, 1999, NEUROSCI LETT, V272, P21, DOI 10.1016/S0304-3940(99)00567-4; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yu QS, 2001, J MED CHEM, V44, P4062, DOI 10.1021/jm010080x; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	127	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156493	10.1371/journal.pone.0156493	http://dx.doi.org/10.1371/journal.pone.0156493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254111	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700033
J	Uchitomi, H; Ogawa, K; Orimo, S; Wada, Y; Miyake, Y				Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Orimo, Satoshi; Wada, Yoshiaki; Miyake, Yoshihiro			Effect of Interpersonal Interaction on Festinating Gait Rehabilitation in Patients with Parkinson's Disease	PLOS ONE			English	Article							RHYTHMIC AUDITORY-STIMULATION; FRACTAL DYNAMICS; MOVEMENT; SYNCHRONIZATION; IMPAIRMENT; MECHANISM; SPEECH	Although human walking gait rhythms are generated by native individual gait dynamics, these gait dynamics change during interactions between humans. A typical phenomenon is synchronization of gait rhythms during cooperative walking. Our previous research revealed that fluctuation characteristics in stride interval of subjects with Parkinson's disease changed from random to 1/f fluctuation as fractal characteristics during cooperative walking with the gait assist system Walk-Mate, which emulates a human interaction using interactive rhythmic cues. Moreover, gait dynamics were relearned through Walk-Mate gait training. However, the system's clinical efficacy was unclear because the previous studies did not focus on specific gait rhythm disorder symptoms. Therefore, this study aimed to evaluate the effect of Walk-Mate on festinating gait among subjects with Parkinson's disease. Three within-subject experimental conditions were used: (1) preinteraction condition, (2) interaction condition, and (3) postinteraction condition. The only difference between conditions was the interactive rhythmic cues generated by Walk-Mate. Because subjects with festinating gait gradually and involuntarily decreased their stride interval, the regression slope of stride interval as an index of severity of preinteraction festinating gait was elevated. The regression slope in the interaction condition was more gradual than during the preinteraction condition, indicating that the interactive rhythmic cues contributed to relieving festinating gait and stabilizing gait dynamics. Moreover, the gradual regression slope was carried over to the postinteraction condition, indicating that subjects with festinating gait have the potential to relearn stable gait dynamics. These results suggest that disordered gait dynamics are clinically restored through interactive rhythmic cues and that Walk-Mate may have the potential to assist therapists in more effective rehabilitation.	[Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Orimo, Satoshi] Kanto Cent Hosp, Dept Neurol, Setagaya Ku, Tokyo, Japan; [Wada, Yoshiaki] Nissan Tamagawa Hosp, Dept Rehabil, Setagaya Ku, Tokyo, Japan	Tokyo Institute of Technology	Uchitomi, H (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	uchitomi@myk.dis.titech.ac.jp						Brown P, 1996, BALANCE POSTURE GAIT, P156; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Coelho M, 2014, NONMOTOR SYMPTOMS PA, P45; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; Fahn S., 1987, RECENT DEV PARKINSON, P153; Giladi N, 2001, PARKINSONISM RELAT D, V7, P135, DOI 10.1016/S1353-8020(00)00030-4; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; MATARAZZO JD, 1964, PSYCHOTHER-THEOR RES, V1, P54, DOI 10.1037/h0088571; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Miyake Y., 1994, Proceedings. 3rd IEEE International Workshop on Robot and Human Communication. RO-MAN '94 Nagoya (Cat. No.94TH0679-1), P118, DOI 10.1109/ROMAN.1994.365945; Miyake Y, 1997, IEEE SYS MAN CYBERN, P293, DOI 10.1109/ICSMC.1997.625765; Miyake Y., 2002, T SOC INSTRUMENT CON, VE-2, P195; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Muto T, 2002, P 2002 IEEE INT C SY, P1; Muto T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1240, DOI 10.1109/ICCME.2007.4381942; Muto T, 2011, J ADV COMPUT INTELL, V15, P534, DOI 10.20965/jaciii.2011.p0534; Muto T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-58; Nagaoka Chika, 2007, CONVERSATIONAL INFOR, P331; Orlovsky GN, 1999, NEURAL CONTROL IOCOM; Ota L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112952; Parkinson J., 1817, ASSAY SHAKING PALSY; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Takano K, 2007, NEUROSCI LETT, V417, P196, DOI 10.1016/j.neulet.2007.02.044; Takenaka T, 2006, ADV ENG INFORM, V20, P321, DOI 10.1016/j.aei.2006.01.004; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Uchitomi H, 2012, BIOMEDICAL ENG COGNI, P38; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176; Zhao YJ, 2010, MOVEMENT DISORD, V25, P710, DOI 10.1002/mds.22875; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155540	10.1371/journal.pone.0155540	http://dx.doi.org/10.1371/journal.pone.0155540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253376	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700007
J	Xu, CM; Zhang, ZQ; Cui, KD; Zhao, YH; Han, JK; Liu, F; Mu, W				Xu, Chunmei; Zhang, Zhengqun; Cui, Kaidi; Zhao, Yunhe; Han, Jingkun; Liu, Feng; Mu, Wei			Effects of Sublethal Concentrations of Cyantraniliprole on the Development, Fecundity and Nutritional Physiology of the Black Cutworm Agrotis ipsilon ( Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ANTHRANILIC DIAMIDE INSECTICIDE; SPODOPTERA-LITURA LEPIDOPTERA; ASIAN CORN-BORER; ENZYME-ACTIVITIES; LIFE TABLE; FAT-BODY; CHLORANTRANILIPROLE; RESISTANCE; HEMOLYMPH; TOXICITY	To better understand the sublethal effects of cyantraniliprole on the black cutworm Agrotis ipsilon (Lepidoptera: Noctuidae), several studies were carried out to investigate sublethal effects on development stages, population parameters, feeding indices and nutrient content of A. ipsilon. The result of a bioassay showed that cyantraniliprole had high toxicity against A. ipsilon fourth-instar larvae with an LC50 of 0.354 mu g.g(-1) using an artificial diet. Compared with controls, sublethal doses of cyantraniliprole at LC5, LC20 and LC40 levels prolonged larval and pupal duration and extended mean generation time and total preovipositional period. In addition, survival rate, reproductive value, intrinsic and finite rates of increase and net reproduction rate declined significantly. Meanwhile, cyantraniliprole had markedly anti-feedant effects; decreased the relative growth rate (RGR), the relative consumption rate (RCR), the efficiency of conversion of ingested food (ECI), the efficiency of conversion of digested food (ECD); and increased the approximate digestibility (AD) significantly. This phenomenon contributed to the decrease of nutrient contents, including lipids, protein and carbohydrates, to the point that insufficient energy was available for normal growth. Therefore, sublethal concentrations of cyantraniliprole decreased growth speed and reduced population reproduction of A. ipsilon. This result provides information useful in integrated pest management (IPM) programs for A. ipsilon.	[Xu, Chunmei; Cui, Kaidi; Zhao, Yunhe; Han, Jingkun; Liu, Feng; Mu, Wei] Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An 271018, Shandong, Peoples R China; [Zhang, Zhengqun] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Mu, W (corresponding author), Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An 271018, Shandong, Peoples R China.	muwei@sdau.edu.cn	liu, feng/D-2803-2017; Zhang, Zhengqun/AAW-8239-2020	liu, feng/0000-0002-0271-3632; 	National Natural Science Foundation of China [31572040, 31501651]; Modern Agricultural Industry Technology System of Shandong Province [SDAIT-01-02-09]; Natural Science Foundation of Shangdong Province [ZR2015CQ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agricultural Industry Technology System of Shandong Province; Natural Science Foundation of Shangdong Province	"This work was supported by the National Natural Science Foundation of China, award number 31572040 to Feng Liu and award number 31501651 to Zhengqun Zhang, the Modern Agricultural Industry Technology System of Shandong Province, award number SDAIT-01-02-09 to Wei Mu, and the Natural Science Foundation of Shangdong Province, award number ZR2015CQ017 to Zhengqun Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Akca I, 2015, J ECON ENTOMOL, V108, P1466, DOI 10.1093/jee/tov187; Akkopru EP, 2015, J ECON ENTOMOL, V108, P378, DOI 10.1093/jee/tov011; [Anonymous], 1925, J ECON ENTOMOL; Bielza P, 2015, PEST MANAG SCI, V71, P1068, DOI 10.1002/ps.3886; Binning RR, 2015, PEST MANAG SCI, V71, P601, DOI 10.1002/ps.3901; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chi H, 2015, TWOSEX MSCHART COMPU; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Du JunHui, 2013, Acta Phytophylacica Sinica, V40, P266; Etebari K, 2007, PESTIC BIOCHEM PHYS, V88, P14, DOI 10.1016/j.pestbp.2006.08.005; Gravalos C, 2015, PEST MANAG SCI, V71, P1030, DOI 10.1002/ps.3885; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; Hannig GT, 2009, PEST MANAG SCI, V65, P969, DOI 10.1002/ps.1781; Hardke JT, 2011, FLA ENTOMOL, V94, P272, DOI 10.1653/024.094.0221; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Ioriatti C, 2009, PEST MANAG SCI, V65, P717, DOI 10.1002/ps.1744; Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a; Khosravi Roya, 2010, Journal of Plant Protection Research, V50, P423, DOI 10.2478/v10045-010-0071-8; Knight AL, 2007, PEST MANAG SCI, V63, P180, DOI 10.1002/ps.1318; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Lai TC, 2011, PEST MANAG SCI, V67, P1468, DOI 10.1002/ps.2201; Lai TC, 2011, J PEST SCI, V84, P381, DOI 10.1007/s10340-011-0366-1; Liu ZL, 2008, PESTIC BIOCHEM PHYS, V91, P122, DOI 10.1016/j.pestbp.2008.03.003; Murillo AC, 2015, PEST MANAG SCI, V71, P752, DOI 10.1002/ps.3847; Nath BS, 2000, PESTIC BIOCHEM PHYS, V68, P127, DOI 10.1006/pest.2000.2509; Nath BS, 1997, ECOTOX ENVIRON SAFE, V36, P169, DOI 10.1006/eesa.1996.1504; Nathan SS, 2006, PESTIC BIOCHEM PHYS, V84, P98, DOI 10.1016/j.pestbp.2005.05.006; Nathan SS, 2005, PHYTOPARASITICA, V33, P187, DOI 10.1007/BF03029978; Perveen F, 2000, ANN ENTOMOL SOC AM, V93, P1131, DOI 10.1603/0013-8746(2000)093[1131:EOSDOC]2.0.CO;2; Rehan A, 2015, NEOTROP ENTOMOL, V44, P513, DOI 10.1007/s13744-015-0306-5; Enriquez CLR, 2010, J ECON ENTOMOL, V103, P662, DOI 10.1603/EC09244; ROE JH, 1954, J BIOL CHEM, V208, P889; Sang Song, 2014, Journal of South China Agricultural University, V35, P64; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Schoonhoven L. M., 2005, Insect-plant biology; Song YueQin, 2013, Acta Entomologica Sinica, V56, P446; STOYENOFF JL, 1994, OECOLOGIA, V97, P158, DOI 10.1007/BF00323145; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Tiwari S, 2013, PEST MANAG SCI, V69, P1066, DOI 10.1002/ps.3468; Tuan SJ, 2016, J ECON ENTOMOL, V109, P13, DOI 10.1093/jee/tov265; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Yin XH, 2009, J ECON ENTOMOL, V102, P357, DOI 10.1603/029.102.0146; Yu H., 2015, ACTA ENTOMOL SINICA, V6; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu WeiLi, 2012, Acta Phytophylacica Sinica, V39, P277; Zhang RM, 2015, PEST MANAG SCI, V71, P250, DOI 10.1002/ps.3791; Zhang YJ, Patent No. [No 200810112399, 200810112399]; Zhao YH, 2016, PESTIC BIOCHEM PHYS, V129, P49, DOI 10.1016/j.pestbp.2015.10.017	52	42	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156555	10.1371/journal.pone.0156555	http://dx.doi.org/10.1371/journal.pone.0156555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249654	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700052
J	Banerjee, A; Chakraborty, S; Chakraborty, A; Chakrabarti, S; Ray, K				Banerjee, Antara; Chakraborty, Subhadip; Chakraborty, Abhijit; Chakrabarti, Saikat; Ray, Kunal			Functional and Structural Analyses of CYP1B1 Variants Linked to Congenital and Adult-Onset Glaucoma to Investigate the Molecular Basis of These Diseases	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CYTOCHROME P4501B1 CYP1B1; MUTATION SPECTRUM; JAPANESE PATIENTS; INDIAN PATIENTS; GENE-MUTATIONS; HAPLOTYPE BACKGROUNDS; ESSENTIAL DYNAMICS; PROTEIN DYNAMICS; EYE DEVELOPMENT	Glaucoma, the leading cause of irreversible blindness, appears in various forms. Mutations in CYP1B1 result in primary congenital glaucoma (PCG) by an autosomal recessive mode of inheritance while it acts as a modifier locus for primary open angle glaucoma (POAG). We investigated the molecular basis of the variable phenotypes resulting from the defects in CYP1B1 by using subclones of 23 CYP1B1 mutants reported in glaucoma patients, in a cell based system by measuring the dual activity of the enzyme to metabolize both retinol and 17 beta-estradiol. Most variants linked to POAG showed low steroid metabolism while null or very high retinol metabolism was observed in variants identified in PCG. We examined the translational turnover rates of mutant proteins after the addition of cycloheximide and observed that the levels of enzyme activity mostly corroborated the translational turnover rate. We performed extensive normal mode analysis and molecular-dynamics-simulations-based structural analyses and observed significant variation of fluctuation in certain segmental parts of the mutant proteins, especially at the B-C and F-G loops, which were previously shown to affect the dynamic behavior and ligand entry/ exit properties of the cytochrome P450 family of proteins. Our molecular study corroborates the structural analysis, and suggests that the pathologic state of the carrier of CYP1B1 mutations is determined by the allelic state of the gene. To our knowledge, this is the first attempt to dissect biological activities of CYP1B1 for correlation with congenital and adult onset glaucomas.	[Banerjee, Antara; Chakraborty, Subhadip; Ray, Kunal] Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Chakraborty, Abhijit; Chakrabarti, Saikat] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Ray, Kunal] Acad Sci & Innovat Res AcSIR, Cent Rd Res Inst, Delhi Mathura Rd, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Road Research Institute (CRRI)	Ray, K (corresponding author), Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Chakrabarti, S (corresponding author), Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Ray, K (corresponding author), Acad Sci & Innovat Res AcSIR, Cent Rd Res Inst, Delhi Mathura Rd, New Delhi 110025, India.	saikat@iicb.res.in; kunalray@acsir.res.in			Council of Scientific and Industrial Research (CSIR), Government of India [CM-0016, MLP-0016, SIP-007, BSC-0121]; CSIR Network project GENESIS [BSC0121]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Network project GENESIS	The Council of Scientific and Industrial Research (CSIR), Government of India supported the study through funding grants CM-0016, MLP-0016, SIP-007 to KR and BSC-0121 to SC, http://www.csir.res.in. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Ananya Ray-Soni for critically proofreading the manuscript to improve the language and grammar of the manuscript. We also thank CSIR-IICB for providing infrastructural support and CSIR Network project GENESIS (BSC0121) for financial support.	Abu-Amero KK, 2011, MOL VIS, V17, P2911; Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Acharya M, 2006, MOL VIS, V12, P399; Acharya M, 2008, J GENET, V87, P265, DOI 10.1007/s12041-008-0041-3; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1999, PROTEINS, V35, P283, DOI 10.1002/(SICI)1097-0134(19990515)35:3<283::AID-PROT2>3.0.CO;2-R; Amini A. M NM, 2005, IRAN J SCI TECHNOL A, V29, P1; [Anonymous], 1984, J CHEM PHYS, V81, P511; [Anonymous], 1984, CANONICAL DYNAMICS E, V31, P1695; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bayat B, 2008, MOL VIS, V14, P508; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bhattacharjee A, 2008, MOL VIS, V14, P841; Campos-Mollo E, 2009, MOL VIS, V15, P417; Chakrabarti S, 2006, INVEST OPHTH VIS SCI, V47, P43, DOI 10.1167/iovs.05-0912; Chakrabarti S, 2007, INVEST OPHTH VIS SCI, V48, P5439, DOI 10.1167/iovs.07-0629; Chakrabarti Subhabrata, 2003, Hum Genet, V113, P556; Chavarria-Soley G, 2006, MOL VIS, V12, P523; Chen YH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1443, DOI 10.1001/archopht.126.10.1443; Chitsazian F, 2007, J MOL DIAGN, V9, P382, DOI 10.2353/jmoldx.2007.060157; Chouldhary D, 2008, PHARMACOGENET GENOM, V18, P665, DOI 10.1097/FPC.0b013e3282ff5a36; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; El-Gayar S, 2009, MOL VIS, V15, P1325; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Firasat S, 2008, MOL VIS, V14, P2002; Fuse N, 2010, JPN J OPHTHALMOL, V54, P1, DOI 10.1007/s10384-009-0769-1; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; HAYWARD S, 1995, PROTEINS, V23, P177, DOI 10.1002/prot.340230207; HAYWARD S, 1995, ANNU REV PHYS CHEM, V46, P223, DOI 10.1146/annurev.pc.46.100195.001255; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Hess B, 1997, J COMPUTATIONAL CHEM; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hilal L, 2010, MOL VIS, V16, P1215; Hollander David A, 2006, Trans Am Ophthalmol Soc, V104, P183; Hollander DA, 2006, AM J OPHTHALMOL, V142, P993, DOI 10.1016/j.ajo.2006.07.054; Jansson I, 2001, PHARMACOGENETICS, V11, P793, DOI 10.1097/00008571-200112000-00007; Kakiuchi-Matsumoto T, 2001, AM J OPHTHALMOL, V131, P345, DOI 10.1016/S0002-9394(00)00808-4; Kim HJ, 2011, MOL VIS, V17, P2093; Kitao A, 1998, PROTEINS, V33, P496, DOI 10.1002/(SICI)1097-0134(19981201)33:4<496::AID-PROT4>3.3.CO;2-T; Kumar A, 2007, MOL VIS, V13, P667; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Li N, 2011, EXP EYE RES, V93, P572, DOI 10.1016/j.exer.2011.07.009; LIEHR JG, 1986, J BIOL CHEM, V261, P6865; Lopez-Garrido MP, 2010, CLIN GENET, V77, P70, DOI 10.1111/j.1399-0004.2009.01284.x; Lopez-Garrido MP, 2009, CLIN GENET, V76, P552, DOI 10.1111/j.1399-0004.2009.01242.x; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Maden M, 2001, POSTGRAD MED J, V77, P489, DOI 10.1136/pmj.77.910.489; Maihofner C, 2001, INVEST OPHTH VIS SCI, V42, P2616; Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Michels-Rautenstrauss KG, 2001, J GLAUCOMA, V10, P354, DOI 10.1097/00061198-200108000-00017; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mookherjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045077; Ng SK, 2014, CLIN EXP OPHTHALMOL, V42, P25, DOI 10.1111/ceo.12234; Ohtake Y, 2003, BRIT J OPHTHALMOL, V87, P302, DOI 10.1136/bjo.87.3.302; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Panicker SG, 2002, INVEST OPHTH VIS SCI, V43, P1358; Panicker SG, 2004, INVEST OPHTH VIS SCI, V45, P1149, DOI 10.1167/iovs.03-0404; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2010, INVEST OPHTH VIS SCI, V51, P249, DOI 10.1167/iovs.09-3880; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plasilova M, 1999, J MED GENET, V36, P290; Reddy ABM, 2004, MOL VIS, V10, P696; Reddy ABM, 2003, INVEST OPHTH VIS SCI, V44, P4200, DOI 10.1167/iovs.02-0945; Scheetz TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058657; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777; Sivadorai P, 2008, CLIN GENET, V74, P82, DOI 10.1111/j.1399-0004.2008.01024.x; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilov IR, 2002, INVEST OPHTH VIS SCI, V43, P1820; Su CC, 2012, EYE, V26, P1369, DOI 10.1038/eye.2012.159; Suri F, 2009, OPHTHALMOLOGY, V116, P2101, DOI 10.1016/j.ophtha.2009.04.045; Suri F, 2008, MOL VIS, V14, P2349; Tanwar M, 2009, MOL VIS, V15, P1200; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074; Zenteno JC, 2008, J GLAUCOMA, V17, P189, DOI 10.1097/IJG.0b013e31815678c3	96	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156252	10.1371/journal.pone.0156252	http://dx.doi.org/10.1371/journal.pone.0156252			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243976	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100022
J	Li, D; Du, XLL; Ren, YH; Liu, PJ; Li, ST; Yang, J; Lv, M; Chen, L; Wang, X; Li, EX; Yang, J; Yi, M				Li, Dan; Du, Xianglin L.; Ren, Yinghong; Liu, Peijun; Li, Shuting; Yang, Jiao; Lv, Meng; Chen, Ling; Wang, Xin; Li, Enxiao; Yang, Jin; Yi, Min			Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer	PLOS ONE			English	Article							FACTOR-RECEPTOR GENE; RACIAL-DIFFERENCES; ASIAN/PACIFIC ISLANDER; PROGNOSTIC-FACTORS; DISPARITIES; MUTATIONS; ASSOCIATION; VETERANS; REGISTRY; ACCESS	Ethnic disparities in lung and bronchial cancer diagnoses and disease-specific survival (DSS) rates in the United States are well known. However, few studies have specifically assessed these differences in Asian subgroups. The primary objectives of the retrospective analysis described herein were to identify any significant differences in clinicopathologic features, treatment, and survival rate between Asian lung cancer patients and lung cancer patients in other broad ethnic groups in the United States and to determine the reasons for these differences among subgroups of Asian patients with lung or bronchial cancer. We searched the Surveillance, Epidemiology, and End Results Program database to identify patients diagnosed with lung or bronchial cancer from 1990 to 2012. Differences in clinicopathologic features, treatment, and DSS rate in four broad ethnic groups and eight Asian subgroups were compared. The study population consisted of 849,088 patients, 5.2% of whom were of Asian descent. Female Asian patients had the lowest lung and bronchial cancer incidence rates, whereas male black patients had the highest rates. Asian patients had the best 5-year DSS rate. In our Asian subgroup analysis, Indian/Pakistani patients had the best 5-year DSS rate, whereas Hawaiian/Pacific Islander patients had the worst 5-year DSS rates. We found the differences in DSS rate among the four broad ethnic groups and eight Asian subgroups when we grouped patients by age and disease stage, as well. Asian patients had better DSS rates than those in the other three broad ethnic groups in almost every age and disease-stage group, especially in older patients and those with advanced-stage disease. In conclusion, we found that clinicopathologic features and treatment of lung and bronchial cancer differ by ethnicity in the United States, and the differences impact survival in each ethnic group.	[Li, Dan; Li, Shuting; Yang, Jiao; Lv, Meng; Chen, Ling; Wang, Xin; Li, Enxiao; Yang, Jin; Yi, Min] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian 710049, Shaanxi, Peoples R China; [Li, Dan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian 710049, Shaanxi, Peoples R China; [Du, Xianglin L.] Univ Texas Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Ren, Yinghong] Shangluo Cent Hosp, Dept Internal Med, Shangluo, Shaanxi, Peoples R China; [Liu, Peijun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Translat Med, Xian 710049, Shaanxi, Peoples R China; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center	Yang, J; Yi, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian 710049, Shaanxi, Peoples R China.; Yi, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.	yangjin@mail.xjtu.edu.cn; myi@mdanderson.org	Yi, Min/J-8963-2017	Yi, Min/0000-0001-8662-6546				Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191; Chang ET, 2009, CANCER EPIDEM BIOMAR, V18, P2248, DOI 10.1158/1055-9965.EPI-09-0332; Chen SL, 2008, AM J SURG, V196, P495, DOI 10.1016/j.amjsurg.2008.06.018; Ferketich AK, 2013, CANCER-AM CANCER SOC, V119, P847, DOI 10.1002/cncr.27824; Finlay GA, 2002, CHEST, V122, P1938, DOI 10.1378/chest.122.6.1938; Gadgeel SM, 2003, CANCER METAST REV, V22, P39, DOI 10.1023/A:1022207917249; Ganti AK, 2014, CLIN LUNG CANCER, V15, P152, DOI 10.1016/j.cllc.2013.11.004; Gomez SL, 2011, CANCER EPIDEM BIOMAR, V20, P545, DOI 10.1158/1055-9965.EPI-10-0965; Hamid MS, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/269304; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; Ignatius SH, 2009, J THORAC ONCOL, V4, P1083, DOI 10.1097/JTO.0b013e3181b27b15; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kim HJ, 2013, ONCOL LETT, V5, P271, DOI 10.3892/ol.2012.950; Leggett MD, 2008, ANN SURG ONCOL, V15, P2493, DOI 10.1245/s10434-008-0022-z; Martinez SR, 2008, CANCER-AM CANCER SOC, V112, P1162, DOI 10.1002/cncr.23261; Meza R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121323; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; Nimako K, 2013, EUR J CANCER CARE, V22, P79, DOI 10.1111/j.1365-2354.2012.01373.x; Ou SHI, 2008, CANCER-AM CANCER SOC, V112, P2011, DOI 10.1002/cncr.23397; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; Ou SI, 2008, J CLIN ONCOL, V26; Ou SHI, 2008, J THORAC ONCOL, V3, P216, DOI 10.1097/JTO.0b013e318164545d; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tomizawa Y, 2005, CLIN CANCER RES, V11, P6816, DOI 10.1158/1078-0432.CCR-05-0441; Trinh QD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv054; Williams CD, 2013, J CLIN ONCOL, V31, P475, DOI 10.1200/JCO.2012.44.1170; Wisnivesky JP, 2005, AM J RESP CRIT CARE, V171, P1158, DOI 10.1164/rccm.200411-1475OC; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986; Yoshino I, 2002, SURGERY, V131, pS242, DOI 10.1067/msy.2002.119796; Zell JA, 2008, CANCER, V112, P136, DOI 10.1002/cncr.23146; Zheng L, 2012, CANCER EPIDEM BIOMAR, V21, P1841, DOI 10.1158/1055-9965.EPI-12-0560	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156617	10.1371/journal.pone.0156617	http://dx.doi.org/10.1371/journal.pone.0156617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244238	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100055
J	Rivera, J; Canals, M; Lastras, G; Hermida, N; Amblas, D; Arrese, B; Martin-Sosa, P; Acosta, J				Rivera, Jesus; Canals, Miquel; Lastras, Galderic; Hermida, Nuria; Amblas, David; Arrese, Beatriz; Martin-Sosa, Pablo; Acosta, Juan			Morphometry of Concepcion Bank: Evidence of Geological and Biological Processes on a Large Volcanic Seamount of the Canary Islands Seamount Province	PLOS ONE			English	Article							EL HIERRO; GLOBAL DISTRIBUTION; CONTINENTAL-MARGIN; ROCKALL TROUGH; NORTH FLANK; EVOLUTION; HISTORY; ORIGIN; FLOW; DEEP	Concepcion Bank is the largest seamount in the Canary Islands Seamount Province (CISP), an oceanic area off NW Africa including 16 main seamounts, the Canaries archipelago and the Selvagens subarchipelago. The Bank is located 90 km northeast of Lanzarote Island and has been identified as a candidate Marine Protected Area (MPA) to be included in the Natura 2000 network. A compilation of complementary datasets consisting of multibeam bathymetry, TOPAS seismic reflection profiles, side scan sonar sonographs, Remotely Operated Vehicle video records and seafloor samples allowed describing in detail and ground truthing the submarine landforms and bioconstructions exhibited by the bank. The Concepcion Bank presently rises up to 2,433 m above the adjacent seafloor and exhibits two main domains: an extensive summit plateau and steep flanks. The sub-round summit plateau is 50km by 45 km and ranges from 158 to 1,485 m depth. The steep flanks that bound it descend to depths ranging between 1,700 and 2,500 m and define a seamount base that is 66km by 53 km. This morphology is the result of constructive and erosive processes involving different time scales, volumes of material and rates of change. The volcanic emplacement phase probably lasted 25-30 million years and was likely responsible for most of the 2,730 km(3) of material that presently form the seamount. Subsequently, marine abrasion and, possibly, subaerial erosion modulated by global sea level oscillations, levelled the formerly emerging seamount summit plateau, in particular its shallower (<400 m), flatter (<0.5 degrees) eastern half. Subsidence associated to the crustal cooling that followed the emplacement phase further contributed the current depth range of the seamount. The deeper and steeper (2.3 degrees) western half of Concepcion Bank may result from tectonic tilting normal to a NNE-SSW fracture line. This fracture may still be expressed on the seafloor surface at some scarps detected on the seamount's summit. Sediment waves and cold-water coral (CWC) mounds on the bank summit plateau are the youngest features contributing to its final shaping, and may be indicative of internal wave effects. Numerous submarine canyons generally less than 10 km in length are incised on the bank's flanks. The most developed, hierarchized canyon system runs southwest of the bank, where it merges with other canyons coming from the southern bulges attached to some sections of the seamount flanks. These bulges are postulated as having an intrusive origin, as no major headwall landslide scars have been detected and their role as deposition areas for the submarine canyons seems to be minor. The results presented document how geological processes in the past and recent to subrecent oceanographic conditions and associated active processes determined the current physiography, morphology and sedimentary patterns of Concepcion Bank, including the development and decline of CWC mounds The setting of the seamount in the regional crustal structure is also discussed.	[Rivera, Jesus; Hermida, Nuria; Arrese, Beatriz; Acosta, Juan] Inst Espanol Oceanog, Corazon Maria 8, E-28002 Madrid, Spain; [Canals, Miquel; Lastras, Galderic; Amblas, David] Univ Barcelona, GRC Geociencies Marines, E-08028 Barcelona, Spain; [Martin-Sosa, Pablo] Inst Espanol Oceanog, Via Espaldon,Parcela 8, E-38180 Santa Cruz De Tenerife, Spain	Spanish Institute of Oceanography; University of Barcelona; Spanish Institute of Oceanography	Rivera, J (corresponding author), Inst Espanol Oceanog, Corazon Maria 8, E-28002 Madrid, Spain.	jesus.rivera@md.ieo.es	Rivera, Jesus/I-8926-2016; Canals, Miquel/F-4922-2013; Lastras, Galderic/A-6487-2013	Rivera, Jesus/0000-0002-9766-7105; Canals, Miquel/0000-0001-5267-7601; Lastras, Galderic/0000-0002-8756-3855; Hermida, Nuria/0000-0001-7841-7197	EU [07/NAT/E000732]; EC [603418]; Generalitat de Catalunya [2014 SGR 1068]	EU(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya)	The data used in this article has been gathered in the scope of Life+ INDEMARES Project (07/NAT/E000732) funded by the EU. The coordination of the project was carried out by Fundacion Biodiversidad from the Spanish Ministry of Agriculture, Food and Environment. The technical and scientific work was led by the Instituto Espanol de Oceanografia. The involvement of UB researchers in the analysis of the dataset was made possible by the EC funded research project MIDAS (GA n. 603418). Generalitat de Catalunya supported GRC Geociencies Marines through grant 2014 SGR 1068.	Acosta J, 2005, MAR GEOPHYS RES, V26, P77, DOI 10.1007/s11001-005-4766-6; Acosta J, 2005, GEOPHYSICS CANARY IS, P41, DOI DOI 10.1007/S11001-004-1161-7; Adams EW, 2000, J SEDIMENT RES, V70, P814, DOI 10.1306/2DC4093A-0E47-11D7-8643000102C1865D; Anguita F, 2000, J VOLCANOL GEOTH RES, V103, P1, DOI 10.1016/S0377-0273(00)00195-5; ANGUITA F, 1975, EARTH PLANET SC LETT, V27, P11, DOI 10.1016/0012-821X(75)90155-7; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; BALLARD RD, 1979, J GEOPHYS RES, V84, P5407, DOI 10.1029/JB084iB10p05407; Biescas B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033971; Boehlert GW, 2013, AM GEOPHYS UNION GEO, V43, P319; BOSSHARD E, 1970, J GEOPHYS RES, V75, P4901, DOI 10.1029/JB075i026p04901; Carbo A, 2005, GEOPHYSICS CANARY IS, P113; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; CHAPMAN DC, 1992, GEOPHYS ASTRO FLUID, V64, P31, DOI 10.1080/03091929208228084; Clague DA, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003791; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2006, UNEP WCMC BIODIVERS; Clouard V, 2001, GEOLOGY, V29, P695, DOI 10.1130/0091-7613(2001)029<0695:HMPHAF>2.0.CO;2; Correa TBS, 2012, MAR GEOL, V326, P14, DOI 10.1016/j.margeo.2012.06.008; CRAIG CH, 1988, J GEOPHYS RES-SOLID, V93, P10408, DOI 10.1029/JB093iB09p10408; Danobeitia J.J., 1988, REV SOC GEOL ESPANA, V1, P143; Danobeitia JJ, 1989, ESTUDIO MEDIANTE SIS; DICKSON RR, 1985, PROG OCEANOGR, V14, P103, DOI 10.1016/0079-6611(85)90008-4; EPP D, 1989, NATURE, V337, P254, DOI 10.1038/337254a0; FavalliM M, 2005, B VOLCANOL, V68, P157, DOI 10.1007/s00445-005-0429-3; Freiwald A, 2004, UNEP WCMC CAMB UK, V84; Gee MJR, 2001, MAR GEOL, V177, P271, DOI 10.1016/S0025-3227(01)00153-0; Geldmacher J, 2005, EARTH PLANET SC LETT, V237, P85, DOI 10.1016/j.epsl.2005.04.037; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Gregg TKP, 1996, GEOLOGY, V24, P981, DOI 10.1130/0091-7613(1996)024<0981:SLFIAM>2.3.CO;2; Grosse P, 2012, GEOMORPHOLOGY, V136, P114, DOI 10.1016/j.geomorph.2011.06.001; Guillou H, 1996, J VOLCANOL GEOTH RES, V73, P141, DOI 10.1016/0377-0273(96)00021-2; Harris RN, 2004, GEOLOGY, V32, P725, DOI 10.1130/G20387.1; Heezen B.C., 1959, GEOLOGICAL SOC AM SP, DOI DOI 10.1130/SPE65-P1; Hernandez-Guerra A, 2001, SCI MAR, V65, P177, DOI 10.3989/scimar.2001.65s1177; Hernandez-Guerra A, 2007, SCI MAR, V65; Hinz K, 1982, GEOLOGY NW AFRICAN C, P34, DOI [DOI 10.1007/978-3-642-68409-8_, DOI 10.1007/978-3-642-68409-8_3]; Hobson R., 2019, SPATIAL ANAL GEOMORP, P221; Howe JA, 2006, MAR PETROL GEOL, V23, P165, DOI 10.1016/j.marpetgeo.2005.08.003; IEO, 2013, PROYECT LIFE INDEMAR; IHO, 2008, STAND UND FEAT NAM G; Jackson J.A., 2005, GLOSSARY GEOLOGY; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; Klugel A, 2011, GEOLOGY, V39, P855, DOI 10.1130/G32006.1; Knoll M, 2002, DEEP-SEA RES PT II, V49, P3427, DOI 10.1016/S0967-0645(02)00105-4; Kuhlmann H, 2004, MAR GEOL, V207, P209, DOI 10.1016/j.margeo.2004.03.017; Lancelot Y, 1980, DEEP SEA DRILLING PR; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Machin F, 2006, PROG OCEANOGR, V70, P416, DOI 10.1016/j.pocean.2006.03.019; Mason E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006665; Masson DG, 1996, GEOLOGY, V24, P231, DOI 10.1130/0091-7613(1996)024<0231:CCOTVI>2.3.CO;2; Masson DG, 2002, EARTH-SCI REV, V57, P1, DOI 10.1016/S0012-8252(01)00069-1; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Neumann E, 2005, AGU SPRING M; Pelegri JL, 2006, PROG OCEANOGR, V70, P366, DOI 10.1016/j.pocean.2006.03.018; Pitcher TJ., 2008, SEAMOUNTS ECOLOGY FI; Pomar L, 2012, EARTH-SCI REV, V111, P56, DOI 10.1016/j.earscirev.2011.12.005; Quevedo-Gonzalez L, 2012, CARACTERISTICAS SEDI; Richardson PL, 2000, PROG OCEANOGR, V45, P209, DOI 10.1016/S0079-6611(99)00053-1; RICHARDSON PL, 1991, DYNAM ATMOS OCEANS, V15, P241, DOI 10.1016/0377-0265(91)90022-8; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; Roden GI, 1987, GEOPHYS MONOGR SER, V43, P335, DOI DOI 10.1029/GM043P0335; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Schmidt R, 2000, SEAMOUNTS ISLAND BUI; SCHMINCKE HU, 1973, GEOL SOC AM BULL, V84, P633, DOI 10.1130/0016-7606(1973)84<633:MEATRI>2.0.CO;2; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; SMITH DK, 1992, J GEOPHYS RES-SOL EA, V97, P1645, DOI 10.1029/91JB02507; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Staudigel H, 2010, OCEANOGRAPHY, V23, P58, DOI 10.5670/oceanog.2010.62; Svensen H, 2003, GEO-MAR LETT, V23, P351, DOI 10.1007/s00367-003-0141-2; TOMCZAK M JR, 1981, Progress in Oceanography, V10, P173, DOI 10.1016/0079-6611(81)90011-2; UCHUPI E, 1976, AAPG BULL, V60, P809; UNEP World Conservation Monitoring Center & Census of Marine Life on Seamounts Program Data Analysis Working Group, 2006, SEAM DEEP SEA COR FI; Urgeles R, 1999, J GEOPHYS RES-SOL EA, V104, P25331, DOI 10.1029/1999JB900243; Urgeles R, 1997, J GEOPHYS RES-SOL EA, V102, P20305, DOI 10.1029/97JB00649; Van den Bogaard P., 2013, SCI REP, P3; VOGT PR, 1984, J GEOPHYS RES, V89, P1085, DOI 10.1029/JB089iB13p11085; Watts AB, 1995, J GEOPHYS RES-SOL EA, V100, P24487, DOI 10.1029/95JB02630; Watts AB, 2001, B VOLCANOL, V63, P8; Weigel W., 1978, Marine Geophysical Researches, V3, P381, DOI 10.1007/BF00347674; Weigel W., 1982, GEOLOGY NW AFRICAN C, P132, DOI [10.1007/978-3-642-68409-8_8, DOI 10.1007/978-3-642-68409-8_8]; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; White M, 2004, OASIS REP CONTRACT; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	89	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156337	10.1371/journal.pone.0156337	http://dx.doi.org/10.1371/journal.pone.0156337			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243626	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100029
J	Elshikha, AS; Lu, YQ; Chen, MJ; Akbar, M; Zeumer, L; Ritter, A; Elghamry, H; Mahdi, MA; Morel, L; Song, SH				Elshikha, Ahmed S.; Lu, Yuanqing; Chen, Mong-Jen; Akbar, Mohammad; Zeumer, Leilani; Ritter, Andrea; Elghamry, Hanaa; Mahdi, Mahmoud A.; Morel, Laurence; Song, Sihong			Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus	PLOS ONE			English	Article							I INTERFERON; IMMUNE TOLERANCE; MICE; ERYTHEMATOSUS; THERAPY; DISEASE; ALPHA(1)-ANTITRYPSIN; AUTOIMMUNITY; EXPRESSION; LIPOPOLYSACCHARIDE	Systemic lupus erythematosus (SLE) is an autoimmune disorder with a worldwide distribution and considerable mortality and morbidity. Although the pathogenesis of this disease remains elusive, over-reactive dendritic cells (DCs) play a critical role in the disease development. It has been shown that human alpha-1 antitrypsin (hAAT) has protective effects in type 1 diabetes and rheumatoid arthritis mouse models. In the present study, we tested the effect of AAT on DC differentiation and functions, as well as its protective effect in a lupus-prone mouse model. We showed that hAAT treatment significantly inhibited LPS (TLR4 agonist) and CpG (TLR9 agonist) -induced bone-marrow (BM)-derived conventional and plasmacytoid DC (cDC and pDC) activation and reduced the production of inflammatory cytokines including IFN-I, TNF-alpha and IL-1 beta. In MRL/lpr mice, hAAT treatment significantly reduced BM-derived DC differentiation, serum autoantibody levels, and importantly attenuated renal pathology. Our results for the first time demonstrate that hAAT inhibits DC activation and function, and it also attenuates autoimmunity and renal damage in the MRL/lpr lupus model. These results imply that hAAT has a therapeutic potential for the treatment of SLE in humans.	[Elshikha, Ahmed S.; Lu, Yuanqing; Chen, Mong-Jen; Akbar, Mohammad; Ritter, Andrea; Song, Sihong] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Zeumer, Leilani; Morel, Laurence] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Elshikha, Ahmed S.; Elghamry, Hanaa; Mahdi, Mahmoud A.] Zagazig Univ, Dept Pharmaceut, Zagazig, Sharkia, Egypt	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Egyptian Knowledge Bank (EKB); Zagazig University	Song, SH (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Elghamry, Hanaa/AGR-0035-2022	Elghamry, Hanaa/0000-0002-4917-2570	University of Florida; Grifols Inc [62632]; Egypt Government Scholarship	University of Florida(University of Florida); Grifols Inc; Egypt Government Scholarship	This study was supported in part by grants from University of Florida, Grifols Inc (62632). Ahmed S. Elshikha was supported by an Egypt Government Scholarship.	Andersson LIM, 2008, HUM IMMUNOL, V69, P625, DOI 10.1016/j.humimm.2008.07.010; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bergin DA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007116; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carreno LJ, 2009, IMMUNOLOGY, V128, P334, DOI 10.1111/j.1365-2567.2009.03138.x; Chen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138184; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Colonna L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1911; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Finke D, 2009, AUTOIMMUNITY, V42, P349, DOI 10.1080/08916930902831829; Grimstein C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-21; Grimstein C, 2010, J GENE MED, V12, P35, DOI 10.1002/jgm.1409; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Henry JY, 2013, IMMUNOLOGY, V139, P377, DOI 10.1111/imm.12087; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang HH, 2004, INT J CANCER, V112, P1042, DOI 10.1002/ijc.20494; Iwata Y, 2009, J RHEUMATOL, V36, P306, DOI 10.3899/jrheum.080318; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; Janciauskiene SM, 2007, J BIOL CHEM, V282, P8573, DOI 10.1074/jbc.M607976200; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ma H, 2010, DIABETOLOGIA, V53, P2198, DOI 10.1007/s00125-010-1829-2; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marcondes AM, 2014, BLOOD; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Nickerson KM, 2013, J IMMUNOL, V190, P3889, DOI 10.4049/jimmunol.1203525; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Mackern-Oberti JP, 2015, AUTOIMMUN REV, V14, P127, DOI 10.1016/j.autrev.2014.10.010; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Petrache I, 2009, BIOL-TARGETS THER, V3, P193; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102151; Scott JL, 2015, J IMMUNOL; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Song S, 2004, GENE THER, V11, P181, DOI 10.1038/sj.gt.3302156; Sriram U, 2007, J IMMUNOL, V179, P6446, DOI 10.4049/jimmunol.179.10.6446; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THEOFILOPOULOS AN, 1981, IMMUNOL REV, V55, P179, DOI 10.1111/j.1600-065X.1981.tb00343.x; Wan SG, 2008, ARTHRITIS RHEUM, V58, P1741, DOI 10.1002/art.23515; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Xie J, 2014, GENET MOL RES, V13, P1251, DOI 10.4238/2014.February.27.10; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273; Zhu JK, 2005, J CLIN INVEST, V115, P1869, DOI 10.1172/JCI23049	56	29	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156583	10.1371/journal.pone.0156583	http://dx.doi.org/10.1371/journal.pone.0156583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232337	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000046
J	Biscarini, F; Cozzi, P; Casella, L; Riccardi, P; Vattari, A; Orasen, G; Perrini, R; Tacconi, G; Tondelli, A; Biselli, C; Cattivelli, L; Spindel, J; McCouch, S; Abbruscato, P; Vale, G; Piffanelli, P; Greco, R				Biscarini, Filippo; Cozzi, Paolo; Casella, Laura; Riccardi, Paolo; Vattari, Alessandra; Orasen, Gabriele; Perrini, Rosaria; Tacconi, Gianni; Tondelli, Alessandro; Biselli, Chiara; Cattivelli, Luigi; Spindel, Jennifer; McCouch, Susan; Abbruscato, Pamela; Vale, Giampiero; Piffanelli, Pietro; Greco, Raffaella			Genome-Wide Association Study for Traits Related to Plant and Grain Morphology, and Root Architecture in Temperate Rice Accessions	PLOS ONE			English	Article							ORYZA-SATIVA L.; NORTHERN LIMIT REGION; LINKAGE DISEQUILIBRIUM; COMPLEX TRAITS; POPULATION-STRUCTURE; GREEN-REVOLUTION; COMMON DISEASES; GENE; GROWTH; YIELD	Background In this study we carried out a genome-wide association analysis for plant and grain morphology and root architecture in a unique panel of temperate rice accessions adapted to European pedo-climatic conditions. This is the first study to assess the association of selected phenotypic traits to specific genomic regions in the narrow genetic pool of temperate japonica. A set of 391 rice accessions were GBS-genotyped yielding-after data editing-57000 polymorphic and informative SNPS, among which 54% were in genic regions. Results In total, 42 significant genotype-phenotype associations were detected: 21 for plant morphology traits, 11 for grain quality traits, 10 for root architecture traits. The FDR of detected associations ranged from 3.10(-7) to 0.92 (median: 0.25). In most cases, the significant detected associations co-localised with QTLs and candidate genes controlling the phenotypic variation of single or multiple traits. The most significant associations were those for flag leaf width on chromosome 4 (FDR = 3.10(-7)) and for plant height on chromosome 6 (FDR = 0.011). Conclusions We demonstrate the effectiveness and resolution of the developed platform for high-throughput phenotyping, genotyping and GWAS in detecting major QTLs for relevant traits in rice. We identified strong associations that may be used for selection in temperate irrigated rice breeding: e.g. associations for flag leaf width, plant height, root volume and length, grain length, grain width and their ratio. Our findings pave the way to successfully exploit the narrow genetic pool of European temperate rice and to pinpoint the most relevant genetic components contributing to the adaptability and high yield of this germplasm. The generated data could be of direct use in genomic-assisted breeding strategies.	[Biscarini, Filippo; Casella, Laura; Riccardi, Paolo; Vattari, Alessandra; Abbruscato, Pamela; Piffanelli, Pietro; Greco, Raffaella] PTP Sci Pk, I-26900 Lodi, Italy; [Cozzi, Paolo] IBBA CNR, Lodi, Italy; [Orasen, Gabriele; Perrini, Rosaria; Biselli, Chiara; Vale, Giampiero] CREA Council Agr Res & Econ, Rice Res Unit, I-13100 Vercelli, Italy; [Tacconi, Gianni; Tondelli, Alessandro; Cattivelli, Luigi; Vale, Giampiero] CREA Council Agr Res & Econ, Genom Res Ctr, I-29017 Fiorenzuola Darda, Piacenza, Italy; [Spindel, Jennifer; McCouch, Susan] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Biotecnologia Agraria (IBBA-CNR); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Cornell University	Biscarini, F (corresponding author), PTP Sci Pk, I-26900 Lodi, Italy.	filippo.biscarini@ptp.it	Cozzi, Paolo/AFM-1008-2022; Biscarini, Filippo/H-3334-2019; Spindel, Jennifer/F-1373-2017; Tondelli, Alessandro/AAJ-1720-2020; cattivelli, luigi/AAE-7046-2020; Valè, Giampiero/ABF-1492-2020; Tondelli, Alessandro/I-7433-2015	Biscarini, Filippo/0000-0002-3901-2354; Tondelli, Alessandro/0000-0001-9299-7773; cattivelli, luigi/0000-0002-6067-4600; Valè, Giampiero/0000-0003-2158-9726; Tondelli, Alessandro/0000-0001-9299-7773; Cozzi, Paolo/0000-0003-0388-6874	European research project "GS-Ruse"; European research project "Eurigen"; Italian national research project "Risinnova"; Division Of Integrative Organismal Systems [1026555] Funding Source: National Science Foundation	European research project "GS-Ruse"; European research project "Eurigen"; Italian national research project "Risinnova"; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research leading to these results has received funding from the European research projects "GS-Ruse" (http://www.first-gsruse.net/) and "Eurigen" (Action of the AGRI GEN RES PROGRAM) and from the Italian national research project "Risinnova" (http://risinnova.entecra.it/).; The research leading to these results has received funding from the European research projects "GS-Ruse" (http://www.first-gsruse.net/) and "Eurigen" (Action 49 of the AGRI GEN RES PROGRAM) and from the Italian national research project "Risinnova" (http://risinnova.entecra.it/).	Ahmadi N, 2014, RICE, V7, DOI 10.1186/s12284-014-0029-y; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amarawathi Y, 2008, MOL BREEDING, V21, P49, DOI 10.1007/s11032-007-9108-8; [Anonymous], 2014, TEMPERATE RICE GLOBA; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bacciu N, 2012, P 16 QTL MAS WORKSH, P24; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biselli C, 2014, RICE, V7, DOI 10.1186/1939-8433-7-1; Bohmanova J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-421; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Chen YL, 2015, PLANT MOL BIOL REP, V33, P69, DOI 10.1007/s11105-014-0731-3; Chung PJ, 2009, PLANT J, V59, P764, DOI 10.1111/j.1365-313X.2009.03908.x; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; El Nahry AH, 2011, AGR WATER MANAGE, V98, P517, DOI 10.1016/j.agwat.2010.09.012; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Faivre-Rampant O, 2011, MOL BREEDING, V27, P233, DOI 10.1007/s11032-010-9426-0; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Hemamalini GS, 2000, EUPHYTICA, V112, P69, DOI 10.1023/A:1003854224905; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Hu YF, 2009, BIOCHEM BIOPH RES CO, V388, P266, DOI 10.1016/j.bbrc.2009.07.162; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102448; Ichitani K, 1997, BREEDING SCI, V47, P145; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Jiang D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118169; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kaur S, 2013, CRITICAL RE IN PRESS; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li N, 2015, ADV SEED BIOL, V11, P78; Liang YS, 2011, RICE SCI, V18, P265, DOI 10.1016/S1672-6308(12)60004-3; Lim JH, 2014, MOL CELLS, V37, P149, DOI 10.14348/molcells.2014.2336; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Matusmoto T, 2016, RICE SCI, V23, P51, DOI 10.1016/j.rsci.2016.01.006; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nagasawa N, 2013, PLANT J, V75, P592, DOI 10.1111/tpj.12223; O'Brien AMP, 2014, LIVEST SCI, V166, P121, DOI 10.1016/j.livsci.2014.05.007; Okumoto Y, 1996, EUPHYTICA, V92, P63, DOI 10.1007/BF00022829; Perrier X, 2003, GENETIC DIVERSITY CU; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2018, R LANG ENV STAT COMP; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Serraj R, 2011, PLANT PROD SCI, V14, P1, DOI 10.1626/pps.14.1; Shen GJ, 2014, PLANT SCI, V215, P11, DOI 10.1016/j.plantsci.2013.10.004; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tonini, 2011, OPPORTUNITIES GLOBAL; VanLiere JM, 2008, THEOR POPUL BIOL, V74, P130, DOI 10.1016/j.tpb.2008.05.006; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Werck-Reichhart Daniele, 2002, Arabidopsis Book, V1, pe0028, DOI 10.1199/tab.0028; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yue Bing, 2006, Acta Genetica Sinica, V33, P824, DOI 10.1016/S0379-4172(06)60116-9; Zhang GH, 2014, MOL PLANT; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093017; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zuo JR, 2014, ANNU REV GENET, V48, P99, DOI 10.1146/annurev-genet-120213-092138	78	50	54	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155425	10.1371/journal.pone.0155425	http://dx.doi.org/10.1371/journal.pone.0155425			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228161	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500019
J	Freitas, C; Deschenes, S; Au, BN; Smith, K; Schmitz, N				Freitas, Cassandra; Deschenes, Sonya; Au, Bonnie; Smith, Kimberley; Schmitz, Norbert			Risk of Diabetes in Older Adults with Co-Occurring Depressive Symptoms and Cardiometabolic Abnormalities: Prospective Analysis from the English Longitudinal Study of Ageing	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; TYPE-2; METAANALYSIS; ASSOCIATION; PREVALENCE; OBESITY; HYPERTENSION; INFLAMMATION; AGREEMENT	High depressive symptoms and cardiometabolic abnormalities are independently associated with an increased risk of diabetes. The purpose of this study was to assess the association of co-occurring depressive symptoms and cardiometabolic abnormalities on risk of diabetes in a representative sample of the English population aged 50 years and older. Data were from the English Longitudinal Study of Ageing. The sample comprised of 4454 participants without diabetes at baseline. High depressive symptoms were based on a score of 4 or more on the 8-item binary Centre for Epidemiologic Studies-Depression scale. Cardiometabolic abnormalities were defined as 3 or more cardiometabolic risk factors (hypertension, impaired glycemic control, systemic inflammation, low high-density lipoprotein cholesterol, high triglycerides, and central obesity). Cox proportional hazards regressions assessed the association between co-occurring depressive symptoms and cardiometabolic abnormalities with incidence of diabetes. Multiple imputation by chained equations was performed to account for missing data. Covariates included age, sex, education, income, smoking status, physical activity, alcohol consumption, and cardiovascular comorbidity. The follow-up period consisted of 106 months, during which 193 participants reported a diagnosis of diabetes. Diabetes incidence rates were compared across the following four groups: 1) no or low depressive symptoms and no cardiometabolic abnormalities (reference group, n = 2717); 2) high depressive symptoms only (n = 338); 3) cardiometabolic abnormalities only (n = 1180); and 4) high depressive symptoms and cardiometabolic abnormalities (n = 219). Compared to the reference group, the hazard ratio for diabetes was 1.29 (95% CI 0.63, 2.64) for those with high depressive symptoms only, 3.88 (95% CI 2.77, 5.44) for those with cardiometabolic abnormalities only, and 5.56 (95% CI 3.45, 8.94) for those with both high depressive symptoms and cardiometabolic abnormalities, after adjusting for socio-demographic, lifestyle and clinical variables. These findings suggest that those with high depressive symptoms and cardiometabolic abnormalities are at a particularly increased risk of type 2 diabetes.	[Freitas, Cassandra; Schmitz, Norbert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Freitas, Cassandra; Deschenes, Sonya; Schmitz, Norbert] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Deschenes, Sonya; Schmitz, Norbert] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Au, Bonnie] Sunnybrook Hlth Sci Ctr, Primary Care Res Unit, Toronto, ON M4N 3M5, Canada; [Smith, Kimberley] Brunel Univ London, Dept Life Sci, Uxbridge, Middx, England	McGill University; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Brunel University	Freitas, C (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Freitas, C (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	cassandra.freitas@mail.mcgill.ca	Deschenes, Sonya/G-6341-2017; Schmitz, Norbert/AAH-3624-2020; Schmitz, Norbert/A-5177-2010	Schmitz, Norbert/0000-0001-7777-6323; Smith, Kimberley/0000-0002-1323-627X				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 2015, MY COMM AW PROGR OLD; [Anonymous], 2014, DIAB PUBL HLTH RES M; Assmann SF, 1996, EPIDEMIOLOGY, V7, P286, DOI 10.1097/00001648-199605000-00012; Au B, 2014, J PSYCHOSOM RES, V77, P180, DOI 10.1016/j.jpsychores.2014.07.012; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Council S, 1992, ALLIED DUNBAR NATL F; Cracknell R, 2010, HOUSE COMMONS LIB RE, V2010, P44; Demakakos P, 2010, DIABETOLOGIA, V53, P1877, DOI 10.1007/s00125-010-1785-x; Demakakos P, 2010, DIABETES CARE, V33, P792, DOI 10.2337/dc09-1663; El Fakiri F, 2007, J CLIN EPIDEMIOL, V60, P1271, DOI 10.1016/j.jclinepi.2007.02.014; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; Ford ES, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-35; Freitas C, 2015, INT J GERIATR PSYCHI; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hamer M, 2009, PSYCHONEUROENDOCRINO, V34, P1050, DOI 10.1016/j.psyneuen.2009.02.004; Holman N, 2011, DIABETIC MED, V28, P575, DOI 10.1111/j.1464-5491.2010.03216.x; International Diabetes Federation, 2014, IDF DIAB ATL UPD POS; Jacoby R, 2002, PSYCHIAT ELDERLY; Jokela M, 2014, MOL PSYCHIATR, V19, P910, DOI 10.1038/mp.2013.162; Jones GRD, 2011, MED J AUSTRALIA, V195, P45, DOI 10.5694/j.1326-5377.2011.tb03190.x; Kirkman MS, 2012, DIABETES CARE, V35, P2650, DOI 10.2337/dc12-1801; Knol MJ, 2006, DIABETOLOGIA, V49, P837, DOI 10.1007/s00125-006-0159-x; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mezuk B, 2008, DIABETES CARE, V31, P2383, DOI 10.2337/dc08-0985; Musselman DL, 2003, BIOL PSYCHIAT, V54, P317, DOI 10.1016/S0006-3223(03)00569-9; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Saad MAN, 2014, ARQ BRAS CARDIOL, V102, P263, DOI 10.5935/abc.20140013; Office for National Statistics, 2013, POP EST UK ENGL WAL; Okura Y, J CLIN EPIDEMIOLOGY, V57, P1096; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Patel SB, 2008, CURR HYPERTENS REP, V10, P131, DOI 10.1007/s11906-008-0025-y; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raghunathan TE, 2004, ANNU REV PUBL HEALTH, V25, P99, DOI 10.1146/annurev.publhealth.25.102802.124410; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Schmitz N, 2007, PSYCHOSOM MED, V69, P332, DOI 10.1097/PSY.0b013e31804259e0; Steffick DE, 2000, DOCUMENTION AFFECTIV; Steptoe A., 2012, INT J EPIDEMIOLOGY; The University of Wisconsin-Madison Social Science Computing Cooperative, 2013, MULT IMP STAT; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Vogelzangs N, 2011, J CLIN PSYCHIAT, V72, P598, DOI 10.4088/JCP.10m06559; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	53	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155741	10.1371/journal.pone.0155741	http://dx.doi.org/10.1371/journal.pone.0155741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227974	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500030
J	Kang, TY; Hong, JM; Jung, JW; Kang, HW; Cho, DW				Kang, Tae-Yun; Hong, Jung Min; Jung, Jin Woo; Kang, Hyun-Wook; Cho, Dong-Woo			Construction of Large-Volume Tissue Mimics with 3D Functional Vascular Networks	PLOS ONE			English	Article							PERFUSION CULTURE; OXYGEN-TRANSPORT; SCAFFOLD; FABRICATION; TRANSPLANTATION; ANGIOGENESIS; JUNCTIONS; SURFACE; REPAIR	We used indirect stereolithography (SL) to form inner-layered fluidic networks in a porous scaffold by introducing a hydrogel barrier on the luminal surface, then seeded the networks separately with human umbilical vein endothelial cells and human lung fibroblasts to form a tissue mimic containing vascular networks. The artificial vascular networks provided channels for oxygen transport, thus reducing the hypoxic volume and preventing cell death. The endothelium of the vascular networks significantly retarded the occlusion of channels during whole-blood circulation. The tissue mimics have the potential to be used as an in vitro platform to examine the physiologic and pathologic phenomena through vascular architecture.	[Kang, Tae-Yun] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Hong, Jung Min; Jung, Jin Woo; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyungbuk, South Korea; [Kang, Hyun-Wook] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Dept Biomed Engn, Ulsan, South Korea	Yale University; Pohang University of Science & Technology (POSTECH); Ulsan National Institute of Science & Technology (UNIST)	Cho, DW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, Pohang, Gyungbuk, South Korea.	dwcho@postech.ac.kr	Kang, Hyun-Wook/AAY-1766-2021		National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2012-0001235]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST), No. 2012-0001235, (http://www.nrf.re.kr/nrf_eng_cms/).	Araujo JV, 2008, J BIOMAT SCI-POLYM E, V19, P1261, DOI 10.1163/156856208786052335; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688; Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327; Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109; Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225; Dejana E, 1996, J CLIN INVEST, V98, P1949, DOI 10.1172/JCI118997; Dunn JCY, 2006, TISSUE ENG, V12, P705, DOI 10.1089/ten.2006.12.705; El-Sabbagh AM, 2013, ASAIO J, V59, P474, DOI 10.1097/MAT.0b013e31829f0e6e; Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017; Hoganson DM, 2011, LAB CHIP, V11, P700, DOI 10.1039/c0lc00158a; Huang H, 2007, BIOMATERIALS, V28, P3815, DOI 10.1016/j.biomaterials.2007.05.004; Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105; Jung JW, 2012, INT J PRECIS ENG MAN, V13, P445, DOI 10.1007/s12541-012-0057-8; Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7; Kang HW, 2012, TISSUE ENG PART C-ME, V18, P719, DOI [10.1089/ten.tec.2011.0621, 10.1089/ten.TEC.2011.0621]; Kang TY, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015007; Kang TY, 2013, LANGMUIR, V29, P701, DOI 10.1021/la303552m; Kang TY, 2013, ACTA BIOMATER, V9, P4716, DOI 10.1016/j.actbio.2012.08.042; Kang TY, 2011, ACTA BIOMATER, V7, P3345, DOI 10.1016/j.actbio.2011.05.015; Le Guelte A, 2011, METHODS MOL BIOL, V763, P265, DOI 10.1007/978-1-61779-191-8_18; Liska R, 2005, J APPL POLYM SCI, V97, P2286, DOI 10.1002/app.22025; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038; Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]; Morgan JP, 2013, NAT PROTOC, V8, P1820, DOI 10.1038/nprot.2013.110; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318; Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316; Sakai Y, 2004, MAT SCI ENG C-BIO S, V24, P379, DOI 10.1016/j.msec.2003.12.007; Seol YJ, 2012, SOFT MATTER, V8, P1730, DOI 10.1039/c1sm06863f; Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851; STEIN PD, 1974, CIRC RES, V35, P608, DOI 10.1161/01.RES.35.4.608; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Verseijden F, 2012, J TISSUE ENG REGEN M, V6, P169, DOI 10.1002/term.410; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109	40	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156529	10.1371/journal.pone.0156529	http://dx.doi.org/10.1371/journal.pone.0156529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228079	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500153
J	Lauro, F; Giancotti, LA; Ilari, S; Dagostino, C; Gliozzi, M; Morabito, C; Malafoglia, V; Raffaeli, W; Muraca, M; Goffredo, BM; Mollace, V; Muscoli, C				Lauro, Filomena; Giancotti, Luigino Antonio; Ilari, Sara; Dagostino, Concetta; Gliozzi, Micaela; Morabito, Chiara; Malafoglia, Valentina; Raffaeli, William; Muraca, Maurizio; Goffredo, Bianca M.; Mollace, Vincenzo; Muscoli, Carolina			Inhibition of Spinal Oxidative Stress by Bergamot Polyphenolic Fraction Attenuates the Development of Morphine Induced Tolerance and Hyperalgesia in Mice	PLOS ONE			English	Article							NITRIC-OXIDE; ANTINOCICEPTIVE TOLERANCE; SUPEROXIDE-DISMUTASE; GLUTAMINE-SYNTHETASE; THERMAL HYPERALGESIA; NEUROPATHIC PAIN; REACTIVE OXYGEN; ESSENTIAL OIL; MODEL; PEROXYNITRITE	Citrus Bergamia Risso, commonly known as Bergamot, is a fruit whose Essential Oil and Bergamot Polyphenolic Fraction have numerous medicinal properties. It is also an excellent antioxidant and in this study, for the first time, its potential effect on morphine induced tolerance in mice has been investigated. Our studies revealed that development of antinociceptive tolerance to repeated doses of morphine in mice is consistently associated with increased formation of superoxide, malondialdehyde and tyrosine-nitrated proteins in the dorsal horn of the spinal cord such as the enzyme glutamine synthase. Nitration of this protein is intimately linked to inactivation of its biological function and resulting increase of glutamate levels in the spinal cord. Administration of Bergamot Polyphenolic Fraction (5-50 mg/kg) attenuated tolerance development. This effect was accompanied by reduction of superoxide and malondialdehyde production, prevention of GS nitration, re-establishment of its activity and of glutamate levels. Our studies confirmed the main role of free radicals during the cascade of events induced by prolonged morphine treatment and the co-administration of natural derivatives antioxidant such as Bergamot Polyphenolic Fraction can be an important therapeutic approach to restore opioids analgesic efficacy.	[Lauro, Filomena; Giancotti, Luigino Antonio; Ilari, Sara] San Raffaele Roma Srl, Catanzaro, Italy; [Dagostino, Concetta] Univ Parma, Dept Surg Sci, I-43100 Parma, Italy; [Dagostino, Concetta] YAP Young Pain Collaborat, Parma, Italy; [Gliozzi, Micaela; Mollace, Vincenzo; Muscoli, Carolina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Inst Res Food Safety & Hlth IRC FSH, Catanzaro, Italy; [Morabito, Chiara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Malafoglia, Valentina; Raffaeli, William] ISAL Fdn, Inst Res Pain, Torre Pedrera, RN, Italy; [Muraca, Maurizio; Goffredo, Bianca M.] Childrens Hosp Bambino Gesu, Res Inst, Res Labs, Rome, Italy	University of Parma; Magna Graecia University of Catanzaro; Sapienza University Rome; IRCCS Bambino Gesu	Muscoli, C (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Inst Res Food Safety & Hlth IRC FSH, Catanzaro, Italy.	muscoli@unicz.it	ilari, sara/C-2628-2017; Dagostino, Concetta/K-2815-2016; Gliozzi, Micaela/D-4405-2015; Malafoglia, Valentina/K-6495-2016; Muraca, Maurizio/G-3063-2012; Giancotti, Luigi/P-3450-2019	Dagostino, Concetta/0000-0002-6746-6716; Malafoglia, Valentina/0000-0002-1533-704X; Giancotti, Luigi/0000-0003-1837-9891; Goffredo, Bianca/0000-0001-9933-3240; ilari, sara/0000-0002-6756-6530; GIANCOTTI, ALDO/0000-0003-2117-8062; Raffaeli, William/0000-0003-0240-8993; Lauro, Filomena/0000-0001-8212-8603	Programma Operativo Nazionale "Ricerca e Competitivita" (PON "RC") [PON03PE_00078_1, PON03PE_00078_2]; Giovani Ricercatori [GR-2010-2318370]	Programma Operativo Nazionale "Ricerca e Competitivita" (PON "RC"); Giovani Ricercatori	This work was supported by grants from: Programma Operativo Nazionale "Ricerca e Competitivita" 2007-2013 (PON "R&C") PON03PE_00078_1 to Vincenzo Mollace; Programma Operativo Nazionale "Ricerca e Competitivita" 2007-2013 (PON "R&C") PON03PE_00078_2 to Vincenzo Mollace; Giovani Ricercatori GR-2010-2318370 to Carolina Muscoli. The funder provided support in the form of salaries for authors [FL, LAG, SI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdel-Zaher AO, 2010, NEUROCHEM RES, V35, P1557, DOI 10.1007/s11064-010-0215-2; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Batista PA, 2010, J PAIN, V11, P1222, DOI 10.1016/j.jpain.2010.02.022; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Corasaniti MT, 2007, BRIT J PHARMACOL, V151, P518, DOI 10.1038/sj.bjp.0707237; DAO DN, 1991, STROKE, V22, P1312, DOI 10.1161/01.STR.22.10.1312; Esposti MD, 2002, METHODS, V26, P335, DOI 10.1016/S1046-2023(02)00039-7; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; FOLEY KM, 1995, ANTI-CANCER DRUG, V6, P4, DOI 10.1097/00001813-199504003-00002; KITTO KF, 1992, NEUROSCI LETT, V148, P1, DOI 10.1016/0304-3940(92)90790-E; KOLESNIKOV YA, 1992, EUR J PHARMACOL, V221, P399, DOI 10.1016/0014-2999(92)90732-J; Kuhad A, 2008, INDIAN J EXP BIOL, V46, P108; Laird K, 2012, LETT APPL MICROBIOL, V54, P169, DOI 10.1111/j.1472-765X.2011.03190.x; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; Li T, 2012, BRAIN RES, V1433, P80, DOI 10.1016/j.brainres.2011.11.045; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandalari G, 2007, J APPL MICROBIOL, V103, P2056, DOI 10.1111/j.1365-2672.2007.03456.x; Mattson MP, 2002, METHOD ENZYMOL, V352, P455; McInnis J, 2002, J PHARMACOL EXP THER, V301, P478, DOI 10.1124/jpet.301.2.478; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Meotti FC, 2006, BIOCHEM PHARMACOL, V72, P1707, DOI 10.1016/j.bcp.2006.08.028; Mollace V, 2008, J CARDIOVASC PHARM T, V13, P120, DOI 10.1177/1074248407313821; Mollace V, 2011, FITOTERAPIA, V82, P309, DOI 10.1016/j.fitote.2010.10.014; Muscoli C, 2004, PAIN, V111, P96, DOI 10.1016/j.pain.2004.06.004; Muscoli C, 2013, J BIOL REGULATORS HO, V28, P105; Muscoli C, 2007, J CLIN INVEST, V117, P3530, DOI 10.1172/JCI32420; Muscoli C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/950947; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Raygude Kiran S., 2012, Inflammopharmacology, V20, P331, DOI 10.1007/s10787-012-0122-z; Salerno Raffaele, 2016, PharmaNutrition, V4, pS1, DOI 10.1016/j.phanu.2015.10.001; Salvemini D, 2002, PULM PHARMACOL THER, V15, P439, DOI 10.1006/pupt.2002.0374; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Salvemini D, 2009, ARCH BIOCHEM BIOPHYS, V484, P238, DOI 10.1016/j.abb.2008.11.005; Shao HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100938; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Valsecchi AE, 2008, J NEUROCHEM, V107, P230, DOI 10.1111/j.1471-4159.2008.05614.x; Wang Y, 2012, NAT MED, V18, P385, DOI 10.1038/nm.2633; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; Warleta F, 2011, NUTRIENTS, V3, P839, DOI 10.3390/nu3100839; Wei A, 2010, J AGR FOOD CHEM, V58, P7218, DOI 10.1021/jf101077s	41	22	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156039	10.1371/journal.pone.0156039	http://dx.doi.org/10.1371/journal.pone.0156039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227548	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500055
J	Peng, J; Liu, JR; Zhang, L; Luo, JY; Dong, HL; Ma, Y; Zhao, XH; Chen, BL; Sui, N; Zhou, ZG; Meng, YL				Peng, Jun; Liu, Jingran; Zhang, Lei; Luo, Junyu; Dong, Helin; Ma, Yan; Zhao, Xinhua; Chen, Binglin; Sui, Ning; Zhou, Zhiguo; Meng, Yali			Effects of Soil Salinity on Sucrose Metabolism in Cotton Leaves	PLOS ONE			English	Article							CARBOHYDRATE-METABOLISM; PHOSPHATE SYNTHASE; FUNCTIONAL LEAVES; CARBON PRODUCTION; SALT; PHOTOSYNTHESIS; GROWTH; PIGMENTS; TOLERANT; ENZYMES	This study investigated sucrose metabolism of the youngest fully expanded main-stem leaf (MSL) and the subtending leaf of cotton (Gossypium hirsutum L.) boll (LSCB) of salt-tolerant (CCRI-79) and salt-sensitive (Simian 3) cultivars and its relationship to boll weight under low, medium and high soil salinity stress in Dafeng, China, in 2013 and 2014. The results showed that with increased soil salinity, 1) both the chlorophyll content and net photosynthetic rate (Pn) decreased, while the internal CO2 concentration firstly declined, and then increased in the MSL and LSCB; 2) carbohydrate contents in the MSL reduced significantly, while sucrose and starch contents in the LSCB increased, as did the activities of sucrose phosphate synthase (SPS) and sucrose synthase (SuSy) in both the MSL and LSCB; 3) but invertase activity in both the MSL and LSCB did not change significantly. Our study also showed that the LSCB was more sensitive to soil salinity than was the MSL. Of the measured physiological indices, higher SPS activity, mainly controlled by sps3, may contribute to adaption of the LSCB to soil salinity stress because SPS is beneficial for efficiently sucrose synthesis, reduction of cellular osmotic potential and combined actions of Pn, and sucrose transformation rate and SPS may contribute to the reduction in boll weight under soil salinity stress.	[Peng, Jun; Chen, Binglin; Zhou, Zhiguo; Meng, Yali] Nanjing Agr Univ, Key Lab Crop Physiol & Ecol Southern China, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Peng, Jun; Liu, Jingran; Zhang, Lei; Luo, Junyu; Dong, Helin; Ma, Yan; Zhao, Xinhua] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Liu, Jingran] Jiangsu Normal Univ, Sch Life Sci, Inst Integrat Plant Biol, Xuzhou, Peoples R China; [Sui, Ning] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Jiangsu Normal University; Zhejiang Chinese Medical University	Meng, YL (corresponding author), Nanjing Agr Univ, Key Lab Crop Physiol & Ecol Southern China, Minist Agr, Nanjing, Jiangsu, Peoples R China.	giscott@njau.edu.cn; mengyl@njau.edu.cn		Ma, Yan/0000-0001-6897-5064	National Natural Science Foundation of China [31301262, 31501257]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest [201503109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP); Special Fund for Agro-scientific Research in the Public Interest	The authors are grateful for financial support from the National Natural Science Foundation of China ( 31301262 and 31501257), Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC-MCP), and the Special Fund for Agro-scientific Research in the Public Interest ( 201503109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirjani Mohammad Reza, 2011, International Journal of Botany, V7, P73, DOI 10.3923/ijb.2011.73.81; ASHLEY DA, 1972, CROP SCI, V12, P69, DOI 10.2135/cropsci1972.0011183X001200010023x; Balibrea ME, 2000, PHYSIOL PLANTARUM, V110, P503, DOI 10.1111/j.1399-3054.2000.1100412.x; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; CONSTABLE GA, 1980, AUST J PLANT PHYSIOL, V7, P539, DOI 10.1071/PP9800539; Desingh R., 2007, General and Applied Plant Physiology, V33, P221; Dong He-zhong, 2012, Yingyong Shengtai Xuebao, V23, P566; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; HENDRIX DL, 1994, AGR FOREST METEOROL, V70, P153, DOI 10.1016/0168-1923(94)90054-X; HUBER SC, 1992, PLANT PHYSIOL, V99, P1275, DOI 10.1104/pp.99.4.1275; Huber SC, 1996, ANNU REV PLANT PHYS, V47, P431, DOI 10.1146/annurev.arplant.47.1.431; HUBER SC, 1982, PLANT PHYSIOL, V69, P691, DOI 10.1104/pp.69.3.691; Khan HA, 2015, J PLANT PHYSIOL, V182, P1, DOI 10.1016/j.jplph.2015.05.002; Khelil A, 2007, PLANT PHYSIOL BIOCH, V45, P551, DOI 10.1016/j.plaphy.2007.05.003; Kreuzwieser J, 2002, PLANT CELL ENVIRON, V25, P1039, DOI 10.1046/j.1365-3040.2002.00886.x; LAFTA AM, 1995, PLANT PHYSIOL, V109, P637, DOI 10.1104/pp.109.2.637; Li CR, 2002, PLANT SCI, V163, P313, DOI 10.1016/S0168-9452(02)00100-0; Li NY, 2008, AQUAT BOT, V88, P303, DOI 10.1016/j.aquabot.2007.12.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [鲁少尉 Lu Shaowei], 2012, [华北农学报, Acta Agriculturae Boreali-Sinica], V27, P136; LUNN JE, 1995, PLANTA, V197, P385, DOI 10.1007/BF00202661; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Pattanagul W, 2008, INDIAN J EXP BIOL, V46, P736; Poljakoff-Mayber A., 1999, HDB PLANT CROP STRES, P125; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Shu HM, 2009, EUR J AGRON, V31, P61, DOI 10.1016/j.eja.2009.03.004; WULLSCHLEGER SD, 1990, CROP SCI, V30, P1259, DOI 10.2135/cropsci1990.0011183X003000060021x; Yang XH, 2005, PHYSIOL PLANTARUM, V124, P343, DOI 10.1111/j.1399-3054.2005.00518.x; Zhang Guo-wei, 2011, Yingyong Shengtai Xuebao, V22, P1771; Zhang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112807; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; 胡根海, 2007, [棉花学报, Cotton Science], V19, P69	35	28	28	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156241	10.1371/journal.pone.0156241	http://dx.doi.org/10.1371/journal.pone.0156241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228029	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500091
J	Huang, YC; Kuo, YH; Huang, YH; Chen, CS; Ho, DR; Shi, CS				Huang, Yun-Ching; Kuo, Yi-Hung; Huang, Yan-Hua; Chen, Chih-Shou; Ho, Dong-Ru; Shi, Chung-Sheng			The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction	PLOS ONE			English	Article							CIGARETTE-SMOKING; OXIDATIVE STRESS; BLADDER; PLASMA; TISSUE	Tobacco use is associated with erectile dysfunction (ED) via a number of mechanisms including vascular injury and oxidative stress in corporal tissue. Adipose derived stem cells (ADSC) have been shown to ameliorate vascular/corporal injury and oxidative stress by releasing cytokines, growth factors and antioxidants. We assessed the therapeutic effects of intracavernous injection of ADSC in a rat model of tobacco-associated ED. Thirty male rats were used in this study. Ten rats exposed to room air only served as negative controls. The remaining 20 rats were passively exposed to cigarette smoke (CS) for 12 weeks. At the 12-week time point, ADSC were isolated from paragonadal fat in all rats. Amongst the 20 CS exposed rats, 10 each were assigned to one of the two following conditions: (i) injection of phosphate buffered saline (PBS) into the corpora cavernosa (CS+PBS); or (ii) injection of autologous ADSC in PBS into the corpora cavernosa (CS+ADSC). Negative control animals received PBS injection into the corpora cavernosa (normal rats [NR] + PBS). After injections all rats were returned to their previous air versus CS exposure state. Twenty-eight days after injection, all rats were placed in a metabolic cage for 24-hour urine collection to be testing for markers of oxidative stress. After 24-hour urine collection all 30 rats also underwent erectile function testing via intracavernous pressure (ICP) testing and were then sacrificed. Corporal tissues were obtained for histological assessment and Western blotting. Mean body weight was significantly lower in CS-exposed rats than in control animals. Mean ICP, ICP /mean arterial pressure ratio, serum nitric oxide level were significantly lower in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Urine markers for oxidative stress were significantly higher in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Mean expression of corporal nNOS and histological markers for endothelial and smooth muscle cells was significantly lower, and tissue apoptotic index significantly higher, in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Our findings confirm that chronic tobacco exposure causes ultrastructural damage to the corporal tissue and increases systemic oxidative stress states. Treatment with ADSC ameliorates these adverse effects and holds promise as a potential therapy for tobacco-related ED.	[Huang, Yun-Ching; Chen, Chih-Shou; Ho, Dong-Ru; Shi, Chung-Sheng] Chang Gung Mem Hosp, Dept Surg, Div Urol, Chiayi, Taiwan; [Huang, Yun-Ching; Shi, Chung-Sheng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Kuo, Yi-Hung] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi, Taiwan; [Huang, Yan-Hua] Calif State Univ, Coll Profess Studies, Sch Hlth & Human Serv, Dept Occupat Therapy, Dominguez Hills, Carson, CA USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Shi, CS (corresponding author), Chang Gung Mem Hosp, Dept Surg, Div Urol, Chiayi, Taiwan.; Shi, CS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	csshi@mail.cgu.edu.tw	huang, yan/GWM-4747-2022	Chen, Chih-Shou/0000-0002-5785-2373; Ho, Dong-Ru/0000-0002-1805-0538; Shi, Chung-Sheng/0000-0002-5548-7675	National Science Council, Taiwan [MOST 103-2314-B-182A-104]; Chang Gung Medical Foundation, Taiwan [CMRPG6E0351]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation, Taiwan	YCH and CSS received a grant from National Science Council, Taiwan (MOST 103-2314-B-182A-104) and Chang Gung Medical Foundation, Taiwan (CMRPG6E0351). All the funding or sources of support received during this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaal A, 2015, ADV DRUG DELIVER REV, V82-83, P137, DOI 10.1016/j.addr.2014.11.012; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Bonafede R, 2016, EXP CELL RES, V340, P150, DOI 10.1016/j.yexcr.2015.12.009; Cao SY, 2014, J SEX MED, V11, P2376, DOI 10.1111/jsm.12641; Chae SY, 2004, BIOMATERIALS, V25, P843, DOI 10.1016/S0142-9612(03)00605-7; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Erdelmeier I, 1998, CHEM RES TOXICOL, V11, P1184, DOI 10.1021/tx970180z; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Huang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140728; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Huang YC, 2010, J UROLOGY, V183, P1232, DOI 10.1016/j.juro.2009.11.012; Hwang TIS, 2010, J SEX MED, V7, P2817, DOI 10.1111/j.1743-6109.2010.01837.x; Imamura M, 2007, AM J PHYSIOL-REG I, V293, pR2081, DOI 10.1152/ajpregu.00406.2007; Kaiser J, 2010, SCIENCE, V329, P1132, DOI 10.1126/science.329.5996.1132; Kleinman KP, 2000, J CLIN EPIDEMIOL, V53, P71, DOI 10.1016/S0895-4356(99)00150-X; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Lin WY, 2011, BJU INT, V107, P1839, DOI 10.1111/j.1464-410X.2010.09597.x; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Mobley David, 2015, Rev Urol, V17, P220; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pan F, 2015, MOL MED REP, V12, P3725, DOI 10.3892/mmr.2015.3847; Rosen RC, 2003, AM J CARDIOL, V92, p9M, DOI 10.1016/S0002-9149(03)00824-5; Singhal SS, 2015, TOXICOL APPL PHARM, V289, P361, DOI 10.1016/j.taap.2015.10.006; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tostes RC, 2008, J SEX MED, V5, P1284, DOI 10.1111/j.1743-6109.2008.00804.x; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118951; Ypsilantis P, 2013, NICOTINE TOB RES, V15, P206, DOI 10.1093/ntr/nts113	36	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156725	10.1371/journal.pone.0156725	http://dx.doi.org/10.1371/journal.pone.0156725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257818	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700116
J	Kim, H; Lee, KI; Jang, M; Namkoong, S; Park, R; Ju, H; Choi, I; Oh, WK; Park, J				Kim, Hyunju; Lee, Kang Il; Jang, Minsu; Namkoong, Sim; Park, Rackhyun; Ju, Hyunwoo; Choi, Inho; Oh, Won Keun; Park, Junsoo			Conessine Interferes with Oxidative Stress-Induced C2C12 Myoblast Cell Death through Inhibition of Autophagic Flux	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; ALKALOID CONESSINE; SKELETAL-MUSCLES; CANCER-THERAPY; PROTEIN; ANTAGONISTS; DISEASE	Conessine, a steroidal alkaloid isolated from Holarrhena floribunda, has anti-malarial activity and interacts with the histamine H3 receptor. However, the cellular effects of conessine are poorly understood. Accordingly, we evaluated the involvement of conessine in the regulation of autophagy. We searched natural compounds that modulate autophagy, and conessine was identified as an inhibitor of autophagic flux. Conessine treatment induced the formation of autophagosomes, and p62, an autophagic adapter, accumulated in the autophagosomes. Reactive oxygen species such as hydrogen peroxide (H2O2) result in muscle cell death by inducing excessive autophagic flux. Treatment with conessine inhibited H2O2-induced autophagic flux in C2C12 myoblast cells and also interfered with cell death. Our results indicate that conessine has the potential effect to inhibit muscle cell death by interfering with autophagic flux.	[Kim, Hyunju; Lee, Kang Il; Jang, Minsu; Namkoong, Sim; Park, Rackhyun; Ju, Hyunwoo; Choi, Inho; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju 26493, South Korea; [Oh, Won Keun] Seoul Natl Univ, Coll Pharm, Korea Bioact Nat Mat Bank, Seoul 08826, South Korea	Yonsei University; Seoul National University (SNU)	Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju 26493, South Korea.	junsoo@yonsei.ac.kr		Park, Junsoo/0000-0002-2355-6760; Oh, Won Keun/0000-0003-0761-3064	Leading Space Core Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning [2013M1A3A3A02042433]	Leading Space Core Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Leading Space Core Technology Development Program through the NRF funded by the Ministry of Science, ICT & Future Planning (2013M1A3A3A02042433) (http://www.nrf.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Dua VK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-194; Kesidou E, 2013, NEURAL REGEN RES, V8, P2275, DOI 10.3969/j.issn.1673-5374.2013.24.007; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lee KI, 2015, BIOCHEM BIOPH RES CO, V462, P402, DOI 10.1016/j.bbrc.2015.04.145; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Namkoong S, 2015, AUTOPHAGY, V11, P756, DOI 10.1080/15548627.2015.1034412; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Paris R., 1951, GAZ MED FR, P79; Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410; Ryu HW, 2014, DNA CELL BIOL, V33, P128, DOI 10.1089/dna.2013.2089; Ryu HW, 2013, BIOCHEM BIOPH RES CO, V433, P121, DOI 10.1016/j.bbrc.2013.02.053; Santora VJ, 2008, BIOORG MED CHEM LETT, V18, P1490, DOI 10.1016/j.bmcl.2007.12.059; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Yoon JH, 2012, MOL BIOL REP, V39, P1087, DOI 10.1007/s11033-011-0835-x; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhao C, 2008, J MED CHEM, V51, P5423, DOI 10.1021/jm8003625; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zirihi GN, 2005, BIOORG MED CHEM LETT, V15, P2637, DOI 10.1016/j.bmcl.2005.03.021	24	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157096	10.1371/journal.pone.0157096	http://dx.doi.org/10.1371/journal.pone.0157096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257813	gold, Green Submitted, Green Published			2022-12-27	WOS:000377369700176
J	Larkin, DJ; Jacobi, SK; Hipp, AL; Kramer, AT				Larkin, Daniel J.; Jacobi, Sarah K.; Hipp, Andrew L.; Kramer, Andrea T.			Keeping All the PIECES: Phylogenetically Informed Ex Situ Conservation of Endangered Species	PLOS ONE			English	Article							PLANT CONSERVATION; FOREST MANAGEMENT; DIVERSITY; ECOLOGY; EXTINCTION; PATTERNS; THREAT	Ex situ conservation in germplasm and living collections is a major focus of global plant conservation strategies. Prioritizing species for ex situ collection is a necessary component of this effort for which sound strategies are needed. Phylogenetic considerations can play an important role in prioritization. Collections that are more phylogenetically diverse are likely to encompass more ecological and trait variation, and thus provide stronger conservation insurance and richer resources for future restoration efforts. However, phylogenetic criteria need to be weighed against other, potentially competing objectives. We used ex situ collection and threat rank data for North American angiosperms to investigate gaps in ex situ coverage and phylogenetic diversity of collections and to develop a flexible framework for prioritizing species across multiple objectives. We found that ex situ coverage of 18,766 North American angiosperm taxa was low with respect to the most vulnerable taxa: just 43% of vulnerable to critically imperiled taxa were in ex situ collections, far short of a year-2020 goal of 75%. In addition, species held in ex situ collections were phylogenetically clustered (P < 0.001), i.e., collections comprised less phylogenetic diversity than would be expected had species been drawn at random. These patterns support incorporating phylogenetic considerations into ex situ prioritization in a manner balanced with other criteria, such as vulnerability. To meet this need, we present the 'PIECES' index (Phylogenetically Informed Ex situ Conservation of Endangered Species). PIECES integrates phylogenetic considerations into a flexible framework for prioritizing species across competing objectives using multi-criteria decision analysis. Applying PIECES to prioritizing ex situ conservation of North American angiosperms, we show strong return on investment across multiple objectives, some of which are negatively correlated with each other. A spreadsheet-based decision support tool for North American angiosperms is provided; this tool can be customized to align with different conservation objectives.	[Larkin, Daniel J.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Larkin, Daniel J.; Jacobi, Sarah K.; Kramer, Andrea T.] Chicago Bot Garden, Plant Sci & Conservat, Glencoe, IL USA; [Hipp, Andrew L.] Morton Arboretum, Herbarium, Lisle, IL USA; [Hipp, Andrew L.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago)	Larkin, DJ (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.; Larkin, DJ (corresponding author), Chicago Bot Garden, Plant Sci & Conservat, Glencoe, IL USA.	djlarkin@umn.edu	Kramer, Andrea T/K-8427-2017	Kramer, Andrea T/0000-0002-0956-0157; Larkin, Daniel/0000-0001-6378-0495	National Science Foundation (US) Division of Environmental Biology [DEB-1354426, DEB-1354551]; NSF [DEB-1354426, DEB-1354551]; Division Of Environmental Biology [1354551] Funding Source: National Science Foundation	National Science Foundation (US) Division of Environmental Biology(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (US) Division of Environmental Biology (http://www.nsf.gov/div/index.jsp?div=DEB) under the following awards: DEB-1354426 and DEB-1354551.; This work was supported by NSF awards DEB-1354426 and DEB-1354551. We thank Botanic Gardens Conservation International and NatureServe for provision of data, and the Hipp and Havens-Kramer lab groups for feedback on previous versions of this manuscript.	Ananda J, 2009, ECOL ECON, V68, P2535, DOI 10.1016/j.ecolecon.2009.05.010; [Anonymous], 2013, NATURESERVE EXPL ONL; [Anonymous], 2013, PLANTSEARCH ONL DAT; Araya YN, 2012, J ECOL, V100, P1434, DOI 10.1111/1365-2745.12004; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BGCI, 2014, TECHN BACKGR DOC SUP; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2012, ECOLOGY, V93, pS52, DOI 10.1890/11-0502.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cheung WWL, 2008, ECOL ECON, V66, P193, DOI 10.1016/j.ecolecon.2007.09.001; Commoner B., 1971, N Y; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Falk DA, 1991, GENETICS CONSERVATIO; Farnsworth E, 2000, ANNU REV ECOL SYST, V31, P107, DOI 10.1146/annurev.ecolsys.31.1.107; Farnsworth EJ, 2006, BIOL CONSERV, V128, P1, DOI 10.1016/j.biocon.2005.09.010; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Griffiths KE, 2015, CONSERV BIOL, V29, P370, DOI 10.1111/cobi.12390; Guerrant EO, 2014, INT J PLANT SCI, V175, P11, DOI 10.1086/674131; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hipp AL, 2015, AM J BOT, V102, P647, DOI 10.3732/ajb.1500119; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jackson PW, 2009, TRENDS PLANT SCI, V14, P578, DOI 10.1016/j.tplants.2009.08.011; Kangas J, 2005, FOREST ECOL MANAG, V207, P133, DOI 10.1016/j.foreco.2004.10.023; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Kew RBG, 2015, STAT WORLDS PLANTS 2; Larkin DJ, 2015, J APPL ECOL, V52, P1638, DOI 10.1111/1365-2664.12516; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; MathWorks, 2013, MATLAB REF MAN; Maunder M., 2004, EX SITU PLANT CONSER; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nemhauser GL., 1988, INTEGER COMBINATORIA, DOI [10.1002/9781118627372, DOI 10.1002/9781118627372]; Orme D., 2013, CAPER COMP ANAL PHYL; Pammenter NW., 2000, PLANT SPEC BIOL, V15, P153, DOI [10.1046/j.1442-1984.2000.00035.x, DOI 10.1046/J.1442-1984.2000.00035.X]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pence VC, 2014, INT J PLANT SCI, V175, P40, DOI 10.1086/673301; Proches S, 2008, BIOSCIENCE, V58, P151, DOI 10.1641/B580209; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2014, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Saslis-Lagoudakis CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022275; Schatz GE, 2009, TRENDS PLANT SCI, V14, P638, DOI 10.1016/j.tplants.2009.08.012; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Verdu M, 2012, P ROY SOC B-BIOL SCI, V279, P1761, DOI 10.1098/rspb.2011.2268; Whitfeld TJS, 2014, J PLANT ECOL, V7, P202, DOI 10.1093/jpe/rtt020; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Zanne AE, 2013, DRYAD DIGITAL REPOSI; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	56	10	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156973	10.1371/journal.pone.0156973	http://dx.doi.org/10.1371/journal.pone.0156973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257671	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700165
J	Veroux, M; Zerbo, D; Basile, G; Gozzo, C; Sinagra, N; Giaquinta, A; Sanfiorenzo, A; Veroux, P				Veroux, Massimiliano; Zerbo, Domenico; Basile, Giusi; Gozzo, Cecilia; Sinagra, Nunziata; Giaquinta, Alessia; Sanfiorenzo, Angelo; Veroux, Pierfrancesco			Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; BILATERAL-NEPHRECTOMY; MANAGEMENT	Introduction To evaluate the feasibility of simultaneous unilateral nephrectomy with kidney transplantation and to determine the effect of this procedure on perioperative morbidity and mortality and graft and patient survival. Methods Between January 2000 and May 2015, 145 patients with autosomal dominant polycystic kidney disease (ADPKD) underwent kidney transplantation. Of those, 40 (27.5%) underwent concurrent ipsilateral native nephrectomy (group NT). Patients in group NT were compared with patients with ADPKD not undergoing concurrent nephrectomy (group NT-) and asymptomatic patients undergoing pretransplant nephrectomy (group PNT). Results The average follow-up was 66 months. The graft survival rate at 1 and 5 years was 95% and 87.5% versus 93% and 76.2% in the NT and NT- groups, respectively (P = .903 and P = .544, respectively); 1-year patient survival was 100% for NT and 97% for NT- patients (P = .288), whereas 5-year patient survival was 100% and 92% for NT and NT- groups, respectively (P = .128). After propensity score matching (34 patients per group) no significant differences were observed in 1-year (97.1% in NT and 94.1%; P = 1) and 5-year (88.2% in NT and 91.2% in NT-; P = 1) graft survival, and in 1-year (100% for both groups; P = 1) and 5-year (100% in NT and 94.1% in NT-; P = 1) patient survival. Perioperative mortality was 0% among NT and 1.2% among NT- patients, whereas perioperative surgical complications were similar in both groups. One- and 5-year graft and patient survival were similar between the NT and PNT groups, but patients in the PNT group had significantly lower levels of hemoglobin and residual diuresis volumes at the time of transplant. Moreover, PNT patients had a longer pretransplant dialysis and a longer time on the waiting list. Conclusions Simultaneous unilateral nephrectomy does not have a negative effect on patient and graft survival in patients with ADPKD and is associated with low morbidity. Pretransplant nephrectomy should be restricted only to highly symptomatic patients, whereas unilateral nephrectomy in asymptomatic patients should be performed during kidney transplantation only if massive kidney size precludes graft positioning.	[Veroux, Pierfrancesco] Univ Hosp Catania, Dept Med & Surg Sci, Vasc Surg & Organ Transplant Unit, Via Santa Sofia 84, I-95123 Catania, Italy; Univ Hosp Catania, Adv Technol GF Ingrassia, Via Santa Sofia 84, I-95123 Catania, Italy	University of Catania; University of Catania	Veroux, P (corresponding author), Univ Hosp Catania, Dept Med & Surg Sci, Vasc Surg & Organ Transplant Unit, Via Santa Sofia 84, I-95123 Catania, Italy.	veroux@unict.it	veroux, pierfrancesco/K-5195-2018; Veroux, Massimiliano/K-4821-2018	Veroux, Massimiliano/0000-0002-2780-6421; Gozzo, Cecilia/0000-0001-8997-6605				Ahmad SB, 2016, TRANSPLANTATION, V100, P407, DOI 10.1097/TP.0000000000000838; Akoh Jacob A, 2015, World J Nephrol, V4, P468, DOI 10.5527/wjn.v4.i4.468; [Anonymous], 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI 10.1093/ndt/gft218; Bennett WM, 2013, NEPHROL DIAL TRANSPL, V28, P245, DOI 10.1093/ndt/gfs176; Brazda E, 1996, Ann Transplant, V1, P15; CASSUTOVIGUIER E, 1991, CLIN NEPHROL, V36, P105; Dengu F, 2015, EXP CLIN TRANSPLANT, V13, P209, DOI 10.6002/ect.2015.0104; Dinckan A, 2013, ANN TRANSPL, V18, P697, DOI 10.12659/AOT.889377; Drognitz O, 2006, TRANSPLANTATION, V81, P874, DOI 10.1097/01.tp.0000203319.93328.27; Fuller TF, 2005, J UROLOGY, V174, P2284, DOI 10.1097/01.ju.0000181208.06507.aa; Ghavamian R, 2012, BJU INT, V110, pE1008, DOI 10.1111/j.1464-410X.2012.11386.x; Glassmann DT, 2000, J UROLOGY, V164, P661, DOI 10.1016/S0022-5347(05)67276-X; Guo PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129317; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Ismail HR, 2005, TRANSPLANTATION, V80, P1124, DOI 10.1097/01.tp.0000179109.51593.87; Johnston O, 2005, RENAL FAILURE, V27, P309, DOI 10.1081/JDI-200056606; Kanaan N, 2014, NAT REV NEPHROL, V10, P455, DOI 10.1038/nrneph.2014.104; KEITH DS, 1994, J AM SOC NEPHROL, V4, P1661; Kirkman MA, 2011, BJU INT, V108, P590, DOI 10.1111/j.1464-410X.2010.09938.x; Kramer A, 2009, J UROLOGY, V181, P724, DOI 10.1016/j.juro.2008.10.008; Lucas SM, 2010, J UROLOGY, V5, P2054, DOI DOI 10.1016/J.JUR0.2010.06.150; Martin AD, 2012, BJU INT, V110, pE1003, DOI 10.1111/j.1464-410X.2012.11379.x; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Neeff HP, 2013, NEPHROL DIAL TRANSPL, V28, P466, DOI 10.1093/ndt/gfs118; Nunes P, 2007, TRANSPL P, V39, P2483, DOI 10.1016/j.transproceed.2007.07.035; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Patel P, 2011, ANN ROY COLL SURG, V93, P391, DOI 10.1308/003588411X582690; RAYNER BL, 1990, CLIN NEPHROL, V34, P122; Rozanski J, 2005, TRANSPL P, V37, P666, DOI 10.1016/j.transproceed.2004.12.115; Shumate AM, 2016, J UROLOGY, V195, P141, DOI 10.1016/j.juro.2015.07.114; Skauby MH, 2012, TRANSPLANTATION, V94, P383, DOI 10.1097/TP.0b013e31825812b9; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; TURNER BI, 1983, J UROLOGY, V130, P240, DOI 10.1016/S0022-5347(17)51082-4; Tyson MD, 2013, J UROLOGY, V190, P2170, DOI 10.1016/j.juro.2013.05.057; Veroux M, 2016, TRANSPLANTATION, V100, pE3, DOI 10.1097/TP.0000000000000982; Yamamoto T, 2012, TRANSPLANTATION, V93, P794, DOI 10.1097/TP.0b013e318246f910	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155481	10.1371/journal.pone.0155481	http://dx.doi.org/10.1371/journal.pone.0155481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257690	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700015
J	Greulich, F; Rudat, C; Farin, HF; Christoffels, VM; Kispert, A				Greulich, Franziska; Rudat, Carsten; Farin, Henner F.; Christoffels, Vincent M.; Kispert, Andreas			Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development	PLOS ONE			English	Article							T-BOX GENES; SMOOTH-MUSCLE; EXPRESSION; HEART; TBX20; ORIGIN; CELLS; ROLES; REPRESSION; POPULATION	The epicardium, the outermost layer of the heart, is an essential source of cells and signals for the formation of the cardiac fibrous skeleton and the coronary vasculature, and for the maturation of the myocardium during embryonic development. The molecular factors that control epicardial mobilization and differentiation, and direct the epicardial-myocardial cross-talk are, however, insufficiently understood. The T-box transcription factor gene Tbx18 is specifically expressed in the epicardium of vertebrate embryos. Loss of Tbx18 is dispensable for epicardial development, but may influence coronary vessel maturation. In contrast, over-expression of an activator version of TBX18 severely impairs epicardial development by premature differentiation of epicardial cells into SMCs indicating a potential redundancy of Tbx18 with other repressors of the T-box gene family. Here, we show that Tbx2 and Tbx20 are co-expressed with Tbx18 at different stages of epicardial development. Using a conditional gene targeting approach we find that neither the epicardial loss of Tbx2 nor the combined loss of Tbx2 and Tbx18 affects epicardial development. Similarly, we observed that the heterozygous loss of Tbx20 with and without additional loss of Tbx18 does not impact on epicardial integrity and mobilization in mouse embryos. Thus, Tbx18 does not function redundantly with Tbx2 or Tbx20 in epicardial development.	[Greulich, Franziska; Rudat, Carsten; Farin, Henner F.; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Hannover Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de	Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366; Greulich, Franziska/0000-0001-8780-8528	Hannover Biomedical Research School (HBRS); German Research Foundation (DFG)	Hannover Biomedical Research School (HBRS); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Hannover Biomedical Research School (HBRS) to FG, and by grants from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and for the Clinical Research Group KFO136 at Hannover Medical School to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, J CLIN INVEST, V121, P534, DOI 10.1172/JCI44350; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Begemann G, 2002, MECH DEVELOP, V114, P137, DOI 10.1016/S0925-4773(02)00040-0; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Diman NYSG, 2014, CIRC RES, V115, P834, DOI 10.1161/CIRCRESAHA.115.304379; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Greulich F, 2012, CARDIOVASC RES, V96, P476, DOI 10.1093/cvr/cvs277; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Jahr M, 2008, DEV DYNAM, V237, P3088, DOI 10.1002/dvdy.21713; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Perez-Pomares JM, 2011, CIRC RES, V109, P1429, DOI 10.1161/CIRCRESAHA.111.245589; Masters M, 2014, STEM CELL RES, V13, P683, DOI 10.1016/j.scr.2014.04.007; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Norden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045100; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Schlueter J, 2012, J CARDIOVASC TRANSL, V5, P641, DOI 10.1007/s12265-012-9377-4; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Singh R, 2012, CELL MOL LIFE SCI, V69, P1377, DOI 10.1007/s00018-011-0884-2; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Trowe MO, 2010, DEV BIOL, V342, P51, DOI 10.1016/j.ydbio.2010.03.014; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wakker V, 2010, GENESIS, V48, P195, DOI 10.1002/dvg.20596; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Wu SP, 2013, DEV BIOL, V383, P307, DOI 10.1016/j.ydbio.2013.08.019; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	59	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156787	10.1371/journal.pone.0156787	http://dx.doi.org/10.1371/journal.pone.0156787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253890	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700061
J	Casper, C; Hascoet, JM; Ertl, T; Gadzinowski, JS; Carnielli, V; Rigo, J; Lapillonne, A; Couce, ML; Vagero, M; Palmgren, I; Timdahl, K; Hernell, O				Casper, Charlotte; Hascoet, Jean-Michel; Ertl, Tibor; Gadzinowski, Janusz S.; Carnielli, Virgilio; Rigo, Jacques; Lapillonne, Alexandre; Couce, Maria L.; Vagero, Marten; Palmgren, Ingrid; Timdahl, Kristina; Hernell, Olle			Recombinant Bile Salt-Stimulated Lipase in Preterm Infant Feeding: A Randomized Phase 3 Study	PLOS ONE			English	Article							HUMAN-MILK; INTRAUTERINE GROWTH; PANCREATIC LIPASE; DOCOSAHEXAENOIC ACID; CONTROLLED-TRIAL; LIPID DIGESTION; ABSORPTION; BORN; PASTEURIZATION; RESTRICTION	Introduction Feeding strategies are critical for healthy growth in preterm infants. Bile salt-stimulated lipase (BSSL), present in human milk, is important for fat digestion and absorption but is inactivated during pasteurization and absent in formula. This study evaluated if recombinant human BSSL (rhBSSL) improves growth in preterm infants when added to formula or pasteurized breast milk. Patients and Methods LAIF (Lipase Added to Infant Feeding) was a randomized, double-blind, placebo-controlled phase 3 study in infants born before 32 weeks of gestation. The primary efficacy variable was growth velocity (g/kg/day) during 4 weeks intervention. Follow-up visits were at 3 and 12 months. The study was performed at 54 centers in 10 European countries. Results In total 415 patients were randomized (rhBSSL n = 207, placebo n = 208), 410 patients were analyzed (rhBSSL n = 206, placebo n = 204) and 365 patients were followed until 12 months. Overall, there was no significantly improved growth velocity during rhBSSL treatment compared to placebo (16.77 vs. 16.56 g/kg/day, estimated difference 0.21 g/kg/day, 95% CI [-0.40; 0.83]), nor were secondary endpoints met. However, in a predefined subgroup, small for gestational age infants, there was a significant effect on growth in favor of rhBSSL during treatment. The incidence of adverse events was higher in the rhBSSL group during treatment. Conclusions Although this study did not meet its primary endpoint, except in a subgroup of infants small for gestational age, and there was an imbalance in short-term safety, these data provide insights in nutrition, growth and development in preterm infants.	[Casper, Charlotte] Univ Toulouse 3, Neonatol Unit, F-31062 Toulouse, France; [Hascoet, Jean-Michel] Univ Lorraine, Dept Neonatol, Nancy, France; [Ertl, Tibor] Univ Pecs, Sch Med, Dept Neonatol, Pecs, Hungary; [Gadzinowski, Janusz S.] Poznan Univ Med Sci, Chair & Dept Neonatol, Poznan, Poland; [Carnielli, Virgilio] Polytech Univ Marche, Ancona, Italy; [Carnielli, Virgilio] Salesis Children Hosp, Ancona, Italy; [Rigo, Jacques] Univ Liege, Dept Neonatol, Liege, Belgium; [Lapillonne, Alexandre] Paris Descartes Univ, EA 7328, Necker Enfants Malades Hosp, Paris, France; [Couce, Maria L.] Univ Clin Hosp, Dept Neonatol, Santiago De Compostela, Spain; [Vagero, Marten; Palmgren, Ingrid; Timdahl, Kristina] Swedish Orphan Biovitrum Sobi, Stockholm, Sweden; [Hernell, Olle] Umea Univ, Pediat, Dept Clin Sci, Umea, Sweden	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Lorraine; University of Pecs; Poznan University of Medical Sciences; Marche Polytechnic University; University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Complexo Hospitalario Universitario de Santiago de Compostela; Umea University	Timdahl, K (corresponding author), Swedish Orphan Biovitrum Sobi, Stockholm, Sweden.	kristina.timdahl@sobi.com	Couce, Maria Luz/R-8981-2019	Tscherning, Charlotte/0000-0001-7111-8979; Gadzinowski, Janusz/0000-0001-8397-6989; Couce, Maria Luz/0000-0003-4861-9905	Swedish Orphan Biovitrum AB (publ)	Swedish Orphan Biovitrum AB (publ)	This study was fully funded by Swedish Orphan Biovitrum AB (publ). The sponsor designed the study in agreement with external medical experts and was responsible for analyzing the study results. The sponsor decided to publish the data, and the article was prepared in collaboration with the study investigators.	Andersson EL, 2011, J LIPID RES, V52, P1949, DOI 10.1194/jlr.M015685; Andersson Y, 2007, ACTA PAEDIATR, V96, P1445, DOI 10.1111/j.1651-2227.2007.00450.x; Barone G, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-28; Bayley N., 2006, J PSYCHOEDUC ASSESS, V25, P180, DOI [10.1177/0734282906297199, DOI 10.1177/0734282906297199]; BJORKSTEN B, 1980, BMJ-BRIT MED J, V281, P765, DOI 10.1136/bmj.281.6243.765; Casper C, 2014, J PEDIATR GASTR NUTR, V59, P61, DOI 10.1097/MPG.0000000000000365; CHEN Q, 1994, BBA-LIPID LIPID MET, V1210, P239, DOI 10.1016/0005-2760(94)90127-9; Clark RH, 2003, PEDIATRICS, V111, P986, DOI 10.1542/peds.111.5.986; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Eidelman AI, 2012, BREASTFEED MED, V7, P323, DOI 10.1089/bfm.2012.0067; Funkquist EL, 2007, ACTA PAEDIATR, V96, P596, DOI 10.1111/j.1651-2227.2007.00222.x; Hascoet JMS, 2015, E PAS; Henderson TR, 1998, J PEDIATR-US, V132, P876, DOI 10.1016/S0022-3476(98)70323-3; HERNELL O, 1975, EUR J CLIN INVEST, V5, P267, DOI 10.1111/j.1365-2362.1975.tb02294.x; Lapillonne A, 2013, J PEDIATR-US, V162, pS90, DOI 10.1016/j.jpeds.2012.11.058; Li X, 2007, PEDIATR RES, V62, P537, DOI 10.1203/PDR.0b013e3181559e75; Lindquist S, 2010, CURR OPIN CLIN NUTR, V13, P314, DOI 10.1097/MCO.0b013e328337bbf0; Llanos A, 2005, PEDIATR RES, V58, P735, DOI 10.1203/01.PDR.0000180542.68526.A2; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; McLeod G, 2013, J PAEDIATR CHILD H, V49, pE332, DOI 10.1111/jpc.12013; Miller J, 2012, AM J CLIN NUTR, V95, P648, DOI 10.3945/ajcn.111.026351; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Pilling EL, 2008, BEST PRACT RES CL EN, V22, P447, DOI 10.1016/j.beem.2008.03.002; Sharma R, 2013, CLIN PERINATOL, V40, P27, DOI 10.1016/j.clp.2012.12.012; SHIRAI K, 1982, J BIOL CHEM, V257, P1253; Uauy R, 2000, PEDIATR RES, V47, P127, DOI 10.1203/00006450-200001000-00022; Yang YQ, 2000, PEDIATR RES, V47, P184, DOI 10.1203/00006450-200002000-00006	27	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156071	10.1371/journal.pone.0156071	http://dx.doi.org/10.1371/journal.pone.0156071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244221	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100014
J	Cui, A; Quon, G; Rosenberg, AM; Yeung, RSM; Morris, Q				Cui, Ang; Quon, Gerald; Rosenberg, Alan M.; Yeung, Rae S. M.; Morris, Quaid		BBOP Study Consortium	Gene Expression Deconvolution for Uncovering Molecular Signatures in Response to Therapy in Juvenile Idiopathic Arthritis	PLOS ONE			English	Article							TERM-FOLLOW-UP; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; BLOOD; DEFENSINS; CELLS; INTERLEUKIN-8; NEUTROPHILS; PREDICTORS; PEPTIDES	Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre-and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including a-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.	[Cui, Ang] Univ Toronto, Div Engn Sci, Toronto, ON, Canada; [Quon, Gerald; Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Rosenberg, Alan M.] Univ Saskatchewan, Dept Pediat, Div Rheumatol, Saskatoon, SK, Canada; [Yeung, Rae S. M.] Hosp Sick Children, Div Rheumatol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Med Sci, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Cui, Ang] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Quon, Gerald] Univ Calif Davis, Mol & Cellular Biol, Davis, CA 95616 USA	University of Toronto; University of Toronto; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Morris, Q (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.; Yeung, RSM (corresponding author), Hosp Sick Children, Div Rheumatol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Yeung, RSM (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Med Sci, Toronto, ON, Canada.; Morris, Q (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Morris, Q (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	rae.yeung@sickkids.ca; quaid.morris@utoronto.ca	Morris, Quaid/ABE-8343-2020; Roth, Johannes/AAA-8408-2021	Roth, Johannes/0000-0002-6109-1503; Lang, Bianca/0000-0002-5686-4276; Guzman, Jaime/0000-0001-8977-2581; Rezaei, Elham/0000-0001-6719-8013; Huber, Adam/0000-0002-6616-1689; Quon, Gerald/0000-0002-1716-0153; Turvey, Stuart/0000-0003-1599-1065; Benseler, Susanne Maria/0000-0001-5756-3638; Yeung, Rae/0000-0003-2361-725X; Houghton, Kristin/0000-0001-7174-1007; Cabral, David A./0000-0003-1840-9210; Morris, Quaid/0000-0002-2760-6999	Natural Sciences and Engineering Research Council (NSERC); Early Researcher Award from the Ontario Research Fund; Canadian Institutes of Health Research (CIHR) [82517, QNT-69301]; Canadian Arthritis Network [SRI-IJD-01]; Arthritis Society; University of Saskatchewan; Manitoba Institute of Child Health; McGill University; Memorial University; University of British Columbia; University of Sherbrooke	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Early Researcher Award from the Ontario Research Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; Arthritis Society; University of Saskatchewan; Manitoba Institute of Child Health; McGill University; Memorial University; University of British Columbia; University of Sherbrooke	This study was funded by a Natural Sciences and Engineering Research Council (NSERC) operating grant and an Early Researcher Award from the Ontario Research Fund to QM, team grants from the Canadian Institutes of Health Research (CIHR grant numbers 82517 and QNT-69301), Canadian Arthritis Network (SRI-IJD-01), and The Arthritis Society. Additional funding was provided by the University of Saskatchewan, Manitoba Institute of Child Health, McGill University, Memorial University, University of British Columbia, and University of Sherbrooke.	Arthritis P-I-R, 1991, ENHANCED PRODUCTION, V87, P463; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; BEAULIEU AD, 1994, ARTHRITIS RHEUM, V37, P855, DOI 10.1002/art.1780370613; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; BRENNAN FM, 1990, EUR J IMMUNOL, V20, P2141, DOI 10.1002/eji.1830200938; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; ENDRESEN GKM, 1977, SCAND J RHEUMATOL, V6, P237, DOI 10.3109/03009747709095457; Espinosa M, 2012, PEDIATR REV, V33, P303, DOI 10.1542/pir.33-7-303; Flato B, 2003, J RHEUMATOL, V30, P386; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Guzman J, 2014, ANN RHEUM DIS, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jarvis JN, 2009, ARTHRITIS RHEUM-US, V60, P1488, DOI 10.1002/art.24450; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Matheson LA, 2008, J IMMUNOL METHODS, V339, P82, DOI 10.1016/j.jim.2008.08.003; Matsushima K, 1989, Cytokine, V1, P2, DOI 10.1016/1043-4666(89)91043-0; Minden K, 2002, ARTHRITIS RHEUM-US, V46, P2392, DOI 10.1002/art.10444; Moncrieffe H, 2010, PHARMACOGENET GENOM, V20, P665, DOI 10.1097/FPC.0b013e32833f2cd0; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oen K, 2002, BEST PRACT RES CL RH, V16, P347, DOI 10.1053/berh.2002.0233; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Petty RE, 2004, J RHEUMATOL, V31, P390; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Quon G, 2013, GENOME MED, V5, DOI 10.1186/gm433; Quon G, 2009, BIOINFORMATICS, V25, P2882, DOI 10.1093/bioinformatics/btp378; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Vaschetto R, 2007, J LEUKOCYTE BIOL, V81, P1022, DOI 10.1189/jlb.0706435; Vordenbaumen S, 2011, POLYMERS-BASEL, V3, P1268, DOI 10.3390/polym3031268; Zak M, 2000, RHEUMATOLOGY, V39, P198, DOI 10.1093/rheumatology/39.2.198	36	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156055	10.1371/journal.pone.0156055	http://dx.doi.org/10.1371/journal.pone.0156055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244050	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100013
J	Hedrick, T; Danskin, B; Larsen, RS; Ollerenshaw, D; Groblewski, P; Valley, M; Olsen, S; Waters, J				Hedrick, Tristan; Danskin, Bethanny; Larsen, Rylan S.; Ollerenshaw, Doug; Groblewski, Peter; Valley, Matthew; Olsen, Shawn; Waters, Jack			Characterization of Channelrhodopsin and Archaerhodopsin in Cholinergic Neurons of Cre-Lox Transgenic Mice	PLOS ONE			English	Article							ACTIVATION; MODULATION; RECEPTORS	The study of cholinergic signaling in the mammalian CNS has been greatly facilitated by the advent of mouse lines that permit the expression of reporter proteins, such as opsins, in cholinergic neurons. However, the expression of opsins could potentially perturb the physiology of opsin-expressing cholinergic neurons or mouse behavior. Indeed, the published literature includes examples of cellular and behavioral perturbations in preparations designed to drive expression of opsins in cholinergic neurons. Here we investigate expression of opsins, cellular physiology of cholinergic neurons and behavior in two mouse lines, in which channelrhodopsin-2 (ChR2) and archaerhodopsin (Arch) are expressed in cholinergic neurons using the Cre-lox system. The two mouse lines were generated by crossing ChAT-Cre mice with Cre-dependent reporter lines Ai32(ChR2-YFP) and Ai35(Arch-GFP). In most mice from these crosses, we observed expression of ChR2 and Arch in only cholinergic neurons in the basal forebrain and in other putative cholinergic neurons in the forebrain. In small numbers of mice, off-target expression occurred, in which fluorescence did not appear limited to cholinergic neurons. Whole-cell recordings from fluorescently-labeled basal forebrain neurons revealed that both proteins were functional, driving depolarization (ChR2) or hyperpolarization (Arch) upon illumination, with little effect on passive membrane properties, spiking pattern or spike waveform. Finally, performance on a behavioral discrimination task was comparable to that of wild-type mice. Our results indicate that ChAT-Cre x reporter line crosses provide a simple, effective resource for driving indicator and opsin expression in cholinergic neurons with few adverse consequences and are therefore an valuable resource for studying the cholinergic system.	[Hedrick, Tristan] Northwestern Univ, 303 E Chicago Ave, Chicago, IL 60611 USA; [Danskin, Bethanny; Larsen, Rylan S.; Ollerenshaw, Doug; Groblewski, Peter; Valley, Matthew; Olsen, Shawn; Waters, Jack] Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98103 USA	Northwestern University; Allen Institute for Brain Science	Waters, J (corresponding author), Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98103 USA.	jackw@alleninstitute.org		Danskin, Bethanny/0000-0002-4832-1220; Valley, Matthew/0000-0002-7204-5457; Larsen, Rylan/0000-0002-7136-1175	Allen Institute for Brain Science; National Institute of Mental Health [5T32MH067564]; National Institute of Neurological Disorders and Stroke [NS078067]; Allen Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078067] Funding Source: NIH RePORTER	Allen Institute for Brain Science; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Allen Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Allen Institute for Brain Science; National Institute of Mental Health award number 5T32MH067564 to TH; National Institute of Neurological Disorders and Stroke award number NS078067 to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful for the hard work and technical support of the many staff members in the Allen Institute. We also thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line, used in the development of the Ai32D and Ai35D mouse lines. Funding was provided by the Allen Institute for Brain Science, award number 5T32MH067564 from the National Institute of Mental Health and award number NS078067 from the National Institute of Neurological Disorders and Stroke. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of health and National Institute of Neurological Disorders and Stroke. We thank the Allen Institute founders, Paul G Allen and Jody Allen, for their vision, encouragement and support.	Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hay YA, 2016, CEREB CORTEX, V26, P2549, DOI 10.1093/cercor/bhv085; Hedrick T, 2015, J NEUROPHYSIOL, V113, P2195, DOI 10.1152/jn.00716.2014; Hedrick T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011046; Holler T, 1996, NEUROSCI LETT, V212, P107, DOI 10.1016/0304-3940(96)12808-1; Kalmbach A, 2014, J NEUROPHYSIOL, V111, P258, DOI 10.1152/jn.00244.2013; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Luchicchi Antonio, 2014, Front Synaptic Neurosci, V6, P24, DOI 10.3389/fnsyn.2014.00024; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saunders A, 2015, ELIFE, V4, DOI 10.7554/eLife.06412; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007	18	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156596	10.1371/journal.pone.0156596	http://dx.doi.org/10.1371/journal.pone.0156596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243816	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100051
J	Xu, YB; Guo, JY; Wang, LL; Jiang, R; Jin, XL; Liu, J; Fan, SD; Quan, CS; Ha, NC				Xu, Yongbin; Guo, Jianyun; Wang, Lulu; Jiang, Rui; Jin, Xiaoling; Liu, Jing; Fan, Shengdi; Quan, Chun-Shan; Ha, Nam-Chul			The Crystal Structure of the YknZ Extracellular Domain of ABC Transporter YknWXYZ from Bacillus amyloliquefaciens	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFLUX PUMP; SUBTILIS; MODEL; MACB; TOPOLOGY; TOOLS	Bacillus possesses the peptide toxin Sporulation-Delaying Protein (SDP), which can kill cells within a biofilm to support continued growth, thereby delaying the onset of biofilm sporulation. The four-component transporter YknWXYZ acts as a major SDP efflux pump to protect cells against the endogenous SDP toxin, for which YknYZ is a non-canonical ATP-binding cassette (ABC)-type transporter. YknYZ consists of the following two components: (1) an individual protein (YknY) and (2) a respective permease (YknZ). To date, the crystal structure, molecular function, and mechanism of action of the integral membrane protein YknZ remain to be elucidated. In this study, to characterize the structural and biochemical roles of YknZ in the functional assembly of YknWXYZ, we predicted and overexpressed the YknZ extracellular domain. We determined the crystal structure of B. amyloliquefaciens YknZ at a resolution of 2.0 angstrom. The structure revealed that the YknZ extracellular region exhibits significant structural similarity with the MacB periplasmic domain, which is a non-canonical ABC-type transporter in the tripartite macrolide-specific efflux pump in Gram-negative bacteria. We also found that the YknZ extracellular domain can directly bind to an extracellular component of YknX. This structural and biochemical study provides insights into the assembly of YknWXYZ, which may be relevant to understanding cannibalistic peptide toxin resistance in Bacillus and controlling bacterial growth.	[Xu, Yongbin; Guo, Jianyun; Jin, Xiaoling; Liu, Jing; Fan, Shengdi; Quan, Chun-Shan] Dalian Nationalities Univ, Coll Life Sci, Dept Bioengn, Dalian 116600, Peoples R China; [Xu, Yongbin] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Liaoning, Peoples R China; [Wang, Lulu] Dalian Polytech Univ, Sch Biol Engn, Dalian 116034, Liaoning, Peoples R China; [Jiang, Rui] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110004, Liaoning, Peoples R China; [Ha, Nam-Chul] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151742, South Korea	Dalian Minzu University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Polytechnic University; Northeastern University - China; Seoul National University (SNU)	Xu, YB (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Dept Bioengn, Dalian 116600, Peoples R China.; Xu, YB (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Liaoning, Peoples R China.	yongbinxu@dlnu.edu.cn			National Natural Science Foundation of China [31200556, 21402024, 21272031]; China Postdoctoral Science Foundation [2013M540229]; Fundamental Research Funds for the Central Universities [DC201502020203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 31200556 to Y. Xu, Grant No. 21402024 to R. Jiang, and Grant No. 21272031 to C.S. Quan), the China Postdoctoral Science Foundation (Grant No. 2013M540229 to Y. Xu) and the Fundamental Research Funds for the Central Universities (Grant No. DC201502020203 to Y. Xu). This work made use of the BL17U beamline at the Shanghai Synchrotron Radiation Facility (SSRF) (Shanghai, China).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamsa A, 2012, MOL MICROBIOL, V84, P486, DOI 10.1111/j.1365-2958.2012.08038.x; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Song S, 2015, J MICROBIOL, V53, P355, DOI 10.1007/s12275-015-5248-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yamada Y, 2012, J BACTERIOL, V194, P4386, DOI 10.1128/JB.00223-12; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00100; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010	24	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155846	10.1371/journal.pone.0155846	http://dx.doi.org/10.1371/journal.pone.0155846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243566	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100009
J	Li, K; Dan, Z; Gesang, LB; Wang, H; Zhou, YJ; Du, YL; Ren, Y; Shi, YX; Nie, YQ				Li, Kang; Dan, Zeng; Gesang, Luobu; Wang, Hong; Zhou, Yongjian; Du, Yanlei; Ren, Yi; Shi, Yixiang; Nie, Yuqiang			Comparative Analysis of Gut Microbiota of Native Tibetan and Han Populations Living at Different Altitudes	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; DIET; COMMUNITY; BUTYRATE; CHILDREN; CANCER; AGE	The factors driving the composition of gut microbiota are still only partly understood but appear to include environmental, cultural, and genetic factors. In order to obtain more insight into the relative importance of these factors, we analyzed the microbiome composition in subjects of Tibetan or Han descent living at different altitudes. DNA was isolated from stool samples. Using polymerase chain reaction methodology, the 16S rRNA V1-V3 regions were amplified and the sequence information was analyzed by principal coordinates analysis and Lefse analyses. Contrasting the Tibetan and Han populations both living at the 3600 m altitude, we found that the Tibetan microbiome is characterized by a relative abundance of Prevotella whereas the Han stool was enriched in Bacteroides. Comparing the microbiome of Han stool obtained from populations living at different altitudes revealed a more energy efficient flora in samples from those living at higher altitude relative to their lower-altitude counterparts. Comparison of the stool microbiome of Tibetan herders living at 4800 m to rural Tibetans living at 3600 m altitude shows that the former have a flora enriched in butyrate-producing bacteria, possibly in response to the harsher environment that these herders face. Thus, the study shows that both altitude and genetic/cultural background have a significant influence on microbiome composition, and it represents the first attempt to compare stool microbiota of Tibetan and Han populations in relation to altitude.	[Li, Kang; Wang, Hong; Zhou, Yongjian; Du, Yanlei; Nie, Yuqiang] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou 510180, Guangdong, Peoples R China; [Li, Kang; Dan, Zeng; Gesang, Luobu] Peoples Hosp Tibet Autonomous Reg, High Altitude Med Res Inst, Lhasa 850000, Peoples R China; [Ren, Yi; Shi, Yixiang] Shanghai Major Biopharm Technol Co Ltd, Shanghai 201203, Peoples R China	Guangzhou Medical University	Nie, YQ (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou 510180, Guangdong, Peoples R China.	nieyqiang@sina.com			National "Twelfth Five-Year" Plan for Science & Technology Support of China [2013BAI05B04]; Natural Science Foundation of Guangdong Province, China [2014A030313679]; Key project for Natural Science Foundation in Tibet Autonomous Region, China	National "Twelfth Five-Year" Plan for Science & Technology Support of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Key project for Natural Science Foundation in Tibet Autonomous Region, China	This study was supported by a grant from the National "Twelfth Five-Year" Plan for Science & Technology Support of China (2013BAI05B04), the Natural Science Foundation of Guangdong Province, China (2014A030313679), and the Key project for Natural Science Foundation in Tibet Autonomous Region, China (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Dan Z, 2013, WORLD CHINESE J DIGE; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Konstantinov SR, 2013, TRENDS MOL MED, V19, P454, DOI 10.1016/j.molmed.2013.06.002; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lai-Yu K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093631, DOI 10.1371/J0URNAL.P0NE.0093631]; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Liu Z., 2012, CHINA TIBETOLOGY, V1, P92; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Spaan M, 2013, ANTIVIR RES, V98, P469, DOI 10.1016/j.antiviral.2013.04.003; Toivanen P, 2003, ANN RHEUM DIS, V62, P807, DOI 10.1136/ard.62.9.807; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; vanGylswyk NO, 1996, INT J SYST BACTERIOL, V46, P559, DOI 10.1099/00207713-46-2-559; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11	41	48	57	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155863	10.1371/journal.pone.0155863	http://dx.doi.org/10.1371/journal.pone.0155863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232599	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000008
J	Vanwolleghem, G; Van Dyck, D; De Meester, F; De Bourdeaudhuij, I; Cardon, G; Gheysen, F				Vanwolleghem, Griet; Van Dyck, Delfien; De Meester, Femke; De Bourdeaudhuij, Ilse; Cardon, Greet; Gheysen, Freja			Which Socio-Ecological Factors Associate with a Switch to or Maintenance of Active and Passive Transport during the Transition from Primary to Secondary School?	PLOS ONE			English	Article							ENVIRONMENT WALKABILITY SCALE; PHYSICAL-ACTIVITY; NEIGHBORHOOD ENVIRONMENT; WALKING; ADOLESCENTS; TRAVEL; CHILDHOOD; VALIDITY	Objectives The aim was to investigate which individual, psychosocial and physical neighborhood environmental factors associate with children's switch to or maintenance of active/passive transport to school and to leisure time destinations during the transition from primary to secondary school. Methods Children (n = 313) filled out a questionnaire in the last year of primary school and 2 years later to assess socio-demographic characteristics and self-reported transport. One of their parents completed a questionnaire to assess parental perceptions of psychosocial and physical neighborhood environmental factors. Results The increase of the home-school distance was significantly associated with children's switch to or maintenance of passive transport to school compared to a switch to (OR = 0.81; p = 0.03) and maintenance (OR = 0.87; p = 0.03) of active transport to school. Low SES was associated with children's switch to active transport to school compared to maintenance of active transport (OR = 3.67; p = 0.07). For transport to leisure time destinations, other factors such as parental perceived neighborhood safety from traffic and crime (OR = 2.78; p = 0.004), a positive social norm (OR = 1.49; p = 0.08), positive attitudes (OR = 1.39; p = 0.08) (i.e. more benefits, less barriers) towards their children's physical activity and poor walking/cycling facilities in the neighborhood (OR = 0.70; p = 0.06) were associated with children's maintenance of active transport to leisure time destinations compared to a switch to or maintenance of passive transport. Conclusions This longitudinal study can give directions for interventions promoting children's active transport during the transition to secondary school. It is necessary to promote different possibilities at primary school for children to use active transport when going to secondary school. Walking/cycling a part of the home-school trip can be a possible solution for children who will be living at non-feasible distances from secondary school. Providing safe neighborhoods, combined with programs for parents stimulating a positive social norm and positive attitudes towards physical activity during primary school, can be effective.	[Vanwolleghem, Griet; Van Dyck, Delfien; De Bourdeaudhuij, Ilse; Cardon, Greet; Gheysen, Freja] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Van Dyck, Delfien] Res Fdn Flanders FWO, Brussels, Belgium; [De Meester, Femke] Vlaams Inst Gezondheidspromotie & Ziekteprevent V, Brussels, Belgium	Ghent University	Cardon, G (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, B-9000 Ghent, Belgium.	Greet.Cardon@Ugent.be	Van Dyck, Delfien/AAO-8981-2020; De+Bourdeaudhuij, Ilse/AAC-5528-2019	De+Bourdeaudhuij, Ilse/0000-0001-9969-7597; Van Dyck, Delfien/0000-0003-1783-9075; Cardon, Greet/0000-0003-4983-6557	Ghent University Special Research Fund (BOF) [BOF 08/24J/134]; Research Foundation Flanders (FWO) [FWO12/PDO/158]	Ghent University Special Research Fund (BOF)(Ghent University); Research Foundation Flanders (FWO)(FWO)	This research was supported by a Ghent University Special Research Fund (BOF). BOF 08/24J/134; http://www.ugent.be/nl/onderzoek/financiering/bof/oproepen.htm. DVD is supported by Research Foundation Flanders (FWO). FWO12/PDO/158; www.fwo.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, INTRO PRACTICE STAT; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Cardon GM, 2012, PEDIATR EXERC SCI, V24, P369, DOI 10.1123/pes.24.3.369; Carlson JA, 2015, HEALTH PLACE, V32, P1, DOI 10.1016/j.healthplace.2014.12.008; Carver A, 2009, J URBAN HLTH B NEW Y, V87, P29, DOI DOI 10.1007/S11524-009-9402-3; Carver A, 2014, J TRANSP HEALTH, V1, P267, DOI 10.1016/j.jth.2014.01.004; Carver A, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-126; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Chillon P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-61; D'Haese S, 2015, HEALTH PLACE, V33, P132, DOI 10.1016/j.healthplace.2015.03.004; D'Haese S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0171-y; D'Haese S, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-88; De Bourdeaudhuij I, 2005, OBES RES, V13, P1097, DOI 10.1038/oby.2005.128; De Meester F, 2013, SOC SCI MED, V81, P1, DOI 10.1016/j.socscimed.2013.01.013; de Vries H, 1988, HLTH ED RES, V3, P273, DOI [10.1093/her/3.3.273, DOI 10.1093/HER/3.3.273]; Ducheyne F, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-142; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Hume C, 2009, AM J PREV MED, V36, P195, DOI 10.1016/j.amepre.2008.10.011; Johansson M, 2006, J ENVIRON PSYCHOL, V26, P156, DOI 10.1016/j.jenvp.2006.05.005; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Leslie E, 2010, J SCI MED SPORT, V13, P597, DOI 10.1016/j.jsams.2010.04.004; Mandic S, 2015, J SCI MED SPORT, V18, P432, DOI 10.1016/j.jsams.2014.06.012; McDonald NC, 2008, AM J PREV MED, V34, P341, DOI 10.1016/j.amepre.2008.01.004; Panter JR, 2010, J EPIDEMIOL COMMUN H, V64, P41, DOI 10.1136/jech.2009.086918; Panter J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-83; Philippaerts RM, 2006, INT J SPORTS MED, V27, P131, DOI 10.1055/s-2005-837619; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Rosenberg D, 2009, PREV MED, V49, P213, DOI 10.1016/j.ypmed.2009.07.011; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Sallis J, SCORING GUIDELINES N; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; Schoeppe S, 2015, J TRANSP HEALTH, V2, P336, DOI 10.1016/j.jth.2015.05.001; Steinbach R, 2012, HEALTH PLACE, V18, P917, DOI 10.1016/j.healthplace.2012.02.005; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thomson L., 2009, TIMES HAVE CHANGED A; Timperio A, 2004, PREV MED, V38, P39, DOI 10.1016/j.ypmed.2003.09.026; Vanwolleghem G, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0136-6; Verstraete S, 2006, THESIS GHENT U	39	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156531	10.1371/journal.pone.0156531	http://dx.doi.org/10.1371/journal.pone.0156531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232718	gold, Green Published, Green Submitted			2022-12-27	WOS:000376883000041
J	Levy, S; Dedeoglu, F; Gaffin, JM; Garvey, KC; Harstad, E; MacGinnitie, A; Rufo, PA; Huang, Q; Ziemnik, RE; Wisk, LE; Weitzman, ER				Levy, Sharon; Dedeoglu, Fatma; Gaffin, Jonathan M.; Garvey, Katharine C.; Harstad, Elizabeth; MacGinnitie, Andrew; Rufo, Paul A.; Huang, Qian; Ziemnik, Rosemary E.; Wisk, Lauren E.; Weitzman, Elissa R.			A Screening Tool for Assessing Alcohol Use Risk among Medically Vulnerable Youth	PLOS ONE			English	Article							ADOLESCENT SUBSTANCE USE; MOTIVATIONAL INTERVENTION; SOCIOECONOMIC-STATUS; COLLEGE-STUDENTS; UNITED-STATES; MARIJUANA USE; DRINKING; HEALTH; PREVALENCE; CHILDREN	Background In an effort to reduce barriers to screening for alcohol use in pediatric primary care, the National Institute on Alcoholism and Alcohol Abuse (NIAAA) developed a two -question Youth Alcohol Screening Tool derived from population-based survey data. It is unknown whether this screening tool, designed for use with general populations, accurately identifies risk among youth with chronic medical conditions (YCMC). This growing population, which comprises nearly one in four youth in the US, faces a unique constellation of drinking-related risks. Method To validate the NIAAA Youth Alcohol Screening Tool in a population of YCMC, we performed a cross-sectional validation study with a sample of 388 youth ages 9-18 years presenting for routine subspecialty care at a large children's hospital for type 1 diabetes, persistent asthma, cystic fibrosis, inflammatory bowel disease, or juvenile idiopathic arthritis. Participants self-administered the NIAAA Youth Alcohol Screening Tool and the Diagnostic Interview Schedule for Children as a criterion standard measure of alcohol use disorders (AUD). Receiver operating curve analysis was used to determine cut points for identifying youth at moderate and highest risk for an AUD. Results Nearly one third of participants (n = 118; 30.4%) reported alcohol use in the past year; 86.4% (106) of past year drinkers did not endorse any AUD criteria, 6.8% (n = 8) of drinkers endorsed a single criterion, and 6.8% of drinkers met criteria for an AUD. Using the NIAAA tool, optimal cut points found to identify youth at moderate and highest risk for an AUD were >= 6 and >= 12 drinking days in the past year, respectively. Conclusions The NIAAA Youth Alcohol Screening Tool is highly efficient for detecting alcohol use and discriminating disordered use among YCMC. This brief screen appears feasible for use in specialty care to ascertain alcohol-related risk that may impact adversely on health status and disease management.	[Levy, Sharon; Huang, Qian; Ziemnik, Rosemary E.] Boston Childrens Hosp, Adolescent Subst Abuse Program, Div Dev Behav Pediat, Boston, MA USA; [Levy, Sharon; Harstad, Elizabeth; Wisk, Lauren E.; Weitzman, Elissa R.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Dedeoglu, Fatma] Boston Childrens Hosp, Rheumatol Program, Div Immunol, Boston, MA USA; [Gaffin, Jonathan M.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Garvey, Katharine C.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Harstad, Elizabeth] Boston Childrens Hosp, Div Dev Med, Boston, MA USA; [MacGinnitie, Andrew] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Rufo, Paul A.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Wisk, Lauren E.; Weitzman, Elissa R.] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Levy, S (corresponding author), Boston Childrens Hosp, Adolescent Subst Abuse Program, Div Dev Behav Pediat, Boston, MA USA.	Sharon.Levy@childrens.harvard.edu	Wisk, Lauren/H-7392-2019; Rufo, Paul/F-6458-2019; Milford, Bethany/C-4389-2018	GAFFIN, JONATHAN/0000-0003-2213-4504	National Institute on Alcohol Abuse and Alcoholism [1R01AA021913-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI106945] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grant #1R01AA021913-01 from The National Institute on Alcohol Abuse and Alcoholism.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson P., 2005, ALCOHOL PRIMARY HLTH; Baer JS, 2001, AM J PUBLIC HEALTH, V91, P1310, DOI 10.2105/AJPH.91.8.1310; Bava S, 2010, NEUROPSYCHOL REV, V20, P398, DOI 10.1007/s11065-010-9146-6; Borsari B, 2000, J CONSULT CLIN PSYCH, V68, P728, DOI 10.1037//0022-006X.68.4.728; BRADY KT, 1993, AM J PSYCHIAT, V150, P1707; Britto MT, 2000, ARCH PEDIAT ADOL MED, V154, P478, DOI 10.1001/archpedi.154.5.478; Chung T, 2012, PEDIATRICS, V129, P205, DOI 10.1542/peds.2011-1828; Crosnoe R, 2006, SOCIOL EDUC, V79, P44, DOI 10.1177/003804070607900103; Gilbert AL, 2014, J ADOLESCENT HEALTH, V55, P672, DOI 10.1016/j.jadohealth.2014.05.016; Goodman E, 2002, ARCH PEDIAT ADOL MED, V156, P448, DOI 10.1001/archpedi.156.5.448; Haller DM, 2014, CAN MED ASS J; Hingson Ralph W, 2004, Traffic Inj Prev, V5, P228, DOI 10.1080/15389580490465256; Kelly SM, 2014, PEDIATRICS, V133, P819, DOI 10.1542/peds.2013-2346; Levy S, 2013, ASS MED ED RES SUBST; Levy S, 2014, JAMA PEDIATR, V168, P822, DOI 10.1001/jamapediatrics.2014.774; Levy S, 2014, CAN MED ASSOC J, V186, P565, DOI 10.1503/cmaj.140303; Miller PM, 2006, ALCOHOL ALCOHOLISM, V41, P306, DOI 10.1093/alcalc/agl022; Miller-Hagan RS, 2002, DIABETES EDUCATOR, V28, P233, DOI 10.1177/014572170202800209; Monti PM, 2007, ADDICTION, V102, P1234, DOI 10.1111/j.1360-0443.2007.01878.x; Murphy DA, 2012, AIDS PATIENT CARE ST, V26, P95, DOI 10.1089/apc.2011.0157; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Institute on Alcohol Abuse and Alcoholism, 2011, RFA AA 12 008 EV NIA; National Institute on Alcohol Abuse and Alcoholism, 2011, NIH PUBLICATION; Neighbors CJ, 2010, J STUD ALCOHOL DRUGS, V71, P384, DOI 10.15288/jsad.2010.71.384; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Perrin JM, 2014, HEALTH AFFAIR, V33, P2099, DOI 10.1377/hlthaff.2014.0832; Rodriguez RN, 2011, WIRES COMPUT STAT, V3, P1, DOI 10.1002/wics.131; Sawyer SM, 2007, LANCET, V369, P1481, DOI 10.1016/S0140-6736(07)60370-5; Schilling EA, 2009, J ADOLESCENT HEALTH, V44, P335, DOI 10.1016/j.jadohealth.2008.08.006; Shaffer D, 2007, DIAGNOSTIC INTERVIEW; Shrier LA, 2014, ADDICT BEHAV, V39, P173, DOI 10.1016/j.addbeh.2013.09.028; Stern SA, 2007, J SUBST ABUSE TREAT, V32, P153, DOI 10.1016/j.jsat.2006.07.009; Tait RJ, 2004, DRUG ALCOHOL DEPEN, V74, P289, DOI 10.1016/j.drugalcdep.2004.01.003; Van Cleave J, 2010, JAMA-J AM MED ASSOC, V303, P623, DOI 10.1001/jama.2010.104; Weitzman ER, 2015, PEDIATRICS, V136, P450, DOI 10.1542/peds.2015-0722; Williams JF, 2011, PEDIATRICS, V128, pE1330, DOI 10.1542/peds.2011-1754; Wilson CR, 2004, PEDIATRICS, V114, pE536, DOI 10.1542/peds.2004-0098; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Winters KC, 2007, PSYCHOL ADDICT BEHAV, V21, P249, DOI 10.1037/0893-164X.21.2.249; Young A, 2008, J STUD ALCOHOL DRUGS, V69, P39, DOI 10.15288/jsad.2008.69.39	43	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156240	10.1371/journal.pone.0156240	http://dx.doi.org/10.1371/journal.pone.0156240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227975	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500090
J	Paukkeri, EL; Korhonen, R; Hamalainen, M; Pesu, M; Eskelinen, A; Moilanen, T; Moilanen, E				Paukkeri, Erja-Leena; Korhonen, Riku; Hamalainen, Mari; Pesu, Marko; Eskelinen, Antti; Moilanen, Teemu; Moilanen, Eeva			The Inflammatory Phenotype in Failed Metal-On-Metal Hip Arthroplasty Correlates with Blood Metal Concentrations	PLOS ONE			English	Article							TOTAL JOINT REPLACEMENT; ADVERSE-REACTIONS; WEAR; PROSTHESES; FAILURE; COBALT; DEBRIS; SENSITIVITY; TOXICITY; BEARINGS	Introduction Hip arthroplasty is the standard treatment of a painful hip destruction. The use of modern metal-on-metal (MOM) bearing surfaces gained popularity in total hip arthroplasties during the last decade. Recently, worrisome failures due to adverse reaction to metal debris (ARMD), including pseudotumor response, have been widely reported. However, the pathogenesis of this reaction remains poorly understood. The aim of the present study was to investigate the ARMD response by flow cytometry approach. Methods Sixteen patients with a failed Articular Surface Replacement (ASR) hip prosthesis were included in the study. Samples of pseudotumor tissues collected during revision surgery were degraded by enzyme digestion and cells were typed by flow cytometry. Whole blood chromium and cobalt concentrations were analyzed with mass spectrometry before revision surgery. Results Flow cytometry analysis showed that the peri-implant pseudotumor tissue expressed two principal phenotypes, namely macrophage-dominated and T-lymphocyte-dominated response; the average portions being 54% (macrophages) and 25% (T-lymphocytes) in macrophage-dominated inflammation and 20% (macrophages) and 54% (T-lymphocytes) in T-lymphocyte-dominated response. The percentages of B-lymphocytes and granulocytes were lower in both phenotypes. Interestingly, the levels of blood chromium and cobalt were significantly higher in patients with macrophage-dominated response. Conclusions The results suggest that the adverse tissue reactions induced by MOM wear particles contain heterogeneous pathogeneses and that the metal levels are an important factor in the determination of the inflammatory phenotype. The present results support the hypothesis that higher metal levels cause cytotoxicity and tissue injury and macrophages are recruited to clear the necrotic debris. On the other hand, the adverse response developed in association with lower metal levels is T-lymphocyte-dominated and is likely to reflect hypersensitivity reaction.	[Paukkeri, Erja-Leena; Korhonen, Riku; Hamalainen, Mari; Moilanen, Teemu; Moilanen, Eeva] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland; [Paukkeri, Erja-Leena; Korhonen, Riku; Hamalainen, Mari; Moilanen, Teemu; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Pesu, Marko] Univ Tampere, Inst Biomed Technol, Immunoregulat, FIN-33101 Tampere, Finland; [Pesu, Marko] Tampere Univ Hosp, Dept Dermatol, Tampere, Finland; [Eskelinen, Antti; Moilanen, Teemu] Coxa Hosp Joint Replacement, Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Coxa Hospital for Joint Replacement	Moilanen, E (corresponding author), Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland.; Moilanen, E (corresponding author), Tampere Univ Hosp, Tampere, Finland.	eeva.moilanen@uta.fi	Eskelinen, Antti/AAW-9209-2021; Eskelinen, Antti/AAW-9223-2021; Pesu, Marko/L-6344-2013	Eskelinen, Antti/0000-0003-0302-0253; Pesu, Marko/0000-0002-7541-3921; Korhonen, Riku/0000-0002-7264-517X; Hamalainen, Mari/0000-0002-6409-3758	Academy of Finland; Pirkanmaa Hospital District, Tampere, Finland; Cancer Foundation Finland sr [150117] Funding Source: researchfish	Academy of Finland(Academy of Finland); Pirkanmaa Hospital District, Tampere, Finland; Cancer Foundation Finland sr	This study was supported by grants from the Academy of Finland and the competitive research funds of Pirkanmaa Hospital District, Tampere, Finland. EP is a student in National FinPharma Doctoral Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Orthopaedic Association, ANN REP 2008 2009; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; Brown C, 2007, J MATER SCI-MATER M, V18, P819, DOI 10.1007/s10856-006-0015-z; BROWN GC, 1977, J BONE JOINT SURG AM, V59, P164, DOI 10.2106/00004623-197759020-00004; Cadosch D, 2009, J BIOMED MATER RES A, V91A, P1252, DOI 10.1002/jbm.a.32625; Campbell P, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/01.blo.0000238777.34939.82; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128; COLEMAN RF, 1973, BMJ-BRIT MED J, V1, P527, DOI 10.1136/bmj.1.5852.527; Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x; Daniel J, 2004, J BONE JOINT SURG BR, V86B, P177, DOI 10.1302/0301-620X.86B2.14600; Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612; Eskelinen A, 2005, ACTA ORTHOP, V76, P28, DOI 10.1080/00016470510030292; EVANS EM, 1974, J BONE JOINT SURG BR, VB 56, P626, DOI 10.1302/0301-620X.56B4.626; Firkins PJ, 2001, BIO-MED MATER ENG, V11, P143; Fisher J, 2011, J BONE JOINT SURG BR, V93B, P1001, DOI 10.1302/0301-620X.93B8.26936; Gill HS, 2012, TRENDS MOL MED, V18, P145, DOI 10.1016/j.molmed.2011.12.002; GOLDBERG MA, 1994, J BIOL CHEM, V269, P4355; Grammatopoulos George, 2013, J Bone Joint Surg Am, V95, pe81, DOI 10.2106/JBJS.L.00775; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; Hart AJ, 2014, J BONE JOINT SURG AM, V96A, P1091, DOI 10.2106/JBJS.M.00957; JONES DA, 1975, J BONE JOINT SURG BR, V57, P289, DOI 10.1302/0301-620X.57B3.289; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Medicines and healthcare products regulatory agency, MED DEV AL ALL MET O; Migaud H, 2004, J ARTHROPLASTY, V19, P23, DOI 10.1016/j.arth.2004.09.005; Mittal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063470; National Joint Registry for England and Wales, 8 ANN REP; Natu S, 2012, J CLIN PATHOL, V65, P409, DOI 10.1136/jclinpath-2011-200398; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034; Reito A, 2014, INT ORTHOP, V38, P1353, DOI 10.1007/s00264-014-2300-7; Reito A, 2013, CLIN ORTHOP RELAT R, V471, P2954, DOI 10.1007/s11999-013-3023-6; Revell PA, 2014, JOINT REPLACEMENT TE, P298; Samelko L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067127; Santavirta S, 2003, ACTA ORTHOP SCAND, V74, P380; Savarino L, 2002, J BIOMED MATER RES, V63, P467, DOI 10.1002/jbm.10299; Schmalzried TP, 2004, CLIN ORTHOP RELAT R, P94; Seppanen M, 2012, ACTA ORTHOP, V83, P207, DOI 10.3109/17453674.2012.693016; Thomas P, 2009, ALLERGY, V64, P1157, DOI 10.1111/j.1398-9995.2009.01966.x; Tyson-Capper AJ, 2013, ANN RHEUM DIS, V72, P460, DOI 10.1136/annrheumdis-2012-202468; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Williams S, 2008, J BONE JOINT SURG AM, V90A, P111, DOI 10.2106/JBJS.H.00485	47	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155121	10.1371/journal.pone.0155121	http://dx.doi.org/10.1371/journal.pone.0155121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227536	gold, Green Published			2022-12-27	WOS:000376882500010
J	Mwangungulu, SP; Sumaye, RD; Limwagu, AJ; Siria, DJ; Kaindoa, EW; Okumu, FO				Mwangungulu, Stephen Peter; Sumaye, Robert David; Limwagu, Alex Julius; Siria, Doreen Josen; Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch			Crowdsourcing Vector Surveillance: Using Community Knowledge and Experiences to Predict Densities and Distribution of Outdoor-Biting Mosquitoes in Rural Tanzania	PLOS ONE			English	Article							DAR-ES-SALAAM; RIFT-VALLEY FEVER; PARTICIPATORY-GIS; CARBON-DIOXIDE; MALARIA; TRANSMISSION; MANAGEMENT; DESIGN; DENGUE; CHIKUNGUNYA	Lack of reliable techniques for large-scale monitoring of disease-transmitting mosquitoes is a major public health challenge, especially where advanced geo-information systems are not regularly applicable. We tested an innovative crowd-sourcing approach, which relies simply on knowledge and experiences of residents to rapidly predict areas where disease-transmitting mosquitoes are most abundant. Guided by community-based resource persons, we mapped boundaries and major physical features in three rural Tanzanian villages. We then selected 60 community members, taught them basic map-reading skills, and offered them gridded maps of their own villages (grid size: 200mx200m) so they could identify locations where they believed mosquitoes were most abundant, by ranking the grids from one (highest density) to five (lowest density). The ranks were interpolated in ArcGIS-10 (ESRI-USA) using inverse distance weighting (IDW) method, and re-classified to depict areas people believed had high, medium and low mosquito densities. Finally, we used odor-baited mosquito traps to compare and verify actual outdoor mosquito densities in the same areas. We repeated this process for 12 months, each time with a different group of 60 residents. All entomological surveys depicted similar geographical stratification of mosquito densities in areas classified by community members as having high, medium and low vector abundance. These similarities were observed when all mosquito species were combined, and also when only malaria vectors were considered. Of the 12,412 mosquitoes caught, 60.9% (7,555) were from areas considered by community members as having high mosquito densities, 28% (3,470) from medium density areas, and 11.2% (1,387) from low density areas. This study provides evidence that we can rely on community knowledge and experiences to identify areas where mosquitoes are most abundant or least abundant, even without entomological surveys. This crowd-sourcing method could be further refined and validated to improve community-based planning of mosquito control operations at low-cost.	[Mwangungulu, Stephen Peter; Sumaye, Robert David; Limwagu, Alex Julius; Siria, Doreen Josen; Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Mwangungulu, Stephen Peter] Ardhi Univ, Sch Geospatial Sci & Technol, Dar Es Salaam, Tanzania; [Sumaye, Robert David] Inst Trop Med, B-2000 Antwerp, Belgium; [Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa	Ifakara Health Institute; Institute of Tropical Medicine (ITM); University of Witwatersrand	Okumu, FO (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.; Okumu, FO (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa.	fredros@ihi.or.tz		Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694; Sumaye, Robert/0000-0001-9734-3226	Global Health Discovery Program of the Bill & Melinda Gates Foundation [53214, OPP103574]; Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada(TM) [0012-01-01-01-01]; Wellcome Trust Fellowships in Public Health and Tropical Medicine [WT102350/Z/13/Z, 100540/Z/12/Z]; Grand Challenges Explorations Award	Global Health Discovery Program of the Bill & Melinda Gates Foundation; Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada(TM); Wellcome Trust Fellowships in Public Health and Tropical Medicine; Grand Challenges Explorations Award	This work was funded by a Grand Challenges Explorations Award, from the Global Health Discovery Program of the Bill & Melinda Gates Foundation (Grant Numbers: 53214 and OPP103574), the Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada (TM) (Grant Number: 0012-01-01-01-01). Fredros Okumu and Emmanuel Kaindoa were also supported by Wellcome Trust Fellowships in Public Health and Tropical Medicine (Grant numbers: WT102350/Z/13/Z and 100540/Z/12/Z respectively).; We would like to thank all community members who participated in community participatory mapping exercises, and all volunteers for their participation in sampling mosquitoes during the entire study period. This work was funded by a Grand Challenges Explorations Award, from the Global Health Discovery Program of the Bill & Melinda Gates Foundation (Grant Numbers: 53214 and OPP103574), the Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada (TM) (Grant Number: 0012-01-01-01-01). Fredros Okumu and Emmanuel Kaindoa were also supported by Wellcome Trust Fellowships in Public Health and Tropical Medicine (Grant numbers: WT102350/Z/13/Z and 100540/Z/12/Z respectively). We thank Lina Finda and Paul Kaefer for conducting rigorous grammar and language checks in the manuscript	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Carter R, 2002, INT J PARASITOL, V32, P1617, DOI 10.1016/S0020-7519(02)00190-X; Chaki PP, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-21; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335; Cinderby S, 2005, APPL GEOGR, V25, P143, DOI 10.1016/j.apgeog.2005.03.003; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Dongus S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-37; Driedger SM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-53; Dunn CE, 2007, PROG HUM GEOG, V31, P616, DOI 10.1177/0309132507081493; Duval-Diop D, 2010, COMMUNITY DEV, V41, P32, DOI 10.1080/15575330903288854; Elwood S., 1998, CARTOGR GEOGR INFORM, V25, P77, DOI [10.1559/152304098782594553, DOI 10.1559/152304098782594553]; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376; Gao H, 2011, IEEE INTELL SYST, V26, P10, DOI 10.1109/MIS.2011.52; Geubbels E, 2015, INT J EPIDEMIOL; Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255; Gutierrez J, 2008, ENVIRON PLANN B, V35, P480, DOI 10.1068/b33043; Hanafi-Bojd AA, 2012, ACTA TROP, V122, P132, DOI 10.1016/j.actatropica.2012.01.003; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; Hudson-Smith A, 2009, SOC SCI COMPUT REV, V27, P524, DOI 10.1177/0894439309332299; Luengo-Oroz MA, 2012, J MED INTERNET RES, V14; Maman S, 2009, FIELD METHOD, V21, P368, DOI 10.1177/1525822X09341718; McCall MK, 2005, GEOGR J, V171, P340, DOI 10.1111/j.1475-4959.2005.00173.x; McCall MK, 2003, HABITAT INT, V27, P549, DOI 10.1016/S0197-3975(03)00005-5; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Moi ML, 2010, EMERG INFECT DIS, V16, P1770, DOI 10.3201/eid1611.101061; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Okolloh Ory, 2009, PARTICIPATORY LEARNI, V59, P65; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261; Sandstrom P, 2003, AMBIO, V32, P557, DOI 10.1639/0044-7447(2003)032[0557:CRBPMR]2.0.CO;2; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Simonsen PE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0507-5; Sims MH, 2014, J HOSP MED, V9, P451, DOI 10.1002/jhm.2204; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; STEPHENS C, 1995, B WORLD HEALTH ORGAN, V73, P97; Stevens M, 2010, WROKSH UB CROWDS; Sumaye RD, 2012, MALARIAWORLD J, V3; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Sumaye RD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003536; Unabor H, 2014, INT J SCI ENG RES, V5, P2; Weiner D., 2003, URISA J, V15, P61; Whitla P, 2009, CONT MANAGEMENT RES, V5; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2014, DENG OUTBR UN REP TA; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Zimmerman J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1677	60	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156388	10.1371/journal.pone.0156388	http://dx.doi.org/10.1371/journal.pone.0156388			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253869	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700023
J	Bauldry, S; Shanahan, MJ; Russo, R; Roberts, BW; Damian, R				Bauldry, Shawn; Shanahan, Michael J.; Russo, Rosemary; Roberts, Brent W.; Damian, Rodica			Attractiveness Compensates for Low Status Background in the Prediction of Educational Attainment	PLOS ONE			English	Article							TO-HIP RATIO; PHYSICAL ATTRACTIVENESS; PERSONALITY-TRAITS; CAREER SUCCESS; BEAUTY; METAANALYSIS; STUDENTS; ABILITY; INCOME; MODEL	Background People who are perceived as good looking or as having a pleasant personality enjoy many advantages, including higher educational attainment. This study examines (1) whether associations between physical/personality attractiveness and educational attainment vary by parental socioeconomic resources and (2) whether parental socioeconomic resources predict these forms of attractiveness. Based on the theory of resource substitution with structural amplification, we hypothesized that both types of attractiveness would have a stronger association with educational attainment for people from disadvantaged backgrounds (resource substitution), but also that people from disadvantaged backgrounds would be less likely to be perceived as attractive (amplification). Methods This study draws on data from the National Longitudinal Study of Adolescent to Adult Health-including repeated interviewer ratings of respondents' attractiveness-and trait-state structural equation models to examine the moderation (substitution) and mediation (amplification) of physical and personality attractiveness in the link between parental socioeconomic resources and educational attainment. Results Both perceived personality and physical attractiveness have stronger associations with educational attainment for people from families with lower levels of parental education (substitution). Further, parental education and income are associated with both dimensions of perceived attractiveness, and personality attractiveness is positively associated with educational attainment (amplification). Results do not differ by sex and race/ethnicity. Further, associations between perceived attractiveness and educational attainment remain after accounting for unmeasured family-level confounders using a sibling fixed-effects model. Conclusions Perceived attractiveness, particularly personality attractiveness, is a more important psychosocial resource for educational attainment for people from disadvantaged backgrounds than for people from advantaged backgrounds. People from disadvantaged backgrounds, however, are less likely to be perceived as attractive than people from advantaged backgrounds.	[Bauldry, Shawn] Univ Alabama Birmingham, Dept Sociol, Birmingham, AL 35294 USA; [Shanahan, Michael J.; Russo, Rosemary] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA; [Roberts, Brent W.] Univ Illinois, Dept Psychol, Urbana, IL 61801 USA; [Damian, Rodica] Univ Houston, Dept Psychol, Houston, TX USA	University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Urbana-Champaign; University of Houston System; University of Houston	Bauldry, S (corresponding author), Univ Alabama Birmingham, Dept Sociol, Birmingham, AL 35294 USA.	sgbauldry@gmail.com	Bauldry, Shawn/ABG-7064-2020; Roberts, Brent/HCH-8716-2022	Bauldry, Shawn/0000-0002-6679-3125	National Institute of Childhood Health and Human Development [R01 HD061622-01]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, P01HD031921] Funding Source: NIH RePORTER	National Institute of Childhood Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Institute of Childhood Health and Human Development; R01 HD061622-01; SB, MS, RR.; This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Beaujean AA, 2011, PERS INDIV DIFFER, V51, P709, DOI 10.1016/j.paid.2011.06.023; Biddle JE, 1998, J LABOR ECON, V16, P172, DOI 10.1086/209886; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bollen KA, 2010, SOC FORCES, V89, P1, DOI 10.1353/sof.2010.0072; Borghans L, 2008, J HUM RESOUR, V43, P815; Bowles S, 2001, J ECON LIT, V39, P1137, DOI 10.1257/jel.39.4.1137; Cheng H, 2014, SOC INDIC RES, V117, P653, DOI 10.1007/s11205-013-0364-1; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Dunn L, 1981, PPVT R MANUAL; Entwisle DR., 1997, CHILDREN SCH INEQUAL; Ferguson E, 2011, PERS INDIV DIFFER, V51, P201, DOI 10.1016/j.paid.2011.03.030; Fletcher JM, 2009, ECON LETT, V105, P321, DOI 10.1016/j.econlet.2009.09.006; French MT, 2009, LABOUR ECON, V16, P373, DOI 10.1016/j.labeco.2009.01.001; FRIEZE IH, 1991, J APPL SOC PSYCHOL, V21, P1039, DOI 10.1111/j.1559-1816.1991.tb00458.x; Furnham A, 2006, PERS INDIV DIFFER, V41, P443, DOI 10.1016/j.paid.2006.02.007; Giordano PC, 2003, ANNU REV SOCIOL, V29, P257, DOI 10.1146/annurev.soc.29.010202.100047; Gordon RA, 2013, MONOGR SOC RES CHILD, P78; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Hamermesh D.S., 2011, BEAUTY PAYS WHY ATTR; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Hosoda M, 2003, PERS PSYCHOL, V56, P431, DOI 10.1111/j.1744-6570.2003.tb00157.x; JACKSON LA, 1995, SOC PSYCHOL QUART, V58, P108, DOI 10.2307/2787149; Jaeger MM, 2011, SOC FORCES, V89, P983; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; Judge TA, 1999, PERS PSYCHOL, V52, P621, DOI 10.1111/j.1744-6570.1999.tb00174.x; KENEALY P, 1988, J SOC PSYCHOL, V128, P373, DOI 10.1080/00224545.1988.9713754; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; McAbee ST, 2013, PSYCHOL ASSESSMENT, V25, P532, DOI 10.1037/a0031748; Mirowsky J, 2003, SOCIAL CAUSES PSYCHO; Mobius MM, 2006, AM ECON REV, V96, P222, DOI 10.1257/000282806776157515; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Ng TWH, 2005, PERS PSYCHOL, V58, P367, DOI 10.1111/j.1744-6570.2005.00515.x; Poropat AE, 2009, PSYCHOL BULL, V135, P322, DOI 10.1037/a0014996; Rhodes J. E, 2009, STAND ME RISKS REWAR; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; RITTS V, 1992, REV EDUC RES, V62, P413, DOI 10.2307/1170486; Ross CE, 2006, SOC SCI MED, V63, P1400, DOI 10.1016/j.socscimed.2006.03.013; Ross CE, 2011, SOC SCI MED, V72, P591, DOI 10.1016/j.socscimed.2010.11.028; Ross CE, 2001, AM SOCIOL REV, V66, P568, DOI 10.2307/3088923; ROSZELL P, 1989, J PSYCHOL, V123, P547, DOI 10.1080/00223980.1989.10543009; Shanahan MJ, 2007, TWIN RES HUM GENET, V10, P285, DOI 10.1375/twin.10.2.285; Shanahan MJ, 2014, SOC FORCES, V93, P209, DOI 10.1093/sf/sou050; Shanahan MJ, 2014, DEV PSYCHOL, V50, P1407, DOI 10.1037/a0031130; StataCorp, 2013, STATA STAT SOFTW REL; Swami V, 2006, SEX ROLES, V54, P201, DOI 10.1007/s11199-006-9338-3; Swanberg AB, 2010, EDUC PSYCHOL-UK, V30, P75, DOI 10.1080/01443410903410474; WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004	49	11	11	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155313	10.1371/journal.pone.0155313	http://dx.doi.org/10.1371/journal.pone.0155313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249216	Green Submitted, Green Published, gold			2022-12-27	WOS:000377184700010
J	Martinez-Sernandez, V; Orbegozo-Medina, RA; Romaris, F; Paniagua, E; Ubeira, FM				Martinez-Sernandez, Victoria; Orbegozo-Medina, Ricardo A.; Romaris, Fernanda; Paniagua, Esperanza; Ubeira, Florencio M.			Usefulness of ELISA Methods for Assessing LPS Interactions with Proteins and Peptides	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; ANTIMICROBIAL PEPTIDE; ENDOTOXIN REMOVAL; BIOLOGICAL-ACTIVITY; FASCIOLA-HEPATICA; ESCHERICHIA-COLI; KAPPA-B; HEMOGLOBIN; NEUTRALIZATION; RECEPTORS	Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, can trigger severe inflammatory responses during bacterial infections, possibly leading to septic shock. One approach to combatting endotoxic shock is to neutralize the most conserved part and major mediator of LPS activity (lipid A) with LPS-binding proteins or peptides. Although several available assays evaluate the biological activity of these molecules on LPS (e.g. inhibition of LPS-induced TNF-alpha production in macrophages), the development of simple and cost-effective methods that would enable preliminary screening of large numbers of potential candidate molecules is of great interest. Moreover, it would be also desirable that such methods could provide information about the possible biological relevance of the interactions between proteins and LPS, which may enhance or neutralize LPS-induced inflammatory responses. In this study, we designed and evaluated different types of ELISA that could be used to study possible interactions between LPS and any protein or peptide. We also analysed the usefulness and limitations of the different ELISAs. Specifically, we tested the capacity of several proteins and peptides to bind FITC-labeled LPSs from Escherichia coli serotypes O111:B4 and O55:B5 in an indirect ELISA and in two competitive ELISAs including casein hydrolysate (hCAS) and biotinylated polymyxin B (captured by deglycosylated avidin; PMX) as LPS-binding agents in the solid phase. We also examined the influence of pH, detergents and different blocking agents on LPS binding. Our results showed that the competitive hCAS-ELISA performed under mildly acidic conditions can be used as a general method for studying LPS interactions, while the more restrictive PMX-ELISA may help to identify proteins/peptides that are likely to have neutralizing properties in vitro or in vivo.	[Martinez-Sernandez, Victoria; Orbegozo-Medina, Ricardo A.; Romaris, Fernanda; Paniagua, Esperanza; Ubeira, Florencio M.] Univ Santiago de Compostela, Lab Parasitol, Dept Microbiol & Parasitol, Fac Farm, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Lab Parasitol, Dept Microbiol & Parasitol, Fac Farm, Santiago De Compostela, Spain.	fm.ubeira@usc.es		Ubeira, Florencio/0000-0001-7312-2752; Romaris Martinez, Fernanda/0000-0002-0633-674X; Paniagua Crespo, Maria Esperanza/0000-0002-4435-0200; Orbegozo Medina, Ricardo Alfredo/0000-0002-5281-9718	Ministerio de Ciencia e Innovacion, Spain [AGL2011-30563-C03]; Xunta de Galicia, Spain [GPC2014/058]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	This work was funded by Ministerio de Ciencia e Innovacion, Spain, Grant AGL2011-30563-C03; Xunta de Galicia, Spain, Grant GPC2014/058; and the European Fund for Regional Development (FEDER). VMS holds a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario) and RAOM is recipient of a fellowship from the Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anspach FB, 2001, J BIOCHEM BIOPH METH, V49, P665, DOI 10.1016/S0165-022X(01)00228-7; Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Bahl N, 2011, J BIOL CHEM, V286, P37793, DOI 10.1074/jbc.M111.245472; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Brandenburg K, 2003, J BIOL CHEM, V278, P47660, DOI 10.1074/jbc.M304743200; Chen XM, 2006, J MED CHEM, V49, P7754, DOI 10.1021/jm0610447; Cheng X, 2015, NUTRIENTS, V7, P3119, DOI 10.3390/nu7053119; Das D, 2015, CHEMPHYSCHEM, V16, P753, DOI 10.1002/cphc.201402739; David SA, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P413; de Haas CJC, 1999, INFECT IMMUN, V67, P2790, DOI 10.1128/IAI.67.6.2790-2796.1999; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; Drago-Serrano ME, 2012, INT IMMUNOPHARMACOL, V12, P1, DOI 10.1016/j.intimp.2011.11.002; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Geumann C, 2010, ANAL BIOCHEM, V402, P161, DOI 10.1016/j.ab.2010.03.037; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Howe J, 2008, MED CHEM, V4, P520, DOI 10.2174/157340608786242089; Huang JX, 2012, J LIPIDS, V2012, DOI 10.1155/2012/475153; Hurley JC, 2013, TOXINS, V5, P2589, DOI 10.3390/toxins5122589; Jang H, 2009, BMB REP, V42, P462, DOI 10.5483/BMBRep.2009.42.7.462; KACA W, 1994, J BIOL CHEM, V269, P25078; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; Kang Y, 2000, PROCESS BIOCHEM, V36, P85, DOI 10.1016/S0032-9592(00)00182-5; Kellogg TA, 1999, J SURG RES, V85, P136, DOI 10.1006/jsre.1999.5595; Kurasawa T, 1996, FEMS IMMUNOL MED MIC, V13, P293, DOI 10.1111/j.1574-695X.1996.tb00254.x; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; Martin L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00404; Martinez-Sernandez V, 2014, BIO PROTOCOL, V4, pe1298; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; Mukhopadhya A, 2014, FOOD SCI NUTR, V2, P712, DOI 10.1002/fsn3.153; OHNO N, 1989, EUR J BIOCHEM, V186, P629, DOI 10.1111/j.1432-1033.1989.tb15253.x; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Porro M, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P403; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Rodriguez E, 2008, ALLERGY, V63, P219, DOI 10.1111/j.1398-9995.2007.01564.x; Roth RJ, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P389; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Srivastava RM, 2012, J BIOL CHEM, V287, P1980, DOI 10.1074/jbc.M111.302893; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; TAKADA K, 1994, INFECT IMMUN, V62, P1171, DOI 10.1128/IAI.62.4.1171-1175.1994; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; VOGT RF, 1987, J IMMUNOL METHODS, V101, P43, DOI 10.1016/0022-1759(87)90214-6; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391	54	9	9	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156530	10.1371/journal.pone.0156530	http://dx.doi.org/10.1371/journal.pone.0156530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249227	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700050
J	Park, J; Park, JW; Oh, H; Maria, FS; Kang, J; Tian, XC				Park, Joonghoon; Park, Jong Woo; Oh, Hawmok; Maria, Fernanda S.; Kang, Jaeku; Tian, Xiuchun			Gene-Specific Assessment of Guanine Oxidation as an Epigenetic Modulator for Cardiac Specification of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							C-G TRANSVERSIONS; METHYLATION PATTERNS; DNA OXIDATION; 8-OXOGUANINE; CARDIOMYOGENESIS; DIFFERENTIATION; EXPRESSION; BASE; DEMETHYLATION; INHERITANCE	Epigenetics have essential roles in development and human diseases. Compared to the complex histone modifications, epigenetic changes on mammalian DNA are as simple as methylation on cytosine. Guanine, however, can be oxidized as an epigenetic change which can undergo base-pair transversion, causing a genetic difference. Accumulating evidence indicates that reactive oxygen species (ROS) are important signaling molecules for embryonic stem cell (ESC) differentiation, possibly through transient changes on genomic DNA such as 7,8-dihydro-8-oxoguanine (8-oxoG). Technical limitations on detecting such DNA modifications, however, restrict the investigation of the role of 8-oxoG in ESC differentiation. Here, we developed a Hoogsteen base pairing-mediated PCR-sequencing assay to detect 8-oxoG lesions that can subsequently cause G to T transversions during PCR. We then used this assay to assess the epigenetic and transient 8-oxoG formation in the Tbx5 gene of R1 mouse ESCs subjected to oxidative stress by removing 2-mercaptoethanol (2ME) from the culture media. To our surprise, significantly higher numbers of 8-oxoG-mediated G.C to C.G transversion, not G.C to T.A, were detected at 7th and 9th base position from the transcription start site of exon 1 of Tbx5 in ESCs in the (-) 2ME than (+) 2ME group (p < 0.05). This was consistent with the decrease in the amount of amplifiable of DNA harboring the 8-oxoG lesions at the Tbx5 promoter region in the oxidative stressed ESCs. The ESCs responded to oxidative stress, possibly through the epigenetic effects of guanine oxidation with decreased proliferation (p < 0.05) and increased formation of beating embryoid bodies (EBs; p < 0.001). Additionally, the epigenetic changes of guanine induced up-regulation of Ogg1 and PolB, two base excision repairing genes for 8-oxoG, in ESCs treated with (-) 2ME (p < 0.01). Together, we developed a gene-specific and direct quantification assay for guanine oxidation. Using oxidative stressed mouse ESCs, we validated this assay and assessed the epigenetic effects of 8-oxoG by studying expression of DNA repair genes, ESC proliferation, and EB formation.	[Park, Joonghoon; Maria, Fernanda S.; Tian, Xiuchun] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Park, Joonghoon; Maria, Fernanda S.; Tian, Xiuchun] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Park, Jong Woo; Oh, Hawmok] Sungkyunkwan Univ, Sch Pharm, Res Ctr Epigenome Regulat, Suwon 440746, South Korea; [Maria, Fernanda S.] Univ Sao Paulo, Dept Anim Reprod, Coll Vet Med, BR-05508 Sao Paulo, Brazil; [Kang, Jaeku] Konyang Univ, Dept Pharmacol, Coll Med, Daejeon 302718, South Korea; [Park, Joonghoon] LG Life Sci R&D Pk, Daejon 305380, South Korea	University of Connecticut; University of Connecticut; Sungkyunkwan University (SKKU); Universidade de Sao Paulo; Konyang University; Konyang University Hospital	Tian, XC (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.; Tian, XC (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	xiuchun.tian@uconn.edu	Kang, Jaeku/D-4933-2011	Kang, Jaeku/0000-0002-8660-7940	USDA [58-1265-0-040]; Multi-state Research Project [W2171]; Basic Science Research Program through National Research Foundation (NRF) of Korea; Ministry of Education [NRF-2015R1D1A3A01019948]; LG Life Sciences	USDA(United States Department of Agriculture (USDA)); Multi-state Research Project; Basic Science Research Program through National Research Foundation (NRF) of Korea; Ministry of Education; LG Life Sciences	This study was supported by funding from the USDA (58-1265-0-040) and Multi-state Research Project (W2171) to XT, and from the Basic Science Research Program through the National Research Foundation (NRF) of Korea, the Ministry of Education (NRF-2015R1D1A3A01019948), to JK. LG Life Sciences provided support in the form of salaries for authors (JP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bartsch C, 2011, FREE RADICAL BIO MED, V51, P432, DOI 10.1016/j.freeradbiomed.2011.04.029; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; CastroObregon S, 1996, FEBS LETT, V381, P93, DOI 10.1016/0014-5793(96)00088-9; Cheedipudi S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00019; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Clark Tyson A, 2011, Genome Integr, V2, P10, DOI 10.1186/2041-9414-2-10; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Henderson PT, 2002, BIOCHEMISTRY-US, V41, P914, DOI 10.1021/bi0156355; Heo JS, 2011, J CELL BIOCHEM, V112, P1880, DOI 10.1002/jcb.23108; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Inbar-Feigenberg M, 2013, FERTIL STERIL, V99, P607, DOI 10.1016/j.fertnstert.2013.01.117; Jena NR, 2005, J PHYS CHEM B, V109, P14205, DOI 10.1021/jp050646j; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jin J, 2014, MOL MED REP, V10, P761, DOI 10.3892/mmr.2014.2315; Kim C, 2009, CLONING STEM CELLS, V11, P89, DOI 10.1089/clo.2008.0053; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kremer TM, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-16; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; NEGISHI K, 1992, CARCINOGENESIS, V13, P1615, DOI 10.1093/carcin/13.9.1615; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Olinski R, 2007, ACTA BIOCHIM POL, V54, P11, DOI 10.18388/abp.2007_3265; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Sheng W, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-46; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Takimoto K, 1999, MUTAT RES-GEN TOX EN, V445, P93, DOI 10.1016/S1383-5718(99)00138-2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WIGLER MH, 1981, CELL, V24, P285, DOI 10.1016/0092-8674(81)90317-2; Wu M, 2014, CELL RES, V24, P1201, DOI 10.1038/cr.2014.113; Yamamura N, 2012, EXP MOL PATHOL, V93, P35, DOI 10.1016/j.yexmp.2012.03.012; Yan SF, 2014, CURR PHARM DESIGN, V20, P1604, DOI 10.2174/13816128113199990544; Yoshihara M, 2014, DNA RES, V21, P603, DOI 10.1093/dnares/dsu023; Zarakowska E, 2014, MUTAT RES-GEN TOX EN, V764, P58, DOI 10.1016/j.mrgentox.2013.09.002; Zhou LM, 2014, PHARMAZIE, V69, P198, DOI 10.1691/ph.2014.3822	49	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155792	10.1371/journal.pone.0155792	http://dx.doi.org/10.1371/journal.pone.0155792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249188	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700020
J	Shao, PL; Liao, JD; Wong, TW; Wang, YC; Leu, S; Yip, HK				Shao, Pei-Lin; Liao, Jiunn-Der; Wong, Tak-Wah; Wang, Yi-Cheng; Leu, Steve; Yip, Hon-Kan			Enhancement of Wound Healing by Non-Thermal N-2/Ar Micro-Plasma Exposure in Mice with Fractional-CO2-Laser-Induced Wounds	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NITRIC-OXIDE; HUMAN SKIN; REPAIR; STERILIZATION; ANGIOGENESIS; REGENERATION; MECHANISMS; EXPRESSION; MIGRATION	Micro-plasma is a possible alternative treatment for wound management. The effect of micro-plasma on wound healing depends on its composition and temperature. The authors previously developed a capillary-tube-based micro-plasma system that can generate micro-plasma with a high nitric oxide-containing species composition and mild working temperature. Here, the efficacy of micro-plasma treatment on wound healing in a laser-induced skin wound mouse model was investigated. A partial thickness wound was created in the back skin of each mouse and then treated with micro-plasma. Non-invasive methods, namely wound closure kinetics, optical coherence tomography (OCT), and laser Doppler scanning, were used to measure the healing efficiency in the wound area. Neo-tissue growth and the expressions of matrix metallopeptidase-3 (MMP-3) and laminin in the wound area were assessed using histological and immunohistochemistry (IHC) analysis. The results show that micro-plasma treatment promoted wound healing. Micro-plasma treatment significantly reduced the wound bed region. The OCT images and histological analysis indicates more pronounced tissue regrowth in the wound bed region after micro-plasma treatment. The laser Doppler images shows that micro-plasma treatment promoted blood flow in the wound bed region. The IHC results show that the level of laminin increased in the wound bed region after micro-plasma treatment, whereas the level of MMP-3 decreased. Based on these results, micro-plasma has potential to be used to promote the healing of skin wounds clinically.	[Shao, Pei-Lin; Liao, Jiunn-Der; Wang, Yi-Cheng] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan; [Liao, Jiunn-Der] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Wong, Tak-Wah] Natl Cheng Kung Univ, Dept Dermatol, Dept Biochem & Mol Biol, Med Coll & Hosp, Tainan 70101, Taiwan; [Leu, Steve; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung 83301, Taiwan; [Leu, Steve; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Kaohsiung 83301, Taiwan; [Shao, Pei-Lin] Asia Univ, Dept Nursing, Taichung 41354, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Asia University Taiwan	Liao, JD (corresponding author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.	jdliao@mail.ncku.edu.tw	Leu, Steve/D-6807-2011; Sun, Cheuk-Kwan/K-5723-2012	Leu, Steve/0000-0002-1738-1028; 	Ministry of Science and Technology of Taiwan [NSC 101-2321-B-006-012, MOST 103-2622-B-006-010]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (grant number: NSC 101-2321-B-006-012 and MOST 103-2622-B-006-010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283; Beckrich K, 1999, NURS ECON, V17, P263; Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399, DOI 10.1615/CritRevBiomedEng.v37.i4-5.50; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Granger DL, 1996, METHOD ENZYMOL, V268, P142; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Halfmann H, 2007, J PHYS D APPL PHYS, V40, P4145, DOI 10.1088/0022-3727/40/14/008; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hosoya A, 2008, HISTOCHEM CELL BIOL, V130, P1165, DOI 10.1007/s00418-008-0499-3; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanta Jiri, 2011, Acta Medica (Hradec Kralove), V54, P97; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Thi MHN, 2014, PLASMA PROCESS POLYM, V11, P1076, DOI 10.1002/ppap.201400072; Ngo MHT, 2014, PLASMA PROCESS POLYM, V11, P80, DOI 10.1002/ppap.201300098; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Orringer JS, 2004, ARCH DERMATOL, V140, P1326, DOI 10.1001/archderm.140.11.1326; Podoleanu AG, 2000, OPT EXPRESS, V7, P292, DOI 10.1364/OE.7.000292; RIGAL C, 1991, J INVEST DERMATOL, V96, P777, DOI 10.1111/1523-1747.ep12471745; SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523; Schwentker A, 2002, NITRIC OXIDE-BIOL CH, V7, P1, DOI 10.1016/S1089-8603(02)00002-2; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; STANLEY JR, 1981, J INVEST DERMATOL, V77, P240, DOI 10.1111/1523-1747.ep12480082; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tomic-Canic Marjana, 2008, Adv Skin Wound Care, V21, P487, DOI 10.1097/01.ASW.0000323563.59885.1c; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Welzel J, 2001, SKIN RES TECHNOL, V7, P1, DOI 10.1034/j.1600-0846.2001.007001001.x; Weng CC, 2011, INT J RADIAT BIOL, V87, P936, DOI 10.3109/09553002.2011.577503; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Yu Y, 2011, J HUAZHONG U SCI-MED, V31, P390, DOI 10.1007/s11596-011-0387-2; Zheng Z, 2014, WOUND REPAIR REGEN, V22, P660, DOI 10.1111/wrr.12212	45	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156699	10.1371/journal.pone.0156699	http://dx.doi.org/10.1371/journal.pone.0156699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248979	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700068
J	Wu, KY; Chen, CNN; Soong, K				Wu, Kuoyan; Chen, Ching-Nen Nathan; Soong, Keryea			Long Distance Dispersal Potential of Two Seagrasses Thalassia hemprichii and Halophila ovalis	PLOS ONE			English	Article							DECIPIENS OSTENFELD HYDROCHARITACEAE; SEED RESERVE; FRAGMENTS; HABITAT; MARINE; COLONIZATION; MECHANISMS	The wide distribution of many seagrasses may be attributable to exploitation of currents. However, many species have seeds heavier than seawater, limiting surface floating, and thus, deep water becomes a potential barrier between suitable habitats. In this investigation, we studied the dispersal potential of various life history stages of two species of seagrasses, Thalassia hemprichii and Halophila ovalis, at Dongsha Atoll and Penghu Islands in Taiwan Strait, west Pacific. The adult plants of both species, often dislodged naturally from substrate by waves, could float, but only that of T. hemprichii could float for months and still remain alive and potentially able to colonize new territories. The seedlings of T. hemprichii could also float for about a month once failing to anchor to substrate of coral sand, but that of H. ovalis could not. The fruits and seeds of T. hemprichii could both float, but for too short a duration to enable long distance travel; those seeds released from long floating fruits had low germination rates in our tests. Obviously, their seeds are not adaptive for long distance dispersal. Fruits and seeds of H. ovalis do not float. The potential of animals as vectors was tested by feeding fruits and seeds of both species to a goose, a duck, and two fish in the laboratory. The fruits and seeds of T. hemprichii were digested and could no longer germinate; those of H. ovalis could pass through the digestive tracts and have a much higher germination rates than uningested controls. Therefore, birds could be important vectors for long distance dispersal of H. ovalis. The two seagrasses adopted very different dispersal mechanisms for long distance travel, and both exploited traits originally adaptive for other purposes.	[Wu, Kuoyan; Chen, Ching-Nen Nathan; Soong, Keryea] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Chen, Ching-Nen Nathan; Soong, Keryea] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University	Soong, K (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan.; Soong, K (corresponding author), Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan.	keryea@gmail.com			Ministry of Science and Technology, Taiwan [MOST 102-2221E-110-053-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by MOST 102-2221-E-110-053-MY2 to CNC by the Ministry of Science and Technology, Taiwan [www.most.gov.tw]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN JR, 1994, MAR ECOL PROG SER, V103, P119, DOI 10.3354/meps103119; BIRCH WR, 1981, AQUAT BOT, V11, P79, DOI 10.1016/0304-3770(81)90048-6; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Connell J, 1970, DYNAMICS POPULATION; Corlett RT, 2009, BIOTROPICA, V41, P592, DOI 10.1111/j.1744-7429.2009.00503.x; Di Carlo G, 2005, MAR BIOL, V147, P1261, DOI 10.1007/s00227-005-0035-0; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Hall LM, 2006, MAR ECOL PROG SER, V310, P109, DOI 10.3354/meps310109; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Ko C, 2004, TAXONOMIC DISTRIBUT; van Dijk JK, 2009, MAR ECOL PROG SER, V390, P67, DOI 10.3354/meps08190; KUO J, 1992, BOT MAR, V35, P197, DOI 10.1515/botm.1992.35.3.197; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; Lee CL, 2015, MAR ECOL PROG SER, V525, P65, DOI 10.3354/meps11220; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lo L, 2014, INVESTIGATION BREEDI; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; MCMILLAN C, 1988, AQUAT BOT, V31, P177, DOI 10.1016/0304-3770(88)90047-2; MCMILLAN C, 1989, AQUAT BOT, V34, P375, DOI 10.1016/0304-3770(89)90080-6; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; OPDAM P, 1991, LANDSCAPE ECOL, V5, P93, DOI 10.1007/BF00124663; Ostenfeld C, 1908, REP DAN BIOL STN, V16, P1; Royo AA, 2008, CAN J FOREST RES, V38, P1634, DOI 10.1139/X07-247; SCHUETTE JL, 1995, PLANT PHYSIOL, V108, P1251, DOI 10.1104/pp.108.3.1251; SETCHELL WILLIAM ALBERT, 1929, UNIV CALIFORNIA PUBL BOT, V14, P389; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Shie I, 2011, FISH RES I SPECIAL R, V34, P27; Shie I, 2014, FISH RES I SPECIAL R, V45, P24; Soong K, 2013, PLOS ONE, DOI [10.1371/journal.pone0074143, DOI 10.1371/JOURNAL.PONE0074143]; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; Thomson FJ, 2010, J ECOL, V98, P1310, DOI 10.1111/j.1365-2745.2010.01724.x; Wilkinson DM, 1997, J BIOGEOGR, V24, P61, DOI 10.1111/j.1365-2699.1997.tb00050.x; Yamamuro M, 2005, J OCEANOGR, V61, P183, DOI 10.1007/s10872-005-0030-6	42	20	20	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156585	10.1371/journal.pone.0156585	http://dx.doi.org/10.1371/journal.pone.0156585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248695	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700056
J	Lima, MJ; Muir, KR; Docherty, HM; McGowan, NWA; Forbes, S; Heremans, Y; Heimberg, H; Casey, J; Docherty, K				Lima, Maria J.; Muir, Kenneth R.; Docherty, Hilary M.; McGowan, Neil W. A.; Forbes, Shareen; Heremans, Yves; Heimberg, Harry; Casey, John; Docherty, Kevin			Generation of Functional Beta-Like Cells from Human Exocrine Pancreas	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; IN-VITRO EXPANSION; EPITHELIAL-MESENCHYMAL TRANSITION; ISLET-LIKE CLUSTERS; SECRETING CELLS; EFFICIENT DIFFERENTIATION; ACINAR-CELLS; TRANSDIFFERENTIATION; EXPRESSION	Transcription factor mediated lineage reprogramming of human pancreatic exocrine tissue could conceivably provide an unlimited supply of islets for transplantation in the treatment of diabetes. Exocrine tissue can be efficiently reprogrammed to islet-like cells using a cocktail of transcription factors: Pdx1, Ngn3, MafA and Pax4 in combination with growth factors. We show here that overexpression of exogenous Pax4 in combination with suppression of the endogenous transcription factor ARX considerably enhances the production of functional insulin-secreting beta-like cells with concomitant suppression of alpha-cells. The efficiency was further increased by culture on laminin-coated plates in media containing low glucose concentrations. Immunocytochemistry revealed that reprogrammed cultures were composed of similar to 45% islet-like clusters comprising >80% monohormonal insulin(+) cells. The resultant beta-like cells expressed insulin protein levels at similar to 15-30% of that in adult human islets, efficiently processed proinsulin and packaged insulin into secretory granules, exhibited glucose responsive insulin secretion, and had an immediate and prolonged effect in normalising blood glucose levels upon transplantation into diabetic mice. We estimate that approximately 3 billion of these cells would have an immediate therapeutic effect following engraftment in type 1 diabetes patients and that one pancreas would provide sufficient tissue for numerous transplants.	[Lima, Maria J.; Muir, Kenneth R.; Docherty, Hilary M.; Docherty, Kevin] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland; [McGowan, Neil W. A.; Casey, John] Univ Edinburgh, Royal Edinburgh Infirm, Dept Surg, Edinburgh EH16 4SU, Midlothian, Scotland; [Forbes, Shareen] Univ Edinburgh, Endocrinol Unit, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Heremans, Yves; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, B-1090 Brussels, Belgium	University of Aberdeen; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Vrije Universiteit Brussel	Lima, MJ (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	m.lima@abdn.ac.uk	Lima, Maria Joao/HHR-9895-2022; Forbes, Shareen/AAG-1816-2021	Lima, Maria Joao/0000-0003-0597-7892; Forbes, Shareen/0000-0002-9127-0641; Heimberg, Harry/0000-0003-1954-7375	Medical Research Council [MR/J015277/1]; National Services Division of NHS Scotland; Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative [85664]; MRC [MR/J015377/1] Funding Source: UKRI; Medical Research Council [MR/J015377/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Services Division of NHS Scotland; Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medical Research Council MR/J015277/1. The Scottish National Islet Transplant Programme is funded by the National Services Division of NHS Scotland. KRM was funded by a Fellowship from the Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative 85664.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bar Y, 2012, J BIOL CHEM, V287, P17269, DOI 10.1074/jbc.M111.319152; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Corritore E, 2014, CELL REPROGRAM, V16, P456, DOI 10.1089/cell.2014.0025; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Furuya F, 2013, J BIOL CHEM, V288, P16155, DOI 10.1074/jbc.M112.438192; Gage BK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144100; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Koizumi M, 2004, SURGERY, V136, P449, DOI 10.1016/j.surg.2004.05.024; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Lima MJ, 2012, MOL CELL ENDOCRINOL, V358, P69, DOI 10.1016/j.mce.2012.02.024; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, J BIOL CHEM; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; Muir KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140352; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Spijker S, 1997, J BIOL CHEM, V272, P4116, DOI 10.1074/jbc.272.7.4116; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	55	23	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156204	10.1371/journal.pone.0156204	http://dx.doi.org/10.1371/journal.pone.0156204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243814	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100020
J	Sousa, FF; Mendes, SM; Santos-Amaya, OF; Araujo, OG; Oliveira, EE; Pereira, EJG				Sousa, Fernanda F.; Mendes, Simone M.; Santos-Amaya, Oscar F.; Araujo, Octavio G.; Oliveira, Eugenio E.; Pereira, Eliseu J. G.			Life-History Traits of Spodoptera frugiperda Populations Exposed to Low-Dose Bt Maize	PLOS ONE			English	Article							EUROPEAN CORN-BORER; HELIOTHIS-VIRESCENS LEPIDOPTERA; HELICOVERPA-ZEA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS; FALL ARMYWORM; INSECT RESISTANCE; TRANSGENIC COTTON; CRY1F RESISTANCE; NATURAL ENEMIES	Exposure to Bacillus thuringiensis (Bt) toxins in low-and moderate-dose transgenic crops may induce sublethal effects and increase the rate of Bt resistance evolution, potentially compromising control efficacy against target pests. We tested this hypothesis using the fall armyworm Spodoptera frugiperda, a major polyphagous lepidopteran pest relatively tolerant to Bt notorious for evolving field-relevant resistance to single-gene Bt maize. Late-instar larvae were collected from Bt Cry1Ab and non-Bt maize fields in five locations in Brazil, and their offspring was compared for survival, development, and population growth in rearing environment without and with Cry1Ab throughout larval development. Larval survival on Cry1Ab maize leaves varied from 20 to 80% among the populations. Larvae reared on Cry1Ab maize had seven-day delay in development time in relation to control larvae, and such delay was shorter in offspring of armyworms from Cry1Ab maize. Population growth rates were 50-70% lower for insects continuously exposed to Cry1Ab maize relative to controls, showing the population-level effect of Cry1Ab, which varied among the populations and prior exposure to Cry1Ab maize in the field. In three out of five populations, armyworms derived from Bt maize reared on Cry1Ab maize showed higher larval weight, faster larval development and better reproductive performance than the armyworms derived from non-Bt maize, and one of these populations showed better performance on both Cry1Ab and control diets, indicating no fitness cost of the resistance trait. Altogether, these results indicate that offspring of armyworms that developed on field-grown, single-gene Bt Cry1Ab maize had reduced performance on Cry1Ab maize foliage in two populations studied, but in other three populations, these offspring had better overall performance on the Bt maize foliage than that of the armyworms from non-Bt maize fields, possibly because of Cry1Ab resistance alleles in these populations. Implications of these findings for resistance management of S. frugiperda in Bt crops are discussed.	[Sousa, Fernanda F.; Santos-Amaya, Oscar F.; Oliveira, Eugenio E.; Pereira, Eliseu J. G.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Santos-Amaya, Oscar F.; Pereira, Eliseu J. G.] Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, BR-36570900 Vicosa, MG, Brazil; [Mendes, Simone M.; Araujo, Octavio G.] Embrapa Milho & Sorgo, Nucleo Fitossanidade, BR-35701970 Sete Lagoas, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pereira, EJG (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Pereira, EJG (corresponding author), Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, BR-36570900 Vicosa, MG, Brazil.	eliseu.pereira@ufv.br	Pereira, Eliseu José Guedes/C-5365-2015; de Oliveira, Eugênio Eduardo/F-4045-2016; de Oliveira, Eugenio Eduardo/ABE-8935-2021; Amaya, Oscar Fernando Santos/AAO-7338-2020	Pereira, Eliseu José Guedes/0000-0002-8957-6465; de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Amaya, Oscar Fernando Santos/0000-0001-5259-0370; Mendes, Simone/0000-0002-9773-9017	Arthur Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for Research Aid (FAPEMIG); National Council of Scientific and Technological Development (CNPq); CAPES Foundation; Brazilian Ministry of Education	Arthur Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education	The authors are thankful for funds provided by the Arthur Bernardes Foundation (FUNARBE), the Minas Gerais State Foundation for Research Aid (FAPEMIG), the National Council of Scientific and Technological Development (CNPq), and the CAPES Foundation, Brazilian Ministry of Education. They also thank the staff and research assistants at the Brazilian Agricultural Research Corporation, Maize and Sorghum Center (Embrapa Milho & Sorgo), especially those in the Nucleo de Fitossanidade, that hosted and assisted F. F. Sousa in her master thesis research project.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; de Moraes ARA, 2015, BRAGANTIA, V74, P50, DOI 10.1590/1678-4499.0367; Alves Leite N, 2014, B INSECTOL, V67, P265; Andow DA, 2015, J ECON ENTOMOL; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bernardi O, 2015, J ECON ENTOMOL, V108, P2711, DOI 10.1093/jee/tov219; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chen Mao, 2006, Insect Science, V13, P409, DOI 10.1111/j.1744-7917.2006.00110.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Eizaguirre M, 2005, J ECON ENTOMOL, V98, P464, DOI 10.1603/0022-0493-98.2.464; Environmental Protection Agency, 1998, FIFRA SCI ADV PAN M; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Fernandes OD, 2010, REV BRAS MILHO SORGO, V2, P25, DOI DOI 10.18512/1980-6477/RBMS.V2N2P25-35; Frizzas MR, 2014, CIENC RURAL, V44, P203, DOI 10.1590/S0103-84782014000200002; Garcia M, 2015, PEST MANAG SCI, V71, P1631, DOI 10.1002/ps.3971; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Gulzar A, 2015, ECOTOXICOLOGY, V24, P1815, DOI 10.1007/s10646-015-1517-6; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; James C., 2013, GLOBAL STATUS COMMER; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; JOHNSON MT, 1992, ENVIRON ENTOMOL, V21, P586, DOI 10.1093/ee/21.3.586; Kasten P. Jr., 1978, Revista de Agricultura, V53, P68; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Leite NA, 2016, ENTOMOL EXP APPL, V158, P236, DOI 10.1111/eea.12399; Li B, 2015, PEST MANAG SCI, V71, P1433, DOI 10.1002/ps.3948; Liu XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090366; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Lourencao ALF, 2013, CIENTIFICA, V41, P164; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; MACINTOSH SC, 1990, J INVERTEBR PATHOL, V56, P258, DOI 10.1016/0022-2011(90)90109-J; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Mendes SM, 2012, BIOSCI J, V28, P753; Mendes SM, 2011, PESQUI AGROPECU BRAS, V46, P239, DOI 10.1590/S0100-204X2011000300003; Nyouki FFR, 1996, J ENTOMOL SCI, V31, P52, DOI 10.18474/0749-8004-31.1.52; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Onstad DW, 2013, J ECON ENTOMOL, V106, P1103, DOI 10.1603/EC12287; Onstad DW, 2014, INSECT RESISTANCE MA, P1, DOI DOI 10.1016/B978-0-12-396955-2.00001-1; Peck SL, 1999, J ECON ENTOMOL, V92, P1, DOI 10.1093/jee/92.1.1; Pereira EJG, 2011, J APPL ENTOMOL, V135, P17, DOI 10.1111/j.1439-0418.2009.01488.x; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Ritchie S.W, 1992, IOWA STATE U SCI TEC; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; SALAMA HS, 1981, J INVERTEBR PATHOL, V38, P220, DOI 10.1016/0022-2011(81)90126-9; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Santos-Amaya OF, 2016, CROP PROT, V81, P154, DOI 10.1016/j.cropro.2015.12.014; Santos-Amaya OF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18243; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sedaratian A, 2013, J APPL ENTOMOL, V137, P540, DOI 10.1111/jen.12030; Siegfried BD, 2001, ENTOMOL EXP APPL, V100, P15, DOI 10.1023/A:1019250807782; Southwood TRE, 2000, ECOLOGICAL METHODS; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer NP, 2001, J ECON ENTOMOL, V94, P1268, DOI 10.1603/0022-0493-94.5.1268; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Uesugi A, 2015, ECOL ENTOMOL, V40, P221, DOI 10.1111/een.12177; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Waquil JM, 2010, REV BRAS MILHO SORGO, V3, P161; Waquil JM, 2013, PESQUI AGROPECU BRAS, V48, P1529, DOI 10.1590/S0100-204X2013001200001; WESELOH RM, 1983, J INVERTEBR PATHOL, V41, P99, DOI 10.1016/0022-2011(83)90240-9; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x; Zoerb AC, 2003, CROP PROT, V22, P179, DOI 10.1016/S0261-2194(02)00143-6	74	26	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156608	10.1371/journal.pone.0156608	http://dx.doi.org/10.1371/journal.pone.0156608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243977	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100053
J	Bhargava, M; Kandpal, SD; Aggarwal, P; Sati, HC				Bhargava, Madhavi; Kandpal, S. D.; Aggarwal, Pradeep; Sati, Hem Chandra			Overweight and Obesity in School Children of a Hill State in North India: Is the Dichotomy Urban-Rural or Socio-Economic? Results from a Cross-Sectional Survey	PLOS ONE			English	Article							NUTRITION TRANSITION; CHILDHOOD OBESITY; PREVALENCE; ADOLESCENTS; UNDERNUTRITION; BURDEN	Introduction Overweight and obesity are a public health problem in India not only in adults but also in children. The authors sought to estimate the prevalence of overweight and obesity in school-going children of 6-17 years of age and examine its demographic and dietary correlates in context of their urban-rural status and socio-economic status. Methods In this cross-sectional survey height and weight were measured in 1266 school children in government and private schools of urban and rural areas. Dietary assessment was done using single day 24-hour dietary recall method. The data were analyzed using SPSS (IBM SPSS Statistics Version 19) and WHO AnthroPlus Software. Factorial ANOVA was used for testing interaction within and between subgroups for continuous variables and Chi-square test was used for categorical variables. Results It was found that the overall prevalence of overweight was 15.6% of which 5.4% were obese, with maximum prevalence in boys attending urban private schools. The mean caloric intake in the study population with 24-hour dietary recall method was 1558.2 kilocalories (SD: 428 kilocalories). Conclusion Overweight and obesity is a significant problem in school-going children. Higher socio-economic status continues to remain an important driver of this epidemic in the younger generation and affects demographic and dietary determinants of this problem.	[Bhargava, Madhavi] Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangalore, Karnataka, India; [Kandpal, S. D.; Aggarwal, Pradeep] SRH Univ, Himalayan Inst Med Sci, Dept Community Med, Dehra Dun, India; [Sati, Hem Chandra] All India Inst Med Sci, New Delhi, India	Yenepoya (Deemed to be University); All India Institute of Medical Sciences (AIIMS) New Delhi	Bhargava, M (corresponding author), Yenepoya Univ, Dept Community Med, Yenepoya Med Coll, Mangalore, Karnataka, India.	madhavibhargava4@gmail.com	Bhargava, Madhavi Anurag/D-6701-2018; Aggarwal, Pradeep/AAO-7256-2021	Bhargava, Madhavi Anurag/0000-0001-7480-566X; Aggarwal, Pradeep/0000-0003-1415-0483; KANDPAL, S D/0000-0002-6543-2272				Aggarwal T, 2008, INDIAN PEDIATR, V45, P500; Bulbul T, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-86; Chaturvedi S, 1996, Indian Pediatr, V33, P197; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ghosh A, 2011, ASIA-PAC J PUBLIC HE, V23, P928, DOI 10.1177/1010539511428697; Gopalan C, 1989, NUTR VALUE INDIAN FO; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Gupta DK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017221; Hasan HH, 2012, INT RES J PHARM, V3, P226; Hoque ME, 2014, NUTR REV, V72, P541, DOI 10.1111/nure.12130; Hussain M, 2013, MEDICA INNOVATICA, V2, P15; International Institute for Population Sciences (IIPS) and Macro International, 2007, NAT FAM HLTH SURV NF; Jacob SK, 2014, INT J SCI STUDY, V2, P16; Jafar TH, 2008, ARCH DIS CHILD, V93, P373, DOI 10.1136/adc.2007.125641; Kapil Umesh, 2002, Indian Pediatr, V39, P449; Kaur S, 2008, ASIA PAC J CLIN NUTR, V17, P592; Khadilkar VV, 2011, INT J PEDIATR OBES, V6, pE216, DOI 10.3109/17477166.2010.541463; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Midha Tanu, 2011, J Indian Med Assoc, V109, P538; Misra A, 2011, ANN NUTR METAB, V58, P203, DOI 10.1159/000329431; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Organization WH, 2016, GLOBAL STATUS REPORT; Organization WH, 2009, GLOB HLTH RISKS MORT; Pati S, 2014, EPIDEMIOLOGY BIOSTAT, V9, P18; Pauline M, 2012, PUBLIC HEALTH NUTR, V15, P2348, DOI 10.1017/S1368980012000134; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Premanath M, 2010, INDIAN PEDIATR, V47, P171, DOI 10.1007/s13312-010-0027-0; Ramachandran A, 2002, DIABETES RES CLIN PR, V57, P185, DOI 10.1016/S0168-8227(02)00056-6; Sathyamala C, 2014, J CLIN DIAGN RES, V8, pPC6, DOI 10.7860/JCDR/2014/7369.4389; Shah JS, 2013, ANN TROP MED PUBLIC, V6, P408, DOI 10.4103/1755-6783.127775; Shetty PS, 2002, PUBLIC HEALTH NUTR, V5, P175, DOI 10.1079/PHN2001291; Srihari G, 2007, INDIAN PEDIATR, V44, P204; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS	34	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156283	10.1371/journal.pone.0156283	http://dx.doi.org/10.1371/journal.pone.0156283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227780	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500102
J	Brinkmann, BH; Patterson, EE; Vite, C; Vasoli, VM; Crepeau, D; Stead, M; Howbert, JJ; Cherkassky, V; Wagenaar, JB; Litt, B; Worrell, GA				Brinkmann, Benjamin H.; Patterson, Edward E.; Vite, Charles; Vasoli, Vincent M.; Crepeau, Daniel; Stead, Matt; Howbert, J. Jeffry; Cherkassky, Vladimir; Wagenaar, Joost B.; Litt, Brian; Worrell, Gregory A.			Forecasting Seizures Using Bivariate Intracranial EEG Measures and SVM in Naturally Occurring Canine Epilepsy (vol 10, e0133900, 2015)	PLOS ONE			English	Correction														Wagenaar, Joost/0000-0003-0837-7120; Brinkmann, Benjamin/0000-0002-2392-8608	NINDS NIH HHS [U24 NS063930, U01 NS073557] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS063930, U01NS073557] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brinkmann BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133900	1	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156476	10.1371/journal.pone.0156476	http://dx.doi.org/10.1371/journal.pone.0156476			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227650	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500146
J	Foster, GM; Coleman, M; Thomsen, E; Ranson, H; Yangalbe-Kalnone, E; Moundai, T; Kodindo, ID; Nakebang, A; Mahamat, A; Peka, M; Kerah-Hinzoumbe, C				Foster, Geraldine Marie; Coleman, Michael; Thomsen, Edward; Ranson, Hilary; Yangalbe-Kalnone, Elise; Moundai, Tchomfienet; Kodindo, Israel Demba; Nakebang, Amen; Mahamat, Adoum; Peka, Mallaye; Kerah-Hinzoumbe, Clement			Spatial and Temporal Trends in Insecticide Resistance among Malaria Vectors in Chad Highlight the Importance of Continual Monitoring	PLOS ONE			English	Article							ANOPHELES-ARABIENSIS; AREA; IMPLEMENTATION; IDENTIFICATION; TRANSMISSION; MUTATION; KDR	Background A longitudinal Anopheles gambiae s.l. insecticide resistance monitoring programme was established in four sentinel sites in Chad 2008-2010. When this programme ended, only sporadic bioassays were performed in a small number of sites. Methods WHO diagnostic dose assays were used to measure the prevalence of insecticide resistance to 0.1% bendiocarb, 4% DDT, 0.05% deltamethrin, 1% fenitrothion, and 0.75% permethrin in the main malaria vectors at the beginning and end of the malaria transmission season for three years 2008-2010, with subsequent collections in 2011 and 2014. Species and molecular identification of An. gambiae M and S forms and kdr genotyping was performed using PCR-RLFP; circumsporozoite status was assessed using ELISA. Results Between 2008 and 2010, significant changes in insecticide resistance profiles to deltamethrin and permethrin were seen in 2 of the sites. No significant changes were seen in resistance to DDT in any site during the study period. Testing performed after the period of routine monitoring had ended showed dramatic increases to DDT and pyrethroid resistance in 3 sites. No resistance to organophosphate or carbamate insecticides was detected. An. arabiensis was the predominate member of the An. gambiae complex in all 4 sites; adult collections showed temporal variation in species composition in only 1 site. Kdr analysis identified both 1014F and 1014S alleles in An. gambiae S only. Circumsporozoite analysis showed the highest vector infection rates were present in Donia, a site with extensive use of agricultural insecticides. Conclusions During the monitoring gap of four years, significant changes occurred in resistance prevalence in 3 of the 4 sites (p = <0.001), endangering the efficacy of currently implemented malaria control interventions. Significant changes in insecticide resistance profiles and a lack of kdr resistance alleles in adult populations highlight the urgent need for comprehensive entomological monitoring to be implemented and sustained in country.	[Foster, Geraldine Marie; Coleman, Michael; Thomsen, Edward; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Yangalbe-Kalnone, Elise; Moundai, Tchomfienet; Kodindo, Israel Demba; Nakebang, Amen; Kerah-Hinzoumbe, Clement] Programme Natl Lutte Paludisme, Ndjamena, Chad; [Mahamat, Adoum] Minist Sante Publ, Programme Natl Lutte Onchocercose, Ndjamena, Chad; [Peka, Mallaye] Minist Sante Publ, Programme Natl Lutte Trypanosomiase Humaine Afric, Ndjamena, Chad	Liverpool School of Tropical Medicine; University of Liverpool	Ranson, H (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England.	hilary.ranson@lstmed.ac.uk	Thomsen, Edward/AAH-3299-2020	Thomsen, Edward/0000-0003-1136-6430; Coleman, Michael/0000-0003-4186-3526; Ranson, Hilary/0000-0003-2332-8247	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) [AY0588]	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization)	This investigation received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR) (Grant AY0588). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PLAN NAT DEV SAN 2 P; BROWN A W, 1958, Bull World Health Organ, V18, P309; Churcher TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7054; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; ELISSA N, 1993, ANN SOC BELG MED TR, V73, P291; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; HAMON J, 1968, Medecine Tropicale, V28, P521; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Jones CM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-24; Kerah-Hinzoumbe C., 2009, BMC INFECT DIS, V9, P71, DOI DOI 10.1186/1471-2334-9-71; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Labbo R, 2012, MED VET ENTOMOL, V26, P386, DOI 10.1111/j.1365-2915.2012.01011.x; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; PASKEWITZ SM, 1990, MED VET ENTOMOL, V4, P367, DOI 10.1111/j.1365-2915.1990.tb00453.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Thomsen EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099822; Tungu P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-21; Tuschman M, 2013, GLOBAL MALARIA PROGR; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; WHO, 2013, TEST PROC INS RES MA; WIRTZ RA, 1987, J MED ENTOMOL, V24, P433, DOI 10.1093/jmedent/24.4.433; Witzig C, 2013, HEREDITY, V110, P389, DOI 10.1038/hdy.2012.112; Wondji C, 2005, MOL ECOL, V14, P3683, DOI 10.1111/j.1365-294X.2005.02699.x; World Health Organization, 2012, WHO GLOB MAL PROGR G	32	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155746	10.1371/journal.pone.0155746	http://dx.doi.org/10.1371/journal.pone.0155746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228026	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000376882500031
J	Higuchi, T; Endo, M; Hanamura, T; Gohno, T; Niwa, T; Yamaguchi, Y; Horiguchi, J; Hayashi, S				Higuchi, Toru; Endo, Megumi; Hanamura, Toru; Gohno, Tatsuyuki; Niwa, Toshifumi; Yamaguchi, Yuri; Horiguchi, Jun; Hayashi, Shin-ichi			Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer	PLOS ONE			English	Article							ANION-TRANSPORTING POLYPEPTIDES; OVARIAN SUPPRESSION; DEPENDENT GROWTH; MCF-7 CELLS; EXPRESSION; TAMOXIFEN; ANASTROZOLE; RECURRENCE; EXEMESTANE; ADAPTATION	Aromatase inhibitors (AIs) effectively treat hormone receptor-positive postmenopausal breast cancer, but some patients do not respond to treatment or experience recurrence. Mechanisms of AI resistance include ligand-independent activation of the estrogen receptor (ER) and signaling via other growth factor receptors; however, these do not account for all forms of resistance. Here we present an alternative mechanism of AI resistance. We ectopically expressed aromatase in MCF-7 cells expressing green fluorescent protein as an index of ER activity. Aromatase-overexpressing MCF-7 cells were cultured in estrogen-depleted medium supplemented with testosterone and the AI, letrozole, to establish letrozole-resistant (LR) cell lines. Compared with parental cells, LR cells had higher mRNA levels of steroid sulfatase (STS), which converts estrone sulfate (E1S) to estrone, and the organic anion transporter peptides (OATPs), which mediate the uptake of E1S into cells. LR cells proliferated more in E1S-supplemented medium than did parental cells, and LR proliferation was effectively inhibited by an STS inhibitor in combination with letrozole and by ER-targeting drugs. Analysis of ER-positive primary breast cancer tissues showed a significant correlation between the increases in the mRNA levels of STS and the OATPs in the LR cell lines, which supports the validity of this AI-resistant model. This is the first study to demonstrate the contribution of STS and OATPs in E1S metabolism to the proliferation of AI-resistant breast cancer cells. We suggest that E1S metabolism represents a new target in AI-resistant breast cancer treatment.	[Higuchi, Toru; Endo, Megumi; Hanamura, Toru; Gohno, Tatsuyuki; Niwa, Toshifumi; Hayashi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan; [Higuchi, Toru; Horiguchi, Jun] Gunma Univ, Grad Sch Med, Dept Visceral & Thorac Organ Surg, Maebashi, Gunma 371, Japan; [Hanamura, Toru] Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano 390, Japan; [Yamaguchi, Yuri] Saitama Canc Ctr, Res Inst Clin Oncol, 818 Komuro, Ina, Saitama 3620806, Japan; [Hayashi, Shin-ichi] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epi Genome & Dis, Sendai, Niyagi 980, Japan	Tohoku University; Gunma University; Shinshu University; Tohoku University	Hayashi, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol & Funct Dynam, Sendai, Miyagi 980, Japan.; Hayashi, S (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epi Genome & Dis, Sendai, Niyagi 980, Japan.	shin@med.tohoku.ac.jp	Hanamura, Toru/AAE-5184-2020	Hanamura, Toru/0000-0002-6934-8588; Niwa, Toshifumi/0000-0002-9580-9042	Ministry of Education, Culture, Sports, Science and Technology, Japan [23591344]; Ministry of Health, Labor and Welfare, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (23591344, https://kaken.nii.ac.jp); a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan (http://www.mhlw.go.jp); and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (http://www.nibio.go.jp/information/).	Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Banerjee M, 2015, DRUG DISCOV TODAY, V20, P618, DOI 10.1016/j.drudis.2014.11.011; Banerjee N, 2014, BREAST CANCER RES TR, V145, P647, DOI 10.1007/s10549-014-2990-y; Banerjee N, 2012, J PHARMACOL EXP THER, V342, P510, DOI 10.1124/jpet.112.192344; Barone I, 2009, CANCER RES, V69, P4724, DOI 10.1158/0008-5472.CAN-08-4194; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Becker MA, 2011, MOL ENDOCRINOL, V25, P516, DOI 10.1210/me.2010-0373; Bogina G, 2011, VIRCHOWS ARCH, V459, P1, DOI 10.1007/s00428-011-1097-7; Coombes RC, 2013, BREAST CANC RES TREA; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; De Amicis F, 2010, BREAST CANCER RES TR, V121, P1, DOI 10.1007/s10549-009-0436-8; Doyle LA, 1999, P NATL ACAD SCI USA, V96, P2569; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Fujii R, 2014, J STEROID BIOCHEM, V144, P513, DOI 10.1016/j.jsbmb.2014.08.019; Fujiki N, 2014, J STEROID BIOCHEM, V139, P61, DOI 10.1016/j.jsbmb.2013.08.012; Hagenbuch B, 2003, BBA-BIOMEMBRANES, V1609, P1, DOI 10.1016/S0005-2736(02)00633-8; Hamidovic Alma, 2010, J Oncol Pharm Pract, V16, P39, DOI 10.1177/1078155209104380; Hanamura T, 2013, BREAST CANCER RES TR, V139, P731, DOI 10.1007/s10549-013-2595-x; Ishida H, 2007, BREAST CANCER RES TR, V106, P215, DOI 10.1007/s10549-007-9495-x; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Johnston SRD, 2006, CLIN CANCER RES, V12, p1061S, DOI 10.1158/1078-0432.CCR-05-2125; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lamba JK, 2002, ADV DRUG DELIVER REV, V54, P1271, DOI 10.1016/S0169-409X(02)00066-2; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Matsumoto M, 2008, ENDOCR-RELAT CANCER, V15, P451, DOI 10.1677/ERC-07-0227; Miki Y, 2006, CANCER RES, V66, P535, DOI 10.1158/0008-5472.CAN-05-1070; Miyoshi Y, 2003, CLIN CANCER RES, V9, P2288; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; O'Hara J, 2012, CLIN CANCER RES, V18, P3305, DOI 10.1158/1078-0432.CCR-11-3300; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Pagani O, 2014, NEW ENGL J MED, V371, P107, DOI 10.1056/NEJMoa1404037; Pasqualini JR, 1980, BREAST CANC RES TREA, V8, P233; Poirier D, 2011, J STEROID BIOCHEM, V125, P83, DOI 10.1016/j.jsbmb.2010.12.007; PROST O, 1984, CANCER RES, V44, P661; Purohit A, 2000, CANCER RES, V60, P3394; Rasmussen LM, 2007, BREAST CANCER RES TR, V106, P191, DOI 10.1007/s10549-007-9494-y; Sabnis GJ, 2013, BREAST CANCER RES TR, V138, P699, DOI 10.1007/s10549-013-2474-5; Santen RJ, 2008, ADV EXP MED BIOL, V630, P19; SANTNER SJ, 1984, J CLIN ENDOCR METAB, V59, P29, DOI 10.1210/jcem-59-1-29; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Takagi K, 2010, ENDOCR-RELAT CANCER, V17, P415, DOI 10.1677/ERC-09-0257; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Utsumi T, 1999, CANCER RES, V59, P377; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; VIGNON F, 1980, ENDOCRINOLOGY, V106, P1079, DOI 10.1210/endo-106-4-1079; Wlcek K, 2008, CANCER BIOL THER, V7, P1452, DOI 10.4161/cbt.7.9.6282; Yamaguchi Y, 2005, CANCER RES, V65, P4653, DOI 10.1158/0008-5472.CAN-04-3236	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155844	10.1371/journal.pone.0155844	http://dx.doi.org/10.1371/journal.pone.0155844			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228187	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500036
J	Moukandja, IP; Essone, JCBB; Sagara, I; Kassa, RFK; Ondzaga, J; Douki, JBL; Akotet, MB; Mba, DN; Ndouo, FST				Moukandja, Irsne Pegha; Essone, Jean Claude Biteghe Bi; Sagara, Issaka; Kassa, Roland Fabrice Kassa; Ondzaga, Julien; Douki, Jean-Bernard Lekana; Akotet, Marielle Bouyou; Mba, Dieudonne Nkoghe; Ndouo, Fousseyni S. Toure			Marked Rise in the Prevalence of Asymptomatic Plasmodium falciparum Infection in Rural Gabon	PLOS ONE			English	Article							MALARIA TRANSMISSION; SRI-LANKA; CHILDREN; SCHOOLCHILDREN; ANEMIA; IMPACT; PARASITEMIA; BURDEN; ATTACK; WOMEN	Control strategies implemented a decade ago led to a marked reduction in the prevalence of malaria in many countries. In Dienga, southeastern Gabon, the prevalence of microscopic P. falciparum infection was 7% in 2003, close to the pre-elimination threshold of 5%. The aim of this work was to determine the prevalence of P. falciparum infection in the same community a decade later. A cohort of 370 individuals aged from 3 to 85 years living in Dienga was investigated for P. falciparum infection; during six passages (P) in 15-month period. Demographic data were collected, along with behaviors and attitudes towards malaria. Plasmodium infection was diagnosed by microscopy (ME), followed by PCR to detect submicroscopic infection. The prevalence of P. falciparum infection in P1, P2, P3, P4, P5 and P6 was respectively 43.5%(25.1% ME+, 18.4% PCR+); 40.9%(27.0% ME+, 13.9% PCR+), 52.7%(26.1% ME+, 26.6% PCR+); 34.1%(14.1% ME+, 20% PCR+), 57.7%(25.4.% ME+, 32.3% PCR+); and 46.2%(21.4% ME+, 24.8% PCR+) with an overall average of 45.9%(95% CI [37.0-54.7], 23.2% ME+ and 22.7% PCR+). P4 and P5 prevalences were statically different throughout the six passages. Microscopic prevalence was significantly higher than that observed ten years ago (23% [n = 370] vs 7%[n = 323], p < 0.001). Asymptomatic infections were the most frequent (96%). Gametocytes were detected in levels ranging from 5.9% to 13.9%. Insecticide-treated nets, indoor residual insecticides, and self-medication were used by respectively 33.2%(95% CI [29.0-37.4]), 17.7%(95% CI [15.5-19.9]) and 12.1%(95% CI [10.6-13.6]) of the study population. A near-threefold increase in P. falciparum infection has been observed in a rural area of southeastern Gabon during a 10-year period. Most infections were asymptomatic, but these subjects likely represent a parasite reservoir. These findings call for urgent reinforcement of preventive measures.	[Moukandja, Irsne Pegha; Essone, Jean Claude Biteghe Bi; Kassa, Roland Fabrice Kassa; Ondzaga, Julien; Douki, Jean-Bernard Lekana; Mba, Dieudonne Nkoghe; Ndouo, Fousseyni S. Toure] CIRMF, BP 769, Franceville, Gabon; [Moukandja, Irsne Pegha; Essone, Jean Claude Biteghe Bi; Douki, Jean-Bernard Lekana] Ecole Doctorale Reg EDR Infectiol Trop, BP 876, Franceville, Gabon; [Douki, Jean-Bernard Lekana; Akotet, Marielle Bouyou] Univ Sci Sante, Fac Med, Dept Parasitol Mycol Med Trop, BP 4009, Libreville, Gabon; [Sagara, Issaka] Univ Bamako, Fac Med & Odontostomatol, MRTC, Dept Epidemiol & Affect Parasitaires, BP 1805, Bamako, Mali; [Ndouo, Fousseyni S. Toure] CIRMF, UPARAM, BP 769, Franceville, Gabon	University of Bamako	Ndouo, FST (corresponding author), CIRMF, BP 769, Franceville, Gabon.; Ndouo, FST (corresponding author), CIRMF, UPARAM, BP 769, Franceville, Gabon.	fousseyni@yahoo.fr			Centre International de Recherches Medicale de Franceville	Centre International de Recherches Medicale de Franceville	The study was funded by Centre International de Recherches Medicale de Franceville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina Oluwagbemiga O, 2013, Malar Res Treat, V2013, P487250, DOI 10.1155/2013/487250; Al Serouri AW, 2000, PARASITOLOGY, V121, P337, DOI 10.1017/S0031182099006502; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Bi Essone BAI Jean Claude Biteghe, 2014, IJAR, V2, P117; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Boudin C, 2003, Bull Soc Pathol Exot, V96, P335; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Bouyou-Akotet MK, 2013, J INFECT DEV COUNTR, V7, P983, DOI 10.3855/jidc.3347; Bouyou-Akotet MK, 2010, AM J TROP MED HYG, V82, P202, DOI 10.4269/ajtmh.2010.09-0267; Bouyou-Akotet MK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-52; Bouyou-Akotet Marielle Karine, 2011, Sante, V21, P199, DOI 10.1684/san.2011.0266; Bouyou-Akotet MK, 2010, J ANTIMICROB CHEMOTH, V65, P438, DOI 10.1093/jac/dkp467; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-300; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Emilio V, 2014, MALARIA CLIN PRESENT; Fabrice Kassa Roland, 2014, J LIFE SCI; Fernando D, 2003, T ROY SOC TROP MED H, V97, P633, DOI 10.1016/S0035-9203(03)80093-7; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P479, DOI 10.4269/ajtmh.1991.45.479; Giha HA, 2005, MICROBES INFECT, V7, P1196, DOI 10.1016/j.micinf.2005.04.004; Gonzalez MA, 2000, B WORLD HEALTH ORGAN, V78, P97; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Kurtzhals JAL, 1999, T ROY SOC TROP MED H, V93, P623, DOI 10.1016/S0035-9203(99)90073-1; Le Port A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-193; Lekana-Douki Jean-Bernard, 2011, Sante, V21, P193, DOI 10.1684/san.2011.0263; Mawili-Mboumba DP, 2014, ACTA TROP, V134, P29, DOI 10.1016/j.actatropica.2014.01.007; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-375; Mawili-Mboumba DP, 2010, DIAGN MICR INFEC DIS, V66, P162, DOI 10.1016/j.diagmicrobio.2009.09.011; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Mourou JR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-321; Noland GS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-168; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Robert V., 2003, Bulletin de la Societe de Pathologie Exotique, V96, P6; Stresman GH, 2014, AM J TROP MED HYG, V91, P1101, DOI 10.4269/ajtmh.14-0355; Thomas CJ, 2000, T ROY SOC TROP MED H, V94, P159, DOI 10.1016/S0035-9203(00)90257-8; Toure FS, 2006, CLIN MED RES, V4, P175, DOI [10.3121/cmr.4.3.175, 10.3121/cmr.4.1.1]; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2008, WORLD MALARIA REPORT; Yimer F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0749-5; Zang-Edou ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013221	50	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0153899	10.1371/journal.pone.0153899	http://dx.doi.org/10.1371/journal.pone.0153899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228058	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500002
J	Stevanovic, A; Rossaint, R; Veldeman, M; Bilotta, F; Coburn, M				Stevanovic, Ana; Rossaint, Rolf; Veldeman, Michael; Bilotta, Federico; Coburn, Mark			Anaesthesia Management for Awake Craniotomy: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							BRAIN-TUMOR PATIENTS; GENERAL-ANESTHESIA; ELOQUENT CORTEX; INTRAOPERATIVE SEIZURES; POSTOPERATIVE NAUSEA; BISPECTRAL INDEX; LOCAL-ANESTHESIA; DUPLICATE PUBLICATION; CONSCIOUS SEDATION; SCALP BLOCK	Background Awake craniotomy (AC) renders an expanded role in functional neurosurgery. Yet, evidence for optimal anaesthesia management remains limited. We aimed to summarise the latest clinical evidence of AC anaesthesia management and explore the relationship of AC failures on the used anaesthesia techniques. Methods Two authors performed independently a systematic search of English articles in PubMed and EMBASE database 1/2007-12/2015. Search included randomised controlled trials (RCTs), observational trials, and case reports (n>4 cases), which reported anaesthetic approach for AC and at least one of our pre-specified outcomes: intraoperative seizures, hypoxia, arterial hypertension, nausea and vomiting, neurological dysfunction, conversion into general anaesthesia and failure of AC. Random effects meta-analysis was used to estimate event rates for four outcomes. Relationship with anaesthesia technique was explored using logistic meta-regression, calculating the odds ratios (OR) and 95% confidence intervals [95%CI]. Results We have included forty-seven studies. Eighteen reported asleep-awake-asleep technique (SAS), twenty-seven monitored anaesthesia care (MAC), one reported both and one used the awake-awake-awake technique (AAA). Proportions of AC failures, intraoperative seizures, new neurological dysfunction and conversion into general anaesthesia (GA) were 2% [95%CI: 1-3], 8% [95%CI: 6-11], 17% [95%CI: 12-23] and 2% [95%CI: 2-3], respectively. Meta-regression of SAS and MAC technique did not reveal any relevant differences between outcomes explained by the technique, except for conversion into GA. Estimated OR comparing SAS to MAC for AC failures was 0.98 [95%CI: 0.36-2.69], 1.01 [95%CI: 0.52-1.88] for seizures, 1.66 [95%CI: 1.35-3.70] for new neurological dysfunction and 2.17 [95%CI: 1.22-3.85] for conversion into GA. The latter result has to be interpreted cautiously. It is based on one retrospective high-risk of bias study and significance was abolished in a sensitivity analysis of only prospectively conducted studies. Conclusion SAS and MAC techniques were feasible and safe, whereas data for AAA technique are limited. Large RCTs are required to prove superiority of one anaesthetic regime for AC.	[Stevanovic, Ana; Rossaint, Rolf; Veldeman, Michael; Coburn, Mark] Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, D-52062 Aachen, Germany; [Veldeman, Michael] Rhein Westfal TH Aachen, Univ Hosp, Dept Neurosurg, D-52062 Aachen, Germany; [Bilotta, Federico] Univ Roma La Sapienza, Dept Anaesthesiol Crit Care & Pain Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Sapienza University Rome	Coburn, M (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, D-52062 Aachen, Germany.	mcoburn@ukaachen.de	Veldeman, Michael/ABH-2816-2020	Veldeman, Michael/0000-0003-3648-6842; Kowark, Ana/0000-0002-7433-8675				Abdou SA, 2010, EGYPT J ANAESTH, V26, P293, DOI 10.1016/j.egja.2010.05.005; Ali MZ, 2009, NEUROSCIENCES, V14, P263; Andersen JH, 2010, DAN MED BULL, V57; Beez T, 2013, ACTA NEUROCHIR, V155, P1301, DOI 10.1007/s00701-013-1759-0; Bekker AY, 2001, ANESTH ANALG, V92, P1251; Bilotta F, 2014, BRIT J NEUROSURG, V28, P363, DOI 10.3109/02688697.2013.854313; Bilotta F, 2013, J CLIN ANESTH, V25, P359, DOI 10.1016/j.jclinane.2013.01.012; Bilotta F, 2009, CURR OPIN ANESTHESIO, V22, P560, DOI 10.1097/ACO.0b013e3283302339; Boetto J, 2015, WORLD NEUROSURG, V84, P1838, DOI 10.1016/j.wneu.2015.07.075; Brown T, 2013, J NEUROSURG ANESTH, V25, P240, DOI 10.1097/ANA.0b013e318290c230; Cai TL, 2013, BRIT J NEUROSURG, V27, P396, DOI 10.3109/02688697.2012.743969; Carrabba G, 2008, MINIM INVAS NEUROSUR, V51, P208, DOI 10.1055/s-2008-1073132; Caulo M, 2007, AM J NEURORADIOL, V28, P1480, DOI 10.3174/ajnr.A0597; Chacko AG, 2013, CLIN NEUROL NEUROSUR, V115, P329, DOI 10.1016/j.clineuro.2012.10.022; Chaki T, 2014, J NEUROSURG ANESTHES; Computing S, 1991, COMP S; Conte V, 2013, J NEUROSURG ANESTH, V25, P279, DOI 10.1097/ANA.0b013e3182913afd; Dahyot-Fizelier C, 2012, Ann Fr Anesth Reanim, V31, pe229, DOI 10.1016/j.annfar.2012.08.003; De Sloovere V, 2009, EUR J ANAESTH, V26, P443, DOI 10.1097/EJA.0b013e32831bc70c; Deeks J J, 2003, Health Technol Assess, V7, piii; Deras P, 2012, NEUROSURGERY, V71, P764, DOI 10.1227/NEU.0b013e3182647ab8; Fabling JM, 2000, ANESTH ANALG, V91, P358, DOI 10.1097/00000539-200008000-00023; Garavaglia MM, 2014, J NEUROSURG ANESTH, V26, P226, DOI 10.1097/ANA.0b013e3182a58aba; Ghisi D, 2005, Minerva Anestesiol, V71, P533; Gonen T, 2014, J NEUROSURG, V121, P1133, DOI 10.3171/2014.7.JNS132657; Grossman R, 2007, ISRAEL MED ASSOC J, V9, P380; Grossman R, 2013, ANN SURG ONCOL, V20, P1722, DOI 10.1245/s10434-012-2748-x; Guilfoyle MR, 2013, ANESTH ANALG, V116, P1093, DOI 10.1213/ANE.0b013e3182863c22; Gupta DK, 2007, CLIN NEUROL NEUROSUR, V109, P335, DOI 10.1016/j.clineuro.2007.01.008; Hansen E, 2013, ACTA NEUROCHIR, V155, P1417, DOI 10.1007/s00701-013-1801-2; Hervey-Jumper SL, 2015, J NEUROSURG, V123, P325, DOI 10.3171/2014.10.JNS141520; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ilmberger J, 2008, J NEUROSURG, V109, P583, DOI 10.3171/JNS/2008/109/10/0583; Jadavji-Mithani R, 2015, CAN J NEUROL SCI, V42, P7, DOI 10.1017/cjn.2014.127; July J, 2009, SURG NEUROL, V71, P621, DOI 10.1016/j.surneu.2007.12.022; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Li TD, 2015, EXP THER MED, V9, P1962, DOI 10.3892/etm.2015.2359; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lobo F, 2007, J NEUROSURG ANESTH, V19, P183, DOI 10.1097/ANA.0b013e31805f66ad; Low D, 2007, ANN ACAD MED SINGAP, V36, P326; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; McNicholas E, 2014, A A CASE REP, V2, P40, DOI 10.1097/ACC.0b013e3182a8ee71; Pereira LCM, 2009, ACTA NEUROCHIR, V151, P1215, DOI 10.1007/s00701-009-0363-9; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Nossek E, 2013, NEUROSURGERY, V73, P135, DOI 10.1227/01.neu.0000429847.91707.97; Nossek E, 2013, J NEUROSURG, V118, P243, DOI 10.3171/2012.10.JNS12511; de Amorim RLO, 2008, ARQ NEURO-PSIQUIAT, V66, P534, DOI 10.1590/S0004-282X2008000400018; Olsen KS, 2008, EUR J ANAESTH, V25, P662, DOI 10.1017/S0265021508003633; Osborn I, 2010, J NEUROSURG ANESTH, V22, P187, DOI 10.1097/ANA.0b013e3181d48846; Ott C, 2014, NEUROSURGERY, V75, P117, DOI 10.1227/NEU.0000000000000359; Ouyang MW, 2013, CURR MED RES OPIN, V29, P1033, DOI 10.1185/03007995.2013.811071; Ouyang MW, 2013, CURR MED RES OPIN, V29, P1039, DOI 10.1185/03007995.2013.811070; Pemberton PL, 2002, ANAESTHESIA, V57, P1244; Peruzzi P, 2011, J NEUROSURG, V114, P633, DOI 10.3171/2010.5.JNS1041; Pinsker MO, 2007, MINIM INVAS NEUROSUR, V50, P281, DOI 10.1055/s-2007-985825; Rajan S, 2013, J CLIN NEUROSCI, V20, P1068, DOI 10.1016/j.jocn.2012.09.031; Rughani AI, 2011, J NEUROSURG ANESTH, V23, P18, DOI 10.1097/ANA.0b013e3181ebf050; Sacko O, 2011, NEUROSURGERY, V68, P1192, DOI 10.1227/NEU.0b013e31820c02a3; Sanai N, 2008, NEW ENGL J MED, V358, P18, DOI 10.1056/NEJMoa067819; Sanus GZ, 2015, TURK NEUROSURG, V25, P210, DOI 10.5137/1019-5149.JTN.8176-13.1; Sartorius CJ, 1998, J NEUROSURG, V88, P349, DOI 10.3171/jns.1998.88.2.0349; Sartorius CJ, 1997, SURG NEUROL, V47, P380, DOI 10.1016/S0090-3019(96)00340-0; See JJ, 2007, ANN ACAD MED SINGAP, V36, P319; Serletis D, 2007, J NEUROSURG, V107, P1, DOI 10.3171/JNS-07/07/0001; Shen SL, 2013, ANN PHARMACOTHER, V47, P1391, DOI 10.1177/1060028013504082; Shinoura Nobusada, 2013, Surg Neurol Int, V4, P149, DOI 10.4103/2152-7806.122003; Sinha PK, 2007, NEUROL INDIA, V55, P376, DOI 10.4103/0028-3886.33308; Sokhal N, 2015, INDIAN J ANAESTH, V59, P300, DOI 10.4103/0019-5049.156878; Souter MJ, 2007, J NEUROSURG ANESTH, V19, P38, DOI 10.1097/01.ana.0000211027.26550.24; Surbeck W, 2015, ACTA NEUROCHIR, V157, P77, DOI 10.1007/s00701-014-2249-8; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Viswanathan M, 2013, AHRQ METHODS EFFECTI; von Elm E, 2004, JAMA-J AM MED ASSOC, V291, P974, DOI 10.1001/jama.291.8.974; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wood J, 2008, ORG RES METHODS; Wrede KH, 2011, CLIN NEUROL NEUROSUR, V113, P880, DOI 10.1016/j.clineuro.2011.06.010; Yamaguchi S, 2012, JPN J CLIN ONCOL, V42, P270, DOI 10.1093/jjco/hys016; Zhang Z, 2008, CHINESE MED J-PEKING, V121, P1800, DOI 10.1097/00029330-200809020-00009	80	61	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156448	10.1371/journal.pone.0156448	http://dx.doi.org/10.1371/journal.pone.0156448			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228013	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500137
J	Zhang, YY; Zhou, YL; Li, SX; Yang, DH; Wu, XL; Chen, ZM				Zhang, Yuanyuan; Zhou, Yunlian; Li, Shuxian; Yang, Dehua; Wu, Xiling; Chen, Zhimin			The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children	PLOS ONE			English	Article							LACTATE-DEHYDROGENASE; MACROLIDE-RESISTANT; INFECTION; CYTOKINES; EPIDEMIOLOGY; PREDNISOLONE	Objective To analyze the clinical characteristics of refracory Mycoplasma pneumoniae pneumonia (RMPP), and explore the related factors predicting RMPP. Methods Retrospective analysis was performed on 634 children with Mycoplasma pneumoniae pneumonia (MPP) hospitalized in our hospital between January 1, 2011 and December 31, 2014. The clinical features, laboratory data, radiological findings between the RMPP group and the general Mycoplasma pneumoniae pneumonia (GMPP) group were compared and the predictive values of related factors were analyzed. Results The median age of the RMPP patients (n = 145) was much older than that of the GMPP patients (n = 489) (P<0.01). We also found more severe presentations, higher incidence of extra-pulmonary complications and more serious radiological findings in RMPP group, which needed oxygen more often, longer antibiotics administration and intensive care (P<0.05). Meanwhile, the levels of C-reactive protein (CRP), lactic dehydrogenase (LDH), immunoglobulin A (IgM), interleukin (IL)-6, IL-10, interferon gamma (IFN-gamma) and the percentage of neutrophils, CD8+ in RMPP group were significantly higher than those in GMPP group (P<0.05); while the levels of prealbumin (PAB) were lower than that in GMPP group (P<0.01). In ROC curve analysis, the percentage of neutrophil, CRP, LDH, PAB, IL-6, IL-10 and IFN-gamma were useful for differentiating patients with RMPP from those with GMPP. Multiple logistic regression analysis showed that the CRP >= 16.5mg/L, LDH >= 417IU/L and IL-6 >= 14.75pg/ml were significant predictors regarding to RMPP. Conclusions CRP >= 16.5mg/L, LDH >= 417IU/L and IL-6 >= 14.75pg/ml might be the significant predictors of RMPP in children, which can aid in early recognition of RMPP.	[Zhang, Yuanyuan; Zhou, Yunlian; Li, Shuxian; Yang, Dehua; Wu, Xiling; Chen, Zhimin] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Chen, ZM (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Pulmonol, Hangzhou 310003, Zhejiang, Peoples R China.	drchenzm@163.com	zhang, yuanyuan/GYA-4428-2022		National Natural Science Foundation [81200022, 81401301, 81501374]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation (81200022, 81401301, 81501374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumagawa K, 2008, PEDIATR INT, V50, P511, DOI 10.1111/j.1442-200X.2008.02622.x; Cao B, 2010, CLIN INFECT DIS, V51, P189, DOI 10.1086/653535; Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022; Drent M, 1996, EUR RESPIR J, V9, P1736, DOI 10.1183/09031936.96.09081736; FERNALD GW, 1983, YALE J BIOL MED, V56, P475; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Hawkins S, 2011, CURR OPIN PEDIATR, V23, P126, DOI 10.1097/MOP.0b013e328341579c; Inamura N, 2014, J INFECT CHEMOTHER, V20, P270, DOI 10.1016/j.jiac.2014.01.001; Khan FY, 2009, BRAZ J INFECT DIS, V13, P77, DOI 10.1590/S1413-86702009000100018; Kim CK, 2001, CHEST, V120, P1101, DOI 10.1378/chest.120.4.1101; Lee KY, 2006, PEDIATR PULM, V41, P263, DOI 10.1002/ppul.20374; Liu Jin-rong, 2012, Zhonghua Er Ke Za Zhi, V50, P915; Luo ZX, 2014, PEDIATR PULM, V49, P377, DOI 10.1002/ppul.22752; Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701; Nakajima M, 2000, INTERNAL MED, V39, P1097, DOI 10.2169/internalmedicine.39.1097; Narita M, 2007, PEDIATR PULM, V42, P397, DOI 10.1002/ppul.20445; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Oishi T, 2011, J INFECT CHEMOTHER, V17, P803, DOI 10.1007/s10156-011-0265-7; Radisic M, 2000, CLIN INFECT DIS, V31, P1507, DOI 10.1086/317498; Sekine H, 2009, J MED MICROBIOL, V58, P697, DOI 10.1099/jmm.0.007872-0; Socan M, 2001, CLIN INFECT DIS, V32, pE31, DOI 10.1086/318446; Subspecialty Group of Respiratory Diseases The Society of Pediatrics Chinese Medical Association, 2013, Zhonghua Er Ke Za Zhi, V51, P745; Suzuki S, 2006, ANTIMICROB AGENTS CH, V50, P709, DOI 10.1128/AAC.50.2.709-712.2006; Takiguchi Y, 2001, INTERNAL MED, V40, P345, DOI 10.2169/internalmedicine.40.345; Tamura A, 2008, J INFECTION, V57, P223, DOI 10.1016/j.jinf.2008.06.012; Tan TQ, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.1.1; Tanaka H, 2002, CHEST, V121, P1493, DOI 10.1378/chest.121.5.1493; Uehara S, 2011, PEDIATR INT, V53, P264, DOI 10.1111/j.1442-200X.2010.03316.x; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Waitest KB, 2008, FUTURE MICROBIOL, V3, P635, DOI 10.2217/17460913.3.6.635; Wang MJ, 2014, INT J INFECT DIS, V29, P18, DOI 10.1016/j.ijid.2014.07.020; Wang RS, 2004, PEDIATR INFECT DIS J, V23, P564, DOI 10.1097/01.inf.0000130074.56368.4b; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; Zhou YL, 2014, ANTIMICROB AGENTS CH, V58, P1034, DOI 10.1128/AAC.01806-13	35	82	105	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156465	10.1371/journal.pone.0156465	http://dx.doi.org/10.1371/journal.pone.0156465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227519	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500145
J	Angrisano, T; Pero, R; Brancaccio, M; Coretti, L; Florio, E; Pezone, A; Calabro, V; Falco, G; Keller, S; Lembo, F; Avvedimento, VE; Chiariotti, L				Angrisano, Tiziana; Pero, Raffaela; Brancaccio, Mariarita; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Calabro, Viola; Falco, Geppino; Keller, Simona; Lembo, Francesca; Avvedimento, Vittorio Enrico; Chiariotti, Lorenzo			Cyclical DNA Methylation and Histone Changes Are Induced by LPS to Activate COX-2 in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							CYCLOOXYGENASE-2 GENE-EXPRESSION; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; UP-REGULATION; COLON-CANCER; CHROMATIN; PATTERNS; PROSTAGLANDINS; INFECTIONS; PREVENTION	Bacterial lipopolysaccharide (LPS) induces release of inflammatory mediators both in immune and epithelial cells. We investigated whether changes of epigenetic marks, including selected histone modification and DNA methylation, may drive or accompany the activation of COX-2 gene in HT-29 human intestinal epithelial cells upon exposure to LPS. Here we describe cyclical histone acetylation (H3), methylation (H3K4, H3K9, H3K27) and DNA methylation changes occurring at COX-2 gene promoter overtime after LPS stimulation. Histone K27 methylation changes are carried out by the H3 demethylase JMJD3 and are essential for COX-2 induction by LPS. The changes of the histone code are associated with cyclical methylation signatures at the promoter and gene body of COX-2 gene.	[Angrisano, Tiziana; Calabro, Viola; Falco, Geppino] Univ Naples Federico II, Dipartimento Biol, Monte St Angelo Via Cintia 21, I-80126 Naples, Italy; [Pero, Raffaela; Brancaccio, Mariarita; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Keller, Simona; Avvedimento, Vittorio Enrico; Chiariotti, Lorenzo] Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy; [Pero, Raffaela; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Keller, Simona; Chiariotti, Lorenzo] Ist Endocrinol & Oncol Sperimentale CNR, Via S Pansini 5, I-80131 Naples, Italy; [Lembo, Francesca] Univ Naples Federico II, Dipartimento Farm, Via D Montesano 47, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Angrisano, T (corresponding author), Univ Naples Federico II, Dipartimento Biol, Monte St Angelo Via Cintia 21, I-80126 Naples, Italy.; Chiariotti, L (corresponding author), Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.; Chiariotti, L (corresponding author), Ist Endocrinol & Oncol Sperimentale CNR, Via S Pansini 5, I-80131 Naples, Italy.	tangrisa@unina.it; chiariot@unina.it	Pezone, Antonio/Y-2016-2019; Brancaccio, Mariarita/AAC-4285-2021; Chiariotti, Lorenzo/AAC-5262-2022; Angrisano, Tiziana/AAC-5353-2022; Pezone, Antonio/AAL-3765-2021; Coretti, Lorena/ADL-9896-2022; Calabro, Viola/H-6156-2013; PERO, Raffaela/L-1461-2015	Pezone, Antonio/0000-0002-0068-6212; Brancaccio, Mariarita/0000-0002-4161-512X; Pezone, Antonio/0000-0002-0068-6212; Angrisano, Tiziana/0000-0002-5940-5278; falco, geppino/0000-0001-6193-7233; Coretti, Lorena/0000-0002-1289-7842; FLORIO, ERMANNO/0000-0001-6961-0059; PERO, Raffaela/0000-0003-2182-5530; Calabro, Viola/0000-0002-6508-8889	Epigenomics Flagship Project - EPIGEN; C.N.R.; POR Campania FSE; Project CREME; Regione Campania; Associazione Italiana per la Ricerca sul Cancro-AIRC [IG 16983]; EPIGEN Flagship Project	Epigenomics Flagship Project - EPIGEN; C.N.R.(Consiglio Nazionale delle Ricerche (CNR)); POR Campania FSE(Regione Campania); Project CREME; Regione Campania(Regione Campania); Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); EPIGEN Flagship Project	This work was supported by grant from Epigenomics Flagship Project - EPIGEN, C.N.R. to LCh, by POR Campania FSE 2007-2013, Project CREME, to TA, by Regione Campania, l.5, to LCh, and by Associazione Italiana per la Ricerca sul Cancro-AIRC (IG 16983) to VEA. LCo, fellowship by EPIGEN Flagship Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2013, J INVEST DERMATOL, V133, P2101, DOI 10.1038/jid.2013.143; Angrisano T, 2012, MED MICROBIOL IMMUN, V201, P249, DOI 10.1007/s00430-011-0227-9; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chiariotti L, 2013, MED MICROBIOL IMMUN, V202, P327, DOI 10.1007/s00430-013-0301-6; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Debnath T, 2013, MOLECULES, V18, P7253, DOI 10.3390/molecules18067253; Dhiman VK, 2015, ONCOTARGET, V6, P42575, DOI 10.18632/oncotarget.6471; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Mehta S, 2015, IMMUNOL CELL BIOL, V93, P233, DOI 10.1038/icb.2014.101; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michikawa Y, 2013, CLIN MED INSIGHTS-GA, V6, P13, DOI 10.4137/CGast.S11917; Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Park GY, 2004, AM J PHYSIOL-LUNG C, V286, pL956, DOI 10.1152/ajplung.00338.2003; Pero R, 2011, INT J MED MICROBIOL, V301, P140, DOI 10.1016/j.ijmm.2010.06.009; Singh VP, 2003, PROSTAG OTH LIPID M, V71, P163, DOI 10.1016/S1098-8823(03)00038-8; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Suzuki M, 2003, INFECT IMMUN, V71, P3503, DOI 10.1128/IAI.71.6.3503-3511.2003; Tagliaferri D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147683; Toyota M, 2000, CANCER RES, V60, P4044; Tsujii M, 2013, DIGESTION, V87, P12, DOI 10.1159/000343898; Wang DZ, 2008, CANCER LETT, V267, P197, DOI 10.1016/j.canlet.2008.03.004; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7	34	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156671	10.1371/journal.pone.0156671	http://dx.doi.org/10.1371/journal.pone.0156671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253528	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700049
J	Ericsson, E; Tesselaar, E; Sjoberg, F				Ericsson, Elin; Tesselaar, Erik; Sjoberg, Folke			Effect of Electrode Belt and Body Positions on Regional Pulmonary Ventilation- and Perfusion-Related Impedance Changes Measured by Electric Impedance Tomography	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; PRONE POSITION; BEAM CT; EIT; GRAVITY; POSTURE; TIME	Ventilator-induced or ventilator-associated lung injury (VILI/VALI) is common and there is an increasing demand for a tool that can optimize ventilator settings. Electrical impedance tomography (EIT) can detect changes in impedance caused by pulmonary ventilation and perfusion, but the effect of changes in the position of the body and in the placing of the electrode belt on the impedance signal have not to our knowledge been thoroughly evaluated. We therefore studied ventilation-related and perfusion-related changes in impedance during spontaneous breathing in 10 healthy subjects in five different body positions and with the electrode belt placed at three different thoracic positions using a 32-electrode EIT system. We found differences between regions of interest that could be attributed to changes in the position of the body, and differences in impedance amplitudes when the position of the electrode belt was changed. Ventilation-related changes in impedance could therefore be related to changes in the position of both the body and the electrode belt. Perfusion-related changes in impedance were probably related to the interference of major vessels. While these findings give us some insight into the sources of variation in impedance signals as a result of changes in the positions of both the body and the electrode belt, further studies on the origin of the perfusion-related impedance signal are needed to improve EIT further as a tool for the monitoring of pulmonary ventilation and perfusion.	[Ericsson, Elin; Tesselaar, Erik; Sjoberg, Folke] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Tesselaar, Erik] Linkoping Univ, Dept Med & Hlth Sci, Dept Radiat Phys, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Univ, Dept Hand & Plast Surg, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Univ, Burn Clin, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Tesselaar, E (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Tesselaar, E (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Dept Radiat Phys, Linkoping, Sweden.	erik.tesselaar@liu.se						Adler A, 2002, PHYSIOL MEAS, V33, P679; Albert RK, 2000, AM J RESP CRIT CARE, V161, P1660, DOI 10.1164/ajrccm.161.5.9901037; Beillas P, 2009, STAPP CAR CRASH JO, V53, P127; Bodenstein M, 2009, CRIT CARE MED, V37, P713, DOI 10.1097/CCM.0b013e3181958d2f; Caruana LR, 2015, ANAESTH INTENS CARE, V43, P88, DOI 10.1177/0310057X1504300113; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Drake R, 2014, GRAYS ANATOMY STUDEN, P121; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Elke G, 2013, PHYSIOL MEAS, V34, P1303, DOI 10.1088/0967-3334/34/10/1303; Eyuboglu B M, 1987, Clin Phys Physiol Meas, V8 Suppl A, P167, DOI 10.1088/0143-0815/8/4A/021; Ferrario D, 2012, IEEE T BIO-MED ENG, V59, P3000, DOI 10.1109/TBME.2012.2209116; Frerichs I, 1996, PHYSIOL MEAS, V17, pA149, DOI 10.1088/0967-3334/17/4A/019; Frerichs I, 2002, J APPL PHYSIOL, V93, P660, DOI 10.1152/japplphysiol.00081.2002; Frerichs I, 2002, IEEE T MED IMAGING, V21, P646, DOI 10.1109/TMI.2002.800585; Frerichs I, 2001, J APPL PHYSIOL, V91, P39, DOI 10.1152/jappl.2001.91.1.39; Frerichs I, 2009, RESPIRATION, V77, P282, DOI 10.1159/000193994; Galvin I, 2007, BRIT J ANAESTH, V98, P420, DOI 10.1093/bja/aem036; Gattinoni L, 2013, AM J RESP CRIT CARE, V188, P1286, DOI 10.1164/rccm.201308-1532CI; Glenny RW, 2009, INTENS CARE MED, V35, P1833, DOI 10.1007/s00134-009-1649-3; Grant CA, 2011, CRIT CARE, V15, DOI 10.1186/cc9985; Hayes A. R., 2013, SCI C, V57, P111; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; LEATHARD AD, 1994, PHYSIOL MEAS, V15, pA137, DOI 10.1088/0967-3334/15/2A/018; Li Y, 2014, ACTA ANAESTH SCAND, V58, P716, DOI 10.1111/aas.12323; Nguyen DT, 2012, PHYSIOL MEAS, V33, P695, DOI 10.1088/0967-3334/33/5/695; Noordegraaf AV, 1998, PHYSIOL MEAS, V19, P263, DOI 10.1088/0967-3334/19/2/013; Noordegraaf AV, 1996, PHYSIOL MEAS, V17, P179, DOI 10.1088/0967-3334/17/3/004; Pelosi P, 2002, EUR RESPIR J, V20, P1017, DOI 10.1183/09031936.02.00401702; Pulletz S, 2010, ACTA ANAESTH SCAND, V54, P751, DOI 10.1111/j.1399-6576.2010.02233.x; Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x; Riedel T, 2005, INTENS CARE MED, V31, P1522, DOI 10.1007/s00134-005-2734-x; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; West JB, 1978, REGIONAL DIFFERENCES, V74, P426; Wolf GK, 2013, CRIT CARE MED, V41, P1296, DOI 10.1097/CCM.0b013e3182771516	35	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155913	10.1371/journal.pone.0155913	http://dx.doi.org/10.1371/journal.pone.0155913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253433	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700010
J	Lohkamp, LN; Schinz, M; Gehlhaar, C; Guse, K; Thomale, UW; Vajkoczy, P; Heppner, FL; Koch, A				Lohkamp, Laura-Nanna; Schinz, Maren; Gehlhaar, Claire; Guse, Katrin; Thomale, Ulrich-Wilhelm; Vajkoczy, Peter; Heppner, Frank L.; Koch, Arend			MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CODON 132 MUTATION; CANCER ETIOLOGY; IDH2 MUTATIONS; PHASE-3 TRIAL; FUSION GENE; GLIOMAS; P53; TUMORS; TEMOZOLOMIDE	Giant Cell Glioblastoma (gcGBM) and Pleomorphic Xanthoastrocytoma (PXA) are rare astroglial tumors of the central nervous system. Although they share certain histomorphological and immunohistochemical features, they are characterized by different clinical behavior and prognosis. Nevertheless, few cases remain uncertain, as their histomorphological hallmarks and immunophenotypes do correspond to the typical pattern neither of gcGBM nor PXA. Therefore, in addition to the routinely used diagnostic histochemical and immunohistochemical markers like Gomori, p53 and CD34, we analyzed if genetic variations like MGMT promoter methylation, mutations in the IDH1/2 genes, or BRAF mutations, which are actually used as diagnostic, prognostic and predictive molecular markers in anaplastic glial tumors, could be helpful in the differential diagnostic of both tumor entities. We analyzed 34 gcGBM and 20 PXA for genetic variations in the above-named genes and found distinct distributions between both groups. MGMT promoter hypermethylation was observed in 3 out of 20 PXA compared to 14 out of 34 gcGBM (15% vs. 41.2%, p-value 0.09). BRAF V600E mutations were detected in 50% of the PXA but not in any of the gcGBM (50% vs. 0%, p-value < 0.001). IDH1 R132 and IDH R172 mutations were not present in any of the PXA and gcGBM cases. Our data indicate, that in addition to the histological and immunohistochemical evaluation, investigation of MGMT promoter methylation and in particular BRAF V600E mutations represent reliable additional tools to sustain differentiation of gcGBM from PXA on a molecular basis. Based on these data specific BRAF kinase inhibitors could represent a promising agent in the therapy of PXA and their use should be emphasized.	[Lohkamp, Laura-Nanna; Schinz, Maren; Gehlhaar, Claire; Guse, Katrin; Heppner, Frank L.; Koch, Arend] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Thomale, Ulrich-Wilhelm; Vajkoczy, Peter] Charite, Dept Neurosurg & Pediat Neurosurg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lohkamp, LN (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	Laura-Nanna.Lohkamp@charite.de	Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917				Antonelli M, 2015, PEDIATR BLOOD CANCER, V62, P724, DOI 10.1002/pbc.25272; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bar EE, 2008, J NEUROPATH EXP NEUR, V67, P878, DOI 10.1097/NEN.0b013e3181845622; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Chamberlain MC, 2013, J NEURO-ONCOL, V114, P237, DOI 10.1007/s11060-013-1176-5; Chang HT, 2006, CHILD NERV SYST, V22, P609, DOI 10.1007/s00381-005-0005-3; Dahiya S, 2014, NEURO-ONCOLOGY, V16, P318, DOI 10.1093/neuonc/not146; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Dougherty MJ, 2010, NEURO-ONCOLOGY, V12, P621, DOI 10.1093/neuonc/noq007; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giannini C, 2001, NEUROGENETICS, V3, P159, DOI 10.1007/s100480100116; Giannini C, 1999, CANCER, V85, P2033, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.3.CO;2-Q; Giannini C., 2007, WHO CLASSIFICATION T; Gomori E, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-8; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hussain SP, 1998, CANCER RES, V58, P4023; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kaulich K, 2002, J NEUROPATH EXP NEUR, V61, P1092, DOI 10.1093/jnen/61.12.1092; Kleihues P BP, 2007, WHO CLASSIFICATION T, P46; Kleinschmidt-DeMasters BK, 2013, AM J SURG PATHOL, V37, P685, DOI 10.1097/PAS.0b013e31827f9c5e; Koelsche C, 2014, BRAIN PATHOL, V24, P221, DOI 10.1111/bpa.12111; Korshunov A, 2009, ACTA NEUROPATHOL, V118, P401, DOI 10.1007/s00401-009-0550-z; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187; Marucci G, 2011, J NEURO-ONCOL, V105, P397, DOI 10.1007/s11060-011-0605-6; MeyerPuttlitz B, 1997, AM J PATHOL, V151, P853; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reifenberger G, 2003, ACTA NEUROPATHOL, V105, P358, DOI 10.1007/s00401-002-0652-3; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wick WG, 2013, NEUROLOGY, V81, P1515, DOI 10.1212/WNL.0b013e3182a95680; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zakrzewska M, 2009, CANCER GENET CYTOGEN, V193, P93, DOI 10.1016/j.cancergencyto.2009.04.023	44	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156422	10.1371/journal.pone.0156422	http://dx.doi.org/10.1371/journal.pone.0156422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253461	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700028
J	Robach, P; Trebes, G; Lasne, F; Buisson, C; Mechin, N; Mazzarino, M; de la Torre, X; Roustit, M; Kerivel, P; Botre, F; Bouzat, P				Robach, Paul; Trebes, Gilles; Lasne, Francoise; Buisson, Corinne; Mechin, Nathalie; Mazzarino, Monica; de la Torre, Xavier; Roustit, Matthieu; Kerivel, Patricia; Botre, Francesco; Bouzat, Pierre			Drug Use on Mont Blanc: A Study Using Automated Urine Collection	PLOS ONE			English	Article							HIGH-ALTITUDE; LIQUID-CHROMATOGRAPHY; EXERCISE CAPACITY; ACETAZOLAMIDE; SLEEP; PHARMACOLOGY; PERFORMANCE; PATTERNS; MASS	Mont Blanc, the summit of Western Europe, is a popular but demanding high-altitude ascent. Drug use is thought to be widespread among climbers attempting this summit, not only to prevent altitude illnesses, but also to boost physical and/or psychological capacities. This practice may be unsafe in this remote alpine environment. However, robust data on medication during the ascent of Mont Blanc are lacking. Individual urine samples from male climbers using urinals in mountain refuges on access routes to Mont Blanc (Gouter and Cosmiques mountain huts) were blindly and anonymously collected using a hidden automatic sampler. Urine samples were screened for a wide range of drugs, including diuretics, glucocorticoids, stimulants, hypnotics and phosphodiesterase 5 (PDE-5) inhibitors. Out of 430 samples analyzed from both huts, 35.8% contained at least one drug. Diuretics (22.7%) and hypnotics (12.9%) were the most frequently detected drugs, while glucocorticoids (3.5%) and stimulants (3.1%) were less commonly detected. None of the samples contained PDE-5 inhibitors. Two substances were predominant: the diuretic acetazolamide (20.6%) and the hypnotic zolpidem (8.4%). Thirty three samples were found positive for at least two substances, the most frequent combination being acetazolamide and a hypnotic (2.1%). Based on a novel sampling technique, we demonstrate that about one third of the urine samples collected from a random sample of male climbers contained one or several drugs, suggesting frequent drug use amongst climbers ascending Mont Blanc. Our data suggest that medication primarily aims at mitigating the symptoms of altitude illnesses, rather than enhancing performance. In this hazardous environment, the relatively high prevalence of hypnotics must be highlighted, since these molecules may alter vigilance.	[Robach, Paul; Kerivel, Patricia] Ecole Natl Sports Montagne, Site Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [Robach, Paul; Roustit, Matthieu] Univ Grenoble Alpes, HP2, Grenoble, France; [Robach, Paul; Roustit, Matthieu] INSERM, HP2, Grenoble, France; [Trebes, Gilles] CHU Grenoble, Pole Urgences Med Aigue, F-38043 Grenoble, France; [Lasne, Francoise; Buisson, Corinne; Mechin, Nathalie] Agence Francaise Lutte Dopage, Dept Anal, Chatenay Malabry, France; [Mazzarino, Monica; de la Torre, Xavier; Botre, Francesco] Federaz Med Sport Italiana, Lab Antidoping, Rome, Italy; [Roustit, Matthieu] CHU Grenoble, INSERM, Pharmacol Clin, Pole Rech,CIC1406, F-38043 Grenoble, France; [Botre, Francesco] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Bouzat, Pierre] CHU Grenoble, Pole Anesthesie Reanimat, F-38043 Grenoble, France; [Bouzat, Pierre] Univ Grenoble Alpes, INSERM, U836, Inst Neurosci, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Sapienza University Rome; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Robach, P (corresponding author), Ecole Natl Sports Montagne, Site Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France.; Robach, P (corresponding author), Univ Grenoble Alpes, HP2, Grenoble, France.; Robach, P (corresponding author), INSERM, HP2, Grenoble, France.	paul.robach@ensm.sports.gouv.fr	de la Torre, Xavier/AAO-3059-2020; Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014; Botre, Francesco/AFL-3227-2022; Roustit, Matthieu/M-6927-2014	de la Torre, Xavier/0000-0001-8037-6750; Bouzat, Pierre/0000-0003-4667-6738; Botre, Francesco/0000-0001-5296-8126; Roustit, Matthieu/0000-0003-4475-1626	Agence Francaise de Lutte contre le Dopage; Fondation Petzl; Federation Francaise des Clubs Alpins et de Montagne	Agence Francaise de Lutte contre le Dopage; Fondation Petzl; Federation Francaise des Clubs Alpins et de Montagne	This study was supported by the Agence Francaise de Lutte contre le Dopage, the Fondation Petzl and the Federation Francaise des Clubs Alpins et de Montagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beaumont M, 2007, SLEEP, V30, P1527, DOI 10.1093/sleep/30.11.1527; BRADWELL AR, 1986, LANCET, V1, P1001; CAMPINSFALCO P, 1994, J CHROMATOGR B, V654, P85, DOI 10.1016/0378-4347(94)00005-0; Cheron-Launay M, 2011, ADDICT BEHAV, V36, P743, DOI 10.1016/j.addbeh.2011.02.013; Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR; Cone EJ, 2003, J ANAL TOXICOL, V27, P386, DOI 10.1093/jat/27.7.386; Docherty JR, 2008, BRIT J PHARMACOL, V154, P606, DOI 10.1038/bjp.2008.124; Dubowitz G, 1998, BRIT MED J, V316, P587, DOI 10.1136/bmj.316.7131.587; Fischler M, 2009, AM J RESP CRIT CARE, V180, P346, DOI 10.1164/rccm.200808-1348OC; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HERRAEZHERNANDEZ R, 1992, J CHROMATOGR-BIOMED, V582, P181, DOI 10.1016/0378-4347(92)80317-J; Jackson SJ, 2010, HIGH ALT MED BIOL, V11, P217, DOI 10.1089/ham.2010.1003; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Luks AM, 2008, HIGH ALT MED BIOL, V9, P195, DOI 10.1089/ham.2008.1025; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; Mazzarino M, 2016, J PHARMACEUT BIOMED, V117, P47, DOI 10.1016/j.jpba.2015.08.007; Messner R., 2013, DESNIVEL MAGAZINE; ONeil D., 2013, OUTSIDE MAGAZINE; Petzl-Foundation, 2012, MONT BLANC CAN WE RE; Roggla G, 1993, Schweiz Z Sportmed, V41, P103; Subedi BH, 2010, WILD ENVIRON MED, V21, P345, DOI 10.1016/j.wem.2010.09.006; Tsianos G, 2006, EUR J APPL PHYSIOL, V96, P32, DOI 10.1007/s00421-005-0066-8; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; WADA, 2016, WORLD ANT AG 2016 PR	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156786	10.1371/journal.pone.0156786	http://dx.doi.org/10.1371/journal.pone.0156786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253728	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700060
J	Rose, O; Mennemann, H; John, C; Lautenschlager, M; Mertens-Keller, D; Richling, K; Waltering, I; Hamacher, S; Felsch, M; Herich, L; Czarnecki, K; Schaffert, C; Jaehde, U; Koberlein-Neu, J				Rose, Olaf; Mennemann, Hugo; John, Carina; Lautenschlaeger, Marcus; Mertens-Keller, Damaris; Richling, Katharina; Waltering, Isabel; Hamacher, Stefanie; Felsch, Moritz; Herich, Lena; Czarnecki, Kathrin; Schaffert, Corinna; Jaehde, Ulrich; Koeberlein-Neu, Juliane			Priority Setting and Influential Factors on Acceptance of Pharmaceutical Recommendations in Collaborative Medication Reviews in an Ambulatory Care Setting - Analysis of a Cluster Randomized Controlled Trial (WestGem-Study)	PLOS ONE			English	Review							DRUG-RELATED PROBLEMS; THERAPY MANAGEMENT SERVICES; ILLNESS RATING-SCALE; APPROPRIATENESS INDEX; PHARMACIST INTERVENTIONS; COMMUNITY PHARMACIES; DIABETES-MELLITUS; PATIENT OUTCOMES; ELDERLY-PATIENTS; ADHERENCE	Background Medication reviews are recognized services to increase quality of therapy and reduce medication risks. The selection of eligible patients with potential to receive a major benefit is based on assumptions rather than on factual data. Acceptance of interprofessional collaboration is crucial to increase the quality of medication therapy. Objective The research question was to identify and prioritize eligible patients for a medication review and to provide evidence-based criteria for patient selection. Acceptance of the prescribing general practitioner to implement pharmaceutical recommendations was measured and factors influencing physicians' acceptance were explored to obtain an impression on the extent of collaboration in medication review in an ambulatory care setting. Methods Based on data of a cluster-randomized controlled study (WestGem-study), the correlation between patient parameters and the individual performance in a medication review was calculated in a multiple logistic regression model. Physician's acceptance of the suggested intervention was assessed using feedback forms. Influential factors were analyzed. Results The number of drugs in use (p = 0.001), discrepancies between prescribed and used medicines (p = 0.014), the baseline Medication Appropriateness Index score (p<0.001) and the duration of the intervention (p = 0.006) could be identified as influential factors for a major benefit from a medication review, whereas morbidity (p>0.05) and a low kidney function (p>0.05) do not predetermine the outcome. Longitudinal patient care with repeated reviews showed higher interprofessional acceptance and superior patient benefit. A total of 54.9% of the recommendations in a medication review on drug therapy were accepted for implementation. Conclusions The number of drugs in use and medication reconciliation could be a first rational step in patient selection for a medication review. Most elderly, multimorbid patients with polymedication experience a similar chance of receiving a benefit from a medication review. Longitudinal patient care should be preferred over confined medication reviews. The acceptance of medication reviews by physicians supports further implementation into health care systems.	[Rose, Olaf; Jaehde, Ulrich] Univ Bonn, Inst Pharm, Clin Pharm, Bonn, Germany; [Czarnecki, Kathrin; Schaffert, Corinna; Koeberlein-Neu, Juliane] Univ Wuppertal, Schumpeter Sch Business & Econ, Dept Hlth Care Management & Publ Hlth, Wuppertal, Germany; [Mennemann, Hugo] Univ Appl Sci Muenster, Dept Social Sci, Munster, Germany; [Waltering, Isabel] Univ Munster, Dept Pharmaceut & Med Chem, Clin Pharm, Munster, Germany; [Hamacher, Stefanie; Felsch, Moritz; Herich, Lena] Univ Cologne, Inst Med Stat Informat & Epidemiol IMSIE, Cologne, Germany; [Rose, Olaf; John, Carina; Lautenschlaeger, Marcus; Mertens-Keller, Damaris; Richling, Katharina; Waltering, Isabel] Elefanten Apotheke, Steinfurt, Germany	University of Bonn; University of Wuppertal; University of Applied Sciences, Muenster; University of Munster; University of Cologne	Rose, O (corresponding author), Univ Bonn, Inst Pharm, Clin Pharm, Bonn, Germany.; Rose, O (corresponding author), Elefanten Apotheke, Steinfurt, Germany.	rose@elefantenapo.de	Koeberlein-Neu, Juliane/M-1644-2015	Koeberlein-Neu, Juliane/0000-0002-3451-7847; Hamacher, Stefanie/0000-0003-2158-9101	European Union; state of North Rhine-Westphalia [GW 2076]; Elefanten-Apotheke, Steinfurt, Germany	European Union(European Commission); state of North Rhine-Westphalia; Elefanten-Apotheke, Steinfurt, Germany	The WestGem-study was funded by the European Union and the state of North Rhine-Westphalia (Ziel 2, IuK & Gender Med.NRW, GW 2076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Participating study pharmacists were employed by a pharmacy called Elefanten-Apotheke, Steinfurt, Germany during the study and received the funding as a salary. They also received funded research materials from the pharmacy. The pharmacy played no active role as all pharmacists were blinded to the patients and physicians. The pharmacy had no commercial interest in the findings of the study. The funder provided support in the form of salaries for authors [CJ, ML, DMK, KR, IW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barnett MJ, 2009, J MANAGE CARE PHARM, V15, P18, DOI 10.18553/jmcp.2009.15.1.18; Bulajeva A, 2014, RES SOC ADMIN PHARM, V10, P731, DOI 10.1016/j.sapharm.2014.02.005; Castelino RL, 2010, ANN PHARMACOTHER, V44, P1922, DOI 10.1345/aph.1P373; Chau SH, 2016, INT J CLIN PHARM-NET, V38, P46, DOI 10.1007/s11096-015-0199-8; Chinthammit C, 2015, J MANAG CARE SPEC PH, V21, P381, DOI 10.18553/jmcp.2015.21.5.381; Chisholm-Burns MA, 2010, MED CARE, V48, P923, DOI 10.1097/MLR.0b013e3181e57962; de Oliveira DR, 2010, J MANAGE CARE PHARM, V16, P185, DOI 10.18553/jmcp.2010.16.3.185; Doucette WR, 2005, CLIN THER, V27, P1104, DOI 10.1016/S0149-2918(05)00146-3; Geurts MME, 2012, BRIT J CLIN PHARMACO, V74, P16, DOI 10.1111/j.1365-2125.2012.04178.x; Gustafsson M, 2015, EUR J CLIN PHARMACOL, V71, P507, DOI 10.1007/s00228-015-1825-z; HALLYNCK TH, 1981, BRIT J CLIN PHARMACO, V11, P523, DOI 10.1111/j.1365-2125.1981.tb01163.x; Hanlon J, 2013, DRUG AGING, V30, P893, DOI 10.1007/s40266-013-0118-4; Hanlon JT, 1996, AM J MED, V100, P428, DOI 10.1016/S0002-9343(97)89519-8; HANLON JT, 1992, J CLIN EPIDEMIOL, V45, P1045, DOI 10.1016/0895-4356(92)90144-C; Heisler M, 2008, CIRCULATION, V117, P2884, DOI 10.1161/CIRCULATIONAHA.107.724104; Heisler M, 2012, CIRCULATION, V125, P2863, DOI 10.1161/CIRCULATIONAHA.111.089169; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; [International Pharmaceutical Federation World Health Organization], 2006, HDB 2006 ED; Isaksen SF, 1999, ANN PHARMACOTHER, V33, P406, DOI 10.1345/aph.18268; Isetts BJ, 2008, J AM PHARM ASSOC, V48, P203, DOI 10.1331/JAPhA.2008.07108; Kassam R, 2003, ANN PHARMACOTHER, V37, P40; Kaufmann CP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006376; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Krolop L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003139; Latif A, 2013, RES SOC ADMIN PHARM, V9, P949, DOI 10.1016/j.sapharm.2013.01.005; Machado M, 2008, ANN PHARMACOTHER, V42, P1195, DOI 10.1345/aph.1K618; Machado M, 2007, ANN PHARMACOTHER, V41, P1569, DOI 10.1345/aph.1K151; Messerli M, 2016, DEV CLIN PHARM SWITZ; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Obarcanin E, 2015, INT J CLIN PHARM-NET, V37, P790, DOI 10.1007/s11096-015-0122-3; Patterson SM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008165.pub2; Pauly A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139302; Pellegrino AN, 2009, DRUGS, V69, P393, DOI 10.2165/00003495-200969040-00001; Pharmaceutical care Network Europe, 2016, MED REV DEF APPR; Pharmaceutical Society of Australia, 2012, GUID PHARM PROV US R; Pharmaceutical Society of Australia, 2012, GUID PHARM PROV RES; Pourrat X, 2015, INT J CLIN PHARM-NET, V37, P1172, DOI 10.1007/s11096-015-0182-4; Raimbault-Chupin M, 2013, INT J CLIN PHARM-NET, V35, P847, DOI 10.1007/s11096-013-9821-9; Rose O, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0305-y; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; SAMSA GP, 1994, J CLIN EPIDEMIOL, V47, P891, DOI 10.1016/0895-4356(94)90192-9; Spinewine A, 2006, J AM GERIATR SOC, V54, P720, DOI 10.1111/j.1532-5415.2006.00668_8.x; Vinks THAM, 2009, DRUG AGING, V26, P123, DOI 10.2165/0002512-200926020-00004; Woertman W, 2013, J CLIN EPIDEMIOL, V66, P752, DOI 10.1016/j.jclinepi.2013.01.009; Wolf C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142011; Zermansky AG, 2006, AGE AGEING, V35, P586, DOI 10.1093/ageing/afl075	46	20	20	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156304	10.1371/journal.pone.0156304	http://dx.doi.org/10.1371/journal.pone.0156304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253380	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700018
J	Sheng, XH; Wang, LG; Ni, HM; Wang, LX; Qi, XL; Xing, SH; Guo, Y				Sheng, Xihui; Wang, Ligang; Ni, Hemin; Wang, Lixian; Qi, Xiaolong; Xing, Shuhan; Guo, Yong			Comparative Analyses between Skeletal Muscle miRNAomes from Large White and Min Pigs Revealed MicroRNAs Associated with Postnatal Muscle Hypertrophy	PLOS ONE			English	Article							ADIPOGENIC DIFFERENTIATION; CELL-PROLIFERATION; GROWTH; TARGETS; EXPRESSION; MYOSTATIN; PROTEIN; PATHWAY; BETA; RNA	The molecular mechanism regulated by microRNAs (miRNAs) that underlies postnatal hypertrophy of skeletal muscle is complex and remains unclear. Here, the miRNAomes of longissimus dorsi muscle collected at five postnatal stages (60, 120, 150, 180, and 210 days after birth) from Large White (commercial breed) and Min pigs (indigenous breed of China) were analyzed by Illumina sequencing. We identified 734 miRNAs comprising 308 annotated miRNAs and 426 novel miRNAs, of which 307 could be considered pig-specific. Comparative analysis between two breeds suggested that 60 and 120 days after birth were important stages for skeletal muscle hypertrophy and intramuscular fat accumulation. A total of 263 miRNAs were significantly differentially expressed between two breeds at one or more developmental stages. In addition, the differentially expressed miRNAs between every two adjacent developmental stages in each breed were determined. Notably, ssc-miR-204 was significantly more highly expressed in Min pig skeletal muscle at all postnatal stages compared with its expression in Large White pig skeletal muscle. Based on gene ontology and KEGG pathway analyses of its predicted target genes, we concluded that ssc-miR-204 may exert an impact on postnatal hypertrophy of skeletal muscle by regulating myoblast proliferation. The results of this study will help in elucidating the mechanism underlying postnatal hypertrophy of skeletal muscle modulated by miRNAs, which could provide valuable information for improvement of pork quality and human myopathy.	[Sheng, Xihui; Ni, Hemin; Qi, Xiaolong; Xing, Shuhan; Guo, Yong] Beijing Agr Univ, Anim Sci & Technol Coll, Beijing 102206, Peoples R China; [Sheng, Xihui; Ni, Hemin; Qi, Xiaolong; Guo, Yong] Beijing Agr Univ, Beijing Key Lab Tradit Chinese Vet Med, Beijing 102206, Peoples R China; [Wang, Ligang; Wang, Lixian] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet Resources & Germplasm Inn, Beijing 100193, Peoples R China	Beijing University of Agriculture; Beijing University of Agriculture; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Guo, Y (corresponding author), Beijing Agr Univ, Anim Sci & Technol Coll, Beijing 102206, Peoples R China.	shengxh03@163.com; y63guo@126.com			Beijing Natural Science Foundation [6132003]; National Natural Science Foundation of China [31402049]; Beijing Municipal Commission of Education [KM201410020006]; Beijing Nova Program [xx2016030]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by grants from the Beijing Natural Science Foundation (XHS, Grant No. 6132003), National Natural Science Foundation of China (XHS, Grant No. 31402049), the science and technology project of Beijing Municipal Commission of Education (XHS, Grant No. KM201410020006) and Beijing Nova Program (XHS, Grant No. xx2016030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2014, J CELL SCI, V127, P599, DOI 10.1242/jcs.136648; ALLEN RE, 1979, J ANIM SCI, V49, P115, DOI 10.2527/jas1979.491115x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Civelek M, 2013, HUM MOL GENET, V22, P3023, DOI 10.1093/hmg/ddt159; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gagan J, 2011, J BIOL CHEM, V286, P19431, DOI 10.1074/jbc.M111.219006; Greco S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039732; He HH, 2015, INT J MOL MED, V35, P1587, DOI 10.3892/ijmm.2015.2160; Hitachi K, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00408; Hitachi K, 2014, INT J BIOCHEM CELL B, V47, P93, DOI 10.1016/j.biocel.2013.12.003; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hou XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052123; Hua J, 2015, REJUVENATION RES; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; LEE YB, 1974, J ANIM SCI, V38, P532, DOI 10.2527/jas1974.383532x; LEFAUCHEUR L, 1986, MEAT SCI, V16, P199, DOI 10.1016/0309-1740(86)90026-4; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Liu LY, 2015, BIOCHEM BIOPH RES CO, V457, P621, DOI 10.1016/j.bbrc.2015.01.037; MASCARELLO F, 1992, J ANIM SCI, V70, P1806, DOI 10.2527/1992.7061806x; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Oksbjerg N, 2004, DOMEST ANIM ENDOCRIN, V27, P219, DOI 10.1016/j.domaniend.2004.06.007; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Phelan JN, 1997, ANAT REC, V247, P179, DOI 10.1002/(SICI)1097-0185(199702)247:2<179::AID-AR4>3.0.CO;2-T; Picard B, 2002, REPROD NUTR DEV, V42, P415, DOI 10.1051/rnd:2002035; Qin LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072418; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Sharma S, 2012, EMBO MOL MED, V4, P617, DOI 10.1002/emmm.201200234; Shi L, 2015, CELL SIGNAL, V27, P1895, DOI 10.1016/j.cellsig.2015.05.001; SWATLAND HJ, 1973, J ANIM SCI, V37, P536, DOI 10.2527/jas1973.372536x; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Trenerry Marissa K., 2011, BMC Physiology, V11, P6, DOI 10.1186/1472-6793-11-6; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Wang XL, 2015, INT J CLIN EXP PATHO, V8, P5017; WIGMORE PMC, 1983, GROWTH, V47, P67; Wong CF, 2008, J BIOL CHEM, V283, P9836, DOI 10.1074/jbc.M709614200; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu D, 2015, MOL MED REP; Wu XJ, 2015, FEBS LETT, V589, P645, DOI 10.1016/j.febslet.2015.01.030; Xiao JJ, 2012, J MOL CELL CARDIOL, V53, P751, DOI 10.1016/j.yjmcc.2012.08.024; Xu J, 2012, KIDNEY INT, V82, P401, DOI 10.1038/ki.2012.84; Yan BA, 2013, J EXP BIOL, V216, P1265, DOI 10.1242/jeb.079590; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	61	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156780	10.1371/journal.pone.0156780	http://dx.doi.org/10.1371/journal.pone.0156780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253583	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700059
J	Mandal, AK				Mandal, Anil K.			Acute Corneal Hydrops in Children with Primary Infantile Glaucoma: A Report of 31 Cases over 23 Years at the LVPEI	PLOS ONE			English	Article							COMBINED TRABECULOTOMY-TRABECULECTOMY; PRIMARY CONGENITAL GLAUCOMA; PRIMARY DEVELOPMENTAL GLAUCOMA; C-AUGMENTED TRABECULECTOMY; ILLUMINATED MICROCATHETER; EXTERNAL TRABECULOTOMY; VISUAL-ACUITY; CIRCUMFERENTIAL TRABECULOTOMY; PEDIATRIC GLAUCOMA; CHILDHOOD GLAUCOMA	Purpose Relatively little data exist regarding the outcomes of children with primary infantile glaucoma presenting with acute corneal hydrops. The aim of our study was to determine the surgical outcome of children of infantile glaucoma who presented with acute corneal hydrops. Methods In total, 38 eyes of 31 consecutive children of infantile glaucoma presented with acute corneal hydrops who underwent primary combined trabeculotomy-trabeculectomy (CTT) by a single surgeon from January 1990 to December 2012 at the LV Prasad Eye Institute (LVPEI), a tertiary eye care centre in Southern India were enrolled in this retrospective study. Primary outcome measures were intraocular pressure (IOP) control (IOP <= 16 mmHg under anaesthesia or IOP <= 21 mmHg without anaesthesia) and clearance of corneal edema. Secondary outcome measures were visual acuity (VA), corneal diameter, bleb appearance, intraoperative and postoperative complications. Results Mean age at presentation was 6.4 months (range, 2-11 months) and seven eyes (23%) had bilateral affliction. At presentation, all eyes (100%) had moderate to severe degree of corneal edema with a mean preoperative IOP of 25.6 +/- 5.1 mmHg. Postoperatively, the IOP reduced to 12.0 +/- 3.8 mmHg (difference = -13.6, 95% CI = -15.7 to -11.5, t = -13.18, p<0.0001), and the percentage reduction in IOP was 53.05%. Preoperatively 83% of the eyes were on antiglaucoma medication, and postoperatively 2 eyes (5.3%) required 1 antiglaucoma medication for control of IOP. Preoperatively, corneal edema was present in all eyes and postoperatively it cleared in all of them. Significant myopic astigmatism was present in 28 eyes (74%), the commonest being compound myopic astigmatism (75%) followed by simple myopic astigmatism (21%). Normal VA (best-corrected VA; BCVA >= 20/60) was achieved in 44.4% of the eyes and 22.2% eyes had low vision (BCVA, <20/60 to 20/400). Complete success (IOP control and clearance of corneal oedema) was obtained in 94.7% eyes. There were no significant intraoperative or postoperative complications. Two thirds of the patients showed low, elevated functional filtering bleb. No patient had any bleb leak, blebitis or bleb related endophthalmitis. The median follow-up was 36 months (range 2-228 months). Conclusions Primary CTT is safe and effective in controlling IOP, resulting in complete clearance of corneal edema with modest visual improvement in children of infantile glaucoma presenting with acute corneal hydrops. The outcome of the study will have a positive impact on counseling the parents preoperatively.	[Mandal, Anil K.] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Mandal, AK (corresponding author), LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India.	mandal@lvpei.org	Mandal, Anil/AAY-4809-2020		Hyderabad Eye Research Foundation	Hyderabad Eye Research Foundation	This study was supported by Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazmi A, 2005, BRIT J OPHTHALMOL, V89, P449, DOI 10.1136/bjo.2004.047761; BECK AD, 1995, ARCH OPHTHALMOL-CHIC, V113, P1200, DOI 10.1001/archopht.1995.01100090126034; Biglan AW, 2006, J AAPOS, V10, P7, DOI 10.1016/j.jaapos.2005.10.001; BIGLAN AW, 1979, J PEDIAT OPHTH STRAB, V16, P377; Chen TC, 2014, OPHTHALMOLOGY, V121, P2107, DOI 10.1016/j.ophtha.2014.05.010; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; ELDER MJ, 1994, BRIT J OPHTHALMOL, V78, P745, DOI 10.1136/bjo.78.10.745; Girkin CA, 2012, J AAPOS, V16, P424, DOI 10.1016/j.jaapos.2012.05.013; HAAS J, 1968, INVEST OPHTH VISUAL, V7, P140; Hoskins H D Jr, 1984, J Pediatr Ophthalmol Strabismus, V21, P153; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; Ishida Kyoko, 2005, Ophthalmol Clin North Am, V18, P431, DOI 10.1016/j.ohc.2005.05.009; Khaw PT, 1996, BRIT J OPHTHALMOL, V80, P495, DOI 10.1136/bjo.80.6.495; Khitri MR, 2012, J AAPOS, V16, P376, DOI 10.1016/j.jaapos.2012.05.007; Ko F, 2015, PROG BRAIN RES, V221, P177, DOI 10.1016/bs.pbr.2015.06.005; Lim ME, 2015, J AAPOS, V19, P145, DOI 10.1016/j.jaapos.2015.01.008; Luntz M H, 1984, J Pediatr Ophthalmol Strabismus, V21, P150; Mandal AK, 2007, EYE, V21, P764, DOI 10.1038/sj.eye.6702324; Mandal AK, 1997, OPHTHALMOLOGY, V104, P996, DOI 10.1016/S0161-6420(97)30195-X; Mandal AK, 2006, EYE, V20, P135, DOI 10.1038/sj.eye.6701817; Mandal AK, 2004, OPHTHALMOLOGY, V111, P283, DOI 10.1016/j.ophtha.2003.05.027; Mandal AK, 1998, OPHTHALMOLOGY, V105, P974, DOI 10.1016/S0161-6420(98)96022-5; Mandal AK, 1999, OPHTHALMIC SURG LAS, V30, P473; Mandal AK., 2006, PEDIAT GLAUCOMAS; Mandal AK, 2013, NEW ENGL J MED, V369, P74, DOI 10.1056/NEJMicm1213817; Mandal Anil K., 2002, Indian Journal of Ophthalmology, V50, P13; Mandal Anil K., 1993, Indian Journal of Ophthalmology, V41, P51; MAYER DL, 1995, INVEST OPHTH VIS SCI, V36, P671; MCPHERSON SD, 1980, OPHTHALMOLOGY, V87, P302; MCPHERSON SD, 1973, AM J OPHTHALMOL, V76, P918, DOI 10.1016/0002-9394(73)90081-0; MCPHERSON SD, 1983, AM J OPHTHALMOL, V95, P427, DOI 10.1016/0002-9394(83)90260-X; Mullaney PB, 1999, ARCH OPHTHALMOL-CHIC, V117, P457; OCONNOR G, 1994, BRIT J OPHTHALMOL, V78, P735, DOI 10.1136/bjo.78.10.735; Papadopoulos M, 2014, EYE, V28, P931, DOI 10.1038/eye.2014.140; Patil B, 2015, OPHTHALMOLOGY, V122, P87, DOI 10.1016/j.ophtha.2014.07.029; Rao GN, 2015, EYE, V29, P30, DOI 10.1038/eye.2014.239; Richardson K T Jr, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P833; Sarkisian SR, 2010, J AAPOS, V14, P412, DOI 10.1016/j.jaapos.2010.07.010; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; Temkar S, 2015, AM J OPHTHALMOL, V159, P490, DOI 10.1016/j.ajo.2014.12.001; Wright KW, 2012, PEDIAT OPHTHALMOLOGY, P231; Zacharia PT, 1998, OPHTHALMIC SURG LAS, V29, P318; Zagora SL, 2015, AM J OPHTHALMOL, V159, P788, DOI 10.1016/j.ajo.2015.01.019	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156108	10.1371/journal.pone.0156108	http://dx.doi.org/10.1371/journal.pone.0156108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249057	Green Published, gold			2022-12-27	WOS:000377184700029
J	Sassi, C; Ridge, PG; Nalls, MA; Gibbs, R; Ding, JH; Lupton, MK; Troakes, C; Lunnon, K; Al-Sarraj, S; Brown, KS; Medway, C; Lord, J; Turton, J; Morgan, K; Powell, JF; Kauwe, JS; Cruchaga, C; Bras, J; Goate, AM; Singleton, AB; Guerreiro, R; Hardy, J				Sassi, Celeste; Ridge, Perry G.; Nalls, Michael A.; Gibbs, Raphael; Ding, Jinhui; Lupton, Michelle K.; Troakes, Claire; Lunnon, Katie; Al-Sarraj, Safa; Brown, Kristelle S.; Medway, Christopher; Lord, Jenny; Turton, James; Morgan, Kevin; Powell, John F.; Kauwe, John S.; Cruchaga, Carlos; Bras, Jose; Goate, Alison M.; Singleton, Andrew B.; Guerreiro, Rita; Hardy, John		ARUK Consortium	Influence of Coding Variability in APP-A beta Metabolism Genes in Sporadic Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; DEGRADING ENZYMES; COMMON VARIANTS; SEQUENCING DATA; RECEPTOR LR11; SORL1; ABCA7	The cerebral deposition of A beta(42), a neurotoxic proteolytic derivate of amyloid precursor protein (APP), is a central event in Alzheimer's disease (AD)(Amyloid hypothesis). Given the key role of APP-A beta metabolism in AD pathogenesis, we selected 29 genes involved in APP processing, A beta degradation and clearance. We then used exome and genome sequencing to investigate the single independent (single-variant association test) and cumulative (gene-based association test) effect of coding variants in these genes as potential susceptibility factors for AD, in a cohort composed of 332 sporadic and mainly late-onset AD cases and 676 elderly controls from North America and the UK. Our study shows that common coding variability in these genes does not play a major role for the disease development. In the single-variant association analysis, the main hits, none of which statistically significant after multiple testing correction (1.9e(-4)<p-value<0.05), were found to be rare coding variants (0.009%<MAF<1.4%) with moderate to strong effect size (1.84<OR<Inf) that map to genes mainly involved in A beta extracellular degradation (TTR, ACE), clearance (LRP1) and APP trafficking and recycling (SORL1). These results were partially replicated in the gene-based analysis (c-alpha and SKAT tests), that reports ECE1, LYZ and TTR as nominally associated to AD (1.7e(-3) <p-value <0.05). In concert with previous studies, we suggest that 1) common coding variability in APP-A beta genes is not a critical factor for AD development and 2) A beta degradation and clearance, rather than A beta production, may play a key role in the etiology of sporadic AD.	[Sassi, Celeste; Bras, Jose; Guerreiro, Rita; Hardy, John] UCL Inst Neurol, Dept Mol Neurosci, Weston Res Labs, Reta Lila, London, England; [Sassi, Celeste; Nalls, Michael A.; Gibbs, Raphael; Ding, Jinhui; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Sassi, Celeste] Charite, Dept Expt Neurol, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Sassi, Celeste] German Ctr Neurodegenerat Dis DZNE, Berlin Site, Berlin, Germany; [Ridge, Perry G.; Kauwe, John S.] Brigham Young Univ, Neurosci, Dept Biol, Provo, UT 84602 USA; [Lupton, Michelle K.; Troakes, Claire; Lunnon, Katie; Al-Sarraj, Safa; Powell, John F.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Lupton, Michelle K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Brown, Kristelle S.; Medway, Christopher; Lord, Jenny; Turton, James; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Translat Cell Sci Human Genet, Nottingham NG7 2RD, England; [Cruchaga, Carlos] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Icahn Med Inst, New York, NY 10029 USA	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Brigham Young University; University of London; King's College London; QIMR Berghofer Medical Research Institute; University of Nottingham; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Hardy, J (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, Weston Res Labs, Reta Lila, London, England.	j.hardy@ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Powell, John F/G-4412-2011; Lunnon, Katie/C-4638-2012; Guerreiro, Rita J L/A-1327-2011; Cruchaga, Carlos/ABF-4065-2020; Bras, Jose MT/A-1428-2011; Hardy, John/C-2451-2009; Gibbs, J. Raphael/A-3984-2010; Lord, Jenny/GYJ-1039-2022; Lord, Jenny/AAR-5643-2021; Kauwe, John/AAC-6646-2021; Kehoe, Patrick/P-8760-2018	Powell, John F/0000-0001-6124-439X; Lunnon, Katie/0000-0001-7570-6065; Cruchaga, Carlos/0000-0002-0276-2899; Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Lord, Jenny/0000-0002-0539-9343; Kauwe, John/0000-0001-8641-2468; Goate, Alison/0000-0002-0576-2472; Kehoe, Patrick/0000-0002-7542-1139; Bras, Jose/0000-0001-8186-0333; Troakes, Claire/0000-0002-1790-7376; Todd, Stephen/0000-0002-2312-9195; Morgan, Kevin/0000-0002-8217-2396; Lowe, James/0000-0002-9856-1599; McGuinness, Bernadette/0000-0002-7028-5633; Hooper, Nigel/0000-0002-5811-3484; Turton, James/0000-0003-2681-0477; Guerreiro, Rita/0000-0001-5879-3486	Alzheimer's Research UK; Medical Research Council (MRC); Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Big Lottery; Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services) [ZO1 AG000950-10]; ARUK; AS; Brains for Dementia Research programme - Alzheimer's Research UK; Alzheimer's Society;  [P50 AG016574];  [U01 AG006786];  [R01 AG18023]; NATIONAL INSTITUTE ON AGING [U01AG052411, RF1AG044546, Z01AG000950, ZIAAG000950, R01AG018023, R01AG044546, P50AG016574, P01AG003991, U24AG021886, ZIAAG000957, P50AG005681, U01AG006786, P01AG026276] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; Medical Research Council [G1100695, MR/L016397/1] Funding Source: researchfish; MRC [G1100695, MR/L016397/1] Funding Source: UKRI	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust/MRC Joint Call in Neurodegeneration Award; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Big Lottery; Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services); ARUK(Alzheimer's Research UK (ARUK)); AS; Brains for Dementia Research programme - Alzheimer's Research UK; Alzheimer's Society; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer's Research UK and Alzheimer's Society.; This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. The Alzheimer's Research UK (ARUK) Consortium: Peter Passmore, David Craig, Janet Johnston, Bernadette McGuinness, Stephen Todd, Queen's University Belfast, UK; Reinhard Heun, Royal Derby Hospital, UK; Heike Kolsch, University of Bonn, Germany; Patrick G. Kehoe, University of Bristol, UK; Nigel M. Hooper, University of Leeds, UK; Emma R.L.C. Vardy, University of Newcastle, UK; David M. Mann, Stuart Pickering-Brown, University of Manchester, UK; Kristelle Brown, James Lowe, Kevin Morgan, University of Nottingham, UK; A. David Smith, Gordon Wilcock, Donald Warden, University of Oxford (OPTIMA), UK; Clive Holmes, University of Southampton, UK.; Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer's Research UK and Alzheimer's Society.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Benitez BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003685; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Cuenco KT, 2011, NEUROBIOL AGING, V32, P249, DOI 10.1016/j.neurobiolaging.2009.02.014; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Feulner TM, 2010, MOL PSYCHIATR, V15, P756, DOI 10.1038/mp.2008.141; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liu GY, 2014, MOL NEUROBIOL, V50, P757, DOI 10.1007/s12035-014-8670-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miyashita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058618; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Nalivaeva NN, 2004, ANN NY ACAD SCI, V1035, P21, DOI 10.1196/annals.1332.002; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rossi GP, 1999, CARDIOVASC RES, V43, P300, DOI 10.1016/S0008-6363(99)00110-8; Sassi C, 2014, NEUROBIOL AGING; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Steinberg S, 2015, NAT GENET; Tan EK, 2009, NEUROBIOL AGING, V30, P1048, DOI 10.1016/j.neurobiolaging.2007.10.013; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019229; Wati H, 2009, BRAIN PATHOL, V19, P48, DOI 10.1111/j.1750-3639.2008.00166.x; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zou K, 2009, J BIOL CHEM, V284, P31914, DOI 10.1074/jbc.M109.011437	53	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0150079	10.1371/journal.pone.0150079	http://dx.doi.org/10.1371/journal.pone.0150079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249223	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700001
J	Song, XZ; Peng, C; Li, GS; He, ZG; Wang, HZ				Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu			Optimization of Operation Parameters for Helical Flow Cleanout with Supercritical CO2 in Horizontal Wells Using Back-Propagation Artificial Neural Network	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENETIC ALGORITHM; PERMEABILITY PREDICTION; WELLBORE CLEANOUT; COMPLEX NETWORK; CARBON-DIOXIDE; OIL; SVM; TEMPERATURE; MODEL	Sand production and blockage are common during the drilling and production of horizontal oil and gas wells as a result of formation breakdown. The use of high-pressure rotating jets and annular helical flow is an effective way to enhance horizontal wellbore cleanout. In this paper, we propose the idea of using supercritical CO2 (SC-CO2) as washing fluid in water-sensitive formation. SC-CO2 is manifested to be effective in preventing formation damage and enhancing production rate as drilling fluid, which justifies tis potential in wellbore cleanout. In order to investigate the effectiveness of SC-CO2 helical flow cleanout, we perform the numerical study on the annular flow field, which significantly affects sand cleanout efficiency, of SC-CO2 jets in horizontal wellbore. Based on the field data, the geometry model and mathematical models were built. Then a numerical simulation of the annular helical flow field by SC-CO2 jets was accomplished. The influences of several key parameters were investigated, and SC-CO2 jets were compared to conventional water jets. The results show that flow rate, ambient temperature, jet temperature, and nozzle assemblies play the most important roles on wellbore flow field. Once the difference between ambient temperatures and jet temperatures is kept constant, the wellbore velocity distributions will not change. With increasing lateral nozzle size or decreasing rear/forward nozzle size, suspending ability of SC-CO2 flow improves obviously. A back-propagation artificial neural network (BP-ANN) was successfully employed to match the operation parameters and SC-CO2 flow velocities. A comprehensive model was achieved to optimize the operation parameters according to two strategies: cost-saving strategy and local optimal strategy. This paper can help to understand the distinct characteristics of SC-CO2 flow. And it is the first time that the BP-ANN is introduced to analyze the flow field during wellbore cleanout in horizontal wells.	[Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu] China Univ Petr, State Key Lab Petr Resource & Prospecting, Beijing, Peoples R China; [Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu] China Univ Petr, Coll Petr Engn, Beijing, Peoples R China	China University of Petroleum; China University of Petroleum	Song, XZ (corresponding author), China Univ Petr, State Key Lab Petr Resource & Prospecting, Beijing, Peoples R China.; Song, XZ (corresponding author), China Univ Petr, Coll Petr Engn, Beijing, Peoples R China.	songxz@cup.edu.cn			Science Foundation of China University of Petroleum, Beijing [2462013 BJRC002, YJRC-2013-04]; National Natural Science Foundation of China [U1562212, 51304226]	Science Foundation of China University of Petroleum, Beijing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is funded by Science Foundation of China University of Petroleum, Beijing (No. 2462013 BJRC002 and No. YJRC-2013-04 received by XZS; URL: www.cup.edu.cn), National Natural Science Foundation of China (U1562212 received by GSL; URL: http://www.nsfc.gov.cn/) and National Natural Science Foundation of China (No. 51304226 received by HZW; URL: www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adankon Mathias M., 2015, ENCY BIOMETRICS, P1504; Ahmadi MA, 2013, GEOPHYS PROSPECT, V61, P582, DOI 10.1111/j.1365-2478.2012.01080.x; Al-Adwani F, 2009, SPE DRILL COMPLETION, V24, P599, DOI 10.2118/114050-PA; Arora S, 201010065902 ARXIV; Balabin RM, 2011, ANALYST, V136, P1703, DOI 10.1039/c0an00387e; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chen WH, 2005, COMPUT OPER RES, V32, P2617, DOI 10.1016/j.cor.2004.03.019; Danquigny J, 2013, P SPE ARCT EXTR ENV; Duan MQ, 2009, SPE DRILL COMPLETION, V24, P229, DOI 10.2118/106707-PA; El-Abbasy MS, 2014, AUTOMAT CONSTR, V45, P50, DOI 10.1016/j.autcon.2014.05.003; Fenghour A, 1998, J PHYS CHEM REF DATA, V27, P31, DOI 10.1063/1.556013; Fomin YD, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022111; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2015, PHYS LETT A, V379, P790, DOI 10.1016/j.physleta.2014.09.004; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gupta A.P., 2006, THESIS LOUISIANA STA; Gupta A.P., 2005, P SPE ANN TECHN C EX; HASAN AR, 1994, SPE PROD FACIL, V9, P211, DOI 10.2118/22948-PA; Hobbs D, 2002, OIL GAS J, V100, P52; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Ihmels EC, 2001, IND ENG CHEM RES, V40, P4470, DOI 10.1021/ie001135g; Irani R, 2011, J PETROL SCI ENG, V78, P6, DOI 10.1016/j.petrol.2011.05.006; Irani R, 2011, EXPERT SYST APPL, V38, P9862, DOI 10.1016/j.eswa.2011.02.046; Ishida T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052788; Kankar PK, 2011, EXPERT SYST APPL, V38, P1876, DOI 10.1016/j.eswa.2010.07.119; Kaydani H, 2011, J PETROL SCI ENG, V78, P497, DOI 10.1016/j.petrol.2011.07.017; Kolle JJ., 2000, P ETCE OMAE 2000 JOI; Li GS, 2012, P IADC SPE AS PAC DR; Li J, 2001, SPE J, V6, P356, DOI 10.2118/74710-PA; Lin YC, 2008, COMP MATER SCI, V43, P752, DOI 10.1016/j.commatsci.2008.01.039; Marcano-Cedeno A, 2011, EXPERT SYST APPL, V38, P9573, DOI 10.1016/j.eswa.2011.01.167; Mellit A, 2010, SOL ENERGY, V84, P807, DOI 10.1016/j.solener.2010.02.006; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; Pakhale GK., 2010, INT J ENG TECHNOLOGY, V2, P245, DOI 10.7763/IJET.2010.V2.128; Peng S, 2012, P IADC SPE AS PAC DR; Pradhan B, 2013, COMPUT GEOSCI-UK, V51, P350, DOI 10.1016/j.cageo.2012.08.023; Ramadan A, 2001, J PETROL SCI ENG, V30, P129, DOI 10.1016/S0920-4105(01)00108-5; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rosine R.S., 2005, 2005 SPEICOTA COILED, DOI [10.2118/94057-MS, DOI 10.2118/94057-MS]; Sach M, 2008, SPE PROD OPER, V23, P379, DOI 10.2118/106857-PA; Samanta B, 2003, ENG APPL ARTIF INTEL, V16, P657, DOI 10.1016/j.engappai.2003.09.006; Sanchez RA, 1999, SPE J, V4, P101, DOI 10.2118/56406-PA; Shah SN, 2007, INT J MULTIPHAS FLOW, V33, P51, DOI 10.1016/j.ijmultiphaseflow.2006.06.006; Song X., 2012, IADC SPE AS PAC DRIL; Song XZ, 2010, J PETROL SCI ENG, V75, P71, DOI 10.1016/j.petrol.2010.10.015; Song XZ, 2014, SPE J, V19, P45, DOI 10.2118/156335-PA; Song XZ, 2010, PETROL SCI, V7, P385, DOI 10.1007/s12182-010-0082-0; Span R, 1996, J PHYS CHEM REF DATA, V25, P1509, DOI 10.1063/1.555991; Terry H, 2010, P IADC SPE AS PAC DR; VESOVIC V, 1990, J PHYS CHEM REF DATA, V19, P763, DOI 10.1063/1.555875; Wang YL, 2010, P 20 INT OFFSH POL E; Wang YY, 2011, P 21 INT OFFSH POL E; Wu TK, 2008, EXPERT SYST APPL, V34, P1846, DOI 10.1016/j.eswa.2007.02.026; Yu SW, 2008, APPL MATH COMPUT, V195, P66, DOI 10.1016/j.amc.2007.04.088; Yu YF, 2009, MODELLING SIMULATION, P333; Zhou Y, 2003, P CAN INT PETR C JUN	60	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156358	10.1371/journal.pone.0156358	http://dx.doi.org/10.1371/journal.pone.0156358			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249026	gold, Green Submitted, Green Published			2022-12-27	WOS:000377184700038
J	Wilke, S; Groenveld, D; Grittner, U; List, J; Floel, A				Wilke, Skadi; Groenveld, Dennis; Grittner, Ulrike; List, Jonathan; Floeel, Agnes			cSPider - Evaluation of a Free and Open-Source Automated Tool to Analyze Corticomotor Silent Period	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MILD COGNITIVE IMPAIRMENT; HUMAN MOTOR CORTEX; CORTICAL EXCITABILITY; INTRACORTICAL INHIBITION; SPORTS CONCUSSION; BRAIN-STIMULATION; IFCN COMMITTEE; MUSCLE; INDIVIDUALS	Background The corticomotor silent period (CSP), as assessed noninvasively by transcranial magnetic stimulation (TMS) in the primary motor cortex, has been found to reflect intracortical inhibitory mechanisms. Analysis of CSP is mostly conducted manually. However, this approach is time-consuming, and comparison of results from different laboratories may be compromised by inter-rater variability in analysis. No open source program for automated analysis is currently available. Methods/Results Here, we describe cross-validation with the manual analysis of an in-house written automated tool to assess CSP (cSPider). Results from automated routine were compared with results of the manual evaluation. We found high inter-method reliability between automated and manual analysis (p<0.001), and significantly reduced time for CSP analysis (median = 10.3 sec for automated analysis of 10 CSPs vs. median = 270 sec for manual analysis of 10 CSPs). cSPider can be downloaded free of charge. Conclusion cSPider allows automated analysis of CSP in a reliable and time-efficient manner. Use of this open-source tool may help to improve comparison of data from different laboratories.	[Wilke, Skadi; Groenveld, Dennis; List, Jonathan; Floeel, Agnes] Charite, Dept Neurol, D-13353 Berlin, Germany; [Groenveld, Dennis] Univ Twente, Dept Biomed Engn, POB 217, NL-7500 AE Enschede, Netherlands; [Grittner, Ulrike; Floeel, Agnes] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Floeel, Agnes] Charite, NeuroCure Cluster Excellence, D-13353 Berlin, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Twente; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wilke, S; Floel, A (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.; Floel, A (corresponding author), Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany.; Floel, A (corresponding author), Charite, NeuroCure Cluster Excellence, D-13353 Berlin, Germany.	skadi.wilke@charite.de; agnes.floeel@charite.de	Grittner, Ulrike/I-2026-2019; Floel, Agnes/A-9426-2017	Grittner, Ulrike/0000-0003-2595-0224; Wilke, Skadi/0000-0002-1424-516X	Deutsche Forschungsgemeinschaft [Fl- 365 379-8/1, 379-10/1, 379-11/1, DFG-Exc-257]; Bundesministerium fur Bildung und Forschung [FKZ0315673A, 01EO0801, 01GY1144]; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Charite Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AF: Fl- 365 379-8/1; 379-10/1; 379-11/1; DFG-Exc-257, http://www.dfg.de/), and Bundesministerium fur Bildung und Forschung (AF: FKZ0315673A; 01EO0801; 01GY1144, https://www.bmbf.de/). JL is a participant in the Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health (http://www.charite.de/charite/, https://www.bihealth.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; [Anonymous], 2014, NATURE, V514, P536, DOI 10.1038/514536a; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Durkovic J, 2008, MANAG INFORATION SYS, V3; Easterbrook SM, 2014, NAT GEOSCI, V7, P779, DOI 10.1038/ngeo2283; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hautzinger M., 2006, BECK DEPRESSIONS INV; Ho KH, 1998, EXP BRAIN RES, V122, P433, DOI 10.1007/s002210050531; Huang YD, 2013, BRIEF BIOINFORM, V14, P391, DOI 10.1093/bib/bbs078; Inghilleri M, 1996, EXP BRAIN RES, V109, P467; Julkunen P, 2013, J NEUROSCI METH, V217, P75, DOI 10.1016/j.jneumeth.2013.04.019; Kallioniemi E, 2014, CLIN NEUROPHYSIOL, V125, P2247, DOI 10.1016/j.clinph.2014.03.012; King NKK, 2006, J NEUROSCI METH, V150, P96, DOI 10.1016/j.jneumeth.2005.06.007; List J, 2014, BRAIN STIMUL, V7, P381, DOI 10.1016/j.brs.2014.02.006; Macdonell RAL, 2001, NEUROLOGY, V57, P706, DOI 10.1212/WNL.57.4.706; McClintock SM, 2011, BIOL PSYCHIAT, V70, P19, DOI 10.1016/j.biopsych.2011.02.031; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Menzler K, 2014, EPILEPSIA, V55, P362, DOI 10.1111/epi.12515; Nilsson J, 1997, J CLIN NEUROPHYSIOL, V14, P136, DOI 10.1097/00004691-199703000-00006; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poston B, 2012, EUR J NEUROSCI, V36, P2964, DOI 10.1111/j.1460-9568.2012.08212.x; Rabago CA, 2009, CLIN NEUROPHYSIOL, V120, P1577, DOI 10.1016/j.clinph.2009.04.020; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Tataroglu C, 2004, SEIZURE-EUR J EPILEP, V13, P481, DOI 10.1016/j.seizure.2003.11.003; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; van Kuijk AAA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-1; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156066	10.1371/journal.pone.0156066	http://dx.doi.org/10.1371/journal.pone.0156066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249017	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700028
J	Martinez, G; Dozo, MT; Gelfo, JN; Marani, H				Martinez, Gaston; Teresa Dozo, Maria; Gelfo, Javier N.; Marani, Hernan			Cranial Morphology of the Late Oligocene Patagonian Notohippid Rhynchippus equinus Ameghino, 1897 (Mammalia, Notoungulata) with Emphases in Basicranial and Auditory Region	PLOS ONE			English	Article							DESEADAN LATE OLIGOCENE; ANATOMY; SKULL; OSTEOLOGY; XENARTHRA; BOLIVIA; PALEOECOLOGY; BIOGEOGRAPHY; PLACENTALIA; ARGENTINA	"Notohippidae" is a probably paraphyletic family of medium sized notoungulates with complete dentition and early tendency to hypsodonty. They have been recorded from early Eocene to early Miocene, being particularly diverse by the late Oligocene. Although Rhynchippus equinus Ameghino is one of the most frequent notohippids in the fossil record, there are scarce data about cranial osteology other than the classical descriptions which date back to the early last century. In this context, we describe the exceptionally preserved specimen MPEF PV 695 (based on CT scanning technique and 3D reconstruction) with the aim of improving our knowledge of the species, especially regarding auditory region (petrosal, tympanic and surrounding elements), sphenoidal and occipital complexes. Besides a modular description of the whole skull, osteological correlates identified on the basicranium are used to infer some soft-tissue elements, especially those associated with vessels that supply the head, mainly intracranially. One of the most informative elements was the petrosal bone, whose general morphology matches that expected for a toxodont. The endocranial surface, together with the surrounding parietal, basisphenoid, occipital, and squamosal, enabled us to propose the location and communication of main venous sinuses of the lateral head wall (temporal, inferior and sigmoid sinuses), whereas the tympanic aspect and the identification of a posterior carotid artery canal provided strong evidence in support of an intratympanic course of the internal carotid artery, a controversial issue among notoungulates. Regarding the arrangement of tympanic and paratympanic spaces, the preservation of the specimen allowed us to appreciate the three connected spaces that constitute a heavily pneumatized middle ear; the epitympanic sinus, the tympanic cavity itself, and the ventral expansion of the tympanic cavity through the notably inflated bullae. We hope this study stimulates further inquires and provides potentially informative data for future research involving other representatives of the order.	[Martinez, Gaston; Teresa Dozo, Maria] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Geol & Paleontol, Puerto Madryn, Chubut, Argentina; [Martinez, Gaston] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Gelfo, Javier N.] Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Gelfo, Javier N.] Univ Nacl La Plata, Fac Ciencias Nat & Museo, RA-1900 La Plata, Buenos Aires, Argentina; [Marani, Hernan] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; National University of La Plata; Museo La Plata; Universidad Nacional de la Patagonia San Juan Bosco	Martinez, G (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Geol & Paleontol, Puerto Madryn, Chubut, Argentina.; Martinez, G (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina.	gmartinez@cenpat-conicet.gob.ar	Gelfo, Javier N./AAW-1905-2021	Gelfo, Javier N./0000-0002-9989-5902				Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; Ameghino F., 1897, B I GEOGRAFICO ARGEN, V18, P405; Ameghino F., 1895, B I GEOGRAFICO ARGEN, V15, P1; Ameghino F., 1901, B ACAD NACL CIENCIAS, V16, P349; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Billet G, 2008, ZOOL J LINN SOC-LOND, V152, P153, DOI 10.1111/j.1096-3642.2007.00388.x; Billet G, 2013, J VERTEBR PALEONTOL, V33, P455, DOI 10.1080/02724634.2013.722153; Billet G, 2011, J SYST PALAEONTOL, V9, P481, DOI 10.1080/14772019.2010.528456; Billet G, 2011, NATURWISSENSCHAFTEN, V98, P509, DOI 10.1007/s00114-011-0795-y; Billet G, 2010, J MAMM EVOL, V17, P21, DOI 10.1007/s10914-009-9123-0; Billet G, 2009, ZOOL J LINN SOC-LOND, V155, P458, DOI 10.1111/j.1096-3642.2008.00445.x; Bond M., 1986, ACT 4 C ARG PAL BIOE, V2, P173; Bond Mariano, 1993, Ameghiniana, V30, P59; Bown Thomas M., 1993, Journal of Vertebrate Paleontology, V13, p27A; Buckley M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2671; Cerdeno E, 2015, J SYST PALAEONTOL, V13, P943, DOI 10.1080/14772019.2014.982727; Cerdeno E, 2010, J VERTEBR PALEONTOL, V30, P1805, DOI 10.1080/02724634.2010.520781; CIFELLI R L, 1989, Bulletin of the Museum of Comparative Zoology, V152, P1; Cifelli R.L., 1985, Topics in Geobiology, V4, P249; CIFELLI RL, 1993, MAMMAL PHYLOGENY : PLACENTALS, P195; Feruglio E., 1949, DESCRIPCION GEOLOGIC; Forasiepi AM, 2015, PALAEONTOL Z, V89, P611, DOI 10.1007/s12542-014-0233-5; Gabbert SL, 2004, B AM MUS NAT HIST, P177, DOI 10.1206/0003-0090(2004)285<0177:C>2.0.CO;2; Lopez DAG, 2011, AMEGHINIANA, V48, P3, DOI 10.5710/AMGH.v48i1(262); Gaudin TJ, 2011, ANN CARNEGIE MUS, V80, P5, DOI 10.2992/007.080.0102; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Kondrashov P.E., 2004, PALEOGENE MAMMALS NE, V26, P195; Kondrashov PE, 2005, RES 2 C LAT AM PAL V, P144; Kramarz AG, 2011, PALAEONTOL Z, V85, P185, DOI 10.1007/s12542-010-0087-4; Lema H., 2001, B SERVICIO GEOLOGICO, V261, P1; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Loomis FB., 1914, DESEADO FORMATION PA; Lopez Guillermo M., 2010, P143; MacPhee RDE, 2014, B AM MUS NAT HIST, P1; MacPhee RDE, 1981, CONTRIB PRIMATOL, V18, P1; Macrini TE, 2010, J ANAT, V233, P442; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Moore W.J., 1981, MAMMALIAN SKULL; Muchlinski MN, 2008, ANAT REC, V291, P1221, DOI 10.1002/ar.20742; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; O'Leary MA, 2010, B AM MUS NAT HIST, P4; Owen R., 1853, PHILOS T ROY SOC LON, V143, P291, DOI DOI 10.1098/RSTL.1853.0011; Patterson B., 1972, P247; PATTERSON B, 1977, Fieldiana Geology, V33, P397; Patterson B., 1934, Field Museum Publications Chicago Geological Series, V6, P83; Patterson B., 1932, FIELD MUSEUM NATURAL, V6, P1; Patterson B., 1936, FIELD MUSEUM NATURAL, V6, P199; Pezzuchi H., 2000, B SERVICIO GEOLOGICO, V244, P1; Re G., 2010, PALEONTOLOGY GRAN BA, P46; REGUERO MA, 1996, NATURALIA PATAGONICA, V4, P43; Reguero MA, 2007, J PALEONTOL, V81, P1301, DOI 10.1666/05-100.1; Reig O.A., 1981, Monographiae Naturae, P1; Roth S., 1903, ANALES MUSEO LA PLAT, V5, P1; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; Rougier Guillermo W., 2006, P269; Shockey BJ, 1997, J VERTEBR PALEONTOL, V17, P584, DOI 10.1080/02724634.1997.10011005; Simpson G. G., 1936, American Museum Novitates, V824, P1; SIMPSON GEORGE GAYLORD, 1934, AMER MUS NOVITATES, V750, P1; SIMPSON GEORGE GAYLORD, 1948, BULL AMER MUS NAT HIST, V91, P1; SIMPSON GEORGE GAYLORD, 1932, AMER MUS NOVITATES [NEW YORK], V578, P1; SIMPSON GEORGE GAYLORD, 1932, AMER MUS NOVITATES [NEW YORK], V577, P1; Simpson GG., 1967, B AM MUS NAT HIST, V137, P1; SORIA M F, 1989, Anais da Academia Brasileira de Ciencias, V61, P157; Dozo MT, 2016, J MAMM EVOL, V23, P1, DOI 10.1007/s10914-015-9298-5; Dozo MT, 2010, J VERTEBR PALEONTOL, V30, P1818, DOI 10.1080/02724634.2010.521534; van der Klaauw CJ, 1931, B AM MUS NAT HIST, V62, P1; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Welker F, 2015, NATURE, V522, P81, DOI 10.1038/nature14249; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible John R., 1993, American Museum Novitates, V3072, P1; Wible JR, 2010, ANN CARNEGIE MUS, V79, P1, DOI 10.2992/007.079.0101; Wible JR, 2009, J MAMM EVOL, V16, P199, DOI 10.1007/s10914-009-9116-z; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321; Wible John R., 1995, American Museum Novitates, V3149, P1; WIBLE JR, 1987, ZOOL J LINN SOC-LOND, V91, P107, DOI 10.1111/j.1096-3642.1987.tb01725.x; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wible JR, 2004, ANN CARNEGIE MUS, V73, P117; Wible JR, 2000, B AM MUS NAT HIST, P4	79	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156558	10.1371/journal.pone.0156558	http://dx.doi.org/10.1371/journal.pone.0156558			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232883	Green Published, gold			2022-12-27	WOS:000376883000042
J	Chen, J; Moinard, M; Xu, JP; Wang, SX; Foulongne-Oriol, M; Zhao, RL; Hyde, KD; Callac, P				Chen, Jie; Moinard, Magalie; Xu, Jianping; Wang, Shouxian; Foulongne-Oriol, Marie; Zhao, Ruilin; Hyde, Kevin D.; Callac, Philippe			Genetic Analyses of the Internal Transcribed Spacer Sequences Suggest Introgression and Duplication in the Medicinal Mushroom Agaricus subrufescens	PLOS ONE			English	Article							CONCERTED EVOLUTION; HETEROKARYONS; CULTIVATION; BURNETTII; LINKAGE; MARKER; REGION; BRAZIL; FUNGI; MAP	The internal transcribed spacer (ITS) region of the nuclear ribosomal RNA gene cluster is widely used in fungal taxonomy and phylogeographic studies. The medicinal and edible mushroom Agaricus subrufescens has a worldwide distribution with a high level of polymorphism in the ITS region. A previous analysis suggested notable ITS sequence heterogeneity within the wild French isolate CA487. The objective of this study was to investigate the pattern and potential mechanism of ITS sequence heterogeneity within this strain. Using PCR, cloning, and sequencing, we identified three types of ITS sequences, A, B, and C with a balanced distribution, which differed from each other at 13 polymorphic positions. The phylogenetic comparisons with samples from different continents revealed that the type C sequence was similar to those found in Oceanian and Asian specimens of A. subrufescens while types A and B sequences were close to those found in the Americas or in Europe. We further investigated the inheritance of these three ITS sequence types by analyzing their distribution among single-spore isolates from CA487. In this analysis, three co-dominant markers were used firstly to distinguish the homokaryotic offspring from the heterokaryotic offspring. The homokaryotic offspring were then analyzed for their ITS types. Our genetic analyses revealed that types A and B were two alleles segregating at one locus ITSI, while type C was not allelic with types A and B but was located at another unlinked locus ITSII. Furthermore, type C was present in only one of the two constitutive haploid nuclei (n) of the heterokaryotic (n+n) parent CA487. These data suggest that there was a relatively recent introduction of the type C sequence and a duplication of the ITS locus in this strain. Whether other genes were also transferred and duplicated and their impacts on genome structure and stability remain to be investigated.	[Chen, Jie; Moinard, Magalie; Foulongne-Oriol, Marie; Callac, Philippe] INRA, MycSA, Villenave Dornon, France; [Chen, Jie; Hyde, Kevin D.] Mae Fah Luang Univ, Ctr Excellence Fungal Res, Chiang Rai, Thailand; [Chen, Jie; Hyde, Kevin D.] Mae Fah Luang Univ, Sch Sci, Chiang Rai, Thailand; [Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Wang, Shouxian] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Wang, Shouxian] Beijing Engn Res Ctr Edible Mushroom, Beijing, Peoples R China; [Zhao, Ruilin] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	INRAE; Mae Fah Luang University; Mae Fah Luang University; McMaster University; Beijing Academy of Agriculture & Forestry; Chinese Academy of Sciences; Institute of Microbiology, CAS	Callac, P (corresponding author), INRA, MycSA, Villenave Dornon, France.	philippe.callac@bordeaux.inra.fr	Foulongne-Oriol, Marie/AAB-9831-2019; Hyde, Kevin D/F-7890-2010; Chen, Jie/E-6836-2019	Callac, Philippe/0000-0001-6860-0983; Foulongne-Oriol, Marie/0000-0002-5668-5286; Chen, Jie/0000-0001-9298-4892	French Ministry of Foreign Affairs; Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences [KJCX20151408]; National Natural Science Foundation of China [31000013, 31360014, 31470152]; Thailand Research Fund Grant [BRG 5580009]	French Ministry of Foreign Affairs; Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thailand Research Fund Grant(Thailand Research Fund (TRF))	This research was supported by the French Ministry of Foreign Affairs ( project AGASIA of the regional program Bio-Asie; PC), the Special Science and Technology Innovation Project of Beijing Academy of Agriculture and Forestry Sciences ( KJCX20151408; SW), the National Natural Science Foundation of China ( Project ID: 31000013, 31360014 and 31470152; RZ) and the Thailand Research Fund Grant ( BRG 5580009; KDH) entitled "Taxonomy, Phylogeny and Biochemistry of Thai Basidiomycetes." The funders had no role in study design, data colletion and analysis, decision to publish, or preparation of the manuscript.	Callac P, 1997, FEMS MICROBIOL LETT, V146, P235, DOI 10.1111/j.1574-6968.1997.tb10199.x; Chen J, 2016, PHYTOTAXA, V252, P1, DOI 10.11646/phytotaxa.252.1.1; COEN ES, 1983, CELL, V33, P849, DOI 10.1016/0092-8674(83)90027-2; de Brito MR, 2016, APPL MICROBIOL BIOT, V100, P781, DOI 10.1007/s00253-015-7070-7; Fell JW, 2007, FEMS YEAST RES, V7, P1399, DOI 10.1111/j.1567-1364.2007.00297.x; Foulongne-Oriol M, 2016, G3-GENES GENOM GENET, V6, P1217, DOI 10.1534/g3.115.025718; Foulongne-Oriol M, 2014, APPL MICROBIOL BIOT, V98, P7879, DOI 10.1007/s00253-014-5844-y; Foulongne-Oriol M, 2010, FUNGAL GENET BIOL, V47, P226, DOI 10.1016/j.fgb.2009.12.003; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Gui Y, 2015, FUNGAL BIOL-UK, V119, P79, DOI 10.1016/j.funbio.2014.10.005; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hijri M, 1999, FUNGAL GENET BIOL, V26, P141, DOI 10.1006/fgbi.1998.1112; HILLIS DM, 1991, SCIENCE, V251, P308, DOI 10.1126/science.1987647; James TY, 2009, MYCOL RES, V113, P583, DOI 10.1016/j.mycres.2009.01.006; Kerrigan RW, 2005, MYCOLOGIA, V97, P12, DOI 10.3852/mycologia.97.1.12; KERRIGAN RW, 1994, EXP MYCOL, V18, P193, DOI 10.1006/emyc.1994.1020; KERRIGAN RW, 1992, MYCOLOGIA, V84, P575, DOI 10.2307/3760324; Kerrigan RW, 1993, REP TOTTORI MYCOL I, V31, P188; Largeteau ML, 2011, APPL MICROBIOL BIOT, V92, P897, DOI 10.1007/s00253-011-3630-7; Li Y, 2013, MOL PHYLOGENET EVOL, V68, P373, DOI 10.1016/j.ympev.2013.04.010; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Llarena-Hernandez CR, 2014, J SCI FOOD AGR, V94, P77, DOI 10.1002/jsfa.6200; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Rees BJ, 2013, MYCOLOGIA, V105, P1043, DOI 10.3852/12-404; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith ME, 2007, MYCORRHIZA, V18, P15, DOI 10.1007/s00572-007-0148-z; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thongklang N, 2016, MYCOSCIENCE, V57, P239, DOI 10.1016/j.myc.2016.02.003; Thongklang N, 2014, FUNGAL BIOL-UK, V118, P1013, DOI 10.1016/j.funbio.2014.10.004; Wang DM, 2005, CAN J MICROBIOL, V51, P113, DOI 10.1139/W04-118; Weitemier K, 2015, PEERJ, V2, DOI 10.7717/peerj.718; Wisitrassameewong K, 2012, CHIANG MAI J SCI, V39, P281; Wisitrassameewong K, 2012, SAUDI J BIOL SCI, V19, P131, DOI 10.1016/j.sjbs.2012.01.003; Zhao RL, 2016, FUNGAL DIVERS; Zhao RL, 2011, FUNGAL DIVERS, V51, P279, DOI 10.1007/s13225-011-0136-7	35	18	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156250	10.1371/journal.pone.0156250	http://dx.doi.org/10.1371/journal.pone.0156250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228131	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500094
J	Domergue, S; Bony, C; Maumus, M; Toupet, K; Frouin, E; Rigau, V; Vozenin, MC; Magalon, G; Jorgensen, C; Noel, D				Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Frouin, Eric; Rigau, Valerie; Vozenin, Marie-Catherine; Magalon, Guy; Jorgensen, Christian; Noel, Daniele			Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars	PLOS ONE			English	Article							REPAIR; SCAFFOLD; THERAPY; KELOIDS; GRAFTS; UPDATE; INJURY; MODEL	Hypertrophic scars (HTS) are characterized by excessive amount of collagen deposition and principally occur following burn injuries or surgeries. In absence of effective treatments, the use of mesenchymal stem/stromal cells, which have been shown to attenuate fibrosis in various applications, seems of interest. The objectives of the present study were therefore to evaluate the effect of human adipose tissue-derived mesenchymal stem cells (hASC) on a pre-existing HTS in a humanized skin graft model in Nude mice and to compare the efficacy of hASCs versus stromal vascular fraction (SVF). We found that injection of SVF or hASCs resulted in an attenuation of HTS as noticed after clinical evaluation of skin thickness, which was associated with lower total collagen contents in the skins of treated mice and a reduced dermis thickness after histological analysis. Although both SVF and hASCs were able to significantly reduce the clinical and histological parameters of HTS, hASCs appeared to be more efficient than SVF. The therapeutic effect of hASCs was attributed to higher expression of TGF beta 3 and HGF, which are important anti-fibrotic mediators, and to higher levels of MMP-2 and MMP-2/TIMP-2 ratio, which reflect the remodelling activity responsible for fibrosis resorption. These results demonstrated the therapeutic potential of hASCs for clinical applications of hypertrophic scarring.	[Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Jorgensen, Christian; Noel, Daniele] Hop St Eloi, INSERM, U1183, F-34295 Montpellier, France; [Domergue, Sophie; Bony, Claire; Maumus, Marie; Toupet, Karine; Frouin, Eric; Jorgensen, Christian; Noel, Daniele] Univ Montpellier, UFR Med, F-34967 Montpellier, France; [Domergue, Sophie] Hop Gui De Chauliac, Chirurg Plast Reconstructrice & Esthet, F-34295 Montpellier, France; [Frouin, Eric; Rigau, Valerie] Hop Gui De Chauliac, Biopathol, F-34295 Montpellier, France; [Vozenin, Marie-Catherine] CHU Vaudois, Radiat Oncol Lab, Lausanne, Switzerland; [Magalon, Guy] Hop Conception, Chirurg Plast, F-13005 Marseille, France; [Jorgensen, Christian; Noel, Daniele] Hop Lapeyronie, Serv Immunorhumatol Therapeut, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier	Noel, D (corresponding author), Hop St Eloi, INSERM, U1183, F-34295 Montpellier, France.; Noel, D (corresponding author), Univ Montpellier, UFR Med, F-34967 Montpellier, France.; Noel, D (corresponding author), Hop Lapeyronie, Serv Immunorhumatol Therapeut, F-34295 Montpellier, France.	daniele.noel@inserm.fr	Vozenin, Marie-Catherine/AAR-2268-2021; Noel, Daniele/E-5719-2016; Maumus, Marie/AAD-1725-2019	Vozenin, Marie-Catherine/0000-0002-2109-8073; Noel, Daniele/0000-0002-3498-3776; Frouin, Eric/0000-0002-8432-3194; jorgensen, christian/0000-0001-6947-8094	Inserm Institute; University of Montpellier; Centre Hospitalier Regional Universitaire of Montpellier; Agence Nationale pour la Recherche [ANR-11-INSB-005]	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier; Centre Hospitalier Regional Universitaire of Montpellier; Agence Nationale pour la Recherche(French National Research Agency (ANR))	Work in the laboratory Inserm U1183 was supported by the Inserm Institute, the University of Montpellier and funding from the Centre Hospitalier Regional Universitaire of Montpellier. We also thank the Agence Nationale pour la Recherche for support of the national infrastructure: "ECELLFRANCE: Development of a national adult mesenchymal stem cell based therapy platform" (ANR-11-INSB-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178; Badiavas EV, 2003, J CELL PHYSIOL, V196, P245, DOI 10.1002/jcp.10260; Ramos MLC, 2008, J BURN CARE RES, V29, P363, DOI 10.1097/BCR.0b013e3181667557; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duscher D., 2015, GERONTOLOGY; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gimble JM, 2012, REGEN MED, V7, P225, DOI [10.2217/RME.11.119, 10.2217/rme.11.119]; Granel B, ANN RHEUM DIS; Jackson WM, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt111; Kim WS, 2007, J DERMATOL SCI, V48, P15, DOI 10.1016/j.jdermsci.2007.05.018; Kokai LE, 2014, TRANSL RES, V163, P399, DOI 10.1016/j.trsl.2013.11.009; Kolle SFT, 2013, LANCET, V382, P1113, DOI 10.1016/S0140-6736(13)61410-5; Laverdet B, 2014, PATHOL BIOL, V62, P108, DOI 10.1016/j.patbio.2014.01.002; Liu SY, 2014, J INVEST DERMATOL, V134, P2648, DOI 10.1038/jid.2014.169; Liu YL, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt526; Maumus M, 2013, STEM CELL RES, V11, P834, DOI 10.1016/j.scr.2013.05.008; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033; Rabello FB, 2014, CLINICS, V69, P565, DOI 10.6061/clinics/2014(08)11; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Semon JA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt391; Song C, 2014, ANN PLAS SURG, V73, pS108, DOI 10.1097/SAP.0000000000000256; Travers RL, 2015, INT J OBESITY, V39, P762, DOI 10.1038/ijo.2014.195; Usunier B, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/340257; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Yang DY, 2007, PLAST RECONSTR SURG, V119, P104, DOI 10.1097/01.prs.0000244828.80490.62; Yasuda K, 2012, CYTOTHERAPY, V14, P1089, DOI 10.3109/14653249.2012.693157	29	34	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156161	10.1371/journal.pone.0156161	http://dx.doi.org/10.1371/journal.pone.0156161			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227960	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500074
J	Leekitcharoenphon, P; Raufu, I; Nielsen, MT; Lund, BSR; Ameh, JA; Ambali, AG; Sorensen, G; Le Hello, S; Aarestrup, FM; Hendriksen, RS				Leekitcharoenphon, Pimlapas; Raufu, Ibrahim; Nielsen, Mette T.; Lund, Birthe S. Rosenqvist; Ameh, James A.; Ambali, Abdul G.; Sorensen, Gitte; Le Hello, Simon; Aarestrup, Frank M.; Hendriksen, Rene S.			Investigating Salmonella Eko from Various Sources in Nigeria by Whole Genome Sequencing to Identify the Source of Human Infections	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; CHICKENS; PREVALENCE; RESISTANCE; SEROTYPES; SEROVARS; REGION; IBADAN	Twenty-six Salmonella enterica serovar Eko isolated from various sources in Nigeria were investigated by whole genome sequencing to identify the source of human infections. Diversity among the isolates was observed and camel and cattle were identified as the primary reservoirs and the most likely source of the human infections.	[Leekitcharoenphon, Pimlapas; Nielsen, Mette T.; Aarestrup, Frank M.; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Nielsen, Mette T.; Aarestrup, Frank M.; Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [Raufu, Ibrahim; Ambali, Abdul G.] Univ Ilorin, Dept Vet Microbiol, Fac Vet Med, Ilorin, Nigeria; [Lund, Birthe S. Rosenqvist; Sorensen, Gitte] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Ameh, James A.] Univ Abuja, Dept Vet Microbiol & Parasitol, Fac Vet Med, Abuja, Nigeria; [Le Hello, Simon] Ctr Natl Reference Salmonella, Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France	Technical University of Denmark; University of Ilorin; Technical University of Denmark; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hendriksen, RS (corresponding author), Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark.; Hendriksen, RS (corresponding author), European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark.	rshe@food.dtu.dk	Le Hello, Simon/K-6584-2018; Leekitcharoenphon, Pimlapas/AAB-5487-2021	Le Hello, Simon/0000-0001-7993-4305; Hendriksen, Rene S./0000-0003-2934-8214; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142; Aarestrup, Frank/0000-0002-7116-2723	Danish Council for Strategic Research [09067103]; Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Center for Genomic Epidemiology; World Health Organization Global Foodborne Infections Network	This work was supported by the Danish Council for Strategic Research ( grant number: 09067103), Center for Genomic Epidemiology ( www.genomicepidemiology.org), and by the World Health Organization Global Foodborne Infections Network ( www.who.int/gfn).	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Carattoli A, 2014, ANTIMICROB AGENTS CH; Fashae K, 2014, FOLIA MICROBIOL, V59, P69, DOI 10.1007/s12223-013-0270-6; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garcia-Migura L, 2012, MICROB DRUG RESIST, V18, P88, DOI 10.1089/mdr.2011.0064; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Hendriksen RS, 2011, FOODBORNE PATHOG DIS; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Raufu I, 2013, J APPL MICROBIOL, V115, P1059, DOI 10.1111/jam.12304; Raufu I, 2009, FOODBORNE PATHOG DIS, V6, P425, DOI 10.1089/fpd.2008.0150; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tusevljak N, 2012, FOODBORNE PATHOG DIS, V9, P487, DOI 10.1089/fpd.2011.1063; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Wouafo M, 2010, MICROB DRUG RESIST, V16, P171, DOI 10.1089/mdr.2009.0127; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	22	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156212	10.1371/journal.pone.0156212	http://dx.doi.org/10.1371/journal.pone.0156212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228329	Green Submitted, gold, Green Published			2022-12-27	WOS:000376882500081
J	Li, L; Lee, NJ; Glicksberg, BS; Radbill, BD; Dudley, JT				Li, Li; Lee, Nathan J.; Glicksberg, Benjamin S.; Radbill, Brian D.; Dudley, Joel T.			Data-Driven Identification of Risk Factors of Patient Satisfaction at a Large Urban Academic Medical Center	PLOS ONE			English	Article							COMMUNICATION-SKILLS; PATIENTS PERCEPTIONS; INPATIENT CARE; EXPERIENCE; HCAHPS	Background The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey is the first publicly reported nationwide survey to evaluate and compare hospitals. Increasing patient satisfaction is an important goal as it aims to achieve a more effective and efficient healthcare delivery system. In this study, we develop and apply an integrative, data-driven approach to identify clinical risk factors that associate with patient satisfaction outcomes. Methods We included 1,771 unique adult patients who completed the HCAHPS survey and were discharged from the inpatient Medicine service from 2010 to 2012. We collected 266 clinical features including patient demographics, lab measurements, medications, disease categories, and procedures. We developed and applied a data-driven approach to identify risk factors that associate with patient satisfaction outcomes. Findings We identify 102 significant risk factors associating with 18 surveyed questions. The most significantly recurrent clinical risk factors were: self-evaluation of health, education level, Asian, White, treatment in BMT oncology division, being prescribed a new medication. Patients who were prescribed pregabalin were less satisfied particularly in relation to communication with nurses and pain management. Explanation of medication usage was associated with communication with nurses (q = 0.001); however, explanation of medication side effects was associated with communication with doctors (q = 0.003). Overall hospital rating was associated with hospital environment, communication with doctors, and communication about medicines. However, patient likelihood to recommend hospital was associated with hospital environment, communication aboutmedicines, pain management, and communication with nurse. Conclusions Our study identified a number of putatively novel clinical risk factors for patient satisfaction that suggest new opportunities to better understand and manage patient satisfaction. Hospitals can use a data-driven approach to identify clinical risk factors for poor patient satisfaction to support development of specific interventions to improve patients' experience of care.	[Li, Li; Glicksberg, Benjamin S.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 770 Lexington Ave,15th Floor, New York, NY 10065 USA; [Lee, Nathan J.; Radbill, Brian D.] Icahn Sch Med Mt Sinai, Dept Med, One Gustave L Levy Pl, New York, NY 10029 USA; [Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, One Gustave L Levy Pl, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 770 Lexington Ave,15th Floor, New York, NY 10065 USA.; Radbill, BD (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, One Gustave L Levy Pl, New York, NY 10029 USA.; Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, One Gustave L Levy Pl, New York, NY 10029 USA.	brian.radbill@mountsinai.org; joel.dudley@mssm.edu	Glicksberg, Benjamin/I-9500-2019	Glicksberg, Benjamin/0000-0003-4515-8090; Li, Li/0000-0001-6746-4297	Mount Sinai Institution fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023515] Funding Source: NIH RePORTER	Mount Sinai Institution fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by Mount Sinai Institution fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LA, 1993, PATIENT EDUC COUNS, V20, P27, DOI 10.1016/0738-3991(93)90114-C; [Anonymous], 2014, HCAHPS PAT LEV CORR; Boulding W, 2011, AM J MANAG CARE, V17, P41; Centers for Medicare & Medicaid Services (CMS) HHS, 2011, Fed Regist, V76, P26490; Cowen ME, 1998, MED CARE, V36, P1108, DOI 10.1097/00005650-199807000-00016; Elliott MN, 2012, HEALTH SERV RES, V47, P1482, DOI 10.1111/j.1475-6773.2012.01389.x; Elliott MN, 2010, MED CARE RES REV, V67, P56, DOI 10.1177/1077558709339066; Elliott MN, 2009, MED CARE, V47, P842, DOI 10.1097/MLR.0b013e318197b22a; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Glickman SW, 2010, CIRC-CARDIOVASC QUAL, V3, P188, DOI 10.1161/CIRCOUTCOMES.109.900597; Goldstein E, 2010, MED CARE RES REV, V67, P74, DOI 10.1177/1077558709341066; Hurvich CM., 1993, J TIME SER ANAL, V14, P271, DOI DOI 10.1111/J.1467-9892.1993.TB00144.X; Ihaka RGR, 1996, J COMPUT GRAPH STAT, V5, P5; Jensen BF, 2011, PATIENT EDUC COUNS, V84, P163, DOI 10.1016/j.pec.2010.08.028; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Lehrman WG, 2010, MED CARE RES REV, V67, P38, DOI 10.1177/1077558709341323; Lyratzopoulos G, 2012, BMJ QUAL SAF, V21, P21, DOI 10.1136/bmjqs-2011-000088; Manary MP, 2013, NEW ENGL J MED, V368, P201, DOI 10.1056/NEJMp1211775; Medicine Io, 2001, CROSSING QUALITY CHA; O'Leary KJ, 2013, J HOSP MED, V8, P315, DOI 10.1002/jhm.2041; Radtke K, 2013, CLIN NURSE SPEC, V27, P19, DOI 10.1097/NUR.0b013e3182777011; Rao JK, 2007, MED CARE, V45, P340, DOI 10.1097/01.mlr.0000254516.04961.d5; Saha S, 2003, AM J MED QUAL, V18, P256, DOI 10.1177/106286060301800606; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Zhang Y, 2007, AM J MED QUAL, V22, P42, DOI 10.1177/1062860606296329	28	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156076	10.1371/journal.pone.0156076	http://dx.doi.org/10.1371/journal.pone.0156076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27228056	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500062
J	Bhatara, A; Laukka, P; Boll-Avetisyan, N; Granjon, L; Elfenbein, HA; Banziger, T				Bhatara, Anjali; Laukka, Petri; Boll-Avetisyan, Natalie; Granjon, Lionel; Elfenbein, Hillary Anger; Banziger, Tanja			Second Language Ability and Emotional Prosody Perception	PLOS ONE			English	Article							RECOGNITION; CHINESE	The present study examines the effect of language experience on vocal emotion perception in a second language. Native speakers of French with varying levels of self-reported English ability were asked to identify emotions from vocal expressions produced by American actors in a forced-choice task, and to rate their pleasantness, power, alertness and intensity on continuous scales. Stimuli included emotionally expressive English speech (emotional prosody) and non-linguistic vocalizations (affect bursts), and a baseline condition with Swiss-French pseudo-speech. Results revealed effects of English ability on the recognition of emotions in English speech but not in non-linguistic vocalizations. Specifically, higher English ability was associated with less accurate identification of positive emotions, but not with the interpretation of negative emotions. Moreover, higher English ability was associated with lower ratings of pleasantness and power, again only for emotional prosody. This suggests that second language skills may sometimes interfere with emotion recognition from speech prosody, particularly for positive emotions.	[Bhatara, Anjali; Granjon, Lionel] CNRS, UMR 8242, Lab Psychol Percept, Paris, France; [Bhatara, Anjali; Granjon, Lionel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Laukka, Petri] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Laukka, Petri] Sodertorn Univ, Sch Social Sci, Huddinge, Sweden; [Boll-Avetisyan, Natalie] Univ Potsdam, Dept Linguist, Potsdam, Germany; [Elfenbein, Hillary Anger] Washington Univ, John M Olin Sch Business, St Louis, MO 63130 USA; [Banziger, Tanja] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Stockholm University; Sodertorn University; University of Potsdam; Washington University (WUSTL); Mid-Sweden University	Bhatara, A (corresponding author), CNRS, UMR 8242, Lab Psychol Percept, Paris, France.; Bhatara, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	bhatara@gmail.com	Laukka, Petri/B-5259-2008	Laukka, Petri/0000-0001-8771-6818; Boll-Avetisyan, Natalie/0000-0001-5446-946X	Marie Curie Incoming International Fellowship, Cordis, European Commission [302452]	Marie Curie Incoming International Fellowship, Cordis, European Commission	This work was funded by a Marie Curie Incoming International Fellowship, Cordis, European Commission, Project 302452 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrov R, 2013, TRAMES-J HUMANIT SOC, V17, P159, DOI 10.3176/tr.2013.2.04; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhatara A, 2013, J ACOUST SOC AM, V134, P3828, DOI 10.1121/1.4823848; Boll-Avetisyan N, 2016, BILING-LANG COGN, V19, P971, DOI 10.1017/S1366728915000425; Bryant GA, 2008, J COGN CULT, V8, P135, DOI 10.1163/156770908X289242; Cordaro DT, 2016, EMOTION, V16, P117, DOI 10.1037/emo0000100; Dromey C, 2005, SPEECH COMMUN, V47, P351, DOI 10.1016/j.specom.2004.09.010; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Elfenbein HA, 2003, CURR DIR PSYCHOL SCI, V12, P159, DOI 10.1111/1467-8721.01252; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Graham C., 2001, IRAL-INT REV APPL LI, V39, P19, DOI DOI 10.1515/IRAL.39.1.19; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Laukka P, 2010, P LREC 2010 WORKSH C, P53; Laukka P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00353; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Paulmann S, 2014, COGNITION EMOTION, V28, P230, DOI 10.1080/02699931.2013.812033; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; R Core Team, R LANG ENV STAT COMP; Sauter D, 2010, CURR DIR PSYCHOL SCI, V19, P36, DOI 10.1177/0963721409359290; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Shochi T, 2010, SPEECH PROSODY  0226, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhu YY, 2013, DUTCH J APPL LINGUIS, V2, P170, DOI 10.1075/dujal.2.2.03zhu	26	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156855	10.1371/journal.pone.0156855	http://dx.doi.org/10.1371/journal.pone.0156855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DN6XB	27253326	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700066
J	Burger, MC; Zeiner, PS; Jahnke, K; Wagner, M; Mittelbronn, M; Steinbach, JP				Burger, Michael C.; Zeiner, Pia S.; Jahnke, Kolja; Wagner, Marlies; Mittelbronn, Michel; Steinbach, Joachim P.			Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; RISK-FACTORS; MALIGNANT GLIOMAS; RANDOMIZED-TRIAL; DISSEMINATION; EFFICACY; OUTCOMES; RECURRENCE; CYTARABINE; PATTERNS	Leptomeningeal dissemination of a primary brain tumor is a condition which is challenging to treat, as it often occurs in rather late disease stages in highly pretreated patients. Its prognosis is dismal and there is still no accepted standard of care. We report here a good clinical effect with a partial response in three out of nine patients and a stable disease with improvement on symptoms in two more patients following systemic anti-angiogenic treatment with bevacizumab (BEV) alone or in combination with chemo-and/or radiotherapy in a series of patients with leptomeningeal dissemination from primary brain tumors (diffuse astrocytoma WHO degrees II, anaplastic astrocytoma WHO degrees III, anaplastic oligodendroglioma WHO degrees III, primitive neuroectodermal tumor and glioblastoma, both WHO degrees IV). This translated into effective symptom control in five out of nine patients, but only moderate progression-free and overall survival times were reached. Partial responses as assessed by RANO criteria were observed in three patients (each one with anaplastic oligodendroglioma, primitive neuroectodermal tumor and glioblastoma). In these patients progression-free survival (PFS) intervals of 17, 10 and 20 weeks were achieved. In three patients (each one with diffuse astrocytoma, anaplastic astrocytoma and primitive neuroectodermal tumor) stable disease was observed with PFS of 13, 30 and 8 weeks. Another three patients (all with glioblastoma) were primary non-responders and deteriorated rapidly with PFS of 3 to 4 weeks. No severe adverse events were seen. These experiences suggest that the combination of BEV with more conventional therapy schemes with chemo-and/or radiotherapy may be a palliative treatment option for patients with leptomeningeal dissemination of brain tumors.	[Burger, Michael C.; Steinbach, Joachim P.] Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Zeiner, Pia S.; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Zeiner, Pia S.; Jahnke, Kolja] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Wagner, Marlies] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Burger, MC (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany.	michael.burger@kgu.de	Wagner, Marlies/AAZ-5487-2021; Wagner, Marlies/AAL-3357-2020; Wagner, Marlies/GQA-9181-2022	Mittelbronn, Michel/0000-0002-2998-052X				Alatakis S, 2001, SURG NEUROL, V56, P33, DOI 10.1016/S0090-3019(01)00459-1; Bae JS, 2011, J KOREAN NEUROSURG S, V49, P334, DOI 10.3340/jkns.2011.49.6.334; Chamberlain MC, 2003, NEUROSURGERY, V52, P324, DOI 10.1227/01.NEU.0000043929.31608.62; Dardis C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00220; Braganca KC, 2010, J NEURO-ONCOL, V100, P443, DOI 10.1007/s11060-010-0200-2; Fiorentino A, 2012, INT J NEUROSCI, V122, P691, DOI 10.3109/00207454.2012.704456; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Glantz MJ, 1999, J CLIN ONCOL, V17, P3110, DOI 10.1200/JCO.1999.17.10.3110; Herrlinger U, 2004, BRIT J CANCER, V91, P219, DOI 10.1038/sj.bjc.6601953; Hsieh PC, 2008, CHILD NERV SYST, V24, P1463, DOI 10.1007/s00381-008-0697-2; Huang TY, 1999, J NEURO-ONCOL, V45, P9, DOI 10.1023/A:1006377312403; Karaca M, 2006, NEUROL INDIA, V54, P428; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Li KG, 2011, MED ONCOL, V28, P1116, DOI 10.1007/s12032-010-9580-6; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mandel JJ, 2014, J NEURO-ONCOL, V120, P597, DOI 10.1007/s11060-014-1592-1; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; Noh JH, 2015, ACTA NEUROCHIR, V157, P569, DOI 10.1007/s00701-015-2344-5; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Privitera G, 2009, J ONCOL, V2009, DOI 10.1155/2009/247873; Ruben JD, 2006, INT J RADIAT ONCOL, V65, P499, DOI 10.1016/j.ijrobp.2005.12.002; Saito R, 2003, J NEURO-ONCOL, V61, P227, DOI 10.1023/A:1022536828345; Sandmann T, 2015, J CLIN ONCOL, V33, P2735, DOI 10.1200/JCO.2015.61.5005; SCHWANINGER M, 1992, J NEURO-ONCOL, V12, P93; Scott BJ, 2014, J NEURO-ONCOL, V119, P361, DOI 10.1007/s11060-014-1486-2; Sengupta S, 2015, OXF MED CASE REP, P254, DOI 10.1093/omcr/omv010; Slongo ML, 2007, NEURO-ONCOLOGY, V9, P384, DOI 10.1215/15228517-2007-032; Taal W, 2014, LANCET ONCOL, V15, P943, DOI 10.1016/S1470-2045(14)70314-6; Thompson EM, 2011, J NEURO-ONCOL, V103, P353, DOI 10.1007/s11060-010-0397-0; VERTOSICK FT, 1990, NEUROSURGERY, V27, P516, DOI 10.1227/00006123-199010000-00002; Vredenburgh JJ, 2010, ONCOLOGIST, V15, P1329, DOI 10.1634/theoncologist.2010-0105; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Zuniga RM, 2009, J NEURO-ONCOL, V91, P329, DOI 10.1007/s11060-008-9718-y	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155315	10.1371/journal.pone.0155315	http://dx.doi.org/10.1371/journal.pone.0155315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253224	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700005
J	de Baaij, JHF; Kompatscher, A; Viering, DHHM; Bos, C; Bindels, RJM; Hoenderop, JGJ				de Baaij, Jeroen H. F.; Kompatscher, Andreas; Viering, Daan H. H. M.; Bos, Caro; Bindels, Rene J. M.; Hoenderop, Joost G. J.			P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis	PLOS ONE			English	Article							RENAL TUBULAR TRANSPORT; RECEPTOR SUBUNITS; P2X(6) RECEPTORS; ION CHANNELS; ATP; NUCLEOTIDES; ACTIVATION; PURINOCEPTORS; FAMILY; ALPHA	ATP-mediated signaling is an important regulator of electrolyte transport in the kidney. The purinergic cation channel P2X6 has been previously localized to the distal convoluted tubule (DCT), a nephron segment important for Mg2+ and Na+ reabsorption, but its role in ion transport remains unknown. In this study, P2x6 knockout (P2x6(-/-)) mice were generated to investigate the role of P2X6 in renal electrolyte transport. The P2x6(-/-) animals displayed a normal phenotype and did not differ physiologically from wild type mice. Differences in serum concentration and 24-hrs urine excretion of Na+, K+, Mg2+ and Ca2+ were not detected between P2x6(+/+), P2x6(+/-) and P2x6(-/-) mice. Quantitative PCR was applied to examine potential compensatory changes in renal expression levels of other P2x subunits and electrolyte transporters, including P2x1-5, P2x7, Trpm6, Ncc, Egf, Cldn16, Scnn1, Slc12a3, Slc41a1, Slc41a3, Cnnm2, Kcnj10 and Fxyd2. Additionally, protein levels of P2X2 and P2X4 were assessed in P2x6(+/+) and P2x6(-/-) mouse kidneys. However, significant changes in expression were not detected. Furthermore, no compensatory changes in gene expression could be demonstrated in heart material isolated from P2x6(-/-) mice. Except for a significant (P<0.05) upregulation of P2x2 in the heart of P2x6(-/-) mice compared to the P2x6(+/+) mice. Thus, our data suggests that purinergic signaling via P2X6 is not significantly involved in the regulation of renal electrolyte handling under normal physiological conditions.	[de Baaij, Jeroen H. F.; Kompatscher, Andreas; Viering, Daan H. H. M.; Bos, Caro; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Bos, Caro/V-2390-2017; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014; Viering, Daan/T-7808-2018	Bos, Caro/0000-0001-5016-9435; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Viering, Daan/0000-0002-6398-0646	Netherlands Organization for Scientific Research [NWO VICI 016.130.668]; EURenOmics project from the European Union [305608]; NWO [Rubicon 825.14.021]; Dutch Kidney Foundation [Kolff 14OKG17]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EURenOmics project from the European Union; NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO VICI 016.130.668) and the EURenOmics project from the European Union seventh Framework Programme (FP7/2007-2013, agreement no. 305608). Dr. Jeroen de Baaij is supported by grants from NWO (Rubicon 825.14.021) and the Dutch Kidney Foundation (Kolff 14OKG17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulkumaran N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00194; Banfi C, 2005, J MOL CELL CARDIOL, V39, P929, DOI 10.1016/j.yjmcc.2005.09.002; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Booth JWR, 2012, CLIN NEPHROL, V78, P154, DOI 10.5414/CN107325; Cheung KK, 2015, PURINERG SIGNAL, V11, P127, DOI 10.1007/s11302-014-9441-4; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; CUSACK NJ, 1990, ANN NY ACAD SCI, V603, P172; Dai LJ, 2001, AM J PHYSIOL-RENAL, V281, pF833, DOI 10.1152/ajprenal.0349.2000; de Baaij JHF, 2014, PFLUG ARCH EUR J PHY, V466, P1941, DOI 10.1007/s00424-014-1440-3; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Diaz-Hernandez JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123121; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim MJ, 2014, NEPHROL DIAL TRANSPL, V29, P1350, DOI 10.1093/ndt/gfu019; Le KT, 1998, J NEUROSCI, V18, P7152; Leipziger J, 2011, CURR OPIN NEPHROL HY, V20, P518, DOI 10.1097/MNH.0b013e3283487393; Marques RD, 2012, AM J PHYSIOL-RENAL, V302, pF487, DOI 10.1152/ajprenal.00570.2011; Menzies RI, 2015, ACTA PHYSIOL, V213, P232, DOI 10.1111/apha.12412; Musa H, 2009, N-S ARCH PHARMACOL, V379, P541, DOI 10.1007/s00210-009-0403-2; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Sprinthall R., 2011, BASIC STATISTICAL AN; Stokes L, 2011, HYPERTENSION, V58, P1086, DOI 10.1161/HYPERTENSIONAHA.111.176180; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Wildman SSP, 2008, NEPHRON PHYSIOL, V108, P60, DOI 10.1159/000122028; Wildman SSP, 2009, J AM SOC NEPHROL, V20, P1480, DOI 10.1681/ASN.2008070686	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156803	10.1371/journal.pone.0156803	http://dx.doi.org/10.1371/journal.pone.0156803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254077	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700062
J	Penterling, C; Drexler, GA; Bohland, C; Stamp, R; Wilke, C; Braselmann, H; Caldwell, RB; Reindl, J; Girst, S; Greubel, C; Siebenwirth, C; Mansour, WY; Borgmann, K; Dollinger, G; Unger, K; Friedl, AA				Penterling, Corina; Drexler, Guido A.; Boehland, Claudia; Stamp, Ramona; Wilke, Christina; Braselmann, Herbert; Caldwell, Randolph B.; Reindl, Judith; Girst, Stefanie; Greubel, Christoph; Siebenwirth, Christian; Mansour, Wael Y.; Borgmann, Kerstin; Dollinger, Guenther; Unger, Kristian; Friedl, Anna A.			Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair	PLOS ONE			English	Article							DAMAGE RESPONSE PROTEIN; DEACETYLASE INHIBITORS; VALPROIC ACID; ONCOMETABOLITE 2-HYDROXYGLUTARATE; TRANSCRIPTIONAL REPRESSION; H3K4 DEMETHYLASE; GASTRIC-CANCER; TUMOR-CELLS; CHROMATIN; RBP2	Histone demethylases have recently gained interest as potential targets in cancer treatment and several histone demethylases have been implicated in the DNA damage response. We investigated the effects of siRNA-mediated depletion of histone demethylase Jarid1A (KDM5A, RBP2), which demethylates transcription activating tri- and dimethylated lysine 4 at histone H3 (H3K4me3/me2), on growth characteristics and cellular response to radiation in several cancer cell lines. In unirradiated cells Jarid1A depletion lead to histone hyperacetylation while not affecting cell growth. In irradiated cells, depletion of Jarid1A significantly increased cellular radiosensitivity. Unexpectedly, the hyperacetylation phenotype did not lead to disturbed accumulation of DNA damage response and repair factors 53BP1, BRCA1, or Rad51 at damage sites, nor did it influence resolution of radiation-induced foci or rejoining of reporter constructs. We conclude that the radiation sensitivity observed following depletion of Jarid1A is not caused by a deficiency in repair of DNA double-strand breaks.	[Penterling, Corina; Drexler, Guido A.; Boehland, Claudia; Stamp, Ramona; Friedl, Anna A.] Univ Munich, Dept Radiat Oncol, Munich, Germany; [Wilke, Christina; Braselmann, Herbert; Caldwell, Randolph B.; Unger, Kristian] Helmholtz Ctr Munich, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Reindl, Judith; Girst, Stefanie; Greubel, Christoph; Dollinger, Guenther] Univ Bundeswehr Munchen, Inst Angew Phys & Messtech, Neubiberg, Germany; [Siebenwirth, Christian] Tech Univ Munich, Dept Radiat Oncol, D-80290 Munich, Germany; [Mansour, Wael Y.; Borgmann, Kerstin] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany; [Mansour, Wael Y.] Cairo Univ, Natl Canc Inst, Dept Tumor Biol, Cairo, Egypt; [Unger, Kristian; Friedl, Anna A.] Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Bundeswehr University Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Friedl, AA (corresponding author), Univ Munich, Dept Radiat Oncol, Munich, Germany.; Friedl, AA (corresponding author), Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany.	anna.friedl@lrz.uni-muenchen.de	Friedl, Anna A/B-1628-2010; Unger, Kristian/F-3730-2018	Friedl, Anna A/0000-0002-7425-6151; Unger, Kristian/0000-0002-0374-2320; Reindl, Judith/0000-0002-3238-8586; Mansour, Wael/0000-0003-0641-2885; Caldwell, Randolph/0000-0003-3933-3243	European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration) [FP7-249689]; Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics"	European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration); Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics"(German Research Foundation (DFG))	This work was supported by European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration), FP7-249689, www.doremi-noe.net, to AAF and GD; Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics", www.dfg.de, to AAF and GD. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R A LANGUAGE AND ENV; Auer S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-139; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Blattmann C, 2012, STRAHLENTHER ONKOL, V188, P168, DOI 10.1007/s00066-011-0028-5; Braselmann H, 2014, CFASSAY STAT ANAL CO; Chang LJ, 2012, CANCER BIOL THER, V13, P1047, DOI 10.4161/cbt.21047; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Drexler GA, 2015, J BIOSCIENCES, V40, P629, DOI 10.1007/s12038-015-9535-3; Drexler GA, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0350-7; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fukuda T, 2015, CANCER SCI, V106, P1050, DOI 10.1111/cas.12717; Ganai SA, 2015, J BIOMOL STRUCT DYN, V33, P1185, DOI 10.1080/07391102.2014.938247; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Girst S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02511; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P423, DOI 10.1007/s00411-008-0182-z; Grigaravicius P, 2009, CHEMPHYSCHEM, V10, P79, DOI 10.1002/cphc.200800725; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Hable V, 2009, NUCL INSTRUM METH B, V267, P2090, DOI 10.1016/j.nimb.2009.03.071; Hable V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041943; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Hou JL, 2012, AM J TRANSL RES, V4, P247; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huang Po-Hsien, 2011, Mol Cell Pharmacol, V3, P39; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Kawano T, 2010, INT J ONCOL, V37, P787, DOI 10.3892/ijo_00000728; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Khoury-Haddad H, 2015, CELL CYCLE, V14, P950, DOI 10.1080/15384101.2015.1014147; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Klein BJ, 2014, CELL REP, V6, P325, DOI 10.1016/j.celrep.2013.12.021; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kralj M, 2003, CANCER GENE THER, V10, P457, DOI 10.1038/sj.cgt.7700588; Kuo YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125343; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li LP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-81; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111; Liang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069784; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Makita N, 2015, ONCOL REP, V34, P1185, DOI 10.3892/or.2015.4089; Mannironi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086002; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nagy Z, 2009, TRENDS CELL BIOL, V19, P617, DOI 10.1016/j.tcb.2009.08.010; Neumayer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110994; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; PERRY M, 1981, J BIOL CHEM, V256, P3313; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Reindl J, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066005; Seiler DM, 2011, CHROMOSOME RES, V19, P883, DOI 10.1007/s10577-011-9244-1; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Takata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075622; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Vasireddy Raja S, 2010, J Vis Exp, DOI 10.3791/2203; Wang X., 2014, B PATIENTS RHEUM ART, V2014, P1; Williams K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096545; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zinner R, 2007, ADV ENZYME REGUL, V47, P223, DOI 10.1016/j.advenzreg.2007.01.005	99	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156599	10.1371/journal.pone.0156599	http://dx.doi.org/10.1371/journal.pone.0156599			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253695	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700041
J	Agudelo, M; Figueroa, G; Parira, T; Yndart, A; Munoz, K; Atluri, V; Samikkannu, T; Nair, MP				Agudelo, Marisela; Figueroa, Gloria; Parira, Tiyash; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.			Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; GENE-EXPRESSION; COMBINATION; MECHANISMS; RESPONSES; DRINKING; RATS	Epigenetic mechanisms have been shown to play a role in alcohol use disorders (AUDs) and may prove to be valuable therapeutic targets. However, the involvement of histone deacetylases (HDACs) on alcohol-induced oxidative stress of human primary monocyte-derived dendritic cells (MDDCs) has not been elucidated. In the current study, we took a novel approach combining ex vivo, in vitro and in silico analyses to elucidate the mechanisms of alcohol-induced oxidative stress and role of HDACs in the periphery. ex vivo and in vitro analyses of alcohol-modulation of class I HDACs and activity by MDDCs from self-reported alcohol users and non-alcohol users was performed. Additionally, MDDCs treated with alcohol were assessed using qRT-PCR, western blot, and fluorometric assay. The functional effects of alcohol-induce oxidative stress were measured in vitro using PCR array and in silico using gene expression network analysis. Our findings show, for the first time, that MDDCs from self-reported alcohol users have higher levels of class I HDACs compare to controls and alcohol treatment in vitro differentially modulates HDACs expression. Further, HDAC inhibitors (HDACi) blocked alcohol-induction of class I HDACs and modulated alcohol-induced oxidative stress related genes expressed by MDDCs. In silico analysis revealed new target genes and pathways on the mode of action of alcohol and HDACi. Findings elucidating the ability of alcohol to modulate class I HDACs may be useful for the treatment of alcohol-induced oxidative damage and may delineate new potential immune-modulatory mechanisms.	[Agudelo, Marisela; Figueroa, Gloria; Parira, Tiyash; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Agudelo, Marisela; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.] Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Agudelo, M (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.; Agudelo, M (corresponding author), Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	magudelo@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institute on Alcohol Abuse and Alcoholism [K99/R00 AA021264, R00 AA021264]; National Institute on Drug Abuse [R01DA034547]; Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine; FIU- Office of Research and Economic Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA021264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034547] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine; FIU- Office of Research and Economic Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is supported by the National Institute on Alcohol Abuse and Alcoholism, award K99/R00 AA021264 and partially by the National Institute on Drug Abuse, award # R01DA034547. Additional support as part of startup package has been received from the Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, and FIU- Office of Research and Economic Development.; This research is supported by the National Institute on Alcohol Abuse and Alcoholism, award R00 AA021264 and partially by the National Institute on Drug Abuse, award # R01DA034547. Additional support as part of startup package has been received from the Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, and FIU- Office of Research and Economic Development.	Agudelo M, 2013, DRUG ALCOHOL DEPEN, V133, P789, DOI 10.1016/j.drugalcdep.2013.08.023; Agudelo M, 2012, ALCOHOL, V46, P635, DOI 10.1016/j.alcohol.2012.03.005; Agudelo M, 2011, ALCOHOL CLIN EXP RES, V35, P1550, DOI 10.1111/j.1530-0277.2011.01492.x; Aloman C, 2007, GASTROENTEROLOGY, V132, P698, DOI 10.1053/j.gastro.2006.11.016; Aloman C, 2011, ALCOHOL CLIN EXP RES, V35, P776, DOI 10.1111/j.1530-0277.2010.01397.x; [Anonymous], 2010, RETH DRINK ALC YOUR; Lopez-Moreno JA, 2015, ALCOHOL CLIN EXP RES, V39, P1939, DOI 10.1111/acer.12850; Arora DS, 2013, NEUROPSYCHOPHARMACOL, V38, P1674, DOI 10.1038/npp.2013.65; Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Chang SL, 2014, INT REV NEUROBIOL, V118, P403, DOI 10.1016/B978-0-12-801284-0.00013-0; Del Boca FK, 2000, ADDICTION, V95, pS347; Dolganiuc A, 2003, ALCOHOL CLIN EXP RES, V27, P1023, DOI 10.1097/01.ALC.0000071745.63433.32; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Greenfield TK, 2014, ALCOHOL RES-CURR REV, V36, P39; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kirpich I, 2013, ALCOHOL CLIN EXP RES, V37, P1920, DOI 10.1111/acer.12172; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Liu XQ, 2011, INT J CLIN EXP MED, V4, P252; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nair MPN, 2005, AAPS J, V7, pE572, DOI 10.1208/aapsj070358; Pandey D, 2014, ARTERIOSCL THROM VAS, V34, P1556, DOI 10.1161/ATVBAHA.114.303685; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Romeo J, 2010, P NUTR SOC, V69, P341, DOI 10.1017/S0029665110001904; Saiyed ZM, 2011, NEUROCHEM INT, V58, P656, DOI 10.1016/j.neuint.2011.02.004; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Sarkar S, 2013, ALCOHOL CLIN EXP RES, V37, P1082, DOI 10.1111/acer.12077; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sun JY, 2011, CL LYMPH MYELOM LEUK, V11, P152, DOI 10.3816/CLML.2011.n.036; Szabo G, 2004, ALCOHOL CLIN EXP RES, V28, P824, DOI 10.1097/01.ALC.0000127104.80398.9B; Szabo G, 1999, CONSEQUENCES ALCOHOL, P830; Wang R, 2010, NEUROSCI LETT, V483, P137, DOI 10.1016/j.neulet.2010.07.080; Warnault V, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.4; Watson P Marc D, 2009, Commun Integr Biol, V2, P11; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	39	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156421	10.1371/journal.pone.0156421	http://dx.doi.org/10.1371/journal.pone.0156421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249803	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700043
J	Cruz-Rivera, E; Malaquias, MAE				Cruz-Rivera, Edwin; Malaquias, Manuel Antonio E.			Ecosystem Alterations and Species Range Shifts: An Atlantic-Mediterranean Cephalaspidean Gastropod in an Inland Egyptian Lake	PLOS ONE			English	Article							SYSTEMATIC REVISION; MARINE; QARUN; MOLLUSCA; QUARUN; OCEAN; SALINIZATION; MESOGRAZERS; DIVERSITY; INFERENCE	The eastern Atlantic and Mediterranean marine Cephalaspidea gastropod Haminoea orbignyana was collected from Lake Qarun (Fayoum, Egypt), a landlocked lake that has undergone a shift from freshwater to estuarine conditions in the past 100 years. Species identity was confirmed by both morphological (anatomical dissection and scanning electron microscopy) and molecular methods (COI gene phylogeny). Observations suggested a robust population of H. orbignyana in the lake with a density of ca. 64 individuals/m(2) and ca. 105 egg masses/m(2) during surveys conducted in the summer of 2013. The vast majority of snails and egg masses were found under rocks. Observations of egg masses in the lab showed a gradual change from whitish to yellow-green as the eggs matured and the release of veliger larvae alone after about a week. Although adult cephalaspideans readily consumed filamentous red and green algae, and cyanobacteria, laboratory trials showed that they consumed significantly more of the red alga Ceramium sp., than of the green alga Cladophora glomerata, with consumption of Oscillatoria margaritifera being similar to those on the two algae. When grown on these resources for 16 days, H. orbignyana maintained their mass on the rhodophyte and cyanobacterium, but not in starvation controls. No cephalaspideans grew over the course of this experiment. Lake Qarun has been periodically restocked with Mediterranean fishes and prawns since the 1920s to maintain local fisheries, which represents a possible route of colonization for H. orbignyana. Yet, based on literature records, it seems more likely that invasion of the lake by this gastropod species has occurred only within the last 20 years. As human activities redistribute species through direct and indirect means, the structure of the community of this inland lake has become unpredictable and the long-term effects of these recent introductions are unknown.	[Cruz-Rivera, Edwin] Univ Virgin Isl, Dept Biol Sci, 2 John Brewers Bay, St Thomas, VI 00802 USA; [Malaquias, Manuel Antonio E.] Univ Bergen, Phylogenet Systemat & Evolut Res Grp, Sect Taxon & Evolut, Dept Nat Hist,Univ Museum Bergen, PB 7800, N-5020 Bergen, Norway	University of the Virgin Islands; University of Bergen	Malaquias, MAE (corresponding author), Univ Bergen, Phylogenet Systemat & Evolut Res Grp, Sect Taxon & Evolut, Dept Nat Hist,Univ Museum Bergen, PB 7800, N-5020 Bergen, Norway.	Manuel.Malaquias@uib.no	Malaquias, Manuel/N-2450-2019	Malaquias, Manuel/0000-0002-9668-945X; Cruz-Rivera, Edwin/0000-0002-5376-9863	Faculty Improvement Grant from the American University in Cairo	Faculty Improvement Grant from the American University in Cairo	ECR was supported by a Faculty Improvement Grant from the American University in Cairo. MAEM received no specific funding for this work.	Abd Ellah RG., 2009, EGYPT J FISH MAR SCI, V1, P51; ABDELMALEK SA, 1980, HYDROBIOLOGIA, V75, P201, DOI 10.1007/BF00006483; Abu-Zied RH, 2011, J PALEOLIMNOL, V45, P167, DOI 10.1007/s10933-010-9489-2; Allen RM, 2014, MAR BIOL RES, V10, P515, DOI 10.1080/17451000.2013.831177; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Birks Hilary H., 2001, Aquatic Ecology, V35, P405, DOI 10.1023/A:1013265310922; Bouchet P, 2015, HAMINOEA ORBIGNYANA; Bower DS, 2012, WILDLIFE RES, V39, P705, DOI 10.1071/WR11214; CARLSON C., 2003, MICRONESICA, V35-36, P272; Cheek CA, 2016, ECOL FRESHW FISH, V25, P340, DOI 10.1111/eff.12214; Crocetta F, 2013, ZOOKEYS, P91, DOI 10.3897/zookeys.277.4362; Cruz-Rivera E, 2006, CORAL REEFS, V25, P617, DOI 10.1007/s00338-006-0134-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eilertsen MH, 2013, ZOOL J LINN SOC-LOND, V167, P389, DOI 10.1111/zoj.12013; El-Shabrawy GM, 2009, MONOGR BIOL, V89, P95; El-Shabrawy GM, 2001, J EGYPTIAN ACAD SOC, V2, P29; EL-ZARKA SALAH EL-DIN, 1963, JOUR CONS, V28, P126; EZZAT AA, 1979, J FISH BIOL, V14, P39, DOI 10.1111/j.1095-8649.1979.tb03493.x; Flower RJ, 2006, J PALEOLIMNOL, V35, P1, DOI 10.1007/s10933-005-6393-2; Fouda M, INFORM SHEET RAMSAR; Gardner EW, 2012, MEM I EGYPT, V18, P1; GIBSON GD, 1995, MAR ECOL PROG SER, V121, P139, DOI 10.3354/meps121139; GIBSON GD, 1989, VELIGER, V32, P409; Gillis PL, 2011, ENVIRON POLLUT, V159, P1702, DOI 10.1016/j.envpol.2011.02.032; Gosliner Terrence M., 2006, Proceedings of the California Academy of Sciences, V57, P1003; Hanson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077457; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISHAK MM, 1980, AQUACULTURE, V21, P365, DOI 10.1016/0044-8486(80)90072-1; ISHAK MM, 1982, AQUACULTURE, V27, P251, DOI 10.1016/0044-8486(82)90060-6; James KR, 2003, AUST J BOT, V51, P703, DOI 10.1071/BT02110; Lapointe NWR, 2012, BIOL INVASIONS, V14, P1931, DOI 10.1007/s10530-012-0204-2; Lowe S., 2000, ENCY BIOL INVASIONS; Luque G, 2014, BIOL INVASIONS, V16, P981, DOI 10.1007/s10530-013-0561-5; Macali A, 2013, SCI MAR, V77, P649, DOI 10.3989/scimar.03858.05M; Malaquias MAE, 2006, J MOLLUS STUD, V72, P89, DOI 10.1093/mollus/eyi052; Malaquias MAE, 2004, J MAR BIOL ASSOC UK, V84, P767, DOI 10.1017/S0025315404009890h; Malaquias MAE, 2008, ZOOL J LINN SOC-LOND, V153, P453, DOI 10.1111/j.1096-3642.2008.00369.x; Mansour H. A., 2008, Egyptian Journal of Biology, V10, P54; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; MESHAL AH, 1977, J CONSEIL, V37, P137; Miyazono S, 2015, SCI TOTAL ENVIRON, V511, P444, DOI 10.1016/j.scitotenv.2014.12.079; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Naguib M., 1961, Kieler Meeresforschungen, V17, P94; Neves R, 2009, J MOLLUS STUD, V75, P127, DOI 10.1093/mollus/eyp004; Ohnheiser LT, 2013, ZOOL J LINN SOC-LOND, V167, P273, DOI 10.1111/zoj.12000; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; POINER A, 1989, TETRAHEDRON, V45, P617; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rambaut A., 2007, TRACER V1 4; Rogers CN, 1998, MAR ECOL PROG SER, V166, P301, DOI 10.3354/meps166301; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSE K D, 1972, Nautilus, V85, P141; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Schaefer K, 1996, OPHELIA, V45, P17, DOI 10.1080/00785326.1996.10432460; Smith EA., 1908, J MOLLUS STUD, V8, P9; Soliman G.F., 1989, B I OCEANOGR FISH AR, V15, P93; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Too CC, 2014, ZOOTAXA, V3794, P355, DOI 10.11646/zootaxa.3794.3.3; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wahed MSMA, 2015, AQUAT GEOCHEM, V21, P31, DOI 10.1007/s10498-015-9253-3; Zabbey N, 2013, J MAR BIOL ASSOC UK, V93, P249, DOI 10.1017/S0025315411001615; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	66	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156760	10.1371/journal.pone.0156760	http://dx.doi.org/10.1371/journal.pone.0156760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248835	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700077
J	Batistel, F; Osorio, JS; Ferrari, A; Trevisi, E; Socha, MT; Loor, JJ				Batistel, Fernanda; Osorio, Johan S.; Ferrari, Annarita; Trevisi, Erminio; Socha, Michael T.; Loor, Juan J.			Immunometabolic Status during the Peripartum Period Is Enhanced with Supplemental Zn, Mn, and Cu from Amino Acid Complexes and Co from Co Glucoheptonate	PLOS ONE			English	Article							ORGANIC TRACE MINERALS; TRANSITION DAIRY-COWS; OXIDATIVE STRESS; LIVER-FUNCTION; ANTIINFLAMMATORY RESPONSE; REPRODUCTIVE-PERFORMANCE; INFLAMMATORY CONDITIONS; IMMUNE-RESPONSE; SMARTAMINE M; METABOLISM	The peripartum (or transition) period is the most-critical phase in the productive life of lactating dairy cows and optimal supply of trace minerals through more bioavailable forms could minimize the negative effects associated with this phase. Twenty Holstein cows received a common prepartal diet and postpartal diet. Both diets were partially supplemented with an inorganic (INO) mix of Zn, Mn, and Cu to supply 35, 45, and 6 ppm, respectively, of the diet dry matter (DM). Cows were assigned to treatments in a randomized completed block design, receiving an daily oral bolus with INO or organic trace minerals (AAC) Zn, Mn, Cu, and Co to achieve 75, 65, 11, and 1 ppm supplemental, respectively, in the diet DM. Liver tissue and blood samples were collected throughout the experiment. The lower glutamic-oxaloacetic transaminase concentration after 15 days in milk in AAC cows indicate lower hepatic cell damage. The concentration of cholesterol and albumin increased, while IL-6 decreased over time in AAC cows compared with INO indicating a lower degree of inflammation and better liver function. Although the acute-phase protein ceruloplasmin tended to be lower in AAC cows and corresponded with the reduction in the inflammatory status, the tendency for greater serum amyloid A concentration in AAC indicated an inconsistent response on acute-phase proteins. Oxygen radical absorbance capacity increased over time in AAC cows. Furthermore, the concentrations of nitric oxide, nitrite, nitrate, and the ferric reducing ability of plasma decreased with AAC indicating a lower oxidative stress status. The expression of IL10 and ALB in liver tissue was greater overall in AAC cows reinforcing the anti-inflammatory response detected in plasma. The greater overall expression of PCK1 in AAC cows indicated a greater gluconeogenic capacity, and partly explained the greater milk production response over time. Overall, feeding organic trace minerals as complexed with amino acids during the transition period improved liver function and decreased inflammation and oxidative stress.	[Batistel, Fernanda; Osorio, Johan S.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA; [Batistel, Fernanda; Osorio, Johan S.; Loor, Juan J.] Univ Illinois, Div Nutr Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA; [Ferrari, Annarita; Trevisi, Erminio] Univ Cattolica Sacro Cuore, Ist Zootecn Fac Sci Agr Alimentari & Ambientali, I-29122 Piacenza, Italy; [Socha, Michael T.] Zinpro Corp, Eden Prairie, MN 55344 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Catholic University of the Sacred Heart; Zinpro Corporation	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA.; Loor, JJ (corresponding author), Univ Illinois, Div Nutr Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012; Batistel, Fernanda/AAD-3867-2019; Osorio, Johan/J-3703-2019; Ferrari, Anna Rita/AAB-9899-2019	Loor, Juan J./0000-0003-1586-4365; Osorio, Johan/0000-0001-6192-0917; Ferrari, Anna Rita/0000-0002-5397-6184; Batistel, Fernanda/0000-0001-7313-7153	National Institute of Food and Agriculture [ILLU-538-914]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Zinpro Corporation	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Zinpro Corporation	Juan Loor (JL) was supported by National Institute of Food and Agriculture (Grant: ILLU-538-914). Fernanda Batistel (FB) was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Zinpro Corporation provided support to JL and Michael Socha (MS). Zinpro Corporation had a role in the study design and provided financial support to cover costs of animal use, data collection, and sample analyses. The specific roles of the authors are articulated in the 'author contributions' section.	ALDRED AR, 1993, ACUTE PHASE PROTEINS, P21; Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bertoni G, 2015, ANIM PROD SCI, V55, P943, DOI 10.1071/AN14863; Bertoni G., 1993, 8 INT S TRAC EL MAN, P662; Bertoni G, 2013, VET CLIN N AM-FOOD A, V29, P413, DOI 10.1016/j.cvfa.2013.04.004; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BROWN DH, 1980, J MED CHEM, V23, P729, DOI 10.1021/jm00181a006; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Celi P, 2011, OXID STRESS APPL BAS, P191, DOI 10.1007/978-1-61779-071-3_13; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Credille BC, 2014, J VET INTERN MED, V28, P1606, DOI 10.1111/jvim.12418; Doepel L, 2009, J DAIRY SCI, V92, P3233, DOI 10.3168/jds.2008-1595; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Eldaim MAA, 2010, J DAIRY RES, V77, P27, DOI 10.1017/S0022029909990276; Elsasser TH, 2000, BIOLOGY OF ANIMAL STRESS, P77, DOI 10.1079/9780851993591.0077; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Goff JP, 2002, J DAIRY SCI, V85, P1427, DOI 10.3168/jds.S0022-0302(02)74210-0; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Henning SM, 1997, FREE RADICAL BIO MED, V23, P936, DOI 10.1016/S0891-5849(97)00097-X; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Huzzey JM, 2015, PREV VET MED, V120, P291, DOI 10.1016/j.prevetmed.2015.04.011; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Jacometo CB, 2015, J DAIRY SCI, V98, P7717, DOI 10.3168/jds.2015-9359; Jahan N, 2015, VET IMMUNOL IMMUNOP, V165, P119, DOI 10.1016/j.vetimm.2015.04.003; Jansen T., 2012, FRONT PHARMACOL, V16, P3016; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lee SH, 2013, ENDOCRINOLOGY, V154, P1029, DOI 10.1210/en.2012-1445; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; NRC, 2001, NUTR REQ DAIR CATTL, V7th; Osorio JS, 2016, J DAIRY SCI, V99, P1868, DOI 10.3168/jds.2015-10040; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Rabiee AR, 2010, J DAIRY SCI, V93, P4239, DOI 10.3168/jds.2010-3058; REYNOLDS CK, 1988, J DAIRY SCI, V71, P1803, DOI 10.3168/jds.S0022-0302(88)79749-0; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Satre MA, 2001, FEBS LETT, V491, P266, DOI 10.1016/S0014-5793(01)02211-6; Schweigert FJ, 2001, CURR OPIN CLIN NUTR, V4, P477, DOI 10.1097/00075197-200111000-00002; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; SKINNER JG, 1991, VET REC, V128, P147, DOI 10.1136/vr.128.7.147; SOBOCINSKI PZ, 1982, ANN NY ACAD SCI, V389, P354, DOI 10.1111/j.1749-6632.1982.tb22149.x; Sordillo LM, 2014, ANIM PROD SCI, V54, P1204, DOI 10.1071/AN14503; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Spears JW, 2008, VET J, V176, P70, DOI 10.1016/j.tvjl.2007.12.015; Spears JW, 2003, J NUTR, V133, p1506S, DOI 10.1093/jn/133.5.1506S; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Swecker WS, 2014, VET CLIN N AM-FOOD A, V30, P671, DOI 10.1016/j.cvfa.2014.07.008; Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348; Trevisi E, 2013, J DAIRY SCI, V96, P5712, DOI 10.3168/jds.2012-6375; Trevisi E., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P489; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Van Merris V, 2004, J DAIRY SCI, V87, P980, DOI 10.3168/jds.S0022-0302(04)73243-9; Wang RL, 2013, BIOL TRACE ELEM RES, V152, P16, DOI 10.1007/s12011-012-9585-4; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	65	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155804	10.1371/journal.pone.0155804	http://dx.doi.org/10.1371/journal.pone.0155804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243218	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100007
J	Fischer, S; Hirche, C; Diehm, Y; Nuutila, K; Kiefer, J; Gazyakan, E; Bueno, EM; Kremer, T; Kneser, U; Pomahac, B				Fischer, Sebastian; Hirche, Christoph; Diehm, Yannick; Nuutila, Kristo; Kiefer, Jurij; Gazyakan, Emre; Bueno, Ericka M.; Kremer, Thomas; Kneser, Ulrich; Pomahac, Bohdan			Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue	PLOS ONE			English	Article							LONG-TERM; BREAST RECONSTRUCTION; IN-VIVO; AUGMENTATION; SATISFACTION; ZAFIRLUKAST; OUTCOMES	Background The fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization. Materials and Methods We incubated 20 samples of fibrotic capsule as well as 12 full thickness skin grafts harvested from the female breast site for 24 hours with different doses of collagenase. Outcome measures involved histological assessment of thickness and density of the capsule tissue as well as the skin grafts. Furthermore, we performed a collagen assay and immunohistochemistry staining for collagen subtypes. Results Collagenase treatment was able to degrade human capsule contracture tissue ex-vivo. The remaining collagen subtype after degradation was type 4 only. 0.3 mg/ml of collagenase was most effective in reducing capsule thickness when compared with higher concentrations. Of note, effectiveness was inversely related to capsule density, such that there was less reduction in thickness with higher capsule densities and vice versa. Furthermore, the application of 0.3 mg/ml collagenase did not lead to thinning or perforation of full thickness skin grafts. Conclusion Adjustment of collagenase dose will depend on thickness and density of the contracted capsule. A concentration of 0.3 mg/ml seems to be safe and effective in an ex-vivo setting. The remaining collagen subtype 4 is suitable to serve as a neo-capsule/acellular tissue matrix. Collagenase treatment for capsular contracture may soon become a clinical reality.	[Fischer, Sebastian; Diehm, Yannick; Nuutila, Kristo; Bueno, Ericka M.; Pomahac, Bohdan] Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA; [Fischer, Sebastian; Hirche, Christoph; Diehm, Yannick; Kiefer, Jurij; Gazyakan, Emre; Kremer, Thomas; Kneser, Ulrich] Heidelberg Univ, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Burn Trauma Ctr, Ludwigshafen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA.; Fischer, S (corresponding author), Heidelberg Univ, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Burn Trauma Ctr, Ludwigshafen, Germany.	sfischer4@partners.org	Pomahac, Bohdan/AAH-1792-2019	Pomahac, Bohdan/0000-0003-3703-8240; , Sebastian/0000-0003-3445-1902				Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26; Cordeiro PG, 2014, PLAST RECONSTR SURG, V134, P588, DOI 10.1097/PRS.0000000000000523; Fischer S, 2015, PLAST RECONSTR SURG, V136, P981, DOI 10.1097/PRS.0000000000001698; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; Gryskiewicz Joe M, 2003, Aesthet Surg J, V23, P98, DOI 10.1067/maj.2003.19; Handel N, 2006, PLAST RECONSTR SURG, V117, P757, DOI 10.1097/01.prs.0000201457.00772.1d; Holmich LR, 2007, ANN PLAS SURG, V59, P597, DOI 10.1097/SAP.0b0l3e3I803c7c78; Holzer LA, 2009, NEW ENGL J MED, V361, P2579; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; LEMPERLE G, 1980, ACTA CHIR BELG, V79, P159; LEMPERLE G, 1993, AESTHET PLAST SURG, V17, P317, DOI 10.1007/BF00437105; Levine LA, 2015, J SEX MED, V12, P248, DOI 10.1111/jsm.12731; Marques M, 2010, PLAST RECONSTR SURG, V126, P769, DOI 10.1097/PRS.0b013e3181e5f7bf; Mazzocchi M, 2012, INT J IMMUNOPATH PH, V25, P935, DOI 10.1177/039463201202500411; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Peimer CA, 2015, J HAND SURG-AM, V40, P1597, DOI 10.1016/j.jhsa.2015.04.036; Reid Russell R, 2005, Aesthet Surg J, V25, P26, DOI 10.1016/j.asj.2004.12.003; Rohrich RJ, 1999, PLAST RECONSTR SURG, V103, P1759, DOI 10.1097/00006534-199905060-00033; Scuderi N, 2007, INT J IMMUNOPATH PH, V20, P577, DOI 10.1177/039463200702000315; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SPEAR SL, 1991, PLAST RECONSTR SURG, V87, P483, DOI 10.1097/00006534-199103000-00015; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; van Ravenzwaay B, 2004, HUM EXP TOXICOL, V23, P421, DOI 10.1191/0960327104ht471oa; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Young VL, 1998, PLAST RECONSTR SURG, V102, P884, DOI 10.1097/00006534-199809030-00043	27	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156428	10.1371/journal.pone.0156428	http://dx.doi.org/10.1371/journal.pone.0156428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232716	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000033
J	Yu, ZW; Liu, JM; Wang, XW; Zhu, XJ; Wang, DX; Han, GQ				Yu, Zhiwen; Liu, Jiming; Wang, Xiaowei; Zhu, Xianjun; Wang, Daxing; Han, Guoqiang			Efficient Vaccine Distribution Based on a Hybrid Compartmental Model	PLOS ONE			English	Article							SARS; TRANSMISSION; COMPUTATION; STRATEGIES; CHOLERA; HAITI	To effectively and efficiently reduce the morbidity and mortality that may be caused by outbreaks of emerging infectious diseases, it is very important for public health agencies to make informed decisions for controlling the spread of the disease. Such decisions must incorporate various kinds of intervention strategies, such as vaccinations, school closures and border restrictions. Recently, researchers have paid increased attention to searching for effective vaccine distribution strategies for reducing the effects of pandemic outbreaks when resources are limited. Most of the existing research work has been focused on how to design an effective age-structured epidemic model and to select a suitable vaccine distribution strategy to prevent the propagation of an infectious virus. Models that evaluate age structure effects are common, but models that additionally evaluate geographical effects are less common. In this paper, we propose a new SEIR (susceptible-exposed-infectious sC recovered) model, named the hybrid SEIR-V model (HSEIR-V), which considers not only the dynamics of infection prevalence in several age-specific host populations, but also seeks to characterize the dynamics by which a virus spreads in various geographic districts. Several vaccination strategies such as different kinds of vaccine coverage, different vaccine releasing times and different vaccine deployment methods are incorporated into the HSEIR-V compartmental model. We also design four hybrid vaccination distribution strategies (based on population size, contact pattern matrix, infection rate and infectious risk) for controlling the spread of viral infections. Based on data from the 2009-2010 H1N1 influenza epidemic, we evaluate the effectiveness of our proposed HSEIR-V model and study the effects of different types of human behaviour in responding to epidemics.	[Yu, Zhiwen; Wang, Xiaowei; Zhu, Xianjun; Wang, Daxing; Han, Guoqiang] S China Univ Technol, Sch Engn & Comp Sci, Guangzhou 510641, Guangdong, Peoples R China; [Liu, Jiming] Hong Kong Baptist Univ, Dept Comp, Kowloon Tong, Hong Kong, Peoples R China	South China University of Technology; Hong Kong Baptist University	Yu, ZW (corresponding author), S China Univ Technol, Sch Engn & Comp Sci, Guangzhou 510641, Guangdong, Peoples R China.; Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp, Kowloon Tong, Hong Kong, Peoples R China.	zhwyu@scut.edu.cn; jiming@comp.hkbu.edu.hk			Hong Kong Research Grants Council [HKBU211212, HKBU12202415]; NSFC [61332002, 61300044, 61472145, 61572199, 61502173]; Guangdong Natural Science Funds for Distinguished Young Scholars [S2013050014677]; Fundamental Research Funds for the Central Universities [2014G0007, 2015PT016]; Guangdong Key Laboratory of Popular High Performance Computers [SZU-GDPHPCL2015]; Science and Technology Planning Project of Guangdong Province, China [2015A050502011, 2013B090500015, 2016A050503015]; Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen [KC2013ZDZJ0007A]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Key Laboratory of Popular High Performance Computers; Science and Technology Planning Project of Guangdong Province, China; Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen	The authors thank the staff of the Centre for Health Protection (CHP) of the Department of Health in Hong Kong for their sharing of the 2009 H1N1 prevalence data, and they thank Xia Shang for all of his earlier inputs. The authors would like to thank the handling editor and the anonymous reviewers for their constructive comments. They would like to acknowledge the funding support from Hong Kong Research Grants Council (HKBU211212 & HKBU12202415). The authors are grateful for the constructive advice received from the anonymous reviewers of this paper. The work described in this paper was partially funded by the grants from the NSFC No. 61332002, No. 61300044, No. 61472145, No. 61572199, and No. 61502173, the grant from the Guangdong Natural Science Funds for Distinguished Young Scholars (No. S2013050014677), the Fundamental Research Funds for the Central Universities (No. 2014G0007 and 2015PT016), the grant from Guangdong Key Laboratory of Popular High Performance Computers (No. SZU-GDPHPCL2015), the grant from Science and Technology Planning Project of Guangdong Province, China (No. 2015A050502011, No. 2013B090500015, No. 2016A050503015), the grant from Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen (Project No. KC2013ZDZJ0007A).	ANDERSON R M, 1991; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Chen JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118521; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cruz-Aponte M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-207; Daley D. J., 2001, EPIDEMIC MODELLING I; Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Drazen JM, 2003, NEW ENGL J MED, V349, P319, DOI 10.1056/NEJMp038118; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ghosh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014307; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Hancock PA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003809; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Hsieh YH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-106; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lee S, 2012, B MATH BIOL, V74, P958, DOI 10.1007/s11538-011-9704-y; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Liu JM, 2011, J MED SYST, V35, P1153, DOI 10.1007/s10916-011-9734-x; Mandavilli A, 2003, NAT MED, V9, P487, DOI 10.1038/nm0503-487; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Mbah MLN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024577; Medlock Jan, 2009, PLoS Curr, V1, pRRN1134; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Moss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014505; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Oles K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063813; Oles K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036026; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Piccardi C, 1998, IEEE T BIO-MED ENG, V45, P591, DOI 10.1109/10.668749; Poletto C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00476; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Shim E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S4; Tang SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010911; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; US Government Accountability Office, 2005, INFL VACC SHORT 2004; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119923; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065271; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123; Yu ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118085; Yuan EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115826; Zamiri A, 2015, IEEE J BIOMED HEALTH, V19, P735, DOI 10.1109/JBHI.2014.2338213; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032203; Zhou XC, 2013, IEEE T BIO-MED ENG, V60, P446, DOI 10.1109/TBME.2012.2228264; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132; Zhou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027169; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	64	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155416	10.1371/journal.pone.0155416	http://dx.doi.org/10.1371/journal.pone.0155416			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27233015	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000003
J	Abualhassan, N; Sapozhnikov, L; Pawlick, RL; Kahana, M; Pepper, AR; Bruni, A; Gala-Lopez, B; Kin, T; Mitrani, E; Shapiro, AMJ				Abualhassan, Nasser; Sapozhnikov, Lena; Pawlick, Rena L.; Kahana, Meygal; Pepper, Andrew R.; Bruni, Antonio; Gala-Lopez, Boris; Kin, Tatsuya; Mitrani, Eduardo; Shapiro, A. M. James			Lung-Derived Microscaffolds Facilitate Diabetes Reversal after Mouse and Human Intraperitoneal Islet Transplantation	PLOS ONE			English	Article							MEDIATED INFLAMMATORY REACTION; EXTRACELLULAR-MATRIX; PANCREATIC-ISLETS; GROWTH-FACTOR; IN-VITRO; CELL; SCAFFOLDS; SURVIVAL; APOPTOSIS; RAT	There is a need to develop three-dimensional structures that mimic the natural islet tissue microenvironment. Endocrine micro-pancreata (EMPs) made up of acellular organ-derived micro-scaffolds seeded with human islets have been shown to express high levels of key beta-cell specific genes and secrete quantities of insulin per cell similar to freshly isolated human islets in a glucose-regulated manner for more than three months in vitro. The aim of this study was to investigate the capacity of EMPs to restore euglycemia in vivo after transplantation of mouse or human islets in chemically diabetic mice. We proposed that the organ-derived EMPs would restore the extracellular components of the islet microenvironment, generating favorable conditions for islet function and survival. EMPs seeded with 500 mouse islets were implanted intraperitoneally into streptozotocin-induced diabetic mice and reverted diabetes in 67% of mice compared to 13% of controls (p = 0.018, n = 9 per group). Histological analysis of the explanted grafts 60 days post-transplantation stained positive for insulin and exhibited increased vascular density in a collagen-rich background. EMPs were also seeded with human islets and transplanted into the peritoneal cavity of immune-deficient diabetic mice at 250 islet equivalents (IEQ), 500 IEQ and 1000 IEQ. Escalating islet dose increased rates of normoglycemia (50% of the 500 IEQ group and 75% of the 1000 IEQ group, n = 3 per group). Human c-peptide levels were detected 90 days post-transplantation in a dose-response relationship. Herein, we report reversal of diabetes in mice by intraperitoneal transplantation of human islet seeded on EMPs with a human islet dose as low as 500 IEQ.	[Abualhassan, Nasser; Pawlick, Rena L.; Pepper, Andrew R.; Bruni, Antonio; Gala-Lopez, Boris; Shapiro, A. M. James] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Sapozhnikov, Lena; Kahana, Meygal; Mitrani, Eduardo] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Jerusalem, Israel; [Kin, Tatsuya; Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada	University of Alberta; Hebrew University of Jerusalem; University of Alberta	Mitrani, E (corresponding author), Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Jerusalem, Israel.	mitrani@vms.huji.ac.il	Kin, Tatsuya/A-3776-2012	Kin, Tatsuya/0000-0002-5179-6067; Sapozhnikov, Lena/0000-0001-9191-5115	Canadian National Transplantation Research Program (CNTRP); Saudi Arabian Cultural Bureau; JDRF Canadian Clinical Trial Network Fellowship; AIHS CRIO Team Award [201201154]; CNTRP; University of Alberta; Alberta Diabetes Institute (ADI); Alberta Diabetes Foundation; Diabetes Research Institute Foundation of Canada (DRIFCan); Alberta Innovates Health Solutions (AIHS) Clinician Fellowship; Betalin Therapeutics Ltd. Israel; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Alberta Innovates [201400496, 201201154, 201400106] Funding Source: researchfish	Canadian National Transplantation Research Program (CNTRP); Saudi Arabian Cultural Bureau; JDRF Canadian Clinical Trial Network Fellowship; AIHS CRIO Team Award; CNTRP; University of Alberta(University of Alberta); Alberta Diabetes Institute (ADI); Alberta Diabetes Foundation; Diabetes Research Institute Foundation of Canada (DRIFCan); Alberta Innovates Health Solutions (AIHS) Clinician Fellowship; Betalin Therapeutics Ltd. Israel; Canada Research Chair in Transplantation Surgery and Regenerative Medicine; Alberta Innovates Healthcare Solutions; Alberta Innovates	NA is supported through the Canadian National Transplantation Research Program (CNTRP) and Saudi Arabian Cultural Bureau. AP is supported primarily through a JDRF Canadian Clinical Trial Network Fellowship, and further supplemented through an AIHS CRIO Team Award (No. 201201154) and the CNTRP. AB is supported through scholarships from the University of Alberta, the Alberta Diabetes Institute (ADI) and the Alberta Diabetes Foundation. Other funding includes: the Diabetes Research Institute Foundation of Canada (DRIFCan). BGL is supported through an Alberta Innovates Health Solutions (AIHS) Clinician Fellowship, and also receives support from the CNTRP. EM is supported by Betalin Therapeutics Ltd. (2015) Israel. AMJS is supported through a Canada Research Chair in Transplantation Surgery and Regenerative Medicine and through Alberta Innovates Healthcare Solutions as a Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, Diabetes, V46, P271; AO ZL, 1993, TRANSPLANTATION, V56, P524, DOI 10.1097/00007890-199309000-00007; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233; Bretland AJ, 2001, CELL PROLIFERAT, V34, P199, DOI 10.1046/j.1365-2184.2001.00198.x; Bruni A, 2014, DIABETES METAB SYNDR, V7, P211, DOI 10.2147/DMSO.S50789; Chatenoud L, 2003, NAT REV IMMUNOL, V3, P123, DOI 10.1038/nri1000; Citro A, 2012, J CLIN INVEST, V122, P3647, DOI 10.1172/JCI63089; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Eich T, 2007, NEW ENGL J MED, V356, P2754, DOI 10.1056/NEJMc070201; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004; Gala-Lopez BL, 2016, DIABETES, V65, P451, DOI 10.2337/db15-0764; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034; Jalili RB, 2011, J CELL PHYSIOL, V226, P1813, DOI 10.1002/jcp.22515; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Kawahara T, 2011, AM J TRANSPLANT, V11, P2700, DOI 10.1111/j.1600-6143.2011.03717.x; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; LORENZ D, 1977, ACTA DIABETOL LAT, V14, P199, DOI 10.1007/BF02580968; LUCASCLERC C, 1993, MOL CELL ENDOCRINOL, V94, P9, DOI 10.1016/0303-7207(93)90046-M; Motta PM, 1997, MICROSC RES TECHNIQ, V37, P384, DOI 10.1002/(SICI)1097-0029(19970601)37:5/6<384::AID-JEMT3>3.3.CO;2-L; Nagata N, 2002, J BIOMAT SCI-POLYM E, V13, P579, DOI 10.1163/15685620260178418; Nagata N, 2001, CELL TRANSPLANT, V10, P447; Nilsson B, 2011, CURR OPIN ORGAN TRAN, V16, P620, DOI 10.1097/MOT.0b013e32834c2393; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Pedraza E, 2013, CELL TRANSPLANT, V22, P1123, DOI 10.3727/096368912X657440; Pepper Andrew R, 2013, World J Transplant, V3, P48, DOI 10.5500/wjt.v3.i4.48; Pepper AR, 2009, XENOTRANSPLANTATION, V16, P502, DOI 10.1111/j.1399-3089.2009.00548.x; Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88; Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Senior PA, 2012, CAN J DIABETES, V36, P32, DOI 10.1016/j.jcjd.2012.01.002; Shamis Y, 2011, TISSUE ENG PART C-ME, V17, P861, DOI 10.1089/ten.tec.2010.0717; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Sionov RV, 2015, TISSUE ENG PT A, V21, P2691, DOI [10.1089/ten.tea.2014.0711, 10.1089/ten.TEA.2014.0711]; Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; VANDEIJNEN JHM, 1994, CELL TISSUE RES, V277, P115, DOI 10.1007/BF00303087; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; WAHOFF DC, 1994, SURGERY, V116, P742; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang RN, 1999, J HISTOCHEM CYTOCHEM, V47, P499, DOI 10.1177/002215549904700408; Wilson DB, 2005, NATURE, V438, pE5, DOI 10.1038/nature04423; Yoon Ji-Won, 2005, Am J Ther, V12, P580, DOI 10.1097/01.mjt.0000178767.67857.63; Zand MS, 2005, TRANSPLANTATION, V79, P1507, DOI 10.1097/01.TP.0000164159.20075.16; Zhang Y, 2012, AM J PATHOL, V181, P1296, DOI 10.1016/j.ajpath.2012.06.032; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	59	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156053	10.1371/journal.pone.0156053	http://dx.doi.org/10.1371/journal.pone.0156053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227978	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500060
J	Gonzalez-Paredes, FJ; Mesa, GH; Arraez, DM; Reyes, RM; Abrante, B; Diaz-Flores, F; Salido, E; Quintero, E; Hernandez-Guerra, M				Javier Gonzalez-Paredes, Francisco; Hernandez Mesa, Goretti; Morales Arraez, Dalia; Marcelino Reyes, Raquel; Abrante, Beatriz; Diaz-Flores, Felicitas; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel			Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRRHOTIC RAT LIVERS; NITRIC-OXIDE; INSULIN-RESISTANCE; PORTAL-HYPERTENSION; THROMBOXANE A(2); CELL ACTIVATION; STEATOHEPATITIS; MICROCIRCULATION; PROSTANOIDS; ACID	Introduction Metabolic syndrome induces endothelial dysfunction, a surrogate marker of cardiovascular disease. In parallel, metabolic syndrome is frequently associated with non-alcoholic fatty liver disease (NAFLD), which may progress to cirrhosis. The aim of the present study was to evaluate intrahepatic endothelial dysfunction related to cyclooxygenase end products and oxidative stress as possible mechanisms involved in the pathophysiology of NAFLD. Materials and Methods Sprague-Dawley rats were fed standard diet (control-diet, CD) or high-fat-diet (HFD) for 6 weeks. Metabolic syndrome was assessed by recording arterial pressure, lipids, glycemia and rat body weight. Splanchnic hemodynamics were measured, and endothelial dysfunction was evaluated using concentration-effect curves to acetylcholine. Response was assessed with either vehicle, L-N-G-Nitroarginine (L-NNA), indomethacin, tempol, or a thromboxane receptor antagonist, SQ 29548. We quantified inflammation, fibrosis, oxidative stress, nitric oxide (NO) bioavailability and thromboxane B-2 levels. Results HFD rats exhibited metabolic syndrome together with the presence of NAFLD. Compared to control-diet livers, HFD livers showed increased hepatic vascular resistance unrelated to inflammation or fibrosis, but with decreased NO activity and increased oxidative stress. Endothelial dysfunction was observed in HFD livers compared with CD rats and improved after cyclooxygenase inhibition or tempol pre-incubation. However, pre-incubation with SQ 29548 did not modify acetylcholine response. Conclusions Our study provides evidence that endothelial dysfunction at an early stage of NAFLD is associated with reduced NO bioavailability together with increased cyclooxygenase end products and oxidative stress, which suggests that both pathways are involved in the pathophysiology and may be worth exploring as therapeutic targets to prevent progression of the disease.	[Javier Gonzalez-Paredes, Francisco; Abrante, Beatriz; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Inst Biomed Technol, Tenerife, Spain; [Javier Gonzalez-Paredes, Francisco; Abrante, Beatriz; Salido, Eduardo; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain; [Hernandez Mesa, Goretti; Morales Arraez, Dalia; Marcelino Reyes, Raquel; Quintero, Enrique; Hernandez-Guerra, Manuel] Univ Hosp Canary Isl, Dept Gastroenterol, Tenerife, Spain; [Diaz-Flores, Felicitas] Univ Hosp Canary Isl, Cent Lab, Tenerife, Spain; [Quintero, Enrique; Hernandez-Guerra, Manuel] Univ La Laguna, Dept Med & Psychiat, Tenerife, Spain	Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna; Universidad de la Laguna	Hernandez-Guerra, M (corresponding author), Univ La Laguna, Inst Biomed Technol, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ La Laguna, Ctr Biomed Res Canary Isl CIBICAN, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ Hosp Canary Isl, Dept Gastroenterol, Tenerife, Spain.; Hernandez-Guerra, M (corresponding author), Univ La Laguna, Dept Med & Psychiat, Tenerife, Spain.	mhernandezguerra@gmail.com	Quintero, Enrique/C-3841-2017; Salido, Eduardo/I-2232-2015	Quintero, Enrique/0000-0002-7244-8125; Salido, Eduardo/0000-0001-9599-9854; Hernandez-Guerra, Manuel/0000-0002-3478-9981				Antman EM, 2005, CIRCULATION, V112, P759, DOI 10.1161/CIRCULATIONAHA.105.568451; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; Ervin R Bethene, 2009, Natl Health Stat Report, P1; Failli P, 2000, GASTROENTEROLOGY, V119, P479, DOI 10.1053/gast.2000.9354; Feletou M, 2011, BRIT J PHARMACOL, V164, P894, DOI 10.1111/j.1476-5381.2011.01276.x; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Francque SM, 2016, J HEPATOL IN PRESS; Francque S, 2012, LAB INVEST, V92, P1428, DOI 10.1038/labinvest.2012.103; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Gracia-Sancho J, 2008, HEPATOLOGY, V47, P1248, DOI 10.1002/hep.22166; Gracia-Sancho J, 2007, J HEPATOL, V47, P220, DOI 10.1016/j.jhep.2007.03.014; Graupera M, 2005, AM J PHYSIOL-GASTR L, V288, pG763, DOI 10.1152/ajpgi.00300.2004; Graupera M, 2003, J HEPATOL, V39, P515, DOI 10.1016/S0168-8278(03)00347-7; Graupera M, 2003, HEPATOLOGY, V37, P172, DOI 10.1053/jhep.2003.50004; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; Hernandez-Guerra M, 2013, HEPATOLOGY, V57, P1564, DOI 10.1002/hep.26152; Hernanz R, 2014, CLIN SCI, V126, P111, DOI 10.1042/CS20120651; Ijaz S, 2005, MICROVASC RES, V70, P129, DOI 10.1016/j.mvr.2005.08.001; Inoue E, 2012, J ENDOCRINOL, V213, P285, DOI 10.1530/JOE-12-0014; KIKUGAWA K, 1992, ANAL BIOCHEM, V202, P249, DOI 10.1016/0003-2697(92)90102-D; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lobato NS, 2011, NUTR METAB CARDIOVAS, V21, P808, DOI 10.1016/j.numecd.2010.02.006; Marrone G, 2015, GUT, V64, P1434, DOI 10.1136/gutjnl-2014-308338; Martinez-Revelles S, 2013, ANTIOXID REDOX SIGN, V18, P51, DOI 10.1089/ars.2011.4335; Maruyama J, 1999, J APPL PHYSIOL, V86, P1687, DOI 10.1152/jappl.1999.86.5.1687; Matsumoto K, 2002, J ENDOCRINOL, V175, P217, DOI 10.1677/joe.0.1750217; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; NOUCHI T, 1987, ALCOHOL CLIN EXP RES, V11, P287, DOI 10.1111/j.1530-0277.1987.tb01309.x; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Pasarin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032785; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rosado E, 2012, J CELL MOL MED, V16, P2461, DOI 10.1111/j.1582-4934.2012.01563.x; Sacerdoti D, 2015, PROSTAG OTH LIPID M, V120, P80, DOI 10.1016/j.prostaglandins.2015.05.008; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Steib CJ, 2007, J HEPATOL, V47, P228, DOI 10.1016/j.jhep.2007.03.019; TESFAMARIAM B, 1990, J CLIN INVEST, V85, P929, DOI 10.1172/JCI114521; Virdis A, 2007, HYPERTENSION, V49, P679; Xiang LH, 2006, AM J PHYSIOL-REG I, V290, pR134, DOI 10.1152/ajpregu.00295.2005; Yokoyama Y, 2003, AM J PHYSIOL-GASTR L, V284, pG453, DOI 10.1152/ajpgi.00315.2002	50	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156650	10.1371/journal.pone.0156650	http://dx.doi.org/10.1371/journal.pone.0156650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227672	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500161
J	Kim, KS; Choi, JB; Bae, WJ; Kim, SJ; Cho, HJ; Hong, SH; Lee, JY; Kim, SH; Kim, HW; Cho, SY; Kim, SW				Kim, Kang Sup; Choi, Jin Bong; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Kim, Sang Hoon; Kim, Hyun Woo; Cho, Su Yeon; Kim, Sae Woong			Comparison of Photoselective Vaporization versus Holmium Laser Enucleation for Treatment of Benign Prostate Hyperplasia in a Small Prostate Volume	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; RANDOMIZED CLINICAL-TRIAL; TRANSURETHRAL RESECTION; FOLLOW-UP; METAANALYSIS; OBSTRUCTION; GREATER; AGE	Objective Photoselective vaporization of the prostate (PVP) using GreenLight and Holmium laser enucleation of the prostate (HoLEP) is an important surgical technique for management of benign prostate hyperplasia (BPH). We aimed to compare the effectiveness and safety of PVP using a 120WGreenLight laser with HoLEP in a small prostate volume. Methods Patients who underwent PVP or HoLEP surgery for BPH at our institutions were reviewed from May 2009 to December 2014 in this retrospective study. Among them, patients with prostate volumes < 40 mL based on preoperative trans-rectal ultrasonography were included in this study. Peri-operative and post-operative parameters-such as International Prostate Symptom Score (IPSS), quality of life (QoL), maximum urinary flow rate (Qmax), post-void residual urine volume (PVR), and complications-were compared between the groups. Results PVP was performed in 176 patients and HoLEP in162 patients. Preoperative demographic data were similar in both groups, with the exception of PVR. Operative time and catheter duration did not show significant difference. Significant improvements compared to preoperative values were verified at the postoperative evaluation in both groups in terms of IPSS, QoL, Qmax, and PVR. Comparison of the postoperative parameters between the PVP and HoLEP groups demonstrated no significant difference, with the exception of IPSS voiding subscore at 1 month postoperatively (5.9 vs. 3.8, P< 0.001). There was no significant difference in postoperative complications between the two groups. Conclusion Our data suggest that PVP and HoLEP are efficient and safe surgical treatment options for patients with small prostate volume.	[Kim, Kang Sup; Choi, Jin Bong; Bae, Woong Jin; Kim, Su Jin; Cho, Hyuk Jin; Hong, Sung-Hoo; Lee, Ji Youl; Kim, Sae Woong] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea; [Kim, Sang Hoon; Kim, Hyun Woo; Cho, Su Yeon] Catholic Univ Korea, St Pauls Hosp, Coll Med, Dept Urol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kim, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Urol, Seoul, South Korea.	ksw1227@catholic.ac.kr	Cho, Hyuk Jin/AAU-7753-2020	Cho, Hyuk Jin/0000-0003-2599-2950	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - the Ministry of Health & Welfare, Republic of Korea [HI15C0099]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - the Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea ( grant number: HI15C0099).	Al-Ansari A, 2010, EUR UROL, V58, P349, DOI 10.1016/j.eururo.2010.05.026; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Capitan C, 2011, EUR UROL, V60, P734, DOI 10.1016/j.eururo.2011.05.043; Cho KJ, 2013, INT NEUROUROL J, V17, P83, DOI 10.5213/inj.2013.17.2.83; Choi YM, 2013, OPHTHALMOLOGY, V120, P3, DOI 10.1016/j.ophtha.2012.07.062; Cornu JN, 2015, EUR UROL, V67, P1066, DOI 10.1016/j.eururo.2014.06.017; Elkoushy MA, 2015, J ENDOUROL, V29, P797, DOI 10.1089/end.2015.0060; Elmansy H, 2012, J UROLOGY, V188, P216, DOI 10.1016/j.juro.2012.02.2576; Elshal AM, 2014, J UROLOGY, V191, P148, DOI 10.1016/j.juro.2013.06.113; Kaplan SA, 2006, J UROLOGY, V175, P217, DOI 10.1016/S0022-5347(05)00041-8; Kim KS, 2015, LASER MED SCI, V30, P1387, DOI 10.1007/s10103-015-1740-7; Kuntz RM, 2004, J ENDOUROL, V18, P183, DOI 10.1089/089277904322959842; Lee MH, 2014, KOREAN J UROL, V55, P737, DOI 10.4111/kju.2014.55.11.737; Lee YH, 2005, UROLOGY, V65, P498, DOI 10.1016/j.urology.2004.10.082; Madersbacher S, 1997, BRIT J UROL, V80, P72, DOI 10.1046/j.1464-410X.1997.00220.x; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; Rosier PFWM, 1995, NEUROUROL URODYNAM, V14, P625, DOI 10.1002/nau.1930140604; Sandhu JS, 2010, J UROLOGY, V183, P1515, DOI 10.1016/j.juro.2009.12.025; Teng JF, 2013, BJU INT, V111, P312, DOI 10.1111/j.1464-410X.2012.11395.x; Yin L, 2013, J ENDOUROL, V27, P604, DOI 10.1089/end.2012.0505	20	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156133	10.1371/journal.pone.0156133	http://dx.doi.org/10.1371/journal.pone.0156133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227564	gold, Green Published			2022-12-27	WOS:000376882500070
J	Sim, J; Teece, L; Dennis, MS; Roffe, C				Sim, Julius; Teece, Lucy; Dennis, Martin S.; Roffe, Christine		SO2S Study Team	Validation and Recalibration of Two Multivariable Prognostic Models for Survival and Independence in Acute Stroke	PLOS ONE			English	Article							PREDICTION MODELS; EXTERNAL VALIDATION; SCALE	Introduction Various prognostic models have been developed for acute stroke, including one based on age and five binary variables ('six simple variables' model; SSVMod) and one based on age plus scores on the National Institutes of Health Stroke Scale (NIHSSMod). The aims of this study were to externally validate and recalibrate these models, and to compare their predictive ability in relation to both survival and independence. Methods Data from a large clinical trial of oxygen therapy (n = 8003) were used to determine the discrimination and calibration of the models, using C-statistics, calibration plots, and Hosmer-Lemeshow statistics. Methods of recalibration in the large and logistic recalibration were used to update the models. Results For discrimination, both models functioned better for survival (C-statistics between .802 and .837) than for independence (C-statistics between .725 and .735). Both models showed slight shortcomings with regard to calibration, over-predicting survival and under-predicting independence; the NIHSSMod performed slightly better than the SSVMod. For the most part, there were only minor differences between ischaemic and haemorrhagic strokes. Logistic recalibration successfully updated the models for a clinical trial population. Conclusions Both prognostic models performed well overall in a clinical trial population. The choice between them is probably better based on clinical and practical considerations than on statistical considerations.	[Sim, Julius; Teece, Lucy] Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England; [Dennis, Martin S.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Roffe, Christine] Univ Hosp North Midlands NHS Trust, Stroke Res Stoke, Stoke On Trent, Staffs, England; [Roffe, Christine] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England	Keele University; University of Edinburgh; Keele University	Sim, J (corresponding author), Keele Univ, Inst Primary Care & Hlth Sci, Keele ST5 5BG, Staffs, England.	j.sim@keele.ac.uk	Teece, Lucy/AAD-7423-2019; Roffe, Christine/AAT-5611-2020	Teece, Lucy/0000-0001-6669-8534; Roffe, Christine/0000-0002-5259-6649; Sim, Julius/0000-0002-1816-1676	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme [09/104/21]; National Institute for Health Research [09/104/21] Funding Source: researchfish	National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme (project number 09/104/21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Arora A, 2005, BR J CARDIOL, V12, P456; Ayis SA, 2013, J NEUROL NEUROSUR PS, V84, P288, DOI 10.1136/jnnp-2012-303657; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Collin C, 1988, Int Disabil Stud, V10, P61; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dennis M, 2003, STROKE, V34, P127, DOI 10.1161/01.STR.0000044165.41303.50; Dennis M, 2008, STROKE, V39, P1665, DOI 10.1161/STROKEAHA.107.510271; Hemingway H, 2013, BMJ-BRIT MED J, V345; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Lewis S, 2008, J NEUROL NEUROSUR PS, V79, P397, DOI 10.1136/jnnp.2007.126045; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; New PW, 2006, NEUROEPIDEMIOLOGY, V26, P4, DOI 10.1159/000089536; Reid JM, 2007, J NEUROL NEUROSUR PS, V78, P1390, DOI 10.1136/jnnp.2007.118802; Roffe C, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-99; Steyeberg EW, 2009, CLIN PREDICTION MODE; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Teale EA, 2012, CLIN REHABIL, V26, P771, DOI 10.1177/0269215511433068; Tealea E, 2013, CEREBROVASC DIS EXTR, V3, P97, DOI 10.1159/000351142; TEASDALE G, 1974, LANCET, V2, P81; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Wyatt JC, 1995, BMJ-BRIT MED J, V311, P1359	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0153527	10.1371/journal.pone.0153527	http://dx.doi.org/10.1371/journal.pone.0153527			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227988	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000376882500001
J	Stromberg, LR; Hengartner, NW; Swingle, KL; Moxley, RA; Graves, SW; Montano, GA; Mukundan, H				Stromberg, Loreen R.; Hengartner, Nicolas W.; Swingle, Kirstie L.; Moxley, Rodney A.; Graves, Steven W.; Montano, Gabriel A.; Mukundan, Harshini			Membrane Insertion for the Detection of Lipopolysaccharides: Exploring the Dynamics of Amphiphile-in-Lipid Assays	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; HIGH-DENSITY-LIPOPROTEIN; ESCHERICHIA-COLI O26; TOLL-LIKE RECEPTORS; BINDING-PROTEIN; (LPS)-BINDING PROTEIN; BIOLOGICAL-ACTIVITIES; BACTERIAL-ENDOTOXINS; PATHOGEN DETECTION; MOLECULAR-BASIS	Shiga toxin-producing Escherichia coli is an important cause of foodborne illness, with cases attributable to beef, fresh produce and other sources. Many serotypes of the pathogen cause disease, and differentiating one serotype from another requires specific identification of the O antigen located on the lipopolysaccharide (LPS) molecule. The amphiphilic structure of LPS poses a challenge when using classical detection methods, which do not take into account its lipoglycan biochemistry. Typically, detection of LPS requires heat or chemical treatment of samples and relies on bioactivity assays for the conserved lipid A portion of the molecule. Our goal was to develop assays to facilitate the direct and discriminative detection of the entire LPS molecule and its O antigen in complex matrices using minimal sample processing. To perform serogroup identification of LPS, we used a method called membrane insertion on a waveguide biosensor, and tested three serogroups of LPS. The membrane insertion technique allows for the hydrophobic association of LPS with a lipid bilayer, where the exposed O antigen can be targeted for specific detection. Samples of beef lysate were spiked with LPS to perform O antigen specific detection of LPS from E. coli O157. To validate assay performance, we evaluated the biophysical interactions of LPS with lipid bilayers both in-and outside of a flow cell using fluorescence microscopy and fluorescently doped lipids. Our results indicate that membrane insertion allows for the qualitative and reliable identification of amphiphilic LPS in complex samples like beef homogenates. We also demonstrated that LPS-induced hole formation does not occur under the conditions of the membrane insertion assays. Together, these findings describe for the first time the serogroup-specific detection of amphiphilic LPS in complex samples using a membrane insertion assay, and highlight the importance of LPS molecular conformations in detection architectures.	[Stromberg, Loreen R.; Graves, Steven W.; Mukundan, Harshini] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Stromberg, Loreen R.; Mukundan, Harshini] Los Alamos Natl Lab, Phys Chem & Appl Spect, Los Alamos, NM USA; [Stromberg, Loreen R.; Graves, Steven W.; Mukundan, Harshini] New Mexico Consortium, Los Alamos, NM USA; [Hengartner, Nicolas W.] Los Alamos Natl Lab, Theoret Biol & Biophys, Los Alamos, NM USA; [Swingle, Kirstie L.; Montano, Gabriel A.] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM USA; [Moxley, Rodney A.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE USA	University of New Mexico; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Nebraska System; University of Nebraska Lincoln	Mukundan, H (corresponding author), Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA.	harshini@lanl.gov		Stromberg, Loreen/0000-0003-1715-1211; Moxley, Rodney/0000-0002-5377-7716; Hengartner, Nicolas/0000-0002-4157-134X	National Institute of Food and Agriculture, U.S. Department of Agriculture [2012-68003-30155]; National Nuclear Security Administration of the United States Department of Energy [DE-AC52-06NA25396]; Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001035]; Los Alamos National Laboratory Directed Research and Development (LDRD); Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture's National Institute of Food and Agriculture [2012-68003-30155]; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Nuclear Security Administration of the United States Department of Energy(National Nuclear Security Administration); Photosynthetic Antenna Research Center, an Energy Frontier Research Center - United States Department of Energy, Office of Science, Basic Energy Sciences; Los Alamos National Laboratory Directed Research and Development (LDRD)(United States Department of Energy (DOE)Los Alamos National Laboratory); Agriculture and Food Research Initiative Competitive from the United States Department of Agriculture's National Institute of Food and Agriculture; Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance	LRS RAM SWG HM were supported in part by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2012-68003-30155. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the United States Department of Energy under contract No. DE-AC52-06NA25396. Work by G.A.M and K.L.S. was supported by Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences under Award No. DE-SC0001035. Nicholas Hengartner was supported by a Los Alamos National Laboratory Directed Research and Development (LDRD) award (project title, Integrative Biosurveillance, PI Mukundan and McMahon). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was performed, in part, at the Center for Integrated Nanotechnologies, an Office of Science User Facility operated for the United States Department of Energy's Office of Science. Los Alamos National Laboratory, an affirmative action equal opportunity employer, is operated by Los Alamos National Security, LLC, for the National Nuclear Security Administration of the United States Department of Energy under contract No. DE-AC52-06NA25396. Work by G.A.M and K.L.S. was supported by Photosynthetic Antenna Research Center, an Energy Frontier Research Center funded by the United States Department of Energy, Office of Science, Basic Energy Sciences under Award No. DE-SC0001035. H.M., R.A.M, S.W.G and L.R.S. were supported by Agriculture and Food Research Initiative Competitive Grant No. 2012-68003-30155 from the United States Department of Agriculture's National Institute of Food and Agriculture. N.H. was supported by Los Alamos National Laboratory Directed Research Award, Integrative Biosurveillance (Mukundan and McMahon).	Adams PG, 2015, SCI REP-UK, V5, DOI 10.1038/srep10331; Adams PG, 2014, BIOPHYS J, V106, P2395, DOI 10.1016/j.bpj.2014.04.016; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alam JM, 2011, CHEM PHYS LIPIDS, V164, P166, DOI 10.1016/j.chemphyslip.2010.12.008; Alonso-Urmeneta B, 1998, CLIN DIAGN LAB IMMUN, V5, P749, DOI 10.1128/CDLI.5.6.749-754.1998; Aurell CA, 1998, BIOCHEM BIOPH RES CO, V253, P119, DOI 10.1006/bbrc.1998.9773; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Bergstrand A, 2006, COLLOID SURFACE B, V53, P9, DOI 10.1016/j.colsurfb.2006.06.007; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Brooks BW, 2004, VET MICROBIOL, V103, P77, DOI 10.1016/j.vetmic.2004.07.008; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DIN ZZ, 1993, BIOCHEMISTRY-US, V32, P4579, DOI 10.1021/bi00068a014; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Erridge C, 2002, MICROBES INFECT, V4, P837, DOI 10.1016/S1286-4579(02)01604-0; Fode-Vaughan KA, 2003, LETT APPL MICROBIOL, V37, P239, DOI 10.1046/j.1472-765X.2003.01386.x; GALL D, 1994, J IMMUNOASSAY, V15, P277, DOI 10.1080/15321819408009578; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Harrison M, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-64; Hegde NV, 2012, FOODBORNE PATHOG DIS, V9, P1044, DOI 10.1089/fpd.2012.1231; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; James EA, 1996, APPL BIOCHEM BIOTECH, V60, P189, DOI 10.1007/BF02783583; JAY JM, 1981, J FOOD PROTECT, V44, P275, DOI 10.4315/0362-028X-44.4.275; JAY JM, 1979, APPL ENVIRON MICROB, V38, P885, DOI 10.1128/AEM.38.5.885-890.1979; Jucker BA, 1998, COLLOID SURFACE B, V11, P33, DOI 10.1016/S0927-7765(98)00029-0; Kale RR, 2008, J AM CHEM SOC, V130, P8169, DOI 10.1021/ja800842v; Karch H, 1999, DIAGN MICR INFEC DIS, V34, P229, DOI 10.1016/S0732-8893(99)00031-0; Lamoureux L, 2015, PROC SPIE, V9310, DOI 10.1117/12.2079658; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Martinez JS, 2005, J MATER CHEM, V15, P4639, DOI 10.1039/b502329g; McIntosh TJ, 2000, CURR OPIN STRUC BIOL, V10, P481, DOI 10.1016/S0959-440X(00)00118-4; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; MOHAMMED AH, 1988, VET MICROBIOL, V18, P27, DOI 10.1016/0378-1135(88)90113-7; MOROI Y, 1991, J COLLOID INTERF SCI, V141, P581, DOI 10.1016/0021-9797(91)90355-C; Mukundan H, 2012, TUBERCULOSIS, V92, P407, DOI 10.1016/j.tube.2012.05.009; Mukundan H, 2012, TUBERCULOSIS, V92, P38, DOI 10.1016/j.tube.2011.09.006; Mukundan H, 2009, PROC SPIE, V7167, DOI 10.1117/12.809530; Mukundan H, 2010, ANAL CHEM, V82, P136, DOI 10.1021/ac901497g; Mukundan H, 2009, SENSOR ACTUAT B-CHEM, V138, P453, DOI 10.1016/j.snb.2009.01.073; Mukundan H, 2009, SENSORS-BASEL, V9, P5783, DOI 10.3390/s90705783; Mukundan H, 2009, BIOCONJUGATE CHEM, V20, P222, DOI 10.1021/bc800283e; Nieradka K, 2014, SENSOR ACTUAT B-CHEM, V198, P114, DOI 10.1016/j.snb.2014.03.023; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nowotny A, 1984, HDB ENDOTOXIN, V1, P308; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; RAETZ CRH, 1993, J BACTERIOL, V175, P5745, DOI 10.1128/JB.175.18.5745-5753.1993; Rangin M, 2004, J AM CHEM SOC, V126, P5038, DOI 10.1021/ja039822x; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; REINHOLD RB, 1971, P SOC EXP BIOL MED, V137, P334, DOI 10.3181/00379727-137-35572; RUCKENSTEIN E, 1975, J PHYS CHEM-US, V79, P2622, DOI 10.1021/j100591a010; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Safarikova M, 2001, LETT APPL MICROBIOL, V33, P36, DOI 10.1046/j.1472-765X.2001.00941.x; Sakamuri RM, 2014, J MICROBIOL METH, V103, P112, DOI 10.1016/j.mimet.2014.05.012; Sakamuri RM, 2013, PROC SPIE, V8812, DOI 10.1117/12.2029605; Sakamuri RM, 2013, TUBERCULOSIS, V93, P301, DOI 10.1016/j.tube.2013.02.015; SAMUEL G, 2004, RELATIONSHIPS ESCHER, V186, P6536; Santos NC, 2003, CHEMBIOCHEM, V4, P96, DOI 10.1002/cbic.200390020; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Seydel U, 2000, CHEM IMMUNOL, V74, P5; SHARMA S K, 1986, Biotechnology and Applied Biochemistry, V8, P5; SHNYRA A, 1993, INFECT IMMUN, V61, P5351, DOI 10.1128/IAI.61.12.5351-5360.1993; Son I, 2014, FOOD MICROBIOL, V40, P31, DOI 10.1016/j.fm.2013.11.016; Sowers EG, 1996, J CLIN MICROBIOL, V34, P1286, DOI 10.1128/JCM.34.5.1286-1289.1996; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stromberg LR, 2015, J MICROBIOL METH, V116, P1, DOI 10.1016/j.mimet.2015.06.008; Su WQ, 2015, JALA-J LAB AUTOM, V20, P354, DOI 10.1177/2211068215572136; Sutcliffe L, 2005, TUBERCULOSIS, V85, P205, DOI 10.1016/j.tube.2004.12.002; TAKADA H, 1989, CRIT REV MICROBIOL, V16, P477, DOI 10.3109/10408418909104475; TAKAHASHI K, 1992, J IMMUNOL METHODS, V153, P67, DOI 10.1016/0022-1759(92)90306-E; Viktorov AV, 2007, BIOCHEM MOSC-SUPPL S, V1, P35, DOI 10.1134/S1990750807010052; Vreugdenhil ACE, 2001, J CLIN INVEST, V107, P225, DOI 10.1172/JCI10832; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wurfel MM, 1997, J IMMUNOL, V158, P3925; WURFEL MM, 1994, J EXP MED, V180, P1025, DOI 10.1084/jem.180.3.1025	86	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156295	10.1371/journal.pone.0156295	http://dx.doi.org/10.1371/journal.pone.0156295			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227979	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500105
J	Benson, NU; Asuquo, FE; Williams, AB; Essien, JP; Ekong, CI; Akpabio, O; Olajire, AA				Benson, Nsikak U.; Asuquo, Francis E.; Williams, Akan B.; Essien, Joseph P.; Ekong, Cyril I.; Akpabio, Otobong; Olajire, Abaas A.			Source Evaluation and Trace Metal Contamination in Benthic Sediments from Equatorial Ecosystems Using Multivariate Statistical Techniques	PLOS ONE			English	Article							QUA IBOE ESTUARY; PEARL RIVER DELTA; HEAVY-METALS; SURFACE SEDIMENTS; RISK-ASSESSMENT; SOURCE IDENTIFICATION; POLLUTION; WATER; SOUTH; SPECIATION	Trace metals (Cd, Cr, Cu, Ni and Pb) concentrations in benthic sediments were analyzed through multi-step fractionation scheme to assess the levels and sources of contamination in estuarine, riverine and freshwater ecosystems in Niger Delta (Nigeria). The degree of contamination was assessed using the individual contamination factors (ICF) and global contamination factor (GCF). Multivariate statistical approaches including principal component analysis (PCA), cluster analysis and correlation test were employed to evaluate the interrelationships and associated sources of contamination. The spatial distribution of metal concentrations followed the pattern Pb>Cu>Cr>Cd>Ni. Ecological risk index by ICF showed significant potential mobility and bioavailability for Cu, Cu and Ni. The ICF contamination trend in the benthic sediments at all studied sites was Cu>Cr>Ni>Cd>Pb. The principal component and agglomerative clustering analyses indicate that trace metals contamination in the ecosystems was influenced by multiple pollution sources.	[Benson, Nsikak U.; Williams, Akan B.] Covenant Univ, Dept Chem, Environm Chem Unit, Ota, Nigeria; [Asuquo, Francis E.] Univ Calabar, Fac Marine Sci, Calabar, Nigeria; [Essien, Joseph P.] Univ Uyo, Dept Microbiol, Uyo, Nigeria; [Ekong, Cyril I.] Ritman Univ, Dept Chem Sci, Ikot Ekpene, Akwa Ibom State, Nigeria; [Akpabio, Otobong] Univ Uyo, Dept Chem, Uyo, Akwa Ibom State, Nigeria; [Olajire, Abaas A.] Univ Technol, Dept Pure & Appl Chem, Ind & Environm Chem Unit, Ogbomosho, Nigeria	Covenant University; University of Calabar; University of Uyo; University of Uyo	Benson, NU (corresponding author), Covenant Univ, Dept Chem, Environm Chem Unit, Ota, Nigeria.	nsikak.benson@cu.edu.ng	Benson, Nsikak/F-6522-2011	Benson, Nsikak/0000-0002-1285-579X; Essien, Joseph/0000-0002-7844-9954; Asuquo, Francis Emile/0000-0002-8964-0949				*AOAC, 1975, METH SOIL AN; Arabie P., 1996, CLUSTERING CLASSIFIC, DOI DOI 10.1142/1930; ASUQUO FE, 1991, MAR POLLUT BULL, V22, P150; Bastami KD, 2014, MAR POLLUT BULL, V81, P262, DOI 10.1016/j.marpolbul.2014.01.029; Benson NU, 2008, ENVIRON MONIT ASSESS, V146, P253, DOI 10.1007/s10661-007-0077-5; Benson Nsikak U., 2008, Environmentalist, V28, P275, DOI 10.1007/s10669-007-9140-6; Benson Nsikak U., 2008, Environmentalist, V28, P195, DOI 10.1007/s10669-007-9127-3; Benson NU, 2007, CURRENT SCI, V96, P781; Chang ML, 2007, J ENV ENG MANAGE, V17, P143; Cheng Z, 2013, CHEMOSPHERE, V90, P2142, DOI 10.1016/j.chemosphere.2012.11.017; Diaz-de Alba M, 2011, J HAZARD MATER, V190, P177, DOI 10.1016/j.jhazmat.2011.03.020; Dong AG, 2012, ACTA OCEANOL SIN, V31, P88, DOI 10.1007/s13131-012-0195-y; Essien JP, 2009, ENVIRON RES, V109, P690, DOI 10.1016/j.envres.2009.04.005; Essien Joseph P., 2008, Toxicological and Environmental Chemistry, V90, P259, DOI 10.1080/02772240701550497; Essien JP, 2005, WORLD J MICROB BIOT, V21, P567, DOI 10.1007/s11274-004-3910-9; Everitt B. S., 2001, CLUSTER ANAL; Folk R.L., 1974, PETROLOGY SEDIMENTAR; Forstner U, 2008, TRENDS CHALLENGES SE, V8, P281; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; GIBBS RJ, 1993, ENVIRON POLLUT, V81, P297, DOI 10.1016/0269-7491(93)90212-7; Goher M.E., 2014, EGYPT J AQUATIC RES, V40, P213, DOI [10.1016/j.ejar.2014.09.004, DOI 10.1016/j.ejar.2014.09.004]; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Ianni C, 2010, MICROCHEM J, V96, P203, DOI 10.1016/j.microc.2009.07.016; Ip CCM, 2007, ENVIRON POLLUT, V147, P311, DOI 10.1016/j.envpol.2006.06.028; Islam MS, 2015, ECOL INDIC, V48, P282, DOI 10.1016/j.ecolind.2014.08.016; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Li F, 2013, BIOL TRACE ELEM RES, V155, P301, DOI 10.1007/s12011-013-9789-2; Lin YC, 2013, MAR POLLUT BULL, V76, P266, DOI 10.1016/j.marpolbul.2013.08.027; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; Luis AT, 2011, SCI TOTAL ENVIRON, V409, P4312, DOI 10.1016/j.scitotenv.2011.06.052; Maanan M, 2015, ENVIRON SCI POLLUT R, V20, P4729; Morelli G, 2014, MAR POLLUT BULL, V89, P435, DOI 10.1016/j.marpolbul.2014.10.002; Nemati K, 2009, MICROCHEM J, V91, P227, DOI 10.1016/j.microc.2008.12.001; Nguyen HL, 2009, WATER AIR SOIL POLL, V200, P119, DOI 10.1007/s11270-008-9898-2; Parvaresh H, 2011, BIOL TRACE ELEM RES, V143, P1121, DOI 10.1007/s12011-010-8891-y; Passos ED, 2010, MICROCHEM J, V96, P50, DOI 10.1016/j.microc.2010.01.018; Radojevic M., 1999, PRACTICAL ENV ANAL; Ray WD, 1992, J R STAT SOC A, DOI [10.2307/2982904, DOI 10.2307/2982904]; Sahuquillo A, 2003, TRAC-TREND ANAL CHEM, V22, P152, DOI 10.1016/S0165-9936(03)00303-0; Saleem M, 2015, ENV NANOTECHNOLOGY M, P1; Schumacher B., 2002, METHODS DETERMINATIO; Singh KP, 2005, WATER AIR SOIL POLL, V166, P321, DOI 10.1007/s11270-005-5268-5; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Udosen E. D., 2006, Trends in Applied Sciences Research, V1, P292; Wang JW, 2014, MAR POLLUT BULL, V87, P364, DOI 10.1016/j.marpolbul.2014.07.048; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; XLSTAT, 2015, XLSTAT PRO; Zhang CS, 2008, GEODERMA, V146, P378, DOI 10.1016/j.geoderma.2008.06.013; Zhang HG, 2011, J ENVIRON SCI-CHINA, V23, P1937, DOI 10.1016/S1001-0742(10)60644-4; Zhao S, 2012, J HAZARD MATER, V241, P164, DOI 10.1016/j.jhazmat.2012.09.023; Zhuang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094145; [No title captured]	54	34	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156485	10.1371/journal.pone.0156485	http://dx.doi.org/10.1371/journal.pone.0156485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257934	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700067
J	Biljecki, F; Ohori, KA; Ledoux, H; Peters, R; Stoter, J				Biljecki, Filip; Ohori, Ken Arroyo; Ledoux, Hugo; Peters, Ravi; Stoter, Jantien			Population Estimation Using a 3D City Model: A Multi-Scale Country-Wide Study in the Netherlands	PLOS ONE			English	Article							AREAL INTERPOLATION; BUILDING POPULATION; LAND-COVER; URBAN-POPULATION; CENSUS; STOCK; CLASSIFICATION; ACCURACY; DENSITY; IMAGERY	The remote estimation of a region's population has for decades been a key application of geographic information science in demography. Most studies have used 2D data (maps, satellite imagery) to estimate population avoiding field surveys and questionnaires. As the availability of semantic 3D city models is constantly increasing, we investigate to what extent they can be used for the same purpose. Based on the assumption that housing space is a proxy for the number of its residents, we use two methods to estimate the population with 3D city models in two directions: (1) disaggregation (areal interpolation) to estimate the population of small administrative entities (e.g. neighbourhoods) from that of larger ones (e.g. municipalities); and (2) a statistical modelling approach to estimate the population of large entities from a sample composed of their smaller ones (e.g. one acquired by a government register). Starting from a complete Dutch census dataset at the neighbourhood level and a 3D model of all 9.9 million buildings in the Netherlands, we compare the population estimates obtained by both methods with the actual population as reported in the census, and use it to evaluate the quality that can be achieved by estimations at different administrative levels. We also analyse how the volume-based estimation enabled by 3D city models fares in comparison to 2D methods using building footprints and floor areas, as well as how it is affected by different levels of semantic detail in a 3D city model. We conclude that 3D city models are useful for estimations of large areas (e.g. for a country), and that the 3D approach has clear advantages over the 2D approach.	[Biljecki, Filip; Ohori, Ken Arroyo; Ledoux, Hugo; Peters, Ravi; Stoter, Jantien] Delft Univ Technol, Geoinformat 3D, Delft, Netherlands	Delft University of Technology	Biljecki, F (corresponding author), Delft Univ Technol, Geoinformat 3D, Delft, Netherlands.	f.biljecki@tudelft.nl	Biljecki, Filip/B-9829-2013	Biljecki, Filip/0000-0002-6229-7749; Stoter, Jantien/0000-0002-1393-7279	Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; TU Delft Open Access Fund	Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; TU Delft Open Access Fund	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The publication of this paper was funded by the TU Delft Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the received financial support.	Akbar M, 2013, ENVIRON MODELL SOFTW, V39, P24, DOI 10.1016/j.envsoft.2011.12.006; Alahmadi M, 2016, IEEE J-STARS, V9, P1959, DOI 10.1109/JSTARS.2014.2374175; Alahmadi M, 2015, INT J REMOTE SENS, V36, P4315, DOI 10.1080/01431161.2015.1079666; Alahmadi M, 2013, COMPUT ENVIRON URBAN, V41, P167, DOI 10.1016/j.compenvurbsys.2013.06.002; ALGARNI AM, 1995, MATH COMPUT MODEL, V22, P95, DOI 10.1016/0895-7177(95)00104-A; Anderson SJ, 2010, INT J REMOTE SENS, V31, P5733, DOI 10.1080/01431161.2010.496798; Anderson W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100037; Aringer K., 2014, INNOVATIONS 3D GEOIN, P143; Bagan H, 2012, REMOTE SENS ENVIRON, V127, P210, DOI 10.1016/j.rse.2012.09.011; Bahu Jean-Marie, 2014, International Journal of 3-D Information Modeling, V3, P1, DOI 10.4018/ij3dim.2014070101; Bakillah M, 2014, INT J GEOGR INF SCI, V28, P1940, DOI 10.1080/13658816.2014.909045; Bartie P, 2010, COMPUT ENVIRON URBAN, V34, P518, DOI 10.1016/j.compenvurbsys.2010.06.002; Belgiu M, 2014, REMOTE SENS-BASEL, V6, P1347, DOI 10.3390/rs6021347; Biljecki F., 2014, ISPRS ANN PHOTOGRAMM, V2, P31, DOI [10.5194/isprsannals-II-2-31-2014, DOI 10.5194/ISPRSANNALS-II-2-31-2014]; Biljecki F, 2016, ISPRS J PHOTOGRAMM, V116, P42, DOI 10.1016/j.isprsjprs.2016.03.003; Biljecki F, 2015, ISPRS INT GEO-INF, V4, P2842, DOI 10.3390/ijgi4042842; Biljecki F, 2015, INT J GEOGR INF SCI, V29, P2269, DOI 10.1080/13658816.2015.1073292; Biljecki F, 2014, COMPUT ENVIRON URBAN, V48, P1, DOI 10.1016/j.compenvurbsys.2014.05.004; Billen R., 2014, 3D CITY MODELS URBAN, P1; Boeters R, 2015, INT J GEOGR INF SCI, V29, P2248, DOI 10.1080/13658816.2015.1072201; Brinegrar SJ, 2010, CARTOGR GEOGR INF SC, V37, P273, DOI 10.1559/152304010793454327; Chen K, 2002, INT J REMOTE SENS, V23, P37, DOI 10.1080/01431160010014297; de Kluijver H., 2003, Computers, Environment and Urban Systems, V27, P85, DOI 10.1016/S0198-9715(01)00038-2; Deng CB, 2010, INT J REMOTE SENS, V31, P5673, DOI 10.1080/01431161.2010.496806; Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007; Dong PL, 2010, INT J REMOTE SENS, V31, P5571, DOI 10.1080/01431161.2010.496804; Ehrlich D, 2005, GEOINFORMATION DISAS, P901; Eicher C. L., 2001, CARTOGR GEOGR INF SC, V28, P125, DOI [10.1559/152304001782173727, DOI 10.1559/152304001782173727]; Fisher PF, 1996, PROF GEOGR, V48, P299, DOI 10.1111/j.0033-0124.1996.00299.x; FISHER PF, 1995, ENVIRON PLANN A, V27, P211, DOI 10.1068/a270211; Fisher-Gewirtzman D, 2013, SURV REV, V45, P451, DOI 10.1179/1752270613Y.0000000059; Flowerdew R., 1991, PAPERS REG SCI, V70, P303, DOI DOI 10.1007/BF01434424; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Goetz M, 2013, INT J GEOGR INF SCI, V27, P845, DOI 10.1080/13658816.2012.721552; GOODCHILD MF, 1980, GEO-PROCESSING, V1, P297; Greger K, 2015, T GIS, V19, P129, DOI 10.1111/tgis.12086; Groger G, 2012, ISPRS J PHOTOGRAMM, V71, P12, DOI 10.1016/j.isprsjprs.2012.04.004; Haala N, 2010, ISPRS J PHOTOGRAMM, V65, P570, DOI 10.1016/j.isprsjprs.2010.09.006; Hargreaves AJ, 2015, COMPUT ENVIRON URBAN, V54, P280, DOI 10.1016/j.compenvurbsys.2015.08.001; Harvey JT, 2002, INT J REMOTE SENS, V23, P2071, DOI 10.1080/01431160110075901; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hecht R., 2015, INT J CART, V1, P18, DOI [https://doi.org/10.1080/23729333.2015.1055644, 10.1080/23729333.2015.1055644, DOI 10.1080/23729333.2015.1055644]; Hecht R, 2013, ISPRS INT J GEO-INF, V2, P1066, DOI 10.3390/ijgi2041066; Henn A, 2012, GEOINFORMATICA, V16, P281, DOI 10.1007/s10707-011-0131-x; Hermosilla T, 2012, LANDSCAPE URBAN PLAN, V106, P124, DOI 10.1016/j.landurbplan.2012.02.008; Hermosilla T., 2012, P GEOPROCESSING 2012, P232; Hillson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112241; Holt J. B., 2004, CARTOGR GEOGR INF SC, V31, P103, DOI [10.1559/1523040041649407, DOI 10.1559/1523040041649407]; INSPIRE Thematic Working Group Buildings, 2013, D2 8 3 2 INSPIRE DAT; Kaden Robert, 2014, International Journal of 3-D Information Modeling, V3, P35, DOI 10.4018/ij3dim.2014040103; Kavgic M, 2010, BUILD ENVIRON, V45, P1683, DOI 10.1016/j.buildenv.2010.01.021; Kennedy E, 2004, J QUANT CRIMINOL, V20, P243, DOI 10.1023/B:JOQC.0000037733.74321.14; Kohler N, 2002, BUILD RES INF, V30, P226, DOI 10.1080/09613210110102238; Kolbe, 2009, 3D GEOINFORMATION SC, P15, DOI DOI 10.1007/978-3-540-87395-2_2; Kolbe T. H., 2015, PHOTOGRAMMETRIC WEEK, P343; Kolbe TH, 2007, INT ARCH PHOTOGRAMME, VXXXVI-2, P8; KRAUS S P, 1974, Remote Sensing of Environment, V3, P35, DOI 10.1016/0034-4257(74)90036-4; Kressler F., 2008, OBJECT BASED IMAGE A, P611; Kunze C, 2015, COMPUT ENVIRON URBAN, V53, P4, DOI 10.1016/j.compenvurbsys.2015.04.002; Langford M, 2006, COMPUT ENVIRON URBAN, V30, P161, DOI 10.1016/j.compenvurbsys.2004.07.001; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Langford M, 2013, GEOGR ANAL, V45, P324, DOI 10.1111/gean.12012; Ledoux H, 2011, INT J GEOGR INF SCI, V25, P557, DOI 10.1080/13658811003623277; Levy P.S., 2008, SAMPLING POPULATIONS, P121; Lin J, 2015, APPL GEOGR, V58, P41, DOI 10.1016/j.apgeog.2015.01.006; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Liu X., 2002, P 3 S REM SENS URB A, P153; Liu XH, 2008, INT J GEOGR INF SCI, V22, P431, DOI 10.1080/13658810701492225; Lo CP, 2008, GISCI REMOTE SENS, V45, P131, DOI 10.2747/1548-1603.45.2.131; LO CP, 1995, INT J REMOTE SENS, V16, P17, DOI 10.1080/01431169508954369; LO CP, 1977, ANN ASSOC AM GEOGR, V67, P246, DOI 10.1111/j.1467-8306.1977.tb01137.x; Lu DS, 2006, INT J REMOTE SENS, V27, P3553, DOI 10.1080/01431160600617202; Lu ZY, 2011, PHOTOGRAMM ENG REM S, V77, P1145, DOI 10.14358/PERS.77.11.1145; Lu ZY, 2010, INT J REMOTE SENS, V31, P5587, DOI 10.1080/01431161.2010.496801; Lwin KK, 2016, INT J GEOGR INF SCI, V30, P1579, DOI 10.1080/13658816.2016.1143099; Lwin KK, 2011, GEOJOURNAL LIB, V100, P87, DOI 10.1007/978-94-007-0671-2_6; Lwin K, 2009, T GIS, V13, P401, DOI 10.1111/j.1467-9671.2009.01171.x; Maantay J.A., 2007, CARTOGR GEOGR INF SC, V34, P77, DOI [DOI 10.1559/152304007781002190, 10.1559/152304007781002190]; Meinel G, 2009, BUILD RES INF, V37, P468, DOI 10.1080/09613210903159833; Mennis J, 2003, PROF GEOGR, V55, P31; Mennis J., 2006, CARTOGR GEOGR INF SC, V33, P179, DOI [10.1559/152304006779077309, DOI 10.1559/152304006779077309]; Mennis J, 2009, GEOGR COMPASS, V3, P727, DOI 10.1111/j.1749-8198.2009.00220.x; Musialski P, 2013, COMPUT GRAPH FORUM, V32, P146, DOI 10.1111/cgf.12077; Neidhart H., 2004, INT ARCH PHOTOGRAM B, V35, P715; Nouvel R, 2015, ENERG BUILDINGS, V107, P204, DOI 10.1016/j.enbuild.2015.08.021; Ogren M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155328; Ohori KA, 2015, ISPRS INT J GEO-INF, V4, P1055, DOI 10.3390/ijgi4031055; Ohori KA, 2015, INT J GEOGR INF SCI, V29, P1166, DOI 10.1080/13658816.2015.1010535; Pozzi F, 2005, PHOTOGRAMM ENG REM S, V71, P719, DOI 10.14358/PERS.71.6.719; Qiu F, 2010, CARTOGR GEOGR INF SC, V37, P239, DOI 10.1559/152304010792194949; Rottensteiner F, 2014, ISPRS J PHOTOGRAMM, V93, P256, DOI 10.1016/j.isprsjprs.2013.10.004; Sadahiro Y., 1999, J GEOGR SYST, V1, P323, DOI [DOI 10.1007/S101090050017, 10.1007/s101090050017]; Serna A, 2014, ISPRS J PHOTOGRAMM, V93, P243, DOI 10.1016/j.isprsjprs.2014.03.015; Shiravi S, 2015, ENVIRON PLANN B, V42, P708, DOI 10.1068/b130144p; Silvan-Cardenas JL, 2010, INT J REMOTE SENS, V31, P5605, DOI 10.1080/01431161.2010.496800; Sirmacek B, 2012, IEEE J-STARS, V5, P59, DOI 10.1109/JSTARS.2011.2178399; Spoorenberg T, 2015, POPULATION SOC, V527, P1; Spoorenberg T, 2015, ASIAN POPUL STUD, V11, P4, DOI 10.1080/17441730.2014.972084; Sridharan H, 2013, GEOGR ANAL, V45, P238, DOI 10.1111/gean.12010; Steiger E, 2015, COMPUT ENVIRON URBAN, V54, P255, DOI 10.1016/j.compenvurbsys.2015.09.007; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Stoter J, 2016, GEOINFORMATIONSSYSTE, V3, P100; Stoter J, 2008, INT J GEOGR INF SCI, V22, P907, DOI 10.1080/13658810701739039; Stoter J, 2015, LECT NOTES GEOINF CA, P207, DOI 10.1007/978-3-319-12181-9_13; Sutton P., 1997, Computers, Environment and Urban Systems, V21, P227, DOI 10.1016/S0198-9715(97)01005-3; Suveg D, 2004, ISPRS J PHOTOGRAMM, V58, P202, DOI 10.1016/j.isprsjprs.2003.09.006; Swanson DA, 2012, POPUL RES POLICY REV, V31, P235, DOI 10.1007/s11113-012-9227-8; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tobler WR, 1969, AREA, V1, P30; Truong-Hong L, 2015, COMPUT GRAPH-UK, V49, P82, DOI 10.1016/j.cag.2015.03.001; Tutschku K, 1998, IEEE INFOCOM SER, P1054, DOI 10.1109/INFCOM.1998.662915; Ural S, 2011, INT J APPL EARTH OBS, V13, P841, DOI 10.1016/j.jag.2011.06.004; van der Sande C, 2010, SENSORS-BASEL, V10, P8198, DOI 10.3390/s100908198; van Oosterom P, 2015, COMPUT GRAPH-UK, V49, P92, DOI 10.1016/j.cag.2015.01.007; van Winden K, 2016, T GIS, V20, P664, DOI 10.1111/tgis.12186; Vine MF, 1997, ENVIRON HEALTH PERSP, V105, P598, DOI 10.2307/3433605; VROM, 2008, GEOM BAG VERD; Wandl DIA, 2014, LANDSCAPE URBAN PLAN, V130, P50, DOI 10.1016/j.landurbplan.2014.06.010; WELCH R, 1980, REMOTE SENS ENVIRON, V9, P1, DOI 10.1016/0034-4257(80)90043-7; Wright JK, 1936, GEOGR REV, V26, P103, DOI 10.2307/209467; Wu C., 2005, Computers, Environment and Urban Systems, V29, P558, DOI 10.1016/j.compenvurbsys.2005.01.006; Wu CS, 2007, GEOGR ANAL, V39, P26, DOI 10.1111/j.1538-4632.2006.00694.x; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]; Wu SS, 2008, PROF GEOGR, V60, P121, DOI 10.1080/00330120701724251; Xie YH, 2015, IEEE GEOSCI REMOTE S, V12, P1111, DOI 10.1109/LGRS.2014.2385597; Xie YC, 1995, COMPUT ENVIRON URBAN, V19, P287, DOI 10.1016/0198-9715(95)00028-3; Xie ZX, 2006, GISCI REMOTE SENS, V43, P233, DOI 10.2747/1548-1603.43.3.233; Xiong B, 2015, ISPRS J PHOTOGRAMM, V101, P275, DOI 10.1016/j.isprsjprs.2015.01.002; Xiong B, 2014, ISPRS J PHOTOGRAMM, V93, P227, DOI 10.1016/j.isprsjprs.2014.01.007; Yew Yuan, 1997, Computers, Environment and Urban Systems, V21, P245, DOI 10.1016/S0198-9715(97)01003-X; Zandbergen PA, 2010, CARTOGR GEOGR INF SC, V37, P199, DOI 10.1559/152304010792194985; Zhan FB, 2010, INT J REMOTE SENS, V31, P5689, DOI 10.1080/01431161.2010.496802; Zhu LL, 2015, REMOTE SENS-BASEL, V7, P6710, DOI 10.3390/rs70606710; Zoraghein H, 2016, COMPUT ENVIRON URBAN, V58, P19, DOI 10.1016/j.compenvurbsys.2016.03.004	134	37	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156808	10.1371/journal.pone.0156808	http://dx.doi.org/10.1371/journal.pone.0156808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27254151	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700063
J	Yao, ZQ; Yu, RJ				Yao, Ziqing; Yu, Rongjun			The Spreading of Social Energy: How Exposure to Positive and Negative Social News Affects Behavior	PLOS ONE			English	Article							PROSOCIAL VIDEO GAMES; MEDIA VIOLENCE; ENTERTAINMENT; INFORMATION; COOPERATION; INCREASES; AGGRESSION; COGNITION; THOUGHTS; EMPATHY	Social news, unlike video games or TV programs, conveys real-life interactions. Theoretically, social news in which people help or harmeach other and violate rules should influence both prosocial and violation behaviors. In two experiments, we demonstrated the spreading effects of social news in a social interaction context emphasizing social conventions and a nonsocial interaction context emphasizing moral norms. Across the two studies, the results showed that positive social news increased cooperation (decreased defection) but had no effect on cheating, whereas negative social news increased cheating but with no change in cooperation (or defection). We conclude that there is a spreading impact of positive social news in the conventional norm domain and of negative social news in the moral norm domain.	[Yao, Ziqing; Yu, Rongjun] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Yao, Ziqing; Yu, Rongjun] S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Yu, Rongjun] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Yu, Rongjun] Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, Singapore 117548, Singapore; [Yu, Rongjun] Natl Univ Singapore, Ctr Life Sci, Neurobiol Aging Programme, Singapore 117548, Singapore	South China Normal University; South China Normal University; National University of Singapore; National University of Singapore; National University of Singapore	Yu, RJ (corresponding author), S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.; Yu, RJ (corresponding author), S China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Yu, RJ (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.; Yu, RJ (corresponding author), Natl Univ Singapore, Singapore Inst Neurotechnol SINAPSE, Ctr Life Sci, Singapore 117548, Singapore.; Yu, RJ (corresponding author), Natl Univ Singapore, Ctr Life Sci, Neurobiol Aging Programme, Singapore 117548, Singapore.	psyyr@nus.edu.sg	Yu, Rongjun/AAV-2615-2020	Yu, Rongjun/0000-0003-0123-1524; Yao, Ziqing/0000-0002-8639-4180	National Natural Science Foundation of China [31371128]; MOE [R-581-000-191-112]; National University of Singapore [WBS R-581-000-166-133]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); National University of Singapore(National University of Singapore)	Funded by the National Natural Science Foundation of China (No. 31371128), MOE Tier 1: R-581-000-191-112, and National University of Singapore Grant WBS R-581-000-166-133 to RY for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C.A., 2007, VIOLENT VIDEO GAME E, DOI DOI 10.1111/j.1469-8986.2009.00925.x; Anderson CA, 2003, J PERS SOC PSYCHOL, V84, P960, DOI 10.1037/0022-3514.84.5.960; Anderson CA, 2001, PSYCHOL SCI, V12, P353, DOI 10.1111/1467-9280.00366; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Bandura A, 2001, MEDIA PSYCHOL, V3, P265, DOI 10.1207/S1532785XMEP0303_03; Bandura A., 2012, HDB THEORIES SOCIAL, V1, P349, DOI [10.4135/9781446249215.n18, DOI 10.4135/9781446249215.N18]; Bandura A., 1986, SOCIAL FOUNDATIONS O; Bandura A., 1992, SOCIAL REFERENCING S, P175, DOI DOI 10.1007/978-1-4899-2462-9_8; BERKOWITZ L, 1987, J PERS SOC PSYCHOL, V52, P721, DOI 10.1037/0022-3514.52.4.721; Buckley KE, 2006, LEA COMMUN SER, P363; Cialdini RB, 2003, CURR DIR PSYCHOL SCI, V12, P105, DOI 10.1111/1467-8721.01242; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Colman AM, 2003, BEHAV BRAIN SCI, V26, P139, DOI 10.1017/S0140525X03000050; Eisenberg J, 2004, J MORAL EDUC, V33, P163, DOI 10.1080/0305724042000215276; ENTMAN RM, 1989, J POLIT, V51, P347, DOI 10.2307/2131346; Ferguson CJ, 2008, CRIM JUSTICE BEHAV, V35, P311, DOI 10.1177/0093854807311719; Ferguson CJ, 2002, AM PSYCHOL, V57, P446, DOI 10.1037//0003-066X.57.6-7.446b; Garcia SM, 2002, J PERS SOC PSYCHOL, V83, P843, DOI 10.1037/0022-3514.83.4.843; Gentile DA, 2009, PERSONALITY SOCIAL P; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Gino F, 2009, PSYCHOL SCI, V20, P393, DOI 10.1111/j.1467-9280.2009.02306.x; Greitemeyer T, 2011, CURR DIR PSYCHOL SCI, V20, P251, DOI 10.1177/0963721411415229; Greitemeyer T, 2011, J SOC PSYCHOL, V151, P121, DOI 10.1080/00224540903365588; Greitemeyer T, 2010, J PERS SOC PSYCHOL, V98, P211, DOI 10.1037/a0016997; Greitemeyer T, 2009, J EXP SOC PSYCHOL, V45, P186, DOI 10.1016/j.jesp.2008.08.003; GRIECO JM, 1988, J POLIT, V50, P600, DOI 10.2307/2131460; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; HOLLOWAY S, 1977, J PERS SOC PSYCHOL, V35, P514, DOI 10.1037/0022-3514.35.7.514; HORNSTEIN HA, 1975, J PERS SOC PSYCHOL, V32, P1038, DOI 10.1037/0022-3514.32.6.1038; Huesmann LR, 2007, CAMB HANDB PSYCHOL, P545; Huesmann LR, 2003, DEV PSYCHOL, V39, P201, DOI 10.1037/0012-1649.39.2.201; Jordan J, 2011, PERSONALITY SOCIAL P; Keizer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065137; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kelly D, 2007, MIND LANG, V22, P117, DOI 10.1111/j.1468-0017.2007.00302.x; Kohut  A., 2010, AM SPENDING MORE TIM; Kurzban R, 2015, ANNU REV PSYCHOL, V66, P575, DOI 10.1146/annurev-psych-010814-015355; Lee CS, 2012, COMPUT HUM BEHAV, V28, P331, DOI 10.1016/j.chb.2011.10.002; Maier J.A., 2012, PSYCHOL ENTERTAINMEN, P267; Nichols S, 2002, COGNITION, V84, P221, DOI 10.1016/S0010-0277(02)00048-3; Oliver MB, 2011, J MEDIA PSYCHOL-GER, V23, P29, DOI 10.1027/1864-1105/a000029; Oliver MB, 2011, J COMMUN, V61, P984, DOI 10.1111/j.1460-2466.2011.01585.x; Rakoczy H, 2013, CHILD DEV PERSPECT, V7, P17, DOI 10.1111/cdep.12010; Ramos RA, 2016, PSYCHOL POP MEDIA CU, V5, P119, DOI 10.1037/ppm0000041; Ramos RA, 2013, PSYCHOL POP MEDIA CU, V2, P2, DOI 10.1037/a0030119; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Sachdeva S, 2009, PSYCHOL SCI, V20, P523, DOI 10.1111/j.1467-9280.2009.02326.x; Safin V, 2013, BEHAV PROCESS, V99, P145, DOI 10.1016/j.beproc.2013.07.008; Saleem M, 2012, AGGRESSIVE BEHAV, V38, P281, DOI 10.1002/ab.21428; Schmidt MFH, 2012, CURR DIR PSYCHOL SCI, V21, P232, DOI 10.1177/0963721412448659; Schmitt DP, 2004, J PERS SOC PSYCHOL, V86, P560, DOI 10.1037/0022-3514.86.4.560; Sheese BE, 2005, PSYCHOL SCI, V16, P354, DOI 10.1111/j.0956-7976.2005.01539.x; Shu LL, 2012, J PERS SOC PSYCHOL, V102, P1164, DOI 10.1037/a0028381; Shu LL, 2011, PERS SOC PSYCHOL B, V37, P330, DOI 10.1177/0146167211398138; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x; von Hippel W, 2005, PERS SOC PSYCHOL B, V31, P1347, DOI 10.1177/0146167205274899	58	5	6	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156062	10.1371/journal.pone.0156062	http://dx.doi.org/10.1371/journal.pone.0156062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253877	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700013
J	Zhu, FJ; Schlupp, I; Tiedemann, R				Zhu, Fangjun; Schlupp, Ingo; Tiedemann, Ralph			Sequence Evolution and Expression of the Androgen Receptor and Other Pathway-Related Genes in a Unisexual Fish, the Amazon Molly, Poecilia formosa, and Its Bisexual Ancestors	PLOS ONE			English	Article							HYBRID ORIGIN; SEX REVERSAL; ESTROGEN; TELEOST; HYBRIDIZATION; MODEL; AROMATASE; POLYPLOIDY; ISOFORMS; GOLDFISH	The all-female Amazon molly (Poecilia formosa) originated from a single hybridization of two bisexual ancestors, Atlantic molly (Poecilia mexicana) and sailfin molly (Poecilia latipinna). As a gynogenetic species, the Amazon molly needs to copulate with a heterospecific male, but the genetic information of the sperm-donor does not contribute to the next generation, as the sperm only acts as the trigger for the diploid eggs' embryogenesis. Here, we study the sequence evolution and gene expression of the duplicated genes coding for androgen receptors (ars) and other pathway-related genes, i.e., the estrogen receptors (ers) and cytochrome P450, family19, subfamily A, aromatase genes (cyp19as), in the Amazon molly, in comparison to its bisexual ancestors. Mollies possess-as most other teleost fish-two copies of the ar, er, and cyp19a genes, i.e., ara/ar beta, era/er beta 1, and cyp19a1 (also referred as cyp19a1a)/cyp19a2 (also referred to as cyp19a1b), respectively. Non-synonymous single nucleotide polymorphisms (SNPs) among the ancestral bisexual species were generally predicted not to alter protein function. Some derived substitutions in the P. mexicana and one in P. formosa are predicted to impact protein function. We also describe the gene expression pattern of the ars and pathway-related genes in various tissues (i.e., brain, gill, and ovary) and provide SNP markers for allele specific expression research. As a general tendency, the levels of gene expression were lowest in gill and highest in ovarian tissues, while expression levels in the brain were intermediate in most cases. Expression levels in P. formosa were conserved where expression did not differ between the two bisexual ancestors. In those cases where gene expression levels significantly differed between the bisexual species, P. formosa expression was always comparable to the higher expression level among the two ancestors. Interestingly, er beta 1 was expressed neither in brain nor in gill in the analyzed three molly species, which implies a more important role of era in the estradiol synthesis pathway in these tissues. Furthermore, our data suggest that interactions of steroid-signaling pathway genes differ across tissues, in particular the interactions of ars and cyp19as.	[Zhu, Fangjun; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany; [Schlupp, Ingo] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Potsdam; University of Oklahoma System; University of Oklahoma - Norman	Tiedemann, R (corresponding author), Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany.	tiedeman@uni-potsdam.de		Tiedemann, Ralph/0000-0002-2604-6336	University of Potsdam	University of Potsdam	Financial support was provided by the University of Potsdam.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AVISE JC, 1991, EVOLUTION, V45, P1530, DOI 10.1111/j.1558-5646.1991.tb02657.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; Bohne A, 2013, MOL BIOL EVOL, V30, P2268, DOI 10.1093/molbev/mst124; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Cao MX, 2012, COMP BIOCHEM PHYS A, V162, P303, DOI 10.1016/j.cbpa.2012.03.021; Chakraborty T, 2011, J STEROID BIOCHEM, V123, P115, DOI 10.1016/j.jsbmb.2010.11.015; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Choi Y., 2012, P ACM C BIOINF COMP, P414, DOI 10.1145/2382936.2382989; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; DARNELL RM, 1968, COPEIA, P354; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Gabor CR, 2012, PHYSIOL BEHAV, V105, P885, DOI 10.1016/j.physbeh.2011.10.024; Gabor CR, 2010, HORM BEHAV, V57, P427, DOI 10.1016/j.yhbeh.2010.01.012; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Iwanowicz LR, 2014, FISH SHELLFISH IMMUN, V40, P109, DOI 10.1016/j.fsi.2014.06.021; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katsu Y, 2013, J APPL TOXICOL, V33, P41, DOI 10.1002/jat.1707; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kishida M, 2001, ENDOCRINOLOGY, V142, P740, DOI 10.1210/en.142.2.740; Kobayashi H, 2005, ZOOL SCI, V22, P1163, DOI 10.2108/zsj.22.1163; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; Lamatsch DK, 2000, CYTOGENET CELL GENET, V91, P148, DOI 10.1159/000056836; Lampert KP, 2008, PHILOS T R SOC B, V363, P2901, DOI 10.1098/rstb.2008.0040; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Laudet V, 2002, NUCL RECEPTOR FACTSB; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; MerchantLarios H, 1997, GEN COMP ENDOCR, V107, P373, DOI 10.1006/gcen.1997.6946; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Niemeitz Andreas, 2002, Acta Ethologica, V5, P45, DOI 10.1007/s10211-002-0065-2; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piferrer F, 2001, AQUACULTURE, V197, P229, DOI 10.1016/S0044-8486(01)00589-0; Ptacek MB, 2005, ANIM BEHAV, V70, P1339, DOI 10.1016/j.anbehav.2005.03.019; R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673; Reitzel AM, 2010, MOL BIOL EVOL, V27, P2211, DOI 10.1093/molbev/msq129; Ryan MJ, 1996, ANIM BEHAV, V52, P1225, DOI 10.1006/anbe.1996.0270; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; SCHARTL M, 1995, EVOLUTION, V49, P827, DOI 10.1111/j.1558-5646.1995.tb02319.x; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; Schedina Ina Maria, 2014, BMC Research Notes, V7, P1, DOI 10.1186/1756-0500-7-249; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; Schlupp I, 2002, J BIOGEOGR, V29, P1, DOI 10.1046/j.1365-2699.2002.00651.x; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Schupp I, 2005, BIOL LETT-UK, V1, P169, DOI 10.1098/rsbl.2005.0306; Sone K, 2005, GEN COMP ENDOCR, V143, P151, DOI 10.1016/j.ygcen.2005.03.007; Sorensen PW, 2005, GEN COMP ENDOCR, V140, P164, DOI 10.1016/j.ygcen.2004.11.006; SORENSEN PW, 1994, ACTA PHYSIOL SCAND, V152, P191, DOI 10.1111/j.1748-1716.1994.tb09799.x; Stacey N, 2009, HORMONAL PHEROMONES; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tiedemann R, 2005, MOL ECOL NOTES, V5, P586, DOI 10.1111/j.1471-8286.2005.00993.x; Tiwary BK, 2009, MOL BIOL EVOL, V26, P123, DOI 10.1093/molbev/msn233; TURNER BJ, 1980, EVOLUTION, V34, P917, DOI 10.1111/j.1558-5646.1980.tb04029.x; Unal G, 2014, COMP BIOCHEM PHYS B, V172, P67, DOI 10.1016/j.cbpb.2014.04.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VRIJENHOEK RC, 1989, EVOLUTION ECOLOGY UN, P24; Zhang ZH, 2014, SCI CHINA LIFE SCI, V57, P889, DOI 10.1007/s11427-014-4707-1	76	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156209	10.1371/journal.pone.0156209	http://dx.doi.org/10.1371/journal.pone.0156209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249369	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700031
J	Eissa, N; Hussein, H; Wang, HX; Rabbi, MF; Bernstein, CN; Ghia, JE				Eissa, Nour; Hussein, Hayam; Wang, Hongxing; Rabbi, Mohammad F.; Bernstein, Charles N.; Ghia, Jean-Eric			Stability of Reference Genes for Messenger RNA Quantification by Real-Time PCR in Mouse Dextran Sodium Sulfate Experimental Colitis	PLOS ONE			English	Review							HOUSEKEEPING GENES; NORMALIZING GENES; RT-PCR; EXPRESSION; SELECTION; MODELS; IDENTIFICATION; CELLS; QPCR	Background Many animal models have been developed to characterize the complexity of colonic inflammation. In dextran sodium sulfate (DSS) experimental colitis in mice the choice of reference genes is critical for accurate quantification of target genes using quantitative real time PCR (RT-qPCR). No studies have addressed the performance of reference genes in mice DSS-experimental colitis. This study aimed to determine the stability of reference genes expression (RGE) in DSS-experimental murine colitis. Methods Colitis was induced in male C57BL/6 mice using DSS5% for 5 days, control group received water. RNA was extracted from inflamed and non-inflamed colon. Using RT-qPCR, comparative analysis of 13 RGE was performed according to predefined criteria and relative colonic TNF-alpha and IL-1 beta gene expression was determined by calculating the difference in the threshold cycle. Results Colitis significantly altered the stability of mucosal RGE. Commonly used glyceraldehyde-3-phosphate dehydrogenase (Gapdh), beta-actin (Actb), or beta 2-microglobulin (beta 2m) showed the highest variability within the inflamed and control groups. Conversely, TATA-box-binding protein (Tbp) and eukaryotic translation elongation factor 2 (Eef2) were not affected by inflammation and were the most stable genes. Normalization of colonic TNF-alpha and IL-1 beta mRNA levels was dependent on the reference gene used. Depending on the genes used to normalize the data, statistical significance varied from significant when TBP/Eef2 were used to non-significant when Gapdh, Actb or beta 2m were used. Conclusions This study highlights the appropriate choice of RGE to ensure adequate normalization of RT-qPCR data when using this model. Suboptimal RGE may explain controversial results from published studies. We recommend using Tbp and Eef2 instead of Gapdh, Actb or beta 2m as reference genes.	[Eissa, Nour; Wang, Hongxing; Rabbi, Mohammad F.; Ghia, Jean-Eric] Univ Manitoba, Immunol, Winnipeg, MB, Canada; [Eissa, Nour; Ghia, Jean-Eric] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Hussein, Hayam] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Bernstein, Charles N.; Ghia, Jean-Eric] Univ Manitoba, Internal Med Sect Gastroenterol, Winnipeg, MB, Canada; [Bernstein, Charles N.; Ghia, Jean-Eric] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada; [Wang, Hongxing] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University System of Ohio; Ohio State University; University of Manitoba; University of Manitoba; Capital Medical University	Ghia, JE (corresponding author), Univ Manitoba, Immunol, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, Internal Med Sect Gastroenterol, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada.	Jean-Eric.Ghia@umanitoba.ca	, 复之-王红星/ABF-3671-2020; Eissa, Nour/E-1464-2013	Eissa, Nour/0000-0002-3484-6720; Ghia, Jean-Eric/0000-0002-3018-9719; Hussein, Hayam/0000-0003-4595-3094	Canadian Foundation for Innovation; Crohn's and Colitis Canada; Research Manitoba; Canadian Institutes of Health Research; Children's Hospital Research Institute of Manitoba	Canadian Foundation for Innovation(Canada Foundation for Innovation); Crohn's and Colitis Canada; Research Manitoba; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Hospital Research Institute of Manitoba	This study was supported by grants from Canadian Foundation for Innovation, Crohn's and Colitis Canada, Research Manitoba, the Canadian Institutes of Health Research to JEG and the Children's Hospital Research Institute of Manitoba to NE and JEG.	Adachi H, 2015, GENES CELLS, V20, P625, DOI 10.1111/gtc.12254; Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chassaing B, 2014, CURRENT PROTOCOLS IM; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; COOPER HS, 1993, LAB INVEST, V69, P238; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Liu L- L, 2015, PLOS ONE, V10; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Munyaka PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142536; Munyaka PM, 2016, J BASIC MICROBIOLOGY; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Park KT, 2011, INFLAMM BOWEL DIS, V17, P1603, DOI 10.1002/ibd.21488; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rabbi MF, 2014, BIOCHEM PHARMACOL, V89, P386, DOI 10.1016/j.bcp.2014.03.003; Reid LH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-150; Ren SW, 2010, MOL VIS, V16, P1076; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Troost FJ, 2006, PHYSIOL GENOMICS, V25, P242, DOI 10.1152/physiolgenomics.00114.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980	40	49	49	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156289	10.1371/journal.pone.0156289	http://dx.doi.org/10.1371/journal.pone.0156289			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244258	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100024
J	Huang, XQ; Xue, J; Lin, M; Zhu, YS				Huang, Xiaoqiang; Xue, Jing; Lin, Min; Zhu, Yushan			Use of an Improved Matching Algorithm to Select Scaffolds for Enzyme Design Based on a Complex Active Site Model	PLOS ONE			English	Article							ATOMIC-LEVEL ACCURACY; COMPUTATIONAL DESIGN; CRYSTAL-STRUCTURE; DIRECTED EVOLUTION; KEMP ELIMINASE; SEQUENCE SELECTION; PENICILLIN ACYLASE; PROTEIN DESIGN; CATALYSIS; ESTERASE	Active site preorganization helps native enzymes electrostatically stabilize the transition state better than the ground state for their primary substrates and achieve significant rate enhancement. In this report, we hypothesize that a complex active site model for active site preorganization modeling should help to create preorganized active site design and afford higher starting activities towards target reactions. Our matching algorithm ProdaMatch was improved by invoking effective pruning strategies and the native active sites for ten scaffolds in a benchmark test set were reproduced. The root-mean squared deviations between the matched transition states and those in the crystal structures were <1.0 angstrom for the ten scaffolds, and the repacking calculation results showed that 91% of the hydrogen bonds within the active sites are recovered, indicating that the active sites can be preorganized based on the predicted positions of transition states. The application of the complex active site model for de novo enzyme design was evaluated by scaffold selection using a classic catalytic triad motif for the hydrolysis of p-nitrophenyl acetate. Eighty scaffolds were identified from a scaffold library with 1,491 proteins and four scaffolds were native esterase. Furthermore, enzyme design for complicated substrates was investigated for the hydrolysis of cephalexin using scaffold selection based on two different catalytic motifs. Only three scaffolds were identified from the scaffold library by virtue of the classic catalytic triad-based motif. In contrast, 40 scaffolds were identified using a more flexible, but still preorganized catalytic motif, where one scaffold corresponded to the a-amino acid ester hydrolase that catalyzes the hydrolysis and synthesis of cephalexin. Thus, the complex active site modeling approach for de novo enzyme design with the aid of the improved ProdaMatch program is a promising approach for the creation of active sites with high catalytic efficiencies towards target reactions.	[Huang, Xiaoqiang; Xue, Jing; Lin, Min; Zhu, Yushan] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China	Tsinghua University	Zhu, YS (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	yszhu@tsinghua.edu.cn			National Natural Science Foundation of China [21276136, 21476123]; National High Technology Research and Development (863) Program of China [2012AA021204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development (863) Program of China(National High Technology Research and Development Program of China)	YZ was financially supported by the National Natural Science Foundation of China (Grant Numbers: 21276136, 21476123), and the National High Technology Research and Development (863) Program of China (Grant Number: 2012AA021204).	Arnold FH, 1998, ACCOUNTS CHEM RES, V31, P125, DOI 10.1021/ar960017f; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Barends TRM, 2003, J BIOL CHEM, V278, P23076, DOI 10.1074/jbc.M302246200; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Benson DE, 2000, P NATL ACAD SCI USA, V97, P6292, DOI 10.1073/pnas.97.12.6292; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Fazelinia H, 2009, PROTEIN SCI, V18, P180, DOI 10.1002/pro.2; Frushicheva MP, 2014, CURR OPIN CHEM BIOL, V21, P56, DOI 10.1016/j.cbpa.2014.03.022; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Huang XQ, 2013, PROTEIN SCI, V22, P929, DOI 10.1002/pro.2275; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larsen NA, 2002, NAT STRUCT BIOL, V9, P17, DOI 10.1038/nsb742; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Lei YL, 2011, PROTEIN SCI, V20, P1566, DOI 10.1002/pro.685; Levisson M, 2012, PROTEINS, V80, P1545, DOI 10.1002/prot.24041; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; McVey CE, 2001, J MOL BIOL, V313, P139, DOI 10.1006/jmbi.2001.5043; Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Rajagopalan S, 2014, NAT CHEM BIOL, V10, P386, DOI 10.1038/nchembio.1498; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Tian Y, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2742-x; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xue J, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2915-2; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang CS, 2012, PROTEINS, V80, P1078, DOI 10.1002/prot.24009; Zhu XL, 2009, J COMPUT CHEM, V30, P256, DOI 10.1002/jcc.21050	54	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156559	10.1371/journal.pone.0156559	http://dx.doi.org/10.1371/journal.pone.0156559			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243223	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100047
J	Hoebel, J; Rattay, P; Prutz, F; Rommel, A; Lampert, T				Hoebel, Jens; Rattay, Petra; Pruetz, Franziska; Rommel, Alexander; Lampert, Thomas			Socioeconomic Status and Use of Outpatient Medical Care: The Case of Germany	PLOS ONE			English	Article							INCOME-RELATED INEQUALITIES; SELF-REPORTED UTILIZATION; HEALTH-CARE; SERVICES UTILIZATION; PARTICIPATION; ADULTS; INTERVIEW; PATIENT; ACCESS; ASSOCIATION	Background Socially disadvantaged people have an increased need for medical care due to a higher burden of health problems and chronic diseases. In Germany, outpatient care is chiefly provided by office-based general practitioners and specialists in private practice. People are free to choose the physician they prefer. In this study, national data were used to examine differences in the use of outpatient medical care by socioeconomic status (SES). Methods The analyses were based on data from 6,754 participants in the Robert Koch Institute's German Health Interview and Examination Survey for Adults (DEGS1) aged between 18 and 69 years. The number of outpatient physician visits during the past twelve months was assessed for several medical specializations. SES was determined based on education, occupation, and income. Associations between SES and physician visits were analysed using logistic regression and zero-truncated negative binomial regression for count data. Results After adjusting for sociodemographic factors and health indicators, outpatients with low SES had more contacts with general practitioners than outpatients with high SES (men: incidence rate ratio [IRR] = 1.25; 95% confidence interval [CI] = 1.08-1.46; women: IRR = 1.20; 95% CI = 1.07-1.34). The use of specialists was lower in people with low SES than in those with high SES when sociodemographic factors and health indicators were adjusted for (men: odds ratio [OR] = 0.68; 95% CI = 0.51-0.91; women: OR = 0.56; 95% CI = 0.41-0.77). This applied particularly to specialists in internal medicine, dermatology, and gynaecology. The associations remained after additional adjustment for the type of health insurance and the regional density of office-based physicians. Conclusion The findings suggest that socially disadvantaged people are seen by general practitioners more often than the socially better-off, who are more likely to visit a medical specialist. These differences may be due to differences in patient preferences, physician factors, physician-patient interaction, and potential barriers to accessing specialist care.	[Hoebel, Jens; Rattay, Petra; Lampert, Thomas] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany; [Pruetz, Franziska; Rommel, Alexander] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Hlth Reporting, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Hoebel, J (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany.	j.hoebel@rki.de			ministry finances the RKI	ministry finances the RKI	The German Health Interview and Examination Survey for Adults (DEGS) is part of the Federal Health Monitoring (FHM) in Germany. The FHM is administered by the Robert Koch Institute (RKI) on behalf of the German Federal Ministry of Health. The ministry finances the RKI and gives substantial funds for the FHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are employees of the RKI. No one of the authors received specific funding for this work.	Baumeister SE, 2004, GESUNDHEITSWESEN, V66, P175, DOI 10.1055/s-2004-813028; Bergmann E, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1365, DOI 10.1007/s00103-005-1167-6; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bormann C., 2014, HLTH CARE UTILIZATIO, P29, DOI [10.1007/978-1-4614-9191-0_3, DOI 10.1007/978-1-4614-9191-0_3]; Boyle Sean, 2011, Health Syst Transit, V13, P1; Brauns H, 2003, ADV CROSS NATL COMP, P221, DOI [10.1007/978-1-4419-9186-7_11, DOI 10.1007/978-1-4419-9186-7_11]; Bremer P, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0036-0; Bremer P, 2013, PRAVENT GESUNDHEIT, V8, P15, DOI 10.1007/s11553-012-0368-8; Busse R, 2014, HEALT SYST TRANSIT, V16, P1; Cox B, 2009, INT J PUBLIC HEALTH, V54, P55, DOI 10.1007/s00038-009-7104-y; Cylus J, 2015, HEALTH POLICY, V119, P1133, DOI 10.1016/j.healthpol.2015.07.004; Devaux M, 2015, EUR J HEALTH ECON, V16, P21, DOI 10.1007/s10198-013-0546-4; Droomers M, 2004, EUR J PUBLIC HEALTH, V14, P311, DOI 10.1093/eurpub/14.3.311; Ernst J, 2014, GESUNDHEITSWESEN, V76, P187, DOI 10.1055/s-0033-1361150; European Commission, 2013, HLTH IN EU FIN REP C; GANZEBOOM HBG, 1992, SOC SCI RES, V21, P1, DOI 10.1016/0049-089X(92)90017-B; Garcia-Armesto Sandra, 2010, Health Syst Transit, V12, P1; Geyer S, 2015, ARCH GYNECOL OBSTET, V291, P623, DOI 10.1007/s00404-014-3421-3; Gruber S, 2010, J PUBLIC HEALTH-HEID, V18, P351, DOI 10.1007/s10389-010-0321-2; Hoebel J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-913; Hoebel J, 2013, DTSCH ARZTEBL INT, V110, P679, DOI 10.3238/arztebl.2013.0679; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; JanSSen Christian, 2012, Psychosoc Med, V9, pDoc07, DOI 10.3205/psm000085; Jordan S, 2015, BUNDESGESUNDHEITSBLA, V58, P942, DOI 10.1007/s00103-015-2200-z; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Kassenarztliche Bundesvereinigung, 2011, BUND 2011; Klein J., 2014, HLTH CARE UTILIZATIO, P117; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lostao L, 2007, J EPIDEMIOL COMMUN H, V61, P416, DOI 10.1136/jech.2006.047126; Lungen M, 2009, AUSMASS GRUNDE UNGLE; Lungen M, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-1; Mackenbach, 2006, HLTH INEQUALITIES EU; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot MG., 2006, SOCIAL DETERMINANTS; Mielck A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-52; O'Malley MS, 2001, AM J PUBLIC HEALTH, V91, P49; Peersman W, 2014, EUR J PUBLIC HEALTH, V24, P91, DOI 10.1093/eurpub/ckt079; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; Reibling N, 2010, GESUNDHEITSWESEN, V72, P447, DOI 10.1055/s-0029-1234101; Ruckert IM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-232; Sass AC, 2015, BUNDESGESUNDHEITSBLA, V58, P533, DOI 10.1007/s00103-015-2146-1; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Seidel D, 2009, J CANCER RES CLIN, V135, P533, DOI 10.1007/s00432-008-0485-0; Sorensen TH, 2009, HEALTH POLICY, V92, P180, DOI 10.1016/j.healthpol.2009.03.011; Starker A, 2013, BUNDESGESUNDHEITSBLA, V56, P858, DOI 10.1007/s00103-012-1655-4; Stirbu I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-288; Swart Enno, 2012, Psychosoc Med, V9, pDoc10, DOI 10.3205/psm000088; Terraneo M, 2015, SOC SCI MED, V126, P154, DOI 10.1016/j.socscimed.2014.12.028; Thode N, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P296, DOI 10.1007/s00103-004-1004-3; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; von dem Knesebeck O, 2009, GESUNDHEITSWESEN, V71, P59, DOI 10.1055/s-0028-1119371; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Zok K, 2005, WIDOMONITOR, V2, P1	54	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155982	10.1371/journal.pone.0155982	http://dx.doi.org/10.1371/journal.pone.0155982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232878	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000010
J	Maeyashiki, A; Akahane, M; Sugiura, H; Ohkusa, Y; Okabe, N; Imamura, T				Maeyashiki, Akie; Akahane, Manabu; Sugiura, Hiroaki; Ohkusa, Yasushi; Okabe, Nobuhiko; Imamura, Tomoaki			Development and Application of an Alert System to Detect Cases of Food Poisoning in Japan	PLOS ONE			English	Article							SPONTANEOUS REPORTING SYSTEM; SIGNAL-DETECTION; DAILY QUESTIONNAIRE; ODDS RATIO; HEALTH	Recent public health concerns regarding commercial food products have increased the need to develop an automated method to detect food product-related health events. We developed and verified a method for the early detection of potentially harmful events caused by commercial food products. We collected data from daily internet-based questionnaires examining the presence or absence of symptoms and information about food purchased by the respondents. Using these data, we developed a method to detect possible health concerns regarding commercialized food products. To achieve this, we combined the signal detection method used in the reporting system of adverse effects of pharmaceutical products and the Early Aberration Reporting System (EARS) used by the United States Centers for Disease Control. Whiteleg shrimp (Litopenaeus vannamei), which had odds ratio and Odds(-) of 8.99 and 4.13, respectively, was identified as a possible causative food product for diarrhea and vomiting. In conclusion, this study demonstrated that food distributors can implement post-marketing monitoring of the safety of food products purchased via the internet.	[Maeyashiki, Akie; Akahane, Manabu; Sugiura, Hiroaki; Imamura, Tomoaki] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Sch Med, Kashihara, Nara 634, Japan; [Ohkusa, Yasushi] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Okabe, Nobuhiko] Kawasaki City Publ Hlth Inst Publ Hlth, Kawasaki, Kanagawa, Japan	Nara Medical University; National Institute of Infectious Diseases (NIID)	Maeyashiki, A (corresponding author), Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Sch Med, Kashihara, Nara 634, Japan.	hamue@naramed-u.ac.jp	Akahane, Manabu/GYD-5539-2022		Health Labour Sciences Research Grant; Tomoaki Imamura	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Tomoaki Imamura	This study was supported by a Health Labour Sciences Research Grant. The author who received the funding is Tomoaki Imamura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, EMERG INFECT DIS, V3, P581; Centers for Disease Control and Prevention, NAT STRAT BIOS; Council for International Organizations of Medical Sciences, 2010, PRACT ASP SIGN DET P; Dart RC, 2009, DRUG ALCOHOL DEPEN, V105, pS26, DOI 10.1016/j.drugalcdep.2009.08.011; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; Hepburn P, 2008, FOOD CHEM TOXICOL, V46, P9, DOI 10.1016/j.fct.2007.09.008; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Lindquist M, 1999, PHARMACOEPIDEM DR S, V8, pS15, DOI 10.1002/(SICI)1099-1557(199904)8:1+<S15::AID-PDS402>3.3.CO;2-2; Meyboom RHB, 1997, DRUG SAFETY, V16, P355, DOI 10.2165/00002018-199716060-00002; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; Newkirk R, 2011, FOODBORNE PATHOG DIS, V8, P433, DOI 10.1089/fpd.2010.0731; Ooba N, 2010, PHARMACOEPIDEM DR S, V19, P1159, DOI 10.1002/pds.2014; Rothman KJ, 2004, PHARMACOEPIDEM DR S, V13, P519, DOI 10.1002/pds.1001; Sano T, 2013, INT J ENVIRON HEAL R, V23, P247, DOI 10.1080/09603123.2012.717916; Sugiura H, 2010, EPIDEMIOL INFECT, V138, P1493, DOI 10.1017/S095026880999149X; Sugiura H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1872; Sumi Y, 2008, J TOXICOL SCI, V33, P485, DOI 10.2131/jts.33.485; van der Heijden PGM, 2002, STAT MED, V21, P2027, DOI 10.1002/sim.1157; van Puijenbroek EP, 2003, DRUG SAFETY, V26, P293, DOI 10.2165/00002018-200326050-00001; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; van Puijenbroek EP, 2001, BRIT J CLIN PHARMACO, V52, P579, DOI 10.1046/j.0306-5251.2001.01501.x; van Puijenbroek EP, 1999, BRIT J CLIN PHARMACO, V47, P689, DOI 10.1046/j.1365-2125.1999.00957.x; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; World Health Organization, SAF MED GUID DET REP	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156395	10.1371/journal.pone.0156395	http://dx.doi.org/10.1371/journal.pone.0156395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231884	gold, Green Published, Green Submitted			2022-12-27	WOS:000376883000028
J	Christoforou, E; Anta, AF; Santos, A				Christoforou, Evgenia; Anta, Antonio Fernandez; Santos, Agustin			A Mechanism for Fair Distribution of Resources without Payments	PLOS ONE			English	Article								We design a mechanism for Fair and Efficient Distribution of Resources (FEDoR) in the presence of strategic agents. We consider a multiple-instances, Bayesian setting, where in each round the preference of an agent over the set of resources is a private information. We assume that in each of r rounds n agents are competing for k non-identical indivisible goods, (n > k). In each round the strategic agents declare how much they value receiving any of the goods in the specific round. The agent declaring the highest valuation receives the good with the highest value, the agent with the second highest valuation receives the second highest valued good, etc. Hence we assume a decision function that assigns goods to agents based on their valuations. The novelty of the mechanism is that no payment scheme is required to achieve truthfulness in a setting with rational/strategic agents. The FEDoR mechanism takes advantage of the repeated nature of the framework, and through a statistical test is able to punish the misreporting agents and be fair, truthful, and socially efficient. FEDoR is fair in the sense that, in expectation over the course of the rounds, all agents will receive the same good the same amount of times. FEDoR is an eligible candidate for applications that require fair distribution of resources over time. For example, equal share of bandwidth for nodes through the same point of access. But further on, FEDoR can be applied in less trivial settings like sponsored search, where payment is necessary and can be given in the form of a flat participation fee. FEDoR can be a good candidate in a setting like that to solve the problem of starvation of publicity slots for some advertisers that have a difficult time determining their true valuations. To this extent we perform a comparison with traditional mechanisms applied to sponsored search, presenting the advantage of FEDoR.	[Christoforou, Evgenia; Anta, Antonio Fernandez; Santos, Agustin] IMDEA Networks Inst, Madrid, Spain; [Christoforou, Evgenia] Univ Carlos III Madrid, Madrid, Spain; [Santos, Agustin] Univ Rey Juan Carlos, Madrid, Spain	Universidad Carlos III de Madrid; Universidad Rey Juan Carlos	Christoforou, E (corresponding author), IMDEA Networks Inst, Madrid, Spain.; Christoforou, E (corresponding author), Univ Carlos III Madrid, Madrid, Spain.	evgenia.christoforou@imdea.org			Regional Government of Madrid (CM) grant Cloud4BigData - FSE FEDER [S2013/ICE-2894]; Spanish Ministry of Economy and Competitiveness grant HyperAdapt [TEC2014-55713-R]; Spanish Ministry of Education grant [FPU2013-03792]; NSF of China grant [61520106005]; Real Colegio Complutense at Harvard (RCC); EC	Regional Government of Madrid (CM) grant Cloud4BigData - FSE FEDER; Spanish Ministry of Economy and Competitiveness grant HyperAdapt; Spanish Ministry of Education grant; NSF of China grant; Real Colegio Complutense at Harvard (RCC); EC(European CommissionEuropean Commission Joint Research Centre)	This work has been partially funded by the Regional Government of Madrid (CM) grant Cloud4BigData (S2013/ICE-2894) cofunded by FSE & FEDER, the Spanish Ministry of Economy and Competitiveness grant HyperAdapt (TEC2014-55713-R), the Spanish Ministry of Education grant FPU2013-03792, the NSF of China grant 61520106005, the EC H2020 grants ReCred and NOTRE, and the Real Colegio Complutense at Harvard (RCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGUS JE, 1994, SIAM REV, V36, P652, DOI 10.1137/1036146; Arrow K. J., 2012, SOCIAL CHOICE INDIVI, V3rd; Ausubel L., 2006, COMBINATORIAL AUCTIO, V17, P22; Edelman B., 2005, INTERNET ADVERTISING; Guo M., 2010, AAMAS, P881; Guo MY, 2009, LECT NOTES COMPUT SC, V5929, P244; Hartline JD, 2008, ACM S THEORY COMPUT, P75; Jackson MO, 2007, ECONOMETRICA, V75, P241, DOI 10.1111/j.1468-0262.2007.00737.x; Levin H, 2011, SIAM J COMPUT, V40, P1892, DOI 10.1137/080734017; Locher T, 2006, P 5 WORKSH HOT TOP N, P85; Moscibroda T, 2009, IEEE INFOCOM SER, P972, DOI 10.1109/INFCOM.2009.5062008; Piatek M., 2007, P NSDI, V7; Procaccia Ariel D, 2013, ACM T ECON COMPUT, V1, P1, DOI [10.1145/2542174.2542175, DOI 10.1145/2542174.2542175]; Rahman R, 2010, IEEE ICC; Santos Agustin, 2014, Networked Systems. Second International Conference, NETYS 2014. Revised Selected Papers. LNCS: 8593, P70, DOI 10.1007/978-3-319-09581-3_6; Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066575; SATTERTHWAITE MA, 1975, J ECON THEORY, V10, P187, DOI 10.1016/0022-0531(75)90050-2; Schummer J, 2007, ALGORITHMIC GAME THEORY, P243	18	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155962	10.1371/journal.pone.0155962	http://dx.doi.org/10.1371/journal.pone.0155962			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227992	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500046
J	Reed, AP; Bucci, G; Abd-Wahab, F; Tucker, SJ				Reed, Alan P.; Bucci, Giovanna; Abd-Wahab, Firdaus; Tucker, Stephen J.			Dominant-Negative Effect of a Missense Variant in the TASK-2 (KCNK5) K+ Channel Associated with Balkan Endemic Nephropathy	PLOS ONE			English	Article							SENSITIVE BACKGROUND K-2P; POTASSIUM CHANNELS; K2P CHANNELS; MECHANISM; PORE; TRANSPORT; PHYSIOLOGY; MUTATION; DISEASE	TASK-2, a member of the Two-Pore Domain (K2P) subfamily of K+ channels, is encoded by the KCNK5 gene. The channel is expressed primarily in renal epithelial tissues and a potentially deleterious missense variant in KCNK5 has recently been shown to be prevalent amongst patients predisposed to the development of Balkan Endemic Nephropathy (BEN), a chronic tubulointerstitial renal disease of unknown etiology. In this study we show that this variant (T108P) results in a complete loss of channel function and is associated with a major reduction in TASK-2 channel subunits at the cell surface. Furthermore, these mutant subunits have a suppressive or 'dominant-negative' effect on channel function when coexpressed with wild-type subunits. This missense variant is located at the extracellular surface of the M2 transmembrane helix and by using a combination of structural modelling and further functional analysis we also show that this highly-conserved threonine residue is critical for the correct function of other K2P channels. These results therefore provide further structural and functional insights into the possible pathophysiological effects of this missense variant in TASK-2.	[Reed, Alan P.; Bucci, Giovanna; Abd-Wahab, Firdaus; Tucker, Stephen J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Tucker, Stephen J.] Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford, England	University of Oxford; University of Oxford	Tucker, SJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.; Tucker, SJ (corresponding author), Univ Oxford, OXION Initiat Ion Channels & Dis, Oxford, England.	stephen.tucker@physics.ox.ac.uk	Tucker, Stephen J./ABE-7468-2020	Tucker, Stephen J./0000-0001-8996-2000	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust; BBSRC [BB/N009274/1, BB/J00037X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N009274/1, BB/J00037X/1] Funding Source: researchfish; British Heart Foundation [PG/09/016/26992] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust.	Andres-Enguix I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00237; Antigny F, 2016, CIRCULATION, V133, P1371, DOI 10.1161/CIRCULATIONAHA.115.020951; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bayliss DA, 2015, PFLUG ARCH EUR J PHY, V467, P917, DOI 10.1007/s00424-014-1633-9; Cohen A, 2008, J BIOL CHEM, V283, P19448, DOI 10.1074/jbc.M801273200; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Guo ZH, 2014, J NEUROPHYSIOL, V112, P568, DOI 10.1152/jn.00267.2014; Lafreniere RG, 2010, NAT MED, V16, P1157, DOI 10.1038/nm.2216; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lopez-Cayuqueo KI, 2015, PFLUG ARCH EUR J PHY, V467, P1043, DOI 10.1007/s00424-014-1627-7; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Morton MJ, 2005, P NATL ACAD SCI USA, V102, P16102, DOI 10.1073/pnas.0506870102; Nagaoka Y, 2008, CHEMBIOCHEM, V9, P1725, DOI 10.1002/cbic.200800133; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Pathan AR, 2011, HYPERTENSION, V58, P539, DOI 10.1161/HYPERTENSIONAHA.111.179390; Pavlovic NM, 2013, CLIN KIDNEY J, V6, P257, DOI 10.1093/ckj/sft049; Piechotta PL, 2011, EMBO J, V30, P3607, DOI 10.1038/emboj.2011.268; Rapedius M, 2012, CHANNELS, V6, P473, DOI 10.4161/chan.22153; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Schewe M, 2016, CELL, V164, P937, DOI 10.1016/j.cell.2016.02.002; Sepulveda FV, 2015, PHYSIOL REV, V95, P179, DOI 10.1152/physrev.00016.2014; Stefanovic V, 2011, PATHOL BIOL, V59, P286, DOI 10.1016/j.patbio.2009.05.002; Stefanovic V, 2015, CLIN NEPHROL, V83, pS64, DOI 10.5414/CNP83S064; Toncheva D, 1996, NEPHRON, V72, P564, DOI 10.1159/000188940; Toncheva D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/920723; Toncheva D, 1998, EUR J EPIDEMIOL, V14, P389, DOI 10.1023/A:1007445120729; Tucker SJ, 1996, J BIOL CHEM, V271, P5866, DOI 10.1074/jbc.271.10.5866; Veale EL, 2016, BRIT J PHARMACOL, V173, P1639, DOI 10.1111/bph.13465; Veale EL, 2014, MOL PHARMACOL, V85, P671, DOI 10.1124/mol.113.091199; Wang WH, 1997, ANNU REV PHYSIOL, V59, P413, DOI 10.1146/annurev.physiol.59.1.413; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Zilberberg N, 2001, NEURON, V32, P635, DOI 10.1016/S0896-6273(01)00503-7	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156456	10.1371/journal.pone.0156456	http://dx.doi.org/10.1371/journal.pone.0156456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228168	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500141
J	Da Silveira, NS; Niebuhr, BBS; Muylaert, RD; Ribeiro, MC; Pizo, MA				Da Silveira, Natalia Stefanini; Niebuhr, Bernardo Brandao S.; Muylaert, Renata de Lara; Ribeiro, Milton Cezar; Pizo, Marco Aurelio			Effects of Land Cover on the Movement of Frugivorous Birds in a Heterogeneous Landscape	PLOS ONE			English	Article							WHITE-THROATED ROBINS; SEED DISPERSAL; ANIMAL MOVEMENT; HABITAT USE; SEARCH PATTERNS; FOREST BIRDS; LEVY FLIGHT; ECOLOGY; RESPONSES; SUCCESS	Movement is a key spatiotemporal process that enables interactions between animals and other elements of nature. The understanding of animal trajectories and the mechanisms that influence them at the landscape level can yield insight into ecological processes and potential solutions to specific ecological problems. Based upon optimal foraging models and empirical evidence, we hypothesized that movement by thrushes is highly tortuous (low average movement speeds and homogeneous distribution of turning angles) inside forests, moderately tortuous in urban areas, which present intermediary levels of resources, and minimally tortuous (high movement speeds and turning angles next to 0 radians) in open matrix types (e.g., crops and pasture). We used data on the trajectories of two common thrush species (Turdus rufiventris and Turdus leucomelas) collected by radio telemetry in a fragmented region in Brazil. Using a maximum likelihood model selection approach we fit four probability distribution models to average speed data, considering short-tailed, long-tailed, and scale-free distributions (to represent different regimes of movement variation), and one distribution to relative angle data. Models included land cover type and distance from forest-matrix edges as explanatory variables. Speed was greater farther away from forest edges and increased faster inside forest habitat compared to urban and open matrices. However, turning angle was not influenced by land cover. Thrushes presented a very tortuous trajectory, with many displacements followed by turns near 180 degrees. Thrush trajectories resembled habitat and edge dependent, tortuous random walks, with a well-defined movement scale inside each land cover type. Although thrushes are habitat generalists, they showed a greater preference for forest edges, and thus may be considered edge specialists. Our results reinforce the importance of studying animal movement patterns in order to understand ecological processes such as seed dispersal in fragmented areas, where the percentage of remaining habitat is dwindling.	[Da Silveira, Natalia Stefanini; Niebuhr, Bernardo Brandao S.; Muylaert, Renata de Lara; Ribeiro, Milton Cezar] Univ Estadual Paulista, Dept Ecol, Spatial Ecol & Conservat Lab, Sao Paulo, Brazil; [Pizo, Marco Aurelio] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Da Silveira, NS (corresponding author), Univ Estadual Paulista, Dept Ecol, Spatial Ecol & Conservat Lab, Sao Paulo, Brazil.	nat.stefanini@gmail.com	Da Silveira, Natália Stefanini/AAG-2576-2021; Muylaert, Renata L./AAD-7248-2020; Niebuhr, Bernardo Brandão/O-2339-2016	Muylaert, Renata L./0000-0002-6466-6210; Niebuhr, Bernardo Brandão/0000-0002-0453-315X	Centro Nacional de Desenvolvimento Cientifico e tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2013/50421-2]; Brazilian Research Council (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation FAPESP [2013/50421-2]; CNPq	Centro Nacional de Desenvolvimento Cientifico e tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Centro Nacional de Desenvolvimento Cientifico e tecnologico (http://http://www.cnpq.br/) (MAP and MCR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://http://www.capes.gov.br/) (NSS); and Fundacao de Amparo a pesquisa do Estado de Sao Paulo 2013/50421-2 (http://http://www.fapesp.br/) (MCR and MAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to everyone who assisted us in data collection and technical support, to the owners of the areas where the studies were conducted, particularly at Sitio Moinho Velho, to M. Galetti for critically reading the manuscript, and to F. Martello for providing graphic support on the images. We thank the anonymous reviewers for the invaluable suggestions for improving the manuscript. F. Barros, P. Rogeri, A. C. Silveira, F. S. Silveira and many others assisted us in the field. C. J. Leal and M. King for proofreading the manuscript. The Brazilian Research Council (CNPq), the Coordination for the Improvement of Higher Education Personnel (CAPES) and Sao Paulo Research Foundation FAPESP (2013/50421-2) funded our study. MAP and MCR receive research grants from CNPq.	Adams C. E., 2009, URBAN WILDLIFE MANAG; [Anonymous], 1998, QUANTITATIVE ANAL MO; [Anonymous], 2011, BIODIVERSITY HOTSPOT, DOI [10.1007/978-3-642-20992-5_21, DOI 10.1007/978-3-642-20992-5_21]; Armesto JJ, 2001, AUSTRAL ECOL, V26, P311, DOI 10.1046/j.1442-9993.2001.01116.x; Barton PS, 2015, ENVIRON MANAGE, V56, P791, DOI 10.1007/s00267-015-0570-5; Bartumeus F, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434002; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Berry B.J.L., 2008, URBAN ECOLOGY INT PE, P25, DOI [10.1007/978-0-387-73412-5_3, DOI 10.1007/978-0-387-73412-5_3]; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Buckingham DL, 1999, BIRD STUDY, V46, P157, DOI 10.1080/00063659909461127; Byrne RW, 2009, ANIM BEHAV, V77, P619, DOI 10.1016/j.anbehav.2008.11.014; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Clement P., 2000, THRUSHES; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Cohen EB, 2005, J FIELD ORNITHOL, V76, P279, DOI 10.1648/0273-8570-76.3.279; Cohen EB, 2004, AUK, V121, P404, DOI 10.1642/0004-8038(2004)121[0404:SHUAMO]2.0.CO;2; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Del Hoyo J, 2005, HDB BIRDS WORLD CUCK; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FALK JH, 1976, ECOLOGY, V57, P141, DOI 10.2307/1936405; Forman R.T.T., 1986, LANDSCAPE ECOL; Forsman JT, 2001, ANIM BEHAV, V62, P1067, DOI 10.1006/anbe.2001.1856; Franchin Alexandre Gabriel, 2004, Biotemas, V17, P179; Gabriel VA, 2005, THESIS U ESTADUAL PA; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Garcia D, 2013, ECOGRAPHY, V36, P197, DOI 10.1111/j.1600-0587.2012.07519.x; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Gurarie E, 2016, J ANIM ECOL, V85, P69, DOI 10.1111/1365-2656.12379; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hansbauer MM, 2008, BIOL CONSERV, V141, P782, DOI 10.1016/j.biocon.2008.01.002; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Holmes R.T., 1990, P387; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jeltsch F, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-6; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kolzsch A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0424; Lomascolo SB, 2010, WILSON J ORNITHOL, V122, P674, DOI 10.1676/09-167.1; Herrera JM, 2009, BIOL CONSERV, V142, P149, DOI 10.1016/j.biocon.2008.10.008; Morales JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065216; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Motta-Junior José Carlos, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000200038; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Neuschulz EL, 2013, AUSTRAL ECOL, V38, P374, DOI 10.1111/j.1442-9993.2012.02417.x; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pena D, 2014, RELATORIA ADM 2013 S, P5; Pizo MA, 2004, ORNITOL NEOTROP, V15, P117; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Sasal Y, 2013, OIKOS, V122, P95, DOI 10.1111/j.1600-0706.2012.20669.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; SHEDD DH, 1982, AUK, V99, P342; Sick H, 2001, ORNITOLOGIA BRASILEI; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Snow B, 1998, BIRDS AND BERRIES; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Vogel HF, 2012, BIOTA NEOTROP, V12, P241; Vogel HF, 2011, BIOTA NEOTROP, V11, P35, DOI 10.1590/S1676-06032011000300002; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wosniack ME, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0887	82	27	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156688	10.1371/journal.pone.0156688	http://dx.doi.org/10.1371/journal.pone.0156688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257810	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700106
J	Golding, A; Guay, JA; Herrera-Rincon, C; Levin, M; Kaplan, DL				Golding, Anne; Guay, Justin A.; Herrera-Rincon, Celia; Levin, Michael; Kaplan, David L.			A Tunable Silk Hydrogel Device for Studying Limb Regeneration in Adult Xenopus Laevis	PLOS ONE			English	Article							DRUG-DELIVERY; FIBROIN; ENVIRONMENT; CARTILAGE; PATHWAYS; RELEASE; POLYMER	In certain amphibian models limb regeneration can be promoted or inhibited by the local wound bed environment. This research introduces a device that can be utilized as an experimental tool to characterize the conditions that promotes limb regeneration in the adult frog ( Xenopus laevis) model. In particular, this device was designed to manipulate the local wound environment via a hydrogel insert. Initial characterization of the hydrogel insert revealed that this interaction had a significant influence on mechanical forces to the animal, due to the contraction of the hydrogel. The material and mechanical properties of the hydrogel insert were a factor in the device design in relation to the comfort of the animal and the ability to effectively manipulate the amputation site. The tunable features of the hydrogel were important in determining the pro-regenerative effects in limb regeneration, which was measured by cartilage spike formation and quantified by micro-computed tomography. The hydrogel insert was a factor in the observed morphological outcomes following amputation. Future work will focus on characterizing and optimizing the device's observed capability to manipulate biological pathways that are essential for limb regeneration. However, the present work provides a framework for the role of a hydrogel in the device and a path forward for more systematic studies.	[Golding, Anne] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Guay, Justin A.; Herrera-Rincon, Celia; Levin, Michael] Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University; Tufts University; Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Herrera-Rincon, Celia/M-3100-2019; Levin, Michael/A-5918-2011	Herrera-Rincon, Celia/0000-0003-0748-8718; Levin, Michael/0000-0001-7292-8084	NIH [R01 AR005593, R01 AR061988]; W. M. Keck Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation)	NIH (R01 AR005593, R01 AR061988) funding for DK and ML and W. M. Keck Foundation to ML and DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; Ahadian S, 2015, BIOCONJUGATE CHEM, V26, P1984, DOI 10.1021/acs.bioconjchem.5b00360; Alzahrani MM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00214; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; Boudrant J, 2010, PROCESS BIOCH, V45, P1757; Carlson B. M., 2007, PRINCIPLES REGENERAT; Caroline W., 2009, DEV DYNAM, V238, P1226; Carter DR, 2001, J BIOMECHANICS; Chao Edmund Y S, 2003, Eur Cell Mater, V6, P72; Chin MS, 2010, TISSUE ENG PART C-ME, V16, P397, DOI 10.1089/ten.TEC.2009.0185; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Coughlan DC, 2004, J CONTROL RELEASE, V98, P97, DOI 10.1016/j.jconrel.2004.04.014; Dawson Lindsay A, 2016, REGENERATION, DOI [10.1002/reg2.51, DOI 10.1002/REG2.51]; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Haremaki T, 2015, DEV BIOL, V408, P305, DOI 10.1016/j.ydbio.2015.07.013; Hechavarria D, 2010, MED ENG PHYS, V32, P1065, DOI 10.1016/j.medengphy.2010.07.010; Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.2005.12.009; Hudson EP, 2005, CURR OPIN BIOTECH, V16, P637, DOI 10.1016/j.copbio.2005.10.004; Imoto T, 1997, CELL MOL LIFE SCI, V53, P215, DOI 10.1007/PL00000593; Kareska S, 2010, FACTORS AFFECTING HY, V7; KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431; Kramarenko EY, 2006, POLYM SCI SER C+, V48, P1, DOI 10.1134/S1811238206010012; Laftah WA, 2011, POLYM-PLAST TECHNOL, V50, P1475, DOI 10.1080/03602559.2011.593082; Lancerotto L, 2014, ADV WOUND CARE, V3, P626, DOI 10.1089/wound.2013.0491; Leppik LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18353; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; MULLERGERBL M, 1987, J ANAT, V154, P103; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; Olczyk P, 2014, ROLE EXTRACELLULAR M, V2014, P12; Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526; Pufe T, 2004, AM J PATHOL, V164, P185, DOI 10.1016/S0002-9440(10)63109-4; Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024; Rao N, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-32; Ratner BD, 2004, CHEM ENG; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sambasivarao SV, 2013, CURR OPIN STRUC BIOL, V18, P1199, DOI DOI 10.1016/J.MICINF.2011.07.011.INNATE; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Satoh A, 2005, DEV DYNAM, V233, P1444, DOI 10.1002/dvdy.20484; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; SKINNER HCW, 1975, YALE J BIOL MED, V48, P377; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Timasheff SN, 1996, PROTEIN STAB FOLD TH, V379, P253; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Vernon AE, 2003, DEVELOPMENT, V130, P71, DOI 10.1242/dev.00180; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Wiegand C, 2013, WOUND REPAIR REGEN, V21, P793, DOI 10.1111/wrr.12111; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054764; Yuehuei HA., 2003, HDB HISTOLOGY METHOD	56	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155618	10.1371/journal.pone.0155618	http://dx.doi.org/10.1371/journal.pone.0155618			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257960	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700018
J	Lee, YM; Kim, SA; Lee, IK; Kim, JG; Park, KG; Jeong, JY; Jeon, JH; Shin, JY; Lee, DH				Lee, Yu-Mi; Kim, Se-A; Lee, In-Kyu; Kim, Jung-Guk; Park, Keun-Gyu; Jeong, Ji-Yun; Jeon, Jae-Han; Shin, Ji-Yeon; Lee, Duk-Hee			Effect of a Brown Rice Based Vegan Diet and Conventional Diabetic Diet on Glycemic Control of Patients with Type 2 Diabetes: A 12-Week Randomized Clinical Trial	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; BODY-WEIGHT; LOW-FAT; METAANALYSIS; MANAGEMENT; VEGETARIAN; FIBER; INTERVENTIONS	Objective Several intervention studies have suggested that vegetarian or vegan diets have clinical benefits, particularly in terms of glycemic control, in patients with type 2 diabetes (T2D); however, no randomized controlled trial has been conducted in Asians who more commonly depend on plant-based foods, as compared to Western populations. Here, we aimed to compare the effect of a vegan diet and conventional diabetic diet on glycemic control among Korean individuals. Materials and Methods Participants diagnosed with T2D were randomly assigned to follow either a vegan diet (excluding animal-based food including fish; n = 46) or a conventional diet recommended by the Korean Diabetes Association 2011 (n = 47) for 12 weeks. HbA1c levels were measured at weeks 0, 4, and 12, and the primary study endpoint was the change in HbA1c levels over 12 weeks. Results The mean HbA1c levels at weeks 0, 4, and 12 were 7.7%, 7.2%, and 7.1% in the vegan group, and 7.4%, 7.2%, and 7.2% in the conventional group, respectively. Although both groups showed significant reductions in HbA1C levels, the reductions were larger in the vegan group than in the conventional group (-0.5% vs. -0.2%; p-for-interaction = 0.017). When only considering participants with high compliance, the difference in HbA1c level reduction between the groups was found to be larger (-0.9% vs. -0.3%). The beneficial effect of vegan diets was noted even after adjusting for changes in total energy intake or waist circumference over the 12 weeks. Conclusion Both diets led to reductions in HbA1c levels; however, glycemic control was better with the vegan diet than with the conventional diet. Thus, the dietary guidelines for patients with T2D should include a vegan diet for the better management and treatment. However, further studies are needed to evaluate the long-term effects of a vegan diet, and to identify potential explanations of the underlying mechanisms.	[Lee, Yu-Mi; Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Daegu, South Korea; [Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea; [Kim, Se-A; Lee, Duk-Hee] Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea; [Lee, In-Kyu; Kim, Jung-Guk; Park, Keun-Gyu; Jeong, Ji-Yun; Jeon, Jae-Han] Kyungpook Natl Univ, Sch Med, Dept Endocrinol, Daegu, South Korea; [Shin, Ji-Yeon] Eulji Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Jeong, Ji-Yun] Soonchunhyang Univ, Gumi Hosp, Dept Internal Med, Gumi, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University; Eulji University; Soonchunhyang University	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Daegu, South Korea.; Lee, DH (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Daegu, South Korea.; Lee, DH (corresponding author), Kyungpook Natl Univ, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Daegu, South Korea.	lee_dh@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021		Korea Health Industry Development Institute - Ministry of Health Welfare [A111716-12020000100]; Korean Health Technology R&D Project - Ministry of Health and Welfare, Republic of Korea [HI13C0715, HI11C1300]	Korea Health Industry Development Institute - Ministry of Health Welfare; Korean Health Technology R&D Project - Ministry of Health and Welfare, Republic of Korea	This research was supported by the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (A111716-12020000100), as well as the Korean Health Technology R&D Project, funded by the Ministry of Health and Welfare, Republic of Korea (HI13C0715 and HI11C1300).	Ajala O, 2013, AM J CLIN NUTR, V97, P505, DOI 10.3945/ajcn.112.042457; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Barnard ND, 2005, AM J MED, V118, P991, DOI 10.1016/j.amjmed.2005.03.039; Barnard ND, 2006, DIABETES CARE, V29, P1777, DOI 10.2337/dc06-0606; Barnard ND, 2009, NUTR REV, V67, P255, DOI 10.1111/j.1753-4887.2009.00198.x; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Cao YM, 2009, J CLIN LIPIDOL, V3, P19, DOI 10.1016/j.jacl.2008.12.008; Chandalia M, 2000, NEW ENGL J MED, V342, P1392, DOI 10.1056/NEJM200005113421903; Committee of Clinical Practice Guidelines KDA, 2011, 2011 CLIN PRACT GUID; Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Goff LM, 2005, EUR J CLIN NUTR, V59, P291, DOI 10.1038/sj.ejcn.1602076; Kahleova H, 2011, DIABETIC MED, V28, P549, DOI 10.1111/j.1464-5491.2010.03209.x; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Le LT, 2014, NUTRIENTS, V6, P2131, DOI 10.3390/nu6062131; Lee DH, 2008, DIABETES, V57, P3108, DOI 10.2337/db08-0668; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lee DH, 2012, ENVIRON INT, V47, P115, DOI 10.1016/j.envint.2012.06.009; Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x; Livesey G, 2009, AM J CLIN NUTR, V89, P114, DOI 10.3945/ajcn.2008.26842; Mishra S, 2013, EUR J CLIN NUTR, V67, P718, DOI 10.1038/ejcn.2013.92; STORY JA, 1978, AM J CLIN NUTR, V31, pS199, DOI 10.1093/ajcn/31.10.S199; Wang FL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002408; WHO, 2003, WHO TECHN REP SER; Yokoyama Y, 2014, CARDIOVASC DIAGN THE, V4, P373, DOI 10.3978/j.issn.2223-3652.2014.10.04; Yokoyama Y, 2014, JAMA INTERN MED, V174, P577, DOI 10.1001/jamainternmed.2013.14547	28	58	58	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155918	10.1371/journal.pone.0155918	http://dx.doi.org/10.1371/journal.pone.0155918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253526	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700011
J	Wirtz, AL; Mehta, SH; Latkin, C; Zelaya, CE; Galai, N; Peryshkina, A; Mogilnyi, V; Dzhigun, P; Kostetskaya, I; Beyrer, C				Wirtz, Andrea L.; Mehta, Shruti H.; Latkin, Carl; Zelaya, Carla E.; Galai, Noya; Peryshkina, Alena; Mogilnyi, Vladimir; Dzhigun, Petr; Kostetskaya, Irina; Beyrer, Chris			Comparison of Respondent Driven Sampling Estimators to Determine HIV Prevalence and Population Characteristics among Men Who Have Sex with Men in Moscow, Russia	PLOS ONE			English	Article							BEHAVIORAL SURVEILLANCE; METHODOLOGY	Analytically distinct estimators have been proposed for the calculation of population-based estimates derived from respondent-driven sampling (RDS), yet there have been few comparisons of the inferences from these estimators using empirical data. We compared estimates produced by unweighted analysis used to calculate sample proportions and by three available estimators that are used to calculate population proportions, RDS-I, RDS-II (Volz-Heckathorn), and Gile's RDS-SS. Data were derived from a cross-sectional, RDS study of men who have sex with men (MSM) conducted from October 2010 to April 2013 in Moscow, Russia (N = 1,376, recruitment depth: 31 waves). Analyses investigated the influence of key parameters: recruitment depth, homophily, and network size on sample and population estimates. Variability in results produced by the estimators and recruitment depth were statistically compared using the coefficient of variation (CV). Sample proportions had the least variability across different recruitment depths, compared to the RDS estimators. Population estimates tended to differ at lower recruitment depth but were approximately equal after reaching sampling equilibrium, highlighting the importance of sampling to greater recruitment depth. All estimators incorporate inverse probability weighting using self-reported network size, explaining the similarities in across population estimates and the difference of these estimates relative to sample proportions. Current biases and limitations associated with RDS estimators are discussed.	[Wirtz, Andrea L.; Zelaya, Carla E.; Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA; [Mehta, Shruti H.; Galai, Noya] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Latkin, Carl] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Galai, Noya] Univ Haifa, Dept Stat, Har Hakarmel, Israel; [Peryshkina, Alena; Mogilnyi, Vladimir; Dzhigun, Petr; Kostetskaya, Irina] AIDS Infoshare, Moscow, Russia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Haifa	Wirtz, AL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD USA.	awirtz1@jhu.edu	Galai, Noya/HII-8086-2022		National Institute of Mental Health (NIMH) "High Risk Men: Identity, Health Risks, HIV and Stigma" [R01 MH085574-01A2]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NIH [P30AI094189]	National Institute of Mental Health (NIMH) "High Risk Men: Identity, Health Risks, HIV and Stigma"; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this research came from the National Institute of Mental Health (NIMH R01 MH085574-01A2) "High Risk Men: Identity, Health Risks, HIV and Stigma," funded from 2009 - 2014. This research has been facilitated by the infrastructure and resources provided by the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Federal States Statistics Service (Rosstat), 2014, POP AG GROUPS 2012; Gile K, 2011, NETWORK MODEL ASSIST; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Gyarmathy VA, 2014, DRUG ALCOHOL DEPEN, V135, P71, DOI 10.1016/j.drugalcdep.2013.11.020; Handcock MS, 2012, DEDUCERRDSANALYST GR; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Johnston LG, 2013, AIDS BEHAV, V17, P2202, DOI 10.1007/s10461-012-0394-8; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Lu X, 2012, J R STAT SOC A STAT, V175, P191, DOI 10.1111/j.1467-985X.2011.00711.x; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; MARTIN JD, 1971, AM SOCIOL REV, V36, P496, DOI 10.2307/2093089; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Mills HL, 2014, DRUG ALCOHOL DEPEN, V142, P120, DOI 10.1016/j.drugalcdep.2014.06.015; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Volz E., 2012, RESPONDENT DRIVEN SA; Volz E, 2008, J OFF STAT, V24, P79; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; White RG, 2015, J CLIN EPIDEMIOLOGY; Wirtz AL, 2016, AIDS BEHAV, V20, P523, DOI 10.1007/s10461-015-1066-2; Wirtz AL, 2015, EUROSURVEILLANCE B E, V20; Young AM, 2014, J EPIDEMIOL COMMUN H, V68, P792, DOI 10.1136/jech-2014-203935	28	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155519	10.1371/journal.pone.0155519	http://dx.doi.org/10.1371/journal.pone.0155519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248818	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700017
J	McNeil, B; Lowry, D; Larson, S; Griffing, D				McNeil, Bryan; Lowry, Dayv; Larson, Shawn; Griffing, Denise			Feeding Behavior of Subadult Sixgill Sharks (Hexanchus griseus) at a Bait Station	PLOS ONE			English	Article							PREY CAPTURE BEHAVIOR; FUNCTIONAL-MORPHOLOGY; KINEMATIC ANALYSIS; JAW PROTRUSION; NURSE SHARK; MECHANISM; SUCTION; EVOLUTION; PERFORMANCE	This is the first in-situ study of feeding behaviors exhibited by bluntnose sixgill sharks. Bait was placed beneath the Seattle Aquarium pier situated on the waterfront in Elliott Bay, Puget Sound, Washington at 20m of water depth. Cameras and lights were placed around the bait box to record sixgill shark presence and behavior while feeding. Analysis of feeding behavior revealed that sixgills utilize a bite comparable to many other elasmobranchs and aquatic vertebrates, have the ability to protrude their upper jaw, change their feeding behavior based on the situation, and employ sawing and lateral tearing during manipulation. The versatility of their feeding mechanism and the ability of sixgills to change their capture and food manipulation behaviors may have contributed to the species' worldwide distribution and evolutionary success.	[McNeil, Bryan; Larson, Shawn; Griffing, Denise] Seattle Aquarium, Seattle, WA 98101 USA; [Lowry, Dayv] Washington Dept Fish & Wildlife, Olympia, WA USA	Washington Department of Fish & Wildlife (WDFW)	McNeil, B (corresponding author), Seattle Aquarium, Seattle, WA 98101 USA.	b.mcneil@seattleaquarium.org		Lowry, Dayv/0000-0003-1159-3828	Seattle Aquarium; Royal Caribbean Ocean Fund	Seattle Aquarium; Royal Caribbean Ocean Fund	The Seattle Aquarium (www.seattleaquarium.org) supported this study by using its staff, volunteers, facilities, research equipment, and access to Elliott Bay. Any staff member that assisted in the design, data collection and analysis, decision to publish, or preparation of the manuscript are authors on this paper. (BM) The Royal Caribbean Ocean Fund (http://www.royalcaribbean.com/ourCompany/environment/oceanFund.do) supported this study through funds and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (SL)	Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Barans Charles A., 1994, Journal of the Elisha Mitchell Scientific Society, V110, P49; Castro J. I., 1983, SHARKS N AM WATERS; Celona Antonio, 2005, Bollettino del Museo Civico di Storia Naturale di Venezia, V56, P137; Compagno L. J. V., 2002, FAO SPECIES CATALOGU, V2; Compagno L. J. V, 1984, SHARKS WORLD ANNOT 1, V4; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; EBERT DA, 1994, S AFR J MARINE SCI, V14, P213; EBERT DA, 1986, COPEIA, P131; Edmonds MA, 2001, ENVIRON BIOL FISH, V62, P415, DOI 10.1023/A:1012205518704; Ferrara TL, 2011, J BIOMECH, V44, P430, DOI 10.1016/j.jbiomech.2010.09.028; Ferry-Graham LA, 1998, J EXP BIOL, V201, P2433; FerryGraham LA, 1997, J EXP BIOL, V200, P1255; Griffing D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087081; Hammerschlag Neil, 2012, P91; IUCN (n.d.), IUCN REDL THREAT SPE; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Kyne PM, 2012, CONSERVATION STATUS, P156; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; LAUDER GV, 1979, J ZOOL, V187, P543; Lowry D, 2008, J R SOC INTERFACE, V5, P641, DOI 10.1098/rsif.2007.1189; Lowry D, 2007, MAR BIOL, V151, P2013, DOI 10.1007/s00227-007-0642-z; Lowry D, 2007, J EXP MAR BIOL ECOL, V341, P153, DOI 10.1016/j.jembe.2006.07.018; Lowry DC, 2005, THESIS U S FLORIDA, P1; MAISEY J G, 1980, American Museum Novitates, P1; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; Martin RA, 1998, SWIMMING JURASSIC SH; Matott MP, 2005, ENVIRON BIOL FISH, V74, P163, DOI 10.1007/s10641-005-7435-3; MOSS SA, 1972, J ZOOL, V167, P423; MOSS SA, 1977, AM ZOOL, V17, P355; Motta PJ, 1997, J EXP BIOL, V200, P2765; Motta PJ, 2004, CRC MAR BIOL SER, P165; Motta PJ, 2002, COPEIA, P24, DOI 10.1643/0045-8511(2002)002[0024:KAOSFI]2.0.CO;2; MOTTA PJ, 1984, COPEIA, P1; MOTTA PJ, 1982, J MORPHOL, V174, P283, DOI 10.1002/jmor.1051740305; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; NORTON SF, 1993, J EXP BIOL, V176, P11; Sasko DE, 2006, ZOOLOGY, V109, P171, DOI 10.1016/j.zool.2005.12.005; Tricas T.C., 1985, Memoirs of the Southern California Academy of Sciences, V9, P81; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Wainwright PC, 2001, J EXP BIOL, V204, P3039; WESTNEAT MW, 1989, J MORPHOL, V202, P129, DOI 10.1002/jmor.1052020202; Whitenack LB, 2010, BIOL J LINN SOC, V100, P271, DOI 10.1111/j.1095-8312.2010.01421.x; Wilga CD, 1998, J EXP BIOL, V201, P1345; Wilga CD, 2002, BIOL J LINN SOC, V75, P483, DOI 10.1046/j.1095-8312.2002.00037.x; Wilga CD, 2001, AM ZOOL, V41, P1248, DOI 10.1668/0003-1569(2001)041[1248:EOUJPM]2.0.CO;2; Wilga CD, 2000, BIOL J LINN SOC, V71, P165; WU EH, 1994, J MORPHOL, V222, P175, DOI 10.1002/jmor.1052220205; ZANGERL R, 1975, Palaeontology (Oxford), V18, P333	52	13	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156730	10.1371/journal.pone.0156730	http://dx.doi.org/10.1371/journal.pone.0156730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243237	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100067
J	Shuaib, A; Hartwell, A; Kiss-Toth, E; Holcombe, M				Shuaib, Aban; Hartwell, Adam; Kiss-Toth, Endre; Holcombe, Mike			Multi-Compartmentalisation in the MAPK Signalling Pathway Contributes to the Emergence of Oscillatory Behaviour and to Ultrasensitivity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; CELL-CYCLE ARREST; NEGATIVE-FEEDBACK; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; TRANSDUCTION PATHWAYS; COMPLEX-FORMATION; SYSTEMS BIOLOGY; RAS	Signal transduction through the Mitogen Activated Protein Kinase (MAPK) pathways is evolutionarily highly conserved. Many cells use these pathways to interpret changes to their environment and respond accordingly. The pathways are central to triggering diverse cellular responses such as survival, apoptosis, differentiation and proliferation. Though the interactions between the different MAPK pathways are complex, nevertheless, they maintain a high level of fidelity and specificity to the original signal. There are numerous theories explaining how fidelity and specificity arise within this complex context; spatio-temporal regulation of the pathways and feedback loops are thought to be very important. This paper presents an agent based computational model addressing multi-compartmentalisation and how this influences the dynamics of MAPK cascade activation. The model suggests that multi-compartmentalisation coupled with periodic MAPK kinase (MAPKK) activation may be critical factors for the emergence of oscillation and ultrasensitivity in the system. Finally, the model also establishes a link between the spatial arrangements of the cascade components and temporal activation mechanisms, and how both contribute to fidelity and specificity of MAPK mediated signalling.	[Shuaib, Aban; Kiss-Toth, Endre] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Shuaib, Aban; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Shuaib, Aban] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Hartwell, Adam] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England; [Holcombe, Mike] Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Holcombe, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.; Holcombe, M (corresponding author), Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England.	m.holcombe@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Varma, Susheel/0000-0003-1687-2754; Shuaib, Aban/0000-0002-6137-8205	Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant [BB/F016840/1]	Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant BB/F016840/1 (www.bbsrc.ac.uk).	Adra SF, 2008, TECHNICAL REPORT; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Angermann BR, 2012, NAT METHODS, V9, P283, DOI [10.1038/NMETH.1861, 10.1038/nmeth.1861]; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Coakley S, 2006, SIMULATION, V38, P33; Colpoys WE, 2005, CELL SIGNAL, V17, P891, DOI 10.1016/j.cellsig.2004.11.014; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hao Bai, 2014, PLOS COMPUT IN PRESS; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2011, BIOPHYS J, V101, P2572, DOI 10.1016/j.bpj.2011.10.025; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1; Mugler A, 2012, BIOPHYS J, V102, P1069, DOI 10.1016/j.bpj.2012.02.005; Munoz-Garcia J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000330; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Sarma Uddipan, 2012, BMC Res Notes, V5, P287, DOI 10.1186/1756-0500-5-287; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Shankaran H, 2011, MOL CARCINOGEN, V50, P424, DOI 10.1002/mc.20724; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vetterkind S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030409; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhao Q, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055004; Zhou Q, 2012, BRIT J PHARMACOL, V166, P1756, DOI 10.1111/j.1476-5381.2012.01875.x	78	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156139	10.1371/journal.pone.0156139	http://dx.doi.org/10.1371/journal.pone.0156139			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243235	Green Accepted, Green Published, gold			2022-12-27	WOS:000377146100017
J	Yubero, D; Brandi, N; Ormazabal, A; Garcia-Cazorla, A; Perez-Duenas, B; Campistol, J; Ribes, A; Palau, F; Artuch, R; Armstrong, J				Yubero, Delia; Brandi, Nuria; Ormazabal, Aida; Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime; Ribes, Antonia; Palau, Francesc; Artuch, Rafael; Armstrong, Judith		Working Grp	Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism	PLOS ONE			English	Article							EXONIC SPLICING ENHANCER; MOLECULAR DIAGNOSIS; MENDELIAN DISORDERS; HARTNUP DISORDER; GENE; DEFICIENCY; MUTATION; DISEASES; ACID; CHILDHOOD	Background Next-generation sequencing (NGS) technology has allowed the promotion of genetic diagnosis and are becoming increasingly inexpensive and faster. To evaluate the utility of NGS in the clinical field, a targeted genetic panel approach was designed for the diagnosis of a set of inborn errors of metabolism (IEM). The final aim of the study was to compare the findings for the diagnostic yield of NGS in patients who presented with consistent clinical and biochemical suspicion of IEM with those obtained for patients who did not have specific biomarkers. Methods The subjects studied (n = 146) were classified into two categories: Group 1 (n = 81), which consisted of patients with clinical and biochemical suspicion of IEM, and Group 2 (n = 65), which consisted of IEM cases with clinical suspicion and unspecific biomarkers. A total of 171 genes were analyzed using a customtargeted panel of genes followed by Sanger validation. Results Genetic diagnosis was achieved in 50% of patients (73/146). In addition, the diagnostic yield obtained for Group 1 was 78% (63/81), and this rate decreased to 15.4% (10/65) in Group 2 (X-2 = 76.171; p < 0.0001). Conclusions A rapid and effective genetic diagnosis was achieved in our cohort, particularly the group that had both clinical and biochemical indications for the diagnosis.	[Yubero, Delia; Ormazabal, Aida; Artuch, Rafael] Hosp St Joan Deu, Dept Clin Biochem, Barcelona, Spain; [Yubero, Delia; Ormazabal, Aida; Artuch, Rafael] Hosp St Joan Deu, Inst Invest Sanitaria St Joan Deu, Barcelona, Spain; [Brandi, Nuria] Univ Barcelona, Fac Med, Barcelona 7, Spain; [Brandi, Nuria; Palau, Francesc; Armstrong, Judith] Hosp St Joan Deu, Mol & Genet Med Sect, Barcelona, Spain; [Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime] Hosp St Joan Deu, Dept Neurol, Barcelona, Spain; [Ribes, Antonia] Hosp Clin Barcelona, Inst Bioquim Clin, Barcelona, Spain; [Ormazabal, Aida; Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime; Ribes, Antonia; Palau, Francesc; Artuch, Rafael; Armstrong, Judith] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Armstrong, J (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain.	jarmstrong@hsjdbcn.org	Palau, Francesc/A-9391-2014; Martí-Carrera, Itxaso/AGP-5583-2022; Perez-Duenas, Belen/AAG-9054-2019	Palau, Francesc/0000-0002-8635-5421; Martí-Carrera, Itxaso/0000-0003-0578-9568; Yubero, Delia/0000-0001-7742-0589; Malaga, Ignacio/0000-0003-4074-6870; KIZILTAN, GUNES/0000-0001-9284-198X; Olive, Montse/0000-0001-5727-0165; Ribes Rubio, Antonia/0000-0002-2249-246X; Artuch, Rafael/0000-0002-3422-9685	Spanish Ministry of Health (Fondo de Investigacion Sanitaria) [PI11/02350, PI11/00078]; Spanish Ministry of Health (Instituto de Salud Carlos III) [PI11/02350, PI11/00078]; Spanish Ministry of Health (FEDER) [PI11/02350, PI11/00078]; "programa de intensificacion de la actividad investigadora", from ISCIII	Spanish Ministry of Health (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Health (FEDER); "programa de intensificacion de la actividad investigadora", from ISCIII	This research was funded by grants PI11/02350 and PI11/00078 from the Spanish Ministry of Health (Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III and FEDER). R. Artuch is supported by the "programa de intensificacion de la actividad investigadora", from ISCIII.	Azize NAA, 2014, J HUM GENET, V59, P593, DOI 10.1038/jhg.2014.69; Blau N., 2003, PHYS GUIDE LAB DIAGN; Blau N., 2008, LAB GUIDE METHODS BI; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Cao YY, 2014, MOL GENET METAB, V113, P261, DOI 10.1016/j.ymgme.2014.10.004; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; Feng YM, 2015, GENET MED, V17, P99, DOI 10.1038/gim.2014.80; Gu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094100; Homolova K, 2010, HUM MUTAT, V31, P437, DOI 10.1002/humu.21206; Kingsmore SF, 2011, EXPERT REV MOL DIAGN, V11, P855, DOI [10.1586/erm.11.70, 10.1586/ERM.11.70]; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Li N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15769; Miller MJ, 2015, MOL GENET METAB, V116, P139, DOI 10.1016/j.ymgme.2015.08.011; Molero-Luis M, 2013, DEV MED CHILD NEUROL, V55, P559, DOI 10.1111/dmcn.12116; Palhais B, 2015, NUCLEIC ACIDS RES, V43, P4627, DOI 10.1093/nar/gkv275; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Perez-Duenas B, 2011, ARCH NEUROL-CHICAGO, V68, P615, DOI 10.1001/archneurol.2011.80; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Singer D, 2011, CHANNELS, V5, P408, DOI 10.4161/chan.5.5.16470; Trujillano D, 2014, EUR J HUM GENET, V22, P528, DOI 10.1038/ejhg.2013.175; Wang J, 2013, GENET MED, V15, P106, DOI 10.1038/gim.2012.104; Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0; Yohe S, 2015, ARCH PATHOL LAB MED, V139, P204, DOI 10.5858/arpa.2013-0625-OA; Yu H, 2013, MOL GENET METAB, V110, P465, DOI 10.1016/j.ymgme.2013.09.018; Zhang W, 2014, TOP CURR CHEM, V336, P19, DOI 10.1007/128_2012_325	29	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156359	10.1371/journal.pone.0156359	http://dx.doi.org/10.1371/journal.pone.0156359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243974	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100032
J	Parletta, N; Niyonsenga, T; Duff, J				Parletta, Natalie; Niyonsenga, Theophile; Duff, Jacques			Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; DIETARY SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; SUSTAINED ATTENTION; CONTROLLED-TRIAL; ADHD; BEHAVIOR; PREVALENCE; CHILDHOOD; COGNITION	Background There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels. Objectives This study investigated whether erythrocyte n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were lower and n-6 PUFA arachidonic acid (AA) higher in children with ADHD, ASD and controls, and whether lower n-3 and higher n-6 PUFAs correlated with poorer scores on the Australian Twin Behaviour Rating Scale (ATBRS; ADHD symptoms) and Test of Variable Attention (TOVA) in children with ADHD, and Childhood Autism Rating Scale (CARS) in children with ASD. Methods Assessments and blood samples of 565 children aged 3-17 years with ADHD (n = 401), ASD (n = 85) or controls (n = 79) were analysed. One-way ANOVAs with Tukey's post-hoc analysis investigated differences in PUFA levels between groups and Pearson's correlations investigated correlations between PUFA levels and ATBRS, TOVA and CARS scores. Results Children with ADHD and ASD had lower DHA, EPA and AA, higher AA/EPA ratio and lower n-3/n-6 than controls (P < 0.001 except AA between ADHD and controls: P = 0.047). Children with ASD had lower DHA, EPA and AA than children with ADHD (P < 0.001 for all comparisons). ATBRS scores correlated negatively with EPA (r = -.294, P < 0.001), DHA (r = -.424, P < 0.001), n-3/n-6 (r = -.477, P < 0.001) and positively with AA/EPA (r = .222, P <. 01). TOVA scores correlated positively with DHA (r = .610, P < 0.001), EPA (r = .418, P < 0.001) AA (r =.199, P < 0.001), and n-3/n-6 (r = .509, P < 0.001) and negatively with AA/EPA (r = -.243, P < 0.001). CARS scores correlated significantly with DHA (r =. 328, P = 0.002), EPA (r = -.225, P = 0.038) and AA (r = .251, P = 0.021). Conclusions Children with ADHD and ASD had low levels of EPA, DHA and AA and high ratio of n-6/n-3 PUFAs and these correlated significantly with symptoms. Future research should further investigate abnormal fatty acid metabolism in these disorders.	[Parletta, Natalie; Niyonsenga, Theophile] Univ S Australia, Ctr Populat Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Duff, Jacques] Behav Neurotherapy Clin, Doncaster, Vic, Australia; [Duff, Jacques] Australian Autism ADHD Fdn, Doncaster, Vic, Australia	University of South Australia	Duff, J (corresponding author), Behav Neurotherapy Clin, Doncaster, Vic, Australia.; Duff, J (corresponding author), Australian Autism ADHD Fdn, Doncaster, Vic, Australia.	info@autism-ADHD.org.au	Parletta, Natalie/A-7880-2008; Niyonsenga, Theophile/C-3759-2014	Parletta, Natalie/0000-0003-2322-5555; Niyonsenga, Theophile/0000-0002-6723-0316	National Health and Medical Research Council [320860, 631947]; Australian Autism ADHD Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Autism ADHD Foundation	NP is supported by National Health and Medical Research Council Program Grant funding (# 320860 and 631947). The Australian Autism ADHD Foundation funded the cost of HREC and publishing the paper.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Antalis CJ, 2006, PROSTAG LEUKOTR ESS, V75, P299, DOI 10.1016/j.plefa.2006.07.004; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Bos DJ, 2015, NEUROPSYCHOPHARMACOL, V40, P2298, DOI 10.1038/npp.2015.73; Brigandi SA, 2015, INT J MOL SCI, V16, P10061, DOI 10.3390/ijms160510061; Bu B, 2006, PROSTAG LEUKOTR ESS, V74, P215, DOI 10.1016/j.plefa.2006.02.001; Charach A, 2004, J AM ACAD CHILD PSY, V43, P559, DOI 10.1097/00004583-200405000-00009; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Colter AL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-8; Curtis LT, 2008, J ALTERN COMPLEM MED, V14, P79, DOI 10.1089/acm.2007.0610; Gow RV, 2015, CURR OPIN CLIN NUTR, V18, P133, DOI 10.1097/MCO.0000000000000140; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hawkey E, 2014, CLIN PSYCHOL REV, V34, P496, DOI 10.1016/j.cpr.2014.05.005; Howard AL, 2011, J ATTEN DISORD, V15, P403, DOI 10.1177/1087054710365990; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2004, PEDIATRICS, V113, P762; Johnson CR, 2008, J DEV PHYS DISABIL, V20, P437, DOI 10.1007/s10882-008-9111-y; Johnson M, 2009, J ATTEN DISORD, V12, P394, DOI 10.1177/1087054708316261; Joshi K, 2006, PROSTAG LEUKOTR ESS, V74, P17, DOI 10.1016/j.plefa.2005.10.001; Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552; Laasonen M, 2009, PROSTAG LEUKOTR ESS, V81, P79, DOI 10.1016/j.plefa.2009.04.004; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Llorente AM, 2008, CHILD NEUROPSYCHOL, V14, P314, DOI 10.1080/09297040701563578; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Miller CS, 2001, ANN NY ACAD SCI, V933, P1, DOI 10.1017/CBO9780511666452.002; Milte CM, 2015, J ATTEN DISORD, V19, P954, DOI 10.1177/1087054713510562; Milte CM, 2012, NUTRITION, V28, P670, DOI 10.1016/j.nut.2011.12.009; Milte CM, 2011, J CHILD HEALTH CARE, V15, P299, DOI 10.1177/1367493511403953; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Montgomery P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066697; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Ng KH, 2009, BRIT J NUTR, V102, P1635, DOI 10.1017/S0007114509990821; Nikolas MA, 2010, J ABNORM PSYCHOL, V119, P1, DOI 10.1037/a0018010; Parletta N, 2013, J NUTR BIOCHEM, V24, P725, DOI 10.1016/j.jnutbio.2013.01.002; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Pliszka SR, 1998, J CLIN PSYCHIAT, V59, P50; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Richardson AJ, 2004, LIPIDS, V39, P1215, DOI 10.1007/s11745-004-1350-z; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Rowland AS, 2002, MENT RETARD DEV D R, V8, P162, DOI 10.1002/mrdd.10036; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Shamberger RJ, 1997, J ADV MED, V10, P195; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Sinn N, 2008, BIOSCI HYPOTHESES, V1, P103, DOI DOI 10.1016/j.bihy.2008.02.003; Sinn N, 2008, NUTR REV, V66, P558, DOI 10.1111/j.1753-4887.2008.00107.x; Sinn N, 2007, J DEV BEHAV PEDIATR, V28, P82, DOI 10.1097/01.DBP.0000267558.88457.a5; Sinn N, 2006, INT REV RES MENT RET, V32, P159, DOI 10.1016/S0074-7750(06)32006-X; Sinn N, 2010, NUTRIENTS, V2, P128, DOI 10.3390/nu2020128; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1015, DOI 10.1097/chi.0b013e3180686d7e; Transler C, 2010, J ATTEN DISORD, V14, P232, DOI 10.1177/1087054709347250; Vaisman N, 2008, AM J CLIN NUTR, V87, P1170, DOI 10.1093/ajcn/87.5.1170; Vancassel S, 2001, PROSTAG LEUKOTR ESS, V65, P1, DOI 10.1054/plef.2001.0281; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Wiest MM, 2009, PROSTAG LEUKOTR ESS, V80, P221, DOI 10.1016/j.plefa.2009.01.007; Wiles NJ, 2009, EUR J CLIN NUTR, V63, P491, DOI 10.1038/sj.ejcn.1602967; Willemsen LEM, 2008, EUR J NUTR, V47, P183, DOI 10.1007/s00394-008-0712-0; Young GS, 2004, LIPIDS, V39, P117, DOI 10.1007/s11745-004-1209-3; Zablotsky B, 2013, NATL HLTH STAT REPOR	70	58	59	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156432	10.1371/journal.pone.0156432	http://dx.doi.org/10.1371/journal.pone.0156432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232999	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000376883000035
J	Arribas, L; Almansa, I; Miranda, M; Muriach, M; Romero, FJ; Villar, VM				Arribas, Luis; Almansa, Inmaculada; Miranda, Maria; Muriach, Maria; Romero, Francisco J.; Villar, Vincent M.			Serum Malondialdehyde Concentration and Glutathione Peroxidase Activity in a Longitudinal Study of Gestational Diabetes	PLOS ONE			English	Article							OXIDATIVE STRESS; LIPID-PEROXIDATION; NORMAL-PREGNANCY; VITAMIN-E; ANTIOXIDANT ENZYMES; INSULIN-RESISTANCE; CORD BLOOD; SELENIUM; PLASMA; WOMEN	Aims The main goal of this study was to evaluate the presence of oxidative damage and to quantify its level in gestational diabetes. Methods Thirty-six healthy women and thirty-six women with gestational diabetes were studied in the three trimesters of pregnancy regarding their levels of oxidative stress markers. These women were diagnosed with diabetes in the second trimester of pregnancy. Blood glucose levels after 100g glucose tolerance test were higher than 190, 165 or 145 mg/dl, 1, 2 or 3 hours after glucose intake. Results The group of women with gestational diabetes had higher serum malondialdehyde levels, with significant differences between groups in the first and second trimester. The mean values of serum glutathione peroxidase activity in the diabetic women were significantly lower in the first trimester. In the group of women with gestational diabetes there was a negative linear correlation between serum malondialdehyde concentration and glutathione peroxidase activity in the second and third trimester. Conclusions In this observational and longitudinal study in pregnant women, the alterations attributable to oxidative stress were present before the biochemical detection of the HbA1c increase. Usual recommendations once GD is detected (adequate metabolic control, as well as any other normally proposed to these patients) lowered the concentration of malondialdehyde at the end of pregnancy to the same levels of the healthy controls. Serum glutathione peroxidase activity in women with gestational diabetes increased during the gestational period.	[Arribas, Luis] Hosp La Plana, Unidad Diabet, Serv Med Interna, Vila Real, Spain; [Almansa, Inmaculada; Miranda, Maria; Villar, Vincent M.] Univ CEU Cardenal Herrera, Dept Ciencias Biomed, Valencia, Spain; [Muriach, Maria] Univ Jaume 1, Dept Med, Valencia, Spain; [Romero, Francisco J.] Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain	Universidad CEU Cardenal Herrera; Universitat Jaume I; Universidad Catolica de Valencia San Vicente Martir	Romero, FJ (corresponding author), Univ Catolica Valencia San Vicente Martir, Fac Med, Valencia, Spain.	fj.romero@ucv.es	Miranda, María/L-3471-2014; Miranda, María/ABG-5343-2020; Villar, Vincent M/H-5905-2015; Almansa, Inmaculada/F-4183-2016; Muriach, María/AAB-2003-2019	Miranda, María/0000-0002-3738-367X; Miranda, María/0000-0002-3738-367X; Villar, Vincent M/0000-0002-2241-7654; Almansa, Inmaculada/0000-0001-8085-3377; Romero, Francisco J/0000-0001-8701-5907				Arikan S, 2001, GYNECOL OBSTET INVES, V51, P145, DOI 10.1159/000052913; Biondi C, 2005, CURR PHARM DESIGN, V11, P2075, DOI 10.2174/1381612054065747; Bosch-Morell F, 1999, FREE RADICAL BIO MED, V26, P1383, DOI 10.1016/S0891-5849(98)00335-9; CARONE D, 1993, EUR J OBSTET GYN R B, V51, P103, DOI 10.1016/0028-2243(93)90021-4; Ceriello A, 1998, EUR J CLIN INVEST, V28, P329; Chaudhari Lalita, 2003, Indian Journal of Physiology and Pharmacology, V47, P441; Chen XH, 2003, J CLIN ENDOCR METAB, V88, P5963, DOI 10.1210/jc.2003-030544; Coughlan MT, 2004, J CLIN ENDOCR METAB, V89, P3585, DOI 10.1210/jc.2003-031953; Coughlan MT, 2004, PLACENTA, V25, P78, DOI 10.1016/S0143-4004(03)00183-8; Davi G, 1999, CIRCULATION, V99, P224; Djordjevic A, 2004, J Matern Fetal Neonatal Med, V16, P367; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Garamvolgyi Z, 2015, CELL STRESS CHAPERON, V20, P575, DOI 10.1007/s12192-015-0579-y; Gladen BC, 1999, REPROD TOXICOL, V13, P41, DOI 10.1016/S0890-6238(98)00054-9; HANSON U, 1983, OBSTET GYNECOL, V62, P741; Kamath U, 1998, ACTA PAEDIATR, V87, P676, DOI 10.1080/080352598750014102; Kinalski M, 2001, HORM METAB RES, V33, P227, DOI 10.1055/s-2001-14953; Lappas M, 2004, J CLIN ENDOCR METAB, V89, P5627, DOI 10.1210/jc.2003-032097; Lappas M, 2011, ANTIOXID REDOX SIGN, V15, P3061, DOI 10.1089/ars.2010.3765; LAWRENCE RA, 1978, J NUTR, V108, P981, DOI 10.1093/jn/108.6.981; LIND T, 1979, BRIT J OBSTET GYNAEC, V86, P210, DOI 10.1111/j.1471-0528.1979.tb10595.x; Loverro G, 1996, EUR J OBSTET GYN R B, V70, P123, DOI 10.1016/S0301-2115(95)02561-8; McKinney ET, 2000, AM J OBSTET GYNECOL, V183, P874, DOI 10.1067/mob.2000.108877; METZGER BE, 1991, DIABETES, V40, P197, DOI 10.2337/diab.40.2.S197; Mihailovic M, 2000, BIOL TRACE ELEM RES, V73, P47, DOI 10.1385/BTER:73:1:47; Morris JM, 1998, BRIT J OBSTET GYNAEC, V105, P1195, DOI 10.1111/j.1471-0528.1998.tb09974.x; Nielsen LR, 2004, DIABETES CARE, V27, P1200, DOI 10.2337/diacare.27.5.1200; Oostdam N, 2011, J WOMENS HEALTH, V20, P1551, DOI 10.1089/jwh.2010.2703; Orhan Hilmi, 2003, Archives of Gynecology and Obstetrics, V267, P189; Paolisso G, 1996, DIABETOLOGIA, V39, P357, DOI 10.1007/BF00418354; Patrick TE, 2004, HYPERTENS PREGNANCY, V23, P91, DOI 10.1081/PRG-120028285; Peuchant E, 2004, CLIN BIOCHEM, V37, P293, DOI 10.1016/j.clinbiochem.2003.12.005; Poston L, 2004, PLACENTA, V25, pS72, DOI 10.1016/j.placenta.2004.01.003; Radder JK, 2005, NETH J MED, V63, P256; RICHARD MJ, 1992, J CHROMATOGR-BIOMED, V577, P9, DOI 10.1016/0378-4347(92)80593-F; Romero MJ, 1998, FREE RADICAL BIO MED, V25, P993, DOI 10.1016/S0891-5849(98)00118-X; Santra D, 2003, J OBSTET GYNAECOL RE, V29, P300, DOI 10.1046/j.1341-8076.2003.00127.x; Toescu V, 2004, CLIN SCI, V106, P93, DOI 10.1042/CS20030175; Toescu V, 2002, CLIN ENDOCRINOL, V57, P609, DOI 10.1046/j.1365-2265.2002.01638.x; UOTILA J, 1991, EUR J OBSTET GYN R B, V42, P95, DOI 10.1016/0028-2243(91)90168-K; Wender-Ozegowska E, 2004, FREE RADICAL RES, V38, P795, DOI 10.1080/10715760410001700479; WORTH R, 1985, DIABETOLOGIA, V28, P76; ZACHARA BA, 1993, GYNECOL OBSTET INVES, V35, P12, DOI 10.1159/000292655; Zein S, 2014, J TRACE ELEM MED BIO, V28, P65, DOI 10.1016/j.jtemb.2013.09.009; Zhang CL, 2004, EPIDEMIOLOGY, V15, P597, DOI 10.1097/01.ede.0000134864.90563.fa; Zhuang TF, 2014, NUTRIENTS, V6, P3968, DOI 10.3390/nu6093968	46	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155353	10.1371/journal.pone.0155353	http://dx.doi.org/10.1371/journal.pone.0155353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228087	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500017
J	Bai, ZG; Mao, SC; Han, YC; Feng, L; Wang, GP; Yang, BF; Zhi, XY; Fan, ZY; Lei, YP; Du, WL; Li, YB				Bai, Zhigang; Mao, Shuchun; Han, Yingchun; Feng, Lu; Wang, Guoping; Yang, Beifang; Zhi, Xiaoyu; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Li, Yabing			Study on Light Interception and Biomass Production of Different Cotton Cultivars	PLOS ONE			English	Article							RADIATION USE EFFICIENCY; DRY-MATTER PRODUCTION; LEAF-AREA INDEX; CANOPY STRUCTURE; PLANT ARCHITECTURE; SPATIAL-DISTRIBUTION; SIMULATION-MODEL; SOLAR-RADIATION; PHOTOSYNTHESIS; RECONSTRUCTION	Identifying the characteristics of light interception and utilization is of great significance for improving the potential photosynthetic activity of plants. The present research investigates the differences in absorbing and converting photosynthetically active radiation (PAR) among various cotton cultivars. Field experiments were conducted in 2012, 2013 and 2014 in Anyang, Henan, China. Ten cultivars with different maturity and plant architectures were planted at a density of 60,000 plants ha(-1) in randomized blocks, with three replicates. The spatial distribution of light in canopy was measured and quantified with a geo-statistical method, according to which the cumulative amount of intercepted radiation was calculated by Simpson 3/8 rules. Finally, light interception was analyzed in association with the biomass accumulation of different cultivars. The key results were: (1) late-maturing varieties with an incompact plant architecture captured more solar radiation throughout the whole growth period than middle varieties with columnar architecture and even more than early varieties with compact architecture, and they produced more biomass; (2) the highest PAR interception ratio and the maximum biomass accumulation rate occurred during the blossoming and boll-forming stage, when leaf area index (LAI) reached its peak; (3) the distribution within the canopy presented a significant spatial heterogeneity, and at late growing stage, the PAR was mainly intercepted by upper canopies in incompact-type plant communities, but was more homogeneous in columnar-type plants; however, the majority of radiation was transmitted through the canopy in compact-type colonies; (4) there was not a consistent variation relationship between the cumulative intercepted PAR (iPAR) and biomass among these cultivars over the three years of the study. Based on these results, we attempted to clarify the distinction in light spatial distribution within different canopies and the patterns of PAR interception in diverse cotton cultivars with different hereditary characters, thereby providing a significant basis for researchers to select cultivars with appropriate growth period and optimal plant architecture for improvement of light interception and utilization.	[Bai, Zhigang; Mao, Shuchun; Han, Yingchun; Feng, Lu; Wang, Guoping; Yang, Beifang; Zhi, Xiaoyu; Fan, Zhengyi; Lei, Yaping; Du, Wenli; Li, Yabing] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China.	criliyabing1@163.com	Yabing, Li/GLU-9964-2022		National Natural Science Foundation [31371561]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation (31371561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKMAN DP, 1989, J EXP BOT, V40, P855, DOI 10.1093/jxb/40.8.855; ANDRIEU B, 1995, AGR FOREST METEOROL, V75, P103, DOI 10.1016/0168-1923(94)02205-X; Bange MP, 2000, FIELD CROP RES, V68, P143, DOI 10.1016/S0378-4290(00)00116-7; Barthelemy D, 2007, ANN BOT-LONDON, V99, P375, DOI 10.1093/aob/mcl260; Escobar-Gutierrez AJ, 2009, AGR FOREST METEOROL, V149, P1244, DOI 10.1016/j.agrformet.2009.02.011; Fila G, 2011, AGR FOREST METEOROL, V151, P575, DOI 10.1016/j.agrformet.2011.01.004; Friday JB, 2001, AGR FOREST METEOROL, V108, P29, DOI 10.1016/S0168-1923(01)00220-9; Gonias ED, 2011, ENVIRON EXP BOT, V72, P217, DOI 10.1016/j.envexpbot.2011.03.008; GOSSE G, 1986, AGRONOMIE, V6, P47, DOI 10.1051/agro:19860103; Hall AE, 2001, CROP RESPONSE ENV, P40; HERBERT TJ, 1991, ECOLOGY, V72, P17, DOI 10.2307/1938897; Institute of Cotton Research of CAAS, 2013, COTT CULT CHIN, P123; Jost P, 2006, U GEORGIA B, P1305; Kaggwa-Asiimwe R, 2013, FIELD CROP RES, V145, P52, DOI 10.1016/j.fcr.2013.02.005; Kiniry J, 2011, AGRON J, V103, P119, DOI 10.2134/agronj2010.0280; KUROIWA S., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P79; Lambers H, 2008, PLANT PHYSL ECOLOGY, P26; Larsen DR, 1996, AGR FOREST METEOROL, V81, P61, DOI 10.1016/0168-1923(95)02307-0; Leuchner M, 2011, AGR FOREST METEOROL, V151, P1226, DOI 10.1016/j.agrformet.2011.04.014; Li YaBing, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P200; [李振华 Li Zhenhua], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P67; Louarn G, 2008, ANN BOT-LONDON, V101, P1167, DOI 10.1093/aob/mcm170; Ma YunTao, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P151; Maddonni GA, 1996, FIELD CROP RES, V48, P81, DOI 10.1016/0378-4290(96)00035-4; Melo JD, 2014, ELECTR POW SYST RES, V111, P177, DOI 10.1016/j.epsr.2014.02.019; O'Neal ME, 2002, J ECON ENTOMOL, V95, P1190, DOI 10.1603/0022-0493-95.6.1190; QUISENBERRY JE, 1976, CROP SCI, V16, P762, DOI 10.2135/cropsci1976.0011183X001600060005x; Reinhardt D, 2002, EMBO REP, V3, P846, DOI 10.1093/embo-reports/kvf177; Rey H, 2008, ANN BOT-LONDON, V101, P1139, DOI 10.1093/aob/mcm300; Ruiz RA, 2008, EUR J AGRON, V29, P144, DOI 10.1016/j.eja.2008.05.003; Russell G., 1989, Plant canopies: their growth, form and function., P21, DOI 10.1017/CBO9780511752308.003; Sarlikioti V, 2011, ANN BOT-LONDON, V107, P875, DOI 10.1093/aob/mcr006; SASSENRATHCOLE GF, 1995, AGR FOREST METEOROL, V77, P55, DOI 10.1016/0168-1923(95)02238-S; Sinclair TR, 1999, ADV AGRON, V65, P215, DOI 10.1016/S0065-2113(08)60914-1; Singer JW, 2011, FIELD CROP RES, V121, P147, DOI 10.1016/j.fcr.2010.12.007; Sinoquet H, 1998, ANN BOT-LONDON, V82, P203, DOI 10.1006/anbo.1998.0665; Stewart DW, 2003, AGRON J, V95, P1465, DOI 10.2134/agronj2003.1465; Stockle CO, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P145, DOI 10.1016/B978-0-12-374431-9.00007-4; Tang Liang, 2012, Yingyong Shengtai Xuebao, V23, P1269; Tesfaye K, 2006, EUR J AGRON, V25, P60, DOI 10.1016/j.eja.2006.04.014; Tharakan PJ, 2008, BIOENERG RES, V1, P229, DOI 10.1007/s12155-008-9023-9; TOURNEBIZE R, 1995, AGR FOREST METEOROL, V72, P277, DOI 10.1016/0168-1923(94)02162-D; Vargas LA, 2002, BIOMASS BIOENERG, V22, P1, DOI 10.1016/S0961-9534(01)00058-7; Vos J, 2010, J EXP BOT, V61, P2101, DOI 10.1093/jxb/erp345; Watanabe T, 2005, ANN BOT-LONDON, V95, P1131, DOI 10.1093/aob/mci136; Wiechers D, 2011, AGR FOREST METEOROL, V151, P906, DOI 10.1016/j.agrformet.2011.02.016; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Xue XiaoPing, 2006, Cotton Science, V18, P323; Zhang WY, 2015, EUR J AGRON, V67, P1, DOI 10.1016/j.eja.2015.02.010; Zhi X., 2014, PLOS ONE, V9, DOI [DOI 10.1371/JOURNAL.PONE.0113409, 10.1371/journal.pone.0113409]	50	14	15	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156335	10.1371/journal.pone.0156335	http://dx.doi.org/10.1371/journal.pone.0156335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227675	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500116
J	Hegyi, Z; Homolya, L				Hegyi, Zoltan; Homolya, Laszlo			Functional Cooperativity between ABCG4 and ABCG1 Isoforms	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; MULTIDRUG-RESISTANCE PROTEINS; CELLULAR CHOLESTEROL EFFLUX; HIGH-DENSITY-LIPOPROTEIN; SUBCELLULAR-LOCALIZATION; PLASMA-MEMBRANE; MEDIATE CHOLESTEROL; APOPTOSIS; EXPRESSION; CELLS	ABCG4 belongs to the ABCG subfamily, the members of which are half transporters composed of a single transmembrane and a single nucleotide-binding domain. ABCG proteins have a reverse domain topology as compared to other mammalian ABC transporters, and have to form functional dimers, since the catalytic sites for ATP binding and hydrolysis, as well as the transmembrane domains are composed of distinct parts of the monomers. Here we demonstrate that ABCG4 can form homodimers, but also heterodimers with its closest relative, ABCG1. Both the full-length and the short isoforms of ABCG1 can dimerize with ABCG4, whereas the ABCG2 multidrug transporter is unable to form a heterodimer with ABCG4. We also show that contrary to that reported in some previous studies, ABCG4 is predominantly localized to the plasma membrane. While both ABCG1 and ABCG4 have been suggested to be involved in lipid transport or regulation, in accordance with our previous results regarding the long version of ABCG1, here we document that the expression of both the short isoform of ABCG1 as well as ABCG4 induce apoptosis in various cell types. This apoptotic effect, as a functional read-out, allowed us to demonstrate that the dimerization between these half transporters is not only a physical interaction but functional cooperativity. Given that ABCG4 is predominantly expressed in microglial-like cells and endothelial cells in the brain, our finding of ABCG4-induced apoptosis may implicate a new role for this protein in the clearance mechanisms within the central nervous system.	[Hegyi, Zoltan; Homolya, Laszlo] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Homolya, L (corresponding author), Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary.	homolya.laszlo@ttk.mta.hu	Homolya, Laszlo/N-1154-2016	Homolya, Laszlo/0000-0003-1639-8140	Momentum Program of the Hungarian Academy of Sciences [LP 2012-025]	Momentum Program of the Hungarian Academy of Sciences	This work was supported by the Momentum Program of the Hungarian Academy of Sciences (LP 2012-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Annilo T, 2001, CYTOGENET CELL GENET, V94, P196, DOI 10.1159/000048816; Ayaori M, 2006, ARTERIOSCL THROM VAS, V26, P163, DOI 10.1161/01.ATV.0000193513.29074.52; Baldan A, 2006, CURR OPIN LIPIDOL, V17, P227, DOI 10.1097/01.mol.0000226113.89812.bb; Bojanic DD, 2010, J LIPID RES, V51, P169, DOI [10.1194/jlr.M900250-JLR200, 10.1194/M900250-JLR200]; Borge OJ, 1996, BLOOD, V88, P2859, DOI 10.1182/blood.V88.8.2859.bloodjournal8882859; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Cserepes J, 2004, BIOCHEM BIOPH RES CO, V320, P860, DOI 10.1016/j.bbrc.2004.06.037; Do TM, 2012, J ALZHEIMERS DIS, V30, P155, DOI 10.3233/JAD-2012-112189; El Roz A, 2012, ANTICANCER RES, V32, P3007; Engel T, 2001, BIOCHEM BIOPH RES CO, V288, P483, DOI 10.1006/bbrc.2001.5756; Engel T, 2006, FEBS LETT, V580, P4551, DOI 10.1016/j.febslet.2006.07.006; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 2010, ATHEROSCLEROSIS, V208, P75, DOI 10.1016/j.atherosclerosis.2009.06.028; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Gu HM, 2016, ARTERIOSCL THROM VAS, V36, P253, DOI 10.1161/ATVBAHA.115.306592; Haimeur A, 2004, CURR DRUG METAB, V5, P21, DOI 10.2174/1389200043489199; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; Hirata T, 2009, BIOSCI BIOTECH BIOCH, V73, P619, DOI 10.1271/bbb.80694; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Murphy AJ, 2013, NAT MED, V19, P586, DOI 10.1038/nm.3150; Nakamura K, 2004, J BIOL CHEM, V279, P45980, DOI 10.1074/jbc.M408652200; Nelissen K, 2012, J NEUROSCI RES, V90, P60, DOI 10.1002/jnr.22743; Neufeld Edward B, 2014, Biology (Basel), V3, P866, DOI 10.3390/biology3040866; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Osada M, 1999, EXP HEMATOL, V27, P131, DOI 10.1016/S0301-472X(98)00007-1; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Park SW, 2014, AM J PHYSIOL-GASTR L, V307, pG863, DOI 10.1152/ajpgi.00457.2013; Raina A, 2010, APOPTOSIS, V15, P1461, DOI 10.1007/s10495-010-0541-5; Remaley AT, 2002, BIOCHEM BIOPH RES CO, V295, P276, DOI 10.1016/S0006-291X(02)00652-6; Sano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109886; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sarvothaman S, 2015, BLOOD RES, V50, P73, DOI 10.5045/br.2015.50.2.73; Seres L, 2008, BBA-BIOMEMBRANES, V1778, P2378, DOI 10.1016/j.bbamem.2008.06.010; Sigurjonsson OE, 2004, STEM CELLS DEV, V13, P183; Stefulj J, 2009, CIRC RES, V104, P600, DOI 10.1161/CIRCRESAHA.108.185066; Studzian M, 2015, BBA-MOL CELL RES, V1853, P1759, DOI 10.1016/j.bbamcr.2015.04.011; Sumi K, 2007, MOL CELL BIOL, V27, P4248, DOI 10.1128/MCB.01894-06; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Uehara Y, 2008, BRAIN RES, V1217, P239, DOI 10.1016/j.brainres.2008.04.048; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200	60	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156516	10.1371/journal.pone.0156516	http://dx.doi.org/10.1371/journal.pone.0156516			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228027	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000376882500152
J	Torney, CJ; Dobson, AP; Borner, F; Lloyd-Jones, DJ; Moyer, D; Maliti, HT; Mwita, M; Fredrick, H; Borner, M; Hopcraft, JGC				Torney, Colin J.; Dobson, Andrew P.; Borner, Felix; Lloyd-Jones, David J.; Moyer, David; Maliti, Honori T.; Mwita, Machoke; Fredrick, Howard; Borner, Markus; Hopcraft, J. Grant C.			Assessing Rotation-Invariant Feature Classification for Automated Wildebeest Population Counts	PLOS ONE			English	Article								Accurate and on-demand animal population counts are the holy grail for wildlife conservation organizations throughout the world because they enable fast and responsive adaptive management policies. While the collection of image data from camera traps, satellites, and manned or unmanned aircraft has advanced significantly, the detection and identification of animals within images remains a major bottleneck since counting is primarily conducted by dedicated enumerators or citizen scientists. Recent developments in the field of computer vision suggest a potential resolution to this issue through the use of rotation-invariant object descriptors combined with machine learning algorithms. Here we implement an algorithm to detect and count wildebeest from aerial images collected in the Serengeti National Park in 2009 as part of the biennial wildebeest count. We find that the per image error rates are greater than, but comparable to, two separate human counts. For the total count, the algorithm is more accurate than both manual counts, suggesting that human counters have a tendency to systematically over or under count images. While the accuracy of the algorithm is not yet at an acceptable level for fully automatic counts, our results show this method is a promising avenue for further research and we highlight specific areas where future research should focus in order to develop fast and accurate enumeration of aerial count data. If combined with a bespoke image collection protocol, this approach may yield a fully automated wildebeest count in the near future.	[Torney, Colin J.] Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, Cornwall, England; [Dobson, Andrew P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Borner, Felix] Serengeti Natl Pk, Frankfurt Zool Soc, Seronera, Tanzania; [Lloyd-Jones, David J.] POB 1272, Iringa, Tanzania; [Moyer, David] Field Museum Nat Hist, Integrated Res Ctr, 1400 S Lake Shore Dr, Chicago, IL 60605 USA; [Maliti, Honori T.; Mwita, Machoke] Tanzania Wildlife Res Inst, POB 661, Arusha, Tanzania; [Fredrick, Howard] Tanzania Conservat Resource Ctr, Arusha, Tanzania; [Borner, Markus; Hopcraft, J. Grant C.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Borner, Markus; Hopcraft, J. Grant C.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland	University of Exeter; Princeton University; Field Museum of Natural History (Chicago); University of Glasgow; University of Glasgow	Torney, CJ (corresponding author), Univ Exeter, Ctr Math & Environm, Penryn Campus, Penryn, Cornwall, England.	colin.j.torney@gmail.com		Lloyd-Jones, David/0000-0001-7880-5659	James S. McDonnell Foundation; Lord Kelvin Adam Smith Fellowship; British Ecological Society; European Union [641918]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	James S. McDonnell Foundation; Lord Kelvin Adam Smith Fellowship; British Ecological Society; European Union(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CJT is supported by a Complex Systems Scholar Award from the James S. McDonnell Foundation. JGCH is supported by a Lord Kelvin Adam Smith Fellowship, funding from the British Ecological Society and the European Union's Horizon 2020 research and innovation programme under grant agreement No 641918 AfricanBioServices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; BAJZAK D, 1990, WILDLIFE SOC B, V18, P125; Bidder OR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088609; Bolger DT, 2012, METHODS ECOL EVOL, V3, P813, DOI 10.1111/j.2041-210X.2012.00212.x; Bradski G., 2000, DOBBS J SOFTWARE TOO; BRIGGS KT, 1985, J WILDLIFE MANAGE, V49, P405, DOI 10.2307/3801542; CAUGHLEY G, 1976, J WILDLIFE MANAGE, V40, P290, DOI 10.2307/3800428; Caughley G, 1979, SAMPLING TECHNIQUES, P15; Chen Ch, 2010, HDB PATTERN RECOGNIT, V27; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; EVANS CD, 1966, J WILDLIFE MANAGE, V30, P767, DOI 10.2307/3798283; Freund Y, 1995, COMPUTATIONAL LEARNI, P23, DOI [10.1007/3-540-59119-2_166, DOI 10.1007/3-540-59119-2_166]; GODDARD J, 1969, East African Wildlife Journal, V7, P105; Hsu RL, 2002, IEEE T PATTERN ANAL, V24, P696, DOI 10.1109/34.1000242; Klockner A, 2012, PARALLEL COMPUT, V38, P157, DOI 10.1016/j.parco.2011.09.001; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; Laliberte AS, 2003, WILDLIFE SOC B, V31, P362; Lin Y, 2011, IEEE GEOSCI REMOTE S, V8, P426, DOI 10.1109/LGRS.2010.2079913; Liu K, 2014, INT J COMPUT VISION, V106, P342, DOI 10.1007/s11263-013-0634-z; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; McNeill S, 2011, INT GEOSCI REMOTE SE, P4312, DOI 10.1109/IGARSS.2011.6050185; Michel P., 2003, P 5 INT C MULTIMODAL, P258, DOI [10.1145/958432.958479, DOI 10.1145/958432.958479]; MORTON SR, 1990, AUST J ECOL, V15, P307, DOI 10.1111/j.1442-9993.1990.tb01035.x; Mosbech A, 1999, ARCTIC, V52, P188; NORTON-GRIFFITHS M, 1973, East African Wildlife Journal, V11, P135; Oritsland T, 1995, DEV MAR BIO, V4, P77; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Russell J., 1996, Rangifer, V16, P319; Sherley Richard B., 2010, Endangered Species Research, V11, P101, DOI 10.3354/esr00267; SINCLAIR ARE, 1995, SERENGETI, V2; Sirmacek B, 2012, MAN RES LTD PLAN 6 B; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; XU L, 1992, IEEE T SYST MAN CYB, V22, P418, DOI 10.1109/21.155943; Yang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115989	36	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156342	10.1371/journal.pone.0156342	http://dx.doi.org/10.1371/journal.pone.0156342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227888	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000376882500119
J	Zhang, YX; Sun, TZ; Liu, SQ; Dong, L; Liu, CY; Song, WW; Liu, JJ; Gai, SP				Zhang, Yuxi; Sun, Tingzhao; Liu, Shaoqing; Dong, Lei; Liu, Chunying; Song, Wenwen; Liu, Jingjing; Gai, Shupeng			MYC cis-Elements in PsMPT Promoter Is Involved in Chilling Response of Paeonia suffruticosa	PLOS ONE			English	Article							MITOCHONDRIAL PHOSPHATE TRANSPORTER; ARABIDOPSIS-THALIANA; BUD DORMANCY; GIBBERELLIN BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; FREEZING TOLERANCE; GENE-EXPRESSION; RELEASE; INDUCTION	The MPT transports Pi to synthesize ATP. PsMPT, a chilling-induced gene, was previously reported to promote energy metabolism during bud dormancy release in tree peony. In this study, the regulatory elements of PsMPT promoter involved in chilling response were further analyzed. The PsMPT transcript was detected in different tree peony tissues and was highly expressed in the flower organs, including petal, stigma and stamen. An 1174 bp of the PsMPT promoter was isolated by TAIL-PCR, and the PsMPT promoter::GUS transgenic Arabidopsis was generated and analyzed. GUS staining and qPCR showed that the promoter was active in mainly the flower stigma and stamen. Moreover, it was found that the promoter activity was enhanced by chilling, NaCl, GA, ACC and NAA, but inhibited by ABA, mannitol and PEG. In transgenic plants harboring 421 bp of the PsMPT promoter, the GUS gene expression and the activity were significantly increased by chilling treatment. When the fragment from -421 to -408 containing a MYC cis-element was deleted, the chilling response could not be observed. Further mutation analysis confirmed that the MYC element was one of the key motifs responding to chilling in the PsMPT promoter. The present study provides useful information for further investigation of the regulatory mechanism of PsMPT during the endo-dormancy release.	[Zhang, Yuxi; Sun, Tingzhao; Liu, Shaoqing; Dong, Lei; Liu, Chunying; Song, Wenwen; Liu, Jingjing; Gai, Shupeng] Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Changcheng Rd 700, Qingdao, Peoples R China	Qingdao Agricultural University	Gai, SP (corresponding author), Qingdao Agr Univ, Coll Life Sci, Key Lab Plant Biotechnol Univ Shandong Prov, Changcheng Rd 700, Qingdao, Peoples R China.	spgai@qau.edu.cn			National Natural Science Foundation of China [31071828, 31372104, 31471908]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31071828, 31372104 and 31471908).	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Croos JNA, 2004, J BIOENERG BIOMEMBR, V36, P229, DOI 10.1023/B:JOBB.0000031974.35812.c9; Dolce V, 1991, DNA Seq, V2, P133, DOI 10.3109/10425179109039683; FARINI E, 1995, MOL GEN GENET, V246, P734, DOI 10.1007/BF00290720; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Gai SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055297; Gai SP, 2012, GENE, V497, P256, DOI 10.1016/j.gene.2011.12.013; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; HAZEBROEK JP, 1993, PLANT PHYSIOL, V102, P547, DOI 10.1104/pp.102.2.547; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Huang X, 2008, ACTA PHYSIOL PLANT, V30, P797, DOI 10.1007/s11738-008-0184-0; Huang X, 2008, PLANTA, V228, P545, DOI 10.1007/s00425-008-0757-6; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kiiskinen M, 1997, PLANT MOL BIOL, V35, P271, DOI 10.1023/A:1005868715571; Kim JC, 2001, PLANT J, V25, P247, DOI 10.1046/j.1365-313x.2001.00947.x; Kristiansen MT, 2002, HORM RES, V57, P200, DOI 10.1159/000058383; LAM E, 1989, PLANT CELL, V1, P1147, DOI 10.1105/tpc.1.12.1147; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama-Nakashita A, 2005, PLANT J, V42, P305, DOI 10.1111/j.1365-313X.2005.02363.x; Mena M, 2002, PLANT PHYSIOL, V130, P111, DOI 10.1104/pp.005561; Morita A, 1998, FEBS LETT, V423, P81, DOI 10.1016/S0014-5793(98)00067-2; Nakamori K, 2002, PLANT CELL PHYSIOL, V43, P1250, DOI 10.1093/pcp/pcf141; PHELPS A, 1991, BIOCHEMISTRY-US, V30, P248, DOI 10.1021/bi00215a035; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Rentzsch S, 2012, PLANTA, V235, P137, DOI 10.1007/s00425-011-1501-1; Rohde A, 2007, J EXP BOT, V58, P4047, DOI 10.1093/jxb/erm261; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Takabatake R, 1999, PLANT MOL BIOL, V40, P479, DOI 10.1023/A:1006285009435; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Vieweg MF, 2004, MOL PLANT MICROBE IN, V17, P62, DOI 10.1094/MPMI.2004.17.1.62; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Zheng GuoSheng, 2009, Scientia Silvae Sinicae, V45, P48; Zhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043530	45	10	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155780	10.1371/journal.pone.0155780	http://dx.doi.org/10.1371/journal.pone.0155780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228117	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500033
J	Fields, JA; Li, JQ; Gulbronson, CJ; Hendrixson, DR; Thompson, SA				Fields, Joshua A.; Li, Jiaqi; Gulbronson, Connor J.; Hendrixson, David R.; Thompson, Stuart A.			Campylobacter jejuni CsrA Regulates Metabolic and Virulence Associated Proteins and Is Necessary for Mouse Colonization	PLOS ONE			English	Article							RNA-BINDING PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; OXIDATIVE STRESS; POLYSACCHARIDE ADHESIN; CHICKEN COLONIZATION; BACILLUS-SUBTILIS; EPITHELIAL-CELLS; GENOME SEQUENCE; MOTILITY	Campylobacter jejuni infection is a leading bacterial cause of gastroenteritis and a common antecedent leading to Gullian-Barre syndrome. Our previous data suggested that the RNA-binding protein CsrA plays an important role in regulating several important phenotypes including motility, biofilm formation, and oxidative stress resistance. In this study, we compared the proteomes of wild type, csrA mutant, and complemented csrA mutant C. jejuni strains in an effort to elucidate the mechanisms by which CsrA affects virulence phenotypes. The putative CsrA regulon was more pronounced at stationary phase (111 regulated proteins) than at mid-log phase (25 regulated proteins). Proteins displaying altered expression in the csrA mutant included diverse metabolic functions, with roles in amino acid metabolism, TCA cycle, acetate metabolism, and various other cell processes, as well as pathogenesis-associated characteristics such as motility, chemotaxis, oxidative stress resistance, and fibronectin binding. The csrA mutant strain also showed altered autoagglutination kinetics when compared to the wild type. CsrA specifically bound the 5' end of flaA mRNA, and we demonstrated that CsrA is a growth-phase dependent repressor of FlaA expression. Finally, the csrA mutant exhibited reduced ability to colonize in a mouse model when in competition with the wild type, further underscoring the role of CsrA in C. jejuni colonization and pathogenesis.	[Fields, Joshua A.; Li, Jiaqi; Thompson, Stuart A.] Augusta Univ, Dept Med, Div Infect Dis, Augusta, GA 30912 USA; [Fields, Joshua A.] Georgia Mil Coll Augusta, Dept Nat Sci, Augusta, GA 30907 USA; [Gulbronson, Connor J.; Hendrixson, David R.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Thompson, SA (corresponding author), Augusta Univ, Dept Med, Div Infect Dis, Augusta, GA 30912 USA.	stthomps@augusta.edu		Gulbronson, Connor/0000-0002-2977-7185; Thompson, Stuart/0000-0002-0457-6926	Georgia Regents University; National Institutes of Health [R01AI055715, R56AI084160, R01AI103267]; NIH [R01AI065539, T32AI007520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055715, R56AI084160, R01AI103267, T32AI007520, R01AI065539] Funding Source: NIH RePORTER	Georgia Regents University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by a pilot study research grant from Georgia Regents University, by National Institutes of Health grants R01AI055715, R56AI084160, and R01AI103267 (to S.A.T.), and NIH grant R01AI065539 (to D.R.H.). C.J.G. was supported by NIH training grant T32AI007520. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Apel D, 2012, J BACTERIOL, V194, P2342, DOI 10.1128/JB.06041-11; Atack JM, 2008, J BACTERIOL, V190, P5279, DOI 10.1128/JB.00100-08; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bras AM, 1999, J BACTERIOL, V181, P3298; Brondsted L, 2005, APPL ENVIRON MICROB, V71, P3205, DOI 10.1128/AEM.71.6.3205-3212.2005; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Butcher J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1661-7; Cerca N, 2008, FEMS MICROBIOL LETT, V283, P36, DOI 10.1111/j.1574-6968.2008.01142.x; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Flint A, 2014, INFECT IMMUN, V82, P2266, DOI 10.1128/IAI.01528-13; Goller CC, 2008, CURR TOP MICROBIOL, V322, P37; Guccione E, 2010, ENVIRON MICROBIOL, V12, P576, DOI 10.1111/j.1462-2920.2009.02096.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0; Heimesaat MM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-16; Hofreuter D, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00137; Hwang S, 2012, J BACTERIOL, V194, P6883, DOI 10.1128/JB.01636-12; Irsfeld M, 2014, J BASIC MICROB, V54, P1403, DOI 10.1002/jobm.201400054; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Jones MK, 2008, APPL ENVIRON MICROB, V74, P7064, DOI 10.1128/AEM.01810-08; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Joslin SN, 2008, J BACTERIOL, V190, P2422, DOI 10.1128/JB.01827-07; Jowiya W, 2015, INFECT IMMUN, V83, P4884, DOI 10.1128/IAI.01064-15; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kassem II, 2014, MICROBIOLOGYOPEN, V3, P168, DOI 10.1002/mbo3.158; Kim JC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00751; Kudirkiene E, 2012, CURR MICROBIOL, V65, P398, DOI 10.1007/s00284-012-0170-z; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Li J, 2016, UNPUB; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Liu YW, 2014, MICROBIOL-SGM, V160, P2053, DOI 10.1099/mic.0.080713-0; Lynnes T, 2013, FEMS MICROBIOL LETT, V344, P95, DOI 10.1111/1574-6968.12174; Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Morin M, 2016, MOL MICROBIOL; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Pajaniappan M, 2008, MOL MICROBIOL, V68, P474, DOI 10.1111/j.1365-2958.2008.06161.x; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Patterson-Fortin LM, 2013, J MOL BIOL, V425, P3662, DOI 10.1016/j.jmb.2012.12.010; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Rathbun KM, 2009, FEMS MICROBIOL LETT, V300, P188, DOI 10.1111/j.1574-6968.2009.01795.x; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Reuter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054390; Rubinchik S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-141; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stahl M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00005; Stead D, 2000, APPL ENVIRON MICROB, V66, P3110, DOI 10.1128/AEM.66.7.3110-3112.2000; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Svensson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106063; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Trachoo N, 2002, J FOOD PROTECT, V65, P1110, DOI 10.4315/0362-028X-65.7.1110; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; van der Stel AX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00567; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weerakoon DR, 2008, J BACTERIOL, V190, P915, DOI 10.1128/JB.01647-07; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; Yakhnin AV, 2010, MOL MICROBIOL, V76, P690, DOI 10.1111/j.1365-2958.2010.07126.x	74	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156932	10.1371/journal.pone.0156932	http://dx.doi.org/10.1371/journal.pone.0156932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257952	gold, Green Published, Green Submitted			2022-12-27	WOS:000377369700158
J	Einsfeldt, K; Baptista, IC; Castanheira, JC; Pereira, V; Costa-Amaral, IC; da Costa, ES; Ribeiro, MCM; Land, MGP; Alves, TLM; Larentis, AL; Almeida, RV				Einsfeldt, Karen; Baptista, Isis Cavalcante; Castanheira, Juliana Christina; Pereira, Vicente; Costa-Amaral, Isabele Campos; da Costa, Elaine Sobral; Menks Ribeiro, Maria Cecilia; Poirot Land, Marcelo Gerardin; Moitinho Alves, Tito Livio; Larentis, Ariane Leites; Almeida, Rodrigo Volcan			Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMISING CHEMOTHERAPEUTIC-AGENT; CELL-CYCLE ARREST; IN-VITRO; ERWINIA-ASPARAGINASE; EXPRESSION; RESISTANCE; SYNTHETASE; APOPTOSIS; CHILDREN	L-asparaginase is an enzyme used as a chemotherapeutic agent, mainly for treating acute lymphoblastic leukemia. In this study, the gene of L-asparaginase from Zymomonas mobilis was cloned in pET vectors, fused to a histidine tag, and had its codons optimized. The L-asparaginase was expressed extracellularly and intracellularly (cytoplasmically) in Escherichia coli in far larger quantities than obtained from the microorganism of origin, and sufficient for initial cytotoxicity tests on leukemic cells. The in silico analysis of the protein from Z. mobilis indicated the presence of a signal peptide in the sequence, as well as high identity to other sequences of L-asparaginases with antileukemic activity. The protein was expressed in a bioreactor with a complex culture medium, yielding 0.13 IU/mL extracellular L-asparaginase and 3.6 IU/mL intracellular L-asparaginase after 4 h of induction with IPTG. The cytotoxicity results suggest that recombinant L-asparaginase from Z. mobilis expressed extracellularly in E. coli has a cytotoxic and cytostatic effect on leukemic cells.	[Einsfeldt, Karen; Baptista, Isis Cavalcante; Castanheira, Juliana Christina; Moitinho Alves, Tito Livio] Univ Fed Rio de Janeiro UFRJ, COPPE, Programa Engn Quim, Rio De Janeiro, Brazil; [Einsfeldt, Karen; Castanheira, Juliana Christina; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro UFRJ, Inst Quim, Programa Posgrad Bioquim, Rio De Janeiro, Brazil; [Baptista, Isis Cavalcante; da Costa, Elaine Sobral; Menks Ribeiro, Maria Cecilia; Poirot Land, Marcelo Gerardin] Univ Fed Rio de Janeiro UFRJ, Programa Posgrad Clin Med, Rio De Janeiro, Brazil; [Costa-Amaral, Isabele Campos; Larentis, Ariane Leites] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Estudos Saude Trabalhador & Ecol Humana CESTE, Escola Nacl Saude Publ Sergio Arouca ENSP, Programa Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Almeida, RV (corresponding author), Univ Fed Rio de Janeiro UFRJ, COPPE, Programa Engn Quim, Rio De Janeiro, Brazil.	karen.einsfeldt@gmail.com; arianelarentis@fiocruz.br; volcan@iq.ufrj.br	Alves, Tito/AAC-3177-2021; Almeida, Rodrigo V/I-4362-2013; Almeida, Rodrigo/AAE-3019-2019; land, marcelo g p/O-9286-2018; Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo V/0000-0002-0164-6044; Almeida, Rodrigo/0000-0002-0164-6044; land, marcelo g p/0000-0001-9792-3167; 				Abud AKS, 2004, Patent BR, Patent No. [PI0404952-7, 04049527]; Alves TLM, 1998, APPL BIOCHEM BIOTECH, V70-2, P463, DOI 10.1007/BF02920160; Alves TLM, 2014, Patent, Patent No. [BR1020140005854, 1020140005854]; ARISTIDOU AA, 1995, BIOTECHNOL PROGR, V11, P475, DOI 10.1021/bp00034a019; Avramis VI, 2007, ANTICANCER RES, V27, P2561; Avramis VI, 2012, ANTICANCER RES, V32, P2423; Avramis VI, 2005, CLIN PHARMACOKINET, V44, P367, DOI 10.2165/00003088-200544040-00003; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bansal S, 2012, FASEB J, V26, P1161, DOI 10.1096/fj.11-191254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dorrie J, 2001, CANCER RES, V61, P4731; Douer D, 2007, BLOOD, V109, P2744, DOI 10.1182/blood-2006-07-035006; DUNLOP PC, 1980, J BIOL CHEM, V255, P1542; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Ferraz HC, 2000, APPL BIOCHEM BIOTECH, V89, P43, DOI 10.1385/ABAB:89:1:43; Fine BM, 2005, CANCER RES, V65, P291; Fonseca EF, 2004, LAT AM APPL RES, V34, P187; Guo QL, 2002, ACTA PHARMACOL SIN, V23, P946; Holleman A, 2003, BLOOD, V102, P4541, DOI 10.1182/blood-2002-11-3612; HORIG H, 1993, J CELL BIOCHEM, V53, P343, DOI 10.1002/jcb.240530412; Husain I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148877; Khushoo A, 2005, APPL MICROBIOL BIOT, V68, P189, DOI 10.1007/s00253-004-1867-0; Khushoo A, 2004, PROTEIN EXPRES PURIF, V38, P29, DOI 10.1016/j.pep.2004.07.009; Kotzia GA, 2005, J BIOTECHNOL, V119, P309, DOI 10.1016/j.jbiotec.2005.04.016; Kotzia GA, 2007, J BIOTECHNOL, V127, P657, DOI 10.1016/j.jbiotec.2006.07.037; Kozak M, 2000, ACTA BIOCHIM POL, V47, P807, DOI 10.18388/abp.2000_3998; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; Kurtzberg J, 2000, HOLLAND FREI CANC ME; Labrou NE, 2010, CURR MED CHEM, V17, P2183, DOI 10.2174/092986710791299920; LEE SM, 1989, APPL BIOCHEM BIOTECH, V22, P1, DOI 10.1007/BF02922693; Matsuo Y, 1998, LEUKEMIA RES, V22, P567, DOI 10.1016/S0145-2126(98)00050-2; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OHNO R, 1970, BLOOD-J HEMATOL, V35, P250, DOI 10.1182/blood.V35.2.250.250; Panosyan EH, 2004, J PEDIAT HEMATOL ONC, V26, P217, DOI 10.1097/00043426-200404000-00002; Pedreira CE, 2013, TRENDS BIOTECHNOL, V31, P415, DOI 10.1016/j.tibtech.2013.04.008; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Rizzari C, 2013, CURR OPIN ONCOL, V25, pS1, DOI 10.1097/CCO.0b013e32835d7d85; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Sanches M, 2007, CURR CHEM BIOL, V1, P75, DOI DOI 10.2174/2212796810701010075; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Severo JB, 2014, BRAZ J CHEM ENG, V31, P1003, DOI 10.1590/0104-6632.20140314s00002537; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; Stams WAG, 2005, BLOOD, V105, P4223, DOI 10.1182/blood-2004-10-3892; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; TABACCO A, 1979, CLIN CHEM, V25, P336; Tripathi NK, 2009, DEFENCE SCI J, V59, P137, DOI 10.14429/dsj.59.1501; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Verma N, 2007, CRIT REV BIOTECHNOL, V27, P45, DOI 10.1080/07388550601173926; Wilberg KQ, 1997, BRAZ J CHEM ENG, V14; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061	55	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156692	10.1371/journal.pone.0156692	http://dx.doi.org/10.1371/journal.pone.0156692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253887	gold, Green Published			2022-12-27	WOS:000377218700051
J	Zhang, SY; Wu, K; Liu, YF; Lin, YT; Zhang, X; Zhou, J; Zhang, H; Pan, T; Fu, YS				Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting; Fu, Yongshui			Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE(2) Pathway	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; TRANSPLANT TOLERANCE; POSITIVE FEEDBACK; PROSTAGLANDIN E-2; MESSENGER-RNA; T-CELLS; INHIBITION; COX-2; INDOMETHACIN; BIOLOGY	Myeloid-derived suppressor cells (MDSCs) have been known to be a key factor in the regulation of the immune system under numerous conditions such as tumors, infections, autoimmune diseases, and transplantations. In contrast to the proposed deleterious role of MDSCs in tumors and infections, MDSCs with their suppressive function are now proved to have the beneficial potential of suppressing the autoimmune response and promoting tolerance to transplantation. Therefore, the expansion of MDSCs could be a promising therapeutic strategy for many diseases. In this study, we aimed to identify FDA-approved drugs that could aid in the expansion of functional MDSCs. We performed a high-throughput screening (HTS) of FDA-approved drugs based on the in vitro human MDSC-differentiation system and identified finasteride (FIN) to have the best potency to aid the generation of human MDSCs. The FIN-induced MDSCs were quite similar to monocytic MDSCs with regard to their surface phenotype, morphology, immunosuppressive function, and related gene expression. Next, we aimed to determine the mechanism of action of FIN and found that FIN induced the expansion of MDSCs through up-regulation of the COX2/PGE(2) pathway by enhancing the activity of COX2 promoter. In addition, the administration of indomethacin (IND), a COX2 inhibitor, abrogated the effect of FIN. Based on these results, we suggested that FIN could find applications in the future in the expansion of MDSCs. Further development of FIN-like compounds could be a novel strategy for generating functional MDSCs for immunosuppressive therapies in various immune disorder conditions.	[Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yufeng; Zhou, Jie] Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Med Ctr, Program Immunol, Guangzhou, Guangdong, Peoples R China; [Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Blood Center	Pan, T (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.; Pan, T (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China.; Pan, T (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510275, Guangdong, Peoples R China.; Fu, YS (corresponding author), Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China.	pant8@mail.sysu.edu.cn; fuyongshui1969@yahoo.com	Pan, Ting/AAX-1933-2021	Fu, Yongshui/0000-0003-0886-2193	National Natural Science Foundation of China [81273145, 301500740]; Science and Technology Project of Guangzhou city [201509010009]; National Special Research Program for Important Infectious Diseases [2013ZX10001004]; Guangdong Innovative Research Team Program [2009010058]; Natural Science Foundation of Guangdong [2015A030310442]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangzhou city; National Special Research Program for Important Infectious Diseases; Guangdong Innovative Research Team Program; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Natural Science Foundation of China (No. 81273145), Science and Technology Project of Guangzhou city (No. 201509010009) to YS Fu; National Special Research Program for Important Infectious Diseases (No. 2013ZX10001004), Guangdong Innovative Research Team Program (No. 2009010058) to H Zhang; National Natural Science Foundation of China (No. 301500740) and Natural Science Foundation of Guangdong (No. 2015A030310442) to T Pan.	Abastado J-P, 2012, TUMOR MICROENVIRONME, P64; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Black WC, 1996, BIOORG MED CHEM LETT, V6, P725, DOI 10.1016/0960-894X(96)00100-X; Boros P, 2010, HUM IMMUNOL, V71, P1061, DOI 10.1016/j.humimm.2010.08.001; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Di Silverio F, 2005, EUR UROL, V47, P72, DOI 10.1016/j.eururo.2004.08.024; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Dilek N, 2010, CURR OPIN ORGAN TRAN, V15, P765, DOI 10.1097/MOT.0b013e3283401742; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Fujimoto Y, 2005, INT IMMUNOPHARMACOL, V5, P1131, DOI 10.1016/j.intimp.2005.01.014; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giuliano F, 2002, J PHARMACOL EXP THER, V303, P1001, DOI 10.1124/jpet.102.041244; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Guillonneau C, 2015, TRANSPLANTATION, V99, P2017, DOI 10.1097/TP.0000000000000858; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Hartel C, 2004, SCAND J IMMUNOL, V60, P412, DOI 10.1111/j.0300-9475.2004.01481.x; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; Marhaba R, 2007, J IMMUNOL, V179, P5071, DOI 10.4049/jimmunol.179.8.5071; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj Srinivas, 2009, Cancer Res, V69, P7503, DOI 10.1158/0008-5472.CAN-09-2152; Najjar YG, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00049; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Obermajer N, 2012, ONCOIMMUNOLOGY, V1, P762, DOI 10.4161/onci.19681; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Shim JS, 2014, INT J BIOL SCI, V10, P654, DOI 10.7150/ijbs.9224; Smith Angela B, 2009, Ther Clin Risk Manag, V5, P535; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; Wang YG, 2016, SEMIN ARTHRITIS RHEU, V45, P490, DOI 10.1016/j.semarthrit.2015.07.003; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Wysowski DK, 2004, NEW ENGL J MED, V350, P1359; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Yin Y, 2015, J BIOL CHEM, V290, P35, DOI 10.1074/jbc.M114.598631; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhang Q, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/421927; Zhang YJ, 2014, RNA, V20, P1878, DOI 10.1261/rna.045633.114	46	8	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156549	10.1371/journal.pone.0156549	http://dx.doi.org/10.1371/journal.pone.0156549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253400	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700039
J	Eblen, MK; Wagner, RM; RoyChowdhury, D; Patel, KC; Pearson, K				Eblen, Matthew K.; Wagner, Robin M.; RoyChowdhury, Deepshikha; Patel, Katherine C.; Pearson, Katrina			How Criterion Scores Predict the Overall Impact Score and Funding Outcomes for National Institutes of Health Peer-Reviewed Applications	PLOS ONE			English	Article							GRANT APPLICATIONS	Understanding the factors associated with successful funding outcomes of research project grant (R01) applications is critical for the biomedical research community. R01 applications are evaluated through the National Institutes of Health (NIH) peer review system, where peer reviewers are asked to evaluate and assign scores to five research criteria when assessing an application's scientific and technical merit. This study examined the relationship of the five research criterion scores to the Overall Impact score and the likelihood of being funded for over 123,700 competing R01 applications for fiscal years 2010 through 2013. The relationships of other application and applicant characteristics, including demo-graphics, to scoring and funding outcomes were studied as well. The analyses showed that the Approach and, to a lesser extent, the Significance criterion scores were the main predictors of an R01 application's Overall Impact score and its likelihood of being funded. Applicants might consider these findings when submitting future R01 applications to NIH.	[Eblen, Matthew K.; Wagner, Robin M.; RoyChowdhury, Deepshikha; Patel, Katherine C.; Pearson, Katrina] NIH, Off Extramural Res, Bldg 10, Bethesda, MD 20892 USA; [Eblen, Matthew K.; Wagner, Robin M.] CDC, Off Publ Hlth Sci Serv, Atlanta, GA 30333 USA	National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Eblen, MK (corresponding author), NIH, Off Extramural Res, Bldg 10, Bethesda, MD 20892 USA.; Eblen, MK (corresponding author), CDC, Off Publ Hlth Sci Serv, Atlanta, GA 30333 USA.	matteblen@gmail.com						Albright JJ, 2007, ESTIMATING MULTINEVE; [Anonymous], 2012, CORRELATION; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Goldberger A.S., 1991, COURSE ECONOMETRICS; Graves N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4797; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Jayasinghe UW, 2001, EDUC EVAL POLICY AN, V23, P343, DOI 10.3102/01623737023004343; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; Kotchen TA, 2004, JAMA-J AM MED ASSOC, V291, P836, DOI 10.1001/jama.291.7.836; Lindner MD, 2016, AM J EVAL, V37, P238, DOI 10.1177/1098214015582049; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Marsh HW, 2009, REV EDUC RES, V79, P1290, DOI 10.3102/0034654309334143; Martin MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013526; NIH Budget History, 2014, NIH EXTR INTR FUND F; NIH Peer Review, 2013, NIH PEER REV GRANTS; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Viner N, 2004, RES POLICY, V33, P443, DOI 10.1016/j.respol.2003.09.005; Wooldridge J.M, 2006, INTRO ECONOMETRICS, V3	19	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155060	10.1371/journal.pone.0155060	http://dx.doi.org/10.1371/journal.pone.0155060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249058	Green Published, gold			2022-12-27	WOS:000377184700009
J	Lin, HF; Chern, CM; Chen, HM; Yeh, YC; Yao, SC; Huang, MF; Wang, SJ; Chen, CS; Fuh, JL				Lin, Hsiu-Fen; Chern, Chang-Ming; Chen, Hui-Mei; Yeh, Yi-Chun; Yao, Shu-Chih; Huang, Mei-Feng; Wang, Shuu-Jiun; Chen, Cheng-Sheng; Fuh, Jong-Ling			Validation of NINDS-VCI Neuropsychology Protocols for Vascular Cognitive Impairment in Taiwan	PLOS ONE			English	Article							SMALL VESSEL DISEASE; ALZHEIMERS-DISEASE; STROKE; DEMENTIA; CHINESE; STANDARDS; FIGURE; LONG; MOCA	Objective To validate the three time-difference neuropsychological protocols developed by the National Institute of Health/National Institute of Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network for assessment of vascular cognitive impairment (VCI) in Mandarin-speaking subjects and to investigate the clinical application of the shortest form. Methods Patients aged 50 years or older who had a stroke were invited to participate in the study. Clinical diagnosis of VCI was made. The NINDS-VCI Neuropsychology Protocols, 60-, 30-, and two 5-minute protocols, were administered. The criteria validities of the cognitive protocols against the diagnoses of stroke and VCI were determined via Receiver Operating Characteristic (ROC) analysis. The optimal cut-off point for the 5-minute protocols total score was estimated for clinical use in screening. Results Eighty-three patients and 53 controls were recruited during the study period. Patients with stroke performed more poorly than the control group in the three neuropsychological protocols. Forty-two patients with stroke were diagnosed with VCI. VCI was used as the standard to estimate the criteria validities. The area under the ROC curve was 0.78, 0.80, 0.75, and 0.73 for the 60-, 30-, 5-mintue protocol-A and 5-minute protocol-B, respectively. Conclusion These modified neuropsychological protocols can be used as valid instruments when performing comprehensive cognitive assessment or for screening of VCI in Taiwan.	[Lin, Hsiu-Fen] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lin, Hsiu-Fen] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Chern, Chang-Ming; Yao, Shu-Chih; Wang, Shuu-Jiun; Fuh, Jong-Ling] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Chern, Chang-Ming; Yao, Shu-Chih; Wang, Shuu-Jiun; Fuh, Jong-Ling] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Chen, Hui-Mei; Yeh, Yi-Chun; Huang, Mei-Feng] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Hui-Mei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Yeh, Yi-Chun; Huang, Mei-Feng; Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Yeh, Yi-Chun; Huang, Mei-Feng; Chen, Cheng-Sheng] Kaohsiung Med Univ, Dept Psychiat, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Fuh, JL (corresponding author), Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan.	sheng@kmu.edu.tw; jlfuh@vghtpe.gov.tw		Lin, Hsiu-Fen/0000-0001-6343-826X	Ministry of Science and Technology, Taiwan [NSC101-2314-B-075-037-MY2, NSC100-2314-B-037-016-MY3]; Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan [KMUH-103-3R55]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan	The study was funded by grants from the Ministry of Science and Technology, Taiwan (NSC101-2314-B-075-037-MY2; NSC100-2314-B-037-016-MY3), and Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan (KMUH-103-3R55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NIH STROK SCAL TRA 2; Barr A, 1996, J CLIN EXP NEUROPSYC, V18, P810, DOI 10.1080/01688639608408304; Brandt J, 2001, HOPKINS VERBAL LEARN; Chen XL, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0270-z; CHIULLI SJ, 1995, CLIN NEUROPSYCHOL, V9, P219, DOI 10.1080/13854049508400483; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; Goodglass H, 2001, ASSESSMENT APHASIA R, V3rd; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Herbert V, 2014, J INT NEUROPSYCH SOC, V20, P413, DOI 10.1017/S1355617714000101; Kaplan E, 1991, THE WAIS R AS A NEUR; Liu CY, 1998, PSYCHOL REP, V82, P211, DOI 10.2466/PR0.82.1.211-214; Madureira S, 2001, EUR J NEUROL, V8, P621, DOI 10.1046/j.1468-1331.2001.00332.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Noel-Storr AH, 2014, NEUROLOGY, V83, P364, DOI 10.1212/WNL.0000000000000621; O'Sullivan M, 2005, J NEUROL NEUROSUR PS, V76, P1140, DOI 10.1136/jnnp.2004.045963; Reed BR, 2007, BRAIN, V130, P731, DOI 10.1093/brain/awl385; Reian RM, 1993, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Somerville J, 2000, J CLIN EXP NEUROPSYC, V22, P613, DOI 10.1076/1380-3395(200010)22:5;1-9;FT613; Strozyk D, 2010, NEUROBIOL AGING, V31, P1710, DOI 10.1016/j.neurobiolaging.2008.09.011; SWETS JA, 1979, INVEST RADIOL, V14, P109, DOI 10.1097/00004424-197903000-00002; TATEMICHI TK, 1994, STROKE, V25, P1915, DOI 10.1161/01.STR.25.10.1915; Tsai CF, 2012, INT PSYCHOGERIATR, V24, P651, DOI 10.1017/S1041610211002298; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wong A, 2013, J NEUROL NEUROSUR PS, V84, P499, DOI 10.1136/jnnp-2012-304041; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhou AH, 2009, INT J GERIATR PSYCH, V24, P1352, DOI 10.1002/gps.2265	32	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156404	10.1371/journal.pone.0156404	http://dx.doi.org/10.1371/journal.pone.0156404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249647	Green Submitted, gold, Green Published			2022-12-27	WOS:000377184700041
J	Chen, Q; Bei, JJ; Liu, C; Feng, SB; Zhao, WB; Zhou, Z; Yu, ZP; Du, XJ; Hu, HY				Chen, Qiang; Bei, Jun-Jie; Liu, Chuan; Feng, Shi-Bin; Zhao, Wei-Bo; Zhou, Zhou; Yu, Zheng-Ping; Du, Xiao-Jun; Hu, Hou-Yuan			HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization	PLOS ONE			English	Article							ACCELERATES VASCULAR CALCIFICATION; GROUP BOX 1; MEDIATED MINERALIZATION; EXTRACELLULAR VESICLES; ALKALINE-PHOSPHATASE; GROWTH-PLATE; BONE; EXPRESSION; DIFFERENTIATION; OSTEOGENESIS	Numerous clinical conditions have been linked to ectopic mineralization (EM). This process of pathological biomineralization is complex and not fully elucidated, but thought to be started within matrix vesicles (MVs). We hypothesized that high mobility group box 1 (HMGB1), a cytokine associated with biomineralizing process under physiological and pathological conditions, induces EM via promoting MVs secretion from macrophages. In this study, we found that HMGB1 significantly promoted secretion of MVs from macrophages and subsequently led to mineral deposition in elevated Ca/Pi medium in vitro. Transmission electron microscopy of calcifying MVs showed formation of hydroxyapatite crystals in the vesicle interior. Subcutaneous injection into mice with MVs derived from HMGB1-treated cells showed a greater potential to initiate regional mineralization. Mechanistic experiments revealed that HMGB1 activated neutral sphingomyelinase2 (nSMase2) that involved the receptor for advanced glycation end products (RAGE) and p38 MAPK (upstream of nSMase2). Inhibition of nSMase2 with GW4869 or p38 MAPK with SB-239063 prevented MVs secretion and mineral deposition. Collectively, HMGB1 induces MVs secretion from macrophages at least in part, via the RAGE/p38 MAPK/nSMase2 signaling pathway. Our findings thus reveal a novel mechanism by which HMGB1 induces ectopic mineralization.	[Chen, Qiang; Bei, Jun-Jie; Feng, Shi-Bin; Zhao, Wei-Bo; Hu, Hou-Yuan] Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China; [Liu, Chuan; Zhou, Zhou; Yu, Zheng-Ping] Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China; [Du, Xiao-Jun] Monash Univ, Baker IDI Heart & Diabet Inst, Expt Cardiol, Melbourne, Vic 3004, Australia; [Du, Xiao-Jun] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Chen, Qiang] Naval Univ Engn, Dept Out Patient, Wuhan, Peoples R China	Army Medical University; Army Medical University; Baker Heart and Diabetes Institute; Monash University; Monash University; Wuhan Naval University of Engineering	Hu, HY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China.	houyuanhu@hotmail.com			National Natural Science Foundation of China [81270362, 81470561]; State Project For Essential Drug Research and Development [2013ZX09103003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Project For Essential Drug Research and Development	This work was supported by grants from the National Natural Science Foundation of China (No. 81270362 and No. 81470561) and State Project For Essential Drug Research and Development (No. 2013ZX09103003-001). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2015, THROMB HAEMOSTASIS, V114, P994, DOI 10.1160/TH14-12-1073; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Avogaro A, 2014, EXPERT OPIN THER TAR, V18, P595, DOI 10.1517/14728222.2014.894021; Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Cai JJ, 2015, ANTIOXID REDOX SIGN, V23, P1351, DOI 10.1089/ars.2015.6408; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Chen NX, 2013, AM J NEPHROL, V37, P191, DOI 10.1159/000347031; Curti AM, 2009, J THROMB HAEMOST, V7, P701, DOI 10.1111/j.1538-7836.2009.03304.x; De Vilder EYG, 2015, WORLD J CLIN CASES, V3, P556, DOI 10.12998/wjcc.v3.i7.556; DEAN DD, 1992, BONE MINER, V17, P172, DOI 10.1016/0169-6009(92)90731-R; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Filosto S, 2012, J BIOL CHEM, V287, P514, DOI 10.1074/jbc.M111.315481; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Jia L, 2014, BLOOD, V123, P1709, DOI 10.1182/blood-2013-10-529610; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Li QL, 2014, MATRIX BIOL, V33, P23, DOI 10.1016/j.matbio.2013.06.003; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Morhayim J, 2015, FASEB J, V29, P274, DOI 10.1096/fj.14-261404; Nahar NN, 2008, J BONE MINER METAB, V26, P514, DOI 10.1007/s00774-008-0859-z; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Passmore M, 2015, EUR J CARDIO-THORAC, V48, pE20, DOI 10.1093/ejcts/ezv244; Qi SC, 2013, INT ENDOD J, V46, P1153, DOI 10.1111/iej.12112; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shapiro IM, 2015, BONE, V79, P29, DOI 10.1016/j.bone.2015.05.013; Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; Wang YY, 2013, INFLAMMATION, V36, P1592, DOI 10.1007/s10753-013-9704-1; Wang ZH, 2015, J ENDODONT, V41, P871, DOI 10.1016/j.joen.2015.01.006; Yang JP, 2008, J CELL PHYSIOL, V214, P730, DOI 10.1002/jcp.21268; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234; Zhou Zheng, 2011, Front Biosci (Schol Ed), V3, P768, DOI 10.2741/s185	51	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156686	10.1371/journal.pone.0156686	http://dx.doi.org/10.1371/journal.pone.0156686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243975	Green Submitted, Green Published, gold			2022-12-27	WOS:000377146100062
J	Loof, T; Kramer, S; Gaedeke, J; Neumayer, HH; Peters, H				Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm			IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; CD4 T-CELLS; AIRWAY NEUTROPHILIA; CARDIAC FIBROBLASTS; EPITHELIAL-CELLS; RENAL-DISEASE; TGF-BETA; INTERLEUKIN-17; LINEAGE	Background Interleukin-17 (IL-17) is a new pro-inflammatory cytokine involved in immune response and inflammatory disease. The main source of IL-17 is a subset of CD4(+) T-helper cells, but is also secreted by non-immune cells. The present study analyzes expression of IL-17 in the time course of acute anti-thy1 glomerulonephritis and the role of IL-17 as a potential link between inflammation and fibrosis. Methods Anti-thy1 glomerulonephritis was induced into male Wistar rats by OX-7 antibody injection. After that, samples were taken on days 1, 5, 10 (matrix expansion phase), 15 and 20 (resolution phase). PBS-injected animals served as controls. Proteinuria and histological matrixes score served as the main markers for disease severity. In in vitro experiments, NRK-52E cells were used. For cytokine expressions, mRNA and protein levels were analyzed by utilizing RT-PCR, in situ hybridization and immunofluorescence. Results Highest IL-17 mRNA-expression (6.50-fold vs. con; p < 0.05) was found on day 5 after induction of anti-thy1 glomerulonephritis along the maximum levels of proteinuria (113 +/- 13 mg/d; p < 0.001), histological glomerular-matrix accumulation (82%; p < 0.001) and TGF-beta 1 (2.2-fold; p< 0.05), IL-6 mRNA expression (36-fold; p < 0.05). IL-17 protein expression co-localized with the endothelial cell marker PECAM in immunofluorescence. In NRK-52E cells, co-administration of TGF-beta 1 and IL-6 synergistically up-regulated IL-17 mRNA 4986-fold (p < 0.001). Conclusions The pro-inflammatory cytokine IL-17 is up-regulated in endothelial cells during the time course of acute anti-thy1 glomerulonephritis. In vitro, NRK-52E cells secrete IL-17 under pro-fibrotic and pro-inflammatory conditions.	[Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm] Charite, Dept Nephrol, Campus Charite Mitte, D-13353 Berlin, Germany; [Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm] Charite, Ctr Cardiovasc Res, Campus Charite Mitte, D-13353 Berlin, Germany; [Kraemer, Stephanie] German Inst Human Nutr, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Peters, H (corresponding author), Charite, Dept Nephrol, Campus Charite Mitte, D-13353 Berlin, Germany.; Peters, H (corresponding author), Charite, Ctr Cardiovasc Res, Campus Charite Mitte, D-13353 Berlin, Germany.	Harm.Peters@charite.de	Peters, Harm/AAE-5643-2019	Peters, Harm/0000-0003-1441-7512				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; BAGCHUS WM, 1986, LAB INVEST, V55, P680; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Floege J, 1997, Adv Nephrol Necker Hosp, V27, P15; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; HORII Y, 1993, KIDNEY INT, V43, pS71; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kramer S, 2005, AM J PHYSIOL-RENAL, V289, pF359, DOI 10.1152/ajprenal.00442.2004; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Nardelli DT, 2008, FEMS IMMUNOL MED MIC, V53, P265, DOI 10.1111/j.1574-695X.2008.00431.x; NARITA I, 1995, LAB INVEST, V72, P17; NICE Clinical guideline, 2014, CHRONIC KIDNEY DIS A; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Peters H, 2004, KIDNEY INT, V66, P1434, DOI 10.1111/j.1523-1755.2004.00906.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phoon RKS, 2008, J AM SOC NEPHROL, V19, P477, DOI 10.1681/ASN.2007030392; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; Steinmetz OM, 2011, J AM SOC NEPHROL, V22, P472, DOI 10.1681/ASN.2010040435; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; WALDHERR R, 1993, PEDIATR NEPHROL, V7, P471, DOI 10.1007/BF00857578; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156480	10.1371/journal.pone.0156480	http://dx.doi.org/10.1371/journal.pone.0156480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243813	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100040
J	Vargas, DY; Kramer, FR; Tyagi, S; Marras, SAE				Vargas, Diana Y.; Kramer, Fred Russell; Tyagi, Sanjay; Marras, Salvatore A. E.			Multiplex Real-Time PCR Assays that Measure the Abundance of Extremely Rare Mutations Associated with Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; CELL LUNG-CANCER; COLORECTAL-CANCER; MOLECULAR BEACONS; KRAS MUTATIONS; NUCLEIC-ACIDS; HYBRIDIZATION; GEFITINIB; PROBES; THERMODYNAMICS	We describe the use of "SuperSelective" primers that enable the detection and quantitation of somatic mutations whose presence relates to cancer diagnosis, prognosis, and therapy, in real-time PCR assays that can potentially analyze rare DNA fragments present in blood samples (liquid biopsies). The design of these deoxyribonucleotide primers incorporates both a relatively long "5' anchor sequence" that hybridizes strongly to target DNA fragments, and a very short, physically and functionally separate, "3' foot sequence" that is perfectly complementary to the mutant target sequence, but mismatches the wild-type sequence. As few as ten mutant fragments can reliably be detected in the presence of 1,000,000 wild-type fragments, even when the difference between the mutant and the wild type is only a single nucleotide polymorphism. Multiplex PCR assays employing a set of SuperSelective primers, and a corresponding set of differently colored molecular beacon probes, can be used in situations where the different mutations, though occurring in different cells, are located in the same codon. These non-symmetric real-time multiplex PCR assays contain limited concentrations of each SuperSelective primer, thereby enabling the simultaneous determination of each mutation's abundance by comparing its threshold value to the threshold value of a reference gene present in the sample.	[Vargas, Diana Y.; Kramer, Fred Russell; Tyagi, Sanjay; Marras, Salvatore A. E.] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Kramer, Fred Russell; Marras, Salvatore A. E.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07102 USA; [Tyagi, Sanjay] Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kramer, FR (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA.; Kramer, FR (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07102 USA.	fred.kramer@rutgers.edu		Tyagi, Sanjay/0000-0001-7303-5827; Marras, Salvatore/0000-0003-2040-0354	Public Health Research Institute, Rutgers University	Public Health Research Institute, Rutgers University	This research, the open access charge for the publication of this paper, and the salaries of all of the authors of this manuscript were supported by the laboratory's (Public Health Research Institute, Rutgers University) share of the income received from the non-exclusive licensing of molecular beacons technology by PHRI Properties, Inc., which is a nonprofit corporation wholly owned by Rutgers University. Neither PHRI Properties, Inc., nor any of its approximately 75 molecular beacons licensees, had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RF, 2015, CLIN CHIM ACTA, V439, P97, DOI 10.1016/j.cca.2014.10.011; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; Hazbon MH, 2004, J CLIN MICROBIOL, V42, P1236, DOI 10.1128/JCM.42.3.1236-1242.2004; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Holmstrom ED, 2014, BIOPHYS J, V106, P220, DOI 10.1016/j.bpj.2013.11.008; Jia YW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05921; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LOMELI H, 1989, CLIN CHEM, V35, P1826; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Makarov V, 2011, US Patent Application, Patent No. [2011/0129832, 20110129832]; Marras SAE, 2014, Patent Cooperation Treaty Publication WO, Patent No. [2014/124290, 2014124290]; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Poddar SK, 2000, MOL CELL PROBE, V14, P25, DOI 10.1006/mcpr.1999.0278; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shen YQ, 2001, J PHYS CHEM B, V105, P12202, DOI 10.1021/jp0121926; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tie J, 2015, ANN ONCOL, V26, P1715, DOI 10.1093/annonc/mdv177; Todd AV, 2013, Patent Cooperation Treaty PublicationWO, Patent No. [2013/123552, 2013123552]; Tong JHM, 2014, CANCER BIOL THER, V15, P768, DOI 10.4161/cbt.28550; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Tyagi S, 2001, US Patents, Patent No. [6,365,729, 6365729]; Tyagi S, US Patents, Patent No. [6,277,607, 6277607]; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156546	10.1371/journal.pone.0156546	http://dx.doi.org/10.1371/journal.pone.0156546			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244445	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100044
J	Epelboin, Y; Quintric, L; Guevelou, E; Boudry, P; Pichereau, V; Corporeau, C				Epelboin, Yanouk; Quintric, Laure; Guevelou, Eric; Boudry, Pierre; Pichereau, Vianney; Corporeau, Charlotte			The Kinome of Pacific Oyster Crassostrea gigas, Its Expression during Development and in Response to Environmental Factors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-BETA SUPERFAMILY; LIGHT-CHAIN KINASE; TYROSINE KINASE; CAENORHABDITIS-ELEGANS; BIVALVE MOLLUSK; DOPAMINERGIC-NEURONS; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; REPRODUCTIVE-CYCLE	Oysters play an important role in estuarine and coastal marine habitats, where the majority of humans live. In these ecosystems, environmental degradation is substantial, and oysters must cope with highly dynamic and stressful environmental constraints during their lives in the intertidal zone. The availability of the genome sequence of the Pacific oyster Crassostrea gigas represents a unique opportunity for a comprehensive assessment of the signal transduction pathways that the species has developed to deal with this unique habitat. We performed an in silico analysis to identify, annotate and classify protein kinases in C. gigas, according to their kinase domain taxonomy classification, and compared with kinome already described in other animal species. The C. gigas kinome consists of 371 protein kinases, making it closely related to the sea urchin kinome, which has 353 protein kinases. The absence of gene redundancy in some groups of the C. gigas kinome may simplify functional studies of protein kinases. Through data mining of transcriptomes in C. gigas, we identified part of the kinome which may be central during development and may play a role in response to various environmental factors. Overall, this work contributes to a better understanding of key sensing pathways that may be central for adaptation to a highly dynamic marine environment.	[Epelboin, Yanouk; Guevelou, Eric; Boudry, Pierre; Corporeau, Charlotte] IFREMER, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France; [Quintric, Laure] IFREMER, Serv Ressources Informat & Commun, Plouzane, France; [Pichereau, Vianney] UBO, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France; [Guevelou, Eric] Virginia Inst Marine Sci, Coll William & Mary, Aquaculture Genet & Breeding Technol Ctr, Gloucester Point, VA 23062 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; William & Mary; Virginia Institute of Marine Science	Corporeau, C (corresponding author), IFREMER, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France.	charlotte.corporeau@ifremer.fr	Boudry, Pierre/M-3213-2019; PICHEREAU, Vianney/B-2168-2008; PICHEREAU, Vianney/Q-7236-2019; Guévélou, Eric/A-8670-2014; Boudry, Pierre/G-2406-2010	PICHEREAU, Vianney/0000-0003-1078-9407; PICHEREAU, Vianney/0000-0003-1078-9407; Guévélou, Eric/0000-0001-6716-6310; Corporeau, charlotte/0000-0003-1187-358X; Boudry, Pierre/0000-0002-5150-2276				Al Quobaili F, 2012, METABOLISM, V61, P1512, DOI 10.1016/j.metabol.2012.07.011; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Berwick DC, 2012, HUM MOL GENET, V21, P4966, DOI 10.1093/hmg/dds342; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031337; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clark MS, 2013, ECOL EVOL, V3, P3283, DOI 10.1002/ece3.719; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cohen SM, 2015, BIOCHEM BIOPH RES CO, V460, P88, DOI 10.1016/j.bbrc.2015.02.146; Corporeau C, 2011, MAR BIOTECHNOL, V13, P971, DOI 10.1007/s10126-010-9361-4; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Deshmukh K, 2010, PROG BIOPHYS MOL BIO, V102, P1, DOI 10.1016/j.pbiomolbio.2009.12.009; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Epelboin Y, 2015, CHEM RES TOXICOL, V28, P1831, DOI 10.1021/acs.chemrestox.5b00269; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Escoubas JM, 1999, FEBS LETT, V453, P293, DOI 10.1016/S0014-5793(99)00737-1; Fleury E, 2008, GENE, V410, P187, DOI 10.1016/j.gene.2007.12.017; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Glatz G, 2013, J BIOL CHEM, V288, P8596, DOI 10.1074/jbc.M113.452235; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Goodchild CG, 2015, SCI TOTAL ENVIRON, V512, P201, DOI 10.1016/j.scitotenv.2015.01.065; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Gourgou E, 2010, J EXP BIOL, V213, P347, DOI 10.1242/jeb.036277; Green TJ, 2014, FISH SHELLFISH IMMUN, V36, P151, DOI 10.1016/j.fsi.2013.10.026; Green TJ, 2013, FISH SHELLFISH IMMUN, V35, P382, DOI 10.1016/j.fsi.2013.04.051; Gricourt L, 2003, GEN COMP ENDOCR, V134, P44, DOI 10.1016/S0016-6480(03)00217-X; Guevelou E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109728; Guevelou E, 2013, J COMP PHYSIOL B, V183, P597, DOI 10.1007/s00360-013-0743-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo L, 2016, AQUACULT INT, V24, P327, DOI 10.1007/s10499-015-9928-1; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hayashi K, 2012, CELL STRUCT FUNCT, V37, P21; Heide I, 1998, ANN HEMATOL, V77, P199, DOI 10.1007/s002770050443; Herpin A, 2005, FEBS J, V272, P3424, DOI 10.1111/j.1742-4658.2005.04761.x; Herpin A, 2005, MECH DEVELOP, V122, P695, DOI 10.1016/j.mod.2004.12.004; Herpin A, 2002, GENE, V301, P21, DOI 10.1016/S0378-1119(02)01082-X; Hopkins AE, 1936, ADAPTATION FEEDING M; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jouaux A, 2012, GEN COMP ENDOCR, V176, P28, DOI 10.1016/j.ygcen.2011.12.008; Kawabe S, 2010, FISHERIES SCI, V76, P841, DOI 10.1007/s12562-010-0263-1; Kefaloyianni E, 2005, J EXP BIOL, V208, P4427, DOI 10.1242/jeb.01924; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Kolaiti RM, 2011, MAR BIOTECHNOL, V13, P505, DOI 10.1007/s10126-010-9321-z; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Le Quere H, 2009, GENE, V436, P101, DOI 10.1016/j.gene.2009.01.010; Lelong C, 2000, EUR J BIOCHEM, V267, P3986, DOI 10.1046/j.1432-1327.2000.01432.x; Li Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115890, DOI 10.1371/J0URNAL.P0NE.0115890]; Lopez A, 2005, P ACL WORKSH BUILD U, P83; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2005, GENOMIC OVERVIEW PRO, DOI [10.1895/wormbook.1.60.1, DOI 10.1895/W0RMB00K.1.60.1]; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Mantovani J, 2011, FEBS LETT, V585, P967, DOI 10.1016/j.febslet.2010.12.015; Marchi B, 2005, BIOMETALS, V18, P179, DOI 10.1007/s10534-004-6254-x; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Nguyen CL, 2012, MOL CELL BIOL, V32, P3963, DOI 10.1128/MCB.00436-12; PALMER PA, 1995, COMP BIOCHEM PHYS A, V110, P171, DOI 10.1016/0300-9629(94)00105-3; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Portillo-Lopez A, 2003, BIOL CELL, V95, P275, DOI 10.1016/S0248-4900(03)00054-6; POULOS JE, 1995, GEN COMP ENDOCR, V100, P61, DOI 10.1006/gcen.1995.1133; Putzke AP, 2005, DEVELOPMENT, V132, P3185, DOI 10.1242/dev.01900; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roux MM, 2006, DEV BIOL, V300, P416, DOI 10.1016/j.ydbio.2006.09.006; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Smith HK, 2013, GENETICS, V194, P885, DOI 10.1534/genetics.113.152660; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; Sun LL, 2014, MOL BIOL REP, V41, P2757, DOI 10.1007/s11033-014-3130-9; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Sundaram Meera V, 2006, WormBook, P1; Sussarellu R, 2010, MAR GENOM, V3, P133, DOI 10.1016/j.margen.2010.08.005; Takei Y, 2001, COMP BIOCHEM PHYS B, V129, P559, DOI 10.1016/S1096-4959(01)00366-9; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Timmins-Schiffman E, 2013, CONSERV PHYSIOL, V1, DOI [10.1093/conphys/cot009, DOI 10.1093/C0NPHYS/C0T009]; VESELY DL, 1993, COMP BIOCHEM PHYS B, V106, P535, DOI 10.1016/0305-0491(93)90129-S; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang XL, 2015, MOL HUM REPROD, V21, P136, DOI 10.1093/molehr/gau097; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WONG SKF, 1992, J CLIN INVEST, V90, P299, DOI 10.1172/JCI115862; Yamamoto T, 2005, J BIOL CHEM, V280, P16979, DOI 10.1074/jbc.M412433200; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; Zeng Z, 2013, COMP BIOCHEM PHYS B, V166, P203, DOI 10.1016/j.cbpb.2013.09.003; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]	126	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155435	10.1371/journal.pone.0155435	http://dx.doi.org/10.1371/journal.pone.0155435			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231950	Green Published, gold			2022-12-27	WOS:000376883000004
J	Tong, JF; Meng, L; Wang, XW; Liu, LX; Lyu, LD; Wang, C; Li, Y; Gao, Q; Yang, C; Niu, C				Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Liu, Lixia; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Yang, Chen; Niu, Chen			The FBPase Encoding Gene glpX Is Required for Gluconeogenesis, Bacterial Proliferation and Division In Vivo of Mycobacterium marinum	PLOS ONE			English	Article							CENTRAL GLYCOLYTIC GENES; CELL-SIZE; CARBON METABOLISM; ESCHERICHIA-COLI; TUBERCULOSIS; MACROPHAGES; SEQUENCE; GROWTH; SENSOR	Lipids have been identified as important carbon sources for Mycobacterium tuberculosis (Mtb) to utilize in vivo. Thus gluconeogenesis bears a key role for Mtb to survive and replicate in host. A rate-limiting enzyme of gluconeogenesis, fructose 1, 6-bisphosphatase (FBPase) is encoded by the gene glpX. The functions of glpX were studied in M. marinum, a closely related species to Mtb. The glpX deletion strain (Delta glpX) displayed altered gluconeogenesis, attenuated virulence, and altered bacterial proliferation. Metabolic profiles indicate an accumulation of the FBPase substrate, fructose 1, 6-bisphosphate (FBP) and altered gluconeogenic flux when Delta glpX is cultivated in a gluconeogenic carbon substrate, acetate. In both macrophages and zebrafish, the proliferation of Delta glpX was halted, resulting in dramatically attenuated virulence. Intracellular Delta glpX exhibited an elongated morphology, which was also observed when Delta glpX was grown in a gluconeogenic carbon source. This elongated morphology is also supported by the observation of unseparated multi-nucleoid cell, indicating that a complete mycobacterial division in vivo is correlated with intact gluconeogenesis. Together, our results indicate that glpX has essential functions in gluconeogenesis, and plays an indispensable role in bacterial proliferation in vivo and virulence of M. marinum.	[Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Niu, Chen] Fudan Univ, Sch Basic Med Sci, MOE, Shanghai 200433, Peoples R China; [Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Niu, Chen] Fudan Univ, Sch Basic Med Sci, MOH Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Meng, Lu; Gao, Qian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Meng, Lu; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Wang, Xinwei] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Liu, Lixia; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Niu, C (corresponding author), Fudan Univ, Sch Basic Med Sci, MOE, Shanghai 200433, Peoples R China.; Niu, C (corresponding author), Fudan Univ, Sch Basic Med Sci, MOH Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.; Yang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	chenyang@sibs.ac.cn; chniu@fudan.edu.cn	Meng, Lu/GXN-0092-2022; Lyu, Liangdong/C-6557-2014	Lyu, Liangdong/0000-0001-6391-6030	National Natural Science Foundation of China [81201256, 31421061, 81271790]; NIH/FIC Global Infectious Diseases Training Grant [D43TW007887, 08004034-01]; Shanghai Committee of Science and Technology [14140902900]; Fudan's UROP [14107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/FIC Global Infectious Diseases Training Grant; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Fudan's UROP	This research is supported by National Natural Science Foundation of China (81201256 to C. Niu, 31421061 to C. Yang, 81271790 to Q. Gao), a subaward (08004034-01, Amd7) of NIH/FIC Global Infectious Diseases Training Grant (D43TW007887), and the Shanghai Committee of Science and Technology (grant No. 14140902900) to C. Niu. Y. Li is a recipient of Fudan's UROP #14107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cronan MR, 2014, DIS MODEL MECH, V7, P777, DOI 10.1242/dmm.016089; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Ganapathy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8912; Gutka HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138436; Gutka HJ, 2011, APPL BIOCHEM BIOTECH, V164, P1376, DOI 10.1007/s12010-011-9219-x; Gutka HJ, 2011, ACTA CRYSTALLOGR F, V67, P710, DOI 10.1107/S1744309111014722; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Kieser KJ, 2015, P NATL ACAD SCI; Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lerner TR, 2015, CELL MICROBIOL, V17, P1277, DOI 10.1111/cmi.12480; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Myllymaki H, 2015, EXPERT OPIN DRUG DIS, V10, P871, DOI 10.1517/17460441.2015.1049529; Puckett S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004144; Ramakrishnan L., 2014, COLD SPRING HARB SYM, V78, P179; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Vadia S, 2015, CURR OPIN MICROBIOL, V24, P96, DOI 10.1016/j.mib.2015.01.011; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; Zorrilla S, 2007, BIOCHEMISTRY-US, V46, P14996, DOI 10.1021/bi701805e	39	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156663	10.1371/journal.pone.0156663	http://dx.doi.org/10.1371/journal.pone.0156663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27233038	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000051
J	Bai, ZG; Ma, XF; Tian, JZ; Dong, JW; He, JL; Zhan, WF; Xu, LJ; Xu, YK; Jiang, GH				Bai, Zhigang; Ma, Xiaofen; Tian, Junzhang; Dong, Jianwei; He, Jinlong; Zhan, Wenfeng; Xu, Lijuan; Xu, Yikai; Jiang, Guihua			Brain Microstructural Abnormalities Are Related to Physiological Alterations in End-Stage Renal Disease	PLOS ONE			English	Article							DIFFUSION-TENSOR; WHITE-MATTER; COGNITIVE FUNCTION; LIMBIC SYSTEM; HEMODIALYSIS-PATIENTS; IMPAIRMENT; DEPRESSION; EMOTION; ANXIETY; VOLUME	Purpose To study whole-brain microstructural alterations in patients with end-stage renal disease (ESRD) and examine the relationship between brain microstructure and physiological indictors in the disease. Materials and Methods Diffusion tensor imaging data were collected from 35 patients with ESRD (28 men, 18-61 years) and 40 age-and gender-matched healthy controls (HCs, 32 men, 22-58 years). A voxel-wise analysis was then used to identify microstructural alterations over the whole brain in the ESRD patients compared with the HCs. Multiple biochemical measures of renal metabolin, vascular risk factors, general cognitive ability and dialysis duration were correlated with microstructural integrity for the patients. Results Compared to the HCs, the ESRD patients exhibited disrupted microstructural integrity in not only white matter (WM) but also gray matter (GM) regions, as characterized by decreased fractional anisotropy (FA) and increased mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD). Further correlation analyses revealed that the in MD, AD and RD values showed significantly positive correlations with the blood urea nitrogen in the left superior temporal gyrus and significantly negative correlations with the calcium levels in the left superior frontal gyrus (orbital part) in the patients. Conclusion Our findings suggest that ESRD is associated with widespread diffusion abnormalities in both WM and GM regions in the brain, and microstructural integrity of several GM regions are related to biochemical alterations in the disease.	[Bai, Zhigang; Xu, Yikai] Southern Medial Univ, Nanfang Hosp, Dept Med, Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Ma, Xiaofen; Tian, Junzhang; Zhan, Wenfeng; Jiang, Guihua] Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China; [Dong, Jianwei] Guangdong Pharmaceut Univ, Dept Math, Guangzhou, Guangdong, Peoples R China; [He, Jinlong] Inner Mongolia Med Univ, Affiliated Hosp, Image Diagnost Div, Huhehaote City, Inner Mongolia, Peoples R China; [Xu, Lijuan] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Southern Medical University - China; Guangdong Pharmaceutical University; Inner Mongolia Medical University; Chinese Academy of Sciences; Institute of Automation, CAS	Xu, YK (corresponding author), Southern Medial Univ, Nanfang Hosp, Dept Med, Imaging Ctr, Guangzhou, Guangdong, Peoples R China.; Jiang, GH (corresponding author), Guangdong 2 Prov Peoples Hosp, Dept Med Imaging, Guangzhou, Guangdong, Peoples R China.	mayuqin2004@163.com; jiangguihua177@163.com		Tian, Junzhang/0000-0002-6212-1882	National Natural Science Foundation of China [81471639]; Science and Technology Planning Project of Guangdong Province, China [2015A030313723]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China	This work was supported by grants from National Natural Science Foundation of China (No. 81471639); The Science and Technology Planning Project of Guangdong Province, China (No. 2015A030313723).	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Altmann P, 2007, KIDNEY INT, V71, P252, DOI 10.1038/sj.ki.5001932; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Brouns R, 2004, CLIN NEUROL NEUROSUR, V107, P1, DOI 10.1016/j.clineuro.2004.07.012; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Chou MC, 2013, AM J NEURORADIOL, V34, P1945, DOI 10.3174/ajnr.A3511; Cukor D, 2007, CLIN J AM SOC NEPHRO, V2, P484, DOI 10.2215/CJN.00040107; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Foley RN, 2007, J AM SOC NEPHROL, V18, P2644, DOI 10.1681/ASN.2007020220; Galons JP, 1996, J CLIN INVEST, V98, P750, DOI 10.1172/JCI118847; Genova HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078811; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Hsieh TJ, 2009, RADIOLOGY, V252, P518, DOI 10.1148/radiol.2523080484; Jones DK, 2005, NEUROIMAGE, V26, P546, DOI 10.1016/j.neuroimage.2005.02.013; Kim HS, 2011, NEUROREHABILITATION, V29, P111, DOI 10.3233/NRE-2011-0684; Kimmel PL, 2007, ADV CHRONIC KIDNEY D, V14, P328, DOI 10.1053/j.ackd.2007.07.007; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; LIVINGSTON KE, 1971, ARCH NEUROL-CHICAGO, V24, P17, DOI 10.1001/archneur.1971.00480310045003; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; Massy ZA, 2000, NEPHROL DIAL TRANSPL, V15, P81, DOI 10.1093/ndt/15.suppl_5.81; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/306189; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Palmer CA, 2002, NEUROL CLIN, V20, P23, DOI 10.1016/S0733-8619(03)00052-5; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Raphael KL, 2012, AM J NEPHROL, V35, P49, DOI 10.1159/000334872; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Rugg-Gunn FJ, 2002, LANCET, V359, P1748, DOI 10.1016/S0140-6736(02)08615-4; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smogorzewski MJ, 2001, AM J KIDNEY DIS, V38, pS122, DOI 10.1053/ajkd.2001.27419; Stathis P, 2007, ACTA NEUROCHIR SUPPL, V97, P575; Tanaka M, 2007, NEPHROL DIAL TRANSPL, V22, P1658, DOI 10.1093/ndt/gfm008; Tarhan NC, 2004, AM J ROENTGENOL, V182, P809, DOI 10.2214/ajr.182.3.1820809; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tzamaloukas A H, 2004, Niger J Med, V13, P98; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Zhang LJ, 2013, METAB BRAIN DIS, V28, P647, DOI 10.1007/s11011-013-9438-7; Zhang RJ, 2015, EUR RADIOL, V25, P661, DOI 10.1007/s00330-014-3466-5; Zhou SY, 2003, BIOL PSYCHIAT, V54, P427, DOI 10.1016/S0006-3223(03)00007-6	46	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155902	10.1371/journal.pone.0155902	http://dx.doi.org/10.1371/journal.pone.0155902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227649	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500041
J	Haro, C; Rangel-Zuniga, OA; Alcala-Diaz, JF; Gomez-Delgado, F; Perez-Martinez, P; Delgado-Lista, J; Quintana-Navarro, GM; Landa, BB; Navas-Cortes, JA; Tena-Sempere, M; Clemente, JC; Lopez-Miranda, J; Perez-Jimenez, F; Camargo, A				Haro, Carmen; Rangel-Zuniga, Oriol A.; Alcala-Diaz, Juan F.; Gomez-Delgado, Francisco; Perez-Martinez, Pablo; Delgado-Lista, Javier; Quintana-Navarro, Gracia M.; Landa, Blanca B.; Navas-Cortes, Juan A.; Tena-Sempere, Manuel; Clemente, Jose C.; Lopez-Miranda, Jose; Perez-Jimenez, Francisco; Camargo, Antonio			Intestinal Microbiota Is Influenced by Gender and Body Mass Index	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; METABOLIC SYNDROME; OBESITY; DIET; SEX; AGE; PREVALENCE; MICE; MEN	Intestinal microbiota changes are associated with the development of obesity. However, studies in humans have generated conflicting results due to high inter-individual heterogeneity in terms of diet, age, and hormonal factors, and the largely unexplored influence of gender. In this work, we aimed to identify differential gut microbiota signatures associated with obesity, as a function of gender and changes in body mass index (BMI). Differences in the bacterial community structure were analyzed by 16S sequencing in 39 men and 36 post-menopausal women, who had similar dietary background, matched by age and stratified according to the BMI. We observed that the abundance of the Bacteroides genus was lower in men than in women (P<0.001, Q = 0.002) when BMI was > 33. In fact, the abundance of this genus decreased in men with an increase in BMI (P<0.001, Q<0.001). However, in women, it remained unchanged within the different ranges of BMI. We observed a higher presence of Veillonella (84.6% vs. 47.2%; X-2 test P = 0.001, Q = 0.019) and Methanobrevibacter genera (84.6% vs. 47.2%; X-2 test P = 0.002, Q = 0.026) in fecal samples in men compared to women. We also observed that the abundance of Bilophila was lower in men compared to women regardless of BMI (P = 0.002, Q = 0.041). Additionally, after correcting for age and sex, 66 bacterial taxa at the genus level were found to be associated with BMI and plasma lipids. Microbiota explained at P = 0.001, 31.17% variation in BMI, 29.04% in triglycerides, 33.70% in high-density lipoproteins, 46.86% in low-density lipoproteins, and 28.55% in total cholesterol. Our results suggest that gut microbiota may differ between men and women, and that these differences may be influenced by the grade of obesity. The divergence in gut microbiota observed between men and women might have a dominant role in the definition of gender differences in the prevalence of metabolic and intestinal inflammatory diseases.	[Haro, Carmen; Rangel-Zuniga, Oriol A.; Alcala-Diaz, Juan F.; Gomez-Delgado, Francisco; Perez-Martinez, Pablo; Delgado-Lista, Javier; Quintana-Navarro, Gracia M.; Lopez-Miranda, Jose; Perez-Jimenez, Francisco; Camargo, Antonio] Univ Cordoba, Lipids & Atherosclerosis Unit, Reina Sofia Univ Hosp, IMIBIC,Nutrigen GC9, Cordoba, Spain; [Haro, Carmen; Rangel-Zuniga, Oriol A.; Alcala-Diaz, Juan F.; Gomez-Delgado, Francisco; Perez-Martinez, Pablo; Delgado-Lista, Javier; Quintana-Navarro, Gracia M.; Tena-Sempere, Manuel; Lopez-Miranda, Jose; Perez-Jimenez, Francisco; Camargo, Antonio] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain; [Landa, Blanca B.; Navas-Cortes, Juan A.] CSIC, IAS, Cordoba, Spain; [Tena-Sempere, Manuel] Univ Cordoba, Reina Sofia Univ Hosp, IMIBIC, Dept Cell Biol Physiol & Immunol, Cordoba, Spain; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Universidad de Cordoba; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Camargo, A (corresponding author), Univ Cordoba, Lipids & Atherosclerosis Unit, Reina Sofia Univ Hosp, IMIBIC,Nutrigen GC9, Cordoba, Spain.; Camargo, A (corresponding author), Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Cordoba, Spain.	antonio.camargo@imibic.org	Landa, Blanca B/K-9629-2014; Alcala-Diaz, Juan F./Q-4455-2019; Navas-Cortes, Juan A/H-3381-2014; HARO, CARMEN/P-3104-2016; Navas-Cortes, Juan A./M-2060-2019; Delgado, Francisco Gomez/H-4552-2015; Camargo, Antonio/G-9720-2015; Alcala-Diaz, Juan Francisco/F-5329-2016; Jimenez, Francisco Perez/AAJ-9559-2021; Tena-Sempere, Manuel/AAX-3602-2021; Lopez-Miranda, Jose/Y-8306-2019	Landa, Blanca B/0000-0002-9511-3731; Alcala-Diaz, Juan F./0000-0002-4572-3611; Navas-Cortes, Juan A/0000-0001-6480-1104; HARO, CARMEN/0000-0002-1355-8359; Delgado, Francisco Gomez/0000-0002-0216-2084; Camargo, Antonio/0000-0002-0415-4184; Alcala-Diaz, Juan Francisco/0000-0002-4572-3611; Tena-Sempere, Manuel/0000-0002-4741-5567; Lopez-Miranda, Jose/0000-0002-8844-0718; Rangel-Zuniga, Oriol Alberto/0000-0003-3495-5705; Delgado Lista, Francisco Javier/0000-0002-2982-2716; QUINTANA-NAVARRO, GRACIA MARIA/0000-0003-4413-4062	Fundacion Patrimonio Comunal Olivarero; Junta de Andalucia (Consejeria de Salud); Junta de Andalucia (Consejeria de Agricultura y Pesca); Junta de Andalucia (Consejeria de Innovacion, Ciencia y Empresa); Diputaciones de Jaen y Cordoba; Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana; Ministerio de Ciencia e Innovacion [AGL2009-122270, FIS PI10/01041, PI10/02412]; Ministerio de Economia y Competitividad [AGL2012/39615, PIE14/00005, PIE 14/00031, FIS PI13/00023, PI13/00619, CP14/00114]; Consejeria de Innovacion, Ciencia y Empresa, Proyectos de Investigacion de Excelencia, Junta de Andalucia [CTS-5015, CVI-7450]; Consejeria de Salud, Junta de Andalucia [PI0193/09, PI-0252/09, PI-0058/10]; Fondo Europeo de Desarrollo Regional (FEDER); ISCIII research contract (Programa Miguel-Servet) [CP14/00114]; SCIII research contract (Programa Rio-Hortega); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P30DK020541] Funding Source: NIH RePORTER	Fundacion Patrimonio Comunal Olivarero; Junta de Andalucia (Consejeria de Salud)(Junta de Andalucia); Junta de Andalucia (Consejeria de Agricultura y Pesca)(Junta de Andalucia); Junta de Andalucia (Consejeria de Innovacion, Ciencia y Empresa)(Junta de Andalucia); Diputaciones de Jaen y Cordoba; Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana(Spanish Government); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Consejeria de Innovacion, Ciencia y Empresa, Proyectos de Investigacion de Excelencia, Junta de Andalucia(Junta de Andalucia); Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); ISCIII research contract (Programa Miguel-Servet); SCIII research contract (Programa Rio-Hortega); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The CORDIOPREV study is supported by the Fundacion Patrimonio Comunal Olivarero, Junta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca, Consejeria de Innovacion, Ciencia y Empresa), Diputaciones de Jaen y Cordoba, Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud, and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana. It was also partly supported by research grants from the Ministerio de Ciencia e Innovacion (AGL2009-122270 to J LM, FIS PI10/01041 to P P-M; PI10/02412 to F P-J); Ministerio de Economia y Competitividad (AGL2012/39615, PIE14/00005, and PIE 14/00031 to J L-M; FIS PI13/00023 to J D-L, PI13/00619 to F P-J; CP14/00114 to A C); Consejeria de Innovacion, Ciencia y Empresa, Proyectos de Investigacion de Excelencia, Junta de Andalucia (CTS-5015 to F P-J; CVI-7450 to J L-M;); Consejeria de Salud, Junta de Andalucia (PI0193/09 to J L-M, PI-0252/09 to J D-L, and PI-0058/10 to P P-M); and Fondo Europeo de Desarrollo Regional (FEDER). Antonio Camargo is supported by an ISCIII research contract (Programa Miguel-Servet CP14/00114). Juan F. Alcala-Diaz is supported by an SCIII research contract (Programa Rio-Hortega). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala-Diaz JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096297; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Arnlov J, 2006, ANN INTERN MED, V145, P176, DOI 10.7326/0003-4819-145-3-200608010-00005; Bajzer M, 2006, NATURE, V444, P1009, DOI 10.1038/4441009a; Betteridge JD, 2013, INFLAMM BOWEL DIS, V19, P1421, DOI 10.1097/MIB.0b013e318281334d; Bhupathy P, 2010, WOMENS HEALTH, V6, P77, DOI [10.2217/whe.09.80, 10.2217/WHE.09.80]; Bondia-Pons I., 2014, FASEB J; Brant SR, 2008, INFLAMM BOWEL DIS, V14, pS2, DOI 10.1002/ibd.20540; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clemente Jose C, 2015, SCI ADV, V1; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gisbert JP, 2014, ALIMENT PHARM THER, V39, P459, DOI 10.1111/apt.12616; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Luczak ED, 2009, ANNU REV PHYSIOL, V71, P1, DOI 10.1146/annurev.physiol.010908.163156; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mestdagh R, 2012, J PROTEOME RES, V11, P620, DOI 10.1021/pr200938v; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Paisley EA, 1996, J NUTR, V126, P2730; Parkes GC, 2012, NEUROGASTROENT MOTIL, V24, P31, DOI 10.1111/j.1365-2982.2011.01803.x; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Rao PM, 2013, NAT REV ENDOCRINOL, V9, P479, DOI 10.1038/nrendo.2013.122; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Saraswati S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00764; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	54	334	345	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0154090	10.1371/journal.pone.0154090	http://dx.doi.org/10.1371/journal.pone.0154090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228093	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500003
J	Przybysz, P; Dubowik, M; Kucner, MA; Przybysz, K; Przybysz Buzala, K				Przybysz, Piotr; Dubowik, Marcin; Kucner, Marta Anna; Przybysz, Kazimierz; Przybysz Buzala, Kamila			Contribution of Hydrogen Bonds to Paper Strength Properties	PLOS ONE			English	Article							WATER; PULP	The objective of this work was to investigate the influence of hydrogen bonds between fibres on static and dynamic strength properties of paper. A commercial bleached pinewood kraft pulp was soaked in water, refined in a PFI, and used to form paper webs in different solvents, such as water, methanol, ethanol, n-propanol and n-butanol, to determine the effect of their dipole moment on static and dynamic strength properties of resulting paper sheets. Paper which was formed in water, being the solvent of the highest dipole moment among the tested ones, showed the highest breaking length and tear resistance. When paper webs were formed in n-butanol, which was the least polar among the solvents, these parameters were reduced by around 75%. These results provide evidence of the importance of water in paper web formation and strong impact of hydrogen bonds between fibres on strength properties of paper.	[Przybysz, Piotr; Przybysz, Kazimierz; Przybysz Buzala, Kamila] Lodz Univ Technol, Inst Papermaking & Printing Technol, Wolczanska Str 223, PL-90924 Lodz, Poland; [Dubowik, Marcin; Kucner, Marta Anna] Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland	Lodz University of Technology; Lodz University of Technology	Dubowik, M (corresponding author), Lodz Univ Technol, Fac Proc & Environm Engn, Wolczanska 213, PL-90924 Lodz, Poland.	marcin.dubowik1989@gmail.com		Dubowik, Marcin/0000-0001-6809-3205; Przybysz, Piotr/0000-0003-2044-6790	 [LIDER/042/407/L-4/12/NCBR/2013]		This work was supported by LIDER/042/407/L-4/12/NCBR/2013 founded by National Centre for Research and Development, Poland (NCBiR) to PP (www.ncbr.gov.pl).	[Anonymous], 2013, FILTR SEPARAT, V50, P42; Campbell WB, 1933, FOREST SEVICE B, V84; Diniz JMBF, 2004, WOOD SCI TECHNOL, V37, P489, DOI 10.1007/s00226-003-0216-2; Ghosh A.K., 2011, EVAPORATION CONDENSA, V1st ed., DOI [10.5772/21594, DOI 10.5772/21594]; Holik H, 2006, HDB PAPER BOARD; Hubbe MA, 2007, BIORESOURCES, V2, P500; LAIVINS GV, 1994, TAPPI J, V77, P125; Maloney TC, 1998, NORD PULP PAP RES J, V13, P285, DOI 10.3183/npprj-1998-13-04-p285-291; Maloney TC, 1997, APPITA J, V50, P301; Mark R. E., 2001, HDB PHYS TESTING PAP, V1; McMurry J., 2012, ORGANIC CHEM; Monte MC, 2009, WASTE MANAGE, V29, P293, DOI 10.1016/j.wasman.2008.02.002; Niskanen, 1998, PAPER PHYS; Norman B, 2000, PAPERMAKING STOCK PR, P232; Norman B, 2009, PULP AND PAPER CHEMISTRY AND TECHNOLOGY, VOL 3: PAPER CHEMISTRY AND TECHNOLOGY, P173; O'Rourke D, 2005, J IND ECOL, V9, P115, DOI 10.1162/1088198054084608; Page DH, 1965, T FUND RES S, P313; Paulapuro H, 2000, PAPERMAKING SCIENCE; Prosinski S., 1984, WOOD CHEM; Przybysz K, 2007, POLISH PAPER REV, V63, P395; Przybysz K, 2007, POLISH PAPER REV, V63, P221; Przybysz K, 2007, PRZEGLAD PAPIERNICZY, V63, P113; Rantanen J, 2015, CELLULOSE, V22, P4003, DOI 10.1007/s10570-015-0777-x; Rantanen J, 2015, EUR POLYM J, V68, P585, DOI 10.1016/j.eurpolymj.2015.03.045; Schmied FJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02432; Stone J.E., 1968, CELLUL CHEM TECHNOL, V2, P343; Szabo L, 2009, ENVIRON SCI POLICY, V12, P257, DOI 10.1016/j.envsci.2009.01.011; Taipale T, 2010, CELLULOSE, V17, P1005, DOI 10.1007/s10570-010-9431-9; Thompson G, 2001, BIORESOURCE TECHNOL, V77, P275, DOI 10.1016/S0960-8524(00)00060-2; Turnbull PF, 1995, THESIS; Wang XS, 2005, NORD PULP PAP RES J, V20, P442, DOI 10.3183/npprj-2005-20-04-p442-447	31	30	31	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155809	10.1371/journal.pone.0155809	http://dx.doi.org/10.1371/journal.pone.0155809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228172	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500035
J	Wendt, CH; Nelsestuen, G; Harvey, S; Gulcev, M; Stone, M; Reilly, C				Wendt, Chris H.; Nelsestuen, Gary; Harvey, Stephen; Gulcev, Makedonka; Stone, Matthew; Reilly, Cavan			Peptides in Bronchoalveolar Lavage in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							ELASTIN-DERIVED PEPTIDES; NEUTROPHIL ELASTASE; COPD; EMPHYSEMA; INFLAMMATION; MICE	Background Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous disease with a significant public health burden. Currently there is no biomarker that identifies those at risk of developing COPD, progression of disease or disease phenotypes. We performed metabolomic profiling of bronchoalveolar lavage fluid (BALF) from COPD patients to determine if metabolites correlated with clinical measurements such as lung function, functional status and degree of emphysema. Methods Metabolomic components of BALF from 59 subjects with COPD and 20 healthy controls were separated by reversed-phase UPLC and analyzed by ESI-ToF mass spectrometry. We used univariate analysis and multiple regression models to investigate associations between metabolomic features and various clinical variables, such as lung function, functional status as measured by the St. George Respiratory Quotient Score and emphysema as measured by the CT density mask score. Results We identified over 3900 features by mass spectrometry, many consistent with peptides. Subjects with severe COPD had increased concentration of peptides compared to controls (p < 9.526e-05). The peptide concentration correlated with spirometry, specifically pulmonary function tests associated with airflow obstruction. There was no correlation with CT density, i.e. emphysema, or functional status. Conclusions Metabolomic profiling of BALF in COPD patients demonstrated a significant increase in peptides compared to healthy controls that associated strongly to lung function, but not emphysema or functional status.	[Wendt, Chris H.] VA Med Ctr, Dept Med, Minneapolis, MN 55417 USA; [Wendt, Chris H.; Gulcev, Makedonka] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Nelsestuen, Gary; Harvey, Stephen; Stone, Matthew] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Reilly, Cavan] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wendt, CH (corresponding author), VA Med Ctr, Dept Med, Minneapolis, MN 55417 USA.; Wendt, CH (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	wendt005@umn.edu			National Institute of Health [NO1-HR-96140 P, R01HL080041]; National Heart, Lung and Blood Institute (NHLBI) [NO1-HR-96140]; NHLBI [R01HL080041]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080041] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by National Institute of Health NO1-HR-96140 P and National Institute of Health R01HL080041.; The authors wish to thank John Connett, PhD for supplying the samples and clinical data from the FORTE study, Trisha Becker for technical support and the Minnesota Supercomputing Institute for software support and data storage. Support for the FORTE study was provided by the National Heart, Lung and Blood Institute (NHLBI) contracts NO1-HR-96140 (PI: Dr. Connett, Co-Investigator C Wendt). Further support was provided by NHLBI R01HL080041 (PI: C Wendt).	Agusti A, 2011, AM J RESP CRIT CARE, V183, P1129, DOI 10.1164/rccm.201009-1414PP; AKERS S, 1992, AM REV RESPIR DIS, V145, P1077, DOI 10.1164/ajrccm/145.5.1077; Barnes PJ, 2000, CHEST, V117, P10; Betsuyaku T, 1996, AM J RESP CRIT CARE, V154, P720, DOI 10.1164/ajrccm.154.3.8810611; Chapman HA, 2000, CHEST, V117, p295S, DOI 10.1378/chest.117.5_suppl_1.295S; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; Communities & Local Government Department, 2009, GUID MAN HYP JSH2009, P1; D'Armiento JM, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-113; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; KUCICH U, 1983, AM REV RESPIR DIS, V127, pS28; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Mercer PF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-151; Nadel JA, 2000, CHEST, V117, p386S, DOI 10.1378/chest.117.5_suppl_2.386S; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; Owen Caroline A, 2005, Proc Am Thorac Soc, V2, P373, DOI 10.1513/pats.200504-029SR; Pounds SB, 2006, BRIEF BIOINFORM, V7, P25, DOI 10.1093/bib/bbk002; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Shapiro SD, 2000, AM J RESP CELL MOL, V22, P4, DOI 10.1165/ajrcmb.22.1.f173; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; Stone MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084471; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361	24	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155724	10.1371/journal.pone.0155724	http://dx.doi.org/10.1371/journal.pone.0155724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227774	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500027
J	Singh, J; Mukhopadhyay, CS; Kaur, S; Malhotra, P; Sethi, RS; Choudhary, RK				Singh, Jasdeep; Mukhopadhyay, C. S.; Kaur, Simarjeet; Malhotra, Puneet; Sethi, R. S.; Choudhary, R. K.			Identification of the MicroRNA Repertoire in TLR-Ligand Challenged Bubaline PBMCs as a Model of Bacterial and Viral Infection	PLOS ONE			English	Article							MACROPHAGE RESPONSE; IMMUNE-RESPONSES; EXPRESSION; BOVINE; MODULATE; INNATE; RECOGNITION; CYTOKINES; PATHWAY; CELLS	In the present study, we used high-throughput sequencing, miRNA-seq, to discover and explore the expression profiles of known and novel miRNAs in TLR ligand-stimulated vis-a-vis non-stimulated (i.e. Control) peripheral blood mononuclear cells (PBMCs) isolated from blood of healthy Murrah buffaloes. Six small RNA (sRNA) libraries were multiplexed in Ion Torrent PI chip and sequenced on Ion Proton System. The reads obtained were aligned to the Bos taurus genome (UMD3.1 assembly), which is phylogenetically closest species to buffalo (Bubalus bubalis). A total of 160 bovine miRNAs were biocomputationally identified in buffalo PBMCs and 130 putatively novel miRNAs (not enlisted in the bovine mirBase) were identified. All of these 290 miRNAs identified across the six treatment and control samples represent the repertoire of novel miRNAs for the buffalo species. The expression profiles of these miRNAs across the samples have been represented by sample dendrogram and heatmap plots. The uniquely expressed miRNAs in each treatment and control groups were identified. A few miRNAs were expressed at very high levels while the majority of them were moderately expressed. The miRNAs bta-miR-103 and -191 were found to be highly abundant and expressed in all the samples. Other abundantly expressed miRNAs include bta-miR-19b, -29b, -15a, -19a, -30d, -30b-5p and members of let family (let 7a-5p, let 7g & let 7f) in LPS and CpG treated PBMCS and bta-miR-191, -103 & -19b in Poly I:C stimulated PBMCs. Only one novel miRNA (bta-miR-11039) out of 130 identified putatively novel miRNAs, was expressed in all the six samples and differentially expressed (> 2-fold) miRNAs were identified. Six of the differentially expressed miRNAs across the groups (bta-miR-421, bta-let-7i, bta-miR-138, bta-miR-21-5p, bta-miR-222 and bta-miR-27b) were subsequently confirmed by TaqMan quantitative reverse transcription polymerase chain reaction (qRTPCR). Furthermore, the target genes of differentially expressed miRNAs were enriched for the roles in innate immunity and TLR signaling pathways. This maiden study on profiling and cataloguing of bubaline miRNAs expressed in TLR-ligand stimulated PBMCs will provide an important reference point for future studies on regulatory roles of miRNAs in immune system of buffaloes.	[Singh, Jasdeep; Mukhopadhyay, C. S.; Sethi, R. S.; Choudhary, R. K.] Guru Angad Dev Vet & Anim Sci Univ, Post Grad Inst Vet Educ & Res, Sch Anim Biotechnol, Ludhiana, Punjab, India; [Kaur, Simarjeet; Malhotra, Puneet] Guru Angad Dev Vet & Anim Sci Univ, Dept Anim Genet & Breeding, Ludhiana, Punjab, India; [Sethi, R. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK S7N 0W0, Canada	Guru Angad Dev Veterinary & Animal Sciences University (GADVASU); Guru Angad Dev Veterinary & Animal Sciences University (GADVASU); University of Saskatchewan	Mukhopadhyay, CS (corresponding author), Guru Angad Dev Vet & Anim Sci Univ, Post Grad Inst Vet Educ & Res, Sch Anim Biotechnol, Ludhiana, Punjab, India.	csmbioinfo@gmail.com	SETHI, RS/ABC-5353-2020; Mukhopadhyay, Chandra Sekhar/A-1182-2017; Choudhary, Ratan/AEU-0526-2022; Choudhary, Ratan K./AAE-6117-2022	SETHI, RS/0000-0003-0416-8946; Mukhopadhyay, Chandra Sekhar/0000-0002-4545-4204; Choudhary, Ratan K./0000-0001-5601-7635; Singh, Jasdeep/0000-0002-6479-4482	Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India [SERC-LS-293-2011, SR/FT/LS-22/2011]	Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India	The work has been funded by Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India (SERC-LS-293-2011, File Number SR/FT/LS-22/2011 serb.gov.in/pdfs/.../SERBYS-Life-Sciences-List-of-Projects-2012-13.pdf).	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Buchanan R, 2012, VET IMMUNOL IMMUNOP, V145, P453, DOI 10.1016/j.vetimm.2012.01.001; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liang GX, 2015, MOL IMMUNOL, V66, P57, DOI 10.1016/j.molimm.2014.10.014; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mahdipour M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0075-8; Mena A, 2003, OLIGONUCLEOTIDES, V13, P245, DOI 10.1089/154545703322460621; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moles R, 2015, VIRUSES-BASEL, V7, P4047, DOI 10.3390/v7072805; Mutwiri G, 2003, VET IMMUNOL IMMUNOP, V91, P89, DOI 10.1016/S0165-2427(02)00246-5; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Rau CS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0106-y; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Singh J, 2015, INT J ADV RES, V3, P929; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun MJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1110-x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vegh P, 2015, TUBERCULOSIS, V95, P60, DOI 10.1016/j.tube.2014.10.011; Vegh P, 2013, VET IMMUNOL IMMUNOP, V155, P238, DOI 10.1016/j.vetimm.2013.08.004; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	46	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156598	10.1371/journal.pone.0156598	http://dx.doi.org/10.1371/journal.pone.0156598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257788	Green Submitted, gold, Green Published			2022-12-27	WOS:000377369700085
J	Zheng, Z; Zhang, L; Zhu, TT; Huang, JC; Qu, Y; Mu, DZ				Zheng, Zhen; Zhang, Li; Zhu, Tingting; Huang, Jichong; Qu, Yi; Mu, Dezhi			Association between Asthma and Autism Spectrum Disorder: A Meta-Analysis	PLOS ONE			English	Article							ELEVATED SERUM-LEVELS; AUTOIMMUNE-DISEASES; CHILDREN; BRAIN; INFLAMMATION; ALLERGIES; BURDEN; RISK	Objective We conducted a meta-analysis to summarize the evidence from epidemiological studies of the association between asthma and autism spectrum disorder (ASD). Methods A literature search was conducted using PubMed, Embase, and Cochrane library for studies published before February 2nd, 2016. Observational studies investigating the association between asthma and ASD were included. A random effects model was used to calculate the pooled risk estimates for the outcome. Subgroup analysis was used to explore potential sources of heterogeneity and publication bias was estimated using Begg's and Egger's tests. Results Ten studies encompassing 175,406 participants and 8,809 cases of ASD were included in this meta-analysis. In the cross-sectional studies, the prevalence of asthma in ASD was 20.4%, while the prevalence of asthma in controls was 15.4%(P < 0.001). The pooled odds ratio (OR) for the prevalence of asthma in ASD in the cross-sectional studies was 1.26 (95% confidence interval (CI): 0.98-1.61) (P = 0.07), with moderate heterogeneity (I-2 = 65.0%, P = 0.02) across studies. In the case-control studies, the pooled OR for the prevalence of asthma in ASD was 0.98 (95% CI: 0.68-1.43) (P = 0.94), and there was no evidence of an association between asthma and ASD. No evidence of significant publication bias on the association between asthma and ASD was found. Conclusions In conclusion, the results of this meta-analysis do not suggest an association between asthma and ASD. Further prospective studies ascertaining the association between asthma and ASD are warranted.	[Zheng, Zhen; Zhang, Li; Zhu, Tingting; Huang, Jichong; Qu, Yi; Mu, Dezhi] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China; [Zheng, Zhen; Zhang, Li; Zhu, Tingting; Huang, Jichong; Qu, Yi; Mu, Dezhi] Sichuan Univ, Minist Educ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Chengdu 610041, Peoples R China; [Mu, Dezhi] Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA	Sichuan University; Sichuan University; University of California System; University of California San Francisco	Mu, DZ (corresponding author), Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Sichuan Univ, Minist Educ, Key Lab Obstetr & Gynecol & Pediat Dis & Birth De, Chengdu 610041, Peoples R China.; Mu, DZ (corresponding author), Univ Calif San Francisco, Dept Pediat & Neurol, San Francisco, CA 94143 USA.	dezhi.mu@ucsf.edu		Qu, Yi/0000-0002-9993-8810; Mu, Dezhi/0000-0002-2599-7041	National Science Foundation of China [81330016, 81270724]; Grant from the Major State Basic Research Development Program [2013CB967404]; Grants from Ministry of Education of China [313037, IRT0935]; Grant from State Commission of Science Technology of China [2012BAI04B04]; Science and Technology Bureau of Sichuan province [2014SZ0149]; Ministry of Health of China [1311200003303]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant from the Major State Basic Research Development Program; Grants from Ministry of Education of China; Grant from State Commission of Science Technology of China; Science and Technology Bureau of Sichuan province; Ministry of Health of China	This work was supported by the National Science Foundation of China (No. 81330016 to Dezhi Mu and No. 81270724 to Yi Qu), the Grant from the Major State Basic Research Development Program (2013CB967404), the Grants from Ministry of Education of China (313037, IRT0935), the Grant from State Commission of Science Technology of China (2012BAI04B04), the Grant from Science and Technology Bureau of Sichuan province (2014SZ0149), and the Grant of clinical discipline program (neonatology) from the Ministry of Health of China (1311200003303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintunde ME, 2015, J NEUROIMMUNOL, V286, P33, DOI 10.1016/j.jneuroim.2015.07.003; Al-Ayadhi LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-54; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Angelidou A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-89; Asher I, 2014, INT J TUBERC LUNG D, V18, P1269, DOI 10.5588/ijtld.14.0170; Baio Jon, 2012, Morbidity and Mortality Weekly Report, V61, P1; Bakkaloglu B, 2008, EUR J PAEDIATR NEURO, V12, P476, DOI 10.1016/j.ejpn.2007.12.008; Becker KG, 2007, MED HYPOTHESES, V69, P731, DOI 10.1016/j.mehy.2007.02.019; Becker KG, 2010, MED HYPOTHESES, V74, P7, DOI 10.1016/j.mehy.2009.08.033; Chen MH, 2013, RES AUTISM SPECT DIS, V7, P205, DOI 10.1016/j.rasd.2012.08.008; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Goines PE, 2013, NEUROTOXICOL TERATOL, V36, P67, DOI 10.1016/j.ntt.2012.07.006; Grether JK, 2010, AUTISM RES, V3, P323, DOI 10.1002/aur.160; Heuer LS, 2012, J NEUROIMMUNOL, V251, P94, DOI 10.1016/j.jneuroim.2012.07.001; Jyonouchi H, 2010, EXPERT REV CLIN IMMU, V6, P397, DOI [10.1586/eci.10.18, 10.1586/ECI.10.18]; Jyonouchi H, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-52; Kazani S, 2012, AM J RESP CRIT CARE, V186, P35, DOI 10.1164/rccm.201204-0634UP; Koehler AD, 2014, MATERN CHILD HLTH J, V18, P2080, DOI 10.1007/s10995-014-1455-6; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kotey S, 2014, J AUTISM DEV DISORD, V44, P3083, DOI 10.1007/s10803-014-2174-y; Langridge AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050963; Lin TY, 2014, RES AUTISM SPECT DIS, V8, P1333, DOI 10.1016/j.rasd.2014.07.009; Lyall K, 2015, AUTISM RES, V8, P567, DOI 10.1002/aur.1471; Magalhaes ES, 2009, J NEUROIMMUNOL, V216, P108, DOI 10.1016/j.jneuroim.2009.09.015; Mostafa GA, 2013, J NEUROIMMUNOL, V261, P77, DOI 10.1016/j.jneuroim.2013.04.003; Mrozek-Budzyn Dorota, 2013, Przegl Epidemiol, V67, P675; Rosenkranz MA, 2009, NEUROIMAGE, V47, P972, DOI 10.1016/j.neuroimage.2009.05.042; Schieve LA, 2012, RES DEV DISABIL, V33, P467, DOI 10.1016/j.ridd.2011.10.008; Suzuki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020470; Theoharides TC, 2015, EUR J PHARM; Wei HG, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-52; Zerbo O, 2015, BRAIN BEHAV IMMUN, V46, P232, DOI 10.1016/j.bbi.2015.02.001	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156662	10.1371/journal.pone.0156662	http://dx.doi.org/10.1371/journal.pone.0156662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257919	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700097
J	Castell-Miller, CV; Gutierrez-Gonzalez, JJ; Tu, ZJ; Bushley, KE; Hainaut, M; Henrissat, B; Samac, DA				Castell-Miller, Claudia V.; Gutierrez-Gonzalez, Juan J.; Tu, Zheng Jin; Bushley, Kathryn E.; Hainaut, Matthieu; Henrissat, Bernard; Samac, Deborah A.			Genome Assembly of the Fungus Cochliobolus miyabeanus, and Transcriptome Analysis during Early Stages of Infection on American Wildrice (Zizania palustris L.)	PLOS ONE			English	Article							POLYKETIDE VIRULENCE FACTOR; FUNCTIONAL-ANALYSIS; BROWN SPOT; HC-TOXIN; CYTOCHROME-P450 MONOOXYGENASE; MOLECULAR CHARACTERIZATION; MULTIDRUG-RESISTANCE; ASPERGILLUS-NIDULANS; CLADOSPORIUM-FULVUM; CERATO-PLATANIN	The fungus Cochliobolus miyabeanus causes severe leaf spot disease on rice (Oryza sativa) and two North American specialty crops, American wildrice (Zizania palustris) and switchgrass (Panicum virgatum). Despite the importance of C. miyabeanus as a disease-causing agent in wildrice, little is known about either the mechanisms of pathogenicity or host defense responses. To start bridging these gaps, the genome of C. miyabeanus strain TG12bL2 was shotgun sequenced using Illumina technology. The genome assembly consists of 31.79 Mbp in 2,378 scaffolds with an N-50 = 74,921. It contains 11,000 predicted genes of which 94.5% were annotated. Approximately 10% of total gene number is expected to be secreted. The C. miyabeanus genome is rich in carbohydrate active enzymes, and harbors 187 small secreted peptides (SSPs) and some fungal effector homologs. Detoxification systems were represented by a variety of enzymes that could offer protection against plant defense compounds. The non-ribosomal peptide synthetases and polyketide synthases (PKS) present were common to other Cochliobolus species. Additionally, the fungal transcriptome was analyzed at 48 hours after inoculation in planta. A total of 10,674 genes were found to be expressed, some of which are known to be involved in pathogenicity or response to host defenses including hydrophobins, cutinase, cell wall degrading enzymes, enzymes related to reactive oxygen species scavenging, PKS, detoxification systems, SSPs, and a known fungal effector. This work will facilitate future research on C. miyabeanus pathogen-associated molecular patterns and effectors, and in the identification of their corresponding wildrice defense mechanisms.	[Castell-Miller, Claudia V.; Samac, Deborah A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Gutierrez-Gonzalez, Juan J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Gutierrez-Gonzalez, Juan J.; Samac, Deborah A.] USDA ARS Plant Sci Res Unit, St Paul, MN USA; [Tu, Zheng Jin] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Bushley, Kathryn E.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Hainaut, Matthieu; Henrissat, Bernard] Aix Marseille Univ, CNRS UMR 7257, Marseille, France; [Hainaut, Matthieu; Henrissat, Bernard] AFMB, USC 1408, INRA, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Castell-Miller, CV (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN USA.	caste007@umn.edu	Gutierrez-Gonzalez, Juan J/B-1387-2018; Samac, Deborah/ABC-8744-2021; Henrissat, Bernard/J-2475-2012; Bushley, Kathryn E/AAX-6372-2021	Gutierrez-Gonzalez, Juan J/0000-0002-6795-6192; Samac, Deborah/0000-0002-1847-0508; Henrissat, Bernard/0000-0002-3434-8588; 	United States Department of Agriculture-Agricultural Research Service (ARS-USDA); Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; ARS [ARS-0424185] Funding Source: Federal RePORTER	United States Department of Agriculture-Agricultural Research Service (ARS-USDA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by United States Department of Agriculture-Agricultural Research Service (ARS-USDA).r We would like to thank Bruce Elckloff from the Mayo Clinic, Rochester, MN for sequencing the C. miyabeanus isolate, and Dr. B. Gillian Turgeon and Bradford Condon for NRPS sequence data from the C. miyabeanus WK-1C and C. heterostrophus C4 and C5 strains, and other ascomycetes used in the analyses, and to Dr. B. Gillian Turgeon and the U.S. Department of Energy Joint Genome Institute (http://genome.jgi.doe.gov) for sharing the C. miyabeanus WK-1C DNA sequences and proteins. The genome and transcriptome of C. miyabeanus work were sequenced and annotated by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Ahn JH, 2001, BIOSCI BIOTECH BIOCH, V65, P1406, DOI 10.1271/bbb.65.1406; Ahn JH, 1998, MOL GEN GENET, V260, P462, DOI 10.1007/s004380050917; Ahn JH, 1997, MOL PLANT MICROBE IN, V10, P207, DOI 10.1094/MPMI.1997.10.2.207; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; ApelBirkhold PC, 1996, APPL ENVIRON MICROB, V62, P4129, DOI 10.1128/AEM.62.11.4129-4135.1996; Arenas YC, 2010, PHYSIOL MOL PLANT P, V74, P376, DOI 10.1016/j.pmpp.2010.06.003; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Baccelli I., 2005, FRONT PLANT SCI, V5, P1; Baidyaroy D, 2001, PLANT CELL, V13, P1609, DOI 10.1105/tpc.13.7.1609; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhadauria V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-327; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castell-Miller CV, 2012, PLANT PATHOL, V61, P903, DOI 10.1111/j.1365-3059.2011.02581.x; Cheng YQ, 2000, J BIOL CHEM, V275, P4906, DOI 10.1074/jbc.275.7.4906; Cheng YQ, 1999, MICROBIOL-UK, V145, P3539, DOI 10.1099/00221287-145-12-3539; Condon BJ, 2012, PLOS GENET, V9, P1; Condon BJ, 2013, GENOMICS PLANT ASS F, P41; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DATNOFF LE, 1991, PLANT DIS, V75, P729, DOI 10.1094/PD-75-0729; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Degani O., 2014, Advances in Bioscience and Biotechnology, V5, P340, DOI 10.4236/abb.2014.54042; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Ferrer-Sevillano F, 2007, EUKARYOT CELL, V6, P514, DOI 10.1128/EC.00226-06; FUKUSHIMA Y, 1993, BIOORG MED CHEM LETT, V3, P1219, DOI 10.1016/S0960-894X(00)80319-4; Ganem S, 2004, EUKARYOT CELL, V3, P1653, DOI 10.1128/EC.3.6.1653-1663.2004; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; Hartl L, 2012, APPL MICROBIOL BIOT, V93, P533, DOI 10.1007/s00253-011-3723-3; JOHNSON DR, 1992, PLANT DIS, V76, P1193, DOI 10.1094/PD-76-1193; Jorgensen TR, 2007, MICROBIOL-SGM, V153, P1963, DOI 10.1099/mic.0.2006/005090-0; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kim JY, 2014, PROTEOMICS, V14, P2307, DOI 10.1002/pmic.201400066; Kim KH, 2007, MOL PLANT PATHOL, V8, P23, DOI 10.1111/j.1364-3703.2006.00366.x; Kleemann Jochen, 2012, PLoS Pathog, V8, pe1002643, DOI 10.1371/journal.ppat.1002643; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; KOHLS CL, 1987, PLANT DIS, V71, P419, DOI 10.1094/PD-71-0419; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Krupinsky J, 2004, CAN J PLANT PATHOL, V26, P371; Kubicek CP, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P396; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; Leandro MJ, 2006, BIOCHEM J, V395, P543, DOI 10.1042/BJ20051465; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Lev S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Lowe RGT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002515; Lu SW, 2003, P NATL ACAD SCI USA, V100, P5980, DOI 10.1073/pnas.0931375100; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Mingot JM, 1999, J BIOL CHEM, V274, P14545, DOI 10.1074/jbc.274.21.14545; Moffatt AM, 1998, THESIS; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Murphy JM, 1996, MOL PLANT MICROBE IN, V9, P290, DOI 10.1094/MPMI-9-0290; Nyvall RF, 1999, PLANT DIS, V83, P936, DOI 10.1094/PDIS.1999.83.10.936; Oelke E.A., 2007, SAGA GRAIN TRIBUTE M; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oide S, 2007, EUKARYOT CELL, V6, P1339, DOI 10.1128/EC.00111-07; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Ou SH, 1985, RICE DIS; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Porter R, 2010, VARIETY TRIAL RESULT; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; REIMMANN C, 1994, GENE, V146, P221, DOI 10.1016/0378-1119(94)90296-8; Rose MS, 2002, MOL PLANT MICROBE IN, V15, P883, DOI 10.1094/MPMI.2002.15.9.883; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Scott-Craig JS, 1998, APPL ENVIRON MICROB, V64, P1497; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Sexton AC, 2009, FUNGAL GENET BIOL, V46, P201, DOI 10.1016/j.fgb.2008.10.014; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Tonukari NJ, 2003, DNA SEQUENCE, V14, P103, DOI 10.1080/1042517031000073727; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trojer P, 2003, NUCLEIC ACIDS RES, V31, P3971, DOI 10.1093/nar/gkg473; Turgeon BG, 2008, MYCOL RES, V112, P200, DOI 10.1016/j.mycres.2007.10.012; Turgeon BG, 2007, ADV GENET, V57, P219, DOI 10.1016/S0065-2660(06)57006-3; Turgeon BG, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P376; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; VIDHYASEKARAN P, 1992, PHYSIOL MOL PLANT P, V41, P307, DOI 10.1016/0885-5765(92)90018-Q; WOLPERT TJ, 1985, EXPERIENTIA, V41, P1524, DOI 10.1007/BF01964789; XIAO JZ, 1991, PHYTOPATHOLOGY, V81, P58, DOI 10.1094/Phyto-81-58; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yang G, 1996, PLANT CELL, V8, P2139, DOI 10.1105/tpc.8.11.2139; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yoder OC, 1988, ADV PLANT PATHOL, P93, DOI 10.1016/B978-0-12-033706-4.50009-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31	116	5	5	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0154122	10.1371/journal.pone.0154122	http://dx.doi.org/10.1371/journal.pone.0154122			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253872	Green Published, gold, Green Submitted			2022-12-27	WOS:000377218700002
J	Stahel, P; Cant, JP; MacPherson, JAR; Berends, H; Steele, MA				Stahel, Priska; Cant, John P.; MacPherson, Jayden A. R.; Berends, Harma; Steele, Michael A.			A Mechanistic Model of Intermittent Gastric Emptying and Glucose-Insulin Dynamics following a Meal Containing Milk Components	PLOS ONE			English	Article							MINIMAL MODEL; SENSITIVITY; KINETICS; SECRETION; PLASMA	To support decision-making around diet selection choices to manage glycemia following a meal, a novel mechanistic model of intermittent gastric emptying and plasma glucose-insulin dynamics was developed. Model development was guided by postprandial timecourses of plasma glucose, insulin and the gastric emptying marker acetaminophen in infant calves fed meals of 2 or 4 L milk replacer. Assigning a fast, slow or zero first-order gastric emptying rate to each interval between plasma samples fit acetaminophen curves with prediction errors equal to 9% of the mean observed acetaminophen concentration. Those gastric emptying parameters were applied to glucose appearance in conjunction with minimal models of glucose disposal and insulin dynamics to describe postprandial glycemia and insulinemia. The final model contains 20 parameters, 8 of which can be obtained by direct measurement and 12 by fitting to observations. The minimal model of intestinal glucose delivery contains 2 gastric emptying parameters and a third parameter describing the time lag between emptying and appearance of glucose in plasma. Sensitivity analysis of the aggregate model revealed that gastric emptying rate influences area under the plasma insulin curve but has little effect on area under the plasma glucose curve. This result indicates that pancreatic responsiveness is influenced by gastric emptying rate as a consequence of the quasi-exponential relationship between plasma glucose concentration and pancreatic insulin release. The fitted aggregate model was able to reproduce the multiple postprandial rises and falls in plasma glucose concentration observed in calves consuming a normal-sized meal containing milk components.	[Stahel, Priska; Cant, John P.] Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada; [MacPherson, Jayden A. R.; Steele, Michael A.] Univ Alberta, Dept Agr Food & Nutr Serv, Edmonton, AB, Canada; [Berends, Harma] Trouw Nutr R&D, Boxmeer, North Brabant, Netherlands	University of Guelph; University of Alberta	Stahel, P (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada.	pstahel@uoguelph.ca	Cant, John/ABF-5323-2021	Cant, John/0000-0003-2021-1764; Berends, Harma/0000-0003-0535-5575	Trouw Nutrition RD	Trouw Nutrition RD	The co-author Harma Berends is employed by Trouw Nutrition R&D, Boxmeer, The Netherlands, but this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Trouw Nutrition R&D provided support in the form of salary for author Harma Berends, but did not have any additional role in the model design and evaluation, decision to publish, or final preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barosa C, 2012, METABOLISM, V61, P250, DOI 10.1016/j.metabol.2011.06.022; BELL FR, 1973, J PHYSIOL-LONDON, V228, P499, DOI 10.1113/jphysiol.1973.sp010096; Benschop DL, 2009, LIVEST SCI, V122, P177, DOI 10.1016/j.livsci.2008.08.011; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Burattini R, 2012, COMPUT METH PROG BIO, V107, P248, DOI 10.1016/j.cmpb.2011.07.002; Cant J. P., 2006, P69, DOI 10.1079/9781845930059.0069; CLEMENTS JA, 1978, CLIN PHARMACOL THER, V24, P420; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; Dedik L, 2007, DIABETES RES CLIN PR, V77, P377, DOI 10.1016/j.diabres.2006.12.017; Gannon MC, 2001, METABOLISM, V50, P93, DOI 10.1053/meta.2001.19442; Hinshaw L, 2014, AM J PHYSIOL-ENDOC M, V307, pE494, DOI 10.1152/ajpendo.00199.2014; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Le Huerou-Luron I, 1998, COMP BIOCHEM PHYS A, V119, P817, DOI 10.1016/S1095-6433(98)01021-6; MacPherson JAR, J DAIRY SCI IN PRESS; MALAISSE WJ, 1973, DIABETOLOGIA, V9, P167, DOI 10.1007/BF01219778; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; PETIT HV, 1987, J DAIRY SCI, V70, P2570, DOI 10.3168/jds.S0022-0302(87)80326-0; Stellaard F, 2000, SCAND J GASTROENTERO, V35, P819, DOI 10.1080/003655200750023183; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; TOFFOLO G, 1980, DIABETES, V29, P979, DOI 10.2337/diabetes.29.12.979; VIST GE, 1995, J PHYSIOL-LONDON, V486, P523, DOI 10.1113/jphysiol.1995.sp020831; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; Xu C, 2000, J ANIM PHYSIOL AN N, V83, P49, DOI 10.1046/j.1439-0396.2000.00249.x	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156443	10.1371/journal.pone.0156443	http://dx.doi.org/10.1371/journal.pone.0156443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253712	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700030
J	Visser, O; Hautvast, JLA; van der Velden, K; Hulscher, MEJL				Visser, Olga; Hautvast, Jeannine L. A.; van der Velden, Koos; Hulscher, Marlies E. J. L.			Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants	PLOS ONE			English	Article							HEALTH-CARE WORKERS; INCREASE INFLUENZA VACCINATION; CHILDHOOD VACCINATION; BOOSTER VACCINE; PREGNANT-WOMEN; DISEASE BURDEN; UNITED STATES; LOW RATES; ATTITUDES; IMMUNIZATION	Context Several countries have reported a resurgence of pertussis in the last decades. This puts infants (especially <6 months) at risk of severe complications, because they are too young to be fully protected by vaccination. The global pertussis initiative has proposed pertussis vaccination of young infants' close contacts, in order to reduce pertussis transmission and the burden of the disease on infants. Our aim is to explore the perceived determinants (barriers and facilitators) of intention to accept vaccination among the possible target groups of pertussis vaccination for cocooning. Consideration of these determinants is necessary to optimise the uptake of the vaccination. Methods We conducted 13 focus groups and six individual semi-structured interviews with members of possible target groups for pertussis cocooning (i.e. parents, maternity assistants, midwives, and paediatric nurses) in the Netherlands. Here, both maternal pertussis vaccination as well as pertussis cocooning has not been implemented. The topic list was based on a literature review and a barrier framework. All interviews were transcribed verbatim and two researchers performed thematic content analysis. Findings The participants' risk perception, outcome expectations, general vaccination beliefs, moral norms, opinion of others, perceived autonomy, anticipated regret, decisional uncertainty, and perceived organisational barriers were all factors that influenced the intention to accept pertussis vaccination for cocooning. Discussion This study has identified nine perceived determinants that influence the intention to accept pertussis cocooning vaccination. We add the following determinants to the literature: perceived cost-effectiveness (as a concept of outcome expectations), justice (as a concept of moral norms), anticipated regret, and decisional uncertainty. We recommend considering these determinants in vaccination programmes for pertussis cocooning vaccination. Experience, information and trust emerged as predominant themes within these determinants. These themes require particular attention in future research on vaccination acceptance, especially with regard to their role in use and implementation in policy and practice.	[Visser, Olga; Hautvast, Jeannine L. A.; van der Velden, Koos] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Hulscher, Marlies E. J. L.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Visser, O (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	olga.visser@radboudumc.nl	Hautvast, J.L.A./L-4352-2015; Hulscher, Marlies/B-1229-2014; Visser, Olga/G-5077-2016; van der Velden, J./H-8101-2014	Hulscher, Marlies/0000-0002-2160-4810; Visser, Olga/0000-0003-1228-2108; 	Dutch Organisation for Health Research and Development (ZonMw) [204000023]	Dutch Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Dutch Organisation for Health Research and Development (ZonMw) funded the research project that led to this article (project number: 204000023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2013, ARCH DIS CHILD, V98, P552, DOI 10.1136/archdischild-2012-302968; Baron-Epel O, 2012, VACCINE, V30, P3151, DOI 10.1016/j.vaccine.2012.02.074; Baron-Epel O, 2013, HUM VACC IMMUNOTHER, V9, P100, DOI 10.4161/hv.22503; Beck Ulrich, 1992, RISK SOCIETY TOWARDS; Beel ER, 2014, VACCINE, V32, P2540, DOI 10.1016/j.vaccine.2014.03.056; Beel ER, 2013, HUM VACC IMMUNOTHER, V9, P1926, DOI 10.4161/hv.25096; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Blume S, 2006, SOC SCI MED, V62, P628, DOI 10.1016/j.socscimed.2005.06.020; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Burns DL, 2014, J INFECT DIS, V209, pS32, DOI 10.1093/infdis/jit491; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Cheng PJ, 2010, VACCINE, V28, P5641, DOI 10.1016/j.vaccine.2010.05.078; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Clarke M, 2015, VACCINE, V33, P7337, DOI 10.1016/j.vaccine.2015.10.068; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Aguilar-Diaz FD, 2011, ARCH MED RES, V42, P652, DOI 10.1016/j.arcmed.2011.12.006; Dempsey AF, 2015, HUM VACC IMMUNOTHER, P1; Donnan EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-676; Dube E, 2012, HEALTH EDUC RES, V27, P1069, DOI 10.1093/her/cys088; Forsyth KD, 2007, VACCINE, V25, P2634, DOI 10.1016/j.vaccine.2006.12.017; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Goins WP, 2007, INFECT CONT HOSP EP, V28, P1284, DOI 10.1086/521654; Gowda C, 2013, HUM VACC IMMUNOTHER, V9, P1755, DOI 10.4161/hv.25085; Greenberg David P, 2005, Pediatr Infect Dis J, V24, pS39, DOI 10.1097/01.inf.0000160911.65632.e1; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2013, IMPROVING PATIENT CARE: THE IMPLEMENTATION OF CHANGE IN HEALTH CARE, 2ND EDITION, pXIII; Hak E, 2005, VACCINE, V23, P3103, DOI 10.1016/j.vaccine.2005.01.074; Hakim H, 2011, VACCINE, V29, P5963, DOI 10.1016/j.vaccine.2011.06.041; Harmsen IA, 2014, MODEL PARENTS INTENT; Hayles EH, 2016, AUST NZ J OBSTET GYN; Hayles EH, 2015, VACCINE, V33, P228, DOI 10.1016/j.vaccine.2014.10.074; Healy CM, 2011, CLIN INFECT DIS, V52, P157, DOI 10.1093/cid/ciq001; Heininger U, 2014, PEDIATR INFECT DIS J, V33, P147, DOI 10.1097/01.inf.0000435503.44620.74; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Hollmeyer H, 2013, INFLUENZA OTHER RESP, V7, P604, DOI 10.1111/irv.12002; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lagoe C, 2015, PSYCHOL HEALTH MED, V20, P18, DOI 10.1080/13548506.2014.911923; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Leboucher B, 2012, VACCINE, V30, P5472, DOI 10.1016/j.vaccine.2012.06.071; Leder S, 2015, PSYCHOL HEALTH, V30, P165, DOI 10.1080/08870446.2014.954574; Lehmann BA, 2015, J HOSP INFECT, V89, P202, DOI 10.1016/j.jhin.2014.11.009; Lehmann BA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-407; Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009; Looijmans-van den Akker I, 2009, VACCINE, V27, P4724, DOI 10.1016/j.vaccine.2009.05.013; Lu PJ, 2014, VACCINE, V32, P572, DOI 10.1016/j.vaccine.2013.11.077; MacDougall DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009062; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Mercier H, 2011, BEHAV BRAIN SCI, V34, P57, DOI 10.1017/S0140525X10000968; Miller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058; Miller E, 2014, WHO SAGE PERTUSSIS W; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; O'Leary ST, 2015, PEDIATR INFECT DIS J, V34, P1244, DOI 10.1097/INF.0000000000000873; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; Peretti-Watel P, 2014, SOC SCI MED, V109, P10, DOI 10.1016/j.socscimed.2014.02.035; Poltorak M, 2005, SOC SCI MED, V61, P709, DOI 10.1016/j.socscimed.2004.12.014; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Suryadevara M, 2014, VACCINE, V32, P7000, DOI 10.1016/j.vaccine.2014.10.018; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Top KA, 2010, VACCINE, V28, P2169, DOI 10.1016/j.vaccine.2009.12.060; Tuckerman JL, 2015, HUM VACC IMMUNOTHER, V11, P704, DOI 10.1080/21645515.2015.1008886; Urwyler P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-397; Van der Maas N, 2014, KINKHOESTSURVEILLANC; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; Vasilevska M, 2014, INFECT CONT HOSP EP, V35, P699, DOI 10.1086/676427; Wicker S, 2008, EXPERT REV VACCINES, V7, P1325, DOI 10.1586/14760584.7.9.1325; Wiley KE, 2013, VACCINE, V31, P3972, DOI 10.1016/j.vaccine.2013.06.015; Williams WW, 2014, NONINFLUENZA VACCINA, P95; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Wong CY, 2015, HUM VACC IMMUNOTHER, V11, P1165, DOI 10.1080/21645515.2015.1019188; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	78	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155861	10.1371/journal.pone.0155861	http://dx.doi.org/10.1371/journal.pone.0155861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253386	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700008
J	Haraguchi, T; Miyoshi, H; Hiraoka, K; Yokoyama, S; Ishibashi, Y; Hashiguchi, T; Matsuda, K; Hamada, T; Okawa, T; Shiba, N; Ohshima, K				Haraguchi, Toshiaki; Miyoshi, Hiroaki; Hiraoka, Koji; Yokoyama, Shintaro; Ishibashi, Yukinao; Hashiguchi, Toshihiro; Matsuda, Koutaro; Hamada, Tetsuya; Okawa, Takahiro; Shiba, Naoto; Ohshima, Koichi			GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas	PLOS ONE			English	Article							LUMINAL CELL FATE; BREAST-CANCER; MAMMARY-GLAND; LUNG-CANCER; CYCLIN D1; DIFFERENTIATION; METASTASIS; SURVIVAL; SYSTEM; OVEREXPRESSION	Objective Recent studies have investigated the significance of GATA3 expression in patients with various malignant tumors. However, no previous studies have evaluated the clinicopathological importance of GATA3 expression in soft tissue sarcomas (STS) patients. Methods We evaluated GATA3 expression in 76 STS cases using immunohistochemical analysis, and statistically compared clinicopathological characteristics between GATA3-positive and GATA3-negative cases. Result GATA3-positive expression was significantly associated with a higher mitotic count (P < 0.0001). Disease-free survival (DFS) of GATA3-positive cases was significantly shorter than that of cases without GATA3 expression (P = 0.0104). Overall survival (OS) of GATA3-positive cases was significantly shorter than that of cases without GATA3 expression (P = 0.0006). GATA3-positive expression was significantly associated with shorter DFS in both univariate analysis (hazard ratio [HR], 2.719; P = 0.012) and multivariate analysis (HR, 2.711; P = 0.014). GATA3-positive expression was also significantly associated with worse OS in both univariate analysis (HR, 5.730; P = 0.0007) and multivariate analysis (HR, 5.789; P = 0.0008). Conclusion These results indicate that GATA3 is an independent prognostic factor and suggest that evaluation of GATA3 expression might enable more effective clinical follow-up using prognostic stratification of STS patients.	[Haraguchi, Toshiaki; Miyoshi, Hiroaki; Yokoyama, Shintaro; Ishibashi, Yukinao; Hashiguchi, Toshihiro; Matsuda, Koutaro; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Haraguchi, Toshiaki; Hiraoka, Koji; Ishibashi, Yukinao; Matsuda, Koutaro; Hamada, Tetsuya; Okawa, Takahiro; Shiba, Naoto] Kurume Univ, Sch Med, Dept Orthoped Surg, Kurume, Fukuoka 830, Japan; [Yokoyama, Shintaro; Hashiguchi, Toshihiro] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp	Yokoyama, Shintaro/HHC-8479-2022					Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Chen HR, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/643532; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Deyrup AT, 2006, HISTOPATHOLOGY, V48, P42, DOI 10.1111/j.1365-2559.2005.02288.x; Donati V, 2005, CLIN CANCER RES, V11, P6459, DOI 10.1158/1078-0432.CCR-05-0541; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ishibashi Y, 2015, ONCOL REP, V33, P1667, DOI 10.3892/or.2015.3806; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Keshari RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087195; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lahat G, 2008, ANN SURG ONCOL, V15, P2739, DOI 10.1245/s10434-008-9970-6; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Mariani L, 2005, CANCER-AM CANCER SOC, V103, P402, DOI 10.1002/cncr.20778; Miettinen M, 2014, AM J SURG PATHOL, V38, P13, DOI 10.1097/PAS.0b013e3182a0218f; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Peng HW, 2015, MOL MED REP, V11, P881, DOI 10.3892/mmr.2014.2809; Hernandez RAS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0873-z; SHIGA K, 1993, ANTICANCER RES, V13, P1293; Shim BY, 2010, CANCER RES TREAT, V42, P144, DOI 10.4143/crt.2010.42.3.144; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Tokito T, 2016, EUR J CANCER, V55, P7, DOI 10.1016/j.ejca.2015.11.020; Tominaga N, 2012, ANN ONCOL, V23, P3051, DOI 10.1093/annonc/mds120; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Wu YY, 2012, AM J CANCER RES, V2, P104; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	39	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156524	10.1371/journal.pone.0156524	http://dx.doi.org/10.1371/journal.pone.0156524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249072	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700049
J	Heydari, M; Othman, F; Taghieh, M				Heydari, Mohammad; Othman, Faridah; Taghieh, Mahmood			Optimization of Multiple and Multipurpose Reservoir System Operations by Using Matrix Structure (Case Study: Karun and Dez Reservoir Dams)	PLOS ONE			English	Article							GENETIC ALGORITHM; MODEL	Optimal operation of water resources in multiple and multipurpose reservoirs is very complicated. This is because of the number of dams, each dam's location (Series and parallel), conflict in objectives and the stochastic nature of the inflow of water in the system. In this paper, performance optimization of the system of Karun and Dez reservoir dams have been studied and investigated with the purposes of hydroelectric energy generation and providing water demand in 6 dams. On the Karun River, 5 dams have been built in the series arrangements, and the Dez dam has been built parallel to those 5 dams. One of the main achievements in this research is the implementation of the structure of production of hydroelectric energy as a function of matrix inMATLAB software. The results show that the role of objective function structure for generating hydroelectric energy in weighting method algorithm is more important than water supply. Nonetheless by implementing epsilon-constraintmethod algorithm, we can both increase hydroelectric power generation and supply around 85% of agricultural and industrial demands.	[Heydari, Mohammad; Othman, Faridah] Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia; [Taghieh, Mahmood] Amirkabir Univ, Fac Engn, Dept Ind Engn, Tehran, Iran	Universiti Malaya; Amirkabir University of Technology	Othman, F (corresponding author), Univ Malaya, Dept Civil Engn, Fac Engn, Kuala Lumpur, Malaysia.	faridahothman@um.edu.my	OTHMAN, FARIDAH/N-2491-2019; heydari, mohammad/K-8170-2013	OTHMAN, FARIDAH/0000-0002-4952-3676; heydari, mohammad/0000-0002-1251-1583	University Malaya Research Grant [FL026-2012D, FL001-13SUS]; Fundamental Research Grant by Ministry of Higher Education, Malaysia [FRGS: FP016-2014A]; Malaysian International Scholarship (MIS) by the Ministry of Education (MOE, Malaysia)	University Malaya Research Grant; Fundamental Research Grant by Ministry of Higher Education, Malaysia; Malaysian International Scholarship (MIS) by the Ministry of Education (MOE, Malaysia)	The authors would like to acknowledge the University Malaya Research Grant (FL026-2012D, FL001-13SUS), Fundamental Research Grant by Ministry of Higher Education, Malaysia (FRGS: FP016-2014A), and the Malaysian International Scholarship (MIS) by the Ministry of Education (MOE, Malaysia) for their financial support.	Afshar MH, 2009, ENG OPTIMIZ, V41, P275, DOI 10.1080/03052150802441273; Castelletti A, 2008, AUTOMATICA, V44, P1595, DOI 10.1016/j.automatica.2008.03.003; Cheng CT, 2008, WATER RESOUR MANAG, V22, P895, DOI 10.1007/s11269-007-9200-1; Elferchichi A, 2009, BIOSYST ENG, V102, P334, DOI 10.1016/j.biosystemseng.2008.12.009; Georgiou PE, 2008, IRRIGATION SCI, V26, P487, DOI 10.1007/s00271-008-0110-7; Heydari M, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/435752; Holmstrom K., 2003, P NORD MATLAB C; Kumar DN, 2007, J WATER RES PLAN MAN, V133, P192, DOI 10.1061/(ASCE)0733-9496(2007)133:3(192); Labadie JW, 2004, J WATER RES PLAN MAN, V130, P93, DOI 10.1061/(ASCE)0733-9496(2004)130:2(93); Li XA, 2010, J HYDROL, V391, P126, DOI 10.1016/j.jhydrol.2010.07.011; Madani K, 2011, ADV WATER RESOUR, V34, P174, DOI 10.1016/j.advwatres.2010.10.003; Moeini R, 2011, INT J ELEC POWER, V33, P171, DOI 10.1016/j.ijepes.2010.08.012; Mousavi SJ, 2004, WATER RESOUR MANAG, V18, P519, DOI 10.1007/s11269-004-1075-9; Sadegh M, 2010, WATER RESOUR MANAG, V24, P2291, DOI 10.1007/s11269-009-9552-9; Shiau JT, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008765; Toksari MD, 2008, INFORM SCIENCES, V178, P1189, DOI 10.1016/j.ins.2007.06.010; WURBS RA, 1993, J WATER RES PL-ASCE, V119, P455, DOI 10.1061/(ASCE)0733-9496(1993)119:4(455); YEH WWG, 1985, WATER RESOUR RES, V21, P1797, DOI 10.1029/WR021i012p01797; Yin XA, 2011, ECOL MODEL, V222, P224, DOI 10.1016/j.ecolmodel.2010.06.025	19	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156276	10.1371/journal.pone.0156276	http://dx.doi.org/10.1371/journal.pone.0156276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248152	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700034
J	Lin, Q; Qian, J; Zhao, CN; Wang, DL; Liu, CR; Wang, ZD; Sun, CD; Chen, KS				Lin, Qiong; Qian, Jing; Zhao, Chenning; Wang, Dengliang; Liu, Chunrong; Wang, Zhidong; Sun, Chongde; Chen, Kunsong			Low Temperature Induced Changes in Citrate Metabolism in Ponkan (Citrus reticulata Blanco cv. Ponkan) Fruit during Maturation	PLOS ONE			English	Article							ORGANIC-ACIDS; DEFICIT IRRIGATION; GENE-EXPRESSION; WATER-STRESS; SUGARS; GROWTH; QUALITY; ACCUMULATION; SECRETION; MECHANISM	Citrate is the most important organic acid in citrus fruit, and its concentration in fruit cells is regulated mainly by the balance between synthesis and degradation. Ponkan (Citrus reticulate Blanco cv. Ponkan) is one of the major citrus cultivars grew in China, and the fruit are picked before fully mature to avoid bad weather. Greenhouse production is widely used to prolong the maturation period and improve the quality of Ponkan fruit by maintaining adequate temperature and providing protection from adverse weather. In this research, Ponkan fruit cultivated in either a greenhouse or open field were used to investigate differences in the expression of genes related to citrate metabolism during maturation in the two environments. The citrate contents were higher in open field fruit, and were mainly correlated with expressions of CitPEPCs, CitCSs, CitAco3 and CitGAD4, which were significantly increased. In addition, the impacts of low temperature (LT) and water stress (WS) on citrate metabolism in Ponkan were investigated during fruit maturation. The citrate contents in LT fruit were significantly increased, by between 1.4-1.9 fold, compared to the control; it showed no significant difference in fruit with water stress treatment compared to the control fruit. Furthermore, the expressions of CitPEPCs, CitCSs, CitAco3 and CitGAD4 were significantly increased in response to LT treatment, but showed no significant difference in WS compared to the control fruit. Thus, it can be concluded that low temperature may be the main factor influencing citrate metabolism during maturation in Ponkan fruit.	[Lin, Qiong; Qian, Jing; Zhao, Chenning; Sun, Chongde; Chen, Kunsong] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Lab Fruit Qual Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Qiong; Wang, Zhidong] Chinese Acad Agr Sci, Inst Food Sci & Technol, Key Opening Lab Agr Prod Proc & Qual Control, Minist Agr, Beijing 100193, Peoples R China; [Wang, Dengliang; Liu, Chunrong] Quzhou Acad Agr Sci, Quzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Ministry of Agriculture & Rural Affairs	Sun, CD (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Lab Fruit Qual Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	adesun2006@zju.edu.cn			Program of International Science and Technology Cooperation [2011DFB31580]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD38B03]; Project of the Science and Technology Department of Zhejiang Province [2013C02019-1]	Program of International Science and Technology Cooperation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Project of the Science and Technology Department of Zhejiang Province	This research was supported by Program of International Science and Technology Cooperation (2011DFB31580), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03) and the Project of the Science and Technology Department of Zhejiang Province (2013C02019-1).; We thank Prof. Donald Grierson from the University of Nottingham (UK) for his efforts in editing language of the whole paper. This research was supported by Program of International Science and Technology Cooperation (2011DFB31580), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03) and the Project of the Science and Technology Department of Zhejiang Province (2013C02019-1).	ANDERSEN PC, 1995, J AM SOC HORTIC SCI, V120, P36, DOI 10.21273/JASHS.120.1.36; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Bugaud C, 2009, FRUITS, V64, P63, DOI 10.1051/fruits/2009001; Carrari F, 2003, PLANT PHYSIOL, V133, P1322, DOI 10.1104/pp.103.026716; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chen M, 2013, PLANT MOL BIOL REP, V31, P1131, DOI 10.1007/s11105-013-0583-2; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Deng W, 2009, PLANTA, V230, P355, DOI 10.1007/s00425-009-0945-z; des Gachons CP, 2005, J SCI FOOD AGR, V85, P73, DOI 10.1002/jsfa.1919; Ferreyra MLF, 2006, PHYSIOL PLANTARUM, V128, P224, DOI 10.1111/j.1399-3054.2006.00744.x; [龚荣高 GONG Ronggao], 2006, [四川农业大学学报, Journal of Sichuan Agricultural University], V24, P402; Gong RongGao, 2006, Journal of Fruit Science, V23, P805; Gonzalez-Altozano P, 2000, J HORTIC SCI BIOTECH, V75, P388, DOI 10.1080/14620316.2000.11511256; Gonzalez-Altozano P, 1999, J HORTIC SCI BIOTECH; Han DG, 2012, BIOL PLANTARUM, V56, P50, DOI 10.1007/s10535-012-0015-4; Hardy N.W., 2012, PLANT METABOLOMICS M; HARDY PJ, 1968, PLANT PHYSIOL, V43, P224, DOI 10.1104/pp.43.2.224; Hudina M, 2000, PHYTON-ANN REI BOT A, V40, P91; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Kallsen CE, 2011, HORTSCIENCE, V46, P1163, DOI 10.21273/HORTSCI.46.8.1163; Lechaudel M, 2005, J SCI FOOD AGR, V85, P251, DOI 10.1002/jsfa.1968; Li XF, 2000, PLANT PHYSIOL, V123, P1537, DOI 10.1104/pp.123.4.1537; Lin Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119410; Lin Q, 2015, GENE, V554, P64, DOI 10.1016/j.gene.2014.10.025; Lobit P, 2003, J EXP BOT, V54, P2489, DOI 10.1093/jxb/erg264; Morgan MJ, 2013, PLANT PHYSIOL, V161, P397, DOI 10.1104/pp.112.209619; Osorio S, 2012, PLANT METABOLOMICS; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; RUFFNER HP, 1982, VITIS, V21, P247; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Thakur A, 2012, SCI HORTIC-AMSTERDAM, V135, P112, DOI 10.1016/j.scienta.2011.12.013; TIMPA JD, 1986, PLANT PHYSIOL, V82, P724, DOI 10.1104/pp.82.3.724; Wu BH, 2007, J EXP BOT, V58, P2583, DOI 10.1093/jxb/erm126; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yun Z, 2012, J EXP BOT, V63, P2873, DOI 10.1093/jxb/err390; Zhao ZQ, 2003, PLANTA, V217, P794, DOI 10.1007/s00425-003-1043-2; Zhou JY, 2010, SCI HORTIC-AMSTERDAM, V126, P229, DOI 10.1016/j.scienta.2010.07.019	39	32	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156703	10.1371/journal.pone.0156703	http://dx.doi.org/10.1371/journal.pone.0156703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249065	gold, Green Published, Green Submitted			2022-12-27	WOS:000377184700070
J	Boerema, A; Peeters, A; Swolfs, S; Vandevenne, F; Jacobs, S; Staes, J; Meire, P				Boerema, Annelies; Peeters, Alain; Swolfs, Sanne; Vandevenne, Floor; Jacobs, Sander; Staes, Jan; Meire, Patrick			Soybean Trade: Balancing Environmental and Socio-Economic Impacts of an Intercontinental Market	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LAND-USE; FOOD SECURITY; AMAZON; EXTERNALITIES; FORESTS; CONSERVATION; FRONTIER; BRAZIL; POLICY	The trade in soybean, an important animal feed product, exemplifies the environmental and socio-economic impact of global markets and global agricultural policy. This paper analyses the impact of increasing production of soybean in the exporting countries (deforestation and grassland conversion) as well as in importing regions (decrease in permanent grassland by substitution of grass as feed). Ecosystem services monetary values were used to calculate the environmental and socio-economic impact of observed land use changes. This is balanced against the economic value of the global soybean trade. The results prove that consumption choices in one region have real effects on the supply of ecosystem services at a large spatial scale. Conclusively, solutions to make this global market more sustainable are discussed.	[Boerema, Annelies; Swolfs, Sanne; Vandevenne, Floor; Jacobs, Sander; Staes, Jan; Meire, Patrick] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium; [Peeters, Alain] RHEA Res Ctr, Brussels, Belgium; [Jacobs, Sander] Res Inst Nat & Forest INBO, Res Grp Nat & Soc, Brussels, Belgium; [Jacobs, Sander] Belgian Biodivers Platform BBPF, Brussels, Belgium	University of Antwerp; Research Institute for Nature & Forest	Boerema, A (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium.	annelies.boerema@uantwerpen.be	Boerema, Annelies/A-7565-2018; Boerema, Annelies/N-4660-2019	Boerema, Annelies/0000-0001-5094-733X; Boerema, Annelies/0000-0001-5094-733X; Jacobs, Sander/0000-0003-4674-4817				[Anonymous], ENV IND REP 2014 ENV; Bithas K, 2011, ECOL ECON, V70, P1703, DOI 10.1016/j.ecolecon.2011.05.014; Chomitz KM, 2001, 2687 WORLD BANK, P1; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; Dalgaard R, 2008, INT J LIFE CYCLE ASS, V13, P240, DOI 10.1065/lca2007.06.342; Dauvergne P, 2010, J PEASANT STUD, V37, P631, DOI 10.1080/03066150.2010.512451; Dros JM, 2004, MANAGING SOY BOOM 2, P1; EC, 2014, EUR STAT; EEA, 2015, EUR ENV STAT OUTL 20; FAO, 2014, SAT FOOD AGR ORG UN; Farley J, 2012, ECOSYST SERV, V1, P40, DOI 10.1016/j.ecoser.2012.07.002; Fearnside PM, 1999, ENVIRON CONSERV, V26, P305, DOI 10.1017/S0376892999000429; FEFAC (Federation Europeenne des Fabricants D'aliments Composes pour Animaux), 2009, FEED FOOD STAT YB 20; Garrett RD, 2013, LAND USE POLICY, V31, P385, DOI 10.1016/j.landusepol.2012.08.002; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grote U, 2005, ENVIRON SCI POLICY, V8, P439, DOI 10.1016/j.envsci.2005.05.001; Hecht SB, 2005, DEV CHANGE, V36, P375, DOI 10.1111/j.0012-155X.2005.00415.x; Jacobs S., 2014, ECOSYSTEM SERVICES G, DOI [10.1016/B978-0-12-419964-4.02002-3, DOI 10.1016/B978-0-12-419964-4.02002-3]; Klemick H, 2011, J ENVIRON ECON MANAG, V61, P95, DOI 10.1016/j.jeem.2010.07.003; Lv Y, 2010, ECOL ECON, V69, P1436, DOI 10.1016/j.ecolecon.2008.12.014; Macedo MN, 2012, P NATL ACAD SCI; Muller C, 2003, SERIE TEXTOS DISCUSS, V308; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Olsen N, 2009, FINANCIAL COSTS REDD, P1; Peeters A, 2012, GRASSLAND SCI EUR, V17, P17; Peeters A., 2013, ECOSYSTEM SERVICES G, P191, DOI [10.1016/B978-0-12-419964-4.00017-2, DOI 10.1016/B978-0-12-419964-4.00017-2]; Pengue WA, 2005, TRANSGENIC CROPS ARG; Pengue WA, 2004, ENV SOCIOECONOMIC IM; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Schilling M, 2011, ENERG POLICY, V39, P990, DOI 10.1016/j.enpol.2010.11.030; Schmitz C, 2012, GLOBAL ENVIRON CHANG, V22, P189, DOI 10.1016/j.gloenvcha.2011.09.013; Schnepf R.D, 2001, WRS013 USDA MARK TRA; Smaling EMA, 2008, AGR ECOSYST ENVIRON, V128, P185, DOI 10.1016/j.agee.2008.06.005; Steward C, 2007, AGR HUM VALUES, V24, P107, DOI 10.1007/s10460-006-9030-4; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; VERADIAZ M, 2005, TROPICAL DEFORESTATI; Viglizzo EF, 2006, ECOL ECON, V57, P140, DOI 10.1016/j.ecolecon.2005.03.025; Von Witzke H, 2009, EU AGR PRODUCTION TR; Westerdahl H, 2012, P ROY SOC B-BIOL SCI, V279, P577, DOI 10.1098/rspb.2011.0917; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Yu Y, 2013, GLOBAL ENVIRON CHANG, V23, P1178, DOI 10.1016/j.gloenvcha.2013.04.006	43	73	74	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155222	10.1371/journal.pone.0155222	http://dx.doi.org/10.1371/journal.pone.0155222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27244079	gold, Green Submitted, Green Published			2022-12-27	WOS:000377146100003
J	Dynowski, JF; Nebelsick, JH; Klein, A; Roth-Nebelsick, A				Dynowski, Janina F.; Nebelsick, James H.; Klein, Adrian; Roth-Nebelsick, Anita			Computational Fluid Dynamics Analysis of the Fossil Crinoid Encrinus liliiformis (Echinodermata: Crinoidea)	PLOS ONE			English	Article							PARTICLE CAPTURE; PREY CAPTURE; SUSPENSION; FOOD; FLOW; MECHANISMS; PALEOECOLOGY; OCTOCORAL; VELOCITY; FEEDERS	Crinoids, members of the phylum Echinodermata, are passive suspension feeders and catch plankton without producing an active feeding current. Today, the stalked forms are known only from deep water habitats, where flow conditions are rather constant and feeding velocities relatively low. For feeding, they form a characteristic parabolic filtration fan with their arms recurved backwards into the current. The fossil record, in contrast, provides a large number of stalked crinoids that lived in shallow water settings, with more rapidly changing flow velocities and directions compared to the deep sea habitat of extant crinoids. In addition, some of the fossil representatives were possibly not as flexible as today's crinoids and for those forms alternative feeding positions were assumed. One of these fossil crinoids is Encrinus liliiformis, which lived during the middle Triassic Muschelkalk in Central Europe. The presented project investigates different feeding postures using Computational Fluid Dynamics to analyze flow patterns forming around the crown of E. liliiformis, including experimental validation by Particle Image Velocimetry. The study comprises the analysis of different flow directions, velocities, as well as crown orientations. Results show that inflow from lateral and oral leads to direct transport of plankton particles into the crown and onto the oral surface. With current coming from the "rear" (aboral) side of the crinoid, the conical opening of the crown produces a backward oriented flow in its wake that transports particles into the crown. The results suggest that a conical feeding position may have been less dependent on stable flow conditions compared to the parabolic filtration fan. It is thus assumed that the conical feeding posture of E. liliiformis was suitable for feeding under dynamically changing flow conditions typical for the shallow marine setting of the Upper Muschelkalk.	[Dynowski, Janina F.; Roth-Nebelsick, Anita] Staatliches Museum Nat Kunde, Stuttgart, Germany; [Dynowski, Janina F.; Nebelsick, James H.] Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany; [Klein, Adrian] Univ Bonn, Inst Zool, Bonn, Germany	Eberhard Karls University of Tubingen; University of Bonn	Nebelsick, JH (corresponding author), Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany.	nebelsick@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [NE 537/24-1, RO 3250/20-1]; Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung); Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg); bwUniCluster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung); Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg); bwUniCluster	This work was supported by Deutsche Forschungsgemeinschaft, grant number NE 537/24-1 (to JHN) and grant number RO 3250/20-1 (to ARN) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the bwGRiD project (http://www.bw-grid.de) member of the German D-Grid initiative, funded by the Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung) and the Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg), and bwUniCluster (http://www.bwhpc-c5.de) for computational resources, and Dr. Marek Dynowski for helpful advices in HPC. We also thank Prof. Dr. Bleckmann for providing access to the PIV facilities, the technical staff of the SMNS for support in resin model creation, and Jan-Peter Friedrich for critical discussions. David L. Meyer, Michael LaBarbera and two anonymous reviewers is thanked for their thorough reviews and helpful advices for improving this manuscript.	AIGNER T, 1992, SEDIMENT GEOL, V80, P115, DOI 10.1016/0037-0738(92)90035-P; Aigner T., 1985, LECT NOTES EARTH SCI, V3; [Anonymous], 2011, AERODYNAMIK STUMPFEN; AUSICH WI, 1986, PALAEONTOLOGY, V29, P85; Ausich William I., 1999, P3, DOI 10.1017/CBO9780511626159.003; BAUMILLER TK, 1991, B MAR SCI, V48, P731; BAUMILLER TK, 1992, J PALEONTOL, V66, P658, DOI 10.1017/S0022336000024501; BAUMILLER TK, 1989, LETHAIA, V22, P317, DOI 10.1111/j.1502-3931.1989.tb01348.x; Baumiller TK, 1987, ECH BIOL P 6 INT ECH, V1988, P786; Baumiller TK, 2008, ANNU REV EARTH PL SC, V36, P221, DOI [10.1146/annurev.earth.36.031207.124116, 10.1146/annurev.earth36.031207.124116]; Baumiller TK, 2007, PALAEONTOL ELECTRON, V10; Baumiller Tomasz K., 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V190, P279; Baumiller Tomasz K., 1997, Paleontological Society Papers, V3, P45; BEST BA, 1988, BIOL BULL-US, V175, P332, DOI 10.2307/1541723; Birenheide R, 1996, BIOL BULL, V191, P1, DOI 10.2307/1543055; Bohaty J, 2011, ACTA PALAEONTOL POL, V56, P615, DOI 10.4202/app.2010.0020; Breimer A., 1978, TREATISE INVERTEBR T, V1, P9; Brower JC, 2007, J PALEONTOL, V81, P1284, DOI 10.1666/05-034.1; Brower JC, 2011, J PALEONTOL, V85, P369, DOI 10.1666/10-066.1; CONAN G, 1981, DEEP-SEA RES, V28, P441, DOI 10.1016/0198-0149(81)90136-9; Donovan SK, 2008, ZOOTAXA, P31; Dynowski Janina F., 2011, Swiss Journal of Palaeontology, V130, P53, DOI 10.1007/s13358-010-0007-y; Dynowski JF, 2015, THESIS EBERHARD KARL; Featherstone Charles M., 1998, P155; Feist-Burkhardt S., 2008, GEOLOGY CENTRAL EURO, P749, DOI DOI 10.1144/CEV2P.1; Geyer OF., 2011, GEOLOGIE BADEN WURTT, V5; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; GRIMMER JC, 1990, ACTA ZOOL-STOCKHOLM, V71, P61, DOI 10.1111/j.1463-6395.1990.tb01070.x; Hagdorn H, 1991, MUSCHELKALK FIELD GU, P7; Hagdorn Hans, 1999, P164, DOI 10.1017/CBO9780511626159.023; HAUGH BN, 1978, LETHAIA, V11, P145, DOI 10.1111/j.1502-3931.1978.tb01300.x; HEINZELLER T, 1995, ACTA ZOOL-STOCKHOLM, V76, P25, DOI 10.1111/j.1463-6395.1995.tb00979.x; Heinzeller Thomas, 1994, P9; Hess H., 2011, TREATISE INVERTEBRAT, V3, P28; HOLLAND ND, 1987, BIOL BULL, V173, P552, DOI 10.2307/1541700; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; JEFFERIES RPS, 1989, PALAEONTOLOGY, V32, P483; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; Kitazawa K, 2007, MAR BIOL, V152, P959, DOI 10.1007/s00227-007-0746-5; Kitazawa K, 2010, J EXP MAR BIOL ECOL, V395, P80, DOI 10.1016/j.jembe.2010.08.018; LABARBERA M, 1984, AM ZOOL, V24, P71; LASKER HR, 1981, MAR ECOL PROG SER, V5, P61, DOI 10.3354/meps005061; LATOUCHE RW, 1980, MAR BIOL, V60, P39, DOI 10.1007/BF00395604; LAWRENCE JM, 1987, ACQUISITION NUTR FUN, P17; LEONARD AB, 1989, J EXP MAR BIOL ECOL, V127, P81, DOI 10.1016/0022-0981(89)90210-4; Linck O, 1954, AUS DER HEIMAT, V62, P225; Linck O, 1965, JAHRESHEFTE GEOLOGIS, V7, P123; MACURDA DB, 1974, NATURE, V247, P394, DOI 10.1038/247394a0; Messing C.G., 1985, Echinoderms, V1984, P185; Messing Charles G., 1997, Paleontological Society Papers, V3, P3; Meyer D.L., 1982, P25; MEYER DL, 1979, MAR BIOL, V51, P361, DOI 10.1007/BF00389214; MEYER DL, 1973, MAR BIOL, V22, P105, DOI 10.1007/BF00391776; Moore RC, 1978, TREATISE INVERTEBRAT, pT7; PATTERSON MR, 1991, BIOL BULL-US, V180, P93, DOI 10.2307/1542432; PATTERSON MR, 1984, BIOL BULL-US, V167, P613, DOI 10.2307/1541414; Pawson DL, 2007, ZOOTAXA, P749, DOI 10.11646/zootaxa.1668.1.31; Riisgard HU, 2010, MAR ECOL PROG SER, V418, P255, DOI 10.3354/meps08755; Roux M., 1987, Echinoderm Studies, V2, P1; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; SILVESTER NR, 1983, J THEOR BIOL, V103, P265, DOI 10.1016/0022-5193(83)90028-0; TRAGER G, 1993, BIOL BULL-US, V185, P20, DOI 10.2307/1542127; TRAGER GC, 1990, MAR BIOL, V105, P117, DOI 10.1007/BF01344277; VANIERLAND ET, 1984, J PLANKTON RES, V6, P29, DOI 10.1093/plankt/6.1.29; Vogel S, 2020, LIFE MOVING FLUIDS P; Vollrath A., 1957, JAHRESHEFTE GEOLOGIS, V2, P119; WELCH JR, 1978, PALEOBIOLOGY, V4, P89, DOI 10.1017/S0094837300005728; Wildish D., 1997, BENTHIC SUSPENSION F; Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61; Wisshak M, 2009, PALAEOGEOGR PALAEOCL, V271, P77, DOI 10.1016/j.palaeo.2008.09.015; [No title captured]	72	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156408	10.1371/journal.pone.0156408	http://dx.doi.org/10.1371/journal.pone.0156408			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243221	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100037
J	Fransen, HP; Peeters, PHM; Beulens, JWJ; Boer, JMA; de Wit, GA; Onland-Moret, NC; van der Schouw, YT; Bueno-de-Mesquita, HB; Hoekstra, J; Elias, SG; May, AM				Fransen, Heidi P.; Peeters, Petra H. M.; Beulens, Joline W. J.; Boer, Jolanda M. A.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer; Elias, Sjoerd G.; May, Anne M.			Exposure to Famine at a Young Age and Unhealthy Lifestyle Behavior Later in Life	PLOS ONE			English	Article							1944-1945 DUTCH FAMINE; FOOD FREQUENCY QUESTIONNAIRE; EPIC-NL COHORT; BREAST-CANCER; MEDITERRANEAN DIET; RELATIVE VALIDITY; RISK; CONSEQUENCES; CHILDHOOD; DISEASES	Background A healthy diet is important for normal growth and development. Exposure to undernutrition during important developmental periods such as childhood and adolescence can have effects later in life. Inhabitants of the west of the Netherlands were exposed to severe undernutrition during the famine in the last winter of the second World War (1944-1945). Objective We investigated if exposure of women to the Dutch famine during childhood and adolescence was associated with an unhealthy lifestyle later in life. Design We studied 7,525 women from the Prospect-EPIC cohort, recruited in 1993-97 and aged 0-18 years during the Dutch famine. An individual famine score was calculated based on self-reported information about experience of hunger and weight loss. We investigated the association between famine exposure in early life and four lifestyle factors in adulthood: smoking, alcohol consumption, physical activity level and a Mediterranean-style diet. Results Of the 7,525 included women, 46% were unexposed, 38% moderately exposed and 16% severely exposed to the Dutch famine. Moderately and severely exposed women were more often former or current smokers compared to women that did not suffer from the famine: adjusted prevalence ratio 1.10 (95% CI: 1.05; 1.14) and 1.18 (1.12; 1.25), respectively. They also smoked more pack years than unexposed women. Severely exposed women were more often physically inactive than unexposed women, adjusted prevalence ratio 1.32 (1.06; 1.64). Results did not differ between exposure age categories (0-9 and 10-17 years). We found no associations of famine exposure with alcohol consumption and no dose-dependent relations with diet. Conclusions Exposure to famine early in female life may be associated with higher prevalence of smoking and physical inactivity later in life, but not with unhealthy diet and alcohol consumption.	[Fransen, Heidi P.; Peeters, Petra H. M.; Beulens, Joline W. J.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Elias, Sjoerd G.; May, Anne M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Fransen, Heidi P.; Boer, Jolanda M. A.; de Wit, G. Ardine; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Peeters, Petra H. M.; Bueno-de-Mesquita, H. Bas] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Imperial College London; Utrecht University; Utrecht University Medical Center; Universiti Malaya	May, AM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	A.M.May@umcutrecht.nl	Elias, Sjoerd G/E-6057-2011; Onland-Moret, N. Charlotte/G-9185-2011; van der Schouw, Yvonne T./F-8327-2014; May, Anne M/G-9183-2011	Elias, Sjoerd G/0000-0003-3903-4024; Onland-Moret, N. Charlotte/0000-0002-2360-913X; van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937; de Wit, G. Ardine/0000-0002-1375-7657; , jeljer/0000-0001-8252-8906	Dutch research council (NWO-ZonMW) [40-00812-98-10040]	Dutch research council (NWO-ZonMW)	This study was supported by a grant of the Dutch research council (NWO-ZonMW; grant no 40-00812-98-10040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampaabeng SK, 2013, J HEALTH ECON, V32, P1013, DOI 10.1016/j.jhealeco.2013.08.001; [Anonymous], 1944, MALNUTRITION STARV 2; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Burger G, 1948, MALNUTRITION STARV 1; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2004, INT J CANCER, V108, P628, DOI 10.1002/ijc.11584; Elias SG, 2005, CANCER EPIDEM BIOMAR, V14, P1981, DOI 10.1158/1055-9965.EPI-04-0839; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Fracheboud J, 1998, INT J CANCER, V75, P694, DOI 10.1002/(SICI)1097-0215(19980302)75:5<694::AID-IJC6>3.0.CO;2-U; Fransen HP, 2015, PREV MED, V77, P119, DOI 10.1016/j.ypmed.2015.05.014; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Kesternich IS B, 2013, WR1015 RAND LAB POP; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Solis CB, 2015, P NATL ACAD SCI USA, V112, pE738, DOI 10.1073/pnas.1417325112; Struijk EA, 2015, EUR J PUBLIC HEALTH, V25, P144, DOI 10.1093/eurpub/cku045; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; van Abeelen AFM, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/936509; van Abeelen AFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082636; van Abeelen AFM, 2012, DIABETES, V61, P2255, DOI 10.2337/db11-1559; van Abeelen AFM, 2012, EUR HEART J, V33, P538, DOI 10.1093/eurheartj/ehr228; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156609	10.1371/journal.pone.0156609	http://dx.doi.org/10.1371/journal.pone.0156609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244088	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100054
J	Singhal, V; Maffazioli, GD; Ackerman, KE; Lee, H; Elia, EF; Woolley, R; Kolodny, G; Cypess, AM; Misra, M				Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Lee, Hang; Elia, Elisa F.; Woolley, Ryan; Kolodny, Gerald; Cypess, Aaron M.; Misra, Madhusmita			Effect of Chronic Athletic Activity on Brown Fat in Young Women	PLOS ONE			English	Article							ADIPOSE-TISSUE ACTIVITY; BODY-MASS INDEX; SECRETORY DYNAMICS; ENERGY-EXPENDITURE; ANOREXIA-NERVOSA; COLD; HUMANS; LEPTIN; WHITE; THERMOGENESIS	Background The effect of chronic exercise activity on brown adipose tissue (BAT) is not clear, with some studies showing positive and others showing negative associations. Chronic exercise is associated with increased resting energy expenditure (REE) secondary to increased lean mass and a probable increase in BAT. Many athletes are in a state of relative energy deficit suggested by lower fat mass and hypothalamic amenorrhea. States of severe energy deficit such as anorexia nervosa are associated with reduced BAT. There are no data regarding the impact of chronic exercise activity on BAT volume or activity in young women and it is unclear whether relative energy deficiency modifies the effects of exercise on BAT. Purpose We assessed cold induced BAT volume and activity in young female athletes compared with non-athletes, and further evaluated associations of BAT with measures of REE, body composition and menstrual status. Methods The protocol was approved by our Institutional Review Board. Written informed consent was obtained from all participants prior to study initiation. This was a cross-sectional study of 24 women (16 athletes and8 non-athletes) between 18-25 years of age. Athletes were either oligo-amenorrheic (n = 8) or eumenorrheic (n = 8). We used PET/CT scans to determine cold induced BAT activity, VMAX Encore 29 metabolic cart to obtain measures of REE, and DXA for body composition. Results Athletes and non-athletes did not differ for age or BMI. Compared with non-athletes, athletes had lower percent body fat (p = 0.002), higher percent leanmass (p = 0.01) and trended higher in REE (p = 0.09). BAT volume and activity in athletes trended lower than in non-athletes (p = 0.06; p = 0.07, respectively). We found negative associations of BAT activity with duration of amenorrhea (r = -0.46, p = 0.02). BAT volume correlated inversely with leanmass (r = -0.46, p = 0.02), and positively with percent body fat, irisin and thyroid hormones. Conclusions Our study shows a trend for lower BAT in young female athletes compared with non-athletes, and shows associations of brown fat with menstrual status and body composition. Brown fat may undergo adaptive reductions with increasing energy deficit.	[Singhal, Vibha; Misra, Madhusmita] Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA; [Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Lee, Hang; Elia, Elisa F.; Woolley, Ryan; Kolodny, Gerald; Misra, Madhusmita] Harvard Univ, Sch Med, Boston, MA USA; [Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Woolley, Ryan; Misra, Madhusmita] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Ackerman, Kate E.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Elia, Elisa F.; Kolodny, Gerald] Beth Israel Deaconess Med Ctr, Dept Radiol, Div Nucl Med & Mol Imaging, 330 Brookline Ave, Boston, MA 02215 USA; [Cypess, Aaron M.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Singhal, V (corresponding author), Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA.; Singhal, V (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Singhal, V (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.	vsinghal1@partners.org	Singhal, Vibha/AAN-1432-2021; Misra, Madhusmita/X-8807-2018; Singhal, Vibha/AAP-3792-2020; Zamora, Cristina Cuesta/E-2864-2016	Misra, Madhusmita/0000-0002-9405-2981; Zamora, Cristina Cuesta/0000-0003-1121-9561	National Institutes of Health [1 UL1 RR025758-01, 1UL1TR001102-01, 1 R01 HD 060827-01A1, K24 HD071843]; Fundacion Alfonso Martin Escudero; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD071843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, ZIADK075116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Alfonso Martin Escudero; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 1 UL1 RR025758-01, 1UL1TR001102-01, 1 R01 HD 060827-01A1, and K24 HD071843. E. Franquet was supported by Fundacion Alfonso Martin Escudero.	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Baskaran C, 2016, EUR J ENDOCRINOL, V174, P503, DOI 10.1530/EJE-15-0875; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bredella MA, 2013, BONE, V53, P336, DOI 10.1016/j.bone.2012.12.046; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; De Souza MJ, 2007, FERTIL STERIL, V88, P971, DOI 10.1016/j.fertnstert.2006.11.171; Dinas PC, 2015, CLIN ENDOCRINOL, V82, P147, DOI 10.1111/cen.12620; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; Grefhorst A, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0025-y; Haraguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111990; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE373, DOI 10.1152/ajpendo.00041.2005; Monti V, 2006, J AM DIET ASSOC, V106, P9, DOI [10.1016/j.jada.2006.03.015, DOI 10.1016/J.JADA.2006.03.015]; Monti V, 2006, J AM DIET ASSOC, V106, P822, DOI 10.1016/j.jada.2006.03.015; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Vosselman MJ, 2015, INT J OBESITY, V39, P1696, DOI 10.1038/ijo.2015.130; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008	29	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156353	10.1371/journal.pone.0156353	http://dx.doi.org/10.1371/journal.pone.0156353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243823	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100031
J	Chen, XD; Page, A				Chen, Xidan; Page, Andrew			Stability and Instability of Subjective Well-Being in the Transition from Adolescence to Young Adulthood: Longitudinal Evidence from 20991 Young Australians	PLOS ONE			English	Article							LIFE SATISFACTION; SET-POINT; TRAJECTORIES; ADAPTATION; HAPPINESS; UNEMPLOYMENT; ENGAGEMENT; BEHAVIORS; ATTITUDES; MODEL	Purpose This study assessed the long-term stability and instability of subjective well-being during post-school transition (i.e., transition from adolescence to young adulthood) and evaluated the determinants of transition stability. Methods Using two cohorts from a national representative longitudinal study, the Longitudinal Study of Australian Youth (N = 20991), latent profile analysis and latent transition analysis were conducted to examine transition patterns among subjective well-being profiles for youth from age 17 to 25. Multinomial logistic regressions were conducted to evaluate whether key socio-demographic variables were associated with transition stability. Results We identified: (1) three subjective well-being profiles: Low (30%), Moderate (50%), and High (20%); and (2) three major transition patterns among these subjective well-being profiles: stable, partially-stable, and unstable. The majority of youth had stable transition patterns during the transition from adolescence to adulthood. A large percentage of youth (52%) started low in subjective well-being profile and remained in the low subjective-wellbeing profile. Our examination also revealed gender was the most pronounced indicator for transition stability during this time period, with males more likely to have unstable transition patterns than females. Conclusions Results suggest that different subjective well-being status and transition patterns can be identified in the post-high school transition to adulthood, including unstable transitions. By targeting those groups more vulnerable to transition, mental health promotion and interventions may be delivered more effectively.	[Chen, Xidan; Page, Andrew] Univ Western Sydney, Sch Med, Ctr Hlth Res, Sydney, NSW, Australia	Western Sydney University	Chen, XD (corresponding author), Univ Western Sydney, Sch Med, Ctr Hlth Res, Sydney, NSW, Australia.	xidan.chen@uws.edu.au						Antaramian SP, 2009, J PSYCHOEDUC ASSESS, V27, P421, DOI 10.1177/0734282909331744; BACHMAN JG, 1993, DEV PSYCHOL, V29, P220, DOI 10.1037/0012-1649.29.2.220; Basuil DA, 2012, J VOCAT BEHAV, V80, P629, DOI 10.1016/j.jvb.2012.01.017; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Bogart LM, 2007, SOC INDIC RES, V81, P149, DOI 10.1007/s11205-006-0019-6; Bottan NL, 2011, J SOCIO-ECON, V43, P224, DOI 10.1016/j.socec.2011.01.007; Boyce CJ, 2011, PSYCHOL SCI, V22, P1397, DOI 10.1177/0956797611421790; Clark AE, 2008, ECON J, V118, pF222, DOI 10.1111/j.1468-0297.2008.02150.x; Cummins RA, 2003, SOC INDIC RES, V64, P159, DOI 10.1023/A:1024704320683; Diener E, 2006, AM PSYCHOL, V61, P305, DOI 10.1037/0003-066X.61.4.305; Diener E, 2004, ADV CELL AGING GERON, V15, P187; Dietrich J, 2012, DEV PSYCHOL, V48, P1575, DOI 10.1037/a0030188; Easterlin RA, 2006, J ECON PSYCHOL, V27, P463, DOI 10.1016/j.joep.2006.05.002; Ehrhardt J., 2000, J HAPPINESS STUD, V1, P177, DOI [DOI 10.1023/A:1010084410679, 10.1023/A:1010084410679]; Ferro MA, 2015, J AFFECT DISORDERS, V174, P594, DOI 10.1016/j.jad.2014.12.014; Fredricks JA, 2006, DEV PSYCHOL, V42, P698, DOI 10.1037/0012-1649.42.4.698; Fujita F, 2005, J PERS SOC PSYCHOL, V88, P158, DOI 10.1037/0022-3514.88.1.158; Ganzeboom HBG, 1996, SOC SCI RES, V25, P201, DOI 10.1006/ssre.1996.0010; GRAHAM JW, 1991, J CONSULT CLIN PSYCH, V59, P48, DOI 10.1037/0022-006X.59.1.48; Hirschi A, 2009, J VOCAT BEHAV, V74, P145, DOI 10.1016/j.jvb.2009.01.002; JONES FL, 1989, AUST NZ J SOCIOL, V25, P187; Lucas RE, 2005, PSYCHOL SCI, V16, P945, DOI 10.1111/j.1467-9280.2005.01642.x; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Lucas RE, 2007, J RES PERS, V41, P1091, DOI 10.1016/j.jrp.2006.11.005; Lucas RE, 2007, CURR DIR PSYCHOL SCI, V16, P75, DOI 10.1111/j.1467-8721.2007.00479.x; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; MARKS GN, 2003, AUSTR EC REV, V36, P428, DOI DOI 10.1111/J.1467-8462.2003.00299.X; Matthews RA, 2014, J OCCUP HEALTH PSYCH, V19, P168, DOI 10.1037/a0036012; McAdams KK, 2012, SOC INDIC RES, V109, P295, DOI 10.1007/s11205-011-9903-9; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Milyavskaya M, 2009, PERS SOC PSYCHOL B, V35, P1031, DOI 10.1177/0146167209337036; Morin AJS, 2013, QUANT METH EDUC BEHA, P395; Muthen B., 1997, PSYCHOMETRIKA, V75, P1; NCVER (The National Centre for Vocational Education Research), 2010, LONG SURV AUSTR YOUT; Nylund KL, 2006, STABILITY AND INSTAB; Proctor CL, 2009, J HAPPINESS STUD, V10, P583, DOI 10.1007/s10902-008-9110-9; Salmela-Aro K, 2010, J YOUTH ADOLESCENCE, V39, P870, DOI 10.1007/s10964-009-9464-2; Schulenberg JE, 2004, DEV PSYCHOPATHOL, V16, P1119, DOI 10.1017/S0954579404040167; Simons J, 2000, ADDICT BEHAV, V25, P323, DOI 10.1016/S0306-4603(99)00016-7; Starfield Barbara, 2011, Perm J, V15, P63; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Suldo SM, 2006, SOC INDIC RES, V78, P179, DOI 10.1007/s11205-005-8208-2; Suldo SM, 2004, SCHOOL PSYCHOL QUART, V19, P93, DOI 10.1521/scpq.19.2.93.33313; Tolan PH, 2014, J RES ADOLESCENCE, V24, P497, DOI 10.1111/jora.12156; Valois RF, 2001, AM J HEALTH BEHAV, V25, P353, DOI 10.5993/AJHB.25.4.1; Wang M, 2007, J APPL PSYCHOL, V92, P455, DOI 10.1037/0021-9010.92.2.455; Wu CH, 2008, SOC INDIC RES, V86, P101, DOI 10.1007/s11205-007-9103-9; Zullig KJ, 2001, J ADOLESCENT HEALTH, V29, P279, DOI 10.1016/S1054-139X(01)00269-5	48	9	9	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156399	10.1371/journal.pone.0156399	http://dx.doi.org/10.1371/journal.pone.0156399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232183	Green Submitted, Green Published, gold			2022-12-27	WOS:000376883000029
J	Hughes, SM; Shu, ZQ; Levy, CN; Ferre, AL; Hartig, H; Fang, CF; Lentz, G; Fialkow, M; Kirby, AC; Waldorf, KMA; Veazey, RS; Germann, A; von Briesen, H; McElrath, MJ; Dezzutti, CS; Sinclair, E; Baker, CAR; Shacklett, BL; Gao, DY; Hladik, F				Hughes, Sean M.; Shu, Zhiquan; Levy, Claire N.; Ferre, April L.; Hartig, Heather; Fang, Cifeng; Lentz, Gretchen; Fialkow, Michael; Kirby, Anna C.; Waldorf, Kristina M. Adams; Veazey, Ronald S.; Germann, Anja; von Briesen, Hagen; McElrath, M. Juliana; Dezzutti, Charlene S.; Sinclair, Elizabeth; Baker, Chris A. R.; Shacklett, Barbara L.; Gao, Dayong; Hladik, Florian			Cryopreservation of Human Mucosal Leukocytes	PLOS ONE			English	Article							IMMUNE ACTIVATION; CELLS; VIABILITY; RESPONSES; FUNCTIONALITY; RECOVERY; QUALITY; VACCINE; TRIALS; PBMC	Background Understanding how leukocytes in the cervicovaginal and colorectal mucosae respond to pathogens, and how medical interventions affect these responses, is important for developing better tools to prevent HIV and other sexually transmitted infections. An effective cryopreservation protocol for these cells following their isolation will make studying them more feasible. Methods and Findings To find an optimal cryopreservation protocol for mucosal mononuclear leukocytes, we compared cryopreservation media and procedures using human vaginal leukocytes and confirmed our results with endocervical and colorectal leukocytes. Specifically, we measured the recovery of viable vaginal T cells and macrophages after cryopreservation with different cryopreservation media and handling procedures. We found several cryopreservation media that led to recoveries above 75%. Limiting the number and volume of washes increased the fraction of cells recovered by 10-15%, possibly due to the small cell numbers in mucosal samples. We confirmed that our cryopreservation protocol also works well for both endocervical and colorectal leukocytes. Cryopreserved leukocytes had slightly increased cytokine responses to antigenic stimulation relative to the same cells tested fresh. Additionally, we tested whether it is better to cryopreserve endocervical cells on the cytobrush or in suspension. Conclusions Leukocytes from cervicovaginal and colorectal tissues can be cryopreserved with good recovery of functional, viable cells using several different cryopreservation media. The number and volume of washes has an experimentally meaningful effect on the percentage of cells recovered. We provide a detailed, step-by-step protocol with best practices for cryopreservation of mucosal leukocytes.	[Hughes, Sean M.; Levy, Claire N.; Lentz, Gretchen; Fialkow, Michael; Kirby, Anna C.; Waldorf, Kristina M. Adams; Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Shu, Zhiquan; Fang, Cifeng; Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Shu, Zhiquan] Washington State Univ, Sch Mech & Mat Engn, Everett, WA USA; [Ferre, April L.; Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Hartig, Heather] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Veazey, Ronald S.] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Germann, Anja; von Briesen, Hagen] Fraunhofer Inst Biomed Engn IBMT, Div Med Biotechnol, Sulzbach, Germany; [McElrath, M. Juliana; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [McElrath, M. Juliana; Hladik, Florian] Univ Washington, Dept Med, Seattle, WA USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Dezzutti, Charlene S.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Dezzutti, Charlene S.] Magee Womens Res Inst, Pittsburgh, PA USA; [Sinclair, Elizabeth; Baker, Chris A. R.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA USA; [Baker, Chris A. R.] Univ Calif San Francisco, Core Immunol Lab, San Francisco, CA 94143 USA; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med, Div Infect Dis, Davis, CA 95616 USA; [Gao, Dayong] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; University of California System; University of California Davis; University of California System; University of California San Francisco; Tulane University; Fraunhofer Gesellschaft; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of Washington; University of Washington Seattle	Hladik, F (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gao, DY (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.; Hladik, F (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Hladik, F (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.; Gao, DY (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	dayong@uw.edu; florian@uw.edu	Hladik, Florian/G-1041-2012; Shacklett, Barbara/A-7288-2009	Hladik, Florian/0000-0002-0375-2764; Shacklett, Barbara/0000-0002-7067-732X; Shu, Zhiquan/0000-0002-9261-5832; Levy, Claire/0000-0003-3204-211X; Dezzutti, Charlene/0000-0001-5902-5841; Hughes, Sean/0000-0002-9409-9405	University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health [P30 AI027763]; Bill & Melinda Gates Foundation [OPP1032522]; National Institutes of Health [R33 AI0094412, UM1 AI068618, R01 AI057020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057020, UM1AI068618] Funding Source: NIH RePORTER	University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible with help from the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health-funded program (http://www.nih.gov/; P30 AI027763). Funding was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/; OPP1032522 to DG and FH) and the National Institutes of Health (Supplement to R33 AI0094412 to FH and DG, HVTN Mucosal Immunology Group Award to FH (parent award: UM1 AI068618 to MJM), and Administrative Supplement to R01 AI057020 to BLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache SM, 2014, MAGRITTR FORWARD PIP; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Daroczi G, 2015, PANDER R PANDOC WRIT; Ducar C, 2014, J IMMUNOL METHODS, V409, P9, DOI 10.1016/j.jim.2014.03.024; Filbert H, 2013, CANCER IMMUNOL IMMUN, V62, P615, DOI 10.1007/s00262-012-1359-5; Francois, 2015, READR READ TABULAR D; Fuller BJ, CRYO LETTERS, V25, P375; Germann A, 2011, BIOPRESERV BIOBANK, V9, P229, DOI 10.1089/bio.2010.0033; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imaizumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088696; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Liebenberg LJ, 2011, J IMMUNOL METHODS, V367, P47, DOI 10.1016/j.jim.2011.01.013; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429; Neuwirth E., 2014, RCOLORBREWER COLORBR; Pinheiro J, 2015, NLME LINEAR NONLINEA; R Core Team, 2013, R LANG ENV STAT COMP; Sasnoor LM, 2003, J HEMATOTH STEM CELL, V12, P553, DOI 10.1089/152581603322448268; Schulz JC, 2012, J IMMUNOL METHODS, V382, P24, DOI 10.1016/j.jim.2012.05.001; Shu ZQ, 2016, BIOPRESERV BIOBANK, V14, P307, DOI 10.1089/bio.2015.0079; Shu ZQ, 2016, CRYOBIOLOGY, V72, P93, DOI 10.1016/j.cryobiol.2016.03.003; Stroncek DE, 2011, TRANSFUSION, V51, P2647, DOI 10.1111/j.1537-2995.2011.03210.x; Veeraputhiran M, 2010, CYTOTHERAPY, V12, P764, DOI 10.3109/14653241003745896; Wickham H., 2016, TIDYR EASILY TIDY DA; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Xie Y., 2015, DYNAMIC DOCUMENTS R, VSecond edition; Xie Y, 2015, KNITR GEN PURPOSE PA	33	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156293	10.1371/journal.pone.0156293	http://dx.doi.org/10.1371/journal.pone.0156293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232996	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000376883000019
J	Trevino, R; Majcher, C; Rabin, J; Kent, T; Maki, Y; Wingert, T				Trevino, Richard; Majcher, Carolyn; Rabin, Jeff; Kent, Theresa; Maki, Yutaka; Wingert, Timothy			The Effectiveness of an Educational Game for Teaching Optometry Students Basic and Applied Science	PLOS ONE			English	Article							HEALTH-PROFESSIONS	Purpose To compare the effectiveness of an educational board game with interactive didactic instruction for teaching optometry students elements of the core optometric curriculum. Methods Forty-two optometry students were divided into two GPA-matched groups and assigned to either 12 hours of game play (game group) or 12 hours of interactive didactic instruction (lecture group). The same material from the core optometric curriculum was delivered to both groups. Game play was accomplished via an original board game. Written examinations assessed change in knowledge level. A post-intervention opinion survey assessed student attitudes. Results There was no significant difference in pre-or post-intervention test scores between the lecture and game groups (Pre-test: p = 0.9; Post-test: p = 0.5). Post-intervention test scores increased significantly from baseline (Game group: 29.3% gain, Didactic group: 31.5% gain; p < 0.001 for each). The score increase difference between groups was not statistically significant (p = 0.6). The post-intervention attitude survey did not reveal any significant between group differences (p = 0.5). Conclusions Our results indicate that an educational game and interactive didactic instruction can be equally effective in teaching optometry students basic and applied science. Furthermore, both modes of instruction have the potential to be equally engaging and enjoyable experiences.	[Trevino, Richard; Majcher, Carolyn; Rabin, Jeff; Kent, Theresa; Maki, Yutaka; Wingert, Timothy] Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX USA		Trevino, R (corresponding author), Univ Incarnate Word, Rosenberg Sch Optometry, San Antonio, TX USA.	rctrevin@uiwtx.edu			Johnson & Johnson Vision Care Inc.; American Optometric Foundation; Alcon Inc.; Hoya Corp.	Johnson & Johnson Vision Care Inc.(Johnson & JohnsonJohnson & Johnson USA); American Optometric Foundation; Alcon Inc.(Novartis); Hoya Corp.	RT, CM, TK received support from a Johnson & Johnson Vision Care Inc. Innovations in Education Grant from the American Optometric Foundation (http://www.aaopt.org/AOF/Programs/Faculty/Innovation). The Optometry Knowledge Challenge game was developed with educational support grants from Alcon Inc. and Hoya Corp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulmajed H, 2015, MED TEACH, V37, pS27, DOI 10.3109/0142159X.2015.1006609; Aburahma MH, 2015, AM J PHARM EDUC, V79, DOI 10.5688/ajpe79459; Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006466; Akl EA, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-26; Akl EA, 2010, MED TEACH, V32, P16, DOI 10.3109/01421590903473969; Blakely G, 2010, NURS HEALTH SCI, V12, P27, DOI 10.1111/j.1442-2018.2009.00479.x; Blakely G, 2009, J ADV NURS, V65, P259, DOI 10.1111/j.1365-2648.2008.04843.x; Bochennek K, 2007, MED TEACH, V29, P941, DOI 10.1080/01421590701749813; Boctor L, 2013, NURSE EDUC PRACT, V13, P96, DOI 10.1016/j.nepr.2012.07.010; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fitzgerald K., 1997, NURSE ED PRINCIPLES, P261; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Leroy A, 1994, J Am Optom Assoc, V65, P221; Lewis DJ, J CONTIN ED NURS, V20, P80; Mains TE, 2015, POSTGRAD MED J, V91, P361, DOI 10.1136/postgradmedj-2014-132987; Mayer I, 2012, PROCEDIA COMPUT SCI, V15, P233, DOI 10.1016/j.procs.2012.10.075; Meterissian S, 2007, MED TEACH, V29, pE258, DOI 10.1080/01421590701663295; Montpas M, 2004, COMP JEOPARDY GAME V; O'Leary S, 2005, AM J OBSTET GYNECOL, V193, P1848, DOI 10.1016/j.ajog.2005.07.059; Selby G, 2007, MED TEACH, V29, P972, DOI 10.1080/01421590701601584; Yoon B, 2014, J CONTIN EDUC NURS, V45, P110, DOI 10.3928/00220124-20140224-14	21	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156389	10.1371/journal.pone.0156389	http://dx.doi.org/10.1371/journal.pone.0156389			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27233041	Green Submitted, gold, Green Published			2022-12-27	WOS:000376883000027
J	Watanabe, M; Roth, TL; Bauer, SJ; Lane, A; Romick-Rosendale, LE				Watanabe, Miki; Roth, Terri L.; Bauer, Stuart J.; Lane, Adam; Romick-Rosendale, Lindsey E.			Feasibility Study of NMR Based Serum Metabolomic Profiling to Animal Health Monitoring: A Case Study on Iron Storage Disease in Captive Sumatran Rhinoceros (Dicerorhinus sumatrensis)	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; DICEROS-BICORNIS; CREATININE; TISSUE; GENE; IDENTIFICATION; EXTRACTION; CLEARANCE; EQUATIONS; IMBALANCE	A variety of wildlife species maintained in captivity are susceptible to iron storage disease (ISD), or hemochromatosis, a disease resulting from the deposition of excess iron into insoluble iron clusters in soft tissue. Sumatran rhinoceros (Dicerorhinus sumatrensis) is one of the rhinoceros species that has evolutionarily adapted to a low-iron diet and is susceptible to iron overload. Hemosiderosis is reported at necropsy in many African black and Sumatran rhinoceroses but only a small number of animals reportedly die from hemochromatosis. The underlying cause and reasons for differences in susceptibility to hemochromatosis within the taxon remains unclear. Although serum ferritin concentrations have been useful in monitoring the progression of ISD in many species, there is some question regarding their value in diagnosing hemochromatosis in the Sumatran rhino. To investigate the metabolic changes during the development of hemochromatosis and possibly increase our understanding of its progression and individual susceptibility differences, the serum metabolome from a Sumatran rhinoceros was investigated by nuclear magnetic resonance (NMR)-based metabolomics. The study involved samples from female rhinoceros at the Cincinnati Zoo (n = 3), including two animals that died from liver failure caused by ISD, and the Sungai Dusun Rhinoceros Conservation Centre in Peninsular Malaysia (n = 4). Principal component analysis was performed to visually and statistically compare the metabolic profiles of the healthy animals. The results indicated that significant differences were present between the animals at the zoo and the animals in the conservation center. A comparison of the 43 serum metabolomes of three zoo rhinoceros showed two distinct groupings, healthy (n = 30) and unhealthy (n = 13). A total of eighteen altered metabolites were identified in healthy versus unhealthy samples. Results strongly suggest that NMR-based metabolomics is a valuable tool for animal health monitoring and may provide insight into the progression of this and other insidious diseases.	[Watanabe, Miki; Bauer, Stuart J.; Romick-Rosendale, Lindsey E.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Lane, Adam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Lane, Adam] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Roth, Terri L.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Watanabe, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA.	Miki.Watanabe@cchmc.org		Lane, Adam/0000-0002-5522-8112; Romick-Rosendale, Lindsey/0000-0002-7252-1193				Beben T, 2015, ADV CHRONIC KIDNEY D, V22, P337, DOI 10.1053/j.ackd.2015.05.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P342, DOI 10.1006/bcmd.2001.0386; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Candra D, 2012, J ZOO WILDLIFE MED, V43, pS66, DOI 10.1638/2011-0127.1; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; Clauss M, 2012, J ZOO WILDLIFE MED, V43, pS6, DOI 10.1638/2011-0152.1; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dejong CH, 2007, J NUTR S1, V137, p97S; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Dierenfeld ES, 2006, ZOO BIOL, V25, P417, DOI 10.1002/zoo.20107; Dierenfeld ES, 2005, ZOO BIOL, V24, P51, DOI 10.1002/zoo.20043; Dove ADM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049379; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gottschalk M, 2008, NMR BIOMED, V21, P809, DOI 10.1002/nbm.1258; JAMES JH, 1979, LANCET, V2, P772, DOI 10.1016/S0140-6736(79)92119-6; Jones OAH, 2008, MAR ECOL PROG SER, V369, P169, DOI 10.3354/meps07654; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Korenaga M, 2015, LIVER INT, V35, P1303, DOI 10.1111/liv.12675; Kuwahata M, 2008, J NUTR BIOCHEM, V19, P438, DOI 10.1016/j.jnutbio.2007.05.011; MacAulay J, 2006, CAN J GASTROENTEROL, V20, P521, DOI 10.1155/2006/858053; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Nicholson JK, 2011, PHARMACOGENOMICS, V12, P103, DOI 10.2217/PGS.10.157; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niemuth J.N., 2014, Wildlife Biology in Practice, V10, P14; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; Nishitani S, 2002, BIOCHEM BIOPH RES CO, V299, P693, DOI 10.1016/S0006-291X(02)02717-1; Olias P, 2012, J COMP PATHOL, V147, P542, DOI 10.1016/j.jcpa.2012.07.005; Paglia DE, 2012, J ZOO WILDLIFE MED, V43, pS92, DOI 10.1638/2011-0177.1; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Roth TL, 2016, P WORKSH IR OV DIS B, P14; Schock TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059521; Schock TB, 2012, FOOD CHEM, V133, P90, DOI 10.1016/j.foodchem.2011.12.077; Schock TB, 2010, METABOLOMICS, V6, P250, DOI 10.1007/s11306-009-0194-y; Serra MA, 2004, SCAND J GASTROENTERO, V39, P1149, DOI 10.1080/00365520410008024; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Smith JE, 1995, J ZOO WILDLIFE MED, V26, P525; SOETERS PB, 1976, LANCET, V2, P880; Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Tuffnail W, 2009, METABOLOMICS, V5, P33, DOI 10.1007/s11306-008-0143-1; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Watanabe M, 2015, METABOLOMICS, V11, P1302, DOI 10.1007/s11306-015-0789-4; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; YAMATO M, 1995, INT HEPATOL COMMUN, V3, P91, DOI 10.1016/0928-4346(94)00159-3	49	7	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156318	10.1371/journal.pone.0156318	http://dx.doi.org/10.1371/journal.pone.0156318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232336	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000022
J	Yang, Y; Chen, F; Wan, DY; Liu, YH; Yang, L; Feng, HR; Cui, XL; Gao, X; Song, HF				Yang, Yi; Chen, Fang; Wan, Deyou; Liu, Yunhui; Yang, Li; Feng, Hongru; Cui, Xinling; Gao, Xin; Song, Haifeng			Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2 sigma-Fc	PLOS ONE			English	Article							FUSION PROTEIN; PICHIA-PASTORIS; FC FUSION; ANALOG; LIRAGLUTIDE; GLUCOSE; SAFETY; TOLERABILITY; EXENDIN-4; EFFICACY	Human GLP-1 (glucagon-like peptide-1) can produce a remarkable improvement in glycemic control in patients with type 2 diabetes. However, its clinical benefits are limited by its short half-life, which is less than 2 min because of its small size and rapid enzymatic inactivation by dipeptidyl peptidase IV. We engineered GLP-1-IgG2 sigma-Fc, a 68-kDa fusion protein linking a variant human GLP-1 (A8G/G26E/R36G) to a human IgG2 sigma constant heavy-chain. A stably transfected Chinese hamster ovary cell line was obtained using electroporation. Western blotting showed that the expressed protein was immunoreactive to both GLP-1 and IgG antibodies. GLP-1-IgG2 sigma-Fc stimulated insulin secretion from INS-1 cells in a dose-and glucose-dependent manner and increased insulin mRNA expression. The half-life of GLP-1-IgG2 sigma-Fc in cynomolgus monkeys was approximately 57.1 +/- 4.5 h. In the KKAy mouse model of diabetes, one intraperitoneal injection of GLP-1-IgG2 sigma-Fc (1 mg/kg) reduced blood glucose levels for 5 days. A 4-week repeat-administration study identified sustained effects on blood glucose levels. Oral glucose tolerance tests conducted at the beginning and end of this 4-week period showed that GLP-1-IgG2 sigma-Fc produced a stable glucose lowering effect. In addition, KKAy mice treated with GLP-1-IgG2 sigma-Fc showed statistically significant weight loss from day 23. In conclusion, these properties of GLP-1-IgG2 sigma-Fc demonstrated that it represented a potential long-acting GLP-1 receptor agonist for the treatment of type 2 diabetes.	[Yang, Yi; Song, Haifeng] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Yang, Yi; Chen, Fang; Wan, Deyou; Liu, Yunhui; Yang, Li; Feng, Hongru; Cui, Xinling; Gao, Xin; Song, Haifeng] Acad Mil Med Sci, Res Ctr Pharmacokinet, Beijing, Peoples R China	Anhui Medical University; Academy of Military Medical Sciences - China	Song, HF (corresponding author), Anhui Med Univ, Hefei, Anhui, Peoples R China.; Gao, X; Song, HF (corresponding author), Acad Mil Med Sci, Res Ctr Pharmacokinet, Beijing, Peoples R China.	gaox_amms@126.com; bapklab@yahoo.com			Natural Science Foundation of China [81272701]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Haifeng Song; 81272701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiram M, 2013, J CONTROL RELEASE, V172, P144, DOI 10.1016/j.jconrel.2013.07.021; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; ASTRUP A, 2012, INT J OBESITY, V36, P843, DOI DOI 10.1038/IJO.2011.158; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Buse JB, 2011, J CLIN ENDOCR METAB, V96, P1695, DOI 10.1210/jc.2010-2822; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Chung HS, 2011, REGUL PEPTIDES, V170, P1, DOI 10.1016/j.regpep.2011.05.002; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Hashimoto Y, 2000, BIOL PHARM BULL, V23, P941; Hou GJ, 2013, PEPTIDES, V40, P123, DOI 10.1016/j.peptides.2013.01.010; Huang YS, 2008, J PEPT SCI, V14, P588, DOI 10.1002/psc.942; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Levin D, 2015, TRENDS BIOTECHNOL, V33, P27, DOI 10.1016/j.tibtech.2014.11.001; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022; Maccani A, 2014, BIOTECHNOL J, V9, P526, DOI 10.1002/biot.201300305; MacConell L, 2012, DIABETES METAB SYNDR, V5, P29, DOI 10.2147/DMSO.S28387; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Murage EN, 2010, J MED CHEM, V53, P6412, DOI 10.1021/jm100602m; Pratley Richard E, 2008, Rev Diabet Stud, V5, P73, DOI 10.1900/RDS.2008.5.73; Rossman Howard S, 2004, J Manag Care Pharm, V10, pS12; Russell-Jones D, 2010, INT J CLIN PRACT, V64, P1402, DOI 10.1111/j.1742-1241.2010.02465.x; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Siegel EG, 1999, REGUL PEPTIDES, V79, P93, DOI 10.1016/S0167-0115(98)00155-4; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083509; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	32	2	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156449	10.1371/journal.pone.0156449	http://dx.doi.org/10.1371/journal.pone.0156449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232339	gold, Green Submitted, Green Published			2022-12-27	WOS:000376883000038
J	Ruanpeng, D; Chariyalertsak, S; Kaewpoowat, Q; Supindham, T; Settakorn, J; Sukpan, K; Utaipat, U; Miura, T; Kosashunhanan, N; Saokhieo, P; Songsupa, R; Wongthanee, A				Ruanpeng, Darin; Chariyalertsak, Suwat; Kaewpoowat, Quanhathai; Supindham, Taweewat; Settakorn, Jongkolnee; Sukpan, Kornkanok; Utaipat, Utaiwan; Miura, Toshiyuki; Kosashunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika			Cytological Anal Squamous Intraepithelial Lesions Associated with Anal High-Risk Human Papillomavirus Infections among Men Who Have Sex with Men in Northern Thailand	PLOS ONE			English	Article							NATURAL-HISTORY; HIGH PREVALENCE; CANCER; HIV; NEOPLASIA; VACCINATION	Background Anal cancer, one of human papillomavirus (HPV) related malignancies, has increased in recent decades, particularly among men who have sex with men (MSM) and HIV-infected (HIV+) persons. We aimed to explore the prevalence of anal squamous intraepithelial lesions (ASIL) using Papanicolau (Pap) screening among MSM in northern Thailand and its associated factors. Methods Two hundreds MSM aged >= 18 years reporting receptive anal intercourse in the prior 6 months were recruited from July 2012 through January 2013. Medical history and behavioral data were collected by staff interview and computer-assisted self interview. Anal Pap smear, HPV genotyping, and HIV testing were performed. Two pathologists blinded to HPV and HIV status reported cytologic results by Bethesda classification. Results Mean age was 27.2 years (range 18-54). Overall, 86 (43.0%) had ASIL: 28 (14.2%) with atypical cells of undetermined significance (ASCUS), 1 (0.5%) with atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H), 56 (28.4%) with low-grade squamous intraepithelial lesion (LSIL), and 1 (0.5%) with high-grade squamous intraepithelial lesion (HSIL). ASIL was associated by univariate analysis (p <= 0.05) with older age, gender identity other than bisexual (i.e., gay men and transgender women), rectal douching, anal symptoms, genital warts, HIV positivity, and high-risk-HPV infection. However, on multiple logistic regression ASIL was associated only with high-risk HPV type (p = 0.002) and HIV infection (p = 0.01). Conclusions ASIL is quite common in high-risk MSM in northern Thailand and is associated with high-risk HPV types and HIV infection. Routine anal Pap screening should be considered, given the high frequency of ASIL, particularly in the HIV+. High resolution anoscopy (HRA), not done here, should be to confirm PAP smears whose sensitivity and specificity are quite variable. Timely HPV vaccination should be considered for this population.	[Ruanpeng, Darin; Chariyalertsak, Suwat; Kaewpoowat, Quanhathai; Supindham, Taweewat; Utaipat, Utaiwan; Kosashunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Kaewpoowat, Quanhathai] Chiang Mai Univ, Fac Med, Dept Med, Div Infect Dis, Chiang Mai 50000, Thailand; [Settakorn, Jongkolnee; Sukpan, Kornkanok] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand; [Miura, Toshiyuki] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki 852, Japan; [Ruanpeng, Darin] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA	Chiang Mai University; Chiang Mai University; Chiang Mai University; Nagasaki University; University of Minnesota System; University of Minnesota Twin Cities	Chariyalertsak, S (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	suwat@rihes.org		Kaewpoowat, Quanhathai/0000-0002-9444-3552	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [23406032]; National Research University Project under Thailand's Office of the Higher Education Commission	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Research University Project under Thailand's Office of the Higher Education Commission	This study was supported by a Grant-in-Aid for Scientific Research ( B) ( 23406032) to Dr. Toshiyuki Miura from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. It was also supported in part by the National Research University Project under Thailand's Office of the Higher Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora R, 2014, INT J STD AIDS, V25, P726, DOI 10.1177/0956462413518193; Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; Cheng SH, 2014, J MED VIROL, V86, P193, DOI 10.1002/jmv.23825; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Chin-Hong PV, 2002, CLIN INFECT DIS, V35, P1127, DOI 10.1086/344057; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Darragh TM, 2013, INT J GYNECOL PATHOL, V32, P76, DOI 10.1097/PGP.0b013e31826916c7; Deshmukh AA, 2014, VACCINE, V32, P6941, DOI 10.1016/j.vaccine.2014.10.052; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V91, P1; International Agency for Research on Cancer (IARC), 2012, IARC MONOGRAPHS EVAL, V100F; Lacey HB, 1999, SEX TRANSM INFECT, V75, P172, DOI 10.1136/sti.75.3.172; Li AH, 2009, SEX TRANSM INFECT, V85, P503, DOI 10.1136/sti.2009.036707; Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Moscicki AB, 2012, VACCINE, V30, pF24, DOI 10.1016/j.vaccine.2012.05.089; Nelson RA, 2013, J CLIN ONCOL, V31, P1569, DOI 10.1200/JCO.2012.45.2524; Nielsen A, 2012, INT J CANCER, V130, P1168, DOI 10.1002/ijc.26115; Palefsky JM, 1997, J ACQ IMMUN DEF SYND, V14, P415, DOI 10.1097/00042560-199704150-00004; Phanuphak N, 2013, AIDS, V27, P1753, DOI 10.1097/QAD.0b013e328360a509; Piketty C, 2004, SEX TRANSM DIS, V31, P96, DOI 10.1097/01.OLQ.0000109515.75864.2B; Roura E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147029; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Skamperle M, 2013, ACTA DERMATOVEN ALP, V21, P1, DOI 10.2478/v10162-012-0024-1; Soeberg MJ, 2015, CANCER EPIDEMIOL, V39, P842, DOI 10.1016/j.canep.2015.10.008; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Wilkin T, 2015, NEW ENGL J MED, V373, P854, DOI 10.1056/NEJMcp1401303; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983	37	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156280	10.1371/journal.pone.0156280	http://dx.doi.org/10.1371/journal.pone.0156280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227684	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500101
J	Wu, FN; Cen, YJ; Wallis, CM; Trumble, JT; Prager, S; Yokomi, R; Zheng, Z; Deng, XL; Chen, JC; Liang, GW				Wu, Fengnian; Cen, Yijing; Wallis, Christopher M.; Trumble, John T.; Prager, Sean; Yokomi, Ray; Zheng, Zheng; Deng, Xiaoling; Chen, Jianchi; Liang, Guangwen			The Complete Mitochondrial Genome Sequence of Bactericera cockerelli and Comparison with Three Other Psylloidea Species	PLOS ONE			English	Article							TRANSFER-RNA GENES; HEMIPTERA TRIOZIDAE; POTATO; DNA; PROGRAM; PHYLOGENY; PSYLLIDS; NORTH; SULC	Potato psyllid (Bactericera cockerelli) is an important pest of potato, tomato and pepper. Not only could a toxin secreted by nymphs results in serious phytotoxemia in some host plants, but also over the past few years B. cockerelli was shown to transmit "Candidatus Liberibacter solanacearum", the putative bacterial pathogen of potato zebra chip (ZC) disease, to potato and tomato. ZC has caused devastating losses to potato production in the western U.S., Mexico, and elsewhere. New knowledge of the genetic diversity of the B. cockerelli is needed to develop improved strategies to manage pest populations. Mitochondrial genome (mitogenome) sequencing provides important knowledge about insect evolution and diversity in and among populations. This report provides the first complete B. cockerelli mitogenome sequence as determined by next generation sequencing technology (Illumina MiSeq). The circular B. cockerelli mitogenome had a size of 15,220 bp with 13 protein-coding gene (PCGs), 2 ribosomal RNA genes (rRNAs), 22 transfer RNA genes (tRNAs), and a non-coding region of 975 bp. The overall gene order of the B. cockerelli mitogenome is identical to three other published Psylloidea mitogenomes: one species from the Triozidae, Paratrioza sinica; and two species from the Psyllidae, Cacopsylla coccinea and Pachypsylla venusta. This suggests all of these species share a common ancestral mitogenome. However, sequence analyses revealed differences between and among the insect families, in particular a unique region that can be folded into three stem-loop secondary structures present only within the B. cockerelli mitogenome. A phylogenetic tree based on the 13 PCGs matched an existing taxonomy scheme that was based on morphological characteristics. The available complete mitogenome sequence makes it accessible to all genes for future population diversity evaluation of B. cockerelli.	[Wu, Fengnian; Cen, Yijing; Zheng, Zheng; Deng, Xiaoling; Liang, Guangwen] South China Agr Univ, Key Lab Microbial Signals & Dis Control, Coll Agr, Lab Insect Ecol Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Fengnian; Wallis, Christopher M.; Yokomi, Ray; Zheng, Zheng; Chen, Jianchi] ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA USA; [Trumble, John T.; Prager, Sean] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	South China Agricultural University; United States Department of Agriculture (USDA); University of California System; University of California Riverside	Liang, GW (corresponding author), South China Agr Univ, Key Lab Microbial Signals & Dis Control, Coll Agr, Lab Insect Ecol Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Chen, JC (corresponding author), ARS, San Joaquin Valley Agr Sci Ctr, USDA, Parlier, CA USA.	jianchi.chen@ars.usda.gov; gwliang@scau.edu.cn	Wallis, Christopher/AFO-9404-2022; Wu, Fengnian/L-5598-2018	Wallis, Christopher/0000-0003-3855-8256; Wu, Fengnian/0000-0003-1788-1628	Chinese Modern Agricultural Technology Systems [CARS-27]; California Citrus Research Board; ARS [ARS-0422946] Funding Source: Federal RePORTER	Chinese Modern Agricultural Technology Systems; California Citrus Research Board; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the Chinese Modern Agricultural Technology Systems (CARS-27) (XD); California Citrus Research Board (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MATH PROBLEMS ENG; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cantacessi C, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq667; Dolling WR, 1991, HEMIPTERA; Forero D, 2008, REV COLOMB ENTOMOL, V34, P1; GLICK P. A., 1939, U S DEPT AGRIC TECH BULL, V673, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall DW, 1998, HACKBERRY PETIOLE GA; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P1, DOI 10.1007/s10493-008-9203-5; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; Knowlton G. F., 1931, Annals of the Entomological Society of America, V24, P283, DOI 10.1093/aesa/24.2.283; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Li FS, 2011, PSYLIIDOMORPHA CHINA, VI; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liefting LW, 2009, INT J SYST EVOL MICR, V59, P2274, DOI 10.1099/ijs.0.007377-0; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; PAPP RP, 1979, PAN-PAC ENTOMOL, V55, P95; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell CM, 2012, SOUTHWEST ENTOMOL, V37, P521, DOI 10.3958/059.037.0410; Que S, 2015, MITOCHONDR DNA, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Smith PT, 1999, MOL PHYLOGENET EVOL, V11, P236, DOI 10.1006/mpev.1998.0575; Sulc K., 1909, ACTA SOC ENTOMOL BOH, V6, P102; Swisher KD, 2014, SOUTHWEST ENTOMOL, V39, P49, DOI 10.3958/059.039.0106; Swisher KD, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu023; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang HL, 2014, MODEM RHEUMATOLOGY, P1; Wang Y, 2014, INSECT SCI, V21, P278, DOI 10.1111/1744-7917.12112; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077511; Williams ST, 2014, GENE, V533, P38, DOI 10.1016/j.gene.2013.10.005; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu F, 2015, GENOME ANNOUNC, V3; Ye F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1081-1; Zhang S, 2016, MITOCHONDRIAL DNA A, V27, P854, DOI 10.3109/19401736.2014.919474; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	47	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155318	10.1371/journal.pone.0155318	http://dx.doi.org/10.1371/journal.pone.0155318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227976	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500015
J	Florio, AM; Raxworthy, CJ				Florio, Antonia M.; Raxworthy, Christopher J.			A Phylogeographic Assessment of the Malagasy Giant Chameleons (Furcifer verrucosus and Furcifer oustaleti)	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; MOLECULAR APPROACH; MITOCHONDRIAL-DNA; MADAGASCAR; SPECIATION; INFERENCE; DIVERSIFICATION; HYPOTHESES	The Malagasy giant chameleons (Furcifer oustaleti and Furcifer verrucosus) are sister species that are both broadly distributed in Madagascar, and also endemic to the island. These species are also morphologically similar and, because of this, have been frequently misidentified in the field. Previous studies have suggested that cryptic species are nested within this chameleon group, and two subspecies have been described in F. verrucosus. In this study, we utilized a phylogeographic approach to assess genetic diversification within these chameleons. This was accomplished by (1) identifying clades within each species supported by both mitochondrial and nuclear DNA, (2) assessing divergence times between clades, and (3) testing for niche divergence or conservatism. We found that both F. oustaleti and F. verrucosus could be readily identified based on genetic data, and within each species, there are two well-supported clades. However, divergence times are not contemporary and spatial patterns are not congruent. Diversification within F. verrucosus occurred during the Plio-Pleistocene, and there is evidence for niche divergence between a southwestern and southeastern clade, in a region of Madagascar that shows no obvious landscape barriers to dispersal. Diversification in F. oustaleti occurred earlier in the Pliocene or Miocene, and niche conservatism is supported with two genetically distinct clades separated at the Sofia River in northwestern Madagascar. Divergence within F. verrucosus is most consistent with patterns expected from ecologically mediated speciation, whereas divergence in F. oustaleti most strongly matches the patterns expected from the riverine barrier hypothesis.	[Florio, Antonia M.; Raxworthy, Christopher J.] Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Florio, AM (corresponding author), Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA.	aflorio@amnh.org			Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH); U.S. National Science Foundation [DEB 9984496, 0423286, 0641023, 1110593]	Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH); U.S. National Science Foundation(National Science Foundation (NSF))	Research for this project was funded by the Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH - http://www.amnh.org/our-research/richard-gilder-graduate-school) and the U.S. National Science Foundation (DEB 9984496, 0423286, 0641023 and 1110593 - http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research for this project was funded by the Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH) and the U.S. National Science Foundation (DEB 9984496, 0423286, 0641023 and 1110593). Field studies in Madagascar were made possible due through the agreement of the Ministries des Eaux et Forets, the Association Nationale pour la Gestion des Aires Proteges (ANGAP), and the Universite d'Antananarivo, Departement de Biologie Animale (especially D. Rakotondravony and H. Razafindraibe). We also thank the many people who have aided or contributed to this research program including L. Haralson for morphological measurements, and A. Carnaval, R. DeSalle, and S. Perkins for useful feedback. C. Ingram generously provided several sequences for this study. All fieldwork was accomplished with the help of many people, including R. Andrianasolo, B. Falk, S. Mahaviasy, N. Rakotoarisoa, A. Rakotondrazafy, J. Randrianirina, and many local guides, reserve agents, and volunteers too numerous to mention. This manuscript was greatly improved thanks to the insight, comments, and edits made by two anonymous reviewers-thank you for your careful analysis of this study.	AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boettger O., 1894, Zweite Mittheilung Zool Anz, Vxvii, P137; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Bourgat RM, 1968, ANN U MADAGASCAR SCI, V6, P235; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6046; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Brygoo E. R., 1971, Faune de Madagascar, V33, P1; Burbrink FT, 2011, MOL PHYLOGENET EVOL, V60, P445, DOI 10.1016/j.ympev.2011.05.009; Cernansky A, 2010, GEOBIOS-LYON, V43, P605, DOI 10.1016/j.geobios.2010.04.001; Chan LM, 2012, MOL ECOL, V21, P3839, DOI 10.1111/j.1365-294X.2012.05651.x; Conroy CJ, 2009, J AM ASSOC LAB ANIM, V48, P28; Craul M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-83; Cuvier G, 1829, REGNE ANIMAL, V2, P60; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESRI, 2011, DOC MAN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falk BG, 2011, INT J PARASITOL, V41, P967, DOI 10.1016/j.ijpara.2011.05.004; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; GILLETTE C.R., 2010, IRCF REPTILES AMPHIB, V17, P248; Glor RE, 2001, MOL ECOL, V10, P2661, DOI 10.1046/j.0962-1083.2001.01393.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Gray JE, 1831, ANIMAL KINGDOM GRIFF, V9, P53; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillenius D., 1959, Beaufortia, V8, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Klaver C, 1986, ZOOLOGISCHES FORSCHU; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Martin RD, 1972, PHIL T R SOC B, V264, P295; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Mertens R., 1966, Tierreich, V83, P1; Mocquard F., 1894, Compte Rendu Soc Philom, VNo. 9, P3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nei M, 2000, MOL PHYLOGENET EVOL; Nixon K.C., 2002, WINCLADA VERSION 1 0; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Olivieri G, 2007, MOL PHYLOGENET EVOL, V43, P309, DOI 10.1016/j.ympev.2006.10.026; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portik DM, 2012, CONSERV GENET RESOUR, V4, P1, DOI 10.1007/s12686-011-9460-1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Randrianambinina Blanchard, 2010, Madagascar Conservation & Development, V5, P95; Raxworthy CJ, 2008, J ZOOL, V275, P423, DOI 10.1111/j.1469-7998.2008.00460.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy CJ, 2006, COPEIA, P711; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Rocha S, 2005, BELG J ZOOL, V135, P39; Rodriguez-Robles JA, 2007, J BIOGEOGR, V34, P1546, DOI 10.1111/j.1365-2699.2007.01718.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Silvestro D, 2010, RAXMLGUI GRAPHICAL F; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TAKAHATA N, 1985, GENETICS, V110, P325; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tolley KA, 2013, P R SOC B, P280; Tolley KA, 2011, J BIOGEOGR, V38, P1748, DOI 10.1111/j.1365-2699.2011.02529.x; Townsend T, 2002, MOL PHYLOGENET EVOL, V23, P22, DOI 10.1006/mpev.2001.1076; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	95	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154144	10.1371/journal.pone.0154144	http://dx.doi.org/10.1371/journal.pone.0154144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257819	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700006
J	Heininger, U; Andre, P; Chlibek, R; Kristufkova, Z; Kutsar, K; Mangarov, A; Meszner, Z; Nitsch-Osuch, A; Petrovic, V; Prymula, R; Usonis, V; Zavadska, D				Heininger, Ulrich; Andre, Philippe; Chlibek, Roman; Kristufkova, Zuzana; Kutsar, Kuulo; Mangarov, Atanas; Meszner, Zsofia; Nitsch-Osuch, Aneta; Petrovic, Vladimir; Prymula, Roman; Usonis, Vytautas; Zavadska, Dace			Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013	PLOS ONE			English	Article							PRESCHOOL BOOSTER VACCINATION; WHOLE-CELL; BORDETELLA-PERTUSSIS; REDUCED RISK; VACCINES; DISEASE; IMPACT; RESURGENCE; AGE; TRANSMISSION	We undertook an epidemiological survey of the annual incidence of pertussis reported from 2000 to 2013 in ten Central and Eastern European countries to ascertain whether increased pertussis reports in some countries share common underlying drivers or whether there are specific features in each country. The annual incidence of pertussis in the participating countries was obtained from relevant government institutions and/or national surveillance systems. We reviewed the changes in the pertussis incidence rates in each country to explore differences and/or similarities between countries in relation to pertussis surveillance; case definitions for detection and confirmation of pertussis; incidence and number of cases of pertussis by year, overall and by age group; population by year, overall and by age group; pertussis immunization schedule and coverage, and switch from whole-cell pertussis vaccines (wP) to acellular pertussis vaccines (aP). There was heterogeneity in the reported annual incidence rates and trends observed across countries. Reported pertussis incidence rates varied considerably, ranging from 0.01 to 96 per 100,000 population, with the highest rates generally reported in Estonia and the lowest in Hungary and Serbia. The greatest burden appears for the most part in infants (<1 year) in Bulgaria, Hungary, Latvia, Romania, and Serbia, but not in the other participating countries where the burden may have shifted to older children, though surveillance of adults may be inappropriate. There was no consistent pattern associated with the switch from wP to aP vaccines on reported pertussis incidence rates. The heterogeneity in reported data may be related to a number of factors including surveillance system characteristics or capabilities, different case definitions, type of pertussis confirmation tests used, public awareness of the disease, as well as real differences in the magnitude of the disease, or a combination of these factors. Our study highlights the need to standardize pertussis detection and confirmation in surveillance programs across Europe, complemented with carefully-designed seroprevalence studies using the same protocols and methodologies.	[Heininger, Ulrich] Univ Basel Childrens Hosp UKBB, Basel, Switzerland; [Andre, Philippe] Hosp Civils Lyon, Hop Edouard Herriot, Serv Hyg Epidemiol & Prevent, Lyon, France; [Chlibek, Roman] Univ Def, Dept Epidemiol, Hradec Kralove, Czech Republic; [Kristufkova, Zuzana] Slovak Med Univ, Fac Publ Hlth, Bratislava, Slovakia; [Kutsar, Kuulo] Estonian Hlth Board, Tallinn, Estonia; [Mangarov, Atanas] Hosp Infect Dis, Sofia, Bulgaria; [Meszner, Zsofia] Natl Inst Hlth Promot, Paediat Directorate, Budapest, Hungary; [Nitsch-Osuch, Aneta] Med Univ Warsaw, Dept Family Med, Warsaw, Poland; [Petrovic, Vladimir] Univ Novi Sad, Fac Med, Inst Publ Hlth Vojvodina, Novi Sad 21000, Serbia; [Prymula, Roman] Univ Hosp, Hradec Kralove, Czech Republic; [Usonis, Vytautas] Vilnius State Univ, Fac Med, Clin Childrens Dis, Vilnius, Lithuania; [Zavadska, Dace] Riga Stradins Univ, Dept Paediat, Riga, Latvia	CHU Lyon; University of Defence - Czech Republic; Slovak Medical University Bratislava; Medical University of Warsaw; University of Novi Sad; University Hospital Hradec Kralove; Vilnius University; Riga Stradins University	Heininger, U (corresponding author), Univ Basel Childrens Hosp UKBB, Basel, Switzerland.	ulrich.heininger@ukbb.ch	Naselsky, Pavel D/M-4799-2014; Kristufkova, Zuzana/AAB-7549-2019; Petrovic, Vladimir/L-7149-2018; Prymula, Roman/AEG-7401-2022; Chlibek, Roman/P-9084-2016; Usonis, Vytautas/R-6471-2019; Zavadska, Dace/GXF-4730-2022	Naselsky, Pavel D/0000-0002-8891-0273; Petrovic, Vladimir/0000-0002-2052-6232; NITSCH-OSUCH, ANETA/0000-0002-2622-7348; Zavadska, Dace/0000-0003-4892-3763	Sanofi Pasteur, Lyon, France; Sanofi Pasteur	Sanofi Pasteur, Lyon, France; Sanofi Pasteur	This study was funded by Sanofi Pasteur, Lyon, France. The study sponsor contributed to the design of the analysis plan, data collection and structuring, data analysis, and provided advice and input on the drafting of this document, but had no role in the decision to publish.; Editorial assistance with the preparation of the manuscript was provided by Richard Glover, inScience Communications, Springer Healthcare. Funding for this assistance was provided by Sanofi Pasteur.	Andre P, 2013, CLIN INFECT DIS, V57, P1658, DOI 10.1093/cid/cit552; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P385; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P203; Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; Barkoff AM, 2015, PATHOG DIS, P73; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Carlson RM, 2008, PERTUSSIS SURVEILLAN; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 1999, CLIN INFECT DIS, V28, pS107, DOI 10.1086/515057; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dalby T, 2013, EUR J CLIN MICROBIOL, V32, P1285, DOI 10.1007/s10096-013-1874-0; de Celles MD, 2014, P NATL ACAD SCI USA, V111, pE716, DOI 10.1073/pnas.1323795111; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; Dinu S, 2014, DIAGN MICR INFEC DIS, V78, P302, DOI 10.1016/j.diagmicrobio.2013.09.017; Epidemiological information system EPIS, ANN REP EP SIT SLOV; European Centre for Disease Prevention and Control, 2012, ANN EP REP 2012 VACC; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 VACC; European Centre for Disease Prevention and Control (ECDC), 2012, PERT; EUVAC.NET, 2009, PERT SURV REP 2003 2; Arlant LHF, 2014, EXPERT REV ANTI-INFE, V12, P1265, DOI 10.1586/14787210.2014.948846; Fisman DN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-694; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Guiso N, 2014, J INFECTION, V68, pS119, DOI 10.1016/j.jinf.2013.09.022; He Q, 2012, EUROSURVEILLANCE, V9, P17; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; Hviid A, 2006, VACCINE, V24, P1401, DOI 10.1016/j.vaccine.2005.09.019; Institute of Public Health of Serbia, ANN REP COMM DIS 200; Jackson DW, 2014, EPIDEMIOL INFECT, V142, P672, DOI 10.1017/S0950268812003093; Jogi P, 2014, VACCINE, V32, P5311, DOI 10.1016/j.vaccine.2014.07.066; Kaczmarek MC, 2013, MED J AUSTRALIA, V198, P624, DOI 10.5694/mja13.10044; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lutsar I, 2009, EUR J PEDIATR, V168, P407, DOI 10.1007/s00431-008-0754-6; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; National Institute of Hygiene Department of Epidemiology and Chief Sanitary Inspectorate-Department of Communicable Diseases and Infection Prevention and Control, 2013, B NAT I PUBL HLTH; Paradowska-Stankiewicz Iwona, 2012, Przegl Epidemiol, V66, P211; Phillips Carl V, 2004, Epidemiol Perspect Innov, V1, P3, DOI 10.1186/1742-5573-1-3; Plotkin SA, 2014, CLIN INFECT DIS, V58, P830, DOI 10.1093/cid/cit934; Quinn HE, 2011, B WORLD HEALTH ORGAN, V89, P666, DOI 10.2471/BLT.11.086538; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Savrasova L, 2013, RIGAS STRANDINA U 20; Sheridan SL, 2015, VACCINE, V33, P5027, DOI 10.1016/j.vaccine.2015.08.021; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Skoff TH, 2012, ARCH PEDIAT ADOL MED, V166, P344, DOI 10.1001/archpediatrics.2011.1093; Smallridge WE, 2014, J INFECT DIS, V209, P1981, DOI 10.1093/infdis/jiu030; Statistics Lithuania, 2015, POP SOC STAT; Strebel P, 2001, J INFECT DIS, V183, P1353, DOI 10.1086/319853; Torres RSLA, 2015, J PEDIAT-BRAZIL, V91, P333, DOI [10.1016/j.jped.2014.09.004, 10.1016/j.jpedp.2015.04.006]; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; World Health Organization, 2003, WHO REC STAND SURV S; World Health Organization SAGE pertussis working group, 2014, BACKGR PAP WHO; Wymann MN, 2011, VACCINE, V29, P2058, DOI 10.1016/j.vaccine.2011.01.017; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	67	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155949	10.1371/journal.pone.0155949	http://dx.doi.org/10.1371/journal.pone.0155949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257822	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700026
J	Zhao, H; Zhang, FC; Zhu, Q; Wang, J; Hong, WX; Zhao, LZ; Deng, YQ; Qiu, S; Zhang, Y; Cai, WP; Cao, WC; Qin, CF				Zhao, Hui; Zhang, Fu-Chun; Zhu, Qin; Wang, Jian; Hong, Wen-Xin; Zhao, Ling-Zhai; Deng, Yong-Qiang; Qiu, Shuang; Zhang, Yu; Cai, Wei-Ping; Cao, Wu-Chun; Qin, Cheng-Feng			Epidemiological and Virological Characterizations of the 2014 Dengue Outbreak in Guangzhou, China	PLOS ONE			English	Article							VIRUS SEROTYPE 3; FEVER; GUANGDONG; SEQUENCE	Dengue used to be recognized as an imported and sporadic disease in China. Since June 2014, an unexpected large dengue outbreak has attacked Guangzhou, China, resulting in more than 40,000 cases. Among the 1,942 laboratory-confirmed hospitalized dengue cases, 121 were diagnosed as severe dengue according to the 2009 WHO guideline, and 2 patients finally died. Laboratory diagnosis and virus isolation demonstrated that the majority (96%) cases were caused by dengue virus serotype 1 (DENV-1), and the others by serotype 2 (DENV-2). 14 DENV strains were isolated from the sera of acute-phase dengue patients during this outbreak, and the complete envelope (E) gene of 12 DENV-1 strains and two DENV-2 strains were determined using RT-PCR assay. Phylogenetic analysis based on the E gene revealed the DENV-1 strains isolated during the outbreak belonged to genotype I and V, respectively. These isolates formed three clades. DENV-2 isolates were assigned to the same clade belonging to genotype cosmopolitan. These strains isolated in 2014 were closely related to the isolates obtained from the same province, Guangdong, in 2013. No amino acid mutations known to increase virulence were identified throughout the E protein of isolates in 2014. These results indicate that dengue is turning into endemic in Guangdong, China, and extensive seroepidemiological investigation and mosquito control measures are critically needed in the future.	[Zhao, Hui; Deng, Yong-Qiang; Zhang, Yu; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China; [Zhang, Fu-Chun; Zhu, Qin; Wang, Jian; Hong, Wen-Xin; Zhao, Ling-Zhai; Qiu, Shuang; Cai, Wei-Ping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Guangzhou Medical University	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807	Guangzhou Science and Technology Program for Public Wellbeing [2014Y2-00185, 201508020263]; Special Program of Guangdong Provincial Department of Science and Technology [2013A020229001, 2013A020229002]; Special Program of National Science and Technology of China [2013ZX10004805]; National Natural Science Foundation of China [81301491, 31270974]; Excellent Young Scientist Program of the National Natural Science Foundation of China [81522025]; Newton Advanced Fellowship from the Academy of Medical Sciences, UK; NSFC of China [81661130162]	Guangzhou Science and Technology Program for Public Wellbeing; Special Program of Guangdong Provincial Department of Science and Technology; Special Program of National Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship from the Academy of Medical Sciences, UK; NSFC of China(National Natural Science Foundation of China (NSFC))	This study was supported by Guangzhou Science and Technology Program for Public Wellbeing (No. 2014Y2-00185 and No. 201508020263), the Special Program of Guangdong Provincial Department of Science and Technology (2013A020229001 and 2013A020229002), the Special Program of National Science and Technology of China (No. 2013ZX10004805), and the National Natural Science Foundation of China (No. 81301491 and No. 31270974). CF Qin was supported by the Excellent Young Scientist Program of the National Natural Science Foundation of China (No. 81522025) and the Newton Advanced Fellowship from the Academy of Medical Sciences, UK and the NSFC of China (No. 81661130162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hong WX, 2013, J CLIN VIROL, V57, P184, DOI 10.1016/j.jcv.2013.02.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.26421; Jiang Tao, 2012, Virol J, V9, P125, DOI 10.1186/1743-422X-9-125; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Li TG, 2013, BIOMED ENVIRON SCI, V26, P994, DOI 10.3967/bes2013.036; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005; Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9; Schmidt-Chanasit J, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.3.20681; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Wang L J, 2014, ECOL ECON, V04, P29, DOI DOI 10.1016/J.JINF.2015.04.018; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392; Zhao H, 2014, SCI CHINA LIFE SCI, V57, P1149, DOI 10.1007/s11427-014-4782-3; Zhao H, 2012, J VIROL, V86, P7021, DOI 10.1128/JVI.00858-12	25	23	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156548	10.1371/journal.pone.0156548	http://dx.doi.org/10.1371/journal.pone.0156548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257804	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700076
J	Ardrey, J; Desmond, N; Tolhurst, R; Mortimer, K				Ardrey, Jane; Desmond, Nicola; Tolhurst, Rachel; Mortimer, Kevin			The Cooking and Pneumonia Study (CAPS) in Malawi: A Nested Pilot of Photovoice Participatory Research Methodology	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HOUSEHOLD AIR-POLLUTION; HEALTH	The Cooking and Pneumonia Study (CAPS) is a village-level randomised controlled trial of an advanced cookstove intervention to prevent pneumonia in children under the age of 5 in rural Malawi (www.capstudy.org). The trial offers a unique opportunity to gain understanding about the social and cultural factors that may facilitate sustained use of improved cook-stoves. In January 2015, the use of Photovoice as a participatory research methodology was piloted at the CAPS Chikhwawa site. Photovoice is a photographic technique that allows communities (including women and marginalised groups) to share knowledge about their perspectives and priorities. Four households were given digital cameras and asked to collect images over 24-48 hours and were then interviewed on film about their selection. This resulted in over 400 images and a one hour long film that revealed community concerns and could be thematically analysed. The collection of interview data through film was useful for capturing discussion and was acceptable to participants. Photovoice is a feasible participatory research methodology that can play a valuable role in qualitative studies of improved cookstove adoption in challenging resource poor settings.	[Ardrey, Jane; Desmond, Nicola; Tolhurst, Rachel; Mortimer, Kevin] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Ardrey, Jane; Desmond, Nicola] Malawi Liverpool Wellcome Trust, Blantyre, Malawi	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi	Ardrey, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.; Ardrey, J (corresponding author), Malawi Liverpool Wellcome Trust, Blantyre, Malawi.	jane.ardrey@lstmed.ac.uk	Desmond, Nicola/ABA-6504-2020; Desmond, Nicola/GYQ-8574-2022	Desmond, Nicola/0000-0002-2874-8569; Tolhurst, Rachel/0000-0002-3005-6641; Ardrey, Jane/0000-0003-4558-5113; Mortimer, Kevin/0000-0002-8118-8871	Wellcome Trust, through an Engaging Science Grant, 'The Cooking and Pneumonia Study: a focus on food' [106977/Z/15/Z]; CAPS Joint Global Health Trials grant - Wellcome Trust; Medical Research Council UK; Department of International Development UK [MR/K006533/1]; BREATHE Partnership - UK Medical Research Council (MRC) [MR/L009242/1]; BREATHE Partnership - UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MR/L009242/1]; MRC [MR/L009242/1, MR/K006533/1, MR/L002515/1] Funding Source: UKRI; Medical Research Council [MR/L002515/1, MR/K006533/1, MR/L009242/1] Funding Source: researchfish; National Institute for Health Research [CL-2006-12-004] Funding Source: researchfish	Wellcome Trust, through an Engaging Science Grant, 'The Cooking and Pneumonia Study: a focus on food'; CAPS Joint Global Health Trials grant - Wellcome Trust; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of International Development UK; BREATHE Partnership - UK Medical Research Council (MRC); BREATHE Partnership - UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This pilot study was funded by the Wellcome Trust, through an Engaging Science Grant, 'The Cooking and Pneumonia Study: a focus on food' (reference, 106977/Z/15/Z). Additional support was provided through the CAPS Joint Global Health Trials grant funded by the Wellcome Trust, Medical Research Council UK, Department of International Development UK (reference, MR/K006533/1) and the BREATHE Partnership, which is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (reference, MR/L009242/1).	Action P., 2015, GENDER LIVELIHOODS I; Bisung E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/903025; Catalani C, 2010, HEALTH EDUC BEHAV, V37, P424, DOI 10.1177/1090198109342084; Chamber R., 1992, I DEV STUDIES DISCUS, V311; Cornwall A., 1996, PARTICIPATORY RES HL; Dockery G., 1996, PARTICIPATORY RES HL; Freedman DA, 2014, BRIT J SOC WORK, V44, P1301, DOI 10.1093/bjsw/bcs173; Freire P, 1996, PEDAGOGY OPPRESSED; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Guijt I., 1998, MYTH COMMUNITY; Lambe F., 2015, IDENTIFYING BEHAV DR; Lewis JJ, 2012, ENVIRON HEALTH PERSP, V120, P637, DOI 10.1289/ehp.1104194; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Mortimer K, 2012, CHEST, V142, P1308, DOI 10.1378/chest.12-1596; Pool R., 2005, MED ANTHROPOL; Prins E, 2010, ACTION RES-LONDON, V8, P426, DOI 10.1177/1476750310374502; Puzzolo E, 2013, WHAT ARE FACTORS INF; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Republic of Malawi: Integrated Household Survey, 2012, INT HOUS SURV; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Thomas E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2024-7; Wallerstein N, 2010, AM J PUBLIC HEALTH, V100, pS40, DOI 10.2105/AJPH.2009.184036; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Wang CC, 1999, J WOMENS HEALTH, V8, P185, DOI 10.1089/jwh.1999.8.185; Wang CC, 2001, HEALTH EDUC BEHAV, V28, P560, DOI 10.1177/109019810102800504; WHO, 2014, GLOB HLTH OBS; World Bank, 2011, HOUS COOK STOV ENV H	29	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156500	10.1371/journal.pone.0156500	http://dx.doi.org/10.1371/journal.pone.0156500			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254291	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700034
J	Gong, XH; Huang, LD; Liu, X; Li, CY; Mao, XH; Liu, WZ; Huang, X; Chu, HT; Wang, YM; Wu, WQ; Lu, J				Gong, Xuehao; Huang, Leidan; Liu, Xin; Li, Chunyue; Mao, Xuhua; Liu, Weizong; Huang, Xian; Chu, Haiting; Wang, Yumei; Wu, Wanqing; Lu, Jun			Correlation Analysis between Polysomnography Diagnostic Indices and Heart Rate Variability Parameters among Patients with Obstructive Sleep Apnea Hypopnea Syndrome	PLOS ONE			English	Article							BLOOD-PRESSURE; AUTONOMIC ACTIVITY; SPECTRAL-ANALYSIS; RR-INTERVAL; ASSOCIATION; CATECHOLAMINES; OSCILLATIONS; DISEASE; RISK	Heart rate variability (HRV) can reflect the changes in the autonomic nervous system (ANS) that are affected by apnea or hypopnea events among patients with obstructive sleep apnea hypopnea syndrome (OSAHS). To evaluate the possibility of using HRV to screen for OSAHS, we investigated the relationship between HRV and polysomnography (PSG) diagnostic indices using electrocardiography (ECG) and PSG data from 25 patients with OSAHS and 27 healthy participants. We evaluated the relationship between various PSG diagnostic indices (including the apnea hypopnea index [AHI], micro-arousal index [MI], oxygen desaturation index [ODI]) and heart rate variability (HRV) parameters using Spearman's correlation analysis. Moreover, we used multiple linear regression analyses to construct linear models for the AHI, MI, and ODI. In our analysis, the AHI was significantly associated with relative powers of very low frequency (VLF [%]) (r = 0.641, P = 0.001), relative powers of high frequency (HF [%]) (r = -0.586, P = 0.002), ratio between low frequency and high frequency powers (LF/HF) (r = 0.545, P = 0.049), normalized powers of low frequency (LF [n.u.]) (r = 0.506, P = 0.004), and normalized powers of high frequency (HF [n.u.]) (r = -0.506, P = 0.010) among patients with OSAHS. The MI was significantly related to standard deviation of RR intervals (SDNN) (r = 0.550, P = 0.031), VLF [%] (r = 0.626, P = 0.001), HF [%] (r = -0.632, P = 0.001), LF/HF (r = 0.591, P = 0.011), LF [n.u.] (r = 0.553, P = 0.004), HF [n.u.] (r = -0.553, P = 0.004), and absolute powers of very low frequency (VLF [abs]) (r = 0.525, P = 0.007) among patients with OSAHS. The ODI was significantly correlated with VLF [%] (r = 0.617, P = 0.001), HF [%] (r = -0.574, P = 0.003), LF [n.u.] (r = 0.510, P = 0.012), and HF [n.u.] (r = -0.510, P = 0.012) among patients with OSAHS. The linear models for the PSG diagnostic indices were AHI = -38.357+1.318VLF [%], MI = -13.389+11.297LF/HF+0.266SDNN, and ODI = -55.588+1.715VLF [%]. However, the PSG diagnostic indices were not related to the HRV parameters among healthy participants. Our analysis suggests that HRV parameters are powerful tools to screen for OSAHS patients in place of PSG monitoring.	[Gong, Xuehao; Huang, Leidan; Liu, Weizong; Huang, Xian; Chu, Haiting] Shenzhen Univ, Peoples Hosp Shenzhen 2, Affiliated Hosp 1, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China; [Huang, Leidan; Mao, Xuhua] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Liu, Xin; Li, Chunyue; Wu, Wanqing] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Guangdong, Peoples R China; [Mao, Xuhua] Shenzhen Univ, Peoples Hosp Shenzhen 2, Affiliated Hosp 1, Dept Thyroid & Breast Surg, Shenzhen, Guangdong, Peoples R China; [Huang, Xian; Chu, Haiting] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Wang, Yumei] Xili Peoples Hosp Shenzhen, Dept Resp Med, Shenzhen, Guangdong, Peoples R China; [Lu, Jun] Jinan Univ, Peoples Hosp Shenzhen, Clin Coll 2, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Guangzhou Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shenzhen University; Anhui Medical University; Jinan University	Wu, WQ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Guangdong, Peoples R China.; Lu, J (corresponding author), Jinan Univ, Peoples Hosp Shenzhen, Clin Coll 2, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China.	wq.wu@siat.ac.cn; lucy_youran@sina.com			Shenzhen Science and Technology Innovation Committee [JCYJ20140414170821285, CXZZ20140909004122087, JCYJ20150529164154046]; Guangdong Image-guided Therapy Innovation Team [2011S013]	Shenzhen Science and Technology Innovation Committee; Guangdong Image-guided Therapy Innovation Team	This work was supported by Shenzhen Science and Technology Innovation Committee (JCYJ20140414170821285, CXZZ20140909004122087, and JCYJ20150529164154046), http://www.szsti.gov.cn/; and Guangdong Image-guided Therapy Innovation Team (2011S013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Akselrod S., 1998, AUTONOMIC RESPONSES, P101; Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Aydin M, 2004, TEX HEART I J, V31, P132; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; [Diagnostic Classification Steering Committee American Sleep Disorders Association], 1990, INT CLASS SLEEP DIS, Vxii; DUPREZ D, 1995, EUR HEART J, V16, P1050, DOI 10.1093/oxfordjournals.eurheartj.a061046; EWING DJ, 1980, Q J MED, V49, P95; Fleisher LA, 1996, CLIN SCI, V90, P97, DOI 10.1042/cs0900097; FLETCHER EC, 1987, SLEEP, V10, P35, DOI 10.1093/sleep/10.1.35; Francis DP, 2000, CLIN SCI, V99, P125, DOI 10.1042/CS20000016; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Greenwood J, 1997, BR J CARDIOL, V4, P183; Greenwood J, 1997, BR J CARDIOL, V4, P154; Greenwood JP, 1998, HOSP MED, V59, P714; GUILLEMINAULT C, 1984, LANCET, V1, P126; Gula LJ, 2003, ANN NONINVAS ELECTRO, V8, P144, DOI 10.1046/j.1542-474X.2003.08209.x; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JAFFE RS, 1994, J AUTONOM NERV SYST, V46, P37, DOI 10.1016/0165-1838(94)90142-2; Kim YS, 2015, J CRANIOFAC SURG, V26, P1592, DOI 10.1097/SCS.0000000000001782; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lucini D, 1992, Cardiologia, V37, P729; MARRONE O, 1993, CHEST, V103, P722, DOI 10.1378/chest.103.3.722; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Olson EJ, 2003, MAYO CLIN PROC, V78, P1545, DOI 10.4065/78.12.1545; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Park DH, 2008, J KOREAN MED SCI, V23, P226, DOI 10.3346/jkms.2008.23.2.226; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Ponikowski P, 1997, AM J PHYSIOL-HEART C, V272, pH438, DOI 10.1152/ajpheart.1997.272.1.H438; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roche F, 1999, CIRCULATION, V100, P1411, DOI 10.1161/01.CIR.100.13.1411; Sateia MJ, 2003, CLIN CHEST MED, V24, P249, DOI 10.1016/S0272-5231(03)00014-5; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shiomi T, 1996, SLEEP, V19, P370, DOI 10.1093/sleep/19.5.370; Tascilar E, 2009, TOHOKU J EXP MED, V219, P187, DOI 10.1620/tjem.219.187; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	44	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156628	10.1371/journal.pone.0156628	http://dx.doi.org/10.1371/journal.pone.0156628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253187	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700045
J	Romero-Romero, ML; Risso, VA; Martinez-Rodriguez, S; Gaucher, EA; Ibarra-Molero, B; Sanchez-Ruiz, JM				Luisa Romero-Romero, M.; Risso, Valeria A.; Martinez-Rodriguez, Sergio; Gaucher, Eric A.; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.			Selection for Protein Kinetic Stability Connects Denaturation Temperatures to Organismal Temperatures and Provides Clues to Archaean Life	PLOS ONE			English	Article							LABORATORY RESURRECTIONS; ENERGETICS; MUTATIONS; EVOLUTION; RECONSTRUCTION; IDENTIFICATION; COOPERATIVITY; CONSERVATION; RIBONUCLEASE; MECHANISMS	The relationship between the denaturation temperatures of proteins (T-m values) and the living temperatures of their host organisms (environmental temperatures: T-ENV values) is poorly understood. Since different proteins in the same organism may show widely different T-m's, no simple universal relationship between T-m and T-ENV should hold, other than T-m >= T-ENV. Yet, when analyzing a set of homologous proteins from different hosts, T-m's are oftentimes found to correlate with T-ENV's but this correlation is shifted upward on the T-m axis. Supporting this trend, we recently reported T-m's for resurrected Precambrian thioredoxins that mirror a proposed environmental cooling over long geological time, while remaining a shocking similar to 50 degrees C above the proposed ancestral ocean temperatures. Here, we show that natural selection for protein kinetic stability (denaturation rate) can produce a T-m <-> T-ENV correlation with a large upward shift in T-m. A model for protein stability evolution suggests a link between the T-m shift and the in vivo lifetime of a protein and, more specifically, allows us to estimate ancestral environmental temperatures from experimental denaturation rates for resurrected Precambrian thioredoxins. The T-ENV values thus obtained match the proposed ancestral ocean cooling, support comparatively high Archaean temperatures, and are consistent with a recent proposal for the environmental temperature (above 75 degrees C) that hosted the last universal common ancestor. More generally, this work provides a framework for understanding how features of protein stability reflect the environmental temperatures of the host organisms.	[Luisa Romero-Romero, M.; Risso, Valeria A.; Martinez-Rodriguez, Sergio; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Gaucher, Eric A.] Georgia Inst Technol, Sch Chem & Biochem, Sch Biol, Atlanta, GA 30332 USA; [Gaucher, Eric A.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Luisa Romero-Romero, M.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Granada; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Weizmann Institute of Science	Sanchez-Ruiz, JM (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain.	sanchezr@ugr.es	Romero Romero, Maria Luisa/B-2136-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; risso, valeria a/H-2921-2015	Romero Romero, Maria Luisa/0000-0003-3397-6758; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Sanchez Ruiz, Jose Manuel/0000-0002-9056-3928; risso, valeria a/0000-0001-8262-8843	Feder Funds; Spanish Ministry of Economy and Competitiveness [BIO2012-34937, BIO2015-66426-R, CSD2009-00088]; Junta de Andalucia [CVI-12483, P09-CVI-5073]; DuPont Young Professor Award; NASA Exobiology [NNX13AI08G, NNX13AI10G]	Feder Funds(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); DuPont Young Professor Award; NASA Exobiology(National Aeronautics & Space Administration (NASA))	This work was supported by Feder Funds, Grants BIO2012-34937, BIO2015-66426-R and CSD2009-00088 (JMSR) from the Spanish Ministry of Economy and Competitiveness, Grant CVI-12483 (JMSR) from the "Junta de Andalucia", Grant P09-CVI-5073 (BIM) from the "Junta de Andalucia", DuPont Young Professor Award (EAG) and Grants NNX13AI08G & NNX13AI10G (EAG) from NASA Exobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Llera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017068; Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bohley P, 1995, NATURWISSENSCHAFTEN, V82, P544, DOI 10.1007/s001140050230; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Cisneros A, 2009, LAB CLIN RES BODY TE, P392; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Ferguson A, 2009, J MOL BIOL, V389, P619, DOI 10.1016/j.jmb.2009.04.011; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FREIRE E, 1992, BIOCHEMISTRY-US, V31, P250, DOI 10.1021/bi00116a034; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Georgescu RE, 2001, EUR J BIOCHEM, V268, P1477, DOI 10.1046/j.1432-1327.2001.02014.x; Godoy-Ruiz R, 2005, BIOPHYS J, V89, P3320, DOI 10.1529/biophysj.105.067025; Godoy-Ruiz R, 2004, J MOL BIOL, V336, P313, DOI 10.1016/j.jmb.2003.12.048; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Hart KM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001994; HARTL DL, 1985, GENETICS, V111, P655; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGHKIN HR, 1958, AM J BOT, V45, P626, DOI 10.2307/2439237; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; Hren MT, 2009, NATURE, V462, P205, DOI 10.1038/nature08518; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; IbarraMolero B, 1996, BIOCHEMISTRY-US, V35, P14689, DOI 10.1021/bi961836a; Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kaltenbach M, 2014, METHODS MOL BIOL, V1179, P69, DOI 10.1007/978-1-4939-1053-3_5; Kasting JF, 2013, SCIENCE, V339, P44, DOI 10.1126/science.1232662; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; LADBURY JE, 1994, BIOCHEMISTRY-US, V33, P3688, DOI 10.1021/bi00178a027; Romero-Romero ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023050; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Ohsumi Y, 2006, IUBMB LIFE, V58, P363, DOI 10.1080/15216540600758539; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Pedone E, 1999, BIOCHEM J, V339, P309, DOI 10.1042/0264-6021:3390309; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Pey AL, 2008, PROTEINS, V71, P165, DOI 10.1002/prot.21670; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Risso VA, 2015, MOL BIOL EVOL, V32, P440, DOI 10.1093/molbev/msu312; Risso VA, 2014, PROTEINS, V82, P887, DOI 10.1002/prot.24575; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Sanchez IE, 2006, J MOL BIOL, V363, P422, DOI 10.1016/j.jmb.2006.08.020; Sanchez-Romero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070013; Sanchez-Ruiz JM, 2007, BIOPHYS CHEM, V126, P43, DOI 10.1016/j.bpc.2006.05.021; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; van den Boorn SHJM, 2007, GEOLOGY, V35, P939, DOI 10.1130/G24096A.1; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WENT FW, 1953, ANNU REV PLANT PHYS, V4, P347, DOI 10.1146/annurev.pp.04.060153.002023; Wijma HJ, 2013, CURR OPIN STRUC BIOL, V23, P588, DOI 10.1016/j.sbi.2013.04.008; Willems A., 2006, PROKARYOTES; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wordsworth R, 2013, SCIENCE, V339, P64, DOI 10.1126/science.1225759; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	95	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156657	10.1371/journal.pone.0156657	http://dx.doi.org/10.1371/journal.pone.0156657			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253436	Green Submitted, gold, Green Published			2022-12-27	WOS:000377218700048
J	Pericleous, C; Ferreira, I; Borghi, O; Pregnolato, F; McDonnell, T; Garza-Garcia, A; Driscoll, P; Pierangeli, S; Isenberg, D; Ioannou, Y; Giles, I; Meroni, PL; Rahman, A				Pericleous, Charis; Ferreira, Isabel; Borghi, Orietta; Pregnolato, Francesca; McDonnell, Thomas; Garza-Garcia, Acely; Driscoll, Paul; Pierangeli, Silvia; Isenberg, David; Ioannou, Yiannis; Giles, Ian; Meroni, Pier Luigi; Rahman, Anisur			Measuring IgA Anti-beta 2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROOF-OF-CONCEPT; BETA(2)-GLYCOPROTEIN I; ANTICARDIOLIPIN ANTIBODIES; INTERNATIONAL-CONGRESS; BETA2-GLYCOPROTEIN I; REVISED CRITERIA; GLYCOPROTEIN-I; SYNDROME APS; AUTOANTIBODIES	Introduction Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and beta(2)-glycoprotein I (a beta(2)GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the key antigenic epitopes of beta(2)GPI, could add value to these current tests. We performed an observational, multicenter cohort study to evaluate the utility of IgG, IgM and IgA assays to each of CL, beta(2)GPI and DI in APS. Methods Serum from 230 patients with APS (n = 111), SLE but not APS (n = 119), and 200 healthy controls were tested for IgG, IgM and IgA aCL, a beta(2)GPI and aDI activity. Patients with APS were further classified into thrombotic or obstetric APS. Logistic regression and receiver operator characteristic analyses were employed to compare results from the nine different assays. Results All assays displayed good specificity for APS; IgG aCL and IgG a beta(2)GPI assays however, had the highest sensitivity. Testing positive for IgA a beta(2)GPI resulted in a higher hazard ratio for APS compared to IgM a beta(2)GPI. Positive IgG, IgM or IgA aDI were all associated with APS, and in subjects positive for aCL and/or a beta(2)GPI, the presence of aDI raised the hazard ratio for APS by 3-5 fold. IgG aCL, a beta(2)GPI, aDI and IgA aDI were associated with thrombotic but not obstetric complications in patients with APS. Conclusion Measuring IgG aDI and IgA a beta(2)GPI and aDI may be useful in the management of patients with APS, particularly thrombotic APS.	[Pericleous, Charis; Ferreira, Isabel; McDonnell, Thomas; Isenberg, David; Ioannou, Yiannis; Giles, Ian; Rahman, Anisur] UCL, Div Med, Ctr Rheumatol Res, London, England; [Borghi, Orietta; Pregnolato, Francesca; Meroni, Pier Luigi] IRCCS Ist Auxol Italiano, Lab Immunorheumatol, Milan, Italy; [Garza-Garcia, Acely; Driscoll, Paul] MRC Natl Inst Med Res, Struct Biol, London, England; [Pierangeli, Silvia] Univ Texas Med Branch, Dept Internal Med, Div Rheumatol, Galveston, TX 77555 USA; [Ioannou, Yiannis] UCL Hosp, Arthrit Res UK Ctr Adolescent Rheumatol, London, England; [Ioannou, Yiannis] Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England	University of London; University College London; IRCCS Istituto Auxologico Italiano; MRC National Institute for Medical Research; University of Texas System; University of Texas Medical Branch Galveston; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Pericleous, C (corresponding author), UCL, Div Med, Ctr Rheumatol Res, London, England.	c.pericleous@ucl.ac.uk	Giles, Ian/G-7471-2015; meroni, pier luigi/K-8473-2016; Pregnolato, Francesca/AAA-6698-2020; McDonnell, Thomas/Z-2464-2019	Giles, Ian/0000-0001-8913-3894; meroni, pier luigi/0000-0002-3394-1451; Pregnolato, Francesca/0000-0003-0574-5792; Pericleous, Charis/0000-0001-8804-0493; Borghi, Maria Orietta/0000-0001-8967-9678; McDonnell, Thomas/0000-0002-1712-9957; Garza-Garcia, Acely/0000-0003-0307-0138	Arthritis Research UK [19423, 20164]; University College London Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council [U117574559]; Medical Research Council [1087259] Funding Source: researchfish; Rosetrees Trust [M281] Funding Source: researchfish; Versus Arthritis [19423] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); University College London Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	This work was supported by the following sources of funding: 1) Arthritis Research UK: Grant number 19423 - recipients AR, IG, YI, DI; 2) Arthritis Research UK: Grant number 20164 - recipient YI (www.arthritisresearchuk.org/); 3) University College London Hospitals National Institute for Health Research Biomedical Research Centre - support ethically approved work using human samples (www.uclhospitals.brc.nihr.ac.uk/); and 4) Medical Research Council: Grant number U117574559 - recipients AG, PD (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2014, BLOOD, V123, P3478, DOI 10.1182/blood-2013-11-537704; Akhter E, 2013, J RHEUMATOL, V40, P282, DOI 10.3899/jrheum.120084; Andreoli L, 2015, ARTHRITIS RHEUMATOL, V67, P2196, DOI 10.1002/art.39187; Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; Andreoli L, 2011, ANN RHEUM DIS, V70, P380, DOI 10.1136/ard.2010.137281; Banzato A, 2011, THROMB RES, V128, P583, DOI 10.1016/j.thromres.2011.04.021; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Cousins L, 2015, ANN RHEUM DIS, V74, P317, DOI 10.1136/annrheumdis-2014-206483; Craig RJM, 2008, HLTH SURVEY ENGLAND; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; De Laat B, 2009, J THROMB HAEMOST, V7, P1767, DOI 10.1111/j.1538-7836.2009.03588.x; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; de Laat B, 2011, CURR RHEUMATOL REP, V13, P70, DOI 10.1007/s11926-010-0144-8; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giles I, 2009, J IMMUNOL, V182, P4836, DOI 10.4049/jimmunol.0804241; Giles IP, 2003, MOL IMMUNOL, V40, P49, DOI 10.1016/S0161-5890(03)00100-7; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ioannou Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-8; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.x; Ioannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002/art.22306; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 2006, J AUTOIMMUN, V27, P266, DOI 10.1016/j.jaut.2006.09.007; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073/pnas.95.26.15542; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Mahler M, 2012, AUTOIMMUN REV, V12, P313, DOI 10.1016/j.autrev.2012.05.006; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Meroni PL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4549; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mondejar R, 2014, CLIN CHIM ACTA, V431, P174, DOI 10.1016/j.cca.2014.01.047; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Pericleous C, 2015, RHEUMATOLOGY, V54, P722, DOI 10.1093/rheumatology/keu360; Pericleous C, 2011, MOL IMMUNOL, V49, P56, DOI 10.1016/j.molimm.2011.07.024; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; Pierangeli SS, 2000, THROMB HAEMOSTASIS, V84, P388; Reddel SW, 2000, J AUTOIMMUN, V15, P91, DOI 10.1006/jaut.2000.0427; Swadzba J, 2014, LUPUS, V23, P395, DOI 10.1177/0961203314520841; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012280; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Willis R, 2013, ARTHRITIS RHEUM-US, V65, pS3; Willis R, 2012, SEMIN THROMB HEMOST, V38, P360, DOI 10.1055/s-0032-1313564; Wolgast L, 2015, J THROMB HAEMOST, V13, P13	47	35	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156407	10.1371/journal.pone.0156407	http://dx.doi.org/10.1371/journal.pone.0156407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253369	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700026
J	Tuzon, P; Solbes, J				Tuzon, Paula; Solbes, Jordi			Particle Physics in High School: A Diagnose Study	PLOS ONE			English	Article							TEACHERS KNOWLEDGE; MODELS	The science learning process improves when the contents are connected to students' lives. Particle physics has had a great impact in our society in the last years and has changed the theoretical picture about matter fundamental dynamics. Thus, we think that academic contents about matter components and interactions should be updated. With this study we aim to characterize the level of knowledge of high school students about this topic. We built a test with questions about classical atomic models, particle physics, recent discoveries, social implications and students opinions about it. Contrary to our first suspicion, students' answers show a high variability. They have new physics ideas and show a great interest towards modern concepts. We suggest including an updated view of this topic as part of the curriculum.	[Tuzon, Paula; Solbes, Jordi] Univ Valencia, Fac Magisteri, Sci Educ Dept, Valencia 46022, Spain	University of Valencia	Tuzon, P (corresponding author), Univ Valencia, Fac Magisteri, Sci Educ Dept, Valencia 46022, Spain.	paula.tuzon@uv.es	Solbes, Jordi/A-7280-2016; tuzon, paula/L-3653-2014	Solbes, Jordi/0000-0002-8220-209X; tuzon, paula/0000-0003-1344-3751				Acher A, 2007, SCI EDUC, V91, P398, DOI 10.1002/sce.20196; Allday J., 1999, PHYS EDUC, V32, P327; Arons A, 1990, GUIDE INTRO PHYISCS, V28; AUBRECHT GJ, 1989, AM J PHYS, V57, P352, DOI 10.1119/1.16047; Barlow R, 2000, PHYS EDUC, V27, P92; Beringer J, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.010001; Chabay RW, 1999, AM J PHYS, V67, P1045, DOI 10.1119/1.19180; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; FISCHLER H, 1992, INT J SCI EDUC, V14, P181, DOI 10.1080/0950069920140206; Fisher RA, 1954, STAT METHODS RES WOR, V12; GIL D, 1993, INT J SCI EDUC, V15, P255, DOI 10.1080/0950069930150303; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Harald C, 1999, MATH METHODS STAT; HOLM S, 1979, SCAND J STAT, V6, P65; Johnson-Glenberg MC, 2012, P GAM LEARN SOC C, V8.0, P8; Mardia KV, 1979, MULTIVARIATE ANAL, V2; Ostermann F, 2000, ENSENANZA CIENCIAS R, V18, P391; Peffer ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120638; Perez H., 2003, ENSEN CIENC, V21, P135; Pipper CB, 2008, R PROJECT STAT COMPU; Sinarcas V, 2013, ENSEN CIENC, V31, P9, DOI 10.5565/rev/enscien/v31n3.768; Solbes J, 1997, SCI EDUC, V81, P377, DOI 10.1002/(SICI)1098-237X(199707)81:4<377::AID-SCE1>3.0.CO;2-9; Solbes J., 2003, SCI ED, V12, P703, DOI [DOI 10.1023/A:1025660420721, 10.1023/A:1025660420721]; Solbes J, 2014, DIDACTICA CIENCIAS E, V4379, P175; Van Driel JH, 2002, INT J SCI EDUC, V24, P1255, DOI 10.1080/09500690210126711; Van Driel JH, 1999, INT J SCI EDUC, V21, P1141, DOI 10.1080/095006999290110; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482	27	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156526	10.1371/journal.pone.0156526	http://dx.doi.org/10.1371/journal.pone.0156526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253377	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700037
J	Hristova, D; Rutherford, A; Anson, J; Luengo-Oroz, M; Mascolo, C				Hristova, Desislava; Rutherford, Alex; Anson, Jose; Luengo-Oroz, Miguel; Mascolo, Cecilia			The International Postal Network and Other Global Flows as Proxies for National Wellbeing	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ORGANIZATION	The digital exhaust left by flows of physical and digital commodities provides a rich measure of the nature, strength and significance of relationships between countries in the global network. With this work, we examine how these traces and the network structure can reveal the socioeconomic profile of different countries. We take into account multiple international networks of physical and digital flows, including the previously unexplored international postal network. By measuring the position of each country in the Trade, Postal, Migration, International Flights, IP and Digital Communications networks, we are able to build proxies for a number of crucial socioeconomic indicators such as GDP per capita and the Human Development Index ranking along with twelve other indicators used as benchmarks of national well-being by the United Nations and other international organisations. In this context, we have also proposed and evaluated a global connectivity degree measure applying multiplex theory across the six networks that accounts for the strength of relationships between countries. We conclude by showing how countries with shared community membership over multiple networks have similar socioeconomic profiles. Combining multiple flow data sources can help understand the forces which drive economic activity on a global level. Such an ability to infer proxy indicators in a context of incomplete information is extremely timely in light of recent discussions on measurement of indicators relevant to the Sustainable Development Goals.	[Hristova, Desislava; Mascolo, Cecilia] Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England; [Rutherford, Alex; Luengo-Oroz, Miguel] United Nations Global Pulse, New York, NY USA; [Anson, Jose] Universal Postal Union, Bern, Switzerland	University of Cambridge	Hristova, D (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	desislava.hristova@cl.cam.ac.uk	VARRECCHIA, TIWANA/AAJ-8712-2021; Luengo-Oroz, Miguel A/C-2245-2011	Luengo-Oroz, Miguel A/0000-0002-8694-2001; Mascolo, Cecilia/0000-0001-9614-4380	Project LASAGNE (STREP) [318132]; European Commission; EPSRC through Grant GALE [EP/K019392]; Engineering and Physical Sciences Research Council [EP/K019392/1] Funding Source: researchfish; EPSRC [EP/K019392/1] Funding Source: UKRI	Project LASAGNE (STREP); European Commission(European CommissionEuropean Commission Joint Research Centre); EPSRC through Grant GALE(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Desislava Hristova received funding from the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission and EPSRC Grant GALE (EP/K019392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Desislava Hristova was supported by the Project LASAGNE, Contract No. 318132 (STREP), funded by the European Commission and EPSRC through Grant GALE (EP/K019392). We are grateful to Andrei Bejan for the statistics consultation and Noa Zilberman for advice on the DIMES Project data.	Acemoglu D., 2013, NETWORK ORIGINS LARG; Anson J, 2013, ADV REGUL ECON, P36; Arnulf JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106361; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Barigozzi M, 2011, COMM COM INF SC, V116, P163; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Bianconi G, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062806; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Brodka P., 2011, 2011 International Conference on Computational Aspects of Social Networks (CASoN 2011), P237, DOI 10.1109/CASON.2011.6085951; Cardillo A, 2013, EUR PHYS J-SPEC TOP, V215, P23, DOI 10.1140/epjst/e2013-01712-8; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Harmon D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131871; Haythornthwaite C., 2005, Information Communication & Society, V8, P125, DOI 10.1080/13691180500146185; Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581; Hristova D, 2014, KEEP YOUR FRIENDS CL; Iacovacci J, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.042806; Kaluza P, 2010, J R SOC INTERFACE, V7, P1093, DOI 10.1098/rsif.2009.0495; Kivela M, 2014, J COMPLEX NETW, V2, P203, DOI 10.1093/comnet/cnu016; Kwak H., 2010, WWW, P591, DOI DOI 10.1145/1772690.1772751; LLORENTE A, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0128692; Magno G, 2014, LECT NOTES COMPUT SC, V8851, P121, DOI 10.1007/978-3-319-13734-6_9; Menichetti G, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062817; Mucha PJ, 2010, SCIENCE, V328, P876, DOI 10.1126/science.1184819; Nicosia V, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032805; Rutherford A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074628; Schich M, 2014, SCIENCE, V345, P558, DOI 10.1126/science.1240064; Shavitt Y, 2005, ACM SIGCOMM COMP COM, V35, P71, DOI 10.1145/1096536.1096546; Smith R, 1996, BRIT MED J, V313, P1572, DOI 10.1136/bmj.313.7072.1572; State B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122543; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Tufekci Zeynep, 2014, ICWSM, P505; Ugander J., 2011, ARXIV11114503; UN Global Pulse, 2012, BIG DATA DEV CHALLEN; United Nations, 2014, WORLD COUNTS MOBILIS; Universal Postal Union EPSP, 2012, MEAS POST E SERV DEV	41	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155976	10.1371/journal.pone.0155976	http://dx.doi.org/10.1371/journal.pone.0155976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248142	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700024
J	Menezes, L; Canedo, C; Batalha, H; Garda, AA; Gehara, M; Napoli, MF				Menezes, Lucas; Canedo, Clarissa; Batalha-Filho, Henrique; Garda, Adrian Antonio; Gehara, Marcelo; Napoli, Marcelo Felgueiras			Multilocus Phylogeography of the Treefrog Scinax eurydice (Anura, Hylidae) Reveals a Plio-Pleistocene Diversification in the Atlantic Forest	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; SPECIES LIMITS; DIVERSITY; NUCLEAR; BIODIVERSITY; BIOGEOGRAPHY; SYSTEMATICS; STABILITY	We aim to evaluate the genetic structure of an Atlantic Forest amphibian species, Scinax eurydice, testing the congruence among patterns identified and proposed by the literature for Pleistocene refugia, microrefugia, and geographic barriers to gene flow such as major rivers. Furthermore, we aim to evaluate predictions of such barriers and refugia on the genetic structure of the species, such as presence/absence of dispersal, timing since separation, and population expansions/contractions. We sequenced mitochondrial and nuclear genetic markers on 94 tissue samples from 41 localities. We inferred a gene tree and estimated genetic distances using mtDNA sequences. We then ran population clustering and assignment methods, AMOVA, and estimated migration rates among populations identified through mtDNA and nDNA analyses. We used a dated species tree, skyline plots, and summary statistics to evaluate concordance between population's distributions and geographic barriers and Pleistocene refugia. Scinax eurydice showed high mtDNA divergences and four clearly distinct mtDNA lineages. Species tree and population assignment tests supported the existence of two major clades corresponding to northeastern and southeastern Atlantic Forest in Brazil, each one composed of two other clades. Lineage splitting events occurred from late Pliocene to Pleistocene. We identified demographic expansions in two clades, and inexistent to low levels of migrations among different populations. Genetic patterns and demographic data support the existence of two northern Refuge and corroborate microrefugia south of the Doce/Jequitinhonha Rivers biogeographic divide. The results agree with a scenario of recent demographic expansion of lowland taxa. Scinax eurydice comprises a species complex, harboring undescribed taxa consistent with Pleistocene refugia. Two rivers lie at the boundaries among populations and endorse their role as secondary barriers to gene flow.	[Menezes, Lucas; Batalha-Filho, Henrique; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Programa Posgrad Diversidade Anim, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil; [Canedo, Clarissa; Napoli, Marcelo Felgueiras] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil; [Garda, Adrian Antonio] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot Ecol & Zool, LAR, Campus Univ, BR-59078900 Natal, RN, Brazil; [Gehara, Marcelo] Univ Fed Rio Grande do Norte, Programa Posgrad Sistemat & Evolucao, Ctr Biociencias, Campus Univ Lagoa Nova, BR-59078900 Natal, RN, Brazil; [Batalha-Filho, Henrique; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal da Bahia	Napoli, MF (corresponding author), Univ Fed Bahia, Inst Biol, Programa Posgrad Diversidade Anim, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil.; Napoli, MF (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil.; Napoli, MF (corresponding author), Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil.	napoli@ufba.br	Napoli, Marcelo/G-3720-2012; Garda, Adrian Antonio/A-6636-2012; Canedo, Clarissa/C-5657-2014; Filho, Henrique Batalha/H-9355-2012; Gehara, Marcelo/J-6533-2014	Napoli, Marcelo/0000-0003-3843-0543; Garda, Adrian Antonio/0000-0002-1178-1207; Canedo, Clarissa/0000-0003-0637-4663; Filho, Henrique Batalha/0000-0001-7191-2814; 	CNPq [309672/2012-0]; Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) [BOL0596/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [564940/2010-0]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26/111/404/2012, E-26/102.818/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MFN acknowledges the CNPq for research productivity grant (Proc. 309672/2012-0); LM acknowledges the Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) for scholarship (Proc. No. BOL0596/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Celio F. B. Haddad (Universidade Estadual Paulista), Miguel T. Rodrigues (Universidade de Sao Paulo), Ulisses Caramaschi and Jose P. Pombal-Jr (Museu Nacional), Luciana B. Nascimento (Pontificia Universidade Catolica de Minas Gerais), Renato N. Feio (Museu de Zoologia Joao Moojen de Oliveira), Paulo C. A. Garcia (Universidade Federal de Minas Gerais), Gustavo H. C. Vieira (Universidade Federal da Paraiba), and Robson W. Avila (Universidade Regional do Cariri) for allowing us to examine specimens under their care and for data access on related species; to Laboratorio de Pesquisa em Biodiversidade Molecular do Departamento de Vertebrados do Museu Nacional, Universidade Federal do Rio de Janeiro (supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Proc. 564940/2010-0; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Proc. E-26/111/404/2012 and E-26/102.818/2011; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES), for the permission to use the laboratory structure during the research development. MFN acknowledges the CNPq for research productivity grant (Proc. 309672/2012-0); LM acknowledges the Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) for scholarship (Proc No. BOL0596/2012).	Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; Bastazini CV, 2007, HERPETOLOGICA, V63, P459, DOI 10.1655/0018-0831(2007)63[459:WEVBEC]2.0.CO;2; Batalha-Filho H, 2013, MOL PHYLOGENET EVOL, V67, P86, DOI 10.1016/j.ympev.2013.01.007; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brunes TO, 2014, ZOOL SCR, V43, P586, DOI 10.1111/zsc.12079; Cabanne GS, 2013, J ORNITHOL, V154, P371, DOI 10.1007/s10336-012-0901-8; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2007, EVOLUTION, V61, P2942, DOI 10.1111/j.1558-5646.2007.00241.x; Carnaval Ana Carolina, 2014, Proc Biol Sci, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; D'Horta FM, 2011, MOL ECOL, V20, P1923, DOI 10.1111/j.1365-294X.2011.05063.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Feio R.N., 2008, BIOTA, V1, P1; Feio Renato Neves, 2002, Phyllomedusa, V1, P105; Fouquet A, 2012, BIOL J LINN SOC, V106, P356, DOI 10.1111/j.1095-8312.2012.01871.x; Fusinatto LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079504; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Hartmann Marilia T., 2002, Herpetological Review, V33, P222; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maldonado-Coelho M, 2012, BIOL J LINN SOC, V105, P900, DOI 10.1111/j.1095-8312.2011.01823.x; Martins FM, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-36, 10.1186/1471-2148-9-294]; Miller M.A., 2010, P GAT COMP ENV WORKS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pombal-Junior Jose Perez, 1995, Naturalia (Rio Claro), V20, P213; Pritchard J.K., DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Projeto Radambrasil, 1983, 23 24 RIO DE JANEIRO, P775; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribeiro RA, 2011, HEREDITY, V106, P46, DOI 10.1038/hdy.2010.64; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome MTC, 2014, MOL ECOL, V23, P6152, DOI 10.1111/mec.12986; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vasconcelos TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104130; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	61	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154626	10.1371/journal.pone.0154626	http://dx.doi.org/10.1371/journal.pone.0154626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248688	Green Published, gold, Green Submitted			2022-12-27	WOS:000377184700006
J	Zhou, RF; Zhou, XJ; Li, XB; Cai, YF; Liu, FL				Zhou, Rifeng; Zhou, Xiaojian; Li, Xiaobin; Cai, Yufang; Liu, Fenglin			Study of the Microfocus X-Ray Tube Based on a Point-Like Target Used for Micro-Computed Tomography	PLOS ONE			English	Article							BREMSSTRAHLUNG RADIATION; Z-DEPENDENCE; CT	For a micro-Computed Tomography (Micro-CT) system, the microfocus X-ray tube is an essential component because the spatial resolution of CT images, in theory, is mainly determined by the size and stability of the X-ray focal spot of the microfocus X-ray tube. However, many factors, including voltage fluctuations, mechanical vibrations, and temperature changes, can cause the size and the stability of the X-ray focal spot to degrade. A new microfocus X-ray tube based on a point-like micro-target in which the X-ray target is irradiated with an unfocused electron beam was investigated. EGS4 Monte Carlo simulation code was employed for the calculation of the X-ray intensity produced from the point-like micro-target and the substrate. The effects of several arrangements of the target material, target and beam size were studied. The simulation results demonstrated that if the intensity of X-rays generated at the point-like target is greater than half of the X-ray intensity produced on the substrate, the X-ray focal spot is determined in part by the point-like target rather than by the electron beam in the conventional X-ray tube. In theory, since it is able to reduce those unfavorable effects such as the electron beam trajectory swinging and the beam size changing for the microfocus X-ray tube, it could alleviate CT image artifacts caused by the X-ray focal spot shift and size change.	[Zhou, Rifeng; Li, Xiaobin; Cai, Yufang; Liu, Fenglin] Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, ICT Res Ctr, Chongqing 630044, Peoples R China; [Zhou, Rifeng; Cai, Yufang; Liu, Fenglin] Chongqing Univ, Engn Res Ctr ICT Nondestruct Testing, Educ Minist China, Chongqing 630044, Peoples R China; [Zhou, Xiaojian] Minist Environm Protect Peoples Republ China, Nucl & Radiat Safe Ctr, Beijing, Peoples R China	Chongqing University; Chongqing University	Zhou, RF (corresponding author), Chongqing Univ, Key Lab Optoelect Technol & Syst, Educ Minist China, ICT Res Ctr, Chongqing 630044, Peoples R China.; Zhou, RF (corresponding author), Chongqing Univ, Engn Res Ctr ICT Nondestruct Testing, Educ Minist China, Chongqing 630044, Peoples R China.	zhou65112401@cqu.edu.cn	Liu, Fenglin/N-3010-2019	Liu, Fenglin/0000-0002-8952-311X	National Instrumentation Program [2013YQ030629]; Chongqing University Basic Scientific Research Foundation [CDJZR12120006]; National Natural Science Foundation of China [61471070]	National Instrumentation Program; Chongqing University Basic Scientific Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by National Instrumentation Program (http://service.most.gov.cn/) Award Number: 2013YQ030629. Grant Recipient: Rifeng Zhou. Chongqing University Basic Scientific Research Foundation Award Number: CDJZR12120006. Grant Recipient: Rifeng Zhou. National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Award Number: 61471070. Grant Recipient: Fenglin Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose V, 1997, NUCL INSTRUM METH B, V124, P457, DOI 10.1016/S0168-583X(97)00099-2; Aviles JEA, 2011, J X-RAY SCI TECHNOL, V19, P477, DOI 10.3233/XST-2011-0308; Badea CT, 2011, PHYS MED BIOL, V56, P3351, DOI 10.1088/0031-9155/56/11/011; DESOBRY GE, 1991, MED PHYS, V18, P497, DOI 10.1118/1.596653; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Ebel H, 1999, X-RAY SPECTROM, V28, P255, DOI 10.1002/(SICI)1097-4539(199907/08)28:4<255::AID-XRS347>3.0.CO;2-Y; Hames MH, 1993, MEASUREMENT VERY SMA; Hiller J, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085404; HIPPLER R, 1981, PHYS REV LETT, V46, P1622, DOI 10.1103/PhysRevLett.46.1622; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Ihsan A, 2009, NUCL INSTRUM METH B, V267, P3566, DOI 10.1016/j.nimb.2009.08.012; Kalender WA, 2005, COMPUTED TOMOGRAPHY; Kawrakow, 2003, PIRS701 NAT RES COUN; Kim JH, 2015, PHYS MED BIOL, V60, P2047, DOI 10.1088/0031-9155/60/5/2047; Kramers HA, 1923, PHILOS MAG, V46, P836, DOI 10.1080/14786442308565244; Manuel JE, 2014, NUCL INSTRUM METH B, V332, P37, DOI 10.1016/j.nimb.2014.02.025; Mertens JCE, 2014, MATER CHARACT, V92, P36, DOI 10.1016/j.matchar.2014.03.002; Monfared AS, 2014, INT J RADIAT RES, V12, P325; Salamon M, 2008, NUCL INSTRUM METH A, V591, P54, DOI 10.1016/j.nima.2008.03.023; SEMAAN M, 1982, PHYS REV A, V26, P3152, DOI 10.1103/PhysRevA.26.3152; Tavora LMN, 2001, APPL RADIAT ISOTOPES, V54, P59, DOI 10.1016/S0969-8043(00)00165-2; Tian LX, 2009, NUCL INSTRUM METH B, V267, P3495, DOI 10.1016/j.nimb.2009.08.009; Treurniet JA, 2004, 0623 NRC PIRS; Trincavelli J, 2008, SPECTROCHIM ACTA B, V63, P1, DOI 10.1016/j.sab.2007.11.009; Vogeler F, 2011, S DIG IND RAD COMP T; Yu HY, 2006, IEEE T MED IMAGING, V25, P792, DOI 10.1109/TMI.2006.875424	26	10	12	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156224	10.1371/journal.pone.0156224	http://dx.doi.org/10.1371/journal.pone.0156224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249559	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700032
J	Blanquer, A; Hynowska, A; Nogues, C; Ibanez, E; Sort, J; Baro, MD; Ozkale, B; Pane, S; Pellicer, E; Barrios, L				Blanquer, Andreu; Hynowska, Anna; Nogues, Carme; Ibanez, Elena; Sort, Jordi; Dolors Baro, Maria; Ozkale, Berna; Pane, Salvador; Pellicer, Eva; Barrios, Leonardo			Effect of Surface Modifications of Ti40Zr10Cu38Pd12 Bulk Metallic Glass and Ti-6Al-4V Alloy on Human Osteoblasts In Vitro Biocompatibility	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; TITANIUM SURFACE; LINEAGE CELLS; IMPLANTS; ADHESION; DIFFERENTIATION; TOPOGRAPHY; RESISTANT; BEHAVIOR; SEARCH	The use of biocompatible materials, including bulk metallic glasses (BMGs), for tissue regeneration and transplantation is increasing. The good mechanical and corrosion properties of Ti40Zr10Cu38Pd12 BMG and its previously described biocompatibility makes it a potential candidate for medical applications. However, it is known that surface properties like topography might play an important role in regulating cell adhesion, proliferation and differentiation. Thus, in the present study, Ti40Zr10Cu38Pd12 BMG and Ti6-Al-4V alloy were surface-modified electrochemically (nanomesh) or physically (microscratched) to investigate the effect of material topography on human osteoblasts cells (Saos-2) adhesion, proliferation and differentiation. For comparative purposes, the effect of mirror-like polished surfaces was also studied. Electrochemical treatments led to a highly interconnected hierarchical porous structure rich in oxides, which have been described to improve corrosion resistance, whereas microscratched surfaces showed a groove pattern with parallel trenches. Cell viability was higher than 96% for the three topographies tested and for both alloy compositions. In all cases, cells were able to adhere, proliferate and differentiate on the alloys, hence indicating that surface topography plays a minor role on these processes, although a clear cell orientation was observed on microscratched surfaces. Overall, our results provide further evidence that Ti40Zr10Cu38Pd12 BMG is an excellent candidate, in the present two topographies, for bone repair purposes.	[Blanquer, Andreu; Nogues, Carme; Ibanez, Elena; Barrios, Leonardo] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Edifici Cc, Bellaterra, Spain; [Hynowska, Anna; Sort, Jordi; Dolors Baro, Maria; Pellicer, Eva] Univ Autonoma Barcelona, Dept Fis, Edifici Cc, Bellaterra, Spain; [Sort, Jordi] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Ozkale, Berna; Pane, Salvador] ETH, Inst Robot & Intelligent Syst, Multiscale Robot Lab, Zurich, Switzerland	Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barrios, L (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Edifici Cc, Bellaterra, Spain.; Pellicer, E (corresponding author), Univ Autonoma Barcelona, Dept Fis, Edifici Cc, Bellaterra, Spain.	eva.pellicer@uab.cat; lleonard.barrios@uab.cat	Sort, Jordi/GPP-6695-2022; Barrios, Leonardo/L-3315-2014; Blanquer, Andreu/W-5541-2019; Pellicer, Eva/G-2917-2014; Sort, Jordi/F-6582-2014; Nogues, Carme/A-2339-2009; Ibáñez, Elena/K-4320-2014	Barrios, Leonardo/0000-0002-6151-8503; Blanquer, Andreu/0000-0002-3551-1885; Pellicer, Eva/0000-0002-8901-0998; Sort, Jordi/0000-0003-1213-3639; Nogues, Carme/0000-0002-6361-8559; Ibáñez, Elena/0000-0002-0275-6958; Ozkale Edelmann, Berna/0000-0002-3016-9363; Pane, Salvador/0000-0003-0147-8287	Ministerio de Ciencia e Innovacion [TEC2011-29140-C03-03, MAT2014-57960-C03-3-R, MAT2014-57960-C03-1-R]; Generalitat de Catalunya [2014-SGR-524, 2014-SGR-1015]; Seventh Framework Program (EC) [FP7-PEOPLE-2010-ITN-264635]; Universitat Autonoma de Barcelona; Ministerio de Economia y Competitividad [RYC-2012-10839]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Seventh Framework Program (EC); Universitat Autonoma de Barcelona; Ministerio de Economia y Competitividad(Spanish Government); ICREA(ICREA)	This work was supported by Ministerio de Ciencia e Innovacion (www.micinn.es/): TEC2011-29140-C03-03, Carme Nogues; MAT2014-57960-C03-3-R, Carme Nogues; MAT2014-57960-C03-1-R, Jordi Sort; Generalitat de Catalunya (web.gencat.cat/): 2014-SGR-524, Carme Nogues; 2014-SGR-1015, Jordi Sort; Seventh Framework Program (EC) (https://ec.europa.eu/research/fp7/): FP7-PEOPLE-2010-ITN-264635, Maria Dolors Baro; Universitat Autonoma de Barcelona (http://www.uab.cat/): PIF Predoctoral Grant, Andreu Blanquer; Ministerio de Economia y Competitividad (www.micinn.es/): RYC-2012-10839, Eva Pellicer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Blanquer A, 2014, J MATER SCI-MATER M, V25, P163, DOI 10.1007/s10856-013-5041-z; Burleigh TD, 2009, J ELECTROCHEM SOC, V156, pC45, DOI 10.1149/1.3021029; Choe H, 2005, MAT SCI ENG A-STRUCT, V396, P99, DOI 10.1016/j.msea.2005.01.051; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049; de Peppo GM, 2014, INT J NANOMED, V9, P2499, DOI 10.2147/IJN.S58805; Deng ZN, 2014, INT J NANOMED, V9, P5565, DOI 10.2147/IJN.S71625; Fornell J, 2012, J ALLOY COMPD, V536, pS74, DOI 10.1016/j.jallcom.2011.10.057; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059; Hermawan Hendra, 2011, BIOMED ENG, DOI [10.5772/19033, DOI 10.5772/19033]; Huang L, 2012, J BIOMED MATER RES B, V100B, P1472, DOI 10.1002/jbm.b.32715; Hynowska A, 2015, J BIOMED MATER RES B, V103, P1569, DOI 10.1002/jbm.b.33346; Hynowska A, 2013, MATERIALS, V6, P4930, DOI 10.3390/ma6114930; Li HF, 2012, J BIOMED MATER RES B, V100B, P1721, DOI 10.1002/jbm.b.32738; Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019; Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575; Olivares-Navarrete R, 2014, ANN BIOMED ENG, V42, P2551, DOI 10.1007/s10439-014-1108-3; Patel SB, 2014, J MATER CHEM B, V2, P3597, DOI 10.1039/c3tb21731k; Pisarek M, 2012, BIOMEDICAL ENG TECHN, P20, DOI [10.5772/48693, DOI 10.5772/48693]; Qin FX, 2007, MATER TRANS, V48, P1855, DOI 10.2320/matertrans.MJ200713; Qin FX, 2007, MATER TRANS, V48, P515, DOI 10.2320/matertrans.48.515; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Vandrovcova M, 2012, J BIOMED MATER RES A, V100A, P1016, DOI 10.1002/jbm.a.34047; Yang WE, 2010, THIN SOLID FILMS, V518, P7545, DOI 10.1016/j.tsf.2010.05.045; Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9; Zhang EL, 2015, MAT SCI ENG C-MATER, V46, P148, DOI 10.1016/j.msec.2014.10.021; Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]; Zhu LB, 2012, FOOD MICROBIOL, V30, P303, DOI 10.1016/j.fm.2011.12.001; Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044	35	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156644	10.1371/journal.pone.0156644	http://dx.doi.org/10.1371/journal.pone.0156644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243628	Green Published, gold, Green Submitted			2022-12-27	WOS:000377146100059
J	Hubbard, CS; Becerra, L; Heinz, N; Ludwick, A; Rasooly, T; Wu, R; Johnson, A; Schechter, NL; Borsook, D; Nurko, S				Hubbard, Catherine S.; Becerra, Lino; Heinz, Nicole; Ludwick, Allison; Rasooly, Tali; Wu, Rina; Johnson, Adriana; Schechter, Neil L.; Borsook, David; Nurko, Samuel			Abdominal Pain, the Adolescent and Altered Brain Structure and Function	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DORSOLATERAL PREFRONTAL CORTEX; POSTERIOR CINGULATE CORTEX; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; DEFAULT MODE NETWORK; CHRONIC BACK-PAIN; GRAY-MATTER; WORKING-MEMORY	Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder of unknown etiology. Although relatively common in children, how this condition affects brain structure and function in a pediatric population remains unclear. Here, we investigate brain changes in adolescents with IBS and healthy controls. Imaging was performed with a Siemens 3 Tesla Trio Tim MRI scanner equipped with a 32-channel head coil. A high-resolution T1-weighted anatomical scan was acquired followed by a T2-weighted functional scan. We used a surfacebased morphometric approach along with a seed-based resting-state functional connectivity (RS-FC) analysis to determine if groups differed in cortical thickness and whether areas showing structural differences also showed abnormal RS-FC patterns. Patients completed the Abdominal Pain Index and the GI Module of the Pediatric Quality of Life Inventory to assess abdominal pain severity and impact of GI symptoms on health-related quality of life (HRQOL). Disease duration and pain intensity were also assessed. Pediatric IBS patients, relative to controls, showed cortical thickening in the posterior cingulate (PCC), whereas cortical thinning in posterior parietal and prefrontal areas were found, including the dorsolateral prefrontal cortex (DLPFC). In patients, abdominal pain severity was related to cortical thickening in the intra-abdominal area of the primary somatosensory cortex (SI), whereas HRQOL was associated with insular cortical thinning. Disease severitymeasures correlated with cortical thickness in bilateral DLPFC and orbitofrontal cortex. Patients also showed reduced anti-correlations between PCC and DLPFC compared to controls, a finding that may reflect aberrant connectivity between default mode and cognitive control networks. We are the first to demonstrate concomitant structural and functional brain changes associated with abdominal pain severity, HRQOL related to GI-specific symptoms, and disease-specific measures in adolescents with IBS. It is possible such changes will be responsive to therapeutic intervention and may be useful as potential markers of disease progression or reversal.	[Hubbard, Catherine S.; Becerra, Lino; Ludwick, Allison; Rasooly, Tali; Johnson, Adriana; Borsook, David] Boston Childrens Hosp, Ctr Pain & Brain, Waltham, MA 02453 USA; [Hubbard, Catherine S.; Becerra, Lino; Schechter, Neil L.; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Hubbard, Catherine S.; Becerra, Lino; Schechter, Neil L.; Borsook, David] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Heinz, Nicole; Wu, Rina; Nurko, Samuel] Boston Childrens Hosp, Dept Med, Div Gastroenterol, Ctr Motil & Funct Gastrointestinal Disorders, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Hubbard, CS (corresponding author), Boston Childrens Hosp, Ctr Pain & Brain, Waltham, MA 02453 USA.; Hubbard, CS (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Hubbard, CS (corresponding author), Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA.	catherine.hubbard@childrens.harvard.edu		Nurko, Samuel/0000-0003-0936-4807	NINDS [K24 NS064050]; Mayday/Louis Herlands Chair for Pain Systems Neuroscience; Anesthesia Foundation; NIDDK [K24 DK082792]; Behrakis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayday/Louis Herlands Chair for Pain Systems Neuroscience; Anesthesia Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Behrakis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by K24 NS064050 NINDS (DB), the Mayday/Louis Herlands Chair for Pain Systems Neuroscience (DB), the Anesthesia Foundation (DB), K24 DK082792 NIDDK (SN), and the Behrakis Foundation (SN).	Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Apkarian AV, 2010, HUMAN BRAIN IMAGING; Aziz Q, 1997, GASTROENTEROLOGY, V113, P50, DOI 10.1016/S0016-5085(97)70079-9; Aziz Q, 2000, J NEUROSCI, V20, P2657; Baker KS, 2016, CLIN J PAIN, V32, P673, DOI 10.1097/AJP.0000000000000313; Beck AT, 1996, PSYCHOL ASSESS; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Binkofski F, 1998, ANN NEUROL, V44, P811, DOI 10.1002/ana.410440516; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Bruehl S, 2013, J PAIN, V14, P103, DOI 10.1016/j.jpain.2012.10.016; Buckalew N, 2008, PAIN MED, V9, P240, DOI 10.1111/j.1526-4637.2008.00412.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chanda ML, 2011, J PAIN, V12, P792, DOI 10.1016/j.jpain.2011.01.008; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crombez G, 2003, PAIN, V104, P639, DOI 10.1016/S0304-3959(03)00121-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Derbyshire Stuart W G, 2003, ScientificWorldJournal, V3, P1065; Derbyshire SWG, 2003, AM J GASTROENTEROL, V98, P12, DOI 10.1111/j.1572-0241.2003.07168.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Drewes AM, 2006, EXP BRAIN RES, V174, P443, DOI 10.1007/s00221-006-0480-0; Drossman D, 2006, ROME 3 FUNCTIONAL GA; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; ECCLESTON C, 1994, BRIT J CLIN PSYCHOL, V33, P535, DOI 10.1111/j.2044-8260.1994.tb01150.x; Elsenbruch S, 2010, GUT, V59, P489, DOI 10.1136/gut.2008.175000; Elsenbruch S, 2011, BRAIN BEHAV IMMUN, V25, P386, DOI 10.1016/j.bbi.2010.11.010; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Furlong PL, 1998, EVOKED POTENTIAL, V108, P234, DOI 10.1016/S0168-5597(98)00016-1; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hauser G, 2014, WORLD J GASTROENTERO, V20, P6744, DOI 10.3748/wjg.v20.i22.6744; Hayes DJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-60; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Hemington KS, 2016, BRAIN STRUCT FUNCT, V221, P4203, DOI 10.1007/s00429-015-1161-1; Heymen S, 2010, CLIN J PAIN, V26, P104, DOI 10.1097/AJP.0b013e3181bff800; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; Hong JY, 2016, NEUROGASTROENT MOTIL, V28, P127, DOI 10.1111/nmo.12710; Hong JY, 2014, J NEUROSCI, V34, P14252, DOI 10.1523/JNEUROSCI.1683-14.2014; Hong JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084564; Hu WT, 2015, INT J CLIN EXP MED, V8, P4311; Hubbard CS, 2015, NEUROGASTROENT MOTIL, V27, P1282, DOI 10.1111/nmo.12622; Hubbard CS, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0006-14.2014; Hyams JS, 1996, J PEDIATR-US, V129, P220, DOI 10.1016/S0022-3476(96)70246-9; Icenhour A, 2015, NEUROGASTROENT MOTIL, V27, P114, DOI 10.1111/nmo.12489; Irimia A, 2015, NEUROGASTROENT MOTIL, V27, P1075, DOI 10.1111/nmo.12586; Jarcho JM, 2008, ALIMENT PHARM THER, V28, P344, DOI 10.1111/j.1365-2036.2008.03721.x; Jarrahi B, 2015, HUM BRAIN MAPP, V36, P4438, DOI 10.1002/hbm.22929; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; Kennedy PJ, 2014, PSYCHOL MED, V44, P1553, DOI 10.1017/S0033291713002171; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; King CD, 2009, PAIN, V143, P172, DOI 10.1016/j.pain.2008.12.027; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Labus JS, 2013, GASTROENTEROLOGY, V145, P1253, DOI 10.1053/j.gastro.2013.08.016; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Laird KT, 2015, J PEDIATR PSYCHOL, V40, P517, DOI 10.1093/jpepsy/jsu118; Lee MC, 2014, NEUROPHARMACOLOGY, V84, P123, DOI 10.1016/j.neuropharm.2013.06.035; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Liu X, 2016, NEUROGASTROENT MOTIL, V28, P43, DOI 10.1111/nmo.12695; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Ma XF, 2015, CLIN NEUROPHYSIOL, V126, P1190, DOI 10.1016/j.clinph.2014.10.004; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Mao CP, 2014, NEURORADIOLOGY, V56, P903, DOI 10.1007/s00234-014-1391-6; Martinsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108637; Mayer EA, 2015, PAIN, V156, pS50, DOI 10.1097/j.pain.0000000000000106; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Montiel-Castro AJ, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00070; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Naliboff BD, 1998, J PSYCHOSOM RES, V45, P485; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; OLSON CR, 1992, CEREB CORTEX, V2, P485, DOI 10.1093/cercor/2.6.485; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Palecek J, 2004, PHYSIOL RES, V53, pS125; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Petzke F, 2010, SCHMERZ, V24, P146, DOI 10.1007/s00482-010-0903-5; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Portincasa P, 2003, WORLD J GASTROENTERO, V9, P2293; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Qi RF, 2016, BRAIN IMAGING BEHAV, V10, P1127, DOI 10.1007/s11682-015-9478-1; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Ringel Y, 2008, GASTROENTEROLOGY, V134, P396, DOI 10.1053/j.gastro.2007.11.011; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schwetz Ines, 2003, Curr Gastroenterol Rep, V5, P331, DOI 10.1007/s11894-003-0071-1; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Seminowicz DA, 2013, J PAIN, V14, P1573, DOI 10.1016/j.jpain.2013.07.020; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Surdea-Blaga T, 2012, WORLD J GASTROENTERO, V18, P616, DOI 10.3748/wjg.v18.i7.616; Sykes MA, 2003, J BEHAV MED, V26, P361, DOI 10.1023/A:1024209111909; Van Tilburg MAL, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12056; Varni JW, 2006, J DEV BEHAV PEDIATR, V27, P451, DOI 10.1097/00004703-200612000-00001; Varni JW, 2015, J PEDIATR-US, V166, P85, DOI 10.1016/j.jpeds.2014.08.022; Varni JW, 2014, J PEDIATR GASTR NUTR, V59, P347, DOI 10.1097/MPG.0000000000000414; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Verne GN, 2003, PAIN, V103, P99, DOI 10.1016/S0304-3959(02)00416-5; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walker LS, 1997, PSYCHOL ASSESSMENT, V9, P392, DOI 10.1037/1040-3590.9.4.392; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Xue T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052927; Zhang Y, 2015, PAIN MED, V16, P911, DOI 10.1111/pme.12606	141	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156545	10.1371/journal.pone.0156545	http://dx.doi.org/10.1371/journal.pone.0156545			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244227	Green Submitted, gold, Green Published			2022-12-27	WOS:000377146100043
J	Thottakkara, P; Ozrazgat-Baslanti, T; Hupf, BB; Rashidi, P; Pardalos, P; Momcilovic, P; Bihorac, A				Thottakkara, Paul; Ozrazgat-Baslanti, Tezcan; Hupf, Bradley B.; Rashidi, Parisa; Pardalos, Panos; Momcilovic, Petar; Bihorac, Azra			Application of Machine Learning Techniques to High-Dimensional Clinical Data to Forecast Postoperative Complications	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINES; ACUTE KIDNEY INJURY; LOGISTIC-REGRESSION; RISK; CLASSIFICATION; PREDICTION; MORTALITY; ASSOCIATION; PERFORMANCE	Objective To compare performance of risk prediction models for forecasting postoperative sepsis and acute kidney injury. Design Retrospective single center cohort study of adult surgical patients admitted between 2000 and 2010. Patients 50,318 adult patients undergoing major surgery. Measurements We evaluated the performance of logistic regression, generalized additive models, naive Bayes and support vector machines for forecasting postoperative sepsis and acute kidney injury. We assessed the impact of feature reduction techniques on predictive performance. Model performance was determined using the area under the receiver operating characteristic curve, accuracy, and positive predicted value. The results were reported based on a 70/30 cross validation procedure where the data were randomly split into 70% used for training the model and the 30% for validation. Main Results The areas under the receiver operating characteristic curve for different models ranged between 0.797 and 0.858 for acute kidney injury and between 0.757 and 0.909 for severe sepsis. Logistic regression, generalized additive model, and support vector machines had better performance compared to Naive Bayes model. Generalized additive models additionally accounted for non-linearity of continuous clinical variables as depicted in their risk patterns plots. Reducing the input feature space with LASSO had minimal effect on prediction performance, while feature extraction using principal component analysis improved performance of the models. Conclusions Generalized additive models and support vector machines had good performance as risk prediction model for postoperative sepsis and AKI. Feature extraction using principal component analysis improved the predictive performance of all models.	[Thottakkara, Paul; Ozrazgat-Baslanti, Tezcan; Hupf, Bradley B.; Bihorac, Azra] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA; [Rashidi, Parisa] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Thottakkara, Paul; Pardalos, Panos; Momcilovic, Petar] Univ Florida, Ind & Syst Engn, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bihorac, A (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA.	abihorac@anest.ufl.edu	Bihorac, Azra/Q-6500-2016; Rashidi, Parisa/AAP-7261-2020; Pardalos, Panos/AAY-8591-2020	Bihorac, Azra/0000-0002-5745-2863; Rashidi, Parisa/0000-0003-4530-2048; 	National Institute of General Medical Sciences [P50 GM-111152]; Vision Grant Society of Critical Care Medicine; Astute Medial; I Heermann Anesthesia Foundation, Inc; NIH/NCATS Clinical and Translational Sciences Award: University of Florida [UL1: TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vision Grant Society of Critical Care Medicine; Astute Medial; I Heermann Anesthesia Foundation, Inc; NIH/NCATS Clinical and Translational Sciences Award: University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by P50 GM-111152 National Institute of General Medical Sciences http://www.nigms.nih.gov: AB TOB, Vision Grant Society of Critical Care Medicine http://www.sccm.org: AB, Astute Medial, Inc http://www.astutemedical.com/US/Home: AB, I Heermann Anesthesia Foundation, Inc: AB and NIH/NCATS Clinical and Translational Sciences Award: University of Florida UL1: TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, PAT SAF IND TECHN SP; Airaksinen J, 2016, EUR J PUBLIC HEALTH, V26, P417, DOI 10.1093/eurpub/ckv210; American College of Surgeons National Surgical Quality Improvement Program, 2015, SURG RISK CALC 2007; Ben Meskina S, 2013, INF TECHN E SERV ICI; Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Boulle M, 2005, LECT NOTES ARTIF INT, V3587, P228; Chapman A.D., 2006, GUIDE BEST PRACTICES; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chun FKH, 2007, BJU INT, V99, P794, DOI 10.1111/j.1464-410X.2006.06694.x; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; COPELAND GP, 1991, BRIT J SURG, V78, P356; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dombrovskiy VY, 2005, CRIT CARE MED, V33, P2555, DOI 10.1097/01.CCM.0000186748.64438.7B; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Du Y, 2004, ENG MED BIOL SOC 200; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faradmal J, 2014, ASIAN PAC J CANCER P, V15, P5883, DOI 10.7314/APJCP.2014.15.14.5883; Glance LG, 2015, ANESTH ANALG, V120, P526, DOI 10.1213/ANE.0000000000000522; Han SR, 2009, RISK ANAL, V29, P1443, DOI 10.1111/j.1539-6924.2009.01280.x; HASTIE T, 1990, GENERALIZED ADDITIVE, V15; Heydari ST, 2012, J MED SYST, V36, P2449, DOI 10.1007/s10916-011-9711-4; Hobson CE, 2015, CRIT CARE CLIN; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Huang Hsin-Hsiung, 2014, BMC Proc, V8, pS96, DOI 10.1186/1753-6561-8-S1-S96; Huang R, 2015, J HUM NUTR DIET, V28, P604, DOI 10.1111/jhn.12279; Huber M, 2016, ANN VASC SURG, V30, P72, DOI 10.1016/j.avsg.2015.04.092; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Korenkevych D, 2016, ANN SURG, V263, P1219, DOI 10.1097/SLA.0000000000001362; Kovalchik SA, 2015, J EPIDEMIOL COMMUN H, V69, P978, DOI 10.1136/jech-2015-205600; Kurt I, 2008, EXPERT SYST APPL, V34, P366, DOI 10.1016/j.eswa.2006.09.004; Lake APJ, 1997, BRIT J ANAESTH, V78, P228, DOI 10.1093/bja/78.2.228-a; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Mittag F, 2012, HUM MUTAT, V33, P1708, DOI 10.1002/humu.22161; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Osborne JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00370; Ozrazgat-Baslanti T, 2015, ANN SURG; Pang H, 2013, GENET EPIDEMIOL, V37, P276, DOI 10.1002/gepi.21721; Pebesma E., 2005, R NEWS, V5, P9; Pochet NLMM, 2006, ULTRASOUND OBST GYN, V27, P607, DOI 10.1002/uog.2791; Pyle, 1999, DATA PREPARATION DAT; Radford PD, 2015, INT J SURG, V13, P211, DOI 10.1016/j.ijsu.2014.11.049; Ramsay SE, 2015, J EPIDEMIOL COMMUN H, V69, P1224, DOI 10.1136/jech-2015-205542; Richardson R, 2015, SOC PSYCH PSYCH EPID, V50, P1641, DOI 10.1007/s00127-015-1092-4; Shariff-Marco S, 2015, J COMMUN HEALTH, V40, P1287, DOI 10.1007/s10900-015-0052-y; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; U.S. Department of Veterans Affairs VHA, 2015, NAT DRUG FIL REF TER; United States Census Bureau, 2010, AM FACTFINDER 2010; Van den Broeck J, 2005, PLOS MED, V2, P966, DOI 10.1371/journal.pmed.0020267; Verplancke T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-56; Wald R, 2006, J VASC SURG, V43, P460, DOI 10.1016/j.jvs.2005.11.053; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Woo MJ, 2008, STAT MED, V27, P3805, DOI 10.1002/sim.3278; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	59	90	92	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155705	10.1371/journal.pone.0155705	http://dx.doi.org/10.1371/journal.pone.0155705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232332	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000006
J	Dong, TY; Zhang, BW; Jiang, YF; Hu, QB				Dong, Tingyan; Zhang, Bowen; Jiang, Yanfang; Hu, Qiongbo			Isolation and Classification of Fungal Whitefly Entomopathogens from Soils of Qinghai-Tibet Plateau and Gansu Corridor in China	PLOS ONE			English	Article							TABACI HEMIPTERA ALEYRODIDAE; BEMISIA-TABACI; LECANICILLIUM-PSALLIOTAE; NEMATOPHAGOUS FUNGUS; ISARIA-FUMOSOROSEA; BEAUVERIA-BASSIANA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; SERINE-PROTEASE; BIOTYPE	Qinghai-Tibet Plateau and Gansu Corridor of China with distinct geographic and climatic conditions are remote and less disturbed by humans, in which are likely to find some new strains of fungal entomopathogens against B-biotype whiteflies that is a very important invading pest worldwide. In this research, nineteen strains among six species of entomogenous fungi were isolated from the soil samples collected from 32 locations in Qinghai-Tibet Plateau and Gansu Corridor. From the data of isolation rates, it was indicated that the good biodiversity of entomogenous fungi was found in the soil covered good vegetations. On the contrary, no strains were isolated from the desert areas. In addition, the dominant species, Isaria fumosorosea and Metarhizium anisopliae var. anisopliae in the Qinghai-Tibet Plateau are different from the strains of other places based on ITS genetic homology analysis. It was verified that the Qinghai-Tibet Plateau area was less disturbed by human, and the fungi in this place exchanged less compared with other regional species. All of these strains showed the pathogenicity against the B-biotype whitefly with the mortality of more than 30%. However, a few strains of Paecilomyces lilacinus, Lecanicillium psalliotae, Aspergillus ustus, I. fumosorosea and M. anisopliae var. anisopliae had better virulence with LC(50)s of 0.36-26.44x10(6) spores/mL on post-treatment day 6-7. Especially, the L. psalliotae strain LpTS01 was the greatest virulence with LC50 of 0.36x10(6) spores/mL and LT50 of 4.23d. Our research thus presents some new insights to discover new entomopathogenic fungal strains used for B-biotype whitefly biocontrol.	[Dong, Tingyan; Zhang, Bowen; Jiang, Yanfang; Hu, Qiongbo] South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University	Hu, QB (corresponding author), South China Agr Univ, Coll Agr, Key Lab Biopesticide Innovat & Applicat Guangdong, Guangzhou 510642, Guangdong, Peoples R China.	hqbscau@scau.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare of China [201304408]; Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province	Special Fund for Forest Scientific Research in the Public Welfare of China; Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province	This work was supported by the Special Fund for Forest Scientific Research in the Public Welfare of China ( 201304408).; We are grateful to the researcher Wei Wu and Weina Hu for their field assistance. We also appreciate the Doc. Chaoyu Cui provide guidance with identifying the fungal species. At the same time, thanks for the support from the Key Laboratory of Forest Diseases and Insect Pests in Guangdong Province.	Abbott WS, 1925, J AM MOSQUITO CONTR, V3, P265; Abd-Rabou S, 2014, ENTOMOL NEWS, V124, P38, DOI 10.3157/021.124.0106; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Chen XR, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0170-8; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Cuthbertson AGS, 2011, INSECT SCI, V18, P1, DOI 10.1111/j.1744-7917.2010.01383.x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Espinel C, 2008, REV COLOMB ENTOMOL, V34, P163; Faria M, 2001, CROP PROT, V20, P767, DOI 10.1016/S0261-2194(01)00110-7; Fernandez E, 2009, PEST MANAG SCI, V65, P885, DOI 10.1002/ps.1769; Florescu DF, 2009, CLIN TRANSPLANT, V23, P116, DOI 10.1111/j.1399-0012.2008.00895.x; Hewlett PS, 1972, J STORED PRODUCTS RE, V8, P159; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu WG, 2014, J BASIC MICROB, V54, P1331, DOI 10.1002/jobm.201400232; Islam MT, 2011, AFR J MICROBIOL RES, V5, P3409; Jaronski S. T., 2007, Use of entomopathogenic fungi in biological pest management, P91; Li M, 2010, INT J PEST MANAGE, V56, P275, DOI 10.1080/09670871003743428; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Mascarin GM, 2013, BIOL CONTROL, V66, P209, DOI 10.1016/j.biocontrol.2013.05.001; Meyling NV, 2006, MYCOL RES, V110, P188, DOI 10.1016/j.mycres.2005.09.008; Ning WX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10744; Pan CC, 2015, EUR J SOIL BIOL, V68, P25, DOI 10.1016/j.ejsobi.2015.03.003; Panackal AA, 2006, EMERG INFECT DIS, V12, P403, DOI 10.3201/eid1203.050670; Quan QM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092293; Sun BD, 2008, CROP PROT, V27, P1421, DOI 10.1016/j.cropro.2008.07.010; Tanaka K, 2009, STUD MYCOL, P175, DOI 10.3114/sim.2009.64.10; Wang XJ, 2012, ENTOMOL FENNICA, V23, P4; Yang JK, 2005, BIOTECHNOL LETT, V27, P1329, DOI 10.1007/s10529-005-0482-1; Yang JK, 2005, BIOTECHNOL LETT, V27, P1123, DOI 10.1007/s10529-005-8461-0; Yu HY, 2012, BIOSCI BIOTECH BIOCH, V76, P1835, DOI 10.1271/bbb.120173; Zimmermann G, 2008, BIOCONTROL SCI TECHN, V18, P865, DOI 10.1080/09583150802471812; Zou CH, 2014, BIOCONTROL SCI TECHN, V24, P315, DOI 10.1080/09583157.2013.860427	33	9	10	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156087	10.1371/journal.pone.0156087	http://dx.doi.org/10.1371/journal.pone.0156087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228109	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500064
J	Ma, N; Ma, Y; Nakashima, A; Kikkawa, U; Furuyashiki, T				Ma, Ning; Ma, Yan; Nakashima, Akio; Kikkawa, Ushio; Furuyashiki, Tomoyuki			The Loss of Lam2 and Npr2-Npr3 Diminishes the Vacuolar Localization of Gtr1-Gtr2 and Disinhibits TORC1 Activity in Fission Yeast	PLOS ONE			English	Article							RAG GTPASES; COMPLEX; KINASE; DISRUPTION; ACTIVATION; EXPRESSION; RAGULATOR; RAPAMYCIN; MEDIATE; GAP	In mammalian cells, mTORC1 activity is regulated by Rag GTPases. It is thought that the Ragulator complex and the GATOR (GAP activity towards Rags) complex regulate RagA/B as its GDP/GTP exchange factor (GEF) and GTPase-activating protein (GAP), respectively. However, the functions of components in these complexes remain elusive. Using fission yeast as a model organism, here we found that the loss of Lam2 (SPBC1778.05c), a homo-log of a Ragulator component LAMTOR2, as well as the loss of Gtr1 or Gtr2 phenocopies the loss of Npr2 or Npr3, homologs of GATOR components Nprl2 or Nprl3, respectively. These phenotypes were rescued by TORC1 inhibition using pharmacological or genetic means, and the loss of Lam2, Gtr1, Gtr2, Npr2 or Npr3 disinhibited TORC1 activity under nitrogen depletion, as measured by Rps6 phosphorylation. Consistently, overexpression of GDP-locked Gtr1S20L or GTP-locked Gtr2Q60L, which suppress TORC1 activity in budding yeast, rescued the growth defect of.gtr1 cells or.gtr2 cells, respectively, and the loss of Lam2, Npr2 or Npr3 similarly diminished the vacuolar localization and the protein levels of Gtr1 and Gtr2. Furthermore, Lam2 physically interacted with Npr2 and Gtr1. These findings suggest that Lam2 and Npr2-Npr3 function together as a tether for GDP-bound Gtr1 to the vacuolar membrane, thereby suppressing TORC1 activity for multiple cellular functions.	[Ma, Ning; Ma, Yan; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Nakashima, Akio; Kikkawa, Ushio] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399	Japan Society for the Promotion of Science [26460339]; Grants-in-Aid for Scientific Research [16H05132, 15H01289] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Scientific Research ( C) to YM ( No. 26460339) from Japan Society for the Promotion of Science ( https://www.jsps.go.jp/english/e-grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Binda M, 2009, MOL CELL, V35, P563, DOI 10.1016/j.molcel.2009.06.033; Demetriades C, 2014, CELL, V156, P786, DOI 10.1016/j.cell.2014.01.024; Dokudovskaya S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006478; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Liu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139045; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Ma Y, 2007, CURR GENET, V52, P97, DOI 10.1007/s00294-007-0142-1; Ma Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144677; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Neklesa TK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000515; Panchaud N, 2013, CELL CYCLE, V12, P2948, DOI 10.4161/cc.26000; Ryuko S, 2012, MOL GENET GENOMICS, V287, P651, DOI 10.1007/s00438-012-0705-9; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Siam R, 2004, METHODS, V33, P189, DOI 10.1016/j.ymeth.2003.11.013; Sio SO, 2005, J BIOL CHEM, V280, P12231, DOI 10.1074/jbc.M414234200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Toda T, 1996, MOL CELL BIOL, V16, P6752; Valbuena N, 2012, J CELL SCI, V125, P1920, DOI 10.1242/jcs.094219; Wu X, 2011, MOL BIOL CELL, V22, P4124, DOI 10.1091/mbc.E11-06-0525; Zhang TL, 2012, STRUCTURE, V20, P2151, DOI 10.1016/j.str.2012.09.019; Zilio N, 2012, YEAST, V29, P425, DOI 10.1002/yea.2920	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156239	10.1371/journal.pone.0156239	http://dx.doi.org/10.1371/journal.pone.0156239			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227887	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500089
J	Rigden, HM; Alias, A; Havelock, T; O'Donnell, R; Djukanovic, R; Davies, DE; Wilson, SJ				Rigden, Helen M.; Alias, Ahmad; Havelock, Thomas; O'Donnell, Rory; Djukanovic, Ratko; Davies, Donna E.; Wilson, Susan J.			Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER; AUTOFLUORESCENCE BRONCHOSCOPY; CARCINOEMBRYONIC ANTIGEN; PRENEOPLASTIC LESIONS; SMOKING-CESSATION; CELL CARCINOMA; RISK; EXPRESSION; P53	Aims To quantify the extent of squamous metaplasia in bronchial biopsies and relate it to the presence of chronic obstructive pulmonary disease (COPD), a smoking-related pathology. Methods Bronchial biopsies (n = 15 in each group) from smokers with COPD GOLD stage1 and GOLD stage2, smokers without COPD and healthy non-smokers were stained immunohistochemically with a panel of antibodies that facilitated the identification of pseudostratified epithelium and distinction of squamous metaplasia and squamous epithelium from tangentially cut epithelium. The percentage length of each of these epithelial phenotypes was measured as a percent of total epithelial length using computerised image analysis. Sections were also stained for carcinoembryonic antigen and p53, early markers of carcinogenesis, and Ki67, and the percentage epithelial expression measured. Results The extent of squamous metaplasia was significantly increased in both COPD1 and COPD2 compared to healthy smokers and healthy non-smokers. The amount of fully differentiated squamous epithelium was also increased in COPD1 and COPD2 compared to healthy non-smokers, as was the expression of carcinoembryonic antigen. These features correlated with one other. Conclusion In subjects with COPD there is a loss of pseudostratified epithelium accompanied by an increase in squamous metaplasia with transition into a fully squamous epithelium and expression of early markers of carcinogenesis.	[Rigden, Helen M.; Alias, Ahmad; Havelock, Thomas; O'Donnell, Rory; Djukanovic, Ratko; Davies, Donna E.; Wilson, Susan J.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Havelock, Thomas; Djukanovic, Ratko; Davies, Donna E.] Southampton Univ Hosp, NIHR Southampton Resp Biomed Res Unit, Tremona Rd, Southampton, Hants, England	University of Southampton; University of Southampton	Wilson, SJ (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	S.J.Wilson@southampton.ac.uk		Davies, Donna/0000-0002-5117-2991; Djukanovic, Ratko/0000-0001-6039-5612	Histochemistry Research Unit; National Institute for Health Research [NF-SI-0514-10085] Funding Source: researchfish	Histochemistry Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors wish to acknowledge the NIHR Southampton Respiratory Biomedical Research Unit for help with the bronchoscopies and the Histochemistry Research Unit for support with the immunohistochemical staining.	Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; ATHANASSIADOU P, 1995, ACTA CYTOL, V39, P1161; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barnes PJ, 2011, AM J RESP CRIT CARE, V184, P866, DOI 10.1164/rccm.201108-1436ED; Barsky SH, 1998, JNCI-J NATL CANCER I, V90, P1198, DOI 10.1093/jnci/90.16.1198; BENNETT WP, 1993, CANCER RES, V53, P4817; BERTRAM JF, 1981, BRIT MED J, V283, P1567, DOI 10.1136/bmj.283.6306.1567; Boers JE, 1996, AM J RESP CRIT CARE, V153, P411, DOI 10.1164/ajrccm.153.1.8542151; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Breuer RH, 2005, CLIN CANCER RES, V11, P537; Bulut I, 2009, MED PRIN PRACT, V18, P289, DOI 10.1159/000215726; Caramori G, 2011, INT J BIOCHEM CELL B, V43, P1030, DOI 10.1016/j.biocel.2010.08.022; CHANG F, 1993, BRIT J CANCER, V68, P653, DOI 10.1038/bjc.1993.404; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Dragnev KH, 2003, CHEST, V123, p60S, DOI 10.1378/chest.123.1_suppl.60S; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; FisselerEckhoff A, 1996, PATHOL RES PRACT, V192, P552, DOI 10.1016/S0344-0338(96)80105-1; George PJ, 2007, THORAX, V62, P43, DOI 10.1136/thx.2005.052191; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Godtfredsen NS, 2005, JAMA-J AM MED ASSOC, V294, P1505, DOI 10.1001/jama.294.12.1505; Haussinger K, 2005, THORAX, V60, P496, DOI 10.1136/thx.2005.041475; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; JETTEN AM, 1989, ENVIRON HEALTH PERSP, V80, P149, DOI 10.2307/3430740; KLEIN N, 1993, LAB INVEST, V68, P26; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; LEUBE RE, 1991, VIRCHOWS ARCH B, V61, P227; Loewen G, 2007, THORAX, V62, P335, DOI 10.1136/thx.2006.068999; MATHE G, 1982, CANCER DETECT PREV, V5, P461; Merrifield J, 2011, BIOTECH HISTOCHEM, V86, P340, DOI 10.3109/10520295.2010.502844; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; Papi A, 2004, THORAX, V59, P679, DOI 10.1136/thx.2003.018291; Parimon T, 2007, AM J RESP CRIT CARE, V175, P712, DOI 10.1164/rccm.200608-1125OC; Paris C, 2003, EUR RESPIR J, V21, P332, DOI 10.1183/09031936.03.00001503; PETERS EJ, 1993, CHEST, V103, P1429, DOI 10.1378/chest.103.5.1429; Ponticiello A, 2000, EUR RESPIR J, V15, P547, DOI 10.1034/j.1399-3003.2000.15.20.x; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rooney C, 2011, RESPIRATION, V81, P89, DOI 10.1159/000323946; RUSCH V, 1995, CANCER RES, V55, P1365; SAID JW, 1983, LAB INVEST, V49, P563; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; SKILLRUD DM, 1986, ANN INTERN MED, V105, P503, DOI 10.7326/0003-4819-105-4-503; STOCKLEY RA, 1986, THORAX, V41, P17, DOI 10.1136/thx.41.1.17; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Wistuba II, 1999, ONCOGENE, V18, P643, DOI 10.1038/sj.onc.1202349; Wong YC, 1997, IN VIVO, V11, P499; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009	52	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156009	10.1371/journal.pone.0156009	http://dx.doi.org/10.1371/journal.pone.0156009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228128	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000376882500050
J	Zhu, LC; Zhang, SR; Xu, X; Wang, B; Wu, K; Deng, QH; Xia, B; Ma, SL				Zhu, Lucheng; Zhang, Shirong; Xu, Xiao; Wang, Bing; Wu, Kan; Deng, Qinghua; Xia, Bing; Ma, Shenglin			Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review	PLOS ONE			English	Review							PHASE-III TRIAL; DAILY THORACIC RADIOTHERAPY; ELECTIVE NODAL IRRADIATION; CONCURRENT CHEMOTHERAPY; CLINICAL ONCOLOGY; AMERICAN-COLLEGE; CISPLATIN; THERAPY; ETOPOSIDE; FRACTIONATION	Objective Thoracic radiotherapy (TRT) is a critical component of the treatment of limited-stage small cell lung cancer (LS-SCLC). However, the optimal radiation dose/fractionation remains elusive. This study reviewed current evidence and explored the dose-response relationship in patients with LS-SCLC who were treated with radiochemotherapy. Materials and Methods A quantitative analysis was performed through a systematic search of PubMed, Web of Science, and the Cochrane Library. The correlations between the biological effective dose (BED) and median overall survival (mOS), median progression-free survival (mPFS), 1-, 3-, and 5-year overall survival (OS) as well as local relapse (LR) were evaluated. Results In all, 2389 patients in 19 trials were included in this study. Among these 19 trials, seven were conducted in Europe, eight were conducted in Asia and four were conducted in the United States. The 19 trials that were included consisted of 29 arms with 24 concurrent and 5 sequential TRT arms. For all included studies, the results showed that a higher BED prolonged the mOS (R-2 = 0.198, p<0.001) and the mPFS (R-2 = 0.045, p<0.001). The results also showed that increased BED improved the 1-, 3-, and 5-year OS. A 10-Gy increment added a 6.3%, a 5.1% and a 3.7% benefit for the 1-, 3-, and 5-year OS, respectively. Additionally, BED was negatively correlated with LR (R-2 = 0.09, p<0.001). A subgroup analysis of concurrent TRT showed that a high BED prolonged the mOS (p<0.001) and the mPFS (p<0.001), improved the 1-, 3-, and 5-year OS (p<0.001) and decreased the rate of LR (p<0.001). Conclusion This study showed that an increased BED was associated with improved OS, PFS and decreased LR in patients with LS-SCLC who were treated with combined chemoradiotherapy, which indicates that the strategy of radiation dose escalation over a limited time frame is worth exploring in a prospective clinical trial.	[Zhu, Lucheng; Zhang, Shirong; Xia, Bing; Ma, Shenglin] Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China; [Zhu, Lucheng; Zhang, Shirong; Xia, Bing; Ma, Shenglin] Hangzhou First Peoples Hosp, Hangzhou 310006, Zhejiang, Peoples R China; [Xu, Xiao; Wang, Bing; Wu, Kan; Deng, Qinghua] HangZhou Canc Hosp, Hangzhou 310006, Zhejiang, Peoples R China	Nanjing Medical University	Xia, B; Ma, SL (corresponding author), Nanjing Med Univ, Affiliated Hangzhou Hosp, Hangzhou 310006, Zhejiang, Peoples R China.; Xia, B; Ma, SL (corresponding author), Hangzhou First Peoples Hosp, Hangzhou 310006, Zhejiang, Peoples R China.	xb0918@hotmail.com; mashenglin@medmail.com.cn		Zhu, Lucheng/0000-0001-7298-4166	Major Science and Technology Innovation Project of Hangzhou [20112312A01]; National Natural Science Foundation of China [81272611]; Zhejiang Medical Science Foundation of China [2014KYA178]; Hangzhou Key Disease and Discipline Foundation of China [20140733Q15]; Zhejiang Provincial Natural Science Foundation of China [LY15H160010]; Medical Major Project of Hangzhou [20130733Q03]	Major Science and Technology Innovation Project of Hangzhou; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Medical Science Foundation of China; Hangzhou Key Disease and Discipline Foundation of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical Major Project of Hangzhou	This study was supported by grants from Major Science and Technology Innovation Project of Hangzhou (Grant no. 20112312A01; kpb.hz.gov.cn), National Natural Science Foundation of China (Grant no. 81272611; www.nsfc.gov.cn), Zhejiang Medical Science Foundation of China (Grant no. 2014KYA178; www.zjmed.org.cn), Hangzhou Key Disease and Discipline Foundation of China (Grant no. 20140733Q15; www.hzst.gov.cn), Zhejiang Provincial Natural Science Foundation of China (Grant no. LY15H160010; www.zjnsf.gov.cn), and Medical Major Project of Hangzhou (Grant no. 20130733Q03; www.hzst.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiris A, 2001, CANCER J, V7, P437; ARRIAGADA R, 1994, ANTICANCER RES, V14, P333; BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; BUNN PA, 1995, J CLIN ONCOL, V13, P1632, DOI 10.1200/JCO.1995.13.7.1632; CARNEY DN, 1983, CANCER RES, V43, P2806; Chen GY, 2005, INT J RADIAT ONCOL, V61, P70, DOI 10.1016/j.ijrobp.2004.04.058; Colaco R, 2012, LUNG CANCER, V76, P72, DOI 10.1016/j.lungcan.2011.09.015; Dale RG, 1998, BRIT J RADIOL, V71, P465, DOI 10.1259/bjr.71.845.9691890; De Ruysscher D, 2006, RADIOTHER ONCOL, V80, P307, DOI 10.1016/j.radonc.2006.07.029; Fowler JF, 2001, ACTA ONCOL, V40, P712, DOI 10.1080/02841860152619124; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Gronberg BH, 2015, ACTA ONCOL, V30, P1; Hu X, 2012, CANCER-AM CANCER SOC, V118, P278, DOI 10.1002/cncr.26119; Jeremic B, 1997, J CLIN ONCOL, V15, P893, DOI 10.1200/JCO.1997.15.3.893; Jett JR, 2013, CHEST, V143, pE400, DOI 10.1378/chest.12-2363; Jones B, 2001, CLIN ONCOL-UK, V13, P71, DOI 10.1053/clon.2001.9221; KERR KM, 1984, BRIT J CANCER, V50, P343, DOI 10.1038/bjc.1984.181; Komaki R, 2012, INT J RADIAT ONCOL, V83, pE531, DOI 10.1016/j.ijrobp.2012.01.075; Luo MH, 1999, CHINESE J RAD ONCOLO, P222; McClay EF, 2005, AM J CLIN ONCOL-CANC, V28, P81, DOI 10.1097/01.coc.0000139940.52625.d0; Movsas B, 2003, J CLIN ONCOL, V21, P4553, DOI 10.1200/JCO.2003.04.018; Movsas B, 2016, JAMA ONCOL, V2, P359, DOI 10.1001/jamaoncol.2015.3969; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Qiao Tian-kui, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P237; Roof KS, 2003, INT J RADIAT ONCOL, V57, P701, DOI 10.1016/S0360-3016(03)00715-6; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; Rudin CM, 2015, J CLIN ONCOL, V33, P4106, DOI 10.1200/JCO.2015.63.7918; Salama JK, 2013, J THORAC ONCOL, V8, P1043, DOI 10.1097/JTO.0b013e318293d8a4; Schild SE, 2004, INT J RADIAT ONCOL, V59, P943, DOI 10.1016/j.ijrobp.2004.01.055; Schild SE, 2007, J CLIN ONCOL, V25, P3124, DOI 10.1200/JCO.2006.09.9606; Sculier JP, 2008, ANN ONCOL, V19, P1691, DOI 10.1093/annonc/mdn354; Shibamoto Y, 1998, CLIN CANCER RES, V4, P677; Simon M, 2004, CRIT REV ONCOL HEMAT, V49, P119, DOI 10.1016/S1040-8428(03)00118-5; Skarlos DV, 2001, ANN ONCOL, V12, P1231, DOI 10.1023/A:1012295131640; Sun JM, 2013, ANN ONCOL, V24, P2088, DOI 10.1093/annonc/mdt140; Sundstrom S, 2002, J CLIN ONCOL, V20, P4665, DOI 10.1200/JCO.2002.12.111; Takada M, 2002, J CLIN ONCOL, V20, P3054, DOI 10.1200/JCO.2002.12.071; TINNEMANS MMFJ, 1993, BRIT J CANCER, V67, P1217, DOI 10.1038/bjc.1993.228; Turrisi AT, 1999, NEW ENGL J MED, V340, P265, DOI 10.1056/NEJM199901283400403; WILLIAMS MV, 1985, INT J RADIAT ONCOL, V11, P87, DOI 10.1016/0360-3016(85)90366-9; Xia B, 2015, INT J RADIAT ONCOL, V91, P517, DOI 10.1016/j.ijrobp.2014.09.042; Xia B, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-50	44	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156494	10.1371/journal.pone.0156494	http://dx.doi.org/10.1371/journal.pone.0156494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227819	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500148
J	d'Azy, CB; Pereira, B; Naughton, G; Chiambaretta, F; Dutheil, F				d'Azy, Cedric Benoist; Pereira, Bruno; Naughton, Geraldine; Chiambaretta, Frederic; Dutheil, Frederic			Antibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ANTIBIOTIC-PROPHYLAXIS; OCULAR SURFACE; RISK; RESISTANCE	Despite endophthalmitis being the most feared complication, antibioprophylaxis remains controversial in intravitreal injections. Therefore, we conducted a systematic review and meta-analysis on the effects of antibioprophylaxis in intravitreal injections in the prevention of endophthalmitis. The PubMed, Cochrane Library, Embase and Science Direct databases were searched for studies comparing groups with and without antibiotics in intravitreal injection, with the use of the following keywords: "antibiotic*", "endophthalmitis" and "intravitreal injection*". To be included, studies needed to specify number of participants and number of endophthalmitis within each group (with and without antibiotics). We conducted meta-analysis on the prevalence of clinical endophthalmitis including both culture-proven and culture negative samples. Nine studies were included. A total of 88 incidences of endophthalmitis were reported from 174,159 injections (0.051% i.e., one incidence of endophthalmitis for 1979 injections). Specifically, 59 incidences of endophthalmitis were reported from 113,530 injections in the group with antibiotics (0.052% or one incidence of endophthalmitis for 1924 injections) and 29 incidences of endophthalmitis from 60,633 injections in the group without antibiotics (0.048% or one endophthalmitis for 2091 injections). Our meta-analysis did not report a significant difference in the prevalence of clinical endophthalimitis between the two groups with and without topical antibiotics: the odds ratio of clinical endophthalimitis was 0.804 (CI95% 0.384-1.682, p = 0.56) for the antibiotic group compared with the group without antibiotics. In conclusion, we performed the first large meta-analysis demonstrating that antibioprophylaxis is not required in intravitreal injections. Strict rules of asepsis remain the only evidence-based prophylaxis of endophthalmitis. The results support initiatives to reduce the global threat of resistance to antibiotics.	[d'Azy, Cedric Benoist; Chiambaretta, Frederic] Univ Hosp Clermont Ferrand CHU, Ophthalmol, Clermont Ferrand, France; [d'Azy, Cedric Benoist; Dutheil, Frederic] Univ Hosp Clermont Ferrand CHU, Prevent & Occupat Med, Clermont Ferrand, France; [Pereira, Bruno] Univ Hosp Clermont Ferrand CHU, Clin Res Direct, Clermont Ferrand, France; [Naughton, Geraldine; Dutheil, Frederic] Australian Catholic Univ, Fac Hlth, Melbourne, Vic, Australia; [Dutheil, Frederic] Univ Blaise Pascal, Clermont Auvergne Univ, Lab Metab Adaptat Exercise Physiol & Pathol Condi, Clermont Ferrand, France; [Dutheil, Frederic] Res Ctr Human Nutr CRNH Auvergne, Clermont Ferrand, France; [Dutheil, Frederic] Univ Clermont Auvergne, CNRS, UMR Physiol & Psychosocial Stress 6024, LAPSCO, Clermont Ferrand, France	CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Clermont Ferrand; Australian Catholic University; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Dutheil, F (corresponding author), Univ Hosp Clermont Ferrand CHU, Prevent & Occupat Med, Clermont Ferrand, France.; Dutheil, F (corresponding author), Australian Catholic Univ, Fac Hlth, Melbourne, Vic, Australia.; Dutheil, F (corresponding author), Univ Blaise Pascal, Clermont Auvergne Univ, Lab Metab Adaptat Exercise Physiol & Pathol Condi, Clermont Ferrand, France.; Dutheil, F (corresponding author), Res Ctr Human Nutr CRNH Auvergne, Clermont Ferrand, France.; Dutheil, F (corresponding author), Univ Clermont Auvergne, CNRS, UMR Physiol & Psychosocial Stress 6024, LAPSCO, Clermont Ferrand, France.	frederic.dutheil@acu.edu.au	Naughton, Geraldine/M-4094-2017; Dutheil, Frederic/O-9707-2014	Naughton, Geraldine/0000-0002-0534-1627; Pereira, Bruno/0000-0003-3778-7161; Dutheil, Frederic/0000-0002-1468-6029	University Hospital of Clermont-Ferrand, France	University Hospital of Clermont-Ferrand, France	This study was funded by the University Hospital of Clermont-Ferrand, France.	Avery Robert L, 2014, Retina, V34 Suppl 12, pS1, DOI 10.1097/IAE.0000000000000399; Bhatt SS, 2011, RETINA-J RET VIT DIS, V31, P2032, DOI 10.1097/IAE.0b013e31820f4b4f; Bhavsar AR, 2015, RETINA-J RET VIT DIS, V35, P783, DOI 10.1097/IAE.0000000000000392; Bhavsar AR, 2012, ARCH OPHTHALMOL-CHIC, V130, P809, DOI 10.1001/archophthalmol.2012.227; Bhavsar AR, 2009, ARCH OPHTHALMOL-CHIC, V127, P1581, DOI 10.1001/archophthalmol.2009.304; Bodaghi B, 2012, J FR OPHTALMOL, V35, P69, DOI 10.1016/j.jfo.2011.11.005; Cheung CSY, 2012, OPHTHALMOLOGY, V119, P1609, DOI 10.1016/j.ophtha.2012.02.014; Cochereau I, 2013, J FR OPHTALMOL, V36, P72, DOI 10.1016/j.jfo.2012.10.001; Costello P, 2006, RETINA-J RET VIT DIS, V26, P191, DOI 10.1097/00006982-200602000-00012; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; De Caro JJ, 2008, RETINA-J RET VIT DIS, V28, P877, DOI 10.1097/IAE.0b013e31816b3180; de Kaspar HM, 2001, OPHTHALMOLOGY, V108, P470, DOI 10.1016/S0161-6420(00)00545-5; Dossarps D, 2015, AM J OPHTHALMOL, V160, P17, DOI 10.1016/j.ajo.2015.04.013; Fileta JB, 2014, OSLI RETINA, V45, P143, DOI 10.3928/23258160-20140306-08; ISENBERG SJ, 1985, ARCH OPHTHALMOL-CHIC, V103, P1340, DOI 10.1001/archopht.1985.01050090092039; Kim SJ, 2011, OPHTHALMOLOGY, V118, P1358, DOI 10.1016/j.ophtha.2010.12.014; Kim SJ, 2010, OPHTHALMOLOGY, V117, P2372, DOI 10.1016/j.ophtha.2010.03.034; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; McCannel CA, 2011, RETINA-J RET VIT DIS, V31, P654, DOI 10.1097/IAE.0b013e31820a67e4; Meredith TA, 2015, OPHTHALMOLOGY, V122, P817, DOI 10.1016/j.ophtha.2014.10.027; Moshfeghi AA, 2011, RETINA-J RET VIT DIS, V31, P662, DOI 10.1097/IAE.0b013e31821067c4; Moss JM, 2009, OPHTHALMOLOGY, V116, P1498, DOI 10.1016/j.ophtha.2009.02.024; Pachuo M, 2015, PAK J OPHTALMOL, V31; Park Y, 2013, J OCUL PHARMACOL TH, V29, P900, DOI 10.1089/jop.2013.0052; Ramel JC, 2014, J FR OPHTALMOL, V37, P273, DOI 10.1016/j.jfo.2014.01.003; Sigford DK, 2015, CLIN OPHTHALMOL, V9, P773, DOI 10.2147/OPTH.S77067; Storey P, 2014, OPHTHALMOLOGY, V121, P283, DOI 10.1016/j.ophtha.2013.08.037; Stranak Z, 2014, Cesk Slov Oftalmol, V70, P184; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wykoff CC, 2011, AM J OPHTHALMOL, V152, P717, DOI 10.1016/j.ajo.2011.07.002; Yin VT, 2013, JAMA OPHTHALMOL, V131, P456, DOI 10.1001/jamaophthalmol.2013.2379	31	40	41	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156431	10.1371/journal.pone.0156431	http://dx.doi.org/10.1371/journal.pone.0156431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257676	Green Published, gold, Green Submitted			2022-12-27	WOS:000377369700065
J	Winther, KH; Cramon, P; Watt, T; Bjorner, JB; Ekholm, O; Feldt-Rasmussen, U; Groenvold, M; Rasmussen, AK; Hegedus, L; Bonnema, SJ				Winther, Kristian Hillert; Cramon, Per; Watt, Torquil; Bjorner, Jakob Bue; Ekholm, Ola; Feldt-Rasmussen, Ulla; Groenvold, Mogens; Rasmussen, Ase Krogh; Hegedus, Laszlo; Bonnema, Steen Joop			Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy	PLOS ONE			English	Article							PATIENT-CENTERED CARE; MEASURE THYPRO; QUESTIONNAIRE; THYROXINE; RELEVANT; SYMPTOMS; VALIDITY; OUTCOMES; THYDQOL; DESIGN	Background Hypothyroidism is often diagnosed, and subsequently treated, due to health-related quality of life (HRQL) issues. However, HRQL following treatment has never previously been assessed in longitudinal descriptive studies using validated instruments. Objective To investigate disease-specific (ThyPRO) and generic (SF-36) HRQL, following levothyroxine therapy in patients with hypothyroidism due to autoimmune thyroiditis. Methods This prospective cohort study was set at endocrine outpatient clinics at two Danish university hospitals. Seventy-eight consecutive patients were enrolled and completed HRQL questionnaires before, six weeks, and six months after initiation of levothyroxine therapy. Normative ThyPRO (n = 739) and SF-36 (n = 6,638) data were available for comparison and changes in HRQL following treatment were estimated and quantified. Results Prior to treatment, all ThyPRO scales were significantly impacted (p<0.0001), compared to the general population sample. The same was observed for seven of eight SF-36 scales, the exception being Bodily Pain. Tiredness (ThyPRO) and Vitality (SF-36) were the most markedly impacted scales. After six weeks of treatment, nine of thirteen ThyPRO scales had significantly improved. ThyPRO improvements were consistent at six months, where five of eight SF-36 scales had also significantly improved, but deficits persisted for a subset of both ThyPRO and SF-36 scales. Conclusions In this population of hypothyroid patients, HRQL was widely affected before treatment, with tiredness as the cardinal impairment according to both ThyPRO and SF-36. Many aspects of HRQL improved during the first six months of LT4 therapy, but full recovery was not obtained. Our results may help clinicians inform patients about expected clinical treatment effects.	[Winther, Kristian Hillert; Hegedus, Laszlo; Bonnema, Steen Joop] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Winther, Kristian Hillert; Hegedus, Laszlo; Bonnema, Steen Joop] Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, Odense, Denmark; [Cramon, Per; Feldt-Rasmussen, Ulla; Rasmussen, Ase Krogh] Rigshosp, Copenhagen Univ Hosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Watt, Torquil] Gentofte Univ Hosp, Dept Internal Med, Copenhagen, Denmark; [Bjorner, Jakob Bue; Groenvold, Mogens] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bjorner, Jakob Bue] Optum Insight Inc, Eden Prairie, MN USA; [Ekholm, Ola] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Groenvold, Mogens] Bispebjerg Hosp, Dept Palliat Med, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Optum; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Winther, KH (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark.; Winther, KH (corresponding author), Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, Odense, Denmark.	kristian.winther@rsyd.dk	Bonnema, Steen/AAF-1198-2020; Bonnema, Steen/AAE-6558-2021; Feldt-Rasmussen, Ulla/AAB-9218-2021; Watt, Torquil/ABC-3252-2020	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Watt, Torquil/0000-0002-6001-7440; Gronvold, Mogens/0000-0002-3153-780X	Danish Agency for Science, Technology and Innovation: Council for Strategic Research; Danish Agency for Science, Technology and Innovation: Council for Independent Research [09-066886]; Agnes & Knut Morks Foundation; University of Southern Denmark; Region of Southern Denmark; Novo Nordisk Foundation; Odense University Hospital Research Council; Novo Nordisk Fonden [NNF15OC0014622] Funding Source: researchfish	Danish Agency for Science, Technology and Innovation: Council for Strategic Research; Danish Agency for Science, Technology and Innovation: Council for Independent Research; Agnes & Knut Morks Foundation; University of Southern Denmark; Region of Southern Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Odense University Hospital Research Council; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by research grants from the Danish Agency for Science, Technology and Innovation: Council for Strategic Research and Council for Independent Research (ID: 09-066886), and Agnes & Knut Morks Foundation. KHW is supported by grants from the University of Southern Denmark and the Region of Southern Denmark; UFR and LH are supported by an unrestricted grant from the Novo Nordisk Foundation. SB is supported by grants from Odense University Hospital Research Council. JBB is an employee of Optum Patient Insights. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carle A, 2006, EUR J ENDOCRINOL, V154, P21, DOI 10.1530/eje.1.02068; Carle A, 2014, EUR J ENDOCRINOL, V171, P593, DOI 10.1530/EJE-14-0481; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Cramon P, 2015, THYROID, V25, P284, DOI 10.1089/thy.2014.0433; Dayan CM, 2013, EUR THYROID J, V2, P168, DOI 10.1159/000353777; Ekholm O, 2009, SCAND J PUBLIC HEALT, V37, P758, DOI 10.1177/1403494809341095; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hays R., 2005, ASSESSING QUALITY LI, P3; Kelderman-Bolk N, 2015, EUR J ENDOCRINOL, V173, P507, DOI 10.1530/EJE-15-0395; Krysiak R, 2015, CLIN ENDOCRINOL; McMillan C, 2008, VALUE HEALTH, V11, P285, DOI 10.1111/j.1524-4733.2007.00232.x; McMillan CV, 2004, THYROID, V14, P916, DOI 10.1089/thy.2004.14.916; Pedersen IB, 2007, J CLIN ENDOCR METAB, V92, P3122, DOI 10.1210/jc.2007-0732; Quinque EM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-68; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Samuels MH, 2014, CURR OPIN ENDOCRINOL, V21, P377, DOI 10.1097/MED.0000000000000089; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Stewart M, 2000, J FAM PRACTICE, V49, P796; Thvilum M, 2014, THYROID, V24, P802, DOI 10.1089/thy.2013.0555; Thvilum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075789; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Tzelepis F, 2015, PATIENT PREFER ADHER, V9, P831, DOI 10.2147/PPA.S81975; Ware J.E., 2007, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watt T, 2008, QUAL LIFE RES, V17, P1009, DOI 10.1007/s11136-008-9364-z; Watt T, 2007, THYROID, V17, P647, DOI 10.1089/thy.2007.0069; Watt T, 2015, THYROID, V25, P1069, DOI 10.1089/thy.2015.0209; Watt T, 2014, J CLIN ENDOCR METAB, V99, P3708, DOI 10.1210/jc.2014-1322; Watt T, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0126-z; Watt T, 2014, QUAL LIFE RES, V23, P327, DOI 10.1007/s11136-013-0462-1; Watt T, 2010, EUR J ENDOCRINOL, V162, P161, DOI 10.1530/EJE-09-0521; Watt T, 2009, QUAL LIFE RES, V18, P483, DOI 10.1007/s11136-009-9460-8; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Wiersinga WM, 2014, NAT REV ENDOCRINOL, V10, P164, DOI 10.1038/nrendo.2013.258; Winther KH, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-115	39	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156925	10.1371/journal.pone.0156925	http://dx.doi.org/10.1371/journal.pone.0156925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257805	Green Published, Green Submitted, gold			2022-12-27	WOS:000377369700156
J	Ordonez, YM; Fernandez, BR; Lara, LS; Rodriguez, A; Uribe-Velez, D; Sanders, IR				Marcela Ordonez, Yuli; Rocio Fernandez, Belen; Susana Lara, Lidia; Rodriguez, Alia; Uribe-Velez, Daniel; Sanders, Ian R.			Bacteria with Phosphate Solubilizing Capacity Alter Mycorrhizal Fungal Growth Both Inside and Outside the Root and in the Presence of Native Microbial Communities	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; PLANT-GROWTH; FLUORESCENT PSEUDOMONADS; SOIL BACTERIA; IN-VITRO; RHIZOSPHERE; RHIZOBACTERIA; INOCULATION; BIOCONTROL; DIVERSITY	Arbuscular mycorrhizal fungi (AMF) and phosphate solubilizing Pseudomonas bacteria (PSB) could potentially interact synergistically because PSB solubilize phosphate into a form that AMF can absorb and transport to the plant. However, very little is known about the interactions between these two groups of microorganisms and how they influence the growth of each other. We tested whether different strains of bacteria, that have the capacity to solubilize phosphate, are able to grow along AMF hyphae and differentially influence the growth of AMF both outside the roots of carrot in in vitro conditions and inside the roots of potato in the presence of a microbial community. We found strong effects of AMF on the growth of the different bacterial strains. Different bacterial strains also had very strong effects on the growth of AMF extraradical hyphae outside the roots of carrot and on colonization of potato roots by AMF. The differential effects on colonization occurred in the presence of a microbial community. Our results show that these two important groups of rhizosphere microorganisms indeed interact with each other. Such interactions could potentially lead to synergistic effects between the two groups but this could depend on whether the bacteria truly solubilize phosphate in the rhizosphere in the presence of microbial communities.	[Marcela Ordonez, Yuli; Rodriguez, Alia] Univ Nacl Colombia, Dept Biol, Fac Sci, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Rocio Fernandez, Belen] Univ Nacl Colombia, Fac Agron, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Susana Lara, Lidia; Uribe-Velez, Daniel] Univ Nacl Colombia, Inst Biotechnol, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Sanders, Ian R.] Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland.	ian.sanders@unil.ch	Sanders, Ian R/T-9988-2017	Sanders, Ian R/0000-0002-9591-8214; Ordonez, Yuli M/0000-0001-8660-9869				Agnolucci M, 2015, BIOL FERT SOILS, V51, P379, DOI 10.1007/s00374-014-0989-5; Artursson V, 2005, ENVIRON MICROBIOL, V7, P1952, DOI 10.1111/j.1462-2920.2005.00868.x; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Barroso CB, 2005, APPL SOIL ECOL, V29, P73, DOI 10.1016/j.apsoil.2004.09.005; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Bennasar A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-118; Bianciotto V, 2002, ANTON LEEUW INT J G, V81, P365, DOI 10.1023/A:1020544919072; Browne P, 2009, APPL SOIL ECOL, V43, P131, DOI 10.1016/j.apsoil.2009.06.010; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Collavino MM, 2008, BIOL FERT SOILS, V46, P727; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; Gamalero E, 2004, MYCORRHIZA, V14, P185, DOI 10.1007/s00572-003-0256-3; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Hariprasad P, 2009, PLANT SOIL, V316, P13, DOI 10.1007/s11104-008-9754-6; Human Z, 2002, AM J BOT, V89, P947, DOI 10.3732/ajb.89.6.947; Iwamoto T, 2000, FEMS MICROBIOL ECOL, V32, P129, DOI 10.1111/j.1574-6941.2000.tb00707.x; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Jorquera MA, 2008, BIOL FERT SOILS, V44, P1025, DOI 10.1007/s00374-008-0288-0; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Marschner P, 2001, MYCORRHIZA, V11, P297, DOI 10.1007/s00572-001-0136-7; Meyer JB, 2011, APPL ENVIRON MICROB, V77, P7345, DOI 10.1128/AEM.05434-11; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Naik PR, 2008, MICROB ECOL, V56, P492, DOI 10.1007/s00248-008-9368-9; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Nazir R, 2009, FEMS MICROBIOL ECOL, V71, P161; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Owen D, 2015, APPL SOIL ECOL, V86, P41, DOI 10.1016/j.apsoil.2014.09.012; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TISSERANT B, 1993, MYCOL RES, V97, P245, DOI 10.1016/S0953-7562(09)80248-7; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; Toljander JF, 2007, FEMS MICROBIOL ECOL, V61, P295, DOI 10.1111/j.1574-6941.2007.00337.x; Toro M, 1997, APPL ENVIRON MICROB, V63, P4408, DOI 10.1128/AEM.63.11.4408-4412.1997; Trouvelot A., 1986, PHYSIOL GENETICAL AS, P217, DOI DOI 10.12691/AJMR-3-5-5; Uribe D, 1999, REV COLOMB BIOTECNOL, V2, P50; Uribe D, 2010, SOIL BIOL, V21, P235, DOI 10.1007/978-3-642-05076-3_11; Vyas P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-174; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Zhang L, 2016, NEW PHYTOL, V210, P1022, DOI 10.1111/nph.13838	50	61	69	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0154438	10.1371/journal.pone.0154438	http://dx.doi.org/10.1371/journal.pone.0154438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253975	Green Submitted, Green Published, gold			2022-12-27	WOS:000377218700003
J	Valverde, G; Romero, MIB; Espinoza, IF; Cooper, A; Fehren-Schmitz, L; Llamas, B; Haak, W				Valverde, Guido; Romero, Maria Ines Barreto; Espinoza, Isabel Flores; Cooper, Alan; Fehren-Schmitz, Lars; Llamas, Bastien; Haak, Wolfgang			Ancient DNA Analysis Suggests Negligible Impact of the Wari Empire Expansion in Peru's Central Coast during the Middle Horizon	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; MORTUARY PREFERENCES; POPULATIONS; COLLAPSE; AMERICA; STATE	The analysis of ancient human DNA from South America allows the exploration of pre-Columbian population history through time and to directly test hypotheses about cultural and demographic evolution. The Middle Horizon (650-1100 AD) represents a major transitional period in the Central Andes, which is associated with the development and expansion of ancient Andean empires such as Wari and Tiwanaku. These empires facilitated a series of interregional interactions and socio-political changes, which likely played an important role in shaping the region's demographic and cultural profiles. We analyzed individuals from three successive pre-Columbian cultures present at the Huaca Pucllana archaeological site in Lima, Peru: Lima (Early Intermediate Period, 500-700 AD), Wari (Middle Horizon, 8001000 AD) and Ychsma (Late Intermediate Period, 1000-1450 AD). We sequenced 34 complete mitochondrial genomes to investigate the potential genetic impact of the Wari Empire in the Central Coast of Peru. The results indicate that genetic diversity shifted only slightly through time, ruling out a complete population discontinuity or replacement driven by the Wari imperialist hegemony, at least in the region around present-day Lima. However, we caution that the very subtle genetic contribution of Wari imperialism at the particular Huaca Pucllana archaeological site might not be representative for the entire Wari territory in the Peruvian Central Coast.	[Valverde, Guido; Cooper, Alan; Llamas, Bastien; Haak, Wolfgang] Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Romero, Maria Ines Barreto; Espinoza, Isabel Flores] Proyecto Arqueol Huaca Pucllana, Lima, Peru; [Fehren-Schmitz, Lars] Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; [Haak, Wolfgang] Max Planck Inst Sci Human Hist, Jena, Germany	University of Adelaide; University of California System; University of California Santa Cruz	Valverde, G (corresponding author), Univ Adelaide, Sch Biol Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia.	guido.valverde@gmail.com	Haak, Wolfgang/Z-4947-2019; Llamas, Bastien/AAK-1693-2021; Valverde, Guido/ABF-1641-2020; Llamas, Bastien/Y-2781-2018	Haak, Wolfgang/0000-0003-2475-2007; Llamas, Bastien/0000-0002-5550-9176; Llamas, Bastien/0000-0002-5550-9176; Valverde, Guido/0000-0001-6201-6030; Cooper, Alan/0000-0002-7738-7851	Australian Research Council [DP 1095782]	Australian Research Council(Australian Research Council)	Sampling of the Huaca Pucllana archaeological material and ancient DNA work were funded by the Australian Research Council (DP 1095782; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreto MI., 2012, THESIS U NACL MAYOR; Barreto MI, 2010, ARQUEOLOGIA SOC, V22, P55; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Belisle Veronique, 2010, WARI WALLS REGIONAL, P79; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Brown K, 1998, ARCHEOLOGIST, V33, P16; Cooper A, 2000, SCIENCE, V289, P1139; Coutinho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093292; Covey RA, 2013, J ANTHROPOL ARCHAEOL, V32, P538, DOI 10.1016/j.jaa.2013.09.001; Pierre MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043486; Drummond AJ, GENEIOUS V5 4; Eeckhout Peter, 2000, J AM ARCHAEOLOGY, V17-18-19, P217; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fehren-Schmitz L, 2014, P NATL ACAD SCI; Fehren-Schmitz L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127141; Fehren-Schmitz L, 2011, ANN HUM GENET, V75, P266, DOI 10.1111/j.1469-1809.2010.00620.x; Finucane BC, 2007, RADIOCARBON, V49, P579, DOI 10.1017/S003382220004248X; Flores I., 1981, B LIMA, VIII, P65; Flores I, 2013, WARI PUCLLANA TUMBA, P87; Flores I, 2012, LIMA, V25, P57; Flores I., 2005, PUCLLANA ESPLENDOR C; Fu YX, 1997, GENETICS, V147, P915; Fulton TL, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9_1; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Glowacki M, 2012, B ARQUEOLOGIA PUCP, V16, P189; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hogg AG, SHCAL 13 SO HEMISPHE; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Isbell WH, 2004, LAT AM ANTIQ, V15, P3, DOI 10.2307/4141562; ISBELL WH, 1978, AM ANTIQUITY, V43, P372, DOI 10.2307/279393; Isbell WH, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P731, DOI 10.1007/978-0-387-74907-5_37; Kaulicke Peter, 2000, B ARQUEOLOGIA PUCP, V4, P313; Kemp BM, 2009, AM J PHYS ANTHROPOL, V140, P80, DOI 10.1002/ajpa.21037; Kircher M, 2012, METHODS MOL BIOL, V840, P197, DOI 10.1007/978-1-61779-516-9_23; Knapp M, 2012, ANN ANAT, V194, P3, DOI 10.1016/j.aanat.2011.03.008; Lanning E. P., 1967, PERU INCAS; Lewis C, 2009, DIFFICULTIES REJECTI; Lewis CM, 2007, HUM BIOL, V79, P159, DOI 10.1353/hub.2007.0031; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Livi-Bacci M, 2006, POPUL DEV REV, V32, P199, DOI 10.1111/j.1728-4457.2006.00116.x; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; Lumbreras LG, 1980, IMPERIO WARI HIST PE, V1, P9; Lumbreras Luis G., 1974, PEOPLES CULTURES ANC; Lumbreras Luis Guillermo, 1969, PUEBLOS CULTURAS ART; Marcone G., 2010, WARI WALLS REGIONAL, P136; McEwan GF, 1990, LAT AM ANTIQ, V1, P97; Mendisco F, 2014, ANN HUM GENET, V78, P367, DOI 10.1111/ahg.12075; Menzel D, 1964, I ANDEAN STUDIES, V2, P1; Moraga M, 2005, AM J PHYS ANTHROPOL, V127, P170, DOI 10.1002/ajpa.10438; Moraga ML, 2000, AM J PHYS ANTHROPOL, V113, P19, DOI 10.1002/1096-8644(200009)113:1<19::AID-AJPA3>3.0.CO;2-X; Navalte PC., 2012, PERU, V16, P303; O'Fallon BD, 2011, P NATL ACAD SCI US; Owen BD, 1994, 59 ANN M SOC AM ARCH; Patterson T, 1964, NAWPA PACHA, V2, P113; Pringle H., PERUS ROYAL WARI TOM; Reimer PJ, INTCAL13 MARINE13 RA; Reindel M, 2009, NAT SCI ARCHAEOL, P1, DOI 10.1007/978-3-540-87438-6; ROWE JH, 1962, SOUTHWEST J ANTHROP, V18, P40, DOI 10.1086/soutjanth.18.1.3629122; Sandoval JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073006; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; SCHREIBER KJ, 1992, ANTHR PAPERS MUSEUM, V87; Schreiber KJ, 2012, B ARQUEOLOGIA PUCP, V16, P11; Segura Rafael, 2010, WARI WALLS REGIONAL, P113; SHADY R, 1979, AM ANTIQUITY, V44, P676, DOI 10.2307/279106; Shady R, 1988, REV ANDINA, V6, P67; Shady R, 1982, ARQUEOLOGICAS, V19, P15; SLATKIN M, 1995, GENETICS, V139, P457; TAJIMA F, 1989, GENETICS, V123, P585; Topic J.R., 1991, HUARI ADM STRUCTURE, P114; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Tung TA, 2007, AM J PHYS ANTHR, V133; Tung Tiffiny A., 2012, VIOLENCE RITUAL WARI; Valdez LM, 2006, WORLD ARCHAEOL, V38, P672, DOI 10.1080/00438240600963379; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Williams P.R., 2002, GACETA ARQUEOLOGICA, V26, P87; Williams PR, 2002, WORLD ARCHAEOL, V33, P361, DOI 10.1080/00438240120107422; Yang DY, 2005, J ARCHAEOL SCI, V32, P331, DOI 10.1016/j.jas.2004.09.008	80	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155508	10.1371/journal.pone.0155508	http://dx.doi.org/10.1371/journal.pone.0155508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248693	Green Published, Green Submitted, gold			2022-12-27	WOS:000377184700016
J	Huang, L; Wu, B; Zhao, JJ; Li, HT; Chen, WG; Zheng, YL; Ren, XP; Chen, YN; Zhou, XJ; Lei, Y; Liao, BS; Jiang, HF				Huang, Li; Wu, Bei; Zhao, Jiaojiao; Li, Haitao; Chen, Weigang; Zheng, Yanli; Ren, Xiaoping; Chen, Yuning; Zhou, Xiaojing; Lei, Yong; Liao, Boshou; Jiang, Huifang			Characterization and Transferable Utility of Microsatellite Markers in the Wild and Cultivated Arachis Species	PLOS ONE			English	Article							HYPOGAEA L.; ASSOCIATION ANALYSIS; DNA MARKERS; PEANUT; IDENTIFICATION; POLYMORPHISM; DIVERSITY; SEQUENCES; QUALITY; TRAITS	Microsatellite or simple sequence repeat (SSR) is one of the most widely distributed molecular markers that have been widely utilized to assess genetic diversity and genetic mapping for important traits in plants. However, the understanding of microsatellite characteristics in Arachis species and the currently available amount of high-quality SSR markers remain limited. In this study, we identified 16,435 genome survey sequences SSRs (GSS-SSRs) and 40,199 expressed sequence tag SSRs (EST-SSRs) in Arachis hypogaea and its wild relative species using the publicly available sequence data. The GSS-SSRs had a density of 159.9-239.8 SSRs/Mb for wild Arachis and 1,015.8 SSR/Mb for cultivated Arachis, whereas the EST-SSRs had the density of 173.5-384.4 SSR/Mb and 250.9 SSRs/Mb for wild and cultivated Arachis, respectively. The trinucleotide SSRs were predominant across Arachis species, except that the dinucleotide accounted for most in A. hypogaea GSSs. From Arachis GSS-SSR and EST-SSR sequences, we developed 2,589 novel SSR markers that showed a high polymorphism in six diverse A. hypogaea accessions. A genetic linkage map that contained 540 novel SSR loci and 105 anchor SSR loci was constructed by case of a recombinant inbred lines F-6 population. A subset of 82 randomly selected SSR markers were used to screen 39 wild and 22 cultivated Arachis accessions, which revealed a high transferability of the novel SSRs across Arachis species. Our results provided informative clues to investigate microsatellite patterns across A. hypogaea and its wild relative species and potentially facilitate the germplasm evaluation and gene mapping in Arachis species.	[Huang, Li; Wu, Bei; Zhao, Jiaojiao; Chen, Weigang; Zheng, Yanli; Ren, Xiaoping; Chen, Yuning; Zhou, Xiaojing; Lei, Yong; Liao, Boshou; Jiang, Huifang] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Li, Haitao] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Jiang, HF (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	peanutlab@oilcrops.cn			National Natural Science Foundations of China [31401420, 31271764, 31471534, 31371662, 31461143022]; Plant Germplasm Resources Sharing Platform [2015NWB035]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Plant Germplasm Resources Sharing Platform	Support was provided by the National Natural Science Foundations of China (31401420) to LH; National Natural Science Foundations of China (31271764 and 31471534) to HJ; and National Natural Science Foundations of China (31371662 and 31461143022) to BL.; We thank Drs. Yingjie Xiao and Yongqing Jiao for helpful comments to the manuscript. This research was supported by the National Natural Science Foundations of China (31401420, 31271764, 31371662, 31471534 and 31461143022) and the Plant Germplasm Resources Sharing Platform (2015NWB035).	Bosamia TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129127; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; HALWARD TM, 1991, GENOME, V34, P1013, DOI 10.1139/g91-156; Han B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141540; He GH, 1997, EUPHYTICA, V97, P143, DOI 10.1023/A:1002949813052; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Huang L, 2015, THEOR APPL GENET, V128, P1103, DOI 10.1007/s00122-015-2493-1; Jiang HF, 2014, J INTEGR PLANT BIOL, V56, P159, DOI 10.1111/jipb.12132; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Koilkonda P, 2012, MOL BREEDING, V30, P125, DOI 10.1007/s11032-011-9604-8; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krapovickas A., 1994, Bonplandia, V8, P1; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu K, 2005, POWERMARKER INTEGRAT; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105228; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Subramanian V, 2000, GENOME, V43, P656, DOI 10.1139/gen-43-4-656; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van O.J., 2001, JOINMAP R 3 0 SOFTWA; Wang H, 2012, BMC PLANT BIOL, V12, DOI [10.1186/1471-2229-12-10, 10.1186/1471-2229-12-194]; Wang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119454; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Wang Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep10638; Wu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146383; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yasodha R., 2011, Gene Conserve, P51	46	14	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156633	10.1371/journal.pone.0156633	http://dx.doi.org/10.1371/journal.pone.0156633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243460	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100058
J	Dhokane, D; Karre, S; Kushalappa, AC; McCartney, C				Dhokane, Dhananjay; Karre, Shailesh; Kushalappa, Ajjamada C.; McCartney, Curt			Integrated Metabolo-Transcriptomics Reveals Fusarium Head Blight Candidate Resistance Genes in Wheat QTL-Fhb2	PLOS ONE			English	Article							TRANSGENIC ARABIDOPSIS-THALIANA; MARKER-ASSISTED SELECTION; TIME QUANTITATIVE PCR; TRITICUM-AESTIVUM L.; S-TRANSFERASE GENES; ENHANCED RESISTANCE; MYCOTOXIN DEOXYNIVALENOL; MASS-SPECTROMETRY; DEFENSE RESPONSES; RICE CHITINASE	Background Fusarium head blight (FHB) caused by Fusarium graminearum not only causes severe losses in yield, but also reduces quality of wheat grain by accumulating mycotoxins. Breeding for host plant resistance is considered as the best strategy to manage FHB. Resistance in wheat to FHB is quantitative in nature, involving cumulative effects of many genes governing resistance. The poor understanding of genetics and lack of precise phenotyping has hindered the development of FHB resistant cultivars. Though more than 100 QTLs imparting FHB resistance have been reported, none discovered the specific genes localized within the QTL region, nor the underlying mechanisms of resistance. Findings In our study recombinant inbred lines (RILs) carrying resistant (R-RIL) and susceptible (SRIL) alleles of QTL-Fhb2 were subjected to metabolome and transcriptome profiling to discover the candidate genes. Metabolome profiling detected a higher abundance of metabolites belonging to phenylpropanoid, lignin, glycerophospholipid, flavonoid, fatty acid, and terpenoid biosynthetic pathways in R-RIL than in S-RIL. Transcriptome analysis revealed up-regulation of several receptor kinases, transcription factors, signaling, mycotoxin detoxification and resistance related genes. The dissection of QTL-Fhb2 using flanking marker sequences, integrating metabolomic and transcriptomic datasets, identified 4-Coumarate: CoA ligase (4CL), callose synthase (CS), basic Helix Loop Helix (bHLH041) transcription factor, glutathione S-transferase (GST), ABC transporter-4 (ABC4) and cinnamyl alcohol dehydrogenase (CAD) as putative resistance genes localized within the QTL-Fhb2 region. Conclusion Some of the identified genes within the QTL region are associated with structural resistance through cell wall reinforcement, reducing the spread of pathogen through rachis within a spike and few other genes that detoxify DON, the virulence factor, thus eventually reducing disease severity. In conclusion, we report that the wheat resistance QTL-Fhb2 is associated with high rachis resistance through additive resistance effects of genes, based on cell wall enforcement and detoxification of DON. Following further functional characterization and validation, these resistance genes can be used to replace the genes in susceptible commercial cultivars, if nonfunctional, based on genome editing to improve FHB resistance.	[Dhokane, Dhananjay; Karre, Shailesh; Kushalappa, Ajjamada C.] McGill Univ, Dept Plant Sci, Macdonald Campus,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [McCartney, Curt] Agr & Agri Food Canada, 195 Dafoe Rd, Winnipeg, MB R3T 2M9, Canada	McGill University; Agriculture & Agri Food Canada	Kushalappa, AC (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	ajjamada.kushalappa@mcgill.ca	Karre, Shailesh/AAN-7955-2020		Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada; Indian Council of Agricultural Research (ICAR), New Delhi; McGill University	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada; Indian Council of Agricultural Research (ICAR), New Delhi(Indian Council of Agricultural Research (ICAR)); McGill University	The authors would like to thank the Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada for providing grants for the project. DD thanks The Indian Council of Agricultural Research (ICAR), New Delhi for ICAR-International Fellowship, and Innovagrains and McGill University for financial assistance towards his graduate study.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alves MS, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010085; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Blumke A., 2013, Advances in Bioscience and Biotechnology, V4, P810, DOI 10.4236/abb.2013.48106; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Campos L, 2014, MOL PLANT MICROBE IN, V27, P1159, DOI 10.1094/MPMI-04-14-0104-R; Cao A, 2011, MOL PLANT MICROBE IN, V24, P1020, DOI 10.1094/MPMI-03-11-0079; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Dean JD, 2003, FUNCT PLANT BIOL, V30, P821, DOI 10.1071/FP03080; Dedyukhina EG, 2014, EUR J LIPID SCI TECH, V116, P429, DOI 10.1002/ejlt.201300358; Didi V, 2015, J EXP BOT, V66, P5015, DOI 10.1093/jxb/erv222; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Eudes A, 2006, PLANTA, V225, P23, DOI 10.1007/s00425-006-0326-9; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fofana B, 2005, PHYTOPATHOLOGY, V95, P114, DOI 10.1094/PHYTO-95-0114; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Ghaffari Mohammad Reza, 2010, Iranian Journal of Biotechnology, V8, P112; Golkari S, 2007, PLANT BIOTECHNOL J, V5, P38, DOI 10.1111/j.1467-7652.2006.00213.x; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Graca J, 2010, PHYTOCHEM REV, V9, P85, DOI 10.1007/s11101-009-9138-4; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Hamzehzarghani H, 2008, CAN J PLANT PATHOL, V30, P24, DOI 10.1080/07060660809507493; Han Q, 2016, SCI HORTIC-AMSTERDAM, V198, P370, DOI 10.1016/j.scienta.2015.11.047; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kage U, 2016, PLANT BIOTECHNOLOGY; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kosaka A, 2015, TOXINS, V7, P604, DOI 10.3390/toxins7020604; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Kumar A, 2015, J CEREAL SCI, V64, P16, DOI 10.1016/j.jcs.2015.04.005; Kumaraswamy GK, 2012, PLANT PATHOL, V61, P509, DOI 10.1111/j.1365-3059.2011.02528.x; Kumaraswamy GK, 2011, EUR J PLANT PATHOL, V130, P29, DOI 10.1007/s10658-010-9729-3; Kushalappa AC, 2016, CRIT REV PLANT SCI, V35, P38, DOI 10.1080/07352689.2016.1148980; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lanubile A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-710; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li X, 2015, MOL PLANT MICROBE IN, V28, P1237, DOI 10.1094/MPMI-03-15-0062-R; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinovsky FG, 2014, PLANT PHYSIOL, V164, P1443, DOI 10.1104/pp.113.234625; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; MILLER JD, 1985, PHYTOPATHOL Z, V113, P359; Mohammadi M., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P1431; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Parvez MM, 2004, BIOCHEM SYST ECOL, V32, P631, DOI 10.1016/j.bse.2003.12.002; Pohl C.H., 2011, SCI MICROBIAL PATHOG, V3, P61; Preisner M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-50; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Pushpa D, 2014, PLANT MOL BIOL REP, V32, P584, DOI 10.1007/s11105-013-0665-1; Raho N, 2011, J PLANT PHYSIOL, V168, P534, DOI 10.1016/j.jplph.2010.09.004; Ruelland E, 2013, PLANT SIGNAL BEHAV, V8, P307; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Shahrtash M, 2013, ROM J BIOL PLANT BIO, V158, P19; Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103; Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Sudisha J, 2012, PROG BIOL CONTROL, V12, P379, DOI 10.1007/978-94-007-1933-0_17; Takahashi W, 2005, PLANT CELL REP, V23, P811, DOI 10.1007/s00299-004-0900-1; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.x, 10.1111/j.1364-3703.2009.00578.X]; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Voigt CA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00168; Walley JW, 2013, CURR OPIN PLANT BIOL, V16, P520, DOI 10.1016/j.pbi.2013.06.011; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; Walter S, 2015, J EXP BOT, V66, P2583, DOI 10.1093/jxb/erv048; Wang FT, 2015, PHYSIOL MOL PLANT P, V90, P123, DOI 10.1016/j.pmpp.2015.04.007; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Yang ZP, 2003, MOL BREEDING, V12, P309, DOI 10.1023/B:MOLB.0000006834.44201.48; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yogendra KN, 2015, FUNCT PLANT BIOL, V42, P284, DOI 10.1071/FP14177; Yogendra KN, 2014, FUNCT INTEGR GENOMIC, V14, P285, DOI 10.1007/s10142-013-0358-8; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041	106	72	79	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155851	10.1371/journal.pone.0155851	http://dx.doi.org/10.1371/journal.pone.0155851			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232496	Green Published, gold, Green Submitted			2022-12-27	WOS:000376883000007
J	Ramsey, JM; Cooper, JD; Bot, M; Guest, PC; Lamers, F; Weickert, CS; Penninx, BWJH; Bahn, S				Ramsey, Jordan M.; Cooper, Jason D.; Bot, Mariska; Guest, Paul C.; Lamers, Femke; Weickert, Cynthia S.; Penninx, Brenda W. J. H.; Bahn, Sabine			Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BIOMARKERS; INFLAMMATION; ASSOCIATION; DIAGNOSIS; HEALTH; SCHIZOPHRENIA; EPIDEMIOLOGY; INVENTORY; CORTISOL	Women have a consistently higher prevalence of major depressive disorder (MDD) than men. Hypotheses implicating hypothalamic-pituitary -adrenal, -gonadal, and -thyroid axes, immune response, genetic factors, and neurotransmitters have emerged to explain this difference. However, more evidence for these hypotheses is needed and new explanations must be explored. Here, we investigated sex differences in MDD markers using multiplex immunoassay measurements of 171 serum molecules in individuals enrolled in the Netherlands Study of Depression and Anxiety (N-MDD = 231; N-control = 365). We found 28 sex-dependent markers of MDD, as quantified by a significant interaction between sex and log(2-)transformed analyte concentration in a logistic regression with diagnosis (MDD/control) as the outcome variable (p < 0.05; q < 0.30). Among these were a number of male-specific associations between MDD and elevated levels of proteins involved in immune response, including C-reactive protein, trefoil factor 3, cystatin-C, fetuin-A, beta 2-microglobulin, CD5L, FASLG receptor, and tumor necrosis factor receptor 2. Furthermore, only male MDD could be classified with an accuracy greater than chance using the measured serum analytes (area under the ROC curve = 0.63). These findings may have consequences for the generalization of inflammatory hypotheses of depression to males and females and have important implications for the development of diagnostic biomarker tests for MDD. More studies are needed to validate these results, investigate a broader range of biological pathways, and integrate this data with brain imaging, genetic, and other relevant data.	[Ramsey, Jordan M.; Cooper, Jason D.; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Bot, Mariska; Lamers, Femke; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Bot, Mariska; Lamers, Femke; Penninx, Brenda W. J. H.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Weickert, Cynthia S.] Schizophrenia Res Inst, Neurosci Res Australia, Sydney, NSW, Australia; [Weickert, Cynthia S.] Univ New S Wales, Sydney, NSW, Australia; [Bahn, Sabine] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Neuroscience Research Australia; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.; Penninx, BWJH (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.; Penninx, BWJH (corresponding author), Neurosci Campus Amsterdam, Amsterdam, Netherlands.; Bahn, S (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands.	B.Penninx@vumc.nl; sb209@cam.ac.uk	Lamers, Femke/G-5161-2012; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Lamers, Femke/0000-0003-4344-5766; Shannon Weickert, Cynthia/0000-0002-4560-0259; guest, paul/0000-0002-5030-7137	Stanley Medical Research Institute; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (PSYCH-AID project) [286334]; NeuroBasic PharmaPhenomics project [0908]; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust; FP7-Marie Curie Career Integration Grant [PCIG12-GA-2012-334065]; Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]	Stanley Medical Research Institute; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (PSYCH-AID project); NeuroBasic PharmaPhenomics project; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust; FP7-Marie Curie Career Integration Grant; Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Stanley Medical Research Institute, the European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (nr. 286334, PSYCH-AID project), and the NeuroBasic PharmaPhenomics project (no. 0908). JMR was funded by the Edmonton Churchill Scholarship and the Cambridge Commonwealth Trust for the duration of the study. FL is supported by a FP7-Marie Curie Career Integration Grant (PCIG12-GA-2012-334065). The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL), and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). Cynthia Shannon Weickert (CSW) is supported by Schizophrenia Research Institute (utilising infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (#1021970).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2014, R LANG ENV STAT COMP; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilello JA, 2015, J CLIN PSYCHIAT, V76, pE199, DOI 10.4088/JCP.14m09029; Bot M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.88; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chan MK, 2014, PROG NEUROBIOL, V122, P45, DOI 10.1016/j.pneurobio.2014.08.002; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Dudoit S, 2008, SPRINGER SER STAT, P1; Evangelopoulos AA, 2012, INTERN MED J, V42, P517, DOI 10.1111/j.1445-5994.2011.02500.x; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Goldstein JM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00247; Gottschalk MG, 2016, J PSYCHIATR RES, V73, P53, DOI 10.1016/j.jpsychires.2015.11.012; Hinkelmann K, 2012, STRESS, V15, P105, DOI 10.3109/10253890.2011.582200; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Liukkonen T, 2006, BIOL PSYCHIAT, V60, P825, DOI 10.1016/j.biopsych.2006.02.016; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Maronna RA, 2002, TECHNOMETRICS, V44, P307, DOI 10.1198/004017002188618509; Martinez VG, 2014, CELL MOL IMMUNOL, V11, P343, DOI 10.1038/cmi.2014.12; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; NCAR-Research Applications Laboratory, 2015, VER WEATH FOR VER UT; O'Connell Joe, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P73; Owens M, 2014, P NATL ACAD SCI USA, V111, P3638, DOI 10.1073/pnas.1318786111; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pitychoutis PM, 2010, INT J NEUROPSYCHOPH, V13, P675, DOI 10.1017/S1461145710000465; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Ramsey JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078729; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Steeb H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-4; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Wang J, 2013, ROBUST ROBUST LIB; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Young E, 2010, MOL PSYCHIATR, V15, P23, DOI 10.1038/mp.2009.94; Zissis M, 2001, AM J GASTROENTEROL, V96, P2177, DOI 10.1111/j.1572-0241.2001.03881.x	62	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156624	10.1371/journal.pone.0156624	http://dx.doi.org/10.1371/journal.pone.0156624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232630	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000048
J	Ostrowski, PP; Barszczyk, A; Forstenpointner, J; Zheng, WH; Feng, ZP				Ostrowski, Philip P.; Barszczyk, Andrew; Forstenpointner, Julia; Zheng, Wenhua; Feng, Zhong-Ping			Meta-Analysis of Serum Insulin-Like Growth Factor 1 in Alzheimer's Disease	PLOS ONE			English	Article							HORMONE-RELEASING-HORMONE; FACTOR BINDING-PROTEINS; FACTOR-I LEVELS; IGF-I; CEREBROSPINAL-FLUID; COGNITIVE IMPAIRMENT; FACTOR EXPRESSION; BRAIN; ADULT; DEMENTIA	Insulin-like growth factor 1 (IGF-1) serum levels have been reported to be altered in Alzheimer's disease patients, and it was suggested that the changes in IGF-1 serum level may play a role in disease pathology and progression. However, this notion remained controversial due to conflicting findings. We conducted a meta-analysis to determine the relationship between IGF-1 serum levels and Alzheimer's disease. We searched the databases PUBMED, Ovid SP, and Cochrane library for relevant studies. The primary data analyzed was serum IGF-1 from Alzheimer's disease subjects and controls. Pooled weighted mean difference using a random effects model was used to determine the relationship between serum levels and disease state. Nine studies were included in the meta-analysis compromising a total of 1639 subjects. The pooled weighted mean difference was -2.27ng/ml (95% CI: [-22.221, 17.66]) with a P value of 0.82. Thus our finding did not show clear relationship between low IGF-1 and Alzheimer's disease subjects. We did not find evidence of publication bias by analyzing a funnel plot as well as Egger's and Begg's tests. While eight out of the nine studies included in this meta-analysis detected a statistically significant increase or decrease in serum levels of IGF-1 in Alzheimer's disease subjects, the analysis as a whole did not show a significant trend in either direction. Thus, IGF-1 level is likely a critical personalized factor. A large database of clinical trials is required for better understanding the relationship between IGF-1 levels and Alzheimer's disease.	[Ostrowski, Philip P.; Barszczyk, Andrew; Forstenpointner, Julia; Feng, Zhong-Ping] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Zheng, Wenhua] Univ Macau, Fac Hlth Sci, Macau, Peoples R China	University of Toronto; University of Macau	Feng, ZP (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	zp.feng@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (CA) [RGPIN 249962]; Ontario Graduate Scholarship; NSERC	Natural Sciences and Engineering Research Council of Canada (CA)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council of Canada (CA) RGPIN 249962. AB is a recipient of Ontario Graduate Scholarship (PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AB is a recipient of Ontario Graduate Scholarship (PhD). This study is supported by NSERC Discovery Grant to ZPF.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Aberg N. D., 2000, J NEUROSCI, V20, P170; Aguado-Llera D, 2005, J NEUROCHEM, V92, P607, DOI 10.1111/j.1471-4159.2004.02889.x; Alvarez A, 2007, NEUROBIOL AGING, V28, P533, DOI 10.1016/j.neurobiolaging.2006.02.012; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Ben-Gedalya T, 2015, EMBO J, V34, P2820, DOI 10.15252/embj.201592042; Bolos M, 2010, J BIOL CHEM, V285, P17693, DOI 10.1074/jbc.M109.096594; Calvo D, 2013, HIGHER SERUM INSULIN, P13; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Cheng CM, 2005, ENDOCRINOLOGY, V146, P5086, DOI 10.1210/en.2005-0063; Cheng CM, 2000, P NATL ACAD SCI USA, V97, P10236, DOI 10.1073/pnas.170008497; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; de Bruijn RF, 2014, J ALZHEIMERS DIS JAD; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Duron E, 2012, J CLIN ENDOCR METAB, V97, P4673, DOI 10.1210/jc.2012-2063; Engel T, 2006, J NEUROSCI, V26, P5083, DOI 10.1523/JNEUROSCI.0604-06.2006; Fadl NN, 2013, HUM EXP TOXICOL, V32, P721, DOI 10.1177/0960327112467040; Freude S, 2009, FASEB J, V23, P3315, DOI 10.1096/fj.09-132043; GHIGO E, 1993, DEMENTIA, V4, P315, DOI 10.1159/000107339; Giuffrida ML, 2012, MOL NEUROBIOL, V46, P605, DOI 10.1007/s12035-012-8313-6; Gontier G, 2015, J NEUROSCI, V35, P11500, DOI 10.1523/JNEUROSCI.0343-15.2015; Headrick TC, 2010, STAT SIMULATION POWE, Vvii; Hertze J, 2014, CHANGES CEREBROSPINA, V14; Hu YK, 2013, NEUROSCI BULL, V29, P745, DOI 10.1007/s12264-013-1348-5; Johansson P, 2013, PSYCHONEUROENDOCRINO, V38, P1729, DOI 10.1016/j.psyneuen.2013.02.006; Lanz TA, 2008, BIOCHEM PHARMACOL, V75, P1093, DOI 10.1016/j.bcp.2007.11.001; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lupien SB, 2003, J NEUROSCI RES, V74, P512, DOI 10.1002/jnr.10791; Lynch CD, 2001, ENDOCRINOLOGY, V142, P506, DOI 10.1210/en.142.1.506; Mannino GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085483; Murialdo G, 2001, J ENDOCRINOL INVEST, V24, P139, DOI 10.1007/BF03343833; Mustafa A, 1999, DEMENT GERIATR COGN, V10, P446, DOI 10.1159/000017188; Nishijima T, 2010, NEURON, V67, P834, DOI 10.1016/j.neuron.2010.08.007; O'Kusky J, 2012, FRONT NEUROENDOCRIN, V33, P230, DOI 10.1016/j.yfrne.2012.06.002; Parrella E, 2013, AGING CELL, V12, P257, DOI 10.1111/acel.12049; Poirier R, 2012, NEUROSCI LETT, V509, P101, DOI 10.1016/j.neulet.2011.12.048; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ranke MB, 2009, DTSCH ARZTEBL INT, V106, P703, DOI 10.3238/arztebl.2009.0703; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salehi Z, 2008, BIOFACTORS, V33, P99, DOI 10.1002/biof.5520330202; Sevigny JJ, 2008, NEUROLOGY, V71, P1702, DOI 10.1212/01.wnl.0000335163.88054.e7; Shi R, 2001, BRIT J CANCER, V85, P991, DOI 10.1054/bjoc.2001.1961; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Spindler AA, 1996, J AM DIET ASSOC, V96, P1013, DOI 10.1016/S0002-8223(96)00270-2; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sun LY, 2006, AGE, V28, P181, DOI 10.1007/s11357-006-9009-5; Szaruga M, 2015, J EXP MED, V212, P2003, DOI 10.1084/jem.20150892; Szczesniak D, 2015, ADV CLIN EXP MED, V24, P167, DOI 10.17219/acem/38156; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Tei E, 2008, GROWTH HORM IGF RES, V18, P47, DOI 10.1016/j.ghir.2007.07.006; Teppala S, 2010, DIABETES CARE, V33, P2257, DOI 10.2337/dc10-0770; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Tiryakioglu O, 2003, Indian J Med Sci, V57, P543; Torres-Aleman I, 2008, ENDOCRINOLOGY, V149, P5952, DOI 10.1210/en.2008-0905; Trueba-Saiz A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.102; van Nieuwpoort IC, 2008, EUR J ENDOCRINOL, V159, pS53, DOI 10.1530/EJE-08-0279; Vardy ERLC, 2007, J ALZHEIMERS DIS, V12, P285; Vargas T, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.10.017; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM149, DOI 10.1093/gerona/52A.3.M149; Wang W, 2012, NEUROSCI LETT, V531, P20, DOI 10.1016/j.neulet.2012.10.015; Watanabe T, 2005, J AM GERIATR SOC, V53, P1748, DOI 10.1111/j.1532-5415.2005.53524.x; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Westwood AJ, 2014, NEUROLOGY, V82, P1613, DOI 10.1212/WNL.0000000000000382; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200	69	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155733	10.1371/journal.pone.0155733	http://dx.doi.org/10.1371/journal.pone.0155733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227831	gold, Green Published, Green Submitted			2022-12-27	WOS:000376882500028
J	Kim, SE; Kim, HN; Cho, J; Kwon, MJ; Chang, Y; Ryu, S; Shin, H; Kim, HL				Kim, Song E.; Kim, Han-Na; Cho, Juhee; Kwon, Min-Jung; Chang, Yoosoo; Ryu, Seungho; Shin, Hocheol; Kim, Hyung-Lae			Direct and Indirect Effects of Five Factor Personality and Gender on Depressive Symptoms Mediated by Perceived Stress (vol 11, e0154140, 2016)	PLOS ONE			English	Correction													Cho, Juhee/ABD-2280-2021	Chang, Yoosoo/0000-0002-6945-9050				Kim SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154140	1	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157204	10.1371/journal.pone.0157204	http://dx.doi.org/10.1371/journal.pone.0157204			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257678	Green Published, gold			2022-12-27	WOS:000377369700185
J	Karimi, M; Ghazanfari, F; Fadaei, A; Ahmadi, L; Shiran, B; Rabei, M; Fallahi, H				Karimi, Marzieh; Ghazanfari, Farahnaz; Fadaei, Adeleh; Ahmadi, Laleh; Shiran, Behrouz; Rabei, Mohammad; Fallahi, Hossein			The Small-RNA Profiles of Almond (Prunus dulcis Mill.) Reproductive Tissues in Response to Cold Stress	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; BINDING CASSETTE TRANSPORTERS; ARABIDOPSIS-THALIANA; DEGRADOME ANALYSIS; SALT STRESS; DIFFERENTIAL REGULATION; SOLANUM-LYCOPERSICON; MEDICAGO-TRUNCATULA; REGULATED MICRORNAS; POPULUS-EUPHRATICA	Spring frost is an important environmental stress that threatens the production of Prunus trees. However, little information is available regarding molecular response of these plants to the frost stress. Using high throughput sequencing, this study was conducted to identify differentially expressed miRNAs, both the conserved and the non-conserved ones, in the reproductive tissues of almond tolerant H genotype under cold stress. Analysis of 50 to 58 million raw reads led to identification of 174 unique conserved and 59 novel microRNAs (miRNAs). Differential expression pattern analysis showed that 50 miRNA families were expressed differentially in one or both of almond reproductive tissues (anther and ovary). Out of these 50 miRNA families, 12 and 15 displayed up-regulation and down-regulation, respectively. The distribution of conserved miRNA families indicated that miR482f harbor the highest number of members. Confirmation of miRNAs expression patterns by quantitative real-time PCR (qPCR) was performed in cold tolerant (H genotype) alongside a sensitive variety (Sh12 genotype). Our analysis revealed differential expression for 9 miRNAs in anther and 3 miRNAs in ovary between these two varieties. Target prediction of miRNAs followed by differential expression analysis resulted in identification of 83 target genes, mostly transcription factors. This study comprehensively catalogued expressed miRNAs under different temperatures in two reproductive tissues (anther and ovary). Results of current study and the previous RNA-seq study, which was conducted in the same tissues by our group, provide a unique opportunity to understand the molecular basis of responses of almond to cold stress. The results can also enhance the possibility for gene manipulation to develop cold tolerant plants.	[Karimi, Marzieh; Ghazanfari, Farahnaz; Fadaei, Adeleh; Ahmadi, Laleh; Shiran, Behrouz; Rabei, Mohammad] Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, POB 115, Shahrekord, Iran; [Shiran, Behrouz] Shahrekord Univ, Inst Biotechnol, POB 115, Shahrekord, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Bagh E Abrisham Kermansh, Iran; [Fallahi, Hossein] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran	Shahrekord University; Shahrekord University; Razi University; Kermanshah University of Medical Sciences	Shiran, B (corresponding author), Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, POB 115, Shahrekord, Iran.; Shiran, B (corresponding author), Shahrekord Univ, Inst Biotechnol, POB 115, Shahrekord, Iran.; Fallahi, H (corresponding author), Razi Univ, Sch Sci, Dept Biol, Bagh E Abrisham Kermansh, Iran.; Fallahi, H (corresponding author), Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran.	shiran@agr.sku.ac.ir; h.fallahi@razi.ac.ir	Fallahi, Hossein/I-7541-2019; Karimi, Marzieh/ABF-1594-2021; Zhou, Man/S-4256-2016; Shiran, Behrouz/ABF-1831-2020	Fallahi, Hossein/0000-0002-8754-3491; Karimi, Marzieh/0000-0003-2066-2354; Shiran, Behrouz/0000-0001-9997-4718				Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Alisoltani A, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0929-z; Allen E, 2011, BIOCHEM J, V437, P505, DOI 10.1042/BJ20101764; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Baloch IA, 2013, PURE APPL BIOL, V2, P83, DOI DOI 10.19045/BSPAB.2013.23002; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Bhati KK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00488; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Cao X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1130; Chen L, 2012, BIOCHEM BIOPH RES CO, V417, P892, DOI 10.1016/j.bbrc.2011.12.070; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Debouba M, 2006, J PLANT PHYSIOL, V163, P1247, DOI 10.1016/j.jplph.2005.09.012; Din M, 2014, GENE, V535, P198, DOI 10.1016/j.gene.2013.11.034; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Ji Y, 2011, THESIS U SASKATCHEWA; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim S, 2004, MOL CELLS, V18, P300; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Koc I, 2015, BIOTECHNOL BIOTEC EQ, V29, P851, DOI 10.1080/13102818.2015.1061447; Kodad O, 2010, ITEA-INF TEC ECON AG, V106, P142; Kohil D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108851; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kwon SJ, PLANT CELL PHYSL, V48, P1713; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Li BS, 2013, PLANT MOL BIOL, V81, P525, DOI 10.1007/s11103-013-0010-y; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Martinez-Gomez P., 2007, Fruits and nuts, P229; Mawlong T, 2016, INDIAN J EXP BIOL, V54, P26; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miranda C, 2005, HORTSCIENCE, V40, P357, DOI 10.21273/HORTSCI.40.2.357; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Ni ZY, 2012, BIOCHEM BIOPH RES CO, V427, P330, DOI 10.1016/j.bbrc.2012.09.055; Omidvar V, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.02.0008; Piisila M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0434-4; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Ren YY, 2012, FUNCT INTEGR GENOMIC, V12, P327, DOI 10.1007/s10142-012-0271-6; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sonali Bej, 2014, American Journal of Plant Sciences, V5, P748; Sun XC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1416-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Tian YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0226-2; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Valiollahi E, 2014, PLANT BIOTECHNOL REP, V8, P349, DOI 10.1007/s11816-014-0326-3; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang M, 2013, GENE, V530, P26, DOI 10.1016/j.gene.2013.08.009; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhang BH, 2015, J CELL PHYSIOL, V230, P1, DOI 10.1002/jcp.24685; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0271-x; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhou SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122117; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	21	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156519	10.1371/journal.pone.0156519	http://dx.doi.org/10.1371/journal.pone.0156519			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253370	gold, Green Published, Green Submitted			2022-12-27	WOS:000377218700036
J	Luippold, G; Bedenik, J; Voigt, A; Grempler, R				Luippold, Gerd; Bedenik, Jessica; Voigt, Anke; Grempler, Rolf			Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations	PLOS ONE			English	Article							KIDNEY; PATHOGENESIS; MECHANISMS; DISEASE	The chemical induction of diabetes with STZ has gained popularity because of the relative ease of rendering normal animals diabetic. Insulin substitution is required in STZ-rats in long-term studies to avoid ketoacidosis and consequently loss of animals. Aim of the present studies was to test different insulin preparations and different ways of administration in their ability to reduce blood glucose in STZ-induced diabetic rats. Single dosing of the long-acting insulin analogue glargine was able to dose-dependently reduce blood glucose over 4 h towards normoglycemia in STZ-treated rats. However, this effect was not sustained until 8 h post injection. A more sustained glucose-lowering effect was achieved using insulin-releasing implants. In STZ-rats, 1 insulin implant moderately lowered blood glucose levels 10 days after implantation, while 2 implants induced normoglycemia over the whole day. According to the glucose-lowering effect 1 as well as 2 insulin implants significantly reduced HbA(1c) measured after 26 days of implantation. In line with the improved glucose homeostasis due to the implants, urinary glucose excretion was also blunted in STZ-treated rats with 2 implants. Since diabetic nephropathy is one of the complications of longterm diabetes, renal function was characterized in the STZ-rat model. Increases in creatinine clearance and urinary albumin excretion resemble early signs of diabetic nephropathy. These functional abnormalities of the kidney could clearly be corrected with insulin-releasing implants 27 days after implantation. The data show that diabetic STZ-rats respond to exogenous insulin with regard to glucose levels as well as kidney parameters and a suitable dose of insulin implants for glucose control was established. This animal model together with the insulin dosing regimen is suitable to address diabetes-induced early diabetic nephropathy and also to study combination therapies with insulin for the treatment of type 1 diabetes.	[Luippold, Gerd; Bedenik, Jessica; Voigt, Anke] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetabol Dis Res, Biberach, Germany; [Grempler, Rolf] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Translat Med & Clin Pharmacol, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim	Luippold, G (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetabol Dis Res, Biberach, Germany.	gerd.luippold@boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co.	Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors [GL, JB, AV, RG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder did not directly benefit from the study and the study did not involve a product the funder sells.	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; Arora MK, 2013, VASC PHARMACOL, V58, P259, DOI 10.1016/j.vph.2013.01.001; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Garg S, 2010, DIABETES TECHNOL THE, V12, P835, DOI 10.1089/dia.2010.0135; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Mikhailidis DP, 1992, J PHARM MED, V2, P241; Mora-Fernandez C, 2014, J PHYSIOL-LONDON, V592, P3997, DOI 10.1113/jphysiol.2014.272328; Premaratne E, 2015, DIABETES METAB, V41, P5, DOI 10.1016/j.diabet.2014.10.003; RASCH R, 1979, DIABETOLOGIA, V16, P185, DOI 10.1007/BF01219796; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Schneider S, 2004, ARZNEIMITTELFORSCH, V54, P842; Singh P, 2014, ADV CHRONIC KIDNEY D, P21; Slaughter TN, 2013, AM J PHYSIOL-REG I, V305, pR727, DOI 10.1152/ajpregu.00382.2012; THOMPSON CS, 1994, CLIN SCI, V86, P593, DOI 10.1042/cs0860593	15	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156346	10.1371/journal.pone.0156346	http://dx.doi.org/10.1371/journal.pone.0156346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253523	Green Submitted, Green Published, gold			2022-12-27	WOS:000377218700021
J	Wang, Z; Qu, ZG; Fu, CF; Xu, F; Chen, Y; Wang, ZY; Liu, Y				Wang, Zheng; Qu, Zhigang; Fu, Changfeng; Xu, Feng; Chen, Yong; Wang, Zhenyu; Liu, Yi			Interleukin 1 Polymorphisms Contribute to Intervertebral Disc Degeneration Risk: A Meta-Analysis	PLOS ONE			English	Article							GENE POLYMORPHISM; ANNULUS FIBROSUS; ASSOCIATION; IL-1-BETA; BIOLOGY; PAIN; CELL	Objective We performed a meta-analysis to assess association between interleukin 1 (IL-1) polymorphisms and the risk of Intervertebral Disc Degeneration (IDD). Background A series of studies have investigated the association between common single nucleotide polymorphisms in IL-1 and IDD risk; however, the overall results are inconclusive. Methods Two independent investigators conducted a systematic search for relevant available studies. Allele frequencies were extracted from each study. The association between the IL-1 alpha (+889C/T) or IL-1 beta (+3954C/T) polymorphism and IDD risk was measured by odds ratios (OR) with 95% confidence intervals (95% CI). Results Five and six studies, respectively, were ultimately included in the meta-analysis for the IL-1 alpha (+889C/T) and IL-1 beta (+3954C/T) polymorphism. The combined results showed that the IL-1 alpha (+889C/T) polymorphism was significantly associated with increased susceptibility to IDD, particularly in Caucasians (TT versus CC: OR = 2.95, 95% CI: 1.45, 6.04; P-heterogeneity = 0.82; TT versus CC/CT: OR = 2.29, 95% CI: 1.18, 4.47; P-heterogeneity = 0.20). In contrast, the IL-1 beta (+3954C/T) polymorphism showed a trend towards increased risk in Caucasians but no association in Asians. Conclusion This meta-analysis suggested that the IL-1 alpha (+889C/T) polymorphism is significantly associated with risk of IDD, especially in Caucasian populations.	[Wang, Zheng; Qu, Zhigang; Fu, Changfeng; Xu, Feng; Wang, Zhenyu; Liu, Yi] Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China; [Chen, Yong] Jilin Univ, Hosp 1, Dept Neurosurg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China	Jilin University; Jilin University	Wang, ZY; Liu, Y (corresponding author), Jilin Univ, Hosp 1, Dept Spinal Surg, 71 Xinmin Ave, Changchun 130021, Jilin Province, Peoples R China.	wangzheng13@mails.jlu.edu.cn; Liuyi89757@gmail.com						Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berger P, 2002, CYTOKINE, V17, P171, DOI 10.1006/cyto.2001.0974; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Serrano SC, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/302568; Chen ZX, 2015, SCI REP-UK, V5, DOI 10.1038/srep16983; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dominici R, 2002, IMMUNOGENETICS, V54, P82, DOI 10.1007/s00251-002-0445-9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Herkowitz HN, 2004, LUMBAR SPINE; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hulkkonen J, 2000, EUR CYTOKINE NETW, V11, P251; Hwang PY, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026360; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Karppinen J, 2008, SPINE, V33, P1236, DOI 10.1097/BRS.0b013e318170fd0e; Karppinen J, 2009, EUR SPINE J, V18, P1963, DOI 10.1007/s00586-009-1139-x; Kim NK, 2011, ACTA NEUROCHIR, V153, P129, DOI 10.1007/s00701-010-0831-2; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Maeda S, 2000, SPINE, V25, P166, DOI 10.1097/00007632-200001150-00005; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Molinos M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1191; Mu JH, 2013, J NEUROSURG-SPINE, V19, P243, DOI 10.3171/2013.4.SPINE12782; Aparicio JP, 2011, EUR SPINE J, V20, P383, DOI 10.1007/s00586-011-1915-2; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Rannou F, 2004, AM J PATHOL, V164, P915, DOI 10.1016/S0002-9440(10)63179-3; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Schistad EI, 2014, CLIN J PAIN, V30, P869, DOI 10.1097/AJP.0000000000000048; Solovieva S, 2004, EPIDEMIOLOGY, V15, P626, DOI 10.1097/01.ede.0000135179.04563.35; Solovieva S, 2004, PAIN, V109, P8, DOI 10.1016/j.pain.2003.10.020; Solovieva S, 2006, EUR SPINE J, V15, P613, DOI 10.1007/s00586-005-0988-1; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; van den Berg WB, 1999, BEST PRACT RES CL RH, V13, P577, DOI 10.1053/berh.1999.0047; Wang S, 2014, CELL PROLIFERAT, V47, P381, DOI 10.1111/cpr.12121; Yang W, 2015, CLIN CHIM ACTA, V450, P262, DOI 10.1016/j.cca.2015.08.029; Ye Wei, 2007, Yichuan, V29, P923, DOI 10.1360/yc-007-0923	41	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156412	10.1371/journal.pone.0156412	http://dx.doi.org/10.1371/journal.pone.0156412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253397	Green Published, Green Submitted, gold			2022-12-27	WOS:000377218700027
J	Gould, MP; Bosworth, CM; McMahon, S; Grandhi, S; Grimberg, BT; LaFramboise, T				Gould, Meetha P.; Bosworth, Colleen M.; McMahon, Sarah; Grandhi, Sneha; Grimberg, Brian T.; LaFramboise, Thomas			PCR-Free Enrichment of Mitochondrial DNA from Human Blood and Cell Lines for High Quality Next-Generation DNA Sequencing (vol 10, e0139253, 2015)	PLOS ONE			English	Correction													Grimberg, Brian/I-1251-2013	Grimberg, Brian/0000-0002-6015-4912; Bosworth, Colleen/0000-0001-6241-3554	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008056] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Gould MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139253	1	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156884	10.1371/journal.pone.0156884	http://dx.doi.org/10.1371/journal.pone.0156884			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243821	Green Published, Green Submitted, gold			2022-12-27	WOS:000377146100071
J	Waddell, LA; Greig, JD				Waddell, Lisa A.; Greig, Judy D.			Scoping Review of the Zika Virus Literature	PLOS ONE			English	Review							YELLOW-FEVER EPIDEMIC; ARBOVIRUS INFECTIONS; SEXUAL TRANSMISSION; DENGUE VIRUSES; ANTIBODIES; NIGERIA; BRAZIL; FLAVIVIRUSES; MOSQUITOS; OUTBREAK	The global primary literature on Zika virus (ZIKV) (n = 233 studies and reports, up toMarch 1, 2016) has been compiled using a scoping review methodology to systematically identify and characterise the literature underpinning this broad topic using methods that are documented, updateable and reproducible. Our results indicate that more than half the primary literature on ZIKV has been published since 2011. The articles mainly covered three topic categories: epidemiology of ZIKV (surveillance and outbreak investigations) 56.6%(132/233), pathogenesis of ZIKV (case symptoms/outcomes and diagnosis) 38.2%(89/233) and ZIKV studies (molecular characterisation and in vitro evaluation of the virus) 18.5%(43/233). There has been little reported in the primary literature on ZIKV vectors (12/233), surveillance for ZIKV (13/233), diagnostic tests (12/233) and transmission (10/233). Three papers reported on ZIKV prevention/control strategies, one investigated knowledge and attitudes of health professionals and two vectormapping studies were reported. The majority of studies used observational study designs, 89.7%(209/233), of which 62/233 were case studies or case series, while fewer (24/233) used experimental study designs. Several knowledge gaps were identified by this review with respect to ZIKV epidemiology, the importance of potential non-human primates and other hosts in the transmission cycle, the burden of disease in humans, and complications related to human infection with ZIKV. Historically there has been little research on ZIKV; however, given its current spread through Australasia and the Americas, research resources are now being allocated to close many of the knowledge gaps identified in this scoping review. Future updates of this project will probably demonstrate enhanced evidence and understanding of ZIKV and its impact on public health.	[Waddell, Lisa A.; Greig, Judy D.] Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada; [Waddell, Lisa A.] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada	Public Health Agency of Canada; University of Guelph	Waddell, LA (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab Guelph, Guelph, ON, Canada.; Waddell, LA (corresponding author), Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada.	Lisa.Waddell@phac-aspc.gc.ca		waddell, lisa/0000-0003-4887-5124	Public Health Agency of Canada	Public Health Agency of Canada	This study was funded through the Public Health Agency of Canada (http://www.phac-aspc.gc.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6; Agence Regionale de Sante, 2016, SIT EP POINT EP 21 J; Agence Regionale de Sante, 2014, B VEILL SAN, V2; Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227; Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707; Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617; [Anonymous], 2016, DIS OUTBREAK NE 0208; [Anonymous], 2015, RAP RISK ASS ZIK VIR; [Anonymous], 2016, CDC INVESTIGATING 14; Antonjaya, 2012, AM J TROP MED HYG, V87, P122; Araujo J, B WHO; Arksey Hilary., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934; Aubry M, 2015, VOX SANG S1, V109, P189; Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271; Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005; Baba S. S., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P343, DOI 10.1590/S0036-46651998000600002; Babaniyi O.A., 2015, INT J PUBLIC HLTH EP, V4, P110; Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607; Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751; Boche R, 1974, Bull Soc Pathol Exot Filiales, V67, P126; BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BOWEN ETW, 1973, T ROY SOC TROP MED H, V67, P702, DOI 10.1016/0035-9203(73)90041-2; Brust KB, 2014, IDCases, V1, P95, DOI 10.1016/j.idcr.2014.10.009; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014; Camacho E, 2016, EMERG INFECT DIS, V22, DOI 10.3201/eid2205.160023; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009; Cao-Lormeau Roche, 2014, AM J TROP MED HYG, V91, P588; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI [10.3201/eid2006.140138, 10.3201/eid2011.141380]; Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167; Center for Disease Control and Prevention, 2016, ZIK WEBP; Center for Disease Control and Prevention, 2016, SUBJ REV DIAGN TEST; Center for Disease Control ROC (Taiwan), 2016, 1 IMP CAS ZIK VIR IN; Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075; Chevelle C., 2015, ARTHRALGIES AIGUES U; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47; CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149; Crabtree Crockett, 2011, AM J TROP MED HYG, V85, P374; DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91; Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; Diallo D, 2014, ZIKA VIRUS EMERGENCE, V9, pe10; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Direction de la sante Bureau de veille sanitaire, 2016, SURV VEILL SAN POL F; Direction de la Sante - Bureau de Veille sanitaire, 2014, SURV DENG ZIK POL FR; DOWNS W. G., 1965, CARIBBEAN MED J, V27, P39; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3; Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; European Centre for Disease Prevention and Control, 2016, ZIK VIR EP AM POT AS; European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR; FAGBAMI A, 1977, TROP GEOGR MED, V29, P187; FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147; Fokam E B, 2010, East Afr Med J, V87, P262; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Freire CCDM., 2015, BIORXIV, P32839, DOI [10.1101/032839, DOI 10.1101/032839]; GESER A, 1970, Bulletin of the World Health Organization, V43, P539; Goorhuis A, 2015, PROMED; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296; HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224; Hearn P, 2014, AM J TROP MED HYG S1, V91, P62; HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110; Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2; Institut de Veille Sanitaire, 2014, VIR ZIK POL 2013 201; Institut de Veille Sanitaire, 2014, B HEBD INT, V442; JAN C, 1978, B SOC PATHOL EXOT, V71, P140; Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402; Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5; Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3; KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8; Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683; Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Ledermann Crockett, 2012, AM J TROP MED HYG, V87, P170; Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188; LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669; Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Lobo JMD, 2010, AM J TROP MED HYG, V83, P314; Macesic N, 2015, CLIN INFECT DIS, V61, P1445, DOI 10.1093/cid/civ401; MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Mallet HP, 2014, C 15ES JNI BORD 11 1; Mallet HP, 2015, B INFORM SANITAIRES, V20-21, P367; Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15; MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411; Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P55, DOI 10.1016/j.tmaid.2015.07.005; Mattar S, 2015, REV MVZ CORDOBA, V20, P4511, DOI 10.21897/rmvz.53; MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4; Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; MILLER BR, 1991, AM J TROP MED HYG, V45, P399, DOI 10.4269/ajtmh.1991.45.399; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; MONATH TP, 1973, B WORLD HEALTH ORGAN, V49, P235; MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Mossel Kading, 2014, AMERICAN JOURNAL OF, V91, P260; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; New Zealand Public Health, 2015, OUTBR MUMPS LIK ILLN, V13; New Zealand Public Health, 2015, SUMM KEY TRENDS NOT, V13; Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622; Oehler E, 2014, Euro Surveill, V19; OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687; OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0; Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1; Pan American Health Organization, 2016, REP INCR CONG MICR O; Pan American Health Organization, 2016, ZIK EP UPD 17 FEBR 2; Pan American Health Organization, 2015, EP AL ZIK VIR INF 7; Pan American Health Organization (PAHO); World Health Organization, 2016, EPIDEMIOLOGICAL UPDA; Pan American Health Organization. World Health Organization, 2015, EP AL NEUR SYNDR CON; Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915; Pham MT, 2014, SCOPING REV SCOPING, DOI [10.1002/jrsm.1123, DOI 10.1002/JRSM.1123]; PIERRE V, 1994, RES VIROLOGY, V145, P93, DOI 10.1016/S0923-2516(07)80011-2; POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7; Prazeres J, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthal-mol.2016.0267, 10.1001/jamaophthalmol.2016.0267, DOI 10.1001/JAMAOPHTHAL-MOL.2016.0267]; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; REAGAN R L, 1955, Tex Rep Biol Med, V13, P934; REAGAN RL, 1953, TEX REP BIOL MED, V11, P347; RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131; ROBERT V, 1993, B SOC PATHOL EXOT, V86, P90; Robin Y., 1975, Bulletin Soc Path Exot, V68, P249; Rockefeller Foundation, 1951, ROCK FDN ANN REP, P131; RODHAIN F, 1987, B SOC PATHOL EXOT, V80, P155; Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003; SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490; SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262; SALUZZO JF, 1986, ANN INST PASTEUR VIR, V137E, P155, DOI 10.1016/S0769-2617(86)80201-5; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011; SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9; Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5; Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208; Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685; Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7; Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960; Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; TRAORELAMIZANA M, 1994, J MED ENTOMOL, V31, P623, DOI 10.1093/jmedent/31.4.623; Tsegaye, 2014, AM J TROP MED HYG, V91, P53; Tusevljak N, 2012, FOODBORNE PATHOG DIS, V9, P487, DOI 10.1089/fpd.2011.1063; UK government, 2016, HLTH PROTECTION REPO, V10; VANPEENEN PFD, 1975, ANN TROP MED PARASIT, V69, P475, DOI 10.1080/00034983.1975.11687035; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4; Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148; Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7; Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002; Vouga M, 2016, LANCET; Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302; WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123; WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3; Weitzel T, 2016, AM J TROP MED HYG, V95, P255, DOI 10.4269/ajtmh.16-0096; Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017; Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organisation, 2015, PAC SYNDR SURV REP W; World Health Organisation, 2015, PAC SYNDR SURV REP; World Health Organization, 2016, DIS OUTBREAK NE 0212; World Health Organization, 2014, PAC SYNDR SURV WEEK; World Health Organization, 2015, DIS OUTBREAK NE 1215; World Health Organization, 2016, ZIK VIR DIS INT CAS; World Health Organization, 2015, DIS OUTBREAK NE 1221; World Health Organization, 2016, DIS OUTBREAK NE 1212; World Health Organization, 2016, DIS OUTBREAK NE 0121; World Health Organization, 2015, DIS OUTBREAK NE 1222; World Health Organization, 2015, DIS OUTBREAK NE 1127; World Health Organization, 2015, DIS OUTBREAK NE 1113; World Health Organization, 2016, DIS OUTBREAK NE 0129; World Health Organization, 2016, WHOZIKVMOC161; World Health Organization, 2015, PAC SYNDR SURV WEEK; World Health Organization, 2015, DIS OUTBREAK NE 1205; World Health Organization, 2016, ZIK SIT REP NEUR SYN; World Health Organization, 2016, DIS OUTBREAK NE 0120; World Health Organization, 2015, DIS OUTBREAK NE 1021; World Health Organization, 2016, ZIK SIT REP FEBR 16; World Health Organization, 2016, DIS OUTBREAK NE 0127; World Health Organization, 2016, PAC SYNDR SURV WEEK; World Health Organization, 2016, ZIK SIT REP NEUR SYN; World Health Organization, 2015, DIS OUTBREAK NE 1203; World Health Organization, 2015, DIS OUTBREAK NE 1111; World Health Organization, 2016, DIS OUTBREAK NE 0108; World Health Organization, 2015, EP AL NEUR SYNDR CON; World Health Organization, 2016, ZIK VIR MICR GULL BA; Wurapa Ofula, 2012, AM J TROP MED HYG, V87, P126; Wurapa Ofula, 2013, AM J TROP MED HYG, V89, P278; Yasri S., 2015, Asian Pacific Journal of Tropical Disease, V5, P1007, DOI 10.1016/S2222-1808(15)60974-4; Young I, 2014, PREV VET MED, V113, P339, DOI 10.1016/j.prevetmed.2013.11.009; Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14; Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	232	39	43	0	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156376	10.1371/journal.pone.0156376	http://dx.doi.org/10.1371/journal.pone.0156376			45	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244249	gold, Green Published, Green Submitted			2022-12-27	WOS:000377146100034
J	Barber, BK; McNeely, CA; El Sarraj, E; Daher, M; Giacaman, R; Arafat, C; Barnes, W; Abu Mallouh, M				Barber, Brian K.; McNeely, Clea A.; El Sarraj, Eyad; Daher, Mahmoud; Giacaman, Rita; Arafat, Cairo; Barnes, William; Abu Mallouh, Mohammed			Mental Suffering in Protracted Political Conflict: Feeling Broken or Destroyed	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HEALTH; VIOLENCE; WAR; EMERGENCY; TRAUMA; IMPRISONMENT; HUMILIATION; SETTINGS; EXPOSURE	Purpose This mixed-methods exploratory study identified and then developed and validated a quantitative measure of a new construct of mental suffering in the occupied Palestinian territory: feeling broken or destroyed. Methods Group interviews were conducted in 2011 with 68 Palestinians, most aged 30-40, in the West Bank, East Jerusalem, and the Gaza Strip to discern local definitions of functioning. Interview participants articulated of a type of suffering not captured in existing mental health instruments used in regions of political conflict. In contrast to the specific difficulties measured by depression and PTSD (sleep, appetite, energy, flashbacks, avoidance, etc.), participants elaborated a more existential form of mental suffering: feeling that one's spirit, morale and/ or future was broken or destroyed, and emotional and psychological exhaustion. Participants articulated these feelings when describing the rigors of the political and economic contexts in which they live. We wrote survey items to capture these sentiments and administered these items-along with standard survey measures of mental health-to a representative sample of 1,778 32-43 year olds in the occupied Palestinian territory. The same survey questions also were administered to a representative subsample (n = 508) six months earlier, providing repeated measures of the construct. Results Across samples and time, the feeling broken or destroyed scale: 1) comprised a separate factor in exploratory factor analyses, 2) had high inter-item consistency, 3) was reported by both genders and in all regions, 4) showed discriminate validity via moderate correlations with measures of feelings of depression and trauma-related stress, and 5) was more commonly experienced than either feelings of depression or trauma-related stress. Conclusions Feeling broken or destroyed can be reliably measured and distinguished from conventional measures of mental health. Such locally grounded and contextualized measures should be identified and included in assessments of the full impact of protracted political conflict on functioning.	[Barber, Brian K.; McNeely, Clea A.] Univ Tennessee, Knoxville, TN USA; [Barber, Brian K.] New Amer, Washington, DC USA; [El Sarraj, Eyad] Gaza Community Mental Hlth Programme, Gaza, Israel; [Giacaman, Rita] Birzeit Univ, Birzeit, West Bank, Palestine; [Arafat, Cairo] Save Children Fdn, Ramallah, West Bank, Palestine; [Barnes, William] Georgetown Univ, Washington, DC USA; [Abu Mallouh, Mohammed] Al Qattan Fdn, Gaza, Israel	University of Tennessee System; University of Tennessee Knoxville; Birzeit University; Georgetown University	Barber, BK (corresponding author), Univ Tennessee, Knoxville, TN USA.; Barber, BK (corresponding author), New Amer, Washington, DC USA.	bkbarber@gmail.com			Jacobs Foundation, Switzerland; Jacobs Foundation	Jacobs Foundation, Switzerland; Jacobs Foundation	This work was supported by The Jacobs Foundation, Switzerland (www.jacobsfoundation.org).r We thank the Jacobs Foundation for its generous support of this research. In addition, we thank all of the field workers and supervisors who collected the data and the participants who shared so willingly of their lives so we could better understand the experiences of Palestinians in the occupied Palestinian territory. Finally, we thank the staff of the Palestinian Center for Policy and Survey Research for their tireless efforts to ensure the collection of high quality data.	Abu-Zahra Nadia, 2012, UNFREE PALESTINE REG; Almedom AM, 2004, J BIOSOC SCI, V36, P381, DOI 10.1017/S0021932004006832; Assaf, 2014, W BANK GAZA INVESTME; B'Tselem, 2011, EC SOC RIGHTS; Barber B.K., 2009, ADOLESCENTS WAR YOUT, P35, DOI DOI 10.1093/ACPROF:OSO/9780195343359.003.0002; Barber B. K., 2009, ADOLESCENTS WAR YOUT, P207; Barber BK, 2015, ANN M INT SOC POL PS; Barber BK, 2015, LANCET IN PRESS; Barber BK, 2016, SOC SCI MED, V156, P154, DOI 10.1016/j.socscimed.2016.03.011; Barber BK, 2014, SOC SCI MED, V122, P90, DOI 10.1016/j.socscimed.2014.09.055; Barber BK, 2014, CHILD DEV PERSPECT, V8, P125, DOI 10.1111/cdep.12074; Barber BK, 2013, LANCET, V382, P7; Batniji R, 2012, LANCET, V380, P466, DOI 10.1016/S0140-6736(12)61280-X; Berger J, 2006, RACE CLASS, V48, P23, DOI 10.1177/0306396806066645; Betancourt TS, 2012, SOC SCI MED, V74, P1504, DOI 10.1016/j.socscimed.2012.01.030; Betancourt TS, 2009, TRANSCULT PSYCHIATRY, V46, P238, DOI 10.1177/1363461509105815; Bolger EA, 1999, PSYCHOTHER RES, V9, P342, DOI 10.1093/ptr/9.3.342; Cloke K, 2005, INTRACTABILITY; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Dabbagh Nadia Taysir, 2004, Anthropol Med, V11, P201, DOI 10.1080/13648470410001678686; Dowty A, 2006, COOP CONFL, V41, P5, DOI 10.1177/0010836706060930; Eggerman M, 2010, SOC SCI MED, V71, P71, DOI 10.1016/j.socscimed.2010.03.023; Ehlers A, 2000, J ABNORM PSYCHOL, V109, P45, DOI 10.1037/0021-843X.109.1.45; El Sarraj E, 2003, PALEST ISR J, V10; Farmer P, 2004, CURR ANTHROPOL, V45, P305, DOI 10.1086/382250; Fernando GA, 2008, AM J ORTHOPSYCHIAT, V78, P229, DOI 10.1037/a0013940; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Giacaman R, 2007, PUBLIC HEALTH, V121, P563, DOI 10.1016/j.puhe.2006.10.021; Giacaman R, 2013, J MIDDLE E WOMENS ST, V9, P54, DOI 10.2979/jmiddeastwomstud.9.3.54; Giacaman R, 2011, GLOB PUBLIC HEALTH, V6, P547, DOI 10.1080/17441692.2010.528443; Gilligan C, 2009, J PEACE RES, V46, P119, DOI 10.1177/0022343308098407; Hanafi S, 2010, J REFUG STUD, V23, P134, DOI 10.1093/jrs/feq014; Harbom L, 2010, J PEACE RES, V47, P501, DOI 10.1177/0022343310376887; Hass A, 1996, DRINKING THE SEA AT; Jacobsen Juliet C, 2007, Prim Care Companion J Clin Psychiatry, V9, P139; Kleinman A, 1997, SOCIAL SUFFERING; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McNeely C, 2015, J TRAUMA STRESS, V28, P223, DOI 10.1002/jts.22015; McNeely C, 2014, GLOB PUBLIC HEALTH, V9, P495, DOI 10.1080/17441692.2014.903427; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P423, DOI 10.1037/0002-9432.76.4.423; Muldoon OT, 2012, POLIT PSYCHOL, V33, P259, DOI 10.1111/j.1467-9221.2012.00874.x; Neuner F, 2012, SOC SCI MED, V75, P548, DOI 10.1016/j.socscimed.2012.03.028; Neuner F, 2010, SOC SCI MED, V71, P1381, DOI 10.1016/j.socscimed.2010.06.030; Panter-Brick C, 2009, LANCET, V374, P807, DOI 10.1016/S0140-6736(09)61080-1; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Peteet J, 2005, ETHNOGR POLIT VIOLEN, P1; Prilleltensky I, 2012, AM J COMMUN PSYCHOL, V49, P1, DOI 10.1007/s10464-011-9448-8; Rasmussen A, 2014, SOC SCI MED, V109, P44, DOI 10.1016/j.socscimed.2014.03.015; Rasmussen A, 2011, TRANSCULT PSYCHIATRY, V48, P392, DOI 10.1177/1363461511409283; ROY S, 1991, J PALESTINE STUD, V20, P58, DOI 10.1525/jps.1991.20.3.00p0243j; Rytter MJH, 2006, BMJ-BRIT MED J, V332, P1122, DOI 10.1136/bmj.38793.695081.AE; Sarraj E, 2012, LANCET, V380, P1386, DOI 10.1016/S0140-6736(12)61802-9; Schaufeli WB, 2009, CAREER DEV INT, V14, P204, DOI 10.1108/13620430910966406; Shachar N., 2010, GAZA STRIP ITS HIST; Summerfield DA, 2005, BRIT MED J, V331, P50, DOI 10.1136/bmj.331.7507.50-a; Tessler Mark A., 2009, HIST ISRAELI PALESTI, V2nd; Tol WA, 2011, INT J QUAL HEALTH C, V23, P375, DOI 10.1093/intqhc/mzr032; UN, 2012, GAZ 2020 LIV PLAC RE; UNCTAD, TRANSPARENCY, P77, DOI http://unctad.org/en/PublicationsLibrary/gdsapp2011d1_en.pdf; United Nations Conference on Trade and Development (UNCTAD), 2015, REP UNCTAD ASS PAL P; Wakefield, 2007, LOSS SADNESS PSYCHIA; WHO, 2001, WHO INT CLASS FUNCT	63	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156216	10.1371/journal.pone.0156216	http://dx.doi.org/10.1371/journal.pone.0156216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232335	gold, Green Published			2022-12-27	WOS:000376883000014
J	Kwarisiima, D; Balzer, L; Heller, D; Kotwani, P; Chamie, G; Clark, T; Ayieko, J; Mwangwa, F; Jain, V; Byonanebye, D; Petersen, M; Havlir, D; Kamya, MR				Kwarisiima, Dalsone; Balzer, Laura; Heller, David; Kotwani, Prashant; Chamie, Gabriel; Clark, Tamara; Ayieko, James; Mwangwa, Florence; Jain, Vivek; Byonanebye, Dathan; Petersen, Maya; Havlir, Diane; Kamya, Moses R.			Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; INFECTED PATIENTS; PREVALENCE; AWARENESS; COMMUNITY; MORTALITY; COUNTRIES; DISTRICT; THERAPY	Background Antiretroviral therapy scale-up in Sub-Saharan Africa has created a growing, aging HIV-positive population at risk for non-communicable diseases such as hypertension. However, the prevalence and risk factors for hypertension in this population remain incompletely understood. Methods We measured blood pressure and collected demographic data on over 65,000 adults attending multi-disease community health campaigns in 20 rural Ugandan communities (SEARCH Study: NCT01864603). Our objectives were to determine (i) whether HIV is an independent risk factor for hypertension, and (ii) awareness and control of hypertension in HIV-positive adults and the overall population. Results Hypertension prevalence was 14% overall, and 11% among HIV-positive individuals. 79% of patients were previously undiagnosed, 85% were not taking medication, and 50% of patients on medication had uncontrolled blood pressure. Multivariate predictors of hypertension included older age, male gender, higher BMI, lack of education, alcohol use, and residence in Eastern Uganda. HIV-negative status was independently associated with higher odds of hypertension (OR 1.2, 95% CI: 1.1-1.4). Viral suppression of HIV did not significantly predict hypertension among HIV-positives. Significance The burden of hypertension is substantial and inadequately controlled, both in HIV-positive persons and overall. Universal HIV screening programs could provide counseling, testing, and treatment for hypertension in Sub-Saharan Africa.	[Kwarisiima, Dalsone; Mwangwa, Florence; Byonanebye, Dathan; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Balzer, Laura] Harvard Univ, Boston, MA 02115 USA; [Balzer, Laura; Heller, David; Kotwani, Prashant; Chamie, Gabriel; Clark, Tamara; Jain, Vivek; Havlir, Diane] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ayieko, James] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Petersen, Maya] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Heller, David] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA	Harvard University; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California Berkeley; Makerere University; Icahn School of Medicine at Mount Sinai	Kwarisiima, D (corresponding author), Infect Dis Res Collaborat, Kampala, Uganda.	dkwarisiima@mjap.or.ug; mkamya@infocom.co.ug	Byonanebye, Dathan/HDN-5435-2022	Heller, David/0000-0003-0060-8393; Byonanebye, Dathan M/0000-0001-9862-4724	Division of AIDS, NIAID of the National Institutes of Health [U01AI099959]; President's Emergency Plan for AIDS Relief and Gilead Sciences; FOGARTY INTERNATIONAL CENTER [R25TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959] Funding Source: NIH RePORTER	Division of AIDS, NIAID of the National Institutes of Health; President's Emergency Plan for AIDS Relief and Gilead Sciences(Gilead Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this manuscript was supported by Division of AIDS, NIAID of the National Institutes of Health under award number U01AI099959 and in part by the President's Emergency Plan for AIDS Relief and Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adewole OO, 2012, AFR HEALTH SCI, V10, P144; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2014, PROJ MORT BURD DIS 2; [Anonymous], 2005, UG NAT POL GUID HIV; Aoun S, 2000, Curr Hypertens Rep, V2, P478, DOI 10.1007/s11906-000-0031-1; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Balen J, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-7; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bertoia ML, 2012, HYPERTENSION, V60, P639, DOI 10.1161/HYPERTENSIONAHA.112.193714; Chamie G, 2015, LANCET HIV IN PRESS; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Chillo P, 2012, CARDIOVASC J AFR, V23, P90, DOI 10.5830/CVJA-2011-060; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; FORD ES, 1991, HYPERTENSION, V18, P598, DOI 10.1161/01.HYP.18.5.598; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Havlir D, 2015, STUDY PROTOCOL SUSTA; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Jain V, 2013, CLIN INFECT DIS, V56, P598, DOI 10.1093/cid/cis881; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kotwani P, 2014, TROP MED INT HEALTH, V19, P459, DOI 10.1111/tmi.12273; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P8, DOI 10.1093/ije/dyu019; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Mattana J, 1999, AM J MED SCI, V317, P232, DOI 10.1097/00000441-199904000-00004; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Muluneh AT, 2012, ETHIOP J HEALTH SCI, V22, P7; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; NISSINEN A, 1988, AM J EPIDEMIOL, V127, P488, DOI 10.1093/oxfordjournals.aje.a114825; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Petersen M, 2014, JAIDS-J ACQ IMM DEF, V67, pS8, DOI 10.1097/QAI.0000000000000253; Piacentini L, 2009, J INTERN MED, V265, P110, DOI 10.1111/j.1365-2796.2008.02041.x; R Core Team, 2021, R LANGUAGE ENV STAT; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Schwartz T, 2012, INT HEALTH, V4, P30, DOI 10.1016/j.inhe.2011.12.003; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Twagirumukiza M, 2011, J HUM HYPERTENS, V25, P47, DOI 10.1038/jhh.2010.32; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2013, GLOB BRIEF HYP	59	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156309	10.1371/journal.pone.0156309	http://dx.doi.org/10.1371/journal.pone.0156309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232186	Green Published, Green Submitted, gold			2022-12-27	WOS:000376883000021
J	Zhang, WZ; Lu, JY; Chen, JZ; Zhai, TT; Huang, BT; Li, DR; Chen, CZ				Zhang, Wu-Zhe; Lu, Jia-Yang; Chen, Jian-Zhou; Zhai, Tian-Tian; Huang, Bao-Tian; Li, De-Rui; Chen, Chuang-Zhen			A Dosimetric Study of Using Fixed-Jaw Volumetric Modulated Arc Therapy for the Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastasis	PLOS ONE			English	Article							RADIOTHERAPY; TOMOTHERAPY; IMRT	Purpose To study the dosimetric difference between fixed-jaw volumetric modulated radiotherapy (FJ-VMAT) and large-field volumetric modulated radiotherapy (LF-VMAT) for nasopharyngeal carcinoma (NPC) with cervical lymph node metastasis. Methods Computed tomography (CT) datasets of 10 NPC patients undergoing chemoradiotherapy were used to generate LF-VMAT and FJ-VMAT plans in the Eclipse version 10.0 treatment planning system. These two kinds of plans were then compared with respect to planning-target-volume (PTV) coverage, conformity index (CI), homogeneity index (HI), organ-at-risk sparing, monitor units (MUs) and treatment time (TT). Results The FJ-VMAT plans provided lower D-2% of PGTVnd (PTV of lymph nodes), PTV1 (high-risk PTV) and PTV2 (low-risk PTV) than did the LF-VMAT plans, whereas no significant differences were observed in PGTVnx (PTV of primary nasopharyngeal tumor). The FJ-VMAT plans provided lower doses delivered to the planning organ at risk (OAR) volumes (PRVs) of both brainstem and spinal cord, both parotid glands and normal tissue than did the LF-VMAT plans, whereas no significant differences were observed with respect to the oral cavity and larynx. The MUs of the FJ-VMAT plans (683 +/- 87) were increased by 22% +/- 12% compared with the LF-VMAT plans (559 +/- 62). In terms of the TT, no significant difference was found between the two kinds of plans. Conclusions FJ-VMAT was similar or slightly superior to LF-VMAT in terms of PTV coverage and was significantly superior in terms of OAR sparing, at the expense of increased MUs.	[Zhang, Wu-Zhe; Lu, Jia-Yang; Chen, Jian-Zhou; Zhai, Tian-Tian; Huang, Bao-Tian; Li, De-Rui; Chen, Chuang-Zhen] Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China	Shantou University	Chen, CZ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China.	stccz@139.com	Chen, Jianzhou/AAW-1443-2021		Shantou University Medical College Clinical Research Enhancement Initiative [201424]; Shantou Medical Science and Technology Planning Project [(2015) 123]	Shantou University Medical College Clinical Research Enhancement Initiative; Shantou Medical Science and Technology Planning Project	This work was sponsored by Shantou University Medical College Clinical Research Enhancement Initiative (Grant No. 201424) and Shantou Medical Science and Technology Planning Project [Grant No. (2015) 123]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JY, 2014, MED DOSIM, V39, P325, DOI 10.1016/j.meddos.2014.05.006; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Huang B, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140183; Lee FKH, 2014, MED DOSIM, V39, P44, DOI 10.1016/j.meddos.2013.09.004; Lee TF, 2008, RADIOTHER ONCOL, V89, P89, DOI 10.1016/j.radonc.2008.05.010; Lu SH, 2012, RADIOTHER ONCOL, V104, P324, DOI 10.1016/j.radonc.2011.11.017; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Srivastava SP, 2011, MED DOSIM, V36, P6, DOI 10.1016/j.meddos.2009.10.002; Vanetti E, 2009, RADIOTHER ONCOL, V92, P111, DOI 10.1016/j.radonc.2008.12.008; Verbakel WFAR, 2009, INT J RADIAT ONCOL, V74, P252, DOI 10.1016/j.ijrobp.2008.12.033; White P, 2013, J RADIAT RES, V54, P532, DOI 10.1093/jrr/rrs111	11	4	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156675	10.1371/journal.pone.0156675	http://dx.doi.org/10.1371/journal.pone.0156675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231871	Green Submitted, gold, Green Published			2022-12-27	WOS:000376883000052
J	Abhyankar, VV; Wu, MY; Koh, CY; Hatch, AV				Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.			A Reversibly Sealed, Easy Access, Modular (SEAM) Microfluidic Architecture to Establish In Vitro Tissue Interfaces	PLOS ONE			English	Article							CELL-CULTURE; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; ORGANS; MEMBRANES; CHIP; MICROFABRICATION; INTEGRATION; ELASTICITY; ABSORPTION	Microfluidic barrier tissue models have emerged as advanced in vitro tools to explore interactions with external stimuli such as drug candidates, pathogens, or toxins. However, the procedures required to establish and maintain these systems can be challenging to implement for end users, particularly those without significant in-house engineering expertise. Here we present a module-based approach that provides an easy-to-use workflow to establish, maintain, and analyze microscale tissue constructs. Our approach begins with a removable culture insert that is magnetically coupled, decoupled, and transferred between standalone, prefabricated microfluidic modules for simplified cell seeding, culture, and downstream analysis. The modular approach allows several options for perfusion including standard syringe pumps or integration with a self-contained gravity-fed module for simple cell maintenance. As proof of concept, we establish a culture of primary human microvascular endothelial cells (HMVEC) and report combined surface protein imaging and gene expression after controlled apical stimulation with the bacterial endotoxin lipopolysaccharide (LPS). We also demonstrate the feasibility of incorporating hydrated biomaterial interfaces into the microfluidic architecture by integrating an ultra-thin (<1 mu m), self-assembled hyaluronic acid/peptide amphiphile culture membrane with brain-specific Young's modulus (similar to 1kPa). To highlight the importance of including biomimetic interfaces into microscale models we report multi-tiered readouts from primary rat cortical cells cultured on the self-assembled membrane and compare a panel of mRNA targets with primary brain tissue signatures. We anticipate that the modular approach and simplified operational workflows presented here will enable a wide range of research groups to incorporate microfluidic barrier tissue models into their work.	[Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA; [Abhyankar, Vinay V.] Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA	United States Department of Energy (DOE); Sandia National Laboratories; University of Texas System; University of Texas Arlington	Abhyankar, VV; Hatch, AV (corresponding author), Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.; Abhyankar, VV (corresponding author), Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.	vinay.abhyankar@gmail.com; ahatch@sandia.gov		Abhyankar, Vinay/0000-0002-8462-3920	Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories; Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA) [DTRA 10027IA-3167]; NIAID [R01AI98853]; US Department of Energy [DE-AC04-94AL85000]	Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories; Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy(United States Department of Energy (DOE))	This work was funded under Laboratory Directed Research and Development (LDRD) at Sandia National Laboratories and by the Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (IAA number DTRA 10027IA-3167). CK was supported by NIAID grant R01AI98853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Sandia National Laboratories is a multi-program laboratory operated by Sandia Corporation, a Lockheed Martin Company, for the US Department of Energy under contract DE-AC04-94AL85000. Illustrations contained vector art designed by Freepik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci HE, 2015, LAB CHIP, V15, P882, DOI 10.1039/c4lc00999a; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097; Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002; Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k; Chosewood LC, 2009, BIOSAFETY MICROBIOLO; Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k; Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003; Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0; Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303; Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j; Fuerstman MJ, 2007, LAB CHIP, V7, P1479, DOI 10.1039/b706549c; Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9; Geetha T, 2013, J BIOL CHEM; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999; Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454; Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104; Hinsby AM, 2004, FRONT BIOSCI-LANDMRK, V9, P2227, DOI 10.2741/1393; Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Huynh J, 2013, CELL MOL BIOENG, V6, P138, DOI 10.1007/s12195-013-0278-7; Ismagilov RF, 2001, ANAL CHEM, V73, P5207, DOI 10.1021/ac010502a; Kang E, 2013, ADV MATER, V25, P2167, DOI 10.1002/adma.201204619; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lin CC, 2010, JALA-J LAB AUTOM, V15, P253, DOI 10.1016/j.jala.2010.01.013; Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Miller JJ, 2015, J MICROMECH MICROENG, V25, DOI 10.1088/0960-1317/25/1/015011; NAKAYAMA M, 1995, J NEUROSCI, V15, P5238; Nan L, 2014, LAB CHIP, V14, P1060, DOI 10.1039/c3lc51133b; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reichen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052246; Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Temiz Y, 2015, MICROELECTRON ENG, V132, P156, DOI 10.1016/j.mee.2014.10.013; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Van Heirstraeten L, 2014, LAB CHIP, V14, P1519, DOI 10.1039/c3lc51339d; Verbist B, 2015, DRUG DISCOV TODAY, V20, P505, DOI 10.1016/j.drudis.2014.12.014; Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021; Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z; Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x; Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k	65	23	24	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156341	10.1371/journal.pone.0156341	http://dx.doi.org/10.1371/journal.pone.0156341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27227828	gold, Green Submitted, Green Published			2022-12-27	WOS:000376882500118
J	Al-Hadeethi, Y; Al-Jedani, S; Razvi, MAN; Saeed, A; Abdel-Daiem, AM; Ansari, MS; Babkair, SS; Salah, NA; Al-Mujtaba, A				Al-Hadeethi, Y.; Al-Jedani, S.; Razvi, M. A. N.; Saeed, A.; Abdel-Daiem, A. M.; Ansari, M. Shahnawaze; Babkair, Saeed S.; Salah, Numan A.; Al-Mujtaba, A.			Data Fitting to Study Ablated Hard Dental Tissues by Nanosecond Laser Irradiation	PLOS ONE			English	Article							CALCIUM; TEETH; PICOSECOND; THRESHOLD	Laser ablation of dental hard tissues is one of the most important laser applications in dentistry. Many works have reported the interaction of laser radiations with tooth material to optimize laser parameters such as wavelength, energy density, etc. This work has focused on determining the relationship between energy density and ablation thresholds using pulsed, 5 nanosecond, neodymium-doped yttrium aluminum garnet; Nd:Y3Al5O12 (Nd:YAG) laser at 1064 nanometer. For enamel and dentin tissues, the ablations have been performed using laser-induced breakdown spectroscopy (LIBS) technique. The ablation thresholds and relationship between energy densities and peak areas of calcium lines, which appeared in LIBS, were determined using data fitting. Furthermore, the morphological changes were studied using Scanning Electron Microscope (SEM). Moreover, the chemical stability of the tooth material after ablation has been studied using Energy-Dispersive X-Ray Spectroscopy (EDX). The differences between carbon atomic % of non-irradiated and irradiated samples were tested using statistical t-test. Results revealed that the best fitting between energy densities and peak areas of calcium lines were exponential and linear for enamel and dentin, respectively. In addition, the ablation threshold of Nd: YAG lasers in enamel was higher than that of dentin. The morphology of the surrounded ablated region of enamel showed thermal damages. For enamel, the EDX quantitative analysis showed that the atomic % of carbon increased significantly when laser energy density increased.	[Al-Hadeethi, Y.; Al-Jedani, S.; Razvi, M. A. N.; Saeed, A.; Abdel-Daiem, A. M.; Babkair, Saeed S.; Al-Mujtaba, A.] King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia; [Al-Hadeethi, Y.] King Abdulaziz Univ, Lithog Devices Fabricat & Dev Res Grp, DSR, Jeddah 21589, Saudi Arabia; [Saeed, A.] Thamar Univ, Thamar, Yemen; [Abdel-Daiem, A. M.; Salah, Numan A.] Zagazig Univ, Fac Sci, Dept Phys, Zagazig, Egypt; [Ansari, M. Shahnawaze] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University; King Abdulaziz University	Saeed, A (corresponding author), King Abdulaziz Univ, Dept Phys, Fac Sci, Jeddah 21589, Saudi Arabia.; Saeed, A (corresponding author), Thamar Univ, Thamar, Yemen.	Abdusaeed79@hotmail.com	Salah, Numan/I-3954-2012; Al-Hadeethi, Yas/N-7786-2019; Saeed, Abdu/N-6330-2015; Ansari, Mohammad Shahnawaze/Q-1395-2015; RAZVI, MIR ALI NAQI/D-5601-2013; Al-Hadeethi, Yas M/I-1712-2012	Salah, Numan/0000-0002-8233-7373; Al-Hadeethi, Yas/0000-0002-1350-9928; Saeed, Abdu/0000-0002-8506-7188; Ansari, Mohammad Shahnawaze/0000-0001-9082-1811; RAZVI, MIR ALI NAQI/0000-0003-2729-0813; Al-Hadeethi, Yas M/0000-0002-2284-1279	King Abdulaziz City of Science and Technology (KACST) [PS-35-266]	King Abdulaziz City of Science and Technology (KACST)	This work was supported financially by King Abdulaziz City of Science and Technology (KACST) under grant number PS-35-266. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasim SA, 2006, INT ENDOD J, V39, P143, DOI 10.1111/j.1365-2591.2006.01058.x; Alrahabi M, 2015, J TAIBAH UNIV MED SC, V10, P50, DOI 10.1016/j.jtumed.2014.12.005; Alves S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/24/245401; Apel C, 2002, LASER MED SCI, V17, P246, DOI 10.1007/s101030200036; Arnold WH, 2007, ANN ANAT, V189, P183, DOI 10.1016/j.aanat.2006.09.008; Bello-Silva MS, 2013, LASER MED SCI, V28, P171, DOI 10.1007/s10103-012-1107-2; BRANNSTROM M, 1966, ORAL SURG ORAL MED O, V21, P517, DOI 10.1016/0030-4220(66)90411-7; Breschi L, 2003, AM J DENT, V16, P267; Chen H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.2.028004; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Cvetkovic M, 2011, PROG ELECTROMAGN RES, V120, P403, DOI 10.2528/PIER11080405; Daskalova A, 2010, APPL SURF SCI, V257, P1119, DOI 10.1016/j.apsusc.2010.08.037; Eason R., 2007, PULSED LASER DEPOSIT, P628, DOI [10.1002/0470052120, DOI 10.1002/9780470052129]; Frentzen M, 1990, Int Dent J, V40, P323; Gaudiuso R, 2010, SENSORS-BASEL, V10, P7434, DOI 10.3390/s100807434; GOLDMAN L, 1964, NATURE, V203, P417, DOI 10.1038/203417a0; Hamama HH, 2013, AUST DENT J, V58, P283, DOI 10.1111/adj.12093; James KA, 2010, ORAL DEV HISTOLOGY; Ji LF, 2012, LASER MED SCI, V27, P197, DOI 10.1007/s10103-011-0932-z; Kim BM, 2000, APPL PHYS LETT, V76, P4001, DOI 10.1063/1.126847; Kim KS, 2005, PHOTOMED LASER SURG, V23, P216, DOI 10.1089/pho.2005.23.216; Lin S, 2010, SCI RES ESSAYS, V5, P2128; Liu H.-Y., 2013, ADV ANTHR, V03, P71; Momma C, 1997, APPL SURF SCI, V109, P15, DOI 10.1016/S0169-4332(96)00613-7; Murray AK, 2000, PROC SPIE, V3914, P137, DOI 10.1117/12.388039; Murray MM, 1936, BIOCHEM J, V30, P1567, DOI 10.1042/bj0301567; Najeeb S, 2016, MED PRIN PRACT, V25, P201, DOI 10.1159/000443144; Nanci A, 2012, DEV STRUCTURE FUNCTI, V8; Neev J, 1996, IEEE J SEL TOP QUANT, V2, P790, DOI 10.1109/2944.577301; Niemz M. H., 2003, LASER TISSUE INTERAC; Ostertag M, 1997, LASER SURG MED, V21, P384, DOI 10.1002/(SICI)1096-9101(1997)21:4<384::AID-LSM10>3.0.CO;2-B; Poorni S, 2010, CONTEMP CLIN DENT, V1, P223, DOI 10.4103/0976-237X.76388; Quade A, 2010, THIN SOLID FILMS, V518, P4835, DOI 10.1016/j.tsf.2010.02.005; Radziemski LJ, 2000, LASERS INDUCED PLASM; Rode AV, 2002, J APPL PHYS, V92, P2153, DOI 10.1063/1.1495896; Rosalia C, 2012, STRUCTURAL CHANGES H; Rythen M, 2010, EUR J ORAL SCI, V118, P389, DOI 10.1111/j.1600-0722.2010.00755.x; Serafetinides AA, 1999, LASER MED SCI, V14, P168, DOI 10.1007/s101030050080; Sherwood IA, 2010, ESSENTIALS OPERATIVE; Siniaeva ML, 2009, LASER PHYS, V19, P1056, DOI 10.1134/S1054660X09050314; Stabholz Adam, 2003, Compend Contin Educ Dent, V24, P935; Toma S, 2012, THESIS U CALIFORNIA; Tuncdemir AR, 2013, J ADV PROSTHODONT, V5, P44, DOI 10.4047/jap.2013.5.1.44; Vorobyev AY, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3660579; Wang Z, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4906447; WHITE JM, 1994, J DENT RES, V73, P1560, DOI 10.1177/00220345940730091201	46	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156093	10.1371/journal.pone.0156093	http://dx.doi.org/10.1371/journal.pone.0156093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228169	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500066
J	Arund, J; Luman, M; Uhlin, F; Tanner, R; Fridolin, I				Arund, Jurgen; Luman, Merike; Uhlin, Fredrik; Tanner, Risto; Fridolin, Ivo			Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?	PLOS ONE			English	Article							P-CRESYL SULFATE; INDOXYL SULFATE; HUMAN URINE; TOXINS; HEMODIALYSIS; ABSORBENCY; ADEQUACY; INDOLE; FLUIDS; SERUM	The aim of this study was to evaluate the contribution and removal dynamics of the main fluorophores during dialysis by analyzing the spent dialysate samples to prove the hypothesis whether the fluorescence of spent dialysate can be utilized for monitoring removal of any of the protein bound uremic solute. A high performance liquid chromatography system was used to separate and quantify fluorophoric solutes in the spent dialysate sampled at the start and the end of 99 dialysis sessions, including 57 hemodialysis and 42 hemodiafiltration treatments. Fluorescence was acquired at excitation 280 nm and emission 360 nm. The main fluorophores found in samples were identified as indole derivatives: tryptophan, indoxyl glucuronide, indoxyl sulfate, 5-hydroxy-indoleacetic acid, indoleacetyl glutamine, and indoleacetic acid. The highest contribution (35 +/- 11%) was found to arise from indoxyl sulfate. Strong correlation between contribution values at the start and end of dialysis (R-2 = 0.90) indicated to the stable contribution during the course of the dialysis. The reduction ratio of indoxyl sulfate was very close to the decrease of the total fluorescence signal of the spent dialysate (49 +/- 14% vs 51 +/- 13% respectively, P = 0.30, N = 99) and there was strong correlation between these reduction ratio values (R-2 = 0.86). On-line fluorescence measurements were carried out to illustrate the technological possibility for real-time dialysis fluorescence monitoring reflecting the removal of the main fluorophores from blood into spent dialysate. In summary, since a predominant part of the fluorescence signal at excitation 280 nm and emission 360 nm in the spent dialysate originates from protein bound derivatives of indoles, metabolites of tryptophan and indole, the fluorescence signal at this wavelength region has high potential to be utilized for monitoring the removal of slowly dialyzed uremic toxin indoxyl sulfate.	[Arund, Jurgen; Uhlin, Fredrik; Tanner, Risto; Fridolin, Ivo] Tallinn Univ Technol, Dept Biomed Engn, Technomed, EE-19086 Tallinn, Estonia; [Luman, Merike] North Estonia Med Ctr, Dept Dialysis & Nephrol, Tallinn, Estonia; [Uhlin, Fredrik] Linkoping Univ, Dept Nephrol, Reg Ostergotland, Linkoping, Sweden; [Uhlin, Fredrik] Linkoping Univ, Dept Med & Hlth Sci, Fac Hlth Sci, Linkoping, Sweden	Tallinn University of Technology; Linkoping University; Linkoping University	Arund, J (corresponding author), Tallinn Univ Technol, Dept Biomed Engn, Technomed, EE-19086 Tallinn, Estonia.	jurgen.arund@ttu.ee	Fridolin, Ivo/H-5406-2015; Fridolin, Ivo/AAE-8365-2019; Uhlin, Fredrik/AAB-1633-2020	Fridolin, Ivo/0000-0001-7374-4287; Tanner, Risto/0000-0001-6926-2752; Arund, Jurgen/0000-0002-4894-6853; Luman, Merike/0000-0003-4721-149X	County Council of Ostergotland, Sweden; Estonian Science Foundation [8621]; Estonian targeted financed project [SF0140027s07]; Estonian Ministry of Education and Research [IUT 19-2]; European Union through the European Regional Development Fund	County Council of Ostergotland, Sweden; Estonian Science Foundation; Estonian targeted financed project; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union through the European Regional Development Fund(European Commission)	The research was supported in part by the County Council of Ostergotland, Sweden, the Estonian Science Foundation Grant no. 8621 (http://www.etag.ee/en/), the Estonian targeted financed project SF0140027s07 (http://www.etag.ee/en/), Estonian Ministry of Education and Research under institutional research financing IUT 19-2 (http://www.etag.ee/en/), and the European Union through the European Regional Development Fund.	Arund J, 2012, TOXINS, V4, P849, DOI 10.3390/toxins4100849; Banoglu E, 2001, EUR J DRUG METAB PH, V26, P235, DOI 10.1007/BF03226377; BARNETT AL, 1985, CLIN CHEM, V31, P127; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; BRIDGES JW, 1968, BIOCHEM J, V107, P225, DOI 10.1042/bj1070225; Calaf R, 2011, J CHROMATOGR B, V879, P2281, DOI 10.1016/j.jchromb.2011.06.014; Daugirdas JT, 2010, KIDNEY INT, V78, P833, DOI 10.1038/ki.2010.218; de Loor H, 2009, J CHROMATOGR A, V1216, P4684, DOI 10.1016/j.chroma.2009.04.015; Donadio C, 2014, J NEPHROL, V27, P331, DOI 10.1007/s40620-013-0003-6; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076838; Eloot S, 2012, NEPHROL DIAL TRANSPL, V27, P3278, DOI 10.1093/ndt/gfs060; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Fridolin I, 2002, INT J ARTIF ORGANS, V25, P748, DOI 10.1177/039139880202500802; Gutsche B, 1999, BIOCHEM J, V343, P11, DOI 10.1042/0264-6021:3430011; Holmar J, 2013, ENG MED BIOL SOC EMB, DOI [10.1109/EMBC.2013.6611095, DOI 10.1109/EMBC.2013.6611095]; HORIUCHI K, 1994, J BIOCHEM, V115, P362, DOI 10.1093/oxfordjournals.jbchem.a124343; Itoh Yoshiharu, 2013, Mass Spectrom (Tokyo), V2, pS0017, DOI 10.5702/massspectrometry.S0017; Itoh Y, 2012, ANAL BIOANAL CHEM, V403, P1841, DOI 10.1007/s00216-012-5929-3; Jerotskaja J, 2010, BLOOD PURIFICAT, V29, P69, DOI 10.1159/000264269; Kim J, 2015, J MICROBIOL, V53, P421, DOI 10.1007/s12275-015-5273-3; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Meijers BKI, 2009, CLIN J AM SOC NEPHRO, V4, P1932, DOI 10.2215/CJN.02940509; *NAT KIDN FDN, 2006, AM J KIDNEY DIS S, V48, pS2; Perinchery SM, 2010, TALANTA, V80, P1269, DOI 10.1016/j.talanta.2009.09.020; SENFTLEBER FC, 1976, CLIN CHEM, V22, P1522; SWAN JS, 1983, CLIN CHEM, V29, P1082; Uhlin F., 2013, MODELING CONTROL DIA, VVolume 2, P867, DOI [10.1007/978-3-642-27558-6_3, DOI 10.1007/978-3-642-27558-6_3]; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2015, SEMIN DIALYSIS, V28, P114, DOI 10.1111/sdi.12331; Vanholder R, 2014, J AM SOC NEPHROL, V25, P1897, DOI 10.1681/ASN.2013101062; VLADUTIU AO, 1978, CLIN CHEM, V24, P1084	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156541	10.1371/journal.pone.0156541	http://dx.doi.org/10.1371/journal.pone.0156541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228162	Green Published, gold, Green Submitted			2022-12-27	WOS:000376882500155
J	Deguchi, Y; Iwasaki, S; Konishi, A; Ishimoto, H; Ogawa, K; Fukuda, Y; Nitta, T; Inoue, K				Deguchi, Yasuhiko; Iwasaki, Shinichi; Konishi, Akihito; Ishimoto, Hideyuki; Ogawa, Koichiro; Fukuda, Yuichi; Nitta, Tomoko; Inoue, Koki			The Usefulness of Assessing and Identifying Workers' Temperaments and Their Effects on Occupational Stress in the Workplace	PLOS ONE			English	Article							JOB-STRESS; TEMPS-A; FEMALE NURSES; BIPOLAR-II; DEPRESSION; POPULATION; VALIDATION; INSTRUMENT; DISORDERS; EMPLOYEES	The relationship between temperaments and mental disorders has been reported in previous studies, but there has been little attention to temperaments in the occupational safety and health research. The aim of this study was to clarify the effects of temperaments on occupational stress among local government employees. The subjects were 145 Japanese daytime workers in local government. Temperaments were assessed by the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-Auto questionnaire (TEMPS-A). Occupational stress was assessed using the Generic Job Stress Questionnaire (GJSQ). Hierarchical multiple linear regression analysis was used. Hyperthymic temperament predicted a higher level of job control, and a lower level of role ambiguity and job future ambiguity. Irritable temperament predicted a lower level of social support from supervisors and a higher level of role conflict, variance in workload and intragroup conflict. Anxious temperament predicted a lower level of social support from coworkers and a higher level of job future ambiguity. The sample size was small. Only Japanese local government employees were surveyed. Hyperthymic temperament played a protective role, and irritable, anxious temperament played a vulnerable role against one's own occupational stress and recognizing the roles they play in work life would lead to self-insight. Additionally, recognition of the temperaments and temperament-related stressors by one's supervisors or coworkers would facilitate provision of social support.	[Deguchi, Yasuhiko; Iwasaki, Shinichi; Konishi, Akihito; Ishimoto, Hideyuki; Ogawa, Koichiro; Fukuda, Yuichi; Nitta, Tomoko; Inoue, Koki] Osaka City Univ, Grad Sch Med, Dept Neuropsychiat, Osaka 558, Japan	Osaka Metropolitan University	Deguchi, Y (corresponding author), Osaka City Univ, Grad Sch Med, Dept Neuropsychiat, Osaka 558, Japan.	m2012567@med.osaka-cu.ac.jp			JSPS KAKENHI [26860440]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 26860440.	Akiskal H.S., 1992, CYCLOTHYMIC HYPERTHY, P43; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P45, DOI 10.1016/j.jad.2003.10.012; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P29, DOI 10.1016/j.jad.2003.12.009; Akiskal HS, 1998, ACTA PSYCHIAT SCAND, V98, P66, DOI 10.1111/j.1600-0447.1998.tb05969.x; Baba H, 2014, J AFFECT DISORDERS, V161, P1, DOI 10.1016/j.jad.2014.03.004; Calati R, 2011, J PSYCHIATR RES, V45, P309, DOI 10.1016/j.jpsychires.2010.07.004; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Deguchi Yasuhiko, 2013, Osaka City Med J, V59, P91; Eory A, 2015, J AFFECT DISORDERS, V172, P397, DOI 10.1016/j.jad.2014.10.036; Figueira ML, 2010, J AFFECT DISORDERS, V123, P30, DOI 10.1016/j.jad.2009.10.005; GOLDSMITH HH, 1987, CHILD DEV, V58, P505, DOI 10.1111/j.1467-8624.1987.tb01398.x; Guignard JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041043; Guilford J.P., 1957, FUNDAMENTAL STAT PSY, V41st, DOI https://doi.org/10.1002/sce.3730410357; Hantouche EG, 1998, J AFFECT DISORDERS, V50, P163, DOI 10.1016/S0165-0327(98)00112-8; HARATANI T, 1993, JPN J IND HLTH S, V35, pS214; Haratani T, 1996, 25 INT C OCC HLTH 2, P393; Hewitt PL, 2002, PERS INDIV DIFFER, V32, P1049, DOI 10.1016/S0191-8869(01)00109-X; HURRELL JJ, 1988, SCAND J WORK ENV HEA, V14, P27; Kampman O, 2011, J AFFECT DISORDERS, V135, P20, DOI 10.1016/j.jad.2010.12.021; Karam EG, 2015, J AFFECT DISORDERS, V184, P123, DOI 10.1016/j.jad.2015.05.047; Karam EG, 2010, WORLD PSYCHIATRY, V9, P103; Kawamura Y, 2010, PSYCHOPATHOLOGY, V43, P240, DOI 10.1159/000313522; Khazaal Y, 2013, PSYCHIAT QUART, V84, P429, DOI 10.1007/s11126-013-9257-3; Kikuchi Y, 2013, OCCUP MED-OXFORD, V63, P123, DOI 10.1093/occmed/kqs212; Kikuchi Y, 2014, INT J OCCUP MED ENV, V27, P426, DOI 10.2478/s13382-014-0270-z; Maremmani I, 2011, J AFFECT DISORDERS, V130, P275, DOI 10.1016/j.jad.2010.10.006; Maremmani I, 2009, J AFFECT DISORDERS, V117, P186, DOI 10.1016/j.jad.2009.01.007; Matsumoto S, 2005, J AFFECT DISORDERS, V85, P85, DOI 10.1016/j.jad.2003.10.001; Mazzarini L, 2009, J AFFECT DISORDERS, V119, P28, DOI 10.1016/j.jad.2009.03.016; Mendlowicz MV, 2005, J AFFECT DISORDERS, V84, P219, DOI 10.1016/j.jad.2004.01.013; Millon T., 1981, DISORDERS PERSONALIT; Moore DJ, 2005, J AFFECT DISORDERS, V85, P191, DOI 10.1016/S0165-0327(03)00193-9; Nyberg A, 2015, INT ARCH OCC ENV HEA, V88, P1149, DOI 10.1007/s00420-015-1043-0; Pacini M, 2009, ALCOHOL, V43, P397, DOI 10.1016/j.alcohol.2009.05.002; Rovi L, 2013, J AFFECT DISORDERS, V145, P106, DOI 10.1016/j.jad.2012.07.021; Sakai Y, 2005, J AFFECT DISORDERS, V85, P101, DOI 10.1016/j.jad.2004.03.012; Tei-Tominaga M, 2012, DEPRESS RES TREAT, V2012, DOI [DOI 10.1155/2012/469384, 10.1155/2012/469384]; Tei-Tominaga M, 2009, IND HEALTH, V47, P509, DOI 10.2486/indhealth.47.509; Tokuyama M, 2003, PSYCHIAT CLIN NEUROS, V57, P523, DOI 10.1046/j.1440-1819.2003.01158.x; Tsutsumi A, 2001, SCAND J WORK ENV HEA, V27, P146, DOI 10.5271/sjweh.602; Vazquez GH, 2010, J AFFECT DISORDERS, V127, P38, DOI 10.1016/j.jad.2010.04.015; Vazquez GH, 2008, J AFFECT DISORDERS, V108, P25, DOI 10.1016/j.jad.2007.09.011; Vazquez GH, 2012, J AFFECT DISORDERS, V139, P18, DOI 10.1016/j.jad.2011.06.032; Vyssoki B, 2011, J AFFECT DISORDERS, V135, P177, DOI 10.1016/j.jad.2011.07.007; Walsh MA, 2013, J AFFECT DISORDERS, V145, P179, DOI 10.1016/j.jad.2012.07.026; Zaninotto L, 2015, J AFFECT DISORDERS, V184, P51, DOI 10.1016/j.jad.2015.05.036	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156339	10.1371/journal.pone.0156339	http://dx.doi.org/10.1371/journal.pone.0156339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GQ	27227771	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500117
J	Finkel, ZV; Follows, MJ; Liefer, JD; Brown, CM; Benner, I; Irwin, AJ				Finkel, Zoe V.; Follows, Mick J.; Liefer, Justin D.; Brown, Chris M.; Benner, Ina; Irwin, Andrew J.			Phylogenetic Diversity in the Macromolecular Composition of Microalgae	PLOS ONE			English	Article							PROTEIN CONVERSION FACTORS; MARINE MICROALGAE; CELL-WALL; EVOLUTIONARY INHERITANCE; ELEMENTAL STOICHIOMETRY; INTRACELLULAR NITROGEN; CHEMICAL COMPOSITION; N-P; PHYTOPLANKTON; GROWTH	The elemental stoichiometry of microalgae reflects their underlying macromolecular composition and influences competitive interactions among species and their role in the food web and biogeochemistry. Here we provide a new estimate of the macromolecular composition of microalgae using a hierarchical Bayesian analysis of data compiled from the literature. The median macromolecular composition of nutrient-sufficient exponentially growing microalgae is 32.2% protein, 17.3% lipid, 15.0% carbohydrate, 17.3% ash, 5.7% RNA, 1.1% chlorophyll-a and 1.0% DNA as percent dry weight. Our analysis identifies significant phylogenetic differences in macromolecular composition undetected by previous studies due to small sample sizes and the large inherent variability in macromolecular pools. The phylogenetic differences in macromolecular composition lead to variations in carbon-tonitrogen ratios that are consistent with independent observations. These phylogenetic differences in macromolecular and elemental composition reflect adaptations in cellular architecture and biochemistry; specifically in the cell wall, the light harvesting apparatus, and storage pools.	[Finkel, Zoe V.; Liefer, Justin D.; Benner, Ina] Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada; [Follows, Mick J.] MIT, Dept Earth Atmosphere & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Brown, Chris M.] Mt Allison Univ, Dept Chem & Biochem, Sackville, NB E0A 3C0, Canada; [Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB E0A 3C0, Canada	Mount Allison University; Massachusetts Institute of Technology (MIT); Mount Allison University; Mount Allison University	Finkel, ZV (corresponding author), Mt Allison Univ, Environm Sci Program, Sackville, NB E0A 3C0, Canada.	zfinkel@mta.ca	Finkel, Zoe/B-9626-2008	Finkel, Zoe/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319; Liefer, Justin/0000-0001-5161-940X	Gordon and Betty Moore Foundation [3778]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work is a product of Macromolecular models of Marine Microbes grant #3778 supported by the Gordon and Betty Moore Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; BECKER B, 1994, PROTOPLASMA, V181, P233, DOI 10.1007/BF01666398; Becker B, 1998, J PHYCOL, V34, P779, DOI 10.1046/j.1529-8817.1998.340779.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRETT SJ, 1994, PROTOPLASMA, V181, P106, DOI 10.1007/BF01666391; Brown MR, 1997, AQUACULTURE, V151, P315, DOI 10.1016/S0044-8486(96)01501-3; Brown MR, 1996, AQUACULTURE, V143, P341, DOI 10.1016/0044-8486(96)01286-0; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; Daines SJ, 2014, ECOL LETT, V17, P414, DOI 10.1111/ele.12239; Davidson K, 1999, J PLANKTON RES, V21, P811, DOI 10.1093/plankt/21.5.811; DODGE JD, 1973, FINE STRUCTURE ALGAL; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Flynn KJ, 2010, J PHYCOL, V46, P1, DOI 10.1111/j.1529-8817.2009.00756.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jurgens U, 1985, FINE STRUCTURE CHEM, P41; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Laurens LML, 2012, ANAL CHEM, V84, P1879, DOI 10.1021/ac202668c; Loladze I, 2011, ECOL LETT, V14, P244, DOI 10.1111/j.1461-0248.2010.01577.x; Lourenco SO, 2004, EUR J PHYCOL, V39, P17, DOI 10.1080/0967026032000157156; Lourenco SO, 1998, J PHYCOL, V34, P798, DOI 10.1046/j.1529-8817.1998.340798.x; Martiny AC, 2013, NAT GEOSCI, V6, P279, DOI [10.1038/NGEO1757, 10.1038/ngeo1757]; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; MYKLESTAD S, 1974, J EXP MAR BIOL ECOL, V15, P261, DOI 10.1016/0022-0981(74)90049-5; NORTHCOTE DH, 1958, BIOCHEM J, V70, P391, DOI 10.1042/bj0700391; Palmucci M, 2011, J PHYCOL, V47, P313, DOI 10.1111/j.1529-8817.2011.00963.x; Panagiotopoulos C, 2005, LIMNOL OCEANOGR-METH, V3, P419, DOI 10.4319/lom.2005.3.419; PARSONS TR, 1961, J FISH RES BOARD CAN, V18, P1001, DOI 10.1139/f61-063; Peramuna A, 2014, ARCH MICROBIOL, V196, P881, DOI 10.1007/s00203-014-1027-6; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quigg A, 2011, P ROY SOC B-BIOL SCI, V278, P526, DOI 10.1098/rspb.2010.1356; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; RAVEN JA, 1984, NEW PHYTOL, V98, P593, DOI 10.1111/j.1469-8137.1984.tb04152.x; Redfield A. C., 1934, P176; ROBERTS K, 1985, J CELL SCI, P105; SHUTER BJ, 1983, AM NAT, V122, P26, DOI 10.1086/284116; Smayda T. J., 1970, Oceanogr. mar. Biol., V8, P353; Stan Development Team, 2014, RSTAN R INT STAN; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Strickland JDH, 1960, PRACTICAL HDB SEAWAT; Subramanian S, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-150; Talmy D, 2014, BIOGEOSCIENCES, V11, P4881, DOI 10.5194/bg-11-4881-2014; Tang EPY, 1996, J PHYCOL, V32, P80, DOI 10.1111/j.0022-3646.1996.00080.x; U.S. Department of Agriculture Agricultural Research Service, 2013, USDA NAT NUTR DAT ST; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Weber T, 2012, NATURE, V489, P419, DOI 10.1038/nature11357; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Wijffels RH, 2010, SCIENCE, P329; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818	55	100	100	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155977	10.1371/journal.pone.0155977	http://dx.doi.org/10.1371/journal.pone.0155977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228080	Green Published, Green Submitted, gold			2022-12-27	WOS:000376882500048
J	Lin, TY; Chen, KC; Liu, HJE; Liu, AJ; Wang, KL; Shih, CM				Lin, Tsung-Yao; Chen, Ku-Chung; Liu, Hsing-Jin Eugene; Liu, Ann-Jeng; Wang, Kun-Li; Shih, Chwen-Ming			MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; C-ABL; NUCLEOCYTOPLASMIC TRANSPORT; LEPTOMYCIN-B; CML CELLS; APOPTOSIS; CANCER; MESYLATE; RECEPTOR	Chronic myeloid leukemia (CML) is a myeloproliferative disease. Imatinib (IM), the first line treatment for CML, is excessively expensive and induces various side effects in CML patients. Therefore, it is essential to investigate a new strategy for improving CML therapy. Our immunoblot data revealed that RanGTPase activating protein 1 (RanGAP1) protein levels increased by approximately 30-fold in K562 cells compared with those in normal cells. RanGAP1 is one of the important components of RanGTPase system, which regulates the export of nuclear protein. However, whether RanGAP1 level variation influences BCR-ABL nuclear export is still unknown. In this report, using shRNA to downregulate RanGAP1 expression level augmented K562 cell apoptosis by approximately 40% after treatment with 250 nM IM. Immunofluorescence assay also indicated that three-fold of nuclear BCR-ABL was detected. These data suggest that BCR-ABL nuclear entrapment induced by RanGAP1 downregulation can be used to improve IM efficacy. Moreover, our qRT-PCR data indicated a trend of inverse correlation between the RanGAP1 and microRNA (miR)-1301 levels in CML patients. MiR-1301, targeting the RanGAP1 30 untranslated region, decreased by approximately 100-fold in K562 cells compared with that in normal cells. RanGAP1 downregulation by miR-1301 transfection impairs BCR-ABL nuclear export to increase approximately 60% of cell death after treatment of 250 nM IM. This result was almost the same as treatment with 1000 nM IM alone. Furthermore, immunofluorescence assay demonstrated that Tyr-99 of nuclear P73 was phosphorylated accompanied with nuclear entrapment of BCR-ABL after transfection with RanGAP1 shRNA or miR-1301 in IM-treated K562 cells. Altogether, we demonstrated that RanGAP1 downregulation can mediate BCR-ABL nuclear entrapment to activate P73-dependent apoptosis pathway which is a novel strategy for improving current IM treatment for CML.	[Lin, Tsung-Yao; Chen, Ku-Chung; Shih, Chwen-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lin, Tsung-Yao; Chen, Ku-Chung; Shih, Chwen-Ming] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan; [Liu, Hsing-Jin Eugene] Taipei Med Univ, Wan Fang Hosp, Div Hematol Oncol, Dept Med, Taipei, Taiwan; [Liu, Ann-Jeng] Taipei City Hosp, Dept Neurosurg, Ren Ai Branch, Taipei, Taiwan; [Wang, Kun-Li] Natl Taipei Univ Technol, Inst Chem Engn, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei City Hospital; National Taipei University of Technology	Shih, CM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Shih, CM (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan.; Wang, KL (corresponding author), Natl Taipei Univ Technol, Inst Chem Engn, Taipei, Taiwan.	klwang@ntut.edu.tw; cmshih@tmu.edu.tw			Ministry of Science and Technology [MOST 104-2314-B-038-025]; Taipei City Government [104XDAA00078]; NTUT-TMU Joint Research Program [NTUT-TMU-102-03]; Taipei Medical University Aim for the Top University Project-Cancer Translational Center [TMUTOP103002-3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei City Government; NTUT-TMU Joint Research Program; Taipei Medical University Aim for the Top University Project-Cancer Translational Center	Support was provided by contract grant sponsor: Ministry of Science and Technology Contract grant number: MOST 104-2314-B-038-025 [https://www.most.gov.tw/] (Received author: Chwen-Ming Shih); contract grant sponsor: Taipei City Government Contract grant number: 104XDAA00078 [http://english.gov.taipei/] (Received author: Ann-Jeng Liu); contract grant sponsor: NTUT-TMU Joint Research Program Contract grant number: NTUT-TMU-102-03 [http://www.tmu.edu.tw/] (Received author: Chwen-Ming Shih); contract grant sponsor: Taipei Medical University Aim for the Top University Project-Cancer Translational Center, contract grant number: TMUTOP103002-3 [ http://www.tmu.edu.tw/] ( Received author: Chwen-Ming Shih). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud C, 2013, BLOOD, V121, P4439, DOI 10.1182/blood-2013-03-490003; Allan EK, 2009, LEUKEMIA, V23, P1006, DOI 10.1038/leu.2008.367; Aloisi A, 2006, BLOOD, V107, P1591, DOI 10.1182/blood-2005-05-2123; Bayliss R, 2000, TRAFFIC, V1, P448, DOI 10.1034/j.1600-0854.2000.010602.x; Ben-Yehoyada M, 2003, J BIOL CHEM, V278, P34475, DOI 10.1074/jbc.M301051200; Bernardo PS, 2012, LEUKEMIA RES, V36, P1510, DOI 10.1016/j.leukres.2012.08.014; Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079863; Cianfrocca R, 2008, CELL DEATH DIFFER, V15, P354, DOI 10.1038/sj.cdd.4402264; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Dusetzina SB, 2014, J CLIN ONCOL, V32, P306, DOI 10.1200/JCO.2013.52.9123; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Gravina GL, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0085-1; Hehlmann R, 2011, J CLIN ONCOL, V29, P1634, DOI 10.1200/JCO.2010.32.0598; Hershkovitz-Rokah O, 2015, CANCER LETT, V360, P245, DOI 10.1016/j.canlet.2015.02.031; Huang ZL, 2013, ONCOTARGET, V4, P2249, DOI 10.18632/oncotarget.1339; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Khorashad JS, 2015, BLOOD, V125, P1772, DOI 10.1182/blood-2014-08-588855; Larson RA, 2008, BLOOD, V111, P4022, DOI 10.1182/blood-2007-10-116475; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin DY, 2004, MOL CELL BIOL, V24, P10529, DOI 10.1128/MCB.24.24.10529-10541.2004; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Ozaki Toshinori, 2010, Int J Proteomics, V2010, P283863, DOI 10.1155/2010/283863; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pierce GL, 2009, CIRCULATION, V119, P1284, DOI 10.1161/CIRCULATIONAHA.108.804294; Preyer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017020; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tan YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111777; Vigneri P, 2001, NAT MED, V7, P228, DOI 10.1038/84683; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	37	13	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156260	10.1371/journal.pone.0156260	http://dx.doi.org/10.1371/journal.pone.0156260			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228340	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500096
J	Monari, F; Pedrielli, G; Vergani, P; Pozzi, E; Mecacci, F; Serena, C; Neri, I; Facchinetti, F				Monari, Francesca; Pedrielli, Giulia; Vergani, Patrizia; Pozzi, Elisa; Mecacci, Federico; Serena, Caterina; Neri, Isabella; Facchinetti, Fabio			Adverse Perinatal Outcome in Subsequent Pregnancy after Stillbirth by Placental Vascular Disorders	PLOS ONE			English	Article							RISK; MULTICENTER; POPULATION; RECURRENCE; 2ND	Objective To evaluate outcome in the pregnancy following a stillbirth (SB) by a placental vascular disorders. Study Design A prospective, observational, multicenter study was conducted in woman with a history of stillbirth (>22 weeks) between 2005 and June 2013, in 3 Italian University Hospitals. Causes of SB were previously identified after extensive investigations. Pregnant women were enrolled within the first trimester. The main outcome was "adverse neonatal outcome", including perinatal death, fetal growth restriction, early preterm birth <33+6 weeks, hypoxicischemic encephalopathy, intracranial hemorrhage or respiratory distress. Results Out of 364 index pregnancies, 320 women (87.9%) had a subsequent pregnancy during the study period. Forty-seven had an early pregnancy loss. Out of 273 babies, 67 (24.5%) had an adverse perinatal outcome, including 1 SB and 1 early neonatal death (3.7/1000). Women who had a SB related to placental vascular disorders (39.6%), were at higher risk of an adverse neonatal outcome compared with women whose SB was unexplained or resulted from other causes (Adj. OR = 2.1, 95% CI: 1.2-3.8). Moreover, also obesity independently predicts an adverse perinatal outcome (Adj OR = 2.1, 95% CI: 1.1-4.3). Conclusion When previous SB is related to placental vascular disorders there is a high risk for adverse neonatal outcomes in the subsequent pregnancy. Maternal obesity is an additional risk factor.	[Monari, Francesca; Pedrielli, Giulia; Neri, Isabella; Facchinetti, Fabio] Univ Modena & Reggio Emilia, Obstet Unit, Mother Infant Dept, Modena, Italy; [Vergani, Patrizia; Pozzi, Elisa] Univ Milano Bicocca, Dept Obstet & Gynecol, Monza, Italy; [Mecacci, Federico; Serena, Caterina] Univ Florence, Dept Gynecol Perinatol & Human Reprod, Florence, Italy	Universita di Modena e Reggio Emilia; University of Milano-Bicocca; University of Florence	Facchinetti, F (corresponding author), Univ Modena & Reggio Emilia, Obstet Unit, Mother Infant Dept, Modena, Italy.	facchi@unimore.it	Neri, Isabella/P-4506-2016	Neri, Isabella/0000-0003-4019-7373; VERGANI, PATRIZIA/0000-0001-5028-0045; Monari, Francesca/0000-0002-1831-3086				Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Black M, 2008, BJOG-INT J OBSTET GY, V115, P269, DOI 10.1111/j.1471-0528.2007.01562.x; Bukowski R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001633; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Facchinetti F, 2011, J MATERN-FETAL NEO M, V24, P407, DOI 10.3109/14767058.2010.496880; Flenady V, 2009, BMC PREGNANCY CHILDB, V24, P1; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Froen JF, 2009, BMC PREGNANCY CHILDB, V10, P9; Gordon A, 2012, OBSTET GYNECOL, V119, P509, DOI 10.1097/AOG.0b013e31824781f8; Heinonen S, 2000, BIRTH-ISS PERINAT C, V27, P33, DOI 10.1046/j.1523-536x.2000.00033.x; Lamont K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3080; Lurie S, 2007, J REPROD MED, V52, P289; Maignien C, 2014, INT J GYNECOL OBSTET, V127, P275, DOI 10.1016/j.ijgo.2014.06.015; Martinelli I, 2012, BLOOD, V119, P3269, DOI 10.1182/blood-2011-11-391383; Monari F, 2012, EARLY HUM DEV, V88, P251, DOI 10.1016/j.earlhumdev.2011.08.013; Mongelli M, 2013, AUST NZ J OBSTET GYN, V53, P101, DOI 10.1111/ajo.12051; Nijkamp JW, 2013, EUR J OBSTET GYN R B, V166, P37, DOI 10.1016/j.ejogrb.2012.10.008; Ofir K, 2013, J PERINAT MED, V41, P543, DOI 10.1515/jpm-2013-0013; Onwude J L, 2006, J Obstet Gynaecol, V26, P205, DOI 10.1080/01443610500508303; Robson S, 2001, AUST NZ J OBSTET GYN, V41, P29, DOI 10.1111/j.1479-828X.2001.tb01290.x; Salihu HM, 2011, EARLY HUM DEV, V87, P641, DOI 10.1016/j.earlhumdev.2011.05.001; SAMUELOFF A, 1993, J REPROD MED, V38, P883; Sharma PP, 2007, PAEDIATR PERINAT EP, V21, P24, DOI 10.1111/j.1365-3016.2007.00834.x; Vergani P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.098; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044	25	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0155761	10.1371/journal.pone.0155761	http://dx.doi.org/10.1371/journal.pone.0155761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27228078	Green Submitted, Green Published, gold			2022-12-27	WOS:000376882500032
